PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Buchberger, A; Schepergerdes, L; Flasshoff, M; Kunick, C; Koster, RW				Buchberger, Astrid; Schepergerdes, Lena; Flasshoff, Maren; Kunick, Conrad; Koester, Reinhard W.			A novel inhibitor rescues cerebellar defects in a zebrafish model of Down syndrome-associated kinase Dyrk1A overexpression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								The highly conserved dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) plays crucial roles during central nervous system development and homeostasis. Furthermore, its hyperactivity is considered responsible for some neurological defects in individuals with Down syndrome. We set out to establish a zebrafish model expressing human Dyrk1A that could be further used to characterize the interaction between Dyrk1A and neurological phenotypes. First, we revealed the prominent expression of dyrk1a homologs in cerebellar neurons in the zebrafish larval and adult brains. Overexpression of human dyrk1a in postmitotic cerebellar Purkinje neurons resulted in a structural misorganization of the Purkinje cells in cerebellar hemispheres and a compaction of this cell population. This impaired Purkinje cell organization was progressive, leading to an age-dependent dispersal of Purkinje neurons throughout the cerebellar molecular layer with larval swim deficits resulting in mis-coordination of swimming and reduced exploratory behavior in aged adults. We also found that the structural misorganization of the larval Purkinje cell layer could be rescued by pharmacological treatment with Dyrk1A inhibitors. We further reveal the in vivo efficiency of a novel selective Dyrk1A inhibitor, KuFal194. These findings demonstrate that the zebrafish is a well-suited vertebrate organism to genetically model severe neurological diseases with single cell type specificity. Such models can be used to relate molecular malfunction to cellular deficits, impaired tissue formation, and organismal behavior and can also be used for pharmacological compound testing and validation.	[Buchberger, Astrid; Schepergerdes, Lena; Koester, Reinhard W.] Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Cellular & Mol Neurobiol, Braunschweig, Germany; [Flasshoff, Maren; Kunick, Conrad] Tech Univ Carolo Wilhelmina Braunschweig, Inst Med & Pharmaceut Chem, Braunschweig, Germany; [Kunick, Conrad] Tech Univ Carolo Wilhelmina Braunschweig, Ctr Pharmaceut Engn PVZ, Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Braunschweig University of Technology	Koster, RW (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Cellular & Mol Neurobiol, Braunschweig, Germany.	r.Koester@tu-bs.de		Kunick, Conrad/0000-0001-7041-5322	Deutsche Forschungsgemeinschaft [DFG KO 1949/12-1, 427719460]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded in part by the Deutsche Forschungsgemeinschaft (DFG KO 1949/12-1 project: 427719460 to R. W. K.).	Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100853	10.1016/j.jbc.2021.100853	http://dx.doi.org/10.1016/j.jbc.2021.100853			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34090874	gold, Green Published			2022-12-26	WOS:000678068400053
J	Liu, YN; Chen, JR; Xia, P; Stratakis, CA; Cheng, ZK				Liu, Yuening; Chen, Jingrui; Xia, Peng; Stratakis, Constantine A.; Cheng, Zhaokang			Loss of PKA regulatory subunit 1 alpha aggravates cardiomyocyte necrosis and myocardial ischemia/reperfusion injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; TRANSCRIPTION FACTOR NRF2; PROTEIN-KINASE-A; CARNEY COMPLEX; MEDIATED PHOSPHORYLATION; HEART; ACTIVATION; AUTOPHAGY; PATHWAY; STRESS	Reperfusion therapy, the standard treatment for acute myocardial infarction, can trigger necrotic death of cardiomyocytes and provoke ischemia/reperfusion (I/R) injury. However, signaling pathways that regulate cardiomyocyte necrosis remain largely unknown. Our recent genome-wide RNAi screen has identified a potential necrosis suppressor gene PRKAR1A, which encodes PKA regulatory subunit 1 alpha (R1 alpha). R1 alpha is primarily known for regulating PKA activity by sequestering PKA catalytic subunits in the absence of cAMP. Here, we showed that depletion of R1 alpha augmented cardiomyocyte necrosis in vitro and in vivo, resulting in exaggerated myocardial I/R injury and contractile dysfunction. Mechanistically, R1 alpha loss downregulated the Nrf2 antioxidant transcription factor and aggravated oxidative stress following I/R. Degradation of the endogenous Nrf2 inhibitor Keap1 through p62-dependent selective autophagy was blocked by R1 alpha depletion. Phosphorylation of p62 at Ser349 by mammalian target of rapamycin complex 1 (mTORC1), a critical step in p62-Keap1 interaction, was induced by I/R, but diminished by R1 alpha loss. Activation of PKA by forskolin or isoproterenol almost completely abolished hydrogen-peroxide-induced p62 phosphorylation. In conclusion, R1 alpha loss induces unrestrained PKA activation and impairs the mTORC1-p62-Keap1-Nrf2 antioxidant defense system, leading to aggravated oxidative stress, necrosis, and myocardial I/R injury. Our findings uncover a novel role of PKA in oxidative stress and necrosis, which may be exploited to develop new cardioprotective therapies.	[Liu, Yuening; Chen, Jingrui; Xia, Peng; Cheng, Zhaokang] Washington State Univ, Dept Pharmaceut Sci, Spokane, WA 99202 USA; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, NIH, Bethesda, MD USA; [Xia, Peng] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Cardiovasc Res Ctr, Boston, MA 02115 USA	Washington State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard Medical School; Massachusetts General Hospital	Cheng, ZK (corresponding author), Washington State Univ, Dept Pharmaceut Sci, Spokane, WA 99202 USA.	zhaokang.cheng@wsu.edu	Liu, Yuening/GYQ-7182-2022	Liu, Yuening/0000-0002-6891-0006	WSU College of Pharmacy and Pharmaceutical Sciences; National Institute of Child Health and Human Development (NICHD) [Z01-HD008920]; National Institutes of Health; National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health [R00HL119605, R56HL145034, R01HL151472]	WSU College of Pharmacy and Pharmaceutical Sciences; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by WSU College of Pharmacy and Pharmaceutical Sciences (to Z. C.) and the intramural program of National Institute of Child Health and Human Development (NICHD, Z01-HD008920 to C. A. S.), National Institutes of Health. Z. C. was supported by the National Heart, Lung, and Blood Institute (NHLBI, R00HL119605, R56HL145034, R01HL151472), National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; BENJAMIN IJ, 1989, CIRC RES, V65, P657, DOI 10.1161/01.RES.65.3.657; Chen J, 1998, J BIOL CHEM, V273, P1252, DOI 10.1074/jbc.273.2.1252; Cheng ZK, 2019, ACS PHARMACOL TRANSL, V2, P361, DOI 10.1021/acsptsci.9b00052; Cheng ZK, 2017, J BIOL CHEM, V292, P2065, DOI 10.1074/jbc.M116.758268; Cheng ZK, 2012, ARTERIOSCL THROM VAS, V32, P924, DOI 10.1161/ATVBAHA.112.245134; Correa R, 2015, EUR J ENDOCRINOL, V173, pM85, DOI 10.1530/EJE-15-0209; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Davidson SM, 2019, J AM COLL CARDIOL, V73, P89, DOI 10.1016/j.jacc.2018.09.086; Del Re DP, 2019, PHYSIOL REV, V99, P1763, DOI 10.1152/physrev.00022.2018; Ellison GM, 2007, J BIOL CHEM, V282, P11397, DOI 10.1074/jbc.M607391200; Fukunaga N, 2020, AM J TRANSPLANT, V20, P1262, DOI 10.1111/ajt.15724; Haushalter KJ, 2019, AM J PHYSIOL-HEART C, V317, pH1231, DOI 10.1152/ajpheart.00237.2019; Heusch G, 2020, NAT REV CARDIOL, V17, P773, DOI 10.1038/s41569-020-0403-y; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jewell JL, 2019, ELIFE, V8, DOI 10.7554/eLife.43038; Katsumata Y, 2014, HYPERTENSION, V63, P80, DOI 10.1161/HYPERTENSIONAHA.113.01639; Keleku-Lukwete N, 2019, BLOOD ADV, V3, P1285, DOI 10.1182/bloodadvances.2018017574; Kirschner LS, 2005, CANCER RES, V65, P4506, DOI 10.1158/0008-5472.CAN-05-0580; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lai L, 2013, CIRCULATION, V127, P1692, DOI 10.1161/CIRCULATIONAHA.112.001212; Lee LY, 2016, LIVER TRANSPLANT, V22, P91, DOI 10.1002/lt.24303; Lee Y, 2017, CELL REP, V20, P1994, DOI 10.1016/j.celrep.2017.08.019; Linkermann A, 2016, CELL DEATH DIFFER, V23, P1, DOI 10.1038/cdd.2015.151; Liu Y., 2021, CARDIOVASC RES; Liu YN, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14405; Makaula S, 2005, J CARDIOVASC PHARM, V45, P341, DOI 10.1097/01.fjc.0000156825.80951.14; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Ottani F, 2016, J AM COLL CARDIOL, V67, P365, DOI 10.1016/j.jacc.2015.10.081; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Qin QY, 2016, HYPERTENSION, V67, P107, DOI 10.1161/HYPERTENSIONAHA.115.06062; Shanmugam G, 2019, REDOX BIOL, V27, DOI 10.1016/j.redox.2019.101212; Simon JN, 2021, CIRCULATION, V143, P449, DOI 10.1161/CIRCULATIONAHA.120.046761; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Srinivasan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077129; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Wallner M, 2016, CIRC RES, V119, P865, DOI 10.1161/CIRCRESAHA.116.308687; Wang WJ, 2014, J MOL CELL CARDIOL, V72, P305, DOI 10.1016/j.yjmcc.2014.04.006; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Xu BB, 2014, BBA-MOL BASIS DIS, V1842, P1638, DOI 10.1016/j.bbadis.2014.06.002; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Yin ZR, 2008, CIRCULATION, V117, P1414, DOI 10.1161/CIRCULATIONAHA.107.759233; Yin ZR, 2011, MOL ENDOCRINOL, V25, P1786, DOI 10.1210/me.2011-1008	47	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100850	10.1016/j.jbc.2021.100850	http://dx.doi.org/10.1016/j.jbc.2021.100850			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34087234	Green Published, gold			2022-12-26	WOS:000678068400050
J	Nayak, AP; Lim, JM; Arbel, E; Wang, RP; Villalba, DR; Nguyen, TL; Schaible, N; Krishnan, R; Tang, DD; Penn, RB				Nayak, Ajay P.; Lim, John M.; Arbel, Eylon; Wang, Ruping; Villalba, Dominic R.; Nguyen, Tahn L.; Schaible, Niccole; Krishnan, Ramaswamy; Tang, Dale D.; Penn, Raymond B.			Cooperativity between beta-agonists and c-Abl inhibitors in regulating airway smooth muscle relaxation	FASEB JOURNAL			English	Article						actin cytoskeleton; airway smooth muscle; asthma; beta 2 adrenoceptor; c-abl tyrosine kinase	PROTEIN-KINASE-A; ACTIN DEPOLYMERIZATION; ASTHMA PHENOTYPE; ACTIVATION; CONTRACTION; CYTOKINES; CELLS; RHOA	Current therapeutic approaches to avoid or reverse bronchoconstriction rely primarily on beta 2 adrenoceptor agonists (beta-agonists) that regulate pharmacomechanical coupling/cross bridge cycling in airway smooth muscle (ASM). Targeting actin cytoskeleton polymerization in ASM represents an alternative means to regulate ASM contraction. Herein we report the cooperative effects of targeting these distinct pathways with beta-agonists and inhibitors of the mammalian Abelson tyrosine kinase (Abl1 or c-Abl). The cooperative effect of beta-agonists (isoproterenol) and c-Abl inhibitors (GNF-5, or imatinib) on contractile agonist (methacholine, or histamine) -induced ASM contraction was assessed in cultured human ASM cells (using Fourier Transfer Traction Microscopy), in murine precision cut lung slices, and in vivo (flexiVent in mice). Regulation of intracellular signaling that regulates contraction (pMLC20, pMYPT1, pHSP20), and actin polymerization state (F:G actin ratio) were assessed in cultured primary human ASM cells. In each (cell, tissue, in vivo) model, c-Abl inhibitors and beta-agonist exhibited additive effects in either preventing or reversing ASM contraction. Treatment of contracted ASM cells with c-Abl inhibitors and beta-agonist cooperatively increased actin disassembly as evidenced by a significant reduction in the F:G actin ratio. Mechanistic studies indicated that the inhibition of pharmacomechanical coupling by beta-agonists is near optimal and is not increased by c-Abl inhibitors, and the cooperative effect on ASM relaxation resides in further relaxation of ASM tension development caused by actin cytoskeleton depolymerization, which is regulated by both beta-agonists and c-Abl inhibitors. Thus, targeting actin cytoskeleton polymerization represents an untapped therapeutic reserve for managing airway resistance.	[Nayak, Ajay P.; Lim, John M.; Villalba, Dominic R.; Nguyen, Tahn L.; Penn, Raymond B.] Thomas Jefferson Univ, Ctr Translat Med, Korman Resp Inst, Dept Med Pulm & Crit Care Med, Philadelphia, PA 19107 USA; [Arbel, Eylon; Wang, Ruping; Tang, Dale D.] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA; [Schaible, Niccole; Krishnan, Ramaswamy] Harvard Med Sch, Ctr Vasc Biol Res, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Jefferson University; Albany Medical College; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Penn, RB (corresponding author), Thomas Jefferson Univ, Ctr Translat Med, 1020 Locust St, Philadelphia, PA 19107 USA.	Raymond.Penn@jefferson.edu		Arbel, Eylon/0000-0001-7040-3014	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [HL145392, HL110951, HL130304]	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: HL145392, HL110951 and HL130304	Abe K, 2011, AM J RESP CELL MOL, V45, P804, DOI 10.1165/rcmb.2010-0371OC; Adcock Ian M., 2002, Journal of Allergy and Clinical Immunology, V110, pS261, DOI 10.1067/mai.2002.129705; Boterman M, 2005, EUR J PHARMACOL, V516, P85, DOI 10.1016/j.ejphar.2005.04.029; Butler JP, 2002, AM J PHYSIOL-CELL PH, V282, pC595, DOI 10.1152/ajpcell.00270.2001; Callaerts-Vegh Z, 2004, P NATL ACAD SCI USA, V101, P4948, DOI 10.1073/pnas.0400452101; Cleary RA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-105; Fabbro D, 2010, BBA-PROTEINS PROTEOM, V1804, P454, DOI 10.1016/j.bbapap.2009.12.009; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; Guo MH, 2005, BIOCHEMISTRY-US, V44, P13771, DOI 10.1021/bi051255y; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hirshman CA, 2005, AM J PHYSIOL-LUNG C, V288, pL924, DOI 10.1152/ajplung.00463.2004; Hirshman CA, 2001, AM J PHYSIOL-CELL PH, V281, pC1468, DOI 10.1152/ajpcell.2001.281.5.C1468; ITO A, 1994, CIRCULATION, V90, P2425, DOI 10.1161/01.CIR.90.5.2425; Komalavilas P, 2008, AM J PHYSIOL-LUNG C, V294, pL69, DOI 10.1152/ajplung.00235.2007; MacDonald JA, 2016, MOL PHARMACOL, V89, P105, DOI 10.1124/mol.115.100529; Matthey M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2288; Misior AM, 2008, MOL PHARMACOL, V73, P566, DOI 10.1124/mol.107.040519; Morgan SJ, 2014, J BIOL CHEM, V289, P23065, DOI 10.1074/jbc.M114.557652; Nayak AP, 2019, AM J PHYSIOL-LUNG C, V316, pL894, DOI 10.1152/ajplung.00426.2018; Nguyen LP, 2009, P NATL ACAD SCI USA, V106, P2435, DOI 10.1073/pnas.0810902106; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Pascual RM, 2001, AM J PHYSIOL-LUNG C, V281, pL1425, DOI 10.1152/ajplung.2001.281.6.L1425; Penn RB, 2008, N-S ARCH PHARMACOL, V378, P149, DOI 10.1007/s00210-008-0263-1; Pera T, 2019, METHODS MOL BIOL, V1957, P69, DOI 10.1007/978-1-4939-9158-7_4; Pera T, 2018, FASEB J, V32, P862, DOI 10.1096/fj.201700555R; Pera T, 2016, PHARMACOL THERAPEUT, V164, P82, DOI 10.1016/j.pharmthera.2016.04.002; Peters SP, 2007, J ALLERGY CLIN IMMUN, V119, P1454, DOI 10.1016/j.jaci.2007.03.022; Salpeter SR, 2006, ANN INTERN MED, V144, P904, DOI 10.7326/0003-4819-144-12-200606200-00126; Sarria B, 2002, AM J PHYSIOL-LUNG C, V283, pL1125, DOI 10.1152/ajplung.00084.2002; Sharma P, 2017, SCI REP-UK, V7, DOI 10.1038/srep46166; Tang Dale D, 2018, Adv Pharmacol, V81, P1, DOI 10.1016/bs.apha.2017.06.001; Tang DD, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0296-1; Thanawala VJ, 2013, AM J RESP CELL MOL, V48, P220, DOI 10.1165/rcmb.2012-0364OC; Trepat X, 2009, NAT PHYS, V5, P426, DOI 10.1038/NPHYS1269; Usui T, 2014, APOPTOSIS, V19, P387, DOI 10.1007/s10495-013-0934-3; Wang YN, 2018, RESP RES, V19, DOI 10.1186/s12931-017-0709-4; Yan HD, 2011, FASEB J, V25, P389, DOI 10.1096/fj.10-164798; Yoo EJ, 2017, BRIT J PHARMACOL, V174, P4383, DOI 10.1111/bph.14040; Yoshie H, 2018, BIOPHYS J, V114, P2194, DOI 10.1016/j.bpj.2018.02.045; Yu QF, 2018, BRIT J PHARMACOL, V175, P2077, DOI 10.1111/bph.14201; Zhang WW, 2016, J PHYSIOL-LONDON, V594, P4879, DOI 10.1113/JP272132; Zhang WW, 2010, AM J PHYSIOL-CELL PH, V299, pC298, DOI 10.1152/ajpcell.00118.2010; Zhao R, 2008, J BIOL CHEM, V283, P36522, DOI 10.1074/jbc.M805294200	43	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21674	10.1096/fj.202100154R	http://dx.doi.org/10.1096/fj.202100154R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34115899	Green Accepted			2022-12-26	WOS:000667814100031
J	Reichmann-Ariel, D; Sadeh, R; Galante, O; Almog, Y; Fuchs, L				Reichmann-Ariel, Daphna; Sadeh, Re'em; Galante, Ori; Almog, Yaniv; Fuchs, Lior			Central venous catheter insertion- guidewire migration ratio: Right heart to inferior vena cava	PLOS ONE			English	Article							ARRHYTHMIA	Background Central Venous Catheters (CVC) are being used in both intensive care units and general wards for multiple purposes. A previous study Galante et al. (2017) observed that during CVC insertion through Subclavian Vein (SCV) or the Internal Jugular Vein (IJV) the guidewire is sometimes advanced to the Inferior Vena Cava (IVC), and at other times to the right atrium. The rate of IVC wire cannulation and the association with side and point of insertion is unknown. Objective In this study, we describe guidewire migration location during real time CVC cannulation (right atrium versus IVC) and report the association between the insertion site and side of the CVC and the location of guidewire migration, Right Atrium (RA)/Right Ventricle (RV) versus IVC guidewire migration. Methods This is a retrospective study in the medical intensive care unit among patients that have received CVC during the study years 2014-2020. The rate of IVC versus right atrium/right ventricle wire migration during the procedure were analyzed. The association between the side and point of CVC insertion and the wire migration site was analyzed as well. Results One hundred and sixty-six patients were enrolled. 33.7% of wires migrated to the IVC and 66.3% to the versus right atrium/right ventricle. The rate of wire migration to the IVC was similar in the IJV site and the SCV site. There was no association between the side of CVC insertion and wire migration to the IVC. Conclusion About a third of all wire migrations, during CVC Seldinger technique insertion, were identified in the IVC, with no potential for wire associated arrhythmia. There was no association between CVC insertion point (SCV versus IJV) nor the side of insertion and the site of guidewire migration.	[Reichmann-Ariel, Daphna; Fuchs, Lior] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Sadeh, Re'em] Soroka Univ, Clin Res Ctr, Med Ctr, Beer Sheva, Israel; [Galante, Ori; Almog, Yaniv; Fuchs, Lior] Soroka Univ, Med Intens Care Unit, Med Ctr, Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Soroka Medical Center	Reichmann-Ariel, D (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel.	Daphna221@gmail.com		Reichmann-Ariel, Daphna/0000-0002-5152-8919				Andrews RT, MUCH GUIDEWIRE IS TO; Chhabra L, 2012, J ELECTROCARDIOL, V45, P790, DOI 10.1016/j.jelectrocard.2012.06.005; Flannery KR, 2016, AM J EMERG MED, V34, DOI 10.1016/j.ajem.2015.04.064; Focus C, 2012, PRACTICE GUIDELINES; Galante O., 2017, SINGLE OPERATOR ULTR, P1; Lee JM, 2017, AM J EMERG MED, V35, P743, DOI 10.1016/j.ajem.2017.01.016; Lee TY, 1996, J CLIN ANESTH, V8, P348, DOI 10.1016/0952-8180(96)00083-9; da Silva PSL, 2010, J PEDIATR SURG, V45, pE13, DOI 10.1016/j.jpedsurg.2010.05.013; Polderman KH, 2002, INTENS CARE MED, V28, P1, DOI 10.1007/s00134-001-1154-9; STUART RK, 1990, JPEN-PARENTER ENTER, V14, P152, DOI 10.1177/0148607190014002152	10	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252726	10.1371/journal.pone.0252726	http://dx.doi.org/10.1371/journal.pone.0252726			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133420	Green Published, gold			2022-12-26	WOS:000671682700010
J	Jin, JY; Chen, B; Zhan, XY; Zhou, ZY; Liu, H; Dong, Y				Jin, Jingyun; Chen, Bin; Zhan, Xiangyang; Zhou, Zhiyi; Liu, Hui; Dong, Yun			Network pharmacology and molecular docking study on the mechanism of colorectal cancer treatment using Xiao-Chai-Hu-Tang	PLOS ONE			English	Article							ANTIINFLAMMATORY DRUG-USE; 5-FLUOROURACIL; ASPIRIN; POPULATION; FORMULAS; INVASION; CELLS	Background and objective We aimed to predict the targets and signal pathways of Xiao-Chai-Hu-Tang (XCHT) in the treatment of colorectal cancer (CRC) based on network pharmacology, just as well as to further analyze its anti-CRC material basis and mechanism of action. Methods We adopted Traditional Chinese Medicine Systems Pharmacology Database (TCMSP) and Traditional Chinese Medicine Integrated Database (TCMID) databases to screen the active ingredients and potential targets of XCHT. CRC-related targets were retrieved by analyzing published microarray data (accession number GSE110224) from the Gene Expression Omnibus (GEO) database. The common targets were used to construct the "herb-active ingredient-target" network using the Cytoscape 3.8.0 software. Next, we constructed and analyzed protein-to-protein interaction (PPI) using BisoGenet and CytoNCA plug-in in Cytoscape. We then performed Gene Ontology (GO) functional and the Kyoto Encyclopaedia of Genes and Genomes (KEGG) pathway enrichment analyses of target genes using the R package of clusterProfiler. Furthermore, we used the AutoDock Tools software to conduct molecular docking studies on the active ingredients and key targets to verify the network pharmacological analysis results. Results We identified a total of 71 active XCHT ingredients and 20 potential anti-CRC targets. The network analysis revealed quercetin, stigmasterol, kaempferol, baicalein, and acacetin as potential key compounds, and PTGS2, NR3C2, CA2, and MMP1 as potential key targets. The active ingredients of XCHT interacted with most CRC disease targets. We showed that XCHT's therapeutic effect was attributed to its synergistic action (multi-compound, multi-target, and multi-pathway). Our GO enrichment analysis showed 46 GO entries, including 20 biological processes, 6 cellular components, and 20 molecular functions. We identified 11 KEGG signaling pathways, including the IL-17, TNF, Toll-like receptor, and NF-kappa B signaling pathways. Our results showed that XCHT could play a role in CRC treatment by regulating different signaling pathways. The molecular docking experiment confirmed the correlation between five core compounds (quercetin, stigmasterol, kaempferol, baicalein, and acacetin) just as well as PTGS2, NR3C2, CA2, and MMP1. Conclusion In this study, we described the potential active ingredients, possible targets, and key biological pathways responsible for the efficacy of XCHT in CRC treatment, providing a theoretical basis for further research.	[Jin, Jingyun; Zhan, Xiangyang; Liu, Hui] Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Oncol, Shanghai, Peoples R China; [Jin, Jingyun; Zhan, Xiangyang; Dong, Yun] Shanghai Univ Tradit Chinese Med, Shanghai, Peoples R China; [Chen, Bin] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Oncol, Shanghai, Peoples R China; [Zhou, Zhiyi] Shanghai Univ Tradit Chinese Med, Longhua Hosp, Dept Oncol, Shanghai, Peoples R China; [Dong, Yun] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Integrated Tradit Chinese Med & Western Med, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai Jiao Tong University	Liu, H (corresponding author), Shanghai Univ Tradit Chinese Med, Shuguang Hosp, Dept Oncol, Shanghai, Peoples R China.; Dong, Y (corresponding author), Shanghai Univ Tradit Chinese Med, Shanghai, Peoples R China.; Dong, Y (corresponding author), Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Integrated Tradit Chinese Med & Western Med, Shanghai, Peoples R China.	liuhui79@shutcm.edu.cn; dongyun0429@126.com		Dong, Yun/0000-0003-4286-2701	National Natural Science Foundation of China [81703887]; Scientific Research Foundation of Shanghai Science and Technology Commission [18401903000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation of Shanghai Science and Technology Commission	This work was financially supported by the National Natural Science Foundation of China [NO.81703887]; Scientific Research Foundation of Shanghai Science and Technology Commission [No.18401903000]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdellateif MS, 2020, J INFLAMM RES, V13, P1245, DOI 10.2147/JIR.S283069; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; ARRIZA JL, 1987, SCIENCE, V237, P268, DOI 10.1126/science.3037703; Banday MZ, 2016, META GENE, V9, P128, DOI 10.1016/j.mgene.2016.06.001; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao W., 2020, J LIAONING U TRADITI, V22, P173; Chen J, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0757-z; Darband SG, 2018, J CELL PHYSIOL, V233, P6544, DOI 10.1002/jcp.26595; Du J., 2018, WORLD CHINESE MED, V13, P1452; Friis S, 2015, ANN INTERN MED, V163, P347, DOI 10.7326/M15-0039; Gong FX., 2019, J NINGXIA MED U, V41, P584; Guler OO, 2008, METHOD FIND EXP CLIN, V30, P335, DOI 10.1358/mf.2008.30.5.1143022; Han G., 2010, ZHEJIANG J TRADITION, V45, P687; Hua XW, 2017, J CLIN ONCOL, V35, P2806, DOI 10.1200/JCO.2017.72.3569; Huang KF, 2019, EXP DERMATOL, V28, P568, DOI 10.1111/exd.13912; Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]; Li XJ, 2012, CHINESE J CANCER RES, V24, P196, DOI 10.1007/s11670-012-0196-6; Li Z., CHINESE ARCH TRADITI, V2020, P1; Liao HF, 2010, AM J CHINESE MED, V38, P173, DOI 10.1142/S0192415X10007749; Liu XD, 2016, INT J MOL MED, V38, P1250, DOI 10.3892/ijmm.2016.2700; Liu XQ, 2020, ONCOL LETT, V19, P1881, DOI 10.3892/ol.2020.11278; Lu LL, 2018, PHARMACOL RES, V129, P318, DOI 10.1016/j.phrs.2017.11.032; Mao D, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3502460; Menezes-Garcia Z, 2020, GUT MICROBES, V11, P1531, DOI 10.1080/19490976.2020.1765946; Moradi-Marjaneh R, 2018, J CELL PHYSIOL, V233, P5613, DOI 10.1002/jcp.26273; Negi Ram Rattan, 2019, Asian Pac J Cancer Prev, V20, P1675, DOI 10.31557/APJCP.2019.20.6.1675; Ng K, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju345; Patel M, 2018, TRANSL RES, V197, P43, DOI 10.1016/j.trsl.2018.02.002; Prasad N, 2020, MOL BIOL REP, V47, P987, DOI 10.1007/s11033-019-05191-x; Riahi-Chebbi I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36808-z; Rui XJ, 2016, ONCOL LETT, V11, P685, DOI 10.3892/ol.2015.3935; Sezer ED, 2019, J MED FOOD, V22, P1118, DOI 10.1089/jmf.2019.0098; SHAO S., 2020, SHANGHAI J TRADIT CH, V54, P132; Song L, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109120; Tang YC, 2018, INT J ONCOL, V52, P127, DOI 10.3892/ijo.2017.4183; Tiberio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059410; Wang CZ, 2012, AM J CHINESE MED, V40, P657, DOI 10.1142/S0192415X12500498; Wang K, 2020, ONCOL REP, V43, P1103, DOI 10.3892/or.2020.7490; Wang Q, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01233; Xiang YN, 2019, CANCER MED-US, V8, P1958, DOI 10.1002/cam4.2108; Zhang Q, 2017, J CANCER, V8, P3945, DOI 10.7150/jca.22162; Zhao Jinyan, 2017, Afr J Tradit Complement Altern Med, V14, P231, DOI 10.21010/ajtcam.v14i3.25; [赵怡 Zhao Yi], 2020, [中国实验方剂学杂志, Chinese Journal of Experimental Traditional Medical Formulae], V26, P208; Zhou R, 2013, INT J ONCOL, V43, P611, DOI 10.3892/ijo.2013.1972	44	12	12	16	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252508	10.1371/journal.pone.0252508	http://dx.doi.org/10.1371/journal.pone.0252508			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125845	Green Published, gold			2022-12-26	WOS:000664643500007
J	Mawji, A; Li, E; Chandna, A; Kortz, T; Akech, S; Wiens, MO; Kissoon, N; Ansermino, M				Mawji, Alishah; Li, Edmond; Chandna, Arjun; Kortz, Teresa; Akech, Samuel; Wiens, Matthew O.; Kissoon, Niranjan; Ansermino, Mark			Common data elements for predictors of pediatric sepsis: A framework to standardize data collection	PLOS ONE			English	Article							MANAGEMENT; MORTALITY	Background Standardized collection of predictors of pediatric sepsis has enormous potential to increase data compatibility across research studies. The Pediatric Sepsis Predictor Standardization Working Group collaborated to define common data elements for pediatric sepsis predictors at the point of triage to serve as a standardized framework for data collection in resource-limited settings. Methods A preliminary list of pediatric sepsis predictor variables was compiled through a systematic literature review and examination of global guideline documents. A 5-round modified Delphi that involved independent voting and active group discussions was conducted to select, standardize, and prioritize predictors. Considerations included the perceived predictive value of the candidate predictor at the point of triage, intra- and inter-rater measurement reliability, and the amount of time and material resources required to reliably collect the predictor in resource-limited settings. Results We generated 116 common data elements for implementation in future studies. Each common data element includes a standardized prompt, suggested response values, and prioritization as tier 1 (essential), tier 2 (important), or tier 3 (exploratory). Branching logic was added to the predictors list to facilitate the design of efficient data collection methods, such as low-cost electronic case report forms on a mobile application. The set of common data elements are freely available on the Pediatric Sepsis CoLab Dataverse and a web-based feedback survey is available through the Pediatric Sepsis CoLab. Updated iterations will continuously be released based on feedback from the pediatric sepsis research community and emergence of new information. Conclusion Routine use of the common data elements in future studies can allow data sharing between studies and contribute to development of powerful risk prediction algorithms. These algorithms may then be used to support clinical decision making at triage in resource-limited settings. Continued collaboration, engagement, and feedback from the pediatric sepsis research community will be important to ensure the common data elements remain applicable across a broad range of geographical and sociocultural settings.	[Mawji, Alishah; Ansermino, Mark] Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada; [Mawji, Alishah; Wiens, Matthew O.; Ansermino, Mark] BC Childrens Hosp Res Inst, Ctr Int Child Hlth, Vancouver, BC, Canada; [Li, Edmond] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Chandna, Arjun] Angkor Hosp Children, Cambodia Oxford Med Res Unit, Siem Reap, Cambodia; [Chandna, Arjun] Univ Oxford, Ctr Trop Med & Global Hlth, Oxford, England; [Kortz, Teresa] Univ Calif San Francisco, Dept Pediat, Inst Global Hlth Sci, San Francisco, CA USA; [Akech, Samuel] Kenya Govt Med Res Ctr, Wellcome Trust Res Programme, Nairobi, Kenya; [Kissoon, Niranjan] Univ British Columbia, Dept Pediat, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; University of Oxford; University of California System; University of California San Francisco; Kenya Medical Research Institute; University of British Columbia	Mawji, A (corresponding author), Univ British Columbia, Dept Anesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada.; Mawji, A (corresponding author), BC Childrens Hosp Res Inst, Ctr Int Child Hlth, Vancouver, BC, Canada.	alishah.mawji@bcchr.ca	Wiens, Matthew/J-9249-2019	Akech, Samuel/0000-0001-5126-1225; Kissoon, Niranjan/0000-0001-8847-9973; Chandna, Arjun/0000-0003-1313-7922; Mawji, Alishah/0000-0002-1591-947X; Wiens, Matthew/0000-0002-3287-5181	Wellcome Trust Doctoral Training Fellowship; Initiative to Develop African Research Leaders (IDeAL) Wellcome Trust [107769]; National Institute of Allergy and Infectious Diseases, USA [K23AI1440.29]	Wellcome Trust Doctoral Training Fellowship(Wellcome Trust); Initiative to Develop African Research Leaders (IDeAL) Wellcome Trust; National Institute of Allergy and Infectious Diseases, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	AC is supported by a Wellcome Trust Doctoral Training Fellowship. SA was supported by the Initiative to Develop African Research Leaders (IDeAL) Wellcome Trust award (#107769). TK receives salary support from the National Institute of Allergy and Infectious Diseases, USA (K23AI1440.29).	BC Children's Hospital Research Institute, FEEDB SURV PRED STAN; BC Children's Hospital Research Institute, PED SEPS DAT COL; BC Children's Hospital Research Institute, PED SEPS COLABORATOR; Chandna A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-045826; ClinicalTrials.gov [Internet] National Library of Medicine (US), 2020, ID NCT04304235 PED R; COMET Database, COR OUTC MEAS PAED S; Dellinger RP, 2013, CRIT CARE MED, V41, P580, DOI 10.1097/CCM.0b013e31827e83af; Donnelly K, 2006, STUD HEALTH TECHNOL, V121, P279; Dowell SF, 2016, NATURE, V540, P189, DOI 10.1038/540189a; Dunser MW, 2012, INTENS CARE MED, V38, P557, DOI [10.1007/s00134-012-2468-5, 10.1007/s00134-012-2521-4]; Fung JST, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211274; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Keeney S., 2011, DELPHI TECHNIQUE NUR; Li E., 2020, SCHOLARS PORTAL DATA, DOI [10.5683/SP2/02LVVT, DOI 10.5683/SP2/02LVVT]; Mawji A, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05344-w; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; National Library of Medicine (US), 2020, ID NCT04285021 PRED; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Scholars Portal Dataverse, PED SEPS DAT COL; Sheehan J, 2016, CLIN TRIALS, V13, P671, DOI 10.1177/1740774516653238; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Ward SL, 2020, PEDIATR CRIT CARE ME, V21, pE1038, DOI 10.1097/PCC.0000000000002455; Wiens MO, 2016, AFR HEALTH SCI, V16, P162, DOI 10.4314/ahs.v16i1.22; Wooldridge G, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-034960; World Federation of Pediatric Intensive & Critical Care Societies,, PROJ; World Health Organization, 2017, 70 WORLD HLTH ASS IM	26	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0253051	10.1371/journal.pone.0253051	http://dx.doi.org/10.1371/journal.pone.0253051			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111209	Green Published, gold			2022-12-26	WOS:000664642700091
J	Palomba, E; Tirelli, V; de Alteriis, E; Parascandola, P; Landi, C; Mazzoleni, S; Sanchez, M				Palomba, Emanuela; Tirelli, Valentina; de Alteriis, Elisabetta; Parascandola, Palma; Landi, Carmine; Mazzoleni, Stefano; Sanchez, Massimo			A cytofluorimetric analysis of a Saccharomyces cerevisiae population cultured in a fed-batch bioreactor	PLOS ONE			English	Article							FLOW-CYTOMETRY; SYTOX GREEN; FLUORESCENCE PROPERTIES; BACTERIAL VIABILITY; NONQUIESCENT CELLS; BUDDING YEAST; GROWTH; PHASE; QUIESCENT; MODEL	The yeast Saccharomyces cerevisiae is a reference model system and one of the widely used microorganisms in many biotechnological processes. In industrial yeast applications, combined strategies aim to maximize biomass/product yield, with the fed-batch culture being one of the most frequently used. Flow cytometry (FCM) is widely applied in biotechnological processes and represents a key methodology to monitor cell population dynamics. We propose here an application of FCM in the analysis of yeast cell cycle along the time course of a typical S. cerevisiae fed-batch culture. We used two different dyes, SYTOX Green and SYBR Green, with the aim to better define each stage of cell cycle during S. cerevisiae fed-batch culture. The results provide novel insights in the use of FCM cell cycle analysis for the real-time monitoring of S. cerevisiae bioprocesses.	[Palomba, Emanuela] Stn Zool Anton Dohrn, Dept Res Infrastruct Marine Biol Resources RIMAR, Naples, Italy; [Tirelli, Valentina; Sanchez, Massimo] Ist Super Sanita ISS, Core Facil, Rome, Italy; [de Alteriis, Elisabetta] Univ Naples Federico II, Dept Biol, Naples, Italy; [Parascandola, Palma; Landi, Carmine] Univ Salerno, Dept Ind Engn, Salerno, Italy; [Mazzoleni, Stefano] Univ Naples Federico II, Dept Agr Sci, Naples, Italy	Stazione Zoologica Anton Dohrn di Napoli; Istituto Superiore di Sanita (ISS); University of Naples Federico II; University of Salerno; University of Naples Federico II	Sanchez, M (corresponding author), Ist Super Sanita ISS, Core Facil, Rome, Italy.	massimo.sanchez@iss.it	; Sanchez, Massimo/K-4385-2018	Tirelli, Valentina/0000-0001-6021-0833; Sanchez, Massimo/0000-0003-3696-7582				ALBERGHINA L, 1991, BIOTECHNOL PROGR, V7, P299, DOI 10.1021/bp00010a002; ALBERGHINA L, 1993, YEAST, V9, P815, DOI 10.1002/yea.320090802; Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072; Aragon AD, 2008, MOL BIOL CELL, V19, P1271, DOI 10.1091/mbc.E07-07-0666; BARFORD JP, 1981, BIOTECHNOL BIOENG, V23, P1735, DOI 10.1002/bit.260230806; Brehm-Stecher BF., 2014, ENCY FOOD MICROBIOLO, VSecond, P943; Bridier A, 2015, INT J FOOD MICROBIOL, V213, P2, DOI 10.1016/j.ijfoodmicro.2015.07.003; Briggs C, 2005, ACTA HISTOCHEM, V107, P301, DOI 10.1016/j.acthis.2005.06.010; Chau TL, 2001, BIOTECHNOL PROGR, V17, P951, DOI 10.1021/bp010090r; Cui J., 2017, VISUALIZATION BUDDIN; Davidson GS, 2011, MOL BIOL CELL, V22, P988, DOI 10.1091/mbc.E10-06-0499; Delobel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084645; Diaz M, 2010, BIOCHEM ENG J, V48, P385, DOI 10.1016/j.bej.2009.07.013; Dragan AI, 2012, J FLUORESC, V22, P1189, DOI 10.1007/s10895-012-1059-8; Ferrezuelo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2015; Gauthier DJ, 2008, PROTEOMICS, V8, P3848, DOI 10.1002/pmic.200700969; Jayakody LN, 2015, APPL MICROBIOL BIOT, V99, P501, DOI 10.1007/s00253-014-6174-9; Jevtic V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203956; JOHNSTON GC, 1977, EXP CELL RES, V105, P79, DOI 10.1016/0014-4827(77)90154-9; JOHNSTON GC, 1979, J BACTERIOL, V137, P1; Jones KD, 1999, J BIOTECHNOL, V71, P105, DOI 10.1016/S0168-1656(99)00017-6; Jones LJ, 2001, ANAL BIOCHEM, V293, P8, DOI 10.1006/abio.2001.5116; Lebaron P, 1998, APPL ENVIRON MICROB, V64, P2697; Lei F, 2001, J BIOTECHNOL, V88, P205, DOI 10.1016/S0168-1656(01)00269-3; Longin C, 2017, FOOD MICROBIOL, V62, P221, DOI 10.1016/j.fm.2016.10.023; Marie D., 2000, SPRING LAB MAN, P421, DOI 10.1007/978-3-642-57049-0_34; Mattanovich D, 2012, METHODS MOL BIOL, V824, P329, DOI 10.1007/978-1-61779-433-9_17; Mazzoleni S, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0295-4; Mendes-Ferreira A, 2010, APPL ENVIRON MICROB, V76, P7918, DOI 10.1128/AEM.01535-10; Morono Y, 2013, ENVIRON MICROBIOL, V15, P2841, DOI 10.1111/1462-2920.12153; Muller S, 2010, CURR OPIN BIOTECH, V21, P100, DOI 10.1016/j.copbio.2010.01.002; Nandy SK, 2018, MICROBIOL RES, V207, P83, DOI 10.1016/j.micres.2017.11.013; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Paiva B, 2012, BLOOD, V119, P687, DOI 10.1182/blood-2011-07-370460; Parapouli M, 2020, AIMS MICROBIOL, V6, P1, DOI [10.3934/microbiol.2020001, 10.3934/microbio1.2020001]; PATEL AK, 1976, AICHE J, V22, P401, DOI 10.1002/aic.690220227; PHINNEY DA, 1989, CYTOMETRY, V10, P511, DOI 10.1002/cyto.990100506; Reed G., 1991, YEAST TECHNOLOGY, P261; Riesenberg D, 1999, APPL MICROBIOL BIOT, V51, P422, DOI 10.1007/s002530051412; Rosebrock Adam P, 2017, Cold Spring Harb Protoc, V2017, DOI 10.1101/pdb.prot088740; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; Salma M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077600; Santibanez PA, 2016, J GLACIOL, V62, P655, DOI 10.1017/jog.2016.50; Schuler M, 2012, REAL TIME MONITORING; Soifer I, 2016, CURR BIOL, V26, P356, DOI 10.1016/j.cub.2015.11.067; Sommer S, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040619; Svenkrtova A, 2016, BIOGERONTOLOGY, V17, P395, DOI 10.1007/s10522-015-9625-5; Thakur S, 2015, EUR BIOPHYS J BIOPHY, V44, P337, DOI 10.1007/s00249-015-1027-8; van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9; Vees CA, 2020, ANAL BIOANAL CHEM, V412, P2137, DOI 10.1007/s00216-020-02423-z; Vembadi A, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00147; WEI W, 1993, CANCER RES, V53, P1867; Wobus A, 2003, FEMS MICROBIOL ECOL, V46, P331, DOI 10.1016/S0168-6496(03)00249-6; Zhang Hong, 2004, Methods Mol Biol, V241, P77	54	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0248382	10.1371/journal.pone.0248382	http://dx.doi.org/10.1371/journal.pone.0248382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111115	Green Submitted, Green Published, gold			2022-12-26	WOS:000664642700005
J	Buspavanich, P; Lech, S; Lermer, E; Fischer, M; Berger, M; Vilsmaier, T; Kaltofen, T; Keckstein, S; Mahner, S; Behr, J; Thaler, CJ; Batz, F				Buspavanich, Pichit; Lech, Sonia; Lermer, Eva; Fischer, Mirjam; Berger, Maximilian; Vilsmaier, Theresa; Kaltofen, Till; Keckstein, Simon; Mahner, Sven; Behr, Joachim; Thaler, Christian J.; Batz, Falk			Well-being during COVID-19 pandemic: A comparison of individuals with minoritized sexual and gender identities and cis-heterosexual individuals	PLOS ONE			English	Article							QUALITY-OF-LIFE; MENTAL-HEALTH; SOCIAL SUPPORT; DEPRESSION; PREVALENCE; GAY; SATISFACTION; DISPARITIES; DISORDERS; ANXIETY	Background Preliminary empirical data indicates a substantial impact of the COVID-19 pandemic on well-being and mental health. Individuals with minoritized sexual and gender identities are at a higher risk of experiencing such negative changes in their well-being. The objective of this study was to compare levels of well-being among cis-heterosexual individuals and individuals with minoritized sexual and gender identities during the COVID-19 pandemic. Methods Using data obtained in a cross-sectional online survey between April 20 to July 20, 2020 (N = 2332), we compared levels of well-being (WHO-5) across subgroups (cis-individuals with minoritized sexual identities, individuals with minoritized gender identities and cis-heterosexual individuals) applying univariate (two-sample t-test) and multivariate analysis (multivariate linear regression). Results Results indicate overall lower levels of well-being as well as lower levels of well-being in minoritized sexual or gender identities compared to cis-heterosexual individuals. Further, multivariate analyses revealed that living in urban communities as well as being in a relationship were positively associated with higher levels of well-being. Furthermore, a moderation analysis showed that being in a relationship reduces the difference between groups in terms of well-being. Conclusion Access to mental healthcare for individuals with minoritized sexual and gender identities as well as access to gender-affirming resources should be strengthened during COVID-19 pandemic. Healthcare services with low barriers of access such as telehealth and online peer support groups should be made available, especially for vulnerable groups.	[Buspavanich, Pichit; Lech, Sonia; Berger, Maximilian; Behr, Joachim] Brandenburg Med Sch Theodor Fontane, Dept Psychiat Psychotherapy & Psychosomat, Neuruppin, Germany; [Buspavanich, Pichit; Lech, Sonia; Berger, Maximilian] Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Berlin, Germany; [Buspavanich, Pichit; Lech, Sonia; Berger, Maximilian; Behr, Joachim] Free Univ Berlin, Berlin, Germany; [Buspavanich, Pichit; Lech, Sonia; Berger, Maximilian; Behr, Joachim] Humboldt Univ, Berlin, Germany; [Buspavanich, Pichit] Charite Univ Med Berlin, Inst Sexol & Sexual Med, Berlin, Germany; [Lech, Sonia] Charite Univ Med Berlin, Inst Med Sociol & Rehabil Sci, Berlin, Germany; [Lermer, Eva] Ludwig Maximilians Univ Munchen, Ctr Leadership & People Management, Munich, Germany; [Lermer, Eva] FOM Univ Appl Sci Econ & Management, Essen, Germany; [Fischer, Mirjam] Univ Cologne, Inst Sociol & Social Psychol, Cologne, Germany; [Vilsmaier, Theresa; Kaltofen, Till; Keckstein, Simon; Mahner, Sven; Thaler, Christian J.; Batz, Falk] Ludwig Maximilians Univ Munchen, Dept Obstet & Gynecol, Univ Hosp, Munich, Germany; [Vilsmaier, Theresa; Kaltofen, Till; Keckstein, Simon; Mahner, Sven; Thaler, Christian J.; Batz, Falk] Ludwig Maximilians Univ Munchen, Ctr Gynecol Endocrinol & Reprod Med, Univ Hosp, Munich, Germany; [Behr, Joachim] Charite Univ Med Berlin, Res Dept Expt & Mol Psychiat, Dept Psychiat & Psychotherapy, Berlin, Germany; [Behr, Joachim] Univ Potsdam Brandenburg Univ Technol CottbusSenf, Fac Hlth Sci Brandenburg, Potsdam, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Munich; University of Cologne; University of Munich; University of Munich; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Buspavanich, P (corresponding author), Brandenburg Med Sch Theodor Fontane, Dept Psychiat Psychotherapy & Psychosomat, Neuruppin, Germany.; Buspavanich, P (corresponding author), Charite Univ Med Berlin, Dept Psychiat & Psychotherapy, Berlin, Germany.; Buspavanich, P (corresponding author), Free Univ Berlin, Berlin, Germany.; Buspavanich, P (corresponding author), Humboldt Univ, Berlin, Germany.; Buspavanich, P (corresponding author), Charite Univ Med Berlin, Inst Sexol & Sexual Med, Berlin, Germany.	pichit.buspavanich@charite.de	Lermer, Eva/AAG-7647-2019; Buspavanich, Pichit/ABB-4172-2021; Fischer, Mirjam M./J-8192-2019; Lech, Sonia/ABA-8665-2021	Buspavanich, Pichit/0000-0002-4545-2575; Fischer, Mirjam M./0000-0002-4039-7319; Lech, Sonia/0000-0001-9166-1258; Berger, Maximilian/0000-0003-2961-0251; Lermer, Eva/0000-0002-6600-9580	Department of Obstetrics and Gynecology, University Hospital; Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital; Mood Disorders Research Unit of Charite - Universitatsmedizin Medicine Berlin, Department of Psychiatry and Psychotherapy, Campus Charite Berlin Mitte; MHB Open Access Publication Fund - German Research Association (DFG); LMU Munich	Department of Obstetrics and Gynecology, University Hospital; Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital; Mood Disorders Research Unit of Charite - Universitatsmedizin Medicine Berlin, Department of Psychiatry and Psychotherapy, Campus Charite Berlin Mitte; MHB Open Access Publication Fund - German Research Association (DFG)(German Research Foundation (DFG)); LMU Munich	The study was funded by sources of the Department of Obstetrics and Gynecology and Center for Gynecological Endocrinology and Reproductive Medicine, University Hospital, LMU Munich and the Mood Disorders Research Unit of Charite - Universitatsmedizin Medicine Berlin, Department of Psychiatry and Psychotherapy, Campus Charite Berlin Mitte. We acknowledge funding by the MHB Open Access Publication Fund supported by the German Research Association (DFG).	Acciai F, 2017, SOC SCI RES, V68, P163, DOI 10.1016/j.ssresearch.2017.08.003; Ammar A., 2020, EMOTIONAL CONSEQUENC, DOI 10.1371/journal.pone.0240204; Ammar A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176237; [Anonymous], 2020, CORONAVIRUS DIS COVI; Banerjee D., 2020, NAT INDIA, V26; Baptiste-Roberts K, 2017, OBSTET GYN CLIN N AM, V44, P71, DOI 10.1016/j.ogc.2016.11.003; BMBF. German Federal Ministry of Education and Research (BMBF), 2020, INT FIN AID STUD WHA; Bockting WO, 2013, AM J PUBLIC HEALTH, V103, P943, DOI 10.2105/AJPH.2013.301241; Boehmer U, 2019, GERONTOLOGIST, V59, P760, DOI 10.1093/geront/gny109; Braher E, 2007, DIAGNOSTICA, V53, P83, DOI 10.1026/0012-1924.53.2.83; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Bulloch AGM, 2017, J AFFECT DISORDERS, V223, P65, DOI 10.1016/j.jad.2017.06.007; Busch MA, 2013, BUNDESGESUNDHEITSBLA, V56, P733, DOI 10.1007/s00103-013-1688-3; Cochran SD, 2003, J CONSULT CLIN PSYCH, V71, P53, DOI 10.1037/0022-006X.71.1.53; Doerr N, 2021, SOC SCI-BASEL, V10, DOI 10.3390/socsci10010020; Dyar C., 2014, PSYCHOL SEXUAL ORIEN, V1, P441; Erhart M., 2012, ANAL REGIONALER UNTE; European Union Agency for Fundamental Rights, 2020, LONG WAY GO LGBTI EQ; European Union Agency for Fundamental Rights EU LGBT survey, 2014, EUR UN LESB GAY BIS; Eurosurveillance editorial team, 2013, EUROSURVEILLANCE, V18, P20492; Gariepy G, 2016, BRIT J PSYCHIAT, V209, P286, DOI 10.1192/bjp.bp.115.169094; Garthe RC, 2020, PSYCHOL SEX ORIENTAT, V7, P386, DOI 10.1037/sgd0000379; Gonzales G, 2020, J ADOLESCENT HEALTH, V67, P645, DOI 10.1016/j.jadohealth.2020.08.006; Grobe TG, 2019, GESUNDHEITSWESEN, V81, P1011, DOI 10.1055/a-0652-5424; Holst H, 2021, EUR SOC, V23, pS495, DOI 10.1080/14616696.2020.1828979; Israel Tania, 2016, Rural Ment Health, V40, P40; Jarrett Brooke A, 2020, medRxiv, DOI 10.1101/2020.11.02.20224709; Jung S, 2020, J CLIN MED, V9, DOI 10.3390/jcm9113708; Kasprowski D., 2021, DIW WEEKLY REPORT, V11, P42; Ko NY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17165822; Lewis NM, 2009, HEALTH PLACE, V15, P1029, DOI 10.1016/j.healthplace.2009.05.003; Marshal MP, 2011, J ADOLESCENT HEALTH, V49, P115, DOI 10.1016/j.jadohealth.2011.02.005; McConnell EA, 2015, LGBT HEALTH, V2, P55, DOI 10.1089/lgbt.2014.0051; McInroy LB, 2022, PSYCHOL SEX, V13, P387, DOI 10.1080/19419899.2020.1806103; McNeil J., 2017, PSYCHOL SEX ORIENTAT, V4, P341, DOI DOI 10.1037/SGD0000235; Meyer IH, 2003, PSYCHOL BULL, V129, P674, DOI 10.1037/0033-2909.129.5.674; Pakula B, 2016, AM J PUBLIC HEALTH, V106, P1042, DOI 10.2105/AJPH.2016.303083; Panzeri M, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.565823; Pflum SR, 2015, PSYCHOL SEX ORIENTAT, V2, P281, DOI DOI 10.1037/SGD0000122; Ploderl M, 2015, INT REV PSYCHIATR, V27, P367, DOI 10.3109/09540261.2015.1083949; Poge Kathleen, 2020, J Health Monit, V5, P2, DOI 10.25646/6449; Pusch Toralf, 2021, Wirtschaftsdienst, V101, P99, DOI 10.1007/s10273-021-2850-4; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Reay RE, 2020, AUSTRALAS PSYCHIATRY, V28, P514, DOI 10.1177/1039856220943032; Rees SN, 2021, J PSYCHIATR MENT HLT, V28, P578, DOI 10.1111/jpm.12720; Reisner SL, 2015, J ADOLESCENT HEALTH, V56, P274, DOI 10.1016/j.jadohealth.2014.10.264; Rommel A., 2017, INANSPRUCHNAHME PSYC; Ross LE, 2018, J SEX RES, V55, P435, DOI 10.1080/00224499.2017.1387755; Salerno JP, 2020, PSYCHOL TRAUMA-US, V12, pS239, DOI 10.1037/tra0000837; Spiteri G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.9.2000178; Thom J., 2017, 12 MONATS PRAVALENZ; Valentine SE, 2018, CLIN PSYCHOL REV, V66, P24, DOI 10.1016/j.cpr.2018.03.003; van Ackeren I, 2020, DDS-DEUT SCH, V112, P245, DOI 10.31244/dds.2020.02.10; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van de Grift TC, 2018, J SEX MARITAL THER, V44, P138, DOI 10.1080/0092623X.2017.1326190; van Trotsenburg M, 2019, AUST J CLIN ENDOCR M, V12, P95, DOI 10.1007/s41969-019-00077-6; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wang Yunhe, 2021, Mol Psychiatry, V26, P4813, DOI 10.1038/s41380-021-01019-y; Watson RJ, 2019, YOUTH SOC, V51, P30, DOI 10.1177/0044118X16660110; White Hughto Jaclyn M, 2016, Transgend Health, V1, P21; Whitton SW, 2018, J ABNORM PSYCHOL, V127, P265, DOI 10.1037/abn0000332; Wiepjes CM, 2020, ACTA PSYCHIAT SCAND, V141, P486, DOI 10.1111/acps.13164; Williams I., 2012, RURAL MENTAL HLTH IS; World Health Organization, 1998, US WELLB MEAS PRIM H; Yuksel B, 2020, INT J GYNECOL OBSTET, V150, P98, DOI 10.1002/ijgo.13193	65	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252356	10.1371/journal.pone.0252356	http://dx.doi.org/10.1371/journal.pone.0252356			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RP	34101746	Green Published, gold			2022-12-26	WOS:000664641500012
J	Topaz, M; Athamna, A; Ashkenazi, I; Shpitz, B; Freimann, S				Topaz, Moris; Athamna, Abed; Ashkenazi, Itamar; Shpitz, Baruch; Freimann, Sarit			In-vitro model for bacterial growth inhibition of compartmentalized infection treated by an ultra-high concentration of antibiotics	PLOS ONE			English	Article							MANAGEMENT	BackgroundPseudomonas aeruginosa (P. aeruginosa), Escherichia coli (E. coli), and Staphylococcus aureus (S. aureus) are common pathogens encountered in infected cardiovascular-implantable electronic device (CIED). Continuous, in-situ targeted, ultra-high concentration antibiotic (CITA) treatment is a novel antibiotic treatment approach for localized infections. CITA provides sufficient local antibiotic concentrations to heavily infected cavities while avoiding systemic toxicity. AimIn-vitro confirmation of the efficacy of the CITA treatment approach in simulated compartmentalized infections. Materials and methods A rapid automated bacterial culture analyzing system) Uro4 HB&L (was applied to compare the efficacy of selected antibiotics at a standard minimal inhibitory concentration (1MIC), 4MIC, and CITA at 10(3)MIC, for growth inhibition of high bacterial loads (10(6) colony-forming-units/ml) of ATCC strains of P. aeruginosa, E. coli, and S. aureus. Results The addition of gentamicin and amikacin at 1MIC concentrations only temporarily inhibited the exponential growth of E. coli and P. aeruginosa. 4MIC level extended the delay of exponential bacterial growth. Increasing concentrations of vancomycin similarly temporarily delayed S. aureus growth. All tested antibiotics at CITA of 10(3)MIC totally inhibited the exponential growth of the tested bacteria through 72 hours of exposure. (P<0.001). Conclusion In this in-vitro model, CITA at 10(3)MIC effectively inhibited exponential bacterial growth of high loads of P. aeruginosa, E. coli, and S. aureus. This model offers preliminary laboratory support for the benefit of the in-situ antibiotic treatment, providing ultra-high concentrations directly at the compartmentalized infection site, not achievable by the conventional intravenous and oral routes.	[Topaz, Moris; Athamna, Abed; Freimann, Sarit] Hillel Yaffe Med Ctr, Clin Microbiol Lab, Hadera, Israel; [Ashkenazi, Itamar] Technion, Bruce Rappaport Sch Med, Haifa, Israel; [Shpitz, Baruch] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine	Topaz, M (corresponding author), Hillel Yaffe Med Ctr, Clin Microbiol Lab, Hadera, Israel.	mtopazmd@yahoo.com	Ashkenazi, Itamar/AAG-5879-2020	Ashkenazi, Itamar/0000-0002-6305-4159				Alonso B, 2019, EUR J CLIN MICROBIOL, V38, P1737, DOI 10.1007/s10096-019-03606-y; ANWAR H, 1989, ANTIMICROB AGENTS CH, V33, P1824, DOI 10.1128/AAC.33.10.1824; Baddour LM, 2012, NEW ENGL J MED, V367, P842, DOI 10.1056/NEJMcp1107675; Baddour LM, 2010, CIRCULATION, V121, P458, DOI 10.1161/CIRCULATIONAHA.109.192665; Cotogni Paolo, 2015, World J Crit Care Med, V4, P265, DOI 10.5492/wjccm.v4.i4.265; Dall GF, 2018, J ANTIMICROB CHEMOTH, V73, P1830, DOI 10.1093/jac/dky087; Edsberg LE, 2016, J WOUND OSTOMY CONT, V43, P585, DOI 10.1097/WON.0000000000000281; Jones ME, 2003, INT J ANTIMICROB AG, V22, P406, DOI 10.1016/S0924-8579(03)00154-7; Jorgensen JH, 2009, CLIN INFECT DIS, V49, P1749, DOI 10.1086/647952; Junker JPE, 2015, PLAST RECONSTR SURG, V135, P151, DOI 10.1097/PRS.0000000000000801; Koutentakis M, 2014, J THORAC DIS, V6, pS173, DOI 10.3978/j.issn.2072-1439.2013.10.23; Kusumoto FM, 2017, HEART RHYTHM, V14, pE503, DOI 10.1016/j.hrthm.2017.09.001; Nenna A, 2019, GEN THORAC CARDIOVAS, V67, P907, DOI 10.1007/s11748-019-01204-5; Nicksic PJ, 2017, J AM COLL SURGEONS, V225, P817, DOI 10.1016/j.jamcollsurg.2017.08.017; Nuutila K, 2020, ADV WOUND CARE, V9, P48, DOI 10.1089/wound.2019.1018; Perez AA, 2018, ARRHYTH ELECTROPHYSI, V7, P210, DOI 10.15420/aer.2018.33.2; Rajendran M, 2020, RECENT PAT NANOTECHN; Richter SS., 2016, M45ED3EA2E CLIN LAB; Rickard John, 2011, Curr Cardiol Rep, V13, P407, DOI 10.1007/s11886-011-0198-x; Still S, 2020, J CARDIAC SURG, V35, P2825, DOI 10.1111/jocs.14794; Tarakji KG, 2019, NEW ENGL J MED, V380, P1895, DOI 10.1056/NEJMoa1901111; Topaz M, 2012, HEART RHYTHM, V9, pS108; Topaz M, 2021, BURNS TRAUMA, V9, DOI 10.1093/burnst/tkab007; Topaz M, 2020, CIRCULATION, V142; van Vugt TAG, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01626; Wistrand-Yuen E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04059-1; Wong D, 2019, CLIN INFECT DIS, V68, P338, DOI 10.1093/cid/ciy559; Zimmerli W, 2012, FEMS IMMUNOL MED MIC, V65, P158, DOI 10.1111/j.1574-695X.2012.00938.x	28	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252724	10.1371/journal.pone.0252724	http://dx.doi.org/10.1371/journal.pone.0252724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101731	gold, Green Published			2022-12-26	WOS:000664641500023
J	Al-Keilani, MS; Elstaty, RI; Alqudah, MA; Alkhateeb, AM				Al-Keilani, Maha S.; Elstaty, Rana I.; Alqudah, Mohammad A.; Alkhateeb, Asem M.			Immunohistochemical expression of substance P in breast cancer and its association with prognostic parameters and Ki-67 index	PLOS ONE			English	Article							NEUROKININ-1 RECEPTOR; 4/6 INHIBITORS; KI67 INDEX; PROGRESSION; PROLIFERATION; MARKERS; GROWTH; ACTIVATION; RESISTANCE; DIAGNOSIS	Background The neuropeptide substance P is a potential biomarker and therapeutic target in cancer. The main objectives of this study were to investigate the expression level of substance P in different breast cancer molecular subtypes and identify its association with clinicopathological parameters of patients and with Ki-67 index. Methods A retrospective analysis was performed for a total of 164 paraffin-embedded breast cancer tissue samples [42 Her2/neu-enriched, 40 luminal A, 42 luminal B (triple-positive) and 40 triple negative subtypes]. The tissue microarray slides containing specimens were used to determine the expression of substance p and Ki-67 by immunohistochemical staining. Results The mean age of the cohort was 51.35 years. Twenty two percent of cases had low substance P expression levels (TS <= 5), while 78% had high expression levels (TS > 5). A significant association was found between SP expression level and breast cancer molecular subtype (p = 0.002), TNM stage (p = 0.034), pN stage (p = 0.013), axillary lymph node metastasis (p = 0.004), ER and PR statuses (p<0.001) and history of DCIS (p = 0.009). The average percentage of Ki-67 expression was 27.05%. When analyzed as a continuous variable, significant differences were observed between the mean Ki-67 scores and molecular subtype (p = 0.001), grade (p = 0.003), pN stage (p = 0.007), axillary lymph node metastasis (p = 0.001), and ER and PR statuses (p <0.001). Conclusion SP is overexpressed in most of the analyzed tissues and has a negative prognostic value in the breast cancer patients. Besides substance P is a potential therapeutic target in breast cancer.	[Al-Keilani, Maha S.] Jordan Univ Sci & Technol, Coll Pharm, Dept Clin Pharm, Irbid, Jordan; [Elstaty, Rana I.; Alkhateeb, Asem M.] Jordan Univ Sci & Technol, Coll Sci & Art, Dept Biotechnol & Genet Engn, Irbid, Jordan; [Alqudah, Mohammad A.] Jordan Univ Sci & Technol, Coll Med, Dept Pathol & Microbiol, Irbid, Jordan	Jordan University of Science & Technology; Jordan University of Science & Technology; Jordan University of Science & Technology	Al-Keilani, MS (corresponding author), Jordan Univ Sci & Technol, Coll Pharm, Dept Clin Pharm, Irbid, Jordan.	mskeilani@just.edu.jo		Alkhateeb, Asem/0000-0001-8276-5784	deanship of research at Jordan University of Science and Technology [2018266]	deanship of research at Jordan University of Science and Technology	MSA received a fund by the deanship of research at Jordan University of Science and Technology (grant number: 2018266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkabban FM., 2019, CANC BREAST; Aman Nguiessan Alphonse, 2019, Asian Pac J Cancer Prev, V20, P73; Asadi M., 2018, EVALUATION INVOLVEME, V11, DOI [10.5812/ijcm.66567, DOI 10.5812/IJCM.66567]; Bayati S, 2018, ANTI-CANCER DRUG, V29, P243, DOI 10.1097/CAD.0000000000000591; Chen XY, 2016, ONCOTARGETS THER, V9, P3595, DOI 10.2147/OTT.S102356; Edge SB, 2019, EXPERT REV ANTICANC, V19, P309, DOI 10.1080/14737140.2019.1582335; Ermiah E, 2012, J CANCER, V3, P421, DOI 10.7150/jca.4944; Esteban F, 2006, CANCER METAST REV, V25, P137, DOI 10.1007/s10555-006-8161-9; Fasching PA, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-486; Friess H, 2003, LAB INVEST, V83, P731, DOI 10.1097/01.LAB.0000067499.57309.F6; Garcia-Recio S, 2013, CANCER RES, V73, P6424, DOI 10.1158/0008-5472.CAN-12-4573; Garnier A, 2015, INT J ONCOL, V47, P151, DOI 10.3892/ijo.2015.3016; Ge CT, 2019, P NATL ACAD SCI USA, V116, P19635, DOI 10.1073/pnas.1908998116; Gilani SA, 2020, PROGNOSTIC SIGNIFICA; Gutierrez S., 2018, NEUROPEPTIDE INDUCED, V18, P1; Harford-Wright E, 2014, NEUROSCIENCE, V261, P85, DOI 10.1016/j.neuroscience.2013.12.027; Haroon S, 2013, ASIAN PAC J CANCER P, V14, P4353, DOI 10.7314/APJCP.2013.14.7.4353; Hashmi AA, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4653-x; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Javid H, 2019, J PHYSIOL BIOCHEM, V75, P415, DOI 10.1007/s13105-019-00697-1; Jordan VC, 2006, BRIT J PHARMACOL, V147, pS269, DOI 10.1038/sj.bjp.0706399; Jurikova M, 2016, ACTA HISTOCHEM, V118, P544, DOI 10.1016/j.acthis.2016.05.002; Kamranzadeh H, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS_553_18; Kanyilmaz G, 2019, EUR J BREAST HEALTH, V15, P256, DOI 10.5152/ejbh.2019.4778; Kermani TA, 2019, BIOMED RES THER, V6, P2986, DOI 10.15419/bmrat.v6i2.520; Li LT, 2015, MOL MED REP, V11, P1566, DOI 10.3892/mmr.2014.2914; Li XQ, 2013, MOL CANCER RES, V11, P294, DOI 10.1158/1541-7786.MCR-12-0609; Ma J, 2016, INT J GYNECOL CANCER, V26, P845, DOI 10.1097/IGC.0000000000000683; Makki J, 2015, CLIN MED INSIGHTS-PA, V8, DOI 10.4137/CPath.S31563; Mannell A, 2016, S AFR J SURG, V54, P10; Maranta AF, 2020, BREAST, V51, P120, DOI 10.1016/j.breast.2020.03.005; Mayordomo C, 2012, J CELL PHYSIOL, V227, P1358, DOI 10.1002/jcp.22848; Mehboob R, 2015, PATHOL RES PRACT, V211, P203, DOI 10.1016/j.prp.2014.09.016; Munoz M, 2014, INT J ONCOL, V44, P137, DOI 10.3892/ijo.2013.2164; Munoz M, 2013, PEPTIDES, V48, P1, DOI 10.1016/j.peptides.2013.07.024; Nappi O, 2008, EJC SUPPL, V6, P1, DOI 10.1016/j.ejcsup.2008.06.011; Niu Y, 2019, J CANCER, V10, P5504, DOI 10.7150/jca.32628; Palma C, 2006, CURR DRUG TARGETS, V7, P1043, DOI 10.2174/138945006778019282; Park S, 2012, BREAST, V21, P50, DOI 10.1016/j.breast.2011.07.008; Rodriguez PL, 2014, INT J CANCER, V134, P1034, DOI 10.1002/ijc.28433; Sheikhpour R, 2016, INT J BIFURCAT CHAOS, V8, P93; Shokouh TZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001359; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh D, 2000, P NATL ACAD SCI USA, V97, P388, DOI 10.1073/pnas.97.1.388; Soliman NA, 2016, CANCER BIOL MED, V13, P496, DOI 10.20892/j.issn.2095-3941.2016.0066; Spring LM, 2019, CURR ONCOL REP, V21, DOI 10.1007/s11912-019-0769-3; Sun JZ, 2015, ONCOL LETT, V10, P1741, DOI 10.3892/ol.2015.3461; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; van Seijen M., 2019, DUCTAL CARCINOMA SIT, V1, DOI [10.1093/jbi/wbz039, DOI 10.1093/JBI/WBZ039]; Villablanca AC, 1997, MOL CELL ENDOCRINOL, V135, P109, DOI 10.1016/S0303-7207(97)00193-7; Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030; Wang Baona, 2014, Zhonghua Zhong Liu Za Zhi, V36, P273; Weigelt B, 2010, MOL ONCOL, V4, P192, DOI 10.1016/j.molonc.2010.04.004; Wu YM, 2020, CANCER MANAG RES, V12, P3477, DOI 10.2147/CMAR.S250632; Yin YX, 2014, CELL BIOCHEM BIOPHYS, V70, P1145, DOI 10.1007/s12013-014-0034-1	55	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252616	10.1371/journal.pone.0252616	http://dx.doi.org/10.1371/journal.pone.0252616			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086748	Green Published, gold			2022-12-26	WOS:000664640100096
J	Kompas, T; Grafton, RQ; Che, TN; Chu, L; Camac, J				Kompas, Tom; Grafton, R. Quentin; Che, Tuong Nhu; Chu, Long; Camac, James			Health and economic costs of early and delayed suppression and the unmitigated spread of COVID-19: The case of Australia	PLOS ONE			English	Article								We compare the health and economic costs of early and delayed mandated suppression and the unmitigated spread of 'first-wave' COVID-19 infections in Australia in 2020. Using a fit-for-purpose SIQRM-compartment model for susceptible, infected, quarantined, recovered and mortalities on active cases, that we fitted from recorded data, a value of a statistical life year (VSLY) and an age-adjusted value of statistical life (A-VSL), we find that the economic costs of unmitigated suppression are multiples more than for early mandated suppression. We also find that using an equivalent VSLY welfare loss from fatalities to estimated GDP losses, drawn from survey data and our own estimates of the impact of suppression measures on the economy, means that for early suppression not to be the preferred strategy requires that Australia would have to incur more than 12,500-30,000 deaths, depending on the fatality rate with unmitigated spread, to the economy costs of early mandated suppression. We also find that early rather than delayed mandated suppression imposes much lower economy and health costs and conclude that in high-income countries, like Australia, a 'go early, go hard' strategy to suppress COVID-19 results in the lowest estimated public health and economy costs.	[Kompas, Tom; Camac, James] Univ Melbourne, Ctr Excellence Biosecur Risk Anal, Sch Biosci, Melbourne, Vic, Australia; [Kompas, Tom] Univ Melbourne, Sch Ecosyst & Forest Sci, Melbourne, Vic, Australia; [Grafton, R. Quentin; Chu, Long] Australian Natl Univ, Crawford Sch Publ Policy, Canberra, ACT, Australia; [Che, Tuong Nhu] Australian Natl Univ, Crawford Sch Publ Policy, Australian Ctr Biosecur & Environm Econ, Canberra, ACT, Australia	University of Melbourne; University of Melbourne; Australian National University; Australian National University	Kompas, T (corresponding author), Univ Melbourne, Ctr Excellence Biosecur Risk Anal, Sch Biosci, Melbourne, Vic, Australia.; Kompas, T (corresponding author), Univ Melbourne, Sch Ecosyst & Forest Sci, Melbourne, Vic, Australia.	tom.kompas@unimelb.edu.au		Kompas, Tom/0000-0002-0665-0966				Abelson P., 2007, WORKING PAPERS COST; ABS, 2019, 3302 ABS; ABS, 2017, ABS31010; ABS, 2020, ABS5676055003; ABS, 2020, ABS STAT; ABSi, 2020, MEAS IMP COVID 19 MA; Alberini A, 2004, J ENVIRON ECON MANAG, V48, P769, DOI 10.1016/j.jeem.2003.10.005; Australian and New Zealand Intensive Care Society, 2019, CTR OUTC RES EV 2018; Australian Bureau of Statistics Business Indicators, 2020, BUS IMP COVID 19; Australian Department of Health, 2020, IMP COVID 19 AUST EN; Australian Department of Health, 2020, IMPACT COVID 19 THEO; Australian Department of Health, 2020, AUSTR DEP HLTH NOV C; Australian Department of Health, 2016, GUID PREP SUBM PHARM; Australian Institute of Health and Welfare, 2019, AUSTR I HLTH WELF RE; BITRE, 2020, TIM SER STAT INT AIR; Claughton D, 2020, ABC RURAL; Covid19data, 2020, COVID19 DAT COR COVI; Fox GJ, 2020, MED J AUSTRALIA, V212, P468, DOI 10.5694/mja2.50606; Frijters P, 2020, CORONA DILEMMA; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Grafton RQ., 2020, HLTH EC EFFECTS COVI, DOI [10.1101/2020.08.31.20185587, DOI 10.1101/2020.08.31.20185587]; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1574, DOI 10.1001/jama.2020.5394; Green W.H., 2012, ECONOMETRIC ANAL, V7th; Group of Eight Australia, 2020, ROADM REC REP NAT; IHPA. National Hospital Cost Data Collection, 2016, PUBL HOSP COST REP R; IMF, 2020, WEO REP; Independent Hospital Pricing Authority (IHPA), 2020, NAT HOSP COST DAT CO; Johns Hopkins University, 2020, COVID 19 MAP J HOPK; Kontis V, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1112-0; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Litton E, 2020, MED J AUSTRALIA, V212, P463, DOI 10.5694/mja2.50596; Phipps SJ, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200909; Prime Minister and Cabinet, 2019, BEST PRACT REG GUID; Science Media Centre, 2020, EXP COMM ICU REC DAT; Singer Peter, 2020, PROJECT SYNDICATE; Tourism Australia, 2020, EC IMP TOUR; van den Broek-Altenburg E., 2020, INCIDENTAL EC; Verity R, 2020, LANCET INFECT DIS, V20, P669, DOI 10.1016/S1473-3099(20)30243-7; Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9	39	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252400	10.1371/journal.pone.0252400	http://dx.doi.org/10.1371/journal.pone.0252400			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086731	gold, Green Published, Green Submitted			2022-12-26	WOS:000664640100058
J	Ornaghi, S; Maraschini, A; Donati, S				Ornaghi, Sara; Maraschini, Alice; Donati, Serena		Regional Obstet Surveillance Syst	Characteristics and outcomes of pregnant women with placenta accreta spectrum in Italy: A prospective population-based cohort study	PLOS ONE			English	Article							ABNORMALLY INVASIVE PLACENTA; PERIPARTUM HYSTERECTOMY; CESAREAN-SECTION; RISK-FACTORS; OBSTETRIC SURVEILLANCE; ANTENATAL DIAGNOSIS; ULTRASOUND; PATHOPHYSIOLOGY; DISORDERS; DELIVERY	Introduction Placenta accreta spectrum (PAS) is a rare but potentially life-threatening event due to massive hemorrhage. Placenta previa and previous cesarean section are major risk factors for PAS. Italy holds one of the highest rates of primary and repeated cesarean section in Europe; nonetheless, there is a paucity of high-quality Italian data on PAS. The aim of this paper was to estimate the prevalence of PAS in Italy and to evaluate its associated factors, ante- and intra-partum management, and perinatal outcomes. Also, since severe morbidity and mortality in Italy show a North-South gradient, we assessed and compared perinatal outcomes of women with PAS according to the geographical area of delivery. Material and methods This was a prospective population-based study using the Italian Obstetric Surveillance System (ItOSS) and including all women aged 15-50 years with a diagnosis of PAS between September 2014 and August 2016. Six Italian regions were involved in the study project, covering 49% of the national births. Cases were prospectively reported by a trained clinician for each participating maternity unit by electronic data collection forms. The background population comprised all women who delivered in the participating regions during the study period. Results A cohort of 384 women with PAS was identified from a source population of 458 995 maternities for a prevalence of 0.84/1000 (95% CI, 0.75-0.92). Antenatal suspicion was present in 50% of patients, who showed reduced rates of blood transfusion compared to unsuspected patients (65.6% versus 79.7%, P = 0.003). Analyses by geographical area showed higher rates of both concomitant placenta previa and prior CS (62.1% vs 28.7%, P<0.0001) and antenatal suspicion (61.7% vs 28.7%, P<0.0001) in women in Southern compared to Northern Italy. Also, these women had lower rates of hemorrhage >= 2000 mL (29.6% vs 51.2%, P<0.0001), blood transfusion (64.5% vs 87.5%, P = 0.001), and severe maternal morbidity (5.0% vs 11.1%, P = 0.036). Delivery in a referral center for PAS occurred in 71.9% of these patients. Conclusions Antenatal suspicion of PAS is associated with improved maternal outcomes, also among high-risk women with both placenta previa and prior CS, likely because of their referral to specialized centers for PAS management.	[Ornaghi, Sara] Univ Milano Bicocca, Sch Med & Surg, Fdn MBBM, Dept Obstet & Gynecol,San Gerardo Hosp, Monza, Italy; [Maraschini, Alice; Donati, Serena] Italian Natl Inst Hlth, Natl Ctr Dis Prevent & Hlth Promot, Rome, Italy	San Gerardo Hospital; University of Milano-Bicocca; Istituto Superiore di Sanita (ISS)	Ornaghi, S (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Fdn MBBM, Dept Obstet & Gynecol,San Gerardo Hosp, Monza, Italy.	sara.ornaghi@unimib.it	Ornaghi, Sara/GXW-2481-2022; Ornaghi, Sara/K-4261-2018	Ornaghi, Sara/0000-0001-6898-7217	Italian Ministry of Health	Italian Ministry of Health(Ministry of Health, Italy)	S.D. Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	(AgeNaS) ANpiSSR, 2019, NAT OUTC PROGR RAT P; [Anonymous], 2019, Obstet Gynecol, V134, pe150, DOI 10.1097/AOG.0000000000003564; Bailit JL, 2015, OBSTET GYNECOL, V125, P683, DOI 10.1097/AOG.0000000000000680; Baldwin HJ, 2018, OBSTET GYNECOL, V131, P227, DOI 10.1097/AOG.0000000000002434; Baldwin HJ, 2017, ACTA OBSTET GYN SCAN, V96, P1373, DOI 10.1111/aogs.13201; Basili F, 2015, NATL REGISTER BIRTH; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; Boldrini R, 2016, CERTIFICATI ASSISTEN; Buca D, 2018, ULTRASOUND OBST GYN, V52, P304, DOI 10.1002/uog.19070; Caughey AB, 2014, AM J OBSTET GYNECOL, V210, P179, DOI 10.1016/j.ajog.2014.01.026; Chantraine F, 2013, ACTA OBSTET GYN SCAN, V92, P369, DOI 10.1111/aogs.12130; Collins SL, 2015, OBSTET GYNECOL, V126, P645, DOI 10.1097/AOG.0000000000000962; Colmorn LB, 2015, ACTA OBSTET GYN SCAN, V94, P734, DOI 10.1111/aogs.12639; Comstock CH, 2005, ULTRASOUND OBST GYN, V26, P89, DOI 10.1002/uog.1926; Coutinho CM, 2021, ULTRASOUND OBST GYN, V57, P91, DOI 10.1002/uog.23100; Cragin E.B, 1916, NY MED; D'Antonio F, 2013, ULTRASOUND OBST GYN, V42, P509, DOI 10.1002/uog.13194; Donati S, 2016, LINEA GUIDA; Donati S, 2019, ANN I SUPER SANITA, V55, P363, DOI 10.4415/ANN_19_04_10; Donati S, 2018, ACTA OBSTET GYN SCAN, V97, P1317, DOI 10.1111/aogs.13415; Eller AG, 2011, OBSTET GYNECOL, V117, P331, DOI 10.1097/AOG.0b013e3182051db2; Erfani H, 2019, AM J OBSTET GYNECOL, V221, DOI 10.1016/j.ajog.2019.05.035; Esh-Broder E, 2011, BJOG-INT J OBSTET GY, V118, P1084, DOI 10.1111/j.1471-0528.2011.02976.x; Fitzpatrick KE, 2014, BJOG-INT J OBSTET GY, V121, P62, DOI 10.1111/1471-0528.12405; Fitzpatrick KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052893; ISTAT) NIoS, 2019, IT STAT YEARL REP; Jauniaux E, 2019, INT J GYNECOL OBSTET, V146, P20, DOI 10.1002/ijgo.12761; Jauniaux E, 2019, AM J OBSTET GYNECOL, V221, P208, DOI 10.1016/j.ajog.2019.01.233; Jauniaux E, 2018, INT J GYNECOL OBSTET, V140, P265, DOI 10.1002/ijgo.12407; Jauniaux E, 2018, AM J OBSTET GYNECOL, V218, P75, DOI 10.1016/j.ajog.2017.05.067; Jauniaux E, 2017, AM J OBSTET GYNECOL, V217, P27, DOI 10.1016/j.ajog.2017.02.050; Kallianidis AF, 2020, ACTA OBSTET GYN SCAN, V99, P1364, DOI 10.1111/aogs.13892; Kayem G, 2021, BJOG-INT J OBSTET GY, V128, P1646, DOI 10.1111/1471-0528.16647; Keag OE, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002494; Khong TY, 2001, AM J CLIN PATHOL, V116, P703; Kingdom JC, 2020, AM J OBSTET GYNECOL, V223, P322, DOI 10.1016/j.ajog.2020.01.044; Klar M, 2014, J PERINAT MED, V42, P571, DOI 10.1515/jpm-2013-0199; Kramer MS, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.07.007; Longo VL, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03462-1; Maraschini A, 2020, ACTA OBSTET GYN SCAN, V99, P274, DOI 10.1111/aogs.13727; Melcer Y, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.017; Miller DA, 1997, AM J OBSTET GYNECOL, V177, P210, DOI 10.1016/S0002-9378(97)70463-0; Morlando M, 2013, ACTA OBSTET GYN SCAN, V92, P457, DOI 10.1111/aogs.12080; Organisation for Economic Co-operation and Development (OECD), 2021, CAES SECT IND 2019; Pagani G, 2018, ACTA OBSTET GYN SCAN, V97, P25, DOI 10.1111/aogs.13238; Patterson JA, 2014, OBSTET GYNECOL, V123, P126, DOI 10.1097/AOG.0000000000000054; Salmanian B, 2020, AM J OBSTET GYNECOL, V223, DOI 10.1016/j.ajog.2020.04.026; Sandall J, 2018, LANCET, V392, P1349, DOI 10.1016/S0140-6736(18)31930-5; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Schwickert A, 2021, ACTA OBSTET GYN SCAN, V100, P29, DOI 10.1111/aogs.14103; Shamshirsaz AA, 2018, CLIN OBSTET GYNECOL, V61, P841, DOI 10.1097/GRF.0000000000000393; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; Silver RM, 2018, NEW ENGL J MED, V378, P1529, DOI 10.1056/NEJMcp1709324; Silver RM, 2015, AM J OBSTET GYNECOL, V212, P561, DOI 10.1016/j.ajog.2014.11.018; Stivanello E, 2010, ACTA OBSTET GYN SCAN, V89, P321, DOI 10.3109/00016340903508627; Strambi N, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56040180; Tantbirojn P, 2008, PLACENTA, V29, P639, DOI 10.1016/j.placenta.2008.04.008; Thurn L, 2016, BJOG-INT J OBSTET GY, V123, P1348, DOI 10.1111/1471-0528.13547; Tikkanen M, 2011, ACTA OBSTET GYN SCAN, V90, P1140, DOI 10.1111/j.1600-0412.2011.01147.x; van den Akker T, 2016, OBSTET GYNECOL, V128, P1281, DOI 10.1097/AOG.0000000000001736; Visser GHA, 2018, LANCET, V392, P1286, DOI 10.1016/S0140-6736(18)32113-5; Warshak CR, 2010, OBSTET GYNECOL, V115, P65, DOI 10.1097/AOG.0b013e3181c4f12a; World Health Organization Department of Reproductive Health and Research, 2011, EV QUAL CAR SEV PREG	63	5	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252654	10.1371/journal.pone.0252654	http://dx.doi.org/10.1371/journal.pone.0252654			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086797	gold, Green Published			2022-12-26	WOS:000664640100104
J	Shrestha, R; Shrestha, S; Badri, KC; Shrestha, S				Shrestha, Rabi; Shrestha, Sweta; Badri, K. C.; Shrestha, Sunil			Evaluation of nutritional supplements prescribed, its associated cost and patients knowledge, attitude and practice towards nutraceuticals: A hospital based cross-sectional study in Kavrepalanchok, Nepal	PLOS ONE			English	Article							MINERAL SUPPLEMENTS; BENEFIT; VITAMIN	Background There is substantial increment in nutraceutical consumption in Nepal, although the data on its efficacy and safety is scarce. The practices of nutraceutical supplements users in Nepal remain undocumented. Therefore, this study was conducted to study the prescription pattern, cost, knowledge, attitude and practice (KAP) of the patient towards nutraceutical. Methods Descriptive cross-sectional study with stratified purposive sampling (n = 400) (patients from the out-patient departments of Scheer Memorial Adventist Hospital, Kavre, Nepal) was performed using a validated structured questionnaire assessing the socio-demographic characteristics, knowledge, attitude, practice of nutraceutical and total cost patients spent on nutraceutical alone. Pearson Chi-square test (x(2)) was used to investigate the association between socio-demographic variables and patients' KAP (knowledge, attitude and practice) towards nutraceutical. One way ANOVA was performed to compare the cost of nutraceutical among the different outpatient departments. Results More than 80% of patients were found to be consuming nutraceutical on their own. The mostly prescribed nutraceutical were vitamins (40.7%), minerals (23.7%), enzymes (21.1%), proteins (8.8%), probiotics (4.2%) and herbals (2.0%). With the most common reasons for consuming nutraceutical were to maintain good health (70.0%) and healthcare professionals (57.85%) were the most approached source of information for nutraceutical. Nearly half of the patients (46.5%) had an inadequate level of knowledge whereas more than two-third (71.5%) showed a moderate positive attitude towards nutraceutical use. The average amount patients spent was NRs.575.78 [equivalent to USD 4.85] per prescription on nutraceutical alone. The maximum cost amounted to NRs 757.18 [equivalent to USD 6.43] in Orthopedics, and the minimum cost was NRs 399.03 [equivalent to USD 3.36] in Obstetrics and gynecology, respectively. There was a significant difference (p <0.001) in cost of nutraceutical prescribed between the OPD clinics. Conclusion The higher prevalence of inadequate knowledge despite moderate positive attitude towards nutraceutical among patients regarding some significant issues such as safety and interactions of nutraceutical consumption and its' substitution for meals reflects the need to develop an educational strategy to increase general public awareness on the rational use of nutraceutical.	[Shrestha, Rabi] Scheer Mem Adventist Hosp, Dept Pharm, Banepa, Kavre, Nepal; [Shrestha, Sweta; Badri, K. C.] Kathmandu Univ, Sch Sci, Dept Pharm, Dhulikhel, Kavre, Nepal; [Shrestha, Sunil] Nepal Hlth Res & Innovat Fdn, Dept Pharmaceut & Hlth Serv Res, Lalitpur, Nepal	Kathmandu University	Shrestha, S (corresponding author), Kathmandu Univ, Sch Sci, Dept Pharm, Dhulikhel, Kavre, Nepal.	sweta.shrestha@ku.edu.np	KC, Badri/AIA-7736-2022	KC, Badri/0000-0003-2825-8743				Abduallah B., 2013, INDIAN J APPL RES, V3, P169; Al-Johani WM, 2018, J FAM COMMUNITY MED, V25, P169, DOI 10.4103/jfcm.JFCM_156_17; Al-Naggar RA, 2011, ASIAN PAC J CANCER P, V12, P1023; Alhomoud FK, 2016, J CLIN DIAGN RES, V10, pJC5, DOI 10.7860/JCDR/2016/19300.8439; Bagchi D, 2008, FOOD SCI TECHNOL-INT, P1; Brower V, 1998, NAT BIOTECHNOL, V16, P728, DOI 10.1038/nbt0898-728; Chen QM, 2016, AM J MED, V129, P897, DOI 10.1016/j.amjmed.2016.03.036; Cruz A J, 2000, J Med Food, V3, P181, DOI 10.1089/jmf.2000.3.181; Curtis CL, 2004, DRUG DISCOV TODAY, V9, P165, DOI 10.1016/S1359-6446(03)02980-5; Gosavi S, 2016, J CLIN DIAGN RES, V10, pFC1, DOI 10.7860/JCDR/2016/18424.7620; Klopcic M, 2020, FOOD QUAL PREFER, V82, DOI 10.1016/j.foodqual.2019.103863; Lamichhane GP., NUTRAFOODS, V2020, P186; Mahmood NA, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/9814815; Nasri H, 2014, INT J PREVENTIVE MED, V5, P1487; Navyashree R., AWARENESS PRACTICES; Raosoft, SAMPL SIZ CALC; Ravindran A., 2017, IOSR J DENT MED SCI, V16, P12, DOI [10.9790/0853-1605061216, DOI 10.9790/0853-1605061216]; Ronis MJJ, 2018, ANNU REV PHARMACOL, V58, P583, DOI 10.1146/annurev-pharmtox-010617-052844; Santini A, 2018, BRIT J CLIN PHARMACO, V84, P659, DOI 10.1111/bcp.13496; Shao A, 2019, FOOD SCI TECH-INT SE, P619, DOI 10.1016/B978-0-12-816467-9.00039-3; Sharma A, 2014, J CLIN DIAGN RES, V8, pHC10, DOI 10.7860/JCDR/2014/9329.4683; Teoh SL, 2019, INT J FOOD SCI NUTR, V70, P491, DOI 10.1080/09637486.2018.1538326; Trottier G, 2010, NAT REV UROL, V7, P21, DOI 10.1038/nrurol.2009.234; WHO, TECHN CONS NUTR REL	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252538	10.1371/journal.pone.0252538	http://dx.doi.org/10.1371/journal.pone.0252538			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086755	gold, Green Published			2022-12-26	WOS:000664640100082
J	Chen, H; Song, FF; Long, FX				Chen, Hong; Song, Fangfang; Long, Fanxin			WNT7B overexpression rescues bone loss caused by glucocorticoids in mice	FASEB JOURNAL			English	Article						bone; glucocorticoid; osteoblast; osteoporosis; WNT7B	SCLEROSTIN-ANTIBODY; GENE-EXPRESSION; OSTEOBLASTS; ACTIVATION; DIFFERENTIATION; TERIPARATIDE; ALENDRONATE; PREVALENCE; METABOLISM; DICKKOPF-1	Glucocorticoids, widely prescribed for anti-inflammatory and immunosuppressive purposes, are the most common secondary cause for osteoporosis and related fractures. Current anti-resorptive and anabolic therapies are insufficient for treating glucocorticoid-induced osteoporosis due to contraindications or concerns of side effects. Glucocorticoids have been shown to disrupt Wnt signaling in osteoblast-lineage cells, but the efficacy for Wnt proteins to restore bone mass after glucocorticoid therapy has not been examined. Here by using two mouse genetic models wherein WNT7B expression is temporally activated by either tamoxifen or doxycycline in osteoblast-lineage cells, we show that WNT7B recovers bone mass following glucocorticoid-induced bone loss, thanks to increased osteoblast number and function. However, WNT7B overexpression in bone either before or after glucocorticoid treatments does not ameliorate the abnormal accumulation of body fat. The study demonstrates a potent bone anabolic function for WNT7B in countering glucocorticoid-induced bone loss.	[Chen, Hong; Long, Fanxin] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; [Chen, Hong] Chongqing Med Univ, Dept Orthoped, Affiliated Hosp 1, Chongqing, Peoples R China; [Song, Fangfang; Long, Fanxin] Childrens Hosp Philadelphia, Dept Surg, Translat Res Program Pediat Orthoped, Philadelphia, PA 19146 USA; [Song, Fangfang] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol, Wuhan, Peoples R China	Washington University (WUSTL); Chongqing Medical University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Wuhan University	Long, FX (corresponding author), Childrens Hosp Philadelphia, Dept Surg, Translat Res Program Pediat Orthoped, Philadelphia, PA 19146 USA.	longf1@chop.edu			HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01 AR060456, P30 AR057235]	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Grant/Award Number: R01 AR060456 and P30 AR057235	Achiou Z, 2015, BONE, V81, P691, DOI 10.1016/j.bone.2015.09.010; Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Brennan-Speranza TC, 2012, J CLIN INVEST, V122, P4172, DOI 10.1172/JCI63377; Chen H, 2019, FASEB J, V33, P7810, DOI 10.1096/fj.201900201RR; Chen JQ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004145; Colditz J, 2019, J BONE MINER RES, V34, P1314, DOI 10.1002/jbmr.3702; Compston J, 2018, ENDOCRINE, V61, P7, DOI 10.1007/s12020-018-1588-2; Dimitriadis G, 1997, BIOCHEM J, V321, P707, DOI 10.1042/bj3210707; Esen E, 2013, CELL METAB, V17, P745, DOI 10.1016/j.cmet.2013.03.017; Fardet L, 2011, RHEUMATOLOGY, V50, P1982, DOI 10.1093/rheumatology/ker017; File Elizabeth, 2009, Curr Rheumatol Rep, V11, P169; Gasparini SJ, 2016, STEROIDS, V116, P76, DOI 10.1016/j.steroids.2016.10.008; Hildebrandt S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26300-z; Holguin N, 2016, J BONE MINER RES, V31, P2215, DOI 10.1002/jbmr.2900; Joeng KS, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.4; Karner CM, 2017, CELL MOL LIFE SCI, V74, P1649, DOI 10.1007/s00018-016-2425-5; Karner CM, 2015, J CLIN INVEST, V125, P551, DOI 10.1172/JCI78470; Khan AA, 2015, J BONE MINER RES, V30, P3, DOI 10.1002/jbmr.2405; Ledford H, 2020, NATURE, V582, P469, DOI 10.1038/d41586-020-01824-5; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mak W, 2009, CALCIFIED TISSUE INT, V85, P538, DOI 10.1007/s00223-009-9303-1; Malinauskas T, 2014, CURR OPIN STRUC BIOL, V29, P77, DOI 10.1016/j.sbi.2014.10.003; Ohnaka K, 2004, BIOCHEM BIOPH RES CO, V318, P259, DOI 10.1016/j.bbrc.2004.04.025; Overman RA, 2013, ARTHRIT CARE RES, V65, P294, DOI 10.1002/acr.21796; Perl AKT, 2002, P NATL ACAD SCI USA, V99, P10482, DOI 10.1073/pnas.152238499; Rauch A, 2010, CELL METAB, V11, P517, DOI 10.1016/j.cmet.2010.05.005; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Saag KG, 2009, ARTHRITIS RHEUM-US, V60, P3346, DOI 10.1002/art.24879; Shane E, 2014, J BONE MINER RES, V29, P1, DOI 10.1002/jbmr.1998; Shen LX, 2009, J CELL BIOCHEM, V106, P337, DOI 10.1002/jcb.22010; Song DY, 2020, BONE RES, V8, DOI 10.1038/s41413-019-0081-8; Thiele Sylvia, 2014, Bonekey Rep, V3, P552, DOI 10.1038/bonekey.2014.47; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Wang D, 2019, NAT REV DRUG DISCOV, V18, P358, DOI 10.1038/s41573-019-0012-9; Wang FS, 2008, ENDOCRINOLOGY, V149, P1793, DOI 10.1210/en.2007-0910; Yao W, 2016, OSTEOPOROSIS INT, V27, P283, DOI 10.1007/s00198-015-3308-6; Yao W, 2008, ARTHRITIS RHEUM, V58, P1674, DOI 10.1002/art.23454; Zheng DL, 2013, MOL CANCER RES, V11, P482, DOI 10.1158/1541-7786.MCR-12-0520; Zhou H, 2008, J BIOL CHEM, V283, P1936, DOI 10.1074/jbc.M702687200	39	1	1	1	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21683	10.1096/fj.202100151RR	http://dx.doi.org/10.1096/fj.202100151RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118078				2022-12-26	WOS:000667814100048
J	Luo, Y; Wang, YR; Huang, Y				Luo, Ying; Wang, Yirong; Huang, Ying			Schizosaccharomyces pombe Ppr10 and Mpa1 together mediate mitochondrial translational initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; C-OXIDASE DEFICIENCY; STRUCTURAL BASIS; FISSION YEAST; RNA; LRPPRC; POLYADENYLATION; RECOGNITION; EVOLUTION; EFFICIENT	Pentatricopeptide repeat (PPR) proteins are a large family of proteins that act primarily at different posttranscriptional steps of organellar gene expression. Wehave previously found that the Schizosaccharomyces pombe PPR protein mpal10 interacts with mitochondrial translational activator Mpa1, and both are essential for mitochondrial protein synthesis. However, it is unclear how these two proteins function in mitochondrial protein synthesis in S. pombe. In this study, we further investigated the role of Ppr10 and Mpa1 in mitochondrial protein synthesis. Mitochondrial translational initiation requires two initiation factors, Mti2 and Mti3, which bind to the small subunit of the mitochondrial ribosome (mt-SSU) during the formation of the mitochondrial translational initiation complex. Using sucrose gradient sedimentation analysis, we found that disruption of ppr10, mpa1, or the PPR motifs in Ppr10 impairs the association of Mti2 and Mti3 with the mt-SSU, suggesting that both Ppr10 and Mpa1 may be required for the interaction of Mti2 and Mti3 with the mt-SSU during the assembly of mitochondrial translational initiation complex. Loss of Ppr10 perturbs the association of mitochondrially encoded cytochrome b (cob1) and cytochrome c oxidase subunit 1 (cox1) mRNAs with assembled mitochondrial ribosomes. Proteomic analysis revealed that a fraction of Ppr10 and Mpa1 copurified with a subset of mitoribosomal proteins. The PPR motifs of Ppr10 are necessary for its interaction with Mpa1 and that disruption of these PPR motifs impairs mitochondrial protein synthesis. Our results suggest that Ppr10 and Mpa1 function together to mediate mitochondrial translational initiation.	[Luo, Ying; Wang, Yirong; Huang, Ying] Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Microbes & Genom, Nanjing, Peoples R China	Nanjing Normal University	Huang, Y (corresponding author), Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Microbes & Genom, Nanjing, Peoples R China.	yhuang@njnu.edu.cn			National Natural Science Foundation of China [31470778]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX20_1186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research & Practice Innovation Program of Jiangsu Province	This work was supported in part by grants from National Natural Science Foundation of China (31470778 to Y. H.) and Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX20_1186 to Y. W.).	Andres-Colas N, 2017, P NATL ACAD SCI USA, V114, P8883, DOI 10.1073/pnas.1705815114; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Ban T, 2013, J BIOL CHEM, V288, P31540, DOI 10.1074/jbc.M113.496828; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Chicherin IV, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64139-5; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; De Silva D, 2017, NUCLEIC ACIDS RES, V45, P6628, DOI 10.1093/nar/gkx426; De Silva D, 2013, CELL METAB, V18, P712, DOI 10.1016/j.cmet.2013.10.007; Derbikova KS, 2018, BIOCHEMISTRY-MOSCOW+, V83, P87, DOI 10.1134/S0006297918020013; Guillaumot D, 2017, P NATL ACAD SCI USA, V114, P8877, DOI 10.1073/pnas.1705780114; Herbert CJ, 2013, RNA BIOL, V10, P1477, DOI 10.4161/rna.25392; Hillman GA, 2019, J BIOL CHEM, V294, P9813, DOI 10.1074/jbc.RA119.008476; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Jones JL, 2019, J BIOL CHEM, V294, P7528, DOI 10.1074/jbc.RA118.005355; Jung SJ, 2015, FEBS LETT, V589, P822, DOI 10.1016/j.febslet.2015.02.015; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; KEENEY JB, 1994, GENETICS, V136, P849; Kuhl I, 2011, NUCLEIC ACIDS RES, V39, P8029, DOI 10.1093/nar/gkr511; Kummer E, 2021, NAT REV MOL CELL BIO, V22, P307, DOI 10.1038/s41580-021-00332-2; Kuzmenko A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18749; Kuzmenko A, 2014, BIOCHIMIE, V100, P132, DOI 10.1016/j.biochi.2013.07.024; Lagouge M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005423; LIAO HX, 1989, J BIOL CHEM, V264, P7518; Lightowlers RN, 2013, RNA BIOL, V10, P1433, DOI 10.4161/rna.24770; Liu Z, 2020, FEMS MICROBIOL LETT; Luo Y, 2019, FEBS J, V286, P4542, DOI 10.1111/febs.15021; Malecki M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1101-2; Manna S, 2015, BIOCHIMIE, V113, P93, DOI 10.1016/j.biochi.2015.04.004; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perks KL, 2018, CELL REP, V23, P127, DOI 10.1016/j.celrep.2018.03.033; Pinker F, 2013, RNA BIOL, V10, P1457, DOI 10.4161/rna.25273; Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128; Rackham O, 2012, BBA-GENE REGUL MECH, V1819, P1008, DOI 10.1016/j.bbagrm.2011.10.007; Richman TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11884; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; Rudler DL, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay2118; Rutter J, 2015, TRENDS ENDOCRIN MET, V26, P59, DOI 10.1016/j.tem.2014.12.002; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; SCHAFER B, 1991, MOL GEN GENET, V225, P158; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Siira SJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01221-z; Small ID, 2020, PLANT J, V101, P1040, DOI 10.1111/tpj.14578; Spahr H, 2016, NUCLEIC ACIDS RES, V44, P6868, DOI 10.1093/nar/gkw575; Summer S, 2020, NUCLEIC ACIDS RES, V48, P9762, DOI 10.1093/nar/gkaa148; Vakifahmetoglu-Norberg H, 2017, BIOCHEM BIOPH RES CO, V482, P426, DOI 10.1016/j.bbrc.2016.11.088; Waltz F, 2020, TRENDS BIOCHEM SCI, V45, P149, DOI 10.1016/j.tibs.2019.10.004; Wang YR, 2017, NUCLEIC ACIDS RES, V45, P3323, DOI 10.1093/nar/gkx127; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wolf D. A, 2017, COLD SPRING HARB PRO; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651	55	3	3	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1								10.1016/j.jbc.2021.100869	http://dx.doi.org/10.1016/j.jbc.2021.100869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34119521	Green Published, gold			2022-12-26	WOS:000678068400069
J	Menendez-Arias, L				Menendez-Arias, Luis			Decoding molnupiravir-induced mutagenesis in SARS-CoV-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Molnupiravir, a prodrug of the nucleoside derivative beta-D-N-4-hydroxycytidine (NHC), is currently in clinical trials for COVID-19 therapy. However, the biochemical mechanisms involved in molnupiravir-induced mutagenesis had not been explored. In a recent study, Gordon et al. demonstrated that NHC can be incorporated into viral RNA and subsequently extended and used as template for RNA-dependent RNA synthesis, proposing a mutagenesis model consistent with available virological evidence. Their study uncovers molecular mechanisms by which molnupiravir drives SARS-CoV-2 into error catastrophe.	[Menendez-Arias, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Menendez-Arias, Luis] Univ Autonoma Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Menendez-Arias, L (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.; Menendez-Arias, L (corresponding author), Univ Autonoma Madrid, Madrid, Spain.	lmenendez@cbm.csic.es	Menendez Arias, Luis/N-7447-2016	Menendez Arias, Luis/0000-0002-1251-6640	Spanish Ministry of Science and Innovation [PID2019-104176RB-I00/AEI/10.13039/50110001 1033]; Fundacion Ramon Areces (Madrid, Spain)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces (Madrid, Spain)	Work in the author's laboratory is supported by the Spanish Ministry of Science and Innovation (grant PID2019-104176RB-I00/AEI/10.13039/50110001 1033), and an institutional grant of Fundacion Ramon Areces (Madrid, Spain).	Agostini ML, 2019, J VIROL, V93, DOI 10.1128/JVI.01348-19; Cox RM, 2021, NAT MICROBIOL, V6, P11, DOI 10.1038/s41564-020-00835-2; Gordon CJ, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100770; Hillen HS, 2021, CURR OPIN VIROL, V48, P82, DOI 10.1016/j.coviro.2021.03.010; Ma Y, 2021, CHEM SOC REV, V50, P4514, DOI 10.1039/d0cs01084g; Perales C, 2019, FUTURE MED CHEM, V11, P1645, DOI 10.4155/fmc-2018-0457; Rosenke K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22580-8; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; Zhao JY, 2021, ANTIVIR RES, V190, DOI 10.1016/j.antiviral.2021.105078; Zhou S., 2021, J INFECT DIS, DOI [10.1093/infdis/jiab247, DOI 10.1093/INFDIS/JIAB247]	10	27	28	4	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100867	10.1016/j.jbc.2021.100867	http://dx.doi.org/10.1016/j.jbc.2021.100867			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34118236	gold, Green Published			2022-12-26	WOS:000678068400067
J	Flores-Tolentino, M; Beltran-Rodriguez, L; Morales-Linares, J; Ramirez Rodriguez, JR; Ibarra-Manriquez, G; Dorado, O; Villasenor, JL				Flores-Tolentino, Mayra; Beltran-Rodriguez, Leonardo; Morales-Linares, Jonas; Rolando Ramirez Rodriguez, J.; Ibarra-Manriquez, Guillermo; Dorado, Oscar; Luis Villasenor, Jose			Biogeographic regionalization by spatial and environmental components: Numerical proposal	PLOS ONE			English	Article							BETA-DIVERSITY; FOREST; REGIONS; WATER; BIODIVERSITY; ASTERACEAE; FRAMEWORK; PATTERNS; ENDEMISM; AREAS	Regionalization through the analysis of species groups offers important advantages in conservation biology, compared to the single taxon approach in areas of high species richness. We use a systematic framework for biogeographic regionalization at a regional scale based on species turnover and environmental drivers (climate variables and soil properties) mainly of herbaceous plant species richness. To identify phytogeographic regions in the Balsas Depression (BD), we use Asteraceae species, a family widely distributed in Seasonally Dry Tropical Forest (SDTF) and the most diverse of the vascular plants in Mexico. Occurrence records of 571 species were used to apply a quantitative analysis based on the species turnover, the rate of changes in their composition between sites (beta -Simpson index) and the analysis of the identified environmental drivers. Also, the environmental predictors that influence species richness in the SDTF were determined with a redundancy analysis. We identified and named two phytogeographic districts within the SDTF of the BD (Upper Balsas and Lower Balsas). According to the multi-response permutation procedure, floristic composition of the two districts differs significantly, and the richness of exclusive species in Upper Balsas was higher (292 species) than in the Lower Balsas (32 species). The proportion of Mg and Ca in the soil and the precipitation of the driest three-month period were the environmental factors with greatest positive influence on species richness. The division of geographic districts subordinated to the province level, based on diverse families such as Asteraceae, proved to be appropriate to set up strategies for the conservation of the regional flora, since at this scale, variation in species richness is more evident. Our findings are consistent with a growing body of biogeographic literature that indicates that the identification of smaller biotic districts is more efficient for the conservation of biodiversity, particularly of endemic or rare plants, whose distribution responds more to microhabitats variation.	[Flores-Tolentino, Mayra; Morales-Linares, Jonas; Rolando Ramirez Rodriguez, J.] Univ Autonoma Estado Morelos, Ctr Invest Biodivers & Conservac, Cuernavaca, Morelos, Mexico; [Beltran-Rodriguez, Leonardo] Univ Nacl Autonoma Mexico, Jardin Bot Inst Biol, Ciudad De Mexico, Mexico; [Ibarra-Manriquez, Guillermo] Univ Nacl Autonoma Mexico, Inst Invest Ecosistemas & Sustentabil, Morelia, Michoacan, Mexico; [Dorado, Oscar] Univ Autonoma Estado Morelos, Ctr Educ Ambiental & Invest Sierre Huautla, Cuernavaca, Morelos, Mexico; [Luis Villasenor, Jose] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Ciudad De Mexico, Mexico	Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; Universidad Autonoma del Estado de Morelos; Universidad Nacional Autonoma de Mexico	Villasenor, JL (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Ciudad De Mexico, Mexico.	vrios@ib.unam.mx		flores, mayra/0000-0002-4554-1666; Morales-Linares, Jonas/0000-0001-5178-7091	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [732218]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The Consejo Nacional de Ciencia y Tecnologia (CONACYT) provided financial support to MFT (scholarship 732218) to carry out her doctoral studies.	Antonelli A, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0114; Appezzato-da-Gloria B, 2012, FLORA, V207, P878, DOI 10.1016/j.flora.2012.10.003; Arriaga L., 1997, REGIONALIZACION ECOL; Banda-R K, 2016, SCIENCE, V353, P1383, DOI 10.1126/science.aaf5080; Castillo M, 2014, ACTA BOT MEX, V108, P81; Chapman AD., 2005, PRINCIPLES METHODS D; Clarke KR, 1994, CHANGE MARINE COMMUN; Cortes-Flores J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231526; Cortes-Flores J, 2019, OECOLOGIA, V189, P159, DOI 10.1007/s00442-018-4295-z; Cortes-Flores J, 2017, AM J BOT, V104, P39, DOI 10.3732/ajb.1600305; Cruz-Cardenas G, 2014, GEODERMA, V213, P29, DOI 10.1016/j.geoderma.2013.07.014; Di Virgilio G, 2012, J BIOGEOGR, V39, P1862, DOI 10.1111/j.1365-2699.2012.02739.x; Dirzo R, 2011, SEASONALLY DRY TROPI; Ebach MC, 2017, ACTA BIOTHEOR, V65, P167, DOI 10.1007/s10441-017-9310-y; Escalante T, 2017, BIOL J LINN SOC, V120, P349; Espinosa D., 2008, CAPITAL NATURAL MEXI, VI, P33, DOI DOI 10.32800/ABC.2019.42.0187; Espinosa D, 2006, J BIOGEOGR, V33, P1945, DOI 10.1111/j.1365-2699.2006.01566.x; Estrada-Medina H, 2013, TREES-STRUCT FUNCT, V27, P1297, DOI 10.1007/s00468-013-0878-9; Fernandez-Nava R, 1998, POLIBOTANICA, V9, P1; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Funk VA., 2009, SYSTEMATICS EVOLUTIO; Galicia L, 1999, CATENA, V36, P153, DOI 10.1016/S0341-8162(98)00121-0; Gamez N, 2014, J BIOGEOGR, V41, P871, DOI 10.1111/jbi.12249; Gei MG, 2018, NAT ECOL EVOL, V2, P1104, DOI 10.1038/s41559-018-0559-6; Gonzalez R, 2019, BIOTROPICA, V51, P826, DOI 10.1111/btp.12715; Gonzalez-Orozco CE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092558; Gonzalez-Orozco CE, 2014, DIVERS DISTRIB, V20, P46, DOI 10.1111/ddi.12129; Gonzalez-Orozco CE, 2013, J BIOGEOGR, V40, P2156, DOI 10.1111/jbi.12153; Hasselquist NJ, 2010, OECOLOGIA, V164, P881, DOI 10.1007/s00442-010-1725-y; Holt B, 2013, SCIENCE, V339, P74, DOI 10.1126/science.1228282; Huang C, 2020, ZOOTAXA, V4742, P271, DOI 10.11646/zootaxa.4742.2.3; Ibarra-Manriquez G, 2002, J BIOGEOGR, V29, P17, DOI 10.1046/j.1365-2699.2002.00648.x; Ibarra-Manriquez G., 2020, REV MEX BIODIVERS; Jaramillo VJ, 2003, ECOSYSTEMS, V6, P609, DOI 10.1007/s10021-002-0195-4; Jetz W, 2004, ECOL LETT, V7, P1180, DOI 10.1111/j.1461-0248.2004.00678.x; Jost Lou, 2011, P66; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kreft H, 2010, J BIOGEOGR, V37, P2029, DOI 10.1111/j.1365-2699.2010.02375.x; Laffan SW, 2016, METHODS ECOL EVOL, V7, P580, DOI 10.1111/2041-210X.12513; Laffan SW, 2010, ECOGRAPHY, V33, P643, DOI 10.1111/j.1600-0587.2010.06237.x; Lennon JJ, 2001, J ANIM ECOL, V70, P966, DOI 10.1046/j.0021-8790.2001.00563.x; Villasenor JL, 2018, BOT SCI, V96, P332, DOI 10.17129/botsci.1872; Villasenor JL, 2016, REV MEX BIODIVERS, V87, P559, DOI 10.1016/j.rmb.2016.06.017; Mantilla-Contreras J, 2012, J PLANT ECOL, V5, P249, DOI 10.1093/jpe/rtr031; McCune B, 2002, ANAL ECOLOGICAL COMM; Mendenhall W. M., 2016, STAT ENG SCI; Mendez-Toribio M, 2020, J ECOL, V108, P1347, DOI 10.1111/1365-2745.13355; Mendez-Toribio M, 2014, REV MEX BIODIVERS, V85, P1117, DOI 10.7550/rmb.43457; Mielke P. W., 2001, PERMUTATION METHODS; Miles L, 2006, J BIOGEOGR, V33, P491, DOI 10.1111/j.1365-2699.2005.01424.x; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, P3, DOI DOI 10.1007/978-3-642-20992-5_1; Morrone JJ, 2019, REV MEX BIODIVERS, V90, DOI 10.22201/ib.20078706e.2019.90.2980; Morrone Juan J., 2005, Rev. Mex. Biodiv., V76, P207; Morrone JJ, 2018, J BIOGEOGR, V45, P282, DOI 10.1111/jbi.13135; Morrone JJ, 2017, ZOOTAXA, V4277, P277, DOI 10.11646/zootaxa.4277.2.8; Morrone JJ, 2015, AUST SYST BOT, V28, P81, DOI 10.1071/SB14042; Myers N, 1988, Environmentalist, V8, P187, DOI 10.1007/BF02240252; Oksanen J, **DATA OBJECT**; Portillo-Quintero C, 2015, REG ENVIRON CHANGE, V15, P1039, DOI 10.1007/s10113-014-0689-6; Quesada M, 2009, FOREST ECOL MANAG, V258, P1014, DOI 10.1016/j.foreco.2009.06.023; R Development Core Team, R LANGUAGE ENV STAT; Razaq M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171321; Ribeiro GC, 2014, ZOOTAXA, V3847, P241, DOI 10.11646/zootaxa.3847.2.4; Rivera P, 2017, BOT STUD, V58, DOI 10.1186/s40529-017-0166-x; Rodrigues P, 2015, MAMMAL REV, V45, P103, DOI 10.1111/mam.12036; Rodríguez-Jiménez Concepción, 2005, Polibotánica, P73; Rzedowski J., 1978, VEGETACION MEXICO; Rzedowski J., 2013, ACTA BOT MEX, V102, P1, DOI [10.21829/abm102.2013.229, DOI 10.21829/ABM102.2013.229]; Rzedowski J, 1991, ACTA BOT MEX, V14, P3, DOI [DOI 10.21829/ABM14.1991.611, 10.21829/abm14.1991.611]; SanchezAzofeifa A, 2014, TROPICAL DRY FORESTS IN THE AMERICAS: ECOLOGY, CONSERVATION, AND MANAGEMENT, P1; Santiago LS, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa8959; Singh JS., 2017, TROPICAL DRY DECIDUO, DOI [10.1007/978-981-10-7260-4, DOI 10.1007/978-981-10-7260-4]; Smith H., 1941, ANALES ESCUELA NACL, V2, P103; Stan K, 2019, FORESTS, V10, DOI 10.3390/f10050443; Thornhill AH, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0435-x; Trejo I, 2002, BIODIVERS CONSERV, V11, P2063, DOI 10.1023/A:1020876316013; Tuomisto H, 2010, ECOGRAPHY, V33, P2, DOI 10.1111/j.1600-0587.2009.05880.x; Valdez-Hernandez M, 2010, PLANT SOIL, V329, P155, DOI 10.1007/s11104-009-0142-7; van Breugel M, 2019, J ECOL, V107, P566, DOI 10.1111/1365-2745.13126; Vilhena DA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7848; Villaseñor José Luis, 2014, Rev. Mex. Biodiv., V85, pS134, DOI 10.7550/rmb.31987; Villasenor JL, 2007, DIVERS DISTRIB, V13, P871, DOI 10.1111/j.1472-4642.2007.00385.x; Wagner FH, 2016, BIOGEOSCIENCES, V13, P2537, DOI 10.5194/bg-13-2537-2016; Werden LK, 2018, FUNCT ECOL, V32, P2766, DOI 10.1111/1365-2435.13206; Whittaker RJ, 2005, DIVERS DISTRIB, V11, P3, DOI 10.1111/j.1366-9516.2005.00143.x; Xu H, 2015, J ECOL, V103, P1325, DOI 10.1111/1365-2745.12442; Zhang MG, 2016, SCI REP-UK, V6, DOI 10.1038/srep22400	87	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253152	10.1371/journal.pone.0253152	http://dx.doi.org/10.1371/journal.pone.0253152			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129612	Green Published, gold			2022-12-26	WOS:000665475100030
J	Wang, WW; Liu, ZZ; Song, QM; Zhang, XD; Jiao, SK; Xu, Y; Xu, QD; Sheng, DZ				Wang, Weiwei; Liu, Zhuangzhuang; Song, Qimin; Zhang, Xindi; Jiao, Shengkai; Xu, Yao; Xu, Quanda; Sheng, Dezun			Tribological performance of organic molybdenum in the presence of organic friction modifier	PLOS ONE			English	Article							ADDITIVES; AMINE	The tribological performance of organic molybdenum in the present of organic friction modifier was investigated in this study. Three types of organic friction modifiers were selected, which are Glycerol monooleate, Pentaerythritol and N,N-Dimethylhexadecylamine. The organic molybdenum are MoDTC, MoDDP and molybdenum amide. Friction coefficient and wear were studied in block-on-ring test rig with steel test specimens. Experimental results indicate the Pentaerythritol shows synergistic effect with MoDTC in wide range temperature, while increased the friction coefficient of molybdenum amide in high temperature. N,N-Dimethylhexadecylamine shows synergistic effect with molybdenum amide, while hindered the friction reduction performance of MoDTC in low temperature. The presence of Glycerol monooleate reduced friction coefficient of MoDTC in low temperature, while increased the friction coefficient of molybdenum amide in most situations. All the tested organic friction modifiers improved the friction reduction performance of MoDDP. Most of the tested organic friction modifiers reduced the wear of organic molybdenum. The PT shows the best anti-wear performance with MoDTC. The tribo-chemical products in test specimens lubricated with different lubricant formulas indicate that the presences of Pentaerythritol promotes the production of MoS2 in MoDTC. N,N-Dimethylhexadecylamine promotes the production of MoS2 in molybdenum amide. The side products of MoO1.6S1.6 and Cr/MoS2 of MoDDP in high temperature lead to high friction coefficient.	[Wang, Weiwei; Liu, Zhuangzhuang; Song, Qimin; Zhang, Xindi; Jiao, Shengkai; Xu, Yao; Xu, Quanda; Sheng, Dezun] Yantai Univ, Ocean Sch, Yantai, Peoples R China	Yantai University	Wang, WW; Sheng, DZ (corresponding author), Yantai Univ, Ocean Sch, Yantai, Peoples R China.	zhwangww@ytu.edu.cn; shengdezun@163.com			Natural Science Foundation of Shandong Province [ZR2019BEE073]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	The authors acknowledge the financial support provided by the Natural Science Foundation of Shandong Province (ZR2019BEE073) to Weiwei Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebogun A, 2018, TRIBOL LETT, V66, DOI 10.1007/s11249-018-1013-2; Balarini R, 2020, TRIBOL INT, V149, DOI 10.1016/j.triboint.2019.03.044; Bouchet MID, 2018, TRIBOL INT, V119, P600, DOI 10.1016/j.triboint.2017.11.039; Cai T, 2019, TRIBOL INT, V136, P556, DOI 10.1016/j.triboint.2019.04.021; Dawczyk J, 2019, TRIBOL LETT, V67, DOI 10.1007/s11249-019-1221-4; Deshpande P, 2020, TRIBOL LETT, V68, DOI 10.1007/s11249-020-1278-0; Gorbatchev O, 2016, TRIBOL INT, V99, P278, DOI 10.1016/j.triboint.2016.03.035; Guegan J, 2019, TRIBOL LETT, V67, DOI 10.1007/s11249-019-1198-z; Hu HQ, 2008, TRIBOL INT, V41, P549, DOI 10.1016/j.triboint.2007.11.020; Huai WJ, 2020, TRIBOL INT, V141, DOI 10.1016/j.triboint.2019.105944; Khaemba DN, 2017, J PHYS D APPL PHYS, V50, DOI 10.1088/1361-6463/aa5905; Khaemba DN, 2016, RSC ADV, V6, P38637, DOI 10.1039/c6ra00652c; Okubo H., 2018, TRIBOL T, V119, P600; Oumahi C, 2018, RSC ADV, V8, P25867, DOI 10.1039/c8ra03317j; Roshan R, 2011, J TRIBOL-T ASME, V133, DOI 10.1115/1.4004880; Rudnick L.R., 2009, LUBRICANT ADDITIVES, P615; Trindade ED, 2015, LUBR SCI, V27, P217, DOI 10.1002/ls.1270; Wang WW, 2018, LUBR SCI, V30, P33, DOI 10.1002/ls.1401; Yan LL, 2012, TRIBOL INT, V53, P150, DOI 10.1016/j.triboint.2012.04.002; Yue W, 2015, TRIBOL LETT, V58, DOI 10.1007/s11249-015-0508-3; Zahid R, 2018, IND LUBR TRIBOL, V70, P888, DOI 10.1108/ILT-06-2017-0156; Zahid R, 2017, RSC ADV, V7, P26513, DOI 10.1039/c6ra27743h; Zeng QF, 2017, IND LUBR TRIBOL, V69, P190, DOI 10.1108/ILT-05-2016-0101	23	1	1	5	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252203	10.1371/journal.pone.0252203	http://dx.doi.org/10.1371/journal.pone.0252203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111128	Green Published, gold			2022-12-26	WOS:000664642700019
J	Pakseresht, A; Edenbrandt, AK; Lagerkvist, CJ				Pakseresht, Ashkan; Edenbrandt, Anna Kristina; Lagerkvist, Carl Johan			Genetically modified food and consumer risk responsibility: The effect of regulatory design and risk type on cognitive information processing	PLOS ONE			English	Article							PUBLIC PERCEPTIONS; FIELD EXPERIMENT; MODIFIED CROPS; ACCEPTANCE; ATTITUDES; KNOWLEDGE; HAZARDS; SAFETY; ECONOMICS; BENEFITS	The use of agro-biotechnology has raised consumer concerns about environmental, health, socio-economic and ethical risks. This study examines how regulatory policies regarding genetically modified (GM) food production affect consumers' cognitive information processing, in terms of perceived risk, self-control, and risk responsibility. There is further analysis of whether the effect of policy design is moderated by risk type. Data was generated in a field experiment (n = 547), including four different policy scenario treatments (banned, research and development, import, and full commercialization). The results reveal that policy scenarios where GM food is available on the market are associated with higher levels of perceived risk and lower levels of self-control compared with policies where GM food is banned. There was no evidence of policy scenarios affecting consumer willingness to assign personal risk responsibility. However, among participants who indicated health risks as their main concern, there was an effect from the policy scenario on self-risk responsibility as mediated through perceived risk and self-control. The results suggest that health-conscious consumers tend to attribute less responsibility to themselves in situations where a genetically modified product was commercialized. These findings indicate a need to clarify guideline recommendations for health-related risks associated with foods derived from biotechnology.	[Pakseresht, Ashkan; Edenbrandt, Anna Kristina; Lagerkvist, Carl Johan] Swedish Univ Agr Sci, Dept Econ, Uppsala, Sweden; [Pakseresht, Ashkan] Novia Univ, Dept Bioecon, Eknas, Finland	Swedish University of Agricultural Sciences	Pakseresht, A (corresponding author), Swedish Univ Agr Sci, Dept Econ, Uppsala, Sweden.; Pakseresht, A (corresponding author), Novia Univ, Dept Bioecon, Eknas, Finland.	ashkan.pakseresht@novia.fi	Pakseresht, Ashkan/N-8461-2013	Pakseresht, Ashkan/0000-0002-4421-521X	Swedish Foundation for Strategic Environmental Research (MISTRA)	Swedish Foundation for Strategic Environmental Research (MISTRA)(Swedish Foundation for Strategic Research)	This research was supported by the research program MISTRA Biotech on funds from the Swedish Foundation for Strategic Environmental Research (MISTRA), https://www.slu.se/mistrabiotech/en.The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	BANDURA A, 1982, AM PSYCHOL, V37, P122, DOI 10.1037/0003-066X.37.2.122; Bar-Gill O., 2018, BEHAV PUBLIC POLICY, P1; Bauer M.W., 1998, BIOTECHNOLOGY PUBLIC; Boccia F, 2018, FOOD RES INT, V111, P682, DOI 10.1016/j.foodres.2018.06.013; Bredahl L, 1999, APPETITE, V33, P343, DOI 10.1006/appe.1999.0267; Churchill GA., 1986, MARKETING RES METHOD; Conway G, 2000, CONSERV ECOL, V4; Costa-Font M, 2008, FOOD POLICY, V33, P99, DOI 10.1016/j.foodpol.2007.07.002; Crespi M., 2003, EUR J LAW ECON, V16, P327, DOI [DOI 10.1023/A:1025362808108, 10.1023/A:1025362808108]; De Steur H, 2014, TRENDS FOOD SCI TECH, V39, P116, DOI 10.1016/j.tifs.2014.06.010; Deaton A., 2016, W22595 NAT BUR EC RE; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Erdem S, 2012, FOOD POLICY, V37, P661, DOI 10.1016/j.foodpol.2012.07.010; Faber Jorge, 2014, Dental Press J. Orthod., V19, P27, DOI 10.1590/2176-9451.19.4.027-029.ebo; FifeSchaw C, 1996, RISK ANAL, V16, P487, DOI 10.1111/j.1539-6924.1996.tb01095.x; Frewer L, 2004, FOOD CHEM TOXICOL, V42, P1181, DOI 10.1016/j.fct.2004.02.002; Frewer L, 2003, TRENDS FOOD SCI TECH, V14, P319, DOI 10.1016/S0924-2244(03)00064-5; Frewer LJ, 2014, TRENDS FOOD SCI TECH, V40, P211, DOI 10.1016/j.tifs.2014.06.005; Frewer LJ, 1996, RISK ANAL, V16, P473, DOI 10.1111/j.1539-6924.1996.tb01094.x; FREWER LJ, 1994, J FOOD SAFETY, V14, P19, DOI 10.1111/j.1745-4565.1994.tb00581.x; Frewer LJ, 2013, TRENDS FOOD SCI TECH, V30, P142, DOI 10.1016/j.tifs.2013.01.003; GILOVICH T, 1995, PSYCHOL REV, V102, P379, DOI 10.1037/0033-295X.102.2.379; Grunert K. G., 2003, Innovative Food Science & Emerging Technologies, V4, P435, DOI 10.1016/S1466-8564(03)00035-3; Grunert KG, 2005, EUR REV AGRIC ECON, V32, P369, DOI 10.1093/eurrag/jbi011; Harrison GW, 2004, J ECON LIT, V42, P1009, DOI 10.1257/0022051043004577; HARVEY JH, 1993, CC/SOC BEHAV SCI, P8; Hayes A.F., 2012, CISC VIS NETW IND GL; Hayes AF, 2015, MULTIVAR BEHAV RES, V50, P1, DOI 10.1080/00273171.2014.962683; Hayes AF, 2014, BRIT J MATH STAT PSY, V67, P451, DOI 10.1111/bmsp.12028; Heider F., 1958, PSYCHOL INTERPERSONA, DOI DOI 10.1037/14200-000; Henderson J, 2010, AUST J PRIM HEALTH, V16, P344, DOI 10.1071/PY10011; Hess S, 2016, EUR REV AGRIC ECON, V43, P703, DOI 10.1093/erae/jbw011; HOLM S, 1979, SCAND J STAT, V6, P65; Hossain F., 2003, INT J CONSUM STUD, V27, P353, DOI [10.1046/j.1470-6431.2003.00303.x, DOI 10.1046/J.1470-6431.2003.00303.X]; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; KLEIN WM, 1994, ORGAN BEHAV HUM DEC, V59, P410, DOI 10.1006/obhd.1994.1067; Knight JG, 2007, NAT BIOTECHNOL, V25, P507, DOI 10.1038/nbt0507-507; Knowles T, 2007, BRIT FOOD J, V109, P43, DOI 10.1108/00070700710718507; Kolodinsky J, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq1413; Krimsky S., 1992, SOCIAL THEORIES RISK, DOI [10.1177/02704676940140042, DOI 10.1177/02704676940140042]; Lagerkvist CJ, 2015, FOOD CONTROL, V47, P359, DOI 10.1016/j.foodcont.2014.07.026; Lalwani N, 2000, J APPL SOC PSYCHOL, V30, P2233, DOI 10.1111/j.1559-1816.2000.tb02434.x; LANGER EJ, 1976, J PERS SOC PSYCHOL, V34, P191, DOI 10.1037/0022-3514.34.2.191; Leikas S, 2009, APPETITE, V53, P123, DOI 10.1016/j.appet.2009.05.003; Lindell MK, 2000, ENVIRON BEHAV, V32, P461, DOI 10.1177/00139160021972621; List JA, 2011, J ECON PERSPECT, V25, P3, DOI 10.1257/jep.25.3.3; Losey JE, 1999, NATURE, V399, P214, DOI 10.1038/20338; Martinez-Poveda A, 2009, FOOD POLICY, V34, P519, DOI 10.1016/j.foodpol.2009.08.001; McCluskey J. J., 2003, Agricultural and Resource Economics Review, V32, P222; Mielby H, 2013, PUBLIC UNDERST SCI, V22, P155, DOI 10.1177/0963662511430577; Miles S, 2005, BRIT FOOD J, V107, P246, DOI 10.1108/00070700510589521; Miles S, 2001, FOOD QUAL PREFER, V12, P47, DOI 10.1016/S0950-3293(00)00029-X; Mitchell V.W., 1999, EUR J MARKETING, V33, P163, DOI [10.1108/03090569910249229, DOI 10.1108/03090569910249229]; Mulilis JP, 1997, J APPL SOC PSYCHOL, V27, P1750, DOI 10.1111/j.1559-1816.1997.tb01623.x; Nayga RM, 2006, AGR ECON-BLACKWELL, V34, P331, DOI 10.1111/j.1574-0864.2006.00129.x; Niou EM., 2007, BALANCE POWER STABIL; Nordgren LF, 2007, J BEHAV DECIS MAKING, V20, P533, DOI 10.1002/bdm.565; Olsen R., 2008, ENCY SURVEY RES METH, P809, DOI DOI 10.4135/9781412963947; Peterson G, 2000, CONSERV ECOL, V4; Phillips DM, 2013, PSYCHOL MARKET, V30, P739, DOI 10.1002/mar.20642; PIMENTEL D, 1989, BIOSCIENCE, V39, P606, DOI 10.2307/1311090; Pimentel D, 2000, CONSERV ECOL, V4; PLOTT CR, 1982, J ECON LIT, V20, P1485; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Qaim M, 2009, ANNU REV RESOUR ECON, V1, P665, DOI 10.1146/annurev.resource.050708.144203; R Core Team, 2014, R FDN STAT COMP; RAYNER S, 1987, RISK ANAL, V7, P3, DOI 10.1111/j.1539-6924.1987.tb00963.x; Redmond EC, 2004, APPETITE, V43, P309, DOI 10.1016/j.appet.2004.05.003; Rembischevski P, 2020, FOOD SCI TECH-BRAZIL, V40, P779, DOI 10.1590/fst.28219; Schubert D, 2002, NAT BIOTECHNOL, V20, P969, DOI 10.1038/nbt1002-969; Siegrist M, 2008, TRENDS FOOD SCI TECH, V19, P603, DOI 10.1016/j.tifs.2008.01.017; Siegrist M, 2020, NAT FOOD, V1, P343, DOI 10.1038/s43016-020-0094-x; Sjoberg L., 1996, RISKUPPFATTNING INST; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P, 1999, DECISION SCIENCE AND TECHNOLOGY: REFLECTIONS ON THE CONTRIBUTIONS OF WARD EDWARDS, P353; SPARKS P, 1994, RISK ANAL, V14, P799, DOI 10.1111/j.1539-6924.1994.tb00291.x; Sparks P., 1994, Agriculture and Human Values, V11, P19, DOI 10.1007/BF01534445; Stemerding D, 2013, DISCOURSES SYNTHETIC; STIRLING A, 1999, RETHINKING RISK PILO; Straughan R., 1999, BIOTECHNOLOGY-PAKIST, V1, P4; Sunstein CR, 2017, U PENN LAW REV, V165, P1043; Terpstra T, 2008, INT J WATER RESOUR D, V24, P555, DOI 10.1080/07900620801923385; Ueland O, 2012, FOOD CHEM TOXICOL, V50, P67, DOI 10.1016/j.fct.2011.06.006; Van Wezemael L, 2010, FOOD CONTROL, V21, P835, DOI 10.1016/j.foodcont.2009.11.010; Viceisza ACG, 2016, J ECON SURV, V30, P835, DOI 10.1111/joes.12118; Wachinger G., 2010, CAPHAZ NET CONSORTIU; Weiner B, 1996, PSYCHOL INQ, V7, P199, DOI 10.1207/s15327965pli0703_1; WHO, 2014, WHO FREQ ASK QUEST G; Wibeck V., 2002, GENETICALLY MODIFIED; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wohlers Anton E, 2010, Politics Life Sci, V29, P17, DOI 10.2990/29_2_17	92	0	0	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252580	10.1371/journal.pone.0252580	http://dx.doi.org/10.1371/journal.pone.0252580			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106960	gold, Green Published			2022-12-26	WOS:000664642200053
J	Dagne, H; Atnafu, A; Alemu, K; Azale, T; Yitayih, S; Dagnew, B; Maru Alemayehu, A; Andualem, Z; Mequanent Sisay, M; Tadesse, D; Hailu Chekol, S; Mengistu Mamo, E; Simegn, W				Dagne, Henok; Atnafu, Asmamaw; Alemu, Kassahun; Azale, Telake; Yitayih, Sewbesew; Dagnew, Baye; Maru Alemayehu, Abiy; Andualem, Zewudu; Mequanent Sisay, Malede; Tadesse, Demewoz; Hailu Chekol, Soliyana; Mengistu Mamo, Eyerusalem; Simegn, Wudneh			Anxiety and associated factors among Ethiopian health professionals at early stage of COVID-19 pandemic in Ethiopia	PLOS ONE			English	Article							CARE WORKERS; DISORDERS; PREVALENCE; COMORBIDITY; DEPRESSION; PREDICTORS; SEVERITY; STRESS	Introduction In late 2019, a new coronavirus disease known as COVID-19 (novel coronavirus disease 2019) was identified. As there is no any drug to treat this pandemic, the healthcare professionals are disproportionately at higher risk. The mental health outcome is expected to be high. Anxiety is expected to have a significant impact on health professionals, especially among those who work without adequate resources for self-protection. Objectives The objectives of this research was to assess self-reported anxiety symptoms and associated factors among Ethiopian healthcare professionals in the early stages of the pandemic. Methods We have conducted an online cross-sectional study to collect information from healthcare professionals in Ethiopia during the early stage of the outbreak from April 7, 2020 to May 19, 2020. GAD-7 was used for measurement of anxiety. We have used a cut of point of 10 and above to report anxiety symptoms. We have used Google Forms for online data collection and SPSS-22 for analysis. To determine associated factors for anxiety, a binary logistic regression model was used. Variables with p-value < 0.2 during the bivariable binary logistic regression were exported for further analysis in the multivariable binary logistic regression. Finally, variables with p-value <0.05 were considered as significantly associated with the outcomes. Results Three hundred and eighty-eight healthcare professionals filled the online questionnaire; Majority (71.1%) were males. Significant number of respondents (78.9%) reported lack of adequate personal protective equipment (PPE) at the work place. The prevalence of anxiety was 26.8%. Being female (AOR: 1.88; 95% C.I:1.11, 3.19), visiting/treating 30-150 patients per day (AOR: 3.44; 95% C.I:1.51, 7.84), those employed at private healthcare institutions (AOR: 2.40; 95% C.I:1.17, 4.90), who do not believe that COVID-19 is preventable (AOR: 2.04; 95% C.I:1.04, 4.03) and those who reported lack of PPE (AOR: 1.98; 95% C.I:1.04, 3.79) were more likely to be anxious. Conclusions The anxiety prevalence among healthcare professionals in Ethiopia during early stage of COVID-19 pandemic was high. This study shows that lack of preventive equipment, being female, contact with many patients, low self-efficacy and working in private health facilities were risk factors for anxiety. Anxiety prevention among health professionals during COVID-19 pandemic requires a holistic approach including provision of sufficient PPE, improving self-efficacy and addressing problems both at public and private institutions and focusing more on female health professionals.	[Dagne, Henok; Andualem, Zewudu] Univ Gondar, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Coll Med & Hlth Sci, Gondar, Ethiopia; [Atnafu, Asmamaw] Univ Gondar, Inst Publ Hlth, Dept Hlth Syst & Policy, Coll Med & Hlth Sci, Gondar, Ethiopia; [Alemu, Kassahun; Mequanent Sisay, Malede] Univ Gondar, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia; [Azale, Telake] Univ Gondar, Dept Hlth Educ & Behav Sci, Coll Med & Hlth Sci, Gondar, Ethiopia; [Yitayih, Sewbesew; Dagnew, Baye] Univ Gondar, Sch Med, Dept Psychiat, Coll Med & Hlth Sci, Gondar, Ethiopia; [Maru Alemayehu, Abiy] Univ Gondar, Sch Med, Dept Optometry, Coll Med & Hlth Sci, Gondar, Ethiopia; [Tadesse, Demewoz] Ethiopian Natl Blood Bank Serv, Addis Ababa, Ethiopia; [Hailu Chekol, Soliyana; Mengistu Mamo, Eyerusalem] Ghandi Mem Hosp, Addis Ababa, Ethiopia; [Simegn, Wudneh] Univ Gondar, Sch Pharm, Dept Pharmaceut, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar; University of Gondar	Dagne, H (corresponding author), Univ Gondar, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Coll Med & Hlth Sci, Gondar, Ethiopia.	enoch2313@gmail.com	Dagnew, Baye/AAS-3964-2021; Dagnew, Baye/AAL-9572-2020	Dagnew, Baye/0000-0002-2397-5930; Dagnew, Baye/0000-0002-2397-5930; Sisay, Malede Mequanent/0000-0002-8546-0959; Derso, Henok Dagne/0000-0001-7161-0904; Andualem, Zewudu/0000-0002-4731-1696				Adhikari SP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00646-x; Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092; Amstadter AB, 2016, SOC PSYCH PSYCH EPID, V51, P669, DOI 10.1007/s00127-015-1163-6; Arafa A, 2021, J AFFECT DISORDERS, V278, P365, DOI 10.1016/j.jad.2020.09.080; Bahrami F, 2011, IRAN J PSYCHIATRY BE, V5, P83; Barzilay R, 2020, TRANSL PSYCHIAT, V10, DOI 10.1038/s41398-020-00982-4; Bigalke JA, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00333-4; Burkova VN, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13074017; Cai HZ, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.924171; Chen J, 2021, SOC PSYCH PSYCH EPID, V56, P47, DOI 10.1007/s00127-020-01954-1; Choi EPH, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103740; da Silva Neto Raimundo Monteiro, 2021, Prog Neuropsychopharmacol Biol Psychiatry, V104, P110062, DOI 10.1016/j.pnpbp.2020.110062; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581, DOI 10.1001/jama.291.21.2581; Deng YY, 2021, ASIAN J PSYCHIATR, V56, DOI 10.1016/j.ajp.2021.102547; Domschke K, 2013, MOD TR PHARMACOPSYCH, V29, P24, DOI 10.1159/000351932; Du J, 2020, GEN HOSP PSYCHIAT, V67, P144, DOI 10.1016/j.genhosppsych.2020.03.011; Elhadi M, 2020, J PSYCHOSOM RES, V137, DOI 10.1016/j.jpsychores.2020.110221; Felmingham K, 2010, J ABNORM PSYCHOL, V119, P241, DOI 10.1037/a0017551; Gao WJ, 2020, J AFFECT DISORDERS, V263, P292, DOI 10.1016/j.jad.2019.11.121; Gilmour Heather, 2007, Health Rep, V18, P9; Guo J., 2020, PSYCHOL EFFECTS COVI; Guo XJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28033; Gupta AK, 2020, ASIAN J PSYCHIATR, V54, DOI 10.1016/j.ajp.2020.102260; Huang J Z, 2020, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V38, P192, DOI 10.3760/cma.j.cn121094-20200219-00063; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Liu CY, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820001107; Liu Y, 2021, J AFFECT DISORDERS, V278, P144, DOI 10.1016/j.jad.2020.09.004; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Malesza M, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110419; Mallet J, 2021, PROG NEURO-PSYCHOPH, V106, DOI 10.1016/j.pnpbp.2020.110070; Marvaldi M, 2021, NEUROSCI BIOBEHAV R, V126, P252, DOI 10.1016/j.neubiorev.2021.03.024; McLean CP, 2011, J PSYCHIATR RES, V45, P1027, DOI 10.1016/j.jpsychires.2011.03.006; Monterrosa-Castro A, 2020, J INVEST MED, V68, P1228, DOI 10.1136/jim-2020-001456; Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467; Nayak BS, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-044397; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Parkerson HA, 2015, J ANXIETY DISORD, V31, P38, DOI 10.1016/j.janxdis.2015.01.005; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Qiu JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100213; Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185; Sahebi A, 2021, PROG NEURO-PSYCHOPH, V107, DOI 10.1016/j.pnpbp.2021.110247; Sahin MK, 2020, J COMMUN HEALTH, V45, P1168, DOI 10.1007/s10900-020-00921-w; Sareen J, 2013, DEPRESS ANXIETY, V30, P321, DOI 10.1002/da.22077; Senga M, 2016, CLIN INFECT DIS, V63, P454, DOI 10.1093/cid/ciw327; Simonetti V, 2021, J CLIN NURS, V30, P1360, DOI 10.1111/jocn.15685; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tambs K, 2012, ACTA PSYCHIAT SCAND, V125, P203, DOI 10.1111/j.1600-0447.2011.01799.x; van Veen JF, 2009, INT J PSYCHIAT MED, V39, P283, DOI 10.2190/PM.39.3.e; Wang YN, 2021, PSYCHOL HEALTH MED, V26, P13, DOI 10.1080/13548506.2020.1746817; Wilson W, 2020, INDIAN J PSYCHOL MED, V42, P353, DOI 10.1177/0253717620933992; World Health Organization, NOV COR 2019 NCOV SI; Xiao X, 2020, J AFFECT DISORDERS, V274, P405, DOI 10.1016/j.jad.2020.05.081; Zhang CX, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.00306; Zheng RH, 2021, COMPR PSYCHIAT, V104, DOI 10.1016/j.comppsych.2020.152217	58	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252664	10.1371/journal.pone.0252664	http://dx.doi.org/10.1371/journal.pone.0252664			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RP	34101757	Green Published, gold			2022-12-26	WOS:000664641500021
J	Liu, GXH; Harding, JE				Liu, Gordon X. H.; Harding, Jane E.		the PIANO Study Team	Caregiver-reported health-related quality of life of New Zealand children born very and extremely preterm	PLOS ONE			English	Article							EMOTIONAL-PROBLEMS; MOTOR FUNCTION; BIRTH; IMPAIRMENT; INFANTS; MODEL	Background Children born preterm, particularly at earlier gestations, are at increased risk for mortality and morbidity, but later health-related quality of life (HRQoL) is less well described. Neurodevelopmental impairment and socio-economic status may also influence HRQoL. Our aim was to describe the HRQoL of a cohort of New Zealand children born very and extremely preterm, and how this is related to neurodevelopmental impairment, gestational age, and socio-economic deprivation. Methods Children born <30 weeks' gestation or <1500 g birthweight were assessed at 7 years' corrected age. Caregivers completed the Child Health Questionnaire Parent Form (CHQ-PF50), and the Health Utilities Index Mark 2 (HUI-2). Neurodevelopmental impairment was defined as Wechsler full scale intelligence quotient below -1 standard deviation (SD), Movement Assessment Battery for Children total score <= 15 percentile, cerebral palsy, deafness, or blindness. Results Data were collected for 127 children, of whom 60 (47%) had neurodevelopmental impairment. Overall, HRQoL was good: mean (SD) CHQ-PF50 physical summary score = 50.8 (11.1), psychosocial summary score = 49.3 (9.1) [normative mean 50 (10)]; HUI-2 dead-healthy scale = 0.92 (0.09) [maximum 1.0]. Neurodevelopmental impairment, lower gestational age, and higher socio-economic deprivation were all associated with reduced HRQoL. However, on multivariable analysis, only intelligence quotient and motor function were associated with psychosocial HRQoL, while intelligence quotient was associated with physical HRQoL. Conclusions Most seven-year-old children born very and extremely preterm have good HRQoL. Further improvements will require reduced neurodevelopmental impairment.	[Liu, Gordon X. H.; Harding, Jane E.; the PIANO Study Team] Univ Auckland, Liggins Inst, Auckland, New Zealand	University of Auckland	Harding, JE (corresponding author), Univ Auckland, Liggins Inst, Auckland, New Zealand.	j.harding@auckland.ac.nz	Harding, Jane/J-5853-2015	Harding, Jane/0000-0003-2697-1422; Liu, Gordon Xin Hua/0000-0002-4261-9683	Health Research Council of New Zealand [12-095]; Auckland District Health Board Charitable Trust [5486]; Aotearoa Foundation	Health Research Council of New Zealand(Health Research Council of New Zealand); Auckland District Health Board Charitable Trust; Aotearoa Foundation	Funding support was provided by the Health Research Council of New Zealand (12-095; https://www.hrc.govt.nz/), and the Auckland District Health Board Charitable Trust (5486). G.X. H.L. received internship funding from the Aotearoa Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson J., 2014, NZDEP2013 INDEX DEPR; Blencowe H, 2012, LANCET, V379, P2162, DOI 10.1016/S0140-6736(12)60820-4; Brostrom L, 2018, DEV MED CHILD NEUROL, V60, P826, DOI 10.1111/dmcn.13738; Burnett AC, 2019, J DEV BEHAV PEDIATR, V40, P200, DOI 10.1097/DBP.0000000000000646; Chow SW, 2013, REPORT AUSTR NZ NEON; Dathe AK, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7120276; Drukker M, 2003, SOC SCI MED, V57, P825, DOI 10.1016/S0277-9536(02)00453-7; Medina IMF, 2018, WOMEN BIRTH, V31, P325, DOI 10.1016/j.wombi.2017.11.008; French Phillip, 2008, DISABLED PEOPLE RIGH; Germain Nicola, 2019, J Mark Access Health Policy, V7, P1618661, DOI 10.1080/20016689.2019.1618661; Gire C, 2019, ARCH DIS CHILD, V104, P333, DOI 10.1136/archdischild-2018-315046; Goering S, 2015, CURR REV MUSCULOSKE, V8, P134, DOI 10.1007/s12178-015-9273-z; Haverman L, 2017, ARCH DIS CHILD, V102, P393, DOI 10.1136/archdischild-2015-310068; HealthActCHQ, 2013, CHQ SCOR INT MAN; Horsman John, 2003, Health Qual Life Outcomes, V1, P54, DOI 10.1186/1477-7525-1-54; Huhtala M, 2016, ACTA PAEDIATR, V105, P53, DOI 10.1111/apa.13241; Hung GCL, 2015, INT J EPIDEMIOL, V44, P1889, DOI 10.1093/ije/dyv303; Ministry of Health, 2017, 100012017 HISO MIN; Montagna A, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00080; Morris C, 2007, DEV MED CHILD NEUROL, V49, P3, DOI 10.1111/j.1469-8749.2007.tb12609.x; Palisano RJ, 2000, PHYS THER, V80, P974, DOI 10.1093/ptj/80.10.974; Potijk MR, 2015, EUR CHILD ADOLES PSY, V24, P787, DOI 10.1007/s00787-014-0623-y; Raat H, 2002, J CLIN EPIDEMIOL, V55, P67, DOI 10.1016/S0895-4356(01)00411-5; Ranger M, 2014, EUR J PAIN, V18, P844, DOI 10.1002/j.1532-2149.2013.00431.x; Reijneveld SA, 2006, ARCH DIS CHILD-FETAL, V91, pF423, DOI 10.1136/adc.2006.093674; Rogers CE, 2018, J NEURODEV DISORD, V10, DOI 10.1186/s11689-018-9253-x; Schmidt B, 2017, JAMA PEDIATR, V171, P564, DOI 10.1001/jamapediatrics.2017.0238; Spittle AJ, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-3410; Stahlmann N, 2009, NEUROPEDIATRICS, V40, P112, DOI 10.1055/s-0029-1243166; Taylor-Robinson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023163; Torchin H, 2020, SEMIN FETAL NEONAT M, V25, DOI 10.1016/j.siny.2020.101109; Tottman AC, 2020, J PEDIATR GASTR NUTR, V70, P72, DOI 10.1097/MPG.0000000000002471; Van Hus JW, 2014, DEV MED CHILD NEUROL, V56, P587, DOI 10.1111/dmcn.12295; Vargus-Adams J, 2005, ARCH PHYS MED REHAB, V86, P940, DOI 10.1016/j.apmr.2004.10.036; Vederhus BJ, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-53; Vella SA, 2014, J PEDIATR-US, V164, P1469, DOI 10.1016/j.jpeds.2014.01.071; Zhang YL, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1536-x	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0253026	10.1371/journal.pone.0253026	http://dx.doi.org/10.1371/journal.pone.0253026			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101760	gold, Green Published			2022-12-26	WOS:000664641500038
J	Poschenrieder, F; Meiler, S; Lubnow, M; Zeman, F; Rennert, J; Scharf, G; Schaible, J; Stroszczynski, C; Pfeifer, M; Hamer, OW				Poschenrieder, Florian; Meiler, Stefanie; Lubnow, Matthias; Zeman, Florian; Rennert, Janine; Scharf, Gregor; Schaible, Jan; Stroszczynski, Christian; Pfeifer, Michael; Hamer, Okka W.			Severe COVID-19 pneumonia: Perfusion analysis in correlation with pulmonary embolism and vessel enlargement using dual-energy CT data	PLOS ONE			English	Article								Background Gas exchange in COVID-19 pneumonia is impaired and vessel obstruction has been suspected to cause ventilation-perfusion mismatch. Dual-energy CT (DECT) can depict pulmonary perfusion by regional assessment of iodine uptake. Objective The purpose of this study was the analysis of pulmonary perfusion using dual-energy CT in a cohort of 27 consecutive patients with severe COVID-19 pneumonia. Method We retrospectively analyzed pulmonary perfusion with DECT in 27 consecutive patients (mean age 57 years, range 21-73; 19 men and 8 women) with severe COVID-19 pneumonia. Iodine uptake (IU) in regions-of-interest placed into normally aerated lung, ground-glass opacifications (GGO) and consolidations was measured using a dedicated postprocessing software. Vessel enlargement (VE) within opacifications and presence of pulmonary embolism (PE) was assessed by subjective analysis. Linear mixed models were used for statistical analyses. Results Compared to normally aerated lung 106/151 (70.2%) opacifications without upstream PE demonstrated an increased IU, 9/151 (6.0%) an equal IU and 36/151 (23.8%) a decreased IU. The estimated mean iodine uptake (EMIU) in opacifications without upstream PE (GGO 1.77 mg/mL; 95%-CI: 1.52-2.02; p = 0.011, consolidations 1.82 mg/mL; 95%-CI: 1.56-2.08, p = 0.006) was significantly higher compared to normal lung (1.22 mg/mL; 95%-CI: 0.95-1.49). In case of upstream PE, EMIU of opacifications (combined GGO and consolidations) was significantly decreased compared to normal lung (0.52 mg/mL; 95%-CI: -0.07-1.12; p = 0.043). The presence of VE in opacifications correlated significantly with iodine uptake (p<0.001). Conclusions DECT revealed the opacifications in a subset of patients with severe COVID-19 pneumonia to be perfused non-uniformly with some being hypo- and others being hyperperfused. Mean iodine uptake in opacifications (both ground-glass and consolidation) was higher compared to normally aerated lung except for areas with upstream pulmonary embolism. Vessel enlargement correlated with iodine uptake: In summary, in a cohort of 27 consecutive patients with severe COVID-19 pneumonia, dual-energy CT demonstrated a wide range of iodine uptake in pulmonary ground-glass opacifications and consolidations as a surrogate marker for hypo- and hyperperfusion compared to normally aerated lung. Applying DECT to determine which pathophysiology is predominant might help to tailor therapy to the individual patient<prime>s needs.	[Poschenrieder, Florian; Meiler, Stefanie; Rennert, Janine; Scharf, Gregor; Schaible, Jan; Stroszczynski, Christian; Hamer, Okka W.] Regensburg Univ Med Ctr, Dept Radiol, Regensburg, Germany; [Lubnow, Matthias; Pfeifer, Michael] Regensburg Univ Med Ctr, Dept Internal Med 2, Regensburg, Germany; [Zeman, Florian] Regensburg Univ Med Ctr, Ctr Clin Studies, Regensburg, Germany; [Pfeifer, Michael] Donaustauf Hosp, Dept Pneumol, Donaustauf, Germany; [Hamer, Okka W.] Donaustauf Hosp, Dept Radiol, Donaustauf, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Poschenrieder, F (corresponding author), Regensburg Univ Med Ctr, Dept Radiol, Regensburg, Germany.	florian.poschenrieder@ukr.de	Zeman, Florian/GNH-3239-2022					Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Archer SL, 2020, CIRCULATION, V142, P101, DOI 10.1161/CIRCULATIONAHA.120.047915; Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823; Bos LDJ, 2020, ANN AM THORAC SOC, V17, P1161, DOI 10.1513/AnnalsATS.202004-376RL; Caruso D, 2020, RADIOLOGY, V296, pE79, DOI 10.1148/radiol.2020201237; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Connors JM, 2020, J THROMB HAEMOST, V18, P1559, DOI 10.1111/jth.14849; Fuld MK, 2013, RADIOLOGY, V267, P747, DOI 10.1148/radiol.12112789; Gattinoni L, 2020, INTENS CARE MED, V46, P1099, DOI 10.1007/s00134-020-06033-2; Gattinoni L, 2020, AM J RESP CRIT CARE, V201, P1299, DOI 10.1164/rccm.202003-0817LE; Giannis D, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104362; Grillet F, 2020, QUANT IMAG MED SURG, V10, P1852, DOI 10.21037/qims-20-708; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Idilman IS, 2021, EUR RADIOL, V31, P1090, DOI 10.1007/s00330-020-07155-3; Klok FA, 2020, THROMB RES, V191, P145, DOI [10.1016/j.thromres.2020.04.013, 10.1016/j.thromres.2020.04.041]; Lang Min, 2020, Radiol Cardiothorac Imaging, V2, pe200277, DOI 10.1148/ryct.2020200277; Lang M, 2020, LANCET INFECT DIS, V20, P1365, DOI 10.1016/S1473-3099(20)30367-4; Llitjos JF, 2020, J THROMB HAEMOST, V18, P1743, DOI 10.1111/jth.14869; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Menter T, 2020, HISTOPATHOLOGY, V77, P198, DOI 10.1111/his.14134; Middeldorp S, 2020, J THROMB HAEMOST, V18, P1995, DOI 10.1111/jth.14888; Otrakji A, 2016, RADIOGRAPHICS, V36, P38, DOI 10.1148/rg.2016150081; Oudkerk M, 2020, RADIOLOGY, V297, pE216, DOI 10.1148/radiol.2020201629; Peiris JSM, 2003, LANCET, V361, P1767, DOI 10.1016/S0140-6736(03)13412-5; Qanadli Salah D, 2020, Radiol Cardiothorac Imaging, V2, pe200161, DOI 10.1148/ryct.2020200161; Ridge CA, DUAL ENERGY CT PULMO; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Saba L, 2020, J THORAC IMAG, V35, P344, DOI 10.1097/RTI.0000000000000530; Si-Mohamed S, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.02608-2020; Sinha P, 2020, JAMA INTERN MED, V180, P1152, DOI 10.1001/jamainternmed.2020.3313; Tacquard C, 2021, CHEST, V159, P2417, DOI 10.1016/j.chest.2021.01.017; Thieme SF, 2014, BRIT J RADIOL, V87, DOI 10.1259/bjr.20140079; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xiao L, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050491; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252478	10.1371/journal.pone.0252478	http://dx.doi.org/10.1371/journal.pone.0252478			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101734	Green Published, gold			2022-12-26	WOS:000664641500017
J	Vecoven, N; Ernst, D; Drion, G				Vecoven, Nicolas; Ernst, Damien; Drion, Guillaume			A bio-inspired bistable recurrent cell allows for long-lasting memory	PLOS ONE			English	Article							DYNAMICS	Recurrent neural networks (RNNs) provide state-of-the-art performances in a wide variety of tasks that require memory. These performances can often be achieved thanks to gated recurrent cells such as gated recurrent units (GRU) and long short-term memory (LSTM). Standard gated cells share a layer internal state to store information at the network level, and long term memory is shaped by network-wide recurrent connection weights. Biological neurons on the other hand are capable of holding information at the cellular level for an arbitrary long amount of time through a process called bistability. Through bistability, cells can stabilize to different stable states depending on their own past state and inputs, which permits the durable storing of past information in neuron state. In this work, we take inspiration from biological neuron bistability to embed RNNs with long-lasting memory at the cellular level. This leads to the introduction of a new bistable biologically-inspired recurrent cell that is shown to strongly improves RNN performance on time-series which require very long memory, despite using only cellular connections (all recurrent connections are from neurons to themselves, i.e. a neuron state is not influenced by the state of other neurons). Furthermore, equipping this cell with recurrent neuromodulation permits to link them to standard GRU cells, taking a step towards the biological plausibility of GRU. With this link, this work paves the way for studying more complex and biologically plausible neuromodulation schemes as gating mechanisms in RNNs.	[Vecoven, Nicolas; Ernst, Damien; Drion, Guillaume] Univ Liege, Inst Montefiore, Liege, Belgium	University of Liege	Vecoven, N (corresponding author), Univ Liege, Inst Montefiore, Liege, Belgium.	nvecoven@uliege.be			Belgian National Fund of Scientific Research	Belgian National Fund of Scientific Research(Fonds de la Recherche Scientifique - FNRS)	Nicolas Vecoven gratefully acknowledges the financial support of the Belgian National Fund of Scientific Research.	Abadi M., 2016, TENSORFLOW LARGE SCA; Barak O, 2017, CURR OPIN NEUROBIOL, V46, P1, DOI 10.1016/j.conb.2017.06.003; Bellec G, 2019, ARXIV PREPRINT ARXIV; Cho K., 2014, P SSST 8 8 WORKSH SY, P103, DOI DOI 10.3115/V1/W14-4012; Chung J., 2014, NIPS 2014 WORKSH DEE; Drion G, 2015, IEEE DECIS CONTR P, P1923, DOI 10.1109/CDC.2015.7402491; Drion G, 2015, P NATL ACAD SCI USA, V112, pE5361, DOI 10.1073/pnas.1516400112; Franca ACC, 2013, 2013 6TH INTERNATIONAL WORKSHOP ON COOPERATIVE AND HUMAN ASPECTS OF SOFTWARE ENGINEERING (CHASE), P9, DOI 10.1109/CHASE.2013.6614726; Golubitsky M., 2012, SINGULARITIES GROUPS, V1; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Jozefowicz R, 2015, PR MACH LEARN RES, V37, P2342; Lin Z., 2015, ARXIV PREPRINT ARXIV; Marder E, 1996, P NATL ACAD SCI USA, V93, P13481, DOI 10.1073/pnas.93.24.13481; Miconi T, 2017, ELIFE, V6, DOI 10.7554/eLife.20899; Pascanu Razvan, 2013, INT C MACH LEARN PML; Pfeiffer M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00774; Rib L, 2019, IEEE T CIRCUITS-I, V66, P3028, DOI 10.1109/TCSI.2019.2907113; Sussillo D, 2013, NEURAL COMPUT, V25, P626, DOI 10.1162/NECO_a_00409; Tavanaei A, 2019, NEURAL NETWORKS, V111, P47, DOI 10.1016/j.neunet.2018.12.002; Vecoven N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227922; Voelker A., 2019, ADV NEURAL INFORM PR, P15570; Zhou GB, 2016, INT J AUTOM COMPUT, V13, P226, DOI 10.1007/s11633-016-1006-2	25	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252676	10.1371/journal.pone.0252676	http://dx.doi.org/10.1371/journal.pone.0252676			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101750	Green Submitted, Green Published, gold			2022-12-26	WOS:000664641500022
J	Ely, T; Barber, PH; Man, L; Gold, Z				Ely, Taylor; Barber, Paul H.; Man, Lauren; Gold, Zachary			Short-lived detection of an introduced vertebrate eDNA signal in a nearshore rocky reef environment	PLOS ONE			English	Article							DNA; BIODIVERSITY; DEGRADATION; CAPTURE; FISH	Environmental DNA (eDNA) is increasingly used to measure biodiversity of marine ecosystems, yet key aspects of the temporal dynamics of eDNA remain unknown. Of particular interest is in situ persistence of eDNA signals in dynamic marine environments, as eDNA degradation rates have predominantly been quantified through mesocosm studies. To determine in situ eDNA residence times, we introduced an eDNA signal from a non-native fish into a protected bay of a Southern California rocky reef ecosystem, and then measured changes in both introduced and background eDNA signals across a fixed transect over 96 hours. Foreign eDNA signal was no longer detected only 7.5 hours after introduction, a time substantially shorter than the multi-day persistence times in laboratory studies. Moreover, the foreign eDNA signal spread along the entire 38 m transect within 1.5 hours after introduction, indicating that transport and diffusion play a role in eDNA detectability even in protected low energy marine environments. Similarly, native vertebrate eDNA signals varied greatly over the 96 hours of observation as well as within two additional nearby fixed transects sampled over 120 hours. While community structure did significantly change across time of day and tidal direction, neither accounted for the majority of observed variation. Combined, results show that both foreign and native eDNA signatures can exhibit substantial temporal heterogeneity, even on hourly time scales. Further work exploring eDNA decay from lagrangian perspective and quantifying effects of sample and technical replication are needed to better understand temporal variation of eDNA signatures in nearshore marine environments.	[Ely, Taylor; Barber, Paul H.; Man, Lauren; Gold, Zachary] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Ely, Taylor] Univ Hawaii Manoa, Sch Life Sci, Honolulu, HI 96822 USA	University of California System; University of California Los Angeles; University of Hawaii System; University of Hawaii Manoa	Ely, T (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.; Ely, T (corresponding author), Univ Hawaii Manoa, Sch Life Sci, Honolulu, HI 96822 USA.	tely@hawaii.edu		Ely, Taylor/0000-0002-8130-0616; , Lauren Man/0000-0001-9765-6783	National Geographic Young Explorer Grant [992916]; Catalyst Grant: UC Conservation Genomics Consortium [CA-16376437]; Resources Legacy Fund Foundation [12481]; US-NSF Graduate Research Fellowship [1650604]; UCLA Whitcome Research Undergraduate Summer Fellowship	National Geographic Young Explorer Grant(National Geographic Society); Catalyst Grant: UC Conservation Genomics Consortium; Resources Legacy Fund Foundation; US-NSF Graduate Research Fellowship(National Science Foundation (NSF)); UCLA Whitcome Research Undergraduate Summer Fellowship	ZG received the following awards to fund this research: National Geographic Young Explorer Grant (992916, https://www.nationalgeographic.org/funding-opportunities/grants/); Catalyst Grant: UC Conservation Genomics Consortium (CA-16376437, no website); and Resources Legacy Fund Foundation (12481, https://resourceslegacyfund.org/).Z.G.were supported by the US-NSF Graduate Research Fellowship, grant number DEG No. 1650604 (https://www.nsfgrfp.org/).TDE received the UCLA Whitcome Research Undergraduate Summer Fellowship (no grant number or website) to help fund this research. None of the funders played a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andruszkiewicz EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185043; Andruszkiewicz EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176343; Barnes MA, 2014, ENVIRON SCI TECHNOL, V48, P1819, DOI 10.1021/es404734p; Bessey C., 2020, ENV DNA, V2, P493, DOI [10.1002/edn3.74, DOI 10.1002/EDN3.74]; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Caldeira RMA, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002675; Curd EE, 2019, METHODS ECOL EVOL, V10, P1469, DOI 10.1111/2041-210X.13214; Deiner K, 2017, METHODS ECOL EVOL, V8, P1888, DOI 10.1111/2041-210X.12836; Dell'Anno A, 2004, APPL ENVIRON MICROB, V70, P4384, DOI 10.1128/AEM.70.7.4384-4386.2004; Doi H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40233-1; Evans NT, 2016, MOL ECOL RESOUR, V16, P29, DOI 10.1111/1755-0998.12433; Faircloth B., 2014, WEB DOC, V10, pJ9MW2F26; Gao X, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1670-4; Godang R, 1997, PHYS REV LETT, V79, P3829, DOI 10.1103/PhysRevLett.79.3829; Gold Z, 2020, AUTHOREA, P1; Gold Z, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0238557; Goldberg CS, 2016, METHODS ECOL EVOL, V7, P1299, DOI 10.1111/2041-210X.12595; Hartney KB, 1996, J FISH BIOL, V49, P1062; Hsieh TC, 2016, METHODS ECOL EVOL, V7, P1451, DOI 10.1111/2041-210X.12613; Jo T, 2019, ECOL EVOL, V9, P1135, DOI 10.1002/ece3.4802; Kandlikar Gaurav S, 2018, F1000Res, V7, P1734, DOI 10.12688/f1000research.16680.1; Katija K, 2012, J EXP BIOL, V215, P1040, DOI 10.1242/jeb.059279; Katija K, 2009, NATURE, V460, P624, DOI 10.1038/nature08207; Kelly RP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48546-x; Kelly RP, 2018, PEERJ, V6, DOI 10.7717/peerj.4521; Kelly RP, 2016, PEERJ, V4, DOI 10.7717/peerj.2444; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Kushner D, 2013, ECOLOGY, V94; Lubchenco J., 2002, PISCO; Manter DK, 2010, APPL ENVIRON MICROB, V76, P2086, DOI 10.1128/AEM.03017-09; Marotz C, 2019, BIOTECHNIQUES, V67, P29, DOI 10.2144/btn-2018-0192; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Miya M, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150088; Murakami H, 2019, FISHERIES SCI, V85, P327, DOI 10.1007/s12562-018-1282-6; Nguyen BN, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63565-9; Nichols PK, 2019, RAPID ASSESSMENT COR; O'Donnell JL, 2017, PEERJ, V5, DOI 10.7717/peerj.3044; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Port JA, 2016, MOL ECOL, V25, P527, DOI 10.1111/mec.13481; R Core Team, 2021, R LANGUAGE ENV STAT; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Sassoubre LM, 2016, ENVIRON SCI TECHNOL, V50, P10456, DOI 10.1021/acs.est.6b03114; Shogren AJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05223-1; Shuman C., 2015, REEF CHECK CALIFORNI, V8th Edition; Spens J, 2017, METHODS ECOL EVOL, V8, P635, DOI 10.1111/2041-210X.12683; Stock A, 2018, CONSERV BIOL, V32, P1368, DOI 10.1111/cobi.13141; Stoeckle MY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175186; Thomas L.N., 2008, OCEAN MODEL EDDY REG, P177, DOI [DOI 10.1029/177GM04, 10.1029/177gm04]; Thomsen P., 2016, QATAR FDN ANN RES C; Thomsen PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041732; Tillotson MD, 2018, BIOL CONSERV, V220, P1, DOI 10.1016/j.biocon.2018.01.030; Turner CR, 2014, METHODS ECOL EVOL, V5, P676, DOI 10.1111/2041-210X.12206; Usseglio Paolo, 2015, P270; Valentini A, 2016, MOL ECOL, V25, P929, DOI 10.1111/mec.13428; Willette DA, 2017, CONSERV BIOL, V31, P1076, DOI 10.1111/cobi.12888; Yamamoto S, 2017, SCI REP-UK, V7, DOI 10.1038/srep40368	57	5	5	5	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0245314	10.1371/journal.pone.0245314	http://dx.doi.org/10.1371/journal.pone.0245314			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086697	Green Published, gold			2022-12-26	WOS:000664640100004
J	Lim, TZ; Lau, J; Wong, GJ; Tan, KK				Lim, Tian Zhi; Lau, Jerrald; Wong, Gretel Jianlin; Tan, Ker-Kan			Colorectal cancer in patients with single versus double positive faecal immunochemical test results: A retrospective cohort study from a public tertiary hospital	PLOS ONE			English	Article								Background Screening for colorectal cancer (CRC) using the faecal immunochemical test (FIT) is widely advocated. Few studies have compared the rate of detecting colonoscopic pathologies in single compared to double FIT-positive follow-up colonoscopy-compliant individuals in a two-sample national FIT screening program. Objective To compare CRC incidence in double FIT-positive versus single FIT-positive individuals using a retrospective cohort of patients from a tertiary hospital in Singapore. Design Retrospective cohort study. Setting Data was extracted from one public tertiary hospital in Singapore. Participants 1,422 FIT-positive individuals from the national FIT screening program who were referred to the hospital from 1st January 2017 to 31st March 2020 for follow-up consultation and diagnostic colonoscopy. Measurements The exposure of interest was a positive result on both FIT kits. The main outcome was a follow-up diagnostic colonoscopy finding of CRC. The secondary outcome was a diagnostic colonoscopy finding of a colorectal polyp. Results Incidence density of CRC was 1.15 and 13.10 per 100,000 person-months, in the single and double FIT-positive group, respectively. This resulted in an incidence rate ratio of 11.40 (95% CI = 4.34, 35.09). Colorectal polyp detection was significantly higher (p < 0.01) in the double (103 of 173 participants; 59.5%) compared to the single (279 of 671 participants; 41.6%) FIT-positive group. Limitations The key limitation of this study was the relatively small cohort derived from a single tertiary hospital, as this had the effect of limiting the number of incident cases, resulting in comparatively imprecise CIs. Conclusions Double FIT-positive individuals are significantly more likely to have a colonoscopy finding of incident CRC or premalignant polyp than single FIT-positive individuals. Clinicians and policymakers should consider updating their CRC screening protocols accordingly.	[Lim, Tian Zhi; Tan, Ker-Kan] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Lau, Jerrald; Wong, Gretel Jianlin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore	National University of Singapore; National University of Singapore	Tan, KK (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore.	surtkk@nus.edu.sg	Lau, Jerrald/AAE-8411-2022	Lau, Jerrald/0000-0002-3872-6371; Lim, Tian zhi/0000-0002-3940-4147	Singapore Population Health Improvement Centre (SPHERiC) [NMRC/CG/C026/2017_NUHS]	Singapore Population Health Improvement Centre (SPHERiC)	This study was supported by the Singapore Population Health Improvement Centre (SPHERiC) [NMRC/CG/C026/2017_NUHS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chan PWW, 2017, SINGAP MED J, V58, P24, DOI 10.11622/smedj.2017004; Dalton ARH, 2018, J PUBLIC HEALTH-UK, V40, pE46, DOI 10.1093/pubmed/fdw147; Goede SL, 2013, GUT, V62, P727, DOI 10.1136/gutjnl-2011-301917; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Moosavi S, 2016, CAN J GASTROENTEROL, V2016, DOI 10.1155/2016/5914048; Navarro M, 2017, WORLD J GASTROENTERO, V23, P3632, DOI 10.3748/wjg.v23.i20.3632; Statistics Singapore, 2010, GEOGRAPHIC DISTRIBUT	7	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0250460	10.1371/journal.pone.0250460	http://dx.doi.org/10.1371/journal.pone.0250460			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086681	gold, Green Submitted, Green Published			2022-12-26	WOS:000664640100011
J	Spoormakers, TJP; Graat, EAM; Braganca, FMS; van Weeren, PR; Brommer, H				Spoormakers, T. J. P.; Graat, E. A. M.; Braganca, F. M. Serra; van Weeren, P. R.; Brommer, H.			Rater agreement for assessment of equine back mobility at walk and trot compared to quantitative gait analysis	PLOS ONE			English	Article							BASIC 3-DIMENSIONAL KINEMATICS; SUBJECTIVE EVALUATION; HINDLIMB LAMENESS; VERTEBRAL COLUMN; RELIABILITY	Background Lameness assessment in horses is still predominantly performed using subjective methods. Visual assessment is known to have moderate to good intra-rater agreement but relatively poor inter-rater agreement. Little is known about inter- and intra-rater agreement on the evaluation of back motion, for which no objective measurement technique in a clinical setting is available thus far. Objectives To describe inter- and intra-rater agreement of visual evaluation of equine back mobility. Study design Rater reliability study using a fully crossed design in which all horses are rated by all observers. This data is compared with objective gait analysis. Methods Seventy equine professionals (veterinarians and physiotherapists) and veterinary students evaluated videos of 12 healthy horses at walk and trot on a hard, straight line. Nine parameters related to back mobility were scored: general mobility, thoracic, lumbar, lumbosacral flexion and extension and left and right thoracolumbar latero-flexion. All parameters were compared with simultaneously measured quantitative motion parameters. After 1 month, six randomly chosen horses were re-evaluated by 57 observers. Results For each parameter inter- and intra-rater agreements were calculated using intra-class correlation coefficients. For all parameters, inter-rater agreement was very poor (<0.2). The mean intra-rater agreement of all observers and for all parameters was poor (similar to 0.4) but varied between 0.0 and 0.96 for individual observers. There was no correlation between the visual subjective scoring and objective gait analysis measurements. Main limitations Horses were scored from videos and by lack of any existing (semi-) quantitative system, a custom-made system had to be used. Conclusions The poor inter- and intra-rater agreements of visual scoring of mobility of the equine back and the disagreement between subjective and objective gait analysis data, demonstrate the need for the development and introduction of objective, quantitative and repeatable techniques to assess equine back motion.	[Spoormakers, T. J. P.; Braganca, F. M. Serra; van Weeren, P. R.; Brommer, H.] Univ Utrecht, Equine Div, Dept Clin Sci, Fac Vet Med, Utrecht, Netherlands; [Graat, E. A. M.] Wageningen Univ & Res, Dept Anim Sci, Adaptat Physiol, Wageningen, Netherlands	Utrecht University; Wageningen University & Research	Spoormakers, TJP (corresponding author), Univ Utrecht, Equine Div, Dept Clin Sci, Fac Vet Med, Utrecht, Netherlands.	T.J.P.Spoormakers@uu.nl		Spoormakers, Tijn/0000-0001-5093-0458				Arkell M, 2006, VET REC, V159, P346, DOI 10.1136/vr.159.11.346; Braganca PMS, 2018, VET J, V234, P11, DOI 10.1016/j.tvjl.2018.01.006; Brunnekreef JJ, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-17; Denoix JMD, 1999, VET CLIN N AM-EQUINE, V15, P27; Faber M, 2001, Equine Vet J Suppl, P145; Faber M, 2001, AM J VET RES, V62, P757, DOI 10.2460/ajvr.2001.62.757; Faber M, 2000, AM J VET RES, V61, P399, DOI 10.2460/ajvr.2000.61.399; Fuller CJ, 2006, VET J, V171, P281, DOI 10.1016/j.tvjl.2004.10.012; Hammarberg M, 2016, EQUINE VET J, V48, P78, DOI 10.1111/evj.12385; Hardeman AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0222822; Hermet A, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2173-9; JEFFCOTT LB, 1980, EQUINE VET J, V12, P101, DOI 10.1111/j.2042-3306.1980.tb03393.x; Johnston C, 2002, EQUINE VET J, V34, P314, DOI 10.2746/042516402776186010; Keegan KG, 2010, EQUINE VET J, V42, P92, DOI 10.2746/042516409X479568; Keegan KG, 2013, AM J VET RES, V74, P17, DOI 10.2460/ajvr.74.1.17; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; KREBS DE, 1985, PHYS THER, V65, P1027, DOI 10.1093/ptj/65.7.1027; Leelamankong P, 2020, EQUINE VET J, V52, P326, DOI 10.1111/evj.13144; Parkes RSV, 2009, EQUINE VET J, V41, P112, DOI 10.2746/042516408X343000; Peham C, 2001, VET REC, V148, P750, DOI 10.1136/vr.148.24.750; Rhodin M, 2013, VET J, V198, pE39, DOI 10.1016/j.tvjl.2013.09.031; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252536	10.1371/journal.pone.0252536	http://dx.doi.org/10.1371/journal.pone.0252536			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086765	gold, Green Published			2022-12-26	WOS:000664640100081
J	Egri, SB; Shen, K				Egri, Shawn B.; Shen, Kuang			An interdomain hydrogen bond in the Rag GTPases maintains stable mTORC1 signaling in sensing amino acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; COMPLEX REVEALS; TORC1	Cellular growth and proliferation are primarily dictated by the mechanistic target of rapamycin complex 1 (mTORC1), which balances nutrient availability against the cell's anabolic needs. Central to the activity of mTORC1 is the RagA-RagC GTPase heterodimer, which under favorable conditions recruits the complex to the lysosomal surface to promote its activity. The RagA-RagC heterodimer has a unique architecture in that both subunits are active GTPases. To promote mTORC1 activity, the RagA subunit is loaded with GTP and the RagC subunit is loaded with GDP, while the opposite nucleotide-loading configuration inhibits this signaling pathway. Despite its unique molecular architecture, how the Rag GTPase heterodimer maintains the oppositely loaded nucleotide state remains elusive. Here, we applied structure-function analysis approach to the crystal structures of the Rag GTPase heterodimer and identified a key hydrogen bond that stabilizes the GDP-loaded state of the Rag GTPases. This hydrogen bond is mediated by the backbone carbonyl of Asn30 in the nucleotide-binding domain of RagA or Lys84 of RagC and the hydroxyl group on the side chain of Thr210 in the C-terminal roadblock domain of RagA or Ser266 of RagC, respectively. Eliminating this interdomain hydrogen bond abolishes the ability of the Rag GTPase to maintain its functional state, resulting in a distorted response to amino acid signals. Our results reveal that this long-distance interdomain interaction within the Rag GTPase is required for the maintenance and regulation of the mTORC1 nutrient-sensing pathway.	[Egri, Shawn B.; Shen, Kuang] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Shen, K (corresponding author), Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA.	kuang.Shen@umassmed.edu			NIH [K22CA241362]; 2020 Mello Scholarship of the Program in Molecular Medicine	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2020 Mello Scholarship of the Program in Molecular Medicine	This work was supported by a Grant from the NIH (K22CA241362) to K. S. S. B. E. was supported by the 2020 Mello Scholarship of the Program in Molecular Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anandapadamanaban M, 2019, SCIENCE, V366, P203, DOI 10.1126/science.aax3939; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jeong JH, 2012, J BIOL CHEM, V287, P29648, DOI 10.1074/jbc.C112.384420; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Rogala KB, 2019, SCIENCE, V366, P468, DOI 10.1126/science.aay0166; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shen K, 2017, MOL CELL, V68, P552, DOI 10.1016/j.molcel.2017.09.026; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361	12	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100861	10.1016/j.jbc.2021.100861	http://dx.doi.org/10.1016/j.jbc.2021.100861			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34116056	Green Published, gold			2022-12-26	WOS:000678068400061
J	Pascarelli, S; Merzhakupova, D; Uechi, GI; Laurino, P				Pascarelli, Stefano; Merzhakupova, Dalmira; Uechi, Gen-Ichiro; Laurino, Paola			Binding of single-mutant epidermal growth factor (EGF) ligands alters the stability of the EGF receptor dimer and promotes growth signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFICITY-DETERMINING RESIDUES; TIME-RESOLVED FLUORESCENCE; INDUCED APOPTOSIS; A431 CELLS; PROTEIN; KINASE; ACTIVATION; ALGORITHM; SELECTION; MODEL	The epidermal growth factor receptor (EGFR) is a membrane-anchored tyrosine kinase that is able to selectively respond to multiple extracellular stimuli. Previous studies have indicated that the modularity of this system may be caused by ligand-induced differences in the stability of the receptor dimer. However, this hypothesis has not been explored using single-mutant ligands thus far. Herein, we developed a new approach to identify residues responsible for functional divergence by selecting residues in the epidermal growth factor (EGF) ligand that are conserved among orthologs yet divergent between paralogs. Then, we mutated these residues and assessed the mutants' effects on the receptor using a combination of molecular dynamics (MD) and biochemical techniques. Although the EGF mutants had binding affinities for the EGFR comparable with the WT ligand, the EGF mutants showed differential patterns of receptor phosphorylation and cell growth in multiple cell lines. The MD simulations of the EGF mutants indicated that mutations had long-range effects on the receptor dimer interface. This study shows for the first time that a single mutation in the EGF is sufficient to alter the activation of the EGFR signaling pathway at the cellular level. These results also support that biased ligand-receptor signaling in the tyrosine kinase receptor system can lead to differential downstream outcomes and demonstrate a promising new method to study ligand-receptor interactions.	[Pascarelli, Stefano; Merzhakupova, Dalmira; Uechi, Gen-Ichiro; Laurino, Paola] Okinawa Inst Sci & Technol Grad Univ, Prot Engn & Evolut Unit, Onna, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Laurino, P (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Prot Engn & Evolut Unit, Onna, Okinawa, Japan.	paola.laurino@oist.jp			Okinawa Institute of Science and Technology	Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University)	Financial support by the Okinawa Institute of Science and Technology to P. L. is gratefully acknowledged.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ali R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1034-7; Alvarez-Ponce D, 2017, GENOME BIOL EVOL, V9, P1742, DOI 10.1093/gbe/evx117; Arkhipov A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003742; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bakker J, 2017, J CELL SCI, V130, P4087, DOI 10.1242/jcs.209197; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016536; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Chagoyen M, 2016, BRIEF BIOINFORM, V17, P255, DOI 10.1093/bib/bbv045; Chakrabarti S, 2007, J MOL BIOL, V373, P801, DOI 10.1016/j.jmb.2007.08.036; Colell EA, 2018, NUCLEIC ACIDS RES, V46, pW323, DOI 10.1093/nar/gky419; DELASIERRA IML, 1992, EUR BIOPHYS J BIOPHY, V21, P337, DOI 10.1007/BF00188346; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; GALLAY J, 1993, EUR J BIOCHEM, V211, P213, DOI 10.1111/j.1432-1033.1993.tb19888.x; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gocheva G, 2019, MOL PHARMACEUT, V16, P3293, DOI 10.1021/acs.molpharmaceut.9b00250; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Grudinkin PS, 2007, EUR J CELL BIOL, V86, P591, DOI 10.1016/j.ejcb.2007.05.009; Gulli LF, 1996, CELL GROWTH DIFFER, V7, P173; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOMMEL U, 1992, J MOL BIOL, V227, P271, DOI 10.1016/0022-2836(92)90697-I; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibuka S, 2015, J CELL SCI, V128, P2156, DOI 10.1242/jcs.169060; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Knudsen SLJ, 2014, GROWTH FACTORS, V32, P155, DOI 10.3109/08977194.2014.952410; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lahti JL, 2011, FEBS LETT, V585, P1135, DOI 10.1016/j.febslet.2011.03.044; Laisney JAGC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-27; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Lemkul J, 2019, LIVING J COMPUT MOL, V1, P5068, DOI [10.33011/livecoms.1.1.5068, DOI 10.33011/LIVECOMS.1.1.5068]; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lindvall C, 2003, CANCER RES, V63, P1743; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Mehrabi M, 2018, INT J BIOL MACROMOL, V115, P401, DOI 10.1016/j.ijbiomac.2018.04.066; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; Nemoto W, 2013, COMPUT STRUCT BIOTEC, V8, DOI 10.5936/csbj.201308007; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Puddicombe SM, 1996, J BIOL CHEM, V271, P30392, DOI 10.1074/jbc.271.48.30392; Puddicombe SM, 1996, J BIOL CHEM, V271, P15367, DOI 10.1074/jbc.271.26.15367; Purba ER, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020013; Skwark MJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003889; Souriau C, 1999, BIOL CHEM, V380, P451, DOI 10.1515/BC.1999.059; Spielman SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139047; Strachan L, 2001, J BIOL CHEM, V276, P18265, DOI 10.1074/jbc.M006935200; Teppa E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-235; Turk HF, 2015, METHODS MOL BIOL, V1233, P25, DOI 10.1007/978-1-4939-1789-1_3; Tynan CJ, 2011, MOL CELL BIOL, V31, P2241, DOI 10.1128/MCB.01431-10; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Xie G, 2002, GENOME BIOL, V3; Xu MJ, 2017, CANCER METAST REV, V36, P463, DOI 10.1007/s10555-017-9687-8; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhou JQ, 2017, MOL PHYLOGENET EVOL, V113, P126, DOI 10.1016/j.ympev.2017.05.010	72	1	1	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100872	10.1016/j.jbc.2021.100872	http://dx.doi.org/10.1016/j.jbc.2021.100872			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34126069	gold, Green Published, Green Submitted			2022-12-26	WOS:000678068400072
J	Hater, L; Schulte, J; Geukes, K; Buhlmann, U; Back, MD				Hater, Leonie; Schulte, Johanna; Geukes, Katharina; Buhlmann, Ulrike; Back, Mitja D.			Disentangling the contributions of agentic, antagonistic, and neurotic narcissism to drive for thinness and drive for muscularity	PLOS ONE			English	Article							BODY-IMAGE CONCERNS; EATING-DISORDER INVENTORY; CONTINGENT SELF-ESTEEM; HYPERSENSITIVE NARCISSISM; PATHOLOGICAL NARCISSISM; CULTURAL EXPECTATIONS; SHORT VERSION; RISK-FACTOR; WOMEN; IDEAL	Body image concerns revolving around body ideals (thin ideal, muscular ideal) are widespread among women. Whereas a stronger preoccupation with ideal physical appearance is often assumed for narcissistic women, previous empirical findings have been mixed. Following a tripartite structure of agentic, antagonistic, and neurotic narcissism facets, we reexamined whether trait narcissism predicted drive for thinness and drive for muscularity. We further explored the role of importance of appearance as a mediator and moderator of the relation between narcissism and body image concerns. Latent structural equation modeling was applied to self-report data from two independent nonclinical female samples (N-Sample1 = 224, N-Sample2 = 342). Results underlined the importance of distinguishing between narcissism facets: Neurotic (but not agentic or antagonistic) narcissism uniquely predicted drive for thinness and drive for muscularity. Importance of appearance mediated but did not robustly moderate these relations. Hence, neurotic narcissistic women (characterized by hypersensitivity, shame, and a fragile self-esteem) are particularly prone to body image concerns. This vulnerability seems partly driven by how much importance they ascribe to their appearance. Future work might build on these insights to further unravel the processes linking neurotic narcissism to body image concerns and how these can be targeted in practical interventions.	[Hater, Leonie; Schulte, Johanna; Geukes, Katharina; Buhlmann, Ulrike; Back, Mitja D.] Univ Munster, Inst Psychol, Munster, Germany	University of Munster	Hater, L (corresponding author), Univ Munster, Inst Psychol, Munster, Germany.	leonie.hater@uni-muenster.de		Schulte, Johanna/0000-0001-9795-1168; Hater, Leonie/0000-0001-6108-4461				[Anonymous], 2013, DIAGNOSTIC STAT MANU, V5th, P947; Ata RN, 2010, OBESITY FACTS, V3, P41, DOI 10.1159/000276547; Back M. D., 2018, HDB TRAIT NARCISSISM, P57, DOI [10.1007/978-3-319-92171-6_6, DOI 10.1007/978-3-319-92171-6_6]; Back M. D., ENCY PERSONALITY IND; Back MD, 2013, J PERS SOC PSYCHOL, V105, P1013, DOI 10.1037/a0034431; Bardone-Cone AM, 2020, J PERS, V88, P59, DOI 10.1111/jopy.12448; Bollen KA, 2002, ANNU REV PSYCHOL, V53, P605, DOI 10.1146/annurev.psych.53.100901.135239; Boothroyd LG, 2020, J PERS SOC PSYCHOL, V119, P839, DOI 10.1037/pspi0000224; Bozsik F, 2018, SEX ROLES, V79, P609, DOI 10.1007/s11199-017-0886-0; Brunton JN, 2005, J NERV MENT DIS, V193, P140, DOI 10.1097/01.nmd.0000152784.01448.fe; Buote VM, 2011, BODY IMAGE, V8, P322, DOI 10.1016/j.bodyim.2011.06.002; Cain NM, 2008, CLIN PSYCHOL REV, V28, P638, DOI 10.1016/j.cpr.2007.09.006; Campbell WK, 2000, J RES PERS, V34, P329, DOI 10.1006/jrpe.2000.2282; Carlson E.N., 2018, HDB TRAIT NARCISSISM, P275, DOI [10.1007/978-3-319-92171-6_29, DOI 10.1007/978-3-319-92171-6_29]; Carrotte E, 2019, SEX ROLES, V80, P458, DOI 10.1007/s11199-018-0948-y; Cash T. F., 2012, ENCY BODY IMAGE HUMA, P334, DOI DOI 10.1016/B978-0-12-384925-0.00054-7; Cash TF, 2004, INT J EAT DISORDER, V35, P305, DOI 10.1002/eat.10264; Chopik WJ, 2019, PSYCHOL AGING, V34, P1109, DOI 10.1037/pag0000379; Cohen R, 2017, BODY IMAGE, V23, P183, DOI 10.1016/j.bodyim.2017.10.002; Corral S., 1998, EDI 2 INVENTARIO TRA; Crocker J, 2003, J PERS SOC PSYCHOL, V85, P894, DOI 10.1037/0022-3514.85.5.894; Crowe ML, 2019, J PERS, V87, P1151, DOI 10.1111/jopy.12464; Cunningham ML, 2019, INT J EAT DISORDER, V52, P1326, DOI 10.1002/eat.23178; Davis C, 2005, PERS INDIV DIFFER, V39, P349, DOI 10.1016/j.paid.2005.01.013; Davis C, 2000, INT J EAT DISORDER, V27, P67, DOI 10.1002/(SICI)1098-108X(200001)27:1<67::AID-EAT7>3.3.CO;2-6; Fikkan JL, 2012, SEX ROLES, V66, P575, DOI 10.1007/s11199-011-0022-5; Forman-Hoffman Valerie, 2004, Eat Behav, V5, P325, DOI 10.1016/j.eatbeh.2004.04.003; Foster JD, 2003, J RES PERS, V37, P469, DOI 10.1016/S0092-6566(03)00026-6; Frederick DA, 2017, BODY IMAGE, V23, P188, DOI 10.1016/j.bodyim.2017.10.006; Garcia-Garduno JM., 1998, PSICOTHEMA, V10, P725; GARNER DM, 1980, PSYCHOL REP, V47, P483, DOI 10.2466/pr0.1980.47.2.483; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Garner DM, 1991, EATING DISORDER INVE; Girard M, 2018, BODY IMAGE, V26, P103, DOI 10.1016/j.bodyim.2018.07.001; Glover N, 2012, J PERS ASSESS, V94, P500, DOI 10.1080/00223891.2012.670680; Gordon KH, 2010, EAT BEHAV, V11, P288, DOI 10.1016/j.eatbeh.2010.08.004; Grabe S, 2008, PSYCHOL BULL, V134, P460, DOI 10.1037/0033-2909.134.3.460; Grocholewski A, 2011, Z KL PSYCH PSYCHOTH, V40, P85, DOI 10.1026/1616-3443/a000078; Groesz LM, 2002, INT J EAT DISORDER, V31, P1, DOI 10.1002/eat.10005; Grossbard J, 2009, SEX ROLES, V60, P198, DOI 10.1007/s11199-008-9535-y; Hartmann AS, 2018, J CLIN SPORT PSYCHOL, V12, P544, DOI 10.1123/jcsp.2018-0022; Hendin HM, 1997, J RES PERS, V31, P588, DOI 10.1006/jrpe.1997.2204; Hilbert A, 2012, PSYCHOTHER PSYCH MED, V62, P139, DOI 10.1055/s-0032-1306315; Hoffmann S, 2019, BODY IMAGE, V28, P159, DOI 10.1016/j.bodyim.2019.01.011; Holdren M., 2004, THESIS OHIO U OHIO; Horvath S, 2010, J RES PERS, V44, P585, DOI 10.1016/j.jrp.2010.07.002; JACKSON LA, 1992, J RES PERS, V26, P357, DOI 10.1016/0092-6566(92)90065-C; Jauk E., 2021, VALIDATION GERMAN 5; Johnson CL., 1989, J COLL STUD PSYCHOTH, V3, P57, DOI [10.1300/J035v03n02_06, DOI 10.1300/J035V03N02_06]; Kelley CC, 2010, BODY IMAGE, V7, P74, DOI 10.1016/j.bodyim.2009.09.008; Kline RB., 2016, PRINCIPLES PRACTICE, P554; Krizan Z, 2018, PERS SOC PSYCHOL REV, V22, P3, DOI 10.1177/1088868316685018; Lang B, 2020, EAT WEIGHT DISORD-ST, V25, P1213, DOI 10.1007/s40519-019-00753-1; Lin GC, 2010, STRUCT EQU MODELING, V17, P374, DOI 10.1080/10705511.2010.488999; Littrell C.K., 2021, J MENS STUD, V29, P118, DOI [10.1177/1060826520918323, DOI 10.1177/1060826520918323]; Low KG, 2003, SOC BEHAV PERSONAL, V31, P81, DOI 10.2224/sbp.2003.31.1.81; Maples J, 2011, EAT BEHAV, V12, P83, DOI 10.1016/j.eatbeh.2010.10.001; Maslowsky J, 2015, INT J BEHAV DEV, V39, P87, DOI 10.1177/0165025414552301; McCreary DR, 2000, J AM COLL HEALTH, V48, P297, DOI 10.1080/07448480009596271; MCDONALD K, 1992, INT J EAT DISORDER, V11, P289, DOI 10.1002/1098-108X(199204)11:3&lt;289::AID-EAT2260110314&gt;3.0.CO;2-F; Miller JD, 2017, ANNU REV CLIN PSYCHO, V13, P291, DOI 10.1146/annurev-clinpsy-032816-045244; Miller JD, 2016, J PERS DISORD, V30, P1, DOI 10.1521/pedi_2015_29_177; Miller JD, 2011, J PERS, V79, P1013, DOI 10.1111/j.1467-6494.2010.00711.x; Mitchell L, 2017, SPORTS MED, V47, P233, DOI 10.1007/s40279-016-0564-3; Morf CC, 2017, ASSESSMENT, V24, P419, DOI 10.1177/1073191115627010; MORF CC, 1993, PERS SOC PSYCHOL B, V19, P668, DOI 10.1177/0146167293196001; Morf CC, 2001, PSYCHOL INQ, V12, P177, DOI 10.1207/S15327965PLI1204_1; Murray SB, 2016, BODY IMAGE, V16, P17, DOI 10.1016/j.bodyim.2015.10.002; Oberg P., 2001, J AGING IDENTITY, V6, P15, DOI [10.1023/a:1009524612420, DOI 10.1023/A:1009524612420]; Olivardia R, 2001, HARVARD REV PSYCHIAT, V9, P254, DOI 10.1080/713854919; Oosthuizen P, 1998, AUST NZ J PSYCHIAT, V32, P129, DOI 10.3109/00048679809062719; Overstreet NM, 2012, PSYCHOL WOMEN QUART, V36, P314, DOI 10.1177/0361684311435221; Perloff RM, 2014, SEX ROLES, V71, P363, DOI 10.1007/s11199-014-0384-6; Pincus AL, 2009, PSYCHOL ASSESSMENT, V21, P365, DOI 10.1037/a0016530; Polivy J, 2004, J SOC CLIN PSYCHOL, V23, P1, DOI 10.1521/jscp.23.1.1.26986; Purton T, 2018, PERS INDIV DIFFER, V131, P99, DOI 10.1016/j.paid.2018.04.010; Questback GmbH, 2017, EFS SURV; Quittkat HL., 2019, FRONT PSYCHIATRY, P10, DOI [10.3389/fpsyt.2019.00010, DOI 10.3389/FPSYT.2019.00010]; R Core Team, 2020, R LANG ENV STAT COMP; RASKIN R, 1988, J PERS SOC PSYCHOL, V54, P890, DOI 10.1037/0022-3514.54.5.890; Reade JA., 2016, REINVENTION INT J UN, V9; Richter F, 2014, PSYCHOTHER PSYCH MED, V64, P465, DOI 10.1055/s-0034-1394461; Ripoll C, 2010, ADICCIONES, V22, P29, DOI 10.20882/adicciones.212; Rodgers RF, 2018, SEX ROLES, V78, P18, DOI 10.1007/s11199-017-0775-6; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Schermelleh-Engel K, 2003, METHODS PSYCHOL RES, V8, P23, DOI DOI 10.1002/0470010940; Schutz A, 2004, DIAGNOSTICA, V50, P202, DOI 10.1026/0012-1924.50.4.202; Sedikides C, 2021, TRENDS COGN SCI, V25, P67, DOI 10.1016/j.tics.2020.10.010; Sherman ED, 2015, PSYCHOL ASSESSMENT, V27, P1110, DOI 10.1037/pas0000100; Silva C, 2016, REV IBEROAM DIAGN EV, V2, P85, DOI 10.21865/RIDEP42_85; Smolak L, 2008, BODY IMAGE, V5, P251, DOI 10.1016/j.bodyim.2008.03.004; Stangier U., 2003, DERMATOLOGY PSYCHOSO, V4, P66, DOI [10.1159/000072194, DOI 10.1159/000072194]; Stice E, 2002, PSYCHOL BULL, V128, P825, DOI 10.1037//0033-2909.128.5.825; Swami V, 2015, PERS INDIV DIFFER, V87, P185, DOI 10.1016/j.paid.2015.08.006; Thiel A, 1997, PSYCHOTHER PSYCH MED, V47, P365; Thomaes S, 2016, J PERS, V84, P633, DOI 10.1111/jopy.12187; Thompson J. K., 1999, EXACTING BEAUTY THEO, DOI [10.1037/10312-000, DOI 10.1037/10312-000]; Thompson JK, 2001, CURR DIR PSYCHOL SCI, V10, P181, DOI 10.1111/1467-8721.00144; Tiggemann M, 2015, BODY IMAGE, V15, P61, DOI 10.1016/j.bodyim.2015.06.003; Tiggemann Marika, 2004, Body Image, V1, P29, DOI 10.1016/S1740-1445(03)00002-0; Uhlmann LR, 2018, BODY IMAGE, V25, P23, DOI 10.1016/j.bodyim.2018.01.005; Vandereycken W, 1993, EAT DISORD, V1, P7, DOI [10.1080/10640269308248262, DOI 10.1080/10640269308248262]; Waldorf M, 2014, DIAGNOSTICA, V60, P140, DOI 10.1026/0012-1924/a000106; Williamson DA, 2004, BEHAV MODIF, V28, P711, DOI 10.1177/0145445503259853; WISEMAN CV, 1992, INT J EAT DISORDER, V11, P85, DOI 10.1002/1098-108X(199201)11:1&lt;85::AID-EAT2260110112&gt;3.0.CO;2-T; Wright AGC, 2018, CURR OPIN PSYCHOL, V21, P74, DOI 10.1016/j.copsyc.2017.10.001; Zeigler-Hill V, 2008, J PERS, V76, P753, DOI 10.1111/j.1467-6494.2008.00503.x	107	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253187	10.1371/journal.pone.0253187	http://dx.doi.org/10.1371/journal.pone.0253187			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SX8VJ	34129626	Green Published, gold			2022-12-26	WOS:000665475100031
J	Joshi, T; Pandey, SC; Maiti, P; Tripathi, M; Paliwal, A; Nand, M; Sharma, P; Samant, M; Pande, V; Chandra, S				Joshi, Tushar; Pandey, Satish Chandra; Maiti, Priyanka; Tripathi, Manish; Paliwal, Ashutosh; Nand, Mahesha; Sharma, Priyanka; Samant, Mukesh; Pande, Veena; Chandra, Subhash			Antimicrobial activity of methanolic extracts of Vernonia cinerea against Xanthomonas oryzae and identification of their compounds using in silico techniques	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; D-ALANINE; NETWORKS; ANTIOXIDANT; ENZYME	Bacterial Leaf Blight (BLB) disease is an extremely ruinous disease in rice, caused by Xanthomonas oryzae pv. oryzae (Xoo). Although various chemicals are available to manage BLB, they are toxic to the environment as well as humans. Hence there is a need to develop new pesticides as alternatives to hazardous chemicals. Therefore, a study was carried out to discover new potent natural pesticides against Xoo from different solvent extracts of Vernonia cinerea. Among all the fractions, the methanolic extract showed the highest inhibition zone. Further, to gain mechanistic insight of inhibitory action, 40 molecules of methanolic extracts were subjected for in silico study against two enzymes D-alanine-D-alanine ligase (Ddl) and Peptide deformylase (PDF). In silico study showed Rutin and Methanone, [1,4-dimethyl-7-(1- methylethyl)-2- azulenyl]phenyl have a good binding affinity with Ddl while Phenol, 2,4-bis(1-phenylethyl)- and 1,2-Benzenedicarboxylic acid, diisooctyl ester showed an excellent binding affinity to PDF. Finally, the system biology approach was applied to understand the agrochemical's effect in the cell system of bacteria against both the enzymes. Conclusively, these four-hit compounds may have strong potential against Xoo and can be used as biopesticides in the future.	[Joshi, Tushar; Pandey, Satish Chandra; Paliwal, Ashutosh; Pande, Veena] Kumaun Univ, Dept Biotechnol, Bhimtal Campus, Bhimtal, Uttarakhand, India; [Pandey, Satish Chandra; Samant, Mukesh] Soban Singh Jeena Univ, Dept Zool, Cell Mol Biol Lab, Almora, Uttarakhand, India; [Maiti, Priyanka] GB Pant Natl Inst Himalayan Environm, Ctr Environm Assessment & Climate Change, Almora, Uttarakhand, India; [Tripathi, Manish; Chandra, Subhash] Soban Singh Jeena Univ, Dept Bot, Computat Biol & Biotechnol Lab, Almora, Uttarakhand, India; [Nand, Mahesha] GB Pant Natl Inst Himalayan Environm, Environm Informat Syst Himalayan Ecol, Almora, Uttarakhand, India; [Sharma, Priyanka] Kumaun Univ, Dept Bot, DSB Campus, Naini Tal, Uttarakhand, India	Kumaun University; G.B. Pant National Institute of Himalayan Environment & Sustainable Development (GBPNIHESD); G.B. Pant National Institute of Himalayan Environment & Sustainable Development (GBPNIHESD); Kumaun University	Chandra, S (corresponding author), Soban Singh Jeena Univ, Dept Bot, Computat Biol & Biotechnol Lab, Almora, Uttarakhand, India.	scjnu@yahoo.co.in	Chandra, Subhash/AAN-6789-2020; Nand, Mahesha/ACE-1505-2022; Tripathi, Manish/O-2865-2019	Nand, Mahesha/0000-0003-3122-8318; Chandra, Subhash/0000-0002-8978-5427				Abirami P., 2012, EUROP J EXP BIOL, V2, P9; Adamczak A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9010109; Arima H, 2002, BIOSCI BIOTECH BIOCH, V66, P1009, DOI 10.1271/bbb.66.1009; Aubart K, 2006, PROGR MED CHEM, V44, P109, DOI 10.1016/S0079-6468(05)44403-3; Autiero I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006226; Barabasi AL, 2009, SCIENCE, V325, P412, DOI 10.1126/science.1173299; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Bhatt P, 2019, PESTIC BIOCHEM PHYS, V158, P88, DOI 10.1016/j.pestbp.2019.04.015; Chien CC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36575-x; Chithrashree, 2011, BIOL CONTROL, V59, P114, DOI 10.1016/j.biocontrol.2011.06.010; Govindappa M., 2011, International Journal of Plant Physiology and Biochemistry, V3, P6; Groche D, 1998, BIOCHEM BIOPH RES CO, V246, P342, DOI 10.1006/bbrc.1998.8616; Gupta M, 2003, FITOTERAPIA, V74, P148, DOI 10.1016/S0367-326X(02)00291-5; Jabeen R, 2011, PAK J BOT, V43, P1335; Kanugala S, 2019, MICROBIOL RES, V228, DOI 10.1016/j.micres.2019.126301; Kavitha H. U., 2011, International Journal of Agricultural Technology, V7, P449; Kim SI, 2016, SCI REP-UK, V6, DOI 10.1038/srep21209; Kirkpatrick WR, 1998, J CLIN MICROBIOL, V36, P1330, DOI 10.1128/JCM.36.5.1330-1332.1998; Kitamura Y, 2009, ACTA CRYSTALLOGR D, V65, P1098, DOI 10.1107/S0907444909029710; Kitano Hiroaki, 2003, Biosilico, V1, P169, DOI 10.1016/S1478-5382(03)02380-1; Latha LY, 2010, ULTRASTRUCT PATHOL, V34, P219, DOI 10.3109/01913121003651513; Lemkul J, 2019, LIVING J COMPUT MOL, V1, P5068, DOI [10.33011/livecoms.1.1.5068, DOI 10.33011/LIVECOMS.1.1.5068]; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Maiti P, 2021, J BIOMOL STRUCT DYN, V39, P5048, DOI 10.1080/07391102.2020.1784791; Meena R.K., 2020, RESOURCES USE EFFICI, P85, DOI DOI 10.1007/978-981-15-6953-1_3; Mishra D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081996; NEUHAUS FC, 1964, BIOCHEMISTRY-US, V3, P471, DOI 10.1021/bi00892a001; Neumann A, 2002, ARCH MICROBIOL, V177, P420, DOI 10.1007/s00203-002-0409-3; Pathak RK., 2017, SCI REP-UK, V7, P1, DOI [10.1038/s41598-016-0028-x, DOI 10.1038/S41598-016-0028-X]; Rajamurugan R, 2011, PHARM BIOL, V49, P1311, DOI 10.3109/13880209.2011.604334; Sahayaraj K, 2015, RES CHEM INTERMEDIAT, V41, P5495, DOI 10.1007/s11164-014-1676-8; Somasundaram A., 2010, PHARMACOLOGYONLINE, V960, P957; Sonibare MA, 2016, AFR HEALTH SCI, V16, P629, DOI 10.4314/ahs.v16i2.34; Syed-Ab-Rahman SF, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2019.e03151; Verma SK, 2011, PHARMACOPHORE, V2, P114; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Yang MT, 2020, FOOD CHEM, V333, DOI 10.1016/j.foodchem.2020.127458; Yoon J, 2006, BIOINFORMATICS, V22, P3106, DOI 10.1093/bioinformatics/btl533	38	4	4	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252759	10.1371/journal.pone.0252759	http://dx.doi.org/10.1371/journal.pone.0252759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125862	gold, Green Published			2022-12-26	WOS:000664643500014
J	Ivashkin, V; Poluektov, Y; Kogan, E; Shifrin, O; Sheptulin, A; Kovaleva, A; Kurbatova, A; Krasnov, G; Poluektova, E				Ivashkin, V.; Poluektov, Y.; Kogan, E.; Shifrin, O.; Sheptulin, A.; Kovaleva, A.; Kurbatova, A.; Krasnov, G.; Poluektova, E.			Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome	PLOS ONE			English	Article							INTESTINAL BARRIER; PATHOPHYSIOLOGY; DYSFUNCTION; BACTERIA	Background Irritable bowel syndrome (IBS) is a pathologic condition characterized by changes in gut microbiome composition, low-grade inflammation, and disruption of intestinal wall permeability. The interaction between the gut microbiome and the disease manifestation remains unclear. The changing of tight junction proteins and cytokines expression throughout the gastrointestinal tract in IBS patients has not been studied yet. Aim of the study To assess the changes of gut microbiome composition, tight junction proteins, and cytokines expression of intestinal mucosa from the duodenum to the distal part of the colon in IBS patients and healthy volunteers. Methods In 31 IBS patients (16 patients with IBS-D; 15 patients with IBS-C) and 10 healthy volunteers the expression of CLD-2, CLD-3, CLD-5, IL-2, IL-10, and TNF-alpha in mucosal biopsy specimens was determined by morphological and immune-histochemical methods. The qualitative and quantitative composition of the intestinal microbiota was assessed based on 16S rRNA gene sequencing in both groups of patients. Results The expression of IL-2 and TNF-alpha was significantly increased in IBS patients compared with the controls (p<0.001), with a gradual increase from the duodenum to the sigmoid colon. The expression of IL-10, CLD-3, and CLD-5 in mucosal biopsy specimens of these patients was lower than in the control group (p<0.001). Increased ratios of Bacteroidetes and decreased ratios of Firmicutes were noted in IBS patients compared to healthy volunteers (p<0.05). Conclusion IBS patients have impaired gut permeability and persisting low-grade inflammation throughout the gastrointestinal tract. Changes in the gut microbiota may support or exacerbate these changes.	[Ivashkin, V.; Kogan, E.; Shifrin, O.; Sheptulin, A.; Kovaleva, A.; Kurbatova, A.; Poluektova, E.] Sechenov Univ, IM Sechenov First Moscow State Med Univ, Moscow, Russia; [Poluektov, Y.; Krasnov, G.] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia	Sechenov First Moscow State Medical University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Poluektov, Y (corresponding author), Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia.	yuripoul@gmail.com	Shifrin, Oleg/AAE-6733-2022; Anastasia, Kurbatova/R-8385-2017; Poluektov, Yuri/Q-6014-2017	Anastasia, Kurbatova/0000-0002-6154-8163; Poluektova, Elena/0000-0003-1312-120X; Poluektov, Yuri/0000-0002-9710-7490				Antoni L, 2014, WORLD J GASTROENTERO, V20, P1165, DOI 10.3748/wjg.v20.i5.1165; Baj A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061482; Barbalho SM, 2019, EXPERT REV GASTROENT, V13, P345, DOI 10.1080/17474124.2019.1570137; Bennet SMP, 2016, AM J GASTROENTEROL, V111, P1165, DOI 10.1038/ajg.2016.223; Berg LK, 2020, SCAND J GASTROENTERO, V55, P537, DOI 10.1080/00365521.2020.1754455; Camilleri M, 2017, HANDB EXP PHARMACOL, V239, P75, DOI 10.1007/164_2016_102; Chang L, 2012, AM J GASTROENTEROL, V107, P262, DOI 10.1038/ajg.2011.423; Chelius MK, 2001, MICROB ECOL, V41, P252, DOI 10.1007/s002480000087; Cheng P, 2015, MOL MED REP, V12, P3257, DOI 10.3892/mmr.2015.3808; Choghakhori R, 2017, CYTOKINE, V93, P34, DOI 10.1016/j.cyto.2017.05.005; Coss-Adame Enrique, 2014, Curr Gastroenterol Rep, V16, P379, DOI 10.1007/s11894-014-0379-z; Cryan JF, 2019, PHYSIOL REV, V99, P1877, DOI 10.1152/physrev.00018.2018; Duan RQ, 2019, CLIN TRANSL GASTROEN, V10, DOI 10.14309/ctg.0000000000000012; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ford AC, 2017, NEW ENGL J MED, V376, P2566, DOI 10.1056/NEJMra1607547; Gunzel D, 2013, PHYSIOL REV, V93, P525, DOI 10.1152/physrev.00019.2012; Gwee KA, 2003, GUT, V52, P523, DOI 10.1136/gut.52.4.523; Hadjivasilis A, 2019, ANN GASTROENTEROL, V32, P554, DOI 10.20524/aog.2019.0428; Herlemann DPR, 2011, ISME J, V5, P1571, DOI 10.1038/ismej.2011.41; Holtmann GJ, 2016, LANCET GASTROENTEROL, V1, P133, DOI 10.1016/S2468-1253(16)30023-1; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Ishimoto H, 2017, J CLIN BIOCHEM NUTR, V60, P146, DOI 10.3164/jcbn.16-92; Johnson JS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13036-1; Lacy BE, 2016, GASTROENTEROLOGY, V150, P1393, DOI 10.1053/j.gastro.2016.02.031; Macfarlane S, 2005, APPL ENVIRON MICROB, V71, P7483, DOI 10.1128/AEM.71.11.7483-7492.2005; Macsharry J, 2008, SCAND J GASTROENTERO, V43, P1467, DOI 10.1080/00365520802276127; Martinez C, 2012, GUT LIVER, V6, P305, DOI 10.5009/gnl.2012.6.3.305; Ng QX, 2018, J INFLAMM RES, V11, P345, DOI 10.2147/JIR.S174982; Ohira H, 2017, J ATHEROSCLER THROMB, V24, P660, DOI 10.5551/jat.RV17006; Pittayanon R, 2019, GASTROENTEROLOGY, V157, P97, DOI 10.1053/j.gastro.2019.03.049; Ringel Y, 2013, AM J PHYSIOL-GASTR L, V305, pG529, DOI 10.1152/ajpgi.00207.2012; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Samanta P, 2018, J GEN PHYSIOL, V150, P949, DOI 10.1085/jgp.201711868; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Simren M, 2019, GASTROENTEROLOGY, V157, P391, DOI 10.1053/j.gastro.2019.04.019; Tan J, 2014, ADV IMMUNOL, V121, P91, DOI 10.1016/B978-0-12-800100-4.00003-9; Vanheel H, 2014, GUT, V63, P262, DOI 10.1136/gutjnl-2012-303857; Vivinus-Nebot M, 2014, GUT, V63, P744, DOI 10.1136/gutjnl-2012-304066; Wilcz-Villega E, 2014, NEUROGASTROENT MOTIL, V26, P316, DOI 10.1111/nmo.12262; Wouters MM, 2016, GUT, V65, P155, DOI 10.1136/gutjnl-2015-309151; Yan F, 2011, J CLIN INVEST, V121, P2242, DOI 10.1172/JCI44031	42	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252930	10.1371/journal.pone.0252930	http://dx.doi.org/10.1371/journal.pone.0252930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115808	gold, Green Published			2022-12-26	WOS:000664643000041
J	Wu, YH; Huang, YF; Chang, TH; Chen, CC; Wu, PY; Huang, SC; Chou, CY				Wu, Yi-Hui; Huang, Yu-Fang; Chang, Tzu-Hao; Chen, Chien-Chin; Wu, Pei-Ying; Huang, Soon-Cen; Chou, Cheng-Yang			COL11A1 activates cancer-associated fibroblasts by modulating TGF-beta 3 through the NF-kappa B/IGFBP2 axis in ovarian cancer cells	ONCOGENE			English	Article							NF-KAPPA-B; TGF-BETA; BREAST-CANCER; CARCINOMA; GROWTH; EXPRESSION; IL-6; CHEMORESISTANCE; SIGNATURE; SURVIVAL	Ovarian cancer has a unique tumor microenvironment (TME) that enables cancer-associated fibroblasts (CAFs) to interact with cellular and matrix constituents and influence tumor development and migration into the peritoneal cavity. Collagen type XI alpha 1 (COL11A1) is overexpressed in CAFs; therefore this study examines its role during CAF activation in epithelial ovarian cancer (EOC). Coculturing human ovarian fibroblasts (HOFs) with high COL11A1-expressing EOC cells or exposure to the conditioned medium of these cells prompted the expression of COL11A1 and CAF phenotypes. Conversely, coculturing HOFs with low COL11A1-expressing EOC cells or COL11A1-knockdown abrogated COL11A1 overexpression and secretion, in addition to CAF activation. Increased p-SP1 expression attributed to COL11A1-mediated extracellular signal-regulated kinase activation (ERK) induced p65 translocation into the nucleus and augmented its binding to the insulin-like growth factor binding protein 2 (IGFBP2) promoter, ultimately inducing TGF-beta 3 activation. The CAF-cancer cell crosstalk triggered interleukin-6 release, which in turn promoted EOC cell proliferation and invasiveness. These in vitro results were confirmed by in vivo findings in a mouse model, showing that COL11A1 overexpression in EOC cells promoted tumor formation and CAF activation, which was inhibited by TGF-beta 3 antibody. Human tumors with high TGF-beta 3 levels showed elevated expression of COL11A1 and IGFBP2, which was associated with poor survival. Our findings suggest the possibility that anti-TGF-beta 3 treatment strategy may be effective in targeting CAFs in COL11A1-positive ovarian tumors.	[Wu, Yi-Hui] Chi Mei Med Ctr, Dept Med Res, Tainan, Taiwan; [Huang, Yu-Fang; Wu, Pei-Ying; Chou, Cheng-Yang] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Obstet & Gynecol, Tainan, Taiwan; [Chang, Tzu-Hao] Taipei Med Univ, Grad Inst Biomed Informat, Taipei, Taiwan; [Chen, Chien-Chin] Chia Yi Christian Hosp, Dept Pathol, Ditmanson Med Fdn, Chiayi, Taiwan; [Chen, Chien-Chin] Chia Nan Univ Pharm & Sci, Dept Cosmet Sci, Tainan, Taiwan; [Huang, Soon-Cen] Chi Mei Med Ctr, Dept Obstet & Gynecol, Tainan, Taiwan	Chi Mei Hospital; National Cheng Kung University; National Cheng Kung University Hospital; Taipei Medical University; Chia Nan University of Pharmacy & Science; Chi Mei Hospital	Chou, CY (corresponding author), Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Obstet & Gynecol, Tainan, Taiwan.; Huang, SC (corresponding author), Chi Mei Med Ctr, Dept Obstet & Gynecol, Tainan, Taiwan.	hsc.gyn@gmail.com; chougyn@mail.ncku.edu.tw	Chen, Chien-Chin/A-9977-2016; Wu, Pei Ying/AGR-9702-2022	Chen, Chien-Chin/0000-0001-9599-0884; Wu, Yi-Hui/0000-0002-8657-6371; Huang, Soon-Cen/0000-0001-8085-576X	National Science Council (MOST) [108-2314-B-384-011-MY3, 108-2314-B-006-061-MY2]; Chi Mei Medical Center, Liouying Campus [CLFHR10822, CLFHR10911, CMLMOST10901, CLFHR10921]	National Science Council (MOST); Chi Mei Medical Center, Liouying Campus	This work was supported by grants from the National Science Council (MOST: No. 108-2314-B-384-011-MY3 and 108-2314-B-006-061-MY2). The study was also supported by grants from the Chi Mei Medical Center, Liouying Campus (CLFHR10822, CLFHR10911, CMLMOST10901, and CLFHR10921).	Ahmed N, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00256; Barcellos-Hoff MH, 2005, BREAST CANCER RES, V7, P33, DOI 10.1186/bcr972; Bartlett JM, 1997, EUR J CANCER, V33, P2397, DOI 10.1016/S0959-8049(97)00304-3; Bierie B, 2008, CANCER RES, V68, P1809, DOI 10.1158/0008-5472.CAN-07-5597; Biffi G, 2019, CANCER DISCOV, V9, P282, DOI 10.1158/2159-8290.CD-18-0710; Bran G, 2011, IN VIVO, V25, P579; Browning L, 2018, CANCER MANAG RES, V10, P6685, DOI 10.2147/CMAR.S179189; Cancer Genome Atlas Research Network, 2011, Nature, V474, P609, DOI 10.1038/nature10166; Cazals V, 1999, BBA-MOL CELL RES, V1448, P349, DOI 10.1016/S0167-4889(98)00095-0; Chen MF, 2012, CLIN SCI, V122, P459, DOI 10.1042/CS20110434; Cheon DJ, 2014, CLIN CANCER RES, V20, P711, DOI 10.1158/1078-0432.CCR-13-1256; Cirri P, 2011, AM J CANCER RES, V1, P482; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; D'Arcangelo E, 2020, BRIT J CANCER, V122, P931, DOI 10.1038/s41416-019-0705-1; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Erkan M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-88; Fischer H, 2001, CARCINOGENESIS, V22, P875, DOI 10.1093/carcin/22.6.875; Garcia-Pravia C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078327; Hawsawi NM, 2008, CANCER RES, V68, P2717, DOI 10.1158/0008-5472.CAN-08-0192; Hong SH, 2000, FASEB J, V14, P1499, DOI 10.1096/fj.99-0802com; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695534; Mienaltowski MJ, 2014, ADV EXP MED BIOL, V802, P5, DOI 10.1007/978-94-007-7893-1_2; Nallanthighal S, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2442-z; Navab R, 2011, P NATL ACAD SCI USA, V108, P7160, DOI 10.1073/pnas.1014506108; Papageorgis P, 2015, J ONCOL, V2015, DOI 10.1155/2015/587193; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Rada M, 2018, ONCOGENE, V37, P4809, DOI 10.1038/s41388-018-0297-x; Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002; RONNOVJESSEN L, 1995, J CLIN INVEST, V95, P859, DOI 10.1172/JCI117736; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Stover DG, 2007, J CELL BIOCHEM, V101, P851, DOI 10.1002/jcb.21149; Tao LL, 2017, ONCOL LETT, V14, P2611, DOI 10.3892/ol.2017.6497; Verona EV, 2007, CANCER RES, V67, P5737, DOI 10.1158/0008-5472.CAN-07-0444; von Strandmann EP, 2017, TRENDS CANCER, V3, P137, DOI 10.1016/j.trecan.2016.12.005; Worzfeld T, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00024; Wu YH, 2014, ONCOGENE, V33, P3432, DOI 10.1038/onc.2013.307; Wu YH, 2017, INT J CANCER, V141, P2305, DOI 10.1002/ijc.30932; Wu YH, 2015, ONCOTARGET, V6, P23748, DOI 10.18632/oncotarget.4250; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Yeung TL, 2013, CANCER RES, V73, P5016, DOI 10.1158/0008-5472.CAN-13-0023; Yu Y, 2014, BRIT J CANCER, V110, P724, DOI 10.1038/bjc.2013.768; Zigrino P, 2005, BIOCHIMIE, V87, P321, DOI 10.1016/j.biochi.2004.10.025	43	19	19	1	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2021	40	26					4503	4519		10.1038/s41388-021-01865-8	http://dx.doi.org/10.1038/s41388-021-01865-8		JUN 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TC8LA	34117361				2022-12-26	WOS:000660409400001
J	Christodoulou, MD; Culham, A				Christodoulou, Maria D.; Culham, Alastair			When do apples stop growing, and why does it matter?	PLOS ONE			English	Article							GROWTH-PATTERN; BILINEAR MODEL; FRUIT; QUALITY; GALA	Apples in the commercial food chain are harvested up to two weeks before maturity. We explore apple fruit development through the growing season to establish the point at which physical features differentiating those cultivars become evident. This is relevant both for the understanding of the growing process and to ensure that any identification and classification tools can be used both on ripened-on-tree and stored fruit. Current literature presents some contradictory findings on apple growth, we studied 12 apple cultivars in the Brogdale National Fruit Collection, UK over two seasons to establish patterns of growth. Fruit were sampled at regular time points throughout the growing season and four morphometrics (maximum length, maximum diameter, weight, and centroid size) were collected. These were regressed against growing degree days in order to appropriately describe the growth pattern observed. All four morphometrics were adequately described using log-log linear regressions, with adjusted R-2 estimates ranging from 78.3% (maximum length) to 86.7% (weight). For all four morphometrics, a 10% increase in growing degree days was associated with a 1% increase in the morphometric. Our findings refine previous work presenting rapid early growth followed by a plateau in later stages of development and contrast with published expo-linear models. We established that apples harvested for commercial storage purposes, two weeks prior to maturity, showed only a modest decrease in size compared with ripened-on-tree fruit, demonstrating that size morphometric approaches are appropriate for classification of apple fruit at point of harvest.	[Christodoulou, Maria D.] Univ Oxford, Dept Stat, Oxford, England; [Christodoulou, Maria D.; Culham, Alastair] Univ Reading, Univ Reading Herbarium, Sch Biol Sci, Reading, Berks, England	University of Oxford; University of Reading	Culham, A (corresponding author), Univ Reading, Univ Reading Herbarium, Sch Biol Sci, Reading, Berks, England.	a.culham@reading.ac.uk	Christodoulou, Maria/AAH-4213-2021	Christodoulou, Maria/0000-0003-0968-2311	Biotechnology and Biological Sciences Research Council (BBSRC) [1132848]	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) as a PhD CASE Studentship 1132848 (MDC), https://www.bbsrc.ac.uk/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agriculture and Horticulture Development Board, 2020, APPL BEST PRACT GUID; Atay E, 2010, J AGR SCI-TARIM BILI, V16, P1, DOI 10.1501/Tarimbil_0000001115; BLANPIED GD, 1966, P AM SOC HORTIC SCI, V88, P33; Bollard E.G., 1970, BIOCH FRUITS THEIR P, VVolume 1, P387; Buchwald P, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-16; Buchwald P, 2007, MATH BIOSCI, V205, P108, DOI 10.1016/j.mbs.2006.08.013; Christodoulou MD, 2020, BOT J LINN SOC, V194, P385, DOI 10.1093/botlinnean/boaa055; Christodoulou MD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205357; Christodoulou MD., 2021, QUANT PLANT BIOL; Cross J, 2010, APPLE BEST PRACTICE; DENNE M. PATRICIA, 1960, ANN BOT, V24, P397; DENNE PATRICIA M., 1963, NEW ZEALAND JOUR BOT, V1, P265; GOUDRIAAN J, 1990, ANN BOT-LONDON, V66, P695, DOI 10.1093/oxfordjournals.aob.a088084; Knee M., 1993, BIOCH FRUIT RIPENING, P325; LAKSO AN, 1995, J HORTIC SCI, V70, P389, DOI 10.1080/14620316.1995.11515308; Matzinger B, 2013, COMMERCIAL POSTHARVE; Nowosad J., 2018, **DATA OBJECT**; Orlandini S., 1998, ACTA HORTIC, V499, P137; Plotto A, 1997, HORTSCIENCE, V32, P903, DOI 10.21273/HORTSCI.32.5.903; R Core Team, 2020, R LANG ENV STAT COMP; R Studio Team, 2018, RSTUDIO INT DEV R; Rhodes MJC., 1978, NUTR FOOD SCI, V78, P14, DOI [10.1108/eb058700, DOI 10.1108/EB058700]; Saei A, 2008, ACTA HORTIC, V803, P293, DOI 10.17660/ActaHortic.2008.803.37; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Stajnko D, 2013, SCI HORTIC-AMSTERDAM, V160, P306, DOI 10.1016/j.scienta.2013.06.003; Tukey HB, 1942, BOT GAZ, V104, P3, DOI 10.1086/335103; Wargo JM, 2004, HORTTECHNOLOGY, V14, P496, DOI 10.21273/HORTTECH.14.4.0496; WATADA AE, 1984, HORTSCIENCE, V19, P20	28	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252288	10.1371/journal.pone.0252288	http://dx.doi.org/10.1371/journal.pone.0252288			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111161	gold, Green Published, Green Submitted			2022-12-26	WOS:000664642700020
J	Alves, AFF; Miranda, JRA; Reis, F; Oliveira, AA; Souza, SAS; Fortaleza, CMCB; Tanni, SE; Castro, JTS; Pina, DR				Fattori Alves, Allan Felipe; Arruda Miranda, Jose Ricardo; Reis, Fabiano; Oliveira, Abner Alves; Santana Souza, Sergio Augusto; Castelo Branco Fortaleza, Carlos Magno; Tanni, Suzana Erico; Souza Castro, Jose Thiago; Pina, Diana Rodrigues			Automatic algorithm for quantifying lung involvement in patients with chronic obstructive pulmonary disease, infection with SARS-CoV-2, paracoccidioidomycosis and no lung disease patients	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; QUANTIFICATION; MORTALITY	In this work, we aimed to develop an automatic algorithm for the quantification of total volume and lung impairments in four different diseases. The quantification was completely automatic based upon high resolution computed tomography exams. The algorithm was capable of measuring volume and differentiating pulmonary involvement including inflammatory process and fibrosis, emphysema, and ground-glass opacities. The algorithm classifies the percentage of each pulmonary involvement when compared to the entire lung volume. Our algorithm was applied to four different patients groups: no lung disease patients, patients diagnosed with SARS-CoV-2, patients with chronic obstructive pulmonary disease, and patients with paracoccidioidomycosis. The quantification results were compared with a semi-automatic algorithm previously validated. Results confirmed that the automatic approach has a good agreement with the semi-automatic. Bland-Altman (B&A) demonstrated a low dispersion when comparing total lung volume, and also when comparing each lung impairment individually. Linear regression adjustment achieved an R value of 0.81 when comparing total lung volume between both methods. Our approach provides a reliable quantification process for physicians, thus impairments measurements contributes to support prognostic decisions in important lung diseases including the infection of SARS-CoV-2.	[Fattori Alves, Allan Felipe] Botucatu Med Sch, Clin Hosp, Med Phys & Radioprotect Nucleus, Botucatu, SP, Brazil; [Arruda Miranda, Jose Ricardo; Oliveira, Abner Alves; Santana Souza, Sergio Augusto] Sao Paulo State Univ Julio De Mesquita Filho, Inst Biosci, Botucatu, SP, Brazil; [Reis, Fabiano; Souza Castro, Jose Thiago] Univ Estadual Campinas, Radiol & Med Imaging, Campinas, SP, Brazil; [Castelo Branco Fortaleza, Carlos Magno; Tanni, Suzana Erico; Pina, Diana Rodrigues] Sao Paulo State Univ Julio De Mesquita Filho, Med Sch, Botucatu, SP, Brazil	Universidade Estadual Paulista; Universidade Estadual de Campinas; Universidade Estadual Paulista	Pina, DR (corresponding author), Sao Paulo State Univ Julio De Mesquita Filho, Med Sch, Botucatu, SP, Brazil.	diana.pina@unesp.br	Reis, Fabiano/AAT-3162-2020; Fortaleza, Carlos Magno C. B./C-3807-2013; Miranda, Jose/HCI-6099-2022; Pina, Diana rodrigues/AAL-2422-2020; tanni, suzana/C-2264-2012	Fortaleza, Carlos Magno C. B./0000-0003-4120-1258; Pina, Diana rodrigues/0000-0003-1967-1990; tanni, suzana/0000-0002-2587-2759; miranda, jose ricardo de arruda/0000-0002-8306-8056	Brazilian agency named Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPQ [303509/2019-8]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo -Fapesp [2020/05539-9]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES	Brazilian agency named Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo -Fapesp(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Prof. Diana received funding from a Brazilian agency named Conselho Nacional de Desenvolvimento Cientifico e Tecnologico -CNPQ (Process Number 303509/2019-8) and also from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo -Fapesp (Process Number 2020/05539-9). PHD Student Sergio A. S. Souza received a scolarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez M, 2014, MEDICINE, V93, DOI 10.1097/MD.0000000000000167; Bankier AA, 1999, RADIOLOGY, V211, P851, DOI 10.1148/radiology.211.3.r99jn05851; Benoldi D, 1985, Eur J Epidemiol, V1, P150, DOI 10.1007/BF00141809; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Burney PGJ, 2015, EUR RESPIR J, V45, P1239, DOI 10.1183/09031936.00142414; Dai WC, 2020, CAN ASSOC RADIOL J, V71, P195, DOI 10.1177/0846537120913033; De Langhe E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043123; Global Initiative for Chronic Obstructive Lung Disease, 2020, GLOBAL STRATEGY DIAG; Goldin JG, 2013, J THORAC IMAG, V28, P291, DOI 10.1097/RTI.0b013e3182a1d93d; Marchiori E, 2011, EUR J RADIOL, V77, P80, DOI 10.1016/j.ejrad.2009.06.017; ODONNELL DE, 1993, AM REV RESPIR DIS, V148, P1351, DOI 10.1164/ajrccm/148.5.1351; Oliveira M., 2012, REV BRASILEIRA FISIC, V6; Reis F, 2013, MYCOPATHOLOGIA, V175, P181, DOI 10.1007/s11046-012-9607-y; Rosas IO, 2011, CHEST, V140, P1590, DOI 10.1378/chest.10-2545; Sluimer I, 2006, IEEE T MED IMAGING, V25, P385, DOI 10.1109/TMI.2005.862753; Societies FoIR, 2017, GLOB IMP RESP DIS; Tantucci C, 2016, RESPIRATION, V91, P273, DOI 10.1159/000444418; TISIOLOGIA SBDPE, 2004, JORNAL BRASILEIRO EP, V30, pS1; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; Welte T, 2014, DTSCH ARZTEBL INT, V111, P179, DOI 10.3238/arztebl.2014.0179; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; Xu ZY, 2013, MED PHYS, V40, DOI 10.1118/1.4824979; Zavaletta VA, 2007, ACAD RADIOL, V14, P772, DOI 10.1016/j.acra.2007.03.009	24	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0251783	10.1371/journal.pone.0251783	http://dx.doi.org/10.1371/journal.pone.0251783			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111131	Green Published, gold			2022-12-26	WOS:000664642700011
J	Kristof, Z; Eszlari, N; Sutori, S; Gal, Z; Torok, D; Baksa, D; Petschner, P; Sperlagh, B; Anderson, IM; Deakin, JFW; Juhasz, G; Bagdy, G; Gonda, X				Kristof, Zsuliet; Eszlari, Nora; Sutori, Sara; Gal, Zsofia; Torok, Dora; Baksa, Daniel; Petschner, Peter; Sperlagh, Beata; Anderson, Ian M.; Deakin, John Francis William; Juhasz, Gabriella; Bagdy, Gyorgy; Gonda, Xenia			P2RX7 gene variation mediates the effect of childhood adversity and recent stress on the severity of depressive symptoms	PLOS ONE			English	Article							GATED ION-CHANNEL; LIFE EVENTS; P2X7 RECEPTOR; THREATENING EXPERIENCES; MAJOR DEPRESSION; MOOD DISORDERS; POLYMORPHISM; RELEASE; INFLAMMASOME; STIMULATION	The P2X purinoceptor 7 (P2RX7) mediates inflammatory microglial responses and is implicated in neuroimmune mechanisms of depression and neurodegenerative disorders. A number of studies suggest that psychosocial stress may precipitate depression through immune activation. Genetic association studies of P2RX7 variants with depression have been inconclusive. However, nearly all studies have focused on only one single-nucleotide polymorphism (SNP) and have not considered interaction with psychosocial stress. We investigated the effect of several variations in P2RX7 gene using a clumping method in interaction with early adversities and recent stress on depression severity. 1752 subjects provided information on childhood adversities, recent life events, and current depression severity. Participants were genotyped for 681 SNPs in the P2RX7 gene, 335 of them passed quality control and were entered into linear regression models followed by a clumping procedure for main effect and interactions. No significant main effect was observed. Rs74892325 emerged as a top SNP for interaction with childhood adversities and rs61953400 for interaction with recent life events. Our study is the first to investigate several variants in the P2RX7 gene and in interaction with two types of stress, extending our understanding of neuroinflammation in depression, and supporting that the majority of genes influence depression by enhancing sensitivity to stressors.	[Kristof, Zsuliet] Semmelweis Univ, Doctoral Sch Mental Hlth Sci, Budapest, Hungary; [Kristof, Zsuliet; Sperlagh, Beata] Inst Expt Med, Lab Mol Pharmacol, Budapest, Hungary; [Kristof, Zsuliet; Gonda, Xenia] Semmelweis Univ, Dept Psychiat & Psychotherapy, Budapest, Hungary; [Eszlari, Nora; Sutori, Sara; Gal, Zsofia; Torok, Dora; Baksa, Daniel; Petschner, Peter; Juhasz, Gabriella; Bagdy, Gyorgy] Semmelweis Univ, Dept Pharmacodynam, Fac Pharm, Budapest, Hungary; [Eszlari, Nora; Bagdy, Gyorgy; Gonda, Xenia] Semmelweis Univ, Hungarian Brain Res Program, NAP 2 SE New Antidepressant Target Res Grp, Budapest, Hungary; [Sutori, Sara] Pazmany Peter Catholic Univ, Inst Psychol, Fac Humanities & Social Sci, Budapest, Hungary; [Baksa, Daniel; Juhasz, Gabriella] Semmelweis Univ, Hungarian Brain Res Program, SE NAP 2 Genet Brain Imaging Migraine Res Grp, Budapest, Hungary; [Petschner, Peter; Juhasz, Gabriella; Bagdy, Gyorgy; Gonda, Xenia] Semmelweis Univ, Hungarian Acad Sci, MTA SE Neuropsychopharmacol & Neurochem Res Grp, Budapest, Hungary; [Anderson, Ian M.; Deakin, John Francis William] Univ Manchester, Sch Biol Sci Med & Human Sci, Neurosci & Psychiat Unit, Fac Biol,Div Neurosci & Expt Psychol, Manchester, Lancs, England; Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	Semmelweis University; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; Semmelweis University; University of Manchester; University of Manchester	Gonda, X (corresponding author), Semmelweis Univ, Dept Psychiat & Psychotherapy, Budapest, Hungary.; Gonda, X (corresponding author), Semmelweis Univ, Hungarian Brain Res Program, NAP 2 SE New Antidepressant Target Res Grp, Budapest, Hungary.; Gonda, X (corresponding author), Semmelweis Univ, Hungarian Acad Sci, MTA SE Neuropsychopharmacol & Neurochem Res Grp, Budapest, Hungary.	gonda.xenia@med.semmelweis-univ.hu	Gál, Zsófia/X-1022-2019; Sütöri, Sára/AAV-5302-2021; Eszlari, Nora/D-8826-2015; Bagdy, Gyorgy/O-3893-2017; Baksa, Daniel/O-1142-2017	Gál, Zsófia/0000-0002-9441-1497; Sütöri, Sára/0000-0003-3468-0780; Torok, Dora/0000-0001-9213-4345; Eszlari, Nora/0000-0003-4913-028X; Bagdy, Gyorgy/0000-0001-8141-3410; Petschner, Peter/0000-0002-3198-858X; Baksa, Daniel/0000-0002-7826-9179	Sixth Framework Programme of the European Union (NewMood) [LSHM-CT-2004-503474]; Hungarian Brain Research Program [KTIA_13_NAPA-II/14, 2017-1.2.1-NKP-2017-00002]; National Development Agency [KTIA_NAP_13-1-2013-0001]; Hungarian Academy of Sciences; Hungarian National Development Agency; Semmelweis University; Hungarian Brain Research Program; Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group); OTKA [119866, 131629]; National Research, Development and Innovation Office, Hungary under the frame of ERA PerMed [2019-2.1.7-ERA-NET-202000005, ERAPERMED2019-108]; Thematic Excellence Programme (Temateruleti Kivalosagi Program) of the Ministry for Innovation and Technology in Hungary of the Semmelweis University [2020-4.1.1.-TKP2020]; European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska Curie grant [766124]; New National Excellence Program of The Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund [UNKP-19-1-I-PPK,, UNKP-20-4-II-SE-9, UNKP-20-3-II-SE-51];  [TAMOP-4.2.1.B-09/1/KMR-2010-0001]	Sixth Framework Programme of the European Union (NewMood); Hungarian Brain Research Program; National Development Agency; Hungarian Academy of Sciences(Hungarian Academy of Sciences); Hungarian National Development Agency; Semmelweis University; Hungarian Brain Research Program; Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); National Research, Development and Innovation Office, Hungary under the frame of ERA PerMed; Thematic Excellence Programme (Temateruleti Kivalosagi Program) of the Ministry for Innovation and Technology in Hungary of the Semmelweis University; European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska Curie grant; New National Excellence Program of The Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund; 	The study group (not individual authors) was supported by the Sixth Framework Programme of the European Union (NewMood, LSHM-CT-2004-503474); by the Hungarian Brain Research Program (Grants KTIA_13_NAPA-II/14 and 2017-1.2.1-NKP-2017-00002), and the National Development Agency (Grant KTIA_NAP_13-1-2013-0001); by the Hungarian Academy of Sciences, Hungarian National Development Agency, Semmelweis University and the Hungarian Brain Research Program (Grant KTIA_NAP_13-2-2015-0001, MTA-SE-NAP B Genetic Brain Imaging Migraine Research Group); by the Hungarian Academy of Sciences (MTA-SE Neuropsychopharmacology and Neurochemistry Research Group); by OTKA 119866 and 131629; by TAMOP-4.2.1.B-09/1/KMR-2010-0001; by the National Research, Development and Innovation Office, Hungary (2019-2.1.7-ERA-NET-202000005), under the frame of ERA PerMed (ERAPERMED2019-108); and by the Thematic Excellence Programme (Temateruleti Kivalosagi Program, 2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Neurology and Translational Biotechnology thematic programmes of the Semmelweis University and the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska Curie grant agreement No. 766124. Ms. Sara Sutori was supported byUNKP-19-1-I-PPK, Dr. Nora Eszlari by UNKP-20-4-II-SE-9 and Mr. Daniel Baksa by UNKP-20-3-II-SE-51, by the New National Excellence Program of The Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrejew R, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00124; Basso AM, 2009, BEHAV BRAIN RES, V198, P83, DOI 10.1016/j.bbr.2008.10.018; Bennett MR, 2007, AUST NZ J PSYCHIAT, V41, P563, DOI 10.1080/00048670701399994; BERNSTEIN DP, 1994, AM J PSYCHIAT, V151, P1132, DOI 10.1176/ajp.151.8.1132; Bhattacharya A, 2018, PSYCHONEUROENDOCRINO, V98, P95, DOI 10.1016/j.psyneuen.2018.08.015; Bhattacharya A, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00030; Bhattacharya A, 2016, GLIA, V64, P1772, DOI 10.1002/glia.23001; Bhattacharya A, 2013, BRIT J PHARMACOL, V170, P624, DOI 10.1111/bph.12314; BRUGHA T, 1985, PSYCHOL MED, V15, P189, DOI 10.1017/S003329170002105X; BRUGHA TS, 1990, ACTA PSYCHIAT SCAND, V82, P77, DOI 10.1111/j.1600-0447.1990.tb01360.x; Burnstock G, 2017, CNS NEUROL DISORD-DR, V16, P257, DOI 10.2174/1871527315666160922104848; Cheffer A, 2018, MOL PSYCHIATR, V23, P94, DOI 10.1038/mp.2017.188; Csolle C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066547; Czamara D, 2018, PROG NEURO-PSYCHOPH, V82, P272, DOI 10.1016/j.pnpbp.2017.11.003; Dantzer R, 2018, BRAIN BEHAV IMMUN, V74, P28, DOI 10.1016/j.bbi.2018.08.010; Delarasse C, 2009, J NEUROCHEM, V109, P846, DOI 10.1111/j.1471-4159.2009.06008.x; Derogatis LR, 1993, BSI BRIEF SYMPTOM IN; Deussing JM, 2018, TRENDS MOL MED, V24, P736, DOI 10.1016/j.molmed.2018.07.005; Feng WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088575; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Goloncser F, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00325; Gonda X, 2020, RAW DATA; Gonda X, 2019, PHARMACOL THERAPEUT, V194, P22, DOI 10.1016/j.pharmthera.2018.09.002; Gonda X, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22221-z; Halmai Z, 2013, J AFFECT DISORDERS, V150, P104, DOI 10.1016/j.jad.2013.02.033; Hejjas K, 2009, AM J MED GENET B, V150B, P295, DOI 10.1002/ajmg.b.30799; Illes P, 2017, J NEUROSCI, V37, P7049, DOI 10.1523/JNEUROSCI.3103-16.2017; Iwata M, 2016, BIOL PSYCHIAT, V80, P12, DOI 10.1016/j.biopsych.2015.11.026; Juhasz G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116316; Juhasz G, 2011, BIOL PSYCHIAT, V69, P762, DOI 10.1016/j.biopsych.2010.11.019; Juhasz G, 2009, NEUROPSYCHOPHARMACOL, V34, P2019, DOI 10.1038/npp.2009.19; Kendler KS, 2001, PSYCHOL MED, V31, P411, DOI 10.1017/S0033291701003622; Kendler KS, 1997, PSYCHOL MED, V27, P539, DOI 10.1017/S0033291797004716; Kendler KS, 1999, AM J PSYCHIAT, V156, P837, DOI 10.1176/ajp.156.6.837; Kohler-Forsherg O, 2019, ACTA PSYCHIAT SCAND, V139, P404, DOI 10.1111/acps.13016; Lazary J, 2008, BIOL PSYCHIAT, V64, P498, DOI 10.1016/j.biopsych.2008.03.030; Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Lucae S, 2006, HUM MOL GENET, V15, P2438, DOI 10.1093/hmg/ddl166; McGuffin P, 2005, HUM MOL GENET, V14, P3337, DOI 10.1093/hmg/ddi363; Mechawar N, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.212; Metzger MW, 2017, J NEUROSCI, V37, P11688, DOI 10.1523/JNEUROSCI.3487-16.2017; Meyer JH, 2020, LANCET PSYCHIAT, V7, P1064, DOI 10.1016/S2215-0366(20)30255-8; Monif M, 2010, INT J BIOCHEM CELL B, V42, P1753, DOI 10.1016/j.biocel.2010.06.021; Mu YL, 2010, CURR OPIN NEUROBIOL, V20, P416, DOI 10.1016/j.conb.2010.04.010; Ongur D, 2014, HARVARD REV PSYCHIAT, V22, P334, DOI 10.1097/HRP.0000000000000060; Otrokocsi L, 2017, INT J NEUROPSYCHOPH, V20, P813, DOI 10.1093/ijnp/pyx046; Papp L, 2004, J PHARMACOL EXP THER, V310, P973, DOI 10.1124/jpet.104.066712; Pereira VS, 2013, EUR NEUROPSYCHOPHARM, V23, P1769, DOI 10.1016/j.euroneuro.2013.01.008; Pfau ML, 2018, ANNU REV PHARMACOL, V58, P411, DOI 10.1146/annurev-pharmtox-010617-052823; Ribeiro DE, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112778; Richards EM, 2018, EJNMMI RES, V8, DOI 10.1186/s13550-018-0401-9; Soronen P, 2011, AM J MED GENET B, V156B, P435, DOI 10.1002/ajmg.b.31179; Sperlagh B, 2006, PROG NEUROBIOL, V78, P327, DOI 10.1016/j.pneurobio.2006.03.007; Stokes L, 2010, FASEB J, V24, P2916, DOI 10.1096/fj.09-150862; Su WJ, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00412; Tan SJ, 2017, BIOL PHARM BULL, V40, P1260, DOI 10.1248/bpb.b17-00131; Trivedi MH, 2006, AM J PSYCHIAT, V163, P28, DOI 10.1176/appi.ajp.163.1.28; Vereczkei A, 2019, PROG NEURO-PSYCHOPH, V92, P207, DOI 10.1016/j.pnpbp.2019.01.006; Wang DW, 2020, CELL BIOSCI, V10, DOI 10.1186/s13578-020-00388-1; Yue N, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0865-y	61	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252766	10.1371/journal.pone.0252766	http://dx.doi.org/10.1371/journal.pone.0252766			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111150	Green Published, Green Accepted, gold			2022-12-26	WOS:000664642700041
J	Burns, KEA; Pattani, R; Lorens, E; Straus, SE; Hawker, GA				Burns, Karen E. A.; Pattani, Reena; Lorens, Edmund; Straus, Sharon E.; Hawker, Gillian A.			The impact of organizational culture on professional fulfillment and burnout in an academic department of medicine	PLOS ONE			English	Article							WORK-LIFE BALANCE; JOB-SATISFACTION; RESPONSE RATES; MENTAL-HEALTH; PHYSICIAN; CARE; QUALITY; INTERVENTIONS; ERRORS	Physician wellness is vital to career satisfaction, provision of high quality patient care, and the successful education of the next generation of physicians. Despite this, the number of physicians experience symptoms of burnout is rising. To assess the impact of organizational culture on physicians' professional fulfillment and burnout, we surveyed full-time Department of Medicine members at the University of Toronto. A cross-sectional survey assessed: physician factors (age, gender, minority status, disability, desire to reduce clinical workload); workplace culture (efforts to create a collegial environment, respectful/civil interactions, confidence to address unprofessionalism without reprisal, witnessed and/or personally experienced unprofessionalism); professional fulfillment and burnout using the Stanford Professional Fulfillment Index. We used multivariable linear regression to examine the relationship of measures of workplace culture on professional fulfillment and burnout (scores 0-10), controlling for physician factors. Of 419 respondents (52.0% response rate), we included 400 with complete professional fulfillment and burnout data in analyses (60% <= age 50, 45% female). Mean scores for professional fulfillment and burnout were 6.7 +/- 1.9 and 2.8 +/- 1.9, respectively. Controlling for physician factors, professional fulfillment was associated with satisfaction with efforts to create a collegial environment (adjusted beta 0.45, 95% CI 0.21 to 0.70) and agreement that colleagues were respectful/civil (adjusted beta 0.85, 95% CI 0.53 to 1.17). Lower professional fulfillment was associated with higher burnout scores. Controlling for professional fulfillment and physician factors, lower confidence in taking action to address unprofessionalism (adjusted beta -0.22, 95% CI -0.40 to -0.03) was associated with burnout. Organizational culture and physician factors had an impact on professional fulfillment and burnout. Professional fulfillment partially mediated the relationship between organizational culture and burnout. Strategies that promote inclusion, respect and civility, and safe ways to report workplace unprofessionalism are needed in academic medicine.	[Burns, Karen E. A.; Pattani, Reena; Lorens, Edmund; Straus, Sharon E.; Hawker, Gillian A.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Burns, Karen E. A.; Pattani, Reena; Straus, Sharon E.] Unity Hlth Toronto, St Michaels Hosp, Toronto, ON, Canada; [Hawker, Gillian A.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital	Hawker, GA (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.; Hawker, GA (corresponding author), Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada.	g.hawker@utoronto.ca		Burns, Karen/0000-0002-9967-5424				An PG, 2013, J FAM PRACTICE, V62, P24; Asch DA, 1997, J CLIN EPIDEMIOL, V50, P1129, DOI 10.1016/S0895-4356(97)00126-1; Bahji Anees, 2020, Can Med Educ J, V11, pe97, DOI 10.36834/cmej.57019; Burns KEA, 2008, CAN MED ASSOC J, V179, P245, DOI 10.1503/cmaj.080372; Burns KEA, 2019, CAN J ANESTH, V66, P503, DOI 10.1007/s12630-019-01321-y; Burns KEA, 2015, CAN MED ASSOC J, V187, pE198, DOI 10.1503/cmaj.140545; Cummings SM, 2001, HEALTH SERV RES, V35, P1347; DIMATTEO MR, 1993, HEALTH PSYCHOL, V12, P93, DOI 10.1037/0278-6133.12.2.93; Dyrbye LN, 2018, JAMA-J AM MED ASSOC, V320, P1114, DOI 10.1001/jama.2018.12615; Dyrbye LN, 2014, ACAD MED, V89, P443, DOI 10.1097/ACM.0000000000000134; Dyrbye LN, 2013, MAYO CLIN PROC, V88, P1358, DOI 10.1016/j.mayocp.2013.07.016; Erickson SM, 2017, ANN INTERN MED, V166, P659, DOI 10.7326/M16-2697; GROL R, 1985, FAM PRACT, V2, P128, DOI 10.1093/fampra/2.3.128; Haas JS, 2000, J GEN INTERN MED, V15, P122, DOI 10.1046/j.1525-1497.2000.02219.x; Hamidi MS, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3663-z; Han S, 2019, ANN INTERN MED, V170, P784, DOI 10.7326/M18-1422; Hawker G., 2020, J GEN INTERN MED; Hogan AJ, 2019, CAN MED ASSOC J, V191, pE16, DOI 10.1503/cmaj.181008; Jansen NA, 2019, JAMA INTERN MED, V179, P592, DOI 10.1001/jamainternmed.2019.0146; Jha A, 2019, CRISIS HEALTHCARE CA; KLEINBAUM D, 1997, APPL REGRESSION ANAL; Kumar S, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030037; LINN LS, 1985, MED CARE, V23, P1171, DOI 10.1097/00005650-198510000-00006; Linzer M, 2017, J GEN INTERN MED, V32, P56, DOI 10.1007/s11606-016-3856-2; Linzer M, 2009, ANN INTERN MED, V151, P28, DOI 10.7326/0003-4819-151-1-200907070-00006; Liu RX, 2003, COMPUT METH PROG BIO, V71, P141, DOI 10.1016/S0169-2607(02)00058-5; MASLACH C, 1981, J OCCUP BEHAV, V2, P99, DOI 10.1002/job.4030020205; Maslach C, 2017, MED TEACH, V39, P160, DOI 10.1080/0142159X.2016.1248918; MELVILLE A, 1980, SOC SCI MED-MED SOC, V14, P495, DOI 10.1016/0160-7979(80)90050-8; Panagioti M, 2018, JAMA INTERN MED, V178, P1317, DOI 10.1001/jamainternmed.2018.3713; Passmore C, 2002, FAM MED, V34, P281; Porath C, 2013, HARVARD BUS REV, V91, P114; Scheepers RA, 2015, INT J BEHAV MED, V22, P683, DOI 10.1007/s12529-015-9473-3; Shanafelt TD, 2019, MAYO CLIN PROC, V94, P549, DOI 10.1016/j.mayocp.2018.11.035; Shanafelt TD, 2019, MAYO CLIN PROC, V94, P1681, DOI 10.1016/j.mayocp.2018.10.023; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Shanafelt TD, 2012, ARCH INTERN MED, V172, P1377, DOI 10.1001/archinternmed.2012.3199; Shanafelt TD, 2002, ANN INTERN MED, V136, P358, DOI 10.7326/0003-4819-136-5-200203050-00008; Shipman SA, 2013, HEALTH AFFAIR, V32, P1990, DOI 10.1377/hlthaff.2013.0539; Takeuchi M, 2018, TOHOKU J EXP MED, V245, P37, DOI 10.1620/tjem.245.37; Trockel M, 2018, ACAD PSYCHIATR, V42, P11, DOI 10.1007/s40596-017-0849-3; West CP, 2018, J INTERN MED, V283, P516, DOI 10.1111/joim.12752; West CP, 2016, LANCET, V388, P2272, DOI 10.1016/S0140-6736(16)31279-X; Williams ES, 2003, HEALTH CARE MANAGE R, V28, P119, DOI 10.1097/00004010-200304000-00004; Williams ES, 2002, HEALTH SERV RES, V37, P121	45	3	3	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252778	10.1371/journal.pone.0252778	http://dx.doi.org/10.1371/journal.pone.0252778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106959	gold, Green Published			2022-12-26	WOS:000664642200058
J	Henechowicz, TL; Chen, JL; Cohen, LG; Thaut, MH				Henechowicz, Tara L.; Chen, Joyce L.; Cohen, Leonardo G.; Thaut, Michael H.			The prevalence of the Val66Met polymorphism in musicians: Possible evidence for compensatory neuroplasticity from a pilot study	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; SYNAPTIC PLASTICITY; BDNF POLYMORPHISM; BRAIN PLASTICITY; MOTOR; STIMULATION; SYNCHRONIZATION; EXPERTISE; FEEDBACK; FUTURE	The study compared the prevalence of the Val66Met Brain-derived Neurotrophic Factor single nucleotide polymorphism (rs6265) in a sample of musicians (N = 50) to an ethnically matched general population sample from the 1000 Human Genome Project (N = 424). Met-carriers of the polymorphism (Val/Met and Met/Met genotypes) are typically present in 25-30% of the general population and have associated deficits in motor learning and plasticity. Many studies have assessed the benefits of long-term music training for neuroplasticity and motor learning. This study takes a unique genetic approach investigating if the prevalence of the Val66Met BDNF polymorphism, which negatively affects motor learning, is significantly different in musicians from the general population. Our genotype and allele frequency analyses revealed that the distribution of the Val66Met polymorphism was not significantly different in musicians versus the general population (p = 0.6447 for genotype analysis and p = 0.8513 allele analysis). In the Musician sample (N = 50), the prevalence of the Val/Met genotype was 40% and the prevalence of the Met/Met genotype was 2%. In the 1000 Human Genome Project subset (N = 424), the prevalence of Val/Met was 33.25% and the Met/Met genotype prevalence was 4%. Therefore, musicians do exist with the Val66Met polymorphism and the characteristics of long-term music training may compensate for genetic predisposition to motor learning deficits. Since the polymorphism has significant implications for stroke rehabilitation, future studies may consider the implications of the polymorphism in music-based interventions such as Neurologic Music Therapy.	[Henechowicz, Tara L.; Thaut, Michael H.] Univ Toronto, Fac Mus, Mus & Hlth Sci Res Collaboratory, Toronto, ON, Canada; [Chen, Joyce L.] Univ Toronto, Fac Kinesiol, Toronto, ON, Canada; [Cohen, Leonardo G.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Thaut, Michael H.] Univ Toronto, Inst Med Sci, Fac Med, Toronto, ON, Canada	University of Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Toronto	Henechowicz, TL (corresponding author), Univ Toronto, Fac Mus, Mus & Hlth Sci Res Collaboratory, Toronto, ON, Canada.	tara.henechowicz@mail.utoronto.ca		Henechowicz, Tara Lynn/0000-0001-6680-2098				Altenmuller E, 2016, ADV EXP MED BIOL, V957, P197, DOI 10.1007/978-3-319-47313-0_11; Amunts K, 1997, HUM BRAIN MAPP, V5, P206, DOI 10.1002/(SICI)1097-0193(1997)5:3<206::AID-HBM5>3.0.CO;2-7; Brochard R, 2004, BRAIN COGNITION, V54, P103, DOI 10.1016/S0278-2626(03)00264-1; Stewart JC, 2017, J NEUROL PHYS THER, V41, pS17, DOI 10.1097/NPT.0000000000000180; Chaieb L, 2014, NEUROGENETICS, V15, P1, DOI 10.1007/s10048-014-0393-1; Chen JL, 2008, CEREB CORTEX, V18, P2844, DOI 10.1093/cercor/bhn042; Chen JL, 2008, J COGNITIVE NEUROSCI, V20, P226, DOI 10.1162/jocn.2008.20018; Chen JL, 2012, NEUROIMAGE, V59, P1200, DOI 10.1016/j.neuroimage.2011.08.012; Comeau G, 2020, MUSIC MED, V12, P06; Costa-Giomi E, 2005, ANN NY ACAD SCI, V1060, P262, DOI 10.1196/annals.1360.053; Deveci S, 2020, BRAIN RES, V1732, DOI 10.1016/j.brainres.2020.146652; Dinoff A, 2017, EUR J NEUROSCI, V46, P1635, DOI 10.1111/ejn.13603; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; FRANEK M, 1991, INT J PSYCHOPHYSIOL, V11, P277, DOI 10.1016/0167-8760(91)90022-P; Fritsch B, 2010, NEURON, V66, P198, DOI 10.1016/j.neuron.2010.03.035; Fujii S, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00251; Fujioka T, 2012, ANN NY ACAD SCI, V1252, P294, DOI 10.1111/j.1749-6632.2011.06436.x; Furuya S, 2014, J NEUROSCI, V34, P13834, DOI 10.1523/JNEUROSCI.1170-14.2014; Grahn JA, 2012, TOP COGN SCI, V4, P585, DOI 10.1111/j.1756-8765.2012.01213.x; Grau-Sanchez J, 2020, NEUROSCI BIOBEHAV R, V112, P585, DOI 10.1016/j.neubiorev.2020.02.027; Herholz SC, 2012, NEURON, V76, P486, DOI 10.1016/j.neuron.2012.10.011; Hirano M, 2020, CEREB CORTEX, V30, P1148, DOI 10.1093/cercor/bhz154; Hund-Georgiadis M, 1999, EXP BRAIN RES, V125, P417, DOI 10.1007/s002210050698; Joundi RA, 2012, EXP BRAIN RES, V223, P43, DOI 10.1007/s00221-012-3239-9; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Landry SP, 2017, BRAIN COGNITION, V111, P156, DOI 10.1016/j.bandc.2016.12.001; Martins M, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02616; McHughen SA, 2011, EXP BRAIN RES, V213, P415, DOI 10.1007/s00221-011-2791-z; Morin-Moncet O, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197505; Morin-Moncet O, 2014, J NEUROPHYSIOL, V111, P2094, DOI 10.1152/jn.00388.2013; Mosing MA, 2016, INTELLIGENCE, V57, P33, DOI 10.1016/j.intell.2016.04.002; Nooshabadi AS, 2016, BIOSCI BIOTECHNOL RE, V13, P1037, DOI DOI 10.13005/bbra/2130; Palomar-Garcia MA, 2017, CEREB CORTEX, V27, P2768, DOI 10.1093/cercor/bhw120; Park CH, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00400; Pfordresher PQ, 2006, PERCEPT PSYCHOPHYS, V68, P362, DOI 10.3758/BF03193683; Piccirilli M, 2021, J INT NEUROPSYCH SOC, V27, P282, DOI 10.1017/S1355617720000946; Raghavan P, 2015, PHYS MED REH CLIN N, V26, P599, DOI 10.1016/j.pmr.2015.06.008; Repp BH, 2002, J EXP PSYCHOL HUMAN, V28, P1085, DOI 10.1037//0096-1523.28.5.1085; Repp BH, 2007, MUSIC PERCEPT, V24, P367, DOI 10.1525/MP.2007.24.4.367; Rosenkranz K, 2007, J NEUROSCI, V27, P5200, DOI 10.1523/JNEUROSCI.0836-07.2007; Scheurich R, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00458; Schlaug G, 2015, PROG BRAIN RES, V217, P37, DOI 10.1016/bs.pbr.2014.11.020; Schlaug G, 2010, MUSIC PERCEPT, V27, P249, DOI 10.1525/MP.2010.27.4.249; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Spilka MJ, 2010, EXP BRAIN RES, V204, P549, DOI 10.1007/s00221-010-2322-3; Steele CJ, 2013, J NEUROSCI, V33, P1282, DOI 10.1523/JNEUROSCI.3578-12.2013; Tseng YT, 2021, HUM MOVEMENT SCI, V75, DOI 10.1016/j.humov.2020.102748; Tucker MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159608; Ullen F, 2016, PSYCHOL BULL, V142, P427, DOI 10.1037/bul0000033; Ungerleider LG, 2002, NEUROBIOL LEARN MEM, V78, P553, DOI 10.1006/nlme.2002.4091; van Vugt FT, 2015, BRAIN RES, V1606, P54, DOI 10.1016/j.brainres.2015.02.026; Watanabe D, 2007, EXP BRAIN RES, V176, P332, DOI 10.1007/s00221-006-0619-z	52	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0245107	10.1371/journal.pone.0245107	http://dx.doi.org/10.1371/journal.pone.0245107			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106930	Green Submitted, gold, Green Published			2022-12-26	WOS:000664642200005
J	Witte, C; Fowler, JH; Pfeiffer, W; Hungerford, LL; Braun, J; Burchell, J; Papendick, R; Rideout, BA				Witte, Carmel; Fowler, James H.; Pfeiffer, Wayne; Hungerford, Laura L.; Braun, Josephine; Burchell, Jennifer; Papendick, Rebecca; Rideout, Bruce A.			Social network analysis and whole-genome sequencing to evaluate disease transmission in a large, dynamic population: A study of avian mycobacteriosis in zoo birds	PLOS ONE			English	Article							AVIUM SUBSP-AVIUM; NONTUBERCULOUS MYCOBACTERIA; MOLECULAR EPIDEMIOLOGY; TUBERCULOSIS; GENAVENSE; WATER; INFECTION; OUTBREAKS; INTRACELLULARE; ABSCESSUS	This study combined a social network analysis and whole-genome sequencing (WGS) to test for general patterns of contagious spread of a mycobacterial infection for which pathways of disease acquisition are not well understood. Our population included 275 cases diagnosed with avian mycobacteriosis that were nested in a source population of 16,430 birds at San Diego Zoo Wildlife Alliance facilities from 1992 through mid-2014. Mycobacteria species were determined using conventional methods and whole genome sequencing (WGS). Mycobacterium avium avium (MAA) and Mycobacterium genavense were the most common species of mycobacteria identified and were present in different proportions across bird taxa. A social network for the birds was constructed from the source population to identify directly and indirectly connected cases during time periods relevant to disease transmission. Associations between network connectivity and genetic similarity of mycobacteria (as determined by clusters of genotypes separated by few single nucleotide polymorphisms, or SNPs) were then evaluated in observed and randomly generated network permutations. Findings showed that some genotypes clustered along pathways of bird connectivity, while others were dispersed throughout the network. The proportion of directly connected birds having a similar mycobacterial genotype was 0.36 and significant (p<0.05). This proportion was higher (0.58) and significant for MAA but not for M. genavense. Evaluations of SNP distributions also showed genotypes of MAA were more related in connected birds than expected by chance; however, no significant patterns of genetic relatedness were identified for M. genavense, although data were sparse. Integrating the WGS analysis of mycobacteria with a social network analysis of their host birds revealed significant genetic clustering along pathways of connectivity, namely for MAA. These findings are consistent with a contagious process occurring in some, but not all, case clusters.	[Witte, Carmel; Braun, Josephine; Burchell, Jennifer; Papendick, Rebecca; Rideout, Bruce A.] San Diego Zoo Wildlife Alliance, Dis Invest, San Diego, CA 92101 USA; [Witte, Carmel] Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA; [Witte, Carmel] San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA; [Fowler, James H.] Univ Calif San Diego, Dept Polit Sci, La Jolla, CA 92093 USA; [Pfeiffer, Wayne] Univ Calif San Diego, San Diego Supercomp Ctr, La Jolla, CA 92093 USA; [Hungerford, Laura L.] Virginia Maryland Coll Vet Med, Dept Populat Hlth Sci, Blacksburg, VA USA	University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego; University of California System; University of California San Diego	Witte, C (corresponding author), San Diego Zoo Wildlife Alliance, Dis Invest, San Diego, CA 92101 USA.; Witte, C (corresponding author), Univ Calif San Diego, Dept Family Med & Publ Hlth, La Jolla, CA 92093 USA.; Witte, C (corresponding author), San Diego State Univ, Grad Sch Publ Hlth, San Diego, CA 92182 USA.	cwitte@sdzwa.org		Witte, Carmel/0000-0001-9086-3333				Beller K., 1930, ARCH F GEFLUGELKDE, V4, P453; Brown M.J., 1992, Wildfowl, V43, P70; Bryant JM, 2013, LANCET, V381, P1551, DOI 10.1016/S0140-6736(13)60632-7; Bryant JM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-110; Bush M., 1978, P199; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Carpenter N., 2013, INFECT DIS CAPTIVE F, V2nd, P869; Christakis NA, 2013, STAT MED, V32, P556, DOI 10.1002/sim.5408; Cohen T, 2012, CLIN MICROBIOL REV, V25, P708, DOI 10.1128/CMR.00021-12; Crispell J, 2019, ELIFE, V8, DOI 10.7554/eLife.45833; Cromie R.L., 1992, Wildfowl, V43, P211; CROMIE RL, 1991, TUBERCLE, V72, P105, DOI 10.1016/0041-3879(91)90036-R; Csardi G., 2006, INT J COMPLEX SYST, P1695; Dvorska L, 2007, VET MICROBIOL, V119, P366, DOI 10.1016/j.vetmic.2006.09.010; Falkinham JO, 2009, J APPL MICROBIOL, V107, P356, DOI 10.1111/j.1365-2672.2009.04161.x; Falkinham JO, 2018, AIMS MICROBIOL, V4, P428, DOI 10.3934/microbiol.2018.3.428; Falkinham Joseph O 3rd, 2016, Curr Environ Health Rep, V3, P161, DOI 10.1007/s40572-016-0086-z; Falkinham JO, 2008, J WATER HEALTH, V6, P209, DOI [10.2166/wh.2008.232, 10.2166/wh.2008.032]; Falkinham JO, 2015, CLIN CHEST MED, V36, P35, DOI 10.1016/j.ccm.2014.10.003; Falkinham JO, 2011, EMERG INFECT DIS, V17, P419, DOI 10.3201/eid1703.101510; Farine DR, 2017, METHODS ECOL EVOL, V8, P1309, DOI 10.1111/2041-210X.12772; Feldman WH., 1938, AVIAN TUBERCULOSIS I; Fitzgerald SD., 2010, TRANSMISSIBLE DIS HD, V4th, P1; Friend M., 1999, FIELD MANUAL WILDLIF, P93; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Fulton RM., 2013, DIS POULTRY, V13th, P1008; Gardy JL, 2011, NEW ENGL J MED, V364, P730, DOI 10.1056/NEJMoa1003176; Guthrie JL, 2017, ANN NY ACAD SCI, V1388, P59, DOI 10.1111/nyas.13273; Hillebrand-Haverkort ME, 1999, SCAND J INFECT DIS, V31, P63, DOI 10.1080/00365549950161907; Hinshaw HR., 1927, J AM VET MED ASSOC, V71, P764; HOOP RK, 1993, J CLIN MICROBIOL, V31, P990, DOI 10.1128/JCM.31.4.990-993.1993; Kahana LM, 1997, CHEST, V111, P242, DOI 10.1378/chest.111.1.242; Kanamori H, 2016, CLIN INFECT DIS, V62, P1423, DOI 10.1093/cid/ciw122; Kao RR, 2014, TRENDS MICROBIOL, V22, P282, DOI 10.1016/j.tim.2014.02.011; Kauppinen J, 2001, VET MICROBIOL, V81, P41, DOI 10.1016/S0378-1135(01)00330-3; Mahmood M, 2018, INFECT DIS-NOR, V50, P329, DOI 10.1080/23744235.2017.1404630; Manarolla G, 2009, VET MICROBIOL, V133, P323, DOI 10.1016/j.vetmic.2008.07.017; Mangione EJ, 2001, EMERG INFECT DIS, V7, P1039, DOI 10.3201/eid0706.010623; Mansfield KG, 1997, J INFECT DIS, V175, P184, DOI 10.1093/infdis/175.1.184; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Montali RJ, 1998, J INFECT DIS, V178, P1719, DOI 10.1086/314517; MONTALI RJ, 1976, J AM VET MED ASSOC, V169, P920; Mullis SN, 2013, J APPL MICROBIOL, V115, P908, DOI 10.1111/jam.12272; Newman M.E.J., 2010, NETWORKS INTRO; Nikolayevskyy V, 2016, TUBERCULOSIS, V98, P77, DOI 10.1016/j.tube.2016.02.009; Packer S, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3734-8; Palmieri C, 2013, J COMP PATHOL, V148, P126, DOI 10.1016/j.jcpa.2012.06.005; Perkins KM, 2016, MMWR-MORBID MORTAL W, V65, P1117, DOI 10.15585/mmwr.mm6540a6; Pfeiffer W, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173464; Portaels F, 1996, J CLIN MICROBIOL, V34, P319, DOI 10.1128/JCM.34.2.319-323.1996; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Schalk AF., TECHNICAL B N DAKOTA, V5279, P46; Schmitz A, 2018, VET MICROBIOL, V218, P40, DOI 10.1016/j.vetmic.2018.03.026; Schrenzel M, 2008, VET MICROBIOL, V126, P122, DOI 10.1016/j.vetmic.2007.06.016; Shamputa IC, 2004, J CLIN MICROBIOL, V42, P5528, DOI 10.1128/JCM.42.12.5528-5536.2004; Shitaye JE, 2008, VET MICROBIOL, V127, P155, DOI 10.1016/j.vetmic.2007.07.026; Siegel CE, 1991, AAZPA ANN C P, P469; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tobin-D'Angelo MJ, 2004, J INFECT DIS, V189, P98, DOI 10.1086/380492; Vasylyeva TI, 2016, INFECT GENET EVOL, V46, P248, DOI 10.1016/j.meegid.2016.05.042; von Bornstedt S., 1932, ARCH F GEFLUGELK, V41, P241; Walker TM, 2013, LANCET INFECT DIS, V13, P137, DOI 10.1016/S1473-3099(12)70277-3; Warren RM, 2004, AM J RESP CRIT CARE, V169, P610, DOI 10.1164/rccm.200305-714OC; Witte C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237168; Witte CL, 2010, JAVMA-J AM VET MED A, V236, P211, DOI 10.2460/javma.236.2.211; Witte CL, 2008, J VET DIAGN INVEST, V20, P186, DOI 10.1177/104063870802000207; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	67	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252152	10.1371/journal.pone.0252152	http://dx.doi.org/10.1371/journal.pone.0252152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106953	Green Published, gold			2022-12-26	WOS:000664642200031
J	Twiss, SD; Brannan, N; Shuert, CR; Bishop, AM; Pomeroy, PP; Moss, S				Twiss, Sean D.; Brannan, Naomi; Shuert, Courtney R.; Bishop, Amanda M.; Pomeroy, Patrick. P.; Moss, Simon			An external telemetry system for recording resting heart rate variability and heart rate in free-ranging large wild mammals	PLOS ONE			English	Article							SEALS HALICHOERUS-GRYPUS; FEMALE GREY SEALS; RATE MONITOR; COPING STYLES; GRAY SEALS; STRESS; VALIDATION; PATTERNS; RESPONSES; BEHAVIOR	Measures of heart rate variability (and heart rate more generally) are providing powerful insights into the physiological drivers of behaviour. Resting heart rate variability (HRV) can be used as an indicator of individual differences in temperament and reactivity to physical and psychological stress. There is increasing interest in deriving such measures from free ranging wild animals, where individuals are exposed to the natural and anthropogenic stressors of life. We describe a robust, externally mounted heart rate monitor for use in wild mammals, deployed here on wild breeding adult female grey seals (Halichoerus grypus), that delivers millisecond precise measures of inter beat intervals (IBIs), allowing computation of resting HRV parameters. Based on Firstbeat (TM) heart rate belts, our system allows for remote, continuous recording of IBI data from over 30 individuals simultaneously at ranges of up to 200m. We assessed the accuracy of the IBI data provided by the Firstbeat (TM) system using concurrent IBI data derived from in-field electrocardiogram (ECG) recordings. Bland-Altmann analyses demonstrated high correspondence between the two sets of IBI data, with a mean difference of 0.87 +/- 0.16ms. We used generalized additive mixed-effects models to examine the impact of the default Firstbeat (TM) software artefact correction procedure upon the generation of anomalous data (flats and stairs). Artefact correction and individual activity were major causes of flats and stairs. We used simulations and models to assess the impact of these errors on estimates of resting HRV and to inform criteria for subsampling relatively error free IBI traces. These analyses allowed us to establish stringent filtering procedures to remove traces with excessive numbers of artefacts, including flats and stairs. Even with strict criteria for removing potentially erroneous data, the abundance of data yielded by the Firstbeat (TM) system provides the potential to extract robust estimates of resting HRV. We discuss the advantages and limitations of our system for applications beyond the study system described here.	[Twiss, Sean D.; Brannan, Naomi; Shuert, Courtney R.; Bishop, Amanda M.] Univ Durham, Dept Biosci, Durham, England; [Pomeroy, Patrick. P.; Moss, Simon] Univ St Andrews, Scottish Oceans Inst, Sea Mammal Res Unit, St Andrews, Fife, Scotland; [Brannan, Naomi] Southeast Asia Marine Mammal Res SEAMAR, Hong Kong, Peoples R China; [Shuert, Courtney R.] Univ Windsor, Dept Integrat Biol, Windsor, ON, Canada; [Bishop, Amanda M.] Univ Alaska Fairbanks, Water & Environm Res Ctr, Fairbanks, AK USA	Durham University; University of St Andrews; University of Windsor; University of Alaska System; University of Alaska Fairbanks	Twiss, SD (corresponding author), Univ Durham, Dept Biosci, Durham, England.	s.d.twiss@durham.ac.uk		Brannan, Naomi/0000-0002-3939-5017; pomeroy, patrick/0000-0003-1603-5630	UK NERC; NERC [NE/G008930/1]; Esme'e Fairbairn Foundation; Durham Doctoral Studentship scheme	UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Esme'e Fairbairn Foundation; Durham Doctoral Studentship scheme	UK NERC supported the long-term research at the Isle of May through core funding to SMRU. PP was in receipt of NERC grant no. NE/G008930/1 and Esme ' e Fairbairn Foundation funding during the work. AMB and CRS were supported by the Durham Doctoral Studentship scheme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RD, 1997, J EXP BIOL, V200, P2083; [Anonymous], 2010, J NORTHWEST ATL FISH; Barton K., 2014, R package; Bennett KA, 2007, J EXP BIOL, V210, P3043, DOI 10.1242/jeb.009381; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Brannan NBL, 2017, THESIS DURHAM U DURH; Butler PJ, 2004, FUNCT ECOL, V18, P168, DOI 10.1111/j.0269-8463.2004.00821.x; CASTELLINI MA, 1994, AM J PHYSIOL, V266, pR863, DOI 10.1152/ajpregu.1994.266.3.R863; Chaise LL, 2017, POLAR BIOL, V40, P2307, DOI 10.1007/s00300-017-2144-x; Essner A, 2015, PHYSIOL BEHAV, V138, P247, DOI 10.1016/j.physbeh.2014.10.034; Fahlman A, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.604018; FEDAK MA, 1988, CAN J ZOOL, V66, P53, DOI 10.1139/z88-007; Fonfara S, 2015, MAR MAMMAL SCI, V31, P998, DOI 10.1111/mms.12201; Greaves DK, 2004, MAR MAMMAL SCI, V20, P861, DOI 10.1111/j.1748-7692.2004.tb01197.x; Green JA, 2011, COMP BIOCHEM PHYS A, V158, P287, DOI 10.1016/j.cbpa.2010.09.011; Halsey LG, 2019, FUNCT ECOL, V33, P260, DOI 10.1111/1365-2435.13264; Hiby L, 2013, METHODS ECOL EVOL, V4, P252, DOI 10.1111/2041-210x.12008; Hill Labarron K, 2009, Biomed Sci Instrum, V45, P71; HOPSTER H, 1994, CAN J ANIM SCI, V74, P465, DOI 10.4141/cjas94-066; Ingram SN, 2007, J MAR BIOL ASSOC UK, V87, P149, DOI 10.1017/S0025315407054884; Jonckheer-Sheehy VSM, 2012, J VET BEHAV, V7, P205, DOI 10.1016/j.jveb.2011.10.006; Kaufmann T, 2011, BEHAV RES METHODS, V43, P1161, DOI 10.3758/s13428-011-0107-7; Koolhaas JM, 2010, FRONT NEUROENDOCRIN, V31, P307, DOI 10.1016/j.yfrne.2010.04.001; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; KOVACS KM, 1987, J ZOOL, V213, P697, DOI 10.1111/j.1469-7998.1987.tb03735.x; Langton SD, 2011, VET REC, V168, DOI 10.1136/vr.d1047; Lapierre JL, 2004, J EXP BIOL, V207, P3891, DOI 10.1242/jeb.01222; Marchant-Forde RM, 2004, PHYSIOL BEHAV, V80, P449, DOI 10.1016/j.physbeh.2003.09.007; Martinez CAG, 2017, USE R, P1, DOI 10.1007/978-3-319-65355-6; Mohr E, 2002, PHYSIOL BEHAV, V75, P251, DOI 10.1016/S0031-9384(01)00651-5; Oishi K, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01063; Penttila J, 2001, CLIN PHYSIOL, V21, P365, DOI 10.1046/j.1365-2281.2001.00337.x; Pohlin F, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00664; Pomeroy PP, 2000, J ZOOL, V250, P1; Pomeroy PP, 1999, J ANIM ECOL, V68, P235, DOI 10.1046/j.1365-2656.1999.00281.x; Portugal SJ, 2016, PHYSIOL BIOCHEM ZOOL, V89, P251, DOI 10.1086/686322; R Core Team, 2020, R LANG ENV STAT COMP; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Richards SA, 2011, BEHAV ECOL SOCIOBIOL, V65, P77, DOI 10.1007/s00265-010-1035-8; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Saalasti S., 2004, ADV METHODS PROCESSI; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shuert C.R., 2019, THESIS DURHAM U; Shuert CR, 2020, J ANIM ECOL, V89, P2461, DOI 10.1111/1365-2656.13312; Shuert CR, 2019, BEHAV ECOL SOCIOBIOL, V74, DOI 10.1007/s00265-019-2783-8; Shuert CR., 2018, ANIM BIOTELEM, V6, P14, DOI DOI 10.1186/S40317-018-0158-Y; Signer C, 2010, METHODS ECOL EVOL, V1, P75, DOI 10.1111/j.2041-210X.2009.00010.x; Stewart JE, 2014, MAR MAMMAL SCI, V30, P1456, DOI 10.1111/mms.12126; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; THOMPSON D, 1993, J EXP BIOL, V174, P139; Twiss SD, 2000, ANIM BEHAV, V59, P327, DOI 10.1006/anbe.1999.1320; Twiss SD, 2006, MOL ECOL, V15, P1939, DOI 10.1111/j.1365-294X.2006.02927.x; Twiss SD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66597-3; Twiss SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049598; van Rij J., 2017, R PACKAGE; Vincent C, 2001, MAMMALIA, V65, P363, DOI 10.1515/mamm.2001.65.3.363; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Wascher CAF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20655-z; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Wood SN, 2015, J R STAT SOC C-APPL, V64, P139, DOI 10.1111/rssc.12068; Wood SN, 2006, BIOMETRICS, V62, P1025, DOI 10.1111/j.1541-0420.2006.00574.x; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x; Zuur Alain F., 2009, P1	64	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252013	10.1371/journal.pone.0252013	http://dx.doi.org/10.1371/journal.pone.0252013			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086713	Green Published, Green Accepted, gold			2022-12-26	WOS:000664640100029
J	Yalew, M; Adane, B; Damtie, Y; Kefale, B; Dewau, R; Mektu, K; Arefaynie, M; Andargie, A				Yalew, Melaku; Adane, Bezawit; Damtie, Yitayish; Kefale, Bereket; Dewau, Reta; Mektu, Kefale; Arefaynie, Mastewal; Andargie, Assefa			Determinants of change in timely first antenatal booking among pregnant women in Ethiopia: A decomposition analysis	PLOS ONE			English	Article							PUBLIC-HEALTH INSTITUTIONS; CARE VISIT; INITIATION; SERVICES; TIGRAY; PREDICTORS; MORTALITY; DISTRICT; MOTHERS; TRENDS	Background Even though maternal health was highly targeted in different global strategies, maternal mortality could not be decreased as was expected. Besides this, prior decomposition analysis to the possible cause of changes to timely first antenatal booking has not been conducted. Therefore, this study aimed to assess determinants of change in timely first antenatal booking among pregnant women in Ethiopia. Methods The study utilized three consecutive Ethiopia Demographic and Health Survey (EDHS) datasets which were collected through cross-sectional study design. The number of pregnant women who gave birth in 2005, 2011 and 2016 survey included in the analysis was 7,307, 7,908 and 7,590 respectively. The data were analyzed by using Stata/SE version 14.0. Logit-based decomposition analysis was done to identify contributing factors for change in timely first antenatal booking and statistical significance was determined by using P-value. Results The trend of timely first antenatal booking was increased from 6% to 20% in the last ten years. The analysis revealed that 14% of the overall change was because of the change in women's composition. Changes in the composition of women according to region, education and occupation status were the major sources of this change. The remaining, 86% of the change was due to differences in the coefficient. Mostly, the change in behaviors of the Oromia population, those who have lived in the rural areas and male household head were some of the contributing factors for the increase in timely first antenatal booking. Conclusions There was a significant increase in timely first antenatal booking among pregnant women in Ethiopia from 2005 to 2016 EDHS. The change in the women composition according to residency, education and occupation status of women and the difference in behaviors like: behavior of rural residents and male household head contributed to the majority of the change. Interventions targeting the male household head, rural residents and those women who lived in the Oromia region should be emphasized to increase further timely booking. In addition, promoting women in terms of education and creating job opportunities could be the other recalled intervention areas of the country.	[Yalew, Melaku; Damtie, Yitayish; Kefale, Bereket; Arefaynie, Mastewal] Wollo Univ, Sch Publ Hlth, Dept Reprod & Family Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia; [Adane, Bezawit; Dewau, Reta; Andargie, Assefa] Wollo Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Coll Med & Hlth Sci, Dessie, Ethiopia; [Mektu, Kefale] Wollo Univ, Sch Med, Dept Physiol, Coll Med & Hlth Sci, Dessie, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Yalew, M (corresponding author), Wollo Univ, Sch Publ Hlth, Dept Reprod & Family Hlth, Coll Med & Hlth Sci, Dessie, Ethiopia.	meleya7@gmail.com	Arefaynie, Mastewal/AAZ-8374-2021; Dewau, Reta/AAA-4202-2022	Arefaynie, Mastewal/0000-0001-9525-0552; Dewau, Reta/0000-0001-6531-2468; Andargie, Assefa/0000-0002-8409-7545; Kefale Abitew, Bereket/0000-0003-1795-9886				Abame Desta Erkalo, 2019, J Reprod Infertil, V20, P42; Abosse Z, 2010, ETHIOP J HEALTH SCI, V20, P75; AbouZahr C., 2003, PROMISES ACHIEVEMENT; Abuka T., 2016, J PREG CHILD HLTH, V3, P2; Adekanle DA, 2008, ONLINE J HLTH ALLIED, V7, P1; Alderliesten ML, 2007, BJOG-INT J OBSTET GY, V114, P1232, DOI 10.1111/j.1471-0528.2007.01438.x; Alemu Y, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0646-9; Ali S., 2018, J PREG NEONATAL MED, V2; Amo-Adjei J, 2016, TROP MED INT HEALTH, V21, P1552, DOI 10.1111/tmi.12788; Babalola S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-43; Banda I., 2012, MED J AUSTRALIA, V39, P29; Barasa K.S., 2015, AM J THEOR APPL STAT, V4, P322; Bayou YT, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0930-z; Belayneh T, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/132494; Central Statistical Agency (CSA) [Ethiopia] and ICF, 2017, ETH DEM HLTH SURV; Dairo M. D., 2010, Benin Journal of Postgraduate Medicine, V12, P3; Damme TG., 2015, J GYNECOL OBSTET, V26, P103, DOI 10.11648/j.jgo.20150305.12; Dibaba Y, 2009, ETHIOP J HEALTH SCI, V19; Dibaba Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-50; Ewunetie AA, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1748-7; Fagbamigbe AF, 2019, ADV INTEGR MED, V6, P110, DOI 10.1016/j.aimed.2018.12.002; Feyera B, 2017, E AFRICAN J HLTH BIO, V1, P21; Gebrekidan K, 2017, PRAGMAT OBS RES, V8, P223, DOI 10.2147/POR.S140733; Gebremeskel F, 2015, J ENVIRON PUBLIC HEA, V2015, DOI 10.1155/2015/971506; Gebresilassie B, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2490-5; Gedle M., 2017, INT ACAD J HLTH MED, V1, P66; Gidey G., 2018, ASIAN J PHARM CLIN R, V11, P409; Gudayu TW, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-287; Gudu W., 2018, ETHIOPIAN J REPROD H, V10, P25; Habtewold TD, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023956; Haftu Abera, 2018, BMC Res Notes, V11, P872, DOI 10.1186/s13104-018-3987-0; Hussen S., 2016, J WOMENS HLTH CARE, V5, P2167; Jiee S. F., 2018, International Journal of Public Health Research (Malaysia), V8, P956; Kotoh AM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7400-2; Manzi A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-290; Mathai M., 2011, ALTERNATIVE VERSUS S; Mkhari MM., 2016, THESIS; Moller AB, 2017, LANCET GLOB HEALTH, V5, pE977, DOI 10.1016/S2214-109X(17)30325-X; Njiku F., 2017, TANZANIA J HLTH RES, V19; Orsido TT, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2227-5; Oyerinde, 2013, J COMMUNITY MED HLTH, V3, P2, DOI [10.4172/2161-0711.1000e116, DOI 10.4172/2161-0711.1000E116]; Paudel YR, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00242; Powers DA, 2011, STATA J, V11, P556, DOI 10.1177/1536867X1101100404; Saxena V., 2011, INDIAN J PREV SOC ME, V42, P14; Singh S., 2009, BARRIERS SAFE MOTHER, P1; Sinyange Nyambe, 2016, Pan Afr Med J, V25, P109, DOI 10.11604/pamj.2016.25.109.6873; Tafere TE, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0544-3; Tekelab T., 2014, SCI TECHNOL ARTS RES, V3, P108, DOI [10.4314/star.v3i1.17, DOI 10.4314/STAR.V3I1.17]; Tesfaye G, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0412-4; Tessema GA, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4071-8; Tsegay Y, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-30; Tufa G, 2020, INT J WOMENS HEALTH, V12, P657, DOI 10.2147/IJWH.S255009; United Nations Population F, 2014, TRENDS MAT MORT 1990; WHO, 2018, WHO REC ANT CAR CONT; Wolde HF, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0745-2; Wondwossen Lerebo, 2015, Clinics in Mother and Child Health, V12, P171; World Health Organization, 2013, GUIDELINES MANAGEMEN; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Young M, 2012, AM J TROP MED HYG, V87, P6, DOI 10.4269/ajtmh.2012.12-0221; Zegeye AM., 2013, AFR J REPROD HEALTH, V17	60	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251847	10.1371/journal.pone.0251847	http://dx.doi.org/10.1371/journal.pone.0251847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086688	gold, Green Published			2022-12-26	WOS:000664640100023
J	Nguyen, H; Koh, JY; Li, HN; Islas-Robles, A; Venkata, SPM; Wang, JM; Monks, TJ				Nguyen, Huong; Koh, Jia Yi; Li, Hainan; Islas-Robles, Argel; Venkata, Sai Pranathi Meda; Wang, Jie-Mei; Monks, Terrence J.			A novel imidazolinone metformin-methylglyoxal metabolite promotes endothelial cell angiogenesis via the eNOS/HIF-1 alpha pathway	FASEB JOURNAL			English	Article						angiogenesis; endothelial nitric oxide synthase; hypoxia-inducible factor-1 alpha; methylglyoxal; metformin	PERIPHERAL ARTERIAL-DISEASE; HYPOXIA-INDUCIBLE FACTOR-1; NITRIC-OXIDE SYNTHASE; THERAPEUTIC ANGIOGENESIS; IN-VIVO; HIF-1-ALPHA; ACTIVATION; INHIBITION; GROWTH; PHOSPHORYLATION	Peripheral arterial disease (PAD) is one of the major complications of diabetes due to an impairment in angiogenesis. Since there is currently no drug with satisfactory efficacy to enhance blood vessel formation, discovering therapies to improve angiogenesis is critical. An imidazolinone metabolite of the metformin-methylglyoxal scavenging reaction, (E)-1,1-dimethyl-2-(5-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl) guanidine (IMZ), was recently characterized and identified in the urine of type-2 diabetic patients. Here, we report the pro-angiogenesis effect of IMZ (increased aortic sprouting, cell migration, network formation, and upregulated multiple pro-angiogenic factors) in human umbilical vein endothelial cells. Using genetic and pharmacological approaches, we showed that IMZ augmented angiogenesis by activating the endothelial nitric oxide synthase (eNOS)/hypoxia-inducible factor-1 alpha (HIF-1 alpha) pathway. Furthermore, IMZ significantly promoted capillary density in the in vivo Matrigel plug angiogenesis model. Finally, the role of IMZ in post-ischemic angiogenesis was examined in a chronic hyperglycemia mouse model subjected to hind limb ischemia. We observed improved blood perfusion, increased capillary density, and reduced tissue necrosis in mice receiving IMZ compared to control mice. Our data demonstrate the pro-angiogenic effects of IMZ, its underlying mechanism, and provides a structural basis for the development of potential pro-angiogenic agents for the treatment of PAD.	[Nguyen, Huong; Koh, Jia Yi; Li, Hainan; Venkata, Sai Pranathi Meda; Wang, Jie-Mei; Monks, Terrence J.] Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 259 Mack Ave,5146 Applebaum Bldg, Detroit, MI 48201 USA; [Islas-Robles, Argel] Inst In Vitro Sci Inc, Gaithersburg, MD USA; [Wang, Jie-Mei] Wayne State Univ, Ctr Mol Med, Detroit, MI USA	Wayne State University; Wayne State University	Wang, JM; Monks, TJ (corresponding author), Wayne State Univ, Eugene Applebaum Coll Pharm & Hlth Sci, Dept Pharmaceut Sci, 259 Mack Ave,5146 Applebaum Bldg, Detroit, MI 48201 USA.	jiemei.wang@wayne.edu; terrence.monks@wayne.edu	Meda Venkata, Sai Pranathi/GNP-8412-2022; WANG, JIEMEI/D-6317-2012	Meda Venkata, Sai Pranathi/0000-0002-1771-4806; WANG, JIEMEI/0000-0002-8723-4410	NIH/NIDDK [R01 DK109036, R01 DK119222]; Wayne State University new faculty startup funding in the Department of Pharmaceutical Sciences	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Wayne State University new faculty startup funding in the Department of Pharmaceutical Sciences	This work was supported in part by NIH/NIDDK R01 DK109036 (To JMW), R01 DK119222 (To TJM and JMW) and Wayne State University new faculty startup funding in the Department of Pharmaceutical Sciences (To TJM)	Annex BH, 2013, NAT REV CARDIOL, V10, P387, DOI 10.1038/nrcardio.2013.70; Bandyopadhyay A, 2002, ONCOGENE, V21, P3541, DOI 10.1038/sj.onc.1205439; Bir SC, 2012, CARDIOVASC RES, V95, P7, DOI 10.1093/cvr/cvs143; BOGLE RG, 1994, BRIT J PHARMACOL, V111, P1257, DOI 10.1111/j.1476-5381.1994.tb14881.x; Boo YC, 2002, J BIOL CHEM, V277, P3388, DOI 10.1074/jbc.M108789200; Bove PF, 2008, J BIOL CHEM, V283, P17919, DOI 10.1074/jbc.M709914200; Brahimi-Horn C, 2005, CELL SIGNAL, V17, P1, DOI 10.1016/j.cellsig.2004.04.010; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Clark N, 2003, DIABETES CARE, V26, P3333; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Cui HQ, 2018, FOOD CHEM, V265, P227, DOI 10.1016/j.foodchem.2018.04.045; Davies Sean S, 2017, Curr Pharmacol Rep, V3, P51, DOI 10.1007/s40495-017-0081-6; dela Paz NG, 2009, CELL TISSUE RES, V335, P5, DOI 10.1007/s00441-008-0706-5; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Edmonds M, 2006, DRUGS, V66, P913, DOI 10.2165/00003495-200666070-00003; El-Awady MS, 2014, J PHARM PHARMACOL, V66, P835, DOI 10.1111/jphp.12204; Esfahanian N, 2012, MOL MED REP, V5, P1068, DOI 10.3892/mmr.2012.753; Fenton C, 2006, DRUGS, V66, P477, DOI 10.2165/00003495-200666040-00006; Grundy SM, 1999, CIRCULATION, V100, P1134, DOI 10.1161/01.CIR.100.10.1134; Iyer Sunil R, 2017, JACC Basic Transl Sci, V2, P503, DOI 10.1016/j.jacbts.2017.07.012; Joshi MS, 2007, P NATL ACAD SCI USA, V104, P9982, DOI 10.1073/pnas.0506824104; Kasuno K, 2004, J BIOL CHEM, V279, P2550, DOI 10.1074/jbc.M308197200; Kinsky OR, 2016, CHEM RES TOXICOL, V29, P227, DOI 10.1021/acs.chemrestox.5b00497; Krock Bryan L, 2011, Genes Cancer, V2, P1117, DOI 10.1177/1947601911423654; Lee JW, 2004, EXP MOL MED, V36, P1, DOI 10.1038/emm.2004.1; Lekakis JP, 2002, INT J CARDIOL, V86, P317, DOI 10.1016/S0167-5273(02)00413-8; Li F, 2007, MOL CELL, V26, P63, DOI 10.1016/j.molcel.2007.02.024; Li HN, 2017, AM J PHYSIOL-ENDOC M, V313, pE391, DOI 10.1152/ajpendo.00073.2017; Marso SP, 2006, J AM COLL CARDIOL, V47, P921, DOI 10.1016/j.jacc.2005.09.065; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; Mohler ER, 2007, NAT CLIN PRACT CARD, V4, P151, DOI 10.1038/ncpcardio0823; Nigro C, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010188; Norrby K, 2006, J CELL MOL MED, V10, P588, DOI 10.1111/j.1582-4934.2006.tb00423.x; Olson N, 2011, NITRIC OXIDE-BIOL CH, V25, P125, DOI 10.1016/j.niox.2010.12.010; Palmer LA, 2000, MOL PHARMACOL, V58, P1197, DOI 10.1124/mol.58.6.1197; Park YK, 2008, MOL PHARMACOL, V74, P236, DOI 10.1124/mol.108.045278; Raasch W, 2001, BRIT J PHARMACOL, V133, P755, DOI 10.1038/sj.bjp.0704153; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; Ripa RS, 2006, EUR HEART J, V27, P1785, DOI 10.1093/eurheartj/ehl117; Ruggiero-Lopez D, 1999, BIOCHEM PHARMACOL, V58, P1765, DOI 10.1016/S0006-2952(99)00263-4; Schleicher M, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000343; Simons M, 2002, CIRCULATION, V105, P788, DOI 10.1161/hc0802.104407; Stewart DJ, 2009, MOL THER, V17, P1109, DOI 10.1038/mt.2009.70; Tamarat R, 2002, LAB INVEST, V82, P747, DOI 10.1097/01.LAB.0000017372.76297.EB; Tang N, 2004, CANCER CELL, V6, P485, DOI 10.1016/j.ccr.2004.09.026; Thiruvoipati T, 2015, WORLD J DIABETES, V6, P961, DOI 10.4239/wjd.v6.i7.961; Treins C, 2002, J BIOL CHEM, V277, P27975, DOI 10.1074/jbc.M204152200; Uccioli L, 2018, VASC HEALTH RISK MAN, V14, P63, DOI 10.2147/VHRM.S125065; Ucuzian AA, 2010, J BURN CARE RES, V31, P158, DOI 10.1097/BCR.0b013e3181c7ed82; Wang F, 2002, BIOCHEM BIOPH RES CO, V295, P657, DOI 10.1016/S0006-291X(02)00729-5; Wang JM, 2014, ARTERIOSCL THROM VAS, V34, P99, DOI 10.1161/ATVBAHA.113.302104; Yasinska IM, 2003, FEBS LETT, V549, P105, DOI 10.1016/S0014-5793(03)00807-X; Yu JW, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0408-3; Zhou Q, 2019, FOOD CHEM TOXICOL, V129, P291, DOI 10.1016/j.fct.2019.05.004; Zhu ZW, 2015, AM J PHYSIOL-ENDOC M, V308, pE518, DOI 10.1152/ajpendo.00469.2014	56	3	3	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21645	10.1096/fj.202002674RR	http://dx.doi.org/10.1096/fj.202002674RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105824	Green Published			2022-12-26	WOS:000667814100062
J	You, HM; Wang, L; Bu, FT; Meng, HW; Pan, XY; Li, JJ; Zhang, YF; Wang, A; Yin, NN; Huang, C; Li, J				You, Hongmei; Wang, Ling; Bu, Fangtian; Meng, Hongwu; Pan, Xueyin; Li, Juanjuan; Zhang, Yafei; Wang, Ao; Yin, Nana; Huang, Cheng; Li, Jun			The miR-455-3p/HDAC2 axis plays a pivotal role in the progression and reversal of liver fibrosis and is regulated by epigenetics	FASEB JOURNAL			English	Article						epigenetics; HDAC2; HSCs; liver fibrosis; miR-455-3p	HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; HISTONE DEACETYLASES; DNA METHYLATION; ACTIVATION; MICRORNA; REGRESSION; HYPERMETHYLATION; ACETYLATION; APOPTOSIS	Histone deacetylases (HDACs), especially HDAC2, play a role in alleviating liver fibrosis; however, the specific upstream regulation mechanism is unknown. Herein, TargetScan was used to predict the potential upstream targets of HDAC2, and the role of miR-455-3p was explored. The dual luciferase reporter assay showed that miR-455-3p binds to the 3MODIFIER LETTER PRIME UTR of HDAC2 mRNA. Additionally, miR-455-3p was downregulated in the liver tissues of patients with cirrhosis and mice with liver fibrosis, as well as in primary HSCs isolated from fibrotic mouse livers and TGF-beta-treated LX-2 cells. In contrast, it is highly expressed in the reversal stage of hepatic fibrosis and MDI-cultured LX-2 cells. Our functional analyses showed that miR-455-3p overexpression facilitated apoptosis and reduced the expression of pro-fibrotic markers and the proliferation of activated LX-2 cells. On the contrary, miR-455-3p inhibition converted inactivated LX-2 cells into activated, proliferative, fibrogenic cells. Interestingly, restoration of HDAC2 expression partially blocked the function of miR-455-3p. Downregulated miR-455-3p expression can be restored by DNA methyltransferases in activated LX-2 cells. Methylation-specific PCR, bisulfite sequencing PCR, and chromatin immunoprecipitation assays indicated that the methylation level of miR-455-3p promoter CpG islands was elevated in TGF-beta-treated LX-2 cells and that miR-455-3p was downregulated in activated LX-2 cells by DNA hypermethylation, which is mediated by DNMT3b and DNMT1. In conclusion, miR-455-3p acts as a liver fibrosis suppressor by targeting HDAC2, and its deficiency further aggravates the reversal phase of fibrosis. Thus, the epigenetics mediated miR-455-3p/HDAC2 axis may serve as a novel potential therapeutic target for clinical treatment of hepatic fibrosis.	[You, Hongmei; Wang, Ling; Bu, Fangtian; Meng, Hongwu; Pan, Xueyin; Li, Juanjuan; Zhang, Yafei; Wang, Ao; Yin, Nana; Huang, Cheng; Li, Jun] Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Anhui, Peoples R China	Anhui Medical University	Huang, C; Li, J (corresponding author), Anhui Med Univ, Sch Pharm, Anhui Inst Innovat Drugs, Inflammat & Immune Mediated Dis Lab Anhui Prov, Hefei 230032, Anhui, Peoples R China.	huangcheng@ahmu.edu.cn; lj@ahmu.edu.cn			National Natural Science Foundation of China [81770609]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This Study was supported by the National Natural Science Foundation of China (No. 81770609).	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Baylin SB, 1998, ADV CANCER RES, V72, P141; Bian EB, 2012, TOXICOL APPL PHARM, V264, P13, DOI 10.1016/j.taap.2012.06.022; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Calvente CJ, 2020, MOL THER, V28, P653, DOI 10.1016/j.ymthe.2019.09.013; Calvente CJ, 2019, J CLIN INVEST, V129, P4091, DOI 10.1172/JCI122258; Chen PJ, 2016, TOXICOL APPL PHARM, V292, P8, DOI 10.1016/j.taap.2015.12.021; Chen WS, 2016, BBA-MOL CELL RES, V1863, P2881, DOI 10.1016/j.bbamcr.2016.09.010; Chen X, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1032-9; Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684; Cohen-Naftaly Michal, 2011, Therap Adv Gastroenterol, V4, P391, DOI 10.1177/1756283X11413002; D'Ambrosio DN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024993; Feng LF, 2019, METHODS MOL BIOL, V1894, P181, DOI 10.1007/978-1-4939-8916-4_12; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Friedman SL, 2012, P NATL ACAD SCI USA, V109, P9230, DOI 10.1073/pnas.1206645109; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Guo SW, 2019, LIFE SCI, V235, DOI 10.1016/j.lfs.2019.116819; Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604; Hanoun N, 2010, CLIN CHEM, V56, P1107, DOI 10.1373/clinchem.2010.144709; Huang ZW, 2017, DNA CELL BIOL, V36, P759, DOI 10.1089/dna.2017.3799; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Iredale JP, 1998, J CLIN INVEST, V102, P538, DOI 10.1172/JCI1018; Jackaman C, 2017, AGEING RES REV, V36, P105, DOI 10.1016/j.arr.2017.03.008; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kirpich I, 2012, ALCOHOL CLIN EXP RES, V36, P1578, DOI 10.1111/j.1530-0277.2012.01751.x; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Kouzarides T, 2000, EMBO J, V19, P1176, DOI 10.1093/emboj/19.6.1176; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Kumar P, 2017, AM J PHYSIOL-RENAL, V313, pF781, DOI 10.1152/ajprenal.00166.2017; Kumar S, 2017, HUM MOL GENET, V26, P3808, DOI 10.1093/hmg/ddx267; Lakner AM, 2012, HEPATOLOGY, V56, P300, DOI 10.1002/hep.25613; Lan T, 2018, HEPATOLOGY, V68, P1070, DOI 10.1002/hep.29885; Li MW, 2017, INT IMMUNOPHARMACOL, V52, P272, DOI 10.1016/j.intimp.2017.09.020; Li X, 2016, TOXICOL APPL PHARM, V306, P58, DOI 10.1016/j.taap.2016.07.003; Livyatan I, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.33; Long XR, 2014, INT J ONCOL, V44, P1915, DOI 10.3892/ijo.2014.2373; Mallet V, 2008, ANN INTERN MED, V149, P399, DOI 10.7326/0003-4819-149-6-200809160-00006; Mao QD, 2017, BRAZ J MED BIOL RES, V50, DOI [10.1590/1414-431x20176103, 10.1590/1414-431X20176103]; Minokoshi Y, 2002, NATURE, V415, P339, DOI 10.1038/415339a; NISHIGUCHI S, 1995, LANCET, V346, P1051, DOI 10.1016/S0140-6736(95)91739-X; Ogawa T, 2012, GUT, V61, P1600, DOI 10.1136/gutjnl-2011-300717; Pan XY, 2019, THERANOSTICS, V9, P4308, DOI 10.7150/thno.32710; Pan XY, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00553; Proshkina EN, 2015, AGEING RES REV, V24, P218, DOI 10.1016/j.arr.2015.08.005; Ramalho-Carvalho J, 2018, METHODS MOL BIOL, V1708, P447, DOI 10.1007/978-1-4939-7481-8_23; Roderburg C, 2011, HEPATOLOGY, V53, P209, DOI 10.1002/hep.23922; Sarnow P, 2016, ANNU REV VIROL, V3, P309, DOI 10.1146/annurev-virology-110615-042409; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Shao MY, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-1550-0; She HY, 2005, J BIOL CHEM, V280, P4959, DOI 10.1074/jbc.M410078200; Singal AG, 2010, CLIN GASTROENTEROL H, V8, P280, DOI 10.1016/j.cgh.2009.11.018; Su QZ, 2018, ADV DRUG DELIVER REV, V129, P54, DOI 10.1016/j.addr.2018.01.009; Su SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9523; Tang JH, 2013, CLIN SCI, V124, P651, DOI 10.1042/CS20120504; Trautwein C, 2015, J HEPATOL, V62, pS15, DOI 10.1016/j.jhep.2015.02.039; Troeger JS, 2012, GASTROENTEROLOGY, V143, P1073, DOI 10.1053/j.gastro.2012.06.036; Tsay HC, 2019, J HEPATOL, V70, P722, DOI 10.1016/j.jhep.2018.12.016; Tu XL, 2014, J PATHOL, V234, P46, DOI 10.1002/path.4373; Valente S, 2014, J MED CHEM, V57, P701, DOI 10.1021/jm4012627; WANG KK, 1988, HEPATOLOGY, V8, P1679, DOI 10.1002/hep.1840080635; Wang XL, 2021, GUT, V70, P784, DOI 10.1136/gutjnl-2020-322526; Wei S, 2019, MOL THER-NUCL ACIDS, V16, P758, DOI 10.1016/j.omtn.2019.05.001; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Wu J, 2018, BIOCHEM BIOPH RES CO, V503, P977, DOI 10.1016/j.bbrc.2018.06.105; Wu Y, 2018, KOREAN J PHYSIOL PHA, V22, P607, DOI 10.4196/kjpp.2018.22.6.607; Wu YT, 2017, TOXICOL APPL PHARM, V315, P35, DOI 10.1016/j.taap.2016.12.002; Wu YT, 2015, TOXICOL APPL PHARM, V289, P163, DOI 10.1016/j.taap.2015.09.028; Yang XJ, 2003, CURR OPIN GENET DEV, V13, P143, DOI 10.1016/S0959-437X(03)00015-7; Yao Q, 2019, CURR OPIN CHEM BIOL, V51, P11, DOI 10.1016/j.cbpa.2019.01.024; Yin CY, 2013, J CLIN INVEST, V123, P1902, DOI 10.1172/JCI66369; Yu HX, 2019, MOL IMMUNOL, V107, P29, DOI 10.1016/j.molimm.2019.01.004; Zhang HY, 2014, PROTEOMICS, V14, P1977, DOI 10.1002/pmic.201300539; Zhang L, 2020, J AM SOC NEPHROL, V31, P337, DOI 10.1681/ASN.2019070739; Zhou Y, 2020, J CELL BIOCHEM, V121, P651, DOI 10.1002/jcb.29310	79	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21700	10.1096/fj.202002319RRR	http://dx.doi.org/10.1096/fj.202002319RRR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105828				2022-12-26	WOS:000667814100017
J	Wisnewski, AV; Luna, JC; Redlich, CA				Wisnewski, Adam, V; Luna, Julian Campillo; Redlich, Carrie A.			Human IgG and IgA responses to COVID-19 mRNA vaccines	PLOS ONE			English	Article							HALF-LIVES; ANTIBODY; IMMUNOGLOBULINS; IMMUNITY; KINETICS; SERUM	SARS-CoV-2 spike antigen-specific IgG and IgA elicited by infection mediate viral neutralization and are likely an important component of natural immunity, however, limited information exists on vaccine induced responses. We measured COVID-19 mRNA vaccine induced IgG and IgA in serum serially, up to 145 days post vaccination in 4 subjects. Spike antigen-specific IgG levels rose exponentially and plateaued 21 days after the initial vaccine dose. After the second vaccine dose IgG levels increased further, reaching a maximum approximately 7-10 days later, and remained elevated (average of 58% peak levels) during the additional >100 day follow up period. COVID-19 mRNA vaccination elicited spike antigen-specific IgA with similar kinetics of induction and time to peak levels, but more rapid decline in serum levels following both the 1(st) and 2(nd) vaccine doses (<18% peak levels within 100 days of the 2(nd) shot). The data demonstrate COVID-19 mRNA vaccines effectively induce spike antigen specific IgG and IgA and highlight marked differences in their persistence in serum.	[Wisnewski, Adam, V; Luna, Julian Campillo; Redlich, Carrie A.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University	Wisnewski, AV (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	adam.wisnewski@yale.edu		Campillo Luna, Julian/0000-0001-8509-0700	National Institute for Occupational Safety and Health [5T03OH008607-15]	National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH))	National Institute for Occupational Safety and Health, 5T03OH008607-15, to Dr. Carrie A Redlich.	Amanat F, 2020, NAT MED, DOI 10.1038/s41591-020-0913-5; Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Bleier BS, 2021, OTOLARYNG HEAD NECK, V164, P305, DOI 10.1177/0194599820982633; BURNETT D, 1986, THORAX, V41, P337, DOI 10.1136/thx.41.5.337; CURTIS J, 1973, IMMUNOLOGY, V24, P147; Dorner T, 2007, IMMUNITY, V27, P384, DOI 10.1016/j.immuni.2007.09.002; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jackson LA, 2020, NEW ENGL J MED, V383, P1190, DOI 10.1056/NEJMc2026616; Klingler Jeromine, 2020, medRxiv, DOI 10.1101/2020.08.18.20177303; LIEW FY, 1984, EUR J IMMUNOL, V14, P350, DOI 10.1002/eji.1830140414; Lin M, 2014, MUCOSAL IMMUNOL, V7, P511, DOI 10.1038/mi.2013.68; Maeda K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84733-5; Mahajan S., 2020, PERFORMANCE ABBOTT A, P2020, DOI [10.1101/2020.07.29.20164343, DOI 10.1101/2020.07.29.20164343]; MANKARIOUS S, 1988, J LAB CLIN MED, V112, P634; Moncunill G, 2021, J INFECT DIS, V223, P62, DOI 10.1093/infdis/jiaa696; Muramatsu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085582; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Poland GA, 2020, LANCET, V396, P1595, DOI 10.1016/S0140-6736(20)32137-1; Russell MW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.611337; Salazar E, 2020, J CLIN INVEST, V130, P6728, DOI 10.1172/JCI141206; SALONEN EM, 1985, J MED VIROL, V16, P1, DOI 10.1002/jmv.1890160102; Sterlin D, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd2223; STOCKLEY RA, 1979, THORAX, V34, P777, DOI 10.1136/thx.34.6.777; Underdown B. J., 1998, ENCY IMMUNOLOGY, P1196; Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906; Wang ZJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1555; Xiong N, 2012, PROTEIN CELL, V3, P571, DOI 10.1007/s13238-012-2927-3	28	73	74	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0249499	10.1371/journal.pone.0249499	http://dx.doi.org/10.1371/journal.pone.0249499			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133415	Green Submitted, gold, Green Published			2022-12-26	WOS:000671682700014
J	Shan, DC; Zheng, J; Klimowicz, A; Panzenbeck, M; Liu, Z; Feng, D				Shan, Dechao; Zheng, Jie; Klimowicz, Alexander; Panzenbeck, Mark; Liu, Zheng; Feng, Di			Deep learning for discovering pathological continuum of crypts and evaluating therapeutic effects: An implication for in vivo preclinical study	PLOS ONE			English	Article							GLAND SEGMENTATION; MURINE MODEL; COLITIS	Applying deep learning to the field of preclinical in vivo studies is a new and exciting prospect with the potential to unlock decades worth of underutilized data. As a proof of concept, we performed a feasibility study on a colitis model treated with Sulfasalazine, a drug used in therapeutic care of inflammatory bowel disease. We aimed to evaluate the colonic mucosa improvement associated with the recovery response of the crypts, a complex histologic structure reflecting tissue homeostasis and repair in response to inflammation. Our approach requires robust image segmentation of objects of interest from whole slide images, a composite low dimensional representation of the typical or novel morphological variants of the segmented objects, and exploration of image features of significance towards biology and treatment efficacy. Both interpretable features (eg. counts, area, distance and angle) as well as statistical texture features calculated using Gray Level Co-Occurance Matrices (GLCMs), are shown to have significance in analysis. Ultimately, this analytic framework of supervised image segmentation, unsupervised learning, and feature analysis can be generally applied to preclinical data. We hope our report will inspire more efforts to utilize deep learning in preclinical in vivo studies and ultimately make the field more innovative and efficient.	[Shan, Dechao; Liu, Zheng; Feng, Di] Boehringer Ingelheim Pharmaceut, Global Computat Biol & Digital Sci, Ridgefield, CT 06877 USA; [Zheng, Jie; Klimowicz, Alexander; Panzenbeck, Mark] Boehringer Ingelheim Pharmaceut, Immunol & Resp Dis Res, Ridgefield, CT 06877 USA	Boehringer Ingelheim; Boehringer Ingelheim	Feng, D (corresponding author), Boehringer Ingelheim Pharmaceut, Global Computat Biol & Digital Sci, Ridgefield, CT 06877 USA.; Klimowicz, A (corresponding author), Boehringer Ingelheim Pharmaceut, Immunol & Resp Dis Res, Ridgefield, CT 06877 USA.	alexander.klimowicz@boehringer-ingelheim.com; di.feng@boehringer-ingelheim.com		Panzenbeck, Mark/0000-0003-1618-5399; Feng, Di/0000-0002-0964-9995				Binder T, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00173; Charlet R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061473; Chen H, 2017, MED IMAGE ANAL, V36, P135, DOI 10.1016/j.media.2016.11.004; Eichele DD, 2017, WORLD J GASTROENTERO, V23, P6016, DOI 10.3748/wjg.v23.i33.6016; Erben U, 2014, INT J CLIN EXP PATHO, V7, P4557; Graham S, 2019, MED IMAGE ANAL, V52, P199, DOI 10.1016/j.media.2018.12.001; Hira S, 2021, APPL INTELL, V51, P2864, DOI 10.1007/s10489-020-02010-w; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Kersting S, 2013, J INFLAMM RES, V6, P71, DOI 10.2147/JIR.S40092; Kim JJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3678; Korfhage N, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008179; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Miao R., 2021, QUICK ANNOTATOR OPEN; Rathore S, 2019, CANCERS, V11, DOI 10.3390/cancers11111700; Sann H, 2013, LIFE SCI, V92, P708, DOI 10.1016/j.lfs.2013.01.028; Sirinukunwattana K, 2017, MED IMAGE ANAL, V35, P489, DOI 10.1016/j.media.2016.08.008; Tomoyose M, 1998, SCAND J GASTROENTERO, V33, P435; Wang Y, 2019, CELL, V179, P1144, DOI 10.1016/j.cell.2019.10.015; Xu J, 2017, J MED IMAGING, V4, DOI 10.1117/1.JMI.4.2.021107; Xu J, 2011, MED IMAGE ANAL, V15, P851, DOI 10.1016/j.media.2011.04.002; Xu Y, 2017, IEEE T BIO-MED ENG, V64, P2901, DOI 10.1109/TBME.2017.2686418; Zhao HS, 2017, PROC CVPR IEEE, P6230, DOI 10.1109/CVPR.2017.660	22	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252429	10.1371/journal.pone.0252429	http://dx.doi.org/10.1371/journal.pone.0252429			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125849	gold, Green Published			2022-12-26	WOS:000664643500006
J	Ikeda, T; Ogawa, S; Kitazono, T; Nakagawara, J; Minematsu, K; Miyamoto, S; Murakawa, Y; Iwashiro, S; Okayama, Y; Sunaya, T; Hirano, K; Hayasaki, T				Ikeda, Takanori; Ogawa, Satoshi; Kitazono, Takanari; Nakagawara, Jyoji; Minematsu, Kazuo; Miyamoto, Susumu; Murakawa, Yuji; Iwashiro, Sanghun; Okayama, Yutaka; Sunaya, Toshiyuki; Hirano, Kazufumi; Hayasaki, Takanori			Real-world safety and effectiveness of rivaroxaban using Japan-specific dosage during long-term follow-up in patients with atrial fibrillation: XAPASS	PLOS ONE			English	Article							BASE-LINE CHARACTERISTICS; WARFARIN; STROKE; EXPAND; DESIGN	Background The Xarelto Post-Authorization Safety and Effectiveness Study in Japanese Patients with Atrial Fibrillation (XAPASS) was designed to investigate safety and effectiveness during long-term follow-up of rivaroxaban treatment, using reduced doses compared with other global regions, in Japanese patients with non-valvular atrial fibrillation in real-world clinical practice. Methods In this prospective, open-label, single-arm, observational study, 11,308 patients with non-valvular atrial fibrillation newly prescribed rivaroxaban (15/10 mg once daily) at 1416 sites across Japan were enrolled and followed for a mean of 2.5 years. Results In total, 10,664 and 10,628 patients were included in the safety and effectiveness analyses, respectively. In the safety population, mean (standard deviation) age was 73.1 (9.8) years and Congestive heart failure, Hypertension, Age >= 75 years, Diabetes mellitus, previous Stroke/TIA (2 points) (CHADS(2)) score was 2.2 (1.3). Incidences (95% confidence intervals) of any and major bleeding were 3.77 (3.53-4.01) and 1.16 (1.03-1.29) events per 100 patient-years, respectively. Age >= 75 years, creatinine clearance <50 mL/min, diabetes mellitus, and vascular disease were independently associated with incidence of major bleeding. The primary composite effectiveness outcome of stroke, non-central nervous system systemic embolism, and myocardial infarction occurred at an incidence (95% confidence interval) of 1.32 (1.18-1.46) events per 100 patient-years. Age <greater than or equal to>75 years, hypertension, prior ischemic stroke/transient ischemic attack, and concomitant use of antiplatelets were independently associated with incidence of the composite outcome of stroke, non-central nervous system systemic embolism, and myocardial infarction. Conclusion In the XAPASS, a large-scale study involving a broad range of patients with non-valvular atrial fibrillation newly prescribed rivaroxaban using Japan-specific dosage in real-world clinical practice, no unexpected safety or effectiveness concerns were detected during up to 5 years of follow-up.	[Ikeda, Takanori] Toho Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan; [Ogawa, Satoshi] Int Univ Hlth & Welf, Mita Hosp, Tokyo, Japan; [Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan; [Nakagawara, Jyoji] Osaka Namba Clin, Osaka, Japan; [Nakagawara, Jyoji; Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Suita, Osaka, Japan; [Minematsu, Kazuo] Iseikai Med Corp, Osaka, Japan; [Miyamoto, Susumu] Kyoto Univ, Grad Sch Med, Dept Neurosurg, Kyoto, Japan; [Murakawa, Yuji] Teikyo Univ, Mizonokuchi Hosp, Sch Med, Dept Internal Med 4, Kawasaki, Kanagawa, Japan; [Iwashiro, Sanghun; Okayama, Yutaka; Hirano, Kazufumi; Hayasaki, Takanori] Bayer Yakuhin Ltd, Med Affairs & Pharmacovigilance, Osaka, Japan; [Sunaya, Toshiyuki] Bayer Yakuhin Ltd, Res & Dev Japan, Osaka, Japan	Toho University; International University of Health & Welfare; Kyushu University; National Cerebral & Cardiovascular Center - Japan; Kyoto University; Teikyo University; Bayer AG; Bayer AG	Ikeda, T (corresponding author), Toho Univ, Grad Sch Med, Dept Cardiovasc Med, Tokyo, Japan.	takanori.ikeda@med.toho-u.ac.jp			Bayer Yakuhin, Ltd. (Osaka, Japan)	Bayer Yakuhin, Ltd. (Osaka, Japan)	XAPASS is a post-marketing surveillance study funded by Bayer Yakuhin, Ltd. (Osaka, Japan). A steering committee (S1 Appendix) was responsible for developing the protocol and the case report form and for oversight of both the conduct of the study and the database, and is accountable for analysis and publication of the results. Bayer Yakuhin, Ltd provided operational oversight of the study, prepared data and the manuscript, and paid the salaries of its employees (SI, YO, TS, KH, and TH).	Camm AJ, 2012, EUROPACE, V14, P1385, DOI [10.1093/europace/eus305, 10.1093/eurheartj/ehs253]; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Hori M, 2012, CIRC J, V76, P2104, DOI 10.1253/circj.CJ-12-0454; Ikeda T, 2019, J THROMB THROMBOLYS, V48, P653, DOI 10.1007/s11239-019-01934-6; Ikeda T, 2019, J CARDIOL, V74, P60, DOI 10.1016/j.jjcc.2019.01.001; Ikeda T, 2016, TOHOKU J EXP MED, V240, P259, DOI 10.1620/tjem.240.259; Inoue H, 2014, CIRC J, V78, P1997, DOI 10.1253/circj.CJ-66-0092; January CT, 2019, CIRCULATION, V140, pE125, DOI 10.1161/CIR.0000000000000665; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Kirchhof P, 2018, J AM COLL CARDIOL, V72, P141, DOI 10.1016/j.jacc.2018.04.058; Ogawa S, 2018, J ARRYTHM, V34, P167, DOI 10.1002/joa3.12034; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Sakuma I, 2019, HEART VESSELS, V34, P1839, DOI 10.1007/s00380-019-01425-x; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Shimokawa H, 2018, INT J CARDIOL, V258, P126, DOI 10.1016/j.ijcard.2018.01.141; Tanigawa T, 2013, DRUG METAB PHARMACOK, V28, P59, DOI 10.2133/dmpk.DMPK-12-RG-034; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983	17	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0251325	10.1371/journal.pone.0251325	http://dx.doi.org/10.1371/journal.pone.0251325			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115769	Green Published, gold			2022-12-26	WOS:000664643000010
J	Abdalla, TSA; Meiners, J; Riethdorf, S; Konig, A; Melling, N; Gorges, T; Karstens, KF; Izbicki, JR; Pantel, K; Reeh, M				Abdalla, Thaer S. A.; Meiners, Jan; Riethdorf, Sabine; Koenig, Alexandra; Melling, Nathaniel; Gorges, Tobias; Karstens, Karl-F.; Izbicki, Jakob R.; Pantel, Klaus; Reeh, Matthias			Prognostic value of preoperative circulating tumor cells counts in patients with UICC stage I-IV colorectal cancer	PLOS ONE			English	Article							PERIPHERAL-BLOOD; BREAST-CANCER; RT-PCR; SURVIVAL; SURGERY; METAANALYSIS; PROGRESSION; METASTASIS; EXCISION; ANTIGEN	Colorectal cancer (CRC) is one of the leading causes of cancer death worldwide. There is an urgent need to identify prognostic markers for patients undergoing curative resection of CRC. The detection of circulating tumor cells in peripheral blood is a promising approach to identify high-risk patients with disseminated disease in colorectal cancer. This study aims to evaluate the prognostic relevance of preoperative CTCs using the Cellsearch (R) system (CS) in patients, who underwent resection with curative intent of different stages (UICC I-IV) of colorectal cancer. Out of 91 Patients who underwent colorectal resection, 68 patients were included in this study. CTC analysis was performed in patients with CRC UICC stages I-IV immediately before surgery. Data were correlated with clinicopathological parameters and patient outcomes. One or more CTCs/7.5 mL were detected in 45.6% (31/68) of patients. CTCs were detected in all stages of the Union of International Cancer Control (UICC), in stage I (1/4, 25%), in stage II (4/12, 33.3%), in stage III (5/19, 26.3%) and in stage IV (21/33, 63.6%). The detection of >= 1 CTCs/ 7.5ml correlated to the presence of distant overt metastases (p = 0.014) as well as with shorter progression-free (p = 0.008) and overall survival (p = 0.008). Multivariate analyses showed that the detection of >= 1 CTCs/ 7.5ml is an independent prognostic indicator for overall survival (HR, 3.14; 95% CI, 1.18-8.32; p = 0.021). The detection of CTCs is an independent and strong prognostic factor in CRC, which might improve the identification of high-risk patients in future clinical trials.	[Abdalla, Thaer S. A.; Meiners, Jan; Melling, Nathaniel; Karstens, Karl-F.; Izbicki, Jakob R.; Reeh, Matthias] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Riethdorf, Sabine; Gorges, Tobias; Pantel, Klaus] Univ Med Ctr Hamburg Eppendorf, Univ Canc Ctr Hamburg, Ctr Expt Med, Dept Tumor Biol, Hamburg, Germany; [Koenig, Alexandra] Hosp Wilhelmshaven, Dept Gen Surg, Wilhelmshaven, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Abdalla, TSA (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany.	t.abdalla@uke.de	Reeh, Matthias/AAB-6917-2022; Abdalla, Thaer S. A./AFQ-0093-2022	Abdalla, Thaer S. A./0000-0002-0448-2225				Alix-Panabieres C, 2021, CANCER DISCOV, V11, P858, DOI 10.1158/2159-8290.CD-20-1311; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Allemani C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003055; Bork U, 2015, BRIT J CANCER, V112, P1306, DOI 10.1038/bjc.2015.88; Cohen SJ, 2008, J CLIN ONCOL, V26, P3213, DOI 10.1200/JCO.2007.15.8923; Cristofanilli M, 2004, NEW ENGL J MED, V351, P781, DOI 10.1056/NEJMoa040766; de Bono JS, 2008, CLIN CANCER RES, V14, P6302, DOI 10.1158/1078-0432.CCR-08-0872; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gazzaniga P, 2013, J CANCER RES CLIN, V139, P1411, DOI 10.1007/s00432-013-1450-0; Giuliano M, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0440-8; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Heald RJ, 2017, CLIN COLON RECT SURG, V30, P324, DOI 10.1055/s-0037-1606109; HERLYN M, 1979, P NATL ACAD SCI USA, V76, P1438, DOI 10.1073/pnas.76.3.1438; Hoeppner J, 2017, ONCOL RES TREAT, V40, P417, DOI 10.1159/000478863; Hohenberger W, 2009, COLORECTAL DIS, V11, P354, DOI 10.1111/j.1463-1318.2008.01735.x; Huang XZ, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1218-9; Junqueira-Neto S, 2019, ACTA CYTOL, V63, P479, DOI 10.1159/000493969; Kuvendjiska J, 2019, CANCERS, V11, DOI 10.3390/cancers11030397; Labianca R, 2013, ANN ONCOL, V24, P64, DOI 10.1093/annonc/mdt354; Lee MM, 2018, CLIN COLORECTAL CANC, V17, pE569, DOI 10.1016/j.clcc.2018.05.008; Li FY, 2009, J ZHEJIANG UNIV-SC B, V10, P219, DOI 10.1631/jzus.B0820273; Liberko M, 2013, CRIT REV ONCOL HEMAT, V88, P338, DOI 10.1016/j.critrevonc.2013.05.002; Lirici MM, 2016, MINIM INVASIV THER, V25, P226, DOI 10.1080/13645706.2016.1198381; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; Mendis S, 2019, ASIA-PAC J CLIN ONCO, V15, P136, DOI 10.1111/ajco.13135; Nicolazzo C, 2019, CANCERS, V11, DOI 10.3390/cancers11081042; Pox C, 2013, Z GASTROENTEROL, V51, P753, DOI 10.1055/s-0033-1350264; Riethdorf S, 2007, CLIN CANCER RES, V13, P920, DOI 10.1158/1078-0432.CCR-06-1695; Riethdorf S, 2018, ADV DRUG DELIVER REV, V125, P102, DOI 10.1016/j.addr.2018.01.011; Salem ME, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.4_suppl.675; Seeberg LT, 2015, ANN SURG, V261, P164, DOI 10.1097/SLA.0000000000000580; Strey CW, 2018, SURG ENDOSC, V32, P5021, DOI 10.1007/s00464-018-6267-0; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Vojtechova G, 2016, ADV CLIN EXP MED, V25, P1273, DOI 10.17219/acem/63824; Weiser MR, 2018, ANN SURG ONCOL, V25, P1454, DOI 10.1245/s10434-018-6462-1; Went PT, 2004, HUM PATHOL, V35, P122, DOI 10.1016/j.humpath.2003.08.026; Yang CG, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3704-8; Young PE, 2014, J CANCER, V5, P262, DOI 10.7150/jca.7988	40	7	7	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252897	10.1371/journal.pone.0252897	http://dx.doi.org/10.1371/journal.pone.0252897			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111181	gold, Green Published			2022-12-26	WOS:000664642700058
J	Lopez, L; Nguyen, T; Weber, G; Kleimola, K; Bereda, M; Liu, YL; Accorsi, EK; Skates, SJ; Santa Maria, JP; Smith, KR; Kalinich, M				Lopez, Lilah; Nguyen, Thao; Weber, Graham; Kleimola, Katlyn; Bereda, Megan; Liu, Yiling; Accorsi, Emma K.; Skates, Steven J.; Santa Maria, John P.; Smith, Kendal R.; Kalinich, Mark			Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States	PLOS ONE			English	Article								Since March 2020, the United States has lost over 580,000 lives to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19. A growing body of literature describes population-level SARS-CoV-2 exposure, but studies of antibody seroprevalence within school systems are critically lacking, hampering evidence-based discussions on school reopenings. The Lake Central School Corporation (LCSC), a public school system in suburban Indiana, USA, assessed SARS-CoV-2 seroprevalence in its staff and identified correlations between seropositivity and subjective histories and demographics. This study is a cross-sectional, population-based analysis of the seroprevalence of SARS-CoV-2 in LCSC staff measured in July 2020. We tested for seroprevalence with the Abbott Alinity (TM) SARS-CoV-2 IgG antibody test. The primary outcome was the total seroprevalence of SARS-CoV-2, and secondary outcomes included trends of antibody presence in relation to baseline attributes. 753 participants representative of the staff at large were enrolled. 22 participants (2.9%, 95% CI: 1.8% - 4.4%) tested positive for SARS-CoV-2 antibodies. Correcting for test performance parameters, the seroprevalence is estimated at 1.7% (90% Credible Interval: 0.27% - 3.3%). Multivariable logistic regression including mask wearing, travel history, symptom history, and contact history revealed a 48-fold increase in the odds of seropositivity if an individual previously tested positive for COVID-19 (OR: 48, 95% CI: 4-600). Amongst individuals with no previous positive test, exposure to a person diagnosed with COVID-19 increased the odds of seropositivity by 7-fold (OR: 7.2, 95% CI: 2.6-19). Assuming the presence of antibodies is associated with immunity against SARS-CoV-2 infection, these results demonstrate a broad lack of herd immunity amongst the school corporation's staff irrespective of employment role or location. Protective measures like contact tracing, face coverings, and social distancing are therefore vital to maintaining the safety of both students and staff as the school year progresses.	[Lopez, Lilah; Nguyen, Thao; Weber, Graham; Smith, Kendal R.] Lake Cent Sch Corp, St John, IN 02114 USA; [Kleimola, Katlyn] City Evanston, Evanston, IL USA; [Liu, Yiling; Skates, Steven J.] Massachusetts Gen Hosp, Biostat Ctr, Boston, MA 02114 USA; [Liu, Yiling; Skates, Steven J.; Kalinich, Mark] Harvard Med Sch, Boston, MA 02115 USA; [Accorsi, Emma K.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Santa Maria, John P.] Novartis Inst Biomed Res, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Novartis	Smith, KR (corresponding author), Lake Cent Sch Corp, St John, IN 02114 USA.; Kalinich, M (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	mark_kalinich@hms.harvard.edu; mark_kalinich@hms.harvard.edu	Liu, Yiling/GVS-4553-2022; Accorsi, Emma/GMX-1462-2022	Accorsi, Emma/0000-0002-7443-7921; Liu, Yiling/0000-0002-0387-8973	City of Evanston; MGH Biostatistics Center; Harvard T.H. Chan School of Public Health; Novartis Institute for Biomedical Research; Lake Central School Corporation; Harvard Medical School; NIH [T32GM007753, F30 CA224588]	City of Evanston; MGH Biostatistics Center; Harvard T.H. Chan School of Public Health; Novartis Institute for Biomedical Research; Lake Central School Corporation; Harvard Medical School; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	K.K. was supported by the City of Evanston. Y.L. and S.S. were supported by the MGH Biostatistics Center and Harvard Medical School. E.K.A. was supported by the Harvard T.H. Chan School of Public Health. J.S.M was supported by the Novartis Institute for Biomedical Research. K.R.S. was supported by the Lake Central School Corporation. M.K. was supported by Harvard Medical School and NIH grants T32GM007753 and F30 CA224588. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi EK, 2021, EUR J EPIDEMIOL, V36, P179, DOI 10.1007/s10654-021-00727-7; Centers for Disease Control and Prevention (CDC)m, 2021, OP STRAT K 12 SCH PH; Chan HF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76763-2; Github CSSEGISandData, COVID 19; Haischer MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240785; Heavey L, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.21.2000903; Howard JR, 2020, SUNY Series Afr Amer, P1; Indiana Department of Education, LAK CENTR SCH CORP 4; Johns Hopkins University and Medicine, COVID 19 MAP JOHNS H; Kenyon C, 2020, WIDESPREAD USE FACE, DOI [10.1101/2020.03.31.20048652, DOI 10.1101/2020.03.31.20048652]; Lake Central School Corporation, 2020, DEID TOT STAFF DAT; Larremore DB, ESTIMATING SARS COV; Larremore Lab at the University of Colorado Boulder and the Grad Lab at the Harvard T.H. Chan School of Public Health., COVID 19 TEST GROUP; National Center for Education Statistics, SCH STAFF SURV SASS; National Center for Health Statistic (NCHS), MORT REP SYST COR; Papageorge NW, 2021, J POPUL ECON, V34, P691, DOI 10.1007/s00148-020-00818-x; Public School Review, AV PUBL SCH STUD TEA; Stein-Zamir C, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.29.2001352; Toenshoff B., 2020, SSRN, DOI [10.2139/ssrn.3668418, DOI 10.2139/SSRN.3668418]; Tondeur, 2020, SARS COV 2 INFECT PR, DOI [10.1101/2020.06.25.20140178, DOI 10.1101/2020.06.25.20140178]; Torres JP, 2021, CLIN INFECT DIS, V73, pE458, DOI 10.1093/cid/ciaa955; United States Food and Drug Administration, EUA AUTH SER TEST; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Weinstein MC, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2017739; Zhang JJ, 2020, SCIENCE, V368, P1481, DOI 10.1126/science.abb8001	25	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0243676	10.1371/journal.pone.0243676	http://dx.doi.org/10.1371/journal.pone.0243676			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111144	Green Published, Green Submitted, gold			2022-12-26	WOS:000664642700002
J	Kang, Z; Chen, SJ; Shi, LW; He, YP; Gao, X				Kang, Zheng; Chen, Sijia; Shi, Liwan; He, Yipeng; Gao, Xiang			Predictors of heart and lung dose in left-sided breast cancer treated with VMAT relative to 3D-CRT: A retrospective study	PLOS ONE			English	Article							INTENSITY-MODULATED RADIOTHERAPY; RADIATION; THERAPY; POSTMASTECTOMY; METAANALYSIS; RECURRENCE; SURGERY; WOMEN; RISK	Background Before generating radiotherapy plans for breast cancer patients, the choice of plan techniques (three-dimensional conformal radiation therapy (3D-CRT) and volumetric modulated arc therapy (VMAT)) should be made. This study investigated the performance of two geometric indices in aiding the choice of 3D-CRT and VMAT plans in women undergoing left-sided whole breast radiotherapy. Materials and methods 119 patients, previously treated with left-sided breast radiotherapy (61 3D-CRT treatments and 58 VMAT treatments) from a single institution, were retrospectively studied. Two geometric indices, which were cardiac junction (CJ) index and pulmonary junction (PJ) index, were defined and the relationship between these indices and dose of organs at risk (OARs) were evaluated. Two-tailed Student's t-test was performed to compare patient characteristics between 3D-CRT and VMAT. Linear regressions were calculated to investigate the association between geometric indices and absorbed dose of heart and left lung, including mean dose of heart (MHD), V-5, V-30 of heart, and mean dose of left lung (MLLD), V-5, V-10, V-20, V-30, V-40 of left lung. Results The CJ index was strongly correlated with the MHD in 3D-CRT group and VMAT group. The linear regression formulas were MHD = 4826.59 xCJ Index+310.48 (R = 0.857, F = 163.77, P = 0.000) in 3D-CRT plans and MHD = 1789.29xCJ Index+437.50 (R = 0.45, F = 14.23, P = 0.000) in VMAT plans. The intersection of the two formulas was CJ index = 4.2% and MHD = 512.33 cGy. The PJ index demonstrated a strongly positive correlation with MLLD in 3D-CRT group and VMAT group as well. The linear regression formulas were MLLD = 2879.54xPJ Index+999.79 (R = 0.697, F = 55.86, P = 0.000) in 3D-CRT plans and MLLD = 1411.79xPJ Index+1091.88 (R = 0.676, F = 47.11, P = 0.000) in VMAT plans, the intersection of the two formulas was PJ index = 6.3% and MLLD = 1180.46 cGy. Conclusions CJ index and PJ index could be used as a practical tool to select 3D-CRT or VMAT before generating plans. We recommend that VMAT plan is preferable when CJ index is greater than 4.2% and/or PJ index is greater than 14.6%, while 3D-CRT plan is the first choice in the opposite.	[Kang, Zheng; Chen, Sijia; Shi, Liwan; He, Yipeng; Gao, Xiang] Xiamen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xiamen, Fujian, Peoples R China	Xiamen University	Gao, X (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Radiat Oncol, Xiamen, Fujian, Peoples R China.	grandamoy@163.com		Gao, Xiang/0000-0003-4025-2141; Gao, Xiang/0000-0002-3287-4760	Department of radiotherapy at the First Affiliated Hospital of Xiamen University	Department of radiotherapy at the First Affiliated Hospital of Xiamen University	The authors would like to thank the support of Department of radiotherapy at the First Affiliated Hospital of Xiamen University.; This research did not receive any special grant from funding agencies in the public, commercial, or not-for-profit sectors.	Abe O, 2005, LANCET, V366, P2087; Ashby O., 2020, RADIOGRAPHY LOND, DOI [10.1016/j.radi.2020.08.003 32819824, DOI 10.1016/J.RADI.2020.08.00332819824]; Bogue J, 2019, J APPL CLIN MED PHYS, V20, P24, DOI 10.1002/acm2.12527; Cao N, 2019, PHYS MEDICA, V67, P27, DOI 10.1016/j.ejmp.2019.09.240; Coon AB, 2010, INT J RADIAT ONCOL, V78, P104, DOI 10.1016/j.ijrobp.2009.07.1705; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Demirci S, 2009, INT J RADIAT ONCOL, V73, P980, DOI 10.1016/j.ijrobp.2008.11.016; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Grantzau T, 2016, RADIOTHER ONCOL, V121, P402, DOI 10.1016/j.radonc.2016.08.017; Hiatt JR, 2006, INT J RADIAT ONCOL, V65, P1368, DOI 10.1016/j.ijrobp.2006.03.060; Jeba J, 2015, J CLIN DIAGN RES, V9, DOI 10.7860/JCDR/2015/13969.6211; Lazzari G, 2017, CLIN TRANSL RAD ONCO, V7, P43, DOI 10.1016/j.ctro.2017.09.009; Liu HY, 2016, COMPUT MED IMAG GRAP, V54, P1, DOI 10.1016/j.compmedimag.2016.10.001; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Mendez LC, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1069-z; Mo JC, 2017, TECHNOL HEALTH CARE, V25, P851, DOI 10.3233/THC-160746; Rusthoven CG, 2016, ANN ONCOL, V27, P818, DOI 10.1093/annonc/mdw046; Stecklein SR, 2016, CLIN BREAST CANCER, V16, P319, DOI 10.1016/j.clbc.2016.02.001; Taylor CW, 2009, INT J RADIAT ONCOL, V73, P1061, DOI 10.1016/j.ijrobp.2008.05.066; van den Bogaard VAB, 2017, J CLIN ONCOL, V35, P1171, DOI 10.1200/JCO.2016.69.8480; Wang HY, 2016, ONCOTARGET, V7, P75492, DOI 10.18632/oncotarget.12260; Wen G, 2017, J CANCER, V8, P3795, DOI 10.7150/jca.21158	22	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252552	10.1371/journal.pone.0252552	http://dx.doi.org/10.1371/journal.pone.0252552			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106971	gold, Green Published, Green Submitted			2022-12-26	WOS:000664642200051
J	Belmonte-Reche, E; Serrano-Chacon, I; Gonzalez, C; Gallo, J; Banobre-Lopez, M				Belmonte-Reche, Efres; Serrano-Chacon, Israel; Gonzalez, Carlos; Gallo, Juan; Banobre-Lopez, Manuel			Potential G-quadruplexes and i-Motifs in the SARS-CoV-2	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; FORMING SEQUENCES; GENOME; DNA; RNA; PROMOTER; IDENTIFICATION; VISUALIZATION	Quadruplex structures have been identified in a plethora of organisms where they play important functions in the regulation of molecular processes, and hence have been proposed as therapeutic targets for many diseases. In this paper we report the extensive bioinformatic analysis of the SARS-CoV-2 genome and related viruses using an upgraded version of the open-source algorithm G4-iM Grinder. This version improves the functionality of the software, including an easy way to determine the potential biological features affected by the candidates found. The quadruplex definitions of the algorithm were optimized for SARS-CoV-2. Using a lax quadruplex definition ruleset, which accepts amongst other parameters two residue G- and C-tracks, 512 potential quadruplex candidates were discovered. These sequences were evaluated by their in vitro formation probability, their position in the viral RNA, their uniqueness and their conservation rates (calculated in over seventeen thousand different COVID-19 clinical cases and sequenced at different times and locations during the ongoing pandemic). These results were then compared subsequently to other Coronaviridae members, other Group IV (+)ssRNA viruses and the entire viral realm. Sequences found in common with other viral species were further analyzed and characterized. Sequences with high scores unique to the SARS-CoV-2 were studied to investigate the variations amongst similar species. Quadruplex formation of the best candidates were then confirmed experimentally. Using NMR and CD spectroscopy, we found several highly stable RNA quadruplexes that may be suitable therapeutic targets for the SARS-CoV-2.	[Belmonte-Reche, Efres; Gallo, Juan; Banobre-Lopez, Manuel] INL Int Iberian Nanotechnol Lab, Adv Magnet Theranost Nanostruct Lab, Braga, Portugal; [Serrano-Chacon, Israel; Gonzalez, Carlos] CSIC, Inst Quim Fis Rocasolano, Madrid, Spain	International Iberian Nanotechnology Laboratory; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR)	Belmonte-Reche, E (corresponding author), INL Int Iberian Nanotechnol Lab, Adv Magnet Theranost Nanostruct Lab, Braga, Portugal.	efres.belmonte@inl.int	Gonzalez, Carlos/A-4734-2013; Reche, Efres Belmonte/ABI-6410-2020	Gonzalez, Carlos/0000-0001-8796-1282; Reche, Efres Belmonte/0000-0002-9327-6182; Gallo, Juan/0000-0002-2028-3234; Serrano-Chacon, Israel/0000-0002-4303-9349	2014-2020 North Portugal Regional Operational Program (NORTE 2020); European Regional Development Fund (ERDF); Fundacao para a Ciencia e a Tecnoloxia (FCT), ERDF; NORTE 2020; 2014-2020 INTERREG Cooperation Programme Spain-Portugal (POCTEP); Spanish Ministry of Science, Innovation and Universities (MCIU);  [NORTE-01-0145-FEDER-000019];  [NORTE-01-0145-FEDER-031142];  [0624_2IQBIONEURO_6_E];  [BFU2017-89707-P]	2014-2020 North Portugal Regional Operational Program (NORTE 2020); European Regional Development Fund (ERDF)(European Commission); Fundacao para a Ciencia e a Tecnoloxia (FCT), ERDF; NORTE 2020; 2014-2020 INTERREG Cooperation Programme Spain-Portugal (POCTEP); Spanish Ministry of Science, Innovation and Universities (MCIU)(Spanish Government); ; ; ; 	M.B-L & J.G: a. Grants: 1. NORTE-01-0145-FEDER-000019, 2. NORTE-01-0145-FEDER-031142 and 3. 0624_2IQBIONEURO_6_E. b. Funders: 1. 2014-2020 North Portugal Regional Operational Program (NORTE 2020) and the European Regional Development Fund (ERDF), 2. the Fundacao para a Ciencia e a Tecnoloxia (FCT), ERDF and NORTE 2020, 3. 2014-2020 INTERREG Cooperation Programme Spain-Portugal (POCTEP). c. URLS: 1. https://norte2020.pt, https://ec.europa.eu/regional_policy/en/funding/erdf/, 2. https://www.fct.pt, https://norte2020.pt, https://ec.europa.eu/regional_policy/en/funding/erdf/, 3. https://interreg.eu/programme/interregspain-portugal-poctep/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. C.G: a. Grants: BFU2017-89707-P b. Funders: Spanish Ministry of Science, Innovation and Universities (MCIU) c. URL: https://www.ciencia.gob.es d. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Assi H, 2018, NUCLEIC ACIDS RES, V46, P8038, DOI 10.1093/nar/gky735; Abu-Ghazalah RM, 2009, BIOPHYS CHEM, V141, P180, DOI 10.1016/j.bpc.2009.01.013; Amrane S, 2014, J AM CHEM SOC, V136, P5249, DOI 10.1021/ja501500c; Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; [Anonymous], LANCET, DOI [10.1016/S0140-6736%2820%2930211-7, DOI 10.1016/S0140-6736(20)30211-7]; Artusi S, 2015, ANTIVIR RES, V118, P123, DOI 10.1016/j.antiviral.2015.03.016; Bartas M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01583; Bartas M, 2019, MOLECULES, V24, DOI 10.3390/molecules24091711; Beaudoin JD, 2014, NUCLEIC ACIDS RES, V42, P1209, DOI 10.1093/nar/gkt904; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Belmonte-Reche E, 2020, NAR GENOM BIOINFORM, V2, DOI 10.1093/nargab/lqz005; Belmonte-Reche E, 2018, J MED CHEM, V61, P1231, DOI 10.1021/acs.jmedchem.7b01672; Benabou S, 2014, RSC ADV, V4, P26956, DOI 10.1039/c4ra02129k; Benvenuto D, 2020, J MED VIROL, V92, P455, DOI 10.1002/jmv.25688; Bhartiya D, 2016, GENOMICS, V108, P224, DOI 10.1016/j.ygeno.2016.10.004; Biswas B, 2018, ACS INFECT DIS, V4, P744, DOI 10.1021/acsinfecdis.7b00279; Biswas B, 2017, NUCLEIC ACIDS RES, V45, P11268, DOI 10.1093/nar/gkx823; Brazier JA, 2012, CHEM COMMUN, V48, P10739, DOI 10.1039/c2cc30863k; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Capra JA, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000861; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Cui HR, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.567317; Day HA, 2014, BIOORGAN MED CHEM, V22, P4407, DOI 10.1016/j.bmc.2014.05.047; Demkovicova E, 2017, J NUCLEIC ACIDS, V2017, DOI 10.1155/2017/9170371; Ding Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33944-4; Doluca O, 2019, J THEOR BIOL, V463, P92, DOI 10.1016/j.jtbi.2018.12.007; Du Z, 2008, GENOME RES, V18, P233, DOI 10.1101/gr.6905408; Dumetz F, 2019, MOLECULES, V24, DOI 10.3390/molecules24071339; Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109; Fleming AM, 2015, ACS CENTRAL SCI, V1, P226, DOI 10.1021/acscentsci.5b00202; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gotz S, 2019, MOLECULES, V24, DOI 10.3390/molecules24091774; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Harris LM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004562; Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986; Hon J, 2017, BIOINFORMATICS, V33, P3373, DOI 10.1093/bioinformatics/btx413; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Ji DY, 2021, BRIEF BIOINFORM, V22, P1150, DOI 10.1093/bib/bbaa114; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kwok CK, 2017, TRENDS BIOTECHNOL, V35, P997, DOI 10.1016/j.tibtech.2017.06.012; Lau SKP, 2020, EMERG INFECT DIS, V26, P1542, DOI 10.3201/eid2607.200092; Lavezzo E, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006675; Lombardi EP, 2019, MOLECULES, V24, DOI 10.3390/molecules24101942; MANZINI G, 1994, NUCLEIC ACIDS RES, V22, P4634, DOI 10.1093/nar/22.22.4634; Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985; Metifiot M, 2014, NUCLEIC ACIDS RES, V42, P12352, DOI 10.1093/nar/gku999; Mir B, 2017, J AM CHEM SOC, V139, P13985, DOI 10.1021/jacs.7b07383; Miskiewicz Joanna, 2021, Brief Bioinform, V22, DOI 10.1093/bib/bbaa201; Murat P, 2014, NAT CHEM BIOL, V10, P358, DOI [10.1038/nchembio.1479, 10.1038/NCHEMBIO.1479]; Narayanan K, 2003, VIRUS RES, V98, P131, DOI 10.1016/j.virusres.2003.08.021; Norseen J, 2009, J VIROL, V83, P10336, DOI 10.1128/JVI.00747-09; Omaga CA, 2018, BIOCHEMISTRY-US, V57, P2958, DOI 10.1021/acs.biochem.8b00226; Paeschke K, 2011, CELL, V145, P678, DOI 10.1016/j.cell.2011.04.015; Panera N, 2020, DRUGS, V80, P941, DOI 10.1007/s40265-020-01321-z; Peck KM, 2015, ANNU REV VIROL, V2, P95, DOI 10.1146/annurev-virology-100114-055029; Perlman S, 2020, NEW ENGL J MED, V382, P760, DOI 10.1056/NEJMe2001126; Perrone R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073121; Perrone R, 2013, J MED CHEM, V56, P6521, DOI 10.1021/jm400914r; Ravichandran S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007334; Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Ruggiero E, 2019, NUCLEIC ACIDS RES, V47, P11057, DOI 10.1093/nar/gkz937; Ruggiero E, 2018, NUCLEIC ACIDS RES, V46, P3270, DOI 10.1093/nar/gky187; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Shao XL, 2020, MBIO, V11, DOI 10.1128/mBio.02926-19; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Snoussi K, 2001, J MOL BIOL, V309, P139, DOI 10.1006/jmbi.2001.4618; Tan JZ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000428; Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g; Todd AK, 2005, NUCLEIC ACIDS RES, V33, P2901, DOI 10.1093/nar/gki553; Varshney D, 2020, NAT REV MOL CELL BIO, V21, P459, DOI 10.1038/s41580-020-0236-x; Waller ZAE, 2016, CHEM COMMUN, V52, P13511, DOI 10.1039/c6cc06057a; Wang SR, 2016, CELL CHEM BIOL, V23, P1113, DOI 10.1016/j.chembiol.2016.07.019; Wright EP, 2017, NUCLEIC ACIDS RES, V45, P2951, DOI 10.1093/nar/gkx090; Yu GC, 2017, METHODS ECOL EVOL, V8, P28, DOI 10.1111/2041-210X.12628; Zahin M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195625; Zhang RX, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.587829; Zhao CQ, 2021, ANGEW CHEM INT EDIT, V60, P432, DOI 10.1002/anie.202011419; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	80	13	12	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0250654	10.1371/journal.pone.0250654	http://dx.doi.org/10.1371/journal.pone.0250654			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101725	Green Published, Green Submitted, gold			2022-12-26	WOS:000664641500002
J	Levine, BA; Schuett, GW; Booth, W				Levine, Brenna A.; Schuett, Gordon W.; Booth, Warren			Exceptional long-term sperm storage by a female vertebrate	PLOS ONE			English	Article							SEXUAL SELECTION; MULTIPLE PATERNITY; MATING SYSTEMS; TOOL SET; REPTILES; PARTHENOGENESIS; REPRODUCTION; TURTLE; STACKS; BIRDS	Females of many vertebrate species have the capacity to store sperm within their reproductive tracts for prolonged periods of time. Termed long-term sperm storage, this phenomenon has many important physiological, ecological, and evolutionary implications, particularly to the study of mating systems, including male reproductive success and post-copulatory sexual selection. Reptiles appear particularly predisposed to long-term sperm storage, with records in most major lineages, with a strong emphasis on turtles and squamates (lizards, snakes, but not the amphisbaenians). Because facultative parthenogenesis is a competing hypothesis to explain the production of offspring after prolonged separation from males, the identification of paternal alleles through genetic analysis is essential. However, few studies in snakes have undertaken this. Here, we report on a wild-collected female Western Diamond-backed Rattlesnake, Crotalus atrox, maintained in isolation from the time of capture in September 1999, that produced two healthy litters approximately one and six years post capture. Genetic analysis of the 2005 litter, identified paternal contribution in all offspring, thus rejecting facultative parthenogenesis. We conclude that the duration of long-term sperm storage was approximately 6 years (71 months), making this the longest period over which a female vertebrate has been shown to store sperm that resulted in the production of healthy offspring.	[Levine, Brenna A.; Booth, Warren] Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA; [Levine, Brenna A.; Schuett, Gordon W.; Booth, Warren] Chiricahua Desert Museum, Rodeo, NM 88056 USA; [Schuett, Gordon W.] Georgia State Univ, Dept Biol, Atlanta, GA USA; [Schuett, Gordon W.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA	University of Tulsa; University System of Georgia; Georgia State University; University System of Georgia; Georgia State University	Booth, W (corresponding author), Univ Tulsa, Dept Biol Sci, Tulsa, OK 74104 USA.; Booth, W (corresponding author), Chiricahua Desert Museum, Rodeo, NM 88056 USA.	warren-booth@utulsa.edu	Levine, Brenna/AAB-5355-2022	Levine, Brenna/0000-0002-4326-591X; Booth, Warren/0000-0003-2355-0702	Arizona State University West; University of Tulsa; Zoo Atlanta; Chiricahua Desert Museum	Arizona State University West; University of Tulsa; Zoo Atlanta; Chiricahua Desert Museum	Funding was provided by a Research Incentive Award, and a Research Creative Activities Award (Arizona State University West) to GWS, and Faculty Startup Funds from The University of Tulsa to WB. Zoo Atlanta and Chiricahua Desert Museum provided additional financial assistance. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida-Santos S.M., 2002, BIOL VIPERS, P445; Andrews S., 2010, FASTQC QUALITY CONTR; ARNOLD SJ, 1994, AM NAT, V144, pS126, DOI 10.1086/285656; ARNOLD SJ, 1994, AM NAT, V143, P317, DOI 10.1086/285606; Avise J., 2008, CLONALITY GENETICS E; Avise JC, 2015, P NATL ACAD SCI USA, V112, P8867, DOI 10.1073/pnas.1501820112; Ball MA, 2003, J THEOR BIOL, V224, P27, DOI 10.1016/S0022-5193(03)00118-8; Bernal MA, 2015, J FISH BIOL, V86, P1171, DOI 10.1111/jfb.12606; BIRKHEAD TR, 1993, BIOL J LINN SOC, V50, P295, DOI 10.1111/j.1095-8312.1993.tb00933.x; Birkhead TR, 1998, SPERM COMPETITION SE; Booth W, 2016, BIOL J LINN SOC, V118, P172, DOI 10.1111/bij.12744; Booth W, 2011, BIOL J LINN SOC, V104, P934, DOI 10.1111/j.1095-8312.2011.01782.x; Calsbeek R, 2007, EVOL ECOL RES, V9, P495; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Chafin TK, 2018, CONSERV GENET RESOUR, V10, P325, DOI 10.1007/s12686-017-0814-1; Clark RW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090616; Clulow J, 2016, REPROD FERT DEVELOP, V28, P1116, DOI 10.1071/RD15466; de Souza E, 2022, ACTA ZOOL-STOCKHOLM, V103, P244, DOI 10.1111/azo.12369; Dent R, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0036889, 10.1371/journal.pone.0037135]; Devine M.C., 1984, P509; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; Farrell ED, 2014, BIOL J LINN SOC, V111, P119, DOI 10.1111/bij.12179; Firman RC, 2017, TRENDS ECOL EVOL, V32, P368, DOI 10.1016/j.tree.2017.02.010; FOX W, 1956, ANAT REC, V124, P519, DOI 10.1002/ar.1091240303; Friesen CR, 2014, CAN J ZOOL, V92, P33, DOI 10.1139/cjz-2013-0195; GIST DH, 1987, SCANNING MICROSCOPY, V1, P1839; Glaudas X, 2020, OIKOS, V129, P998, DOI 10.1111/oik.07223; Holt WV, 2010, THERIOGENOLOGY, V73, P713, DOI 10.1016/j.theriogenology.2009.07.002; Janicke T, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500983; Jellen BC, 2011, REPROD BIOL PHYLOGEN, V9, P619; Jones OR, 2010, MOL ECOL RESOUR, V10, P551, DOI 10.1111/j.1755-0998.2009.02787.x; Kratochvil L, 2020, MOL ECOL, V29, P4118, DOI 10.1111/mec.15617; Levine BA, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201261; Levine BA, 2019, ECOL EVOL, V9, P11863, DOI 10.1002/ece3.5694; Levine BA, 2015, BIOL J LINN SOC, V114, P436, DOI 10.1111/bij.12434; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; MAGNUSSON WE, 1979, COPEIA, P744; Mastretta-Yanes A, 2015, MOL ECOL RESOUR, V15, P28, DOI 10.1111/1755-0998.12291; Matsuzaki M, 2017, ADV EXP MED BIOL, V1001, P173, DOI 10.1007/978-981-10-3975-1_11; Miller KL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217489; Muniz-Da-Silva DF, 2020, ACTA ZOOL-STOCKHOLM, V101, P69, DOI 10.1111/azo.12271; Olsson M, 2003, P ROY SOC B-BIOL SCI, V270, pS254, DOI 10.1098/rsbl.2003.0079; Olsson M, 2007, BIOL LETTERS, V3, P491, DOI 10.1098/rsbl.2007.0196; Pasquesi GIM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05279-1; Pearse DE, 2001, J HERED, V92, P206, DOI 10.1093/jhered/92.2.206; Pearse DE, 2001, HEREDITY, V86, P378, DOI 10.1046/j.1365-2540.2001.00841.x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RACEY PA, 1979, J REPROD FERTIL, V56, P391; Rochette NC, 2017, NAT PROTOC, V12, P2640, DOI 10.1038/nprot.2017.123; Rohland N, 2012, GENOME RES, V22, P939, DOI 10.1101/gr.128124.111; Roques S, 2006, BIOL CONSERV, V129, P236, DOI 10.1016/j.biocon.2005.10.039; Saint Girons H., 1975, BIOL SPERMATOZOA, P105; Schuett Gordon W., 1992, P169; SCHUETT GW, 1986, COPEIA, P807, DOI 10.2307/1444966; Sever DM, 2002, J EXP ZOOL, V292, P187, DOI 10.1002/jez.1154; SHUSTER SM, 2003, MG BEH ECOL, pR7; Shuster SM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0046; Siegel DS, 2006, HERPETOL CONSERV BIO, V1, P87; Siegel DS, 2008, J MORPHOL, V269, P189, DOI 10.1002/jmor.10588; Silva KMP, 2020, ZOOLOGY, V142, DOI 10.1016/j.zool.2020.125816; Silva KMP, 2020, ANAT REC, V303, P3145, DOI 10.1002/ar.24309; Uller T, 2008, MOL ECOL, V17, P2566, DOI 10.1111/j.1365-294X.2008.03772.x; Wade MJ, 2004, AM NAT, V164, pE83, DOI 10.1086/424531; Watts PC, 2006, NATURE, V444, P1021, DOI 10.1038/4441021a; Zamudio KR, 2000, P NATL ACAD SCI USA, V97, P14427, DOI 10.1073/pnas.011544998	66	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252049	10.1371/journal.pone.0252049	http://dx.doi.org/10.1371/journal.pone.0252049			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086677	Green Published, gold			2022-12-26	WOS:000664640100031
J	Nakanishi, Y; Horimasu, Y; Yamaguchi, K; Sakamoto, S; Masuda, T; Nakashima, T; Miyamoto, S; Iwamoto, H; Ohshimo, S; Fujitaka, K; Hamada, H; Hattori, N				Nakanishi, Yu; Horimasu, Yasushi; Yamaguchi, Kakuhiro; Sakamoto, Shinjiro; Masuda, Takeshi; Nakashima, Taku; Miyamoto, Shintaro; Iwamoto, Hiroshi; Ohshimo, Shinichiro; Fujitaka, Kazunori; Hamada, Hironobu; Hattori, Noboru			IL-18 binding protein can be a prognostic biomarker for idiopathic pulmonary fibrosis	PLOS ONE			English	Article							GENE-EXPRESSION; INTERLEUKIN-18; PIRFENIDONE; EFFICACY; TRIAL	Idiopathic pulmonary fibrosis is a chronic, fibrosing interstitial pneumonia that presents with various clinical courses and progression ranging from rapid to slow. To identify novel biomarkers that can support the diagnosis and/or prognostic prediction of idiopathic pulmonary fibrosis, we performed gene expression analysis, and the mRNA of interleukin-18 binding protein was increasingly expressed in patients with idiopathic pulmonary fibrosis compared with healthy controls. Therefore, we hypothesized that the interleukin-18 binding protein can serve as a diagnostic and/or prognostic biomarker for idiopathic pulmonary fibrosis. We investigated the expression of interleukin-18 binding protein in lung tissue, bronchoalveolar lavage fluid, and serum. Additionally, the correlation between interleukin-18 binding protein expression levels and the extent of fibrosis was investigated using mouse models of lung fibrosis induced by subcutaneous bleomycin injections. Serum interleukin-18 binding protein levels were significantly higher in idiopathic pulmonary fibrosis patients (5.06 ng/mL, interquartile range [IQR]: 4.20-6.35) than in healthy volunteers (3.31 ng/mL, IQR: 2.84-3.99) (p < 0.001). Multivariate logistic regression models revealed that the correlation between serum interleukin-18 binding protein levels and idiopathic pulmonary fibrosis was statistically independent after adjustment for age, sex, and smoking status. Multivariate Cox proportional hazard models revealed that serum interleukin-18 binding protein levels were predictive of idiopathic pulmonary fibrosis disease prognosis independent of other covariate factors (hazard ratio: 1.655, 95% confidence interval: 1.224-2.237, p = 0.001). We also demonstrated a significant positive correlation between lung hydroxyproline expression levels and interleukin-18 binding protein levels in bronchoalveolar lavage fluid from bleomycin-treated mice (Spearman r = 0.509, p = 0.004). These results indicate the utility of interleukin-18 binding protein as a novel prognostic biomarker for idiopathic pulmonary fibrosis.	[Nakanishi, Yu; Horimasu, Yasushi; Yamaguchi, Kakuhiro; Sakamoto, Shinjiro; Masuda, Takeshi; Nakashima, Taku; Miyamoto, Shintaro; Iwamoto, Hiroshi; Fujitaka, Kazunori; Hattori, Noboru] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Internal Med, Minami Ku, Hiroshima, Japan; [Ohshimo, Shinichiro] Hiroshima Univ Hosp, Grad Sch Biomed & Hlth Sci, Dept Emergency & Crit Care Med, Minami Ku, Hiroshima, Japan; [Hamada, Hironobu] Hiroshima Univ Hosp, Dept Phys Anal & Therapeut Sci, Grad Sch Biomed & Hlth Sci, Minami Ku, Hiroshima, Japan	Hiroshima University; Hiroshima University; Hiroshima University	Horimasu, Y (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Mol & Internal Med, Minami Ku, Hiroshima, Japan.	yasushi17@hiroshima-u.ac.jp	Nakashima, Taku/D-1517-2011; Horimasu, Yasushi/AAC-8800-2022	Nakashima, Taku/0000-0002-0035-674X; Horimasu, Yasushi/0000-0002-3390-8491; Iwamoto, Hiroshi/0000-0003-4922-5334	Japan Society for the Promotion of Science (KAKENHI) [19K17676]	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	YH has received research funding from Japan Society for the Promotion of Science (https://www.jsps.go.jp/, KAKENHI Grant No. 19K17676). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albera C, 2016, EUR RESPIR J, V48, P843, DOI 10.1183/13993003.01966-2015; Aravena C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136160; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Drakopanagiotakis F, 2018, MATRIX BIOL, V68-69, P404, DOI 10.1016/j.matbio.2018.01.023; Fix C, 2011, CYTOKINE, V53, P19, DOI 10.1016/j.cyto.2010.10.002; Fujita K, 2011, INT J CANCER, V129, P424, DOI 10.1002/ijc.25705; Gonul Y, 2016, J SURG RES, V202, P33, DOI 10.1016/j.jss.2015.12.026; Guiot J, 2017, LUNG, V195, P273, DOI 10.1007/s00408-017-9993-5; Ha CT, 2016, RADIAT RES, V185, P375, DOI 10.1667/RR14238.1; Hattori N, 2000, J CLIN INVEST, V106, P1341, DOI 10.1172/JCI10531; Horimasu Y, 2017, BMC MED GENET, V18, DOI 10.1186/s12881-017-0449-9; Hoshino T, 2009, AM J RESP CELL MOL, V41, P661, DOI 10.1165/rcmb.2008-0182OC; Izumi S, 2014, NEW ENGL J MED, V371, P781, DOI 10.1056/NEJMc1407776; Izumi Y, 2019, FREE RADICAL BIO MED, V136, P52, DOI 10.1016/j.freeradbiomed.2019.03.024; Ji QW, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/165742; Kim MS, 2019, J IMMUNOL, V203, P2265, DOI 10.4049/jimmunol.1801515; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kitasato Y, 2004, AM J RESP CELL MOL, V31, P619, DOI 10.1165/rcmb.2003-0306OC; Lee R, 2014, AM J PHYSIOL-LUNG C, V306, pL736, DOI 10.1152/ajplung.00210.2013; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Moller B, 2003, RHEUMATOLOGY, V42, P442, DOI 10.1093/rheumatology/keg146; Muhl H, 2000, BIOCHEM BIOPH RES CO, V267, P960, DOI 10.1006/bbrc.1999.2064; Nakanishi K, 2001, CYTOKINE GROWTH F R, V12, P53, DOI 10.1016/S1359-6101(00)00015-0; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038; Platis A, 2008, PERFUSION-UK, V23, P237, DOI 10.1177/0267659108101511; Raghu G, 2019, AM J RESP CRIT CARE, V200, P1089, DOI 10.1164/rccm.201907-1324ED; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Shioya S, 2018, EXP THER MED, V16, P3070, DOI 10.3892/etm.2018.6550; Veenstra KG, 2002, J IMMUNOL, V168, P2282, DOI 10.4049/jimmunol.168.5.2282; Watanabe M, 2019, RESPIRATION, V98, P212, DOI 10.1159/000500576; Xing SS, 2010, MOL MED, V16, P465, DOI 10.2119/molmed.2010.00028; Yu QL, 2009, AM J PHYSIOL-HEART C, V297, pH76, DOI 10.1152/ajpheart.01285.2008; Zhang LM, 2019, BIOMED PHARMACOTHER, V113, DOI 10.1016/j.biopha.2019.108756; Zhang LM, 2019, BIOCHEM BIOPH RES CO, V508, P660, DOI 10.1016/j.bbrc.2018.11.129; Zhang LM, 2018, BIOCHEM BIOPH RES CO, V505, P837, DOI 10.1016/j.bbrc.2018.09.193	39	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252594	10.1371/journal.pone.0252594	http://dx.doi.org/10.1371/journal.pone.0252594			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086758	Green Published, Green Submitted, gold			2022-12-26	WOS:000664640100091
J	Hu, TF; Wang, TF				Hu, Tianfei; Wang, Tengfei			A finite volume-based model for the hydrothermal behavior of soil under freeze-thaw cycles	PLOS ONE			English	Article							HEAT-TRANSPORT; FROZEN SOIL; UNSATURATED SOILS; UNFROZEN SOILS; WATER; MIGRATION	Freeze-thaw cycles in soil are driven by water migration, phase transitions, and heat transfer, which themselves are closely coupled variables in the natural environment. To simulate this complex periglacial process at different time and length scales, a multi-physics model was established by solving sets of equations describing fluid flow and heat transfer, and a dynamic equilibrium equation for phase changes in moisture. This model considers the effects of water-ice phase changes on the hydraulic and thermal properties of soil and the effect of latent heat during phase transition. These equations were then discretized by using the finite volume method and solved using iteration. The open-source software OpenFOAM was used to generate computational code for simulation of coupled heat and fluid transport during freezing and thawing of soil. A set of laboratory freezing tests considering two thermal boundary conditions were carried out, of which the results were obtained to verify the proposed model. In general, the numerical solutions agree well with the measured data. A railway embankment problem, incorporating soil hydrothermal behavior in response to seasonal variations in surface temperature, was finally solved with the finite volume-based approach, indicating the algorithm's robustness and flexibility.	[Hu, Tianfei] Shijiazhuang Tiedao Univ, State Key Lab Mech Behav & Syst Safety Traff Engn, Shijiazhuang, Hebei, Peoples R China; [Hu, Tianfei] Shijiazhuang Tiedao Univ, Sch Civil Engn, Shijiazhuang, Hebei, Peoples R China; [Wang, Tengfei] Southwest Jiaotong Univ, MOE Key Lab High Speed Railway Engn, Chengdu, Peoples R China; [Wang, Tengfei] Southwest Jiaotong Univ, Sch Civil Engn, Chengdu, Peoples R China	Shijiazhuang Tiedao University; Shijiazhuang Tiedao University; Southwest Jiaotong University; Southwest Jiaotong University	Wang, TF (corresponding author), Southwest Jiaotong Univ, MOE Key Lab High Speed Railway Engn, Chengdu, Peoples R China.; Wang, TF (corresponding author), Southwest Jiaotong Univ, Sch Civil Engn, Chengdu, Peoples R China.	w@swjtu.edu.cn		Wang, Tengfei/0000-0003-4079-0687	National Natural Science Foundation of China [42001059, 41901073]; Science and Technology Research Project of Hebei Education Department, China [QN2020180]; Natural Science Foundation of Hebei Province [E2020210044]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Project of Hebei Education Department, China; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	T. Hu: National Natural Science Foundation of China (Grant number 42001059), the Science and Technology Research Project of Hebei Education Department, China (Grant number QN2020180), and Natural Science Foundation of Hebei Province (Grant number E2020210044) T. Wang: National Natural Science Foundation of China (Grant number 41901073) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2000, 200010 NWRC; Greenshields C., 2021, OPENFOAM V9 USER GUI; GROENEVELT PH, 1974, SOIL SCI SOC AM J, V38, P400, DOI 10.2136/sssaj1974.03615995003800030012x; Hansson K, 2006, COLD REG SCI TECHNOL, V44, P20, DOI 10.1016/j.coldregions.2005.06.004; Hansson K, 2004, VADOSE ZONE J, V3, P693, DOI 10.2113/3.2.693; HARLAN RL, 1973, WATER RESOUR RES, V9, P1314, DOI 10.1029/WR009i005p01314; He ZY, 2018, COLD REG SCI TECHNOL, V148, P22, DOI 10.1016/j.coldregions.2018.01.003; Hu TF, 2020, ROCK SOIL MECH, V41, P1781, DOI 10.16285/j.rsm.2019.1263; Jansson P.-E., 1998, SIMULATING MODEL SOI, P0282; Jasak H, 2007, CMND; KAY BD, 1974, SOIL SCI SOC AM J, V38, P395, DOI 10.2136/sssaj1974.03615995003800030011x; KONRAD JM, 1989, COLD REG SCI TECHNOL, V16, P25, DOI 10.1016/0165-232X(89)90004-9; Lai YM, 2013, COLD REG SCI TECHNOL, V87, P6, DOI 10.1016/j.coldregions.2012.12.001; Li QL, 2018, SOILS FOUND, V58, P928, DOI 10.1016/j.sandf.2018.05.003; Ma W., 2014, FROZEN SOILS MECH; Miller R.D., 1980, APPL SOIL PHYS; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Newman GP, 1997, CAN GEOTECH J, V34, P63, DOI 10.1139/cgj-34-1-63; PHILIP J. R., 1957, TRANS AMER GEOPHYS UNION, V38, P222; [盛岱超 Sheng Daichao], 2013, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V35, P2186; Sheng DC, 2013, COLD REG SCI TECHNOL, V95, P27, DOI 10.1016/j.coldregions.2013.08.003; Shoop SA, 1997, COLD REG SCI TECHNOL, V25, P33, DOI 10.1016/S0165-232X(96)00015-8; Simunek J., 2008, HYDRUS SOFTWARE SERI, V3; Tai BW, 2017, COLD REG SCI TECHNOL, V141, P28, DOI 10.1016/j.coldregions.2017.05.009; Teng J., 2018, GEOTECHNIQUE, V69, P1, DOI [10.1680/jgeot.17.P.208, DOI 10.1680/JGEOT.17.P.208]; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wang QZ, 2016, COLD REG SCI TECHNOL, V126, P44, DOI 10.1016/j.coldregions.2016.03.003; Wang TF, 2017, COMPUT GEOTECH, V91, P27, DOI 10.1016/j.compgeo.2017.06.018; Xu X.Z., 2001, PHYS FROZEN SOILS; Zhang S, 2016, GEOTECHNIQUE, V66, P927, DOI 10.1680/jgeot.16.P.016	30	2	2	9	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252680	10.1371/journal.pone.0252680	http://dx.doi.org/10.1371/journal.pone.0252680			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081745	gold, Green Published			2022-12-26	WOS:000664639200045
J	Kung, TFC; Wilkinson, CM; Dirks, CA; Jickling, GC; Colbourne, F				Kung, Tiffany F. C.; Wilkinson, Cassandra M.; Dirks, Christine A.; Jickling, Glen C.; Colbourne, Frederick			Glibenclamide does not improve outcome following severe collagenase-induced intracerebral hemorrhage in rats	PLOS ONE			English	Article							BRAIN EDEMA; INTRAVENOUS GLYBURIDE; CEREBRAL EDEMA; CELL-VOLUME; STROKE; NUMBER; PREVENTION; NUCLEATOR; MECHANISM; DISECTOR	Intracerebral hemorrhage (ICH) is a devastating insult with few effective treatments. Edema and raised intracranial pressure contribute to poor outcome after ICH. Glibenclamide blocks the sulfonylurea 1 transient receptor potential melastatin 4 (Sur1-Trpm4) channel implicated in edema formation. While glibenclamide has been found to improve outcome and reduce mortality in animal models of severe ischemic stroke, in ICH the effects are less clear. In our previous study, we found no benefit after a moderate-sized bleed, while others have reported benefit. Here we tested the hypothesis that glibenclamide may only be effective in severe ICH, where edema is an important contributor to outcome. Glibenclamide (10 mu g/kg loading dose, 200 ng/h continuous infusion) was administered 2 hours post-ICH induced by collagenase injection into the striatum of adult rats. A survival period of 24 hours was maintained for experiments 1-3, and 72 hours for experiment 4. Glibenclamide did not affect hematoma volume (similar to 81 mu L) or other safety endpoints (e.g., glucose levels), suggesting the drug is safe. However, glibenclamide did not lessen striatal edema (similar to 83% brain water content), ionic dyshomeostasis (Na+, K+), or functional impairment (e.g., neurological deficits (median = 10 out of 14), etc.) at 24 hours. It also did not affect edema at 72 h (similar to 86% brain water content), or overall mortality rates (25% and 29.4% overall in vehicle vs. glibenclamide-treated severe strokes). Furthermore, glibenclamide appears to worsen cytotoxic edema in the peri-hematoma region (cell bodies were 46% larger at 24 h, p = 0.0017), but no effect on cell volume or density was noted elsewhere. Overall, these findings refute our hypothesis, as glibenclamide produced no favorable effects following severe ICH.	[Kung, Tiffany F. C.; Wilkinson, Cassandra M.; Dirks, Christine A.; Colbourne, Frederick] Univ Alberta, Dept Psychol, Edmonton, AB, Canada; [Jickling, Glen C.; Colbourne, Frederick] Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada; [Jickling, Glen C.] Univ Alberta, Div Neurol, Fac Med, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Colbourne, F (corresponding author), Univ Alberta, Dept Psychol, Edmonton, AB, Canada.; Colbourne, F (corresponding author), Univ Alberta, Neurosci & Mental Hlth Inst, Edmonton, AB, Canada.	fcolbour@ualberta.ca	Jickling, Glen/J-8790-2019	Jickling, Glen/0000-0003-3543-0820; Kung, Tiffany/0000-0002-9406-5934; Colbourne, Frederick/0000-0002-9567-2082	Canadian Institutes of Health Research (CIHR); CIHR doctoral award; Isaak Walton Killam Memorial scholarship; Dorothy J. Killam Memorial Scholarship; Alberta Innovates (AI) Summer Research Studentship; CIHR CGS-M; Undergraduate Research Initiative (URI); Canada Research Chair in ICH	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR doctoral award(Canadian Institutes of Health Research (CIHR)); Isaak Walton Killam Memorial scholarship; Dorothy J. Killam Memorial Scholarship; Alberta Innovates (AI) Summer Research Studentship; CIHR CGS-M(Canadian Institutes of Health Research (CIHR)); Undergraduate Research Initiative (URI); Canada Research Chair in ICH	This research was funded by a Canadian Institutes of Health Research (CIHR) project grant to F. C. C.W. is supported by a CIHR doctoral award, an Isaak Walton Killam Memorial scholarship, and a Dorothy J. Killam Memorial Scholarship. T.K. is supported by an Alberta Innovates (AI) Summer Research Studentship and a CIHR CGS-M. C.D. is supported by an Undergraduate Research Initiative (URI) stipend, and F.C. is a Canada Research Chair in ICH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar MI, 2011, NEUROHOSPITALIST, V1, P148, DOI 10.1177/1941875211409050; An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Barratt HE, 2014, J CEREBR BLOOD F MET, V34, P1463, DOI 10.1038/jcbfm.2014.107; Caffes N, 2015, INT J MOL SCI, V16, P4973, DOI 10.3390/ijms16034973; Choudhri TF, 1997, STROKE, V28, P2296, DOI 10.1161/01.STR.28.11.2296; Delaloye S, 2009, J NEUROSCI METH, V176, P290, DOI 10.1016/j.jneumeth.2008.09.004; DelBigio MR, 1996, STROKE, V27, P2312, DOI 10.1161/01.STR.27.12.2312; Fingas M, 2007, EXP NEUROL, V208, P277, DOI 10.1016/j.expneurol.2007.08.018; Garcia-Cabezas MA, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00107; GUNDERSEN HJG, 1988, APMIS, V96, P857, DOI 10.1111/j.1699-0463.1988.tb00954.x; Hemphill JC, 2015, STROKE, V46, P2032, DOI 10.1161/STR.0000000000000069; Hof PR, 2001, TRENDS NEUROSCI, V24, P377, DOI 10.1016/S0166-2236(00)01834-8; Inoue H, 2005, EUR J NEUROSCI, V21, P1648, DOI 10.1111/j.1460-9568.2005.04006.x; Ironside N, 2019, STROKE, V50, P1626, DOI 10.1161/STROKEAHA.119.024965; Jiang B, 2017, TRANSL STROKE RES, V8, P183, DOI 10.1007/s12975-016-0506-2; Kalisvaart ACJ., 2020, ABSTRACT TP275 BRAIN, DOI [10.1161/str.51.suppl_1.TP275, DOI 10.1161/STR.51.SUPPL_1.TP275]; Keep R., 2017, PRIMER CEREBROVASCUL, P145, DOI DOI 10.1016/B978-0-12-803058-5.00029-1; Khanna A, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2013.10.FOCUS13404; King ZA, 2018, DRUG DES DEV THER, V12, P2539, DOI 10.2147/DDDT.S150043; Lapchak PA, 2011, TRANSL STROKE RES, V2, P1, DOI 10.1007/s12975-010-0057-x; Liddle LJ, 2020, TRANSL STROKE RES, V11, P1203, DOI 10.1007/s12975-020-00824-x; MacLellan CL, 2008, J CEREBR BLOOD F MET, V28, P516, DOI 10.1038/sj.jcbfm.9600548; MacLellan CL, 2006, BEHAV BRAIN RES, V175, P82, DOI 10.1016/j.bbr.2006.08.001; Manaenko A, 2011, ACTA NEUROCHIR SUPPL, V111, P9, DOI 10.1007/978-3-7091-0693-8_2; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; Mittal MK, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00210; Mokri B, 2001, NEUROLOGY, V56, P1746, DOI 10.1212/WNL.56.12.1746; MOLLER A, 1990, J MICROSC-OXFORD, V159, P61, DOI 10.1111/j.1365-2818.1990.tb03019.x; Mongin Alexander A., 2001, Pathophysiology, V8, P77, DOI 10.1016/S0928-4680(01)00074-8; Nadeau CA, 2019, TRANSL STROKE RES, V10, P287, DOI 10.1007/s12975-018-0636-9; Piao Y, 2013, J TOXICOL PATHOL, V26, P29, DOI 10.1293/tox.26.29; ROSENBERG GA, 1990, STROKE, V21, P801, DOI 10.1161/01.STR.21.5.801; Schallert Timothy, 2006, NeuroRx, V3, P497, DOI 10.1016/j.nurx.2006.08.001; Selim M, 2018, STROKE, V49, P1299, DOI 10.1161/STROKEAHA.117.019541; Sheth KN, 2016, LANCET NEUROL, V15, P1160, DOI 10.1016/S1474-4422(16)30196-X; Simard JM, 2007, LANCET NEUROL, V6, P258, DOI 10.1016/S1474-4422(07)70055-8; Simard JM, 2012, TRANSL STROKE RES, V3, P286, DOI 10.1007/s12975-012-0149-x; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Song MK, 2014, TRANSL STROKE RES, V5, P17, DOI 10.1007/s12975-013-0314-x; Sotocinal SG, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-55; Steckler, 2019, GOOD RES PRACTICE NO; Stokum JA, 2016, J CEREBR BLOOD F MET, V36, P513, DOI 10.1177/0271678X15617172; Tameem A, 2013, BJA EDUC, V13, P113, DOI 10.1093/bjaceaccp/mkt001; Tosun C, 2013, STROKE, V44, P3522, DOI 10.1161/STROKEAHA.113.002904; WEST MJ, 1990, J COMP NEUROL, V296, P1, DOI 10.1002/cne.902960102; Whishaw IQ., 2004, BEHAV LAB RAT, DOI [10.1093/acprof%3Aoso/9780195162851.001.0001, DOI 10.1093/ACPROF%3AOSO/9780195162851.001.0001]; Wilkinson CM, 2020, BRAIN RES, V1728, DOI 10.1016/j.brainres.2019.146593; Wilkinson CM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215952; Williamson MR, 2017, TRANSL STROKE RES, V8, P386, DOI 10.1007/s12975-017-0530-x; Woo SK, 2020, NEUROSCI LETT, V718, DOI 10.1016/j.neulet.2019.134729; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xu FL, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1254; Zheng HP, 2016, CEREBROVASC DIS, V42, P155, DOI 10.1159/000445170; Zhou FF, 2018, BRAIN RES BULL, V142, P18, DOI 10.1016/j.brainresbull.2018.06.006	54	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252584	10.1371/journal.pone.0252584	http://dx.doi.org/10.1371/journal.pone.0252584			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081746	gold, Green Published			2022-12-26	WOS:000664639200029
J	Kilu, W; Merk, D; Steinhilber, D; Proschak, E; Heering, J				Kilu, Whitney; Merk, Daniel; Steinhilber, Dieter; Proschak, Ewgenij; Heering, Jan			Heterodimer formation with retinoic acid receptor RXR alpha modulates coactivator recruitment by peroxisome proliferator-activated receptor PPAR gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RECEPTOR; AGONIST; LIGAND; TARGET	Nuclear receptors (NRs) activate transcription of target genes in response to binding of ligands to their ligand-binding domains (LBDs). Typically, in vitro assays use either gene expression or the recruitment of coactivators to the isolated LBD of the NR of interest to measure NR activation. However, this approach ignores that NRs function as homo- as well as heterodimers and that the LBD harbors the main dimerization interface. Cofactor recruitment is thereby interconnected with oligomerization status as well as ligand occupation of the partnering LBD through allosteric cross talk. Here we present a modular set of homogeneous time-resolved FRET-based assays through which we investigated the activation of PPAR gamma in response to ligands and the formation of heterodimers with its obligatory partner RXR alpha. We introduced mutations into the RXR alpha LBD that prevent coactivator binding but do not interfere with LBD dimerization or ligand binding. This enabled us to specifically detect PPAR gamma coactivator recruitment to PPAR gamma:RXR alpha heterodimers. We found that the RXR alpha agonist SR11237 destabilized the RXR alpha homodimer but promoted formation of the PPAR gamma:RXR alpha heterodimer, while being inactive on PPAR gamma itself. Of interest, incorporation of PPAR gamma into the heterodimer resulted in a substantial gain in affinity for coactivator CBP-1, even in the absence of ligands. Consequently, SR11237 indirectly promoted coactivator binding to PPAR gamma by shifting the oligomerization preference of RXR alpha toward PPAR gamma:RXR alpha heterodimer formation. These results emphasize that investigation of ligand-dependent NR activation should take NR dimerization into account. We envision these assays as the necessary assay tool kit for investigating NRs that partner with RXR alpha.	[Kilu, Whitney; Merk, Daniel; Steinhilber, Dieter; Proschak, Ewgenij] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany; [Steinhilber, Dieter; Proschak, Ewgenij; Heering, Jan] Fraunhofer Inst Translat Med & Pharmacol ITMP, Assay Dev & Screening, Frankfurt, Germany	Goethe University Frankfurt	Heering, J (corresponding author), Fraunhofer Inst Translat Med & Pharmacol ITMP, Assay Dev & Screening, Frankfurt, Germany.	Jan.Heering@itmp.fraunhofer.de		Heering, Jan/0000-0002-4922-1993	Deutsche Forschungsgemeinschaft (DFG) [PR1405/4-2, SFB1039]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	E. P. thanks the Deutsche Forschungsgemeinschaft (DFG; Heisenberg-Professur PR1405/4-2 and SFB1039 A07 and A02) for financial support.	Amoutzias GD, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-34; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Cesario RM, 2001, MOL ENDOCRINOL, V15, P1360, DOI 10.1210/me.15.8.1360; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi SS, 2014, BMB REP, V47, P599, DOI 10.5483/BMBRep.2014.47.11.174; Choo J, 2015, J BIOL CHEM, V290, P25609, DOI 10.1074/jbc.M115.673046; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Fadel L, 2020, J BIOL CHEM, V295, P10045, DOI 10.1074/jbc.RA119.011614; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Gellrich L, 2020, J MED CHEM, V63, P6727, DOI 10.1021/acs.jmedchem.9b02150; Heering J, 2019, METHODS MOL BIOL, V1966, P175, DOI 10.1007/978-1-4939-9195-2_14; Heitel P, 2019, ACS MED CHEM LETT, V10, P203, DOI 10.1021/acsmedchemlett.8b00551; Hirai H, 2010, INT J DEV BIOL, V54, P1589, DOI 10.1387/ijdb.103194hh; Lala DS, 1996, NATURE, V383, P450, DOI 10.1038/383450a0; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Leibowitz MD, 2006, ENDOCRINOLOGY, V147, P1044, DOI 10.1210/en.2005-0690; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perlmann T, 1996, MOL ENDOCRINOL, V10, P958, DOI 10.1210/me.10.8.958; Rastinejad F, 2015, TRENDS BIOCHEM SCI, V40, P16, DOI 10.1016/j.tibs.2014.10.011; Schulman IG, 1998, MOL CELL BIOL, V18, P3483, DOI 10.1128/MCB.18.6.3483; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Uchimura K, 2001, HEPATOLOGY, V33, P91, DOI 10.1053/jhep.2001.21145; Wang N, 2018, J BIOL CHEM, V293, P18180, DOI 10.1074/jbc.RA118.004652; Willems S, 2020, COMMUN CHEM, V3, DOI 10.1038/s42004-020-0331-0; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Zhang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028253	29	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100814	10.1016/j.jbc.2021.100814	http://dx.doi.org/10.1016/j.jbc.2021.100814			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34081964	Green Published, gold			2022-12-26	WOS:000678068400017
J	De Gaetano, GV; Lentini, G; Galbo, R; Coppolino, F; Fama, A; Teti, G; Beninati, C				De Gaetano, Giuseppe Valerio; Lentini, Germana; Galbo, Roberta; Coppolino, Francesco; Fama, Agata; Teti, Giuseppe; Beninati, Concetta			Invasion and trafficking of hypervirulent group B streptococci in polarized enterocytes	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; LIPID RAFTS; ESCHERICHIA-COLI; LINE CACO-2; DISEASE; PROTEIN; DIFFERENTIATION; COLONIZATION; PLASMINOGEN; PATHOGENS	Streptococcus agalactiae (group B streptococcus or GBS) is a commensal bacterium that can frequently behave as a pathogen, particularly in the neonatal period and in the elderly. The gut is a primary site of GBS colonization and a potential port of entry during neonatal infections caused by hypervirulent clonal complex 17 (CC17) strains. Here we studied the interactions between the prototypical CC17 BM110 strain and polarized enterocytes using the Caco-2 cell line. GBS could adhere to and invade these cells through their apical or basolateral surfaces. Basolateral invasion was considerably more efficient than apical invasion and predominated under conditions resulting in weakening of cell-to-cell junctions. Bacterial internalization occurred by a mechanism involving caveolae- and lipid raft-dependent endocytosis and actin re-organization, but not clathrin-dependent endocytosis. In the first steps of Caco-2 invasion, GBS colocalized with the early endocytic marker EEA-1, to later reside in acidic vacuoles. Taken together, these data suggest that CC17 GBS selectively adheres to the lateral surface of enterocytes from which it enters through caveolar lipid rafts using a classical, actin-dependent endocytic pathway. These data may be useful to develop alternative preventive strategies aimed at blocking GBS invasion of the intestinal barrier.	[De Gaetano, Giuseppe Valerio; Lentini, Germana; Coppolino, Francesco; Fama, Agata; Beninati, Concetta] Univ Messina, Dept Human Pathol, Messina, Italy; [Galbo, Roberta] Univ Messina, Dept Chem Biol & Pharmaceut Sci, Messina, Italy; [Teti, Giuseppe] Charybdis Vaccines Srl, Messina, Italy; [Beninati, Concetta] Scylla Biotech Srl, Messina, Italy	University of Messina; University of Messina	Beninati, C (corresponding author), Univ Messina, Dept Human Pathol, Messina, Italy.; Beninati, C (corresponding author), Scylla Biotech Srl, Messina, Italy.	cbeninati@unime.it		De Gaetano, Giuseppe Valerio/0000-0001-9860-8871; Coppolino, Francesco/0000-0002-9672-0824; BENINATI, Concetta/0000-0001-8305-1337; Lentini, Germana/0000-0002-0572-4476	PRIN (Programma di Ricerca Scientifica di Rilevante Interesse Nazionale) [2017M8R7N9_002]; Ministero dell'Universita and Ricerca Scientifica (MIUR) of Italy; Charybdis Vaccines S.r.l.	PRIN (Programma di Ricerca Scientifica di Rilevante Interesse Nazionale)(Ministry of Education, Universities and Research (MIUR)); Ministero dell'Universita and Ricerca Scientifica (MIUR) of Italy(Ministry of Education, Universities and Research (MIUR)); Charybdis Vaccines S.r.l.	Work presented here was supported in part by the PRIN (Programma di Ricerca Scientifica di Rilevante Interesse Nazionale) 2017M8R7N9_002 grant from the Ministero dell'Universita and Ricerca Scientifica (MIUR) of Italy. Charybdis Vaccines S.r.l. and Scylla Biotech S.r.l. did not provide funding for this study in any form and had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida Raul A, 2010, Vet Med Int, V2010, P319192, DOI 10.4061/2010/319192; Alonso A, 2004, INT MICROBIOL, V7, P181; Backert S, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-72; Bouwman LI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054759; Buscetta M, 2016, MOL MICROBIOL, V101, P27, DOI 10.1111/mmi.13357; Carey AJ, 2014, J IMMUNOL, V192, P1718, DOI 10.4049/jimmunol.1202811; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cerquetti M, 2002, FEMS IMMUNOL MED MIC, V32, P211, DOI 10.1016/S0928-8244(01)00301-7; Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124; Cotter P., IMPACT FOOD BIOACTIV, P1; de Cambronne RD, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI136737; De Gaetano GV, 2018, MOL MICROBIOL, V110, P82, DOI 10.1111/mmi.14084; de Pereda JM, 2009, CELL ADHES MIGR, V3, P361, DOI 10.4161/cam.3.4.9525; Delie F, 1997, CRIT REV THER DRUG, V14, P221; Dhakal BK, 2009, J BIOL CHEM, V284, P446, DOI 10.1074/jbc.M805010200; Dramsi S, 1998, ANNU REV CELL DEV BI, V14, P137, DOI 10.1146/annurev.cellbio.14.1.137; Duncan MJ, 2002, CELL MICROBIOL, V4, P783, DOI 10.1046/j.1462-5822.2002.00230.x; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P2861, DOI 10.1128/IAI.65.7.2861-2867.1997; Gaillard JL, 1996, INFECT IMMUN, V64, P1299, DOI 10.1128/IAI.64.4.1299-1308.1996; Hamzaoui N, 2004, CELL MICROBIOL, V6, P817, DOI 10.1111/j.1462-5822.2004.00391.x; Hays C, 2019, ELIFE, V8, DOI 10.7554/eLife.48772; HERMISTON ML, 1995, J CELL BIOL, V129, P489, DOI 10.1083/jcb.129.2.489; Hon KL, 2017, CASE REP PEDIAT, V2017, DOI 10.1155/2017/8418105; Lajoie P, 2010, INT REV CEL MOL BIO, V282, P135, DOI 10.1016/S1937-6448(10)82003-9; Lentini G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32774-8; Lhocine N, 2015, CELL HOST MICROBE, V17, P164, DOI 10.1016/j.chom.2014.12.003; Lin AEJ, 2010, PROTOPLASMA, V244, P75, DOI 10.1007/s00709-010-0164-2; Melin P, 2011, CLIN MICROBIOL INFEC, V17, P1294, DOI 10.1111/j.1469-0691.2011.03576.x; Melin P, 2013, VACCINE, V31, pD31, DOI 10.1016/j.vaccine.2013.05.012; Morey P, 2011, MICROBIOL-SGM, V157, P234, DOI 10.1099/mic.0.040451-0; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; Natoli M, 2011, J CELL PHYSIOL, V226, P1531, DOI 10.1002/jcp.22487; Nikolaitchouk N, 2008, APMIS, V116, P263, DOI 10.1111/j.1600-0463.2008.00808.x; Norkin LC, 2001, EXP CELL RES, V266, P229, DOI 10.1006/excr.2001.5202; Papasergi S, 2010, J BIOL CHEM, V285, P7517, DOI 10.1074/jbc.M109.062075; Patras KA, 2015, MUCOSAL IMMUNOL, V8, P1339, DOI 10.1038/mi.2015.23; Perichon B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169840; PINTO M, 1983, BIOL CELL, V47, P323; PITELKA DR, 1983, J CELL BIOL, V96, P613, DOI 10.1083/jcb.96.3.613; Pizarro-Cerda J, 2010, BIOESSAYS, V32, P496, DOI 10.1002/bies.200900172; RAMOND MJ, 1985, BIOL CELL, V54, P89, DOI 10.1111/j.1768-322X.1985.tb00383.x; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Robins-Browne RM, 2002, J GASTROEN HEPATOL, V17, P467, DOI 10.1046/j.1440-1746.2002.02769.x; Roy CR, 2003, NAT CELL BIOL, V5, P16, DOI 10.1038/ncb0103-16; Sansonetti PJ, 1999, SEMIN IMMUNOL, V11, P193, DOI 10.1006/smim.1999.0175; Shabayek S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00437; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Snoeck V, 2005, MICROBES INFECT, V7, P997, DOI 10.1016/j.micinf.2005.04.003; Soriani M, 2006, J INFECT DIS, V193, P241, DOI 10.1086/498982; Tazi A, 2019, CLIN INFECT DIS, V69, P1740, DOI 10.1093/cid/ciz033; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; van Breemen Richard B, 2005, Expert Opin Drug Metab Toxicol, V1, P175, DOI 10.1517/17425255.1.2.175; Veiga E, 2006, TRENDS CELL BIOL, V16, P499, DOI 10.1016/j.tcb.2006.08.005; Vornhagen J, 2017, TRENDS MICROBIOL, V25, P919, DOI 10.1016/j.tim.2017.05.013; Wells CL, 1998, INFECT IMMUN, V66, P2410, DOI 10.1128/IAI.66.6.2410-2419.1998; Zaas DW, 2009, J BIOL CHEM, V284, P9955, DOI 10.1074/jbc.M808629200	57	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253242	10.1371/journal.pone.0253242	http://dx.doi.org/10.1371/journal.pone.0253242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129624	gold, Green Published			2022-12-26	WOS:000665475100037
J	Reimer, RP; Hokamp, NG; Niehoff, J; Zopfs, D; Lennartz, S; Heidar, M; Wahba, R; Stippel, D; Maintz, D; dos Santos, DP; Wybranski, C				Reimer, Robert Peter; Hokamp, Nils Grosse; Niehoff, Julius; Zopfs, David; Lennartz, Simon; Heidar, Mariam; Wahba, Roger; Stippel, Dirk; Maintz, David; dos Santos, Daniel Pinto; Wybranski, Christian			Value of spectral detector computed tomography for the early assessment of technique efficacy after microwave ablation of hepatocellular carcinoma	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; LIVER; CT; LESIONS; SURVEILLANCE; ARTERIAL	Objectives To investigate whether virtual monoenergetic images (VMI) and iodine maps derived from spectral detector computed tomography (SDCT) improve early assessment of technique efficacy in patients who underwent microwave ablation (MWA) for hepatocellular carcinoma (HCC) in liver cirrhosis. Methods This retrospective study comprised 39 patients with 49 HCC lesions treated with MWA. Biphasic SDCT was performed 7.74.0 days after ablation. Conventional images (CI), VMI and IM were reconstructed. Signal- and contrast-to-noise ratio (SNR, CNR) in the ablation zone (AZ), hyperemic rim (HR) and liver parenchyma were calculated using regions-of-interest analysis and compared between CI and VMI between 40-100 keV. Iodine concentration and perfusion ratio of HR and residual tumor (RT) were measured. Two readers evaluated subjective contrast of AZ and HR, technique efficacy (complete vs. incomplete ablation) and diagnostic confidence at determining technique efficacy. Results Attenuation of liver parenchyma, HR and RT, SNR of liver parenchyma and HR, CNR of AZ and HR were significantly higher in low-keV VMI compared to CI (all p<0.05). Iodine concentration and perfusion ratio differed significantly between HR and RT (all p<0.05; e.g. iodine concentration, 1.6 +/- 0.5 vs. 2.7 +/- 1.3 mg/ml). VMI50keV improved subjective AZ-to-liver contrast, HR-to-liver contrast, visualization of AZ margin and vessels adjacent to AZ compared to CI (all p<0.05). Diagnostic accuracy for detection of incomplete ablation was slightly higher in VMI50keV compared to CI (0.92 vs. 0.89), while diagnostic confidence was significantly higher in VMI50keV (p<0.05). Conclusions Spectral detector computed tomography derived low-keV virtual monoenergetic images and iodine maps provide superior early assessment of technique efficacy of MWA in HCC compared to CI.	[Reimer, Robert Peter; Hokamp, Nils Grosse; Niehoff, Julius; Zopfs, David; Lennartz, Simon; Wahba, Roger; Stippel, Dirk; Maintz, David; dos Santos, Daniel Pinto; Wybranski, Christian] Univ Cologne, Fac Med, Cologne, Germany; [Reimer, Robert Peter; Hokamp, Nils Grosse; Niehoff, Julius; Zopfs, David; Lennartz, Simon; Maintz, David; dos Santos, Daniel Pinto; Wybranski, Christian] Univ Cologne, Univ Hosp Cologne, Dept Diagnost & Intervent Radiol, Cologne, Germany; [Lennartz, Simon] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Heidar, Mariam] Univ Cologne, Fac Med, Cologne, Germany; [Wahba, Roger; Stippel, Dirk] Univ Cologne, Univ Hosp Cologne, Dept General Visceral Canc & Transplant Surg, Cologne, Germany	University of Cologne; University of Cologne; Harvard University; Massachusetts General Hospital; University of Cologne; University of Cologne	Reimer, RP (corresponding author), Univ Cologne, Fac Med, Cologne, Germany.; Reimer, RP (corresponding author), Univ Cologne, Univ Hosp Cologne, Dept Diagnost & Intervent Radiol, Cologne, Germany.	robert.reimer@uk-koeln.de	Niehoff, Julius/AHB-5538-2022	Reimer, Robert/0000-0002-5900-7181	ElseKroner-Fresenius-Stiftung (Bad Homburg, Germany) [2018_EKMS.34]	ElseKroner-Fresenius-Stiftung (Bad Homburg, Germany)	This study has been funded by the ElseKroner-Fresenius-Stiftung (Bad Homburg, Germany; https://www.ekfs.de): specific grant number, 2018_EKMS.34 and intitials of the author who received the funding, NGH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ahmed M, 2014, RADIOLOGY, V273, P241, DOI 10.1148/radiol.14132958; Akinyemiju T, 2017, JAMA ONCOL, V3, P1683, DOI 10.1001/jamaoncol.2017.3055; Boas FE, 2015, J VASC INTERV RADIOL, V26, P69, DOI 10.1016/j.jvir.2014.09.013; Bouda Damien, 2016, J Magn Reson Imaging, V44, P1070, DOI 10.1002/jmri.25369; Brace CL, 2010, J VASC INTERV RADIOL, V21, P1280, DOI 10.1016/j.jvir.2010.02.038; Brace CL, 2009, CURR PROBL DIAGN RAD, V38, P61, DOI 10.1067/j.cpradiol.2007.08.011; Caruso D, 2017, CLIN IMAG, V41, P118, DOI 10.1016/j.clinimag.2016.10.015; Chaiteerakij R, 2017, ANN HEPATOL, V16, P421, DOI 10.5604/16652681.1235485; Chiang J, 2016, RADIOLOGY, V281, P617, DOI 10.1148/radiol.2016152508; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Doerner J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.018375; Dou JP, 2016, ABDOM RADIOL, V41, P650, DOI 10.1007/s00261-016-0662-6; Ehn S, 2018, J APPL CLIN MED PHYS, V19, P204, DOI 10.1002/acm2.12243; European Assoc Study Liver, 2018, J HEPATOL, V69, P182, DOI 10.1016/j.jhep.2018.03.019; Fumarola EM, 2020, MED ONCOL, V37, DOI 10.1007/s12032-020-01364-y; Gamer M., 2012, PACKAGE IRR VAR COEF; Haigron P, 2010, IEEE ENG MED BIOL, V29, P100, DOI 10.1109/MEMB.2009.935459; Heerink WJ, 2018, EUR RADIOL, V28, P3228, DOI 10.1007/s00330-017-5266-1; Heimbach JK, 2018, HEPATOLOGY, V67, P358, DOI 10.1002/hep.29086; Hickson G, 2016, ABDOM RADIOL, V41, P1611, DOI 10.1007/s00261-016-0711-1; Hokamp NG, 2018, EUR J RADIOL, V109, P114, DOI 10.1016/j.ejrad.2018.11.001; Hokamp NG, 2018, ABDOM RADIOL, V43, P2066, DOI 10.1007/s00261-017-1411-1; Hokamp NG, 2020, DIAGN INTERV RADIOL, V26, P68, DOI 10.5152/dir.2019.19136; Hokamp NG, 2019, EUR J RADIOL, V117, P49, DOI 10.1016/j.ejrad.2019.05.019; Hokamp NG, 2019, EUR RADIOL, V29, P2098, DOI 10.1007/s00330-018-5744-0; Huo YR, 2015, J VASC INTERV RADIOL, V26, P1139, DOI 10.1016/j.jvir.2015.04.004; Izaaryene J, 2017, INT J HYPERTHER, V33, P653, DOI 10.1080/02656736.2016.1274435; Lee JK, 2016, ABDOM RADIOL, V41, P659, DOI 10.1007/s00261-016-0725-8; Lee SH, 2011, INVEST RADIOL, V46, P77, DOI 10.1097/RLI.0b013e3181f23fcd; Lennartz S, 2019, CANCER IMAGING, V19, DOI 10.1186/s40644-019-0235-3; Li Y, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20130143; Liang P, 2007, ONCOLOGY-BASEL, V72, P124, DOI 10.1159/000111718; Liu D, 2014, MED PHYS, V41, DOI 10.1118/1.4897381; Matsuda M, 2018, J COMPUT ASSIST TOMO, V42, P937, DOI 10.1097/RCT.0000000000000752; McDevitt JL, 2020, CLIN IMAG, V67, P146, DOI 10.1016/j.clinimag.2020.06.014; Omata M, 2017, HEPATOL INT, V11, P317, DOI 10.1007/s12072-017-9799-9; Park SY, 2014, EUR J RADIOL, V83, pE73, DOI 10.1016/j.ejrad.2013.11.022; Rassouli N, 2017, INSIGHTS IMAGING, V8, P589, DOI 10.1007/s13244-017-0571-4; Reimer RP, 2021, EUR RADIOL, V31, P3468, DOI 10.1007/s00330-020-07379-3; Ringe KI, 2015, ACTA RADIOL, V56, P10, DOI 10.1177/0284185114520858; Schraml C, 2008, ABDOM IMAGING, V33, P643, DOI 10.1007/s00261-007-9351-9; Shuman WP, 2014, AM J ROENTGENOL, V203, P601, DOI 10.2214/AJR.13.11337; Teng W, 2015, LIVER CANCER, V4, P26, DOI 10.1159/000343877; Vandenbroucke F, 2015, INSIGHTS IMAGING, V6, P363, DOI 10.1007/s13244-015-0408-y; Vogel A, 2019, ANN ONCOL, V30, P871, DOI 10.1093/annonc/mdy510; Zhang L, 2018, J VASC INTERV RADIOL, V29, P1455, DOI 10.1016/j.jvir.2018.04.019; Zopfs D., 2020, INVEST RADIOL, P1, DOI [10.1097/RLI.0000000000000600, DOI 10.1097/RLI.0000000000000600]; Zopfs D, 2021, EUR RADIOL, V31, P2340, DOI 10.1007/s00330-020-07298-3	48	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0252678	10.1371/journal.pone.0252678	http://dx.doi.org/10.1371/journal.pone.0252678			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129650	Green Published, gold			2022-12-26	WOS:000665475100009
J	Ashraf, NM; Mostafa, RR; Sakr, RH; Rashad, MZ				Ashraf, Nesma M.; Mostafa, Reham R.; Sakr, Rasha H.; Rashad, M. Z.			Optimizing hyperparameters of deep reinforcement learning for autonomous driving based on whale optimization algorithm	PLOS ONE			English	Article							LEVEL; GAME; GO	Deep Reinforcement Learning (DRL) enables agents to make decisions based on a well-designed reward function that suites a particular environment without any prior knowledge related to a given environment. The adaptation of hyperparameters has a great impact on the overall learning process and the learning processing times. Hyperparameters should be accurately estimated while training DRL algorithms, which is one of the key challenges that we attempt to address. This paper employs a swarm-based optimization algorithm, namely the Whale Optimization Algorithm (WOA), for optimizing the hyperparameters of the Deep Deterministic Policy Gradient (DDPG) algorithm to achieve the optimum control strategy in an autonomous driving control problem. DDPG is capable of handling complex environments, which contain continuous spaces for actions. To evaluate the proposed algorithm, the Open Racing Car Simulator (TORCS), a realistic autonomous driving simulation environment, was chosen to its ease of design and implementation. Using TORCS, the DDPG agent with optimized hyperparameters was compared with a DDPG agent with reference hyperparameters. The experimental results showed that the DDPG's hyperparameters optimization leads to maximizing the total rewards, along with testing episodes and maintaining a stable driving policy.	[Ashraf, Nesma M.; Sakr, Rasha H.; Rashad, M. Z.] Mansoura Univ, Fac Comp & Informat Sci, Comp Sci Dept, Mansoura, Egypt; [Mostafa, Reham R.] Mansoura Univ, Fac Comp & Informat Sci, Informat Syst Dept, Mansoura, Egypt	Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University	Ashraf, NM (corresponding author), Mansoura Univ, Fac Comp & Informat Sci, Comp Sci Dept, Mansoura, Egypt.; Mostafa, RR (corresponding author), Mansoura Univ, Fac Comp & Informat Sci, Informat Syst Dept, Mansoura, Egypt.	nesma.ashraf.89@gmail.com; Reham_2006@mans.edu.eg	Mostafa, Reham/AAZ-2215-2020; Ashraf, Nesma/AAX-2892-2021	Mostafa, Reham/0000-0001-6917-7873; Ashraf, Nesma/0000-0002-0489-2320				Akai N., 2017, 2017 IEEE 20 INT C I, P1, DOI [10.1109/ITSC.2017.8317797, DOI 10.1109/ITSC.2017.8317797]; Amadeo M, 2016, IEEE COMMUN MAG, V54, P98, DOI 10.1109/MCOM.2016.7402268; [Anonymous], 2016, INT J ENG TECHNOL SC, DOI DOI 10.15282/ijets.5.2016.1.2.1041; Bernhard Wymann, 2000, SOFTW SOURCEFORGE NE, V4, P2; Chen Y., 2018, ARXIV PREPRINT ARXIV; Chiappa S, 2017, ARXIV PREPRINT ARXIV; Da Silva FL, 2020, AUTON AGENT MULTI-AG, V34, DOI 10.1007/s10458-019-09430-0; Darrell T, 2017, IEEE DECIS CONTR P; Dorigo M, 2006, IEEE COMPUT INTELL M, V1, P28, DOI 10.1109/MCI.2006.329691; Eberhart R, 1995, P ICNN95 INT C NEUR; Elfwing S, 2018, P GEN EV COMP C; Gadekallu TR, 2021, J REAL-TIME IMAGE PR, V18, P1383, DOI 10.1007/s11554-020-00987-8; Gupta S, 2017, 2017 INTERNATIONAL CONFERENCE ON RECENT TRENDS IN ELECTRICAL, ELECTRONICS AND COMPUTING TECHNOLOGIES (ICRTEECT), P87, DOI 10.1109/ICRTEECT.2017.34; Hemasian-Etefagh F, 2019, J SUPERCOMPUT, V75, P6386, DOI 10.1007/s11227-019-02832-7; Ho-Huu V, 2015, EXPERT SYST APPL, V42, P7057, DOI 10.1016/j.eswa.2015.04.072; Hunt J. J., 2015, ARXIV150902971; Javed AR, 2022, T EMERG TELECOMMUN T, V33, DOI 10.1002/ett.4088; Kaveh A, 2017, MECH BASED DES STRUC, V45, P345, DOI 10.1080/15397734.2016.1213639; Kendall A, 2019, IEEE INT CONF ROBOT, P8248, DOI 10.1109/ICRA.2019.8793742; Ketkar N., 2017, DEEP LEARNING PYTHON, V1, DOI DOI 10.1007/978-1-4842-2766-4; Kingma DP., 2014, ADAM METHOD STOCHAST; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Liessner R, 2019, ICAART; Loiacono D., 2013, ARXIV PREPRINT ARXIV; Lopez PA, 2018, IEEE INT C INTELL TR, P2575, DOI 10.1109/ITSC.2018.8569938; Mafarja MM, 2017, NEUROCOMPUTING, V260, P302, DOI 10.1016/j.neucom.2017.04.053; Mann TA, 2016, ARXIV PREPRINT ARXIV; Maxim Krikun, 2016, CORRABS160908144; Mirjalili S, 2016, ADV ENG SOFTW, V95, P51, DOI 10.1016/j.advengsoft.2016.01.008; Mirzapour F, 2019, J AMB INTEL HUM COMP, V10, P77, DOI 10.1007/s12652-017-0600-7; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Mohammed HM, 2019, COMPUT INTEL NEUROSC, V2019, DOI 10.1155/2019/8718571; Montgomery WD., AM WORKFORCE SELF DR; Oliv D, 2017, APPL ENERG, V200, P141, DOI 10.1016/j.apenergy.2017.05.029; Parker-Holder J., 2020, ADV NEURAL INFORM PR, V33; Paul S, 2019, ARXIV PREPRINT ARXIV; Pham QV, 2020, IEEE T VEH TECHNOL, V69, P4285, DOI 10.1109/TVT.2020.2973294; Prakash DB, 2017, ALEX ENG J, V56, P499, DOI 10.1016/j.aej.2016.10.002; Quiter C., 2018, DEEPDRIVE DEEPDRIVE; Razavi A, 2017, ARXIV PREPRINT ARXIV; Rehman A., 2021, IEEE T NETW SCI ENG, DOI [10.1109/tnse.2020.3032117, DOI 10.1109/TNSE.2020.3032117]; Russell S.J., 2016, ARTIF INTELL; Saidala R. K., 2018, DATA ENG INTELLIGENT, P271; Sallab A. A. A., 2020, ARXIV PREPRINT ARXIV; Schaul T., 2015, ARXIV PREPRINT ARXIV; Sehgal A., 2019, 2019 3 IEEE INT C RO; Silver D, 2014, INT C MACH LEARN PML; Silver D, 2017, NATURE, V550, P354, DOI 10.1038/nature24270; Silver D, 2016, NATURE, V529, P484, DOI 10.1038/nature16961; Stone, 2015, DEEP RECURRENT Q LEA; Sutton RS, 2018, ADAPT COMPUT MACH LE, P1; Sutton RS, 1999, ARTIF INTELL, V112, P181, DOI 10.1016/S0004-3702(99)00052-1; Tirkolaee EB, 2019, COMPUT ELECTR ENG, V77, P457, DOI 10.1016/j.compeleceng.2018.01.040; Trivedi L.N., 2016, INDIAN J SCI TECHNOL, V9, P1, DOI [10.17485/ijst/2016/v9i38/101939, DOI 10.17485/IJST/2016/V9I38/101939]; Uhlenbeck GE, 1930, PHYS REV, V36, P0823, DOI 10.1103/PhysRev.36.823; van Hasselt H, 2016, AAAI CONF ARTIF INTE, P2094; Vinyals O, 2019, NATURE, V575, P350, DOI 10.1038/s41586-019-1724-z; Wahlstrom N, 2015, ARXIV PREPRINT ARXIV; Wang S., 2018, ARXIV PREPRINT ARXIV; Wang Z, 2016, PR INT CONGR SOUND V; Watter M, 2015, ARXIV PREPRINT ARXIV; Yang X., 2008, NATURE INSPIRED META, V2nd; Zheng Z, 2018, SELF ADAPTIVE DOUBLE; Zhong M, MATEC WEB C 2017 EDP, V139, P00157; Zhou Y, 2019, INT C APPL EV COMP P; Zhu Z., 2021, SURVEY DEEP RL AUTON, P1	67	8	8	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252754	10.1371/journal.pone.0252754	http://dx.doi.org/10.1371/journal.pone.0252754			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111168	gold, Green Published			2022-12-26	WOS:000664642700040
J	Hatakeyama, DM; Tasima, LJ; Galizio, ND; Serino-Silva, C; Rodrigues, CFB; Stuginski, DR; St'Anna, SS; Grego, KF; Tashima, AK; Nishiduka, ES; de Morais-Zani, K; Tanaka-Azevedo, AM				Hatakeyama, Daniela Miki; Tasima, Lidia Jorge; Galizio, Nathalia da Costa; Serino-Silva, Caroline; Fabri Bittencourt Rodrigues, Caroline; Stuginski, Daniel Rodrigues; Sant'Anna, Savio Stefanini; Grego, Kathleen Fernandes; Tashima, Alexandre Keiji; Nishiduka, Erika Sayuri; de Morais-Zani, Karen; Tanaka-Azevedo, Anita Mitico			From birth to adulthood: An analysis of the Brazilian lancehead (Bothrops moojeni) venom at different life stages	PLOS ONE			English	Article							CROTALUS-DURISSUS-DURISSUS; SNAKE VENOMICS; INDIVIDUAL VARIABILITY; SEXUAL-DIMORPHISM; ONTOGENIC CHANGES; ATROX VENOM; PITVIPER; ANTIVENOMICS; RATTLESNAKE; PROTEOME	The Brazilian lancehead (Bothrops moojeni) has a wide distribution in Brazil and represents a serious public health hazard. Previous works reported that the symptoms of snakebites caused by B. moojeni juveniles' bites were mainly related to coagulation, while those caused by adults' bites had a more prominent local damage. In this work, we analyzed the venoms of B. moojeni at different life stages to better understand the ontogeny shift in this species. Snakes were grouped by age and sex, and venom pools were formed accordingly. Compositional analyses by one-dimensional electrophoresis (1-DE), chromatography, and mass spectrometry revealed that ontogenetic changes might be mostly related to phospholipase A(2) (PLA(2)) and metalloproteases. Regarding the venoms functional aspect, proteolytic, L-amino acid oxidase, PLA(2), and coagulant in vitro activities were assayed, but only the first and the last ones showed age-related changes, with the venom of snakes up to 1 year-old displaying lower proteolytic and higher coagulant activities, while those from 2 years-old onward presented the opposite relation. The venoms of 3 years-old snakes were exceptions to the compositional and functional pattern of adults as both venoms presented profiles similar to neonates. Sex-related differences were observed in specific groups and were not age-related. In vivo experiments (median lethal dose and hemorrhagic activity) were statistically similar between neonates and adults, however we verified that the adult venom killed mice faster comparing to the neonates. All venoms were mostly recognized by the antibothropic serum and displayed similar profiles to 1-DE in western blotting. In conclusion, the Brazilian lancehead venom showed ontogenetic shift in its composition and activities. Furthermore, this change occurred in snakes from 1 to 2 years-old, and interestingly the venom pools from 3 years-old snakes had particular characteristics, which highlights the importance of comprehensive studies to better understand venom variability.	[Hatakeyama, Daniela Miki; Tasima, Lidia Jorge; Galizio, Nathalia da Costa; Serino-Silva, Caroline; Fabri Bittencourt Rodrigues, Caroline; Stuginski, Daniel Rodrigues; Sant'Anna, Savio Stefanini; Grego, Kathleen Fernandes; de Morais-Zani, Karen; Tanaka-Azevedo, Anita Mitico] Inst Butantan, Lab Herpetol, Sao Paulo, Brazil; [Hatakeyama, Daniela Miki; Tasima, Lidia Jorge; Galizio, Nathalia da Costa; Serino-Silva, Caroline; Fabri Bittencourt Rodrigues, Caroline; de Morais-Zani, Karen; Tanaka-Azevedo, Anita Mitico] Univ Sao Paulo, Inst Pesquisas Tecnol, Inst Butantan, Interunidades Biotecnol, Sao Paulo, Brazil; [Tashima, Alexandre Keiji; Nishiduka, Erika Sayuri] Univ Fed Sao Paulo, Dept Bioquim, Sao Paulo, Brazil	Instituto Butantan; Instituto Butantan; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP)	Tanaka-Azevedo, AM (corresponding author), Inst Butantan, Lab Herpetol, Sao Paulo, Brazil.; Tanaka-Azevedo, AM (corresponding author), Univ Sao Paulo, Inst Pesquisas Tecnol, Inst Butantan, Interunidades Biotecnol, Sao Paulo, Brazil.	amt.azevedo@uol.com.br	Morais-Zani, Karen/B-3821-2014; Hatakeyama, Daniela/GNM-6597-2022; Grego, Kathleen/GOV-3529-2022; Sant'Anna, Sávio S/I-5217-2016; Tashima, Alexandre Keiji/B-8228-2015	Morais-Zani, Karen/0000-0001-9900-8384; Grego, Kathleen/0000-0003-4769-5818; Sant'Anna, Sávio S/0000-0003-2224-0913; Hatakeyama, Daniela Miki/0000-0002-4949-3825; Jorge Tasima, Lidia/0000-0003-1137-5679; Tashima, Alexandre Keiji/0000-0002-1332-8895; Nishiduka, Erika/0000-0002-4091-1170	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [1736737]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/25899-0, 2018/14724-4, 2017/20106-9, 2017/16908-2, 2018/25786-0]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (1736737 to DMH), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2018/25899-0 to LJT, 2018/14724-4 to NCG, 2017/20106-9 to AKT, 2017/16908-2 to KdM-Z, and 2018/25786-0 to AMT-A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu TF, 2017, J PROTEOMICS, V151, P232, DOI 10.1016/j.jprot.2016.07.012; Aguiar WD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222206; Aird SD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-790; Alape-Giron A, 2008, J PROTEOME RES, V7, P3556, DOI 10.1021/pr800332p; Amazonas DR, 2018, J PROTEOMICS, V181, P60, DOI 10.1016/j.jprot.2018.03.032; Amorim FG, 2018, TOXINS, V10, DOI 10.3390/toxins10050177; Andrade DV, 1996, J HERPETOL, V30, P285, DOI 10.2307/1565528; Andrade DV, 1999, HERPETOLOGICA, V55, P200; Antunes TC, 2010, TOXICON, V56, P1443, DOI 10.1016/j.toxicon.2010.08.011; Arlinghaus FT, 2012, TOXICON, V60, P512, DOI 10.1016/j.toxicon.2012.03.001; Boldrini-Franca J, 2010, J PROTEOMICS, V73, P1758, DOI 10.1016/j.jprot.2010.06.001; Bottrall Joshua L, 2010, J Venom Res, V1, P18; Brasil MdaSdo., 2020, ACIDENTE ANIMAIS PE; Braud S, 2000, BIOCHIMIE, V82, P851, DOI 10.1016/S0300-9084(00)01178-0; Calvete JJ, 2011, J PROTEOMICS, V74, P510, DOI 10.1016/j.jprot.2011.01.003; Casewell NR, 2020, TRENDS PHARMACOL SCI, V41, P570, DOI 10.1016/j.tips.2020.05.006; Cavinato RA, 1998, TOXICON, V36, P257, DOI 10.1016/S0041-0101(97)00129-3; CHIPPAUX JP, 1991, TOXICON, V29, P1279, DOI 10.1016/0041-0101(91)90116-9; CURTI B, 1968, J BIOL CHEM, V243, P2306; da Silva CJ, 2003, TOXICON, V41, P251, DOI 10.1016/S0041-0101(02)00287-8; Daltry JC, 1996, NATURE, V379, P537, DOI 10.1038/379537a0; de Carvalho M A, 1998, Cad Saude Publica, V14, P753, DOI 10.1590/S0102-311X1998000400017; Dias GS, 2013, J PROTEOME RES, V12, P4585, DOI 10.1021/pr4007393; Doley R, 2009, CELL MOL LIFE SCI, V66, P2851, DOI 10.1007/s00018-009-0050-2; dos Santos JI, 2011, PROTEINS, V79, P61, DOI 10.1002/prot.22858; Du XY, 2002, TOXICON, V40, P659, DOI 10.1016/S0041-0101(02)00102-2; Durban J, 2017, J PROTEOME RES, V16, P3370, DOI 10.1021/acs.jproteome.7b00414; Durban J, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-234; FINNEY D J, 1971, P333; Fox JW, 2008, PROTEOMICS, V8, P909, DOI 10.1002/pmic.200700777; Fox JW, 2013, TOXICON, V62, P75, DOI 10.1016/j.toxicon.2012.09.009; Fox JW, 2009, J PROTEOMICS, V72, P200, DOI 10.1016/j.jprot.2009.01.015; Freitas-de-Sousa LA, 2015, BIOCHIMIE, V118, P60, DOI 10.1016/j.biochi.2015.08.006; FURTADO FD, 1991, TOXICON, V29, P219, DOI 10.1016/0041-0101(91)90106-2; Furtado MFD, 2006, TOXICON, V48, P401, DOI 10.1016/j.toxicon.2006.06.005; Galizio ND, 2018, J PROTEOMICS, V186, P56, DOI 10.1016/j.jprot.2018.07.007; Gay C, 2016, TOXINS, V8, DOI 10.3390/toxins8010009; Glaudas X, 2019, J ANIM ECOL, V88, P757, DOI 10.1111/1365-2656.12972; Goncalves-Machado L, 2016, J PROTEOMICS, V135, P73, DOI 10.1016/j.jprot.2015.04.029; Grego KF, 2021, J VENOM ANIM TOXINS, V27, DOI [10.1590/1678-9199-JVATITD-2020-0068, 10.1590/1678-9199-jvatitd-2020-0068]; Guercio RAP, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-11; GUTIERREZ JM, 1991, TOXICON, V29, P1273, DOI 10.1016/0041-0101(91)90201-2; GUTIERREZ JM, 1990, TOXICON, V28, P419, DOI 10.1016/0041-0101(90)90080-Q; GUTIERREZ JM, 1985, TOXICON, V23, P887, DOI 10.1016/0041-0101(85)90380-0; Gutierrez JM, 2017, NAT REV DIS PRIMERS, V3, DOI [10.1038/nrdp.2017.79, 10.1038/nrdp.2017.63]; Harlow E., 1988, ANTIBODIES LAB MANUA; Hatakeyama DM, 2020, J VENOM ANIM TOXINS, V26, DOI [10.1590/1678-9199-JVATITD-2020-0018, 10.1590/1678-9199-jvatitd-2020-0018]; HAYES WK, 1991, TOXICON, V29, P867, DOI 10.1016/0041-0101(91)90223-E; Holzer M, 1996, TOXICON, V34, P1149, DOI 10.1016/0041-0101(96)00057-8; Kini RM, 2005, PATHOPHYSIOL HAEMO T, V34, P200, DOI 10.1159/000092424; Kini RM, 2003, TOXICON, V42, P827, DOI 10.1016/j.toxicon.2003.11.002; Kishimoto M, 2001, ANAL BIOCHEM, V298, P136, DOI 10.1006/abio.2001.5381; KOUYOUMDJIAN JA, 1988, REV I MED TROP, V30, P424, DOI 10.1590/S0036-46651988000600007; KOUYOUMDJIAN JA, 1989, REV I MED TROP, V31, P84, DOI 10.1590/S0036-46651989000200004; Kularatne SAM, 2009, T ROY SOC TROP MED H, V103, P924, DOI 10.1016/j.trstmh.2009.04.002; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leloup P, 1975, Acta Zool Pathol Antverp, P173; LOMONTE B, 1983, TOXICON, V21, P379, DOI 10.1016/0041-0101(83)90094-6; Lomonte Bruno, 2020, Toxicon X, V7, P100044, DOI 10.1016/j.toxcx.2020.100044; Lomonte B, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0117-8; Lopez-Lozano JL, 2002, TOXICON, V40, P997, DOI 10.1016/S0041-0101(02)00096-X; Lourenco A, 2013, TOXICON, V69, P75, DOI 10.1016/j.toxicon.2013.01.006; MACKESSY SP, 1988, COPEIA, P92, DOI 10.2307/1445927; Mackessy SP, 2018, TOXINS, V10, DOI 10.3390/toxins10070271; Madrigal M, 2012, J PROTEOMICS, V77, P280, DOI 10.1016/j.jprot.2012.09.003; Margres MJ, 2014, J PROTEOMICS, V96, P145, DOI 10.1016/j.jprot.2013.11.001; Markland FS, 2013, TOXICON, V62, P3, DOI 10.1016/j.toxicon.2012.09.004; Martins Marcio, 2002, P307; Massey DJ, 2012, J PROTEOMICS, V75, P2576, DOI 10.1016/j.jprot.2012.02.035; McCleary RJR, 2016, J PROTEOMICS, V144, P51, DOI 10.1016/j.jprot.2016.05.027; Menezes MC, 2006, TOXICON, V47, P304, DOI 10.1016/j.toxicon.2005.11.007; Modahl CM, 2018, J PROTEOMICS, V187, P223, DOI 10.1016/j.jprot.2018.08.004; Modahl CM, 2016, TOXICON, V119, P8, DOI 10.1016/j.toxicon.2016.04.049; Munekiyo SM, 1998, COMP BIOCHEM PHYS B, V119, P119, DOI 10.1016/S0305-0491(97)00294-0; Nadur-Andrade N, 2012, LASER MED SCI, V27, P65, DOI 10.1007/s10103-011-0914-1; Nogueira C, 2003, J HERPETOL, V37, P653, DOI 10.1670/120-02A; Nunez V, 2009, J PROTEOMICS, V73, P57, DOI 10.1016/j.jprot.2009.07.013; Pedroso AP, 2017, J PROTEOME RES, V16, P1515, DOI 10.1021/acs.jproteome.6b00923; Pimenta DC, 2007, RAPID COMMUN MASS SP, V21, P1034, DOI 10.1002/rcm.2931; Pla D, 2017, J PROTEOMICS, V152, P1, DOI 10.1016/j.jprot.2016.10.006; Queiroz GP, 2008, TOXICON, V52, P842, DOI 10.1016/j.toxicon.2008.10.002; Rodrigues CR, 2020, TOXICON, V184, P19, DOI 10.1016/j.toxicon.2020.05.016; Rosenfeld G., 1971, VENOMOUS ANIMALS THE, P687, DOI DOI 10.1016/B978-0-12-138902-4.50021-0; Saad E, 2012, J TOXICOL ENV HEAL A, V75, P1081, DOI 10.1080/15287394.2012.697839; Saldarriaga MM, 2003, TOXICON, V42, P405, DOI 10.1016/S0041-0101(03)00171-5; Santoro ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145516; Sgrignolli LR, 2011, NEPHRON CLIN PRACT, V119, pC131, DOI 10.1159/000324228; SHINE R, 1991, AM NAT, V138, P103, DOI 10.1086/285207; Sousa LF, 2017, J PROTEOMICS, V159, P32, DOI 10.1016/j.jprot.2017.03.003; Sousa LF, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002442; Tan CH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1828-2; Tashima AK, 2012, MOL CELL PROTEOMICS, V11, P1245, DOI 10.1074/mcp.M112.019331; Tasima LJ, 2020, J VENOM ANIM TOXINS, V26, DOI [10.1590/1678-9199-JVATITD-2019-0053, 10.1590/1678-9199-jvatitd-2019-0053]; THEAKSTON RDG, 1983, B WORLD HEALTH ORGAN, V61, P949; THOMAS RG, 1979, TOXICON, V17, P221, DOI 10.1016/0041-0101(79)90211-3; VACHOVA L, 1993, BIOCHEM MOL BIOL INT, V30, P311; Valdujo PH, 2002, J HERPETOL, V36, P169, DOI 10.2307/1565988; Vitorino Keila A, 2020, Toxicon X, V8, P100056, DOI 10.1016/j.toxcx.2020.100056; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; WILLIAMS V, 1992, TOXICON, V30, P202, DOI 10.1016/0041-0101(92)90473-I; Yamazaki Y, 2003, ARCH BIOCHEM BIOPHYS, V412, P133, DOI 10.1016/S0003-9861(03)00028-6; Zelanis A, 2007, COMP BIOCHEM PHYS C, V145, P601, DOI 10.1016/j.cbpc.2007.02.009; Zelanis A, 2016, J PROTEOMICS, V139, P26, DOI 10.1016/j.jprot.2016.02.030; Zelanis A, 2010, J PROTEOME RES, V9, P2278, DOI 10.1021/pr901027r; Zhou XingDing, 2009, Handbook of venoms and toxins of reptiles, P173	105	3	3	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0253050	10.1371/journal.pone.0253050	http://dx.doi.org/10.1371/journal.pone.0253050			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111213	gold, Green Published			2022-12-26	WOS:000664642700090
J	Mun, Y; Park, KH; Park, SJ; Woo, SJ				Mun, Yongseok; Park, Kyu Hyung; Park, Sang Jun; Woo, Se Joon			Efficacy of anti-vascular endothelial growth factor agents for treating neovascular age-related macular degeneration in vitrectomized eyes	PLOS ONE			English	Article							RETINAL VEIN OCCLUSION; INTRAOCULAR PHARMACOKINETICS; INTRAVITREAL BEVACIZUMAB; RANIBIZUMAB; EDEMA	Purpose To evaluate the efficacy of intravitreal anti-vascular endothelial growth factor (anti-VEGF) agents for treatment of neovascular age-related macular degeneration (nAMD) in vitrectomized eyes. Methods The medical records were reviewed of nAMD patients treated with anti-VEGF agents who previously underwent pars plana vitrectomy (PPV). PPV was performed with complete posterior vitreous detachment induction. Results A total of 44 eyes from 44 patients were included. The mean central foveal thickness (CFT) was 478.50 156.93 mu m at baseline, 414.25 +/- 143.55 mu m (86.6% of baseline) at 1 month after first injection (P < 0.001), and 386.75 <plus/minus> 141.45 mu m (80.8% of baseline) after monthly multiple injections (2.30 +/- 1.07; range, 1-5) (P < 0.001). The mean logarithm of the minimum angle of resolution best-corrected visual acuity visual acuity (BCVA) was 0.85 <plus/minus> 0.57 at baseline, 0.86 +/- 0.63 after the first injection, and 0.84 +/- 0.64 after monthly multiple injections. BCVA improved in 39.5% at 1 month after first injection and 45.2% at 1 month after monthly multiple injections. In the subgroup analysis, CFT of eyes with the posterior capsule decreased significantly to 85.8% and 79.8% of baseline values at 1 month after the first injection and after monthly multiple injections, respectively. CFT of eyes without the posterior capsule decreased to 91.6% and 87.4% of baseline values at 1 month after the first injection and after monthly multiple injections, respectively, without statistical significance. Conclusion Monthly injections of Intravitreal anti-VEGF agents induced favorable anatomical improvement and vision maintenance in vitrectomized eyes with nAMD.	[Mun, Yongseok; Park, Kyu Hyung; Park, Sang Jun; Woo, Se Joon] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Mun, Yongseok; Park, Kyu Hyung; Park, Sang Jun; Woo, Se Joon] Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Woo, SJ (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.; Woo, SJ (corresponding author), Seoul Natl Univ, Bundang Hosp, Seongnam, South Korea.	sejoon1@snu.ac.kr	; Woo, Se Joon/I-7357-2013; Park, Sang Jun/C-3234-2015	Mun, Yongseok/0000-0003-0123-0361; Woo, Se Joon/0000-0003-3692-7169; Park, Sang Jun/0000-0003-0542-2758	National Research Foundation (NRF) [2020R1F1A1072795]; NRF Bio & Medical Technology Development Program [2018M3A9B5021319]; Korean government (MSIT); Seoul National University Bundang Hospital [13-2019-003]	National Research Foundation (NRF); NRF Bio & Medical Technology Development Program; Korean government (MSIT)(Korean Government); Seoul National University Bundang Hospital	This study was supported by the National Research Foundation (NRF) grant 2020R1F1A1072795, the NRF Bio & Medical Technology Development Program (Grant No. 2018M3A9B5021319) funded by the Korean government (MSIT) and a research grant from Seoul National University Bundang Hospital (13-2019-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2013, J OCUL PHARMACOL TH, V29, P612, DOI 10.1089/jop.2013.0009; Ahn SJ, 2014, INVEST OPHTH VIS SCI, V55, P567, DOI 10.1167/iovs.13-13054; Aiello LP, 2004, RETINA-J RET VIT DIS, V24, pS3, DOI 10.1097/00006982-200410001-00002; Bressler SB, 2015, RETINA-J RET VIT DIS, V35, P2516, DOI 10.1097/IAE.0000000000000617; Christoforidis JB, 2013, RETINA-J RET VIT DIS, V33, P946, DOI 10.1097/IAE.0b013e3182753b12; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Holz FG, 2020, RETINA-J RET VIT DIS, V40, P1673, DOI 10.1097/IAE.0000000000002670; Jung JJ, 2016, ACTA OPHTHALMOL, V94, pE249, DOI 10.1111/aos.12840; Kakinoki M, 2012, INVEST OPHTH VIS SCI, V53, P5877, DOI 10.1167/iovs.12-10164; Knudsen LL, 2001, GRAEF ARCH CLIN EXP, V239, P832, DOI 10.1007/s004170100355; Kondo Mineo, 2007, Retin Cases Brief Rep, V1, P195, DOI 10.1097/ICB.0b013e318154b734; Lange C, 2009, GRAEF ARCH CLIN EXP, V247, P137, DOI 10.1007/s00417-008-0926-0; Laugesen CS, 2017, ACTA OPHTHALMOL, V95, P28, DOI 10.1111/aos.13160; Lee SS, 2010, INVEST OPHTH VIS SCI, V51, P2135, DOI 10.1167/iovs.09-3582; McCannel CA, 2009, OPHTHALMOLOGY, V116, P1366, DOI 10.1016/j.ophtha.2009.01.052; Mitchell P, 1997, OPHTHALMOLOGY, V104, P1033, DOI 10.1016/S0161-6420(97)30190-0; Niwa Y, 2015, INVEST OPHTH VIS SCI, V56, P6501, DOI 10.1167/iovs.15-17279; Noma H, 2015, INVEST OPHTH VIS SCI, V56, P1122, DOI 10.1167/iovs.14-15789; Park SJ, 2014, OPHTHALMOLOGY, V121, P1274, DOI 10.1016/j.ophtha.2013.12.024; Park SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080174; Regillo CD, 2008, AM J OPHTHALMOL, V145, P239, DOI 10.1016/j.ajo.2007.10.004; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schramm K, 2014, ACTA OPHTHALMOL, V92, P465, DOI 10.1111/aos.12326; Scupola A, 2015, OPHTHALMOLOGICA, V234, P101, DOI 10.1159/000434732; Short BG, 2008, TOXICOL PATHOL, V36, P49, DOI 10.1177/0192623307310955; Spaide RF, 2006, RETINA-J RET VIT DIS, V26, P383, DOI 10.1097/00006982-200604000-00001; Treuting P. M., 2012, COMP ANATOMY HISTOLO, P395, DOI [10.1016/8978-0-12-802900-8.00021-X, DOI 10.1016/8978-0-12-802900-8.00021-X]; Wareham Nicholas J., 2010, MEDICINE, V11, P602; Woo Se Joon, 2019, Korean J Ophthalmol, V33, P150, DOI 10.3341/kjo.2018.0081; Yancopoulos GD, 2010, CELL, V143, P13, DOI 10.1016/j.cell.2010.09.028; Yanyali A, 2007, AM J OPHTHALMOL, V144, P124, DOI 10.1016/j.ajo.2007.02.048	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252006	10.1371/journal.pone.0252006	http://dx.doi.org/10.1371/journal.pone.0252006			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111133	Green Published, gold			2022-12-26	WOS:000664642700015
J	Nguyen, KT; Sugie, J; Khanna, K; Egan, ME; Birkholz, EA; Lee, J; Beierschmitt, C; Villa, E; Pogliano, J				Nguyen, Katrina T.; Sugie, Joseph; Khanna, Kanika; Egan, MacKennon E.; Birkholz, Erica A.; Lee, Jina; Beierschmitt, Christopher; Villa, Elizabeth; Pogliano, Joe			Selective transport of fluorescent proteins into the phage nucleus	PLOS ONE			English	Article							PHI-KZ; PSEUDOMONAS; SEQUENCE; MECHANISM; FILAMENTS; MUTANTS; DIVERSE; GENOME; SBCB; DNA	Upon infection of Pseudomonas cells, jumbo phages 201 Phi 2-1, Phi PA3, and Phi KZ assemble a phage nucleus. Viral DNA is enclosed within the phage-encoded proteinaceous shell along with proteins associated with DNA replication, recombination and transcription. Ribosomes and proteins involved in metabolic processes are excluded from the nucleus. RNA synthesis occurs inside the phage nucleus and messenger RNA is presumably transported into the cytoplasm to be translated. Newly synthesized proteins either remain in the cytoplasm or specifically translocate into the nucleus. The molecular mechanisms governing selective protein sorting and nuclear import in these phage infection systems are currently unclear. To gain insight into this process, we studied the localization of five reporter fluorescent proteins (GFP(+), sfGFP, GFPmut1, mCherry, CFP). During infection with Phi PA3 or 201 Phi 2-1, all five fluorescent proteins were excluded from the nucleus as expected; however, we have discovered an anomaly with the Phi KZ nuclear transport system. The fluorescent protein GFPmut1, expressed by itself, was transported into the Phi KZ phage nucleus. We identified the amino acid residues on the surface of GFPmut1 required for nuclear targeting. Fusing GFPmut1 to any protein, including proteins that normally reside in the cytoplasm, resulted in transport of the fusion into the nucleus. Although the mechanism of transport is still unknown, we demonstrate that GFPmut1 is a useful tool that can be used for fluorescent labelling and targeting of proteins into the Phi KZ phage nucleus.	[Nguyen, Katrina T.; Sugie, Joseph; Khanna, Kanika; Egan, MacKennon E.; Birkholz, Erica A.; Lee, Jina; Beierschmitt, Christopher; Villa, Elizabeth; Pogliano, Joe] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Pogliano, J (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	jpogliano@ucsd.edu	; Villa, Elizabeth/D-1811-2010	Beierschmitt, Christopher/0000-0003-0151-1091; Sugie, Joseph/0000-0003-2911-1807; Villa, Elizabeth/0000-0003-4677-9809; Khanna, Kanika/0000-0001-7150-0350	National Institute of General Medical Sciences [GM104556, GM129245]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	National Institute of General Medical Sciences, GM104556, Dr. Joe Pogliano National Institute of General Medical Sciences, GM129245, Dr. Joe Pogliano.	ALLGOOD ND, 1991, GENETICS, V127, P671; Chaikeeratisak V, 2019, CELL, V177, P1771, DOI 10.1016/j.cell.2019.05.032; Chaikeeratisak V, 2017, CELL REP, V20, P1563, DOI 10.1016/j.celrep.2017.07.064; Chaikeeratisak V, 2017, SCIENCE, V355, P194, DOI 10.1126/science.aal2130; Charpentier E, 2014, CURR OPIN MICROBIOL, V19, P114, DOI 10.1016/j.mib.2014.07.001; Chatzi KE, 2014, BBA-MOL CELL RES, V1843, P1466, DOI 10.1016/j.bbamcr.2014.02.014; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Cornelissen A, 2012, J VIROL, V86, P1844, DOI 10.1128/JVI.06330-11; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; East-Seletsky A, 2016, NATURE, V538, P270, DOI 10.1038/nature19802; Erb ML, 2014, ELIFE, V3, DOI 10.7554/eLife.03197; Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l; Green ER, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.VMBF-0012-2015; Hegde RS, 2006, TRENDS BIOCHEM SCI, V31, P563, DOI 10.1016/j.tibs.2006.08.004; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Jiang WY, 2013, NAT BIOTECHNOL, V31, P233, DOI 10.1038/nbt.2508; Kraemer JA, 2012, CELL, V149, P1488, DOI 10.1016/j.cell.2012.04.034; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Martinez-Sanchez A, 2014, J STRUCT BIOL, V186, P49, DOI 10.1016/j.jsb.2014.02.015; Martoglio B, 1998, TRENDS CELL BIOL, V8, P410, DOI 10.1016/S0962-8924(98)01360-9; Mendoza SD., 2018, NUCLEUS LIKE COMPART; Mesyanzhinov VV, 2002, J MOL BIOL, V317, P1, DOI 10.1006/jmbi.2001.5396; Monson R, 2011, MICROBIOL-SGM, V157, P859, DOI 10.1099/mic.0.044701-0; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Patel R, 2014, BBA-MOL CELL RES, V1843, P1620, DOI 10.1016/j.bbamcr.2014.02.013; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Peters JM, 2015, CURR OPIN MICROBIOL, V27, P121, DOI 10.1016/j.mib.2015.08.007; PHILLIPS GJ, 1987, J BIOL CHEM, V262, P455; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Ratner HK., 2016, BIOL COLD SPRING HAR, V2016, DOI [10.1101/pdb.top088849, DOI 10.1101/PDB.TOP088849]; Serwer P, 2004, VIROLOGY, V329, P412, DOI 10.1016/j.virol.2004.08.021; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Thomas JA, 2008, VIROLOGY, V376, P330, DOI 10.1016/j.virol.2008.04.004; Thomas JA, 2007, VIROLOGY, V368, P405, DOI 10.1016/j.virol.2007.06.043; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Tsirigotaki A, 2017, NAT REV MICROBIOL, V15, P21, DOI 10.1038/nrmicro.2016.161; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zehr EA, 2014, STRUCTURE, V22, P539, DOI 10.1016/j.str.2014.02.006	38	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0251429	10.1371/journal.pone.0251429	http://dx.doi.org/10.1371/journal.pone.0251429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111132	Green Published, gold, Green Submitted			2022-12-26	WOS:000664642700008
J	Venegas, P; Calderon, F; Riofrio, D; Benitez, D; Ramon, G; Cisneros-Heredia, D; Coimbra, M; Rojo-Alvarez, JL; Perez, N				Venegas, Pablo; Calderon, Francisco; Riofrio, Daniel; Benitez, Diego; Ramon, Giovani; Cisneros-Heredia, Diego; Coimbra, Miguel; Luis Rojo-Alvarez, Jose; Perez, Noel			Automatic ladybird beetle detection using deep-learning models	PLOS ONE			English	Article							NEURAL-NETWORKS; RECOGNITION; SALIENCY; INSECTS; CLASSIFICATION	Fast and accurate taxonomic identification of invasive trans-located ladybird beetle species is essential to prevent significant impacts on biological communities, ecosystem functions, and agricultural business economics. Therefore, in this work we propose a two-step automatic detector for ladybird beetles in random environment images as the first stage towards an automated classification system. First, an image processing module composed of a saliency map representation, simple linear iterative clustering superpixels segmentation, and active contour methods allowed us to generate bounding boxes with possible ladybird beetles locations within an image. Subsequently, a deep convolutional neural network-based classifier selects only the bounding boxes with ladybird beetles as the final output. This method was validated on a 2, 300 ladybird beetle image data set from Ecuador and Colombia obtained from the iNaturalist project. The proposed approach achieved an accuracy score of 92% and an area under the receiver operating characteristic curve of 0.977 for the bounding box generation and classification tasks. These successful results enable the proposed detector as a valuable tool for helping specialists in the ladybird beetle detection problem.	[Venegas, Pablo; Calderon, Francisco; Riofrio, Daniel; Benitez, Diego; Perez, Noel] Univ San Francisco Quito USFQ, Colegio Ciencias & Ingn Politecn, Quito, Ecuador; [Ramon, Giovani; Cisneros-Heredia, Diego] Univ San Francisco Quito USFQ, Inst iBIOTROP, Museo Zool, Quito, Ecuador; [Ramon, Giovani; Cisneros-Heredia, Diego] Univ San Francisco Quito USFQ, Colegio Ciencias Biol & Ambientales COCIBA, Quito, Ecuador; [Coimbra, Miguel] Univ Porto, Fac Ciencias, INESC TEC, Porto, Portugal; [Luis Rojo-Alvarez, Jose] Rey Juan Carlos Univ, Dept Signal Theory & Commun & Telemat Syst & Comp, Fuenlabrada, Spain	INESC TEC; Universidade do Porto; Universidad Rey Juan Carlos	Perez, N (corresponding author), Univ San Francisco Quito USFQ, Colegio Ciencias & Ingn Politecn, Quito, Ecuador.	nperez@usfq.edu.ec	Rojo-Álvarez, José-Luis/F-6520-2016; Perez, Noel/E-1894-2014; Cisneros-Heredia, Diego/D-1744-2011; Benitez, Diego/E-5393-2015	Rojo-Álvarez, José-Luis/0000-0003-0426-8912; Perez, Noel/0000-0003-3166-745X; Venegas, Pablo/0000-0003-3297-4486; Cisneros-Heredia, Diego/0000-0002-6132-2738; Benitez, Diego/0000-0001-6219-067X	Universidad San Francisco de Quito (USFQ) [16870]	Universidad San Francisco de Quito (USFQ)	NP. Collaboration Grants Program (Grant no. 16870), Universidad San Francisco de Quito (USFQ), https://www.usfq.edu.ec/NP.Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta R., 2010, TECHNICAL REPORT; Achanta R, 2012, IEEE T PATTERN ANAL, V34, P2274, DOI 10.1109/TPAMI.2012.120; Alom MZ, 2019, J MED IMAGING, V6, DOI 10.1117/1.JMI.6.1.014006; [Anonymous], 2013, INT WORKSH MULT DISC; [Anonymous], 2013, INSECTA MUNDI; Ayob M, 2012, THESIS U YORK; Bhattacharya S, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102589; Camacho-Cervantes M, 2017, PEERJ, V5, DOI 10.7717/peerj.3296; Cardoso P, 2020, BIOL CONSERV, V242, DOI 10.1016/j.biocon.2020.108426; Caywood MS, 2004, J NEUROPHYSIOL, V91, P2859, DOI 10.1152/jn.00775.2003; Chan TF, 2001, IEEE T IMAGE PROCESS, V10, P266, DOI 10.1109/83.902291; Cheng T, 2016, AIDS BEHAV, V20, P377, DOI 10.1007/s10461-015-1101-3; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; Cisneros-Heredia DF, 2020, PEERJ, V8, DOI 10.7717/peerj.10461; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Curilem M, 2018, IEEE IJCNN; Demsar J, 2006, J MACH LEARN RES, V7, P1; Felzenszwalb PF, 2004, INT J COMPUT VISION, V59, P167, DOI 10.1023/B:VISI.0000022288.19776.77; Gadekallu TR, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9020274; Garg A, 2020, KSII T INTERNET INF, V14, P2997, DOI 10.3837/tiis.2020.07.015; Huynh HX, 2019, L N INST COMP SCI SO, V298, P127, DOI 10.1007/978-3-030-34365-1_10; Hoye TT, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2002545117; Kadir T, 2001, INT J COMPUT VISION, V45, P83, DOI 10.1023/A:1012460413855; Kanan C, 2010, PROC CVPR IEEE, P2472, DOI 10.1109/CVPR.2010.5539947; KASS M, 1987, INT J COMPUT VISION, V1, P321, DOI 10.1007/BF00133570; King DB, 2015, ACS SYM SER, V1214, P1; Lara-Cueva, IEEE T GEOSCI REMOTE; Le VK, 2018, 2018 2ND INTERNATIONAL CONFERENCE ON DIGITAL SIGNAL PROCESSING (ICDSP 2018), P1, DOI 10.1145/3193025.3193026; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Lim S, 2018, I C CONT AUTOMAT ROB, P1128, DOI 10.1109/ICARCV.2018.8581103; Lopez FG, 2006, EUR J OPER RES, V169, P477, DOI 10.1016/j.ejor.2004.08.010; Maity A, 2015, ARXIV PREPRINT ARXIV; Majerus M.E, 2016, NATURAL HIST LADYBIR; Marshall, 2018, BEETLES NATURAL HIST; Mayo M, 2007, KNOWL-BASED SYST, V20, P195, DOI 10.1016/j.knosys.2006.11.012; MUMFORD D, 1989, COMMUN PUR APPL MATH, V42, P577, DOI 10.1002/cpa.3160420503; Orr MC, 2021, NAT ECOL EVOL, V5, P3, DOI 10.1038/s41559-020-01360-5; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pena A, 2020, 2020 IEEE COLOMBIAN CONFERENCE ON APPLICATIONS OF COMPUTATIONAL INTELLIGENCE (IEEE COLCACI 2020); Python Core Team, 2019, PYTH 369 DYN OPEN SO; Reaser JK, 2020, BIOL INVASIONS, V22, P1, DOI 10.1007/s10530-019-02156-w; Sagar R, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9010097; Salazar A, 2020, 2020 IEEE COLOMBIAN CONFERENCE ON APPLICATIONS OF COMPUTATIONAL INTELLIGENCE (IEEE COLCACI 2020); Shi JB, 2000, IEEE T PATTERN ANAL, V22, P888, DOI 10.1109/34.868688; Shokoufandeh A, 1999, IMAGE VISION COMPUT, V17, P445, DOI 10.1016/S0262-8856(98)00124-3; Song KS, 2006, IEEE T INFORM THEORY, V52, P510, DOI 10.1109/TIT.2005.860423; Souza WSR, 2019, IEEE SYS MAN CYBERN, P2285, DOI 10.1109/SMC.2019.8914428; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Tang H, 2020, COMPUT ELECTRON AGR, V178, DOI 10.1016/j.compag.2020.105739; Terry JCD, 2020, METHODS ECOL EVOL, V11, P303, DOI 10.1111/2041-210X.13335; Titos M, 2018, IEEE J-STARS, V11, P1533, DOI 10.1109/JSTARS.2018.2803198; Uemura T., 2020, 2 EAI INT C ROBOTIC, P53; Vandenberg NJ, 2019, ZOOTAXA, V4712, P413, DOI 10.11646/zootaxa.4712.3.7; Vedaldi A, 2008, LECT NOTES COMPUT SC, V5305, P705, DOI 10.1007/978-3-540-88693-8_52; Venegas P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241798; Verma S, 2021, IEEE SENS J, V21, P15867, DOI [10.1109/JSEN.2020.3012478, 10.1080/17508975.2020.1803787]; Wagele H, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-25; Wang J, 2016, PROC CVPR IEEE, P2285, DOI 10.1109/CVPR.2016.251; Wang JH, 2020, IEEE ACCESS, V8, P191694, DOI 10.1109/ACCESS.2020.3032531; Wu XP, 2019, PROC CVPR IEEE, P8779, DOI 10.1109/CVPR.2019.00899; Xie CJ, 2015, COMPUT ELECTRON AGR, V119, P123, DOI 10.1016/j.compag.2015.10.015; Yan Q, 2013, PROC CVPR IEEE, P1155, DOI 10.1109/CVPR.2013.153; Yang LH, 2014, CURR OPIN INSECT SCI, V2, P26, DOI 10.1016/j.cois.2014.06.004; Yao Q, 2012, J INTEGR AGR, V11, P978, DOI 10.1016/S2095-3119(12)60089-6; Zhai Y., 2006, PROC14TH ACM INT C M, DOI DOI 10.1145/1180639.1180824; Zhang PP, 2020, PATTERN RECOGN, V100, DOI 10.1016/j.patcog.2019.107130; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhong YH, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18051489; Zhou ZW, 2018, LECT NOTES COMPUT SC, V11045, P3, DOI 10.1007/978-3-030-00889-5_1	70	4	4	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0253027	10.1371/journal.pone.0253027	http://dx.doi.org/10.1371/journal.pone.0253027			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111201	gold, Green Published			2022-12-26	WOS:000664642700086
J	Clemens, KK; Le, B; Ouedraogo, AM; Mackenzie, C; Vinegar, M; Shariff, SZ				Clemens, Kristin K.; Le, Britney; Ouedraogo, Alexandra M.; Mackenzie, Constance; Vinegar, Marlee; Shariff, Salimah Z.			Childhood food insecurity and incident asthma: A population-based cohort study of children in Ontario, Canada	PLOS ONE			English	Article							PARENTAL SMOKING; FAMILY-HISTORY; HEALTH; ASSOCIATION; DISPARITIES; PREVALENCE; MORBIDITY; NUTRITION; OBESITY; TRENDS	Background Childhood food insecurity has been associated with prevalent asthma in cross-sectional studies. Little is known about the relationship between food insecurity and incident asthma. Methods We used administrative databases linked with the Canadian Community Health Survey, to conduct a retrospective cohort study of children <18 years in Ontario, Canada. Children without a previous diagnosis of asthma who had a household response to the Household Food Security Survey Module (HFSSM) were followed until March 31, 2018 for new asthma diagnoses using a validated administrative coding algorithm. We used multivariable Cox proportional hazard models to examine the association between food insecurity and incident asthma, and adjusted models sequentially for clinical and clinical/socioeconomic risk factors. As additional analyses, we examined associations by HFSSM respondent type, severity of food insecurity, and age of asthma diagnosis. Moreover, we assessed for interaction between food security and child's sex, household smoking status, and maternal asthma on the risk of incident asthma. Results Among the 27,746 included children, 5.1% lived in food insecure households. Over a median of 8.34 years, the incidence of asthma was 7.33/1000 person-years (PY) among food insecure children and 5.91/1000 PY among food secure children (unadjusted hazard ratio [HR] 1.24, 95% CI 1.00 to 1.54, p = 0.051). In adjusted analyses associations were similar (HR 1.16, 95% CI 0.91 to 1.47, p = 0.24 adjusted for clinical risk factors, HR 1.24, 95% CI 0.97 to 1.60, p = 0.09 adjusted for clinical/socioeconomic factors). Associations did not qualitatively change by HFSSM respondent type, severity of food insecurity, and age of asthma diagnosis. There was no evidence of interaction in our models. Conclusions Food insecure children have numerous medical and social challenges. However, in this large population-based study, we did not observe that childhood food insecurity was associated with an increased risk of incident asthma when adjusted for important clinical and socioeconomic confounders.	[Clemens, Kristin K.] Western Univ, Div Endocrinol & Metab, Dept Med, London, ON, Canada; [Clemens, Kristin K.] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada; [Clemens, Kristin K.; Le, Britney; Ouedraogo, Alexandra M.; Shariff, Salimah Z.] ICES, Toronto, ON, Canada; [Clemens, Kristin K.] Lawson Hlth Res Inst, London, ON, Canada; [Clemens, Kristin K.; Mackenzie, Constance] St Josephs Hlth Care, London, ON, Canada; [Mackenzie, Constance] Western Univ, Dept Med, Div Respirol & Clin Pharmacol, London, ON, Canada; [Mackenzie, Constance] Western Univ, Dept Med, Div Toxicol, London, ON, Canada; [Vinegar, Marlee] Western Univ, Schulich Sch Med & Dent, London, ON, Canada; [Shariff, Salimah Z.] Western Univ, Arthur Labatt Family Sch Nursing, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Clemens, KK (corresponding author), Western Univ, Div Endocrinol & Metab, Dept Med, London, ON, Canada.; Clemens, KK (corresponding author), Western Univ, Dept Epidemiol & Biostat, London, ON, Canada.; Clemens, KK (corresponding author), ICES, Toronto, ON, Canada.; Clemens, KK (corresponding author), Lawson Hlth Res Inst, London, ON, Canada.; Clemens, KK (corresponding author), St Josephs Hlth Care, London, ON, Canada.	kristin.clemens@sjhc.london.on.ca	Mackenzie, Constance/GRE-6965-2022	Clemens, Kristin/0000-0001-9636-5597	Ontario Ministry of Health and Long-Term Care (MOHLTC); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute (LHRI)	Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry (SSMD), Western University; Lawson Health Research Institute (LHRI)	This study was completed at the ICES Western site. ICES is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care (MOHLTC). Core funding for ICES Western is provided by the Academic Medical Organization of Southwestern Ontario (AMOSO), the Schulich School of Medicine and Dentistry (SSMD), Western University, and the Lawson Health Research Institute (LHRI). Parts of this material are based on data and information compiled and provided by the MOHLTC and CIHI. The analyses, conclusions, opinions and statements expressed herein are solely those of the authors and do not reflect those of the funding or data sources; no endorsement by ICES, AMOSO, SSMD, LHRI, Western University or the MOHLTC is intended or should be inferred.	Akinbami LJ, 2014, J ALLERGY CLIN IMMUN, V134, P547, DOI 10.1016/j.jaci.2014.05.037; [Anonymous], 2005, CAN MED ASSOC J, V173, pS15, DOI 10.1503/cmaj.045064; Been JV, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001596; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bjerg A, 2007, PEDIATRICS, V120, P741, DOI 10.1542/peds.2006-3742; Burns JS, 2007, CHEST, V132, P238, DOI 10.1378/chest.07-0038; Canadian Community Health Survey, CYCL 2 2 NUTR 2004 G; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clemens KK, 2021, DIABETIC MED, V38, DOI 10.1111/dme.14396; Cook DG, 1997, THORAX, V52, P1081, DOI 10.1136/thx.52.12.1081; Crighton EJ, 2012, CAN J PUBLIC HEALTH, V103, pE384, DOI 10.1007/BF03404447; Drennen CR, 2019, PEDIATRICS, V144, DOI 10.1542/peds.2019-0824; Eicher-Miller HA, 2011, J NUTR, V141, P1738, DOI 10.3945/jn.111.142059; Gershon AS, 2010, AM J EPIDEMIOL, V172, P728, DOI 10.1093/aje/kwq189; Gershon AS, 2010, THORAX, V65, P612, DOI 10.1136/thx.2009.131078; Gershon AS, 2009, CAN RESPIR J, V16, P183, DOI 10.1155/2009/963098; Gong T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106579; Gross RS, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-4113; Health Canada, 2020, DET FOOD SEC STAT; Holgate ST, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.25; Hughes HK, 2017, ACAD PEDIATR, V17, P127, DOI 10.1016/j.acap.2016.11.011; Kallen B, 2013, EUR RESPIR J, V41, P671, DOI 10.1183/09031936.00041912; Kaur J, 2015, J ACAD NUTR DIET, V115, P751, DOI 10.1016/j.jand.2015.01.003; Kirkpatrick SI, 2010, ARCH PEDIAT ADOL MED, V164, P754, DOI 10.1001/archpediatrics.2010.117; Koletzko B, 2017, ANN NUTR METAB, V70, P161, DOI 10.1159/000477781; Leroux J, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112511; Mangini LD, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021683; Mangini LD, 2015, J NUTR, V145, P2756, DOI 10.3945/jn.115.215939; Matheson FI, 2012, CAN J PUBLIC HEALTH, V103, pS12, DOI 10.1007/BF03403823; Matsui EC, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2589; Murray KW, 2010, PEDIATR REV, V31, P124, DOI 10.1542/pir.31-3-124; Oddy WH, 2017, ANN NUTR METAB, V70, P26, DOI 10.1159/000457920; Priftis KN, 2008, ALLERGOL IMMUNOPATH, V36, P343, DOI 10.1016/S0301-0546(08)75867-1; PROOF: Food Insecurity Policy Research, 2018, HOUSEHOLD FOOD INSEC; PROOF: Food Insecurity Policy Research, 2019, HOUSEHOLD FOOD INSEC; Public Health Ontario, 2017, 2011 ONT MARG IND TE; Radhakrishnan D, 2019, ANN AM THORAC SOC, V16, P248, DOI 10.1513/AnnalsATS.201803-187OC; Ribeiro-Silva RD, 2014, PUBLIC HEALTH NUTR, V17, P14, DOI 10.1017/S1368980012005551; Statistics Canada, 2002, GEOGR DIV POST COD C; Story RE, 2007, CURR OPIN PEDIATR, V19, P680, DOI 10.1097/MOP.0b013e3282f1ddfa; Tarasuk V, 2015, CAN MED ASSOC J, V187, pE429, DOI 10.1503/cmaj.150234; To T, 2013, ENVIRON HEALTH PERSP, V121, P46, DOI 10.1289/ehp.1104816; Wadden D, 2021, J ASTHMA, V58, P38, DOI 10.1080/02770903.2019.1658207; YOUNG S, 1991, NEW ENGL J MED, V324, P1168, DOI 10.1056/NEJM199104253241704	44	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252301	10.1371/journal.pone.0252301	http://dx.doi.org/10.1371/journal.pone.0252301			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106966	Green Published, gold			2022-12-26	WOS:000664642200038
J	Malkomes, P; Lunger, I; Oppermann, E; Abou-El-Ardat, K; Oellerich, T; Gunther, S; Canbulat, C; Bothur, S; Schnutgen, F; Yu, WJ; Wingert, S; Haetscher, N; Catapano, C; Dietz, MS; Heilemann, M; Kvasnicka, HM; Holzer, K; Serve, H; Bechstein, WO; Rieger, MA				Malkomes, Patrizia; Lunger, Ilaria; Oppermann, Elsie; Abou-El-Ardat, Khalil; Oellerich, Thomas; Guenther, Stefan; Canbulat, Can; Bothur, Sabrina; Schnuetgen, Frank; Yu, Weijia; Wingert, Susanne; Haetscher, Nadine; Catapano, Claudia; Dietz, Marina S.; Heilemann, Mike; Kvasnicka, Hans-Michael; Holzer, Katharina; Serve, Hubert; Bechstein, Wolf Otto; Rieger, Michael A.			Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53	ONCOGENE			English	Article							TISSUE TRANSGLUTAMINASE; TP53 MUTATION; STEM-CELLS; INHIBITION; EXPRESSION; SURVIVAL; TG2; ADJUVANT; INVASION; DISEASE	Despite a high clinical need for the treatment of colorectal carcinoma (CRC) as the second leading cause of cancer-related deaths, targeted therapies are still limited. The multifunctional enzyme Transglutaminase 2 (TGM2), which harbors transamidation and GTPase activity, has been implicated in the development and progression of different types of human cancers. However, the mechanism and role of TGM2 in colorectal cancer are poorly understood. Here, we present TGM2 as a promising drug target. In primary patient material of CRC patients, we detected an increased expression and enzymatic activity of TGM2 in colon cancer tissue in comparison to matched normal colon mucosa cells. The genetic ablation of TGM2 in CRC cell lines using shRNAs or CRISPR/Cas9 inhibited cell expansion and tumorsphere formation. In vivo, tumor initiation and growth were reduced upon genetic knockdown of TGM2 in xenotransplantations. TGM2 ablation led to the induction of Caspase-3-driven apoptosis in CRC cells. Functional rescue experiments with TGM2 variants revealed that the transamidation activity is critical for the pro-survival function of TGM2. Transcriptomic and protein-protein interaction analyses applying various methods including super-resolution and time-lapse microscopy showed that TGM2 directly binds to the tumor suppressor p53, leading to its inactivation and escape of apoptosis induction. We demonstrate here that TGM2 is an essential survival factor in CRC, highlighting the therapeutic potential of TGM2 inhibitors in CRC patients with high TGM2 expression. The inactivation of p53 by TGM2 binding indicates a general anti-apoptotic function, which may be relevant in cancers beyond CRC.	[Malkomes, Patrizia; Oppermann, Elsie; Canbulat, Can; Holzer, Katharina; Bechstein, Wolf Otto] Goethe Univ Hosp Frankfurt, Dept Gen Visceral & Transplant Surg, Frankfurt, Germany; [Lunger, Ilaria; Abou-El-Ardat, Khalil; Oellerich, Thomas; Bothur, Sabrina; Schnuetgen, Frank; Yu, Weijia; Wingert, Susanne; Haetscher, Nadine; Serve, Hubert; Rieger, Michael A.] Goethe Univ Hosp Frankfurt, Dept Med, Hematol Oncol, Frankfurt, Germany; [Abou-El-Ardat, Khalil; Oellerich, Thomas; Schnuetgen, Frank; Serve, Hubert; Rieger, Michael A.] German Canc Consortium & German Canc Res Ctr DKFZ, Heidelberg, Germany; [Oellerich, Thomas; Schnuetgen, Frank; Serve, Hubert; Rieger, Michael A.] Frankfurt Canc Inst, Frankfurt, Germany; [Guenther, Stefan] Max Planck Inst Heart & Lung Res, Dept Cardiac Dev & Remodelling 1, Bad Nauheim, Germany; [Catapano, Claudia; Dietz, Marina S.; Heilemann, Mike] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, Single Mol Biophys, Frankfurt, Germany; [Kvasnicka, Hans-Michael] Goethe Univ Frankfurt, Senckenberg Inst Pathol, Frankfurt, Germany; [Rieger, Michael A.] Cardio Pulm Inst, Frankfurt, Germany; [Holzer, Katharina] Philipps Univ Marburg, Dept Visceral Thorac & Vasc Surg, Marburg, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt; Philipps University Marburg	Rieger, MA (corresponding author), Goethe Univ Hosp Frankfurt, Dept Med, Hematol Oncol, Frankfurt, Germany.; Rieger, MA (corresponding author), German Canc Consortium & German Canc Res Ctr DKFZ, Heidelberg, Germany.; Rieger, MA (corresponding author), Frankfurt Canc Inst, Frankfurt, Germany.; Rieger, MA (corresponding author), Cardio Pulm Inst, Frankfurt, Germany.	m.rieger@em.uni-frankfurt.de	Malkomes, Patrizia/AAV-3314-2021; Schnütgen, Frank/ABD-8637-2020; Kvasnicka, Hans Michael/E-7993-2011	Schnütgen, Frank/0000-0002-2426-6685; Kvasnicka, Hans Michael/0000-0002-3081-1395; Heilemann, Mike/0000-0002-9821-3578; Yu, Weijia/0000-0001-8471-3048	Else Kroner Fresenius-Stiftung; Deutsche Krebshilfe; LOEWE Centers Cell and Gene Therapy Frankfurt (Hessen State Ministry for Higher Education, Research and the Arts) [III L 4-518/17.004 [2014]]; Frankfurt Cancer Institute (Hessen State Ministry for Higher Education, Research and the Arts) [III L 5 - 519/03/03.001 - [0015]]; Projekt DEAL	Else Kroner Fresenius-Stiftung; Deutsche Krebshilfe(Deutsche Krebshilfe); LOEWE Centers Cell and Gene Therapy Frankfurt (Hessen State Ministry for Higher Education, Research and the Arts); Frankfurt Cancer Institute (Hessen State Ministry for Higher Education, Research and the Arts); Projekt DEAL	The study was supported in part by the Else Kroner Fresenius-Stiftung, the Deutsche Krebshilfe (both to P.M.) and by the LOEWE Centers Cell and Gene Therapy Frankfurt (Hessen State Ministry for Higher Education, Research and the Arts, III L 4-518/17.004 [2014]) and Frankfurt Cancer Institute (Hessen State Ministry for Higher Education, Research and the Arts, III L 5 - 519/03/03.001 - [0015]). Open Access funding enabled and organized by Projekt DEAL.	Advani S, 2019, J SURG ONCOL, V119, P642, DOI 10.1002/jso.25441; Ahvazi B, 2002, EMBO J, V21, P2055, DOI 10.1093/emboj/21.9.2055; Antonyak MA, 2006, P NATL ACAD SCI USA, V103, P18609, DOI 10.1073/pnas.0604844103; Ashour AA, 2014, J CELL MOL MED, V18, P2235, DOI 10.1111/jcmm.12361; Ayinde O, 2017, ONCOTARGET, V8, P20025, DOI 10.18632/oncotarget.15370; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Barrier A, 2006, J CLIN ONCOL, V24, P4685, DOI 10.1200/JCO.2005.05.0229; Begg GE, 2006, P NATL ACAD SCI USA, V103, P19683, DOI 10.1073/pnas.0609283103; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cellura D, 2015, MOL CANCER RES, V13, P1095, DOI 10.1158/1541-7786.MCR-14-0466; Chen JSK, 1999, INT J BIOCHEM CELL B, V31, P817, DOI 10.1016/S1357-2725(99)00045-X; Chhabra A, 2009, ANTICANCER RES, V29, P1909; Condello S, 2018, CANCER RES, V78, P2990, DOI 10.1158/0008-5472.CAN-17-2319; Dienstmann R, 2017, NAT REV CANCER, V17, P79, DOI 10.1038/nrc.2016.126; Dietz P., 2020, METHODS, VS1046-2023, P30024; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fisher ML, 2016, CANCER RES, V76, P7265, DOI 10.1158/0008-5472.CAN-16-2032; FOLK JE, 1966, J BIOL CHEM, V241, P3238; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Nguyen HT, 2018, ONCOL LETT, V16, P9, DOI 10.3892/ol.2018.8679; Harwardt MLIE, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082803; Hilsenbeck O, 2016, NAT BIOTECHNOL, V34, P703, DOI 10.1038/nbt.3626; Hwang JY, 2008, CANCER RES, V68, P5849, DOI 10.1158/0008-5472.CAN-07-6130; Iacopetta B, 2003, HUM MUTAT, V21, P271, DOI 10.1002/humu.10175; Fernandez-Acenero M, 2016, VIRCHOWS ARCH, V469, P611, DOI 10.1007/s00428-016-2020-z; Kang JH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.14; Klock C, 2012, SEMIN IMMUNOPATHOL, V34, P513, DOI 10.1007/s00281-012-0305-0; Kosa K, 1997, BIOCHEM BIOPH RES CO, V232, P737, DOI 10.1006/bbrc.1997.6363; Kotsakis P, 2011, AMINO ACIDS, V41, P909, DOI 10.1007/s00726-010-0790-1; Ku BM, 2013, FASEB J, V27, P3487, DOI 10.1096/fj.12-224220; LEE KN, 1993, BIOCHIM BIOPHYS ACTA, V1202, P1, DOI 10.1016/0167-4838(93)90055-V; LORAND L, 1992, P NATL ACAD SCI USA, V89, P11161, DOI 10.1073/pnas.89.23.11161; Malkomes P, 2016, ANN SURG ONCOL, V23, P2849, DOI 10.1245/s10434-016-5218-z; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mehta Kapil, 2011, Cancers (Basel), V3, P897, DOI 10.3390/cancers3010897; MICANOVIC R, 1994, J BIOL CHEM, V269, P9190; Mishra S, 2006, BIOCHEM BIOPH RES CO, V339, P726, DOI 10.1016/j.bbrc.2005.11.071; Miyoshi N, 2010, ANN SURG ONCOL, V17, P967, DOI 10.1245/s10434-009-0865-y; NAKAOKA H, 1994, SCIENCE, V264, P1593, DOI 10.1126/science.7911253; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; O'Connor ES, 2011, J CLIN ONCOL, V29, P3381, DOI 10.1200/JCO.2010.34.3426; Oliverio S, 1999, J BIOL CHEM, V274, P34123, DOI 10.1074/jbc.274.48.34123; Oono M, 2014, J NEUROCHEM, V128, P403, DOI 10.1111/jnc.12441; PEDERSEN LC, 1994, PROTEIN SCI, V3, P1131, DOI 10.1002/pro.5560030720; Pinkas DM, 2007, PLOS BIOL, V5, P2788, DOI 10.1371/journal.pbio.0050327; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; SARKAR NK, 1957, BIOCHIM BIOPHYS ACTA, V25, P451, DOI 10.1016/0006-3002(57)90512-7; Sauer M, 2017, CHEM REV, V117, P7478, DOI 10.1021/acs.chemrev.6b00667; Shah MA, 2016, J CLIN ONCOL, V34, P843, DOI 10.1200/JCO.2015.63.0558; Shao MH, 2009, CANCER RES, V69, P9192, DOI 10.1158/0008-5472.CAN-09-1257; Soussi T, 2005, HUM MUTAT, V25, P6, DOI 10.1002/humu.20114; Tatsukawa H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-4; Telci D, 2006, FRONT BIOSCI-LANDMRK, V11, P867, DOI 10.2741/1843; Thalheimer FB, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.010; Varga J, 2017, NAT CELL BIOL, V19, P1133, DOI 10.1038/ncb3611; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; Verma A, 2008, CLIN CANCER RES, V14, P2476, DOI 10.1158/1078-0432.CCR-07-4529; Yeo SY, 2016, ELIFE, V5, DOI 10.7554/eLife.07101; Yin J, 2017, CANCER RES, V77, P4973, DOI 10.1158/0008-5472.CAN-17-0388; Zhang H, 2016, CANCER RES, V76, P6410, DOI 10.1158/0008-5472.CAN-16-0595	60	2	2	2	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2021	40	25					4352	4367		10.1038/s41388-021-01847-w	http://dx.doi.org/10.1038/s41388-021-01847-w		JUN 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SY4AZ	34103685	Green Published, hybrid			2022-12-26	WOS:000659032900003
J	Fraiwan, L; Hassanin, O				Fraiwan, Luay; Hassanin, Omnia			Computer-aided identification of degenerative neuromuscular diseases based on gait dynamics and ensemble decision tree classifiers	PLOS ONE			English	Article							CLASSIFICATION	This study proposes a reliable computer-aided framework to identify gait fluctuations associated with a wide range of degenerative neuromuscular disease (DNDs) and health conditions. Investigated DNDs included amyotrophic lateral sclerosis (ALS), Parkinson's disease (PD), and Huntington's disease (HD). We further performed a statistical and classification comparison elucidating the discriminative capability of different gait signals, including vertical ground reaction force (VGRF), stride duration, stance duration, and swing duration. Feature representation of these gait signals was based on statistical amplitude quantification using the root mean square (RMS), variance, kurtosis, and skewness metrics. We investigated various decision tree (DT) based ensemble methods such as bagging, adaptive boosting (AdaBoost), random under-sampling boosting (RUSBoost), and random subspace to tackle the challenge of multi-class classification. Experimental results showed that AdaBoost ensembling provided a 6.49%, 0.78%, 2.31%, and 2.72% prediction rate improvement for the VGRF, stride, stance, and swing signals, respectively. The proposed approach achieved the highest classification accuracy of 99.17%, sensitivity of 98.23%, and specificity of 99.43%, using the VGRF-based features and the adaptive boosting classification model. This work demonstrates the effective capability of using simple gait fluctuation analysis and machine learning approaches to detect DNDs. Computer-aided analysis of gait fluctuations provides a promising advent to enhance clinical diagnosis of DNDs.	[Fraiwan, Luay; Hassanin, Omnia] Abu Dhabi Univ, Dept Elect & Comp Engn, Abu Dhabi, U Arab Emirates; [Fraiwan, Luay] Jordan Univ Sci & Technol, Dept Biomed Engn, Irbid, Jordan	Abu Dhabi University; Jordan University of Science & Technology	Fraiwan, L (corresponding author), Abu Dhabi Univ, Dept Elect & Comp Engn, Abu Dhabi, U Arab Emirates.; Fraiwan, L (corresponding author), Jordan Univ Sci & Technol, Dept Biomed Engn, Irbid, Jordan.	fraiwan@just.edu.jo		Hassanin, Omnia/0000-0003-0329-8650	Abu Dhabi University Research Office [19300518]	Abu Dhabi University Research Office	This work is supported by Abu Dhabi University Research Office (Grant No. 19300518). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamdari A, 2017, HUMAN MODELING FOR BIO-INSPIRED ROBOTICS: MECHANICAL ENGINEERING IN ASSISTIVE TECHNOLOGIES, P37; Andriacchi TP, 2000, J BIOMECH, V33, P1217, DOI 10.1016/S0021-9290(00)00061-0; Athisakthi A, 2017, 2017 2ND WORLD CONGRESS ON COMPUTING AND COMMUNICATION TECHNOLOGIES (WCCCT), P240, DOI 10.1109/WCCCT.2016.66; Beauchet O, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00353; Beyrami SMG, 2020, MEASUREMENT, V156, DOI 10.1016/j.measurement.2020.107579; Bonelli RM, 2012, HAND CLINIC, V106, P507, DOI 10.1016/B978-0-444-52002-9.00030-9; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Dadar M, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa061; Daniya T., 2020, ADV MATH SCI J, V9, P1857, DOI [10.37418/amsj.9.10.53, DOI 10.37418/AMSJ.9.10.53]; Fabbri M., 2017, J PARKINSONS DIS, V7, P1; Galar M, 2012, IEEE T SYST MAN CY C, V42, P463, DOI 10.1109/TSMCC.2011.2161285; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Gupta K, 2019, HEALTH TECHNOL-GER, V9, P547, DOI 10.1007/s12553-018-0274-y; Hannink J, 2017, IEEE J BIOMED HEALTH, V21, P85, DOI 10.1109/JBHI.2016.2636456; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2000, J APPL PHYSIOL, V88, P2045, DOI 10.1152/jappl.2000.88.6.2045; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Haya A., 2020, J RELIABLE INTELLIGE, P233; He K, 1997, J STAT PLAN INFER, V61, P49, DOI 10.1016/S0378-3758(96)00142-5; Hunter SK, 2016, J APPL PHYSIOL, V121, P982, DOI 10.1152/japplphysiol.00475.2016; Islam M. J., 2019, 2019 INT C EL COMP C, P1; Jaiswal MK, 2017, NEURAL REGEN RES, V12, P723, DOI 10.4103/1673-5374.206635; Javed AR, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102572; Joseph J., 2008, J NEUROL NEUROSUR PS, V79, P361; Joutsijoki H, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3025057; Lin CW, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20143857; Manuel GR., 2015, CURR ALZHEIMER RES, V13, P469; McDonough AL, 2001, ARCH PHYS MED REHAB, V82, P419, DOI 10.1053/apmr.2001.19778; Najafabadian B, 2018, IRAN CONF ELECTR ENG, P1482; Pham TD, 2018, IEEE T NEUR SYS REH, V26, P188, DOI 10.1109/TNSRE.2017.2732448; Prabhu P, 2020, PATTERN RECOGN LETT, V139, P10, DOI 10.1016/j.patrec.2018.05.006; Qiang Y., 2018, COMPUT MATH METHOD M, V2018, P1; Raileanu LE, 2004, ANN MATH ARTIF INTEL, V41, P77, DOI 10.1023/B:AMAI.0000018580.96245.c6; Reilmann R, 2019, INT REV NEUROBIOL, V149, P299, DOI 10.1016/bs.irn.2019.10.006; Ren L, 2007, J BIOMECH, V40, P1567, DOI 10.1016/j.jbiomech.2006.07.017; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; SAFAVIAN SR, 1991, IEEE T SYST MAN CYB, V21, P660, DOI 10.1109/21.97458; Salunkhe UR, 2016, PROCEDIA COMPUT SCI, V85, P725, DOI 10.1016/j.procs.2016.05.259; Seiffert C, 2010, IEEE T SYST MAN CY A, V40, P185, DOI 10.1109/TSMCA.2009.2029559; Solomon OM, 2001, IEEE IMTC P, P96, DOI 10.1109/IMTC.2001.928794; Tang WL, 2013, NETW MODEL ANAL HLTH, V2, P1, DOI 10.1007/s13721-012-0020-8; VB SA., 2020, INT J SCI TECHNOLOGY, V9, P6250; Wu YF, 2010, IEEE T NEUR SYS REH, V18, P150, DOI 10.1109/TNSRE.2009.2033062; Xia Y, 2015, BIOMED SIGNAL PROCES, V18, P254, DOI 10.1016/j.bspc.2015.02.002; Yaman MA, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10110651; Yan Y, 2020, IEEE ACCESS, V8, P96363, DOI 10.1109/ACCESS.2020.2996667; Yan Y, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20072006; Zhuang JJ, 2008, CHINESE PHYS B, V17, P852, DOI 10.1088/1674-1056/17/3/021	48	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252380	10.1371/journal.pone.0252380	http://dx.doi.org/10.1371/journal.pone.0252380			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086723	gold, Green Published			2022-12-26	WOS:000664640100056
J	Hammer, KP; Mustroph, J; Stauber, T; Birchmeier, W; Wagner, S; Maier, LS				Hammer, Karin P.; Mustroph, Julian; Stauber, Teresa; Birchmeier, Walter; Wagner, Stefan; Maier, Lars S.			Beneficial effect of voluntary physical exercise in Plakophilin2 transgenic mice	PLOS ONE			English	Article							RIGHT-VENTRICULAR CARDIOMYOPATHY; RECEPTOR KINASE; G-PROTEIN; DYSPLASIA/CARDIOMYOPATHY; EXPRESSION; INCREASE; RECOMMENDATIONS; PARTICIPATION; ABNORMALITIES; ASSOCIATION	Arrhythmogenic right ventricular cardiomyopathy is a hereditary, rare disease with an increased risk for sudden cardiac death. The disease-causing mutations are located within the desmosomal complex and the highest incidence is found in plakophilin2. However, there are other factors playing a role for the disease progression unrelated to the genotype such as inflammation or exercise. Competitive sports have been identified as risk factor, but the type and extend of physical activity as cofactor for arrhythmogenesis remains under debate. We thus studied the effect of light voluntary exercise on cardiac health in a mouse model. Mice with a heterozygous PKP2 loss-of-function mutation were given the option to exercise in a running wheel which was monitored 24 h/d. We analyzed structural and functional development in vivo by echocardiography which revealed that neither the genotype nor the exercise caused any significant structural changes. Ejection fraction and fractional shortening were not influenced by the genotype itself, but exercise did cause a drop in both parameters after 8 weeks, which returned to normal after 16 weeks of training. The electrophysiological analysis revealed that the arrhythmogenic potential was slightly higher in heterozygous animals (50% vs 18% in wt littermates) and that an additional stressor (isoprenaline) did not lead to an increase of arrhythmogenic events pre run or after 8 weeks of running but the vulnerability was increased after 16 weeks. Exercise-induced alterations in Ca handling and contractility of isolated myocytes were mostly abolished in heterozygous animals. No fibrofatty replacements or rearrangement of gap junctions could be observed. Taken together we could show that light voluntary exercise can cause a transient aggravation of the mutation-induced phenotype which is abolished after long term exercise indicating a beneficial effect of long term light exercise.	[Hammer, Karin P.; Mustroph, Julian; Stauber, Teresa; Wagner, Stefan; Maier, Lars S.] Univ Hosp Regensburg, Internal Med 2, Regensburg, Germany; [Birchmeier, Walter] Max Delbruck Ctr Mol Med, Berlin, Germany	University of Regensburg; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Hammer, KP (corresponding author), Univ Hosp Regensburg, Internal Med 2, Regensburg, Germany.	karin.hammer@ukr.de	Wagner, Stefan/AAE-3721-2021	Wagner, Stefan/0000-0002-9471-1166; Hammer, Karin/0000-0003-2015-0682; Mustroph, Julian/0000-0001-9668-7852	Deutsche Forschungsgemeinschaft [HA6017/3-1, 2539/4-1, 2539/5-1, 2539/7-1]; EU HORIZON 2020 [777204]; ReForM C program of the Faculty of Medicine Regensburg; Deutsche Kardiologische Gesellschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU HORIZON 2020; ReForM C program of the Faculty of Medicine Regensburg; Deutsche Kardiologische Gesellschaft	KPH: HA6017/3-1 by Deutsche Forschungsgemeinschaft; https://www.dfg.de/SW: WA 2539/4-1, 5-1 and 7-1 by Deutsche Forschungsgemeinschaft; https://www.dfg.de/LSM: SILICOFCM ID 777204 by EU HORIZON 2020; https://ec.europa.eu/programmes/horizon2020/en KPH, SW, LSM: ReForM C program of the Faculty of Medicine Regensburg; https://www.ukr.de/JM: Clinician Scientist by Deutsche Kardiologische Gesellschaft; https://dgk.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin KM, 2019, NAT REV CARDIOL, V16, P519, DOI 10.1038/s41569-019-0200-7; Benito B, 2011, CIRCULATION, V123, P13, DOI 10.1161/CIRCULATIONAHA.110.938282; Bers DM, 2008, EXCITATION CONTRACTI; BEUCKELMANN DJ, 1992, BASIC RES CARDIOL, V87, P235; BOHM M, 1990, CIRCULATION, V82, P1249, DOI 10.1161/01.CIR.82.4.1249; Cadrin-Tourigny J, 2019, EUR HEART J, V40, P1850, DOI 10.1093/eurheartj/ehz103; Cerrone M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00127-0; Cerrone M, 2012, CARDIOVASC RES, V95, P460, DOI 10.1093/cvr/cvs218; Chang Y, 2015, INT J SPORTS MED, V36, P1, DOI 10.1055/s-0034-1384545; Corrado D, 2000, CIRCULATION, V101, pE101, DOI 10.1161/01.CIR.101.11.e101; CORRADO D, 1990, AM J MED, V89, P588, DOI 10.1016/0002-9343(90)90176-E; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2006, J CARDIOVASC MED, V7, P228, DOI 10.2459/01.JCM.0000219313.89633.45; Corrado D, 2020, EUR HEART J, V41, P1414, DOI 10.1093/eurheartj/ehz669; Cruz FM, 2015, J AM COLL CARDIOL, V65, P1438, DOI 10.1016/j.jacc.2015.01.045; de Lucia C, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00904; Fabritz L, 2011, J AM COLL CARDIOL, V57, P740, DOI 10.1016/j.jacc.2010.09.046; FELDMAN AM, 1988, J CLIN INVEST, V82, P189, DOI 10.1172/JCI113569; Groeneweg JA, 2015, CIRC-CARDIOVASC GENE, V8, P437, DOI 10.1161/CIRCGENETICS.114.001003; Grossmann KS, 2004, J CELL BIOL, V167, P149, DOI 10.1083/jcb.200402096; James CA, 2013, J AM COLL CARDIOL, V62, P1290, DOI 10.1016/j.jacc.2013.06.033; Kim JC, 2019, CIRCULATION, V140, P1015, DOI 10.1161/CIRCULATIONAHA.119.039710; La Gerche A, 2012, EUR HEART J, V33, P998, DOI 10.1093/eurheartj/ehr397; Lou Q, 2011, CIRCULATION, V123, P1881, DOI 10.1161/CIRCULATIONAHA.110.989707; Lubos N, 2020, BASIC RES CARDIOL, V115, DOI 10.1007/s00395-020-0803-5; Marcus FI, 2010, EUR HEART J, V31, P806, DOI [10.1093/eurheartj/ehq025, 10.1161/CIRCULATIONAHA.108.840827]; Maron BJ, 2015, CIRCULATION, V132, pE343, DOI 10.1161/CIR.0000000000000250; Maron BJ, 2004, CIRCULATION, V109, P2807, DOI 10.1161/01.CIR.0000128363.85581.E1; Mazzanti A, 2016, J AM COLL CARDIOL, V68, P2540, DOI 10.1016/j.jacc.2016.09.951; MCKENNA WJ, 1994, BRIT HEART J, V71, P215; Mitchell JH, 2005, J AM COLL CARDIOL, V45, P1364, DOI 10.1016/j.jacc.2005.02.015; NEUMANN J, 1988, LANCET, V2, P936; Ohno S, 2016, J ARRYTHM, V32, P398, DOI 10.1016/j.joa.2016.01.006; Pabel S, 2020, EUROPACE, V22, P1111, DOI 10.1093/europace/euaa079; Padron-Barthe L, 2017, BASIC RES CARDIOL, V112, DOI 10.1007/s00395-017-0640-3; Ping PP, 1997, AM J PHYSIOL-HEART C, V273, pH707, DOI 10.1152/ajpheart.1997.273.2.H707; Potenza DM, 2019, J GEN PHYSIOL, V151, P131, DOI 10.1085/jgp.201812155; Prior D, 2020, HEART LUNG CIRC, V29, P547, DOI 10.1016/j.hlc.2019.12.007; Romero J, 2013, CLIN MED INSIGHTS-CA, V7, P97, DOI 10.4137/CMC.S10940; Ruwald AC, 2015, EUR HEART J, V36, P1735, DOI 10.1093/eurheartj/ehv110; Sato PY, 2011, CIRC RES, V109, P193, DOI 10.1161/CIRCRESAHA.111.247023; Schafers MA, 2001, BASIC RES CARDIOL, V96, P91, DOI 10.1007/s003950170082; Te Riele Anneline S J M, 2015, JACC Clin Electrophysiol, V1, P551, DOI 10.1016/j.jacep.2015.08.004; Tester DJ, 2019, JACC-CLIN ELECTROPHY, V5, P120, DOI 10.1016/j.jacep.2018.09.010; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; UNGERER M, 1994, CIRC RES, V74, P206, DOI 10.1161/01.RES.74.2.206; van Opbergen CJM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174076; Wang YH, 2020, CIRCULATION, V141, P1477, DOI 10.1161/CIRCULATIONAHA.119.043504; Wichter T, 2000, CIRCULATION, V101, P1552, DOI 10.1161/01.CIR.101.13.1552	49	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252649	10.1371/journal.pone.0252649	http://dx.doi.org/10.1371/journal.pone.0252649			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086773	Green Accepted, Green Published, gold			2022-12-26	WOS:000664640100102
J	Kahana, D; Yamin, D				Kahana, Dor; Yamin, Dan			Accounting for the spread of vaccination behavior to optimize influenza vaccination programs	PLOS ONE			English	Article							MASS-MEDIA; NETWORKS; DYNAMICS; MODEL	Vaccination is the most efficient means of preventing influenza infection and its complications. While previous studies have considered the externalities of vaccination that arise from indirect protection against influenza infection, they have often neglected another key factor-the spread of vaccination behavior among social contacts. We modeled influenza vaccination as a socially contagious process. Our model uses a contact network that we developed based on aggregated and anonymized mobility data from the cellphone devices of similar to 1.8 million users in Israel. We calibrated the model to high-quality longitudinal data of weekly influenza vaccination uptake and influenza diagnoses over seven years. We demonstrate how a simple coupled-transmission model accurately captures the spatiotemporal patterns of both influenza vaccination uptake and influenza incidence. Taking the identified complex underlying dynamics of these two processes into account, our model determined the optimal timing of influenza vaccination programs. Our simulation shows that in regions where high vaccination coverage is anticipated, vaccination uptake would be more rapid. Thus, our model suggests that vaccination programs should be initiated later in the season, to mitigate the effect of waning immunity from the vaccine. Our simulations further show that optimally timed vaccination programs can substantially reduce disease transmission without increasing vaccination uptake.	[Kahana, Dor; Yamin, Dan] Tel Aviv Univ, Dept Ind Engn, Fac Engn, Tel Aviv, Israel; [Yamin, Dan] Tel Aviv Univ, Ctr Combatting Pandem, Tel Aviv, Israel	Tel Aviv University; Tel Aviv University	Yamin, D (corresponding author), Tel Aviv Univ, Dept Ind Engn, Fac Engn, Tel Aviv, Israel.; Yamin, D (corresponding author), Tel Aviv Univ, Ctr Combatting Pandem, Tel Aviv, Israel.	dan.yamin@gmail.com		Yamin, Dan/0000-0002-1131-5572	Zimin Institute for Engineering Solutions Advancing Better Lives; Israeli National Institute for Health Policy Research (NIHP) [164-16]; Koret Foundation	Zimin Institute for Engineering Solutions Advancing Better Lives; Israeli National Institute for Health Policy Research (NIHP); Koret Foundation	This work was supported by the Zimin Institute for Engineering Solutions Advancing Better Lives, the Israeli National Institute for Health Policy Research (NIHP) as part of project number 164-16, and the Koret Foundation grant for Smart Cities and Digital Living. The funders had no role in study design, data collection, analysis, decision to publish, or manuscript preparation.	A.Weiss, 2020, medRxiv, DOI 10.1101/2020.06.04.20112417; Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], MACCABI HLTH MAINTEN; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492; Bauch CT, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002452; Campbell E, 2013, SCI REP-UK, V3, DOI 10.1038/srep01905; Chapman GB, 1999, PREV MED, V29, P249, DOI 10.1006/pmed.1999.0535; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Christakis NA, 2007, NEW ENGL J MED, V357, P370, DOI 10.1056/NEJMsa066082; Dan YM, 2014, VACCINE, V32, P4198, DOI 10.1016/j.vaccine.2014.05.015; Dan YM, 2014, ISR J HEALTH POLICY, V3, DOI 10.1186/2045-4015-3-13; Endrich MM, 2009, VACCINE, V27, P4018, DOI 10.1016/j.vaccine.2009.04.029; Epstein JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003955; Fibich G, 2016, PHYS REV E, V94, DOI 10.1103/PhysRevE.94.032305; Fibich G, 2010, OPER RES, V58, P1450, DOI 10.1287/opre.1100.0818; for Disease Control C, 2015, FLU VACCINATION COVE; Fu F, 2011, P ROY SOC B-BIOL SCI, V278, P42, DOI 10.1098/rspb.2010.1107; Galvani AP, 2007, P NATL ACAD SCI USA, V104, P5692, DOI 10.1073/pnas.0606774104; Ghendon Y., 1992, World Health Statistics Quarterly, V45, P306; Granell C., DYNAMICAL INTERPLAY; Grohskopf LA, 2018, MMWR RECOMM REP, V67, DOI 10.15585/mmwr.rr6703a1; Hill AL, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000968; Huang H, 2016, SCI REP-UK, V6, DOI 10.1038/srep37961; Johnson NF, 2020, NATURE, V582, P230, DOI 10.1038/s41586-020-2281-1; Kissling E, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.16.30201; Lipsitch M, 2009, P NATL ACAD SCI USA, V106, P3645, DOI 10.1073/pnas.0900933106; Liu C, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/11/113045; Liu QH, 2016, SCI REP-UK, V6, DOI 10.1038/srep25617; Mao L, 2012, SOC SCI MED, V74, P167, DOI 10.1016/j.socscimed.2011.10.012; Massaro E, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.052817; McKee Chephra, 2016, J Pediatr Pharmacol Ther, V21, P104, DOI 10.5863/1551-6776-21.2.104; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Naboulsi D, 2016, IEEE COMMUN SURV TUT, V18, P124, DOI 10.1109/COMST.2015.2491361; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Prem K, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005697; Putri WCWS, 2018, VACCINE, V36, P3960, DOI 10.1016/j.vaccine.2018.05.057; Rambhia KJ, 2019, CLIN INFECT DIS, V68, P1235, DOI 10.1093/cid/ciy748; Ruan ZY, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.218702; Ruan ZY, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036117; Salathe M, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002199; Shaham A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8327-3; Shropshire AM, 2013, J AM COLL HEALTH, V61, P435, DOI 10.1080/07448481.2013.830619; Tellier R, 2009, J R SOC INTERFACE, V6, pS783, DOI 10.1098/rsif.2009.0302.focus; Vynnycky E., 2010, INTRO INFECT DIS MOD, DOI [10.1093/aje/kwp394, DOI 10.1093/AJE/KWP394]; Wang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep05097; Wang Z, 2016, PHYS REP, V664, P1, DOI 10.1016/j.physrep.2016.10.006; Xia CY, 2019, INFORM SCIENCES, V471, P185, DOI 10.1016/j.ins.2018.08.050; Yaan O., 2012, 2012 46 ANN C INF SC, DOI [10.1109/CISS.2012.6310749, DOI 10.1109/CISS.2012.6310749]; Yamin D, 2013, MANAGE SCI, V59, P2667, DOI 10.1287/mnsc.2013.1725; Yeung MPS, 2016, J PUBLIC HEALTH-UK, V38, P746, DOI 10.1093/pubmed/fdv194; Yoo BK, 2010, HEALTH SERV RES, V45, P1287, DOI 10.1111/j.1475-6773.2010.01127.x	53	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252510	10.1371/journal.pone.0252510	http://dx.doi.org/10.1371/journal.pone.0252510			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086772	gold, Green Published			2022-12-26	WOS:000664640100077
J	Kumar, P; Srivastava, S; Chauhan, S; Patel, R; Marbaniang, SP; Dhillon, P				Kumar, Pradeep; Srivastava, Shobhit; Chauhan, Shekhar; Patel, Ratna; Marbaniang, Strong P.; Dhillon, Preeti			Factors associated with gynaecological morbidities and treatment-seeking behaviour among adolescent girls residing in Bihar and Uttar Pradesh, India	PLOS ONE			English	Article							REPRODUCTIVE-TRACT INFECTIONS; HEALTH-PROBLEMS; CARE; POPULATION; MODELS; WOMEN	Background Gynaecological morbidities are more common than reproductive and contraceptive morbidities and constitute a substantial proportion of disease burden in women. This study aimed to examine the prevalence and factors associated with gynaecological morbidities and the treatment-seeking behaviour among adolescent girls residing in Bihar and Uttar Pradesh, India. Methodology The study utilized data from the Understanding the Lives of Adolescents and Young Adults (UDAYA) survey with a sample size of 14,625 adolescents girls aged 10-19 years. We defined gynaecological morbidity in dichotomous form, created from five questions on different morbidities. Further, the treatment-seeking behaviour was assessed for reported gynaecological morbidities three months prior to the survey. Univariate and bivariate analysis was used to perform analysis to carve out the preliminary results. Additionally, the study employed the heckprobit selection model, a two-equation model, to identify the determinants of outcome variables. Results Overall, about one-fourth (23.6%) of the adolescent girls reported suffering from gynaecological morbidities, and only one-third of them went for treatment. Non-Scheduled Caste/Scheduled Tribe (Non-SC/ST) adolescents were significantly less likely to have gynaecological morbidities (beta: -0.12; CI: -0.18, -0.06) compared to SC/ST counterparts; however, they were more likely to go for the treatment (beta: 0.09; CI: 0.00, 0.19). The adolescents who had 8-9 (beta: 0.17; CI: 0.05, 0.29) or ten and above years of education (beta: 0.21; CI: 0.09, 0.34) had a higher likelihood of going for the treatment than adolescents with no education. Moreover, adolescents who belonged to rural areas were less likely to go for the treatment of gynaecological morbidities (beta: -0.09; CI: -0.17, -0.01) than urban counterparts. Conclusion Multi-pronged interventions are the need of the hour to raise awareness about the healthcare-seeking behaviour for gynaecological morbidities, especially in rural areas. Adolescent girls shall be prioritized as they may lack the knowledge for gynaecological morbidities, and such morbidities may go unnoticed for years. Mobile clinics may be used to disseminate appropriate knowledge among adolescents and screen asymptomatic adolescents for any possible gynaecological morbidity.	[Kumar, Pradeep; Srivastava, Shobhit; Dhillon, Preeti] Int Inst Populat Sci, Dept Math Demog & Stat, Mumbai, Maharashtra, India; [Chauhan, Shekhar] Int Inst Populat Sci, Dept Populat Policies & Programmes, Mumbai, Maharashtra, India; [Patel, Ratna; Marbaniang, Strong P.] Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India	International Institute for Population Sciences; International Institute for Population Sciences; International Institute for Population Sciences	Marbaniang, SP (corresponding author), Int Inst Populat Sci, Dept Publ Hlth & Mortal Studies, Mumbai, Maharashtra, India.	marbaniangstrong@gmail.com	Kumar, Pradeep/AAN-9128-2021; Marbaniang, Strong P/AAN-9493-2021; Srivastava, Shobhit/AAI-1811-2021; CHAUHAN, SHEKHAR/AAH-7233-2020; Kumar, Pradeep/GQV-5790-2022	Kumar, Pradeep/0000-0003-4259-820X; Marbaniang, Strong P/0000-0001-5347-1867; Srivastava, Shobhit/0000-0002-7138-4916; CHAUHAN, SHEKHAR/0000-0002-6926-7649; Dhillon, Preeti/0000-0001-9757-6492	Bill and Melinda Gates Foundation; David and Lucile Packard Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This paper was written using data collected as part of Population Council's UDAYA study, which is funded by the Bill and Melinda Gates Foundation and the David and Lucile Packard Foundation. No additional funds were received for the preparation of the paper.	Ali S, 2017, SOC SCI MED, V177, P127, DOI 10.1016/j.socscimed.2016.11.005; Anuradha C, 2019, INDIAN J OBSTET GYNE, V6, P331, DOI [10.18231/j.ijogr.2019.072, DOI 10.18231/J.IJOGR.2019.072]; Ayub M., 2016, RJLBPCS, V2, P69; Beaulah P, 2018, INDIAN J CONTIN NURS, V19, P103; Bhargava M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234570; Bulut A., 1995, REPROD HEALTH MATTER, V3, P31, DOI [10.1016/0968-8080(95)90157-4, DOI 10.1016/0968-8080(95)90157-4]; Deshpande Ashwini, 2001, REV DEV ECON, V5, P130, DOI [10.1111/1467-9361.00112, DOI 10.1111/1467-9361.00112]; Dheresa M, 2017, J WOMENS HLTH CARE, V06, DOI [10.4172/2167-0420.1000367, DOI 10.4172/2167-0420.1000367]; Gawande KB., 2018, INT J COMMUNITY MED, V5, P1524, DOI [10.18203/2394-6040.ijcmph20181229, DOI 10.18203/2394-6040.IJCMPH20181229]; Gosalia VV., 2012, HINDU, V700, P93; HECKMAN JJ, 1979, ECONOMETRICA, V47, P153, DOI 10.2307/1912352; Hiwarkar Y.A., 2015, INT J RECENT TRENDS, V16, P423; Jejeebhoy S., 2011, SEXUAL REPRODUCTION; Jejeebhoy SJ, 1998, SOC SCI MED, V46, P1275, DOI 10.1016/S0277-9536(97)10056-9; Joshi B. N., 2006, Indian Journal of Pediatrics, V73, P509, DOI 10.1007/BF02759896; Kabir H, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-54; Khanna A, 2005, J HEALTH MANAG, V7, P91, DOI 10.1177/097206340400700103; Kinkor MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225687; Kojima N, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2282-3; Kone S, 2019, BMC MED RES METHODOL, V19, DOI 10.1186/s12874-019-0840-7; Marcoulides KM, 2019, EDUC PSYCHOL MEAS, V79, P874, DOI 10.1177/0013164418817803; Mathew L., 2018, INDIAN J PUBLIC HLTH, V9, P85, DOI [10.5958/0976-5506.2018.00016.5, DOI 10.5958/0976-5506.2018.00016.5]; Mathiyalagen Prakash, 2017, J Family Med Prim Care, V6, P360, DOI 10.4103/2249-4863.220031; Mishra Shailendra Kumar, 2016, Int J Adolesc Med Health, V29, DOI 10.1515/ijamh-2015-0111; MOSTELLER CF, 1977, DATA ANAL REGRESSION; Nagarkar Aarti, 2015, Indian J Sex Transm Dis AIDS, V36, P18, DOI 10.4103/0253-7184.156690; Nandini Bhattacharyya, 2020, Journal of the Anthropological Survey of India, V69, P124, DOI 10.1177/2277436X20927252; Nitika, 2019, J FAM MED PRIM CARE, V8, P2106, DOI 10.4103/jfmpc.jfmpc_262_19; Pervin HH., 2020, INT J REPROD CONTRAC, V9, P3931; Poonia A, 2017, POPULATION TRANSITIO, V121; Population Council, UDAYA, Adolescent Survey, Bihar and Uttar Pradesh, 2015-16, DOI 10.7910/DVN/RRXQNT; Prusty Ranjan Kumar, 2013, Int J MCH AIDS, V2, P103; Rahman M Mizanur, 2004, J Ayub Med Coll Abbottabad, V16, P9; Ramirez JE, 1997, J WOMENS HEALTH, V6, P113, DOI 10.1089/jwh.1997.6.113; Rana M, 2015, J EVOL MED DENT SCI-, V4, P3669, DOI 10.14260/jemds/2015/528; Rasool M., 2017, INT J COMMUNITY MED, V4, P3105, DOI [10.18203/2394-6040.ijcmph20173674, DOI 10.18203/2394-6040.IJCMPH20173674]; Rathod AD, 2016, J OBSTET GYN INDIA, V66, P400, DOI 10.1007/s13224-015-0770-1; Reed HE, 2000, CONSEQUENCES MAT MOR, DOI [10.17226/9800, DOI 10.17226/9800]; Sabarwal S, 2012, INT PERSPECT SEX R H, V38, P90, DOI 10.1363/3809012; Sanjna MV., 2017, PUBLIC HLTH REV INT, V4, P57, DOI 10.17511/ijphr.2017.i2.05; Savarkar T, 2018, DEMOGRAPHIC DIMENSIO, V89; Sharma S., 2017, INT J REPROD CONTRAC, V6, P1945, DOI [10.18203/2320-1770.ijrcog20171954, DOI 10.18203/2320-1770.IJRCOG20171954]; Sivakami M., 2019, HLTH WELLBEING INDIA, P121, DOI 10.1007/978-981-13-6593-5; Susila T, 2014, J OBSTET GYN INDIA, V64, P53, DOI 10.1007/s13224-013-0475-2; Torondel B, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3384-2; UNICEF, 2012, PROGR CHILDR REP CAR; Wijeratne D, 2018, OBSTET GYNAECOL, V20, P237, DOI 10.1111/tog.12515; Yasmin E, 2018, OBSTET GYNAECOL, V20, P147, DOI 10.1111/tog.12510; Yuh T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00303	49	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252521	10.1371/journal.pone.0252521	http://dx.doi.org/10.1371/journal.pone.0252521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086759	Green Published, gold			2022-12-26	WOS:000664640100078
J	Lundblad, J; Rashid, M; Rhodin, M; Andersen, PH				Lundblad, Johan; Rashid, Maheen; Rhodin, Marie; Haubro Andersen, Pia			Effect of transportation and social isolation on facial expressions of healthy horses	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; STRESS; BEHAVIOR; PAIN; SYSTEM	Horses have the ability to generate a remarkable repertoire of facial expressions, some of which have been linked to the affective component of pain. This study describes the facial expressions in healthy horses free of pain before and during transportation and social isolation, which are putatively stressful but ordinary management procedures. Transportation was performed in 28 horses by subjecting them to short-term road transport in a horse trailer. A subgroup (n = 10) of these horses was also subjected to short-term social isolation. During all procedures, a body-mounted, remote-controlled heart rate monitor provided continuous heart rate measurements. The horses' heads were video-recorded during the interventions. An exhaustive dataset was generated from the selected video clips of all possible facial action units and action descriptors, time of emergency, duration, and frequency according to the Equine Facial Action Coding System (EquiFACS). Heart rate increased during both interventions (p<0.01), confirming that they caused disruption in sympato-vagal balance. Using the current method for ascribing certain action units (AUs) to specific emotional states in humans and a novel data-driven co-occurrence method, the following facial traits were observed during both interventions: eye white increase (p<0.001), nostril dilator (p<0.001), upper eyelid raiser (p<0.001), inner brow raiser (p = 0.042), tongue show (p<0.001). Increases in 'ear flicker' (p<0.001) and blink frequency (p<0.001) were also seen. These facial actions were used to train a machine-learning classifier to discriminate between the high-arousal interventions and calm horses, which achieved at most 79% accuracy. Most facial features identified correspond well with previous findings on behaviors of stressed horses, for example flared nostrils, repetitive mouth behaviors, increased eye white, tongue show, and ear movements. Several features identified in this study of pain-free horses, such as dilated nostrils, eye white increase, and inner brow raiser, are used as indicators of pain in some face-based pain assessment tools. In order to increase performance parameters in pain assessment tools, the relations between facial expressions of stress and pain should be studied further.	[Lundblad, Johan; Rhodin, Marie; Haubro Andersen, Pia] Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden; [Rashid, Maheen] Univ Calif Davis, Dept Comp Sci, Davis, CA 95616 USA	Swedish University of Agricultural Sciences; University of California System; University of California Davis	Lundblad, J (corresponding author), Swedish Univ Agr Sci, Dept Anat Physiol & Biochem, Uppsala, Sweden.	Johan.Lundblad@slu.se	Lundblad, Johan/HHM-4824-2022	Lundblad, Johan/0000-0003-4985-6128	platform SLU Future One Health; Swedish Research Council Formas [2020-01840]	platform SLU Future One Health; Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	This study was partly financed by the platform SLU Future One Health awarded to P.H.A and partly financed by the Swedish Research Council Formas, grant no 2020-01840 (http://www.formas.se/) awarded to P.H.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ELAN VERSION 54; Bartlett MS, 2005, PROC CVPR IEEE, P568; Buchanan KL, 2000, TRENDS ECOL EVOL, V15, P156, DOI 10.1016/S0169-5347(99)01812-1; Budzynska M, 2014, J EQUINE VET SCI, V34, P935, DOI 10.1016/j.jevs.2014.05.010; Butler RK, 2009, PROG NEUROBIOL, V88, P184, DOI 10.1016/j.pneurobio.2009.04.003; Chambers CT, 2015, PAIN, V156, P798, DOI 10.1097/j.pain.0000000000000133; Dalla Costa E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092281; Descovich KA, 2017, ALTEX-ALTERN ANIM EX, V34, P409, DOI 10.14573/altex.1607161; Ekman P., 2002, MANUAL INVESTIGATORS; Friend TH., 2001, J ANIM SCI, V79, pE32, DOI [10.2527/jas2001.79E-SupplE32x, DOI 10.2527/JAS2001.79E-SUPPLE32X]; Gleerup KB, 2015, VET ANAESTH ANALG, V42, P103, DOI 10.1111/vaa.12212; Hartmann E, 2012, APPL ANIM BEHAV SCI, V136, P77, DOI 10.1016/j.applanim.2011.10.004; Hintze S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164017; HORNICKE H, 1977, PFLUG ARCH EUR J PHY, V372, P95, DOI 10.1007/BF00582212; Jennings EM, 2014, PROG NEUROBIOL, V121, P1, DOI 10.1016/j.pneurobio.2014.06.003; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kunz M, 2019, PAIN, V160, P535, DOI 10.1097/j.pain.0000000000001424; Lansade L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32993-z; Liapis A, 2017, MULTIMED TOOLS APPL, V76, P5051, DOI 10.1007/s11042-016-3637-2; MAL ME, 1991, APPL ANIM BEHAV SCI, V31, P13, DOI 10.1016/0168-1591(91)90149-R; Mayo LM, 2019, NEUROBIOL STRESS, V10, DOI 10.1016/j.ynstr.2019.100166; McGreevy P., 2004, EQUINE BEHAV GUIDE V, DOI 10.1016/B978-0-7020-2634-8.50006-X; McLennan KM, 2019, APPL ANIM BEHAV SCI, V217, P1, DOI 10.1016/j.applanim.2019.06.001; Merkies K, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9080562; MINTON JE, 1994, J ANIM SCI, V72, P1891, DOI 10.2527/1994.7271891x; Mott RO, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78386-z; Munsters CCBM, 2013, VET REC, V172, P15, DOI 10.1136/vr.100952; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Pons P, 2017, EXPERT SYST APPL, V86, P235, DOI 10.1016/j.eswa.2017.05.063; Rashid M, 2018, MEASURING BEAVIOUR C, P165; Rashid M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231608; Rietmann TR, 2004, J VET MED A, V51, P218, DOI 10.1111/j.1439-0442.2004.00627.x; Rietmann TR, 2004, APPL ANIM BEHAV SCI, V88, P121, DOI 10.1016/j.applanim.2004.02.016; Roberts K, 2016, PHYSIOL BEHAV, V167, P125, DOI 10.1016/j.physbeh.2016.08.029; RUSSELL JA, 1989, J PERS SOC PSYCHOL, V57, P848, DOI 10.1037/0022-3514.57.5.848; Schmidt A, 2010, DOMEST ANIM ENDOCRIN, V39, P205, DOI 10.1016/j.domaniend.2010.06.002; Tateo A, 2012, J VET BEHAV, V7, P33, DOI 10.1016/j.jveb.2011.04.007; von Borstel UK, 2017, APPL ANIM BEHAV SCI, V190, P43, DOI 10.1016/j.applanim.2017.02.018; van Loon JPAM, 2015, VET J, V206, P356, DOI 10.1016/j.tvjl.2015.08.023; Vick SJ, 2007, J NONVERBAL BEHAV, V31, P1, DOI 10.1007/s10919-006-0017-z; Waller BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082686; WARAN NK, 1995, APPL ANIM BEHAV SCI, V43, P71, DOI 10.1016/0168-1591(95)00555-7; Wathan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131738; Wathan J, 2014, CURR BIOL, V24, pR677, DOI 10.1016/j.cub.2014.06.023; WHITE A, 1991, COMP BIOCHEM PHYS A, V99, P343, DOI 10.1016/0300-9629(91)90011-Z; Williams ACD, 2002, BEHAV BRAIN SCI, V25, P439, DOI 10.1017/S0140525X02000080; Young T, 2012, APPL ANIM BEHAV SCI, V140, P33, DOI 10.1016/j.applanim.2012.05.008; ZOLOVICK A, 1966, J ENDOCRINOL, V35, P249, DOI 10.1677/joe.0.0350249	48	8	8	7	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0241532	10.1371/journal.pone.0241532	http://dx.doi.org/10.1371/journal.pone.0241532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086704	Green Published, gold			2022-12-26	WOS:000664640100003
J	McQuaid, C; Halsey, A; Dubois, M; Romero, I; Male, D				McQuaid, Conor; Halsey, Andrea; Dubois, Maeva; Romero, Ignacio; Male, David			Comparison of polypeptides that bind the transferrin receptor for targeting gold nanocarriers	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; CELLULAR UPTAKE; DELIVERY; PEPTIDES; TRANSPORT	The ability to target therapeutic agents to specific tissues is an important element in the development of new disease treatments. The transferrin receptor (TfR) is one potential target for drug delivery, as it expressed on many dividing cells and on brain endothelium, the key cellular component of the blood-brain barrier. The aim of this study was to compare a set of new and previously-described polypeptides for their ability to bind to brain endothelium, and investigate their potential for targeting therapeutic agents to the CNS. Six polypeptides were ranked for their rate of endocytosis by the human brain endothelial cell line hCMEC/D3 and the murine line bEnd.3. One linear polypeptide and two cyclic polypeptides showed high rates of uptake. These peptides were investigated to determine whether serum components, including transferrin itself affected uptake by the endothelium. One of the cyclic peptides was strongly inhibited by transferrin and the other cyclic peptide weakly inhibited. As proof of principle the linear peptide was attached to 2nm glucose coated gold-nanoparticles, and the rate of uptake of the nanoparticles measured in a hydrogel model of the blood-brain barrier. Attachment of the TfR-targeting polypeptide significantly increased the rates of endocytosis by brain endothelium and increased movement of nanoparticles across the cells.	[McQuaid, Conor; Halsey, Andrea; Dubois, Maeva; Romero, Ignacio; Male, David] Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes, Bucks, England; [McQuaid, Conor] Univ Rochester, Dept Neurosci, Rochester, NY USA; [Halsey, Andrea] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Dept Neurosci & Ophthalmol, Birmingham, W Midlands, England	Open University - UK; University of Rochester; University of Birmingham	Male, D (corresponding author), Open Univ, Dept Life Hlth & Chem Sci, Milton Keynes, Bucks, England.	David.Male@Open.ac.uk		Male, David/0000-0002-1242-3137; McQuaid, Conor/0000-0002-5163-8915; Romero, Ignacio/0000-0002-0322-9180	Midatech pharma plc.	Midatech pharma plc.	DM, PhD studentship to support CM. `Delivery of therapeutic cytokines to the CNS, using nanoparticle carriers.' Midatech pharma plc. https://www.midatechpharma.com The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Alkilany AM, 2010, J NANOPART RES, V12, P2313, DOI 10.1007/s11051-010-9911-8; Bourassa P, 2019, MOL PHARMACEUT, V16, P583, DOI 10.1021/acs.molpharmaceut.8b00870; BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801; Crawford L, 2016, J CONTROL RELEASE, V240, P251, DOI 10.1016/j.jconrel.2015.12.041; Cummings Jeffrey, 2018, Alzheimers Dement (N Y), V4, P195, DOI 10.1016/j.trci.2018.03.009; Daas M, 2018, THESIS OPEN U; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016; Demeule M, 2008, J PHARMACOL EXP THER, V324, P1064, DOI 10.1124/jpet.107.131318; Eckenroth BE, 2011, P NATL ACAD SCI USA, V108, P13089, DOI 10.1073/pnas.1105786108; Fatima N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236611; Gang D, 2018, GENES-BASEL, V9, DOI 10.3390/genes9110557; Georgieva Julia V, 2014, Pharmaceutics, V6, P557, DOI 10.3390/pharmaceutics6040557; Gromnicova R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081043; Haqqani AS, 2018, J NEUROCHEM, V146, P735, DOI 10.1111/jnc.14482; Jiang Y, 2015, ACS NANO, V9, P9986, DOI 10.1021/acsnano.5b03521; Johnsen KB, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11220-1; Lajoie JM, 2015, ANNU REV PHARMACOL, V55, P613, DOI 10.1146/annurev-pharmtox-010814-124852; Lee JH, 2001, EUR J BIOCHEM, V268, P2004, DOI 10.1046/j.1432-1327.2001.02073.x; Majerova P, 2020, MOLECULES, V25, DOI 10.3390/molecules25040874; Moura RP, 2019, EXPERT OPIN DRUG DEL, V16, P271, DOI 10.1080/17425247.2019.1583205; Nga BL, 2014, J EXP MED, V211, P233, DOI 10.1084/jem.20131660; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; Oller-Salvia B, 2016, CHEM SOC REV, V45, P4690, DOI 10.1039/c6cs00076b; Pardridge WM, 2008, BIOCONJUGATE CHEM, V19, P1327, DOI 10.1021/bc800148t; Pardridge William M, 2005, NeuroRx, V2, P3; Pasqualini R, 1996, NATURE, V380, P364, DOI 10.1038/380364a0; Paterson Judy, 2016, Drug Discov Today Technol, V20, P49, DOI 10.1016/j.ddtec.2016.07.009; Pulgar VM, 2019, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.01019; Sharma G, 2019, INT J PHARMACEUT, V559, P360, DOI 10.1016/j.ijpharm.2019.01.056; Sreekanthreddy Peddagangannagari, 2015, F1000Res, V4, P1279, DOI 10.12688/f1000research.7142.2; Tsumoto K, 2019, IMMUNOTHERAPY-UK, V11, P119, DOI 10.2217/imt-2018-0130; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zorzi A, 2019, MEDCHEMCOMM, V10, P1068, DOI 10.1039/c9md00018f	36	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252341	10.1371/journal.pone.0252341	http://dx.doi.org/10.1371/journal.pone.0252341			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086733	gold, Green Published, Green Accepted			2022-12-26	WOS:000664640100049
J	Sheng, MZ; Fang, TC; Chen, YH; Chang, MH; Yang, CP; Lin, CH				Sheng, Ming-Zhi; Fang, Ting-Chun; Chen, Yi-Huei; Chang, Ming-Hong; Yang, Chun-Pai; Lin, Ching-Heng			Is either anosmia or constipation associated with cognitive dysfunction in Parkinson's disease?	PLOS ONE			English	Article							TRADITIONAL CHINESE VERSION; SMELL IDENTIFICATION TEST; OLFACTORY DYSFUNCTION; PREFRONTAL CORTEX; ALPHA-SYNUCLEIN; DEMENTIA; SYSTEM; RISK; CONNECTIONS; IMPAIRMENT	Objective To clarify the association of anosmia or constipation with cognitive dysfunction and disease severity in patients with Parkinson's disease (PD). Methods Newly diagnosed patients with PD (less than 5 years) without a clinical diagnosis of dementia were included from February 2017 to August 2018. The subjects were further divided into subgroups based on whether anosmia occurred and the grade of constipation. The severity of PD motor symptoms was rated using the Movement Disorder Society-Sponsored Revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS), and cognitive functions were evaluated by Montreal Cognitive Assessment (MoCA). Statistical analyses including t-tests, chi-square tests, multiple linear regression, and binary logistic regression were used to determine statistical significance. Results A total of 107 newly diagnosed PD patients were included in this study. The MoCA score was significantly lower in the anosmia group (p < 0.001). Constipation was associated with impaired olfaction in a post-hoc test. The correlation coefficient between MoCA and UPSIT score was 0.41 (p < 0.001). Total anosmia and age were associated with cognitive dysfunction (MoCA < 26) (odds ratio, 2.63, p = 0.003; 1.10, p < 0.001, respectively). The anosmia group had a higher MDS-UPDRS part 3 score with beta coefficient of 7.30 (p = 0.02). Furthermore, grade 3 constipation was associated with a higher MDS-UPDRS total score with beta coefficient of 14.88 (p = 0.02). Conclusions Anosmia but not constipation was associated with cognitive impairment in PD patients. Nevertheless, severe constipation was associated with impaired olfaction and PD disease severity. We suggest that the propagation of alpha -synuclein from the olfactory route is distinct from the enteric nervous system, but the intercommunication between these two routes is complex.	[Sheng, Ming-Zhi; Fang, Ting-Chun; Chang, Ming-Hong] Taichung Vet Gen Hosp, Neurol Inst, Taichung, Taiwan; [Chen, Yi-Huei; Lin, Ching-Heng] Taichung Vet Gen Hosp, Dept Med Res, Taichung, Taiwan; [Chang, Ming-Hong] Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan; [Yang, Chun-Pai] Kuang Tien Gen Hosp, Dept Neurol, Taichung, Taiwan	Taichung Veterans General Hospital; Taichung Veterans General Hospital; National Yang Ming Chiao Tung University	Chang, MH (corresponding author), Taichung Vet Gen Hosp, Neurol Inst, Taichung, Taiwan.; Chang, MH (corresponding author), Natl Yang Ming Univ, Sch Med, Dept Neurol, Taipei, Taiwan.	cmh50@ms10.hinet.net		Chang, Ming-Hong/0000-0002-7699-334X				Baba T, 2012, BRAIN, V135, P161, DOI 10.1093/brain/awr321; Beach TG, 2009, ACTA NEUROPATHOL, V117, P613, DOI [10.1007/s00401-009-0538-8, 10.1007/s00401-010-0664-3]; Braak H, 2003, J NEURAL TRANSM, V110, P517, DOI 10.1007/s00702-002-0808-2; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Carmichael ST, 1995, J COMP NEUROL, V363, P615, DOI 10.1002/cne.903630408; Cavaco S, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/976589; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Domellof ME, 2017, PARKINSONISM RELAT D, V38, P41, DOI 10.1016/j.parkreldis.2017.02.017; Doty RL, 2012, NAT REV NEUROL, V8, P329, DOI 10.1038/nrneurol.2012.80; Doty RL, 2009, SEMIN NEUROL, V29, P74, DOI 10.1055/s-0028-1124025; Fullard ME, 2016, PARKINSONISM RELAT D, V25, P45, DOI 10.1016/j.parkreldis.2016.02.013; Gao X, 2011, AM J EPIDEMIOL, V174, P546, DOI 10.1093/aje/kwr119; Ghashghaei H, 2007, NEUROIMAGE, V34, P905, DOI 10.1016/j.neuroimage.2006.09.046; Cersosimo MG, 2018, CELL TISSUE RES, V373, P233, DOI 10.1007/s00441-017-2733-6; Halliday G, 2011, MOVEMENT DISORD, V26, P1015, DOI 10.1002/mds.23669; Hawkes CH, 2007, NEUROPATH APPL NEURO, V33, P599, DOI 10.1111/j.1365-2990.2007.00874.x; Jellinger KA, 2012, MOVEMENT DISORD, V27, P8, DOI 10.1002/mds.23795; Jiang RS, 2010, AMJ RHINOL ALLERGY, V24, P45, DOI 10.2500/ajra.2010.24.3388; Jost WH, 2010, J NEUROL SCI, V289, P69, DOI 10.1016/j.jns.2009.08.020; Lin CH, 2014, PARKINSONISM RELAT D, V20, P1371, DOI 10.1016/j.parkreldis.2014.09.026; Patel RM, 2014, CLIN ANAT, V27, P54, DOI 10.1002/ca.22338; Sauerbier A, 2016, PARKINSONISM RELAT D, V22, pS41, DOI 10.1016/j.parkreldis.2015.09.027; Shipley M., 1991, HUMAN SENSE SMELL PP, P29; Stephenson R, 2010, MOVEMENT DISORD, V25, P2099, DOI 10.1002/mds.23234; Takeda A, 2014, J PARKINSON DIS, V4, P181, DOI 10.3233/JPD-130277; Ubeda-Bannon I, 2014, BRAIN STRUCT FUNCT, V219, P1513, DOI 10.1007/s00429-013-0651-2; Yu CY, 2014, J PARKINSON DIS, V4, P175, DOI 10.3233/JPD-130309	27	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252451	10.1371/journal.pone.0252451	http://dx.doi.org/10.1371/journal.pone.0252451			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086764	Green Published, gold			2022-12-26	WOS:000664640100067
J	Teeluck, M; Samura, A				Teeluck, Mohabeer; Samura, Atsushi			Assessing the appropriateness of the Moving Epidemic Method and WHO Average Curve Method for the syndromic surveillance of acute respiratory infection in Mauritius	PLOS ONE			English	Article							INFLUENZA SURVEILLANCE; INTENSITY LEVELS; THRESHOLDS	Introduction Mauritius introduced Acute respiratory infection (ARI) syndromic surveillance in 2007. The Moving Epidemic Method (MEM) and the World Health Organization Average Curve Method (WHO ACM) have been used widely in several countries to establish thresholds to determine the seasonality of acute respiratory infections. This study aimed to evaluate the appropriateness of these tools for ARI syndromic surveillance in Mauritius, where two or more waves are observed. Method The proportion of attendance due to acute respiratory infections was identified as the transmissibility indicator to describe seasonality using the Moving Epidemic Method and the WHO Average Curve Method. The proportion was obtained from weekly outpatient data between 2012 and 2018 collected from the sentinel acute respiratory infections surveillance. A cross-validation analysis was carried out. The resulting indicators of the goodness of fit model were used to assess the robustness of the seasonal/epidemic threshold of both the Moving Epidemic Method and WHO Average Curve Method. Additionally, a comparative analysis examined the integrity of the thresholds without the year 2017. Result The cross-validation analysis demonstrated no statistically significant differences between the means scores of the indicators when comparing the two waves/seasons curves of WHO ACM and MEM. The only exception being that the Wilcoxon sign rank test strongly supported that the specificity mean score of the two waves/seasons curve for WHO ACM outweighed that of its corresponding wave model for the MEM (P = 0.002). The comparative analysis with 2017 data showed the value of the epidemic threshold remained the same regardless of the methods and the number of seasonal waves. Conclusion The two waves models of the Moving Epidemic Method and WHO Average Curve Method could be deployed for acute respiratory infection syndromic surveillance in Mauritius, considering that two or more activity peaks are observed in a season.	[Teeluck, Mohabeer] Minist Hlth & Wellness, Communicable Dis Control Unit, Port Louis, Mauritius; [Samura, Atsushi] WHO, Country Off Mauritius, Port Louis, Mauritius	World Health Organization	Teeluck, M (corresponding author), Minist Hlth & Wellness, Communicable Dis Control Unit, Port Louis, Mauritius.	mopharm1981@hotmail.com		Teeluck, Mohabeer/0000-0002-5985-3441	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		AbdElGawad B, 2020, J INFECT PUBLIC HEAL, V13, P430, DOI 10.1016/j.jiph.2019.05.005; [Anonymous], 2018, OBSTET GYNECOL, V13, pe49; [Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1; Bangert M, 2017, EPIDEMIOL INFECT, V145, P715, DOI 10.1017/S0950268816002727; Fitzner J, 2018, B WORLD HEALTH ORGAN, V96, P122, DOI 10.2471/BLT.17.194514; Global Burden of Disease Collaborative Network, 2018, GLOB BURD DIS STUD 2; Hall G, 2013, CAN J INFECT DIS MED, V24, P150, DOI 10.1155/2013/386018; Health Sentinel Network of Castilla y Leon, MOV EP METH R PACK; Hirve S, 2015, SEASONAL INFLUENZA V, P99; Hirve S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153003; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Kramer SC, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006742; Lozano J.E., MOVING EPIDEMIC METH; Lucero MG, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2087-9; Ly S, 2017, WEST PAC SURVEILL RE, V8, DOI [10.5365/WPSAR.2017.8.1.002, 10.5365/wpsar.2017.8.1.002]; Mauritius Meteorological Services, CLIM MAUR; Ministry of Health and Quality of Life Mauritius, 2017, 43 MIN HLTH QUAL LIF; Murray JLK, 2018, EUROSURVEILLANCE, V23, P8, DOI 10.2807/1560-7917.ES.2018.23.11.18-00079; Ng Sophia, 2015, Curr Epidemiol Rep, V2, P89; Park K., 2015, PARKS TXB PREVENTIVE, V23rd; Rakocevic B, 2019, EUROSURVEILLANCE, V24, P37, DOI 10.2807/1560-7917.ES.2019.24.12.1800042; Ryan K.J., 2018, SHERRIS MED MICROBIO, V7th edn; Sambala EZ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023335; Spruijt IT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163508; StataCorp, 2021, STATA STAT SOFTWARE; Tay EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077244; Vega T, 2015, INFLUENZA OTHER RESP, V9, P234, DOI 10.1111/irv.12330; Vega T, 2013, INFLUENZA OTHER RESP, V7, P546, DOI 10.1111/j.1750-2659.2012.00422.x; Vette K, 2018, B WORLD HEALTH ORGAN, V96, P558, DOI 10.2471/BLT.18.211508; Vos LM, 2019, EUROSURVEILLANCE, V24, P34, DOI 10.2807/1560-7917.ES.2019.24.20.1800469; World Health Organization, WHO AV CURV SHIN TEC; World Health Organization, WHO AV CURV SHIN; World Health Organization, 2011, WHO STRENGTH RESP PA; World Health Organization, 2017, WHO PAND INFL SEV AS; World Health Organization (WHO), 2013, WHO GLOB EP SURV STA	35	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252703	10.1371/journal.pone.0252703	http://dx.doi.org/10.1371/journal.pone.0252703			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081752	gold, Green Published			2022-12-26	WOS:000664639200047
J	Aladhami, AK; Unger, CA; Ennis, SL; Altomare, D; Ji, H; Hope, MC; Velazquez, KT; Enos, RT				Aladhami, Ahmed K.; Unger, Christian A.; Ennis, Shannon L.; Altomare, Diego; Ji, Hao; Hope, Marion C., III; Velazquez, Kandy T.; Enos, Reilly T.			Macrophage tumor necrosis factor-alpha deletion does not protect against obesity-associated metabolic dysfunction	FASEB JOURNAL			English	Article						insulin resistance; macrophage; metabolism; obesity; TNF-alpha	DIETARY SATURATED FAT; INSULIN-RESISTANCE; ADIPOCYTE INFLAMMATION; SKELETAL-MUSCLE; RECEPTOR; CELLS; GENE; SENSITIVITY; EXPRESSION; LIVER	The pro-inflammatory cytokine, tumor necrosis factor-alpha (TNF-alpha), has been suggested to be a key factor in the induction of obesity-associated metabolic dysfunction. However, the role that macrophage-derived TNF-alpha has on regulating metabolic perturbations in obesity is not completely understood. Therefore, we utilized the TNF-alpha(Flox/Flox) ((F/F)), LyzMcre(+/-) mouse model to determine the impact that macrophage TNF-alpha deletion has on the development of high-fat diet (HFD)-induced obesity. At 10 weeks of age, male littermates were randomly assigned to 1 of 4 groups: TNF-alpha(F/F) low-fat diet (TNF-alpha(F/F) LFD), TNF-alpha(F/F,) (LyzMCre) LFD, TNF-alpha(F/F) HFD, or TNF-alpha(F/F,) (LyzMCre) HFD (n = 16-28/group) and were fed their respective diets for 18 weeks. Body weight was assessed throughout the course of the experiment. Body composition, hepatic lipid accumulation, and metabolic outcomes were also examined. A microarray gene expression experiment was performed from RNA isolated from epididymal adipose tissue of the HFD-fed groups (n = 10/group) and results were verified via qRT-PCR for all groups. Macrophage-derived TNF-alpha deletion significantly reduced adipose tissue TNF-alpha gene expression and circulating TNF-alpha and downregulated genes linked to the toll-like receptor (TLR) and NF kappa B signaling pathways. However, macrophage TNF-alpha deletion had no effect on hindering the development of obesity, hepatic lipid accumulation, or improving glucose metabolism or insulin sensitivity. In conclusion, macrophage-derived TNF-alpha is not a causative factor for the induction of obesity-associated metabolic dysfunction.	[Aladhami, Ahmed K.; Unger, Christian A.; Ennis, Shannon L.; Hope, Marion C., III; Velazquez, Kandy T.; Enos, Reilly T.] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, 6439 Garners Ferry Rd, Columbia, SC 29209 USA; [Altomare, Diego; Ji, Hao] Univ South Carolina, Dept Drug Discovery & Biomed Sci, Coll Pharm, Columbia, SC 29209 USA; [Aladhami, Ahmed K.] Univ Baghdad, Nursing Coll, Baghdad, Iraq	University of South Carolina System; University of South Carolina Columbia; University of South Carolina System; University of South Carolina Columbia; University of Baghdad	Enos, RT (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, 6439 Garners Ferry Rd, Columbia, SC 29209 USA.	enosr@email.sc.edu	Enos, Reilly/AFO-4814-2022	Enos, Reilly/0000-0001-5571-4586; Aladhami, Ahmed/0000-0002-9072-551X; Hope, Marion/0000-0002-4855-5764	NIH-NCCIH [K01-AT010348, R00-AT009206]; University of South Carolina Advanced Support for Innovative Research Excellence (ASPIRE)	NIH-NCCIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina Advanced Support for Innovative Research Excellence (ASPIRE)	This work was supported by grants K01-AT010348 (NIH-NCCIH) and the University of South Carolina Advanced Support for Innovative Research Excellence (ASPIRE) to RTE. KTV is supported by R00-AT009206 (NIH-NCCIH)	Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Bader Jackie, 2020, Oncotarget, V11, P4554, DOI 10.18632/oncotarget.27832; Bader JE, 2019, AM J PHYSIOL-ENDOC M, V316, pE358, DOI 10.1152/ajpendo.00438.2018; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Charkoftaki G, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0191-9; Chen X, 2016, J INTERF CYTOK RES, V36, P580, DOI 10.1089/jir.2016.0022; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Cranford TL, 2016, INT J OBESITY, V40, P844, DOI 10.1038/ijo.2015.244; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Enos RT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167979; Enos RT, 2016, AM J PHYSIOL-GASTR L, V310, pG906, DOI 10.1152/ajpgi.00345.2015; Enos RT, 2015, NUTR RES, V35, P449, DOI 10.1016/j.nutres.2015.04.003; Enos RT, 2014, J NUTR BIOCHEM, V25, P600, DOI 10.1016/j.jnutbio.2014.01.011; Enos RT, 2013, J LIPID RES, V54, P152, DOI 10.1194/jlr.M030700; Fain JN, 2004, INT J OBESITY, V28, P616, DOI 10.1038/sj.ijo.0802594; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Hermoso MA, 2004, MOL CELL BIOL, V24, P4743, DOI 10.1128/MCB.24.11.4743-4756.2004; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Hui XY, 2009, J BIOL CHEM, V284, P14050, DOI 10.1074/jbc.M109.001107; Jager J, 2016, J INTERN MED, V280, P209, DOI 10.1111/joim.12483; Lanthier N, 2010, AM J PHYSIOL-GASTR L, V298, pG107, DOI 10.1152/ajpgi.00391.2009; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Paquot N, 2000, J CLIN ENDOCR METAB, V85, P1316, DOI 10.1210/jc.85.3.1316; Pedley AM, 2017, TRENDS BIOCHEM SCI, V42, P141, DOI 10.1016/j.tibs.2016.09.009; Salles J, 2012, J NUTR BIOCHEM, V23, P1685, DOI 10.1016/j.jnutbio.2011.12.001; Schreyer SA, 1998, J CLIN INVEST, V102, P402, DOI 10.1172/JCI2849; Skurski J, 2020, METABOLISM, V106, DOI 10.1016/j.metabol.2020.154194; Sukkar MB, 2006, J ALLERGY CLIN IMMUN, V118, P641, DOI 10.1016/j.jaci.2006.05.013; SZOKA PR, 1980, J BIOL CHEM, V255, P1367; Tencerova M, 2015, FASEB J, V29, P2959, DOI 10.1096/fj.15-270496; Turner N, 2013, DIABETOLOGIA, V56, P1638, DOI 10.1007/s00125-013-2913-1; Uysal KT, 1998, ENDOCRINOLOGY, V139, P4832, DOI 10.1210/en.139.12.4832; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Velazquez KT, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13412; Ventre J, 1997, DIABETES, V46, P1526, DOI 10.2337/diabetes.46.9.1526; Wascher TC, 2011, MOL MED, V17, P189, DOI 10.2119/molmed.2010.00221; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Yang WS, 2016, CELL PHYSIOL BIOCHEM, V38, P2139, DOI 10.1159/000445570; Zhu QZ, 2020, MOL METAB, V39, DOI 10.1016/j.molmet.2020.101010	46	3	3	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21665	10.1096/fj.202100543RR	http://dx.doi.org/10.1096/fj.202100543RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34131955	Green Accepted			2022-12-26	WOS:000667814100004
J	Schiff, T				Schiff, Tamar			The 2021 FASEB virtual Catalyst Conference on Transplantation Genomics: Ethics of Research and Clinical Applications, January 27, 2021	FASEB JOURNAL			English	Editorial Material									[Schiff, Tamar] NYU, Grossman Sch Med, Div Med Eth, 550 1st Ave, New York, NY 10016 USA	New York University	Schiff, T (corresponding author), NYU, Grossman Sch Med, Div Med Eth, 550 1st Ave, New York, NY 10016 USA.	tamar.schiff2@nyulangone.org							0	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21589	10.1096/fj.202100524	http://dx.doi.org/10.1096/fj.202100524			2	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34131960	Bronze			2022-12-26	WOS:000667814100001
J	Yang, H; Yang, Y; Hu, ZD; Xia, L; Liu, XH; Yu, X; Ma, JY; Li, T; Lu, SH				Yang, Heng; Yang, Yang; Hu, Zhi-dong; Xia, Lu; Liu, Xu-hui; Yu, Xin; Ma, Jia-ye; Li, Tao; Lu, Shui-hua			High rate of completion for weekly rifapentine plus isoniazid treatment in Chinese children with latent tuberculosis infection-A single center study	PLOS ONE			English	Article								Three months of weekly rifapentine plus isoniazid (3HP) is a short course regimen for latent tuberculosis infection treatment with satisfied safety and efficacy. However, research on its use in children is limited. In this study, we evaluated the completion rate and safety of the 3HP regimen among children in China. Participants aged 1-14 years receiving 3HP for TB prevention at Shanghai Public Health Clinical Center were followed from December 2019 to November 2020 to evaluate the safety and completion rate of the treatment. Thirty-one children were eligible for inclusion, but five were excluded from the analysis (three were treated with a lower than recommended dose, and two were lost to follow-up). Of the 26 children included in the analysis, the treatment completion rate was 100%. Adverse drug reactions (ADRs) were reported in 38.5% (10/26) of the patients. The most common ADRs were gastrointestinal symptoms (19.2%,5/26), and all ADRs were rated as Grade 1. The 3HP regimen has a high completion rate, and it seems well tolerated in our study population. However, further randomized controlled clinical trial with larger sample size are warranted.	[Yang, Heng; Yang, Yang; Hu, Zhi-dong; Xia, Lu; Liu, Xu-hui; Ma, Jia-ye; Li, Tao; Lu, Shui-hua] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Yu, Xin] Soochow Univ, Affiliated Infect Hosp, Suzhou, Jiangsu, Peoples R China	Fudan University; Soochow University - China	Li, T; Lu, SH (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.	litaokc@shphc.org.cn; tubercle@shphc.org.cn	Hu, Zhidong/GNN-0373-2022	Hu, Zhidong/0000-0001-8490-4389	Shanghai Clinical key specialist Construction Project (Tuberculosis) [shslczdzk03002]; National Science Foundation of China [81770014]	Shanghai Clinical key specialist Construction Project (Tuberculosis); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Shanghai Clinical key specialist Construction Project (Tuberculosis) (shslczdzk03002) and the National Science Foundation of China (81770014).	[Anonymous], 2017, COMMON TERMINOLOGY C; Behr MA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k2738; COMSTOCK GW, 1974, AM J EPIDEMIOL, V99, P131, DOI 10.1093/oxfordjournals.aje.a121593; Gao L, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01470-2018; Huang HL, 2021, CLIN INFECT DIS, V73, pE1064, DOI 10.1093/cid/ciaa1741; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Moro RN, 2018, ANN AM THORAC SOC, V15, P570, DOI 10.1513/AnnalsATS.201704-326OC; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; Njie GJ, 2018, AM J PREV MED, V55, P244, DOI 10.1016/j.amepre.2018.04.030; Ruan QL, 2021, CLIN MICROBIOL INFEC, V27, P576, DOI 10.1016/j.cmi.2020.06.008; Sandul AL, 2017, CLIN INFECT DIS, V65, P1085, DOI 10.1093/cid/cix505; Sterling TR, 2015, CLIN INFECT DIS, V61, P527, DOI 10.1093/cid/civ323; Sterling TR, 2011, NEW ENGL J MED, V365, P2155, DOI 10.1056/NEJMoa1104875; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Villarino ME, 2015, JAMA PEDIATR, V169, P247, DOI 10.1001/jamapediatrics.2014.3158; WHO, 2019, WHO CONS GUID DRUG R, DOI DOI 10.30978/TB2021-2-86; World Health Organization, 2018, LAT TUB INF UPD CONS; Yuen CM, 2021, CLIN INFECT DIS, V73, pE1135, DOI 10.1093/cid/ciaa1835	18	1	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253159	10.1371/journal.pone.0253159	http://dx.doi.org/10.1371/journal.pone.0253159			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115804	Green Published, gold			2022-12-26	WOS:000664643000051
J	Habtegiorgis, Y; Sisay, T; Kloos, H; Malede, A; Yalew, M; Arefaynie, M; Damtie, Y; Kefale, B; Tegegne, TB; Addisu, E; Lingerew, M; Berhanu, L; Berihun, G; Natnael, T; Abebe, M; Feleke, A; Gizeyatu, A; Ademas, A; Fentaw, Z; Yayeh, TM; Dangura, F; Adane, M				Habtegiorgis, Yohannes; Sisay, Tadesse; Kloos, Helmut; Malede, Asmamaw; Yalew, Melaku; Arefaynie, Mastewal; Damtie, Yitayish; Kefale, Bereket; Tegegne, Tesfaye Birhane; Addisu, Elsabeth; Lingerew, Mistir; Berhanu, Leykun; Berihun, Gete; Natnael, Tarikuwa; Abebe, Masresha; Feleke, Alelgne; Gizeyatu, Adinew; Ademas, Ayechew; Fentaw, Zinabu; Yayeh, Tilaye Matebe; Dangura, Fitsum; Adane, Metadel			Menstrual hygiene practices among high school girls in urban areas in Northeastern Ethiopia: A neglected issue in water, sanitation, and hygiene research	PLOS ONE			English	Article								Background Poor menstrual hygiene practices influence school girls' dignity, well-being and health, school-absenteeism, academic performance, and school dropout in developing countries. Despite this, menstrual hygienic practices are not well understood and have not received proper attention by school WASH programs. Therefore, this study examined the extent of good menstrual hygiene practices and associated factors among high school girls in Dessie City, Amhara Region, northeastern Ethiopia. Methods A school-based cross-sectional study was employed to examine 546 randomly selected high school students in Dessie City, northeastern Ethiopia. Pretested interviewer-administered questionnaires and a school observational checklist were used for data collection. EpiData Version 4.6 and the Statistical Package for the Social Sciences Version 25.0 were used for data entry and analysis, respectively. Bivariate and multivariable logistics regression analyses were employed to identify factors associated with good menstrual hygiene practices. During bivariable analysis, variables with P-values less than 0.25 were retained for multivariable analysis. In the multivariable analysis, variables with a P-value less than 0.05 were declared to be significantly associated with good menstrual hygiene practices. Results Of the respondents, 53.9% (95% CI [49.6, 58.2]) reported good menstrual hygiene practices. The following factors were found to be significantly associated with good menstrual hygiene practices: age range 16-19 years (AOR = 1.93, 95% CI: [1.22-3.06]); school grade level 10 (AOR = 1.90, 95% CI: [1.18-3.07]); maternal education (primary) (AOR = 3.72, 95% CI: [1.81-7.63]), maternal education (secondary) (AOR = 8.54, 95% CI: [4.18-17.44]), maternal education (college) (AOR = 6.78, 95% CI: [3.28-14.02]) respectively]; having regular menses [AOR = 1.85, 95% CI: (1.03-3.32); good knowledge regarding menstruation (AOR = 2.02, 95% CI: [1.32-3.09]); discussing menstrual hygiene with friends (AOR = 1.79, 95% CI: [1.12-2.86]), and obtaining money for pads from the family (AOR = 2.08, 95% CI: [1.15-3.78]). Conclusion We found that more than half of high school girls had good menstrual hygiene practices. Factors significantly associated with good menstrual hygiene practices include high school girls age 16-18 years, girls grade level 10, maternal education being completed primary, secondary and college level, having regular menses, good knowledge regarding menstruation, discussing menstrual hygiene with friends and obtaining money for pads from the family. Therefore, educating of high school student mothers about MHP should be a priority intervention area to eliminate the problem of menstrual hygiene among daughters. Furthermore, in order to improve the MHP among high school girls, further attention is needed to improving knowledge regarding menstruation among high school girls, encouraging high school girls' families to support their daughters by buying sanitary pads and promoting discussions among friends about menstrual hygiene. Schools need to focus on making the school environment conducive to managing menstrual hygiene by increasing awareness of safe MHP and providing adequate water/sanitation facilities.	[Habtegiorgis, Yohannes] Aleta Wondo Primary Hosp, Clin Governance & Qual Improvement Unit, Aleta Wondo, Sidama Regional, Ethiopia; [Sisay, Tadesse; Malede, Asmamaw; Lingerew, Mistir; Berhanu, Leykun; Berihun, Gete; Natnael, Tarikuwa; Abebe, Masresha; Feleke, Alelgne; Gizeyatu, Adinew; Ademas, Ayechew; Adane, Metadel] Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia; [Kloos, Helmut] Univ Calif San Francisco, Dept Biostat & Epidemiol, San Francisco, CA 94143 USA; [Yalew, Melaku; Arefaynie, Mastewal; Damtie, Yitayish; Kefale, Bereket; Tegegne, Tesfaye Birhane; Addisu, Elsabeth] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Reprod & Family Hlth, Dessie, Ethiopia; [Fentaw, Zinabu] Wollo Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Dessie, Ethiopia; [Yayeh, Tilaye Matebe] Wollo Univ, Coll Nat Sci, Dept Stat, Dessie, Ethiopia; [Dangura, Fitsum] Aleta Wondo Primary Hosp, Aleta Wondo, Sidama Regional, Ethiopia	University of California System; University of California San Francisco	Adane, M (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Environm Hlth, Dessie, Ethiopia.	metadel.adane2@gmail.com	Arefaynie, Mastewal/AAZ-8374-2021; Ademas, Ayechew/AAG-5984-2021; Berhanu, Leykun/AAC-6695-2022; Fentaw, Zinabu/ABB-7298-2021; Adane, Metadel/AFQ-9478-2022	Arefaynie, Mastewal/0000-0001-9525-0552; Ademas, Ayechew/0000-0003-2602-162X; Berhanu, Leykun/0000-0002-2998-0917; Adane, Metadel/0000-0002-7039-4768; Habtegiorgis, Yohannes/0000-0003-3677-9004; Fentaw, Zinabu/0000-0002-4577-868X; Kefale Abitew, Bereket/0000-0003-1795-9886				Alka Malhotra, 2016, Waterlines, V35, P277, DOI 10.3362/1756-3488.2016.021; Ameade EPK, 2015, J HLTH EDU RES DEV, V3, P1; Anchebi H, 2017, J WOMENS HLTH CARE, V6, P2167; [Anonymous], 2014, IJST; Baku EA, 2020, AFR J MIDWIFERY WOME, V14, P1; Belayneh Z, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7973-9; Bobhate PS, 2011, J FAMILY REPROD HLTH, V5, P119; Chandra-Mouli V, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0293-6; Chandrasekaran V, 2013, GLOBAL J MED PUBLIC, V2, P1; Chinyama J, 2018, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6360-2; Chothe V, 2014, HEALTH PROMOT PRACT, V15, P319, DOI 10.1177/1524839914525175; CSA, 2013, POPULATION PROJECTIO, V3; Davis J, 2018, TROP MED INT HEALTH, V23, P1350, DOI 10.1111/tmi.13159; DCED,, 2012, DESS CIT ED DEP 2012; El Meselhy HM, 2020, MENOUFIA MED J, V33, P24; Fehintola FO., 2017, INT J REPROD CONTRAC, V6, P1726, DOI DOI 10.18203/2320-1770.ijrcog20171932; Fehr T., 2011, EFFECTS WATER SECURI; Goli S, 2020, CHILD YOUTH SERV REV, V117, DOI 10.1016/j.childyouth.2020.105283; Kelsey JL., 1996, METHODS OBSERVATIONA; Kitesa B., 2016, INT J IMMUNOL, V4, P52, DOI [DOI 10.11648/J.IJI.20160406.12, 10.11648/j.iji.20160406.12]; Kuhlmann AS, 2017, OBSTET GYNECOL SURV, V72, P356, DOI 10.1097/OGX.0000000000000443; Lawan U M, 2010, Afr J Reprod Health, V14, P201; McMahon SA, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-7; Mohammed S, 2020, INT J REPROD MED, V2020; Phillips-Howard PA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013229; Sahin M, 2015, WATERLINES, V34, P3; Sarkar Ishita, 2017, J Family Med Prim Care, V6, P583, DOI 10.4103/2249-4863.222054; Shiferaw MT, 2014, PAN AFR MED J, V17, DOI 10.11604/pamj.2014.17.246.2230; Sommer M, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001962; Sommer M, 2015, COMPARE, V45, P589, DOI 10.1080/03057925.2013.871399; Suman Bodat, 2013, National Journal of Community Medicine, V4, P212; Tegegne TK, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1118; Thakur H, 2014, FPH, V2, P1; UNESCO, 2014, PUB ED MENSTR HYG MA; UNICEF, 2015, WASH SCH GIRLS EC IN; UNICEF, 2013, WASH SCH EMPOWERS GI; UNICEF. UNICEF, 2011, STAT WORLDS CHILDR 2; Upashe SP, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0245-7; van Eijk AM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010290	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0248825	10.1371/journal.pone.0248825	http://dx.doi.org/10.1371/journal.pone.0248825			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106948	Green Published, gold			2022-12-26	WOS:000664642200008
J	Mead, BR; Boyland, EJ; Christiansen, P; Halford, JCG; Jebb, SA; Ahern, AL				Mead, Bethan R.; Boyland, Emma J.; Christiansen, Paul; Halford, Jason C. G.; Jebb, Susan A.; Ahern, Amy L.			Associations between hedonic hunger and BMI during a two-year behavioural weight loss trial	PLOS ONE			English	Article							Y GASTRIC BYPASS; FIT INDEXES; FOOD SCALE; SELF-CONTROL; POWER; OBESITY; ADULTS; INTERVENTIONS; VALIDATION; OVERWEIGHT	Objective Prospective studies on relationships between hedonic hunger and BMI (Body Mass Index) during weight management are lacking. This study examined if hedonic hunger reduced during a behavioural weight management programme, and if hedonic hunger predicted future BMI. Methods Participants were 594 community-dwelling, UK-based adults(396 female; age 56.43 years, s.d. = 12.50, range 20-83 years); 490 participants (82.5%) had obesity. Participants were randomised to a 12- or 52-week behavioural weight management intervention (WW12 or WW52, respectively) or a brief self-help intervention (BI). Relationships between hedonic hunger and BMI over 24 months (baseline, 3, 12, 24 months) were analysed using an autoregressive cross-lagged model. Results Hedonic hunger scores decreased from 2.71 (s.d. = .91) at baseline to 2.41 (s.d. = .88) at 3 months (p < .001, CI .22 to .38), remained reduced to 24 months, and were not affected by intervention arm at any time point (p's>.05). Baseline hedonic hunger scores predicted 3-month scores (B = .76, SE = .03, p < .001, CI .71 to .82), 3-month scores predicted 12-month scores (B = .76, SE = .03, p < .001 CI .72 to .80), and 12-month scores predicted 24-month scores (B = .72, SE = .03, p < .001, CI .64 to .77). Higher hedonic hunger at 3 months predicted higher BMI at 12 months (B = .04, SE = .02, p = .03, CI .01 to .07) but not at 24 months (p>.05). BMI at 12 months was lower in WW52 30.87kg/m(2), s.d. = 5.02) than WW12 (32.12 kg/m(2), s.d. = 5.58, p = .02, CI .16 to 2.34) and BI (32.74 kg/m(2), s.d. = 4.15, p = .01, CI .30 to 3.45). BMI was not affected by intervention at any other time point (p's>.05). Conclusion Hedonic hunger reduced during weight management irrespective of intervention. Early reductions in hedonic hunger appear to be associated with lower BMI in the medium-term. Identifying ways to reduce hedonic hunger during weight loss could aid weight management for some people.	[Mead, Bethan R.; Boyland, Emma J.; Christiansen, Paul; Halford, Jason C. G.] Univ Liverpool, Dept Psychol, Liverpool, Merseyside, England; [Jebb, Susan A.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, England; [Ahern, Amy L.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England	University of Liverpool; University of Oxford; University of Cambridge	Mead, BR (corresponding author), Univ Liverpool, Dept Psychol, Liverpool, Merseyside, England.	b.mead@liverpool.ac.uk	; Mead, Bethan/F-6134-2019	Halford, Jason/0000-0003-1629-3189; Mead, Bethan/0000-0002-9294-517X; Ahern, Amy/0000-0001-5069-4758	National Prevention Research Initiative [MR/J000493/1]; Medical Research Council [MC_UU_12015/4, MC_UU_00006/6]; WW; UKRI	National Prevention Research Initiative(Diabetes UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); WW; UKRI(UK Research & Innovation (UKRI))	The WRAP trial was funded by the National Prevention Research Initiative (https://mrc.ukri.org/research/initiatives/preventionresearch/national-prevention-research-initiative-npri/) research grant MR/J000493/1. ALA is supported by the Medical Research Council (grant MC_UU_12015/4; MC_UU_00006/6). BRM has received funding to their institution fromWW (formerly Weight Watchers International) and UKRI and for her PhD studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahern AL, 2017, LANCET, V389, P2214, DOI 10.1016/S0140-6736(17)30647-5; Ahern AL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-620; Andreeva E, 2019, OBESITY FACTS, V12, P416, DOI 10.1159/000500489; Appelhans BM, 2011, OBESITY, V19, P2175, DOI 10.1038/oby.2011.57; Arbuckle JL, 2013, IBM SPSS AMOS TM 22; Bejarano CM, 2018, ANN BEHAV MED, V52, P773, DOI 10.1093/abm/kax051; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BOLLEN KA, 1989, SOCIOL METHOD RES, V17, P303, DOI 10.1177/0049124189017003004; Bray GA, 2017, OBES REV, V18, P715, DOI 10.1111/obr.12551; BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Cappelleri JC, 2009, INT J OBESITY, V33, P913, DOI 10.1038/ijo.2009.107; Cushing CC, 2014, SURG OBES RELAT DIS, V10, P125, DOI 10.1016/j.soard.2013.05.009; Ely AV, 2015, EAT BEHAV, V19, P72, DOI 10.1016/j.eatbeh.2015.06.015; Espel-Huynh HM, 2018, OBES SCI PRACT, V4, P238, DOI 10.1002/osp4.161; Feig EH, 2018, APPETITE, V123, P317, DOI 10.1016/j.appet.2018.01.013; Hartmann-Boyce J, 2014, OBES REV, V15, P920, DOI 10.1111/obr.12220; Hofmann W, 2009, PERSPECT PSYCHOL SCI, V4, P162, DOI 10.1111/j.1745-6924.2009.01116.x; Horwath CC, 2020, EAT BEHAV, V38, DOI 10.1016/j.eatbeh.2020.101393; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Jones A, 2018, APPETITE, V124, P50, DOI 10.1016/j.appet.2017.05.032; Kim KH, 2005, STRUCT EQU MODELING, V12, P368, DOI 10.1207/s15328007sem1203_2; Lai KK, 2016, MULTIVAR BEHAV RES, V51, P220, DOI 10.1080/00273171.2015.1134306; Lowe MR, 2007, PHYSIOL BEHAV, V91, P432, DOI 10.1016/j.physbeh.2007.04.006; Lowe MR, 2016, HEALTH PSYCHOL, V35, P238, DOI 10.1037/hea0000291; Lowe MR, 2009, APPETITE, V53, P114, DOI 10.1016/j.appet.2009.05.016; O'Neil PM, 2012, EAT BEHAV, V13, P354, DOI 10.1016/j.eatbeh.2012.06.002; Rejeski WJ, 2012, APPETITE, V58, P806, DOI 10.1016/j.appet.2012.01.025; Ribeiro G, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23988-x; Ribeiro G, 2015, ACTA MEDICA PORT, V28, P575, DOI 10.20344/amp.6517; Robinson MA, 2018, HUM RESOUR MANAGE-US, V57, P739, DOI 10.1002/hrm.21852; Schuz B, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0312-3; Stok FM, 2015, EAT BEHAV, V17, P19, DOI 10.1016/j.eatbeh.2014.12.003; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Swinburn B, 1999, PREV MED, V29, P563, DOI 10.1006/pmed.1999.0585; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Teixeira PJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0323-6; Theim KR, 2013, BEHAV MODIF, V37, P790, DOI 10.1177/0145445513501319; Thomas EA, 2013, APPETITE, V65, P96, DOI 10.1016/j.appet.2013.01.015; Ullrich J, 2013, OBES SURG, V23, P474, DOI 10.1007/s11695-012-0818-6; Ullrich J, 2013, OBES SURG, V23, P50, DOI 10.1007/s11695-012-0754-5; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Witt AA, 2014, APPETITE, V74, P1, DOI 10.1016/j.appet.2013.11.010; Yoshikawa T, 2012, PSYCHOL REP, V111, P253, DOI 10.2466/08.02.06.15.PR0.111.4.253-265	44	2	2	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252110	10.1371/journal.pone.0252110	http://dx.doi.org/10.1371/journal.pone.0252110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106941	Green Published, gold			2022-12-26	WOS:000664642200029
J	Salam, MA; Taha, S; Ramadan, M				Salam, Mustafa Abdul; Taha, Sanaa; Ramadan, Mohamed			COVID-19 detection using federated machine learning	PLOS ONE			English	Article							IDENTIFICATION; FRAMEWORK	The current COVID-19 pandemic threatens human life, health, and productivity. AI plays an essential role in COVID-19 case classification as we can apply machine learning models on COVID-19 case data to predict infectious cases and recovery rates using chest x-ray. Accessing patient's private data violates patient privacy and traditional machine learning model requires accessing or transferring whole data to train the model. In recent years, there has been increasing interest in federated machine learning, as it provides an effective solution for data privacy, centralized computation, and high computation power. In this paper, we studied the efficacy of federated learning versus traditional learning by developing two machine learning models (a federated learning model and a traditional machine learning model)using Keras and TensorFlow federated, we used a descriptive dataset and chest x-ray (CXR) images from COVID-19 patients. During the model training stage, we tried to identify which factors affect model prediction accuracy and loss like activation function, model optimizer, learning rate, number of rounds, and data Size, we kept recording and plotting the model loss and prediction accuracy per each training round, to identify which factors affect the model performance, and we found that softmax activation function and SGD optimizer give better prediction accuracy and loss, changing the number of rounds and learning rate has slightly effect on model prediction accuracy and prediction loss but increasing the data size did not have any effect on model prediction accuracy and prediction loss. finally, we build a comparison between the proposed models' loss, accuracy, and performance speed, the results demonstrate that the federated machine learning model has a better prediction accuracy and loss but higher performance time than the traditional machine learning model.	[Salam, Mustafa Abdul] Benha Univ, Fac Comp & Artificial Intelligence, Dept Artificial Intelligence, Banha, Egypt; [Taha, Sanaa] Cairo Univ, Fac Comp & Artificial Intelligence, Dept Informat Technol, Giza, Egypt; [Ramadan, Mohamed] Egyptian E Learning Univ, Fac Comp & Informat, Dept Comp Sci, Giza, Egypt	Egyptian Knowledge Bank (EKB); Benha University; Egyptian Knowledge Bank (EKB); Cairo University	Ramadan, M (corresponding author), Egyptian E Learning Univ, Fac Comp & Informat, Dept Comp Sci, Giza, Egypt.	mustafa.abdo@fci.bu.edu.eg		abdul salam, mustafa/0000-0003-1673-6947				Afshar P, 2020, PATTERN RECOGN LETT, V138, P638, DOI 10.1016/j.patrec.2020.09.010; Ahmad A, 2021, ARCH COMPUT METHOD E, V28, P2645, DOI 10.1007/s11831-020-09472-8; Ardabili SF, 2020, ALGORITHMS, V13, DOI 10.3390/a13100249; Bhattacharya S, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102589; Carrillo-Larco Rodrigo M, 2020, Wellcome Open Res, V5, P56, DOI [10.12688/wellcomeopenres.15819.3, 10.12688/wellcomeopenres.15819.1]; Das NN, 2022, IRBM, V43, P114, DOI 10.1016/j.irbm.2020.07.001; FIBRIANI Ike., MULTIDEEP LEARNING D; Fiorino G, 2020, J CROHNS COLITIS, V14, P1330, DOI 10.1093/ecco-jcc/jjaa058; He Chaoyang, 2020, ARXIV PREPRINT ARXIV; Iwendi C, 2022, MULTIMEDIA SYST, V28, P1223, DOI 10.1007/s00530-021-00774-w; Javed AR, 2020, HUM-CENT COMPUT INFO, V10, DOI 10.1186/s13673-020-00245-7; Kassani Sara Hosseinzadeh, 2020, ARXIV PREPRINT ARXIV; Khanday Akib Mohi Ud Din, 2020, Int J Inf Technol, V12, P731, DOI 10.1007/s41870-020-00495-9; Khmaissia Fadoua, 2020, ARXIV PREPRINT ARXIV; Li T, 2020, IEEE SIGNAL PROC MAG, V37, P50, DOI 10.1109/MSP.2020.2975749; Lian XR, 2017, ADV NEUR IN, V30; Liu Boyi, 2020, ARXIV PREPRINT ARXIV; Manavalan R, 2020, COMPUT ELECTRON AGR, V178, DOI 10.1016/j.compag.2020.105802; Manoj MK, 2020, IEEE GLOBE WORK, DOI 10.1109/GCWkshps50303.2020.9367469; Mukherjee H, 2021, APPL INTELL, V51, P2777, DOI 10.1007/s10489-020-01943-6; Otoom M, 2020, BIOMED SIGNAL PROCES, V62, DOI 10.1016/j.bspc.2020.102149; Pang JJ, 2021, TSINGHUA SCI TECHNOL, V26, P759, DOI 10.26599/TST.2021.9010026; Panwar H, 2020, CHAOS SOLITON FRACT, V138, DOI 10.1016/j.chaos.2020.109944; Reddy GT, 2020, EVOL INTELL, V13, P185, DOI 10.1007/s12065-019-00327-1; Salman Fatima M., 2020, 1 J BIOMEDICAL RES; THaque A. K. M., 2021, ARXIV PREPRINT ARXIV; Tsiknakis N, 2020, EXP THER MED, V20, P727, DOI 10.3892/etm.2020.8797; Nguyen T, 2020, PROC SPIE, V11413, DOI 10.1117/12.2558475; Ulhaq Anwaar, 2020, ARXIV PREPRINT ARXIV; Vaid S, 2020, J BONE JOINT SURG AM, V102, DOI 10.2106/JBJS.20.00715; Wieczorek M, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110203; Yang Q, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3298981; Zhang WS, 2021, IEEE INTERNET THINGS, V8, P15884, DOI 10.1109/JIOT.2021.3056185	34	18	18	9	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252573	10.1371/journal.pone.0252573	http://dx.doi.org/10.1371/journal.pone.0252573			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101762	Green Published, gold			2022-12-26	WOS:000664641500020
J	Wang, XY; Dong, JN; Li, XJ; Cheng, ZN; Zhu, QB				Wang, Xueying; Dong, Jiani; Li, Xiaojing; Cheng, Zeneng; Zhu, Qubo			CPSF4 regulates circRNA formation and microRNA mediated gene silencing in hepatocellular carcinoma	ONCOGENE			English	Article							CIRCULAR RNAS; POLYADENYLATION; IDENTIFICATION; CLEAVAGE; GROWTH	CircRNAs play essential roles in various physiological processes and involves in many diseases, in particular cancer. Global downregulation of circRNA expression has been observed in hepatocellular carcinoma (HCC) in many studies. Previous studies revealed that the pre-mRNA 3 ' end processing complex participates in circRNA cyclization and plays an important role in HCC tumorigenesis. Therefore, we explored the role of CPSF4, for 3 ' end formation and cleavage, in circRNA formation. Clinical research has shown that CPSF4 expression is upregulated in HCC and that high expression of CPSF4 is associated with poor prognosis in HCC patients. Mechanistic studies have demonstrated that CPSF4 reduces the levels of circRNAs, which possess a polyadenylation signal sequence and this decrease in circRNAs reduces the accumulation of miRNA and disrupts the miRNA-mediated gene silencing in HCC. Experiments in cell culture and xenograft mouse models showed that CPSF4 promotes the proliferation of HCC cells and enhances tumorigenicity. Moreover, CPSF4 antagonizes the tumor suppressor effect of its downstream circRNA in HCC. In summary, CPSF4 acts as an oncogene in HCC through circRNA inhibition and disruption of miRNA-mediated gene silencing.	[Wang, Xueying; Dong, Jiani; Cheng, Zeneng; Zhu, Qubo] Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha 2, Peoples R China; [Li, Xiaojing] Shanghai Gen Hosp, Shanghai, Peoples R China		Zhu, QB (corresponding author), Cent South Univ, Xiangya Sch Pharmaceut Sci, Changsha 2, Peoples R China.	qubozhu@csu.edu.cn	Zhu, Qubo/ACT-7180-2022		National Natural Science Foundation of China [C0709-31201056]; Hunan Provincial Natural Science Foundation of China [2018JJ2493]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This work was supported by the National Natural Science Foundation of China (C0709-31201056) and the Hunan Provincial Natural Science Foundation of China (2018JJ2493).	Bachmayr-Heyda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08057; Bezzi M, 2017, CELL RES, V27, P1401, DOI 10.1038/cr.2017.136; Chan SL, 2014, GENE DEV, V28, P2370, DOI 10.1101/gad.250993.114; Chang CC, 2016, BIOSENS BIOELECTRON, V78, P200, DOI 10.1016/j.bios.2015.11.051; Chen Q, 2020, PATHOL RES PRACT, V216, DOI 10.1016/j.prp.2020.152872; Clerici M, 2017, ELIFE, V6, DOI 10.7554/eLife.33111; Ding JY, 2019, BIOL CHEM, V400, P247, DOI 10.1515/hsz-2018-0232; Ebermann Constanze, 2020, F1000Res, V9, DOI 10.12688/f1000research.25060.1; Enuka Y, 2016, NUCLEIC ACIDS RES, V44, P1370, DOI 10.1093/nar/gkv1367; Fabian MR, 2012, NAT STRUCT MOL BIOL, V19, P586, DOI 10.1038/nsmb.2296; Fu LY, 2017, ONCOTARGET, V8, P58405, DOI 10.18632/oncotarget.16881; Greene J, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00038; Han D, 2017, HEPATOLOGY, V66, P1151, DOI 10.1002/hep.29270; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Li XJ, 2020, ONCOGENE, V39, P891, DOI 10.1038/s41388-019-1030-0; Liang DM, 2017, MOL CELL, V68, P940, DOI 10.1016/j.molcel.2017.10.034; Lin XM, 2018, MED SCI MONIT BASIC, V24, P70, DOI 10.12659/MSMBR.909737; Liu SY, 2019, BMC CANCER, V19, P1; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meng XW, 2017, BIOINFORMATICS, V33, P3314, DOI 10.1093/bioinformatics/btx446; Misra A, 2016, RNA BIOL, V13, P259, DOI 10.1080/15476286.2015.1112490; Misra A, 2015, MOL CELL, V58, P819, DOI 10.1016/j.molcel.2015.03.016; Noble CG, 2007, NUCLEIC ACIDS RES, V35, P87, DOI 10.1093/nar/gkl1010; Qiu LP, 2019, LIFE SCI, V231, DOI 10.1016/j.lfs.2019.116660; Qu SB, 2017, RNA BIOL, V14, P992, DOI 10.1080/15476286.2016.1220473; Qu SB, 2015, CANCER LETT, V365, P141, DOI 10.1016/j.canlet.2015.06.003; Song CL, 2019, J CELL PHYSIOL, V234, P2460, DOI 10.1002/jcp.26764; Sun M, 2017, CANCER LETT, V410, P158, DOI 10.1016/j.canlet.2017.09.026; Tan S, 2018, ONCOGENE, V37, P4887, DOI 10.1038/s41388-018-0280-6; Trifonov A, 2016, J PHYS CHEM C, V120, P15743, DOI 10.1021/acs.jpcc.5b11308; Wang ZL, 2013, GLAND SURG, V2, P25, DOI 10.3978/j.issn.2227-684X.2013.02.07; Wilusz JE, 2013, SCIENCE, V340, P440, DOI 10.1126/science.1238522; Wu BW, 2020, J CANCER, V11, P5727, DOI 10.7150/jca.46554; Wu JR, 2019, BIOCHEM CELL BIOL, V97, P722, DOI 10.1139/bcb-2019-0008; Xu S, 2018, PEERJ, V6, DOI 10.7717/peerj.5503; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yang Q, 2019, BBA-MOL CELL RES, V1866, P1533, DOI 10.1016/j.bbamcr.2019.07.001; Yi CH, 2016, CANCER LETT, V381, P1, DOI 10.1016/j.canlet.2016.07.016; Yoshio TD, 1997, MOL CELL BIOL, V17, P3907, DOI 10.1128/MCB.17.7.3907; Yu J, 2018, J HEPATOL, V68, P1214, DOI 10.1016/j.jhep.2018.01.012; Zhang H, 2015, CANCER LETT, V367, P49, DOI 10.1016/j.canlet.2015.07.010; Zhang XW, 2018, ONCOTARGETS THER, V11, P2853, DOI 10.2147/OTT.S158008; Zhong YX, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0827-8	44	6	6	1	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2021	40	25					4338	4351		10.1038/s41388-021-01867-6	http://dx.doi.org/10.1038/s41388-021-01867-6		JUN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SY4AZ	34103682				2022-12-26	WOS:000659032900002
J	Wang, SQ; Yi, PF; Wang, N; Song, M; Li, WH; Zheng, YY				Wang, Shaoqiang; Yi, Pengfei; Wang, Na; Song, Min; Li, Wenhui; Zheng, Yingying			LncRNA TUG1/miR-29c-3p/SIRT1 axis regulates endoplasmic reticulum stress-mediated renal epithelial cells injury in diabetic nephropathy model in vitro	PLOS ONE			English	Article							LONG NONCODING RNA; TUG1; PROLIFERATION; ACCUMULATION; EXPRESSION; FIBROSIS; PROMOTES	Long non-coding RNAs (lncRNAs) are important regulators in diabetic nephropathy. In this study, we investigated the potential role of lncRNA TUG1 in regulating endoplasmic reticulum stress (ERS)-mediated apoptosis in high glucose induced renal tubular epithelial cells. Human renal tubular epithelial cell line HK-2 was challenged with high glucose following transfection with lncRNA TUG1, miR-29c-3p mimics or inhibitor expression plasmid, either alone or in combination, for different experimental purposes. Potential binding effects between TUG1 and miR-29c-3p, as well as between miR-29c-3p and SIRT1 were verified. High glucose induced apoptosis and ERS in HK-2 cells, and significantly decreased TUG1 expression. Overexpressed TUG1 could prevent high glucose-induced apoptosis and alleviated ERS via negatively regulating miR-29c-3p. In contrast, miR-29c-3p increased HK-2 cells apoptosis and ERS upon high glucose-challenge. SIRT1 was a direct target gene of miR-29c-3p in HK-2 cells, which participated in the effects of miR-29c-3p on HK-2 cells. Mechanistically, TUG1 suppressed the expression of miR-29c-3p, thus counteracting its function in downregulating the level of SIRT1. TUG1 regulates miR-29c-3p/SIRT1 and subsequent ERS to relieve high glucose induced renal epithelial cells injury, and suggests a potential role for TUG1 as a promising diagnostic marker of diabetic nephropathy.	[Wang, Shaoqiang; Li, Wenhui] Jining Med Univ, Affiliated Hosp, Dept Thorac Surg, Jinan, Shandong, Peoples R China; [Yi, Pengfei; Wang, Na; Song, Min; Zheng, Yingying] Jining Med Univ, Affiliated Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China	Jining Medical University; Jining Medical University	Zheng, YY (corresponding author), Jining Med Univ, Affiliated Hosp, Dept Endocrinol, Jinan, Shandong, Peoples R China.	zyy926@mail.jnmc.edu.cn		Zheng, Yingying/0000-0002-5684-6430	Research Fund for Academician Lin He New Medicine [JYHL2019FMS11]; Nursery research project of the Affiliated Hospital of Jining Medical University [MP-2018-001]; Teacher Research Support Fund of Jining Medical University [JY2017FS002]; National Natural Science Foundation of China [81802290]; Natural Science Foundation of Shandong Province [ZR2018BH020]	Research Fund for Academician Lin He New Medicine; Nursery research project of the Affiliated Hospital of Jining Medical University; Teacher Research Support Fund of Jining Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This work was supported by the Research Fund for Academician Lin He New Medicine (No. JYHL2019FMS11); Nursery research project of the Affiliated Hospital of Jining Medical University (No. MP-2018-001); Teacher Research Support Fund of Jining Medical University (JY2017FS002); National Natural Science Foundation of China (No. 81802290); Natural Science Foundation of Shandong Province (No. ZR2018BH020).	Beillard E, 2012, RNA, V18, P1091, DOI 10.1261/rna.031831.111; Chen XC, 2018, BMB REP, V51, P280, DOI 10.5483/BMBRep.2018.51.6.025; Dewanjee S, 2018, BIOCHEM PHARMACOL, V155, P32, DOI 10.1016/j.bcp.2018.06.017; Dickhout JG, 2011, CIRC RES, V108, P629, DOI 10.1161/CIRCRESAHA.110.226803; Duan LJ, 2017, BIOCHEM BIOPH RES CO, V484, P598, DOI 10.1016/j.bbrc.2017.01.145; Fan Y, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0842-y; Guo J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01027-5; Guo P, 2018, ONCOL RES, V26, P1083, DOI 10.3727/096504018X15152085755247; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Hong Q, 2018, KIDNEY INT, V93, P1330, DOI 10.1016/j.kint.2017.12.008; Hu RH, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01652-7; Kang XM, 2018, J BIOL CHEM, V293, P8614, DOI 10.1074/jbc.M117.809822; Keri KC, 2018, J COMMUNITY HOSP INT, V8, P200, DOI 10.1080/20009666.2018.1500423; Lei X, 2018, DRUG DES DEV THER, V12, P2785, DOI 10.2147/DDDT.S166525; Lhotak S, 2012, AM J PHYSIOL-RENAL, V303, pF266, DOI 10.1152/ajprenal.00482.2011; Li AL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0527-8; Li Z, 2016, CELL PROLIFERAT, V49, P471, DOI 10.1111/cpr.12269; Lindenmeyer MT, 2008, J AM SOC NEPHROL, V19, P2225, DOI 10.1681/ASN.2007121313; Liu Q, 2015, J NEURO-ONCOL, V122, P283, DOI 10.1007/s11060-015-1718-0; Long JY, 2016, J CLIN INVEST, V126, P4205, DOI 10.1172/JCI87927; Long JY, 2011, J BIOL CHEM, V286, P11837, DOI 10.1074/jbc.M110.194969; Lu ZY, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/7805058; Ma B, 2016, TUMOR BIOL, V37, P4445, DOI 10.1007/s13277-015-4301-6; Pandey VK, 2019, LIFE SCI, V216, P246, DOI 10.1016/j.lfs.2018.11.041; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ravindran S, 2017, J CELL PHYSIOL, V232, P731, DOI 10.1002/jcp.25598; Satirapoj B, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/2852398; Sieber J, 2010, AM J PHYSIOL-RENAL, V299, pF821, DOI 10.1152/ajprenal.00196.2010; Sun ZQ, 2018, EUR J PHARMACOL, V837, P96, DOI 10.1016/j.ejphar.2018.08.022; Tang WX, 2017, ONCOTARGET, V8, P105832, DOI 10.18632/oncotarget.22405; Wakino S, 2015, KIDNEY INT, V88, P691, DOI 10.1038/ki.2015.157; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang M, 2016, MOL CELL ENDOCRINOL, V426, P136, DOI 10.1016/j.mce.2016.02.020; Wang YQ, 2019, INT J ONCOL, V54, P1317, DOI 10.3892/ijo.2019.4699; Xu YT, 2015, TUMOR BIOL, V36, P1643, DOI 10.1007/s13277-014-2763-6; Yi H, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.451; Yu Gan, 2020, Nan Fang Yi Ke Da Xue Xue Bao, V40, P1325, DOI 10.12122/j.issn.1673-4254.2020.09.16; Zhang EB, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.201; Zhong YF, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00624	39	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252761	10.1371/journal.pone.0252761	http://dx.doi.org/10.1371/journal.pone.0252761			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097717	Green Published, gold			2022-12-26	WOS:000664640700017
J	Breda Mascarenhas, LA; Machado, BAS; Rodrigues, LDP; Hodel, KVS; Santos, AAB; Neves, PRF; Andrade, LPCD; Soares, MB; de Andrade, JB; Badaro, R				Breda Mascarenhas, Luis Alberto; Machado, Bruna Aparecida Souza; Rodrigues, Leticia de Alencar Pereira; Saraiva Hodel, Katharine Valeria; Bandeira Santos, Alex Alisson; Freitas Neves, Paulo Roberto; da Silva Andrade, Leone Peter Correia; Soares, Milena Botelho; de Andrade, Jailson Bittencourt; Badaro, Roberto			Potential application of novel technology developed for instant decontamination of personal protective equipment before the doffing step	PLOS ONE			English	Article							SODIUM-HYPOCHLORITE; HEALTH-CARE; INANIMATE SURFACES; BIOFILM FORMATION; CANDIDA-AURIS; DISINFECTION; CONTAMINATION; COVID-19; SYSTEM; INACTIVATION	The use of personal protective equipment (PPE) has been considered the most effective way to avoid the contamination of healthcare workers by different microorganisms, including SARS-CoV-2. A spray disinfection technology (chamber) was developed, and its efficacy in instant decontamination of previously contaminated surfaces was evaluated in two exposure times. Seven test microorganisms were prepared and inoculated on the surface of seven types of PPE (respirator mask, face shield, shoe, glove, cap, safety glasses and lab coat). The tests were performed on previously contaminated PPE using a manikin with a motion device for exposure to the chamber with biocidal agent (sodium hypochlorite) for 10 and 30s. In 96.93% of the experimental conditions analyzed, the percentage reduction was >99% (the number of viable cells found on the surface ranged from 4.3x10(6) to <10 CFU/mL). The samples of E. faecalis collected from the glove showed the lowest percentages reduction, with 86.000 and 86.500% for exposure times of 10 and 30 s, respectively. The log(10) reduction values varied between 0.85 log(10) (E. faecalis at 30 s in glove surface) and 9.69 log(10) (E. coli at 10 and 30 s in lab coat surface). In general, E. coli, S. aureus, C. freundii, P. mirabilis, C. albicans and C. parapsilosis showed susceptibility to the biocidal agent under the tested conditions, with >99% reduction after 10 and 30s, while E. faecalis and P. aeruginosa showed a lower susceptibility. The 30s exposure time was more effective for the inactivation of the tested microorganisms. The results show that the spray disinfection technology has the potential for instant decontamination of PPE, which can contribute to an additional barrier for infection control of healthcare workers in the hospital environment.	[Breda Mascarenhas, Luis Alberto; Machado, Bruna Aparecida Souza; Rodrigues, Leticia de Alencar Pereira; Saraiva Hodel, Katharine Valeria; da Silva Andrade, Leone Peter Correia; Soares, Milena Botelho; de Andrade, Jailson Bittencourt; Badaro, Roberto] Univ Ctr SENAI CIMATEC, SENAI CIMATEC, SENAI Inst Innovat ISI Hlth Adv Syst, CIMATEC ISI SAS, Salvador, BA, Brazil; [Machado, Bruna Aparecida Souza; Bandeira Santos, Alex Alisson; Freitas Neves, Paulo Roberto] Univ Ctr SENAI CIMATEC, Computat Modeling & Ind Technol, Natl Serv Ind Learning SENAI, SENAI CIMATEC, Bahia Blanca, Buenos Aires, Argentina; [Soares, Milena Botelho] Oswaldo Cruz Fdn IGM FIOCRUZ, Goncalo Moniz Inst, Salvador, BA, Brazil	Faculdade de Tecnologia Senai Cimatec	Machado, BAS (corresponding author), Univ Ctr SENAI CIMATEC, SENAI CIMATEC, SENAI Inst Innovat ISI Hlth Adv Syst, CIMATEC ISI SAS, Salvador, BA, Brazil.; Machado, BAS (corresponding author), Univ Ctr SENAI CIMATEC, Computat Modeling & Ind Technol, Natl Serv Ind Learning SENAI, SENAI CIMATEC, Bahia Blanca, Buenos Aires, Argentina.	brunam@fieb.org.br	Machado, Bruna/AAP-6877-2021; Santos, Alex A.B./J-4829-2012; MACHADO, BRUNA/C-3130-2016	MACHADO, BRUNA/0000-0003-1655-0325; B. de Andrade, Jailson/0000-0001-5269-4866				Aboualizadeh E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186375; Adams CE, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17062109; Adams JG, 2020, JAMA-J AM MED ASSOC, V323, P1439, DOI 10.1001/jama.2020.3972; Andre CB, 2018, J BIOMED MATER RES B, V106, P945, DOI 10.1002/jbm.b.33907; [Anonymous], 2020, EUR HEART J, DOI DOI 10.1093/eurheartj/ehaa283; Anvisa, 2020, HUBUNGAN INTERNASION, P1; Anvisa, 2019, BRAZ PHARM, P1; Bagattini Maria, 2015, BMC Res Notes, V8, P551, DOI 10.1186/s13104-015-1534-9; Bansal N, 2000, J APPL MICROBIOL, V89, P663, DOI 10.1046/j.1365-2672.2000.01164.x; Biswal M, 2020, PUBLIC HEALTH, V183, P48, DOI 10.1016/j.puhe.2020.04.045; Bonyadi Z, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6049-5; Cadnum JL, 2020, AM J INFECT CONTROL, V48, P951, DOI 10.1016/j.ajic.2020.06.002; Cadnum JL, 2017, INFECT CONT HOSP EP, V38, P1240, DOI 10.1017/ice.2017.162; Cai LL, 2018, J FOOD SCI, V83, P1326, DOI 10.1111/1750-3841.14149; CEN-European Committee for Standardization, 2006, 145612006 EN CEN; CEN-European Committee for Standardization, 2006, 145622006 EN CEN; Centers for Disease Control and Prevention, 2008, CHEM DIS GUID DIS ST; Chapuis A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01070; Choudhury Gopal Krishna, 2018, J Contemp Dent Pract, V19, P113; Chowdhury S, 2020, EMERG INFECT DIS, V26, P2087, DOI 10.3201/eid2609.191029; Cinar P, 2020, J NATL COMPR CANC NE, V18, P504, DOI 10.6004/jnccn.2020.7572; Clinical and Laboratory Standards Institute, 2009, M44A2 CLIN LAB STAND; Cutts TA., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Dadar M, 2018, MICROB PATHOGENESIS, V117, P128, DOI 10.1016/j.micpath.2018.02.028; De Vries T.A., 1999, QUANT MICROBIOL, V1, P29, DOI DOI 10.1023/A:1010072226737; Dhont S, 2020, RESP RES, V21, DOI 10.1186/s12931-020-01462-5; Diomedi A, 2017, REV CHIL INFECTOL, V34, P156, DOI 10.4067/S0716-10182017000200010; Drohan SE, 2019, P NATL ACAD SCI USA, V116, P6221, DOI 10.1073/pnas.1812231116; El Haddad L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2792-z; FDA, 2020, ENF POL STER DIS DEV, P1; Felice C, 2020, J COMMUN HEALTH, V45, P675, DOI 10.1007/s10900-020-00845-5; Ferrara P, 2020, PUBLIC HEALTH, V185, P1, DOI 10.1016/j.puhe.2020.05.014; Fu LW, 2020, J INFECT PUBLIC HEAL, V13, P730, DOI 10.1016/j.jiph.2020.01.008; Fukuzaki Satoshi, 2006, Biocontrol Science, V11, P147; Godoy LRG, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002553; Gottardi W, 2005, J ANTIMICROB CHEMOTH, V55, P475, DOI 10.1093/jac/dki054; Guridi A, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234747; Health Quality Ontario, 2018, Ont Health Technol Assess Ser, V18, P1; Henwood AF, 2020, J HISTOTECHNOL, V43, P102, DOI 10.1080/01478885.2020.1734718; Ilyas S, 2020, SCI TOTAL ENVIRON, V749, DOI 10.1016/j.scitotenv.2020.141652; Ishikawa S, 2019, BIOCONTROL SCI, V24, P57, DOI 10.4265/bio.24.57; Jackson DS, 2006, J FORENSIC SCI, V51, P827, DOI 10.1111/j.1556-4029.2006.00160.x; James PB, 2020, GLOB PUBLIC HEALTH, V15, P1380, DOI 10.1080/17441692.2020.1762105; Jeong MI, 2018, LWT-FOOD SCI TECHNOL, V96, P663, DOI 10.1016/j.lwt.2018.06.019; Jones RM, 2020, AM J INFECT CONTROL, V48, P46, DOI 10.1016/j.ajic.2019.06.023; Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022; Karim N, 2020, ACS NANO, V14, P12313, DOI 10.1021/acsnano.0c05537; Kawamura M, 2019, J GLOB ANTIMICROB RE, V17, P316, DOI 10.1016/j.jgar.2019.01.015; Keil SD, 2020, VOX SANG, V115, P495, DOI 10.1111/vox.12937; Kenters N, 2017, AM J INFECT CONTROL, V45, pE69, DOI 10.1016/j.ajic.2017.04.290; Tran K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035797; Kohler AT, 2018, J HOSP INFECT, V100, pE40, DOI 10.1016/j.jhin.2018.07.017; Kornacki JL., 2015, ENTEROBACTERIACEAE C, V5th ed 5th, DOI [10.2105/mbef.0222.014, DOI 10.2105/MBEF.0222.014]; Korth J, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104437; Kratzel A, 2020, EMERG INFECT DIS, V26, P1592, DOI 10.3201/eid2607.200915; Kumar Jessica, 2019, Pathog Immun, V4, P260, DOI 10.20411/pai.v4i2.291; Kursumovic E, 2020, ANAESTHESIA, V75, P989, DOI 10.1111/anae.15116; Lai XQ, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.9666; Lemmer K, 2019, HEALTH SECUR, V17, P200, DOI 10.1089/hs.2019.0005; Libonati A, 2019, EUR J PAEDIATR DENT, V20, P73, DOI 10.23804/ejpd.2019.20.01.14; Lineback CB, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0447-5; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Ma QX, 2020, J MED VIROL, V92, P1567, DOI 10.1002/jmv.25805; Mantlo Emily, 2020, F1000Res, V9, P674, DOI [10.12688/f1000research.24651.1, 10.12688/f1000research.24651.2]; Marson FAL, 2020, PULMONOLOGY, V26, P241, DOI 10.1016/j.pulmoe.2020.04.008; Ministerio da Saude do Brasil, 2020, COR BRAS; Montagna MT, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16111895; Munoz-Leyva F, 2020, CAN J ANESTH, V67, P900, DOI 10.1007/s12630-020-01648-x; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; Nikpour S, 2018, J BURN CARE RES, V39, P394, DOI 10.1097/BCR.0000000000000608; Nishida K, 2012, J POWER SOURCES, V199, P155, DOI 10.1016/j.jpowsour.2011.10.026; Nissen K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76442-2; OPAS, 2020, US TUN OUTR TECN DES, P1; de Medeiros MAP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221033; Pereira SSP, 2015, REV ESC ENFERM USP, V49, P675, DOI 10.1590/S0080-623420150000400020; Pires RH, 2013, ANTIMICROB AGENTS CH, V57, P2417, DOI 10.1128/AAC.01308-12; Rizzotti L, 2016, FOOD MICROBIOL, V60, P160, DOI 10.1016/j.fm.2016.07.009; Rhner E, 2020, KNEE SURG SPORT TR A, V28, P3912, DOI 10.1007/s00167-020-05887-9; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Saini V, 2020, GUT PATHOG, V12, DOI 10.1186/s13099-020-00367-4; Sato-Boku A, 2019, BMC ANESTHESIOL, V19, DOI 10.1186/s12871-019-0839-y; SATTAR SA, 1989, EPIDEMIOL INFECT, V102, P493, DOI 10.1017/S0950268800030211; Schrank Cassandra L, 2020, ACS Infect Dis, V6, P1553, DOI 10.1021/acsinfecdis.0c00265; Slaughter RJ, 2019, CLIN TOXICOL, V57, P303, DOI 10.1080/15563650.2018.1543889; Suchomel M, 2019, J HOSP INFECT, V103, P435, DOI 10.1016/j.jhin.2019.08.014; Suen LKP, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0433-y; Tellier R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3707-y; Toth R, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00111-18; Tyan K, 2018, AM J INFECT CONTROL, V46, P1254, DOI 10.1016/j.ajic.2018.04.223; U.S. Environmental Protection Agency, 2002, 821R02022 EPA; Vandini A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108598; Verhougstraete M, 2016, AM J INFECT CONTROL, V44, P714, DOI 10.1016/j.ajic.2015.12.025; Visnovsky LD, 2019, INFECT CONT HOSP EP, V40, P761, DOI 10.1017/ice.2019.111; Wang J, 2020, J HOSP INFECT, V105, P100, DOI 10.1016/j.jhin.2020.03.002; Wang J, 2020, ENVIRON POLLUT, V262, DOI 10.1016/j.envpol.2020.114665; Weber DJ, 2016, CURR OPIN INFECT DIS, V29, P424, DOI 10.1097/QCO.0000000000000284; Wei JT, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197149; WHO, 2020, RESP COMM SPREAD COV, P1, DOI DOI 10.1017/DMP.2020.166; WHO, 2020, INTJENVIRONRESPUBLIC, P7; Wickramatillake A, 2020, OCCUP MED-OXFORD, V70, P330, DOI 10.1093/occmed/kqaa078; Wolfe MK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172734; World Health Organization, 2012, ENV MON CLEAN ROOMS; Yim Wonjun, 2020, medRxiv, DOI 10.1101/2020.07.07.20148551; Yin S, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104397; Yoo A, 2018, J ENDODONT, V44, P269, DOI 10.1016/j.joen.2017.08.025	106	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0250854	10.1371/journal.pone.0250854	http://dx.doi.org/10.1371/journal.pone.0250854			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086691	Green Published, gold			2022-12-26	WOS:000664640100012
J	Hubeny, J; Harnisz, M; Korzeniewska, E; Buta, M; Zielinski, W; Rolbiecki, D; Giebultowicz, J; Nalecz-Jawecki, G; Plaza, G				Hubeny, Jakub; Harnisz, Monika; Korzeniewska, Ewa; Buta, Martyna; Zielinski, Wiktor; Rolbiecki, Damian; Giebultowicz, Joanna; Nalecz-Jawecki, Grzegorz; Plaza, Grazyna			Industrialization as a source of heavy metals and antibiotics which can enhance the antibiotic resistance in wastewater, sewage sludge and river water	PLOS ONE			English	Article							TREATMENT-PLANT; BACTERIAL COMMUNITY; EMERGING CONTAMINANTS; AQUATIC ENVIRONMENT; TREATMENT SYSTEMS; ACTIVATED-SLUDGE; GENES; MUNICIPAL; REMOVAL; SURFACE	The spread of antibiotic resistance is closely related with selective pressure in the environment. Wastewater from industrialized regions is characterized by higher concentrations of these pollutants than sewage from less industrialized areas. The aim of this study was to compare the concentrations of contaminants such as antibiotics and heavy metals (HMs), and to evaluate their impact on the spread of genes encoding resistance to antimicrobial drugs in samples of wastewater, sewage sludge and river water in two regions with different levels of industrialization. The factors exerting selective pressure, which significantly contributed to the occurrence of the examined antibiotic resistance genes (ARGs), were identified. The concentrations of selected gene copy numbers conferring resistance to four groups of antibiotics as well as class 1 and 2 integron-integrase genes were determined in the analyzed samples. The concentrations of six HMs and antibiotics corresponding to genes mediated resistance from 3 classes were determined. Based on network analysis, only some of the analyzed antibiotics correlated with ARGs, while HM levels were correlated with ARG concentrations, which can confirm the important role of HMs in promoting drug resistance. The samples from a wastewater treatment plant (WWTP) located an industrialized region were characterized by higher HM contamination and a higher number of significant correlations between the analyzed variables than the samples collected from a WWTP located in a less industrialized region. These results indicated that treated wastewater released into the natural environment can pose a continuous threat to human health by transferring ARGs, antibiotics and HMs to the environment. These findings shed light on the impact of industrialization on antibiotic resistance dissemination.	[Hubeny, Jakub; Harnisz, Monika; Korzeniewska, Ewa; Buta, Martyna; Zielinski, Wiktor; Rolbiecki, Damian] Univ Warmia & Mazury, Fac Geoengn, Dept Water Protect Engn & Environm Microbiol, Olsztyn, Poland; [Giebultowicz, Joanna] Med Univ Warsaw, Dept Bioanal & Drug Anal, Fac Pharm, Warsaw, Poland; [Nalecz-Jawecki, Grzegorz] Med Univ Warsaw, Dept Environm Hlth Sci, Fac Pharm, Warsaw, Poland; [Plaza, Grazyna] Silesian Tech Univ, Fac Org & Management, Zabrze, Poland	University of Warmia & Mazury; Medical University of Warsaw; Medical University of Warsaw; Silesian University of Technology	Harnisz, M (corresponding author), Univ Warmia & Mazury, Fac Geoengn, Dept Water Protect Engn & Environm Microbiol, Olsztyn, Poland.	monika.harnisz@uwm.edu.pl	Hubeny, Jakub/GOP-3176-2022; Korzeniewska, Ewa/J-6408-2013; Harnisz, Monika/ABC-2697-2021; Giebultowicz, Joanna/M-5956-2018; Harnisz, Monika/N-3040-2018	Zielinski, Wiktor/0000-0002-2383-3457; /0000-0002-3106-2381; Giebultowicz, Joanna/0000-0002-2567-4453; Harnisz, Monika/0000-0002-2907-4199; Nalecz-Jawecki, Grzegorz/0000-0003-4945-3687; Rolbiecki, Damian/0000-0002-4574-5917; , Martyna/0000-0001-9733-045X; Hubeny, Jakub/0000-0002-1208-3419	Polish National Science Centre [2017/M/NZ9/00071]	Polish National Science Centre	This study was supported by the Polish National Science Centre in the form of a grant awarded to GP (2017/M/NZ9/00071).	Anindita Gogoi, 2018, Groundwater for Sustainable Development, V6, P169, DOI 10.1016/j.gsd.2017.12.009; [Anonymous], 2016, DZ USTAW RZECZYPOSP, P1; Ashfaq M, 2019, SCI TOTAL ENVIRON, V688, P653, DOI 10.1016/j.scitotenv.2019.06.285; Barancheshme F, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02603; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Berglund Bjorn, 2015, Infection Ecology & Epidemiology, V5, P28564, DOI 10.3402/iee.v5.28564; Bielen A, 2017, WATER RES, V126, P79, DOI 10.1016/j.watres.2017.09.019; Birosova L, 2014, SCI TOTAL ENVIRON, V490, P440, DOI 10.1016/j.scitotenv.2014.05.030; Burke V, 2016, WATER ENVIRON RES, V88, P652, DOI [10.2175/106143016X14609975746604, 10.2175]; Buta M, 2019, J ECOL ENG, V20, P39, DOI 10.12911/22998993/112797; Calhau V, 2015, J WATER HEALTH, V13, P311, DOI 10.2166/wh.2014.327; Cardoso O, 2014, CHEMOSPHERE, V115, P20, DOI 10.1016/j.chemosphere.2014.02.004; Castiglioni S, 2018, WATER RES, V131, P287, DOI 10.1016/j.watres.2017.12.047; Chen BA, 2015, ENVIRON SCI POLLUT R, V22, P13950, DOI 10.1007/s11356-015-4636-y; Chen H, 2013, ENVIRON INT, V55, P9, DOI 10.1016/j.envint.2013.01.019; Chen QL, 2016, ENVIRON INT, V92-93, P1, DOI 10.1016/j.envint.2016.03.026; Cheng MM, 2014, J SOIL SEDIMENT, V14, P1123, DOI 10.1007/s11368-014-0850-3; Chihomvu P, 2015, INT J MOL SCI, V16, P7352, DOI 10.3390/ijms16047352; Chong J, 2018, NUCLEIC ACIDS RES, V46, pW486, DOI 10.1093/nar/gky310; Deblonde T, 2011, INT J HYG ENVIR HEAL, V214, P442, DOI 10.1016/j.ijheh.2011.08.002; Deng Y, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0100-6; Di Cesare A, 2016, J LIMNOL, V75, P59, DOI 10.4081/jlimnol.2016.1198; Di Cesare A, 2016, WATER RES, V94, P208, DOI 10.1016/j.watres.2016.02.049; Dickinson AW, 2019, ENVIRON INT, V132, DOI 10.1016/j.envint.2019.105117; Tuc DQ, 2017, SCI TOTAL ENVIRON, V575, P758, DOI 10.1016/j.scitotenv.2016.09.118; Domanska W, 2019, OCHRONA SRODOWISKA, P186; Domingues S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002837; Dong HY, 2016, J ENVIRON MANAGE, V178, P11, DOI 10.1016/j.jenvman.2016.04.037; Du J, 2015, ENVIRON SCI POLLUT R, V22, P3715, DOI 10.1007/s11356-014-3552-x; ECDC, 2018, CONS ANT SYST US ATC, P2; ECDC, 2018, CONS ANT SYST US ATC, P19; Edokpayi JN, 2015, INT J ENV RES PUB HE, V12, P7300, DOI 10.3390/ijerph120707300; Fijalkowski K, 2017, J ENVIRON MANAGE, V203, P1126, DOI 10.1016/j.jenvman.2017.05.068; Gao P, 2015, APPL MICROBIOL BIOT, V99, P3971, DOI 10.1007/s00253-015-6404-9; Gawdzik JI, 2010, OCHR SR, V32, P15; Giebultowicz J, 2020, MOLECULES, V25, DOI 10.3390/molecules25061470; Glowny Urzad Statystyczny, 2020, LUDN STAN STRUKT OR, P1; Harrabi M., 2018, ENV NANOTECH MONIT M, V10, P163, DOI [10.1016/J.ENMM.2018.05.006, DOI 10.1016/J.ENMM.2018.05.006]; He LY, 2014, ENVIRON SCI TECHNOL, V48, P13120, DOI 10.1021/es5041267; Huang X, 2015, WATER RES, V70, P109, DOI 10.1016/j.watres.2014.11.048; Hughes D, 2017, ANNU REV MICROBIOL, V71, P579, DOI 10.1146/annurev-micro-090816-093813; Jones L, 2017, ANAL LETT, V50, P724, DOI 10.1080/00032719.2016.1194854; Kaeseberg T, 2018, ENVIRON POLLUT, V239, P638, DOI 10.1016/j.envpol.2018.04.075; Kang CH, 2018, MAR POLLUT BULL, V135, P69, DOI 10.1016/j.marpolbul.2018.07.007; Karkman A, 2018, TRENDS MICROBIOL, V26, P220, DOI 10.1016/j.tim.2017.09.005; Knopp G, 2016, WATER RES, V100, P580, DOI 10.1016/j.watres.2016.04.069; Korzeniewska E, 2013, J ENVIRON MANAGE, V128, P904, DOI 10.1016/j.jenvman.2013.06.051; Kowalska E, 2014, ARCH BIOL SCI, V66, P1371, DOI 10.2298/ABS1404371K; Kummerer K, 2009, CHEMOSPHERE, V75, P417, DOI 10.1016/j.chemosphere.2008.11.086; Kumar M, 2019, ENVIRON INT, V124, P448, DOI 10.1016/j.envint.2018.12.065; Larsson DGJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0571; Le TH, 2016, ANTIMICROB AGENTS CH, V60, P7449, DOI 10.1128/AAC.01556-16; Lerminiaux NA, 2019, CAN J MICROBIOL, V65, P34, DOI 10.1139/cjm-2018-0275; Li HC, 2017, ECOTOX ENVIRON SAFE, V140, P1, DOI 10.1016/j.ecoenv.2017.01.007; Li JN, 2016, ENVIRON SCI POLLUT R, V23, P6826, DOI 10.1007/s11356-015-5916-2; Li LG, 2017, ISME J, V11, P651, DOI 10.1038/ismej.2016.155; Li XY, 2019, J HAZARD MATER, V369, P9, DOI 10.1016/j.jhazmat.2019.02.006; Liu XW, 2019, ENVIRON POLLUT, V252, P1532, DOI 10.1016/j.envpol.2019.06.095; Lu ZH, 2015, SCI TOTAL ENVIRON, V527, P429, DOI 10.1016/j.scitotenv.2015.04.101; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; Makowska N, 2016, CHEMOSPHERE, V144, P1665, DOI 10.1016/j.chemosphere.2015.10.044; Mao DQ, 2015, WATER RES, V85, P458, DOI 10.1016/j.watres.2015.09.010; Martins VV, 2014, ENVIRON SCI POLLUT R, V21, P5873, DOI 10.1007/s11356-014-2509-4; Marx C, 2015, SCI TOTAL ENVIRON, V538, P779, DOI 10.1016/j.scitotenv.2015.08.112; Mironczuk-Chodakowska I, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16193614; Munoz M, 2017, 16 WORLD WAT C 2017, P1; Tran NH, 2018, WATER RES, V133, P182, DOI 10.1016/j.watres.2017.12.029; Nguyen CC, 2019, FRONT ENV SCI ENG, V13, DOI 10.1007/s11783-019-1129-0; Niu HY, 2016, WORLD J ENG, V13, P218, DOI 10.1108/WJE-06-2016-029; Nunez-Delgado A, 2019, MICROBIAL WASTEWATER TREATMENT, P1, DOI 10.1016/B978-0-12-816809-7.00001-4; Olujimi OO, 2012, POL J ENVIRON STUD, V21, P1755; Osinska A, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9030387; Osinska A, 2020, J HAZARD MATER, V381, DOI 10.1016/j.jhazmat.2019.121221; Osinska A, 2016, ENVIRON SCI POLLUT R, V23, P10818, DOI 10.1007/s11356-016-6221-4; Ostman M, 2017, WATER RES, V115, P318, DOI 10.1016/j.watres.2017.03.011; Pal C, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2153-5; Park J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030687; Paul Dipak, 2017, Annals of Agrarian Science, V15, P278, DOI 10.1016/j.aasci.2017.04.001; Pelc W, 2016, ENVIRON TOXICOL CHEM, V35, P2597, DOI 10.1002/etc.3429; Polesel F, 2016, ENVIRON SCI TECHNOL, V50, P10316, DOI 10.1021/acs.est.6b01899; Proia L, 2016, ENVIRON POLLUT, V210, P121, DOI 10.1016/j.envpol.2015.11.035; Pruden A, 2012, ENVIRON SCI TECHNOL, V46, P11541, DOI 10.1021/es302657r; Qian X, 2016, J HAZARD MATER, V315, P61, DOI 10.1016/j.jhazmat.2016.05.002; Rodriguez-Mozaz S, 2015, WATER RES, V69, P234, DOI 10.1016/j.watres.2014.11.021; Rorat A, 2019, INDUSTRIAL AND MUNICIPAL SLUDGE: EMERGING CONCERNS AND SCOPE FOR RESOURCE RECOVERY, P155, DOI 10.1016/B978-0-12-815907-1.00008-8; Sanchez LF, 2016, ECOL ECON, V124, P17, DOI 10.1016/j.ecolecon.2016.01.008; Seiler C, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00399; Tella M, 2013, WASTE MANAGE, V33, P184, DOI 10.1016/j.wasman.2012.07.021; Uyaguari MI, 2013, MAR POLLUT BULL, V76, P77, DOI 10.1016/j.marpolbul.2013.09.027; Vignaroli C, 2018, ENVIRON POLLUT, V237, P406, DOI 10.1016/j.envpol.2018.02.073; Wang MY, 2017, ENVIRON POLLUT, V231, P1578, DOI 10.1016/j.envpol.2017.09.055; Wang Q, 2020, SCI TOTAL ENVIRON, V717, DOI 10.1016/j.scitotenv.2020.137055; Wang SQ, 2019, SCI TOTAL ENVIRON, V671, P443, DOI 10.1016/j.scitotenv.2019.03.147; Xiong WG, 2015, MICROB ECOL, V70, P425, DOI 10.1007/s00248-015-0583-x; Xu J, 2015, CHEMOSPHERE, V119, P1379, DOI 10.1016/j.chemosphere.2014.02.040; Xu Y, 2017, ENVIRON POLLUT, V220, P900, DOI 10.1016/j.envpol.2016.10.074; Xu Y, 2016, ENVIRON POLLUT, V213, P833, DOI 10.1016/j.envpol.2016.03.054; Yang Y, 2017, SCI TOTAL ENVIRON, V596, P303, DOI 10.1016/j.scitotenv.2017.04.102; Yi XZ, 2019, CHEMOSPHERE, V216, P213, DOI 10.1016/j.chemosphere.2018.10.087; Zarei-Baygi A, 2019, ENVIRON SCI TECHNOL, V53, P3599, DOI 10.1021/acs.est.9b00798; Zhang CH, 2016, ARCH ENVIRON PROT, V42, P48, DOI 10.1515/aep-2016-0036; Zhang XH, 2016, ENVIRON POLLUT, V218, P1255, DOI 10.1016/j.envpol.2016.08.081; Zhang XX, 2011, ENVIRON SCI TECHNOL, V45, P2598, DOI 10.1021/es103672x; Zielinska M, 2016, ENVIRON TECHNOL, V37, P2358, DOI 10.1080/09593330.2016.1150350; Zouiten A, 2016, ENVIRON SCI POLLUT R, V23, P15343, DOI 10.1007/s11356-016-6713-2	106	21	21	11	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252691	10.1371/journal.pone.0252691	http://dx.doi.org/10.1371/journal.pone.0252691			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086804	Green Published, gold			2022-12-26	WOS:000664640100109
J	Lee, JY; Ahn, S; Kim, D				Lee, June Young; Ahn, Sejung; Kim, Dohyun			Deep learning-based prediction of future growth potential of technologies	PLOS ONE			English	Article							FORECASTING EMERGING TECHNOLOGIES; EMERGENCE; MODEL	Research papers are a repository of information on the various elements that make up science and technology R&D activities. Generating knowledge maps based on research papers enables identification of specific areas of scientific and technical research as well as understanding of the flow of knowledge between those areas. Recently, as the number of electronic publishing and informatics archives along with the amount of accumulated knowledge related to science and technology has proliferated, the need to utilize the meta-knowledge obtainable from research papers has increased. Therefore, this study devised a model based on meta-knowledge (i.e., text information including citations, abstracts, area codes) for prediction of future growth potential using deep learning algorithms and investigated the applicability of the various forms of meta-knowledge to the prediction of future growth potential. It also proposes how to select the promising technology clusters based on the proposed model.	[Lee, June Young; Ahn, Sejung] Korea Inst Sci & Technol Informat, Future Technol Anal Ctr, Seoul, South Korea; [Kim, Dohyun] Myongji Univ, Dept Ind & Management Engn, Yongin, South Korea	Korea Institute of Science & Technology Information (KISTI); Myongji University	Kim, D (corresponding author), Myongji Univ, Dept Ind & Management Engn, Yongin, South Korea.	ftgog@mju.ac.kr		Ahn, Sejung/0000-0002-7286-4698; Lee, June Young/0000-0001-8606-2429	Korea Institute of Science and Technology Information (KISTI) [K-21-L03-C01-S01]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning [NRF-2017R1E1A1A01077375]	Korea Institute of Science and Technology Information (KISTI)(Korea Institute of Science & Technology Information (KISTI)); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT and Future Planning(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Korea Institute of Science and Technology Information (KISTI) (K-21-L03-C01-S01) and the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT and Future Planning (NRF-2017R1E1A1A01077375).	Agresti A., 1996, INTRO CATEGORICAL DA; Anderson DR., 2019, ESSENTIALS MODERN BU, V8th ed; [Anonymous], 2017, P NEUR INF PROC SYST; Avila-Robinson A, 2013, TECHNOL FORECAST SOC, V80, P1071, DOI 10.1016/j.techfore.2012.07.012; Boyack KW, 2014, J ENG TECHNOL MANAGE, V32, P147, DOI 10.1016/j.jengtecman.2013.07.001; Boyack KW, 2014, J ASSOC INF SCI TECH, V65, P670, DOI 10.1002/asi.22990; Breitzman A, 2015, RES POLICY, V44, P195, DOI 10.1016/j.respol.2014.06.006; Carley SF, 2018, SCIENTOMETRICS, V115, P35, DOI 10.1007/s11192-018-2654-5; Daim TU, 2006, TECHNOL FORECAST SOC, V73, P981, DOI 10.1016/j.techfore.2006.04.004; Devlin J., 2018, ARXIV181004805; Evans JA, 2011, SCIENCE, V331, P721, DOI 10.1126/science.1201765; Fye SR, 2013, TECHNOL FORECAST SOC, V80, P1222, DOI 10.1016/j.techfore.2012.10.026; Gao LD, 2013, TECHNOL FORECAST SOC, V80, P398, DOI 10.1016/j.techfore.2012.10.003; Glanzel W, 2017, SCIENTOMETRICS, V111, P1071, DOI 10.1007/s11192-017-2301-6; Glanzel W, 2012, SCIENTOMETRICS, V91, P399, DOI 10.1007/s11192-011-0591-7; Goldman AW, 2014, J INFORMETR, V8, P43, DOI 10.1016/j.joi.2013.10.009; Guo HN, 2011, SCIENTOMETRICS, V89, P421, DOI 10.1007/s11192-011-0433-7; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Javed AR., 2020, IEEE T INTELL TRANSP; Klavans R, 2017, J ASSOC INF SCI TECH, V68, P984, DOI 10.1002/asi.23734; LeCun Y., 2015, DEEP LEARNING NATURE, V521, P436, DOI [DOI 10.1038/NATURE14539, 10.1038/nature14539]; Lee C, 2018, TECHNOL FORECAST SOC, V127, P291, DOI 10.1016/j.techfore.2017.10.002; Liu L, 2020, P INT C LEARN REPR I; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Raza A, 2019, ENVIRON SCI TECH LET, V6, P624, DOI 10.1021/acs.estlett.9b00476; Rehman A., 2021, IEEE T NETW SCI ENG; Roweis S, 2012, P NEUR INF PROC SYST; Small H, 2006, SCIENTOMETRICS, V68, P595, DOI 10.1007/s11192-006-0132-y; Traag VA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41695-z; Vapnik V., 2013, NATURE STAT LAERNING; Waltman L, 2017, PRO INT CONF SCI INF, P691; Waltman L, 2012, J AM SOC INF SCI TEC, V63, P2378, DOI 10.1002/asi.22748; Zhou Y, 2020, SCIENTOMETRICS, V123, P1, DOI 10.1007/s11192-020-03351-6	34	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252753	10.1371/journal.pone.0252753	http://dx.doi.org/10.1371/journal.pone.0252753			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086769	Green Published, gold			2022-12-26	WOS:000664640100127
J	Lin, SY; Liu, TT; Chen, J; Li, G; Dang, J				Lin, Shuiyu; Liu, Tingting; Chen, Jun; Li, Guang; Dang, Jun			Comparative efficacy of treatments for previously treated patients with advanced esophageal and esophagogastric junction cancer: A network meta-analysis	PLOS ONE			English	Article							DOUBLE-BLIND; OPEN-LABEL; PHASE-3; CHEMOTHERAPY; MULTICENTER; MONOTHERAPY; GENERATION; NIVOLUMAB; BIAS	Background It remains unclear which treatment is the most effective for previously treated patients with advanced esophageal and esophagogastric junction (EGJ) cancer. We conducted a network meta-analysis to address this important issue. Methods PubMed, Embase, Cochrane Library, and Web of Science databases were searched for relevant phase II and III randomized controlled trials (RCTs). Overall survival (OS) was the primary outcome of interest, which was reported as hazard ratio (HR) and 95% confidence intervals (CIs). Results Sixteen RCTs involving 3372 patients and evaluating 15 treatments were included in this network meta-analysis. Ramucirumab+chemotherapy (CT) (HR = 0.52, 95% CI: 0.35-0.77) and use of programmed death receptor 1 (PD-1) inhibitors, including camrelizumab (HR = 0.71, 95% CI: 0.57-0.88), sintilimab (HR = 0.70, 95% CI: 0.50-0.98), nivolumab (HR = 0.76, 95% CI: 0.62-0.94), and pembrolizumab (HR = 0.84, 95% CI: 0.72-0.98), conferred better OS than CT; however, this OS benefit was not observed for PD-L1 inhibitor (avelumab) and other target agents (trastuzumab, everolimus, gefitinib, and anlotinib). In subgroup analysis, ramucirumab+CT and pembrolizumab showed significant improvement in OS, when compared to CT, in esophageal/EGJ adenocarcinoma (AC) cases; moreover, all PD-1 inhibitors had significant OS advantage over CT in treating esophageal squamous cell carcinoma (SCC). Based on treatment ranking in terms of OS, ramucirumab+CT and camrelizumab were ranked the best treatments for patients with AC and SCC, respectively. Conclusions Ramucirumab+CT and PD-1 inhibitors were superior to CT for previously treated cases of advanced esophageal/EGJ cancer. Ramucirumab+CT seemed to be the most effective treatment in patients with esophageal/EGJ AC, while use of PD-1 inhibitors, especially camrelizumab, was likely to be the optimal treatment in patients with esophageal SCC.	[Lin, Shuiyu; Li, Guang; Dang, Jun] China Med Univ, Dept Radiat Oncol, First Hosp, Shenyang, Peoples R China; [Liu, Tingting] Anshan Canc Hosp, Dept Radiat Oncol, Anshan, Peoples R China; [Chen, Jun] Shenyang Chest Hosp, Dept Radiat Oncol, Shenyang, Peoples R China	China Medical University	Dang, J (corresponding author), China Med Univ, Dept Radiat Oncol, First Hosp, Shenyang, Peoples R China.	dangjunsy@163.com	liu, ting/GZM-3326-2022	Dang, Jun/0000-0002-1408-4749				Bang YJ, 2018, ANN ONCOL, V29, P2052, DOI 10.1093/annonc/mdy264; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Chaimani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076654; Dafni U, 2019, LUNG CANCER, V134, P127, DOI 10.1016/j.lungcan.2019.05.029; Dias S, 2010, STAT MED, V29, P932, DOI 10.1002/sim.3767; Dias S, 2014, NICE DSU TECHNICAL S; Dutton SJ, 2014, LANCET ONCOL, V15, P894, DOI 10.1016/S1470-2045(14)70024-5; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ford HER, 2014, LANCET ONCOL, V15, P78, DOI 10.1016/S1470-2045(13)70549-7; Fuchs CS, 2020, J CLIN ONCOL, V38; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hodi FS, 2018, LANCET ONCOL, V19, P1480, DOI 10.1016/S1470-2045(18)30700-9; Howlader N., 2020, SEER CANC STAT REV 1; Huang J, 2020, LANCET ONCOL, V21, P832, DOI 10.1016/S1470-2045(20)30110-8; Huang J, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.4_suppl.95; Kang YK, 2017, LANCET, V390, P2461, DOI 10.1016/S0140-6736(17)31827-5; Kato K, 2019, LANCET ONCOL, V20, P1506, DOI 10.1016/S1470-2045(19)30626-6; Kim J, 2017, NATURE, V541, P169, DOI 10.1038/nature20805; Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007; Ohtsu A, 2013, J CLIN ONCOL, V31, P3935, DOI 10.1200/JCO.2012.48.3552; Salanti G, 2012, RES SYNTH METHODS, V3, P80, DOI 10.1002/jrsm.1037; Shah MA, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.2019.37.15_suppl.4010; Sharma P, 2019, J CLIN ONCOL, V37, DOI 10.1200/JCO.19.00538; Shitara K, 2020, NEW ENGL J MED, V382, P2419, DOI 10.1056/NEJMoa2004413; Shitara K, 2018, LANCET ONCOL, V19, P1437, DOI 10.1016/S1470-2045(18)30739-3; Shitara K, 2018, LANCET, V392, P123, DOI 10.1016/S0140-6736(18)31257-1; Thuss-Patience PC, 2017, LANCET ONCOL, V18, P640, DOI 10.1016/S1470-2045(17)30111-0; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; van Rossum PSN, 2018, NAT REV GASTRO HEPAT, V15, P235, DOI 10.1038/nrgastro.2017.162; van Valkenhoef G, 2016, RES SYNTH METHODS, V7, P80, DOI 10.1002/jrsm.1167; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6; Xu JM, 2020, J CLIN ONCOL, V38; Zhao Y, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5460	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252751	10.1371/journal.pone.0252751	http://dx.doi.org/10.1371/journal.pone.0252751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086780	gold, Green Published			2022-12-26	WOS:000664640100126
J	Naseri, D; Dormiani, K; Hajian, M; Jafarpour, F; Forouzanfar, M; Karimi, N; Nasr-Esfahani, MH				Naseri, Danial; Dormiani, Kianoush; Hajian, Mehdi; Jafarpour, Farnoosh; Forouzanfar, Mahboobeh; Karimi, Naeimeh; Nasr-Esfahani, Mohammad Hossein			Improving germline transmission efficiency in chimeric chickens using a multi-stage injection approach	PLOS ONE			English	Article							CHORIOALLANTOIC MEMBRANE MODEL; TRANSGENIC CHICKENS; EGG-WHITE; IN-VIVO; CULTURE-SYSTEM; EMBRYO; CELLS; EXPRESSION; GENE; GENERATION	Although different strategies have been developed to generate transgenic poultry, low efficiency of germline transgene transmission has remained a challenge in poultry transgenesis. Herein, we developed an efficient germline transgenesis method using a lentiviral vector system in chickens through multiple injections of transgenes into embryos at different stages of development. The embryo chorioallantoic membrane (CAM) vasculature was successfully used as a novel route of gene transfer into germline tissues. Compared to the other routes of viral vector administration, the embryo's bloodstream at Hamburger-Hamilton (HH) stages 14-15 achieved the highest rate of germline transmission (GT), 7.7%. Single injection of viral vectors into the CAM vasculature resulted in a GT efficiency of 2.7%, which was significantly higher than the 0.4% obtained by injection into embryos at the blastoderm stage. Double injection of viral vectors into the bloodstream at HH stages 14-15 and through CAM was the most efficient method for producing germline chimeras, giving a GT rate of 13.6%. The authors suggest that the new method described in this study could be efficiently used to produce transgenic poultry in virus-mediated gene transfer systems.	[Naseri, Danial; Hajian, Mehdi; Jafarpour, Farnoosh; Nasr-Esfahani, Mohammad Hossein] Royan Inst Biotechnol, Dept Reprod Biotechnol, Reprod Biomed Res Ctr, ACECR, Esfahan, Iran; [Dormiani, Kianoush; Forouzanfar, Mahboobeh; Karimi, Naeimeh; Nasr-Esfahani, Mohammad Hossein] Royan Inst Biotechnol, Dept Mol Biotechnol, Cell Sci Res Ctr, ACECR, Esfahan, Iran	Academic Center for Education, Culture & Research (ACECR); Academic Center for Education, Culture & Research (ACECR)	Nasr-Esfahani, MH (corresponding author), Royan Inst Biotechnol, Dept Reprod Biotechnol, Reprod Biomed Res Ctr, ACECR, Esfahan, Iran.; Nasr-Esfahani, MH (corresponding author), Royan Inst Biotechnol, Dept Mol Biotechnol, Cell Sci Res Ctr, ACECR, Esfahan, Iran.	mh.nasr-esfahani@royaninstitute.org		hajian, mehdi/0000-0002-2483-1111; Dormiani, Kianoush/0000-0002-6383-3099; Nasr-Esfahani, Mohammad-Hossein/0000-0003-1983-3435	Royan Institute of Biotechnology [96000275]	Royan Institute of Biotechnology	This work was supported by the Royan Institute of Biotechnology (https://www.royan.org/) (grant number 96000275). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andacht T, 2004, MOL REPROD DEV, V69, P31, DOI 10.1002/mrd.20155; Bahrami S, 2020, CELL J, V22, P133, DOI 10.22074/cellj.2020.6738; Bednarczyk M, 2018, J APPL GENET, V59, P81, DOI 10.1007/s13353-018-0429-6; Borwornpinyo S, 2005, POULTRY SCI, V84, P1477, DOI 10.1093/ps/84.9.1477; Byun SJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05270-8; Byun SJ, 2011, BIOSCI BIOTECH BIOCH, V75, P646, DOI 10.1271/bbb.100721; Cao DN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118626; Chang IK, 1997, CELL BIOL INT, V21, P495, DOI 10.1006/cbir.1997.0173; Chapman SC, 2005, DEVELOPMENT, V132, P935, DOI 10.1242/dev.01652; Cooper CA, 2017, TRANSGENIC RES, V26, P331, DOI 10.1007/s11248-016-0003-0; Deryugina EI, 2008, HISTOCHEM CELL BIOL, V130, P1119, DOI 10.1007/s00418-008-0536-2; Dimitrov L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154303; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Farzaneh M, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201600598; Grinberg I, 2009, LEUKEMIA RES, V33, P1417, DOI 10.1016/j.leukres.2009.02.009; HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404; Han JY, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0234-4; Han JY, 2002, THERIOGENOLOGY, V58, P1531, DOI 10.1016/S0093-691X(02)01061-0; Harvey AJ, 2002, POULTRY SCI, V81, P202, DOI 10.1093/ps/81.2.202; Hen G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036531; Herron LR, 2018, BMC BIOTECHNOL, V18, DOI 10.1186/s12896-018-0495-1; Hu JH, 2019, PRECIS CLIN MED, V2, P140, DOI 10.1093/pcmedi/pbz018; Ishak N, 2020, ENG REP, V2, DOI 10.1002/eng2.12092; Kamihira M, 2005, J VIROL, V79, P10864, DOI 10.1128/JVI.79.17.10864-10874.2005; Kamihira M, 1998, DEV GROWTH DIFFER, V40, P449; Kawabe Y, 2008, J BIOSCI BIOENG, V106, P598, DOI 10.1263/jbb.106.598; Klingenberg M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-339; Koo BC, 2006, FASEB J, V20, P2251, DOI 10.1096/fj.06-5866com; Koo BC, 2017, BIOTECHNOL BIOPROC E, V22, P22, DOI 10.1007/s12257-016-0590-x; Koo BC, 2010, TRANSGENIC RES, V19, P437, DOI 10.1007/s11248-009-9327-3; Kress C, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0056-6; Kwon MS, 2008, MOL REPROD DEV, V75, P1120, DOI 10.1002/mrd.20860; Kwon MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194721; Kwon MS, 2011, BIOCHEM BIOPH RES CO, V410, P890, DOI 10.1016/j.bbrc.2011.06.088; Kwon SC, 2010, BIOL REPROD, V82, P1057, DOI 10.1095/biolreprod.109.081687; Lee HJ, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112245; Lee J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113937; Lee YM, 2006, BIOL REPROD, V75, P380, DOI 10.1095/biolreprod.106.052084; Li BC, 2008, SCI CHINA SER C, V51, P734, DOI 10.1007/s11427-008-0100-2; Lillico SG, 2007, P NATL ACAD SCI USA, V104, P1771, DOI 10.1073/pnas.0610401104; Liu TX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127922; McGrew MJ, 2004, EMBO REP, V5, P728, DOI 10.1038/sj.embor.7400171; Mozdziak PE, 2003, DEV DYNAM, V226, P439, DOI 10.1002/dvdy.10234; NAITO M, 1990, J EXP ZOOL, V254, P322, DOI 10.1002/jez.1402540311; NAITO M, 1994, MOL REPROD DEV, V39, P153, DOI 10.1002/mrd.1080390206; Nakamura Y, 2007, POULTRY SCI, V86, P2182, DOI 10.1093/ps/86.10.2182; Nishida Y, 2008, CANCER RES, V68, P9096, DOI 10.1158/0008-5472.CAN-08-2522; Nowak-Sliwinska P, 2014, ANGIOGENESIS, V17, P779, DOI 10.1007/s10456-014-9440-7; Oishi I, 2016, SCI REP-UK, V6, DOI 10.1038/srep23980; Park TS, 2015, FASEB J, V29, P2386, DOI 10.1096/fj.14-264739; Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; Park TS, 2003, BIOL REPROD, V68, P1657, DOI 10.1095/biolreprod.102.006825; PERRY MM, 1988, NATURE, V331, P70, DOI 10.1038/331070a0; Rapp JC, 2003, TRANSGENIC RES, V12, P569, DOI 10.1023/A:1025854217349; Salmon Patrick, 2007, Curr Protoc Hum Genet, VChapter 12, DOI 10.1002/0471142905.hg1210s54; Tahara Y, 2014, J POULT SCI, V51, P307, DOI 10.2141/jpsa.0130043; Taylor L, 2017, DEVELOPMENT, V144, P928, DOI 10.1242/dev.145367; Tyack SG, 2013, TRANSGENIC RES, V22, P1257, DOI 10.1007/s11248-013-9727-2; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Vu BT., 2018, SCI REP-UK, V8, P1; Yu F, 2010, MOL REPROD DEV, V77, P340, DOI 10.1002/mrd.21147; Zhang ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050817; Zhao ZF, 2018, INT J CANCER, V142, P1440, DOI 10.1002/ijc.31160; Zhu L, 2005, NAT BIOTECHNOL, V23, P1159, DOI 10.1038/nbt1132	65	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0247471	10.1371/journal.pone.0247471	http://dx.doi.org/10.1371/journal.pone.0247471			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086696	Green Submitted, Green Published, gold			2022-12-26	WOS:000664640100009
J	Orabi, KY; Abaza, MS; Luqmani, YA; Al-Attiyah, R				Orabi, Khaled Y.; Abaza, Mohamed S.; Luqmani, Yunus A.; Al-Attiyah, Rajaa			Psiadin and plectranthone selectively inhibit colorectal carcinoma cells proliferation via modulating cyclins signaling and apoptotic pathways	PLOS ONE			English	Article							NF-KAPPA-B; DNA-BINDING ACTIVITY; NATURAL-PRODUCTS; MEDICINAL-PLANTS; ESSENTIAL OILS; LUNG-CANCER; EXPRESSION; INACTIVATION; INDUCTION; DITERPENE	Three scarce terpenes, psiadin, plectranthone and saudinolide, were obtained after chromatographic isolation and purification from the aerial parts of the respective plants. Their identities were established based on their spectral data. Their anticancer effects against two human colorectal carcinoma cell lines, CCL233 and CCL235, along with the potential molecular mechanisms of action, were explored. Psiadin and plectranthone exhibited marked growth inhibition on both cell lines in a time- and dose-dependent manner with minimal cytotoxicity against normal breast cells (HB2). The terpenes even showed superior activities to the tested standards. Flow cytometry showed apoptosis induction and alteration in the cell cycle in colorectal cancer cells treated with both compounds. Nevertheless, it was also found that both compounds inhibited NF-kappa B transcriptional activity, induced mitochondrial membrane potential depolarization and increased the percentage of reactive oxygen species in the treated cancer cells in a dose-dependent manner as well. Since the anticancer effect of psiadin on cancer cells was higher than that produced by plectranthone, only psiadin was tested to determine its possible targets. The results suggested a high degree of specificity of action affecting particular cellular processes in both cancer cells. In conclusion, both terpenes, in particular psiadin, showed significant discriminative therapeutic potential between cancer and normal cells, a value that is missing in current chemotherapies.	[Orabi, Khaled Y.; Luqmani, Yunus A.] Kuwait Univ, Fac Pharm, Dept Pharmaceut Chem, Safat, Kuwait; [Abaza, Mohamed S.] Kuwait Univ, Fac Sci, Dept Biol Sci, Safat, Kuwait; [Al-Attiyah, Rajaa] Kuwait Univ, Fac Med, Dept Microbiol & Immunol, Safat, Kuwait	Kuwait University; Kuwait University; Kuwait University	Orabi, KY (corresponding author), Kuwait Univ, Fac Pharm, Dept Pharmaceut Chem, Safat, Kuwait.	kyorabi@hsc.edu.kw		Orabi, Khaled/0000-0003-0262-4637	Kuwait University Research sector [PC01/12]; Research Unit for Genomics, Proteomics and Cellomics Studies [SRUL02/13];  [GS01/01];  [GS01/03]	Kuwait University Research sector; Research Unit for Genomics, Proteomics and Cellomics Studies; ; 	KY Orabi: this project was financially supported by Kuwait University Research sector (http://www.ovpr.ku.edu.kw/index.php/en/publicationsen/researchsectoren) through research grant number PC01/12. The spectral analyses were obtained at the Research Sector Project Unit (RSPU), Faculty of Science, Kuwait University, supported by grant numbers GS01/01 and GS01/03. Protein expression analysis was done at the Research Unit for Genomics, Proteomics and Cellomics Studies (grant number SRUL02/13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abaza MSI, 2014, INT J MOL MED, V34, P513, DOI 10.3892/ijmm.2014.1795; Adhami VM, 2004, MOL CANCER THER, V3, P933; Ali NAA., 2012, NAT PROD COMMUN, V7; American Cancer Society, 2020, GLOBAL CANC FACTS FI; Aumeeruddy-Elalfi Z, 2015, IND CROP PROD, V71, P197, DOI 10.1016/j.indcrop.2015.03.058; Bak Y, 2011, J AGR FOOD CHEM, V59, P10286, DOI 10.1021/jf2017594; Chen WS, 2011, FRONT BIOSCI-LANDMRK, V16, P1172, DOI 10.2741/3782; Chen YQ, 1998, NAT STRUCT BIOL, V5, P67, DOI 10.1038/nsb0198-67; Cragg GM, 2016, MED PRIN PRACT, V25, P41, DOI 10.1159/000443404; Curtin NJ, 2013, MOL ASPECTS MED, V34, P1217, DOI 10.1016/j.mam.2013.01.006; Dickson MA, 2009, CURR ONCOL, V16, P120; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; ELDOMIATY MM, 1993, PHYTOCHEMISTRY, V34, P467, DOI 10.1016/0031-9422(93)80032-N; Fortin H, 2002, FITOTERAPIA, V73, P346, DOI 10.1016/S0367-326X(02)00080-1; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; Govinden-Soulange J, 2004, BIOL PHARM BULL, V27, P1814, DOI 10.1248/bpb.27.1814; Haridas V, 2001, P NATL ACAD SCI USA, V98, P11557, DOI 10.1073/pnas.191363498; Huang M, 2012, EXPERT OPIN INV DRUG, V21, P1801, DOI 10.1517/13543784.2012.727395; Jia SS, 2013, ONCOL REP, V29, P349, DOI 10.3892/or.2012.2093; Jonville MC, 2011, J ETHNOPHARMACOL, V136, P525, DOI 10.1016/j.jep.2010.06.013; Jonville MC, 2008, J ETHNOPHARMACOL, V120, P382, DOI 10.1016/j.jep.2008.09.005; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kogel D, 2010, ANTI-CANCER AGENT ME, V10, P438, DOI 10.2174/1871520611009060438; KUMAR S, 1992, MOL CELL BIOL, V12, P3094, DOI 10.1128/MCB.12.7.3094; Lee JH, 2002, J BIOL CHEM, V277, P18411, DOI 10.1074/jbc.M201368200; Li P, 2017, ONCOTARGET, V8, P23996, DOI 10.18632/oncotarget.15098; Mahadeo K, 2018, J ETHNOPHARMACOL, V210, P48, DOI 10.1016/j.jep.2017.08.023; McConkey DJ, 2007, ADV EXP MED BIOL, V608, P31; Mignotte B, 1998, EUR J BIOCHEM, V252, P1, DOI 10.1046/j.1432-1327.1998.2520001.x; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MOSSA J S, 1988, International Journal of Crude Drug Research, V26, P81; Mossa J.S., 2000, MED PLANTS SAUDI ARA; Mossa JS, 1996, J NAT PROD, V59, P224, DOI 10.1021/np960119e; MOSSA JS, 1992, PHYTOCHEMISTRY, V31, P2863, DOI 10.1016/0031-9422(92)83648-I; Nakano T, 2020, ANTICANCER RES, V40, P1007, DOI 10.21873/anticanres.14035; Nalini N., 2013, INT J PHARM BIOL ARC, V4; Newman DJ, 2020, J NAT PROD, V83, P770, DOI 10.1021/acs.jnatprod.9b01285; Orabi KY, 2000, J NAT PROD, V63, P1665, DOI 10.1021/np000124p; Park HS, 2011, J FOOD SCI, V76, pT77, DOI 10.1111/j.1750-3841.2011.02099.x; Perciavalle RM, 2013, TRENDS CELL BIOL, V23, P22, DOI 10.1016/j.tcb.2012.08.011; Rahman KMW, 2007, MOL CANCER THER, V6, P2757, DOI 10.1158/1535-7163.MCT-07-0336; Recio MC, 1995, PHYTOTHER RES, V9, P571, DOI 10.1002/ptr.2650090807; Robin V., 1998, Pharmacy and Pharmacology Communications, V4, P61; Sun SY, 2004, JNCI-J NATL CANCER I, V96, P662, DOI 10.1093/jnci/djh123; Varga ZV, 2015, AM J PHYSIOL-HEART C, V309, pH1453, DOI 10.1152/ajpheart.00554.2015; Wen QY, 2019, DIAGN PATHOL, V14, DOI 10.1186/s13000-019-0884-3; Wu DM, 2019, IUBMB LIFE, V71, P81, DOI 10.1002/iub.1944; Yoon JH, 2002, J HEPATOL, V37, P400, DOI 10.1016/S0168-8278(02)00209-X; Zhong ZF, 2011, EUR J PHARMACOL, V667, P50, DOI 10.1016/j.ejphar.2011.03.041; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	52	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252820	10.1371/journal.pone.0252820	http://dx.doi.org/10.1371/journal.pone.0252820			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086816	Green Published, gold			2022-12-26	WOS:000664640100140
J	Ozen, M; Zhao, H; Kalish, F; Yang, Y; Jantzie, LL; Wong, RJ; Stevenson, DK				Ozen, Maide; Zhao, Hui; Kalish, Flora; Yang, Yang; Jantzie, Lauren L.; Wong, Ronald J.; Stevenson, David K.			Inflammation-induced alterations in maternal-fetal Heme Oxygenase (HO) are associated with sustained innate immune cell dysregulation in mouse offspring	PLOS ONE			English	Article							EXPRESSION; CYTOPROTECTION; DEFICIENCY; PROTECTION; PREGNANCY; PROMOTER; MODEL	Heme oxygenase-1 (HO-1) is an evolutionarily conserved stress response enzyme and important in pregnancy maintenance, fetal and neonatal outcomes, and a variety of pathologic conditions. Here, we investigated the effects of an exposure to systemic inflammation late in gestation [embryonic day (E)15.5] on wild-type (Wt) and HO-1 heterozygous (Het, HO-1(+/-)) mothers, fetuses, and offspring. We show that alterations in fetal liver and spleen HO homeostasis during inflammation late in gestation can lead to a sustained dysregulation of innate immune cell populations and intracellular myeloid HO-1 expression in the spleen through young adolescence [postnatal day 25] in mice.	[Ozen, Maide; Jantzie, Lauren L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Div Neonatal Perinatal Med, Baltimore, MD 21205 USA; [Ozen, Maide; Zhao, Hui; Kalish, Flora; Wong, Ronald J.; Stevenson, David K.] Stanford Univ, Dept Pediat, Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA; [Yang, Yang] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Johns Hopkins University; Stanford University; Stanford University	Ozen, M (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Div Neonatal Perinatal Med, Baltimore, MD 21205 USA.; Ozen, M (corresponding author), Stanford Univ, Dept Pediat, Sch Med, Div Neonatal & Dev Med, Stanford, CA 94305 USA.	mozen1@jhmi.edu			Mary L. Johnson Research Fund; Christopher Hess Research Fund; March of Dimes Prematurity Research Center at Stanford University; Ruth L Kirschstein National Research Service Award, Parent T32, NIH/NICHD [5T32 HD007249-30]	Mary L. Johnson Research Fund; Christopher Hess Research Fund; March of Dimes Prematurity Research Center at Stanford University; Ruth L Kirschstein National Research Service Award, Parent T32, NIH/NICHD	This research was funded by Mary L. Johnson Research Fund, Christopher Hess Research Fund, March of Dimes Prematurity Research Center at Stanford University (DKS). Dr. Maide Ozen was supported by Ruth L Kirschstein National Research Service Award, Parent T32, grant number NIH/NICHD; 5T32 HD007249-30 (DKS). The sponsors or funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2000, MOL MED, V6, P391, DOI 10.1007/BF03401783; Andrews M, 2016, J TRACE ELEM MED BIO, V37, P25, DOI 10.1016/j.jtemb.2016.06.001; Araujo JA, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00119; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Carpentier PA, 2011, AM J PATHOL, V178, P2802, DOI 10.1016/j.ajpath.2011.02.042; Chang LC, 2018, CANCER LETT, V416, P124, DOI 10.1016/j.canlet.2017.12.025; Chen SD, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/5416728; Cook MN, 1996, DEV BRAIN RES, V92, P18, DOI 10.1016/0165-3806(95)00194-8; Cunnington AJ, 2012, J IMMUNOL, V189, P5336, DOI 10.4049/jimmunol.1201028; Duvigneau JC, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100475; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fink NR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39620-5; Garcia-Flores V, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01291; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hedblom A, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1342-6; Hudalla H, 2018, PEDIATR RES, V84, P757, DOI 10.1038/s41390-018-0030-z; Kapturczak MH, 2004, AM J PATHOL, V165, P1045, DOI 10.1016/S0002-9440(10)63365-2; Kim KK, 2013, ENDOCRINOL METAB, V28, P214, DOI 10.3803/EnM.2013.28.3.214; Kourula S, 2017, NEONATOLOGY, V112, P376, DOI 10.1159/000479493; Kwon MY, 2015, ONCOTARGET, V6, P24393, DOI 10.18632/oncotarget.5162; Landreth KS, 2002, HUM EXP TOXICOL, V21, P493, DOI 10.1191/0960327102ht287oa; Lee JY, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12591; Leroy MJ, 2007, BIOL REPROD, V76, P769, DOI 10.1095/biolreprod.106.058057; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2298-2; Li XY, 2008, TOXICOL LETT, V176, P169, DOI 10.1016/j.toxlet.2007.10.010; Lin A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01781; Liverman CS, 2006, NEUROSCI LETT, V399, P220, DOI 10.1016/j.neulet.2006.01.064; McCarthy R, 2018, BIOL REPROD, V99, P922, DOI 10.1093/biolre/ioy109; Naito Y, 2014, ARCH BIOCHEM BIOPHYS, V564, P83, DOI 10.1016/j.abb.2014.09.005; Ozen M, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12829; Ozen M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00084; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10919, DOI 10.1073/pnas.94.20.10919; Schulz S, 2015, PEDIATR RES, V77, P640, DOI 10.1038/pr.2015.22; Schumacher A, 2015, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00288; Suttner DM, 1999, FASEB J, V13, P1800, DOI 10.1096/fasebj.13.13.1800; Taha H, 2010, ARTERIOSCL THROM VAS, V30, P1634, DOI 10.1161/ATVBAHA.110.207316; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tsuchihashi SI, 2006, J IMMUNOL, V177, P4749, DOI 10.4049/jimmunol.177.7.4749; Tsur A, 2019, PLACENTA, V75, P1, DOI 10.1016/j.placenta.2018.11.001; Vijayan V, 2018, BIOCHEM PHARMACOL, V153, P159, DOI 10.1016/j.bcp.2018.02.010; Walther M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002579; Wang H, 2011, J PINEAL RES, V50, P418, DOI 10.1111/j.1600-079X.2011.00860.x; Wong RJ, 2012, ACTA PAEDIATR, V101, P827, DOI 10.1111/j.1651-2227.2012.02729.x; Wu ML, 2011, ANTIOXID REDOX SIGN, V15, P1835, DOI 10.1089/ars.2010.3726; Zelenay S, 2007, INT IMMUNOL, V19, P11, DOI 10.1093/intimm/dxl116; Zenclussen ML, 2011, J PATHOL, V225, P293, DOI 10.1002/path.2946; Zhang C, 2007, PLACENTA, V28, P951, DOI 10.1016/j.placenta.2007.04.003; Zhang M, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120596; Zhao H, 2009, PLACENTA, V30, P861, DOI 10.1016/j.placenta.2009.07.012; Zhao H, 2017, J LEUKOCYTE BIOL, V101, P217, DOI 10.1189/jlb.1A0116-020RR; Zhao H, 2015, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00295; Zhao H, 2011, BIOL REPROD, V85, P1005, DOI 10.1095/biolreprod.111.093039; Zollner J, 2019, BIOL REPROD, V100, P505, DOI 10.1093/biolre/ioy193	53	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252642	10.1371/journal.pone.0252642	http://dx.doi.org/10.1371/journal.pone.0252642			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086785	Green Published, gold			2022-12-26	WOS:000664640100100
J	Fuente, R; Gehring, N; Bettoni, C; Gil-Pena, H; Alonso-Duran, L; Michalke, B; Santos, F; Wagner, CA; Rubio-Aliaga, I				Fuente, Rocio; Gehring, Nicole; Bettoni, Carla; Gil-Pena, Helena; Alonso-Duran, Laura; Michalke, Bernhard; Santos, Fernando; Wagner, Carsten A.; Rubio-Aliaga, Isabel			Systemic Jak1 activation causes extrarenal calcitriol production and skeletal alterations provoking stunted growth	FASEB JOURNAL			English	Article						bone mass density; calcitriol; growth plate; Jak; Stat signaling	VITAMIN-D METABOLISM; 1,25-DIHYDROXYVITAMIN D-3; MARKED ALTERATIONS; D-RECEPTOR; PLATE; EXPRESSION; DISEASE; 1-ALPHA-HYDROXYLASE; MUTATION; PATHWAY	Mineral homeostasis is regulated by a complex network involving endocrine actions by calcitriol, parathyroid hormone (PTH), and FGF23 on several organs including kidney, intestine, and bone. Alterations of mineral homeostasis are found in chronic kidney disease and other systemic disorders. The interplay between the immune system and the skeletal system is not fully understood, but cytokines play a major role in modulating calcitriol production and function. One of the main cellular signaling pathways mediating cytokine function is the Janus kinase (JAK)--signal transducer and activator of transcription (STAT) pathway. Here, we used a mouse model (Jak1(S645P+/-)) that resembles a constitutive activating mutation of the Jak1/Stat3 signaling pathway in humans, and shows altered mineral metabolism, with higher fibroblast growth factor 23 (FGF23) levels, lower PTH levels, and higher calcitriol levels. The higher calcitriol levels are probably due to extrarenal calcitriol production. Furthermore, systemic Jak1/Stat3 activation led to growth impairment and skeletal alterations. The growth plate in long bones showed decreased chondrocyte proliferation rates and reduced height of terminal chondrocytes. Furthermore, we demonstrate that Jak1 is also involved in bone remodeling early in life. Jak1(S645P+/-) animals have decreased bone and cortical volume, imbalanced bone remodeling, reduced MAP kinase signaling, and local inflammation. In conclusion, Jak1 plays a major role in bone health probably both, directly and systemically by regulating mineral homeostasis. Understanding the role of this signaling pathway will contribute to a better knowledge in bone growth and in mineral physiology, and to the development of selective Jak inhibitors as osteoprotective agents.	[Fuente, Rocio; Gehring, Nicole; Bettoni, Carla; Wagner, Carsten A.; Rubio-Aliaga, Isabel] Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Fuente, Rocio; Gehring, Nicole; Bettoni, Carla; Wagner, Carsten A.; Rubio-Aliaga, Isabel] Natl Ctr Competence Res NCCR Kidney, Zurich, Switzerland; [Fuente, Rocio; Gil-Pena, Helena; Alonso-Duran, Laura; Santos, Fernando] Univ Oviedo, Div Pediat, Oviedo, Spain; [Michalke, Bernhard] German Res Ctr Environm Hlth GmbH, Dept Environm Sci, Res Unit Analyt, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Santos, Fernando] Hosp Univ Cent Asturias, Dept Pediat, Oviedo, Spain	University of Zurich; University of Oviedo; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Central University Hospital Asturias	Wagner, CA; Rubio-Aliaga, I (corresponding author), Univ Zurich, Inst Physiol, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	Wagnerca@access.uzh.ch; isabel.rubioaliaga@uzh.ch		FUENTE, ROCIO/0000-0002-2311-2836; Rubio-Aliaga, Isabel/0000-0003-1051-9511; Wagner, Carsten/0000-0002-9874-8898	Swiss National Science Foundation (Schweizerische Nationalfonds) [176125]; Instituto Salud Carlos III [PI15/02122]; Marie Sklodowska--Curie Global Fellowship [853717]	Swiss National Science Foundation (Schweizerische Nationalfonds); Instituto Salud Carlos III(Instituto de Salud Carlos III); Marie Sklodowska--Curie Global Fellowship	The project was supported by a grant of the Swiss National Science Foundation (Schweizerische Nationalfonds) to Carsten A Wagner (176125) and a grant of the Instituto Salud Carlos III to Fernando Santos (PI15/02122). Rocio Fuente holds a UMarie Sklodowska--Curie Global Fellowship (Number Grant agreement No 853717)	Abreu MT, 2004, GUT, V53, P1129, DOI 10.1136/gut.2003.036657; Adam S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay4447; Alvarez-Garcia O, 2007, PEDIATR NEPHROL, V22, P954, DOI 10.1007/s00467-007-0456-8; Bikle D, 2020, NAT REV ENDOCRINOL, V16, P234, DOI 10.1038/s41574-019-0312-5; Bikle Daniel D, 2018, Bone Rep, V8, P255, DOI 10.1016/j.bonr.2018.02.004; Bikle DD, 2012, CURR OSTEOPOROS REP, V10, P151, DOI 10.1007/s11914-012-0098-z; Choudhary D, 2005, ARCH BIOCHEM BIOPHYS, V436, P50, DOI 10.1016/j.abb.2005.02.001; Christakos S, 2019, METABOLISM, V98, P112, DOI 10.1016/j.metabol.2019.06.010; Christakos S, 2016, PHYSIOL REV, V96, P365, DOI 10.1152/physrev.00014.2015; Cooper KL, 2013, NATURE, V495, P375, DOI 10.1038/nature11940; Daryadel A, 2021, FASEB J, V35, DOI 10.1096/fj.202002113R; Fernandez-Iglesias A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124519; Fiske CH, 1925, J BIOL CHEM, V66, P375; Fuente R, 2019, FASEB J, V33, P8349, DOI 10.1096/fj.201802007R; Fuente R, 2018, BONE, V116, P187, DOI 10.1016/j.bone.2018.08.004; Gadina M, 2019, RHEUMATOLOGY, V58, P4, DOI 10.1093/rheumatology/key432; Giustina A, 2020, JBMR PLUS, V4, DOI 10.1002/jbm4.10417; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Hernando N, 2021, J PHYSIOL-LONDON, V599, P1131, DOI 10.1113/JP280345; Hilfiker H, 1998, P NATL ACAD SCI USA, V95, P14564, DOI 10.1073/pnas.95.24.14564; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Hutchison MR, 2012, MOL ENDOCRINOL, V26, P1406, DOI 10.1210/me.2012-1063; Kagi L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195427; Levi M, 2019, NAT REV NEPHROL, V15, P482, DOI 10.1038/s41581-019-0159-y; Li Jiliang, 2013, JAKSTAT, V2, pe23930, DOI 10.4161/jkst.23930; Li Q, 2017, ONCOTARGET, V8, P34687, DOI 10.18632/oncotarget.16670; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Maruotti N, 2020, J CELL PHYSIOL, V235, P1915, DOI 10.1002/jcp.29149; Mbalaviele G, 2017, J CLIN INVEST, V127, P2030, DOI 10.1172/JCI93356; Meyer MB, 2019, J BIOL CHEM, V294, P14467, DOI 10.1074/jbc.RA119.010173; Meyer MB, 2017, J BIOL CHEM, V292, P17541, DOI 10.1074/jbc.M117.806901; Meyer MB, 2014, J BIOL CHEM, V289, P19539, DOI 10.1074/jbc.M114.578104; Molinos I, 2006, KIDNEY INT, V70, P1955, DOI 10.1038/sj.ki.5001949; Mornet E, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-40; Murakami K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181126; Naja RP, 2009, ENDOCRINOLOGY, V150, P4024, DOI 10.1210/en.2008-1410; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; O'Shea JJ, 2015, ANNU REV MED, V66, P311, DOI 10.1146/annurev-med-051113-024537; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Panda DK, 2004, J BIOL CHEM, V279, P16754, DOI 10.1074/jbc.M310271200; Parganas E, 1998, CELL, V93, P385, DOI 10.1016/S0092-8674(00)81167-8; Pastor-Arroyo EM, 2020, ACTA PHYSIOL, V230, DOI 10.1111/apha.13526; Pastor-Arroyo EM, 2018, KIDNEY INT, V94, P49, DOI 10.1016/j.kint.2018.02.017; Plum LA, 2010, NAT REV DRUG DISCOV, V9, P941, DOI 10.1038/nrd3318; Ranch D, 2011, J BONE MINER RES, V26, P1883, DOI 10.1002/jbmr.401; Rodig SJ, 1998, CELL, V93, P373, DOI 10.1016/S0092-8674(00)81166-6; Rutherford C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf8566; Sabrautzki S, 2013, AM J PATHOL, V183, P352, DOI 10.1016/j.ajpath.2013.04.027; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shimada T, 2004, J BONE MINER RES, V19, P429, DOI 10.1359/JBMR.0301264; Sims NA, 2020, EXP MOL MED, V52, P1185, DOI 10.1038/s12276-020-0445-6; Stocker A, 2005, J TRACE ELEM MED BIO, V19, P183, DOI 10.1016/j.jtemb.2005.08.004; Umbach AT, 2015, KIDNEY INT, V87, P728, DOI 10.1038/ki.2014.371; Vervloet M, 2019, NAT REV NEPHROL, V15, P109, DOI 10.1038/s41581-018-0087-2; VIETH R, 1979, J BIOL CHEM, V254, P2455; Wakahashi K, 2020, J BONE MINER METAB, V38, P145, DOI 10.1007/s00774-019-01075-z; Zhu JG, 2013, P NATL ACAD SCI USA, V110, P15650, DOI 10.1073/pnas.1315006110	57	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21721	10.1096/fj.202100587R	http://dx.doi.org/10.1096/fj.202100587R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118090				2022-12-26	WOS:000667814100049
J	Griesel, BA; Matsuzaki, S; Batushansky, A; Griffin, TM; Humphries, KM; Olson, AL				Griesel, Beth A.; Matsuzaki, Satoshi; Batushansky, Albert; Griffin, Timothy M.; Humphries, Kenneth M.; Olson, Ann Louise			PFKFB3-dependent glucose metabolism regulates 3T3-L1 adipocyte development	FASEB JOURNAL			English	Article						adipogenesis; adiponectin; glucose metabolism; glucose transport; glucose transporter 4 (GLUT4); phosphofructokinase fructose bisphosphatase 3 (PFKFB3)	INDUCED INSULIN-RESISTANCE; INDUCIBLE 6-PHOSPHOFRUCTO-2-KINASE; DIFFERENTIATION; EXPRESSION; PATHWAY; PREF-1; PFKFB3; GROWTH	Proliferation and differentiation of preadipocytes, and other cell types, is accompanied by an increase in glucose uptake. Previous work showed that a pulse of high glucose was required during the first 3 days of differentiation in vitro, but was not required after that. The specific glucose metabolism pathways required for adipocyte differentiation are unknown. Herein, we used 3T3-L1 adipocytes as a model system to study glucose metabolism and expansion of the adipocyte metabolome during the first 3 days of differentiation. Our primary outcome measures were GLUT4 and adiponectin, key proteins associated with healthy adipocytes. Using complete media with 0 or 5 mM glucose, we distinguished between developmental features that were dependent on the differentiation cocktail of dexamethasone, insulin, and isobutylmethylxanthine alone or the cocktail plus glucose. Cocktail alone was sufficient to activate the capacity for 2-deoxglucose uptake and glycolysis, but was unable to support the expression of GLUT4 and adiponectin in mature adipocytes. In contrast, 5 mM glucose in the media promoted a transient increase in glucose uptake and glycolysis as well as a significant expansion of the adipocyte metabolome and proteome. Using genetic and pharmacologic approaches, we found that the positive effects of 5 mM glucose on adipocyte differentiation were specifically due to increased expression of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3), a key regulator of glycolysis and the ancillary glucose metabolic pathways. Our data reveal a critical role for PFKFB3 activity in regulating the cellular metabolic remodeling required for adipocyte differentiation and maturation.	[Griesel, Beth A.; Griffin, Timothy M.; Humphries, Kenneth M.; Olson, Ann Louise] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 940 Stanton L Young BLVD,Rm 964 BMSB, Oklahoma City, OK 73104 USA; [Matsuzaki, Satoshi; Batushansky, Albert; Griffin, Timothy M.; Humphries, Kenneth M.] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; Oklahoma Medical Research Foundation	Olson, AL (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, 940 Stanton L Young BLVD,Rm 964 BMSB, Oklahoma City, OK 73104 USA.	ann-olson@ouhsc.edu		Olson, Ann Louise/0000-0001-9401-2317	Oklahoma Center for Adult Stem Cell Research; Oklahoma Center for the Advancement of Science and Technology (OCAST) [HR17-018]	Oklahoma Center for Adult Stem Cell Research; Oklahoma Center for the Advancement of Science and Technology (OCAST)	Oklahoma Center for Adult Stem Cell Research; Oklahoma Center for the Advancement of Science and Technology (OCAST), Grant/Award Number: HR17-018	Atsumi T, 2005, DIABETES, V54, P3349, DOI 10.2337/diabetes.54.12.3349; Batushansky A, 2019, OSTEOARTHR CARTILAGE, V27, P1361, DOI 10.1016/j.joca.2019.05.010; Beckermann KE, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138729; Bockus LB, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.007159; Burmistrova O, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48196-z; Church CD, 2014, METHOD ENZYMOL, V537, P31, DOI 10.1016/B978-0-12-411619-1.00003-3; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Green CR, 2016, NAT CHEM BIOL, V12, P15, DOI [10.1038/nchembio.1961, 10.1038/NCHEMBIO.1961]; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; Hensley CT, 2013, J CLIN INVEST, V123, P3678, DOI 10.1172/JCI69600; Holtrup B, 2017, ADIPOCYTE, V6, P224, DOI 10.1080/21623945.2017.1349042; Hudak CS, 2014, CELL REP, V8, P678, DOI 10.1016/j.celrep.2014.06.060; Huo YQ, 2012, J BIOL CHEM, V287, P21492, DOI 10.1074/jbc.M112.370379; Huo YQ, 2010, J BIOL CHEM, V285, P3713, DOI 10.1074/jbc.M109.058446; Jackson RM, 2017, J BIOL CHEM, V292, P18556, DOI 10.1074/jbc.M117.791970; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Krycer JR, 2020, J BIOL CHEM, V295, P13250, DOI 10.1074/jbc.RA120.014907; Liu L, 2016, NAT CHEM BIOL, V12, P345, DOI [10.1038/NCHEMBIO.2047, 10.1038/nchembio.2047]; Nye CK, 2008, J BIOL CHEM, V283, P27565, DOI 10.1074/jbc.M804393200; O'Neal J, 2016, BREAST CANCER RES TR, V160, P29, DOI 10.1007/s10549-016-3968-8; OLSON AL, 1990, PEDIATR RES, V28, P183, DOI 10.1203/00006450-199009000-00001; Rosen ED, 2000, GENE DEV, V14, P1293; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Rosen ED, 2014, CELL, V156, P20, DOI 10.1016/j.cell.2013.12.012; Rotondo F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09450-4; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Sakakibara R, 1997, J BIOCHEM-TOKYO, V122, P122; Shi LL, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.44; Simon-Molas H, 2018, MOL CELL BIOCHEM, V448, P187, DOI 10.1007/s11010-018-3325-9; SMAS CM, 1993, CELL, V73, P725, DOI 10.1016/0092-8674(93)90252-L; Smas CM., 1998, J BIOL CHEM, V48, P31751; Tanner LB, 2018, CELL SYST, V7, P49, DOI 10.1016/j.cels.2018.06.003; Trefely S, 2015, J BIOL CHEM, V290, P25834, DOI 10.1074/jbc.M115.658815; Wellen KE, 2012, NAT REV MOL CELL BIO, V13, P270, DOI 10.1038/nrm3305; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Ye JM, 2004, DIABETOLOGIA, V47, P1306, DOI 10.1007/s00125-004-1436-1; Ye RS, 2013, MOL METAB, V2, P133, DOI 10.1016/j.molmet.2013.04.001; Yi M, 2019, MOL METAB, V20, P1, DOI 10.1016/j.molmet.2018.11.013	39	1	1	2	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21728	10.1096/fj.202100381RR	http://dx.doi.org/10.1096/fj.202100381RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110658	Green Accepted			2022-12-26	WOS:000667814100064
J	Nielsen, NS; Gadeberg, TAF; Poulsen, ET; Harwood, SL; Weberskov, CE; Pedersen, JS; Andersen, GR; Enghild, JJ				Nielsen, Nadia Sukusu; Gadeberg, Trine A. F.; Poulsen, Ebbe Toftgaard; Harwood, Seandean Lykke; Weberskov, Christian E.; Pedersen, Jan Skov; Andersen, Gregers R.; Enghild, Jan J.			Mutation-induced dimerization of transforming growth factor-beta-induced protein may drive protein aggregation in granular corneal dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATTICE; TGFBIP; IDENTIFICATION; ACCUMULATION; PURIFICATION; PATHOGENESIS; PREVALENCE; SURGERY; MODEL; HTRA1	Protein aggregation in the outermost layers of the cornea, which can lead to cloudy vision and in severe cases blindness, is linked to mutations in the extracellular matrix protein transforming growth factor-beta-induced protein (TGFBIp). Among the most frequent pathogenic mutations are R124H and R555W, both associated with granular corneal dystrophy (GCD) characterized by the early-onset formation of amorphous aggregates. The molecular mechanisms of protein aggregation in GCD are largely unknown. In this study, we determined the crystal structures of R124H, R555W, and the lattice corneal dystrophy-associated A546T. Although there were no changes in the monomeric TGFBIp structure of any mutant that would explain their propensity to aggregate, R124H and R555W demonstrated a new dimer interface in the crystal packing, which is not present in wildtype TGFBIp or A546T. This interface, as seen in both the R124H and R555W structures, involves residue 124 of the first TGFBIp molecule and 555 in the second. The interface is not permitted by the Arg124 and Arg555 residues of wildtype TGFBIp and may play a central role in the aggregation exhibited by R124H and R555W in vivo. Using cross-linking mass spectrometry and inline size exclusion chromatography-small-angle X-ray scattering, we characterized a dimer formed by wildtype and mutant TGFBIps in solution. Dimerization in solution also involves interactions between the N- and C-terminal domains of two TGFBIp molecules but was not identical to the crystal packing dimerization. TGFBIp-targeted interventions that disrupt the R124H/R555W crystal packing dimer interface might offer new therapeutic opportunities to treat patients with GCD.	[Nielsen, Nadia Sukusu; Gadeberg, Trine A. F.; Poulsen, Ebbe Toftgaard; Harwood, Seandean Lykke; Weberskov, Christian E.; Andersen, Gregers R.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Sci Pk, Aarhus, Denmark; [Pedersen, Jan Skov] Aarhus Univ, Dept Chem, Aarhus, Denmark; [Pedersen, Jan Skov] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Sci Pk, Aarhus, Denmark.	jje@mbg.au.dk	Pedersen, Jan Skov/A-8346-2008	Pedersen, Jan Skov/0000-0002-7768-0206; Andersen, Gregers Rom/0000-0001-6292-3319; Toftgaard Poulsen, Ebbe/0000-0002-4416-0431; Harwood, Seandean Lykke/0000-0003-4654-8832; Enghild, Jan Johannes/0000-0001-9292-9172	Lundbeck Foundation (BRAINSTRUC) [R155-2015-2666]; Danish Agency for Science, Technology, and Innovation (DanScatt)	Lundbeck Foundation (BRAINSTRUC); Danish Agency for Science, Technology, and Innovation (DanScatt)	T. A. F. G. and G. R. A. were supported by the Lundbeck Foundation (BRAINSTRUC, grant no. R155-2015-2666) and the Danish Agency for Science, Technology, and Innovation (DanScatt).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen RB, 2004, BIOCHEMISTRY-US, V43, P16374, DOI 10.1021/bi048589s; Basaiawmoit RV, 2011, J MOL BIOL, V408, P503, DOI 10.1016/j.jmb.2011.02.052; Brennich ME, 2016, J APPL CRYSTALLOGR, V49, P203, DOI 10.1107/S1600576715024462; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Combe CW, 2015, MOL CELL PROTEOMICS, V14, P1137, DOI 10.1074/mcp.O114.042259; Courtney DG, 2015, INVEST OPHTH VIS SCI, V56, P4653, DOI 10.1167/iovs.15-16922; Courtney DG, 2014, INVEST OPHTH VIS SCI, V55, P977, DOI 10.1167/iovs.13-13279; Dyrlund TF, 2012, J PROTEOME RES, V11, P4231, DOI 10.1021/pr300358k; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Castellanos R, 2017, STRUCTURE, V25, P1740, DOI 10.1016/j.str.2017.09.001; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Han KE, 2016, PROG RETIN EYE RES, V50, P67, DOI 10.1016/j.preteyeres.2015.11.002; Harwood SL, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1016/j.mcpro.2021.100090; Hedegaard CJ, 2003, MOL VIS, V9, P355; IWAMOTO T, 1975, A GRAEF ARCH KLIN EX, V194, P1, DOI 10.1007/BF00408270; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334; Kao AH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002212; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Karring H, 2013, MOL VIS, V19, P861; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Klykov O, 2018, NAT PROTOC, V13, P2964, DOI 10.1038/s41596-018-0074-x; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lakshminarayanan R, 2014, OCUL SURF, V12, P234, DOI 10.1016/j.jtos.2013.12.002; Lee JH, 2010, OPHTHAL EPIDEMIOL, V17, P160, DOI 10.3109/09286581003624939; Lukassen MV, 2020, PROTEOM CLIN APPL, V14, DOI 10.1002/prca.201900072; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nielsen NS, 2020, PROG RETIN EYE RES, V77, DOI 10.1016/j.preteyeres.2020.100843; Nielsen NS, 2017, BIOCHEMISTRY-US, V56, P6470, DOI 10.1021/acs.biochem.7b00668; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Poulsen ET, 2019, J BIOL CHEM, V294, P11817, DOI 10.1074/jbc.RA119.009050; Poulsen ET, 2018, FEBS J, V285, P101, DOI 10.1111/febs.14321; Poulsen ET, 2016, PROTEOMICS, V16, P539, DOI 10.1002/pmic.201500287; Poulsen ET, 2014, PROTEOM CLIN APPL, V8, P168, DOI 10.1002/prca.201300058; Runager K, 2013, BIOCHEMISTRY-US, V52, P2821, DOI 10.1021/bi400212m; Runager K, 2011, J BIOL CHEM, V286, P4951, DOI 10.1074/jbc.M110.181099; Runager K, 2009, ACTA CRYSTALLOGR F, V65, P299, DOI 10.1107/S1744309109005016; Song YZ, 2017, J CATARACT REFR SURG, V43, P1489, DOI 10.1016/j.jcrs.2017.07.038; Steiner EM, 2018, PROTEINS, V86, P912, DOI 10.1002/prot.25523; Stenvang M, 2018, J MOL BIOL, V430, P1116, DOI 10.1016/j.jmb.2018.03.001; Taketani Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16308-2; Venkatraman A, 2017, J PROTEOME RES, V16, P2899, DOI 10.1021/acs.jproteome.7b00188	47	2	2	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100858	10.1016/j.jbc.2021.100858	http://dx.doi.org/10.1016/j.jbc.2021.100858			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097874	Green Published, gold			2022-12-26	WOS:000678068400058
J	Pan, PY; Zhu, JT; Rizvi, A; Zhu, XY; Tanaka, H; Dreyfus, CF				Pan, Ping-Yue; Zhu, Justin; Rizvi, Asma; Zhu, Xinyu; Tanaka, Hikari; Dreyfus, Cheryl F.			Synaptojanin1 deficiency upregulates basal autophagosome formation in astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; SAC1 DOMAIN; SYNJ1 GENE; MUTATION; METABOLISM; TRANSPORT; NEURON; MTOR; NEURODEGENERATION; COMPARTMENT	Macroautophagy dysregulation is implicated in multiple neurological disorders, such as Parkinson's disease. While autophagy pathways are heavily researched in heterologous cells and neurons, regulation of autophagy in the astrocyte, the most abundant cell type in the mammalian brain, is less well understood. Missense mutations in the Synj1 gene encoding Synaptojanin1 (Synj1), a neuron-enriched lipid phosphatase, have been linked to Parkinsonism with seizures. Our previous study showed that the Synj1 haploinsufficient (Synj1(+/-)) mouse exhibits age-dependent autophagy impairment in multiple brain regions. Here, we used cultured astrocytes from Synj1-deficient mice to investigate its role in astrocyte autophagy. We report that Synj1 is expressed in low levels in astrocytes and represses basal autophagosome formation. We demonstrate using cellular imaging that Synj1-deficient astrocytes exhibit hyperactive autophagosome formation, represented by an increase in the size and number of GFP-microtubule-associated protein 1A/1B-light chain 3 structures. Interestingly, Synj1 deficiency is also associated with an impairment in stress-induced autophagy clearance. We show, for the first time, that the Parkinsonism-associated R839C mutation impacts autophagy in astrocytes. The impact of this mutation on the phosphatase function of Synj1 resulted in elevated basal autophagosome formation that mimics Synj1 deletion. We found that the membrane expression of the astrocyte-specific glucose transporter GluT-1 was reduced in Synj1-deficient astrocytes. Consistently, AMP-activated protein kinase activity was elevated, suggesting altered glucose sensing in Synj1-deficient astrocytes. Expressing exogenous GluT-1 in Synj1-deficient astrocytes reversed the autophagy impairment, supporting a role for Synj1 in regulating astrocyte autophagy via disrupting glucose-sensing pathways. Thus, our work suggests a novel mechanism for Synj1-related Parkinsonism involving astrocyte dysfunction.	[Pan, Ping-Yue; Zhu, Justin; Rizvi, Asma; Zhu, Xinyu; Tanaka, Hikari; Dreyfus, Cheryl F.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Pan, PY (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	pingyue.pan@rutgers.edu		Pan, Pingyue/0000-0002-2805-6810	National Institute of Neurological Disorders and Stroke [R01NS112390]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by the National Institute of Neurological Disorders and Stroke R01 grant (R01NS112390) to P.-Y. P. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cao MA, 2020, P NATL ACAD SCI USA, V117, P12428, DOI 10.1073/pnas.2004335117; Cao M, 2017, NEURON, V93, P882, DOI 10.1016/j.neuron.2017.01.019; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Cossec JC, 2012, HUM MOL GENET, V21, P3156, DOI 10.1093/hmg/dds142; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Di Malta C, 2012, P NATL ACAD SCI USA, V109, pE2334, DOI 10.1073/pnas.1209577109; Dong YM, 2015, ELIFE, V4, DOI 10.7554/eLife.05660; Fasano D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0410-7; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; Haffner C, 2000, CURR BIOL, V10, P471, DOI 10.1016/S0960-9822(00)00446-2; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Herrera F, 2009, CELL DEATH DIFFER, V16, P910, DOI 10.1038/cdd.2009.24; Hildebrand MS, 2014, EPILEPSIA, V55, pE18, DOI 10.1111/epi.12519; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kirola L, 2016, PARKINSONISM RELAT D, V31, P124, DOI 10.1016/j.parkreldis.2016.07.014; Kostuk EW, 2019, GLIA, V67, P1542, DOI 10.1002/glia.23627; Krebs CE, 2013, HUM MUTAT, V34, P1200, DOI 10.1002/humu.22372; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Lieberman OJ, 2020, ELIFE, V9, DOI 10.7554/eLife.50843; Lieberman OJ, 2020, J MOL BIOL, V432, P2589, DOI [10.1016/j.jmb.2019.12, 10.1016/j.jmb.2019.12.028]; Lieberman OJ, 2019, NEUROBIOL DIS, V122, P49, DOI 10.1016/j.nbd.2018.04.017; Lindstrom V, 2017, MOL CELL NEUROSCI, V82, P143, DOI 10.1016/j.mcn.2017.04.009; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; McIntire LBJ, 2012, J NEUROSCI, V32, P15271, DOI 10.1523/JNEUROSCI.2034-12.2012; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Moruno-Manchon JF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0599-5; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; OMALLEY EK, 1992, BRAIN RES, V582, P65, DOI 10.1016/0006-8993(92)90317-3; Pan PY, 2020, HUM MOL GENET, V29, P2300, DOI 10.1093/hmg/ddaa080; Pan PY, 2017, J NEUROSCI, V37, P11366, DOI 10.1523/JNEUROSCI.0964-17.2017; Pan PY, 2012, NAT NEUROSCI, V15, P813, DOI 10.1038/nn.3099; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Quadri M, 2013, HUM MUTAT, V34, P1208, DOI 10.1002/humu.22373; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Shinde SR, 2017, CELL REP, V21, P1655, DOI 10.1016/j.celrep.2017.10.053; Smith ED, 2014, J BIOL CHEM, V289, P20615, DOI 10.1074/jbc.M114.568659; Sung K, 2020, J MOL BIOL, V432, P2605, DOI 10.1016/j.jmb.2019.12.041; Taghavi S, 2018, MOL NEUROBIOL, V55, P3477, DOI 10.1007/s12035-017-0535-1; Tremblay ME, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0314-8; Vanhauwaert R, 2017, EMBO J, V36, P1392, DOI 10.15252/embj.201695773; Vijayan V, 2017, J CELL BIOL, V216, P1895, DOI 10.1083/jcb.201611113; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; Wang Q, 2013, JNCI-J NATL CANCER I, V105, P1463, DOI 10.1093/jnci/djt241; Zhu L, 2013, J BIOL CHEM, V288, P32050, DOI 10.1074/jbc.M113.504365	51	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100873	10.1016/j.jbc.2021.100873	http://dx.doi.org/10.1016/j.jbc.2021.100873			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34126070	Green Published, gold			2022-12-26	WOS:000678068400073
J	Zhang, Y; Du, XM; Chen, XM; Tang, HY; Zhou, Q; He, JL; Ding, YB; Wang, YX; Liu, XQ; Geng, YQ				Zhang, Yue; Du, Xinman; Chen, Xuemei; Tang, Hongyu; Zhou, Qin; He, Junlin; Ding, Yubin; Wang, Yingxiong; Liu, Xueqing; Geng, Yanqing			Rictor/mTORC2 is involved in endometrial receptivity by regulating epithelial remodeling	FASEB JOURNAL			English	Article						endometrial receptivity; epithelium remodeling; infertility; Na+ channel function; Rictor	ION CHANNELS; EMBRYO IMPLANTATION; UTERINE RECEPTIVITY; MTOR; RICTOR; RAC1; MICE; ENAC; PROGESTERONE; MECHANISMS	Successful embryo implantation requires well-functioning endometrial luminal epithelial cells to establish uterine receptivity. Inadequate uterine receptivity is responsible for approximately two thirds of implantation failures in humans. However, the regulatory mechanism governing this functional process remains largely unexplored. A previous study revealed that the expression of Rictor, the main member of mTORC2, in mouse epithelial cells is increased on the fourth day of gestation (D4). Here, we provide the first report of the involvement of Rictor in the regulation of endometrial receptivity. Rictor was conditionally ablated in the mouse endometrium using a progesterone receptor cre (PRcre) mouse model. Loss of Rictor altered polarity remodeling and the Na+ channel protein of endometrial cells by mediating Rac-1/PAK1(pPAK1)/ERM(pERM) and Sgk1/pSgk1 signaling, respectively, ultimately resulting in impaired fertility. In the endometrium of women with infertility, the expression of Rictor was changed, along with the morphological transformation and Na+ channel protein of epithelial cells. Our findings demonstrate that Rictor is crucial for the establishment of uterine receptivity in both mice and humans. The present study may help improve the molecular regulatory network of endometrial receptivity and provide new diagnostic and treatment strategies for infertility.	[Zhang, Yue; Du, Xinman; Chen, Xuemei; Tang, Hongyu; He, Junlin; Ding, Yubin; Wang, Yingxiong; Liu, Xueqing; Geng, Yanqing] Chongqing Med Univ, Sch Publ Hlth & Management, Joint Int Res Lab Reprod & Dev, Chongqing 400016, Peoples R China; [Zhou, Qin] Chongqing Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Chongqing, Peoples R China; [Wang, Yingxiong; Geng, Yanqing] Chongqing Med Univ, Coll Basic Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Liu, XQ; Geng, YQ (corresponding author), Chongqing Med Univ, Sch Publ Hlth & Management, Joint Int Res Lab Reprod & Dev, Chongqing 400016, Peoples R China.	100097@cqmu.edu.cn; 102813@cqmu.edu.cn	ZHOU, QIN/GWC-1900-2022	ZHOU, QIN/0000-0001-6306-6419; Geng, Yanqing/0000-0002-5744-8872	National Natural Science Foundation of China (NSFC) [31801247]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31801247	Achache H, 2006, HUM REPROD UPDATE, V12, P731, DOI 10.1093/humupd/dml004; Ahmed SM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14867; Armstrong CM, 1998, NEURON, V20, P371, DOI 10.1016/S0896-6273(00)80981-2; Cha J, 2014, CELL REP, V8, P381, DOI 10.1016/j.celrep.2014.06.027; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chan HC, 2013, ADV EXP MED BIOL, V763, P193; Chauhan BK, 2011, P NATL ACAD SCI USA, V108, P18289, DOI 10.1073/pnas.1108993108; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; Ekizceli G, 2017, BIOTECH HISTOCHEM, V92, P450, DOI 10.1080/10520295.2017.1350749; Enuka Y, 2012, HISTOCHEM CELL BIOL, V137, P339, DOI 10.1007/s00418-011-0904-1; Grewal S, 2008, P NATL ACAD SCI USA, V105, P16189, DOI 10.1073/pnas.0806219105; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harris Thurl E, 2003, Sci STKE, V2003, pre15; He J, 2015, EXP CELL RES, V331, P164, DOI 10.1016/j.yexcr.2014.09.024; HILLE B, 1988, HARVEY LECT, V82, P47; Huang L, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001750; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Joly MM, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-017-0868-8; Kalam SN, 2018, CELL TISSUE RES, V374, P667, DOI 10.1007/s00441-018-2887-x; Kellenberger S, 2002, PHYSIOL REV, V82, P735, DOI 10.1152/physrev.00007.2002; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Lam EWF, 2012, J ENDOCRINOL, V212, P13, DOI 10.1530/JOE-10-0480; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Li QX, 2011, SCIENCE, V331, P912, DOI 10.1126/science.1197454; Maddala R, 2011, DEV BIOL, V360, P30, DOI 10.1016/j.ydbio.2011.09.004; Messinis IE, 2016, EUR J OBSTET GYN R B, V207, P200, DOI 10.1016/j.ejogrb.2016.10.004; Mok KW, 2013, FASEB J, V27, P1137, DOI 10.1096/fj.12-212977; Murphy CR, 2004, CELL RES, V14, P259, DOI 10.1038/sj.cr.7290227; Murphy CR, 2000, HUM REPROD, V15, P2451, DOI 10.1093/humrep/15.12.2451; Naftalin RJ, 2002, REPRODUCTION, V123, P633, DOI 10.1530/rep.0.1230633; NILSSON O, 1974, J REPROD FERTIL, V39, P187, DOI 10.1530/jrf.0.0390187; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Pawar S, 2013, MOL ENDOCRINOL, V27, P1996, DOI 10.1210/me.2013-1206; Ruan YC, 2014, HUM REPROD UPDATE, V20, P517, DOI 10.1093/humupd/dmu006; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Salker MS, 2016, CELL PHYSIOL BIOCHEM, V39, P1295, DOI 10.1159/000447834; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schmidt KM, 2017, ONCOTARGET, V8, P24491, DOI 10.18632/oncotarget.15524; Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013; Shukla V, 2019, REPRODUCTION, V158, P47, DOI 10.1530/REP-18-0611; Stappenbeck TS, 2000, DEVELOPMENT, V127, P2629; Tu Z, 2016, CELL DEATH DIFFER, V23, P169, DOI 10.1038/cdd.2015.98; Vasquez YM, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007787; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; [文乙先 Wen Yixian], 2019, [重庆医科大学学报, Jounral of Chongqing Medical University], V44, P722; Xin QL, 2018, J CLIN INVEST, V128, P175, DOI 10.1172/JCI92862; Xu H, 2016, REPROD BIOMED ONLINE, V32, P207, DOI 10.1016/j.rbmo.2015.11.007; Yang JZ, 2004, CELL BIOL INT, V28, P433, DOI 10.1016/j.cellbi.2004.03.011; Ye XQ, 2020, TRENDS ENDOCRIN MET, V31, P165, DOI 10.1016/j.tem.2019.11.008; Zhang Y, 2018, J HAZARD MATER, V358, P101, DOI 10.1016/j.jhazmat.2018.06.042; Zhang Y, 2015, CELL RES, V25, P139, DOI 10.1038/cr.2014.139	52	3	3	5	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21731	10.1096/fj.202100529RR	http://dx.doi.org/10.1096/fj.202100529RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34131963				2022-12-26	WOS:000667814100075
J	Haque, A; Islam, S; Bari, A; Hossain, A; Athanassiou, CG; Hasan, M				Haque, Aslam; Islam, Saiful; Bari, Abdul; Hossain, Akhtar; Athanassiou, Christos G.; Hasan, Mahbub			Cold storage-mediated rearing of Trichogramma evanescens Westwood on eggs of Plodia interpunctella (Hubner) and Galleria mellonella L.	PLOS ONE			English	Article							EPHESTIA-KUEHNIELLA LEPIDOPTERA; LOW-TEMPERATURE STORAGE; HYMENOPTERA-BRACONIDAE; MEYRICK LEPIDOPTERA; MOTH LEPIDOPTERA; HOST SUITABILITY; PARASITOID WASP; QUALITY; REPRODUCTION; ATTRIBUTES	The egg parasitoid Trichogramma evanescens Westwood is considered as an efficient biological control agent for managing several lepidopteran pests and it is widely distributed throughout the world. Mass rearing protocols of parasitoids that are currently in use in biocontrol programs require a meticulous quality control plan, in order to optimize their efficacy, but also their progeny production capacity. In this paper, the effect of different factors on the quality control in mass rearing of T. evenescens, using Plodia interpunctella (Hubner) and Galleria mellonella L. as host species, were investigated. The impact of egg agewas significant in the rates of parasitism, for both host species tested. Significantly highest percent of parasitoid emergence was noticed in two day-old eggs for both host species, while one day-old eggs day exhibited the maximum emergence when both species were used togetherin the same trials. Age-dependent storage egg preservation at either 4 or 9 degrees C significantly influenced the parasitism percentages on both species. The highest parasitism percentage was recorded in two day-old G. mellonella eggs that are kept for 15 days at 9 degrees C while the lower in one day-old P. interpunctella eggs for 60 d storage. Moreover, the highest parasitoid mortality was recorded in T. evanescens reared either on P. interpunctella or G. mellonella at 20 degrees C. Rearing of the parasitoid on a mixture of eggs of both host species resulted in higher parasitism, but not always in higher rates of parasitoid emergence. The results of the present work provide useful information that can be further utilized in rearing protocols of T. evanescens.	[Haque, Aslam; Islam, Saiful] Rajshahi Univ, Dept Crop Sci & Technol, Rajshahi, Bangladesh; [Bari, Abdul] Atom Energy Res Estab, Inst Food & Radiat Biol, Insect Biotechnol Div, Dhaka, Bangladesh; [Hossain, Akhtar; Hasan, Mahbub] Rajshahi Univ, Dept Zool, Rajshahi, Bangladesh; [Athanassiou, Christos G.] Univ Thessaly, Dept Agr Crop Prod & Rural Environm, Lab Entomol & Agr Zool, N Ionia Magnesia, Greece	University of Rajshahi; University of Rajshahi; University of Thessaly	Hasan, M (corresponding author), Rajshahi Univ, Dept Zool, Rajshahi, Bangladesh.	mmhbgd@yahoo.com		Hasan, Md Mahbub/0000-0003-0900-4959				Abd El-Hafez A, 2001, J AGR SCI, V9, P411; Abd El-Hafez Alia, 1995, Annals of Agricultural Science (Cairo), V40, P901; Agamy E, 2010, J PEST SCI, V83, P53, DOI 10.1007/s10340-009-0273-x; Andrade GS, 2010, REV COLOMB ENTOMOL, V36, P16; Andreadis SS, 2014, PEST MANAG SCI, V70, P814, DOI 10.1002/ps.3619; Athanassiou CG, 2006, J ECON ENTOMOL, V99, P2191, DOI 10.1603/0022-0493-99.6.2191; BAI BR, 1992, ENTOMOL EXP APPL, V64, P37, DOI 10.1007/BF00688992; Ballal CR, 2016, CURR SCI INDIA, V110, P2155, DOI 10.18520/cs/v110/i11/2155-2159; BARRETT M, 1991, ENTOMOL EXP APPL, V59, P29, DOI 10.1007/BF00187963; Bruce AY, 2009, ENVIRON ENTOMOL, V38, P904, DOI 10.1603/022.038.0345; Cave Ronald D., 2000, Biocontrol News and Information, V21, p21N; Chen HL, 2011, BIOL CONTROL, V58, P255, DOI 10.1016/j.biocontrol.2011.04.017; Colinet H, 2010, ANN APPL BIOL, V156, P147, DOI 10.1111/j.1744-7348.2009.00374.x; Colinet H, 2009, ENVIRON ENTOMOL, V38, P242, DOI 10.1603/022.038.0130; Coudron TA, 2007, BIOL CONTROL, V42, P186, DOI 10.1016/j.biocontrol.2007.04.014; Da Fonseca FL, 2005, NEOTROP ENTOMOL, V34, P945, DOI 10.1590/S1519-566X2005000600011; del Pino M, 2020, INSECTS, V11, DOI 10.3390/insects11080482; Desneux N, 2010, J PEST SCI, V83, P197, DOI 10.1007/s10340-010-0321-6; Doyon J, 2005, J INSECT SCI, V5, DOI 10.1093/jis/5.1.4; Eliopoulos PA, 2003, PHYSIOL ENTOMOL, V28, P268, DOI 10.1111/j.1365-3032.2003.00341.x; Firacative C, 2020, J FUNGI, V6, DOI 10.3390/jof6030130; Hansen LS, 2002, J ECON ENTOMOL, V95, P50, DOI 10.1603/0022-0493-95.1.50; Hasan MM, 2020, J ECON ENTOMOL, V113, P1528, DOI 10.1093/jee/toaa014; Hasan MM, 2019, INSECTS, V10, DOI 10.3390/insects10080223; Hassan S.A., 1994, BIOL CONTROL EGG PAR; Hegazi Esmat Mohamed, 2005, Insect Science, V12, P185, DOI 10.1111/j.1005-295X.2005.00023.x; HOKKANEN HMT, 1985, CRC CR REV PLANT SCI, V3, P35, DOI 10.1080/07352688509382203; Hou YY, 2018, J PEST SCI, V91, P1181, DOI 10.1007/s10340-018-0980-2; Johnson JA, 1997, CROP PROT, V16, P519, DOI 10.1016/S0261-2194(97)00037-9; Kaltz O, 1998, HEREDITY, V81, P361, DOI 10.1046/j.1365-2540.1998.00435.x; Krechemer FS, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev072; Leopold RA, 1998, TEMPERATURES SENSITIVITY IN INSECTS AND APPLICATION IN INTEGRATED PEST MANAGEMENT, P235; Levene H., 1960, CONTRIB PROBAB STAT, P278; Lopez SN, 2005, BIOL CONTROL, V33, P123, DOI 10.1016/j.biocontrol.2004.11.003; MARSTON N, 1973, ANN ENTOMOL SOC AM, V66, P1155, DOI 10.1093/aesa/66.5.1155; Mohandass S, 2007, J STORED PROD RES, V43, P302, DOI 10.1016/j.jspr.2006.08.002; PHILLIPS TW, 1994, ENTOMOL EXP APPL, V71, P185, DOI 10.1007/BF02426402; Pitcher SA, 2002, BIOCONTROL, V47, P525, DOI 10.1023/A:1016533116798; Reznik SY, 2020, J INSECT PHYSIOL, V124, DOI 10.1016/j.jinsphys.2020.104072; Reznik SYA., 2007, ENTOMOL REV, V87, P1; RUBERSON JR, 1993, BIOL CONTROL, V3, P39, DOI 10.1006/bcon.1993.1007; Rundle BJ, 2004, J ECON ENTOMOL, V97, P213, DOI 10.1603/0022-0493-97.2.213; SAS, 2008, SASSTAT 92 USERS GUI; SCHMIDT JM, 1985, ENTOMOL EXP APPL, V39, P287, DOI 10.1111/j.1570-7458.1985.tb00472.x; Shoeb MA, 2000, EGYPT ACAD J BIOLSCI, V3, P31; Siam A, 2019, EGYPT J BIOL PEST CO, V29, DOI 10.1186/s41938-019-0139-3; Smith SM, 1996, ANNU REV ENTOMOL, V41, P375, DOI 10.1146/annurev.en.41.010196.002111; Tezze AA, 2004, BIOL CONTROL, V30, P11, DOI 10.1016/j.biocontrol.2003.09.008; VINSON SB, 1980, ANNU REV ENTOMOL, V25, P397, DOI 10.1146/annurev.en.25.010180.002145; Vinson SB, 1998, BIOL CONTROL, V11, P77, DOI 10.1006/bcon.1997.0600; Wang Y, 2020, ENTOMOL GEN, V40, P397, DOI 10.1127/entomologia/2020/1060; Zang LS, 2021, ANNU REV ENTOMOL, V66, P463, DOI 10.1146/annurev-ento-060120-091620; Zhang JJ, 2018, PEST MANAG SCI, V74, P959, DOI 10.1002/ps.4795; Zhang JJ, 2014, BIOCONTROL, V59, P159, DOI 10.1007/s10526-013-9557-4	54	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0253287	10.1371/journal.pone.0253287	http://dx.doi.org/10.1371/journal.pone.0253287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125871	gold, Green Published			2022-12-26	WOS:000664643500030
J	Pan, TH; Lin, SC; Lee, YC; Yu, GY; Song, JH; Pan, J; Titus, M; Satcher, RL; Panaretakis, T; Logothetis, C; Yu-Lee, L; Lin, SH				Pan, Tianhong; Lin, Song-Chang; Lee, Yu-Chen; Yu, Guoyu; Song, Jian H.; Pan, Jing; Titus, Mark; Satcher, Robert L.; Panaretakis, Theocharis; Logothetis, Christopher; Yu-Lee, Li-Yuan; Lin, Sue-Hwa			Statins reduce castration-induced bone marrow adiposity and prostate cancer progression in bone	ONCOGENE			English	Article							ANDROGEN DEPRIVATION THERAPY; ADIPOCYTES; CELLS; GROWTH; RESISTANCE; LNCAP; MODEL; MICROENVIRONMENT; LOCALIZATION; METASTASIS	A fraction of patients undergoing androgen deprivation therapy (ADT) for advanced prostate cancer (PCa) will develop recurrent castrate-resistant PCa (CRPC) in bone. Strategies to prevent CRPC relapse in bone are lacking. Here we show that the cholesterol-lowering drugs statins decrease castration-induced bone marrow adiposity in the tumor microenvironment and reduce PCa progression in bone. Using primary bone marrow stromal cells (BMSC) and M2-10B4 cells, we showed that ADT increases bone marrow adiposity by enhancing BMSC-to-adipocyte transition in vitro. Knockdown of androgen receptor abrogated BMSC-to-adipocyte transition, suggesting an androgen receptor-dependent event. RNAseq analysis showed that androgens reduce the secretion of adipocyte hormones/cytokines including leptin during BMSC-to-adipocyte transition. Treatment of PCa C4-2b, C4-2B4, and PC3 cells with leptin led to an increase in cell cycle progression and nuclear Stat3. RNAseq analysis also showed that androgens inhibit cholesterol biosynthesis pathway, raising the possibility that inhibiting cholesterol biosynthesis may decrease BMSC-to-adipocyte transition. Indeed, statins decreased BMSC-to-adipocyte transition in vitro and castration-induced bone marrow adiposity in vivo. Statin pre-treatment reduced 22RV1 PCa progression in bone after ADT. Our findings with statin may provide one of the mechanisms to the clinical correlations that statin use in patients undergoing ADT seems to delay progression to "lethal" PCa.	[Pan, Tianhong; Satcher, Robert L.] Univ Texas MD Anderson Canc Ctr, Dept Orthoped Oncol, Houston, TX 77030 USA; [Lin, Song-Chang; Lee, Yu-Chen; Yu, Guoyu; Pan, Jing; Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Song, Jian H.; Titus, Mark; Panaretakis, Theocharis; Logothetis, Christopher; Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Yu-Lee, Li-Yuan] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine	Lin, SH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA.; Lin, SH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA.	slin@mdanderson.org			NIH [CA174798, P50 CA140388, P30 CA016672]; Cancer Prevention and Research Institute of Texas [CPRIT RP150179, RP190252]; Prostate Cancer Foundation; University of Texas MD Anderson Moonshot Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention and Research Institute of Texas; Prostate Cancer Foundation; University of Texas MD Anderson Moonshot Program	This work was supported by grants from the NIH (CA174798, P50 CA140388, P30 CA016672), Cancer Prevention and Research Institute of Texas (CPRIT RP150179, RP190252), the Prostate Cancer Foundation, and funds from The University of Texas MD Anderson Moonshot Program.	Abu EO, 1997, J CLIN ENDOCR METAB, V82, P3493, DOI 10.1210/jc.82.10.3493; Alfaqih MA, 2017, NAT REV UROL, V14, P107, DOI 10.1038/nrurol.2016.199; Azemawah V, 2019, CARDIOVASC DRUG THER, V33, P625, DOI 10.1007/s10557-019-06904-x; Caers J, 2007, LEUKEMIA, V21, P1580, DOI 10.1038/sj.leu.2404658; Calvi LM, 2015, BLOOD, V126, P2443, DOI 10.1182/blood-2015-07-533588; Crnalic S, 2010, ENDOCR-RELAT CANCER, V17, P885, DOI 10.1677/ERC-10-0059; Diedrich J, 2015, HORM MOL BIOL CLIN I, V21, P17, DOI 10.1515/hmbci-2014-0045; Diedrich JD, 2016, ONCOTARGET, V7, P64854, DOI 10.18632/oncotarget.11712; Gimble JM, 1996, BONE, V19, P421, DOI 10.1016/S8756-3282(96)00258-X; Gordon Jacob A, 2018, Oncotarget, V9, P19861, DOI 10.18632/oncotarget.24888; Goto T, 2011, BIOCHEM J, V438, P111, DOI 10.1042/BJ20101939; Hardaway AL, 2015, CLIN EXP METASTAS, V32, P353, DOI 10.1007/s10585-015-9714-5; Hardaway AL, 2014, CANCER METAST REV, V33, P527, DOI 10.1007/s10555-013-9484-y; Harshman LC, 2015, JAMA ONCOL, V1, P495, DOI 10.1001/jamaoncol.2015.0829; Herroon MK, 2013, ONCOTARGET, V4, P2108, DOI 10.18632/oncotarget.1482; Jiao SP, 2019, CELL, V179, P1177, DOI 10.1016/j.cell.2019.10.029; Laurent V, 2019, MOL CANCER RES, V17, P821, DOI 10.1158/1541-7786.MCR-18-0748; Laurent V, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10230; Lee YC, 2015, CANCER RES, V75, P4949, DOI 10.1158/0008-5472.CAN-15-1215; Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551; Lin DS, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.510; Liu ZQ, 2015, ONCOTARGET, V6, P34329, DOI 10.18632/oncotarget.6020; Logothetis CJ, 2013, CANCER DISCOV, V3, P849, DOI 10.1158/2159-8290.CD-12-0460; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; Lucas-Herald AK, 2017, CLIN SCI, V131, P1405, DOI 10.1042/CS20170090; Mantalaris A, 2001, J PATHOL, V193, P361, DOI 10.1002/1096-9896(0000)9999:9999<::AID-PATH803>3.0.CO;2-W; Morris EV, 2018, J CELL PHYSIOL, V233, P9159, DOI 10.1002/jcp.26884; Ottewell PD, 2014, ENDOCR-RELAT CANCER, V21, P769, DOI 10.1530/ERC-14-0199; Platz EA, 2006, JNCI-J NATL CANCER I, V98, P1819, DOI 10.1093/jnci/djj499; Roodman GD, 2004, NEW ENGL J MED, V350, P1655, DOI 10.1056/NEJMra030831; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sato K, 2004, J HUM GENET, V49, P29, DOI 10.1007/s10038-003-0103-6; Sato S, 2008, CANCER SCI, V99, P316, DOI 10.1111/j.1349-7006.2007.00690.x; Saxena NK, 2007, J BIOL CHEM, V282, P13316, DOI 10.1074/jbc.M609798200; Sharifi N, 2010, ENDOCR-RELAT CANCER, V17, pR305, DOI 10.1677/ERC-10-0187; Sramkoski RM, 1999, IN VITRO CELL DEV-AN, V35, P403; SUTHERLAND HJ, 1991, BLOOD, V78, P666, DOI 10.1182/blood.V78.3.666.bloodjournal783666; Tang KD, 2016, ONCOTARGET, V7, P4939, DOI 10.18632/oncotarget.6643; TAVASSOLI M, 1974, ARCH PATHOL, V98, P189; TAVASSOLI M, 1976, ACTA ANAT, V94, P65; Tencerova M, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00127; THALMANN GN, 1994, CANCER RES, V54, P2577; Thalmann GN, 2000, PROSTATE, V44, P91; WAINSTEIN MA, 1994, CANCER RES, V54, P6049; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Wu TT, 1998, INT J CANCER, V77, P887, DOI 10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z; Xu LJ, 2018, PROSTATE, V78, P353, DOI 10.1002/pros.23479; Yu-Lee LY, 2018, CANCER RES, V78, P2911, DOI 10.1158/0008-5472.CAN-17-1051; Zhang YX, 2018, P NATL ACAD SCI USA, V115, pE6039, DOI 10.1073/pnas.1806366115	49	5	5	4	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2021	40	27					4592	4603		10.1038/s41388-021-01874-7	http://dx.doi.org/10.1038/s41388-021-01874-7		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TG4PV	34127814	Green Accepted			2022-12-26	WOS:000661408100002
J	Jeffries, R; Abdi, H; Ali, M; Bhuiyan, AMRH; El Shazly, M; Harlass, S; Ishtiak, A; Mazhar, MKA; Prajapati, M; Pang, QY; Singh, B; Tabu, F; Baidjoe, A				Jeffries, Rosanna; Abdi, Hassan; Ali, Mohammad; Bhuiyan, Abu Toha Md Rezuanul Haque; El Shazly, Mohamed; Harlass, Sandra; Ishtiak, Asm; Mazhar, Md Khadimul Anam; Prajapati, Mukeshkumar; Pang, Qing Yuan; Singh, Balwinder; Tabu, Francis; Baidjoe, Amrish			The health response to the Rohingya refugee crisis post August 2017: Reflections from two years of health sector coordination in Cox's Bazar, Bangladesh	PLOS ONE			English	Review							MENTAL-HEALTH	On August 25 2017, an unprecedented influx of Rohingya refugees began from Rakhine State in Myanmar into Bangladesh's district of Cox's Bazar. The scale and acuteness of this humanitarian crisis was unprecedented and unique globally, requiring strong coordination of a multitude of actors. This paper reflects on the health sector coordination from August 2017 to October 2019, focusing on selected achievements and persisting challenges of the health sector strategic advisory group (HSSAG), and the health sector working groups including epidemiology and case management, sexual and reproductive health, community health, mental health and psychosocial support, and emergency preparedness. In the early days of the response, minimum service standards for primary health care were established, a fundamental initial step which enabled the standardization of services based on critical needs. Similarly, establishing standards for community health outreach was the backbone for capitalizing on this important health workforce. Novel approaches were adopted for infectious disease responses for acute watery diarrhoea and varicella, drawing on inter-sectoral collaborations. Sexual and reproductive health services were prioritized from the initial onset of the crisis and improvements in skilled delivery attendance, gender-based violence services, abortion care and family planning were recorded. Mental health service provision was strengthened through community-based approaches although integration of mental health programmes into primary health care has been limited by availability of specialist psychiatrists. Strong, collaborative and legitimate leadership by the health sector strategic advisory group, drawing on inter-sectoral collaborations and the technical expertise of the different technical working groups, were critical in the response and proved effective, despite the remaining challenges to be addressed. Anticipated reductions in funding as the crisis moves into protracted status threatens the achievements of the health sector in provision of health services to the Rohingya refugees.	[Jeffries, Rosanna; Mazhar, Md Khadimul Anam; Prajapati, Mukeshkumar; Pang, Qing Yuan; Singh, Balwinder] WHO, Coxs Bazar, Bangladesh; [Abdi, Hassan] United Nations Populat Fund, Coxs Bazar, Bangladesh; [Ali, Mohammad; Ishtiak, Asm] Minist Hlth, Coxs Bazar, Bangladesh; [Ali, Mohammad; Ishtiak, Asm] Family Welf Coordinat Ctr, Coxs Bazar, Bangladesh; [Bhuiyan, Abu Toha Md Rezuanul Haque] Refugee Relief & Repatriat Commissioners RRRC Off, Coxs Bazar, Bangladesh; [El Shazly, Mohamed; Harlass, Sandra] United Nations High Commissioner Refugees, Coxs Bazar, Bangladesh; [Tabu, Francis] Int Org Migrat Coxs Bazar, Coxs Bazar, Bangladesh; [Baidjoe, Amrish] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England; [Baidjoe, Amrish] WHO, Reg Off South East Asia, Delhi, India	World Health Organization; United Nations Population Fund; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Jeffries, R (corresponding author), WHO, Coxs Bazar, Bangladesh.	rosiejeffries@hotmail.com	Mazhar, Md Khadimul Anam/GRS-7856-2022	Mazhar, Md Khadimul Anam/0000-0002-9303-6541; Pang, Qingyuan/0000-0001-5840-8461; Ishtiak, ASM/0000-0001-9659-8286; Jeffries, Rosanna/0000-0003-2367-2072				[Anonymous], 2017, GUARDIAN 0611; [Anonymous], 2019, NEW HUMANITARIAN; Austin J, 2008, REPROD HEALTH MATTER, V16, P10, DOI 10.1016/S0968-8080(08)31351-2; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Charlson F, 2019, LANCET, V394, P240, DOI 10.1016/S0140-6736(19)30934-1; Chowdhury M.A.K., 2018, REPORT DEMOGRAPHIC P; Conlon CM, 2019, GLOB HEALTH-SCI PRAC, V7, P20, DOI 10.9745/GHSP-D-19-00092; European Commission IASC, INFORM COU PROF MAP; Fetters T, 2020, CONFL HEALTH, V14, DOI 10.1186/s13031-020-00298-6; Funk Michelle, 2008, Ment Health Fam Med, V5, P5; Haddad LB., 2009, REV OBSTET GYNECOL, V2, P9407; Handzel E, 2019, SUMMARY REPORT REPRO; Health Sector WASH Sector Risk Communications Taskforce, 2019, MULT SECT ACUT WAT D; Hoque MA, 2019, SCI TOTAL ENVIRON, V692, P10, DOI 10.1016/j.scitotenv.2019.07.132; Inter Sectoral Coordination Group, 2018, BANGL NATL CYCL CONT; Inter Sectoral Coordination Group, 2019, SIT REP ROH REF GRIS; Inter Sectoral Coordination Group, 2018, 2018 JO RESP PLAN RO; Inter Sectoral Coordination Group, 2019, JO RESP PLAN ROH 201; Inter-Agency Standing Committee (IASC, 2007, IASC GUID MENT HLTH; International Federation of Red Cross and Red Crescent, 2018, BANGL CYCL EARLY ACT; ipa UNICEF, 2018, CURR LEV KNOWL ATT P; Karo B., 2018, EMERG INFECT DIS; Khalil G. M., 1992, NAT HAZ, V6, P11, DOI DOI 10.1007/BF00162096; Ministry of Health and Family Welfare. Government of the People's Republic of Bangladesh, 2016, BANGL ESS HLTH SERV; Natural Hazards Risk Analysis Taskforce, 2019, SUMM REP NATUR HAZ R; NPM-ACAPS Analysis Hub, 2018, CYCL BACKGR ROH CRIS; Nutrition Sector, 2018, EMERG NATE HLTH ASS; Parmar PK, 2019, SEX REPROD HLTH MATT, V27, P39, DOI 10.1080/26410397.2019.1610275; Rahman A., 2008, REGIONAL HLTH FORUM, V12; Rahman M., 2018, REPORT DEMOGRAPHIC P; Reed SJ, 2016, JAMA INTERN MED, V176, P691, DOI 10.1001/jamainternmed.2016.0804; Riley A, 2017, TRANSCULT PSYCHIATRY, V54, P304, DOI 10.1177/1363461517705571; Schnabel L, IMPROVING SEXUAL REP; Silove D, 2017, WORLD PSYCHIATRY, V16, P130, DOI 10.1002/wps.20438; Sphere, 2018, SPH HDB 2018; Sultana S, 2020, INT PERSPECT SEX R H, V46, P45, DOI 10.1363/46e0820; Tay AK, 2019, EPIDEMIOL PSYCH SCI, V28, P489, DOI 10.1017/S2045796019000192; Translators without Borders, 2017, TRANSL BORD RAP ASS; UNFPA, MIN INIT SERV PACK M; UNFPA, 2019, MIN INIT SERV PACK M; UNHCR, 2019, POP FACTSH UNHCR BAN; UNHCR, ROH EMERG; Weissbecker I., 2019, UNCERTAIN SAFETY INT, P117, DOI [DOI 10.1007/978-3-319-72914-5_6, 10.1007/978-3-319-72914-5_6]; WHO, 2019, EWARS EPID HIGH WEEK; Women's Refugee Commission, 2019, CLE CAS NEED DEM ACC; World Health Organization, MAT MORT 2000 2017; World Organization of National Colleges Academies Academic Associations of General Practitioners/Family Physicians World Health Organization, 2008, INT MENT HLTH PRIM C	47	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253013	10.1371/journal.pone.0253013	http://dx.doi.org/10.1371/journal.pone.0253013			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115800	Green Published, gold			2022-12-26	WOS:000664643000042
J	Lee, J; Kang, BJ; Kim, SH				Lee, Jeongmin; Kang, Bong Joo; Kim, Sung Hun			Usefulness of postoperative surveillance MR for women after breast-conservation therapy: Focusing on MR features of early and late recurrent breast cancer	PLOS ONE			English	Article							CONSERVING THERAPY; LOCAL RECURRENCE; FOLLOW-UP; SURVIVAL; RADIOTHERAPY; MAMMOGRAPHY; SURGERY; SOCIETY	Purpose To investigate the imaging characteristics of early and late recurrent breast cancer and the detectability of mammography, ultrasonography, and breast magnetic resonance imaging (MRI) in patients who underwent breast-conservation therapy (BCT). Materials and methods Total of 1312 women with 2026 surveillance breast MRI after BCT between January 2014 and September 2018 were studied. Early recurrence was defined as newly diagnosed breast cancer and/or axillary metastasis within 12 months of surgery. Late recurrence was defined as recurrence after 12months of surgery. We assessed the detectability of recurrent lesions in each postoperative imaging modality and evaluated characteristics of recurrent lesions on postoperative MRI by comparing early and late recurrence groups. Result Of the 2026 cases, 103 were confirmed as recurrent breast cancer by biopsy or surgery. Thirty-one cases were early recurrence, and 72 cases were late recurrence. MRI showed significantly higher detectability for recurrent lesions (102 cases, 99%) than mammography (59.4%, p < 0.001) or ultrasound (68.9%, p < 0.001), or both mammography and ultrasound (81.6%, p < 0.001). The recurrent lesions did not have typical malignant morphologic features, but variable features on MRI. However, early recurrent lesions showed fast enhancement in early dynamic phase regardless of the kinetic pattern of delayed dynamic phase; and late recurrence lesions showed early fast enhancement and delayed washout pattern. There were 19 cases which were not detected on mammography or ultrasound but could only be detected with MRI. Conclusion Postoperative breast MRI showed significantly higher detectability for recurrent lesions than mammography and ultrasound. Early fast enhancement is the most important feature of recurrent lesions on postoperative breast MRI for both early and late recurrence groups. Due to its high possibility of recurrence, further work-up should be considered regardless of their morphologic features.	[Lee, Jeongmin; Kang, Bong Joo; Kim, Sung Hun] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Kang, BJ (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Radiol, Seoul, South Korea.	lionmain@catholic.ac.kr			Department of Biostatistics of the Catholic Research Coordinating Center, Catholic Medical Center, South Korea	Department of Biostatistics of the Catholic Research Coordinating Center, Catholic Medical Center, South Korea	The statistical consultation was supported by Department of Biostatistics of the Catholic Research Coordinating Center, Catholic Medical Center, South Korea.	Abe O, 2005, LANCET, V366, P2087; Cho N, 2017, JAMA ONCOL, V3, P1495, DOI 10.1001/jamaoncol.2017.1256; Drew PJ, 1998, ANN SURG ONCOL, V5, P265, DOI 10.1007/BF02303784; Drukteinis JS, 2012, RADIOGRAPHICS, V32, P219, DOI 10.1148/rg.321115016; Early Breast Canc Trialists Collab, 2011, LANCET, V378, P1707, DOI 10.1016/S0140-6736(11)61629-2; Fowble B., 1991, SF LOCAL REGIONAL RE; Frei KA, 2000, AM J ROENTGENOL, V175, P1577, DOI 10.2214/ajr.175.6.1751577; HASSELL PR, 1990, RADIOLOGY, V176, P731, DOI 10.1148/radiology.176.3.2167500; Houssami N, 2009, ANN ONCOL, V20, P1505, DOI 10.1093/annonc/mdp037; Jung KW, 2014, CANCER RES TREAT, V46, P109, DOI 10.4143/crt.2014.46.2.109; KEMPERMAN H, 1995, EUR J CANCER, V31A, P690, DOI 10.1016/0959-8049(94)00526-B; Khatcheressian JL, 2013, J CLIN ONCOL, V31, P961, DOI 10.1200/JCO.2012.45.9859; Kim EJ, 2017, RADIOLOGY, V284, P656, DOI 10.1148/radiol.2017162123; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; KURTZ JM, 1988, INT J RADIAT ONCOL, V15, P277, DOI 10.1016/S0360-3016(98)90005-0; Levy M, 2016, J NATL COMPR CANC NE, V14, P82, DOI 10.6004/jnccn.2016.0009; Li J, 2010, AM J ROENTGENOL, V195, P799, DOI 10.2214/AJR.10.4305; LOCKER AP, 1990, CLIN RADIOL, V41, P388, DOI 10.1016/S0009-9260(05)80597-5; MENDELSON EB, 1992, RADIOL CLIN N AM, V30, P107; Montgomery DA, 2007, BRIT J CANCER, V96, P1802, DOI 10.1038/sj.bjc.6603815; Monticciolo DL, 2018, J AM COLL RADIOL, V15, P408, DOI 10.1016/j.jacr.2017.11.034; Preda L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1600; Saslow D, 2007, CA-CANCER J CLIN, V57, P75, DOI 10.3322/canjclin.57.2.75; Solomon B, 1998, AM J ROENTGENOL, V170, P966, DOI 10.2214/ajr.170.4.9530045; Viehweg P, 1998, MAGN RESON MATER PHY, V7, P141	25	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252476	10.1371/journal.pone.0252476	http://dx.doi.org/10.1371/journal.pone.0252476			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115797	gold, Green Published			2022-12-26	WOS:000664643000019
J	Searle, PC; Mercer, M; Habit, E; Belk, MC				Searle, Peter C.; Mercer, Margaret; Habit, Evelyn; Belk, Mark C.			Ontogenetic shape trajectory of Trichomycterus areolatus varies in response to water velocity environment	PLOS ONE			English	Article							LIFE-HISTORY PHENOTYPES; BODY SHAPE; MORPHOLOGICAL VARIATION; CHARACTER DISPLACEMENT; PREDATION ENVIRONMENT; NEOTROPICAL CATFISH; REACTION NORMS; DIET SHIFTS; FISH; TELEOSTEI	Body and head shape among fishes both vary between environments influenced by water velocity and across ontogeny. Although the shape changes associated with variation in average water velocity and ontogeny are well documented, few studies have tested for the interaction between these two variables (i.e., does ontogenetic shape variation differ between velocity environments). We use geometric morphometrics to characterize shape differences in Trichomycterus areolatus, a freshwater catfish found in high and low-velocity environments in Chile. We identify a significant interaction between velocity environment and body size (i.e., ontogeny). Ontogenetic patterns of shape change are consistent with other studies, but velocity environment differentially affects the ontogenetic trajectory of shape development in T. areolatus. Shape change over ontogeny appears more constrained in high-velocity environments compared to low-velocity environments.	[Searle, Peter C.; Mercer, Margaret; Belk, Mark C.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Habit, Evelyn] Univ Concepcion, Dept Sistemas Acuat, Fac Ciencias Ambientales, Concepcion, Chile; [Habit, Evelyn] Univ Concepcion, Dept Sistemas Acuat, Ctr EULA, Concepcion, Chile	Brigham Young University; Universidad de Concepcion; Universidad de Concepcion	Searle, PC (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	petersearle94@gmail.com		Searle, Peter/0000-0002-5540-1851	Roger and Victoria Sant Foundation; Department of Biology, Brigham Young University; Direccion de Investigacion, Universidad del Bio-Bio [032904 3/R]; Direccion de Investigacion, Universidad de Concepcion [204.310.041-1.0]	Roger and Victoria Sant Foundation; Department of Biology, Brigham Young University; Direccion de Investigacion, Universidad del Bio-Bio; Direccion de Investigacion, Universidad de Concepcion	Funding for this work was supported by grants to MCB by the Roger and Victoria Sant Foundation and the Department of Biology, Brigham Young University, as well as EH by projects 032904 3/R Direccion de Investigacion, Universidad del Bio-Bio and 204.310.041-1.0 Direccion de Investigacio ' n, Universidad de Concepcion. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DC, 2004, ECOLOGY, V85, P2664, DOI 10.1890/04-0648; Adams DC, 2007, EVOLUTION, V61, P510, DOI 10.1111/j.1558-5646.2007.00063.x; Ahnelt H, 2020, ZOOMORPHOLOGY, V139, P71, DOI 10.1007/s00435-019-00464-2; Arnqvist G, 1998, ECOLOGY, V79, P1847, DOI 10.2307/176693; Baliga VB, 2016, INTEGR COMP BIOL, V56, P416, DOI 10.1093/icb/icw028; Belk MC, 2008, CAN J FISH AQUAT SCI, V65, P401, DOI 10.1139/F07-176; Bernal-Duran V, 2017, SCI MAR, V81, P205, DOI 10.3989/scimar.04555.09A; Bhat A, 2005, ENVIRON BIOL FISH, V73, P211, DOI 10.1007/s10641-005-0561-0; Billman EJ, 2014, METHODS ECOL EVOL, V5, P797, DOI 10.1111/2041-210X.12211; Blasina G, 2016, CR BIOL, V339, P498, DOI 10.1016/j.crvi.2016.07.003; BOCK WJ, 1994, J BIOSCIENCE, V19, P403, DOI 10.1007/BF02703177; Bookstein F.L., 1991, MORPHOMETRIC TOOLS L; BOOKSTEIN FL, 1989, IEEE T PATTERN ANAL, V11, P567, DOI 10.1109/34.24792; Bravi R, 2013, ITAL J ZOOL, V80, P536, DOI 10.1080/11250003.2013.829129; Brinsmead J, 2002, J FISH BIOL, V61, P1619, DOI 10.1006/jfbi.2002.2179; Butler D.G., 2018, ASREML R REFERENCE M, DOI DOI 10.1201/9781351174305; Casatti L, 2006, NEOTROP ICHTHYOL, V4, P203, DOI 10.1590/S1679-62252006000200006; Cattau CE, 2018, NAT ECOL EVOL, V2, P108, DOI 10.1038/s41559-017-0378-1; Chara JD, 2006, J FISH BIOL, V68, P1026, DOI 10.1111/j.0022-1112.2006.00984.x; Chivers DP, 2008, EVOL ECOL, V22, P561, DOI 10.1007/s10682-007-9182-8; Claessen D, 2002, EVOL ECOL RES, V4, P189; Collyer ML, 2007, ECOLOGY, V88, P683, DOI 10.1890/06-0727; de la Hera I, 2014, IBIS, V156, P209, DOI 10.1111/ibi.12112; Dunn NR, 2020, DIVERSITY-BASEL, V12, DOI 10.3390/d12060220; Evelyn H, 2007, BIODIVERS CONSERV, V16, P3179, DOI 10.1007/s10531-007-9171-9; Fitzpatrick Benjamin M., 2012, International Journal of Ecology, P1; Gottardo M, 2015, ARTHROPOD STRUCT DEV, V44, P195, DOI 10.1016/j.asd.2015.01.001; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Grunbaum T, 2007, J EXP ZOOL PART B, V308B, P396, DOI 10.1002/jez.b.21163; Habit E, 2006, FRESHWATER BIOL, V51, P1, DOI 10.1111/j.1365-2427.2005.01461.x; Hassell EMA, 2012, ECOL EVOL, V2, P1738, DOI 10.1002/ece3.278; Heins DC, 2018, ECOL FRESHW FISH, V27, P453, DOI 10.1111/eff.12360; Helfman G., 2009, SPECIAL HABITATS SPE; Hendry AP, 2002, EVOLUTION, V56, P1199; Hernandez G, 2017, J MAMMAL, V98, P1741, DOI 10.1093/jmammal/gyx135; Hjelm J, 2001, OIKOS, V95, P311, DOI 10.1034/j.1600-0706.2001.950213.x; Hugueny B, 1999, J FISH BIOL, V54, P1310, DOI 10.1111/j.1095-8649.1999.tb02057.x; Ingley SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090274; Johnson JB, 2001, OECOLOGIA, V126, P142, DOI 10.1007/s004420000504; Kaliontzopoulou A, 2010, J EVOLUTION BIOL, V23, P1234, DOI 10.1111/j.1420-9101.2010.01984.x; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kern EMA, 2019, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00229; Kern EMA, 2018, GLOBAL CHANGE BIOL, V24, P3791, DOI 10.1111/gcb.14115; Landaeta MF, 2019, HYDROBIOLOGIA, V839, P159, DOI 10.1007/s10750-019-04004-3; Langerhans RB, 2007, J EVOLUTION BIOL, V20, P1171, DOI 10.1111/j.1420-9101.2007.01282.x; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P2231, DOI 10.1111/j.1420-9101.2009.01839.x; Langerhans RB, 2009, J EVOLUTION BIOL, V22, P1057, DOI 10.1111/j.1420-9101.2009.01716.x; Langerhans R. Brian, 2010, P200, DOI 10.1201/b10190-8; Langerhans RB, 2008, INTEGR COMP BIOL, V48, P750, DOI 10.1093/icb/icn092; Langerhans RB, 2003, BIOL J LINN SOC, V80, P689, DOI 10.1111/j.1095-8312.2003.00266.x; Lima-Junior SE, 2003, ENVIRON BIOL FISH, V68, P73, DOI 10.1023/A:1026079011647; Lopez-Ronnero FA, 2020, J FISH BIOL, V97, P212, DOI 10.1111/jfb.14352; MANRIQUEZ A, 1988, STUD NEOTROP FAUNA E, V23, P89, DOI 10.1080/01650528809360749; Marchand LJ, 2021, POLAR BIOL, V44, P17, DOI 10.1007/s00300-020-02768-2; MCLAUGHLIN RL, 1994, ENVIRON BIOL FISH, V39, P289, DOI 10.1007/BF00005130; Mercer M, 2020, DIVERSITY-BASEL, V12, DOI 10.3390/d12060219; Merigoux S, 1998, J FISH BIOL, V52, P556, DOI 10.1111/j.1095-8649.1998.tb02017.x; Meyers PJ, 2014, HYDROBIOLOGIA, V738, P147, DOI 10.1007/s10750-014-1926-1; Monteiro LR, 1997, J MORPHOL, V231, P53, DOI 10.1002/(SICI)1097-4687(199701)231:1<53::AID-JMOR5>3.0.CO;2-P; MOTTA PJ, 1992, NETH J ZOOL, V42, P400; Nickum JG, 1988, FISHERIES, V13, P1, DOI [10.1577/1548-8446-13-2, DOI 10.1577/1548-8446-13-2]; Nonaka E, 2015, AM NAT, V186, pE126, DOI 10.1086/683231; Ocampo EH, 2017, BIOL J LINN SOC, V120, P54; Ofori SA, 2021, TROP ANIM HEALTH PRO, V53, DOI 10.1007/s11250-020-02498-x; Pakkasmaa S, 2000, EVOL ECOL, V14, P721, DOI 10.1023/A:1011691810801; Parsons KJ, 2011, J EVOLUTION BIOL, V24, P1640, DOI 10.1111/j.1420-9101.2011.02301.x; Pergams ORW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006452; Phillips BL, 2004, P NATL ACAD SCI USA, V101, P17150, DOI 10.1073/pnas.0406440101; Pistore Alexandra E., 2019, Evolutionary Ecology Research, V20, P27; R Core Team, 2020, R LANG ENV STAT COMP; Rader RB, 2005, ANIM CONSERV, V8, P239, DOI 10.1017/S1367943005002271; Reis RE, 1998, COPEIA, P177, DOI 10.2307/1447715; Rodriguez-Mendoza R, 2011, HYDROBIOLOGIA, V670, P5, DOI 10.1007/s10750-011-0675-7; Rohlf F. J., 2003, TPSDIG DIGITIZE LAND; Rohlf FJ, 2015, HYSTRIX, V26, P9, DOI 10.4404/hystrix-26.1-11264; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 1996, SYST BIOL, V45, P344, DOI 10.2307/2413569; Rohlf FJ, 2003, TPSRELW32 RELATIVE W; Rohlf FJ, 2003, TPSREGR MULTIVARIATE; Roth-Monzon AJ, 2020, AM NAT, V195, P983, DOI [10.5061/dryad.n02v6wwt0, 10.1086/708513]; Scott S, 2007, REV CHIL HIST NAT, V80, P431; SHEA BT, 1992, J HUM EVOL, V23, P283, DOI 10.1016/S0047-2484(05)80004-1; Sidlauskas B, 2006, ICHTHYOL RES, V53, P24, DOI 10.1007/s10228-005-0310-6; Stearns S.C., 1992, pi; Strelin MM, 2021, EVOL DEV, V23, P231, DOI 10.1111/ede.12363; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; Taylor-Cox ED, 2020, PEERJ, V8, DOI 10.7717/peerj.10352; Thompson D. W., 1917, GROWTH FORM; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Villares GA, 2016, BRAZ J BIOL, V76, P905, DOI 10.1590/1519-6984.04315; WEBB PW, 1984, AM ZOOL, V24, P107; Wesner JS, 2011, BIOL J LINN SOC, V104, P386, DOI 10.1111/j.1095-8312.2011.01715.x; WESTEBERHARD MJ, 1989, ANNU REV ECOL SYST, V20, P249, DOI 10.1146/annurev.es.20.110189.001341; Williams TJ, 2017, BIOL J LINN SOC, V122, P147, DOI 10.1093/biolinnean/blx050; WIMBERGER PH, 1992, BIOL J LINN SOC, V45, P197, DOI 10.1111/j.1095-8312.1992.tb00640.x	96	2	2	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252780	10.1371/journal.pone.0252780	http://dx.doi.org/10.1371/journal.pone.0252780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115773	Green Published, gold			2022-12-26	WOS:000664643000035
J	Singpanomchai, N; Akeda, Y; Tomono, K; Tamaru, A; Santanirand, P; Ratthawongjirakul, P				Singpanomchai, Nuntita; Akeda, Yukihiro; Tomono, Kazunori; Tamaru, Aki; Santanirand, Pitak; Ratthawongjirakul, Panan			Rapid detection of multidrug-resistant tuberculosis based on allele-specific recombinase polymerase amplification and colorimetric detection	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; MUTATIONS; RIFAMPICIN; DNA	Multidrug-resistant tuberculosis (MDR-TB) poses a serious threat to TB control. Early diagnosis and proper treatment are essential factors to limit the spread of the disease. The existing molecular tests for MDR-TB usually require specific instruments, steady power supply, and routine maintenance, which might be obstacles for low-resource settings. This study aimed to develop allele-specific isothermal recombinase polymerase amplification (allele-specific RPA) to simultaneously detect the most common mutations in the rpoB gene at codons 516, 526, and 531, which are associated with rifampicin resistance, and in the katG gene at codon 315, which is related to isoniazid resistance. Allele-specific primers targeting four major mutations, rpoB516, rpoB526, rpoB531, and katG315, were constructed and used in individual RPA reactions. The RPA amplicons were endpoints detected by the naked eye immediately after applying SYBR Green I. The optimised RPA assay was evaluated with the Mycobacterium tuberculosis wild-type strain H37Rv and 141 clinical M. tuberculosis isolates. The results revealed that allele-specific RPA combined with SYBR Green I detection (AS-RPA/SYBR) detected these four major mutations with 100% sensitivity and specificity relative to DNA sequencing. The limits of detection for these particular mutations with AS-RPA/SYBR were 5 ng. As a result of the outstanding performance of AS-RPA/SYBR, including its easy setup, speed, lack of a specific instrument requirement, and lack of cross-reaction with other bacteria, this technique may be integrated for the molecular diagnosis of MDR-TB, especially in low-resource settings.	[Singpanomchai, Nuntita] Chulalongkorn Univ, Fac Allied Hlth Sci, Dept Transfus Med & Clin Microbiol, Program Mol Sci Med Microbiol & Immunol, Bangkok, Thailand; [Akeda, Yukihiro; Tomono, Kazunori] Osaka Univ, Osaka Univ Hosp, Div Infect Control & Prevent, Osaka, Japan; [Tamaru, Aki] Osaka Prefectural Inst Publ Hlth, Dept Bacteriol, Osaka, Japan; [Santanirand, Pitak] Mahidol Univ, Ramathibodi Hosp, Fac Med, Microbiol Unit, Bangkok, Thailand; [Ratthawongjirakul, Panan] Chulalongkorn Univ, Fac Allied Hlth Sci, Res Unit Innovat Diag Antimicrobial Resistance, Dept Transfus Med & Clin Microbiol, Bangkok, Thailand	Chulalongkorn University; Osaka University; Osaka Prefectural Institute of Public Health; Mahidol University; Chulalongkorn University	Ratthawongjirakul, P (corresponding author), Chulalongkorn Univ, Fac Allied Hlth Sci, Res Unit Innovat Diag Antimicrobial Resistance, Dept Transfus Med & Clin Microbiol, Bangkok, Thailand.	panan_etc@yahoo.com		Santanirand, Pitak/0000-0002-3914-1367; Ratthawongjirakul, Panan/0000-0003-3084-0863	Overseas Research Experience Scholarship for Graduate Student; Ratchadaphiseksomphot Endowment Fund 2016 of Chulalongkorn University [NRU-59-012HR]	Overseas Research Experience Scholarship for Graduate Student; Ratchadaphiseksomphot Endowment Fund 2016 of Chulalongkorn University	This study was partially supported by the scholarship from the Overseas Research Experience Scholarship for Graduate Student and the Ratchadaphiseksomphot Endowment Fund 2016 of Chulalongkorn University (NRU-59-012HR). The funders did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, GLOBAL TUBERCULOSIS; [Anonymous], 2014, END TB STRAT; [Anonymous], 2008, WHO POL STAT MOL LIN; Boonaiam S, 2010, CLIN MICROBIOL INFEC, V16, P397, DOI 10.1111/j.1469-0691.2009.02838.x; Boyle DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103091; Ckumdee J, 2016, J CHEM-NY, V2016, DOI 10.1155/2016/3474396; Cracolici V, 2011, ADV APPROACH INTRO Y; Daher RK, 2016, CLIN CHEM, V62, P947, DOI 10.1373/clinchem.2015.245829; Debode F, 2017, BIOTECHNOL AGRON SOC, V21, P3; Faye O, 2015, EUROSURVEILLANCE, V20, P10, DOI 10.2807/1560-7917.ES.2015.20.44.30053; Kamphee H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137791; Law ILG, 2018, ANAL BIOCHEM, V544, P98, DOI 10.1016/j.ab.2017.12.031; Liu YB, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050792; Ma QL, 2017, MOL CELL PROBE, V36, P43, DOI 10.1016/j.mcp.2017.08.004; Madania A, 2012, POL J MICROBIOL, V61, P23, DOI 10.33073/pjm-2012-003; Lobato IM, 2018, TRAC-TREND ANAL CHEM, V98, P19, DOI 10.1016/j.trac.2017.10.015; Millet JP, 2013, EUR SPINE J, V22, P539, DOI 10.1007/s00586-012-2334-8; Mo YJ, 2017, RSC ADV, V7, P49895, DOI 10.1039/c7ra09999a; Ng BYC, 2017, ANAL CHEM, V89, P9017, DOI 10.1021/acs.analchem.7b01685; Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204; Pierre-Audigier C., 2013, J TUBERC RES, V2, P1; Prammananan T, 2008, CLIN MICROBIOL INFEC, V14, P446, DOI 10.1111/j.1469-0691.2008.01951.x; Reechaipichitkul W, 2016, SE ASIAN J TROP MED, V47, P457; Rosser A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1055-3; Ryu YJ, 2015, TUBERC RESPIR DIS, V78, P64, DOI 10.4046/trd.2015.78.2.64; Seifert M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119628; Simner PJ, 2016, J CLIN MICROBIOL, V54, P1089, DOI 10.1128/JCM.02838-15; Singpanomchai N, 2019, J CLIN LAB ANAL, V33, DOI 10.1002/jcla.22655; Uys PW, 2009, J CLIN MICROBIOL, V47, P1484, DOI 10.1128/JCM.02289-08; Veigas B, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-38; Wang R, 2017, ANAL CHEM, V89, P4413, DOI 10.1021/acs.analchem.7b00964; Wang YR, 2010, MOL CELL PROBE, V24, P15, DOI 10.1016/j.mcp.2009.08.001; World Health Oraganization, 2016, US LOOP MED IS AMPL; Yamanaka ES, 2017, MICROCHIM ACTA, V184, P1453, DOI 10.1007/s00604-017-2144-0; Yue J, 2003, J CLIN MICROBIOL, V41, P2209, DOI 10.1128/JCM.41.5.2209-2212.2003	35	3	3	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253235	10.1371/journal.pone.0253235	http://dx.doi.org/10.1371/journal.pone.0253235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115793	gold, Green Published			2022-12-26	WOS:000664643000060
J	Yang, H; Song, X; Zhao, Y; Wang, WT; Cheng, ZN; Zhang, Q; Cheng, DQ				Yang, Huan; Song, Xuan; Zhao, Yun; Wang, Weitong; Cheng, Zhennan; Zhang, Qi; Cheng, Daoquan			Temporal and spatial variations of soil C, N contents and C:N stoichiometry in the major grain-producing region of the North China Plain	PLOS ONE			English	Article							P STOICHIOMETRY; ECOLOGICAL STOICHIOMETRY; CARBON STOCKS; NITROGEN; ECOSYSTEMS; FERTILIZER; LANDSCAPE; STORAGE	Soil C, N contents and C:N stoichiometry are important indicators of soil quality, the variation characteristics of which have great significance for soil carbon-nitrogen cycle and sustainable utilization. Based on 597 observations along with soil profiles of 0-20cm depth in the 1980s and the 2010s, the temporal and spatial variations of soil C, N contents and C:N stoichiometry in the major grain-producing region of the North China Plain were illustrated. Results showed that there were significant changes in soil C, N contents over time, with increasing rates of 60.47% and 50%, respectively. The changes of C, N contents resulting in a general improvement of C:N stoichiometry. There was a significant decline in nugget effects of soil C, N contents from the 1980s to 2010s, the spatial autocorrelation of soil nutrients showed an increasing trend, and the effect of random variation was reduced. C:N stoichiometry was higher in Huixian City and Weihui City, and lower in Yanjin County, an apparent decline was observed in the spatial difference of soil C:N stoichiometry from the 1980s to 2010s. Soil C, N contents and C:N stoichiometry differed among soil types, agricultural land-use types, and topography in space. The temperature, precipitation, and fertilization structure were considered as the main factors that induce the temporal variations. These findings indicated that the soil nutrient elements in the farmland ecosystems changed in varying degrees in both time and space scales, and the variation was influenced by soil types, land-use types, topography, meteorological factors, and fertilization structure.	[Yang, Huan; Wang, Weitong; Cheng, Zhennan; Zhang, Qi] Zhengzhou Univ, Sch Water Conservancy Engn, Zhengzhou, Henan, Peoples R China; [Song, Xuan; Zhao, Yun] Zhengzhou Univ, Sch Software, Zhengzhou, Henan, Peoples R China; [Cheng, Daoquan] Stn Soil & Fertilizer Extens Serv, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Song, X (corresponding author), Zhengzhou Univ, Sch Software, Zhengzhou, Henan, Peoples R China.	songxuan@zzu.edu.cn		song, xuan/0000-0001-9455-3850	 [2017YFD0800605]		Grant number: 2017YFD0800605 Initials of authors who received award:X.S Full names of commercial companies that funded the study or authors: Ministry of Science and Technology of the People's Republic of China Initials of authors who received salary or other funding from commercial companies: Huan Yang, Xuan Song, Yun Zhao, Weitong Wang, Zhennan Cheng, Qi Zhang. URLs to sponsors' websites:http://www.most.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez R, 2018, NUTR CYCL AGROECOSYS, V110, P257, DOI 10.1007/s10705-017-9896-0; Baddeley JA, 2017, GEODERMA, V303, P19, DOI 10.1016/j.geoderma.2017.05.002; Badea Ana-Cornelia, 2014, International Journal of Geology, V8, P1; Baillie IC, 2018, GEODERMA REG, V12, P1, DOI 10.1016/j.geodrs.2017.11.002; Cao Y, 2018, J SOIL SEDIMENT, V18, P1478, DOI 10.1007/s11368-017-1884-0; Chen ShuFeng, 2011, Transactions of the Chinese Society of Agricultural Engineering, V27, P65; Cheng D, 2014, RES APPL BIG DATA MU; Cui Xuhui, 2016, Journal of Beijing Normal University (Natural Science), V52, P472, DOI 10.16360/j.cnki.jbnuns.2016.04.012; Cui YX., 2020, Soil Till Res, P197; DeGryze S, 2004, GLOBAL CHANGE BIOL, V10, P1120, DOI 10.1111/j.1529-8817.2003.00786.x; Deng Q, 2014, SOIL BIOL BIOCHEM, V69, P119, DOI 10.1016/j.soilbio.2013.10.053; Feng C, 2017, LAND DEGRAD DEV, V28, P2457, DOI 10.1002/ldr.2781; Gao Y, 2014, ECOL ENG, V67, P171, DOI 10.1016/j.ecoleng.2014.03.013; Guo X, 2019, J SOIL SEDIMENT, V19, P263, DOI 10.1007/s11368-018-2047-7; Hessen DO, 2013, LIMNOL OCEANOGR, V58, P2219, DOI 10.4319/lo.2013.58.6.2219; J J E, 2000, NATURE, V6812; Jiang YeFeng, 2017, Acta Pedologica Sinica, V54, P1527; Kulmatiski A, 2004, SOIL SCI SOC AM J, V68, P2014, DOI 10.2136/sssaj2004.2014; [刘钦普 Liu Qinpu], 2014, [中国农业科学, Scientia Agricultura Sinica], V47, P3596; Loladze I, 2000, B MATH BIOL, V62, P1137, DOI 10.1006/bulm.2000.0201; Lu XT, 2012, OECOLOGIA, V168, P301, DOI 10.1007/s00442-011-2097-7; Luo You-lin, 2015, Yingyong Shengtai Xuebao, V26, P177; Maaroufi NI, 2020, FRONT FOR GLOB CHANG, V3, DOI 10.3389/ffgc.2020.00016; Maltas A, 2013, SOIL TILL RES, V126, P11, DOI 10.1016/j.still.2012.07.012; [蒙冠霖 Meng Guanlin], 2015, [生态环境学报, Ecology and Environmental Sciences], V24, P785; Meng L, 2021, SCI TOTAL ENVIRON, V751, DOI 10.1016/j.scitotenv.2020.141737; Nyssen J, 2008, GEODERMA, V146, P261, DOI 10.1016/j.geoderma.2008.06.007; Pang Su, 2010, Yingyong Shengtai Xuebao, V21, P1497; Poeplau C, 2018, AGR ECOSYST ENVIRON, V265, P144, DOI 10.1016/j.agee.2018.06.003; Qin H, 1995, LOCAL RECORDS SOIL H; Qu FZ, 2014, GEODERMA, V235, P227, DOI 10.1016/j.geoderma.2014.07.009; Rabbi SMF, 2014, GEODERMA, V216, P10, DOI 10.1016/j.geoderma.2013.10.023; RUIZLOZANO JM, 1995, APPL ENVIRON MICROB, V61, P456, DOI 10.1128/AEM.61.2.456-460.1995; Sardans J, 2012, PERSPECT PLANT ECOL, V14, P33, DOI 10.1016/j.ppees.2011.08.002; Senthilkumar S, 2009, SOIL SCI SOC AM J, V73, P2059, DOI 10.2136/sssaj2008.0392; [孙英君 Sun Yingjun], 2004, [地球科学进展, Advance in Earth Sciences], V19, P268; Tipping E, 2016, BIOGEOCHEMISTRY, V130, P117, DOI 10.1007/s10533-016-0247-z; Traore S, 2015, GEODERMA, V241, P330, DOI 10.1016/j.geoderma.2014.11.027; Wang ShiChao, 2020, Scientia Agricultura Sinica, V53, P782, DOI 10.3864/j.issn.0578-1752.2020.04.010; Wu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038883; [徐冰 XU Bing], 2009, [土壤通报, Journal of Soil Science], V40, P1450; [姚冠荣 Yao Guanrong], 2014, [自然资源学报, Journal of Natural Resources], V29, P1836; You-lin L., 2015, CHIN J APPL ECOL, V26; Yu LF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08511-y; Yu ZP, 2018, GLOBAL CHANGE BIOL, V24, P1308, DOI 10.1111/gcb.13939; Zhang MingKui, 2002, Journal of Zhejiang University (Agriculture and Life Sciences), V28, P277	47	0	0	30	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253160	10.1371/journal.pone.0253160	http://dx.doi.org/10.1371/journal.pone.0253160			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115823	gold, Green Published			2022-12-26	WOS:000664643000052
J	Horoiwa, M; Mandagi, IF; Sutra, N; Montenegro, J; Tantu, FY; Masengi, KWA; Nagano, AJ; Kusumi, J; Yasuda, N; Yamahira, K				Horoiwa, Mizuki; Mandagi, Ixchel F.; Sutra, Nobu; Montenegro, Javier; Tantu, Fadly Y.; Masengi, Kawilarang W. A.; Nagano, Atsushi J.; Kusumi, Junko; Yasuda, Nina; Yamahira, Kazunori			Mitochondrial introgression by ancient admixture between two distant lacustrine fishes in Sulawesi Island	PLOS ONE			English	Article							GENUS ORYZIAS BELONIFORMES; TOOL SET; POPULATION; ADRIANICHTHYIDAE; DIVERSIFICATION; EVOLUTION; SEQUENCE; NUCLEAR; STACKS; ORIGIN	Sulawesi, an island located in a biogeographical transition zone between Indomalaya and Australasia, is famous for its high levels of endemism. Ricefishes (family Adrianichthyidae) are an example of taxa that have uniquely diversified on this island. It was demonstrated that habitat fragmentation due to the Pliocene juxtaposition among tectonic subdivisions of this island was the primary factor that promoted their divergence; however, it is also equally probable that habitat fusions and resultant admixtures between phylogenetically distant species may have frequently occurred. Previous studies revealed that some individuals of Oryzias sarasinorum endemic to a tectonic lake in central Sulawesi have mitochondrial haplotypes that are similar to the haplotypes of O. eversi, which is a phylogenetically related but geologically distant (ca. 190 km apart) adrianichthyid endemic to a small fountain. In this study, we tested if this reflects ancient admixture of O. eversi and O. sarasinorum. Population genomic analyses of genome-wide single-nucleotide polymorphisms revealed that O. eversi and O. sarasinorum are substantially reproductively isolated from each other. Comparison of demographic models revealed that the models assuming ancient admixture from O. eversi to O. sarasinorum was more supported than the models assuming no admixture; this supported the idea that the O. eversi-like mitochondrial haplotype in O. sarasinorum was introgressed from O. eversi. This study is the first to demonstrate ancient admixture of lacustrine or pond organisms in Sulawesi beyond 100 km. The complex geological history of this island enabled such island-wide admixture of lacustrine organisms, which usually experience limited migration.	[Horoiwa, Mizuki; Yasuda, Nina] Univ Miyazaki, Fac Agr, Miyazaki, Japan; [Mandagi, Ixchel F.; Sutra, Nobu; Montenegro, Javier; Yamahira, Kazunori] Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa, Japan; [Mandagi, Ixchel F.; Masengi, Kawilarang W. A.] Sam Ratulangi Univ, Fac Fisheries & Marine Sci, Manado, Indonesia; [Sutra, Nobu] Hasanuddin Univ, Grad Sch, Makassar, Indonesia; [Tantu, Fadly Y.] Tadulako Univ, Fac Anim Husb & Fisheries, Palu, Indonesia; [Nagano, Atsushi J.] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan; [Kusumi, Junko] Kyushu Univ, Fac Social & Cultural Studies, Fukuoka, Japan	University of Miyazaki; University of the Ryukyus; Universitas Sam Ratulangi; Universitas Hasanuddin; Universitas Tadulako; Ryukoku University; Kyushu University	Yamahira, K (corresponding author), Univ Ryukyus, Trop Biosphere Res Ctr, Nishihara, Okinawa, Japan.	yamahira@lab.u-ryukyu.ac.jp	Nagano, Atsushi J./A-2957-2019; Kusumi, Junko/AFT-6398-2022; Montenegro, Javier/HII-5320-2022	Nagano, Atsushi J./0000-0001-7891-5049; Kusumi, Junko/0000-0002-1693-7071; Montenegro, Javier/0000-0002-0289-3274; Yamahira, Kazunori/0000-0002-5184-6554	Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus; Core Research for Evolutional Science and Technology [JPMJCR20S2]; JSPS KAKENHI [26291093, 17H01675]	Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus; Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the Collaborative Research of Tropical Biosphere Research Center, University of the Ryukyus to JK (https://tbc.skr.u-ryukyu.ac.jp/cooperative-studies/), Core Research for Evolutional Science and Technology Grant Number JPMJCR20S2 (https://www.jst.go.jp/kisoken/crest/en/index.html), and JSPS KAKENHI Grant Numbers 26291093 and 17H01675 to KY (https://www.jsps.go.jp/english/egrants/index.html).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott R, 2013, J EVOLUTION BIOL, V26, P229, DOI 10.1111/j.1420-9101.2012.02599.x; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Ansai S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21697-0; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouckaert RR, 2010, BIOINFORMATICS, V26, P1372, DOI 10.1093/bioinformatics/btq110; Bryant D, 2012, MOL BIOL EVOL, V29, P1917, DOI 10.1093/molbev/mss086; Catchen J, 2013, MOL ECOL, V22, P3124, DOI 10.1111/mec.12354; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Cornuet JM, 2014, BIOINFORMATICS, V30, P1187, DOI 10.1093/bioinformatics/btt763; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; de Beaufort LF, 1934, NEDERLAND KOLONIEN G, V10, P180; Echelle AA, 2005, COPEIA, P320, DOI 10.1643/CG-03-093R3; Evans BJ, 2003, SYST BIOL, V52, P794, DOI 10.1080/10635150390251063; Evans BJ, 2003, EVOLUTION, V57, P1931; Excoffier L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003905; Frickhinger KA., 1991, FISCHE; Hall R., 2009, ARIZ GEOL SOC DIG, V22, P245; Hall R, 2011, GEOL SOC SPEC PUBL, V355, P75, DOI 10.1144/SP355.5; Herder F, 2006, P R SOC B, V273, P2209, DOI 10.1098/rspb.2006.3558; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hilgers L, 2019, ELIFE, V8, DOI 10.7554/eLife.46994; Malinsky M, 2018, NAT ECOL EVOL, V2, P1940, DOI 10.1038/s41559-018-0717-x; Mandagi IF, 2018, COPEIA, V106, P297, DOI 10.1643/CI-17-704; Marques DA, 2019, TRENDS ECOL EVOL, V34, P531, DOI 10.1016/j.tree.2019.02.008; Meier JI, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14363; Mokodongan DF, 2015, DATA BRIEF, V5, P281, DOI 10.1016/j.dib.2015.08.032; Mokodongan DF, 2015, MOL PHYLOGENET EVOL, V93, P150, DOI [10.1016/j.ymPev.2015.07.024, 10.1016/j.ympev.2015.07.024]; Moss Steve J., 1998, P133; Nugraha AMS, 2018, PALAEOGEOGR PALAEOCL, V490, P191, DOI 10.1016/j.palaeo.2017.10.033; Parenti LR, 2008, ZOOL J LINN SOC-LOND, V154, P494, DOI 10.1111/j.1096-3642.2008.00417.x; Peterson BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037135; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schwarzer J, 2008, HYDROBIOLOGIA, V615, P201, DOI 10.1007/s10750-008-9561-3; Silvestro D, 2012, ORG DIVERS EVOL, V12, P335, DOI 10.1007/s13127-011-0056-0; Spakman W, 2010, NAT GEOSCI, V3, P562, DOI [10.1038/ngeo917, 10.1038/NGEO917]; Stecher G, 2020, MOL BIOL EVOL, V37, P1237, DOI 10.1093/molbev/msz312; Stelbrink B, 2012, EVOLUTION, V66, P2252, DOI 10.1111/j.1558-5646.2012.01588.x; Sutra N, 2019, EVOLUTION, V73, P1898, DOI 10.1111/evo.13821; Takehana Y, 2005, MOL PHYLOGENET EVOL, V36, P417, DOI 10.1016/j.ympev.2005.01.016; Villeneuve M, 2002, INT J EARTH SCI, V91, P524, DOI 10.1007/s005310100228; von Rintelen K, 2007, MOL PHYLOGENET EVOL, V45, P1033, DOI 10.1016/j.ympev.2007.07.002; von Rintelen T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098917; Whitten AJ, 2002, ECOLOGY SULAWESI; Wilson MEJ, 1999, PALAEOGEOGR PALAEOCL, V145, P303, DOI 10.1016/S0031-0182(98)00127-8; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	45	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0245316	10.1371/journal.pone.0245316	http://dx.doi.org/10.1371/journal.pone.0245316			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111145	Green Submitted, Green Published, gold			2022-12-26	WOS:000664642700003
J	Tran, NT; Labonne, M; Chung, MT; Wang, CH; Huang, KF; Durand, JD; Grudpan, C; Chan, B; Hoang, HD; Panfili, J				Ngan Trong Tran; Labonne, Maylis; Chung, Ming-Tsung; Wang, Chia-Hui; Huang, Kuo-Fang; Durand, Jean-Dominique; Grudpan, Chaiwut; Chan, Bunyeth; Huy Duc Hoang; Panfili, Jacques			Natal origin and migration pathways of Mekong catfish (Pangasius krempfi) using strontium isotopes and trace element concentrations in environmental water and otoliths	PLOS ONE			English	Article							WESTSLOPE CUTTHROAT TROUT; CLIMATE-CHANGE; FRESH-WATER; DESCRIBE MOVEMENTS; FISH; CHEMISTRY; RIVER; SALINITY; SR; CONSERVATION	To improve our knowledge of the migration pathway of a highly threatened fish species along the Mekong River, strontium isotope ratios (Sr-87/Sr-86) and 18 trace element concentrations were measured in the water and in the otoliths of an anadromous catfish, Pangasius krempfi, to infer its natal origin and potential migration pathways. Water was sampled at 18 locations along the mainstream, tributaries and distributaries of the Mekong River. To check for accuracy and precision, measurements of the Sr-87/Sr-86 ratios and trace element concentrations were then compared in two laboratories that use different analytical methods. Differences in trace element concentrations between locations were not significant and could not, therefore, be used to discriminate between migration pathways. However, the Mekong mainstream, tributaries and distributaries could all be discriminated using Sr isotopes. The Sr-87/Sr-86 profiles recorded in P. krempfi otoliths showed that there were three contingents with obligate freshwater hatching and variable spawning sites along the Mekong mainstream, from Phnom Penh (Cambodia) to Nong Khai (Thailand) or further. After hatching, the fish migrated more or less rapidly to the Mekong Delta and then settled for most of their lifetime in brackish water. Spawning habitats and migration routes may be threatened by habitat shifts and the increasing number of hydropower dams along the river, especially the contingents born above Khone Falls (Laos). The conservation of P. krempfi, as well as other migratory fish in the Mekong River, requires agreements, common actions and management by all countries along the Mekong River. This study highlighted the importance of using both Sr/Ca and Sr-87/Sr-86 ratios to understand life history of anadromous fishes as the Sr-87/Sr-86 ratio in the water was shown to be less effective than the Sr/Ca ratio in identifying movements between different saline areas.	[Ngan Trong Tran; Huy Duc Hoang] Univ Sci, Dept Ecol & Evolutionary Biol, Ho Chi Minh City, Vietnam; [Ngan Trong Tran; Huy Duc Hoang] Vietnam Natl Univ, Ho Chi Minh City, Vietnam; [Labonne, Maylis; Durand, Jean-Dominique; Panfili, Jacques] Univ Montpellier, CNRS, IFREMER, IRD,MARBEC, Montpellier, France; [Chung, Ming-Tsung] Univ Tokyo, Atmosphere & Ocean Res Inst, Tokyo, Japan; [Wang, Chia-Hui] Natl Taiwan Ocean Univ, Dept Environm Biol & Fisheries Sci, Keelung, Taiwan; [Huang, Kuo-Fang] Acad Sinica, Inst Earth Sci, Taipei, Taiwan; [Grudpan, Chaiwut] Ubon Ratchathani Univ, Fac Agr, Dept Fishery, Ubon Ratchathani, Thailand; [Chan, Bunyeth] Inland Fisheries Res & Dev Inst, Fisheries Adm, Wonders Mekong Project, Phnom Penh, Cambodia	Vietnam National University Hochiminh City; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Tokyo; National Taiwan Ocean University; Academia Sinica - Taiwan; Ubon Ratchathani University	Tran, NT (corresponding author), Univ Sci, Dept Ecol & Evolutionary Biol, Ho Chi Minh City, Vietnam.; Tran, NT (corresponding author), Vietnam Natl Univ, Ho Chi Minh City, Vietnam.	ttngan@hcmus.edu.vn	Huang, Kuo-Fang/M-2740-2019; Durand, Jean-Dominique/G-3713-2016; Huang, Kuo-Fang/G-2557-2015; Panfili, Jacques/J-9397-2016	Huang, Kuo-Fang/0000-0002-7858-4865; Durand, Jean-Dominique/0000-0002-0261-0377; Huang, Kuo-Fang/0000-0002-7858-4865; Chung, Ming-Tsung/0000-0003-3305-3339; CHAN, Bunyeth/0000-0001-9102-5534; TRAN, Trong-Ngan/0000-0001-7254-2835; Panfili, Jacques/0000-0003-0504-2384	CNRS INSU EC2CO (French National Grant EC2COBiohefect/Ecodyn//Dril/MicrobiEn - MODIM Mapping the natal origin and diversity of Mekong fishes for conservation purpose); CAMPUS FRANCE - PHC ORCHID [42957ZJ]; Vietnam National Foundation for Science and Technology Development (NAFOSTED) [106.06-2017.40]; Vietnam National University HoChiMinh City [GEN2019-18-01]; Joint Research Unit MARBEC Marine Biodiversity, Exploitation and Conservation (Univ Montpellier); French Institut de Recherche pour le Developpement (MARBEC Specific Action); Joint Research Unit MARBEC Marine Biodiversity, Exploitation and Conservation (Ifremer); Joint Research Unit MARBEC Marine Biodiversity, Exploitation and Conservation (CNRS); Joint Research Unit MARBEC Marine Biodiversity, Exploitation and Conservation (IRD)	CNRS INSU EC2CO (French National Grant EC2COBiohefect/Ecodyn//Dril/MicrobiEn - MODIM Mapping the natal origin and diversity of Mekong fishes for conservation purpose); CAMPUS FRANCE - PHC ORCHID; Vietnam National Foundation for Science and Technology Development (NAFOSTED)(National Foundation for Science & Technology Development (NAFOSTED)); Vietnam National University HoChiMinh City; Joint Research Unit MARBEC Marine Biodiversity, Exploitation and Conservation (Univ Montpellier); French Institut de Recherche pour le Developpement (MARBEC Specific Action); Joint Research Unit MARBEC Marine Biodiversity, Exploitation and Conservation (Ifremer); Joint Research Unit MARBEC Marine Biodiversity, Exploitation and Conservation (CNRS); Joint Research Unit MARBEC Marine Biodiversity, Exploitation and Conservation (IRD)	This study was supported by the CNRS INSU EC2CO (French National Grant EC2COBiohefect/Ecodyn//Dril/MicrobiEn - MODIM Mapping the natal origin and diversity of Mekong fishes for conservation purpose) to JP; the CAMPUS FRANCE - PHC ORCHID (PHC ORCHID 2019 PROJECT No 42957ZJ - Natal origin and diversity of fishes in the Mekong Delta) to JP and CHW; the Vietnam National Foundation for Science and Technology Development (NAFOSTED - grant number 106.06-2017.40) to HDH; the Vietnam National University HoChiMinh City (VNU-HCMgrant number GEN2019-18-01) to HDH; the Joint Research Unit MARBEC Marine Biodiversity, Exploitation and Conservation (Univ Montpellier, Ifremer, CNRS, IRD) (MARBEC "Projets Sud") to JP, French Institut de Recherche pour le Developpement (MARBEC Specific Action) to JP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avigliano E, 2020, J FISH BIOL, V97, P1187, DOI 10.1111/jfb.14500; Baird I, 2011, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2011-1.RLTS.T181328A7668262.en, DOI 10.2305/IUCN.UK.2011-1.RLTS.T181328A7668262.EN]; Baran E., 2005, FISHERIES BIOECOLOGY; Baran E., 2007, RELATIONSHIPS BIOECO; Barnett-Johnson R, 2005, CAN J FISH AQUAT SCI, V62, P2425, DOI 10.1139/F05-194; Barnett-Johnson R, 2008, LIMNOL OCEANOGR, V53, P1633, DOI 10.4319/lo.2008.53.4.1633; Baumgartner Lee J., 2021, Aquaculture and Fisheries, V6, P113, DOI 10.1016/j.aaf.2018.12.008; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Brennan SR, 2015, GEOCHIM COSMOCHIM AC, V149, P32, DOI 10.1016/j.gca.2014.10.032; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Carlson AK, 2017, J FISH BIOL, V90, P505, DOI 10.1111/jfb.13155; CGIAR, DROUGHT SAL INTR MEK; Chadwick OA, 1999, NATURE, V397, P491, DOI 10.1038/17276; Chan S, 1999, FISH MIGRATIONS SPAW; Chesney EJ, 1998, MAR ECOL PROG SER, V171, P261, DOI 10.3354/meps171261; Coates D., 2003, MEKONG DEV SERIES, V2; Correia AT, 2014, FISH RES, V149, P76, DOI 10.1016/j.fishres.2013.09.016; Dugan PJ, 2010, AMBIO, V39, P344, DOI 10.1007/s13280-010-0036-1; Duong YT., 2019, CAN THO U J SCI, V11, P81, DOI [10.22144/ctu.jen.2019.027, DOI 10.22144/CTU.JEN.2019.027]; Duponchelle F, 2016, J APPL ECOL, V53, P1511, DOI 10.1111/1365-2664.12665; Elsdon TS, 2008, OCEANOGR MAR BIOL, V46, P297, DOI 10.1201/9781420065756.ch7; Elsdon TS, 2002, CAN J FISH AQUAT SCI, V59, P1796, DOI 10.1139/F02-154; Ferguson JW, 2011, ENVIRON MANAGE, V47, P141, DOI 10.1007/s00267-010-9563-6; Ficke AD, 2007, REV FISH BIOL FISHER, V17, P581, DOI 10.1007/s11160-007-9059-5; Fukushima M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103722; Gillanders BM, 2005, AQUAT LIVING RESOUR, V18, P291, DOI 10.1051/alr:2005033; Gillanders BM., 2009, RELATIONS WATER CHEM; Gillanders BM, 2012, LIMNOL OCEANOGR, V57, P1136, DOI 10.4319/lo.2012.57.4.1136; GOLDSTEIN SJ, 1988, EARTH PLANET SC LETT, V87, P249, DOI 10.1016/0012-821X(88)90013-1; Hauser M, 2020, FRESHWATER BIOL, V65, P325, DOI 10.1111/fwb.13427; Hegg J.C., 2020, SIMULTANEOUS COLLECT, P1; Hegg JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129697; HERUT B, 1993, EARTH PLANET SC LETT, V120, P77, DOI 10.1016/0012-821X(93)90024-4; Hicks AS, 2010, J EXP MAR BIOL ECOL, V394, P86, DOI 10.1016/j.jembe.2010.07.018; Hobbs JA, 2005, MAR FRESHWATER RES, V56, P655, DOI 10.1071/MF04136; Hobbs JA, 2010, ENVIRON BIOL FISH, V89, P557, DOI 10.1007/s10641-010-9672-3; Hogan Z, 2007, J FISH BIOL, V71, P818, DOI 10.1111/j.1095-8649.2007.01549.x; Huang KF, 2011, GEOCHEM GEOPHY GEOSY, V12, DOI 10.1029/2010GC003372; Huang KF, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028253; Humston R, 2010, T AM FISH SOC, V139, P171, DOI 10.1577/T08-192.1; Hussy K, 2021, REV FISH SCI AQUAC, V29, P445, DOI 10.1080/23308249.2020.1760204; ICEM, 2010, MRC STRATEGIC ENV AS; IFRC, VIETN DROUGHT SALTW; Javor BJ, 2016, CAL COOP OCEAN FISH, V57, P109; Jochum KP, 2009, J ANAL ATOM SPECTROM, V24, P1237, DOI 10.1039/b905045k; Junge C, 2014, AQUAT CONSERV, V24, P297, DOI 10.1002/aqc.2391; Kano Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160151; Kennedy BP, 2000, CAN J FISH AQUAT SCI, V57, P2280, DOI 10.1139/cjfas-57-11-2280; Lauri H, 2012, HYDROL EARTH SYST SC, V16, P4603, DOI 10.5194/hess-16-4603-2012; Liu C, 2017, CHEM GEOL, V451, P38, DOI 10.1016/j.chemgeo.2017.01.008; Liu SC, 2007, GEO-SPAT INF SCI, V10, P51, DOI 10.1007/s11806-007-0011-6; Martin J, 2013, J FISH BIOL, V82, P1556, DOI 10.1111/jfb.12089; Martino JC, 2021, MAR FRESHWATER RES, V72, P922, DOI 10.1071/MF20196; Mcnamara A, 2010, CLIMATE CHANGE VULNE; McNutt R.H., 2000, ENV TRACERS SUBSURFA, P233, DOI DOI 10.1007/978-1-4615-4557-6_8; Mekong River Commission, 2005, OV HYDR MEK BAS; Mielach C, 2015, MRC TECH PAP; Milton DA, 2005, MAR ECOL PROG SER, V301, P279, DOI 10.3354/meps301279; MRC, 2003, STAT BAREP; Muhlfeld CC, 2012, CAN J FISH AQUAT SCI, V69, P906, DOI 10.1139/F2012-033; Nguyen AL, 2014, AMBIO, V43, P1059, DOI 10.1007/s13280-014-0519-6; Nguyen N.A., 2017, VIETNAM J SCI TECHNO, V59, P93, DOI [DOI 10.31276/VJSTE.59(1).93, 10.31276/VJSTE.59(1).93]; PALMER MR, 1992, GEOCHIM COSMOCHIM AC, V56, P2099, DOI 10.1016/0016-7037(92)90332-D; Panfili J., 2002, IFREMER IRD COEDITIO, DOI [10.1643/OT-03-266, DOI 10.1643/OT-03-266]; Panfili J, 2015, J EXP MAR BIOL ECOL, V467, P65, DOI 10.1016/j.jembe.2015.03.007; Peucker-Ehrenbrink B, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC002869; PIN C, 1994, ANAL CHIM ACTA, V298, P209, DOI 10.1016/0003-2670(94)00274-6; Poulsen A.F., 2004, MRC TECH PAP; Poulsen AF., 2002, MEKONG RIVER COMMISS; R Core Team, 2020, R LANG ENV STAT COMP; Rainboth W.J., 1996, FISHES CAMBODIAN MEK; Rainboth W.J., 2012, MISCELLANEOUS PUBLIC; Reist JD, 2006, AMBIO, V35, P381, DOI 10.1579/0044-7447(2006)35[381:AOOEOC]2.0.CO;2; RICHTER FM, 1992, EARTH PLANET SC LETT, V109, P11, DOI 10.1016/0012-821X(92)90070-C; Roberts Tyson R., 1995, Natural History Bulletin of the Siam Society, V43, P219; Rosman KJR, 1998, J PHYS CHEM REF DATA, V27, P1275, DOI 10.1063/1.556031; Ruttenberg BI, 2005, MAR ECOL PROG SER, V297, P273, DOI 10.3354/meps297273; Santos RV, 2015, HYDROL PROCESS, V29, P187, DOI 10.1002/hyp.10131; Shao YX, 2018, GEOCHIM COSMOCHIM AC, V239, P90, DOI 10.1016/j.gca.2018.07.036; Steinshouer D.W., 1997, MAPS SHOWING GEOLOGY; Stone R, 2016, SCIENCE, V354, P1084, DOI 10.1126/science.354.6316.1084; Strayer DL, 2010, J N AM BENTHOL SOC, V29, P344, DOI 10.1899/08-171.1; Strohm DD, 2017, T AM FISH SOC, V146, P732, DOI 10.1080/00028487.2017.1301994; Sturrock AM, 2014, MAR ECOL PROG SER, V500, P245, DOI 10.3354/meps10699; Thomas ORB, 2019, REV FISH SCI AQUAC, V27, P458, DOI 10.1080/23308249.2019.1627285; Tran NT, 2019, MAR FRESHWATER RES, V70, P1734, DOI 10.1071/MF18269; Trinh TQ, 2005, P 7 TECHN S MEK FISH, P217; Vengosh A, 1999, WATER RESOUR RES, V35, P1877, DOI 10.1029/1999WR900024; Tri VK, 2012, ENVIRON SCI ENG, P49, DOI 10.1007/978-94-007-3962-8_3; Vu A.V., 2020, J ECOHYDRAULICS, P1, DOI DOI 10.1080/24705357.2020.1855086; Vu V.A., 2009, Asian Fisheries Science, V22, P631; Walther BD, 2008, T AM FISH SOC, V137, P57, DOI 10.1577/T07-029.1; Walther BD, 2009, J GEOCHEM EXPLOR, V102, P181, DOI 10.1016/j.gexplo.2008.10.001; Wells BK, 2003, T AM FISH SOC, V132, P409, DOI 10.1577/1548-8659(2003)132<0409:RBWOAS>2.0.CO;2; Wootton R.J., 1992, FISH ECOLOGY, DOI [10.1007/978-94-011-3832-1, DOI 10.1007/978-94-011-3832-1]; Yang YH, 2014, CHEM GEOL, V385, P35, DOI 10.1016/j.chemgeo.2014.07.012	96	4	4	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252769	10.1371/journal.pone.0252769	http://dx.doi.org/10.1371/journal.pone.0252769			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111178	gold, Green Published, Green Submitted			2022-12-26	WOS:000664642700042
J	Castro, MM; Rosa, D; Ferro, AM; Faustino, A; Paulino, A; Bras, T; Machado, E; Cruz, CP; Belo, ADF; Nozes, P; Portugal, J; Ramoa, S; Mendonca, D; Simoes, F; Duarte, MF; Marum, L				Castro, Maria Miguel; Rosa, Daniela; Ferro, Ana M.; Faustino, Ana; Paulino, Ana; Bras, Teresa; Machado, Eliana; Cruz, Carla Pinto; Belo, Anabela D. F.; Nozes, Paula; Portugal, Joao; Ramoa, Sofia; Mendonca, Diogo; Simoes, Fernanda; Duarte, Maria F.; Marum, Liliana			Genetic diversity and population structure of Cynara cardunculus L. in southern Portugal	PLOS ONE			English	Article							GLOBE ARTICHOKE; WILD CARDOON; CULTIVATED CARDOON; PHENOLIC-COMPOUNDS; PROTEINASES; ENVIRONMENT; INFERENCE; SOFTWARE; DISTANCE; BIOMASS	Cynara cardunculus L. is a cardoon species native to the Mediterranean region, which is composed of three botanical taxa, each having distinct biological characteristics. The aim of this study was to examine wild populations of C. cardunculus established in Portugal, in order to determine their genetic diversity, geographic distribution, and population structure. Based on SSR markers, 121 individuals of C. cardunculus from 17 wild populations of the Portuguese Alentejo region were identified and analysed. Ten SSRs were found to be efficient markers in the genetic diversity analysis. The total number of alleles ranged from 9 to 17 per locus. The expected and observed means in heterozygosity, by population analysed, were 0.591 and 0.577, respectively. The wild population exhibited a high level of genetic diversity at the species level. The highest proportion of genetic variation was identified within a geographic group, while variation was lower among groups. Geographic areas having highest genetic diversity were identified in Alvito, Herdade da Aboboda, Herdade da Revilheira and Herdade de SAo RomAo populations. Moreover, significant genetic differentiation existed between wild populations from North-Alentejo geographic locations (Arraiolos, Evora, Monte da Chamine) and Centro Hortofruticola, compared with other populations. This study reports genetic diversity among a representative number of wild populations and genotypes of C. cardunculus from Portugal. These results will provide valuable information towards future management of C. cardunculus germplasm.	[Castro, Maria Miguel; Rosa, Daniela; Ferro, Ana M.; Faustino, Ana; Paulino, Ana; Bras, Teresa; Duarte, Maria F.; Marum, Liliana] Inst Politecn Beja IPBeja, Ctr Biotecnol Agr & Agroalimentar Alentejo CEBAL, Beja, Portugal; [Rosa, Daniela; Ferro, Ana M.; Faustino, Ana; Duarte, Maria F.; Marum, Liliana] MED Mediterranean Inst Agr Environm & Dev CEBAL, Beja, Portugal; [Paulino, Ana] Univ Lisbon, Ctr Ecol, Fac Ciencia Evolut & Environm Changes cE3c, Lisbon, Portugal; [Bras, Teresa] Univ Nova Lisboa, LAQV REQUIMTE, FCT, Caparica, Portugal; [Machado, Eliana] Univ Evora, MED Inst Mediterraneo Agr Ambiente & Dev, Ap 94, Evora, Portugal; [Cruz, Carla Pinto; Belo, Anabela D. F.] Univ Evora, Escola Ciencias & Tecnol, MED Inst Mediterraneo Agr, Ambiente & Dev, Ap 94, Evora, Portugal; [Cruz, Carla Pinto; Belo, Anabela D. F.] Univ Evora, Escola Ciencias & Tecnol, MED Inst Mediterraneo Agr, Dept Biol, Ap 94, Evora, Portugal; [Nozes, Paula; Portugal, Joao; Ramoa, Sofia] Inst Politecn Beja IPBeja, Dept Biociencias, Beja, Portugal; [Portugal, Joao] Inst Politecn Portalegre, VALORIZA Ctr Invest Valorizacao Recursos Endogeno, Portalegre, Portugal; [Mendonca, Diogo; Simoes, Fernanda] Inst Nacl Invest Agr & Vet IP INIAV IP, Unidade Estrateg Biotecnol & Recursos Genet, Oeiras, Portugal	Instituto Politecnico de Beja; Universidade de Lisboa; Universidade Nova de Lisboa; University of Evora; University of Evora; University of Evora; Instituto Politecnico de Beja; Instituto Politecnico de Portalegre	Marum, L (corresponding author), Inst Politecn Beja IPBeja, Ctr Biotecnol Agr & Agroalimentar Alentejo CEBAL, Beja, Portugal.; Marum, L (corresponding author), MED Mediterranean Inst Agr Environm & Dev CEBAL, Beja, Portugal.	liliana.marum@cebal.pt	Duarte, Fátima/H-5177-2013; Bras, Teresa/AAY-6262-2021; Castro, Maria Miguel/AAK-1395-2020	Duarte, Fátima/0000-0002-2223-7784; Bras, Teresa/0000-0002-8526-6320; Castro, Maria Miguel/0000-0001-5016-2567; Pinto Cruz, Carla/0000-0002-2818-5700; Belo, Anabela/0000-0002-4699-3824; Portugal e Vasconcelos Fernandes, Joao Martim de/0000-0002-3313-887X; Simoes, Fernanda/0000-0001-8503-7563; Marum, Liliana/0000-0002-6938-479X; Rosa, Daniela/0000-0002-9051-9433; Paulino, Ana Filipa Costa/0000-0003-0742-9005	Program Alentejo 2020, through the European Fund for Regional Development (FEDER) [ALT20-03-0145-FEDER-000038, ALT20-03-0145-FEDER039495]; FCT [CEECINST/00131/2018, SFRH/BD/145383/2019, SFRH/BD/110969/2015, UIDB/05183/2020]	Program Alentejo 2020, through the European Fund for Regional Development (FEDER); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The present work was supported by Program Alentejo 2020, through the European Fund for Regional Development (FEDER) (https://ec.europa.eu/regional_policy/pt/funding/erdf/) under the scope of ValBioTecCynara -Economic Valorisation of Cardoon (Cynara cardunculus): Study of natural variability and biotechnological applications (ALT20-03-0145-FEDER-000038) and MedCynaraBioTec -Selection of Cynara cardunculus genotypes for new biotechnological applications: the value chain improvement of cardoon, a well-adapted Mediterranean crop (ALT20-03-0145-FEDER039495). Authors also acknowledge FCT (https://www.fct.pt/) to Contrato -Programa to LM (CEECINST/00131/2018), PhD grant to AP (SFRH/BD/145383/2019), and TB (SFRH/BD/110969/2015). This work was also funded through FCT under the project UIDB/05183/2020 to Mediterranean Institute for Agriculture, Environment and Development (MED) (https://www.med.uevora.pt/pt/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquadro A, 2003, MOL ECOL NOTES, V3, P37, DOI 10.1046/j.1471-8286.2003.00343.x; Acquadro A, 2009, THEOR APPL GENET, V118, P1573, DOI 10.1007/s00122-009-1005-6; Barracosa P, 2018, GENET RESOUR CROP EV, V65, P17, DOI 10.1007/s10722-017-0579-0; Barracosa P, 2019, CHEM BIODIVERS, V16, DOI 10.1002/cbdv.201900498; Barracosa P, 2018, CHEM BIODIVERS, V15, DOI 10.1002/cbdv.201800110; Basnizki J., 1994, Plant Breeding Reviews, V12, P253; Ben Ammar I, 2015, SCI HORTIC-AMSTERDAM, V185, P76, DOI 10.1016/j.scienta.2015.01.017; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Bras T, 2020, SEP PURIF TECHNOL, V236, DOI 10.1016/j.seppur.2019.116283; Bras T, 2015, IND CROP PROD, V67, P137, DOI 10.1016/j.indcrop.2015.01.005; Ciancolini A, 2013, IND CROP PROD, V51, P145, DOI 10.1016/j.indcrop.2013.08.069; Curci PL, 2016, MOL ECOL RESOUR, V16, P562, DOI 10.1111/1755-0998.12457; Curci PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120589; D'Antuono I., 2018, PHYTOCHEMICALS VEGET, DOI [10.2174/97816810873991180101, DOI 10.2174/97816810873991180101]; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Falush D, 2003, GENETICS, V164, P1567; Fernandez J, 2006, IND CROP PROD, V24, P222, DOI 10.1016/j.indcrop.2006.06.010; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Gatto A, 2013, ANN BOT-LONDON, V112, P855, DOI 10.1093/aob/mct150; Gominho J, 2018, BIOMASS BIOENERG, V109, P257, DOI 10.1016/j.biombioe.2018.01.001; GOWER JC, 1966, BIOMETRIKA, V53, P325, DOI 10.1093/biomet/53.3-4.325; Hamrick J. L., 1990, PLANT POPULATION GEN; HARWOOD RR, 1968, P AM SOC HORTIC SCI, V92, P400; Khaldi S, 2012, CR BIOL, V335, P389, DOI 10.1016/j.crvi.2012.04.005; Lanteri S, 2006, THEOR APPL GENET, V112, P1532, DOI 10.1007/s00122-006-0256-8; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; NEI M, 1978, GENETICS, V89, P583; Noorani A, 2013, ACTA HORTIC, V983, P47, DOI 10.17660/ActaHortic.2013.983.4; Pagnotta MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178770; Pandino G, 2020, ACTA HORTIC, V1284, P279, DOI 10.17660/ActaHortic.2020.1284.37; Pandino G, 2011, FOOD CHEM, V126, P417, DOI 10.1016/j.foodchem.2010.11.001; Pandino G, 2010, J AGR FOOD CHEM, V58, P1026, DOI 10.1021/jf903311j; Pavan S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205988; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perrier X, 2006, J CJP; Petropoulos SA, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00459; Porras-Hurtado Liliana, 2013, Frontiers in Genetics, V4, P98, DOI 10.3389/fgene.2013.00098; Portis E, 2005, PLANT BREEDING, V124, P299, DOI 10.1111/j.1439-0523.2005.01098.x; Portis Ezio, 2012, BMC Res Notes, V5, P252, DOI 10.1186/1756-0500-5-252; Pritchard JK, 2000, GENETICS, V155, P945; Raccuia SA, 2004, AUST J AGR RES, V55, P693, DOI 10.1071/AR03038; RamalhoSantos M, 1997, PLANTA, V203, P204, DOI 10.1007/s004250050183; Ramasamy RK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-431; Ramos PAB, 2019, PHYTOCHEM REV, V18, P495, DOI 10.1007/s11101-019-09604-4; Ramos PAB, 2014, IND CROP PROD, V61, P460, DOI 10.1016/j.indcrop.2014.07.042; Ramos PAB, 2013, J AGR FOOD CHEM, V61, P8420, DOI 10.1021/jf402253a; Rottenberg A, 2005, ACTA HORTIC, P307, DOI 10.17660/ActaHortic.2005.681.40; Rottenberg A, 1996, GENET RESOUR CROP EV, V43, P53, DOI 10.1007/BF00126940; Sarmento AC, 2009, PLANTA, V230, P429, DOI 10.1007/s00425-009-0948-9; Scaglione D, 2016, SCI REP-UK, V6, DOI 10.1038/srep19427; Scaglione D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-454; Scavo A, 2020, J AGR FOOD CHEM, V68, P11946, DOI 10.1021/acs.jafc.0c03527; Sonnante G., 2003, Plant Genetic Resources: Characterization and Utilization, V1, P125, DOI 10.1079/PGR200319; Sonnante G, 2011, THEOR APPL GENET, V123, P1215, DOI 10.1007/s00122-011-1661-1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; VERISSIMO P, 1995, BIOTECHNOL LETT, V17, P621, DOI 10.1007/BF00129389; Wang MF, 2003, J AGR FOOD CHEM, V51, P601, DOI 10.1021/jf020792b; WIKLUND A, 1992, BOT J LINN SOC, V109, P75, DOI 10.1111/j.1095-8339.1992.tb00260.x	58	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252792	10.1371/journal.pone.0252792	http://dx.doi.org/10.1371/journal.pone.0252792			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106958	Green Published			2022-12-26	WOS:000664642200059
J	Ribeiro, ARD; Pereira-Silva, L; Vieira, JPS; Larridon, I; Ribeiro, VS; Felitto, G; Siqueira, GS; Alves-Araujo, A; Alves, M				de Oliveira Ribeiro, Andre Rodolfo; Pereira-Silva, Luciana; Silva Vieira, Jessika Paula; Larridon, Isabel; Ribeiro, Vinicius Santos; Felitto, Guilherme; Siqueira, Geovane Souza; Alves-Araujo, Anderson; Alves, Marccus			Cyperus prophyllatus: An endangered aquatic new species of Cyperus L. (Cyperaceae) with a exceptional spikelet disarticulation pattern among about 950 species, including molecular phylogenetic, anatomical and (micro)morphological data	PLOS ONE			English	Article							TAXONOMIC CHANGES; ATLANTIC FOREST; INSIGHTS; CLASSIFICATION; PERFORMANCE; CYPEROIDEAE; MORPHOLOGY; ONTOGENY; REGION; WATER	Cyperus prophyllatus, an endangered new species of Cyperus (Cyperaceae) from an aquatic ecosystem of the Atlantic Forest, Espirito Santo State, southeastern Brazil, is described and illustrated. The spikelet morphology of Cyperus prophyllatus is unique among the c. 950 species of Cyperus in having both a conspicuous spikelet prophyll and a corky rachilla articulation, which remain persistent at the base of the spikelet after disarticulation. Our molecular phylogenetic data support the placement of C. prophyllatus in the C(3)Cyperus Grade and more precisely in the clade representing Cyperus sect. Oxycaryum, which also includes C. blepharoleptos and C. gardneri. Anatomical and (micro)morphological analyses corroborate the phylogenetic results, provide a better understanding of ecology and taxonomy, as well as reveal compatibility of structures with survival and dispersion in aquatic environments. A distribution map, table with distinctive characters of allied species, and conservation status are made available.	[de Oliveira Ribeiro, Andre Rodolfo] Univ Fed Ceara, Dept Fitotecnia, Campus Pici, Fortaleza, Ceara, Brazil; [Pereira-Silva, Luciana] Univ Fed Santa Catarina, Dept Bot, Programa Posgrad Biol Fungos Algas & Plantas, Florianopolis, SC, Brazil; [Pereira-Silva, Luciana; Larridon, Isabel] Royal Bot Gardens, Surrey, England; [Silva Vieira, Jessika Paula] Univ Brasilia, Dept Bot, Campus Univ Darcy Ribeiro, Brasilia, DF, Brazil; [Larridon, Isabel] Univ Ghent, Dept Biol, Systemat & Evolutionary Bot Lab, Ghent, Belgium; [Ribeiro, Vinicius Santos] Univ Fed Ceara, Fac Educ, Fortaleza, Ceara, Brazil; [Felitto, Guilherme; Siqueira, Geovane Souza] Reserva Nat Vale, Linhares, ES, Brazil; [Alves-Araujo, Anderson] Univ Fed Espirito Santo, Dept Ciencias Agr & Biol, Sao Mateus, ES, Brazil; [Alves, Marccus] Univ Fed Pernambuco, Dept Bot, Recife, PE, Brazil	Universidade Federal do Ceara; Universidade Federal de Santa Catarina (UFSC); Royal Botanic Gardens, Kew; Universidade de Brasilia; Ghent University; Universidade Federal do Ceara; Universidade Federal do Espirito Santo; Universidade Federal de Pernambuco	Ribeiro, ARD (corresponding author), Univ Fed Ceara, Dept Fitotecnia, Campus Pici, Fortaleza, Ceara, Brazil.	andre_rodolf@hotmail.com			American Society of Plant Taxonomists; International Association for Plant Taxonomy; Society of Systematic Biologists	American Society of Plant Taxonomists; International Association for Plant Taxonomy; Society of Systematic Biologists	L. Pereira-Silva is grateful for the grants received from the American Society of Plant Taxonomists (Graduate Student Research Grant 2018), the International Association for Plant Taxonomy (Research Grants 2019), and the Society of Systematic Biologists (Mini-ARTS Awards 2018).	Adams CD., 1994, FLORA MESOAMERICANA, V6, P440; Alves M., 2015, JARDIM BOTANICO RIO; [Anonymous], 1971, ANATOMY MONOCOTYLEDO; [Anonymous], 2020, FLOR BRAS 2020 CONST; Arduim, 1997, MANUAL BASICO METODO; Armada C., 2019, ENV DISASTERS MARIAN, DOI 10.2139/ssrn.3442624; Bachman S, 2011, ZOOKEYS, P117, DOI 10.3897/zookeys.150.2109; Leite KRB, 2009, ACTA BOT BRAS, V23, P786, DOI 10.1590/S0102-33062009000300019; Bauters K, 2014, PHYTOTAXA, V166, P1; Boerema A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155222; Borges LAC, 2011, CIENC RURAL, V41, P1202, DOI 10.1590/S0103-84782011000700016; Crang R., 2018, PLANT ANATOMY CONCEP, DOI [10.1111/bjd.15909, DOI 10.1111/BJD.15909]; De Castro O, 2015, ANN BOT-LONDON, V115, P733, DOI 10.1093/aob/mcv001; Ribeiro ARD, 2015, PHYTOTAXA, V204, P153, DOI 10.11646/phytotaxa.204.2.6; DENTON MF, 1983, SYST BOT, V8, P250, DOI 10.2307/2418479; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; ELLIS R P, 1979, Bothalia, V12, P641; ELLIS R P, 1976, Bothalia, V12, P65; Ellison D, 2017, GLOBAL ENVIRON CHANG, V43, P51, DOI 10.1016/j.gloenvcha.2017.01.002; Fahn A, 1990, PLANT ANATOMY; Garcia-Avila F, 2019, INT SOIL WATER CONSE, V7, P286, DOI 10.1016/j.iswcr.2019.04.001; Geremew A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190810; Goetghebeur P., 1998, FAMILIES GENERA VASC, P141, DOI DOI 10.1007/978-3-662-03531-3_15; Haines R.W., 1983, SEDGES RUSHES E AFRI; HEFLER S. M., 2012, REV BRASILEIRA BIOCI, V10, P327; Hefler SM, 2010, ACTA BOT BRAS, V24, P708, DOI 10.1590/S0102-33062010000300014; IUCN, 2019, GUID USING IUCN RED; Jensen WA., 1962, BOT HISTOCHEMISTRY P; JOHANSSON ME, 1993, J ECOL, V81, P81, DOI 10.2307/2261226; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; KAUL RB, 1971, AM J BOT, V58, P808, DOI 10.2307/2441558; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kukenthal G., 1936, PFLANZENREICH REIGNI, V4, P1; Lamiaa FS, 2015, PAK J BOT, V47, P2339; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Larridon I, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01655; Larridon I, 2011, TAXON, V60, P868, DOI 10.1002/tax.603021; Larridon I, 2014, PHYTOTAXA, V166, P33, DOI 10.11646/phytotaxa.166.1.2; Larridon I, 2013, BOT J LINN SOC, V172, P106, DOI 10.1111/boj.12020; Larridon I, 2011, PLANT ECOL EVOL, V144, P327, DOI 10.5091/plecevo.2011.653; Larridon I, 2011, BOT J LINN SOC, V167, P19, DOI 10.1111/j.1095-8339.2011.01160.x; Leite VR, 2015, THESIS U ESTADUAL NO; Lopes JD, 2013, PHYTOTAXA, V84, P25, DOI 10.11646/phytotaxa.84.1.2; Lunkai D., 2010, FLORA CHINA, V23, P219; Estelita MEM, 2012, ACTA BOT BRAS, V26, P275, DOI 10.1590/S0102-33062012000200004; Martins S, 2007, ANAL ANATOMICA ULTRA; Martins S, 2015, AN ACAD BRAS CIENC, V87, P2177, DOI 10.1590/0001-3765201520150175; METCALFE CR, 1969, AM J BOT, V56, P782, DOI 10.2307/2440598; Miller Mark A., 2010, 2010 Gateway Computing Environments Workshop (GCE 2010), DOI 10.1109/GCE.2010.5676129; Muasya AM, 2014, NORD J BOT, V32, P106, DOI 10.1111/j.1756-1051.2012.01700.x; Muasya AM, 2002, BOT J LINN SOC, V138, P145, DOI 10.1046/j.1095-8339.2002.138002145.x; Muller J, 2010, PHYDE PHYLOGENETIC D; Nielsen ET., 1996, PHYSL PLANTS STRESS; Paiva José Geraldo Antunes de, 2006, Acta Bot. Bras., V20, P257, DOI 10.1590/S0102-33062006000200002; Pena-Arancibia JL, 2019, J HYDROL, V574, P946, DOI 10.1016/j.jhydrol.2019.04.064; Pereira-Silva L, 2018, SYST BOT, V43, P741, DOI 10.1600/036364418X697454; Pereira-Silva L, 2016, PHYTOTAXA, V284, P218, DOI 10.11646/phytotaxa.284.3.7; Pott VJ, 2011, BRAZ J BIOL, V71, P255, DOI 10.1590/S1519-69842011000200004; Prevedello JA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213368; Radford A.E., 1974, VASCULAR PLANT SYSTE; Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032; Reid CS, 2017, PLANT ECOL EVOL, V150, P343, DOI 10.5091/plecevo.2017.1262; Reid CS, 2014, BRITTONIA, V66, P292, DOI 10.1007/s12228-014-9324-6; Ribeiro André Rodolfo de Oliveira, 2015, Rodriguésia, V66, P571, DOI 10.1590/2175-7860201566221; Ribeiro MC, 2009, BIOL CONSERV, V142, P1141, DOI 10.1016/j.biocon.2009.02.021; Rocha DC, 2011, PLANTA DANINHA, V29, P7, DOI 10.1590/S0100-83582011000100002; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Santos AJ., 2016, FLORESTA ATLANTICA T, P303; Scatena VL., 1995, ACTA BOT BRAS, V9, P195, DOI 10.1590/S0102-33061995000200002; Sculthorpe CD., 1967, BIOL AQUATIC VASCULA; Semmouri I, 2019, BOT REV, V85, P1, DOI 10.1007/s12229-018-9202-0; Silva Arthur de Lima, 2019, Feddes Repertorium, V130, P65, DOI 10.1002/fedr.201800023; Somavilla NS, 2012, FLORA, V207, P212, DOI 10.1016/j.flora.2012.01.007; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stapleton C, 1994, J AM BAMBOO SOC, V12, P21; Thiers B, 2022, INDEX HERBARIORUM GL; Tucker GC., 1994, SYSTEMATIC BOT MONOG, V43, P1, DOI DOI 10.2307/25027842; Tucker GC., 2007, BOTANICA NO BRASIL P, P311; Tucker GC., 1983, SYST BOT MONOGR, V2, P1; Tucker GC, 2017, KEW BULL, V72, DOI 10.1007/S12225-017-9705-6; Tucker Gordon C., 2015, Rodriguésia, V66, P611, DOI 10.1590/2175-7860201566223; Tucker Gordon C., 2008, Harvard Papers in Botany, V13, P237, DOI 10.3100/1043-4534-13.2.237; Valdemarin KS, 2020, SYST BOT, V45, P537, DOI 10.1600/036364420X15935294613518; Valdemarin KS, 2019, BRITTONIA, V71, P318, DOI 10.1007/s12228-019-09567-y; Verloove F, 2017, PHYTOTAXA, V323, P275, DOI 10.11646/phytotaxa.323.3.6; World Wildlife Fund (WWF), 2020, PANT HAS 126 MOR FIR; World Wildlife Fund (WWF), 2017, CONS UNITS RISK ATTA	87	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0249737	10.1371/journal.pone.0249737	http://dx.doi.org/10.1371/journal.pone.0249737			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106952	Green Published, gold			2022-12-26	WOS:000664642200010
J	Edwards, HM; Dixon, R; de Beyl, CZ; Celhay, O; Rahman, M; Oo, MM; Lwin, T; Lin, Z; San, T; Han, KT; Nyunt, MM; Plowe, C; Stresman, G; Hall, T; Drakeley, C; Hamade, P; Aryal, S; Roca-Feltrer, A; Hlaing, T; Thi, A				Edwards, Hannah M.; Dixon, Ruth; de Beyl, Celine Zegers; Celhay, Olivier; Rahman, Mousumi; Oo, Moe Myint; Lwin, Thandar; Lin, Zaw; San, Thiri; Han, Kay Thwe; Nyunt, Myaing Myaing; Plowe, Christopher; Stresman, Gillian; Hall, Tom; Drakeley, Chris; Hamade, Prudence; Aryal, Siddhi; Roca-Feltrer, Arantxa; Hlaing, Thaung; Thi, Aung			Prevalence and seroprevalence of Plasmodium infection in Myanmar reveals highly heterogeneous transmission and a large hidden reservoir of infection	PLOS ONE			English	Article							DRIED BLOOD SPOTS; MALARIA TRANSMISSION; FALCIPARUM	Malaria incidence in Myanmar has significantly reduced over recent years, however, completeness and timeliness of incidence data remain a challenge. The first ever nationwide malaria infection and seroprevalence survey was conducted in Myanmar in 2015 to better understand malaria epidemiology and highlight gaps in Annual Parasite Index (API) data. The survey was a cross-sectional two-stage stratified cluster-randomised household survey conducted from July-October 2015. Blood samples were collected from household members for ultra-sensitive PCR and serology testing for P. falciparum and P. vivax. Data was gathered on demography and a priori risk factors of participants. Data was analysed nationally and within each of four domains defined by API data. Prevalence and seroprevalence of malaria were 0.74% and 16.01% nationwide, respectively. Prevalent infection was primarily asymptomatic P. vivax, while P. falciparum was predominant in serology. There was large heterogeneity between villages and by domain. At the township level, API showed moderate correlation with P. falciparum seroprevalence. Risk factors for infection included socioeconomic status, domain, and household ownership of nets. Three K13 P. falciparum mutants were found in highly prevalent villages. There results highlight high heterogeneity of both P. falciparum and P. vivax transmission between villages, accentuated by a large hidden reservoir of asymptomatic P. vivax infection not captured by incidence data, and representing challenges for malaria elimination. Village-level surveillance and stratification to guide interventions to suit local context and targeting of transmission foci with evidence of drug resistance would aid elimination efforts.	[Edwards, Hannah M.; Celhay, Olivier; Aryal, Siddhi] Malaria Consortium, Bangkok, Thailand; [Dixon, Ruth; Rahman, Mousumi; Oo, Moe Myint] Malaria Consortium, Yangon, Myanmar; [de Beyl, Celine Zegers; Hamade, Prudence; Roca-Feltrer, Arantxa] Malaria Consortium, London, England; [Lwin, Thandar; Lin, Zaw; San, Thiri; Hlaing, Thaung; Thi, Aung] Minist Hlth & Sports, Yangon, Myanmar; [Han, Kay Thwe] Dept Med Res, Parasitol Res Div, Yangon, Myanmar; [Nyunt, Myaing Myaing; Plowe, Christopher] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Stresman, Gillian; Hall, Tom; Drakeley, Chris] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, London, England	University System of Maryland; University of Maryland Baltimore; University of London; London School of Hygiene & Tropical Medicine	Roca-Feltrer, A (corresponding author), Malaria Consortium, London, England.	a.roca@malariaconsortium.org		Stresman, Gillian/0000-0002-6897-5459; Hall, Tom/0000-0002-9001-6684; Celhay, Olivier/0000-0002-2971-9110	Three Millennium Development Goals Fund (3MDG); United States President's Malaria Initiative (PMI)	Three Millennium Development Goals Fund (3MDG); United States President's Malaria Initiative (PMI)	Funding was supplied by United States President's Malaria Initiative (PMI) and Three Millennium Development Goals Fund (3MDG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams M, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-1038-z; [Anonymous], 2017, R LANG ENV STAT COMP, V55, P275; Ashley EA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-418; Bockarie MJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-15; Chu CS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002224; Cook J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025137; Corran P, 2007, TRENDS PARASITOL, V23, P575, DOI 10.1016/j.pt.2007.08.023; Corran PH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-195; Department of Public Health Myanmar, 2016, NAT STRAT PLAN INT M; Drakeley CJ, 2005, P NATL ACAD SCI USA, V102, P5108, DOI 10.1073/pnas.0408725102; GRAVES PM, 1987, B WORLD HEALTH ORGAN, V65, P869; Helb DA, 2015, P NATL ACAD SCI USA, V112, pE4438, DOI 10.1073/pnas.1501705112; Imwong M, 2007, J INFECT DIS, V195, P927, DOI 10.1086/512241; Kiattibutr K, 2017, INT J PARASITOL, V47, P163, DOI 10.1016/j.ijpara.2016.10.006; Lin E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009047; Lin JT, 2016, J INFECT DIS, V213, P1491, DOI 10.1093/infdis/jiv599; Lin JT, 2014, TRENDS PARASITOL, V30, P183, DOI 10.1016/j.pt.2014.02.004; Longley RJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005888; Longley RJ., 2020, IGG ANTIBODY RESPONS; Malaria Consortium, 2013, CONSULTANCY REPORT A; MEASURE Evaluation, 2019, FRAMEWORK EVALUATING; Michon P, 2007, AM J TROP MED HYG, V76, P997, DOI 10.4269/ajtmh.2007.76.997; Mu TT, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1567-0; Okell LC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2241; Ouattara A, 2015, AM J TROP MED HYG, V92, P1202, DOI 10.4269/ajtmh.14-0605; Singhasivanon P, 2013, SE ASIAN J TROP MED, V44, P73; Singhasivanon P, 2013, SE ASIAN J TROP MED, V44, P166; Slater HC, 2015, NATURE, V528, pS94, DOI 10.1038/nature16040; Smithuis FM, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-364; StataCorp, 2015, STAT STAT SOFTW REL; Tun KM, 2015, LANCET INFECT DIS, V15, P415, DOI 10.1016/S1473-3099(15)70032-0; Tusting LS, 2014, ADV PARASIT, V84, P151, DOI 10.1016/B978-0-12-800099-1.00003-X; Uplekar S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005323; WHO Global Malaria Programme, 2007, MALARIA ELIMINATION; World Health Organization, 2013, STRAT MAL EL GREAT M, V53; World Health Organization, 2015, WORLD MALARIA REPORT; Zainabadi K, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2025-3	37	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252957	10.1371/journal.pone.0252957	http://dx.doi.org/10.1371/journal.pone.0252957			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106995	Green Published, Green Accepted, gold			2022-12-26	WOS:000664642200065
J	Lu, HSY; Mintz, TH				Lu, Helen Shiyang; Mintz, Toben H.			Learning non-adjacent rules and non-adjacent dependencies from human actions in 9-month-old infants	PLOS ONE			English	Article							NONADJACENT DEPENDENCIES; BIOLOGICAL MOTION; SPEECH STREAM; LANGUAGE; SENSITIVITY; COMPUTATIONS; PERCEPTION; SEQUENCES; MUSIC	Seven month old infants can learn simple repetition patterns, such as we-fo-we, and generalize the rules to sequences of new syllables, such as ga-ti-ga. However, repetition rule learning in visual sequences seems more challenging, leading some researchers to claim that this type of rule learning applies preferentially to communicative stimuli. Here we demonstrate that 9-month-old infants can learn repetition rules in sequences of non-communicative dynamic human actions. We also show that when primed with these non-adjacent repetition patterns, infants can learn non-adjacent dependencies that involve memorizing the dependencies between specific human actions-patterns that prior research has shown to be difficult for infants in the visual domain and in speech. We discuss several possible mechanisms that account for the apparent advantage stimuli involving human action sequences has over other kinds of stimuli in supporting non-adjacent dependency learning. We also discuss possible implications for theories of language acquisition.	[Lu, Helen Shiyang; Mintz, Toben H.] Univ Southern Calif, Dept Psychol, Los Angeles, CA 90007 USA; [Mintz, Toben H.] Univ So Calif, Dept Linguist, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Lu, HSY; Mintz, TH (corresponding author), Univ Southern Calif, Dept Psychol, Los Angeles, CA 90007 USA.; Mintz, TH (corresponding author), Univ So Calif, Dept Linguist, Los Angeles, CA 90089 USA.	lushiyan@usc.edu; tmintz@usc.edu	Lu, Helen Shiyang/GZB-1630-2022	Lu, Helen Shiyang/0000-0003-3529-1226; Mintz, Toben/0000-0002-5437-7482	University of Southern California (USC) Graduate School Summer Research and Writing Grant; USC Dornsife College of Letters, Arts, and Sciences	University of Southern California (USC) Graduate School Summer Research and Writing Grant; USC Dornsife College of Letters, Arts, and Sciences	This research was supported in part by a University of Southern California (USC) Graduate School Summer Research and Writing Grant to Helen Shiyang Lu, and research funds from the USC Dornsife College of Letters, Arts, and Sciences to Toben Mintz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir O, 2014, VISION RES, V97, P83, DOI 10.1016/j.visres.2014.02.006; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Baldwin D, 2008, COGNITION, V106, P1382, DOI 10.1016/j.cognition.2007.07.005; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bettoni R, 2021, INFANCY, V26, P319, DOI 10.1111/infa.12384; Bonatti L, 2002, COGNITIVE PSYCHOL, V44, P388, DOI 10.1006/cogp.2002.0779; Bulf H, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01595; Bulf H, 2011, COGNITION, V121, P127, DOI 10.1016/j.cognition.2011.06.010; Cooper RP, 2006, PSYCHOL REV, V113, P887, DOI 10.1037/0033-295X.113.4.887; Creel SC, 2004, J EXP PSYCHOL LEARN, V30, P1119, DOI 10.1037/0278-7393.30.5.1119; Csibra G, 2016, DEV PSYCHOL, V52, P521, DOI 10.1037/dev0000083; Dawson C, 2009, COGNITION, V111, P378, DOI 10.1016/j.cognition.2009.02.010; de Diego-Balaguer R, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00044; Endress AD, 2011, COGNITIVE PSYCHOL, V63, P141, DOI 10.1016/j.cogpsych.2011.07.001; Endress AD, 2009, TRENDS COGN SCI, V13, P348, DOI 10.1016/j.tics.2009.05.005; Fitch WT, 2014, ANN NY ACAD SCI, V1316, P87, DOI 10.1111/nyas.12406; FOX R, 1982, SCIENCE, V218, P486, DOI 10.1126/science.7123249; Gebhart AL, 2009, PSYCHON B REV, V16, P486, DOI 10.3758/PBR.16.3.486; Gomez R, 2005, INFANCY, V7, P183, DOI 10.1207/s15327078in0702_4; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Hauser MD, 2001, COGNITION, V78, pB53, DOI 10.1016/S0010-0277(00)00132-3; Johnson SP, 2009, INFANCY, V14, P2, DOI 10.1080/15250000802569611; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lashley KS., 1951, CEREBRAL MECH BEHAV, P25; Lazareva OF, 2008, BEHAV PROCESS, V77, P199, DOI 10.1016/j.beproc.2007.11.009; Li J, 2015, P 37 ANN M COGNITIVE, P1350; Lisboa IC, 2020, INFANT BEHAV DEV, V60, DOI 10.1016/j.infbeh.2020.101450; Lu HS, DYNAMIC ACTION FACIL; Marchetto E, 2015, J CHILD LANG, V42, P873, DOI 10.1017/S0305000914000452; Marcus GF, 2007, PSYCHOL SCI, V18, P387, DOI 10.1111/j.1467-9280.2007.01910.x; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Monroy CD, 2019, NEUROPSYCHOLOGIA, V126, P92, DOI 10.1016/j.neuropsychologia.2017.05.007; Mueller JL, 2012, P NATL ACAD SCI USA, V109, P15953, DOI 10.1073/pnas.1204319109; Newport EL, 2004, COGNITIVE PSYCHOL, V48, P127, DOI 10.1016/S0010-0285(03)00128-2; NEWTSON D, 1976, J EXP SOC PSYCHOL, V12, P436, DOI 10.1016/0022-1031(76)90076-7; Oakes LM, 2019, BEHAV RES METHODS, V51, P1943, DOI 10.3758/s13428-019-01244-y; Pelucchi B, 2009, COGNITION, V113, P244, DOI 10.1016/j.cognition.2009.07.011; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Rabagliati H, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12704; Reid VM, 2019, NEUROPSYCHOLOGIA, V126, P69, DOI 10.1016/j.neuropsychologia.2017.11.005; Romberg AR, 2013, COGNITIVE SCI, V37, P1290, DOI 10.1111/cogs.12050; RStudio Team, 2020, RSTUDIO INT DEV ENV; Saffran JR, 2007, COGNITION, V105, P669, DOI 10.1016/j.cognition.2006.11.004; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1999, COGNITION, V70, P27, DOI 10.1016/S0010-0277(98)00075-4; Salo VC, 2019, DEV PSYCHOBIOL, V61, P390, DOI 10.1002/dev.21779; Santelmann LM, 1998, COGNITION, V69, P105, DOI 10.1016/S0010-0277(98)00060-2; Simion F, 2008, P NATL ACAD SCI USA, V105, P809, DOI 10.1073/pnas.0707021105; Stahl AE, 2014, CHILD DEV, V85, P1821, DOI 10.1111/cdev.12247; Teinonen T, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-21; Toro JM, 2005, PERCEPT PSYCHOPHYS, V67, P867, DOI 10.3758/BF03193539; van der Kant A, 2020, DEV COGN NEUROS-NETH, V45, DOI 10.1016/j.dcn.2020.100819; Vouloumanos A, 2007, DEVELOPMENTAL SCI, V10, P159, DOI 10.1111/j.1467-7687.2007.00549.x; Vouloumanos A, 2014, COGNITIVE SCI, V38, P1675, DOI 10.1111/cogs.12128; Wang FH, 2019, COGNITIVE PSYCHOL, V113, DOI 10.1016/j.cogpsych.2019.101223; Wang FH, 2018, J EXP PSYCHOL LEARN, V44, P604, DOI 10.1037/xlm0000483; Wang FH, 2017, J EXP PSYCHOL GEN, V146, P1738, DOI 10.1037/xge0000384; Wilson B, 2020, TOP COGN SCI, V12, P843, DOI 10.1111/tops.12381; Wilson M, 2005, PSYCHOL BULL, V131, P460, DOI 10.1037/0033-2909.131.3.460; Zacks JM, 2001, NAT NEUROSCI, V4, P651, DOI 10.1038/88486	61	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252959	10.1371/journal.pone.0252959	http://dx.doi.org/10.1371/journal.pone.0252959			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RW	34106999	gold, Green Published			2022-12-26	WOS:000664642200066
J	Lee, SY; Han, JH; Song, HK; Kim, NJ; Yi, N; Kyong, JS; Choi, BY				Lee, Sang-Yeon; Han, Jin Hee; Song, Hoo-Kang; Kim, Namju Justin; Yi, Nayoung; Kyong, Jeong-Sug; Choi, Byung Yoon			Central auditory maturation and behavioral outcomes after cochlear implantation in prelingual auditory neuropathy spectrum disorder related to OTOF variants (DFNB9): Lessons from pilot study	PLOS ONE			English	Article							HEARING-LOSS; EVOKED POTENTIALS; CHILDREN; OTOFERLIN; MANAGEMENT; RESPONSES; DEAFNESS; INFANTS	The cortical auditory evoked potential (CAEP)-based P1 component acts as a biomarker for cochlear implantation (CI) outcomes in children with auditory neuropathy spectrum disorder (ANSD). To date, early intervention primarily before the age of two years and six months of CI usage is necessary and sufficient to achieve age-appropriate cortical maturation and good prognosis. However, varying degrees of neural dyssynchrony, resulting from the etiological heterogeneity of ANSD, may preclude uniform application of this hypothesis to ensure auditory cortical maturation. Thus, a focused evaluation of those carrying OTOF variants, which may be the salient molecular etiology of prelingual ANSD, would circumvent the issue of heterogeneity. Here, we sought to provide a much better understanding of the brain perspectives (i.e., P1 maturation) in OTOF-associated ANSD subjects and set the stage for an optimal strategy to enhance language development. We conducted a preliminary study comprising 10 subjects diagnosed with OTOF-related ANSD who underwent CI by a single surgeon and subsequently underwent measurements of the P1 component. We observed that DFNB9 subjects who received CI after 2 years of age exhibited "absent" or "anomalous" P1 components that correspond to delayed language development. However, timely implantation, as early as 12 months of age per se, might be insufficient to achieve age-appropriate cortical maturation of DFNB9 in cases with six to seven months of device use. This suggests the importance of sustained rehabilitation in DFNB9 than in other etiologies. Indeed, an additional follow-up study showed that a reduction in P1 latency was linked to an improvement in auditory performance. Collectively, our results suggest that central auditory maturation and successful outcome of CI in DFNB9 may have more demanding requirements, that is, earlier implantation and more sustained rehabilitation. We believe that the current study opens a new path toward genome-based neuroimaging in the field of hearing research.	[Lee, Sang-Yeon] Seoul Natl Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seoul, South Korea; [Han, Jin Hee; Yi, Nayoung; Choi, Byung Yoon] Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea; [Song, Hoo-Kang; Kyong, Jeong-Sug] Hallym Univ Grad Studies, HUGS Ctr Hearing & Speech Res, Dept Audiol & Speech Language Pathol, Seoul, South Korea; [Kim, Namju Justin] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA; [Yi, Nayoung] Chungnam Natl Univ, Coll Med, Dept Otorhinolaryngol Head & Neck Surg, Daejeon, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Hallym University; Vanderbilt University; Chungnam National University	Choi, BY (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Otorhinolaryngol Head & Neck Surg, Seongnam, South Korea.; Kyong, JS (corresponding author), Hallym Univ Grad Studies, HUGS Ctr Hearing & Speech Res, Dept Audiol & Speech Language Pathol, Seoul, South Korea.	j.kyong2@googlemail.com; choiby2010@gmail.com		Choi, Byung Yoon/0000-0001-5125-2118	SNUBH Research Fund [00-2020-13-2018-015, 00-2020-13-2016-014, 00-2020-13-2015-019]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2018R1A2B6004788]	SNUBH Research Fund; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	This research was supported by the SNUBH Research Fund (no.00-2020-13-2018-015, 00-2020-13-2016-014, and 00-2020-13-2015-019 to B.Y.C) and Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2018R1A2B6004788 to J.S.K).	Bae SH, 2013, GENE, V522, P65, DOI 10.1016/j.gene.2013.02.057; Berlin CI, 2010, INT J AUDIOL, V49, P30, DOI 10.3109/14992020903160892; Bidelman GM, 2018, J AM ACAD AUDIOL, V29, P164, DOI 10.3766/jaaa.16167; British Society of Audiology, 2016, RECOMMENDED PROCEDUR; Campbell J., 2011, SEMIN HEAR; Campbell JD., 2011, SEMIN HEAR; Cardon G, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00469; Cardon G, 2013, INT J AUDIOL, V52, P577, DOI 10.3109/14992027.2013.799786; Cardon G, 2012, J AM ACAD AUDIOL, V23, P396, DOI 10.3766/jaaa.23.6.3; Chang MY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001996; Choi BY, 2009, CLIN GENET, V75, P237, DOI 10.1111/j.1399-0004.2008.01128.x; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dorman MF, 2007, J COMMUN DISORD, V40, P284, DOI 10.1016/j.jcomdis.2007.03.007; Emami SF, 2019, INDIAN J OTOLARYNGOL, V71, P238, DOI 10.1007/s12070-018-1445-x; Gilley PM, 2006, CLIN NEUROPHYSIOL, V117, P1772, DOI 10.1016/j.clinph.2006.04.018; Hassan DM, 2011, INT J AUDIOL, V50, P41, DOI 10.3109/14992027.2010.520035; Hood LJ., 2011, SEMIN HEAR; Hosoya M, 2018, LARYNGOSCOPE INVEST, V3, P388, DOI 10.1002/lio2.210; Jin YJ, 2014, INT J PEDIATR OTORHI, V78, P1030, DOI 10.1016/j.ijporl.2014.03.033; Kim BJ., 2018, J TRANSL MED, V16, P1; Kim BJ, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1708-z; Kim SH, 2016, INT J PEDIATR OTORHI, V86, P63, DOI 10.1016/j.ijporl.2016.04.013; Kraus N, 1996, SCIENCE, V273, P971, DOI 10.1126/science.273.5277.971; Lee SY, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10090672; Lee SY, 2020, CLIN EXP OTORHINOLAR, V13, P113, DOI 10.21053/ceo.2019.00990; Lee SY, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174174; Lee SJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72555-w; Manchaiah VKC, 2011, INT J PEDIATR OTORHI, V75, P151, DOI 10.1016/j.ijporl.2010.11.023; Michalski N, 2017, ELIFE, V6, DOI 10.7554/eLife.31013; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pallas SL, 2001, TRENDS NEUROSCI, V24, P417, DOI 10.1016/S0166-2236(00)01853-1; Pangrsic T, 2010, NAT NEUROSCI, V13, P869, DOI 10.1038/nn.2578; Pantelemon Cristina, 2019, J Med Life, V12, P457, DOI 10.25122/jml-2019-0096; Park JH, 2017, EAR HEARING, V38, pE316, DOI 10.1097/AUD.0000000000000437; Paulina P., 2019, INT J PEDIATR OTORHI, V126; Persic D, 2020, HEARING RES, V397, DOI 10.1016/j.heares.2020.107976; Roush P, 2011, AM J AUDIOL, V20, P159, DOI 10.1044/1059-0889(2011/10-0032); Roux I, 2006, CELL, V127, P277, DOI 10.1016/j.cell.2006.08.040; Sanfins MD., 2019, HUMAN AUDITORY SYSTE; Sharma A, 1997, EVOKED POTENTIAL, V104, P540, DOI 10.1016/S0168-5597(97)00050-6; Sharma A, 2005, HEARING RES, V203, P134, DOI 10.1016/j.heares.2004.12.010; Sharma A, 2002, NEUROREPORT, V13, P1365, DOI 10.1097/00001756-200207190-00030; Sharma A, 2016, OTOL NEUROTOL, V37, pE26, DOI 10.1097/MAO.0000000000000904; Sharma A, 2015, HEARING RES, V330, P221, DOI 10.1016/j.heares.2015.06.001; Sharma A, 2011, INT J AUDIOL, V50, P98, DOI 10.3109/14992027.2010.542492; Sharma Anu, 2002, Ear and Hearing, V23, P532, DOI 10.1097/00003446-200212000-00004; Starr A., 2001, AUDITORY NEUROPATHY, P37; Teagle HFB, 2010, EAR HEARING, V31, P325, DOI 10.1097/AUD.0b013e3181ce693b; Wu CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138575; Wunderlich JL, 2006, HEARING RES, V212, P185, DOI 10.1016/j.heares.2005.11.010; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693; Zak M, 2011, INT J MOL MED, V28, P311, DOI 10.3892/ijmm.2011.716	52	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252717	10.1371/journal.pone.0252717	http://dx.doi.org/10.1371/journal.pone.0252717			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097718	gold, Green Published			2022-12-26	WOS:000664640700015
J	Fujiwara, T; Ogura, K; Healey, J				Fujiwara, Tomohiro; Ogura, Koichi; Healey, John			Greater travel distance to specialized facilities is associated with higher survival for patients with soft-tissue sarcoma: US nationwide patterns	PLOS ONE			English	Article							STAGE BREAST-CANCER; RADIATION-THERAPY; GEOGRAPHIC ACCESS; PROGNOSTIC-SIGNIFICANCE; RECTAL-CANCER; DIAGNOSIS; CARE; EXTREMITY; SERIES; TIME	Purpose The survival impact of geographic access to specialized care remains unknown in patients with soft-tissue sarcomas (STS). This study aimed to clarify the association between the patient travel distance and survival outcome and investigate the factors lying behind it. Methods A total of 34 528 patients with STS registered in the National Cancer Data Base, diagnosed from 2004-2016, were investigated. Results Tumor stage correlated with travel distance: patients with metastatic disease stayed closer to home. However, the type of facility showed greatest variation: 37.0%, 51.0%, 73.5%, and 75.9% of patients with <= 10 miles, 10.1-50 miles, 50.1-100 miles, and >100 miles, respectively (P<0.001), had a sarcoma care at academic/research centers. On a multivariable analysis, reduced mortality risk was associated with longer (versus short) travel distance (>100 miles: HR = 0.877; P = 0.001) and management at academic/research (versus non-academic/research) centers (HR = 0.857; P<0.001). The greatest divergence was seen in patients traveling very long distance (>100 miles) to an academic/research center, with a 26.9% survival benefit (HR = 0.731; P<0.001), compared with those traveling short distance (<= 10 miles; 95.4% living in metropolitan area) to a non-academic/research center. There was no significant correlation between travel distance and survival in patients who had care at academic/research centers, whereas a survival benefit of management at academic/research centers was observed in every group of travel distance, regardless of tumor stage. Conclusions This national study demonstrated that increased travel distance was associated with superior survival, attributable to a higher proportion of patients receiving sarcoma care at distant academic/research centers. These data support centralized care for STS. Overcoming referral and travel barriers may enable more patients to be treated at specialized centers and may further improve survival rates for patients with STS, even when it imposes an increased travel burden.	[Fujiwara, Tomohiro; Ogura, Koichi; Healey, John] Mem Sloan Kettering Canc Ctr, Dept Surg, Orthopaed Serv, 1275 York Ave, New York, NY 10021 USA; [Fujiwara, Tomohiro] Okayama Univ, Dept Orthopaed Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan	Memorial Sloan Kettering Cancer Center; Okayama University	Healey, J (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Surg, Orthopaed Serv, 1275 York Ave, New York, NY 10021 USA.	healeyj@mskcc.org			National Institutes of Health/National Cancer Institute Cancer Center Support Grant [P30 CA008748]; Yasuda Medical Foundation; Japan Society for the Promotion of Science [201860336]	National Institutes of Health/National Cancer Institute Cancer Center Support Grant; Yasuda Medical Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The institution of one or more of the authors (J. Healey) has received funding from the National Institutes of Health/National Cancer Institute Cancer Center Support Grant, P30 CA008748. The institution of one or more of the authors (T. Fujiwara) has received a grant-in-aid for overseas research fellowships from the Yasuda Medical Foundation (2018), and a grant-in-aid for overseas research fellowships from the Japan Society for the Promotion of Science (201860336). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambroggi M, 2015, ONCOLOGIST, V20, P1378, DOI 10.1634/theoncologist.2015-0110; Athas WF, 2000, J NATL CANCER I, V92, P269, DOI 10.1093/jnci/92.3.269; Baade PD, 2011, MED J AUSTRALIA, V195, P350, DOI 10.5694/mja10.11204; Baldwin LM, 2008, J RURAL HEALTH, V24, P390, DOI 10.1111/j.1748-0361.2008.00186.x; Benjamin I, 2011, GYNECOL ONCOL, V121, P83, DOI 10.1016/j.ygyno.2010.11.028; BERLIN O, 1990, ACTA ORTHOP SCAND, V61, P475, DOI 10.3109/17453679008993568; Blay JY, 2017, ANN ONCOL, V28, P2852, DOI 10.1093/annonc/mdx484; Blay JY, 2018, CURR OPIN ONCOL, V30, P240, DOI 10.1097/CCO.0000000000000461; BOSANAC EM, 1976, MED CARE, V14, P616, DOI 10.1097/00005650-197607000-00006; Brooks AD, 1998, ANN SURG ONCOL, V5, P41, DOI 10.1007/BF02303763; Campbell NC, 2001, BRIT J CANCER, V84, P910, DOI 10.1054/bjoc.2000.1708; Celaya MO, 2010, RURAL REMOTE HEALTH, V10; Derbel O, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0158406; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dickens C, 2014, INT J CANCER, V135, P2173, DOI 10.1002/ijc.28861; GAYNOR JJ, 1992, J CLIN ONCOL, V10, P1317, DOI 10.1200/JCO.1992.10.8.1317; Goodman DC, 1997, AM J PUBLIC HEALTH, V87, P1144, DOI 10.2105/AJPH.87.7.1144; Gronchi A, 2010, ANN SURG, V251, P506, DOI 10.1097/SLA.0b013e3181cf87fa; Heslin MJ, 1996, J CLIN ONCOL, V14, P473, DOI 10.1200/JCO.1996.14.2.473; Huang B, 2009, J RURAL HEALTH, V25, P366, DOI 10.1111/j.1748-0361.2009.00245.x; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Jong KE, 2004, MED J AUSTRALIA, V180, P618, DOI 10.5694/j.1326-5377.2004.tb06123.x; Koea JB, 2003, ANN SURG ONCOL, V10, P432, DOI 10.1245/ASO.2003.05.014; Lahat G, 2008, ANN SURG ONCOL, V15, P2739, DOI 10.1245/s10434-008-9970-6; Lee B, 2014, ONCOLOGIST, V19, P283, DOI 10.1634/theoncologist.2013-0343; Lintz F, 2012, ORTHOP TRAUMATOL-SUR, V98, pS9, DOI 10.1016/j.otsr.2012.04.006; Liu CY, 2010, ANN SURG ONCOL, V17, P2102, DOI 10.1245/s10434-010-0997-0; Lurkin A, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-150; Massarweh NN, 2014, J CLIN ONCOL, V32, P942, DOI 10.1200/JCO.2013.52.3845; Mohanty S, 2014, J SURG ONCOL, V109, P629, DOI 10.1002/jso.23568; Monson JRT, 2014, ANN SURG, V260, P625, DOI 10.1097/SLA.0000000000000928; Murphy CT, 2016, J CLIN ONCOL, V34, P169, DOI 10.1200/JCO.2015.61.5906; Onega T, 2008, CANCER-AM CANCER SOC, V112, P909, DOI 10.1002/cncr.23229; Parsons MA, 2007, J RURAL HEALTH, V23, P25, DOI 10.1111/j.1748-0361.2006.00064.x; PEABODY TD, 1993, CLIN ORTHOP RELAT R, P19; Pisters PWT, 1996, J CLIN ONCOL, V14, P1679, DOI 10.1200/JCO.1996.14.5.1679; ROOSER B, 1987, ACTA ORTHOP SCAND, V58, P516, DOI 10.3109/17453678709146391; RYDHOLM A, 1983, ACTA ORTHOP SCAND, V54, P333, DOI 10.3109/17453678308996581; Satasivam P, 2014, BJU INT, V113, P57, DOI 10.1111/bju.12459; Schmitz R, 2021, ANN SURG ONCOL, V28, P114, DOI 10.1245/s10434-020-08730-0; Schroen AT, 2005, J CLIN ONCOL, V23, P7074, DOI 10.1200/JCO.2005.06.032; Scoggins JF, 2012, J RURAL HEALTH, V28, P54, DOI 10.1111/j.1748-0361.2011.00371.x; Shi RH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1228-7; Stitzenberg KB, 2007, ARCH DERMATOL, V143, P991, DOI 10.1001/archderm.143.8.991; Stojadinovic A, 2002, J CLIN ONCOL, V20, P4344, DOI 10.1200/JCO.2002.07.154; Stojadinovic A, 2002, ANN SURG, V235, P424, DOI 10.1097/00000658-200203000-00015; Toro JR, 2006, INT J CANCER, V119, P2922, DOI 10.1002/ijc.22239; Tracey E, 2014, INT J GYNECOL CANCER, V24, P1232, DOI 10.1097/IGC.0000000000000213; Wang EH, 2014, INT J RADIAT ONCOL, V90, P993, DOI 10.1016/j.ijrobp.2014.06.038; Wang FH, 2008, PROF GEOGR, V60, P54, DOI 10.1080/00330120701724087; Weitz J, 2003, J CLIN ONCOL, V21, P2719, DOI 10.1200/JCO.2003.02.026; Wendt R, 2019, CANCER EPIDEMIOL, V61, P119, DOI 10.1016/j.canep.2019.05.012; Zagars GK, 2003, CANCER, V97, P2530, DOI 10.1002/cncr.11365	53	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252381	10.1371/journal.pone.0252381	http://dx.doi.org/10.1371/journal.pone.0252381			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086725	gold, Green Published			2022-12-26	WOS:000664640100057
J	Jin, XD; Liu, WY; Miao, J; Tai, ZP; Li, LY; Guan, PP; Liu, JX				Jin, XiaoDong; Liu, WenYe; Miao, Jing; Tai, ZhiPeng; Li, LingYa; Guan, PengPeng; Liu, Jing-Xia			Copper ions impair zebrafish skeletal myofibrillogenesis via epigenetic regulation	FASEB JOURNAL			English	Article						Cu2+; histone protein; methylation; myofibrillogenesis; smyd1b; smyd5	TRANSCRIPTIONAL RESPONSES; HISTONE METHYLTRANSFERASE; MUSCLE; DEFICIENCY; MECHANISMS; SMYD1	Unbalanced copper (Cu2+) homeostasis is associated with the developmental defects of vertebrate myogenesis, but the underlying molecular mechanisms remain elusive. In this study, it was found that Cu2+ stressed zebrafish embryos and larvae showed reduced locomotor speed as well as loose and decreased myofibrils in skeletal muscle, coupled with the downregulated expression of muscle fiber markers mylpfa and smyhc1l and the irregular arrangement of myofibril and sarcomere. Meanwhile, the Cu2+ stressed zebrafish embryos and larvae also showed significant reduction in the expression of H3K4 methyltransferase smyd1b transcripts and H3K4me3 protein as well as in the binding enrichment of H3K4me3 on gene mylpfa promoter in skeletal muscle cells, suggesting that smyd1b-H3K4me3 axis mediates the Cu2+-induced myofibrils specification defects. Additionally, whole genome DNA methylation sequencing unveiled that the gene smyd5 exhibited significant promoter hyper-methylation and increased expression in Cu2+ stressed embryos, and the ectopic expression of smyd5 in zebrafish embryos also induced the myofibrils specification defects as those observed in Cu2+ stressed embryos. Moreover, Cu2+ was shown to suppress myofibrils specification and smyd1b promoter transcriptional activity directly independent of the integral function of copper transporter cox17 and atp7b. All these data may shed light on the linkage of unbalanced copper homeostasis with specific gene promoter methylation and epigenetic histone protein modification as well as the resultant signaling transduction and the myofibrillogenesis defects.	[Jin, XiaoDong; Liu, WenYe; Miao, Jing; Tai, ZhiPeng; Li, LingYa; Liu, Jing-Xia] Huazhong Agr Univ, Minist Agr, Key Lab Freshwater Anim Breeding, Coll Fisheries, Wuhan 430070, Peoples R China; [Guan, PengPeng] Huazhong Agr Univ, Coll Informat, Hubei Engn Technol Res Ctr Agr Big Data, Agr Bioinformat Key Lab Hubei Prov, Wuhan, Peoples R China	Huazhong Agricultural University; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University	Liu, JX (corresponding author), Huazhong Agr Univ, Minist Agr, Key Lab Freshwater Anim Breeding, Coll Fisheries, Wuhan 430070, Peoples R China.	ichliu@mail.hzau.edu.cn			National Natural Science Foundation of China [32070807]; National Key R&D Program of China [2018YFD0900101, 2662018JC024]; Fundamental Research Funds for the Central University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Fundamental Research Funds for the Central University	This work was supported by the National Natural Science Foundation of China (Program No. 32070807 to J.--X. L.), by the National Key R&D Program of China (2018YFD0900101), and by the project 2662018JC024 of the Fundamental Research Funds for the Central University (to J.--X. L.)	Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Attar N, 2020, SCIENCE, V369, P59, DOI 10.1126/science.aba8740; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P217, DOI 10.1081/CLT-100102421; Beck DB, 2012, GENE DEV, V26, P325, DOI 10.1101/gad.177444.111; Brero A, 2009, CLONING STEM CELLS, V11, P319, DOI 10.1089/clo.2008.0083; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Cai MX, 2019, FASEB J, V33, P6209, DOI 10.1096/fj.201801578R; Chen MY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02599; Coda DM, 2015, CELL CYCLE, V14, P1389, DOI 10.1080/15384101.2015.1005993; Coughlin DJ, 1999, BIOL BULL, V196, P145, DOI 10.2307/1542560; Fanni D, 2014, CURR MED CHEM, V21, P3768, DOI 10.2174/0929867321666140601163244; Fujii T, 2016, SCI REP-UK, V6, DOI 10.1038/srep29157; Hawkins TA, 2008, DEVELOPMENT, V135, P1147, DOI 10.1242/dev.018150; Itoh S, 2008, J BIOL CHEM, V283, P9157, DOI 10.1074/jbc.M709463200; Just S, 2011, J CELL SCI, V124, P3127, DOI 10.1242/jcs.084772; Kidder BL, 2017, EPIGENET CHROMATIN, V10, DOI 10.1186/s13072-017-0115-7; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kumar N, 2006, MAYO CLIN PROC, V81, P1371, DOI 10.4065/81.10.1371; Li HQ, 2013, MOL BIOL CELL, V24, P3511, DOI 10.1091/mbc.E13-06-0352; Liu JX, 2017, BBA-GENE REGUL MECH, V1860, P1103, DOI 10.1016/j.bbagrm.2017.09.001; Liu JX, 2013, DEVELOPMENT, V140, P1067, DOI 10.1242/dev.086157; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Marques JP., 2007, APPL STAT USING SPSS; Molitor AM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004091; Myhre JL, 2014, DEV BIOL, V390, P26, DOI 10.1016/j.ydbio.2014.02.022; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Prohaska JR, 2014, ANN NY ACAD SCI, V1314, P1, DOI 10.1111/nyas.12354; ROME LC, 1990, J EXP BIOL, V154, P163; ROME LC, 1984, AM J PHYSIOL, V247, pR272, DOI 10.1152/ajpregu.1984.247.2.R272; Sadeghifar F, 2015, NUCLEIC ACIDS RES, V43, P4477, DOI 10.1093/nar/gkv312; Schmidt K, 2018, J BIOL CHEM, V293, P20085, DOI 10.1074/jbc.RA118.004889; Stender JD, 2012, MOL CELL, V48, P28, DOI 10.1016/j.molcel.2012.07.020; Sun HJ, 2020, ENVIRON POLLUT, V256, DOI 10.1016/j.envpol.2019.113364; Tai ZP, 2019, METALLOMICS, V11, P1452, DOI 10.1039/c9mt00125e; Tan XG, 2006, P NATL ACAD SCI USA, V103, P2713, DOI 10.1073/pnas.0509503103; Tilton FA, 2011, COMP BIOCHEM PHYS C, V153, P9, DOI 10.1016/j.cbpc.2010.07.008; Tracy CM, 2018, CURR OPIN PHYSIOL, V1, P140, DOI 10.1016/j.cophys.2017.10.001; Wang ZY, 2019, CHEMOSPHERE, V222, P991, DOI 10.1016/j.chemosphere.2019.01.177; Wolman M, 2012, DEV NEUROBIOL, V72, P366, DOI 10.1002/dneu.20872; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zhang T, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2020.194612; Zhang T, 2015, TOXICOL SCI, V148, P299, DOI 10.1093/toxsci/kfv184; Zhang YJ, 2018, AQUAT TOXICOL, V205, P156, DOI 10.1016/j.aquatox.2018.10.015; Zhang YJ, 2018, J HAZARD MATER, V344, P1057, DOI 10.1016/j.jhazmat.2017.11.039; Zhao G, 2020, CELL COMMUN SIGNAL, V18, DOI 10.1186/s12964-020-00548-3; Zhao G, 2020, METALLOMICS, V12, P12, DOI 10.1039/c9mt00210c	46	4	4	3	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21686	10.1096/fj.202100183R	http://dx.doi.org/10.1096/fj.202100183R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34101239				2022-12-26	WOS:000667814100054
J	Schnoder, L; Tomic, I; Schwindt, L; Helm, D; Rettel, M; Schulz-Schaeffer, W; Krause, E; Rettig, J; Fassbender, K; Liu, Y				Schnoeder, Laura; Tomic, Inge; Schwindt, Laura; Helm, Dominic; Rettel, Mandy; Schulz-Schaeffer, Walter; Krause, Elmar; Rettig, Jens; Fassbender, Klaus; Liu, Yang			P38 alpha-MAPK phosphorylates Snapin and reduces Snapin-mediated BACE1 transportation in APP-transgenic mice	FASEB JOURNAL			English	Article						Alzheimer's disease; BACE1; mapk14; phosphorylation; Snapin; trafficking	AMYLOID PRECURSOR PROTEIN; RETROGRADE TRANSPORT; BETA-SECRETASE; AXONAL-TRANSPORT; P38 KINASE; TAU; MOUSE; DEGRADATION; INHIBITION; CALCIUM	Amyloid beta peptide (A beta) is the major pathogenic molecule in Alzheimer's disease (AD). BACE1 enzyme is essential for the generation of A beta. Deficiency of p38 alpha-MAPK in neurons increases lysosomal degradation of BACE1 and decreases A beta deposition in the brain of APP-transgenic mice. However, the mechanisms mediating effects of p38 alpha-MAPK are largely unknown. In this study, we used APP-transgenic mice and cultured neurons and observed that deletion of p38 alpha-MAPK specifically in neurons decreased phosphorylation of Snapin at serine, increased retrograde transportation of BACE1 in axons and reduced BACE1 at synaptic terminals, which suggests that p38 alpha-MAPK deficiency promotes axonal transportation of BACE1 from its predominant locations, axonal terminals, to lysosomes in the cell body. In vitro kinase assay revealed that p38 alpha-MAPK directly phosphorylates Snapin. By further performing mass spectrometry analysis and site-directed mutagenic experiments in SH-SY5Y cell lines, we identified serine residue 112 as a p38 alpha-MAPK-phosphorylating site on Snapin. Replacement of serine 112 with alanine did abolish p38 alpha-MAPK knockdown-induced reduction of BACE1 activity and protein level, and transportation to lysosomes in SH-SY5Y cells. Taken together, our study suggests that activation of p38 alpha-MAPK phosphorylates Snapin and inhibits the retrograde transportation of BACE1 in axons, which might exaggerate amyloid pathology in AD brain.	[Schnoeder, Laura; Tomic, Inge; Schwindt, Laura; Fassbender, Klaus; Liu, Yang] Saarland Univ, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany; [Schnoeder, Laura; Tomic, Inge; Schwindt, Laura; Fassbender, Klaus; Liu, Yang] Saarland Univ, German Inst Dementia Prevent DIDP, Homburg, Germany; [Helm, Dominic; Rettel, Mandy] European Mol Biol Lab, Prote Core Facil, Heidelberg, Germany; [Schulz-Schaeffer, Walter] Saarland Univ, Dept Neuropathol, Homburg, Germany; [Krause, Elmar; Rettig, Jens] Saarland Univ, Ctr Integrat Physiol & Mol Med CIPMM, Cellular Neurophysiol, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; European Molecular Biology Laboratory (EMBL); Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Schnoder, L; Liu, Y (corresponding author), Saarland Univ, Dept Neurol, Kirrberger Str, D-66421 Homburg, Germany.	Laura.Schnoeder@uks.eu; a.liu@mx.uni-saarland.de	Liu, Yang/GSD-5476-2022	Liu, Yang/0000-0002-7614-4233; Fassbender, Klaus/0000-0003-3596-868X	Alzheimer Forschung Initiative e.V. [17046]; Deutsche Forschungsgemeinschaft (DFG) [LI1725/2--1]	Alzheimer Forschung Initiative e.V.; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Alzheimer Forschung Initiative e.V. (#17046; to LS) and Deutsche Forschungsgemeinschaft (DFG) (LI1725/2--1; to Y. L.)	Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bodendorf U, 2002, J NEUROCHEM, V80, P799, DOI 10.1046/j.0022-3042.2002.00770.x; Buggia-Prevot V, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-1; Butzlaff M, 2015, HUM MOL GENET, V24, P3623, DOI 10.1093/hmg/ddv107; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Cai QA, 2010, NEURON, V68, P73, DOI 10.1016/j.neuron.2010.09.022; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Decker Y, 2018, BRAIN STRUCT FUNCT, V223, P1001, DOI 10.1007/s00429-017-1595-8; DRUBIN DG, 1986, J CELL BIOL, V103, P2739, DOI 10.1083/jcb.103.6.2739; Dunkley PR, 2008, NAT PROTOC, V3, P1718, DOI 10.1038/nprot.2008.171; Feng TC, 2017, J BIOL CHEM, V292, P1679, DOI 10.1074/jbc.M116.766584; Franken H, 2015, NAT PROTOC, V10, P1567, DOI 10.1038/nprot.2015.101; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Lee S, 2011, J NEUROSCI, V31, P7817, DOI 10.1523/JNEUROSCI.6412-10.2011; Marx H, 2013, NAT BIOTECHNOL, V31, P557, DOI 10.1038/nbt.2585; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Pasternak SH, 2003, J BIOL CHEM, V278, P26687, DOI 10.1074/jbc.M304009200; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Ruan QT, 2020, J NEUROSCI, V40, P107, DOI 10.1523/JNEUROSCI.1808-19.2019; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Savitski MM, 2014, SCIENCE, V346, P55, DOI 10.1126/science.1255784; Schmidt T, 2013, CELL CALCIUM, V54, P105, DOI 10.1016/j.ceca.2013.05.003; Schnoder L, 2016, J BIOL CHEM, V291, P2067, DOI 10.1074/jbc.M115.695916; Schnoder ML, 2020, FASEB J, V34, P9628, DOI 10.1096/fj.201902731RR; Sengupta A, 1998, ARCH BIOCHEM BIOPHYS, V357, P299, DOI 10.1006/abbi.1998.0813; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Tammineni P, 2017, AUTOPHAGY, V13, P982, DOI 10.1080/15548627.2017.1291114; Tammineni P, 2017, ELIFE, V6, DOI 10.7554/eLife.21776; Tian JH, 2005, J NEUROSCI, V25, P10546, DOI 10.1523/JNEUROSCI.3275-05.2005; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wang J, 2008, J PROTEOME RES, V7, P3879, DOI 10.1021/pr8001645; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wolff S, 2006, FEBS LETT, V580, P6477, DOI 10.1016/j.febslet.2006.10.068; Xie K, 2013, NEUROBIOL AGING, V34, P2389, DOI 10.1016/j.neurobiolaging.2013.04.013; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Ye X, 2017, J NEUROSCI, V37, P2639, DOI 10.1523/JNEUROSCI.2851-16.2017; Ye X, 2014, CELL REP, V6, P24, DOI 10.1016/j.celrep.2013.12.008; Yun HJ, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.68; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010; Zhu XW, 2000, J NEUROPATH EXP NEUR, V59, P880, DOI 10.1093/jnen/59.10.880	48	3	3	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21691	10.1096/fj.202100017R	http://dx.doi.org/10.1096/fj.202100017R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118085	Green Published, hybrid			2022-12-26	WOS:000667814100067
J	Quesada-Hidalgo, R; Eberhard, WG; Barrantes, G				Quesada-Hidalgo, Rosannette; Eberhard, William G.; Barrantes, Gilbert			Complex behavioral plasticity is not reduced in spiderlings with miniature brains	PLOS ONE			English	Article							ONTOGENIC CHANGES; SIZE; ALLOMETRY; EVOLUTION; INSECTS; ARANEAE	The brains of smaller animals are smaller than those of their larger relatives, but it is not clear whether their adaptive behavioral flexibility is more limited. Previous interspecific comparisons found that aspects of web construction behavior of very small orb weaving spiders (0.005 mg) were no less precise than those of much larger related orb weavers (30 mg), but the behaviors tested were relatively simple. Here we perform a more sensitive intraspecific test involving the multiple behavioral adjustments of orb web designs made by Leucauge argyra to confinement in very small spaces. Web adjustments of spiderlings as small as similar to 0.1 mg were compared to previously published observations of similar to 80 mg conspecific adults. Spiderlings in constrained spaces made all of the complex adjustments made by adults in at least seven independent web design variables, and their adjustments were no less precise. Rough estimates based on previously published data on total brain volumes and the mean diameters of neuron cell bodies suggested that spiderlings and adult females of Leucauge may have similar numbers of neurons, due to spiderlings having smaller neurons and a greater percentage of body tissues dedicated to the brain. We speculate that this neural similarity may explain why L. argyra spiderlings showed no behavioral deficits compared with adults.	[Quesada-Hidalgo, Rosannette; Eberhard, William G.; Barrantes, Gilbert] Univ Costa Rica, Escuela Biol, San Jose, Costa Rica; [Quesada-Hidalgo, Rosannette; Eberhard, William G.] Smithsonian Trop Res Inst, Panama City, Panama; [Eberhard, William G.] Louisiana State Univ, Museum Nat Sci, Baton Rouge, LA 70803 USA	Universidad Costa Rica; Smithsonian Institution; Smithsonian Tropical Research Institute; Louisiana State University System; Louisiana State University	Quesada-Hidalgo, R (corresponding author), Univ Costa Rica, Escuela Biol, San Jose, Costa Rica.; Quesada-Hidalgo, R (corresponding author), Smithsonian Trop Res Inst, Panama City, Panama.	rquesada@alumni.usp.br		Quesada-Hidalgo, Rosannette/0000-0002-6757-4928	Vicerrectoria de Investigacion of the Universidad de Costa Rica [C0-251]	Vicerrectoria de Investigacion of the Universidad de Costa Rica	GB received financial support from the Vicerrectoria de Investigacion of the Universidad de Costa Rica (project C0-251). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrantes G, 2012, ETHOLOGY, V118, P438, DOI 10.1111/j.1439-0310.2012.02029.x; Barrantes G, 2008, J ARACHNOL, V36, P545, DOI 10.1636/ST07-66.1; Chittka L, 2009, CURR BIOL, V19, pR995, DOI 10.1016/j.cub.2009.08.023; COLE BJ, 1985, P NATL ACAD SCI USA, V82, P8548, DOI 10.1073/pnas.82.24.8548; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; Eberhard W.G., 2020, SPIDER WEBS BEHAV FU; Eberhard WG, 2007, P ROY SOC B-BIOL SCI, V274, P2203, DOI 10.1098/rspb.2007.0675; Eberhard WG, 2011, ADV INSECT PHYSIOL, V40, P155, DOI 10.1016/B978-0-12-387668-3.00004-0; Eberhard WG, 2011, ANIM BEHAV, V81, P813, DOI 10.1016/j.anbehav.2011.01.016; Foelix R. F, 2011, BIOL SPIDERS; Hesselberg T, 2010, ETHOLOGY, V116, P535, DOI 10.1111/j.1439-0310.2010.01760.x; Howse pe, 1974, DESIGN FUNCTION INSE, DOI [10.1007/978-3-642-86666-1%5F13, DOI 10.1007/978-3-642-86666-1%5F13]; Kilmer JT, 2019, ANIM BEHAV, V153, P25, DOI 10.1016/j.anbehav.2019.04.012; Miklos GLG, 1998, DAEDALUS, V127, P197; Polilov AA, 2019, ARTHROPOD STRUCT DEV, V48, P98, DOI 10.1016/j.asd.2018.11.008; Polilov AA, 2015, ANNU REV ENTOMOL, V60, P103, DOI 10.1146/annurev-ento-010814-020924; Quesada R, 2011, ARTHROPOD STRUCT DEV, V40, P521, DOI 10.1016/j.asd.2011.07.002; RCore Team, 2020, R LANG ENV STAT COMP; Sol D, 2009, BIOL LETTERS, V5, P130, DOI 10.1098/rsbl.2008.0621; Spaethe J, 2006, J EXP BIOL, V209, P987, DOI 10.1242/jeb.02124; Striedter GF., 2005, PRINCIPLES BRAIN EVO, DOI [10.1038/nrn1606, DOI 10.1038/NRN1606]; Triana-Cambronero E, 2011, J ARACHNOL, V39, P519, DOI 10.1636/Hi11-36.1; Wilcox D., 2002, UTHSCSA IMAGE TOOL; WILSON EO, 1984, BEHAV ECOL SOCIOBIOL, V16, P89, DOI 10.1007/BF00293108; Zuur Alain F., 2009, P1	25	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0251919	10.1371/journal.pone.0251919	http://dx.doi.org/10.1371/journal.pone.0251919			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133428	Green Published, gold			2022-12-26	WOS:000671682700015
J	Yuan, B; Wu, W; Guo, MJ; Zhou, XD; Xie, SG				Yuan, Bo; Wu, Wei; Guo, Mengjing; Zhou, Xiaode; Xie, Shuguang			Spatial-temporal dynamics and influencing factors of archaeal communities in the sediments of Lancang River cascade reservoirs (LRCR), China	PLOS ONE			English	Article							HYDROPOWER DAMS; BIOLOGICAL INTEGRITY; HYPERSALINE LAKE; MEKONG RIVER; WATER; BACTERIA; ASSEMBLAGES; CONSTRUCTION; DIVERSITY; PATTERNS	The spatial and temporal distribution of the archaeal community and its driving factors in the sediments of large-scale regulated rivers, especially in rivers with cascade hydropower development rivers, remain poorly understood. Quantitative PCR (qPCR) and Illumina MiSeq sequencing of the 16S rRNA archaeal gene were used to comprehensively investigate the spatiotemporal diversity and structure of archaeal community in the sediments of the Lancang River cascade reservoirs (LRCR). The archaeal abundance ranged from 5.11x10(4) to 1.03x10(6) 16S rRNA gene copies per gram dry sediment and presented no temporal variation. The richness, diversity, and community structure of the archaeal community illustrated a drastic spatial change. Thaumarchaeota and Euryyarchaeota were the dominant archaeal phyla in the sediments of the cascade rivers, and Bathyarchaeota was also an advantage in the sediments. PICRUSt metabolic inference analysis revealed a growing number of genes associated with xenobiotic metabolism and carbon and nitrogen metabolism in downstream reservoirs, indicating that anthropogenic pollution discharges might act as the dominant selective force to alter the archaeal communities. Nitrate and C/N ratio were found to play important roles in the formation of the archaeal community composition. In addition, the sediment archaeal community structure was also closely related to the age of the cascade reservoir and hydraulic retention time (HRT). This finding indicates that the engineering factors of the reservoir might be the greatest contributor to the archaeal community structure in the LRCR.	[Yuan, Bo; Wu, Wei; Guo, Mengjing; Zhou, Xiaode] Xian Univ Technol, State Key Lab Ecohydraul Northwest Arid Reg, Xian, Shaanxi, Peoples R China; [Xie, Shuguang] Peking Univ, Coll Environm Sci & Engn, State Key Joint Lab Environm Simulat & Pollut Con, Beijing, Peoples R China	Xi'an University of Technology; Peking University	Yuan, B (corresponding author), Xian Univ Technol, State Key Lab Ecohydraul Northwest Arid Reg, Xian, Shaanxi, Peoples R China.	yuanbo_xut@163.com			National Natural Science Foundation of China [91747206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China under Grant no. 91747206.	Auguet JC, 2008, ENVIRON MICROBIOL, V10, P1080, DOI 10.1111/j.1462-2920.2007.01498.x; Berdjeb L, 2013, FEMS MICROBIOL ECOL, V86, P215, DOI 10.1111/1574-6941.12154; Bhattarai S, 2012, MICROB ECOL, V64, P291, DOI 10.1007/s00248-012-0034-x; Borrel G., 2012, STRATIFICATION ARCHA; Cao ZG, 2010, ECOTOXICOLOGY, V19, P827, DOI 10.1007/s10646-010-0464-5; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casamayor EO, 2000, APPL ENVIRON MICROB, V66, P499, DOI 10.1128/AEM.66.2.499-508.2000; Casamayor EO, 2001, AQUAT MICROB ECOL, V25, P237, DOI 10.3354/ame025237; [陈敬安 Chen Jing'an], 2017, [地球与环境, Earth and Environment], V45, P115; Chen N, 2015, WORLD J MICROB BIOT, V31, P883, DOI 10.1007/s11274-015-1842-1; Cibils Martina L, 2013, J LIMNOL, V72, P79, DOI 10.4081/jlimnol.2013.e7; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Eid R, 2017, BBA-MOL CELL RES, V1864, P399, DOI 10.1016/j.bbamcr.2016.12.002; Fan H, 2015, EARTH-SCI REV, V146, P77, DOI 10.1016/j.earscirev.2015.03.007; Farag IF, 2020, ISME J, V14, P1345, DOI 10.1038/s41396-020-0615-5; Flood M, 2015, ENVIRON TECHNOL, V36, P124, DOI 10.1080/09593330.2014.942385; He DM, 2007, CHINESE SCI BULL, V52, P1, DOI 10.1007/s11434-007-7001-9; Hu B, 2009, WATER RESOUR MANAG, V23, P341, DOI 10.1007/s11269-008-9278-0; Huang YT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01013; Jenerette GD, 2005, GLOBAL CHANGE BIOL, V11, P1873, DOI 10.1111/j.1365-2486.2005.01021.x; Jiang HC, 2007, ENVIRON MICROBIOL, V9, P2603, DOI 10.1111/j.1462-2920.2007.01377.x; Jiang LJ, 2011, ANTON LEEUW INT J G, V99, P739, DOI 10.1007/s10482-011-9548-3; Jung J, 2011, RES MICROBIOL, V162, P1018, DOI 10.1016/j.resmic.2011.07.007; Kansole MMR, 2016, WATER-SUI, V8, DOI 10.3390/w8110508; Kunz MJ, 2011, J GEOPHYS RES-BIOGEO, V116, DOI 10.1029/2010JG001538; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lehours AC, 2007, APPL ENVIRON MICROB, V73, P2016, DOI 10.1128/AEM.01490-06; Li DN, 2019, J HYDROL, V577, DOI 10.1016/j.jhydrol.2019.123989; Li JP, 2013, ECOL ENG, V60, P316, DOI 10.1016/j.ecoleng.2013.07.029; Li JP, 2013, ECOL INDIC, V34, P94, DOI 10.1016/j.ecolind.2013.04.016; Li JP, 2012, FOREST ECOL MANAG, V284, P251, DOI 10.1016/j.foreco.2012.07.050; Li JF, 2015, SCI REP-UK, V5, DOI 10.1038/srep15488; Liew JH, 2016, FRESHWATER BIOL, V61, P1421, DOI 10.1111/fwb.12781; Lovley DR, 2000, BIODEGRADATION, V11, P107, DOI 10.1023/A:1011191220463; Luo ZX, 2014, ENVIRON EARTH SCI, V72, P2225, DOI 10.1007/s12665-014-3128-6; Ma YT, 2016, ARCHAEA, V2016, DOI 10.1155/2016/9278929; Milliman JD, 1997, NATURE, V386, P325, DOI 10.1038/386325a0; MRC, 2010, STAT BAS REP 2010; Mukherjee M, 2016, J GREAT LAKES RES, V42, P39, DOI 10.1016/j.jglr.2015.11.007; O'Mahony MM, 2006, CHEMOSPHERE, V63, P307, DOI 10.1016/j.chemosphere.2005.07.018; Pan J, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00820-1; Pedneault E, 2014, SCI REP-UK, V4, DOI 10.1038/srep04661; Peronico PB, 2020, HYDROBIOLOGIA, V847, P519, DOI 10.1007/s10750-019-04117-9; Piman T, 2016, RIVER RES APPL, V32, P2095, DOI 10.1002/rra.3045; Qian X, 2017, ENVIRON SCI POLLUT R, V24, P17153, DOI 10.1007/s11356-017-9378-6; Rodrigues T, 2014, ARCHAEA, V2014, DOI 10.1155/2014/957145; Schwarz JIK, 2007, SYST APPL MICROBIOL, V30, P239, DOI 10.1016/j.syapm.2006.05.004; Staley C, 2016, MICROB ECOL, V71, P814, DOI 10.1007/s00248-016-0729-5; Swan BK, 2010, APPL ENVIRON MICROB, V76, P757, DOI 10.1128/AEM.02409-09; Syvitski JPM, 2005, SCIENCE, V308, P376, DOI 10.1126/science.1109454; Tao K, 2019, ECOTOX ENVIRON SAFE, V178, P195, DOI 10.1016/j.ecoenv.2019.03.107; Tombolini I, 2014, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2013085; Vila-Costa M, 2013, FEMS MICROBIOL ECOL, V84, P387, DOI 10.1111/1574-6941.12068; Wang FS, 2018, INLAND WATERS, V8, P130, DOI 10.1080/20442041.2018.1469335; Wang HT, 2018, SCI TOTAL ENVIRON, V631-632, P1342, DOI 10.1016/j.scitotenv.2018.03.102; Wang JT, 2015, MICROB ECOL, V69, P135, DOI 10.1007/s00248-014-0465-7; Wang L, 2018, SCI TOTAL ENVIRON, V627, P600, DOI 10.1016/j.scitotenv.2018.01.203; Wang SR, 2015, ENVIRON EARTH SCI, V74, P3685, DOI 10.1007/s12665-015-4727-6; Wang X, 2018, MOL ECOL, V27, P4444, DOI 10.1111/mec.14870; Webster G, 2015, FEMS MICROBIOL ECOL, V91, DOI 10.1093/femsec/fiu025; Weiner JM, 1998, APPL ENVIRON MICROB, V64, P1937; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Wright SA, 2019, RIVER RES APPL, V35, P632, DOI 10.1002/rra.3443; Wu HK, 2019, BIORESOURCE TECHNOL, V289, DOI 10.1016/j.biortech.2019.121746; Xu HZ, 2019, MAR FRESHWATER RES, V70, P169, DOI 10.1071/MF17394; Xu JX, 2010, EARTH SURF PROC LAND, V35, P1666, DOI 10.1002/esp.2006; Yang YY, 2016, MICROB ECOL, V71, P257, DOI 10.1007/s00248-015-0642-3; Ye WJ, 2009, FEMS MICROBIOL ECOL, V70, P263, DOI 10.1111/j.1574-6941.2009.00761.x; Zhai HJ, 2010, ECOL ENG, V36, P361, DOI 10.1016/j.ecoleng.2009.10.002; [张慧珍 Zhang Huizhen], 2018, [海洋学报, Acta Oceanologica Sinica], V40, P113; Zhao QQ, 2020, APPL SOIL ECOL, V153, DOI 10.1016/j.apsoil.2020.103581; Zhong RD, 2019, ENERGY, V179, P685, DOI 10.1016/j.energy.2019.05.059	74	1	1	13	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253233	10.1371/journal.pone.0253233	http://dx.doi.org/10.1371/journal.pone.0253233			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129622	Green Published, gold			2022-12-26	WOS:000665475100036
J	Alnomasy, SF; Alotaibi, BS; Mujamammi, AH; Hassan, EA; Ali, ME				Alnomasy, Sultan F.; Alotaibi, Bader S.; Mujamammi, Ahmed H.; Hassan, Elham A.; Ali, Mohamed E.			Microbial aspects and potential markers for differentiation between bacterial and viral meningitis among adult patients	PLOS ONE			English	Article							REAL-TIME PCR; C-REACTIVE PROTEIN; CEREBROSPINAL-FLUID PLEOCYTOSIS; PNEUMOCOCCAL MENINGITIS; SERUM PROCALCITONIN; PROGNOSTIC-FACTORS; DIAGNOSIS; INFECTIONS; QUANTIFICATION; EPIDEMIOLOGY	Objectives Meningitis is a medical emergency with permanent disabilities and high mortality worldwide. We aimed to determine causative microorganisms and potential markers for differentiation between bacterial and viral meningitis. Methodology Adult patients with acute meningitis were subjected to lumber puncture. Cerebrospinal fluid (CSF) microorganisms were identified using Real-time PCR. PCT and CRP levels, peripheral and CSF-leucocyte count, CSF-protein and CSF-glucose levels were assessed. Results Out of 80 patients, infectious meningitis was confirmed in 75 cases; 38 cases were bacterial meningitis, 34 cases were viral meningitis and three cases were mixed infection. Higher PCT, peripheral and CSF-leukocytosis, higher CSF-protein and lower CSF-glucose levels were more significant in bacterial than viral meningitis patients. Neisseria meningitides was the most frequent bacteria and varicella-zoster virus was the most common virus. Using ROC analyses, serum PCT and CSF-parameters can discriminate bacterial from viral meningitis. Combined ROC analyses of PCT and CSF-protein significantly improved the effectiveness in predicting bacterial meningitis (AUC of 0.998, 100%sensitivity and 97.1%specificity) than each parameter alone (AUC of 0.951 for PCT and 0.996 for CSF-protein). Conclusion CSF-protein and serum PCT are considered as potential markers for differentiating bacterial from viral meningitis and their combination improved their predictive accuracy to bacterial meningitis.	[Alnomasy, Sultan F.; Alotaibi, Bader S.] Shaqra Univ, Coll Appl Med Sci Al Quwayiyah, Dept Med Labs Sci, Riyadh, Saudi Arabia; [Mujamammi, Ahmed H.] King Saud Univ, Coll Med, Clin Biochem Unit, Dept Pathol, Riyadh, Saudi Arabia; [Hassan, Elham A.] Assiut Univ, Fac Med, Dept Gastroenterol & Trop Med, Assiut, Egypt; [Ali, Mohamed E.] Al Azhar Univ, Fac Pharm, Dept Microbiol & Immunol, Assiut, Egypt	Shaqra University; King Saud University; Egyptian Knowledge Bank (EKB); Assiut University; Egyptian Knowledge Bank (EKB); Al Azhar University	Alnomasy, SF (corresponding author), Shaqra Univ, Coll Appl Med Sci Al Quwayiyah, Dept Med Labs Sci, Riyadh, Saudi Arabia.	s.alnomasy@su.edu.sa	Alnomasy, Sultan F./GNP-7843-2022; Ali, Mohamed Ebaid/GQO-7527-2022; Ali, Mohamed Reda/B-8932-2019	Alnomasy, Sultan F./0000-0003-1635-3014; Ali, Mohamed Ebaid/0000-0001-9817-8306; Ali, Mohamed Reda/0000-0002-0795-0709; Hassan, Elham/0000-0003-2575-758X; Mujamammi, Ahmed/0000-0002-7473-8281				Abdelkader NA, 2014, J INFECT PUBLIC HEAL, V7, P106, DOI 10.1016/j.jiph.2013.07.005; Adlhoch C., 2020, AVIAN INFLUENZA OVER, V18; Afifi S, 2007, EUR J CLIN MICROBIOL, V26, P331, DOI 10.1007/s10096-007-0280-x; Agueda S, 2013, BRAZ J INFECT DIS, V17, P401, DOI 10.1016/j.bjid.2012.12.002; Akkaya O, 2017, CLIN LAB, V63, P827, DOI 10.7754/Clin.Lab.2016.160912; Alkholi UM, 2011, J GLOB INFECT DIS, V3, P14, DOI 10.4103/0974-777X.77290; Amarilyo G, 2011, PEDIATR EMERG CARE, V27, P196, DOI 10.1097/PEC.0b013e31820d6543; Anbazhagan D, 2011, BRAZ J MICROBIOL, V42, P448, DOI 10.1590/S1517-83822011000200006; Auburtin M, 2002, AM J RESP CRIT CARE, V165, P713, DOI 10.1164/ajrccm.165.5.2105110; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Brouwer MC, 2010, CLIN MICROBIOL REV, V23, P467, DOI 10.1128/CMR.00070-09; Chretien JP, 2006, MIL MED, V171, P12, DOI 10.7205/MILMED.171.1S.12; Dawod HM., 2019, DIS E FREQUENCY MENI, V9, P158; Dery Mark Alain, 2007, Curr Infect Dis Rep, V9, P301, DOI 10.1007/s11908-007-0047-7; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fouad R, 2014, J TROP MED-US, V2014, DOI 10.1155/2014/213762; Franzen-Rohl E, 2007, J CLIN MICROBIOL, V45, P2516, DOI 10.1128/JCM.00141-07; Frasca D, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00071; Garner-Spitzer E., 2020, OBESITY SEX AFFECT I, V11; Girgis N., 1972, AMPICILLIN COMP PENI; GIRGIS NI, 1993, AM J TROP MED HYG, V48, P97, DOI 10.4269/ajtmh.1993.48.97; Graham AK, 2005, J CLIN MICROBIOL, V43, P1491, DOI 10.1128/JCM.43.3.1491.2005; HANSSON LO, 1993, SCAND J INFECT DIS, V25, P625, DOI 10.3109/00365549309008552; Haran JP, 2013, AM J EMERG MED, V31, P816, DOI 10.1016/j.ajem.2013.01.030; Haran JP, 2013, AM J EMERG MED, V31, P137, DOI 10.1016/j.ajem.2012.06.026; Hofer N, 2012, NEONATOLOGY, V102, P25, DOI 10.1159/000336629; Hong YJ., 2014, DETECTION HERPES SIM, V2014; Huttunen R, 2011, J INTERN MED, V269, P258, DOI 10.1111/j.1365-2796.2010.02332.x; kanwaljeet Singh H., 2016, RES B DIAGNOSTIC VER, V4, P78, DOI [10.1016/j.anndiagpath.2016.12.001, DOI 10.1016/J.ANNDIAGPATH.2016.12.001]; Kapasi AJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160278; Kastenbauer S, 2003, BRAIN, V126, P1015, DOI 10.1093/brain/awg113; Khan FY., 2017, ACUTE BACTERIAL MENI, V2017; Konstantinidis T, 2015, J CLIN LAB ANAL, V29, P169, DOI 10.1002/jcla.21746; Lay MLJ, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-252; LEVY M, 1990, CLIN PEDIATR, V29, P254, DOI 10.1177/000992289002900501; Lu CH, 2002, CLIN NEUROL NEUROSUR, V104, P352, DOI 10.1016/S0303-8467(02)00052-5; Makoo ZB, 2010, AM J INFECT DIS, V6, P93, DOI 10.3844/ajidsp.2010.93.97; Mount HR, 2017, AM FAM PHYSICIAN, V96, P314; PELTOLA H, 1988, J PEDIATR-US, V113, P641, DOI 10.1016/S0022-3476(88)80372-X; Pierrakos C, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02993-5; Portnoy A, 2015, VACCINE, V33, pA240, DOI 10.1016/j.vaccine.2014.11.061; Ray P, 2007, AM J EMERG MED, V25, P179, DOI 10.1016/j.ajem.2006.07.012; Rubinstein CJJJoND., 2013, USING REAL TIME PCR; Sun I, 2018, SINGAP MED J, V59, P257, DOI 10.11622/smedj.2016159; Tsai MH, 2006, INFECTION, V34, P2, DOI 10.1007/s15010-006-4144-6; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; Viallon A, 2011, CRIT CARE, V15, DOI 10.1186/cc10254; Wang X, 2012, J CLIN MICROBIOL, V50, P702, DOI 10.1128/JCM.06087-11; Whitney CG, 2003, NEW ENGL J MED, V348, P1737, DOI 10.1056/NEJMoa022823; Wu HM, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-26; Yang Y., 2019, DIAGNOSTIC FORMULA D, V9; Youssef FG, 2004, ANN EPIDEMIOL, V14, P44, DOI 10.1016/S1047-2797(03)00075-9; Yuan CC, 2001, J VIROL METHODS, V91, P109	53	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0251518	10.1371/journal.pone.0251518	http://dx.doi.org/10.1371/journal.pone.0251518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115780	gold, Green Published			2022-12-26	WOS:000664643000011
J	Cunningham, M; Iafolla, M; Kanjanapan, Y; Cerocchi, O; Butler, M; Siu, LL; Bedard, PL; Ross, K; Hansen, B; Spreafico, A; Feld, JJ				Cunningham, Morven; Iafolla, Marco; Kanjanapan, Yada; Cerocchi, Orlando; Butler, Marcus; Siu, Lillian L.; Bedard, Philippe L.; Ross, Kendra; Hansen, Bettina; Spreafico, Anna; Feld, Jordan J.			Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy	PLOS ONE			English	Article							ADVERSE EVENTS; MANAGEMENT; IPILIMUMAB; NIVOLUMAB; INJURY	Background and aims Immune checkpoint inhibitors (ICI) are increasingly used in cancer therapy. Elevated liver enzymes frequently occur in patients treated with ICI but evaluation is poorly described. We sought to better understand causes of liver enzyme elevation, investigation and management. Methods Patients treated with anti-PD-1, PDL-1 or CTLA-4 therapy in Phase I/II clinical trials between August 2012 and December 2018 were included. Clinical records of patients with significant liver enzyme elevations were retrospectively reviewed. Results Of 470 ICI-treated patients, liver enzyme elevation occurred in 102 (21.6%), attributed to disease progression (56; 54.9%), other drugs/toxins (7; 6.9%), other causes (22; 21.6%) and ICI immunotoxicity (17; 16.7%; 3.6% of total cohort). Immunotoxicity was associated with higher peak ALT than other causes of enzyme elevation (N = 17; M = 217, 95% CI 145-324 for immunotoxicity, N = 103; M = 74, 95% CI 59-92 for other causes; ratio of means 0.34, 95% CI 0.19-0.60, p = <0.001) and higher ALT:AST ratio (M = 1.27, 95% CI 0.78-2.06 for immunotoxicity, M = 0.69, 95% CI 0.59-0.80 for other causes, ratio of means 0.54, 95% CI 0.36-0.82, p = 0.004). Immunotoxicity was more often seen in patients with prior CPI exposure (41.2% of immunotoxicity vs 15.9% of patients without, p = 0.01), anti-CTLA-4 -containing ICI treatments (29.4% of immunotoxicity vs 6.8% of patients without, p = <0.001) and other organ immunotoxicity (76.5% of immunotoxicity vs 19.2% of patients without, p = <0.001). Cause for enzyme elevation was established in most patients after non-invasive investigation. Liver biopsy was reserved for four patients with atypical treatment response. Conclusions Liver enzyme elevation is common in patients receiving ICI, but often has a cause other than immunotoxicity. A biochemical signature with higher ALT and ALT/AST ratio, a history of prior ICI exposure and other organ immunotoxicities may help to identify patients at a higher likelihood of immunotoxicity. Liver biopsy can be safely deferred in most patients. We propose an approach to diagnostic evaluation in patients with liver enzyme elevations following ICI exposure.	[Cunningham, Morven; Cerocchi, Orlando; Hansen, Bettina; Feld, Jordan J.] Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada; [Iafolla, Marco; Kanjanapan, Yada; Butler, Marcus; Siu, Lillian L.; Bedard, Philippe L.; Ross, Kendra; Spreafico, Anna] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Cunningham, M (corresponding author), Univ Hlth Network, Toronto Ctr Liver Dis, Toronto, ON, Canada.	morven.cunningham@uhn.ca	Spreafico, Anna/AHD-6430-2022; Spreafico, Anna/AFV-8984-2022	Spreafico, Anna/0000-0002-3034-3042; Spreafico, Anna/0000-0002-3034-3042; Cunningham, Morven/0000-0003-2617-9523				Andrade RJ, 2019, J HEPATOL, V70, P1222, DOI 10.1016/j.jhep.2019.02.014; [Anonymous], 2017, COMMON TERMINOLOGY C; Bhave P, 2018, J HEPATOL, V69, P976, DOI 10.1016/j.jhep.2018.06.012; Brahmer JR, 2018, J ONCOL PRACT, V14, P247, DOI 10.1200/JOP.18.00005; Chalasani NP, 2014, AM J GASTROENTEROL, V109, P950, DOI 10.1038/ajg.2014.131; Cohen JV, 2021, MODERN PATHOL, V34, P426, DOI 10.1038/s41379-020-00653-1; DANAN G, 1993, J CLIN EPIDEMIOL, V46, P1323, DOI 10.1016/0895-4356(93)90101-6; Das S, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0805-8; De Martin E, 2018, J HEPATOL, V68, P1181, DOI 10.1016/j.jhep.2018.01.033; Haanen JBAG, 2017, ANN ONCOL, V28, P119, DOI 10.1093/annonc/mdx225; Hoofnagle JH, 2019, NEW ENGL J MED, V381, P264, DOI 10.1056/NEJMra1816149; Huffman BM, 2018, AM J CLIN ONCOL-CANC, V41, P760, DOI 10.1097/COC.0000000000000374; Jennings JJ, 2019, EXPERT OPIN DRUG MET, V15, P231, DOI 10.1080/17425255.2019.1574744; Parlati L, 2018, J HEPATOL, V69, P1396, DOI 10.1016/j.jhep.2018.08.014; Riveiro-Barciela M, 2019, J HEPATOL, V70, P564, DOI 10.1016/j.jhep.2018.10.020; Spain L, 2016, CANCER TREAT REV, V44, P51, DOI 10.1016/j.ctrv.2016.02.001; Tsung I, 2019, ALIMENT PHARM THER, V50, P800, DOI 10.1111/apt.15413; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Wang WJ, 2017, INT J CANCER, V141, P1018, DOI 10.1002/ijc.30678; Weber JS, 2016, LANCET ONCOL, V17, P943, DOI 10.1016/S1470-2045(16)30126-7; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750	21	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253070	10.1371/journal.pone.0253070	http://dx.doi.org/10.1371/journal.pone.0253070			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115819	gold, Green Published			2022-12-26	WOS:000664643000046
J	Davis, SM; Owuor, N; Odoyo-June, E; Wambua, J; Omanga, E; Lukobo, M; Laube, C; Mwandi, Z; Suraratdecha, C; Kioko, UM; Rotich, W; Kataka, J; Ng'eno, C; Mohan, D; Toledo, C; Aoko, A; Anyango, J; Oneya, D; Orenjuro, K; Mgamb, E; Serrem, K; Juma, A				Davis, Stephanie M.; Owuor, Nandi; Odoyo-June, Elijah; Wambua, Jonesmus; Omanga, Eunice; Lukobo, Mainza; Laube, Catharine; Mwandi, Zebedee; Suraratdecha, Chutima; Kioko, Urbanus M.; Rotich, Wesley; Kataka, Jacquin; Ng'eno, Caroline; Mohan, Diwakar; Toledo, Carlos; Aoko, Appolonia; Anyango, John; Oneya, Daniel; Orenjuro, Kennedy; Mgamb, Elizabeth; Serrem, Kennedy; Juma, Ambrose			Making voluntary medical male circumcision services sustainable: Findings from Kenya's pilot models, baseline and year 1	PLOS ONE			English	Article							HIV PREVENTION; MEN	Voluntary medical male circumcision is a crucial HIV prevention program for men in sub-Saharan Africa. Kenya is one of the first countries to achieve high population coverage and seek to transition the program to a more sustainable structure designed to maintain coverage while making all aspects of service provision domestically owned and implemented. Using pre-defined metrics, we created and evaluated three models of circumcision service delivery (static, mobile and mixed) to identify which had potential for sustaining high circumcision coverage among 10-14-year-olds group, a historically high-demand and accessible age group, at the lowest possible cost. We implemented each model in two distinct geographic areas, one in Siaya and the other in Migori county, and assessed multiple aspects of each model's sustainability. These included numerical achievements against targets designed to reach 80% coverage over two years; quantitative expenditure outcomes including unit expenditure plus its primary drivers; and qualitative community perception of program quality and sustainability based on Likert scale. Outcome values at baseline were compared with those for year one of model implementation using bivariate linear regression, unpaired t-tests and Wilcoxon rank tests as appropriate. Across models, numerical target achievement ranged from 45-140%, with the mixed models performing best in both counties. Unit expenditures varied from approximately $57 in both countries at baseline to $44-$124 in year 1, with the lowest values in the mixed and static models. Mean key informant perception scores generally rose significantly from baseline to year 1, with a notable drop in the area of community engagement. Consistently low scores were in the aspects of domestic financing for service provision. Sustainability-focused circumcision service delivery models can successfully achieve target volumes at lower unit expenditures than existing models, but strategies for domestic financing remain a crucial challenge to address for long-term maintenance of the program.	[Davis, Stephanie M.; Suraratdecha, Chutima; Toledo, Carlos] US Ctr Dis Control & Prevent, Atlanta, GA USA; [Owuor, Nandi; Wambua, Jonesmus; Omanga, Eunice; Mwandi, Zebedee] Jhpiego, Nairobi, Kenya; [Odoyo-June, Elijah; Aoko, Appolonia] US Ctr Dis Control & Prevent, Nairobi, Kenya; [Lukobo, Mainza; Laube, Catharine; Mohan, Diwakar] Jhpiego, Baltimore, MD USA; [Kioko, Urbanus M.; Rotich, Wesley] Univ Nairobi, Nairobi, Kenya; [Kataka, Jacquin] Ctr Hlth Solut, Shinda Project, Siaya, Kenya; [Ng'eno, Caroline] Univ Maryland, Baltimore, MD 21201 USA; [Ng'eno, Caroline] Timiza Project, Migori, Kenya; [Anyango, John] Hlth Dept, Siaya, Siaya County, Kenya; [Oneya, Daniel; Orenjuro, Kennedy; Mgamb, Elizabeth] Hlth Dept, Migori, Migori County, Kenya; [Serrem, Kennedy; Juma, Ambrose] Minist Hlth, Natl STD AIDS Control Program NASCOP, Nairobi, Kenya	Centers for Disease Control & Prevention - USA; Jhpiego; Jhpiego; University of Nairobi; University System of Maryland; University of Maryland Baltimore	Odoyo-June, E (corresponding author), US Ctr Dis Control & Prevent, Nairobi, Kenya.	yed0@cdc.gov		Odoyo-June, Elijah/0000-0002-1370-2306; Kioko, Urbanus/0000-0002-4612-1233; , Eunice/0000-0003-2579-4014	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [GH001469]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research was supported by the President's Emergency Plan for AIDS Relief (PEPFAR; state.gov/pepfar) through the Centers for Disease Control and Prevention (CDC) under the terms of Cooperative Agreement GH001469. Funding was awarded to CDC (not to an individual). CDC performed study design, decision to publish, and manuscript preparation (PEPFAR was not involved).	[Anonymous], PEPFAR STRATEGIC DOC; Auvert B, 2006, PLOS MED, V3, P705, DOI 10.1371/journal.pmed.0030226; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Central Bureau of Statistics Ministry of Health Kenya ., 2003, KENYA DEMOGRAPHIC HL; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Hayes RJ, 2019, NEW ENGL J MED, V381, P207, DOI 10.1056/NEJMoa1814556; Kenya National Bureau of Statistics , KEN 2009 KEN POP HOU; Kenya National Bureau of Statistics Ministry of Health/Kenya National AIDS Control Council Kenya Medical Research Institute National Council for Population Development ICF International, 2014, KENYA DEMOGRAPHIC HL; Makhema J, 2019, NEW ENGL J MED, V381, P230, DOI 10.1056/NEJMoa1812281; Ministry of Health and Child Care Zimbabwe ., ZIMB SUST TRANS PLAN, P2019; Ministry of Health Kenya ., NAT VOL MED MAL CIRC, V2nd ed; Obiero WO., AIDS 2016 C DURB S A; PEPFAR, 2018, PEPFAR LAT GLOB RES; UNAIDS, 2015, UND FAST TRACK; UNAIDS and WHO Progress Brief 2019, VOL MED MAL CIRC REM; UNAIDS Science Panel /, MAK END AIDS REAL CO; Unicef, COUNTR PROF KEN; United Nations. Department of Economic and Social Affairs Population Dynamics, WORLD POPULATION PRO; WHO, 2007, WHO TECH REP SER, V935, P1; WHO/UNAIDS/JHPIEGO, 2008, MAN MAL CIRC LOC AN; World Health Organization , 2017, ZIMB AD SEX REPR HLT; World Health Organization , CHAPT SUST VMMC SERV; World Health Organization , 2019, UNAIDS WHO PROGR BRI; World Health Organization (WHO); Joint United Nations Programme on HIV/AIDS (UNAIDS), 2011, JOINT STRAT ACT FRAM, P2012	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252725	10.1371/journal.pone.0252725	http://dx.doi.org/10.1371/journal.pone.0252725			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115784	Green Published, gold			2022-12-26	WOS:000664643000030
J	Gupte, A; Jyot, J; Ravi, M; Ramphal, R				Gupte, Asmita; Jyot, Jeevan; Ravi, Malleswari; Ramphal, Reuben			High pyocyanin production and non-motility of Pseudomonas aeruginosa isolates are correlated with septic shock or death in bacteremic patients	PLOS ONE			English	Article							BLOOD-STREAM INFECTIONS; III PROTEIN SECRETION; ANTIMICROBIAL THERAPY; CLINICAL-OUTCOMES; RISK-FACTORS; VIRULENCE; MORTALITY; FLAGELLIN; PHAGOCYTOSIS; PATHOGENESIS	Studies of the outcome of Pseudomonas aeruginosa bacteremia (Pab) have focused mainly on antibiotic appropriateness. However, P. aeruginosa possesses many virulence factors whose roles in outcomes have not been examined in humans, except for the type III secretion system (T3SS) toxins. The purpose of this study was to examine the role of virulence factors other than the T3SS toxins. Bacterial isolates were collected from 75 patients who suffered from Pa blood stream infections. Host factors such as neutropenia, immunosuppression, comorbidities, time to effective antibiotics, source of bacteremia, and presence of multidrug resistant (MDR) isolate were studied. The isolates were analyzed for the presence of toxin genes, proteolytic activity, swimming and twitching motility, and pyocyanin production. The data were analyzed to ascertain which virulence factors correlated with poor outcomes defined as septic shock or death (SS) within 7 days. Septic shock or death occurred in 25/75 patients. Univariate analysis identified age as a host factor that exerted a significant effect on these outcomes. Ineffective antibiotics administered during the first 24 hours of treatment or MDR P. aeruginosa did not influence the frequency of SS, nor did the presence of lasB, exoA, exoS exoU, plcH genes and proteolytic activity. However, 6/8 patients infected with non-motile isolates, developed SS, p = 0.014 and 5/6 isolates that produced large amounts of pyocyanin (>18ug/ml), were associated with SS, p = 0.014. Multivariate analysis indicated that the odds ratio (OR) for development of SS with a non-motile isolate was 6.8, with a 95% confidence interval (CI) (1.37, 51.5), p = 0.030 and with high pyocyanin producing isolates, an OR of 16.9, 95% CI = (2.27, 360), p = .017. This study evaluating the role of microbial factors that significantly effect outcomes following Pa bloodstream infection suggests that P. aeruginosa strains showing high pyocyanin production and the lack of motility independently increase the risk of SS.	[Gupte, Asmita; Jyot, Jeevan; Ravi, Malleswari; Ramphal, Reuben] Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA; [Jyot, Jeevan] Univ Florida, Coll Pharm, Dept Pharmaceut Outcomes & Policy, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gupte, A; Ramphal, R (corresponding author), Univ Florida, Dept Med, Div Infect Dis & Global Med, Gainesville, FL 32611 USA.	asmita.gupte@medicine.ufl.edu; reuben.ramphal@medicine.ufl.edu			National Institutes of Health [1R01AI078770-01A1]; University of Florida-Gatorade	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida-Gatorade	This work was supported in part by grant from National Institutes of Health grant 1R01AI078770-01A1 to RR. This work was supported in part by University of Florida-Gatorade internal funding to AG. There was no additional external funding received for this study.	Allen L, 2005, J IMMUNOL, V174, P3643, DOI 10.4049/jimmunol.174.6.3643; Amiel E, 2010, INFECT IMMUN, V78, P2937, DOI 10.1128/IAI.00144-10; Arora SK, 2005, INFECT IMMUN, V73, P4395, DOI 10.1128/IAI.73.7.4395-4398.2005; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Beasley KL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240351; BODEY GP, 1985, ARCH INTERN MED, V145, P1621, DOI 10.1001/archinte.145.9.1621; Bowers DR, 2013, ANTIMICROB AGENTS CH, V57, P1270, DOI 10.1128/AAC.02235-12; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; Dasgupta N, 2000, J BACTERIOL, V182, P357, DOI 10.1128/JB.182.2.357-364.2000; El-Solh AA, 2012, CRIT CARE MED, V40, P1157, DOI 10.1097/CCM.0b013e3182377906; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Floyd M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005987; Hall S, 2016, TOXINS, V8, DOI 10.3390/toxins8080236; Hauser AR, 2002, CRIT CARE MED, V30, P521, DOI 10.1097/00003246-200203000-00005; Howell HA, 2013, MBIO, V4, DOI 10.1128/mBio.00032-13; Jyot J, 2011, J INFECT DIS, V203, P1369, DOI 10.1093/infdis/jir045; Kang CI, 2003, CLIN INFECT DIS, V37, P745, DOI 10.1086/377200; Kang CI, 2005, ANTIMICROB AGENTS CH, V49, P760, DOI 10.1128/AAC.49.2.760-766.2005; Koh AY, 2009, INFECT IMMUN, V77, P5300, DOI 10.1128/IAI.00501-09; Kurahashi K, 1999, J CLIN INVEST, V104, P743, DOI 10.1172/JCI7124; Lau GW, 2004, INFECT IMMUN, V72, P4275, DOI 10.1128/IAI.72.7.4275-4278.2004; Le Berre R, 2011, CRIT CARE MED, V39, P2113, DOI 10.1097/CCM.0b013e31821e899f; Lodise TP, 2007, ANTIMICROB AGENTS CH, V51, P3510, DOI 10.1128/AAC.00338-07; MAHENTHIRALINGAM E, 1995, INFECT IMMUN, V63, P4519, DOI 10.1128/IAI.63.11.4519-4523.1995; Maschmeyer G, 2000, EUR J CLIN MICROBIOL, V19, P915, DOI 10.1007/s100960000410; Micek ST, 2005, ANTIMICROB AGENTS CH, V49, P1306, DOI 10.1128/AAC.49.4.1306-1311.2005; Miller LC, 2015, J MED CHEM, V58, P1298, DOI 10.1021/jm5015082; MONTIE TC, 1982, INFECT IMMUN, V38, P1296, DOI 10.1128/IAI.38.3.1296-1298.1982; NICAS TI, 1985, CAN J MICROBIOL, V31, P387, DOI 10.1139/m85-074; Osmon S, 2004, CHEST, V125, P607, DOI 10.1378/chest.125.2.607; Pena C, 2015, CLIN INFECT DIS, V60, P539, DOI 10.1093/cid/ciu866; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Recio R, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01759-19; Recio R, 2020, EUR J CLIN MICROBIOL, V39, P671, DOI 10.1007/s10096-019-03780-z; Roy-Burman A, 2001, J INFECT DIS, V183, P1767, DOI 10.1086/320737; Shaver CM, 2004, INFECT IMMUN, V72, P6969, DOI 10.1128/IAI.72.12.6969-6977.2004; SOKOL PA, 1979, J CLIN MICROBIOL, V9, P538; Sonawane A, 2006, INFECT IMMUN, V74, P7035, DOI 10.1128/IAI.00551-06; TOTTEN PA, 1990, J BACTERIOL, V172, P7188, DOI 10.1128/jb.172.12.7188-7199.1990; VASIL ML, 1986, J PEDIATR-US, V108, P800, DOI 10.1016/S0022-3476(86)80748-X; Vidal F, 1996, ARCH INTERN MED, V156, P2121, DOI 10.1001/archinte.156.18.2121; Woods DE, 1997, CAN J MICROBIOL, V43, P541, DOI 10.1139/m97-077	43	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253259	10.1371/journal.pone.0253259	http://dx.doi.org/10.1371/journal.pone.0253259			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115807	gold, Green Published			2022-12-26	WOS:000664643000061
J	Hailu, AW; Degarege, A; Adamu, H; Costa, D; Villier, V; Mouhajir, A; Favennec, L; Razakandrainibe, R; Petros, B				Hailu, Ambachew W.; Degarege, Abraham; Adamu, Haileeyesus; Costa, Damien; Villier, Venceslas; Mouhajir, Abdelmounaim; Favennec, Loic; Razakandrainibe, Romy; Petros, Beyene			Molecular characterization of Cryptosporidium spp. from humans in Ethiopia	PLOS ONE			English	Article							IMPENETRABLE NATIONAL-PARK; GORILLA-GORILLA-BERINGEI; GIARDIA-DUODENALIS; HIV/AIDS PATIENTS; DISEASE; INFECTIONS; BURDEN; PARVUM; IDENTIFICATION; CHILDREN	Data on the distribution and genotype of Cryptosporidium species is limited in Ethiopia. This study examined the presence and genetic diversity of Cryptosporidium species circulating in Ethiopian human population. Stool samples collected from patients who visited rural (n = 94) and urban (n = 93) health centers in Wurgissa and Hawassa district, respectively, were examined for the presence of Cryptosporidium spp. using microscopy, nested PCR and real-time PCR. To detect infection with PCR, analysis of 18S ribosomal RNA was performed. Subtyping was performed by sequencing a fragment of GP60 gene. The overall prevalence of infection was 46% (n = 86) by microscope and PCR. When 48 (out of 86) PCR positive samples were genotyped, two species were identified: C. parvum (n = 40) and C. hominis (n = 8). When 15 of the 40 C. parvum isolates were subtyped, zoonotic subtypes of IIaA14G1R1 (n = 1), IIaA15G2R1 (n = 1), IIaA16G1R1 (n = 2), IIaA16G3R1 (n = 2), IIaA17G1R1 (n = 1), IIaA19G1R1 (n = 1), IIaA20G1R1 (n = 3), IIaA22G1R1 (n = 1), IIaA22G2R1 (n = 1), IIdA23G1 (n = 1) and IIdA24G1 (n = 1) were identified. When 6 of the 8 C. hominis isolates were subtyped, subtypes IaA20 (n = 5), and IdA21(n = 1) were identified. This study suggests that C. parvum and C. hominis are causes of cryptosporidiosis in human in the Wurgissa district and Hawassa in Ethiopia. Zoonotic transmission might be the main route of transmission.	[Hailu, Ambachew W.; Petros, Beyene] Biomed Sci Stream Addis Ababa Univ, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia; [Degarege, Abraham] Univ Nebraska Med Ctr, Coll Publ Hlth, Dept Epidemiol, Omaha, NE USA; [Adamu, Haileeyesus] Addis Ababa Univ, Inst Biotechnol, Addis Ababa, Ethiopia; [Costa, Damien; Villier, Venceslas; Mouhajir, Abdelmounaim; Favennec, Loic; Razakandrainibe, Romy] Univ Rouen Normandie, CHU Rouen, CNR, Lab Expert Cryptosporidioses,ESCAPE,EA7510, Rouen, France	University of Nebraska System; University of Nebraska Medical Center; Addis Ababa University; CHU de Rouen; Universite de Reims Champagne-Ardenne	Hailu, AW (corresponding author), Biomed Sci Stream Addis Ababa Univ, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.	ambalake@gmail.com	Razakandrainibe, Romy/AAZ-3315-2021; costa, damien/AAL-4465-2020; Woreta, Ambachew/AAZ-3283-2021	Woreta, Ambachew/0000-0003-2958-5471; VILLIER, Venceslas/0000-0003-3679-7616; Degarege, Abraham/0000-0002-1537-6639				Adamu H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002831; Ahmed SA, 2018, INT J HYG ENVIR HEAL, V221, P743, DOI 10.1016/j.ijheh.2018.04.006; Alemu A, 2011, ASIAN PAC J TROP MED, V4, P661, DOI 10.1016/S1995-7645(11)60168-5; Anberber Manyazewal, 2017, Journal of Advanced Veterinary Research, V7, P59; Bouzid M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006553; Bouzid M, 2013, CLIN MICROBIOL REV, V26, P115, DOI 10.1128/CMR.00076-12; Brook EJ, 2009, VET J, V179, P378, DOI 10.1016/j.tvjl.2007.10.023; Chalmers RM, 2008, EMERG INFECT DIS, V14, P496, DOI 10.3201/eid1403.071320; Chalmers RM, 2013, J INFECTION, V67, P231, DOI 10.1016/j.jinf.2013.04.019; Chalmers RM, 2011, J MED MICROBIOL, V60, P1598, DOI 10.1099/jmm.0.034181-0; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Cheesbrough M., 2009, DISTRICT LAB PRACT 1, V2nd, P196; Couso-Perez S, 2020, PARASITOL RES, V119, P249, DOI 10.1007/s00436-019-06529-x; de Lucio A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159992; Desai Niyati T, 2012, Trop Parasitol, V2, P91, DOI 10.4103/2229-5070.105173; Dessi G, 2020, PARASITOL RES, V119, P4211, DOI 10.1007/s00436-020-06947-2; Diaz P, 2018, PARASITOL RES, V117, P3081, DOI 10.1007/s00436-018-6000-x; Diaz P, 2015, PARASITOL RES, V114, P4099, DOI 10.1007/s00436-015-4639-0; Fayer R., 2008, CRYPTOSPORIDIUM CRYP, V2nd; Fayer R, 2010, EXP PARASITOL, V124, P90, DOI 10.1016/j.exppara.2009.03.005; Feng YY, 2018, TRENDS PARASITOL, V34, P997, DOI 10.1016/j.pt.2018.07.009; Flecha MJ, 2015, TROP MED INT HEALTH, V20, P1213, DOI 10.1111/tmi.12535; Food and Agriculture Organization of The United Nations (FAO), 2018, AFR SUST LIV 2050 LI; Graczyk TK, 2001, PARASITOL RES, V87, P368, DOI 10.1007/s004360000337; Hadfield SJ, 2011, J CLIN MICROBIOL, V49, P918, DOI 10.1128/JCM.01733-10; HENRIKSEN SA, 1981, ACTA VET SCAND, V22, P594; Ibrahim MA, 2016, PARASITOL RES, V115, P2439, DOI 10.1007/s00436-016-4996-3; Innes EA, 2020, TRENDS PARASITOL, V36, P290, DOI 10.1016/j.pt.2019.12.016; Insulander M, 2013, EPIDEMIOL INFECT, V141, P1009, DOI 10.1017/S0950268812001665; Iqbal A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031139; Kalinova J, 2018, ACTA TROP, V179, P36, DOI 10.1016/j.actatropica.2017.12.019; Khurana Sumeeta, 2018, Trop Parasitol, V8, P2, DOI 10.4103/tp.TP_34_17; Koehler AV, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2462-4; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lassen B, 2014, ACTA VET SCAND, V56, DOI 10.1186/1751-0147-56-36; Lim YAL, 2011, INFECT GENET EVOL, V11, P968, DOI 10.1016/j.meegid.2011.03.007; Martins TA, 2018, RES VET SCI, V118, P181, DOI 10.1016/j.rvsc.2018.02.002; Misic Z, 2007, PARASITOLOGY, V134, P351, DOI 10.1017/S0031182006001508; Nader JL, 2019, NAT MICROBIOL, V4, P826, DOI 10.1038/s41564-019-0377-x; Nizeyi JB, 1999, J PARASITOL, V85, P1084, DOI 10.2307/3285672; Partida-Rodriguez O, 2017, ARCH MED RES, V48, P690, DOI 10.1016/j.arcmed.2017.11.015; Pumipuntu N, 2018, VET WORLD, V11, P681, DOI 10.14202/vetworld.2018.681-686; Qi M, 2015, VET PARASITOL, V209, P169, DOI 10.1016/j.vetpar.2015.02.030; Robertson LJ, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.575881; Shimelis T, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1554-x; Shirley DAT, 2012, CURR OPIN INFECT DIS, V25, P555, DOI 10.1097/QCO.0b013e328357e569; Smith Huw, 2007, P173, DOI 10.1201/9781420052275.ch6; Snelling WJ, 2007, J INFECT DEV COUNTR, V1, P242, DOI 10.3855/jidc.360; Sulaiman IM, 2005, J CLIN MICROBIOL, V43, P2805, DOI 10.1128/JCM.43.6.2805-2809.2005; Toledo RD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175311; Vieira PM, 2015, FOLIA PARASIT, V62, DOI 10.14411/fp.2015.002; Xiao L., 2020, INHUNTERS TROPICAL M, V10th, P712, DOI [10.1016/B978-0-323-55512-8.00096-X, DOI 10.1016/B978-0-323-55512-8.00096-X]; Yu Jae-Ran, 2004, Korean Journal of Parasitology, V42, P1, DOI 10.3347/kjp.2004.42.1.1; Zhao Z, 2015, PARASITOLOGY, V142, P800, DOI 10.1017/S0031182014001929	55	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253186	10.1371/journal.pone.0253186	http://dx.doi.org/10.1371/journal.pone.0253186			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115820	Green Published, gold			2022-12-26	WOS:000664643000056
J	Shiferaw, MB; Sinishaw, MA; Amare, D; Alem, G; Asefa, D; Klinkenberg, E				Shiferaw, Melashu Balew; Sinishaw, Mulusew Alemneh; Amare, Desalegne; Alem, Genetu; Asefa, Dawit; Klinkenberg, Eveline			Prevalence of active tuberculosis disease among healthcare workers and support staff in healthcare settings of the Amhara region, Ethiopia	PLOS ONE			English	Article							INFECTION-CONTROL MEASURES; DRUG-RESISTANT TUBERCULOSIS; ADDIS-ABABA; FACILITIES; KNOWLEDGE; ATTITUDES; STATES; TB	Background Health care workers (HCWs) are at an increased risk of acquiring tuberculosis (TB) compared to the general population, because of the frequent face to face contact or potential exposure to TB through shared air or space with infectious patient(s), regardless of economic setting and local TB incidence. Information on the burden of active TB disease among HCWs will help guide control measures, can be utilized to evaluate the effectiveness of TB infection prevention programs in the health care setting, and guide necessary actions. However, data on TB among HCW in Ethiopia is limited. Therefore, this study aimed to determine the prevalence of active TB disease among healthcare workers and support staff in healthcare settings in the Amhara region of Ethiopia. Methods A cross-sectional study design was used to recruit a total of 580 randomly selected study participants in the Amhara region. Data were collected over four months in selected hospitals and health centers. Implementation of TB prevention and control measures was evaluated using a standardized checklist. The main outcome indicator was active TB as measured by a laboratory diagnosis using GeneXpert technology. Results A total of 580 study participants were enrolled. The mean age was 31.3 (7.8 standard deviation) years, with about two-thirds (65.3%) aged between 18-24 years. A total of 9 (1.6%) MTB cases were detected, 4 (1.4%) in HCWs and 5 (1.7%) in support staff, which did not significantly differ (P = 0.50). About 90% of the participants had not received TB infection prevention and control training ever. More than half (54%) of the study participants worked in poorly ventilated rooms. Triage of coughing patients was not practiced in 32% of the studied facilities (health centers and hospitals). Conclusions The magnitude of TB among healthcare workers and support staff in healthcare settings was higher than in the general population (140 per 100000 population). The status of implementation of tuberculosis prevention and control measures indicated missed opportunities. Hence, strict implementation of developed infection control plans of TB in healthcare settings needs to be improved.	[Shiferaw, Melashu Balew] Amhara Publ Hlth Inst, Res & Technol Transfer Directorate, Bahir Dar, Ethiopia; [Sinishaw, Mulusew Alemneh] Bahir Dar Univ, Dept Clin Chem, Coll Med & Hlth Sci, Bahir Dar, Ethiopia; [Amare, Desalegne] Bahir Dar Univ, Coll Med & Hlth Sci, Sch Publ Hlth, Bahir Dar, Ethiopia; [Alem, Genetu] Amhara Reg Hlth Bur, Bahir Dar, Ethiopia; [Asefa, Dawit] KNCV TB Fdn USAID Challenge TB, Addis Ababa, Ethiopia; [Klinkenberg, Eveline] KNCV TB Fdn, The Hague, Netherlands; [Klinkenberg, Eveline] Univ Amsterdam, Med Ctr, Amsterdam Inst Global Hlth & Dev, Dept Global Hlth, Amsterdam, Netherlands	Bahir Dar University; Bahir Dar University; KNCV Tuberculosis Foundation; University of Amsterdam	Shiferaw, MB (corresponding author), Amhara Publ Hlth Inst, Res & Technol Transfer Directorate, Bahir Dar, Ethiopia.	bmelashu@gmail.com	Shiferaw, Melashu/GPT-3320-2022	Sinishaw, Mulusew Alemneh/0000-0002-5737-7496	Global Health Bureau, Office of Infectious Disease, US Agency for International Development through Challenge TB [AID-OAAA-14-00029]; American people through the United States Agency for International Development (USAID)/Challenge TB project	Global Health Bureau, Office of Infectious Disease, US Agency for International Development through Challenge TB; American people through the United States Agency for International Development (USAID)/Challenge TB project(United States Agency for International Development (USAID))	MBS received the award. The Global Health Bureau, Office of Infectious Disease, US Agency for International Development, financially supported this study through Challenge TB under the terms of Cooperative Agreement No. AID-OAAA-14-00029. This study is made possible by the generous support of the American people through the United States Agency for International Development (USAID)/Challenge TB project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government.	Amhara National Regional State Health Bureau, 2017, REG HLTH BUR ANN REP; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P749; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; [Anonymous], 2009, FONDLY WE HOPE FERVE; [Anonymous], 2019, WHO GUIDELINES TUBER; Ayuk JN., 2013, CROSS SECTIONAL STUD; Baussano I, 2011, EMERG INFECT DIS, V17, P488, DOI 10.3201/eid1703.100947; Brouwer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114364; Buregyeya E, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-360; Chapman HJ, 2017, MEDICC REV, V19, P16, DOI 10.37757/MR2017.V19.N1.4; CSIS Global Health Policy Center, 2016, ETH MOV TUB EL SUCC; Engelbrecht M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1984-2; Federal Democratic Republic of Ethiopia Ministry of Health, 2018, NAT GUID TB DR TB LE; Gizaw GD, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0062-3; International Health Conference, 2002, Bull World Health Organ, V80, P983; Iram S, 2015, PAK J MED SCI, V31, P105, DOI 10.12669/pjms.311.6970; Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x; Jesudas Christopher Devasahayam, 2013, Indian J Chest Dis Allied Sci, V55, P149; Joshi B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201731; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Kanyina Evalyne Wambui, 2017, Pan Afr Med J, V28, P4, DOI 10.11604/pamj.supp.2017.28.1.8222; Lin Y, 2015, TROP MED INT HEALTH, V20, P1196, DOI 10.1111/tmi.12537; O'Donnell MR, 2010, ANN INTERN MED, V153, P516, DOI 10.7326/0003-4819-153-8-201010190-00008; Ogbonnaya LU, 2011, NIGER J CLIN PRACT, V14, P270, DOI 10.4103/1119-3077.86765; Sanchez JL, 2015, MIL MED, V180, P276, DOI 10.7205/MILMED-D-14-00433; Shrestha A, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2828-4; Stop TB partnership, KEY POP BRIEF HLTH C; Tamir K, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1608-y; Tenna A, 2013, INFECT CONT HOSP EP, V34, P1289, DOI 10.1086/673979; The Federal Ministry of Health and the Ethiopian Public Health Institute, 2014, IMPLEMENTATION GUIDE; Tudor C, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-891; Verkuijl S, 2016, CLIN INFECT DIS, V62, pS231, DOI 10.1093/cid/civ1184; Verver S, 2017, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4578-z; Wang XN, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0407-6; World Health Organization, 2013, GUIDELINES MANAGEMEN; Wu ZY, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4871-9; 侯月云, 2012, [中华医院感染学杂志, Chinese Journal of Nosocomiology], V22, P4428	37	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253177	10.1371/journal.pone.0253177	http://dx.doi.org/10.1371/journal.pone.0253177			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115821	gold, Green Published			2022-12-26	WOS:000664643000055
J	Cameron, L; Rocque, R; Penner, K; Mauro, I				Cameron, Laura; Rocque, Rhea; Penner, Kailey; Mauro, Ian			Evidence-based communication on climate change and health: Testing videos, text, and maps on climate change and Lyme disease in Manitoba, Canada	PLOS ONE			English	Article							PUBLIC PERCEPTIONS; CHALLENGES; EXPERIENCE; ENGAGEMENT; FRAMEWORK; EMOTIONS; MODEL	Given the climate crisis and its cumulative impacts on public health, effective communication strategies that engage the public in adaptation and mitigation are critical. Many have argued that a health frame increases engagement, as do visual methodologies including online and interactive platforms, yet to date there has been limited research on audience responses to health messaging using visual interventions. This study explores public attitudes regarding communication tools focused on climate change and climate-affected Lyme disease through six focus groups (n = 61) in rural and urban southern Manitoba, Canada. The results add to the growing evidence of the efficacy of visual and storytelling methods in climate communications and argues for a continuum of mediums: moving from video, text, to maps. Findings underscore the importance of tailoring both communication messages and mediums to increase uptake of adaptive health and environmental behaviours, for some audiences bridging health and climate change while for others strategically decoupling them.	[Cameron, Laura; Rocque, Rhea; Penner, Kailey; Mauro, Ian] Univ Winnipeg, Prairie Climate Ctr, Winnipeg, MB, Canada	University of Winnipeg	Cameron, L (corresponding author), Univ Winnipeg, Prairie Climate Ctr, Winnipeg, MB, Canada.	lp.cameron@uwinnipeg.ca			Public Health Agency of Canada [1819-HQ000156]	Public Health Agency of Canada	This research was funded by the Public Health Agency of Canada, grant number 1819-HQ000156. The funders were involved in supporting the research question development, but were not involved in the collection, analysis, or interpretation of data.	Aenishaenslin C, 2017, TICKS TICK-BORNE DIS, V8, P112, DOI 10.1016/j.ttbdis.2016.10.006; Akerlof K, 2010, INT J ENV RES PUB HE, V7, P2559, DOI 10.3390/ijerph7062559; Arnold A, 2018, PALG STUD ENV SOCIOL, P1, DOI 10.1007/978-3-319-69383-5; Asmi F, 2019, J ENVIRON PLANN MAN, V62, P2393, DOI 10.1080/09640568.2018.1541171; Ballantyne AG, 2018, ENVIRON COMMUN, V12, P638, DOI 10.1080/17524032.2017.1412997; Ballantyne AG, 2016, WIRES CLIM CHANGE, V7, P329, DOI 10.1002/wcc.392; Bouchard C, 2019, Can Commun Dis Rep, V45, P83, DOI 10.14745/ccdr.v45i04a02; Braasch G, 2013, B ATOM SCI, V69, P33, DOI 10.1177/0096340213508628; Cameron L., 2020, REV, P1; Cameron L, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10614-1; Cardwell FS, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-208; Centre PC., 2020, CLIMATE ATLAS CANADA; Chadwick AE, 2016, HEALTH COMMUN, V31, P782, DOI 10.1080/10410236.2014.1002030; Chapman DA, 2016, GLOBAL ENVIRON CHANG, V41, P172, DOI 10.1016/j.gloenvcha.2016.10.003; Chilton NB, 2020, J MED ENTOMOL, V57, P156, DOI 10.1093/jme/tjz155; Cook BR., 2019, WIRES COMPUT STAT, V10, P1; Corner A, 2014, WIRES CLIM CHANGE, V5, P411, DOI 10.1002/wcc.269; Creswell J.W., 2022, CONCISE INTRO MIXED, V2nd ed.; Dransch D, 2010, INT J DIGIT EARTH, V3, P292, DOI 10.1080/17538941003774668; Feldman L, 2018, RISK ANAL, V38, P585, DOI 10.1111/risa.12868; Gabriele-Rivet V, 2017, J MED ENTOMOL, V54, P862, DOI 10.1093/jme/tjx036; Goldberg MH, 2019, SCI COMMUN, V41, P659, DOI 10.1177/1075547019874361; Harris DM., 2019, PROF GEOGR, P1; Harris DM, 2017, ENERGY RES SOC SCI, V31, P179, DOI 10.1016/j.erss.2017.05.027; Hewitson B, 2017, WIRES CLIM CHANGE, V8, DOI 10.1002/wcc.470; Hoijer B, 2010, PUBLIC UNDERST SCI, V19, P717, DOI 10.1177/0963662509348863; Kahan DM., 2015, SSRN ELECT J, V14; Koteyko N, 2015, ENVIRON COMMUN, V9, P149, DOI 10.1080/17524032.2015.1029297; Leal W, 2019, CLIM CHANG MANAG, P1, DOI 10.1007/978-3-319-98294-6_1; Lowe T, 2006, PUBLIC UNDERST SCI, V15, P435, DOI 10.1177/0963662506063796; Loy LS, 2020, J ENVIRON PSYCHOL, V67, DOI 10.1016/j.jenvp.2020.101388; Maibach E., 2011, GEORG MASON U CENT C; Maibach EW, 2015, ANN GLOB HEALTH, V81, P396, DOI 10.1016/j.aogh.2015.08.010; Markowitz DM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02364; Marshall G, 2015, DONT EVEN THINK IT W; McDonald RI, 2015, J ENVIRON PSYCHOL, V44, P109, DOI 10.1016/j.jenvp.2015.10.003; Mildenberger M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159774; Morris BS, 2019, CLIMATIC CHANGE, V154, P19, DOI 10.1007/s10584-019-02425-6; Myers TA, 2012, CLIMATIC CHANGE, V113, P1105, DOI 10.1007/s10584-012-0513-6; Nelder M P, 2018, Can Commun Dis Rep, V44, P231, DOI 10.14745/ccdr.v44i10a01; O'Neill SJ, 2014, WIRES CLIM CHANGE, V5, P73, DOI 10.1002/wcc.249; Ogden NH, 2014, ENVIRON HEALTH PERSP, V122, P631, DOI 10.1289/ehp.1307799; Ouariachi T, 2019, ENVIRON EDUC RES, V25, P701, DOI 10.1080/13504622.2018.1545156; Parker WS, 2019, B AM METEOROL SOC, V100, P1643, DOI 10.1175/BAMS-D-17-0325.1; Ripoche M, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040603; Sakellari M, 2015, PUBLIC UNDERST SCI, V24, P827, DOI 10.1177/0963662514537028; Schneider B., 2018, HDB CLIMATE CHANGE C, V3; Schneider B., 2018, FEELING RED BLUE CON, V2, P289, DOI [10.1007/978-3-319-70066-3_19, DOI 10.1007/978-3-319-70066-3_19]; Schneider B, 2012, WIRES CLIM CHANGE, V3, P185, DOI 10.1002/wcc.162; Schweizer S, 2013, ENVIRON COMMUN, V7, P42, DOI 10.1080/17524032.2012.753634; Smith N, 2013, PUBLIC UNDERST SCI, V22, P16, DOI 10.1177/0963662512440913; Swart R. J., 2017, Climate Services, V6, P12, DOI 10.1016/j.cliser.2017.06.008; Wang SS, 2018, WIRES CLIM CHANGE, V9, DOI 10.1002/wcc.509; Watts N, 2018, LANCET, V391, P581, DOI 10.1016/S0140-6736(17)32464-9; Weathers MR, 2016, ENVIRON COMMUN, V10, P593, DOI 10.1080/17524032.2015.1050436; Weber EU, 2013, NAT CLIM CHANGE, V3, P312, DOI 10.1038/nclimate1859	56	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252952	10.1371/journal.pone.0252952	http://dx.doi.org/10.1371/journal.pone.0252952			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111202	gold, Green Published			2022-12-26	WOS:000664642700072
J	Nieland, K; Labbe, A; Schweitzer, C; Gicquel, G; Kleintjens, J; Ostawal, A; Treur, M; Falvey, H				Nieland, Kaspar; Labbe, Antoine; Schweitzer, Cedric; Gicquel, Gaetan; Kleintjens, Joris; Ostawal, Amrita; Treur, Maarten; Falvey, Heather			A cost-effectiveness analysis of iStent inject combined with phacoemulsification cataract surgery in patients with mild-to-moderate open-angle glaucoma in France	PLOS ONE			English	Article							VISUAL-FIELD LOSS; INTRAOCULAR-PRESSURE; COMPLICATIONS; PERSISTENCE; ADHERENCE; HEALTH; STENT	Objective To investigate the cost-effectiveness of implementing iStent inject trabecular bypass stent (TBS) in conjunction with cataract surgery (Cat Sx) in patients with mild-to-moderate glaucoma from a societal perspective in France. The secondary objective was to explore the economic impact of iStent inject TBS in patients who comply to different degrees with their anti-glaucoma medications. Methods A previously published Markov model was adapted to estimate the cost-effectiveness of treatment with iStent inject TBS + Cat Sx versus Cat Sx alone over a lifetime time horizon in patients with mild-to-moderate open-angle glaucoma in France. Progression was modeled by health states reflecting increasing stages of vision loss. Disease progression was obtained from the two-year randomized clinical trial assessing safety and effectiveness of both interventions. French specific health-state utilities and costs were obtained through a targeted literature review. Model structure and inputs were validated by French ophthalmologists. Outcomes were expressed as incremental cost per quality-adjusted life-year (QALY) gained. The robustness of results was tested through sensitivity analyses. Results iStent inject TBS + Cat Sx reduced the number of medications needed and risk of blindness. Incremental cost and QALYs were Euro75 and 0.065 leading to an incremental cost-effectiveness ratio (ICER) of Euro1,154/QALY gained. ICER ranged from dominating for non-persistent patients to Euro31,127 patients fully persistent with their medication regime. Results from one-way sensitivity analysis had a maximum ICER of Euro29,000 when varying input parameters. iStent inject TBS + Cat Sx had an 86% chance of being cost-effective at a willingness-to-pay threshold of Euro30,000 per QALY gained. Conclusion Results demonstrate that iStent inject TBS + Cat Sx is a cost-effective intervention for intraocular pressure reduction when compared to Cat Sx alone in France.	[Nieland, Kaspar; Kleintjens, Joris; Treur, Maarten] Pharmerit Int, Rotterdam, Netherlands; [Labbe, Antoine] Quinze Vingts Natl Ophthalmol Hosp, IHU FOReSIGHT, INSERM, Dept Ophthalmol 3,DHOS,CIC 1423, Paris, France; [Labbe, Antoine] Paris Saclay Univ, Ambroise Pare Hosp, AP HP, Dept Ophthalmol, Boulogne, France; [Schweitzer, Cedric] Univ Bordeaux, CHU Bordeaux, Bordeaux Populat Hlth Res Ctr, Dept Ophthalmol,INSERM,ISPED,U1219, Bordeaux, France; [Gicquel, Gaetan] Glaukos Corp, Paris, France; [Ostawal, Amrita] Pharmerit Int, Berlin, Germany; [Falvey, Heather] Glaukos Corp, San Clemente, CA 92672 USA	CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; UDICE-French Research Universities; Universite Paris Saclay; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Falvey, H (corresponding author), Glaukos Corp, San Clemente, CA 92672 USA.	heatherfalvey@gmail.com			Glaukos Corporation	Glaukos Corporation	Funding for this study was provided to Pharmerit International by Glaukos Corporation. HF and GG are current employees of Glaukos Corporation and provided ideas and support for the study design, data collection, and manuscript development. KN, JK, AO, and MT are current or former employees of Pharmerit International, now called OPEN Health, an independent research organization, and maintained independent scientific control over the study, including final study design, data collection and analysis, interpretation of results, and preparation of the manuscript. AL and CS received consultant fees for their role in study design, interpretation of results and review of the manuscript. All authors jointly decided to publish the manuscript.	[Anonymous], 2017, Br J Ophthalmol, V101, P130, DOI 10.1136/bjophthalmol-2016-EGSguideline.003; [Anonymous], 2018, ASTM C33C33M 18, DOI DOI 10.1520/C0033_C0033M-18; ASTM International, 2016, STANDARD TEST METHOD, DOI DOI 10.1520/D5298-16; Bahler CK, 2012, AM J OPHTHALMOL, V153, P1206, DOI 10.1016/j.ajo.2011.12.017; Belhassen M, 2016, THERAPIE, V71, P491, DOI 10.1016/j.therap.2016.02.033; Boland M. V., 2012, TREATMENT GLAUCOMA C; C.C.d.A. Medicaux, 2018, ASSURANCE MALADIE CC; Cameron D, 2018, GLOBAL HEALTH ACTION, V11, DOI 10.1080/16549716.2018.1447828; Cedrone C, 2012, J GLAUCOMA, V21, P1, DOI 10.1097/IJG.0b013e3182027796; Conlon R, 2017, CAN J OPHTHALMOL, V52, P114, DOI 10.1016/j.jcjo.2016.07.013; Cramer JA, 2008, VALUE HEALTH, V11, P44, DOI 10.1111/j.1524-4733.2007.00213.x; De Keyser M, 2016, EYE VISION, V3, DOI 10.1186/s40662-016-0041-y; DETSKY AS, 1990, ANN INTERN MED, V113, P147, DOI 10.7326/0003-4819-113-2-147; DICOM_Jocelyne M, 2019, ALLOCATION ADULTES H; Fong D, 2017, MACAU VISITOR PROFIL; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P804, DOI 10.1016/j.ajo.2011.10.024; Haute Autorite de Sante, METH HLTH EC EV; Hayashi K, 2001, J CATARACT REFR SURG, V27, P1779, DOI 10.1016/S0886-3350(01)01036-7; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Inoue K, 2014, CLIN OPHTHALMOL, V8, P903, DOI 10.2147/OPTH.S44708; Iordanous Y, 2014, J GLAUCOMA, V23, pE112, DOI 10.1097/IJG.0b013e31829d9bc7; Newman-Casey PA, 2016, J GLAUCOMA, V25, pE668, DOI 10.1097/IJG.0000000000000320; Ordonez JE, 2019, CURR MED RES OPIN, V35, P329, DOI 10.1080/03007995.2018.1506022; Patel V, 2019, J MED ECON, V22, P390, DOI 10.1080/13696998.2019.1572013; Reardon G, 2011, PATIENT PREFER ADHER, V5, P441, DOI 10.2147/PPA.S23780; Robin A, 2011, INDIAN J OPHTHALMOL, V59, pS93, DOI 10.4103/0301-4738.73693; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Samuelson TW., 2019, OPHTHALMOLOGY; Schweitzer C, 2016, INVEST OPHTH VIS SCI, V57, P5882, DOI 10.1167/iovs.16-20104; Sheybani A, 2015, J CATARACT REFR SURG, V41, P1905, DOI 10.1016/j.jcrs.2015.01.019; Song J, 2016, CLIN OPHTHALMOL, V10, P137, DOI 10.2147/OPTH.S84996; Tseng VL, 2012, JAMA-J AM MED ASSOC, V308, P493, DOI 10.1001/jama.2012.9014; van Gestel A, 2010, EYE, V24, P1759, DOI 10.1038/eye.2010.133; van Gestel A, 2012, GLAUCOMA MANAGEMENT; van Gestel A, 2012, ACTA OPHTHALMOL, V90, P20, DOI 10.1111/j.1755-3768.2011.02318.x; Weinreb RN, 2004, LANCET, V363, P1711, DOI 10.1016/S0140-6736(04)16257-0; Weinreb RN, 2014, JAMA-J AM MED ASSOC, V311, P1901, DOI 10.1001/jama.2014.3192; Zhang XM, 2019, EYE CONTACT LENS, V45, P11, DOI 10.1097/ICL.0000000000000544	38	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252130	10.1371/journal.pone.0252130	http://dx.doi.org/10.1371/journal.pone.0252130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111130	Green Published, gold			2022-12-26	WOS:000664642700018
J	Sloan, A; Cutts, T; Griffin, BD; Kasloff, S; Schiffman, Z; Chan, M; Audet, J; Leung, A; Kobasa, D; Stein, DR; Safronetz, D; Poliquin, G				Sloan, Angela; Cutts, Todd; Griffin, Bryan D.; Kasloff, Samantha; Schiffman, Zachary; Chan, Mable; Audet, Jonathan; Leung, Anders; Kobasa, Darwyn; Stein, Derek R.; Safronetz, David; Poliquin, Guillaume			Simulated sunlight decreases the viability of SARS-CoV-2 in mucus	PLOS ONE			English	Article							DISINFECTION; TRANSMISSION	The novel coronavirus, SARS-CoV-2, has spread into a pandemic since its emergence in Wuhan, China in December of 2019. This has been facilitated by its high transmissibility within the human population and its ability to remain viable on inanimate surfaces for an extended period. To address the latter, we examined the effect of simulated sunlight on the viability of SARS-CoV-2 spiked into tissue culture medium or mucus. The study revealed that inactivation took 37 minutes in medium and 107 minutes in mucus. These times-to-inactivation were unexpected since they are longer than have been observed in other studies. From this work, we demonstrate that sunlight represents an effective decontamination method but the speed of decontamination is variable based on the underlying matrix. This information has an important impact on the development of infection prevention and control protocols to reduce the spread of this deadly pathogen.	[Sloan, Angela; Cutts, Todd; Griffin, Bryan D.; Kasloff, Samantha; Schiffman, Zachary; Chan, Mable; Audet, Jonathan; Leung, Anders; Kobasa, Darwyn; Stein, Derek R.; Safronetz, David; Poliquin, Guillaume] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada; [Schiffman, Zachary; Kobasa, Darwyn; Safronetz, David] Univ Manitoba, Dept Med Microbiol & Infect Dis, Winnipeg, MB, Canada; [Poliquin, Guillaume] Univ Manitoba, Fac Hlth Sci, Coll Med, Dept Pediat & Child Hlth, Winnipeg, MB, Canada; [Griffin, Bryan D.] Sunnybrook Res Inst, Biol Sci, Toronto, ON, Canada; [Stein, Derek R.] Cadham Prov Lab, Winnipeg, MB, Canada	Public Health Agency of Canada; University of Manitoba; University of Manitoba; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Sloan, A; Poliquin, G (corresponding author), Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada.; Poliquin, G (corresponding author), Univ Manitoba, Fac Hlth Sci, Coll Med, Dept Pediat & Child Hlth, Winnipeg, MB, Canada.	angela.sloan@canada.ca; guillaume.poliquin@canada.ca	; Cutts, Todd/G-6296-2017	Griffin, Bryan D/0000-0002-7950-1873; Cutts, Todd/0000-0001-7691-5619				[Anonymous], 2020, NOV COR JAP EXCH; [Anonymous], 2017, E2197171 ASTM INT; [Anonymous], 2020, G17303 ASTM; [Anonymous], 2020, NOV COR REP KOR EXCH; [Anonymous], 2020, NOV COR THAIL EXCH; [Anonymous], 2020, 1 TRAV REL CAS 2019; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Beck SE, 2017, WATER RES, V109, P207, DOI 10.1016/j.watres.2016.11.024; Biryukov J, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00441-20; Calgua B, 2014, FOOD ENVIRON VIROL, V6, P260, DOI 10.1007/s12560-014-9157-1; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Heilingloh Christiane Silke, 2020, Am J Infect Control, V48, P1273, DOI 10.1016/j.ajic.2020.07.031; Huang L, 2020, J INFECTION, V80, pE1, DOI 10.1016/j.jinf.2020.03.006; JENSEN MM, 1964, APPL MICROBIOL, V12, P418, DOI 10.1128/AEM.12.5.418-420.1964; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Mphaphlele M, 2015, AM J RESP CRIT CARE, V192, P477, DOI 10.1164/rccm.201501-0060OC; PERKINS JE, 1947, AM J PUBLIC HEALTH, V37, P529; Pirtle E C, 1991, Rev Sci Tech, V10, P733; Ratnesar-Shumate S, 2020, J INFECT DIS, V222, P214, DOI 10.1093/infdis/jiaa274; REED L. J., 1938, AMER JOUR HYG, V27, P493; Ren SY, 2020, WORLD J CLIN CASES, V8, P1391, DOI 10.12998/wjcc.v8.i8.1391; Riddell S, 2020, VIROL J, V17, DOI 10.1186/s12985-020-01418-7; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Sabino CP, 2020, PHOTODIAGN PHOTODYN, V32, DOI 10.1016/j.pdpdt.2020.101995; Sattar SA, 2003, J VIROL METHODS, V112, P3, DOI 10.1016/S0166-0934(03)00192-7; Tang LW, 2021, SCI TOTAL ENVIRON, V751, DOI 10.1016/j.scitotenv.2020.141816; Tobkisja WK, 213482007 ISO; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Wang WL, 2020, JAMA-J AM MED ASSOC, V323, P1843, DOI 10.1001/jama.2020.3786; Watson M, 2016, SEMIN ONCOL NURS, V32, P241, DOI 10.1016/j.soncn.2016.05.005; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x	31	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0253068	10.1371/journal.pone.0253068	http://dx.doi.org/10.1371/journal.pone.0253068			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111204	gold, Green Submitted, Green Published			2022-12-26	WOS:000664642700093
J	Ratuski, AS; Weary, DM				Ratuski, Anna S.; Weary, Daniel M.			A break from the pups: The effects of loft access on the welfare of lactating laboratory rats	PLOS ONE			English	Article							MATERNAL-BEHAVIOR; ANIMAL-WELFARE; LITTERS; RESPONSES; SOWS; CARE; SYSTEMS; HPA	Rats (Rattus norvegicus) bred for research are typically confined with their litters until weaning, but will spend time away from pups when given the opportunity. We aimed to assess how dam welfare is affected by the ability to escape from their pups. Rat dams (n = 16) were housed in cages either with or without an elevated loft. We measured time dams spent in lofts, time spent nursing, and affective states using elevated plus maze and anticipatory behavior testing. We predicted that 1) dams housed with lofts would use them increasingly as pups aged, 2) dams without a loft would spend more time passively nursing (i.e. initiated by pups rather than the dam) and more total time nursing as pups aged, and 3) dams housed with lofts would show evidence of a more positive affective state. Dams housed with lofts spent more time in the loft with increasing pup age; dams spent on average (mean +/- SE) 27 +/- 5% of their time in the loft when pups were 1 wk old, increasing to 52 +/- 5% of their time at 3 wks. When pups were 3 wks old, dams with lofts spent less time passively nursing (10 +/- 2% of total time, compared to 27 +/- 4% for dams without a loft) and less time nursing overall (36 +/- 4% of time versus 59 +/- 2% for dams without a loft). Rats without loft access showed increased anticipatory behavior potentially indicative of negative affective state (24.5 +/- 1.8 behaviors per minute in wk 3 compared to 18.8 +/- 1.0 in wk 1). These findings indicate that rat dams in laboratories choose to spend time away from their pups when provided the opportunity, particularly later in lactation; an inability to do so is associated with increased passive nursing and negative affect.	[Ratuski, Anna S.; Weary, Daniel M.] Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada	University of British Columbia	Weary, DM (corresponding author), Univ British Columbia, Fac Land & Food Syst, Anim Welf Program, Vancouver, BC, Canada.	dan.weary@ubc.ca	Weary, Daniel/A-8868-2010	Weary, Daniel/0000-0002-0917-3982; Ratuski, Anna/0000-0002-6389-4158	Natural Sciences and Engineering Research Council [RGPIN-2016-04620]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC))	The study was funded by a Natural Sciences and Engineering Research Council grant to DW (RGPIN-2016-04620). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADER R, 1970, ANIM BEHAV, V18, P144, DOI 10.1016/0003-3472(70)90083-7; Anderson C, 2020, ANIM WELFARE, V29, P231, DOI 10.7120/09627286.29.3.231; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; CRAMER CP, 1990, DEV PSYCHOBIOL, V23, P479, DOI 10.1002/dev.420230604; Dawson L, 2013, APPL ANIM BEHAV SCI, V147, P224, DOI 10.1016/j.applanim.2013.04.001; DEVITERNE D, 1990, DEV PSYCHOBIOL, V23, P349, DOI 10.1002/dev.420230406; Fraser D, 1997, ANIM WELFARE, V6, P187; Friard O, 2016, METHODS ECOL EVOL, V7, P1325, DOI 10.1111/2041-210X.12584; Gaskill BN, 2015, J AM ASSOC LAB ANIM, V54, P497; GROTA LJ, 1974, HORM BEHAV, V5, P275, DOI 10.1016/0018-506X(74)90014-2; GROTA LJ, 1969, ANIM BEHAV, V17, P722, DOI 10.1016/S0003-3472(69)80019-9; HUGHES CW, 1978, DEV PSYCHOBIOL, V11, P329, DOI 10.1002/dev.420110406; Leidinger CS, 2019, LAB ANIM-UK, V53, P53, DOI 10.1177/0023677218777536; Macri S, 2004, EUR J NEUROSCI, V20, P1017, DOI 10.1111/j.1460-9568.2004.03541.x; Macri S, 2008, BEHAV BRAIN RES, V191, P227, DOI 10.1016/j.bbr.2008.03.031; Makowska IJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147595; Makowska IJ, 2013, APPL ANIM BEHAV SCI, V148, P1, DOI 10.1016/j.applanim.2013.07.017; MYERS MM, 1989, DEV PSYCHOBIOL, V22, P29, DOI 10.1002/dev.420220104; Pajor EA, 1999, APPL ANIM BEHAV SCI, V65, P105, DOI 10.1016/S0168-1591(99)00046-5; Pitts AD, 2002, APPL ANIM BEHAV SCI, V76, P291, DOI 10.1016/S0168-1591(02)00012-6; RANTZER D, 1995, SWED J AGR RES, V25, P61; Schrader AJ., 2018, PLOS ONE, V13, P1; Spinka M, 2019, ANIM WELFARE; Spinka M., 2011, ANIM WELFARE, P27; Stern J.M., 1996, ADV STUD BEHAV, V25, P243; STRUBBE JH, 1980, PHYSIOL BEHAV, V25, P775, DOI 10.1016/0031-9384(80)90383-2; TRIVERS RL, 1974, AM ZOOL, V14, P249; Van Der Harst JE, 2003, ANIM BEHAV, V66, P493, DOI 10.1006/anbe.2003.2201; Van der Horst JE, 2007, ANIM WELFARE, V16, P67; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Weary DM, 2008, APPL ANIM BEHAV SCI, V110, P24, DOI 10.1016/j.applanim.2007.03.025; Weary DM, 2002, APPL ANIM BEHAV SCI, V76, P279, DOI 10.1016/S0168-1591(02)00011-4; Weaver SR, 2016, LAB ANIM-UK, V50, P370, DOI 10.1177/0023677215617388; Wehrmeister TD, 2010, PHARMACOL BIOCHEM BE, V97, P301, DOI 10.1016/j.pbb.2010.08.014; Wheeler RR, 2015, LAB ANIM-UK, V49, P10, DOI 10.1177/0023677214547404	35	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0253020	10.1371/journal.pone.0253020	http://dx.doi.org/10.1371/journal.pone.0253020			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101761	gold, Green Published			2022-12-26	WOS:000664641500037
J	Kato, Y; Kumar, S; Lessard, C; Bailey, JL				Kato, Yoku; Kumar, Satheesh; Lessard, Christian; Bailey, Janice L.			ACRBP (Sp32) is involved in priming sperm for the acrosome reaction and the binding of sperm to the zona pellucida in a porcine model	PLOS ONE			English	Article							PROTEIN-TYROSINE PHOSPHORYLATION; CAPACITATED HUMAN SPERM; MOUSE SPERM; BOAR SPERM; IN-VITRO; CALCIUM-CHANNELS; MAMMALIAN SPERM; IP3 RECEPTORS; SPERMATOZOA; IDENTIFICATION	In boar sperm, we have previously shown that capacitation is associated with the appearance of the p32 tyrosine phosphoprotein complex. The principal tyrosine phosphoprotein involved in this complex is the acrosin-binding protein (ACRBP), which regulates the autoconversion of proacrosin to intermediate forms of acrosin in both boar and mouse sperm. However, the complete biological role of ACRBP has not yet been elucidated. In this study, we tested the hypothesis that tyrosine phophorylation and the presence of the ACRBP in the sperm head are largely necessary to induce capacitation, the acrosome reaction (AR) and sperm-zona pellucida (ZP) binding, all of which are necessary steps for fertilization. In vitro fertilization (IVF) was performed using matured porcine oocytes and pre-capacitated boar sperm cultured with anti-phosphotyrosine antibodies or antibodies against ACRBP. Anti-ACRBP antibodies reduced capacitation and spontaneous AR (P<0.05). Sperm-ZP binding declined in the presence of anti-phosphotyrosine or anti-ACRBP antibodies. The localisation of anti-ACRBP antibodies on the sperm head, reduced the ability of the sperm to undergo the AR in response to solubilized ZP or by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase. These results support our hypothesis that tyrosine phosphorylated proteins and ACRBP are present upon the sperm surface in order to participate in sperm-ZP binding, and that ACRBP upon the surface of the sperm head facilitates capacitation and the AR in the porcine.	[Kato, Yoku; Kumar, Satheesh; Lessard, Christian; Bailey, Janice L.] Univ Laval, Dept Sci Anim, Ctr Rech Reprod Dev & Sante Intergenerat, Laval, PQ, Canada; [Kato, Yoku] Vitrolife KK, Minato Ku, Tokyo, Japan; [Kumar, Satheesh] Tamil Nadu Vet & Anim Sci Univ, Madras Vet Coll, Dept Vet Biochem, Madras, Tamil Nadu, India; [Bailey, Janice L.] Fonds Rech Quebec Nat & Technol, Quebec City, PQ, Canada	Laval University; Tamil Nadu Veterinary & Animal Sciences University	Bailey, JL (corresponding author), Univ Laval, Dept Sci Anim, Ctr Rech Reprod Dev & Sante Intergenerat, Laval, PQ, Canada.; Bailey, JL (corresponding author), Fonds Rech Quebec Nat & Technol, Quebec City, PQ, Canada.	janice.bailey@frq.gouv.qc.ca		Kato, Yoku/0000-0002-2412-4708	Natural Sciences and Engineering Research Council of Canada (NSERC) of Canada [RGPIN-2017-06386]; Centre de recherche en reproduction, developpement et santeintergenerationnelle	Natural Sciences and Engineering Research Council of Canada (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Centre de recherche en reproduction, developpement et santeintergenerationnelle	This research was financed by the Natural Sciences and Engineering Research Council of Canada (NSERC) of Canada (Discovery Grant RGPIN-2017-06386 to JLB). YK was supported by institutional scholarships from the Facultedes sciences de l'agriculture et de l'alimentation and the Centre de recherche en reproduction, developpement et santeintergenerationnelle.	Abeydeera LR, 1997, BIOL REPROD, V57, P729, DOI 10.1095/biolreprod57.4.729; Aitken R John, 2010, Handb Exp Pharmacol, P99, DOI 10.1007/978-3-642-02062-9_7; Arcelay E, 2008, INT J DEV BIOL, V52, P463, DOI 10.1387/ijdb.072555ea; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581, DOI 10.1071/BI9510581; BABA T, 1994, J BIOL CHEM, V269, P10133; Bailey JL, 2010, SYST BIOL REPROD MED, V56, P334, DOI 10.3109/19396368.2010.512377; Bernabo N, 2010, MOL CELL ENDOCRINOL, V323, P224, DOI 10.1016/j.mce.2010.02.025; Bi M, 2003, BIOCHEM J, V375, P477, DOI 10.1042/BJ20030753; BORDIER C, 1981, J BIOL CHEM, V256, P1604; Bureau M, 2000, ZYGOTE, V8, P139, DOI 10.1017/S0967199400000915; Campagna C, 2001, BIOL REPROD, V65, P554, DOI 10.1095/biolreprod65.2.554; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Choi YH, 1998, BIOL REPROD, V59, P1328, DOI 10.1095/biolreprod59.6.1328; Chung JJ, 2014, CELL, V157, P808, DOI 10.1016/j.cell.2014.02.056; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Darszon A, 2005, INT REV CYTOL, V243, P79, DOI 10.1016/S0074-7696(05)43002-8; Darszon A, 2001, DEV BIOL, V240, P1, DOI 10.1006/dbio.2001.0387; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; Dorval V, 2002, BIOL REPROD, V67, P1538, DOI 10.1095/biolreprod.102.004127; Dorval W, 2003, MOL HUM REPROD, V9, P125, DOI 10.1093/molehr/gag017; Druart X, 2009, REPRODUCTION, V137, P205, DOI 10.1530/REP-08-0225; Dube C, 2005, J ANDROL, V26, P519, DOI 10.2164/jandrol.04163; Dube C, 2003, J ANDROL, V24, P727; Ecroyd H, 2003, BIOL REPROD, V69, P1801, DOI 10.1095/biolreprod.103.017350; Ficarro S, 2003, J BIOL CHEM, V278, P11579, DOI 10.1074/jbc.M202325200; Flesch FM, 1999, BIOCHEM BIOPH RES CO, V262, P787, DOI 10.1006/bbrc.1999.1300; Funahashi H, 1997, BIOL REPROD, V57, P49, DOI 10.1095/biolreprod57.1.49; GalantinoHomer HL, 1997, BIOL REPROD, V56, P707, DOI 10.1095/biolreprod56.3.707; GARDNER AM, 1994, MOL BIOL CELL, V5, P193, DOI 10.1091/mbc.5.2.193; Geussova G, 2002, MOL REPROD DEV, V63, P366, DOI 10.1002/mrd.10156; Gupta SK, 2011, ASIAN J ANDROL, V13, P97, DOI 10.1038/aja.2010.72; Harper C, 2005, J CELL SCI, V118, P1673, DOI 10.1242/jcs.02297; Holt OJ, 2006, J BIOCHEM, V140, P7, DOI 10.1093/jb/mvj126; Jose O, 2010, BIOCHEM BIOPH RES CO, V395, P530, DOI 10.1016/j.bbrc.2010.04.059; Jungnickel MK, 2001, NAT CELL BIOL, V3, P499, DOI 10.1038/35074570; Kalab P, 1998, MOL REPROD DEV, V51, P304, DOI 10.1002/(SICI)1098-2795(199811)51:3&lt;304::AID-MRD10&gt;3.0.CO;2-2; Kanemori Y, 2016, P NATL ACAD SCI USA, V113, pE3696, DOI 10.1073/pnas.1522333113; Kaneto M, 2002, ANIM REPROD SCI, V73, P197, DOI 10.1016/S0378-4320(02)00128-8; Kato Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129285; Kongmanas K, 2015, J CELL PHYSIOL, V230, P449, DOI 10.1002/jcp.24728; Kumar V, 2008, BIOL REPROD, V79, P190, DOI 10.1095/biolreprod.107.066704; Kuroda Y, 1999, LIFE SCI, V65, P135, DOI 10.1016/S0024-3205(99)00230-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lawson C, 2007, MOL HUM REPROD, V13, P307, DOI 10.1093/molehr/gam012; Leclerc P, 1996, BIOL REPROD, V55, P684, DOI 10.1095/biolreprod55.3.684; Liu DY, 2006, HUM REPROD, V21, P1002, DOI 10.1093/humrep/dei435; Rodriguez AL, 2017, PORCINE HEALTH MANAG, V3, DOI 10.1186/s40813-017-0062-5; Minelli A, 2000, MOL REPROD DEV, V56, P527, DOI 10.1002/1098-2795(200008)56:4&lt;527::AID-MRD11&gt;3.0.CO;2-R; Mitra K, 2004, BIOL REPROD, V70, P887, DOI 10.1095/biolreprod.103.022780; Naaby-Hansen S, 2002, DEV BIOL, V242, P236, DOI 10.1006/dbio.2001.0527; NagDas SK, 2005, BIOL REPROD, V72, P164, DOI 10.1095/biolreprod.104.033530; Nixon B, 2010, J CELL PHYSIOL, V224, P71, DOI 10.1002/jcp.22090; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; Olson GE, 2004, BIOL REPROD, V71, P1128, DOI 10.1095/biolreprod.104.029975; Ono T, 2001, P NATL ACAD SCI USA, V98, P3282, DOI 10.1073/pnas.041625098; Pommer AC, 2003, BIOL REPROD, V68, P1208, DOI 10.1095/biolreprod.102.011106; Redgrove KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050851; Rossato M, 2001, MOL HUM REPROD, V7, P119, DOI 10.1093/molehr/7.2.119; Simpson AJG, 2005, NAT REV CANCER, V5, P615, DOI 10.1038/nrc1669; Sosa CM, 2016, BIOL REPROD, V94, DOI 10.1095/biolreprod.115.133231; Stetson I, 2012, J PROTEOMICS, V75, P5920, DOI 10.1016/j.jprot.2012.07.027; Strzezek J, 1998, J VET MED A, V45, P459, DOI 10.1111/j.1439-0442.1998.tb00849.x; Tardif S, 2003, BIOL REPROD, V68, P207, DOI 10.1095/biolreprod.102.005082; Tardif S, 1999, MOL REPROD DEV, V54, P292, DOI 10.1002/(SICI)1098-2795(199911)54:3&lt;292::AID-MRD10&gt;3.0.CO;2-F; Tardif S, 2001, BIOL REPROD, V65, P784, DOI 10.1095/biolreprod65.3.784; Tardif S, 2012, MOL HUM REPROD, V18, P298, DOI 10.1093/molehr/gas009; Tardif S, 2010, J BIOL CHEM, V285, P24863, DOI 10.1074/jbc.M110.123125; Teijeiro JM, 2012, REPRODUCTION, V143, P773, DOI 10.1530/REP-11-0314; Tomes CN, 2004, DEV BIOL, V265, P399, DOI 10.1016/j.ydbio.2003.09.032; Treiman M, 1998, TRENDS PHARMACOL SCI, V19, P131, DOI 10.1016/S0165-6147(98)01184-5; Urner F, 2003, REPRODUCTION, V125, P17, DOI 10.1530/rep.0.1250017; van Gestel RA, 2007, MOL HUM REPROD, V13, P445, DOI 10.1093/molehr/gam030; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697; Whitehurst AW, 2010, CANCER RES, V70, P7652, DOI 10.1158/0008-5472.CAN-10-0840; Yanagimachi R., 1994, P189; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166	80	7	7	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251973	10.1371/journal.pone.0251973	http://dx.doi.org/10.1371/journal.pone.0251973			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086710	Green Published, gold			2022-12-26	WOS:000664640100028
J	Leuenberger, A; Winkler, MS; Cambaco, O; Cossa, H; Kihwele, F; Lyatuu, I; Zabre, HR; Farnham, A; Macete, E; Munguambe, K				Leuenberger, Andrea; Winkler, Mirko S.; Cambaco, Olga; Cossa, Herminio; Kihwele, Fadhila; Lyatuu, Isaac; Zabre, Hyacinthe R.; Farnham, Andrea; Macete, Eusebio; Munguambe, Khatia			Health impacts of industrial mining on surrounding communities: Local perspectives from three sub-Saharan African countries	PLOS ONE			English	Article							EXTRACTIVE INDUSTRIES; QUALITATIVE RESEARCH; PARTICIPATION; INTERVIEWS; PROJECT; GHANA; MINE	Industrial mining projects can play an important role in global sustainable development if associated health risks are minimised and opportunities maximised. While a broad body of evidence from quantitative studies exists that establishes the interlinkages between mining operations and effects on public health, little research has been conducted investigating health impacts from the perspective of affected communities. This is particularly true in sub-Saharan Africa, where about a third of the remaining global mineral resources are endowed and health-related indicators for sustainable development are lagging behind. In this multi-country qualitative study, we explore community perceptions regarding impacts of industrial mining on their health and well-being. In nine study sites in Burkina Faso, Mozambique and Tanzania, we conducted 83 participatory focus group discussions with a total of 791 participants (385 men, 406 women). Our findings reveal a broad range of perceived impacts on environmental, economic and social determinants of health, with secondary health implications related to morbidity, mortality and well-being. Overall, perceived negative impacts prevailed, mainly related to environmental pollution, change in livelihoods or social disruption. Perceived positive impacts on health and well-being were related to interventions implemented by the mines such as new or improved water sources, health care facilities, roads and schools. The consistency of these findings across countries and study sites suggests a structural problem and indicates a pressing need to address health by acting on the wider determinants of health in mining regions. Participatory health impact assessment should be strengthened in host countries to foster strategic interventions, include marginalised population groups, and protect and promote the health of local communities. By including community perspectives on health before and during project implementation, policymakers can take advantage of economic opportunities while avoiding the pitfalls, bringing their communities closer to achieving good health and well-being goals by 2030 and beyond.	[Leuenberger, Andrea; Winkler, Mirko S.; Cossa, Herminio; Lyatuu, Isaac; Zabre, Hyacinthe R.; Farnham, Andrea] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Leuenberger, Andrea; Winkler, Mirko S.; Cossa, Herminio; Lyatuu, Isaac; Zabre, Hyacinthe R.; Farnham, Andrea] Univ Basel, Basel, Switzerland; [Cambaco, Olga; Cossa, Herminio; Macete, Eusebio; Munguambe, Khatia] Manhica Hlth Res Ctr, Maputo, Mozambique; [Kihwele, Fadhila; Lyatuu, Isaac] Ifakara Hlth Inst, Dar Es Salaam, Tanzania; [Zabre, Hyacinthe R.] Res Inst Hlth Sci, Ouagadougou, Burkina Faso; [Munguambe, Khatia] Eduardo Mondlane Univ, Fac Med, Maputo, Mozambique	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Centro de Investigacao em Saude de Manhica; Ifakara Health Institute; Eduardo Mondlane University	Leuenberger, A (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Leuenberger, A (corresponding author), Univ Basel, Basel, Switzerland.	andrea.leuenberger@swisstph.ch		Lyatuu, Isaac/0000-0001-5694-7648; Farnham, Andrea/0000-0002-0830-0927; Cossa, Herminio Fernando Humberto/0000-0002-5771-2637; Winkler, Mirko/0000-0001-7387-3863	Swiss Programme for Research on Global Issues for Development (r4d Programme) by the Swiss Agency for Development and Cooperation (SDC); Swiss Programme for Research on Global Issues for Development (r4d Programme) by the Swiss National Science Foundation (SNSF);  [169461]	Swiss Programme for Research on Global Issues for Development (r4d Programme) by the Swiss Agency for Development and Cooperation (SDC); Swiss Programme for Research on Global Issues for Development (r4d Programme) by the Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); 	This work was supported by the Swiss Programme for Research on Global Issues for Development (r4d Programme, http://www.r4d.ch/), which is a joint funding initiative by the Swiss Agency for Development and Cooperation (SDC) and the Swiss National Science Foundation (SNSF). The grant (No. 169461) was awarded to the principle investigator of the research project framing this study (MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboagye DC, 2019, INQUIRY-J HEALTH CAR, V56, DOI 10.1177/0046958019845292; Akpalu W, 2017, ECOL ECON, V142, P104, DOI 10.1016/j.ecolecon.2017.06.025; Anaf J, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0453-2; [Anonymous], 2006, HLTH IMPACT ASSESSME; Antabe R, 2017, HUM ECOL RISK ASSESS, V23, P798, DOI 10.1080/10807039.2017.1285691; AUDA-NEPAD, 2015, AG 2063 FRAM DOC; Bawole JN, 2013, ENVIRON MANAGE, V52, P385, DOI 10.1007/s00267-013-0086-9; Benshaul-Tolonena A., 2019, EXTRACTIVE IND SOC; Berman N, 2017, AM ECON REV, V107, P1564, DOI 10.1257/aer.20150774; Brisbois B, 2019, EXTRACT IND SOC, V6, P250, DOI 10.1016/j.exis.2018.10.017; BRITTEN N, 1995, BRIT MED J, V311, P251, DOI 10.1136/bmj.311.6999.251; Buse K, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0098-8; Cameron C, 2011, ENVIRON IMPACT ASSES, V31, P433, DOI 10.1016/j.eiar.2010.03.001; Carney JG, 2016, J IMMIGR MINOR HEALT, V18, P673, DOI 10.1007/s10903-015-0328-4; Carvalho FP, 2017, FOOD ENERGY SECUR, V6, P61, DOI 10.1002/fes3.109; Collins Nina., 2017, GUIDE GENDER IMPACT; Cronje F, 2013, JAMBA-J DISASTER RIS, V5, DOI 10.4102/jamba.v5i2.78; CSDH, 2008, CLOS GAP GEN HLTH EQ; den Broeder L, 2017, ENVIRON IMPACT ASSES, V66, P33, DOI 10.1016/j.eiar.2017.06.004; Dietler D, 2020, IMPACT MINING PROJEC; Dietler D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114155; Dietler D, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12020235; Drexhage J., 2017, GROWING ROLE MINERAL; Emel J, 2012, SUSTAINABILITY-BASEL, V4, P257, DOI 10.3390/su4020257; Emmanuel AY, 2018, J HEALTH POLLUT, V8, P43, DOI 10.5696/2156-9614-8.17.43; Esteves AM, 2012, IMPACT ASSESS PROJ A, V30, P34, DOI 10.1080/14615517.2012.660356; Farnham A, 2020, JMIR RES PROTOC, V9, DOI 10.2196/17138; Fraser J, 2019, EXTRACT IND SOC, V6, P788, DOI 10.1016/j.exis.2019.05.011; Furu P, 2021, HLTH IMPACT ASSESSME; Gamu J, 2015, EXTRACT IND SOC, V2, P162, DOI 10.1016/j.exis.2014.11.001; Gulis G, 2019, HEALTH PROMOT INT, V34, P373, DOI 10.1093/heapro/daz052; Harris P, 2018, ENVIRON IMPACT ASSES, V68, P59, DOI 10.1016/j.eiar.2017.10.002; Harris-Roxas B, 2012, IMPACT ASSESS PROJ A, V30, P43, DOI 10.1080/14615517.2012.666035; IFC, 2009, PROJ PEOPL HDB ADDR; Jacob T, 2018, EXTRACT IND SOC, V5, P287, DOI 10.1016/j.exis.2018.02.001; Karakaya E, 2018, RESOUR POLICY, V58, P257, DOI 10.1016/j.resourpol.2018.05.014; Knoblauch AM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103633; Knoblauch AM, 2014, INT J ENV RES PUB HE, V11, P12997, DOI 10.3390/ijerph111212997; Leuenberger A, 2019, ENVIRON IMPACT ASSES, V79, DOI 10.1016/j.eiar.2019.106288; Mactaggart F, 2018, GLOB PUBLIC HEALTH, V13, P899, DOI 10.1080/17441692.2016.1240821; Mamo N, 2019, J DEV ECON, V139, P28, DOI 10.1016/j.jdeveco.2019.02.001; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Moretti F, 2011, PATIENT EDUC COUNS, V82, P420, DOI 10.1016/j.pec.2011.01.005; Morgan RK, 2012, IMPACT ASSESS PROJ A, V30, P5, DOI 10.1080/14615517.2012.661557; Mzembe AN, 2014, EXTRACT IND SOC, V1, P225, DOI 10.1016/j.exis.2014.06.002; Niederberger T., 2016, OPEN CUT MINING TRAN, P538; O'Faircheallaigh C, 2017, THIRD WORLD Q, V38, P1181, DOI 10.1080/01436597.2017.1279539; O'Keefe E, 2010, INT J HEALTH SERV, V40, P339, DOI 10.2190/HS.40.2.o; Oster E, 2012, J EUR ECON ASSOC, V10, P1025, DOI 10.1111/j.1542-4774.2012.01075.x; Owen JR, 2020, ENVIRON DEV SUSTAIN, V22, P4907, DOI 10.1007/s10668-019-00410-8; Poland BD, 1995, QUAL INQ, DOI DOI 10.1177/107780049500100302; POPE C, 1995, BRIT MED J, V311, P42, DOI 10.1136/bmj.311.6996.42; Porgo M, 2017, HUM ECOL RISK ASSESS, V23, P641, DOI 10.1080/10807039.2016.1263930; Sandham LA, 2019, LAND-BASEL, V8, DOI 10.3390/land8100150; Schrecker T, 2018, HEALTH PLACE, V52, P135, DOI 10.1016/j.healthplace.2018.05.005; Standard & Poor Global, 2020, MARKET INTELLIGENCE; Thondoo M, 2020, ENVIRON INT, V144, DOI 10.1016/j.envint.2020.106027; Thondoo M, 2021, REV EUR COMP INT ENV, V30, P107, DOI 10.1111/reel.12347; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; USGS, 2019, 2015 MINERALS YB; Utzinger Jurg, 2004, Clin Occup Environ Med, V4, P9, DOI 10.1016/j.coem.2003.09.004; von der Goltz J, 2019, J DEV ECON, V139, P1, DOI 10.1016/j.jdeveco.2018.05.005; WHO European Centre for Health Policy, 1999, GOTH CONS PAP; Winkler MS, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17092988; Winkler MS, 2020, IMPACT ASSESS PROJ A, V38, P225, DOI 10.1080/14615517.2019.1694783; Winkler MS, 2013, B WORLD HEALTH ORGAN, V91, P298, DOI 10.2471/BLT.12.112318; Wong LP, 2008, SINGAP MED J, V49, P256; Yakovleva N, 2017, EXTRACT IND SOC, V4, P426, DOI 10.1016/j.exis.2017.06.010	69	7	7	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252433	10.1371/journal.pone.0252433	http://dx.doi.org/10.1371/journal.pone.0252433			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086737	gold, Green Published			2022-12-26	WOS:000664640100065
J	Liu, JY; Zhang, J; Kim, SH; Lee, HS; Marinoia, E; Song, WY				Liu, Jiayou; Zhang, Jie; Kim, Sun Ha; Lee, Hyun-Sook; Marinoia, Enrico; Song, Won-Yong			Characterization of Brassica rapa metallothionein and phytochelatin synthase genes potentially involved in heavy metal detoxification	PLOS ONE			English	Article							ARABIDOPSIS METALLOTHIONEINS; CADMIUM ACCUMULATION; TRANSPORTER; EXPRESSION; TOLERANCE; ZINC; FAMILY; COPPER; PLANTS; IRT1	Brassica rapa is an important leafy vegetable that can potentially accumulate high concentrations of cadmium (Cd), posing a risk to human health. The aim of the present study was to identify cadmium detoxifying molecular mechanisms in B. rapa using a functional cloning strategy. A cDNA library constructed from roots of B. rapa plants treated with Cd was transformed into the Cd sensitive yeast mutant strain DTY167 that lacks the yeast cadmium factor (YCF1), and resistant yeast clones were selected on Cd containing media. Two hundred genes potentially conferring cadmium resistance were rescued from the surviving yeast clones and sequenced. Sequencing analysis revealed that genes encoding for metallothionein (MT)1, MT2a, MT2b and MT3, and phytochelatin synthase (PCS)1 and PCS2 accounted for 35.5%, 28.5%, 4%, 11.3%, 18.7% and 2%, respectively of the genes identified. MTs and PCSs expressing DTY167 cells showed resistance to Cd as well as to Zn. PCS1 expressing yeast cells were also more resistant to Pb compared to those expressing MTs or PCS2. RT-PCR results showed that Cd treatment strongly induced the expression levels of MTs in the root and shoot. Furthermore, the different MTs and PCSs exhibited tissue specific expression. The results indicate that MTs and PCS genes potentially play a central role in detoxifying Cd and other toxic metals in B. rapa.	[Liu, Jiayou; Zhang, Jie; Marinoia, Enrico; Song, Won-Yong] Foshan Univ, Dept Hort, Int Res Ctr Environm Membrane Biol, Foshan, Guangdong, Peoples R China; [Kim, Sun Ha; Lee, Hyun-Sook; Song, Won-Yong] Chungnam Natl Univ, Coll Agr & Life Sci, Daejeon, South Korea	Foshan University; Chungnam National University	Song, WY (corresponding author), Foshan Univ, Dept Hort, Int Res Ctr Environm Membrane Biol, Foshan, Guangdong, Peoples R China.; Song, WY (corresponding author), Chungnam Natl Univ, Coll Agr & Life Sci, Daejeon, South Korea.	songwy@fosu.edu.cn	Zhang, Jie/E-4768-2013	Zhang, Jie/0000-0002-8344-5907; Song, Won-Yong/0000-0003-3833-6944	National Natural Science Foundation of China [31972488]; National Research Foundation (NRF) of Korea [NRF-2016R1A2B4012478]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation (NRF) of Korea(National Research Foundation of Korea)	This work was supported by grants from the National Natural Science Foundation of China (31972488 to W.Y.S.), and the National Research Foundation (NRF) of Korea (NRF-2016R1A2B4012478 to W.Y.S.).	An ZG, 2006, J EXP BOT, V57, P3575, DOI 10.1093/jxb/erl102; Bai JY, 2019, B ENVIRON CONTAM TOX, V102, P146, DOI 10.1007/s00128-018-2487-1; Bellostas N, 2007, SCI HORTIC-AMSTERDAM, V114, P234, DOI 10.1016/j.scienta.2007.06.015; Blaudez D, 2003, PLANT CELL, V15, P2911, DOI 10.1105/tpc.017541; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cobbett CS, 2000, CURR OPIN PLANT BIOL, V3, P211, DOI 10.1016/S1369-5266(00)00066-2; Connolly EL, 2002, PLANT CELL, V14, P1347, DOI 10.1105/tpc.001263; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Fischer S, 2014, ENVIRON SCI TECHNOL, V48, P7552, DOI 10.1021/es405234p; Godt J, 2006, J OCCUP MED TOXICOL, V1, DOI 10.1186/1745-6673-1-22; Gong JM, 2003, P NATL ACAD SCI USA, V100, P10118, DOI 10.1073/pnas.1734072100; GRILL E, 1987, P NATL ACAD SCI USA, V84, P439, DOI 10.1073/pnas.84.2.439; Guo WJ, 2003, NEW PHYTOL, V159, P369, DOI 10.1046/j.1469-8137.2003.00813.x; Guo WJ, 2008, PLANT PHYSIOL, V146, P1697, DOI 10.1104/pp.108.115782; Ha SB, 1999, PLANT CELL, V11, P1153, DOI 10.1105/tpc.11.6.1153; Hegelund JN, 2012, PLANT PHYSIOL, V159, P1125, DOI 10.1104/pp.112.197798; Huo J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201454; Korshunova YO, 1999, PLANT MOL BIOL, V40, P37, DOI 10.1023/A:1026438615520; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lee J, 2004, PLANT MOL BIOL, V54, P805, DOI 10.1007/s11103-004-0190-6; Liu Y, 2007, J ENVIRON SCI HEAL B, V42, P219, DOI 10.1080/03601230601125404; Lv YY, 2013, PLANT SOIL, V367, P507, DOI 10.1007/s11104-012-1486-y; Matsumura H, 1999, PLANT J, V20, P719, DOI 10.1046/j.1365-313X.1999.00640.x; Paschal DC, 2000, ARCH ENVIRON CON TOX, V38, P377, DOI 10.1007/s002449910050; Rafiq MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111461; Rani A, 2014, INT J ENVIRON HEAL R, V24, P378, DOI 10.1080/09603123.2013.835032; RAUSER WE, 1995, PLANT PHYSIOL, V109, P1141, DOI 10.1104/pp.109.4.1141; Ren YJ, 2012, PLANT CELL ENVIRON, V35, P770, DOI 10.1111/j.1365-3040.2011.02450.x; Rizwan M, 2018, SCI TOTAL ENVIRON, V631-632, P1175, DOI 10.1016/j.scitotenv.2018.03.104; ROBINSON NJ, 1993, BIOCHEM J, V295, P1; Rossi G, 2002, ACTA BIOTECHNOL, V22, P133, DOI 10.1002/1521-3846(200205)22:1/2&lt;133::AID-ABIO133&gt;3.0.CO;2-3; Sarwar N, 2010, J SCI FOOD AGR, V90, P925, DOI 10.1002/jsfa.3916; Sasaki A, 2012, PLANT CELL, V24, P2155, DOI 10.1105/tpc.112.096925; Sekhar K, 2011, ENVIRON EXP BOT, V72, P131, DOI 10.1016/j.envexpbot.2011.02.017; Selvam A, 2009, J HAZARD MATER, V167, P170, DOI 10.1016/j.jhazmat.2008.12.103; Shanmugaraj B.M., 2019, CADMIUM TOXICITY TOL, P1; Singh S., 2018, SURESH GYAN VIHAR U, V4, P5; Song WY, 2010, PLANT CELL, V22, P2237, DOI 10.1105/tpc.109.070185; Song WY, 2004, PLANT PHYSIOL, V135, P1027, DOI 10.1104/pp.103.037739; Song Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177978; Tchounwou P.B., 2012, EXP S, V101, P133, DOI [10.1007/978-3-7643-8340-4_6, 10.1007/978-3-7643-8340-4, DOI 10.1007/978-3-7643-8340-4_6]; Tennstedt P, 2009, PLANT PHYSIOL, V149, P938, DOI 10.1104/pp.108.127472; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Zarros A, 2008, PNEUMON, V21, P172; Zhang LX, 2019, J EXP BOT, V70, P5865, DOI 10.1093/jxb/erz310; ZHOU JM, 1994, PLANT CELL, V6, P875, DOI 10.1105/tpc.6.6.875	49	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252899	10.1371/journal.pone.0252899	http://dx.doi.org/10.1371/journal.pone.0252899			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086824	gold, Green Published			2022-12-26	WOS:000664640100153
J	Liu, Z; Ming, WH; Li, JM; Zhou, CY; Zhang, LH				Liu, Zhen; Ming, Weihua; Li, Jieming; Zhou, Cuiying; Zhang, Lihai			Numerical prediction of the optimal shield tunneling strategy for tunnel construction in karst regions	PLOS ONE			English	Article							DEFORMATION; PRESSURES; SPEED	Shield tunneling in karst areas poses significant challenges, as vibration caused by the shield machine can disturb the stability of the karst caves, ultimately resulting in the collapse of a tunnel. In the present study, a numerical model involving an iteration process was developed based on the Mindlin solution scheme to identify the optimal shield tunneling speed for minimizing the disturbance to karst cave stability. The developed model was then implemented to investigate an underground tunnel constructed in a karst region with different shield tunneling strategies. By using the variation in the energy density of a karst cave as a performance index, the model predicts that when approaching the affected zone of a karst carve (e.g., approximately 5 m from the carve), the shield tunneling machine should be controlled within a certain speed (i.e., < 30 mm/min). Once the shield tunneling machine moves into the affected zone of the cave, the speed of the machine needs to be decelerated to 11 mm/min, and the speed of 30 mm/min can be restored when the shield machine moves out of the affected zone. This finding demonstrates that the developed model could potentially be used to identify the optimal shield tunneling speed to minimize the disturbance to karst cave stability and ensure the safety of tunnel construction in karst regions.	[Liu, Zhen; Ming, Weihua; Zhou, Cuiying] Sun Yat Sen Univ, Sch Civil Engn, Guangzhou, Peoples R China; [Liu, Zhen; Ming, Weihua; Li, Jieming; Zhou, Cuiying] Sun Yat Sen Univ, Guangdong Engn Res Ctr Major Infrastruct Safety, Guangzhou, Peoples R China; [Zhang, Lihai] Univ Melbourne, Dept Infrastruct Engn, Melbourne, Vic, Australia	Sun Yat Sen University; Sun Yat Sen University; University of Melbourne	Zhou, CY (corresponding author), Sun Yat Sen Univ, Sch Civil Engn, Guangzhou, Peoples R China.; Zhou, CY (corresponding author), Sun Yat Sen Univ, Guangdong Engn Res Ctr Major Infrastruct Safety, Guangzhou, Peoples R China.	zhoucy@mail.sysu.edu.cn	Zhang, Lihai/F-6823-2014	Zhang, Lihai/0000-0002-1282-992X	National Natural Science Foundation of China (NSFC) [41472257, 41530638]; National Key Research and Development Project [2017YFC0804605]; Special Fund Key Project of Applied Science and Technology Research and Development in Guangdong [2015B090925016, 2016B010124007]; Special Support Programme for High Level Talents in Guangdong [2015TQ01Z344]; Science and technology planning project in Guangzhou [201803030005]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project; Special Fund Key Project of Applied Science and Technology Research and Development in Guangdong; Special Support Programme for High Level Talents in Guangdong; Science and technology planning project in Guangzhou	This research presented is funded by the National Natural Science Foundation of China (NSFC) (Grant No. 41472257, 41530638), the National Key Research and Development Project (Grant No. 2017YFC0804605), the Special Fund Key Project of Applied Science and Technology Research and Development in Guangdong (Grant No. 2015B090925016, No. 2016B010124007), the Special Support Programme for High Level Talents in Guangdong (Grant No. 2015TQ01Z344), the Science and technology planning project in Guangzhou (Grant No. 201803030005).	Alber M, 2000, TUNN UNDERGR SP TECH, V15, P55, DOI 10.1016/S0886-7798(00)00029-8; Aypin Ye, 2014, SOBRANIE SOCHINENIJ, V2; Bai TH, 2016, ROCK SOIL MECH, V37, P2040, DOI 10.16285/j.rsm.2016.07.027; Cao Q, 2018, IOP C SER EARTH ENV, V108, DOI 10.1088/1755-1315/108/3/032066; Cui QL, 2015, NAT HAZARDS, V77, P129, DOI 10.1007/s11069-014-1585-6; Fang M., 2016, ZHONGSHAN DAXUE XUEB, DOI [10.13471/j.cnki.acta.snus.2016.01.014, DOI 10.13471/J.CNKI.ACTA.SNUS.2016.01.014]; Hehua Zhu., 2007, CHINA CIV ENG J, V12, P245; Huang MS, 2009, TUNN UNDERGR SP TECH, V24, P410, DOI 10.1016/j.tust.2008.11.005; Jie Li, 2017, MOD TUNN TECHNOL, DOI [10.13807/j.cnki.mtt.2017.03.020, DOI 10.13807/J.CNKI.MTT.2017.03.020]; Li CL, 2016, ROCK SOIL MECH, V37, P759, DOI 10.16285/j.rsm.2016.03.019; [李围 LI Wei], 2006, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V28, P1277; Li XC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212923; Liang RZ, 2018, TUNN UNDERGR SP TECH, V71, P94, DOI 10.1016/j.tust.2017.08.010; Liu Z., 2012, ELECT J GEOTECH ENG, V17, P2555; LIU Z., 2012, 3D NUMERICAL STABILI, V05; Liu Z, 2019, INT J COMPUT MAT SCI, V8, DOI 10.1142/S2047684118500288; Liu Z, 2014, GEOTECH GEOL ENG, V32, P1211, DOI 10.1007/s10706-014-9791-2; Liu Z, 2015, J COASTAL RES, P776, DOI 10.2112/SI73-133.1; Mindlin RD, 1936, PHYSICS-J GEN APPL P, V7, P195, DOI 10.1063/1.1745385; Shan RL, 2018, GEOTECH GEOL ENG, V36, P95, DOI 10.1007/s10706-017-0309-6; Shi CH, 2017, KSCE J CIV ENG, V21, P1933, DOI 10.1007/s12205-016-0804-y; Sun HS, 2013, COMPUT GEOTECH, V50, P143, DOI 10.1016/j.compgeo.2013.01.009; Verruijt A, 1996, GEOTECHNIQUE, V46, P753, DOI 10.1680/geot.1996.46.4.753; Verruijt A, 1998, INT J SOLIDS STRUCT, V35, P2795, DOI 10.1016/S0020-7683(97)00194-7; Wang H., 2012, GUANGZHOU DITIE SANH; Wang W, 2019, GEOSYSTEM ENG, V22, P81, DOI 10.1080/12269328.2018.1475265; Xia Y., 2015, RES APPL SCOPE END P; Yang JL, 2017, UNDERGR SPACE, V2, P45, DOI 10.1016/j.undsp.2017.04.002; YI X, 1993, CAN GEOTECH J, V30, P476, DOI 10.1139/t93-041; Zhang ZX, 2013, ENVIRON EARTH SCI, V69, P1891, DOI 10.1007/s12665-012-2021-4; Zhang ZG, 2011, TUNN UNDERGR SP TECH, V26, P345, DOI 10.1016/j.tust.2010.11.005; Zhao J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112436; Zheng G, 2015, COMPUT GEOTECH, V65, P220, DOI 10.1016/j.compgeo.2014.12.013; Zhou C, 2017, SAFETY SCI, V98, P145, DOI 10.1016/j.ssci.2017.06.012; Zhou CY, 2015, ENGINEERING GEOLOGY FOR SOCIETY AND TERRITORY, VOL 6: APPLIED GEOLOGY FOR MAJOR ENGINEERING PROJECTS, P583, DOI 10.1007/978-3-319-09060-3_105; Zhu HH, 2008, FRONT STRUCT CIV ENG, V2, P350, DOI 10.1007/s11709-008-0051-5; Zhu W., 2007, GUANGZHOU METROLINE	37	1	1	18	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252733	10.1371/journal.pone.0252733	http://dx.doi.org/10.1371/journal.pone.0252733			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086794	gold, Green Published			2022-12-26	WOS:000664640100123
J	Marufa, SA; Hsieh, TH; Liou, JC; Chen, HY; Peng, CW				Marufa, Siti Ainun; Hsieh, Tsung-Hsun; Liou, Jian-Chiun; Chen, Hsin-Yung; Peng, Chih-Wei			Neuromodulatory effects of repetitive transcranial magnetic stimulation on neural plasticity and motor functions in rats with an incomplete spinal cord injury: A preliminary study	PLOS ONE			English	Article							THETA-BURST STIMULATION; GROWTH-ASSOCIATED PROTEIN-43; ELECTRICAL-STIMULATION; CEREBROSPINAL-FLUID; CORTEX STIMULATION; EVOKED POTENTIALS; CENTRAL PAIN; RECOVERY; GAP-43; INTERLEUKIN-6	We investigated the effects of intermittent theta-burst stimulation (iTBS) on locomotor function, motor plasticity, and axonal regeneration in an animal model of incomplete spinal cord injury (SCI). Aneurysm clips with different compression forces were applied extradurally around the spinal cord at T10. Motor plasticity was evaluated by examining the motor evoked potentials (MEPs). Long-term iTBS treatment was given at the post-SCI 5th week and continued for 2 weeks (5 consecutive days/week). Time-course changes in locomotor function and the axonal regeneration level were measured by the Basso Beattie Bresnahan (BBB) scale, and growth-associated protein (GAP)-43 expression was detected in brain and spinal cord tissues. iTBS-induced potentiation was reduced at post-1-week SCI lesion and had recovered by 4 weeks post-SCI lesion, except in the severe group. Multiple sessions of iTBS treatment enhanced the motor plasticity in all SCI rats. The locomotor function revealed no significant changes between pre- and post-iTBS treatment in SCI rats. The GAP-43 expression level in the spinal cord increased following 2 weeks of iTBS treatment compared to the sham-treatment group. This preclinical model may provide a translational platform to further investigate therapeutic mechanisms of transcranial magnetic stimulation and enhance the possibility of the potential use of TMS with the iTBS scheme for treating SCIs.	[Marufa, Siti Ainun; Peng, Chih-Wei] Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan; [Marufa, Siti Ainun] Univ Muhammadiyah Malang, Phys Therapy Dept, Fac Hlth Sci, Malang, Indonesia; [Hsieh, Tsung-Hsun] Chang Gung Univ, Sch Phys Therapy, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Grad Inst Rehabil Sci, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Mem Hosp, Neurosci Res Ctr, Taoyuan, Taiwan; [Hsieh, Tsung-Hsun] Chang Gung Univ, Hlth Aging Res Ctr, Taoyuan, Taiwan; [Liou, Jian-Chiun; Peng, Chih-Wei] Taipei Med Univ, Sch Biomed Engn, Coll Biomed Engn, Taipei, Taiwan; [Chen, Hsin-Yung] Chang Gung Univ, Dept Occupat Therapy, Coll Med, Taoyuan, Taiwan; [Chen, Hsin-Yung] Chang Gung Univ, Grad Inst Behav Sci, Coll Med, Taoyuan, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Int PhD Program Biomed Engn, Coll Biomed Engn, Taipei, Taiwan; [Peng, Chih-Wei] Taipei Med Univ, Sch Gerontol Hlth Management, Coll Nursing, Taipei, Taiwan	Taipei Medical University; Universitas Muhammadiyah Malang; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Taipei Medical University; Chang Gung University; Chang Gung University; Taipei Medical University; Taipei Medical University	Peng, CW (corresponding author), Taipei Med Univ, Grad Inst Biomed Mat & Tissue Engn, Coll Biomed Engn, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Sch Biomed Engn, Coll Biomed Engn, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Int PhD Program Biomed Engn, Coll Biomed Engn, Taipei, Taiwan.; Peng, CW (corresponding author), Taipei Med Univ, Sch Gerontol Hlth Management, Coll Nursing, Taipei, Taiwan.	cwpeng@tmu.edu.tw	Marufa, Siti Ainun/AIE-1774-2022	marufa, siti ainun/0000-0002-7001-346X; Peng, Chih-Wei/0000-0001-9744-4094; Chen, Hsin-Yung/0000-0002-5165-3840	Ministry of Science and Technology [106-2221-E-038-010-MY3, 108-2314-B-038-017, 109-2314-B-038-132, 109-2221-E-038-005-MY3]; Higher Education Sprout Project by the Ministry of Education in Taiwan [DP2-108-21121-01-N-08-02, DP2-110-21121-01-N-02-01]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Higher Education Sprout Project by the Ministry of Education in Taiwan	The present study was generously funded by the Ministry of Science and Technology (106-2221-E-038-010-MY3, 108-2314-B-038-017, 109-2314-B-038-132, and 109-2221-E-038-005-MY3) and the Higher Education Sprout Project by the Ministry of Education (DP2-108-21121-01-N-08-02 and DP2-110-21121-01-N-02-01) in Taiwan to C.W. Peng.	AIGNER L, 1995, CELL, V83, P269, DOI 10.1016/0092-8674(95)90168-X; Andre-Obadia N, 2006, CLIN NEUROPHYSIOL, V117, P1536, DOI 10.1016/j.clinph.2006.03.025; Awad BI, 2015, WORLD NEUROSURG, V83, P232, DOI 10.1016/j.wneu.2013.01.043; Aydin-Abidin S, 2008, EXP BRAIN RES, V188, P249, DOI 10.1007/s00221-008-1356-2; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Benito J, 2012, Top Spinal Cord Inj Rehabil, V18, P106, DOI 10.1310/sci1802-106; BENOWITZ LI, 1989, J NEUROSCI, V9, P990; Calancie B, 1999, J NEUROTRAUM, V16, P49, DOI 10.1089/neu.1999.16.49; Cantone M, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9080200; Chen YY, 2016, ARCH PHYS MED REHAB, V97, P1610, DOI 10.1016/j.apmr.2016.03.017; Chidlow G, 2012, NEUROBIOL DIS, V48, P568, DOI 10.1016/j.nbd.2012.07.026; Curt A, 1998, ARCH PHYS MED REHAB, V79, P81, DOI 10.1016/S0003-9993(98)90213-1; Defrin R, 2007, ARCH PHYS MED REHAB, V88, P1574, DOI 10.1016/j.apmr.2007.07.025; DELAMONTE SM, 1995, AM J PATHOL, V147, P934; Di Lazzaro V, 1999, CLIN NEUROPHYSIOL, V110, P1297, DOI 10.1016/S1388-2457(99)00060-7; Fakhoury M, 2015, REV NEUROSCIENCE, V26, P397, DOI 10.1515/revneuro-2015-0001; Fassett HJ, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00380; Fonoff ET, 2009, BEHAV BRAIN RES, V196, P63, DOI 10.1016/j.bbr.2008.07.027; Freund P, 2013, NEUROSCIENTIST, V19, P116, DOI 10.1177/1073858412449192; Froc DJ, 2000, J NEUROSCI, V20, P438, DOI 10.1523/JNEUROSCI.20-01-00438.2000; Gharooni AA, 2018, SPINAL CORD, V56, P762, DOI 10.1038/s41393-018-0152-5; Gnanapavan S, 2014, J NEUROIMMUNOL, V276, P18, DOI 10.1016/j.jneuroim.2014.07.008; Grasselli G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020791; Hakkoum D, 2007, J NEUROCHEM, V100, P747, DOI 10.1111/j.1471-4159.2006.04257.x; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hamada M, 2013, CEREB CORTEX, V23, P1593, DOI 10.1093/cercor/bhs147; Hsieh TH, 2015, CEREB CORTEX, V25, P1806, DOI 10.1093/cercor/bht421; Hsieh TH, 2015, J MED BIOL ENG, V35, P62, DOI 10.1007/s40846-015-0006-y; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hulsebosch CE, 2002, ADV PHYSIOL EDUC, V26, P238, DOI 10.1152/advan.00039.2002; JACOBSON RD, 1986, J NEUROSCI, V6, P1843; Jette F, 2013, NEUROREHAB NEURAL RE, V27, P636, DOI 10.1177/1545968313484810; Kang BS, 2009, ARCH PHYS MED REHAB, V90, P1766, DOI 10.1016/j.apmr.2009.04.008; Kerschensteiner M, 2004, J EXP MED, V200, P1027, DOI 10.1084/jem.20040452; Kjell J, 2016, DIS MODEL MECH, V9, P1125, DOI 10.1242/dmm.025833; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Krassioukov A, 2009, RESP PHYSIOL NEUROBI, V169, P157, DOI 10.1016/j.resp.2009.08.003; Kumru H, 2010, NEUROREHAB NEURAL RE, V24, P435, DOI 10.1177/1545968309356095; Lanza GS, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10110806; Lanza G, 2019, BRAIN STIMUL, V12, P1579, DOI 10.1016/j.brs.2019.07.008; LEWKO JP, 1995, RESTOR NEUROL NEUROS, V7, P225, DOI 10.3233/RNN-1994-7405; Maeda F, 2000, EXP BRAIN RES, V133, P425, DOI 10.1007/s002210000432; McAllister SM, 2009, CLIN NEUROPHYSIOL, V120, P820, DOI 10.1016/j.clinph.2009.02.003; Moreno-Duarte I, 2014, NEUROIMAGE, V85, P1003, DOI 10.1016/j.neuroimage.2013.05.097; Morgante F, 2006, BRAIN, V129, P1059, DOI 10.1093/brain/awl031; Mori F, 2009, PROG BRAIN RES, V175, P429, DOI 10.1016/S0079-6123(09)17528-3; Nardone R, 2015, BRAIN RES, V1619, P139, DOI 10.1016/j.brainres.2014.09.036; OESTREICHER AB, 1986, J NEUROCHEM, V46, P1366, DOI 10.1111/j.1471-4159.1986.tb01748.x; OESTREICHER AB, 1981, BRAIN RES BULL, V6, P145, DOI 10.1016/S0361-9230(81)80040-8; Onifer SM, 2007, ILAR J, V48, P385, DOI 10.1093/ilar.48.4.385; Oyinbo CA, 2011, ACTA NEUROBIOL EXP, V71, P281; Petersen JA, 2012, NEUROREHAB NEURAL RE, V26, P939, DOI 10.1177/1545968312438437; Petrosyan HA, 2017, NEUROSCI LETT, V642, P37, DOI 10.1016/j.neulet.2017.01.065; Poon PC, 2007, SPINE, V32, P2853, DOI 10.1097/BRS.0b013e31815b7e6b; Ridding MC, 2007, NAT REV NEUROSCI, V8, P559, DOI 10.1038/nrn2169; Rong H, 2018, SPINE, V43, pE126, DOI 10.1097/BRS.0000000000002279; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Rossini PM, 2007, NEUROLOGY, V68, P484, DOI 10.1212/01.wnl.0000250268.13789.b2; Rotenberg A, 2010, CLIN NEUROPHYSIOL, V121, P104, DOI 10.1016/j.clinph.2009.09.008; Sangari S, 2019, J NEUROSCI, V39, P7872, DOI 10.1523/JNEUROSCI.1106-19.2019; Sekhon LHS, 2001, SPINE, V26, pS2, DOI 10.1097/00007632-200112151-00002; Sjogren M, 2001, DEMENT GERIATR COGN, V12, P257, DOI 10.1159/000051268; SKENE JHP, 1981, J CELL BIOL, V89, P86, DOI 10.1083/jcb.89.1.86; Song WG, 2016, EXP NEUROL, V277, P46, DOI 10.1016/j.expneurol.2015.12.008; Suppa A, 2011, EXP NEUROL, V227, P296, DOI 10.1016/j.expneurol.2010.11.020; Suppa A, 2014, MOVEMENT DISORD, V29, P97, DOI 10.1002/mds.25668; Tazoe T, 2015, ARCH PHYS MED REHAB, V96, pS145, DOI 10.1016/j.apmr.2014.07.418; Teunissen CE, 2006, NEUROPATH APPL NEURO, V32, P318, DOI 10.1111/j.1365-2990.2006.00730.x; Trepel C, 1998, CEREB CORTEX, V8, P719, DOI 10.1093/cercor/8.8.719; Tsai S Y, 1992, Electromyogr Clin Neurophysiol, V32, P615; Wassermann EM, 2001, CLIN NEUROPHYSIOL, V112, P1367, DOI 10.1016/S1388-2457(01)00585-5; Wen JX, 2015, J NEUROTRAUM, V32, P875, DOI 10.1089/neu.2013.3321; Wischnewski M, 2015, BRAIN STIMUL, V8, P685, DOI 10.1016/j.brs.2015.03.004; Wu SW, 2012, BRAIN STIMUL, V5, P315, DOI 10.1016/j.brs.2011.04.001; Yang G, 2017, INT J MOL MED, V39, P437, DOI 10.3892/ijmm.2017.2848; Yang Q, 2019, EXP NEUROL, V320, DOI 10.1016/j.expneurol.2019.112962; Yoon EJ, 2013, BRAIN RES, V1540, P64, DOI 10.1016/j.brainres.2013.10.007; Zareen N, 2017, EXP NEUROL, V297, P179, DOI 10.1016/j.expneurol.2017.08.004	80	5	5	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252965	10.1371/journal.pone.0252965	http://dx.doi.org/10.1371/journal.pone.0252965			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086836	Green Accepted, Green Published, gold			2022-12-26	WOS:000664640100157
J	Polanunu, NFA; Wahyuni, S; Hamid, F				Polanunu, Nurul Fadilah Ali; Wahyuni, Sitti; Hamid, Firdaus			Seroprevalence and associated risk factors of Toxoplasma gondii infection among pregnant mother in Makassar, Indonesia	PLOS ONE			English	Article								The protozoan parasite, Toxoplasma gondii is estimated to infect one-third of the world's population. Infection in pregnant women can cause severe conditions for their babies. Until now, there is no data regarding Toxoplasma infection from Makassar pregnant mothers. This study aims to obtain information on Toxoplasma specific antibodies and to measure the risk factor associate with parasite infection. This cross-sectional study conducted in 9 of 47 primary health centres (Puskesmas) in Makassar. Blood samples and questionnaires were collected from 184 pregnant women aged 15-42 years old from September to October 2020. ELISA technique was used to examine the IgG and IgM antibodies. Univariable and multivariable analyses were carried out to measure factors that independently associate with Toxoplasma antibody positivity. Our result showed the range of Toxoplasma IgM and IgG are 0.06-1.01 and 0.09-3.01, respectively. While no one of our participants has an acute Toxoplasma gondii infection (IgM positive), we found 32,6% pregnant mothers are exposed to parasite (positive IgG). Contact with cats [OR(95%CI): 10.45(3.77-28.99)], consume chicken satay [OR(95%CI): 9.72(3.71-25.48)] and consume un-boiled water/ filtered water [OR(95%CI): 5.98(1.77-20.23)] are independently associate with positive Toxoplasma IgG antibody. Based on the result, we conclude that pregnant women in Makassar are exposed to T. gondii and the oocyst and tissue cyst of parasite contaminates food and water in Makassar.	[Polanunu, Nurul Fadilah Ali; Wahyuni, Sitti] Hasanuddin Univ, Dept Parasitol, Fac Med, South Sulawesi, Indonesia; [Polanunu, Nurul Fadilah Ali] Univ Muslim Indonesia, Dept Parasitol, Fac Med, Makassar, South Sulawesi, Indonesia; [Wahyuni, Sitti] Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia; [Hamid, Firdaus] Hasanuddin Univ, Dept Microbiol, Fac Med, Makassar, South Sulawesi, Indonesia	Universitas Hasanuddin; University of Indonesia; Universitas Hasanuddin	Wahyuni, S (corresponding author), Hasanuddin Univ, Dept Parasitol, Fac Med, South Sulawesi, Indonesia.; Wahyuni, S (corresponding author), Univ Indonesia, Dept Parasitol, Fac Med, Jakarta, Indonesia.	sittiwahyuni@gmail.com			Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia [007/SP2H/LT/DRPM/2020]	Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK))	This study was supported by the Kementerian Riset Teknologi Dan Pendidikan Tinggi Republik Indonesia (grant no. 007/SP2H/LT/DRPM/2020 to SW).	Alvarado-Esquivel C, 2018, J INT MED RES, V46, P1626, DOI 10.1177/0300060518757928; Avelino Mariza Martins, 2004, Braz J Infect Dis, V8, P164, DOI 10.1590/S1413-86702004000200007; Badan Pusat Statistik, 2020, BAD PUS STAT SUL SEL; Bamba S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2583-6; Berrebi A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.002; Bogitsh B.J., 2012, HUMAN PARASITOLOGY, V11, P430, DOI [10.1016/B978-0-323-40161-6.00280-1, DOI 10.1016/B978-0-323-40161-6.00280-1]; Centers for Disease Control and Prevention, 2018, PAR TOX TOX INF, V24, P7; DUBEY JP, 1970, J PARASITOL, V56, P447, DOI 10.2307/3277601; Dwinata IM., 2016, POTENTIAL RISK FACTO, V5, P116, DOI [10.15562/bmj.v5i1.277, DOI 10.15562/BMJ.V5I1.277]; Fakhfakh N., 2013, FACTEURS RISQUE TOXO, P188; Gyang VP, 2015, REV SOC BRAS MED TRO, V48, P56, DOI 10.1590/0037-8682-0310-2014; Heukelbach J, 2007, EMERG INFECT DIS, V13, P287, DOI 10.3201/eid1302.060686; Jiang RL, 2018, MICROB PATHOGENESIS, V123, P398, DOI 10.1016/j.micpath.2018.07.041; Jones JL, 2001, AM J EPIDEMIOL, V154, P357, DOI 10.1093/aje/154.4.357; Liu XC, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0277-3; Mahdy MAK., 2017, INFECT DIS POVERTY, V6, P4, DOI [10.1186/s40249-016-0222-x, DOI 10.1186/S40249-016-0222-X]; Markus MM., 2014, MANSONS TROP DIS, P652, DOI [10.1016/B978-0-7020-5101-2.00049-2, DOI 10.1016/B978-0-7020-5101-2.00049-2]; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Montoya JG, 2008, CLIN INFECT DIS, V47, P554, DOI 10.1086/590149; Mose JM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7589278; Ponnappan S, 2011, ANTIOXID REDOX SIGN, V14, P1551, DOI 10.1089/ars.2010.3228; Retmanasari A, 2017, ECOHEALTH, V14, P162, DOI 10.1007/s10393-016-1198-5; Rostami A, 2020, CLIN MICROBIOL INFEC, V26, P673, DOI 10.1016/j.cmi.2020.01.008; Sarr A, 2020, VECTOR-BORNE ZOONOT, V20, P15, DOI 10.1089/vbz.2019.2481; Vueba AN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241908; Wong WK, 2013, SCAND J INFECT DIS, V45, P357, DOI 10.3109/00365548.2012.737017; Zemene E, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-337	27	1	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0245572	10.1371/journal.pone.0245572	http://dx.doi.org/10.1371/journal.pone.0245572			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086692	gold, Green Published			2022-12-26	WOS:000664640100005
J	Schubiger, CB; Gorman, ME; Johns, JL; Arkoosh, MR; Dietrich, JP				Schubiger, Carla B.; Gorman, M. Elena; Johns, Jennifer L.; Arkoosh, Mary R.; Dietrich, Joseph P.			Sablefish (Anoplopoma fimbra Pallas, 1814) plasma biochemistry and hematology reference intervals including blood cell morphology	PLOS ONE			English	Article							CHEMISTRY REFERENCE INTERVALS; SEX; INTERFERENCES; TEMPERATURE; AQUACULTURE; PARAMETERS; GROWTH	Plasma biochemistry and hematology reference intervals are integral health assessment tools in all medical fields, including aquatic animal health. As sablefish (Anoplopoma fimbria) are becoming aquaculturally and economically more important, this manuscript provides essential reference intervals (RI) for their plasma biochemistry and hematology along with reference photomicrographs of blood cells in healthy, fasted sablefish. Blood cell morphology can differ between fish species. In addition, blood cell counts and blood chemistry can vary between fish species, demographics, water conditions, seasons, diets, and culture systems, which precludes the use of RI's from other fish species. For this study, blood was collected for plasma biochemistry and hematology analysis between June 20 and July 18, 2019, from healthy, yearling sablefish, hatched and reared in captivity on a commercial diet. Overnight fast of 16-18 hours did not sufficiently reduce lipids in the blood, which led to visible lipemia and frequent rupture of blood cells during analysis. Therefore, sablefish should be fasted for 24 to 36 hours before blood is collected to reduce hematology artifacts or possible reagent interference in plasma biochemistry analysis. Lymphocytes were the most dominant leukocytes (98%), while eosinophils were rare, and basophils were not detected in sablefish. Neutrophils were very large cells with Dohle bodies. In mammals and avian species, Dohle bodies are usually signs of toxic change from inflammation, but no such association was found in these fish. In conclusion, lipemia can interfere with sablefish blood analysis, and available removal methods should be evaluated as fasting for up to 36 h might not always be feasible. Also, more studies are required to establish RI for different developmental stages and rearing conditions.	[Schubiger, Carla B.; Gorman, M. Elena; Johns, Jennifer L.] Oregon State Univ, Carlson Coll Vet Med, Corvallis, OR 97331 USA; [Arkoosh, Mary R.; Dietrich, Joseph P.] NOAA, Environm & Fisheries Sci Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Newport, OR USA	Oregon State University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Schubiger, CB (corresponding author), Oregon State Univ, Carlson Coll Vet Med, Corvallis, OR 97331 USA.	Carla.schubiger@oregonstate.edu		Johns, Jennifer/0000-0003-4373-5982; Schubiger, Carla/0000-0002-6433-3125	Oregon Sea Grant Program Development Award [NA18OAR4170072]; Oregon State University Agricultural Research Foundation [9026A]	Oregon Sea Grant Program Development Award; Oregon State University Agricultural Research Foundation	This study was funded by an Oregon Sea Grant Program Development Award #NA18OAR4170072 awarded to Dr. Carla B. Schubiger and partially supported by an Oregon State University Agricultural Research Foundation Grant #9026A awarded to Dr. Carla B. Schubiger.	ACKMAN RG, 1967, J FISH RES BOARD CAN, V24, P2563, DOI 10.1139/f67-206; Ahmed I, 2020, AQUACULT INT, V28, P869, DOI 10.1007/s10499-019-00501-3; Arkoosh MR, 2018, AQUAC RES, V49, P205, DOI 10.1111/are.13449; Arkoosh MR, 2015, J AQUAT ANIM HEALTH, V27, P96, DOI 10.1080/08997659.2015.1019159; Arnold JE, 2005, VET CLIN PATH, V34, P115, DOI 10.1111/j.1939-165X.2005.tb00023.x; Arnold JE, 2014, VET CLIN PATH, V43, P613, DOI 10.1111/vcp.12214; Calmarza P, 2011, BIOCHEM MEDICA, V21, P160, DOI 10.11613/BM.2011.025; Cook MA, 2015, AQUACULT ENG, V69, P43, DOI 10.1016/j.aquaeng.2015.09.003; Copes Palsson, 2000, IIFET 2000 P, P1; Dimeski G, 2005, CLIN CHEM, V51, P2425, DOI 10.1373/clinchem.2005.058644; Fazio F, 2019, AQUACULTURE, V500, P237, DOI 10.1016/j.aquaculture.2018.10.030; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; Geffre A, 2011, VET CLIN PATH, V40, P107, DOI 10.1111/j.1939-165X.2011.00287.x; GLICK MR, 1986, CLIN CHEM, V32, P470; Goetz FW, 2018, FISH OCEANOGR, V27, P127, DOI 10.1111/fog.12239; Goetz FW, 2021, J WORLD AQUACULT SOC, V52, P607, DOI 10.1111/jwas.12769; Grant KR, 2015, CLIN LAB MED, V35, P681, DOI [10.1016/j.cll.2015.05.015, 10.1016/j.cvex.2014.09.007]; Guzman JM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184413; Hanselman DH, 2015, CAN J FISH AQUAT SCI, V72, P238, DOI 10.1139/cjfas-2014-0251; HINE PM, 1986, J FISH BIOL, V29, P711, DOI 10.1111/j.1095-8649.1986.tb04987.x; Hrubec TC, 2000, VET CLIN PATH, V29, P7, DOI 10.1111/j.1939-165X.2000.tb00389.x; Hrubec TC, 1996, AM J VET RES, V57, P624; HUNN JB, 1991, PROG FISH CULT, V53, P184, DOI 10.1577/1548-8640(1991)053&lt;0184:IOSOTB&gt;2.3.CO;2; Huppert, 2001, WSGAV02; Huynh TB, 2019, GEN COMP ENDOCR, V279, P88, DOI 10.1016/j.ygcen.2018.12.013; Johnson RB, 2020, AQUAC RES, V51, P3191, DOI 10.1111/are.14654; Kim Jun-Hwan, 2017, Fisheries and Aquatic Sciences, V20, P1; Lafferty KD, 2015, ANNU REV MAR SCI, V7, P471, DOI 10.1146/annurev-marine-010814-015646; LAMAS J, 1994, J FISH BIOL, V45, P839, DOI 10.1111/j.1095-8649.1994.tb00949.x; Laposata M., 2014, LAB MED DIAGNOSIS DI, V3rd ed.; Lee JSF, 2017, AQUACULTURE, V479, P91, DOI 10.1016/j.aquaculture.2017.05.010; Luckenbach JA, 2017, AQUACULTURE, V479, P285, DOI 10.1016/j.aquaculture.2017.05.037; Luckenbach JA, 2016, FISH PHYSIOL BIOCHEM, V42, P233, DOI 10.1007/s10695-015-0132-z; Magerhans A, 2010, AQUACULTURE, V306, P63, DOI 10.1016/j.aquaculture.2010.05.015; MASON JC, 1983, CAN J FISH AQUAT SCI, V40, P2126, DOI 10.1139/f83-247; Masuda M., 2010, US NMFS MAR FISH REV, V72, P26; Matsche MA, 2014, VET CLIN PATH, V43, P387, DOI 10.1111/vcp.12174; McDonald D. G., 1992, P55; National Oceanic and Atmospheric Administration, 2018, PAC COAST GROUNDF FI, P158; NATT MP, 1952, POULTRY SCI, V31, P735, DOI 10.3382/ps.0310735; Nicklason PM, 2020, AQUAC RES, V51, P2667, DOI 10.1111/are.14606; Nickum J, 2004, FISHERIES, V29, P26; Nikolac N, 2014, BIOCHEM MEDICA, V24, P57, DOI 10.11613/BM.2014.008; NOAA Fisheries, 2019, LAND; NOAA Fisheries, 2019, STAT STOCK, P20; Parvin, 2016, STAT QUALITY CONTROL; PHLEGER CF, 1970, COMMER FISH REV, V32, P31; Rodgveller, 2015, STOCK ASSESS FISH EV, V2014, P576; Shigdar S, 2007, J FISH BIOL, V70, P973, DOI 10.1111/j.1095-8649.2007.01351.x; SILBERGELD EK, 1974, B ENVIRON CONTAM TOX, V11, P20, DOI 10.1007/BF01685023; Soleimani Neda, 2020, J Anal Methods Chem, V2020, P9857636, DOI 10.1155/2020/9857636; Sonu SC, 2014, NOAA TECH MEMO NMFS; SULLIVAN KM, 1983, BIOL BULL, V164, P315, DOI 10.2307/1541147; SULLIVAN KM, 1982, CAN J FISH AQUAT SCI, V39, P1012, DOI 10.1139/f82-136; Van Pelt TI, 1997, COMP BIOCHEM PHYS A, V118, P1393, DOI 10.1016/S0300-9629(97)00240-5; WEINER W, 1955, J CLIN PATHOL, V8, P324, DOI 10.1136/jcp.8.4.324; Witeska Malgorzata, 2013, Zoology and Ecology, V23, P275, DOI 10.1080/21658005.2013.846963	57	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0246982	10.1371/journal.pone.0246982	http://dx.doi.org/10.1371/journal.pone.0246982			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086702	gold, Green Published			2022-12-26	WOS:000664640100008
J	Broughel, J; Kotrous, M				Broughel, James; Kotrous, Michael			The benefits of coronavirus suppression: A cost-benefit analysis of the response to the first wave of COVID-19 in the United States	PLOS ONE			English	Article							SURVIVORS; LOCKDOWN; LIFE	This paper estimates the benefits and costs of state suppression policies to "bend the curve" during the initial outbreak of COVID-19 in the United States. We employ an approach that values benefits and costs in terms of additions or subtractions to total production. Relative to a baseline in which only the infected and at-risk populations mitigate the spread of coronavirus, we estimate that total benefits of suppression policies to economic output are between $632.5 billion and $765.0 billion from early March 2020 to August 1, 2020. Relative to private mitigation, output lost due to suppression policies is estimated to be between $214.2 billion and $331.5 billion. The cost estimate is based on the duration of nonessential business closures and stay-at-home orders, which were enforced between 42 and 65 days. Our results indicate that the net benefits of suppression policies to slow the spread of COVID-19 are positive and may be substantial. We discuss uncertainty surrounding several parameters and employ alternative methods for valuing mortality benefits, which also suggest that suppression measures had positive net benefits.	[Broughel, James; Kotrous, Michael] George Mason Univ, Mercatus Ctr, Arlington, VA 22201 USA	George Mason University	Broughel, J (corresponding author), George Mason Univ, Mercatus Ctr, Arlington, VA 22201 USA.	jbroughel@mercatus.gmu.edu		Kotrous, Michael/0000-0003-1957-5827; Broughel, James/0000-0002-2586-9082				A.Atkeson, 2020, medRxiv, DOI 10.1101/2020.10.22.20217984; Anand S, 2020, LANCET, V396, P1335, DOI 10.1016/S0140-6736(20)32009-2; Arias Elizabeth, 2020, Natl Vital Stat Rep, V69, P1; Atkeson A, 2021, 618 FED RSV BANK MPL; Atkeson A., 2021, NBER WORK PAP SER, V28434; Azevedo JP, 2021, WORLD BANK RES OBSER, V36, P1, DOI 10.1093/wbro/lkab003; Bodenstein M, 2021, 2110 CAMBR INET, DOI [10.17863/CAM.65420, DOI 10.17863/CAM.65420]; Briggs AH, 2021, HEALTH ECON, V30, P699, DOI 10.1002/hec.4208; Bright Candace Forbes, 2020, Soc Sci Humanit Open, V2, P100069, DOI 10.1016/j.ssaho.2020.100069; Brooks JT, 2021, JAMA-J AM MED ASSOC, V325, P998, DOI 10.1001/jama.2021.1505; Broughel J., 2020, REGULATION EC OPPORT, P221; Broughel J., 2020, RETHINKING VALUE LIF; Broughel J, 2021, CONTEMP ECON POLICY, V39, P156, DOI 10.1111/coep.12483; Colmer J, 2020, OXFORD REV ECON POL, V36, pS56, DOI 10.1093/oxrep/graa022; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Dennis JM, 2021, CRIT CARE MED, V49, P209, DOI 10.1097/CCM.0000000000004747; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Fischer CB, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249891; Gandhi M, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2026913; Goolsbee A, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104311; Greenstone M., 2020, DOES SOCIAL DISTANCI, DOI DOI 10.2139/SSRN.3561244; Grosse SD, 2009, MED CARE, V47, pS94, DOI 10.1097/MLR.0b013e31819c9571; Hammitt JK, 2020, J RISK UNCERTAINTY, V61, P129, DOI 10.1007/s11166-020-09338-1; Horwitz LI, 2021, J HOSP MED, V16, P90, DOI 10.12788/jhm.3552; Hugonnier J, 2018, 1820 HEDG U YORK; Institute for Health Metrics and Evaluation, 2020, COVID 19 HOSP NEEDS; JONESLEE MW, 1992, ECON J, V102, P80, DOI 10.2307/2234853; Kaseda ET, 2020, CLIN NEUROPSYCHOL, V34, P1498, DOI 10.1080/13854046.2020.1811894; Levin AT, 2020, EUR J EPIDEMIOL, V35, P1123, DOI 10.1007/s10654-020-00698-1; Makridis C., 2020, SSRN J, DOI [10.2139/ssrn.3570731, DOI 10.2139/SSRN.3570731]; Meyerowitz-Katz G, 2020, INT J INFECT DIS, V101, P138, DOI 10.1016/j.ijid.2020.09.1464; MISHAN EJ, 1971, J POLIT ECON, V79, P687, DOI 10.1086/259784; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Mulligan CB., 2020, 202048 B FRIEDM I; Neumann PJ, 2014, NEW ENGL J MED, V371, P796, DOI 10.1056/NEJMp1405158; Nordvig AS, 2021, NEUROL-CLIN PRACT, V11, pE135, DOI 10.1212/CPJ.0000000000000897; Ong KC, 2005, CHEST, V128, P1393, DOI 10.1378/chest.128.3.1393; Peerutin S., 2019, ARCHITECTURE SA, V95, P5, DOI [10.1002/9781119540106.ch31, DOI 10.1002/9781119540106.CH31]; Pirkis J, 2021, LANCET PSYCHIAT, V8, P579, DOI 10.1016/S2215-0366(21)00091-2; Qureshi AI, 2020, ACCIDENT ANAL PREV, V146, DOI 10.1016/j.aap.2020.105747; Ruhl AP, 2017, INTENS CARE MED, V43, P980, DOI 10.1007/s00134-017-4827-8; Russell TW., 2020, EURO SURVEILL, V25, P10; Schelling TC., 1984, CHOICE CONSEQUENCE P, P113; Scherbina A., 2020, AM ENTERP EC POL WOR; Siripanthong B, 2020, HEART RHYTHM, V17, P1463, DOI 10.1016/j.hrthm.2020.05.001; Thunstrom L, 2020, J BENEFIT-COST ANAL, V11, P179, DOI 10.1017/bca.2020.12; Torio CM., 2016, HEALTHCARE COST UTIL; U.S. Bureau of Economic Analysis, 2020, GROSS DOMESTIC PRODU; U.S. Bureau of Economic Analysis, GROSS DOMESTIC PRODU; U.S. Bureau of Labor Statistics, FED RES EC DAT; U.S. Centers for Disease Control and Prevention, 2020, COR DIS 2019 COVID 1; U.S. Centers for Disease Control and Prevention, 2021, IS YOU AR SICK; U.S. Centers for Disease Control and Prevention, 2021, DAIL COVID 19 VIR RT; U.S. Centers for Disease Control and Prevention, 2021, COVID NET COVID 19 A; U.S. Centers for Disease Control and Prevention, 2021, COVID 19 PAND PLANN; U.S. Centers for Disease Control and Prevention, 2021, PROV COVID 19 DEATH; Univ of Groningen Univ of Cali Davis, FED RES EC DAT; Viscusi WK, 2020, J RISK UNCERTAINTY, V61, P101, DOI 10.1007/s11166-020-09337-2; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	60	12	12	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252729	10.1371/journal.pone.0252729	http://dx.doi.org/10.1371/journal.pone.0252729			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QS	34081757	Green Published			2022-12-26	WOS:000664639200049
J	Gough, RE; Jones, MC; Zacharchenko, T; Le, S; Yu, M; Jacquemet, G; Muench, S; Yan, J; Humphries, JD; Jorgensen, C; Humphries, MJ; Goult, BT				Gough, Rosemarie E.; Jones, Matthew C.; Zacharchenko, Thomas; Le, Shimin; Yu, Miao; Jacquemet, Guillaume; Muench, Ste P.; Yan, Jie; Humphries, Jonathan D.; Jorgensen, Claus; Humphries, Martin J.; Goult, Benjamin T.			Talin mechanosensitivity is modulated by a direct interaction with cyclin-dependent kinase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAXILLIN LD MOTIFS; ACTIN-BINDING; EXTRACELLULAR-MATRIX; INTEGRIN ADHESOME; VINCULIN-BINDING; CELL-DIVISION; RECOGNITION; PROTEIN; PHOSPHORYLATION; TRANSDUCTION	Talin (TLN1) is a mechanosensitive component of adhesion complexes that directly couples integrins to the actin cytoskeleton. In response to force, talin undergoes switch-like behavior of its multiple rod domains that modulate interactions with its binding partners. Cyclin-dependent kinase-1 (CDK1) is a key regulator of the cell cycle, exerting its effects through synchronized phosphorylation of a large number of protein targets. CDK1 activity maintains adhesion during interphase, and its inhibition is a prerequisite for the tightly choreographed changes in cell shape and adhesion that are required for successful mitosis. Using a combination of biochemical, structural, and cell biological approaches, we demonstrate a direct interaction between talin and CDK1 that occurs at sites of integrin-mediated adhesion. Mutagenesis demonstrated that CDK1 contains a functional talin-binding LD motif, and the binding site within talin was pinpointed to helical bundle R8. Talin also contains a consensus CDK1 phosphorylation motif centered on S1589, a site shown to be phosphorylated by CDK1 in vitro. A phosphomimetic mutant of this site within talin lowered the binding affinity of the cytoskeletal adaptor KANK and weakened the response of this region to force as measured by single molecule stretching, potentially altering downstream mechanotransduction pathways. The direct binding of the master cell cycle regulator CDK1 to the primary integrin effector talin represents a coupling of cell proliferation and cell adhesion machineries and thereby indicates a mechanism by which the microenvironment can control cell division in multicellular organisms.	[Gough, Rosemarie E.; Goult, Benjamin T.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Jones, Matthew C.; Zacharchenko, Thomas; Humphries, Jonathan D.; Humphries, Martin J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Ctr Cell Matrix Res, Manchester, Lancs, England; [Le, Shimin; Yu, Miao; Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore; [Jacquemet, Guillaume] Abo Akad Univ, Fac Sci & Engn, Cell Biol Dept, Turku, Finland; [Jacquemet, Guillaume] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Jacquemet, Guillaume] Abo Akad Univ, Turku, Finland; [Muench, Ste P.] Univ Leeds, Astbury Ctr Struct Biol, Sch Biomed Sci, Leeds, W Yorkshire, England; [Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore, Singapore; [Jorgensen, Claus] Univ Manchester, Canc Res UK Manchester Inst, Manchester, Lancs, England	University of Kent; University of Manchester; National University of Singapore; Abo Akademi University; University of Turku; Abo Akademi University; University of Leeds; National University of Singapore; Cancer Research UK; University of Manchester	Goult, BT (corresponding author), Univ Kent, Sch Biosci, Canterbury, Kent, England.; Humphries, MJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Ctr Cell Matrix Res, Manchester, Lancs, England.	martin.humphries@manchester.ac.uk; b.t.goult@kent.ac.uk	Humphries, Jonathan D./AAE-7760-2022; Goult, Benjamin T/B-3127-2009; Yan, Jie/G-2725-2012	Humphries, Jonathan D./0000-0002-8953-7079; Goult, Benjamin T/0000-0002-3438-2807; Yan, Jie/0000-0002-8555-7291; Gough, Rosemarie/0000-0002-5587-4683; Jacquemet, Guillaume/0000-0002-9286-920X; Le, Shimin/0000-0003-2359-1897; Jorgensen, Claus/0000-0002-7841-943X; Jones, Matthew/0000-0003-4723-3277	BBSRC [BB/N007336/1, BB/S007245/1]; HFSP [RGP00001/2016]; Cancer Research UK [C13329/A21671, A25236]; Cancer Research UK Institute Award [A19258]; Rosetrees Trust [M286]; European Research Council [ERC-2017COG 772577]; University of Kent studentship; Wellcome Trust ISSF Research Fellowship [204825/Z/16/Z]; Sigrid Juselius Foundation; Cancer Society of Finland; Abo Akademi University Research Foundation; Drug Discovery and Diagnostics strategic funding	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); HFSP(Human Frontier Science Program); Cancer Research UK(Cancer Research UK); Cancer Research UK Institute Award; Rosetrees Trust(Rosetrees Trust); European Research Council(European Research Council (ERC)European Commission); University of Kent studentship; Wellcome Trust ISSF Research Fellowship(Wellcome Trust); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Abo Akademi University Research Foundation; Drug Discovery and Diagnostics strategic funding	B. T. G. was funded by BBSRC (BB/N007336/1 and BB/S007245/1) and HFSP (RGP00001/2016). M. J. H. and C. J. were funded by Cancer Research UK (C13329/A21671). C. J. is also funded by a Cancer Research UK Institute Award (A19258), Cancer Research UK (A25236), Rosetrees Trust (M286), and European Research Council (ERC-2017COG 772577). R. E. G. was funded by a University of Kent studentship. T. Z. is funded by a Wellcome Trust ISSF Research Fellowship (204825/Z/16/Z). G. J. was supported by grants from the Sigrid Juselius Foundation, the Cancer Society of Finland, and Abo Akademi University Research Foundation (G. J., CoE CellMech) and by Drug Discovery and Diagnostics strategic funding to Abo Akademi University (G. J.).	Alam T, 2014, BIOCHEM J, V460, P317, DOI 10.1042/BJ20140298; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Bouchet BP, 2016, ELIFE, V5, DOI 10.7554/eLife.18124; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown NR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7769; Cadart C, 2014, DEV CELL, V29, P159, DOI 10.1016/j.devcel.2014.04.009; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chang YC, 2014, STRUCTURE, V22, P1810, DOI 10.1016/j.str.2014.09.020; Chastney MR, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202003038; Chen H, 2011, BIOPHYS J, V100, P517, DOI 10.1016/j.bpj.2010.12.3700; Dao VT, 2009, J CELL SCI, V122, P2996, DOI 10.1242/jcs.041301; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Goedhart J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76603-3; Gough RE, 2018, FEBS LETT, V592, P2108, DOI 10.1002/1873-3468.13081; Goult BT, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.592951; Goult BT, 2018, J CELL BIOL, V217, P3776, DOI 10.1083/jcb.201808061; Goult BT, 2013, J BIOL CHEM, V288, P8238, DOI 10.1074/jbc.M112.438119; Haining AWM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005599; Han S. J., 2021, TALIN VINCULIN PRECO TALIN VINCULIN PRECO; Hemmings L, 1996, J CELL SCI, V109, P2715; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Horton ER, 2016, EXP CELL RES, V343, P7, DOI 10.1016/j.yexcr.2015.10.025; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Jones MC, 2018, J CELL BIOL, V217, P3203, DOI 10.1083/jcb.201802088; Khan RB, 2021, METHODS MOL BIOL, V2217, P115, DOI 10.1007/978-1-0716-0962-0_9; Kumar A, 2016, J CELL BIOL, V213, P371, DOI 10.1083/jcb.201510012; Kumar M, 2020, NUCLEIC ACIDS RES, V48, pD296, DOI 10.1093/nar/gkz1030; Lancaster OM, 2014, SEMIN CELL DEV BIOL, V34, P109, DOI 10.1016/j.semcdb.2014.02.015; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Le SM, 2016, METHODS, V94, P13, DOI 10.1016/j.ymeth.2015.08.020; Le SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv554; Lesman A, 2014, J CELL BIOL, V205, P155, DOI 10.1083/jcb.201309029; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Marchesi S, 2014, DEV CELL, V31, P420, DOI 10.1016/j.devcel.2014.09.009; McCann RO, 1997, P NATL ACAD SCI USA, V94, P5679, DOI 10.1073/pnas.94.11.5679; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGrath DA, 2013, NAT STRUCT MOL BIOL, V20, P1407, DOI 10.1038/nsmb.2707; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Robertson J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7265; Roux Kyle J, 2018, Curr Protoc Protein Sci, V91, DOI 10.1002/cpps.51; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Skinner SP, 2015, ACTA CRYSTALLOGR D, V71, P154, DOI 10.1107/S1399004714026662; Sun ZQ, 2016, NAT CELL BIOL, V18, P941, DOI 10.1038/ncb3402; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Toyoshima F, 2007, J CELL PHYSIOL, V213, P407, DOI 10.1002/jcp.21227; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Whitewood AJ, 2018, FEBS LETT, V592, P1751, DOI 10.1002/1873-3468.13074; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Yan J, 2015, CELL MOL BIOENG, V8, P151, DOI 10.1007/s12195-014-0364-5; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6880; Yao MX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11966; Yuan GH, 2017, ANGEW CHEM INT EDIT, V56, P5490, DOI 10.1002/anie.201700411; Zacharchenko T, 2016, STRUCTURE, V24, P1130, DOI 10.1016/j.str.2016.04.016; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zhao XD, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa837e	70	12	12	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100837	10.1016/j.jbc.2021.100837	http://dx.doi.org/10.1016/j.jbc.2021.100837			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34118235	Green Submitted, gold, Green Accepted, Green Published			2022-12-26	WOS:000678068400037
J	Liu, LW; Yu, HS; Long, Y; You, ZF; Ogawa, R; Du, YN; Huang, CY				Liu, Longwei; Yu, Hongsheng; Long, Yi; You, Zhifeng; Ogawa, Rei; Du, Yanan; Huang, Chenyu			Asporin inhibits collagen matrix-mediated intercellular mechanocommunications between fibroblasts during keloid progression	FASEB JOURNAL			English	Article						ASPN; fibroblast; fibrosis; intercellular mechanocommunication; keloid	EXTRACELLULAR-MATRIX; HYPERTROPHIC SCARS; GASTRIC-CANCER; GROWTH-FACTOR; EXPRESSION; PATTERN; TENSION; CD44; MECHANOTRANSDUCTION; MECHANOBIOLOGY	Keloids are fibrotic lesions that grow unceasingly and invasively and are driven by local mechanical stimuli. Unlike other fibrotic diseases and normal wound healing, keloids exhibit little transformation of dermal fibroblasts into alpha-SMA(+) myofibroblasts. This study showed that asporin is the most strongly expressed gene in keloids and its gene-ontology terms relate strongly to ECM metabolism/organization. Experiments with human dermal cells (HDFs) showed that asporin overexpression/treatment abrogated the HDF ability to adopt a perpendicular orientation when subjected to stretching tension. It also induced calcification of the surrounding 3D collagen matrix. Asporin overexpression/treatment also prevented the HDFs from remodeling the surrounding 3D collagen matrix, leading to a disorganized network of thick, wavy collagen fibers that resembled keloid collagen architecture. This in turn impaired the ability of the HDFs to contract the collagen matrix. Asporin treatment also made the fibroblasts impervious to the fibrous collagen contraction of alpha-SMA(+) myofibroblasts, which normally activates fibroblasts. Thus, by calcifying collagen, asporin prevents fibroblasts from linearly rearranging the surrounding collagen; this reduces both their mechanosensitivity and mechanosignaling to each other through the collagen network. This blocks fibroblast activation and differentiation into the mature myofibroblasts that efficiently remodel the extracellular matrix. Consequently, the fibroblasts remain immature, highly proliferative, and continue laying down abundant extracellular matrix, causing keloid growth and invasion. Notably, dermal injection of asporin-overexpressing HDFs into murine wounds recapitulated keloid collagen histopathological characteristics. Thus, disrupted interfibroblast mechanocommunication may promote keloid progression. Asporin may be a new diagnostic biomarker and therapeutic target for keloids.	[Liu, Longwei; Yu, Hongsheng; Long, Yi; You, Zhifeng; Du, Yanan] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China; [Ogawa, Rei] Nippon Med Sch, Dept Plast Reconstruct & Aesthet Surg, Tokyo, Japan; [Huang, Chenyu] Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Dermatol, Beijing 102218, Peoples R China	Tsinghua University; Nippon Medical School; Tsinghua University	Du, YN (corresponding author), Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Sch Med, Dept Biomed Engn, Beijing 100084, Peoples R China.; Huang, CY (corresponding author), Tsinghua Univ, Beijing Tsinghua Changgung Hosp, Sch Clin Med, Dept Dermatol, Beijing 102218, Peoples R China.	duyanan@tsinghua.edu.cn; huangchenyu@tsinghua.edu.cn	HUANG, CHENYU/GVT-7299-2022; Huang, Chenyu/I-4410-2018; You, zhifeng/GZH-2746-2022; Liu, Longwei/GNP-0820-2022	Huang, Chenyu/0000-0001-9521-5650; You, zhifeng/0000-0002-8983-5041; Liu, Longwei/0000-0003-4229-9066; Yu, Hongsheng/0000-0001-7296-1538	Beijing Natural Science Foundation [JQ18022]; National Key R&D Program of China [2016YFC1000810]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Key R&D Program of China	Beijing Natural Science Foundation, Grant/Award Number: JQ18022; National Key R&D Program of China, Grant/Award Number: 2016YFC1000810	Akaishi S, 2008, ANN PLAS SURG, V60, P445, DOI 10.1097/SAP.0b013e3181238dd7; Amadeu T, 2003, PATHOL RES PRACT, V199, P469, DOI 10.1078/0344-0338-00447; Arjunan S, 2020, STEM CELL RES THER, V11, DOI 10.1186/s13287-020-01609-7; Arno AI, 2014, BURNS, V40, P1255, DOI 10.1016/j.burns.2014.02.011; Baker BM, 2015, NAT MATER, V14, P1262, DOI [10.1038/NMAT4444, 10.1038/nmat4444]; Bot PT, 2013, CURR VASC PHARMACOL, V11, P13; Boyce DE, 2001, BRIT J PLAST SURG, V54, P511, DOI 10.1054/bjps.2001.3638; Cao GY, 2006, AM J PATHOL, V169, P325, DOI 10.2353/ajpath.2006.060206; Chen C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0605-5; Chen L, 2020, FASEB J, V34, P13125, DOI 10.1096/fj.202000380RR; Coentro JQ, 2019, ADV DRUG DELIVER REV, V146, P37, DOI 10.1016/j.addr.2018.08.009; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Cross SE, 2007, NAT NANOTECHNOL, V2, P780, DOI 10.1038/nnano.2007.388; Di Marco E, 2016, CLIN SCI, V130, P1363, DOI 10.1042/CS20160249; Ding Q, 2015, ONCOL REP, V33, P1783, DOI 10.3892/or.2015.3791; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Eckhardt A, 2019, J ORTHOP RES, V37, P769, DOI 10.1002/jor.24211; EHRLICH HP, 1994, AM J PATHOL, V145, P105; Gauglitz GG, 2011, MOL MED, V17, P113, DOI 10.2119/molmed.2009.00153; Gosain A, 2004, WORLD J SURG, V28, P321, DOI 10.1007/s00268-003-7397-6; Henry SP, 2001, J BIOL CHEM, V276, P12212, DOI 10.1074/jbc.M011290200; Hsu CK, 2018, J INVEST DERMATOL, V138, P208, DOI 10.1016/j.jid.2017.05.041; Huang C, 2017, BRIT J DERMATOL, V177, P1248, DOI 10.1111/bjd.15576; Huang CY, 2020, FASEB J, V34, P13171, DOI 10.1096/fj.202001157R; Huang CY, 2019, INT WOUND J, V16, P852, DOI 10.1111/iwj.13104; Huang CY, 2017, INT WOUND J, V14, P764, DOI 10.1111/iwj.12693; Huang CY, 2013, J PLAST RECONSTR AES, V66, pE351, DOI 10.1016/j.bjps.2013.08.002; Huang CY, 2013, PRS-GLOB OPEN, V1, DOI 10.1097/GOX.0b013e31829c4597; Huang CY, 2013, TRENDS MOL MED, V19, P555, DOI 10.1016/j.molmed.2013.05.005; Huang CY, 2014, INT WOUND J, V11, P517, DOI 10.1111/j.1742-481X.2012.01118.x; Huang CY, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-60; Huang CY, 2012, ARCH DERMATOL RES, V304, P589, DOI 10.1007/s00403-012-1278-5; Huang CY, 2012, AESTHET PLAST SURG, V36, P387, DOI 10.1007/s00266-011-9821-x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; KELLY AP, 1988, DERMATOL CLIN, V6, P413, DOI 10.1016/S0733-8635(18)30653-3; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Lee JYY, 2004, AM J DERMATOPATH, V26, P379, DOI 10.1097/00000372-200410000-00006; Lee TY, 1999, ANN PLAS SURG, V43, P179; Lin HH, 2015, ONCOTARGET, V6, P20946, DOI 10.18632/oncotarget.4173; Liu LW, 2020, P NATL ACAD SCI USA, V117, P10832, DOI 10.1073/pnas.1910650117; Liu LW, 2017, NAT MATER, V16, P1252, DOI [10.1038/NMAT5024, 10.1038/nmat5024]; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Louw L, 2000, PROSTAG LEUKOTR ESS, V63, P237, DOI 10.1054/plef.2000.0207; Ma XY, 2013, BIOPHYS J, V104, P1410, DOI 10.1016/j.bpj.2013.02.017; Maris P, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001871; Mochimaru H, 2009, INVEST OPHTH VIS SCI, V50, P4410, DOI 10.1167/iovs.08-3044; Ogawa R, 2011, J NIPPON MED SCH, V78, P68, DOI 10.1272/jnms.78.68; Ong CT, 2010, BRIT J DERMATOL, V162, P1302, DOI 10.1111/j.1365-2133.2010.09660.x; Osman OS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-260; Rezakhaniha R, 2012, BIOMECH MODEL MECHAN, V11, P461, DOI 10.1007/s10237-011-0325-z; Rochette A, 2017, BRIT J CANCER, V116, P775, DOI 10.1038/bjc.2017.15; Satoyoshi R, 2015, ONCOGENE, V34, P650, DOI 10.1038/onc.2013.584; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shen WY, 1998, BRIT J OPHTHALMOL, V82, P1063, DOI 10.1136/bjo.82.9.1063; Shih Barbara, 2010, Eplasty, V10, pe24; Simkova D, 2016, ONCOTARGET, V7, P52045, DOI 10.18632/oncotarget.10471; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Syed F, 2012, WOUND REPAIR REGEN, V20, P688, DOI 10.1111/j.1524-475X.2012.00823.x; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tan S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01810; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Turner C H, 1998, J Orthop Sci, V3, P346, DOI 10.1007/s007760050064; Wang HL, 2014, BIOPHYS J, V107, P2592, DOI 10.1016/j.bpj.2014.09.044; Wang LL, 2017, CANCER LETT, V398, P24, DOI 10.1016/j.canlet.2017.04.001; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wang ZC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.603187; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Yu MH, 2017, KOREAN J RADIOL, V18, P323, DOI 10.3348/kjr.2017.18.2.323; Ziyrek M, 2015, BALK MED J, V32, P377, DOI 10.5152/balkanmedj.2015.15707	70	7	7	2	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21705	10.1096/fj.202100111R	http://dx.doi.org/10.1096/fj.202100111R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105826				2022-12-26	WOS:000667814100020
J	Sanchez-Alegria, K; Bastian-Eugenio, CE; Vaca, L; Arias, C				Sanchez-Alegria, Karina; Ernesto Bastian-Eugenio, Carlos; Vaca, Luis; Arias, Clorinda			Palmitic acid induces insulin resistance by a mechanism associated with energy metabolism and calcium entry in neuronal cells	FASEB JOURNAL			English	Article						intraneuronal Ca2+; neuronal insulin resistance; neuronal beta-oxidation; palmitic acid; PKC activation	FREE FATTY-ACIDS; PANCREATIC BETA-CELLS; K-ATP CHANNELS; ENDOPLASMIC-RETICULUM; GLUCOSE-PRODUCTION; ACTIVATION; BRAIN; RECEPTOR; PHOSPHORYLATION; GPR40	Palmitic acid (PA) is a saturated fatty acid whose high consumption has been largely associated with the development of different metabolic alterations, such as insulin resistance, metabolic syndrome, and type 2 diabetes. Particularly in the brain, insulin signaling disruption has been linked to cognitive decline and is considered a risk factor for Alzheimer's disease. Cumulative evidence has demonstrated the participation of PA in the molecular cascade underlying cellular insulin resistance in peripheral tissues, but its role in the development of neuronal insulin resistance and the mechanisms involved are not fully understood. It has generally been accepted that the brain does not utilize fatty acids as a primary energy source, but recent evidence shows that neurons possess the machinery for fatty acid beta-oxidation. However, it is still unclear under what conditions neurons use fatty acids as energy substrates and the implications of their oxidative metabolism in modifying insulin-stimulated effects. In the present work, we have found that neurons differentiated from human neuroblastoma MSN exposed to high but nontoxic concentrations of PA generate ATP through mitochondrial metabolism, which is associated with an increase in the cytosolic Ca2+ and diminished insulin signaling in neurons. These findings reveal a novel mechanism by which saturated fatty acids produce Ca2+ entry and insulin resistance that may play a causal role in increasing neuronal vulnerability associated with metabolic diseases.	[Sanchez-Alegria, Karina; Arias, Clorinda] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, AP 70-228, Ciudad De Mexico 04510, Mexico; [Ernesto Bastian-Eugenio, Carlos; Vaca, Luis] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Genet Mol, Ciudad De Mexico, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Arias, C (corresponding author), Univ Nacl Autonoma Mexico, Inst Invest Biomed, Dept Med Genom & Toxicol Ambiental, AP 70-228, Ciudad De Mexico 04510, Mexico.	carias@unam.mx		Vaca, Luis/0000-0003-2266-4847	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [A1-S9559]; UNAMDireccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM) [IN202318]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); UNAMDireccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM)	Consejo Nacional de Ciencia y Tecnologia (CONACYT), Grant/Award Number: A1-S9559; UNAMDireccion General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA, UNAM), Grant/Award Number: IN202318	Alfonzo-Mendez MA, 2018, BBA-MOL CELL RES, V1865, P842, DOI 10.1016/j.bbamcr.2018.03.006; Ardestani A, 2018, TRENDS ENDOCRIN MET, V29, P737, DOI 10.1016/j.tem.2018.07.003; Arnold SE, 2014, NEUROBIOL DIS, V67, P79, DOI 10.1016/j.nbd.2014.03.011; Benoit SC, 2009, J CLIN INVEST, V119, P2577, DOI 10.1172/JCI36714; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Burnstock G, 2007, CELL MOL LIFE SCI, V64, P1471, DOI 10.1007/s00018-007-6497-0; Busquets O, 2017, MECH AGEING DEV, V162, P38, DOI 10.1016/j.mad.2016.11.002; Calvo-Ochoa E, 2017, NEUROCHEM INT, V110, P75, DOI 10.1016/j.neuint.2017.09.008; Calvo-Ochoa E, 2014, J CEREBR BLOOD F MET, V34, P1001, DOI 10.1038/jcbfm.2014.48; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Cheng CM, 2003, J NEUROSCI RES, V73, P1, DOI 10.1002/jnr.10634; Chiu SL, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-7; Chudobaa C, 2019, BIOL CHEM, V400, P991, DOI 10.1515/hsz-2018-0477; Clegg DJ, 2011, PHYSIOL BEHAV, V103, P10, DOI 10.1016/j.physbeh.2011.01.010; Clore JN, 2002, METABOLISM, V51, P1471, DOI 10.1053/meta.2002.35202; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dhopeshwarkar G A, 1973, Adv Lipid Res, V11, P109; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Flores-Leon M, 2019, NEUROCHEM RES, V44, P1745, DOI 10.1007/s11064-019-02810-8; Gao D, 2010, J BIOL CHEM, V285, P29965, DOI 10.1074/jbc.M110.128694; Grant W B, 1999, J Alzheimers Dis, V1, P197; Grapov D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048852; Hromadkova L, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118737; Huopio H, 2002, AM J PHYSIOL-ENDOC M, V283, pE207, DOI 10.1152/ajpendo.00047.2002; Itoh Y, 2005, HEPATOL RES, V33, P171, DOI 10.1016/j.hepres.2005.09.028; Itoh Y, 2003, NATURE, V422, P173, DOI 10.1038/nature01478; Jo YH, 2009, J NEUROPHYSIOL, V101, P2305, DOI 10.1152/jn.91294.2008; Kim JY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04175-w; Kishore P, 2011, J CLIN INVEST, V121, P4916, DOI 10.1172/JCI58035; Kumar A, 2009, FRONT AGING NEUROSCI, V1, DOI 10.3389/neuro.24.002.2009; Kwon B, 2014, BBA-MOL CELL RES, V1843, P1402, DOI 10.1016/j.bbamcr.2014.04.004; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Lam TKT, 2002, AM J PHYSIOL-ENDOC M, V283, pE682, DOI 10.1152/ajpendo.00038.2002; Lipp P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004556; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Liu ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184818; Liu ZG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05217-z; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; McFadden JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115642; McLean FH, 2019, NUTR METAB, V16, DOI 10.1186/s12986-019-0352-9; Mcnay EC, 2011, NEUROBIOL LEARN MEM, V96, P432, DOI 10.1016/j.nlm.2011.08.005; Melo HM, 2020, CELL REP, V30, P2180, DOI 10.1016/j.celrep.2020.01.072; Moschella PC, 2007, J MOL CELL CARDIOL, V43, P754, DOI 10.1016/j.yjmcc.2007.09.015; Nalecz Katarzyna A., 2004, Molecular Aspects of Medicine, V25, P551; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Panov A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/472459; Hernandez-Caceres MP, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00176; Pearson-Leary J, 2018, BEHAV BRAIN RES, V338, P32, DOI 10.1016/j.bbr.2017.09.033; Pereira SS, 2014, CURR OBES REP, V3, P422, DOI 10.1007/s13679-014-0124-9; Pilitsis JG, 2001, NEUROCHEM RES, V26, P1265, DOI 10.1023/A:1014227231130; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; REYNOLDS CP, 1986, J NATL CANCER I, V76, P375; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Ribeiro MC, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00067; Ruddock MW, 2008, J BIOCHEM, V144, P599, DOI 10.1093/jb/mvn105; Sampson SR, 2006, MOL GENET METAB, V89, P32, DOI 10.1016/j.ymgme.2006.04.017; Sanchez-Alegria K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123725; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schnell S, 2007, MOL CELL ENDOCRINOL, V263, P173, DOI 10.1016/j.mce.2006.09.013; Schonfeld P, 2013, J CEREBR BLOOD F MET, V33, P1493, DOI 10.1038/jcbfm.2013.128; Shapiro H, 2005, BIOCHEM BIOPH RES CO, V335, P97, DOI 10.1016/j.bbrc.2005.07.042; Sierra AY, 2008, J BIOL CHEM, V283, P6878, DOI 10.1074/jbc.M707965200; Snowden SG, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002266; Spinelli M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02221-9; Sun XL, 2010, J NEUROCHEM, V112, P377, DOI 10.1111/j.1471-4159.2009.06450.x; Choi E, 2007, MOL CELL ENDOCRINOL, V272, P50, DOI 10.1016/j.mce.2007.04.004; Takahashi S, 2014, ASN NEURO, V6, DOI 10.1177/1759091414550997; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zamarbide M, 2014, HIPPOCAMPUS, V24, P733, DOI 10.1002/hipo.22263; Zhao WQ, 1999, J BIOL CHEM, V274, P34893, DOI 10.1074/jbc.274.49.34893	72	4	5	4	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21712	10.1096/fj.202100243R	http://dx.doi.org/10.1096/fj.202100243R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110637				2022-12-26	WOS:000667814100036
J	Guarnieri, FDF; Briso, ALF; Ramos, FDES; Esteves, LMB; Omoto, EM; Sundfeld, RH; Fagundes, TC				Finotti Guarnieri, Fabricio Daniel; Fraga Briso, Andre Luiz; Ramos, Fernanda de Souza e Silva; Bueno Esteves, Lara Maria; Omoto, Erika Mayumi; Sundfeld, Renato Herman; Fagundes, Ticiane Cestari			Use of auxiliary devices during retreatment of direct resin composite veneers	PLOS ONE			English	Article							REMOVAL; FLUORESCENCE; RESTORATION; LIGHT; QUALITY; REPAIR; LOUPES	The removal of direct composite veneers, when the retreatment is necessary, represents a challenge to the clinician, since the healthy dental structure must be preserved. Thus, the aim of this study was to compare the accuracy provided by different auxiliary devices during retreatment of direct composite veneers. Seventy-five bovine teeth were prepared for direct composite veneers, scanned (T1), and restored. Specimens were divided into 5 groups for retreatment: conventional high-speed handpiece without auxiliary device (WD); high-speed handpiece with a white LED (WL); high-speed handpiece with an UV light (UL); electric motor and multiplier 1/5 handpiece (EM); and conventional high-speed handpiece using magnifying loupe (ML). After retreatments, other scanning was performed (T2). Changes on dental wear or composite residues areas, as well as, the average between wear and presence of residues were measured. Data were submitted to Kruskal-Wallis and Dunn's post-test (p <= 0.05). There were greater areas of wear for ML, being statistically superior to WD and EM groups. The ML presented smaller residues areas, being statistically lower than the WD and EM groups. Regarding the average between wear and the presence of resin residues, additional wear occurred after re-preparation, regardless of the group. Magnifying loupe promoted greater areas of wear and smaller areas of resin residues than conventional high-speed handpiece and electric motor. Both techniques using light accessories did not differ from other ones.	[Finotti Guarnieri, Fabricio Daniel; Fraga Briso, Andre Luiz; Ramos, Fernanda de Souza e Silva; Bueno Esteves, Lara Maria; Omoto, Erika Mayumi; Sundfeld, Renato Herman; Fagundes, Ticiane Cestari] Sao Paulo State Univ UNESP, Sch Dent, Dept Prevent & Restorat Dent, Aracatuba, SP, Brazil	Universidade Estadual Paulista	Fagundes, TC (corresponding author), Sao Paulo State Univ UNESP, Sch Dent, Dept Prevent & Restorat Dent, Aracatuba, SP, Brazil.	ticiane.fagundes@unesp.br	Briso, Andre/C-2792-2012; Briso, Andre/AID-8946-2022	Briso, Andre/0000-0002-6126-1760; Bueno Esteves, Lara Maria/0000-0002-4032-6502; Fagundes, Ticiane/0000-0002-3418-0498; de Souza e Silva Ramos, Fernanda/0000-0003-2222-2424; Omoto, Erika Mayumi/0000-0002-2685-6259	Sao Paulo Research Foundation (FAPESP) [2019/12437-0]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES) [001]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was funded by the Sao Paulo Research Foundation (FAPESP -https://fapesp.br) Grant number: 2019/12437-0. "This study was financed in part of Coordenacao de Aperfeicoamento de Pessoal de Ni ' vel Superior Brazil (CAPES) Financial Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar Estefania Queiroga de Santana e, 2016, Dental Press J. Orthod., V21, P43, DOI 10.1590/2177-6709.21.6.043-050.oar; Alothman Yousef, 2018, Open Access Maced J Med Sci, V6, P2402, DOI 10.3889/oamjms.2018.353; Baumann DF, 2011, J OROFAC ORTHOP, V72, P125, DOI 10.1007/s00056-011-0010-y; Bush MA., 2010, GEN DENT, V58, P214; Campbell Stuart C, 2013, Dent Update, V40, P194; Chan Kenneth H, 2014, Photonics Lasers Med, V3, P37; Conceicao LD, 2019, FORENSIC SCI INT, V305, DOI 10.1016/j.forsciint.2019.110032; Cortes Mariana, 2013, Eur J Dent, V7, P429, DOI 10.4103/1305-7456.120676; da Silva TM, 2014, OPER DENT, V39, P407, DOI 10.2341/12-464-L; Martins BMD, 2018, J DENT, V78, P22, DOI 10.1016/j.jdent.2018.09.001; Demarco FF, 2015, DENT MATER, V31, P1214, DOI 10.1016/j.dental.2015.07.005; Dettwiler C, 2020, OPER DENT, V45, P62, DOI 10.2341/19-032-L; Dettwiler C, 2018, DENT TRAUMATOL, V34, P353, DOI 10.1111/edt.12425; Forgie AH, 2001, J ORAL REHABIL, V28, P309, DOI 10.1046/j.1365-2842.2001.00680.x; Geminiani A, 2014, J PROSTHET DENT, V112, P51, DOI 10.1016/j.prosdent.2014.02.007; Gordan VV, 2014, J DENT, V42, P1528, DOI 10.1016/j.jdent.2014.09.005; Kanzow P, 2019, J DENT, V86, P1, DOI 10.1016/j.jdent.2019.05.021; Kanzow P, 2018, J DENT, V69, P1, DOI 10.1016/j.jdent.2017.09.010; Kenyon BJ, 2005, J AM DENT ASSOC, V136, P1101, DOI 10.14219/jada.archive.2005.0313; Kim BR, 2016, PHOTODIAGN PHOTODYN, V13, P114, DOI 10.1016/j.pdpdt.2016.01.005; Kiran R, 2020, J ESTHET RESTOR DENT, V32, P310, DOI 10.1111/jerd.12536; Klein C, 2020, CLIN ORAL INVEST, V24, P2735, DOI 10.1007/s00784-019-03135-0; Lee YK, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.4.040901; Lemos Cleidiel A. A, 2016, Acta odontol. latinoam., V29, P7; Lowe Robert A, 2015, Compend Contin Educ Dent, V36, P300; McGowan Steve, 2016, Compend Contin Educ Dent, V37, P164; Meller C, 2017, CLIN ORAL INVEST, V21, P347, DOI 10.1007/s00784-016-1797-0; Nedelcu R, 2018, BMC ORAL HEALTH, V18, DOI 10.1186/s12903-018-0489-3; Perrin P, 2014, CLIN ORAL INVEST, V18, P2055, DOI 10.1007/s00784-014-1197-2; Ribeiro AA, 2017, AM J ORTHOD DENTOFAC, V151, P292, DOI 10.1016/j.ajodo.2016.06.040; Rocha RS, 2017, ANGLE ORTHOD, V87, P440, DOI 10.2319/081916-629.1; Salomao FM, 2019, J ESTHET RESTOR DENT, V31, P58, DOI 10.1111/jerd.12412; Sitbon Y, 2014, BRIT DENT J, V216, P125, DOI 10.1038/sj.bdj.2014.48; Wen W, 2019, J AM DENT ASSOC, V150, P49, DOI 10.1016/j.adaj.2018.09.022; Yoshino F, 2018, JPN DENT SCI REV, V54, P160, DOI 10.1016/j.jdsr.2018.06.002; Yu HY, 2019, INT J ORAL SCI, V11, DOI 10.1038/s41368-019-0057-y; Zubizarreta-Macho A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041098	37	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252171	10.1371/journal.pone.0252171	http://dx.doi.org/10.1371/journal.pone.0252171			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133430	Green Published, gold			2022-12-26	WOS:000671682700018
J	Zhao, ZX; Guo, YY; Liu, YY; Sun, LC; Chen, B; Wang, CY; Chen, TT; Wang, YQ; Li, YW; Dong, Q; Ai, LQ; Wang, R; Gu, YY; Li, X				Zhao, Zhangxiang; Guo, YingYing; Liu, Yaoyao; Sun, Lichun; Chen, Bo; Wang, Chengyu; Chen, Tingting; Wang, Yuquan; Li, Yawei; Dong, Qi; Ai, Liqiang; Wang, Ran; Gu, Yunyan; Li, Xia			Individualized lncRNA differential expression profile reveals heterogeneity of breast cancer	ONCOGENE			English	Article							LONG NONCODING RNAS; SUBTYPES; REPAIR	Long non-coding RNAs (lncRNAs) play key regulatory roles in breast cancer. However, population-level differential expression analysis methods disregard the heterogeneous expression of lncRNAs in individual patients. Therefore, we individualized lncRNA expression profiles for breast invasive carcinoma (BRCA) using the method of LncRNA Individualization (LncRIndiv). After evaluating the robustness of LncRIndiv, we constructed an individualized differentially expressed lncRNA (IDElncRNA) profile for BRCA and investigated the subtype-specific IDElncRNAs. The breast cancer subtype-specific IDElncRNA showed frequent co-occurrence with alterations of protein-coding genes, including mutations, copy number variation and differential methylation. We performed hierarchical clustering to subdivide TNBC and revealed mesenchymal subtype and immune subtype for TNBC. The TNBC immune subtype showed a better prognosis than the TNBC mesenchymal subtype. LncRNA PTOV1-AS1 was the top differentially expressed lncRNA in the mesenchymal subtype. And biological experiments validated that the upregulation of PTOV1-AS1 could downregulate TJP1 (ZO-1) and E-Cadherin, and upregulate Vimentin, which suggests PTOV1-AS1 may promote epithelial-mesenchymal transition and lead to migration and invasion of TNBC cells. The mesenchymal subtype showed a higher fraction of M2 macrophages, whereas the immune subtype was more associated with CD4 + T cells. The immune subtype is characterized by genomic instability and upregulation of immune checkpoint genes, thereby suggesting a potential response to immunosuppressive drugs. Last, drug response analysis revealed lncRNA ENSG00000230082 (PRRT3-AS1) is a potential resistance biomarker for paclitaxel in BRCA treatment. Our analysis highlights that IDElncRNAs can characterize inter-tumor heterogeneity in BRCA and the new TNBC subtypes indicate novel insights into TNBC immunotherapy.	[Zhao, Zhangxiang; Liu, Yaoyao; Chen, Bo; Wang, Chengyu; Chen, Tingting; Wang, Yuquan; Li, Yawei; Dong, Qi; Ai, Liqiang; Gu, Yunyan] Harbin Med Univ, Dept Syst Biol, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Guo, YingYing] Harbin Med Univ, Coll Pharm, Minist Educ, China Key Lab Cardiovasc Res,Dept Pharmacol,State, Harbin, Peoples R China; [Guo, YingYing] Harbin Med Univ, Heilongjiang Acad Med Sci, Northern Translat Med Res & Cooperat, Harbin, Peoples R China; [Sun, Lichun] Harbin Med Univ, Dept Breast Med Oncol, Canc Hosp, Harbin, Peoples R China; [Wang, Ran] Harbin Med Univ, Dept Physiol, Harbin, Peoples R China; [Li, Xia] Harbin Med Univ, Dept Bioinformat, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University; Harbin Medical University	Gu, YY (corresponding author), Harbin Med Univ, Dept Syst Biol, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.; Li, X (corresponding author), Harbin Med Univ, Dept Bioinformat, Coll Bioinformat Sci & Technol, Harbin, Peoples R China.	guyunyan@ems.hrbmu.edu.cn; lixia@hrbmu.edu.cn	li, xia/HHZ-7468-2022	Gu, Yunyan/0000-0001-5693-4126; Wang, Chengyu/0000-0003-2384-0822; Zhao, Zhangxiang/0000-0001-7467-7223; Chen, Tingting/0000-0002-3918-5132	National Natural Science Foundation of China [61673143, 61873075]; National Key R&D Program of China [2018YFC2000100]; Postdoctoral Scientific Research Developmental Fund [LBH-Q16166]; Fundamental Research Funds for the Heilongjiang Provincial Universities [31041180010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key R&D Program of China; Postdoctoral Scientific Research Developmental Fund; Fundamental Research Funds for the Heilongjiang Provincial Universities	This work was supported by the National Natural Science Foundation of China [grant number: 61673143, 61873075], the National Key R&D Program of China [grant number: 2018YFC2000100], the Postdoctoral Scientific Research Developmental Fund [no. LBH-Q16166] and the Fundamental Research Funds for the Heilongjiang Provincial Universities [grant number: 31041180010].	Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Bareche Y, 2018, ANN ONCOL, V29, P895, DOI 10.1093/annonc/mdy024; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Bhan A, 2015, BBA-REV CANCER, V1856, P151, DOI 10.1016/j.bbcan.2015.07.001; Chen BB, 2018, METHODS MOL BIOL, V1711, P243, DOI 10.1007/978-1-4939-7493-1_12; Dai XF, 2017, J CANCER, V8, P3131, DOI 10.7150/jca.18457; Ding JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9554; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2013, BREAST, V22, pS3, DOI 10.1016/j.breast.2013.07.001; Huang X, 2018, Zhonghua Yi Xue Za Zhi, V98, P1213, DOI 10.3760/cma.j.issn.0376-2491.2018.16.005; Jiang YZ, 2019, CANCER CELL, V35, P428, DOI 10.1016/j.ccell.2019.02.001; Knijnenburg TA, 2018, CELL REP, V23, P239, DOI 10.1016/j.celrep.2018.03.076; Lehmann BD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157368; Li TW, 2017, CANCER RES, V77, pE108, DOI 10.1158/0008-5472.CAN-17-0307; Li YY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15095-1; Luo J, 2010, PHARMACOGENOMICS J, V10, P278, DOI 10.1038/tpj.2010.57; Marchese FP, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1348-2; Nath A, 2019, P NATL ACAD SCI USA, V116, P22020, DOI 10.1073/pnas.1909998116; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Peng FD, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0666-z; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Pusztai L, 2015, CLIN CANCER RES, V21, P3575, DOI 10.1158/1078-0432.CCR-14-3121; Rahman M, 2015, BIOINFORMATICS, V31, P3666, DOI 10.1093/bioinformatics/btv377; Rotte A, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1259-z; Schmitt AM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a026492; Senkus E, 2015, ANN ONCOL, V26, pV8, DOI 10.1093/annonc/mdv298; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sun BY, 2020, ONCOL LETT, V19, P595, DOI 10.3892/ol.2019.11182; Tang JM, 2018, ONCOGENE, V37, P4723, DOI 10.1038/s41388-018-0310-4; Thapar R, 2018, MOLECULES, V23, DOI 10.3390/molecules23112789; Thorsson V, 2018, IMMUNITY, V48, P812, DOI [10.1016/j.immuni.2018.03.023, 10.1016/j.immuni.2019.08.004]; Wang HW, 2015, BIOINFORMATICS, V31, P62, DOI 10.1093/bioinformatics/btu522; Wu SC, 2010, CELL RES, V20, P1109, DOI 10.1038/cr.2010.114; Xing F, 2018, CANCER RES, V78, P4316, DOI 10.1158/0008-5472.CAN-18-1102; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Youness RA, 2019, NON-CODING RNA RES, V4, P36, DOI 10.1016/j.ncrna.2019.01.003; Zhang TZ, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819843889; Zheng RN, 2018, BIOCHEM BIOPH RES CO, V498, P1002, DOI 10.1016/j.bbrc.2018.03.104	38	8	8	1	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2021	40	27					4604	4614		10.1038/s41388-021-01883-6	http://dx.doi.org/10.1038/s41388-021-01883-6		JUN 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TG4PV	34131286	hybrid, Green Published			2022-12-26	WOS:000661812800001
J	Takagi, K; Tanaka, A; Yoshioka, N; Morita, Y; Yoshida, R; Kanzaki, Y; Watanabe, N; Yamauchi, R; Komeyama, S; Sugiyama, H; Shimojo, K; Imaoka, T; Sakamoto, G; Ohi, T; Goto, H; Ishii, H; Morishima, I; Murohara, T				Takagi, Kensuke; Tanaka, Akihito; Yoshioka, Naoki; Morita, Yasuhiro; Yoshida, Ruka; Kanzaki, Yasunori; Watanabe, Naoki; Yamauchi, Ryota; Komeyama, Shotaro; Sugiyama, Hiroki; Shimojo, Kazuki; Imaoka, Takuro; Sakamoto, Gaku; Ohi, Takuma; Goto, Hiroki; Ishii, Hideki; Morishima, Itsuro; Murohara, Toyoaki			In-hospital mortality among consecutive patients with ST-Elevation myocardial infarction in modern primary percutaneous intervention era similar to Insights from 15-year data of single-center hospital-based registry similar to	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; SEGMENT ELEVATION; CARDIOGENIC-SHOCK; THROMBOLYTIC THERAPY; PROGNOSTIC VALUE; CARDIAC RUPTURE; FREE-WALL; MANAGEMENT; OCCLUSION; RISK	Objective To clarify the association of detailed angiographic findings with in-hospital outcome after primary percutaneous coronary intervention (p-PCI) for ST-elevation myocardial infarction (STEMI) in Japan. Background Data regarding the association of detailed angiographic findings with in-hospital outcome after STEMI are limited in the p-PCI era. Methods Between January-2004 and December-2018, 1735 patients with STEMI (mean age, 68.5 years; female, 24.6%) who presented to the hospital in the 24-hours after symptom onset and underwent p-PCI were evaluated using the disease registries. The registry is an ongoing, retrospective, single-center hospital-based registry. Results The 30-day mortality rate and in-hospital mortality rate were 7.7% and 9.2%, respectively. Independent predictors of in-hospital mortality were ejection fraction (EF) < 40% [adjusted Odds Ratio (aOR), 4.446, p < 0.001], culprit lesions in the left coronary artery (LCA) (aOR, 2.940, p < 0.001) compared with those in the right coronary artery, Killip class > II (aOR, 7.438; p < 0.001), chronic kidney disease (CKD) (aOR, 4.056; p < 0.001), final thrombolysis in myocardial infarction (TIMI) grades 0/1/2 (aOR, 1.809; p = 0.03), absence of robust collaterals (aOR, 17.309; p = 0.01) and hypertension (aOR, 0.449; p = 0.01). Conclusions Among the consecutive patients with STEMI, the in-hospital mortality rate after p-PCI significantly improved in the second half. Not only CKD, Killip class > II, and EF < 40%, but also the angiographic findings such as culprit lesions in the LCA, absence of very robust collaterals, and final TIMI grades <3 were associated with an increased risk of in-hospital mortality.	[Takagi, Kensuke; Yoshioka, Naoki; Morita, Yasuhiro; Kanzaki, Yasunori; Watanabe, Naoki; Yamauchi, Ryota; Komeyama, Shotaro; Sugiyama, Hiroki; Shimojo, Kazuki; Imaoka, Takuro; Sakamoto, Gaku; Ohi, Takuma; Goto, Hiroki; Morishima, Itsuro] Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Japan; [Takagi, Kensuke; Tanaka, Akihito; Yoshioka, Naoki; Yoshida, Ruka; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi, Japan; [Ishii, Hideki] Fujita Hlth Univ, Bantane Hosp, Dept Cardiol, Nagoya, Aichi, Japan; [Takagi, Kensuke] Natl Cerebral & Cardiovasc Ctr, Dept Cardiol, Osaka, Japan	Ogaki Municipal Hospital; Nagoya University; Fujita Health University; National Cerebral & Cardiovascular Center - Japan	Morishima, I (corresponding author), Ogaki Municipal Hosp, Dept Cardiol, Ogaki, Japan.	morishima-i@muc.biglobe.ne.jp		takagi, kensuke/0000-0003-3999-8536				Ali M, 2018, HERZ, V43, P741, DOI 10.1007/s00059-017-4621-y; Allahwala UK, 2020, AM J CARDIOL, V125, P1455, DOI 10.1016/j.amjcard.2020.02.023; Cui Y, 2017, CIRC J, V81, P520, DOI 10.1253/circj.CJ-16-0799; Figueras J, 1998, J AM COLL CARDIOL, V32, P135, DOI 10.1016/S0735-1097(98)00180-6; Figueras J, 2008, CIRCULATION, V118, P2783, DOI 10.1161/CIRCULATIONAHA.108.776690; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; French JK, 1996, BMJ-BRIT MED J, V312, P1637, DOI 10.1136/bmj.312.7047.1637; French JK, 2010, AM J CARDIOL, V105, P59, DOI 10.1016/j.amjcard.2009.08.653; Fresco C, 1996, J HYPERTENS, V14, P743, DOI 10.1097/00004872-199606000-00010; Granger CB, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.008096; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Hara M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011105; Hicks KA, 2018, J AM COLL CARDIOL, V71, P1021, DOI 10.1016/j.jacc.2017.12.048; Hirji SA, 2017, AM HEART J, V194, P116, DOI 10.1016/j.ahj.2017.08.023; HUEY BL, 1988, J AM COLL CARDIOL, V12, P1156, DOI 10.1016/0735-1097(88)92594-6; Ibanez B, 2018, EUR HEART J, V39, P119, DOI 10.1093/eurheartj/ehx393; Ilia R, 2003, AM J CARDIOL, V92, P54, DOI 10.1016/S0002-9149(03)00465-X; Ishihara M, 2006, AM J CARDIOL, V97, P1558, DOI 10.1016/j.amjcard.2005.12.044; Ishihara M, 2015, CIRC J, V79, P1255, DOI 10.1253/circj.CJ-15-0217; Kasanuki H, 2005, AM HEART J, V150, P411, DOI 10.1016/j.ahj.2004.10.001; Keeley EC, 2003, LANCET, V361, P13, DOI 10.1016/S0140-6736(03)12113-7; KENNER MD, 1995, AM J CARDIOL, V76, P861, DOI 10.1016/S0002-9149(99)80250-1; Kim EK, 2016, AM HEART J, V171, P56, DOI 10.1016/j.ahj.2015.10.016; Kim SS, 2011, J CARDIOL, V57, P290, DOI 10.1016/j.jjcc.2011.01.014; Kimura K, 2019, CIRC J, V83, P1085, DOI 10.1253/circj.CJ-19-0133; Kinjo K, 2003, AM J CARDIOL, V92, P1150, DOI 10.1016/j.amjcard.2003.07.021; Kristensen SD, 2014, EUR HEART J, V35, P1957, DOI 10.1093/eurheartj/eht529; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; McNamara RL, 2016, J AM COLL CARDIOL, V68, P626, DOI 10.1016/j.jacc.2016.05.049; Menon V, 2000, J AM COLL CARDIOL, V36, P1110, DOI 10.1016/S0735-1097(00)00878-0; Miyachi H, 2016, HEART VESSELS, V31, P1740, DOI 10.1007/s00380-015-0791-9; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Ndrepepa G, 2008, J AM COLL CARDIOL, V52, P2008, DOI 10.1016/j.jacc.2008.05.009; Ozaki Y, 2018, CARDIOVASC INTERV TH, V33, P178, DOI 10.1007/s12928-018-0516-y; PASSAMANI E, 1985, NEW ENGL J MED, V312, P932; Pedersen F, 2014, J AM COLL CARDIOL, V64, P2101, DOI 10.1016/j.jacc.2014.08.037; RENTROP KP, 1985, J AM COLL CARDIOL, V5, P587; Slater J, 2000, J AM COLL CARDIOL, V36, P1117, DOI 10.1016/S0735-1097(00)00845-7; Suzuki N, 2020, CARDIOVASC INTERV TH, V35, P105, DOI 10.1007/s12928-020-00653-7; Tsutsui H, 2019, CIRC J, V83, P2084, DOI 10.1253/circj.CJ-19-0342; Veltman CE, 2012, EUR HEART J, V33, P1367, DOI 10.1093/eurheartj/ehs034; Webb JG, 2000, J AM COLL CARDIOL, V36, P1084, DOI 10.1016/S0735-1097(00)00876-7	43	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252503	10.1371/journal.pone.0252503	http://dx.doi.org/10.1371/journal.pone.0252503			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115767	Green Published, gold			2022-12-26	WOS:000664643000020
J	Karnjus, I; Prosen, M; Licen, S				Karnjus, Igor; Prosen, Mirko; Licen, Sabina			Nurses' core disaster-response competencies for combating COVID-19-A cross-sectional study	PLOS ONE			English	Article							NURSING-EDUCATION; PREPAREDNESS; KNOWLEDGE; STUDENTS; HEALTH	The core competencies in disaster nursing, nurses' roles in disaster management and the potential barriers are assessed with a view to developing disaster nursing in Slovenia. Despite training and experience, many indicators show nurses are deficient in skills involving emergency and disaster-preparedness competencies. Nurses report little familiarity with disaster-planning skills, the implementation of disaster guidelines and assessment of patients subject to a disaster circumstance. A cross-sectional descriptive study was conducted based on data collected through an online survey. 118 registered nurses from different clinical settings in Slovenia participated in the study. Data were collected according to the Slovenian version of the Disaster Nursing Core Competencies Scale (Sl-DNCC-Scale). The scale was limited to a 7-point Likert response format (from 1 = strongly disagree to 7 = strongly agree). The results show the registered nurses perceive the core competencies of disaster nursing to be important to their preparedness for disaster situations (median = 161; range 74-189). Registered nurses who work in nursing homes and nurse managers are more aware of the importance of acquiring the listed competencies for unexpected events (p = 0.011 and 0.060 respectively) and the importance of their active role in disaster management (p = 0.027 and p = 0.004, respectively). To effectively deal with a disaster, nurses must be well prepared for unexpected events and more actively involved in disaster management. This study demonstrates that nurses regard the core disaster nursing competencies as important and greatly needed in various healthcare facilities. Future studies in this area should focus on ways to implement these competencies in nursing education.	[Karnjus, Igor; Prosen, Mirko; Licen, Sabina] Univ Primorska, Fac Hlth Sci, Izola, Slovenia	University of Primorska	Licen, S (corresponding author), Univ Primorska, Fac Hlth Sci, Izola, Slovenia.	sabina.licen@fvz.upr.si	Prosen, Mirko/R-5722-2018; Licen, Sabina/S-4574-2018	Prosen, Mirko/0000-0001-9943-9037; Licen, Sabina/0000-0002-8795-7985				Al Thobaity A, 2016, AUSTRALAS EMERG NURS, V19, P11, DOI 10.1016/j.aenj.2015.12.001; Al Thobaity A, 2015, AUSTRALAS EMERG NURS, V18, P156, DOI 10.1016/j.aenj.2015.03.001; Al Thobaity A, 2017, INT EMERG NURS, V31, P64, DOI 10.1016/j.ienj.2016.10.003; Allison M., 2020, TIMELINE COVID 19 NE; Benedek DM, 2007, ANNU REV PUBL HEALTH, V28, P55, DOI 10.1146/annurev.publhealth.28.021406.144037; Blake SC, 2012, DISASTER MED PUBLIC, V6, P424, DOI 10.1001/dmp.2012.65; Daily E, 2010, PREHOSP DISASTER MED, V25, P387, DOI 10.1017/S1049023X00008438; Davidson PM, 2020, J ADV NURS, V76, P2460, DOI 10.1111/jan.14468; Dujic D, GUIDELINES MED EMERG; European Centre for Disease Prevention and Control, 2020, SIT UPD WORLDW; Fink A, 2008, UJMA, P222; Gowing JR, 2017, PREHOSP DISASTER MED, V32, P321, DOI 10.1017/S1049023X1700019X; Hugelius K, 2019, INT EMERG NURS, V45, P1, DOI 10.1016/j.ienj.2019.03.007; International Council of Nurses, 2019, COR COMP DIS NURS VE; Jackson D, 2020, J CLIN NURS, V29, P3584, DOI 10.1111/jocn.15347; Kalanlar B, 2019, J TRAUMA NURS, V26, P164, DOI 10.1097/JTN.0000000000000417; Kalanlar B, 2018, INT J DISAST RISK RE, V28, P475, DOI 10.1016/j.ijdrr.2017.12.008; Labrague LJ, 2018, INT NURS REV, V65, P41, DOI 10.1111/inr.12369; Li SM., 2016, CHIN NURS RES, V3, P154, DOI [10.1016/j.cnre.2016.11.003, DOI 10.1016/j.cnre.2016.11.003]; Li Y, 2020, J AM GERIATR SOC, V68, P1899, DOI 10.1111/jgs.16689; National Institute of Public Health, 2020, COR DIS COVID 19; Nilsson J, 2016, NURSE EDUC PRACT, V17, P102, DOI 10.1016/j.nepr.2015.09.012; Park HY, 2017, APPL NURS RES, V37, P1, DOI 10.1016/j.apnr.2017.06.004; Pourvakhshoori N, 2017, INT EMERG NURS, V31, P58, DOI 10.1016/j.ienj.2016.06.004; Powers R., INT DISASTER NURSING, P1, DOI [10.1097/01.NURSE.0000522010.36514.dc, DOI 10.1097/01.NURSE.0000522010.36514.DC]; Prosen M., 2020, SLOVENIAN NURSING RE, V54, P113, DOI [10.14528/snr.2020.54.2.3037, DOI 10.14528/SNR.2020.54.2.3037]; Said NB, 2020, INT EMERG NURS, V48, DOI 10.1016/j.ienj.2019.100806; Sugg MM, 2021, SCI TOTAL ENVIRON, V752, DOI 10.1016/j.scitotenv.2020.141946; Wang J, 2020, NURS EDUC TODAY, V84, DOI 10.1016/j.nedt.2019.104208; World Health Organization (WHO), 2020, COR DIS COVID 19 SIT; Xu HW, 2020, J AM MED DIR ASSOC, V21, P1371, DOI 10.1016/j.jamda.2020.08.002	31	5	5	4	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252934	10.1371/journal.pone.0252934	http://dx.doi.org/10.1371/journal.pone.0252934			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111208	gold, Green Published			2022-12-26	WOS:000664642700066
J	Gurm, Z; Seth, M; Daher, E; Pielsticker, E; Qureshi, MI; Zainea, M; Tucciarone, M; Hanzel, G; Henke, PK; Sukul, D				Gurm, Zoya; Seth, Milan; Daher, Edouard; Pielsticker, Elizabeth; Qureshi, M. Imran; Zainea, Mark; Tucciarone, Michael; Hanzel, George; Henke, Peter K.; Sukul, Devraj			Prevalence of coronary risk factors in contemporary practice among patients undergoing their first percutaneous coronary intervention: Implications for primary prevention	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; SEX-DIFFERENCES; HEART-DISEASE; US ADULTS; SMOKING; OBESITY; TRENDS; WOMEN; STATEMENT	Background Cigarette smoking, hypertension, dyslipidemia, diabetes, and obesity are conventional risk factors (RFs) for coronary artery disease (CAD). Population trends for these RFs have varied in recent decades. Consequently, the risk factor profile for patients presenting with a new diagnosis of CAD in contemporary practice remains unknown. Objectives To examine the prevalence of RFs and their temporal trends among patients without a history of myocardial infarction or revascularization who underwent their first percutaneous coronary intervention (PCI). Methods We examined the prevalence and temporal trends of RFs among patients without a history of prior myocardial infarction, PCI, or coronary artery bypass graft surgery who underwent PCI at 47 non-federal hospitals in Michigan between 1/1/2010 and 3/31/2018. Results Of 69,571 men and 38,930 women in the study cohort, 95.5% of patients had 1 or more RFs and nearly half (55.2% of women and 48.7% of men) had >= 3 RFs. The gap in the mean age at the time of presentation between men and women narrowed as the number of RFs increased with a gap of 6 years among those with 2 RFs to <1 year among those with 5 RFs. Compared with patients without a current/recent history of smoking, those with a current/recent history of smoking presented a decade earlier (age 56.8 versus 66.9 years; p <0.0001). Compared with patients without obesity, patients with obesity presented 4.0 years earlier (age 61.4 years versus 65.4 years; p <0.0001). Conclusions Modifiable RFs are widely prevalent among patients undergoing their first PCI. Smoking and obesity are associated with an earlier age of presentation. Population-level interventions aimed at preventing obesity and smoking could significantly delay the onset of CAD and the need for PCI.	[Gurm, Zoya] Wayne State Univ, Sch Med, Detroit, MI USA; [Seth, Milan; Henke, Peter K.; Sukul, Devraj] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA; [Daher, Edouard] Ascens St John Hosp, Detroit, MI USA; [Pielsticker, Elizabeth] Henry Ford Allegiance Hlth, Jackson, MI USA; [Qureshi, M. Imran] Sinai Grace Hosp, Detroit Med Ctr, Detroit, MI USA; [Zainea, Mark] McLaren Macomb Hosp, Mt Clemens, MI USA; [Tucciarone, Michael] Beaumont Hosp, Troy, MI USA; [Hanzel, George] Emory Univ, Struct Heart & Valve Ctr, Atlanta, GA 30322 USA	Wayne State University; University of Michigan System; University of Michigan; Detroit Medical Center; Beaumont Health; Emory University	Sukul, D (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA.	dsukul@med.umich.edu		tucciarone, michael/0000-0002-7716-6637	Blue Cross Blue Shield of Michigan	Blue Cross Blue Shield of Michigan	The BMC2 coordinating center is supported by a grant from Blue Cross Blue Shield of Michigan to the University of Michigan. The sponsor had no role in the study design or decision to publish this work.	Albrektsen G, 2016, JAMA INTERN MED, V176, P1673, DOI 10.1001/jamainternmed.2016.5451; BarrettConnor E, 1997, CIRCULATION, V95, P252, DOI 10.1161/01.CIR.95.1.252; Carroll M, 2020, TOTAL HIGH DENSITY L; Chriqui JF, 2013, CURR OBES REP, V2, P200, DOI 10.1007/s13679-013-0063-x; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Geiss LS, 2006, AM J PREV MED, V30, P371, DOI 10.1016/j.amepre.2005.12.009; KANNEL WB, 1987, AM HEART J, V114, P413, DOI 10.1016/0002-8703(87)90511-4; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Larsen GK, 2013, JAMA INTERN MED, V173, P1261, DOI 10.1001/jamainternmed.2013.6075; Madala MC, 2008, J AM COLL CARDIOL, V52, P979, DOI 10.1016/j.jacc.2008.04.067; Mahmood SS, 2014, LANCET, V383, P999, DOI 10.1016/S0140-6736(13)61752-3; Mensah GA, 2017, CIRC RES, V120, P366, DOI 10.1161/CIRCRESAHA.116.309115; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; Moscucci M, 2006, CIRCULATION, V113, P814, DOI 10.1161/CIRCULATIONAHA.105.541995; Naghavi M, 2017, LANCET, V390, P1151, DOI 10.1016/S0140-6736(17)32152-9; NCDR, CATHPCI REG V4 4 COD; Njolstad I, 1996, CIRCULATION, V93, P450; Smith PH, 2014, DRUG ALCOHOL DEPEN, V142, P333, DOI 10.1016/j.drugalcdep.2014.07.003; Stramba-Badiale M, 2006, EUR HEART J, V27, P994, DOI 10.1093/eurheartj/ehi819; Weintraub WS, 2011, CIRCULATION, V124, P967, DOI 10.1161/CIR.0b013e3182285a81; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0250801	10.1371/journal.pone.0250801	http://dx.doi.org/10.1371/journal.pone.0250801			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106945	Green Published, gold			2022-12-26	WOS:000664642200012
J	Shepley-McTaggart, A; Sagum, CA; Oliva, I; Rybakovsky, E; DiGuilio, K; Liang, J; Bedford, MT; Cassel, J; Sudol, M; Mullin, JM; Harty, RN				Shepley-McTaggart, Ariel; Sagum, Cari A.; Oliva, Isabela; Rybakovsky, Elizabeth; DiGuilio, Katie; Liang, Jingjing; Bedford, Mark T.; Cassel, Joel; Sudol, Marius; Mullin, James M.; Harty, Ronald N.			SARS-CoV-2 Envelope (E) protein interacts with PDZ-domain-2 of host tight junction protein ZO1	PLOS ONE			English	Article							CORONAVIRUS; DIMERIZATION; ZO-1	Newly emerged SARS-CoV-2 is the cause of an ongoing global pandemic leading to severe respiratory disease in humans. SARS-CoV-2 targets epithelial cells in the respiratory tract and lungs, which can lead to amplified chloride secretion and increased leak across epithelial barriers, contributing to severe pneumonia and consolidation of the lungs as seen in many COVID-19 patients. There is an urgent need for a better understanding of the molecular aspects that contribute to SARS-CoV-2-induced pathogenesis and for the development of approaches to mitigate these damaging pathologies. The multifunctional SARS-CoV-2 Envelope (E) protein contributes to virus assembly/egress, and as a membrane protein, also possesses viroporin channel properties that may contribute to epithelial barrier damage, pathogenesis, and disease severity. The extreme C-terminal (ECT) sequence of E also contains a putative PDZ-domain binding motif (PBM), similar to that identified in the E protein of SARS-CoV-1. Here, we screened an array of GST-PDZ domain fusion proteins using either a biotin-labeled WT or mutant ECT peptide from the SARS-CoV-2 E protein. Notably, we identified a singular specific interaction between the WT E peptide and the second PDZ domain of human Zona Occludens-1 (ZO1), one of the key regulators of TJ formation/integrity in all epithelial tissues. We used homogenous time resolve fluorescence (HTRF) as a second complementary approach to further validate this novel modular E-ZO1 interaction. We postulate that SARS-CoV-2 E interacts with ZO1 in infected epithelial cells, and this interaction may contribute, in part, to tight junction damage and epithelial barrier compromise in these cell layers leading to enhanced virus spread and severe dysfunction that leads to morbidity. Prophylactic/therapeutic intervention targeting this virus-host interaction may effectively reduce airway and/or gastrointestinal barrier damage and mitigate virus spread.	[Shepley-McTaggart, Ariel; Liang, Jingjing; Harty, Ronald N.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA; [Sagum, Cari A.; Bedford, Mark T.] Univ Texas, Dept Epigenet & Mol Carcinogenesis, MD Anderson Canc Ctr, Smithville, TX USA; [Oliva, Isabela; Cassel, Joel] Wistar Inst Anat & Biol, Wistar Canc Ctr Mol Screening, 3601 Spruce St, Philadelphia, PA 19104 USA; [Rybakovsky, Elizabeth; DiGuilio, Katie; Mullin, James M.] Lankenau Inst Med Res, Wynnewood, PA USA; [Sudol, Marius] Icahn Sch Med Mt Sinai, Dept Med, New York, NY 10029 USA	University of Pennsylvania; University of Texas System; UTMD Anderson Cancer Center; The Wistar Institute; Lankenau Medical Center; Lankenau Institute for Medical Research; Icahn School of Medicine at Mount Sinai	Harty, RN (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA.	rharty@vet.upenn.edu			University of Pennsylvania School of Veterinary Medicine COVID-19 Pilot Award; University of Pennsylvania School of Medicine Institute for Translational Medicine and Therapeutics Pilot Award; NIH NIAID [AI138052, AI139392, T32-AI070077]; UT MDACC Protein Array & Analysis Core (PAAC) CPRIT [RP180804]; Emergent Ventures Program at the Mercatus Center at George Mason University	University of Pennsylvania School of Veterinary Medicine COVID-19 Pilot Award; University of Pennsylvania School of Medicine Institute for Translational Medicine and Therapeutics Pilot Award; NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UT MDACC Protein Array & Analysis Core (PAAC) CPRIT; Emergent Ventures Program at the Mercatus Center at George Mason University	Funding was provided in part from a University of Pennsylvania School of Veterinary Medicine COVID-19 Pilot Award, a University of Pennsylvania School of Medicine Institute for Translational Medicine and Therapeutics Pilot Award, a Fast Grant from the Emergent Ventures Program at the Mercatus Center at George Mason University, and NIH NIAID awards (AI138052, AI139392) to RNH, a Fast Grant from the Emergent Ventures Program at the Mercatus Center at George Mason University to JMM, and a NIH NIAID award to ASM (T32-AI070077). Probing of arrayed methyl reader domains was made possible via the UT MDACC Protein Array & Analysis Core (PAAC) CPRIT in the form of a grant to MTB (RP180804). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam I, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00405; [Anonymous], 2015, METHODS MOL BIOL, DOI DOI 10.1007/978-1-4939-2438-7_1; Balda MS, 2003, J CELL BIOL, V160, P423, DOI 10.1083/jcb.200210020; Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Caillet-Saguy C, 2021, FEBS J, V288, P5148, DOI 10.1111/febs.15881; Castano-Rodriguez C, 2018, MBIO, V9, DOI 10.1128/mBio.02325-17; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; De Diego ML, 2014, VIRUS RES, V194, P124, DOI 10.1016/j.virusres.2014.07.024; De Maio F, 2020, MICROBES INFECT, V22, P592, DOI 10.1016/j.micinf.2020.08.006; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711; Georgiadis A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015730; Guttman JA, 2009, BBA-BIOMEMBRANES, V1788, P832, DOI 10.1016/j.bbamem.2008.10.028; Han ZY, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008231; Hao SY, 2020, MBIO, V11, DOI 10.1128/mBio.02852-20; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Heinemann U, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20236020; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jimenez-Guardeno JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005215; Jimenez-Guardeno JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004320; Lee S, 2020, EMERG MICROBES INFEC, V9, P2169, DOI 10.1080/22221751.2020.1827985; Liang JJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006132; Lo Cascio E, 2021, COMPUT STRUCT BIOTEC, V19, P1838, DOI 10.1016/j.csbj.2021.03.014; Lu RY, 2014, MOL BIOL REP, V41, P6591, DOI 10.1007/s11033-014-3543-5; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; McIntosh K., 1974, CORONAVIRUSES COMP R; Mukherjee S, 2020, BIOPHYS CHEM, V266, DOI 10.1016/j.bpc.2020.106452; Muller SL, 2005, J BIOL CHEM, V280, P3747, DOI 10.1074/jbc.M411365200; Rodgers LS, 2013, J CELL SCI, V126, P1565, DOI 10.1242/jcs.113399; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Ruch TR, 2012, VIRUSES-BASEL, V4, P363, DOI 10.3390/v4030363; Sarkar M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237300; Satarker S, 2020, ARCH MED RES, V51, P482, DOI 10.1016/j.arcmed.2020.05.012; Schoeman D, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.02086; Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0; Schwayer C, 2019, CELL, V179, P937, DOI 10.1016/j.cell.2019.10.006; Shepley-McTaggart Ariel, 2020, bioRxiv, DOI 10.1101/2020.12.22.422708; Teoh KT, 2010, MOL BIOL CELL, V21, P3838, DOI 10.1091/mbc.E10-04-0338; Tomar PPS I.T., 2020, BIOCHEM BIOPH RES CO; Toto A, 2020, PROTEIN SCI, V29, P2038, DOI 10.1002/pro.3936; Utepbergenov DI, 2006, J BIOL CHEM, V281, P24671, DOI 10.1074/jbc.M512820200; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; WHO, 2004, SUMM PROB SARS CAS O; World Health Organization, 2021, COR DIS COVID 19 SIT; Wu JW, 2007, J BIOL CHEM, V282, P35988, DOI 10.1074/jbc.M703826200; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	50	22	22	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0251955	10.1371/journal.pone.0251955	http://dx.doi.org/10.1371/journal.pone.0251955			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106957	Green Submitted, gold, Green Published			2022-12-26	WOS:000664642200022
J	Candela, L; Boeri, L; Capogrosso, P; Cazzaniga, W; Pozzi, E; Belladelli, F; Baudo, A; Ravizzoli, A; Ventimiglia, E; Vigano, P; Alfano, M; Abbate, C; Cornelius, J; Mattei, A; Montorsi, F; Salonia, A				Candela, Luigi; Boeri, Luca; Capogrosso, Paolo; Cazzaniga, Walter; Pozzi, Edoardo; Belladelli, Federico; Baudo, Andrea; Ravizzoli, Andrea; Ventimiglia, Eugenio; Vigano, Paola; Alfano, Massimo; Abbate, Costantino; Cornelius, Julian; Mattei, Agostino; Montorsi, Francesco; Salonia, Andrea			Correlation among isolated teratozoospermia, sperm DNA fragmentation and markers of systemic inflammation in primary infertile men	PLOS ONE			English	Article							HUMAN SPERMATOZOA; OXIDATIVE STRESS; MORPHOLOGY; DAMAGE; NEUTROPHIL; FERTILE; ASSOCIATION; DECLINE	Aim To assess the prevalence of isolated teratozoospermia (iTZS) in a cohort of infertile and fertile men; explore the relationship between iTZS, inflammatory parameters and sperm DNA fragmentation index (SDF) in the same cohort. Materials and methods 1824 infertile men and 103 fertile controls. Semen analysis, the neutrophil-to-lymphocyte ratio (NLR) and serum hormones were investigated. DFI was tested in infertile men only. According to 2010 WHO semen analysis, patients were categorized in 3 sub-groups of isolated sperm defects: isolated oligozoospermia (iOZS), isolated asthenozoospermia (iAZS) and iTZS. Descriptive statistics and linear regression models tested the association between clinical variables and inflammatory markers. Results Among infertile men, iAZS, iTZS, and iOZS were found in 13.9%, 11.9% and 4.1% participants, respectively. iTZS was found in 37 (35.9%) fertile men. Infertile men with iTZS had higher NLR values than those with iOZS, iAZS and men with normal semen parameters (all p<0.001). FSH and LH were higher and inhibin B lower in iOZS infertile men compared to all other groups (p<less than or equal to>0.001). Hormonal characteristics were similar between iTZS infertile and fertile men. Similarly, iTZS infertile men had higher SDF than all other groups (all p<0.001). Infertile men with iTZS had higher NLR values than fertile men with iTZS (p<0.01). Linear regression analysis showed that, in infertile men, iTZS was associated with SDF and NLR (all p <= 0.01). Conclusions iTZS was found in 11.9% of infertile men but it was even more prevalent in fertile controls. Infertile men with iTZS had higher NLR than fertile controls and increased SDF values than infertile participant with iAZS, iOZS, or normal semen parameters. No differences in hormonal characteristics were found between infertile and fertile men with iTZS.	[Candela, Luigi; Boeri, Luca; Capogrosso, Paolo; Cazzaniga, Walter; Pozzi, Edoardo; Belladelli, Federico; Baudo, Andrea; Ravizzoli, Andrea; Ventimiglia, Eugenio; Alfano, Massimo; Abbate, Costantino; Montorsi, Francesco; Salonia, Andrea] IRCCS Osped San Raffaele, Div Expt Oncol, Unit Urol, URI, Milan, Italy; [Candela, Luigi; Cazzaniga, Walter; Pozzi, Edoardo; Belladelli, Federico; Baudo, Andrea; Ravizzoli, Andrea; Montorsi, Francesco; Salonia, Andrea] Univ Vita Salute San Raffaele, Milan, Italy; [Boeri, Luca] Univ Milan, Dept Urol, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Capogrosso, Paolo] Osped Circolo & Macchi Fdn, Dept Urol & Androl, Varese, Italy; [Vigano, Paola] IRCCS Osped San Raffaele, Dept Obstet & Gynaecol, Milan, Italy; [Vigano, Paola] IRCCS Osped San Raffaele, Reprod Sci Lab, Div Genet & Cell Biol, Milan, Italy; [Cornelius, Julian; Mattei, Agostino] Luzerner Kantonsspital, Dept Urol, Luzern, Switzerland	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Ospedale Circolo & Fondazione Macchi; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Lucerne Cantonal Hospital	Salonia, A (corresponding author), IRCCS Osped San Raffaele, Div Expt Oncol, Unit Urol, URI, Milan, Italy.; Salonia, A (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.	salonia.andrea@hsr.it	Pozzi, Edoardo/AAC-5170-2019; Boeri, Luca/AAC-4848-2022; Cornelius, Julian/AAY-3069-2021; Cazzaniga, Walter/AFZ-0495-2022	Pozzi, Edoardo/0000-0002-0228-7039; Cazzaniga, Walter/0000-0002-0372-5694; Belladelli, Federico/0000-0002-2165-659X; Alfano, Massimo/0000-0002-6904-9158				Agarwal A, 2018, ANDROLOGIA, V50, DOI 10.1111/and.13126; Agarwal A, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-45; Aitken RJ, 2013, MOL HUM REPROD, V19, P475, DOI 10.1093/molehr/gat025; Alharbi M, 2020, ASIAN J ANDROL, V22, P348, DOI 10.4103/aja.aja_99_19; Ammar O, 2020, ANDROLOGY-US, V8, P1095, DOI 10.1111/andr.12778; Aykan S, 2017, WORLD J MENS HEALTH, V35, P51, DOI 10.5534/wjmh.2017.35.1.51; Azenabor Alfred, 2015, J Reprod Infertil, V16, P123; Aziz N, 2007, HUM REPROD, V22, P1413, DOI 10.1093/humrep/dem016; Barati E, 2020, CELL MOL LIFE SCI, V77, P93, DOI 10.1007/s00018-019-03253-8; Belloc S, 2014, J ASSIST REPROD GEN, V31, P527, DOI 10.1007/s10815-014-0194-3; Bisht S, 2017, NAT REV UROL, V14, P470, DOI 10.1038/nrurol.2017.69; Boeri L, 2020, ANDROLOGIA, DOI 10.1111/and.13861; Boeri L, 2019, HUM REPROD, V34, P209, DOI 10.1093/humrep/dey348; Braham A, 2019, ANDROLOGIA, V51, DOI 10.1111/and.13252; Brahem S, 2011, J ASSIST REPROD GEN, V28, P41, DOI 10.1007/s10815-010-9482-8; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choy JT, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa390; Cito G, 2019, WORLD J MENS HEALTH, V37, P347, DOI 10.5534/wjmh.180110; Cocuzza Marcello, 2007, Int. braz j urol., V33, P603, DOI 10.1590/S1677-55382007000500002; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Danis RB, 2019, CURR UROL REP, V20, DOI 10.1007/s11934-019-0911-7; De Braekeleer M, 2015, J ASSIST REPROD GEN, V32, P615, DOI 10.1007/s10815-015-0433-2; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Forget Patrice, 2017, BMC Res Notes, V10, P12, DOI 10.1186/s13104-016-2335-5; Ganzer LM, 2017, FERTIL STERIL, V108, pE137, DOI 10.1016/j.fertnstert.2017.07.415; Geoffroy-Siraudin C, 2012, ASIAN J ANDROL, V14, P584, DOI 10.1038/aja.2011.173; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hermosilla C, 2014, PARASITOLOGY, V141, P1489, DOI 10.1017/S0031182014000316; Hotaling JM, 2011, FERTIL STERIL, V95, P1141, DOI 10.1016/j.fertnstert.2010.09.029; Imtiaz Fauzia, 2012, Int Arch Med, V5, P2, DOI 10.1186/1755-7682-5-2; Kotani K, 2012, INT J PREVENTIVE MED, V3, P428; Kovac JR, 2017, ASIAN J ANDROL, V19, P39, DOI 10.4103/1008-682X.189211; Levine H, 2017, HUM REPROD UPDATE, V23, P646, DOI 10.1093/humupd/dmx022; Lu JC, 2018, REPROD BIOL ENDOCRIN, V16, DOI 10.1186/s12958-018-0345-y; Majzoub A, 2018, ARAB J UROL, V16, P87, DOI 10.1016/j.aju.2017.11.014; Menkveld R, 2011, ASIAN J ANDROL, V13, P59, DOI 10.1038/aja.2010.67; Le MT, 2019, REPROD MED BIOL, V18, P390, DOI 10.1002/rmb2.12297; Moskovtsev SI, 2009, UROLOGY, V74, P789, DOI 10.1016/j.urology.2009.05.043; Muratori M, 2015, MOL MED, V21, DOI 10.2119/molmed.2014.00158; Ombelet W, 1997, HUM REPROD, V12, P1015; Oumaima A, 2018, ENVIRON SCI POLLUT R, V25, P13775, DOI 10.1007/s11356-018-1417-4; Oztekin U, 2019, CUREUS, V11, DOI 10.7759/cureus.5242; Patel P, 2019, J UROLOGY, V202, P801, DOI 10.1097/JU.0000000000000288; Rosales C, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00113; Rowe P.J., 2000, WHO MANUAL STANDARDI; Sachdeva K, 2020, GENET TEST MOL BIOMA, V24, P195, DOI 10.1089/gtmb.2019.0180; Sakkas D, 1999, REV REPROD, V4, P31, DOI 10.1530/ror.0.0040031; Salonia A, 2020, EUROPEAN ASS UROLOGY; SCHIRREN C, 1977, ANDROLOGIA, V9, P191; Schulte RT, 2010, J ASSIST REPROD GEN, V27, P3, DOI 10.1007/s10815-009-9359-x; Selders GS, 2017, REGEN BIOMATER, V4, P55, DOI 10.1093/rb/rbw041; Sengupta P, 2018, HUM EXP TOXICOL, V37, P247, DOI 10.1177/0960327117703690; Ventimiglia E, 2018, ANDROLOGY-US, V6, P559, DOI 10.1111/andr.12489; Ventimiglia E, 2016, EUR UROL, V70, P920, DOI 10.1016/j.eururo.2016.06.015; Zahorec R, 2001, Bratisl Lek Listy, V102, P5; Zhang TC, 2018, MOL MED REP, V18, P1297, DOI 10.3892/mmr.2018.9112; Zini A, 2002, UROLOGY, V60, P1069, DOI 10.1016/S0090-4295(02)01975-1; Zini A, 2006, CAN MED ASSOC J, V175, P495, DOI 10.1503/cmaj.060218	58	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0251608	10.1371/journal.pone.0251608	http://dx.doi.org/10.1371/journal.pone.0251608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097690	gold, Green Published			2022-12-26	WOS:000664640700002
J	Rodriguez-Sabate, C; Rodriguez, M; Morales, I				Rodriguez-Sabate, Clara; Rodriguez, Manuel; Morales, Ingrid			Studying the functional connectivity of the primary motor cortex with the binarized cross recurrence plot: The influence of Parkinson's disease	PLOS ONE			English	Article							DEFAULT MODE NETWORK; BASAL GANGLIA; INDUCED DYSKINESIA; ANATOMY; BLOCKS; PERFORMANCE; MOVEMENTS; PRECUNEUS; MOTION	Two new recurrence plot methods (the binary recurrence plot and binary cross recurrence plot) were introduced here to study the long-term dynamic of the primary motor cortex and its interaction with the primary somatosensory cortex, the anterior motor thalamus of the basal ganglia motor loop and the precuneous nucleus of the default mode network. These recurrence plot methods: 1. identify short-term transient interactions; 2. identify long-lasting delayed interactions that are common in complex systems; 3. work with non-stationary blood oxygen level dependent (BOLD) data; 4. may study the relationship of centers with non-linear functional interactions; 5 may compare different experimental groups performing different tasks. These methods were applied to BOLD time-series obtained in 20 control subjects and 20 Parkinson ' s patients during the execution of motor activity and body posture tasks (task-block design). The binary recurrence plot showed the task-block BOLD response normally observed in the primary motor cortex with functional magnetic resonance imaging methods, but also shorter and longer BOLD-fluctuations than the task-block and which provided information about the long-term dynamic of this center. The binary cross recurrence plot showed short-lasting and long-lasting functional interactions between the primary motor cortex and the primary somatosensory cortex, anterior motor thalamus and precuneous nucleus, interactions which changed with the resting and motor tasks. Most of the interactions found in healthy controls were disrupted in Parkinson's patients, and may be at the basis of some of the motor disorders and side-effects of dopaminergic drugs commonly observed in these patients.	[Rodriguez-Sabate, Clara; Rodriguez, Manuel; Morales, Ingrid] Univ La Laguna, Dept Physiol, Lab Neurobiol & Expt Neurol, Fac Med, Tenerife, Canary Islands, Spain; [Rodriguez-Sabate, Clara; Rodriguez, Manuel; Morales, Ingrid] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Rodriguez-Sabate, Clara] Getafe Univ Hosp, Dept Psychiat, Madrid, Spain	Universidad de la Laguna; CIBERNED; Hospital Universitario de Getafe	Rodriguez, M (corresponding author), Univ La Laguna, Dept Physiol, Lab Neurobiol & Expt Neurol, Fac Med, Tenerife, Canary Islands, Spain.; Rodriguez, M (corresponding author), Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain.	mrdiaz@ull.es	Rodriguez Diaz, Manuel/L-1024-2014	Rodriguez Diaz, Manuel/0000-0001-7569-2898	Center foe Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED) [2014/6-4]	Center foe Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED)	MR, 2014/6-4, Center foe Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED).	Aceves-Fernandez MA, 2019, COMPUT MATH METHOD M, V2019, DOI 10.1155/2019/6408941; Arce-McShane FI, 2016, P NATL ACAD SCI USA, V113, P5083, DOI 10.1073/pnas.1600788113; Astafiev SV, 2004, NAT NEUROSCI, V7, P542, DOI 10.1038/nn1241; Bianciardi M, 2007, NEUROIMAGE, V37, P489, DOI 10.1016/j.neuroimage.2007.05.025; Blesa J, 2017, EXP NEUROL, V298, P148, DOI 10.1016/j.expneurol.2017.10.002; Bologna M, 2020, BRAIN, V143, P727, DOI 10.1093/brain/awz344; Bologna M, 2018, BRAIN, V141, P2432, DOI 10.1093/brain/awy155; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Buckner RL, 2019, NAT REV NEUROSCI, V20, P593, DOI 10.1038/s41583-019-0212-7; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chua K. C., 2008, Journal of Medical Engineering & Technology, V32, P263, DOI 10.1080/03091900600863794; Daneault JF, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-76; Desrochers P, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9040079; Eroglu D, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042919; Eusebi P, 2018, NPJ PARKINSON DIS, V4, DOI 10.1038/s41531-018-0069-x; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Ganapathy R, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016211; Gharabawi GM, 2005, SCHIZOPHR RES, V77, P119, DOI 10.1016/j.schres.2005.03.008; GILADI N, 1992, NEUROLOGY, V42, P333, DOI 10.1212/WNL.42.2.333; Gorges M, 2015, NEUROBIOL AGING, V36, P1727, DOI 10.1016/j.neurobiolaging.2014.12.026; Groth A, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.046220; Heunis T, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1086-7; Hirata Y, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.016203; Gonzalez-Gomez GH, 2018, CHAOS, V28, DOI 10.1063/1.5024685; Iwanski JS, 1998, CHAOS, V8, P861, DOI 10.1063/1.166372; Jo HJ, 2013, J APPL MATH, DOI 10.1155/2013/935154; KALUZNY P, 1993, BIOL CYBERN, V68, P527, DOI 10.1007/BF00200812; Karayannidou A, 2009, J PHYSIOL-LONDON, V587, P3795, DOI 10.1113/jphysiol.2009.170183; Khodabakhshi MB, 2020, BIOMED ENG-BIOMED TE, V65, P507, DOI 10.1515/bmt-2019-0121; Knoblich G, 2004, J EXP PSYCHOL HUMAN, V30, P657, DOI 10.1037/0096-1523.30.4.657; Lee S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8090164; Lehericy S, 2005, P NATL ACAD SCI USA, V102, P12566, DOI 10.1073/pnas.0502762102; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mohan Akansha, 2016, Yale Journal of Biology and Medicine, V89, P49; Nelson AB, 2014, ANNU REV NEUROSCI, V37, P117, DOI 10.1146/annurev-neuro-071013-013916; PARENT A, 1995, BRAIN RES REV, V20, P91, DOI 10.1016/0165-0173(94)00007-C; Petrof I, 2015, J NEUROPHYSIOL, V113, P2400, DOI 10.1152/jn.00949.2014; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Rodriguez M, 2004, NEUROIMAGE, V22, P1480, DOI 10.1016/j.neuroimage.2004.02.040; Rodriguez-Sabate C, 2019, BEHAV BRAIN RES, V372, DOI 10.1016/j.bbr.2019.112048; Rodriguez-Sabate C, 2019, PARKINSONISM RELAT D, V63, P100, DOI 10.1016/j.parkreldis.2019.02.031; Rodriguez-Sabate C, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101708; Rodriguez-Sabate C, 2017, BRAIN IMAGING BEHAV, V11, P417, DOI 10.1007/s11682-016-9512-y; Rodriguez-Sabate C, 2015, HUM BRAIN MAPP, V36, P1335, DOI 10.1002/hbm.22705; ROLAND PE, 1982, J NEUROPHYSIOL, V48, P467, DOI 10.1152/jn.1982.48.2.467; Sabate M, 2008, NEUROPSYCHOLOGY, V22, P462, DOI 10.1037/0894-4105.22.4.462; Schinkel S, 2007, COGN NEURODYNAMICS, V1, P317, DOI 10.1007/s11571-007-9023-z; Shirota Y, 2019, PARKINSONISM RELAT D, V66, P125, DOI 10.1016/j.parkreldis.2019.07.022; Song JH, 2015, EUR REV MED PHARMACO, V19, P2001; Starkstein S, 2015, J NEUROPSYCH CLIN N, V27, P121, DOI 10.1176/appi.neuropsych.13030053; Takakura IT, 2017, BRAZ J CARDIOVA SURG, V32, P245, DOI 10.21470/1678-9741-2016-0035; Ticini LF, 2019, COGN NEUROSCI-UK, V10, P20, DOI 10.1080/17588928.2018.1424128; van Eimeren T, 2009, ARCH NEUROL-CHICAGO, V66, P877, DOI 10.1001/archneurol.2009.97; Vasconcelos DB, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.056207; Vercruysse S, 2014, CEREB CORTEX, V24, P3154, DOI 10.1093/cercor/bht170; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Yokoi A, 2018, J NEUROSCI, V38, P1430, DOI 10.1523/JNEUROSCI.2798-17.2017; Ziv I, 1999, ACTA NEUROL SCAND, V99, P106, DOI 10.1111/j.1600-0404.1999.tb00666.x	58	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252565	10.1371/journal.pone.0252565	http://dx.doi.org/10.1371/journal.pone.0252565			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RH	34097691	gold, Green Published			2022-12-26	WOS:000664640700011
J	Thulani, UB; Mettananda, KCD; Warnakulasuriya, DTD; Peiris, TSG; Kasturiratne, KTAA; Ranawaka, UK; Chakrewarthy, S; Dassanayake, AS; Kurukulasooriya, SAF; Niriella, MA; de Silva, ST; Pathmeswaran, AP; Kato, N; de Silva, HJ; Wickremasinghe, AR				Thulani, U. B.; Mettananda, K. C. D.; Warnakulasuriya, D. T. D.; Peiris, T. S. G.; Kasturiratne, K. T. A. A.; Ranawaka, U. K.; Chakrewarthy, S.; Dassanayake, A. S.; Kurukulasooriya, S. A. F.; Niriella, M. A.; de Silva, S. T.; Pathmeswaran, A. P.; Kato, N.; de Silva, H. J.; Wickremasinghe, A. R.			Validation of the World Health Organization/International Society of Hypertension (WHO/ISH) cardiovascular risk predictions in Sri Lankans based on findings from a prospective cohort study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; METABOLIC SYNDROME; SEX-DIFFERENCES; ARTERY-DISEASE; FRAMINGHAM; PREVALENCE; ASIA; PREVENTION; MODELS; ADULTS	Introduction and objectives There are no cardiovascular (CV) risk prediction models for Sri Lankans. Different risk prediction models not validated for Sri Lankans are being used to predict CV risk of Sri Lankans. We validated the WHO/ISH (SEAR-B) risk prediction charts prospectively in a population-based cohort of Sri Lankans. Method We selected 40-64 year-old participants from the Ragama Medical Officer of Health (MOH) area in 2007 by stratified random sampling and followed them up for 10 years. Ten-year risk predictions of a fatal/non-fatal cardiovascular event (CVE) in 2007 were calculated using WHO/ISH (SEAR-B) charts with and without cholesterol. The CVEs that occurred from 2007-2017 were ascertained. Risk predictions in 2007 were validated against observed CVEs in 2017. Results Of 2517 participants, the mean age was 53.7 year (SD: 6.7) and 1132 (45%) were males. Using WHO/ISH chart with cholesterol, the percentages of subjects with a 10-year CV risk <10%, 10-19%, 20%-29%, 30-39%, >= 40% were 80.7%, 9.9%, 3.8%, 2.5% and 3.1%, respectively. 142 non-fatal and 73 fatal CVEs were observed during follow-up. Among the cohort, 9.4% were predicted of having a CV risk >= 20% and 8.6% CVEs were observed in the risk category. CVEs were within the predictions of WHO/ISH charts with and without cholesterol in both high (>= 20%) and low(<20%) risk males, but only in low(<20%) risk females. The predictions of WHO/ISH charts, with-and without-cholesterol were in agreement in 81% of subjects (? = 0.429; p<0.001). Conclusions WHO/ISH (SEAR B) risk prediction charts with-and without-cholesterol may be used in Sri Lanka. Risk charts are more predictive in males than in females and for lower-risk categories. The predictions when stratifying into 2 categories, low risk (<20%) and high risk (>= 20%), are more appropriate in clinical practice.	[Thulani, U. B.; Kasturiratne, K. T. A. A.; Pathmeswaran, A. P.; Wickremasinghe, A. R.] Univ Kelaniya, Dept Publ Hlth, Fac Med, Ragama, Sri Lanka; [Mettananda, K. C. D.; Dassanayake, A. S.; Kurukulasooriya, S. A. F.] Univ Kelaniya, Dept Pharmacol, Fac Med, Ragama, Sri Lanka; [Warnakulasuriya, D. T. D.] Univ Kelaniya, Dept Physiol, Fac Med, Ragama, Sri Lanka; [Peiris, T. S. G.] Univ Moratuwa, Dept Math, Fac Engn, Moratuwa, Sri Lanka; [Ranawaka, U. K.; Niriella, M. A.; de Silva, S. T.; de Silva, H. J.] Univ Kelaniya, Dept Med, Fac Med, Ragama, Sri Lanka; [Chakrewarthy, S.] Univ Kelaniya, Dept Biochem, Fac Med, Ragama, Sri Lanka; [Kato, N.] Natl Ctr Global Hlth & Med, Shinjuku Ku, Tokyo, Japan	University Kelaniya; University Kelaniya; University Kelaniya; University Moratuwa; University Kelaniya; University Kelaniya; National Center for Global Health & Medicine - Japan	Mettananda, KCD (corresponding author), Univ Kelaniya, Dept Pharmacol, Fac Med, Ragama, Sri Lanka.	Chamila@kln.ac.lk	Ranawaka, Udaya/O-1529-2018; Mettananda, Kukulege Chamila Dinushi/Y-3222-2019	Ranawaka, Udaya/0000-0002-4050-062X; Mettananda, Kukulege Chamila Dinushi/0000-0002-3328-1553	International Cooperation Research Grant [17-C-1]; National Centre for Global Health and Medicine, Japan	International Cooperation Research Grant; National Centre for Global Health and Medicine, Japan	This work was supported by the International Cooperation Research Grant (17-C-1), National Centre for Global Health and Medicine, Japan. The funder had no roles in study design, data collection, analysis, or decision to publish.	Appelman Y, 2015, ATHEROSCLEROSIS, V241, P211, DOI 10.1016/j.atherosclerosis.2015.01.027; Barzi F, 2007, J EPIDEMIOL COMMUN H, V61, P115, DOI 10.1136/jech.2005.044842; Bhopal R, 2005, J PUBLIC HEALTH-UK, V27, P93, DOI 10.1093/pubmed/fdh202; Cappuccio FP, 2002, BRIT MED J, V325, P1271, DOI 10.1136/bmj.325.7375.1271; Chia YC, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007324; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Chow CK, 2008, ATHEROSCLEROSIS, V196, P943, DOI 10.1016/j.atherosclerosis.2007.02.027; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Damen JAAG, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2416; Dassanayake AS, 2009, J GASTROEN HEPATOL, V24, P1284, DOI 10.1111/j.1440-1746.2009.05831.x; Dean J, 2015, NAT REV CARDIOL, V12, P406, DOI 10.1038/nrcardio.2015.72; Enas E A, 1996, Indian Heart J, V48, P343; Ezzati M, 2003, LANCET, V362, P271, DOI 10.1016/S0140-6736(03)13968-2; Garg N, 2017, INDIAN HEART J, V69, P458, DOI 10.1016/j.ihj.2017.01.015; Gopal DP, 2016, INT J PUBLIC HEALTH, V61, P525, DOI 10.1007/s00038-015-0733-4; Gupta M, 2006, CIRCULATION, V113, pE924, DOI 10.1161/CIRCULATIONAHA.105.583815; Hussain SM, 2013, INT J VASC MED, V2013, DOI 10.1155/2013/786801; Kanjilal S, 2008, VASC HEALTH RISK MAN, V4, P199, DOI 10.2147/vhrm.2008.04.01.199; Liau SY, 2010, HEART ASIA, V2, P15, DOI 10.1136/ha.2009.001115; Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634; MENDIS S, 1994, INT J CARDIOL, V46, P135, DOI 10.1016/0167-5273(94)90034-5; Mendis S, 2011, J CLIN EPIDEMIOL, V64, P1451, DOI 10.1016/j.jclinepi.2011.02.001; Nanditha A, 2016, DIABETES CARE, V39, P472, DOI 10.2337/dc15-1536; Narasimhan S, 2012, CARDIOL REV, V20, P304, DOI 10.1097/CRD.0b013e3182532286; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P37; Raghu A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133618; Ramachandran A, 2012, WORLD J DIABETES, V3, P110, DOI 10.4239/wjd.v3.i6.110; Ranasinghe P, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4041-1; Ranawaka UK, 2016, CEYLON MED J, V61, P11, DOI 10.4038/cmj.v61i1.8253; Regitz-Zagrosek V, 2017, PHYSIOL REV, V97, P1, DOI 10.1152/physrev.00021.2015; Rodriguez F, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.011874; SHAUKAT N, 1995, BRIT HEART J, V74, P318; Stadtman T., 1957, METHODS ENZYMOLOGY; Tan YY, 2010, MATURITAS, V65, P149, DOI 10.1016/j.maturitas.2009.09.023; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Ventura-Clapier R, 2017, CARDIOVASC RES, V113, P711, DOI 10.1093/cvr/cvx066; WHO, 2007, WHO INT SOC HYP RISK; WHO, CARD DIS POCK GUID; WHO/IDF, 2006, DEF DIAGN DIAB MEL I; Woodward M, 2006, INT J EPIDEMIOL, V35, P1412, DOI 10.1093/ije/dyl222; World Health Organization, 2007, PREV CARD DIS GUID A	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252267	10.1371/journal.pone.0252267	http://dx.doi.org/10.1371/journal.pone.0252267			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097699	gold, Green Published			2022-12-26	WOS:000664640700007
J	Bhatt, SP; Guleria, R; Kabra, SK				Bhatt, Surya Prakash; Guleria, Randeep; Kabra, S. K.			Metabolic alterations and systemic inflammation in overweight/obese children with obstructive sleep apnea	PLOS ONE			English	Article							C-REACTIVE PROTEIN; OBESE CHILDREN; BODY-FAT; GENE POLYMORPHISMS; ASIAN INDIANS; ADOLESCENTS; EPIDEMIOLOGY	Aim and objective Systemic inflammation has been documented in obstructive sleep apnea (OSA). However studies on childhood OSA and systemic inflammation are limited. This study aimed to determine the relation between OSA in overweight/obese children and various inflammatory markers. Material and methods In this cross sectional study, we enrolled 247 overweight/ obese children from pediatric outpatient services. We evaluated demographic and clinical details, anthropometric parameters, body composition and estimation of inflammatory cytokines such as interleukin (IL) 6, IL-8, IL-10, IL-17, IL-18, IL-23, macrophage migration inhibitory factor (MIF), high sensitive C-reactive protein (Hs-CRP), tumor necrosis factor-alpha (TNF-alpha), plasminogen activator inhibitor-1 (PAI-1) and leptin levels. Overnight polysomnography was performed. Findings A total of 247 children (190 with OSA and 57 without OSA) were enrolled. OSA was documented on polysomnography in 40% of patients. We observed significantly high values body mass index, waist circumference (WC), % body fat, fasting blood glucose (FBG), alanine transaminase (ALT), alkaline phosphate, fasting insulin and HOMA-IR in children with OSA. Inflammatory markers IL-6, IL-8, IL-17, IL-18, MIF, Hs CRP, TNF- alpha, PAI-1, and leptin levels were significantly higher in OSA patients (p<0.05). There was strong positive correlation of IL-6, IL-8, IL-17, IL-23, MIF, Hs CRP, TNF-A, PAI-1 and leptin with BMI, % body fat, AHI, fasting Insulin, triglyceride, FBG, WC, HOMA-IR, AST and ALT. Conclusion Children with OSA have increased obesity, insulin resistance and systemic inflammation. Further studies are require to confirm our findings and evaluate their utility in diagnosis of OSAs, assessing severity and possible interventions.	[Bhatt, Surya Prakash; Guleria, Randeep] All India Inst Med Sci, Dept Pulm Crit Care & Sleep Med, New Delhi, India; [Kabra, S. K.] All India Inst Med Sci, Dept Pediat, Pediat Pulmonol Div, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Bhatt, SP (corresponding author), All India Inst Med Sci, Dept Pulm Crit Care & Sleep Med, New Delhi, India.	suryabhat@gmail.com	Bhatt, Surya/K-5263-2019; Bhatt, Surya Prakash/X-5941-2018	Bhatt, Surya/0000-0001-9489-9747; Bhatt, Surya Prakash/0000-0001-9489-9747	Department of Biotechnology, Ministry of Science and Technology, Government of India	Department of Biotechnology, Ministry of Science and Technology, Government of India(Department of Biotechnology (DBT) IndiaMinistry of Science and Technology, Government of India)	This study was fully supported by a grant from the Department of Biotechnology, Ministry of Science and Technology, Government of India. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200; Arens R, 2011, AM J RESP CRIT CARE, V183, P782, DOI 10.1164/rccm.201008-1249OC; BaHammam AS, 2014, SLEEP BREATH, V18, P767, DOI 10.1007/s11325-014-0939-3; Bhatt SP, 2013, ATHEROSCLEROSIS, V230, P157, DOI 10.1016/j.atherosclerosis.2013.07.006; Bhattacharjee R, 2012, CHEST, V141, P682, DOI 10.1378/chest.11-1777; Bhushan B, 2009, RESP MED, V103, P386, DOI 10.1016/j.rmed.2008.10.001; Edwards KM, 2011, SLEEP, V34, P161, DOI 10.1093/sleep/34.2.161; Gileles-Hillel A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/605280; Goldbart AD, 2006, CHEST, V130, P143, DOI 10.1378/chest.130.1.143; Gozal D, 2008, SLEEP MED, V9, P254, DOI 10.1016/j.sleep.2007.04.013; Huang YS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004944; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Kaditis AG, 2005, AM J RESP CRIT CARE, V171, P282, DOI 10.1164/rccm.200407-928OC; Kalra M, 2005, OBES RES, V13, P1175, DOI 10.1038/oby.2005.139; Khalyfa A, 2012, PEDIATR PULM, V47, P1001, DOI 10.1002/ppul.22560; Khalyfa A, 2011, J PEDIATR-US, V158, P81, DOI 10.1016/j.jpeds.2010.07.032; Kheirandish-Gozal L, 2015, INT J OBESITY, V39, P1094, DOI 10.1038/ijo.2015.37; Kheirandish-Gozal L, 2013, RESP PHYSIOL NEUROBI, V189, P338, DOI 10.1016/j.resp.2013.03.016; LEON C, 2015, MEDIAT INFLAMM, V2015, P93409, DOI DOI 10.1155/2015/493409; Li AM, 2006, PEDIATR PULM, V41, P1175, DOI 10.1002/ppul.20508; Li AM, 2010, THORAX, V65, P991, DOI 10.1136/thx.2010.134858; Ludwig DS, 2007, NEW ENGL J MED, V357, P2325, DOI 10.1056/NEJMp0706538; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Mathew JL, 2014, PAEDIATR RESPIR REV, V15, P211, DOI 10.1016/j.prrv.2013.09.001; Redline S, 2007, AM J RESP CRIT CARE, V176, P401, DOI 10.1164/rccm.200703-375OC; Sogut A, 2016, TUBERK TORAK, V64, P283, DOI 10.5578/tt.21009; Sung RYT, 2001, ARCH DIS CHILD, V85, P263, DOI 10.1136/adc.85.3.263; Tauman R, 2007, SLEEP, V30, P443, DOI 10.1093/sleep/30.4.443; Verhulst SL, 2007, ARCH DIS CHILD, V92, P205, DOI 10.1136/adc.2006.101089; Verhulst SL, 2009, OBESITY, V17, P1178, DOI 10.1038/oby.2008.673; Vikram NK, 2003, ATHEROSCLEROSIS, V168, P305, DOI 10.1016/S0021-9150(03)00096-0	31	11	11	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252353	10.1371/journal.pone.0252353	http://dx.doi.org/10.1371/journal.pone.0252353			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086720	Green Published, gold			2022-12-26	WOS:000664640100053
J	den Hartog, I; Zwep, LB; Vestjens, SMT; Harms, AC; Voorn, GP; de Lange, DW; Bos, WJW; Hankemeier, T; van de Garde, EMW; van Hasselt, JGC				den Hartog, Ilona; Zwep, Laura B.; Vestjens, Stefan M. T.; Harms, Amy C.; Voorn, G. Paul; de Lange, Dylan W.; Bos, Willem J. W.; Hankemeier, Thomas; van de Garde, Ewoudt M. W.; van Hasselt, J. G. Coen			Metabolomic profiling of microbial disease etiology in community-acquired pneumonia	PLOS ONE			English	Article							PLASMA; TUBERCULOSIS; DIAGNOSIS	Diagnosis of microbial disease etiology in community-acquired pneumonia (CAP) remains challenging. We undertook a large-scale metabolomics study of serum samples in hospitalized CAP patients to determine if host-response associated metabolites can enable diagnosis of microbial etiology, with a specific focus on discrimination between the major CAP pathogen groups S. pneumoniae, atypical bacteria, and respiratory viruses. Targeted metabolomic profiling of serum samples was performed for three groups of hospitalized CAP patients with confirmed microbial etiologies: S. pneumoniae (n = 48), atypical bacteria (n = 47), or viral infections (n = 30). A wide range of 347 metabolites was targeted, including amines, acylcarnitines, organic acids, and lipids. Single discriminating metabolites were selected using Student's T-test and their predictive performance was analyzed using logistic regression. Elastic net regression models were employed to discover metabolite signatures with predictive value for discrimination between pathogen groups. Metabolites to discriminate S. pneumoniae or viral pathogens from the other groups showed poor predictive capability, whereas discrimination of atypical pathogens from the other groups was found to be possible. Classification of atypical pathogens using elastic net regression models was associated with a predictive performance of 61% sensitivity, 86% specificity, and an AUC of 0.81. Targeted profiling of the host metabolic response revealed metabolites that can support diagnosis of microbial etiology in CAP patients with atypical bacterial pathogens compared to patients with S. pneumoniae or viral infections.	[den Hartog, Ilona; Zwep, Laura B.; Harms, Amy C.; Hankemeier, Thomas; van Hasselt, J. G. Coen] Leiden Univ, Leiden Acad Ctr Drug Res, Div Syst Biomed & Pharmacol, Leiden, Netherlands; [Zwep, Laura B.] Leiden Univ, Math Inst, Leiden, Netherlands; [Zwep, Laura B.] Leiden Univ, Leiden Ctr Data Sci, Leiden, Netherlands; [Vestjens, Stefan M. T.; Voorn, G. Paul] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands; [de Lange, Dylan W.] Univ Utrecht, Univ Med Ctr Utrecht, Intens Care, Utrecht, Netherlands; [de Lange, Dylan W.] Univ Utrecht, Univ Med Ctr Utrecht, Natl Poison Informat Ctr, Utrecht, Netherlands; [Bos, Willem J. W.] St Antonius Hosp, Dept Internal Med, Nieuwegein, Netherlands; [Bos, Willem J. W.] Leiden Univ, Dept Internal Med, Med Ctr, Leiden, Netherlands; [van de Garde, Ewoudt M. W.] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [van de Garde, Ewoudt M. W.] St Antonius Hosp, Dept Clin Pharm, Nieuwegein, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; St. Antonius Hospital Utrecht; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; St. Antonius Hospital Utrecht	van Hasselt, JGC (corresponding author), Leiden Univ, Leiden Acad Ctr Drug Res, Div Syst Biomed & Pharmacol, Leiden, Netherlands.	coen.vanhasselt@lacdr.leidenuniv.nl	De Lange, Dylan W/ABB-8172-2020	De Lange, Dylan W/0000-0002-0191-7270; Zwep, Laura/0000-0002-6817-2859; Hankemeier, Thomas/0000-0001-7871-2073	ZonMW, the Netherlands Organization for Health Research and Development [541001007]; Dutch Research Council (NWO)	ZonMW, the Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and DevelopmentNetherlands Government); Dutch Research Council (NWO)(Netherlands Organization for Scientific Research (NWO))	This work is part of the research program 'Metabolomic fingerprint biomarkers to guide antibiotic therapy and reduce resistance' with project number 541001007, which is financed by ZonMW, the Netherlands Organization for Health Research and Development associated with the Dutch Research Council (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamko DJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1709-6; Antcliffe D, 2017, EBIOMEDICINE, V18, P244, DOI 10.1016/j.ebiom.2017.03.034; Banoei MM, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1672-7; Bjarnason A, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy010; Emwas AH, 2019, METABOLITES, V9, DOI 10.3390/metabo9070123; Endeman H, 2008, SCAND J INFECT DIS, V40, P715, DOI 10.1080/00365540802014864; Gutierrez F, 2003, CLIN INFECT DIS, V36, P286, DOI 10.1086/345852; Khovidhunkit W, 2004, J LIPID RES, V45, P1169, DOI 10.1194/jlr.R300019-JLR200; Kothe H, 2008, EUR RESPIR J, V32, P139, DOI 10.1183/09031936.00092507; Laiakis EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012655; Lau SKP, 2015, J CLIN MICROBIOL, V53, P3750, DOI 10.1128/JCM.01568-15; Meijvis SCA, 2011, LANCET, V377, P2023, DOI 10.1016/S0140-6736(11)60607-7; Ning P, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2049-2; Pearce EL, 2013, IMMUNITY, V38, P633, DOI 10.1016/j.immuni.2013.04.005; Postma DF, 2015, NEW ENGL J MED, V372, P1312, DOI 10.1056/NEJMoa1406330; Saleh MAA., 2018, CLIN CHEM LAB MED; Slupsky CM, 2009, J PROTEOME RES, V8, P5550, DOI 10.1021/pr9006427; Sorde R, 2011, ARCH INTERN MED, V171, P166, DOI 10.1001/archinternmed.2010.347; Statnikov A, 2005, INT J MED INFORM, V74, P491, DOI 10.1016/j.ijmedinf.2005.05.002; van Elden LJR, 2001, J CLIN MICROBIOL, V39, P196, DOI 10.1128/JCM.39.1.196-200.2001; Varma S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-91; Wiersinga WJ, 2018, NETH J MED, V76, P4; World Health Organization, 2014, WHO REPORT; Wunderink RG, 2014, NEW ENGL J MED, V370, P543, DOI 10.1056/NEJMcp1214869; Yzerman EPF, 2002, J CLIN MICROBIOL, V40, P3232, DOI 10.1128/JCM.40.9.3232-3236.2002; Zhou AP, 2015, TUBERCULOSIS, V95, P294, DOI 10.1016/j.tube.2015.02.038; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	27	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252378	10.1371/journal.pone.0252378	http://dx.doi.org/10.1371/journal.pone.0252378			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086721	Green Published, gold			2022-12-26	WOS:000664640100055
J	Grenzebach, J; Wegner, TGG; Einhauser, W; Bendixen, A				Grenzebach, Jan; Wegner, Thomas G. G.; Einhaeuser, Wolfgang; Bendixen, Alexandra			Pupillometry in auditory multistability	PLOS ONE			English	Article							BINOCULAR-RIVALRY; PUPIL-DILATION; LOCUS-COERULEUS; PERCEPTION; ATTENTION; STABILITY; AROUSAL; STATE; SIZE; PRINCIPLES	In multistability, a constant stimulus induces alternating perceptual interpretations. For many forms of visual multistability, the transition from one interpretation to another ("perceptual switch") is accompanied by a dilation of the pupil. Here we ask whether the same holds for auditory multistability, specifically auditory streaming. Two tones were played in alternation, yielding four distinct interpretations: the tones can be perceived as one integrated percept (single sound source), or as segregated with either tone or both tones in the foreground. We found that the pupil dilates significantly around the time a perceptual switch is reported ("multistable condition"). When participants instead responded to actual stimulus changes that closely mimicked the multistable perceptual experience ("replay condition"), the pupil dilated more around such responses than in multistability. This still held when data were corrected for the pupil response to the stimulus change as such. Hence, active responses to an exogeneous stimulus change trigger a stronger or temporally more confined pupil dilation than responses to an endogenous perceptual switch. In another condition, participants randomly pressed the buttons used for reporting multistability. In Study 1, this "random condition" failed to sufficiently mimic the temporal pattern of multistability. By adapting the instructions, in Study 2 we obtained a response pattern more similar to the multistable condition. In this case, the pupil dilated significantly around the random button presses. Albeit numerically smaller, this pupil response was not significantly different from the multistable condition. While there are several possible explanations-related, e.g., to the decision to respond-this underlines the difficulty to isolate a purely perceptual effect in multistability. Our data extend previous findings from visual to auditory multistability. They highlight methodological challenges in interpreting such data and suggest possible approaches to meet them, including a novel stimulus to simulate the experience of perceptual switches in auditory streaming.	[Grenzebach, Jan; Wegner, Thomas G. G.; Bendixen, Alexandra] Tech Univ Chemnitz, Inst Phys, Cognit Syst Lab, Chemnitz, Germany; [Grenzebach, Jan; Wegner, Thomas G. G.; Einhaeuser, Wolfgang] Tech Univ Chemnitz, Inst Phys, Phys Cognit Grp, Chemnitz, Germany	Technische Universitat Chemnitz; Technische Universitat Chemnitz	Bendixen, A (corresponding author), Tech Univ Chemnitz, Inst Phys, Cognit Syst Lab, Chemnitz, Germany.	alexandra.bendixen@physik.tu-chemnitz.de		Wegner, Thomas/0000-0002-4889-6155; Bendixen, Alexandra/0000-0001-8211-9619; Einhauser, Wolfgang/0000-0001-7516-9589; Grenzebach, Jan/0000-0003-1438-4597	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [BE4284/4-1, EI852/8-1, 325414673]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, individual grants BE4284/4-1 [to AB] and EI852/8-1 [to WE], project no. 325414673). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATTNEAVE F, 1971, SCI AM, V225, P62, DOI 10.1038/scientificamerican1271-62; Barniv D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144788; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BLAKE R, 1989, PSYCHOL REV, V96, P145, DOI 10.1037/0033-295X.96.1.145; BLAKE R, 1992, VISUAL NEUROSCI, V8, P469, DOI 10.1017/S0952523800004971; BRADSHAW J, 1967, NATURE, V216, P515, DOI 10.1038/216515a0; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brascamp J.W, 2021, ELIFE, V10; Brascamp J, 2018, ANNU REV PSYCHOL, V69, P77, DOI 10.1146/annurev-psych-010417-085944; Brascamp JW, 2006, J VISION, V6, P1244, DOI 10.1167/6.11.8; Brascamp JW, 2018, J VISION, V18, DOI 10.1167/18.7.3; Bregman A.S., 1994, AUDITORY SCENE ANAL; Carter OL, 2007, PSYCHOPHARMACOLOGY, V195, P415, DOI 10.1007/s00213-007-0930-9; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Denham S, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00025; Denham S, 2012, J NEUROSCI METH, V210, P79, DOI 10.1016/j.jneumeth.2012.04.004; Einhauser W, 2008, P NATL ACAD SCI USA, V105, P1704, DOI 10.1073/pnas.0707727105; Einhauser W, 2017, COGN SCI TECHNOL, P141, DOI 10.1007/978-981-10-0213-7_7; Einhauser W, 2017, J VISION, V17, DOI 10.1167/17.1.34; Einhauser Wolfgang, 2010, Front Hum Neurosci, V4, P18, DOI 10.3389/fnhum.2010.00018; Fahle MW, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00120; Farkas D, 2016, J ACOUST SOC AM, V139, P1762, DOI 10.1121/1.4945720; Fechner GT, 1861, ABHANDLUNGEN MATH PH, V5, P340; Frasle S, 2014, J NEUROSCI, V34, P1738, DOI 10.1523/JNEUROSCI.4403-13.2014; FRIEDMAN D, 1973, ELECTROEN CLIN NEURO, V34, P475, DOI 10.1016/0013-4694(73)90065-5; Gigante G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000430; Gilzenrat MS, 2010, COGN AFFECT BEHAV NE, V10, P252, DOI 10.3758/CABN.10.2.252; HESS EH, 1964, SCIENCE, V143, P1190, DOI 10.1126/science.143.3611.1190; Higgins NC, 2020, NEUROIMAGE, V204, DOI 10.1016/j.neuroimage.2019.116220; Hupe JM, 2009, J VISION, V9, DOI 10.1167/9.7.10; Joshi S, 2016, NEURON, V89, P221, DOI 10.1016/j.neuron.2015.11.028; Kaernbach C, 1999, NEUROREPORT, V10, P713, DOI 10.1097/00001756-199903170-00010; Kashino M, 2012, PHILOS T R SOC B, V367, P977, DOI 10.1098/rstb.2011.0370; Kiesel A, 2008, PSYCHOPHYSIOLOGY, V45, P250, DOI 10.1111/j.1469-8986.2007.00618.x; Kleinschmidt A, 1998, P ROY SOC B-BIOL SCI, V265, P2427, DOI 10.1098/rspb.1998.0594; Kleinschmidt A, 2012, PHILOS T R SOC B, V367, P988, DOI 10.1098/rstb.2011.0367; Knapen T, 2011, J NEUROSCI, V31, P10293, DOI 10.1523/JNEUROSCI.1727-11.2011; Kornmeier J, 2004, PSYCHOPHYSIOLOGY, V41, P1, DOI 10.1046/j.1469-8986.2003.00126.x; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Leopold DA, 1999, TRENDS COGN SCI, V3, P254, DOI 10.1016/S1364-6613(99)01332-7; Lumer ED, 1998, SCIENCE, V280, P1930, DOI 10.1126/science.280.5371.1930; Mathot Sebastiaan, 2018, J Cogn, V1, P16, DOI 10.5334/joc.18; McCloy DR, 2017, J ACOUST SOC AM, V141, P2440, DOI 10.1121/1.4979340; Mill RW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002925; Naber M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020910; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; Preuschoff K, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00115; Rankin J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004555; Rubin N, 2003, TRENDS NEUROSCI, V26, P289, DOI 10.1016/S0166-2236(03)00128-0; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Schwartz JL, 2012, PHILOS T R SOC B, V367, P896, DOI 10.1098/rstb.2011.0254; SIMPSON HM, 1969, PERCEPT MOTOR SKILL, V29, P495, DOI 10.2466/pms.1969.29.2.495; SIMPSON HM, 1968, PERCEPT PSYCHOPHYS, V3, P185, DOI 10.3758/BF03212726; SIMPSON HM, 1969, PSYCHOPHYSIOLOGY, V6, P115, DOI 10.1111/j.1469-8986.1969.tb02890.x; Snyder JS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00015; Struber D, 2002, COGNITIVE BRAIN RES, V14, P370, DOI 10.1016/S0926-6410(02)00139-8; Thaler L, 2013, VISION RES, V76, P31, DOI 10.1016/j.visres.2012.10.012; Tong F, 1998, NEURON, V21, P753, DOI 10.1016/S0896-6273(00)80592-9; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1111/1469-8986.3850816; van Dam LCJ, 2005, VISION RES, V45, P2417, DOI 10.1016/j.visres.2005.03.013; van Noorden LPAS, 1975, TEMPORAL COHERENCE P, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]; Wetzel N, 2016, DEV PSYCHOBIOL, V58, P382, DOI 10.1002/dev.21377; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wilson HR, 2003, P NATL ACAD SCI USA, V100, P14499, DOI 10.1073/pnas.2333622100; Zekveld AA, 2018, TRENDS HEAR, V22, DOI 10.1177/2331216518777174; Zhao SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12048-1	66	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252370	10.1371/journal.pone.0252370	http://dx.doi.org/10.1371/journal.pone.0252370			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086770	gold, Green Published			2022-12-26	WOS:000664640100054
J	Klasson, M; Lindberg, M; Sarndahl, E; Westberg, H; Bryngelsson, IL; Tuerxun, K; Persson, A				Klasson, Maria; Lindberg, Magnus; Sarndahl, Eva; Westberg, Hakan; Bryngelsson, Ing-Liss; Tuerxun, Kedeye; Persson, Alexander			Dose- and time-dependent changes in viability and IL-6, CXCL8 and CCL2 production by HaCaT-cells exposed to cobalt. Effects of high and low calcium growth conditions	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT; SKIN INFLAMMATION; NICKEL; INTERLEUKIN-6; DIFFERENTIATION; KERATINOCYTES; MCP-1; SENSITIZATION; ACCUMULATION; RECRUITMENT	Background Sensitization requires exposure to an allergen with subsequent production of a "danger "signal. In the skin, keratinocytes are the main producers of these signals. Objective To compare dose- and time-effects of cobalt on the viability of and cytokine release from HaCaT cells cultured at low or high calcium. Method To model two separate states of differentiation of keratinocytes, HaCaT cells were cultured under low or high calcium conditions. HaCaT were exposed to different concentrations of cobalt chloride (10 mu m to 5 mM) over time (30 minutes- 48 hours). Cell viability was measured with the Cell-Titer Blue Viability assay. Cytokine production was measured using a bead-based immunoassay and flow cytometry. Gene expression was quantified using qPCR. Data was analyzed by ANOVA and linear mixed model. Results Viability of the cells was dose- and time-dependent. A linear mixed statistical model showed that cobalt exposure induces increase in IL-6, CXCL8 and CCL2 production over time and whereas increase of IL-6 and a decrease of CCL2 was associated with increasing cobalt chloride concentrations. When comparing the cells incubated under high and low calcium conditions, the more differentiated cells in the high concentration were found to exert a stronger response in terms of IL-6 release. Conclusions Our data suggest that cobalt chloride triggered an alarm system in HaCaT cells, and proinflammatory cytokines/chemokines were secreted in a dose- and time-dependent manner. When high and low calcium incubations were compared, the difference was seen only for IL-6. These findings indicate that the effect of cobalt chloride on cell toxicity occurs throughout the living epidermis.	[Klasson, Maria; Lindberg, Magnus; Sarndahl, Eva; Westberg, Hakan; Tuerxun, Kedeye; Persson, Alexander] Orebro Univ, Sch Med & Hlth, Dept Med Sci, Orebro, Sweden; [Klasson, Maria; Lindberg, Magnus; Sarndahl, Eva; Westberg, Hakan; Tuerxun, Kedeye; Persson, Alexander] Orebro Univ, Inflammatory Response & Infect Susceptibil Ctr iR, Orebro, Sweden; [Klasson, Maria; Westberg, Hakan; Bryngelsson, Ing-Liss] Univ Hosp Orebro, Dept Occupat & Environm Med, Orebro, Sweden; [Lindberg, Magnus] Univ Hosp Orebro, Dept Dermatol, Orebro, Sweden	Orebro University; Orebro University; Orebro University; Orebro University	Klasson, M (corresponding author), Orebro Univ, Sch Med & Hlth, Dept Med Sci, Orebro, Sweden.; Klasson, M (corresponding author), Orebro Univ, Inflammatory Response & Infect Susceptibil Ctr iR, Orebro, Sweden.; Klasson, M (corresponding author), Univ Hosp Orebro, Dept Occupat & Environm Med, Orebro, Sweden.	maria.klasson@regionorebrolan.se			Knowledge Foundation [20160044]; RegionOrebro County [OLL-888151]; Grant Hudfonden [2499/2016:1]	Knowledge Foundation; RegionOrebro County; Grant Hudfonden	This project was funded by the Synergy15-grant from the Knowledge Foundation (ES), grant number 20160044, URL: www.kks.se, Grant Hudfonden (ML), grant number 2499/2016:1, URL: www.hudfonden.se, and the ALF funding RegionOrebro County (MK), grant number OLL-888151, URL: www.regionorebrolan.se.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonifas J, 2010, TOXICOL IN VITRO, V24, P973, DOI 10.1016/j.tiv.2009.12.023; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Bresson C, 2006, BIOCHIMIE, V88, P1619, DOI 10.1016/j.biochi.2006.09.003; CAMARASA JM, 1967, ACTA DERM-VENEREOL, V47, P287; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; CASTELLSRODELLAS A, 1992, ACTA DERM-VENEREOL, V72, P165; Cho KA, 2012, INT IMMUNOL, V24, P147, DOI 10.1093/intimm/dxr110; Deyrieux AF, 2007, CYTOTECHNOLOGY, V54, P77, DOI 10.1007/s10616-007-9076-1; Ermolli M, 2001, TOXICOLOGY, V159, P23, DOI 10.1016/S0300-483X(00)00373-5; Fall S, 2015, CONTACT DERMATITIS, V72, P297, DOI 10.1111/cod.12346; Filon FL, 2004, INT ARCH OCC ENV HEA, V77, P85, DOI 10.1007/s00420-003-0455-4; Filon FL, 2009, TOXICOL IN VITRO, V23, P574, DOI 10.1016/j.tiv.2009.01.015; Gallucci RM, 2001, J INTERF CYTOK RES, V21, P603, DOI 10.1089/10799900152547867; Gault N, 2010, TOXICOL IN VITRO, V24, P92, DOI 10.1016/j.tiv.2009.08.027; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; HAMMOND MEW, 1995, J IMMUNOL, V155, P1428; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hernandez-Quintero M, 2006, CELL TISSUE RES, V325, P77, DOI 10.1007/s00441-006-0173-9; Hohensinner PJ, 2006, FEBS LETT, V580, P3532, DOI 10.1016/j.febslet.2006.05.043; Julander A, 2010, ANN OCCUP HYG, V54, P340, DOI 10.1093/annhyg/meq002; Kaur S, 2014, DERMAT RES PRACT, V2014, DOI 10.1155/2014/415638; Kaur S, 2012, DERMATOLOGY, V225, P54, DOI 10.1159/000339866; KEMENY L, 1994, INT ARCH ALLERGY IMM, V104, P317, DOI 10.1159/000236686; Klasson M, 2017, CONTACT DERMATITIS, V77, P201, DOI 10.1111/cod.12790; Lee EG, 2013, J IMMUNOTOXICOL, V10, P192, DOI 10.3109/1547691X.2012.707700; Lehmann B, 1997, J INVEST DERMATOL, V108, P78, DOI 10.1111/1523-1747.ep12285640; Mai WH, 2018, TOXICOL IND HEALTH, V34, P36, DOI 10.1177/0748233717738633; Micallef L, 2009, EXP DERMATOL, V18, P143, DOI 10.1111/j.1600-0625.2008.00775.x; Midander K, 2016, REGUL TOXICOL PHARM, V81, P381, DOI 10.1016/j.yrtph.2016.09.021; MILLER EJ, 1992, AM REV RESPIR DIS, V146, P427, DOI 10.1164/ajrccm/146.2.427; Morrison BE, 2003, J CLIN INVEST, V112, P1862, DOI 10.1172/JCI200318125; Navarini AA, 2011, J ALLERGY CLIN IMMUN, V128, P1128, DOI 10.1016/j.jaci.2011.09.009; Negus RPM, 1998, J LEUKOCYTE BIOL, V63, P758, DOI 10.1002/jlb.63.6.758; Ortega R, 2009, TOXICOL LETT, V188, P26, DOI 10.1016/j.toxlet.2009.02.024; Pastore S, 2011, J DERMATOL SCI, V63, P104, DOI 10.1016/j.jdermsci.2011.04.011; Rui F, 2010, CONTACT DERMATITIS, V62, P225, DOI 10.1111/j.1600-0536.2009.01650.x; RYSTEDT I, 1983, CONTACT DERMATITIS, V9, P195, DOI 10.1111/j.1600-0536.1983.tb04357.x; SCHULZ BS, 1993, J IMMUNOL, V151, P4399; Sun ZW, 2015, INT IMMUNOPHARMACOL, V29, P642, DOI 10.1016/j.intimp.2015.09.016; TURKSEN K, 1992, P NATL ACAD SCI USA, V89, P5068, DOI 10.1073/pnas.89.11.5068; Wenzel U, 1997, KIDNEY INT, V51, P770, DOI 10.1038/ki.1997.108; Williams IR, 1996, LIFE SCI, V58, P1485, DOI 10.1016/0024-3205(96)00042-2; Wilson VG, 2014, METHODS MOL BIOL, V1195, P33, DOI 10.1007/7651_2013_42; Yang CT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021971; Yang CT, 2011, MOL CELLS, V31, P531, DOI 10.1007/s10059-011-1025-3; Yazdi AS, 2007, J INVEST DERMATOL, V127, P1853, DOI 10.1038/sj.jid.5700815	46	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252159	10.1371/journal.pone.0252159	http://dx.doi.org/10.1371/journal.pone.0252159			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086734	Green Published, gold			2022-12-26	WOS:000664640100035
J	Richter, M; Mazeres, F; Brinkmann, K				Richter, Michael; Mazeres, Florence; Brinkmann, Kerstin			Clarity of task difficulty moderates the impact of the explicit achievement motive on physical effort in hand grip tasks	PLOS ONE			English	Article							CARDIOVASCULAR REACTIVITY; EGO-INVOLVEMENT; MOTIVATION; PERFORMANCE; IMPLICIT; FORCE; INTENSITY; GENDER; TESTS; SCALE	Stable personality dispositions, like motives, are often assumed to exert a direct, stable impact on behavior. This also applies to the explicit achievement motive, which is supposed to influence the behavior that individuals select and how strongly they engage in it. Drawing on motivational intensity theory, we demonstrated in two studies that explicit achievement motive strength only predicted exerted force in a hand grip task if task difficulty was unclear. If task difficulty was clear, explicit achievement motive strength did not influence exerted force. Our findings suggest that the availability of information about the difficulty of motive satisfaction moderates the impact of the explicit achievement motive on behavior.	[Richter, Michael] Liverpool John Moores Univ, Sch Psychol, Effort Lab, Liverpool, Merseyside, England; [Mazeres, Florence; Brinkmann, Kerstin] Univ Geneva, Geneva Motivat Lab, Geneva, Switzerland	Liverpool John Moores University; University of Liverpool; University of Geneva	Richter, M (corresponding author), Liverpool John Moores Univ, Sch Psychol, Effort Lab, Liverpool, Merseyside, England.	m.richter@ljmu.ac.uk		Brinkmann, Kerstin/0000-0002-2075-9677	Swiss National Science Foundation [100019_162389]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation (http://www.snf.ch) grant 100019_162389 awarded to Kerstin Brinkmann (KB) and Michael Richter (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1987, ADV EXP SOC PSYCHOL, V20, P1, DOI 10.1016/S0065-2601(08)60411-6; Andraszewicz S, 2015, J MANAGE, V41, P521, DOI 10.1177/0149206314560412; ATKINSON JW, 1956, J ABNORM SOC PSYCH, V53, P361, DOI 10.1037/h0043477; Barreto P, 2015, BIOL PSYCHOL, V109, P166, DOI 10.1016/j.biopsycho.2015.05.006; BIERNAT M, 1989, J PERS, V57, P69, DOI 10.1111/j.1467-6494.1989.tb00761.x; Brandstatter, 2020, INVESTIGATING UNIFIE, P1, DOI DOI 10.1027/1015-5759/A000571; Bray SR, 2012, BIOL PSYCHOL, V89, P195, DOI 10.1016/j.biopsycho.2011.10.008; BREHM JW, 1989, ANNU REV PSYCHOL, V40, P109, DOI 10.1146/annurev.ps.40.020189.000545; Brinkmann K, 2017, INT J PSYCHOPHYSIOL, V119, P119, DOI 10.1016/j.ijpsycho.2017.01.010; Brinkmann K, 2012, MOTIV EMOTION, V36, P232, DOI 10.1007/s11031-011-9236-7; Brunstein, 2010, IMPLICIT MOTIVES, P151; Brunstein JC, 2002, Z PADAGOG PSYCHOL, V16, P51, DOI 10.1024//1010-0652.16.1.51; Cantor N., 1989, PERSONALITY PSYCHOL, P32; Capa RL, 2008, PSYCHOPHYSIOLOGY, V45, P859, DOI 10.1111/j.1469-8986.2008.00675.x; Capa RL, 2008, INT J PSYCHOPHYSIOL, V70, P144, DOI 10.1016/j.ijpsycho.2008.06.007; Chatelain M, 2016, BIOL PSYCHOL, V115, P94, DOI 10.1016/j.biopsycho.2016.01.014; Diedenhofen B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121945; Eksioglu M, 2006, ERGONOMICS, V49, P180, DOI 10.1080/00140130500465527; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FILION RDL, 1970, Q J EXP PSYCHOL, V22, P398, DOI 10.1080/14640747008401913; Gendolla G. H. E., 2019, OXFORD HDB HUMAN MOT, P373, DOI DOI 10.1093/OXFORDHB/9780190666453.013.21; Gendolla GHE, 2005, PSYCHOPHYSIOLOGY, V42, P595, DOI 10.1111/j.1469-8986.2005.00314.x; Gendolla GHE, 2006, PERS SOC PSYCHOL B, V32, P1188, DOI 10.1177/0146167206288945; Gropel P, 2016, PSYCHOL SPORT EXERC, V27, P93, DOI 10.1016/j.psychsport.2016.08.007; Heckhausen H., 2018, MOTIVATION ACTION, P369; Hittner JB, 2003, J GEN PSYCHOL, V130, P149, DOI 10.1080/00221300309601282; Jackson D.N., 1984, PERSONALITY RES FORM, V3rd ed.; Knoop E, 2017, IEEE INT C INT ROBOT, P4982; Lang JWB, 2006, EUR J PSYCHOL ASSESS, V22, P216, DOI 10.1027/1015-5759.22.3.216; Locke EA, 2002, AM PSYCHOL, V57, P705, DOI 10.1037//0003-066X.57.9.705; Lowell, 1953, ACHIEVEMENT MOTIVE A, DOI DOI 10.1037/H0054241; Masson MEJ, 2011, BEHAV RES METHODS, V43, P679, DOI 10.3758/s13428-010-0049-5; Mazeres F, 2019, J RES PERS, V82, DOI 10.1016/j.jrp.2019.06.012; McClelland D.C., 1987, HUMAN MOTIVATION; MCCLELLAND DC, 1989, PSYCHOL REV, V96, P690, DOI 10.1037/0033-295X.96.4.690; McGorry RW, 2010, J OCCUP ENVIRON HYG, V7, P298, DOI 10.1080/15459621003711360; Mohiyeddini C., 2014, PSYCHOL EMOTIONS MOT, P153; Morse JL, 2006, APPL ERGON, V37, P737, DOI 10.1016/j.apergo.2005.11.008; Muller F, 2020, MOTIV SCI, V6, P93, DOI 10.1037/mot0000141; Mulder, 2020, BICPACK WHAT PACKAGE; Mulder J, 2022, SOCIOL METHOD RES, V51, P471, DOI 10.1177/0049124119882459; NORMAN DA, 1975, COGNITIVE PSYCHOL, V7, P44, DOI 10.1016/0010-0285(75)90004-3; Pervin LA., 2008, HDB PERSONALITY THEO; R Core Team, 2020, R LANG ENV STAT COMP; Revelle W., 2021, PSYCH PROCEDURES PER; Richter M, 2015, MOTIV EMOTION, V39, P25, DOI 10.1007/s11031-014-9429-y; Richter M, 2014, INT J PSYCHOPHYSIOL, V93, P227, DOI 10.1016/j.ijpsycho.2014.05.002; Richter M, 2013, SOC PERSONAL PSYCHOL, V7, P1, DOI 10.1111/spc3.12007; Richter M, 2012, PSYCHOPHYSIOLOGY, V49, P704, DOI 10.1111/j.1469-8986.2011.01350.x; Schultheiss O. C., 2005, HDB COMPETENCE MOTIV, P31; Schultheiss OC, 2007, J PERS ASSESS, V89, P197, DOI 10.1080/00223890701357431; Shoda Y, 1999, COHERENCE OF PERSONALITY, P155; Silvestrini N, 2018, BIOL PSYCHOL, V132, P45, DOI 10.1016/j.biopsycho.2017.11.002; Silvia PJ, 2013, INT J PSYCHOPHYSIOL, V88, P200, DOI 10.1016/j.ijpsycho.2013.04.007; Silvia PJ, 2012, BIOL PSYCHOL, V90, P192, DOI 10.1016/j.biopsycho.2012.03.017; Sokolowski K, 2000, J PERS ASSESS, V74, P126, DOI 10.1207/S15327752JPA740109; Sonne MW, 2015, J ELECTROMYOGR KINES, V25, P130, DOI 10.1016/j.jelekin.2014.10.017; SPANGLER WD, 1992, PSYCHOL BULL, V112, P140, DOI 10.1037/0033-2909.112.1.140; Stanek J. C., 2016, MOTIVATIONAL SCI, V2, P49, DOI 10.1037/mot0000028; Stanton SJ., 2010, IMPLICIT MOTIVES, P245, DOI [10.1093/acprof:oso/9780195335156.003.0009, DOI 10.1093/ACPROF:OSO/9780195335156.003.0009]; Wegner M, 2014, INT J SPORT PSYCHOL, V45, P621, DOI 10.7352/IJSP.2014.45.621; Winter DG, 1998, PSYCHOL REV, V105, P230, DOI 10.1037/0033-295X.105.2.230; Wright RA, 2004, MOTIVATIONAL ANALYSES OF SOCIAL BEHAVIOR, P187; Wright RA, 2008, SOC PERSONAL PSYCHOL, V2, P682, DOI 10.1111/j.1751-9004.2008.00093.x	64	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252713	10.1371/journal.pone.0252713	http://dx.doi.org/10.1371/journal.pone.0252713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086786	Green Published, Green Accepted, gold			2022-12-26	WOS:000664640100114
J	Skupien-Jaroszek, A; Walczak, A; Czaban, I; Pels, KK; Szczepankiewicz, AA; Krawczyk, K; Ruszczycki, B; Wilczynski, GM; Dzwonek, J; Magalska, A				Skupien-Jaroszek, Anna; Walczak, Agnieszka; Czaban, Iwona; Pels, Katarzyna Karolina; Szczepankiewicz, Andrzej Antoni; Krawczyk, Katarzyna; Ruszczycki, Blazej; Wilczynski, Grzegorz Marek; Dzwonek, Joanna; Magalska, Adriana			The interplay of seizures-induced axonal sprouting and transcription-dependent Bdnf repositioning in the model of temporal lobe epilepsy	PLOS ONE			English	Article							DE-LANGE-SYNDROME; NEUROTROPHIC FACTOR; NUCLEAR-ENVELOPE; EPIGENETIC REGULATION; HISTONE ACETYLATION; SYNAPTIC PLASTICITY; CORTICAL-NEURONS; GENE-EXPRESSION; ACTINOMYCIN-D; CHROMATIN	The Brain-Derived Neurotrophic Factor is one of the most important trophic proteins in the brain. The role of this growth factor in neuronal plasticity, in health and disease, has been extensively studied. However, mechanisms of epigenetic regulation of Bdnf gene expression in epilepsy are still elusive. In our previous work, using a rat model of neuronal activation upon kainate-induced seizures, we observed a repositioning of Bdnf alleles from the nuclear periphery towards the nuclear center. This change of Bdnf intranuclear position was associated with transcriptional gene activity. In the present study, using the same neuronal activation model, we analyzed the relation between the percentage of the Bdnf allele at the nuclear periphery and clinical and morphological traits of epilepsy. We observed that the decrease of the percentage of the Bdnf allele at the nuclear periphery correlates with stronger mossy fiber sprouting-an aberrant form of excitatory circuits formation. Moreover, using in vitro hippocampal cultures we showed that Bdnf repositioning is a consequence of transcriptional activity. Inhibition of RNA polymerase II activity in primary cultured neurons with Actinomycin D completely blocked Bdnf gene transcription and repositioning occurring after neuronal excitation. Interestingly, we observed that histone deacetylases inhibition with Trichostatin A induced a slight increase of Bdnf gene transcription and its repositioning even in the absence of neuronal excitation. Presented results provide novel insight into the role of BDNF in epileptogenesis. Moreover, they strengthen the statement that this particular gene is a good candidate to search for a new generation of antiepileptic therapies.	[Skupien-Jaroszek, Anna; Walczak, Agnieszka; Czaban, Iwona; Pels, Katarzyna Karolina; Szczepankiewicz, Andrzej Antoni; Krawczyk, Katarzyna; Ruszczycki, Blazej; Wilczynski, Grzegorz Marek; Dzwonek, Joanna; Magalska, Adriana] Polish Acad Sci, Nencki Inst Expt Biol, Lab Mol & Syst Neuromorphol, Warsaw, Poland; [Magalska, Adriana] Polish Acad Sci, Nencki Inst Expt Biol, Lab Mol Basis Cell Motil, Warsaw, Poland	Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences	Dzwonek, J; Magalska, A (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Lab Mol & Syst Neuromorphol, Warsaw, Poland.; Magalska, A (corresponding author), Polish Acad Sci, Nencki Inst Expt Biol, Lab Mol Basis Cell Motil, Warsaw, Poland.	j.dzwonek@nencki.edu.pl; a.magalska@nencki.edu.pl		Szczepankiewicz, Andrzej/0000-0002-1502-3147; Skupien-Jaroszek, Anna/0000-0002-8448-3606; Ruszczycki, Blazej/0000-0002-0262-1463; Dzwonek, Joanna/0000-0002-3834-2175; Magalska, Adriana/0000-0002-0517-7134	Polish National Science Centre [2015/17/B/NZ4/02540, 2018/29/B/NZ4/01473, UMO-2015/18/E/NZ3/00730, 2014/15/N/NZ3/04468]; ETIUDA grant from the Polish National Science Centre [UMO-2019/32/T/NZ4/00502]	Polish National Science Centre; ETIUDA grant from the Polish National Science Centre	JD was supported by the Polish National Science Centre grant No 2015/17/B/NZ4/02540, AS was supported by the Polish National Science Centre grant No 2018/29/B/NZ4/01473, AM was supported by the Polish National Science Centre grant No UMO-2015/18/E/NZ3/00730. AAS was supported by the Polish National Science Centre grant No 2014/15/N/NZ3/04468. KKP was partially supported by the ETIUDA grant from the Polish National Science Centre no. UMO-2019/32/T/NZ4/00502. https://www.ncn.gov.pl The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Bagheri A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051109; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Bokota G, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-03984-1; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chang JF, 2010, P NATL ACAD SCI USA, V107, P21836, DOI 10.1073/pnas.1002130107; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Costa A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00253; Cremer Marion, 2008, V463, P205, DOI 10.1007/978-1-59745-406-3_15; Crepaldi L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003699; Dabrowski M, 2003, J NEUROCHEM, V85, P1279, DOI 10.1046/j.1471-4159.2003.01753.x; DANGIO GJ, 1981, CANCER-AM CANCER SOC, V47, P2302, DOI 10.1002/1097-0142(19810501)47:9<2302::AID-CNCR2820470933>3.0.CO;2-K; Danzer SC, 2002, J NEUROSCI, V22, P9754; Deardorff MA, 2012, NATURE, V489, P313, DOI 10.1038/nature11316; DEVINSKY O, 1984, AM J PSYCHIAT, V141, P651; Dobrzynska A, 2016, NUCLEUS-PHILA, V7, P233, DOI 10.1080/19491034.2016.1183848; Dorsett D, 2010, CURR BIOL, V20, pR886, DOI 10.1016/j.cub.2010.09.036; Egecioglu D, 2011, CURR OPIN CELL BIOL, V23, P338, DOI 10.1016/j.ceb.2011.01.001; Eskiw CH, 2010, COLD SH Q B, V75, P501, DOI 10.1101/sqb.2010.75.046; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Forsberg EC, 2001, BIOESSAYS, V23, P820, DOI 10.1002/bies.1117; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; GALL CM, 1993, EXP NEUROL, V124, P150, DOI 10.1006/exnr.1993.1186; Goetze S, 2007, SEMIN CELL DEV BIOL, V18, P707, DOI 10.1016/j.semcdb.2007.08.007; Goetze S, 2007, MOL CELL BIOL, V27, P4475, DOI 10.1128/MCB.00208-07; Good Katrina V, 2017, Epigenetics, V12, P934, DOI 10.1080/15592294.2017.1380760; GRIMM RA, 1980, CANCER CHEMOTH PHARM, V4, P195; Guarda A, 2009, EXP CELL RES, V315, P1895, DOI 10.1016/j.yexcr.2009.01.019; Guilhem D, 1996, NEUROSCIENCE, V72, P923, DOI 10.1016/0306-4522(96)00005-X; Hellier JL, 1998, EPILEPSY RES, V31, P73, DOI 10.1016/S0920-1211(98)00017-5; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Ito S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5450; Khatua S, 2004, J PEDIAT HEMATOL ONC, V26, P777, DOI 10.1097/00043426-200411000-00020; Kim J, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201600194; Koh DXP, 2016, J NEUROCHEM, V139, P369, DOI 10.1111/jnc.13773; Koppel I, 2013, NEUROPHARMACOLOGY, V75, P106, DOI 10.1016/j.neuropharm.2013.07.015; Koyama R, 2005, NEUROSCIENTIST, V11, P282, DOI 10.1177/1073858405278266; Kuzniewska B, 2016, MOL NEUROBIOL, V53, P1478, DOI 10.1007/s12035-014-9089-7; Leite JP, 1996, EPILEPSY RES, V26, P219, DOI 10.1016/S0920-1211(96)00055-1; Lin TW, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2019.107734; Lubin FD, 2008, J NEUROSCI, V28, P10576, DOI 10.1523/JNEUROSCI.1786-08.2008; Lund E, 2013, NUCLEUS-AUSTIN, V4, P424, DOI 10.4161/nucl.26865; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; Merkenschlager M, 2016, ANNU REV GENOM HUM G, V17, P17, DOI 10.1146/annurev-genom-083115-022339; Murray KD, 2000, J COMP NEUROL, V418, P411, DOI 10.1002/(SICI)1096-9861(20000320)418:4<411::AID-CNE4>3.0.CO;2-F; Nassan M, 2015, BIPOLAR DISORD, V17, P645, DOI 10.1111/bdi.12323; Niedringhaus M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042631; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pavlidis E, 2014, BRAIN DEV-JPN, V36, P837, DOI 10.1016/j.braindev.2013.12.008; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; R Core Team, 2020, R LANG ENV STAT COMP; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rowley MJ, 2018, NAT REV GENET, V19, P789, DOI 10.1038/s41576-018-0060-8; Ruszczycki B, 2019, FRONT NEUROANAT, V13, DOI 10.3389/fnana.2019.00081; Saha RN, 2011, NAT NEUROSCI, V14, P848, DOI 10.1038/nn.2839; Sakharkar AJ, 2016, BRAIN STRUCT FUNCT, V221, P4691, DOI 10.1007/s00429-016-1196-y; Scharfman HE, 2002, EXP NEUROL, V174, P201, DOI 10.1006/exnr.2002.7869; Schmauss C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08171; Schmidt HD, 2012, J NEUROCHEM, V120, P202, DOI 10.1111/j.1471-4159.2011.07571.x; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Serebryannyy LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28460; Shen N, 2016, INT J NEUROSCI, V126, P436, DOI 10.3109/00207454.2015.1026967; Simonato M, 2014, EPILEPSY BEHAV, V38, P125, DOI 10.1016/j.yebeh.2013.09.013; Skupien A, 2014, J CELL SCI, V127, P5038, DOI 10.1242/jcs.154542; Somech R, 2005, J CELL SCI, V118, P4017, DOI 10.1242/jcs.02521; Stertz L, 2014, REV BRAS PSIQUIATR, V36, P39, DOI 10.1590/1516-4446-2013-1094; SUZUKI F, 1995, NEUROSCIENCE, V64, P665, DOI 10.1016/0306-4522(94)00463-F; Szepesi Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063314; Takahashi M, 1999, BRAIN RES, V818, P579, DOI 10.1016/S0006-8993(98)01355-9; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TATTERSALL MHN, 1975, CLIN PHARMACOL THER, V17, P701; Timmusk T, 1999, J BIOL CHEM, V274, P1078; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; van Steensel B, 2019, NAT REV MOL CELL BIO, V20, P327, DOI 10.1038/s41580-019-0114-6; Verrotti A, 2013, SEIZURE-EUR J EPILEP, V22, P356, DOI 10.1016/j.seizure.2013.01.017; Vignoli B, 2016, NEURON, V92, P873, DOI 10.1016/j.neuron.2016.09.031; Walczak A, 2013, J NEUROSCI, V33, P2507, DOI 10.1523/JNEUROSCI.1085-12.2013; Webb C, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00151; Wenzel HJ, 2000, HIPPOCAMPUS, V10, P244, DOI 10.1002/1098-1063(2000)10:3<244::AID-HIPO5>3.0.CO;2-7; Wiebe S, 2000, CAN J NEUROL SCI, V27, pS6, DOI 10.1017/S0317167100000561; Wilczynski GM, 2008, J CELL BIOL, V180, P1021, DOI 10.1083/jcb.200708213; Williams SK, 2007, CURR OPIN GENET DEV, V17, P88, DOI 10.1016/j.gde.2007.02.001; Zhang XY, 2016, SCHIZOPHR RES, V170, P41, DOI 10.1016/j.schres.2015.11.009; Zhao HL, 2015, MOL CELL, V59, P984, DOI 10.1016/j.molcel.2015.07.019; Zocchi L, 2012, EPIGENETICS-US, V7, P695, DOI 10.4161/epi.20733; Zuleger N, 2011, NUCLEUS-PHILA, V2, P339, DOI 10.4161/nucl.2.5.17846	89	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0239111	10.1371/journal.pone.0239111	http://dx.doi.org/10.1371/journal.pone.0239111			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086671	Green Published, gold			2022-12-26	WOS:000664640100002
J	Robert, P; Nguyen, PMC; Richard, A; Grenier, C; Chevrollier, A; Munier, M; Grimaud, L; Proux, C; Champin, T; Lelievre, E; Sarzi, E; Vessieres, E; Henni, S; Prunier, D; Reynier, P; Lenaers, G; Fassot, C; Henrion, D; Loufrani, L				Robert, Pauline; Phuc Minh Chau Nguyen; Richard, Alexis; Grenier, Celine; Chevrollier, Arnaud; Munier, Mathilde; Grimaud, Linda; Proux, Coralyne; Champin, Tristan; Lelievre, Eric; Sarzi, Emmanuelle; Vessieres, Emilie; Henni, Samir; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Fassot, Celine; Henrion, Daniel; Loufrani, Laurent			Protective role of the mitochondrial fusion protein OPA1 in hypertension	FASEB JOURNAL			English	Article						hypertension; mitochondria; Opa1; oxidative stress; vascular function	NITRIC-OXIDE; BLOOD-PRESSURE; ENDOTHELIAL DYSFUNCTION; RESISTANCE ARTERIES; MORPHOLOGY; CELLS; VASODILATION; BIOGENESIS; ACTIVATION; INHIBITION	Hypertension is associated with excessive reactive oxygen species (ROS) production in vascular cells. Mitochondria undergo fusion and fission, a process playing a role in mitochondrial function. OPA1 is essential for mitochondrial fusion. Loss of OPA1 is associated with ROS production and cell dysfunction. We hypothesized that mitochondria fusion could reduce oxidative stress that defect in fusion would exacerbate hypertension. Using (a) Opa1 haploinsufficiency in isolated resistance arteries from Opa1(+/-) mice, (b) primary vascular cells from Opa1(+/-) mice, and (c) RNA interference experiments with siRNA against Opa1 in vascular cells, we investigated the role of mitochondria fusion in hypertension. In hypertension, Opa1 haploinsufficiency induced altered mitochondrial cristae structure both in vascular smooth muscle and endothelial cells but did not modify protein level of long and short forms of OPA1. In addition, we demonstrated an increase of mitochondrial ROS production, associated with a decrease of superoxide dismutase 1 protein expression. We also observed an increase of apoptosis in vascular cells and a decreased VSMCs proliferation. Blood pressure, vascular contractility, as well as endothelium-dependent and -independent relaxation were similar in Opa1(+/-), WT, L-NAME-treated Opa1(+/-) and WT mice. Nevertheless, chronic NO-synthase inhibition with L-NAME induced a greater hypertension in Opa1(+/-) than in WT mice without compensatory arterial wall hypertrophy. This was associated with a stronger reduction in endothelium-dependent relaxation due to excessive ROS production. Our results highlight the protective role of mitochondria fusion in the vasculature during hypertension by limiting mitochondria ROS production.	[Robert, Pauline; Phuc Minh Chau Nguyen; Richard, Alexis; Grenier, Celine; Chevrollier, Arnaud; Munier, Mathilde; Grimaud, Linda; Proux, Coralyne; Champin, Tristan; Lelievre, Eric; Vessieres, Emilie; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Fassot, Celine; Henrion, Daniel; Loufrani, Laurent] Univ Angers, MITOVASC Inst, Angers, France; [Robert, Pauline; Phuc Minh Chau Nguyen; Richard, Alexis; Grenier, Celine; Chevrollier, Arnaud; Munier, Mathilde; Grimaud, Linda; Proux, Coralyne; Champin, Tristan; Lelievre, Eric; Vessieres, Emilie; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Fassot, Celine; Henrion, Daniel; Loufrani, Laurent] Univ Angers, CARFI Facil, Angers, France; [Robert, Pauline; Phuc Minh Chau Nguyen; Richard, Alexis; Grenier, Celine; Chevrollier, Arnaud; Munier, Mathilde; Grimaud, Linda; Proux, Coralyne; Champin, Tristan; Vessieres, Emilie; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Fassot, Celine; Henrion, Daniel; Loufrani, Laurent] UMR CNRS 6015, Angers, France; [Robert, Pauline; Phuc Minh Chau Nguyen; Richard, Alexis; Grenier, Celine; Chevrollier, Arnaud; Munier, Mathilde; Grimaud, Linda; Proux, Coralyne; Champin, Tristan; Vessieres, Emilie; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Fassot, Celine; Henrion, Daniel; Loufrani, Laurent] INSERM U1083, Angers, France; [Sarzi, Emmanuelle] INSERM, Inst Neurosci Montpellier, U1051, Montpellier, France; [Henni, Samir; Prunier, Delphine; Reynier, Pascal; Lenaers, Guys; Henrion, Daniel] Univ Hosp CHU Angers, Angers, France	Universite d'Angers; Universite d'Angers; Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Loufrani, L (corresponding author), INSERM U1083, MITOVASC, CNRS UMR 6015, 3 Rue Roger Amsler, F-49045 Angers, France.	laurent.loufrani@inserm.fr	CHEVROLLIER, Arnaud/GSD-3887-2022; CHEVROLLIER, Arnaud/P-6630-2019; Munier, Mathilde/AAX-3770-2021; Munier, Mathilde/AAD-8239-2022; CHEVROLLIER, Arnaud/K-2853-2015	CHEVROLLIER, Arnaud/0000-0002-5135-6643; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Munier, Mathilde/0000-0001-7194-6846; CHEVROLLIER, Arnaud/0000-0002-5135-6643; Grenier, Celine/0000-0003-4521-9404; Reynier, Pascal/0000-0003-0802-4608	Region Pays de la Loire (Mitovasc project); Foundation for Medical Research [FRM -DPC20171138957]; GRRC (Groupe de Reflexion sur la Recherche Cardiovasculaire, France)	Region Pays de la Loire (Mitovasc project)(Region Pays de la Loire); Foundation for Medical Research; GRRC (Groupe de Reflexion sur la Recherche Cardiovasculaire, France)	This work was supported by the Region Pays de la Loire (Mitovasc project), by the Foundation for Medical Research (FRM -DPC20171138957) and by GRRC (Groupe de Reflexion sur la Recherche Cardiovasculaire, France)	Bartolak-Suki E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57301-1; Bautista LE, 2003, J HUM HYPERTENS, V17, P223, DOI 10.1038/sj.jhh.1001537; Berger JM, 2015, ATHEROSCLEROSIS, V239, P252, DOI 10.1016/j.atherosclerosis.2015.01.012; Bertholet AM, 2013, BRAIN, V136, P1518, DOI 10.1093/brain/awt060; Bouvet C, 2007, HYPERTENSION, V50, P248, DOI 10.1161/HYPERTENSIONAHA.107.088716; Caffarra Malvezzi Cristina, 2020, Vasc Biol, V2, pR85, DOI 10.1530/VB-20-0002; Caffin F, 2013, J PHYSIOL-LONDON, V591, P6017, DOI 10.1113/jphysiol.2013.263079; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen L, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.003012; Chevrollier A, 2012, INT J BIOCHEM CELL B, V44, P980, DOI 10.1016/j.biocel.2012.03.006; Codron P, 2018, AMYOTROPH LAT SCL FR, V19, P446, DOI 10.1080/21678421.2018.1431787; Cousin M, 2010, HYPERTENSION, V55, P109, DOI 10.1161/HYPERTENSIONAHA.108.127456; Dai Y, 2011, INVEST OPHTH VIS SCI, V52, P2468, DOI 10.1167/iovs.10-5873; de la Barca JMC, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-21116; Dowell FJ, 1996, BRIT J PHARMACOL, V117, P341, DOI 10.1111/j.1476-5381.1996.tb15196.x; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Formichi P, 2015, J NEUROL SCI, V351, P99, DOI 10.1016/j.jns.2015.02.047; Frezza C, 2006, CELL, V126, P177, DOI 10.1016/j.cell.2006.06.025; Fulop L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025199; Jin HS, 2011, AM J HYPERTENS, V24, P1127, DOI 10.1038/ajh.2011.131; Kalliovalkama J, 1999, CARDIOVASC RES, V42, P773, DOI 10.1016/S0008-6363(98)00346-0; Kao SH, 2015, INVEST OPHTH VIS SCI, V56, P2269, DOI 10.1167/iovs.14-16288; Katakam PVG, 2013, ARTERIOSCL THROM VAS, V33, P752, DOI 10.1161/ATVBAHA.112.300560; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Kluge MA, 2013, CIRC RES, V112, P1171, DOI 10.1161/CIRCRESAHA.111.300233; Lahera V, 2017, CURR HYPERTENS REP, V19, DOI 10.1007/s11906-017-0710-9; Lakatta EG, 2003, CIRCULATION, V107, P139, DOI 10.1161/01.CIR.0000048892.83521.58; Le Page S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164066; Lin YY, 2019, J APPL PHYSIOL, V126, P1661, DOI 10.1152/japplphysiol.00038.2019; Liu N, 2017, J CELL MOL MED, V21, P3190, DOI 10.1111/jcmm.13223; Liu YP, 2008, MED BIOL ENG COMPUT, V46, P469, DOI 10.1007/s11517-008-0331-1; Loufrani L, 2001, FASEB J, V15, P117, DOI 10.1096/fj.01-0505fje; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Makino A, 2010, DIABETOLOGIA, V53, P1783, DOI 10.1007/s00125-010-1770-4; Mironov SL, 2005, J BIOL CHEM, V280, P715, DOI 10.1074/jbc.M409819200; Olichon A, 2003, J BIOL CHEM, V278, P7743, DOI 10.1074/jbc.C200677200; Olichow A, 2007, J CELL PHYSIOL, V211, P423, DOI 10.1002/jcp.20950; Ong SB, 2010, CIRCULATION, V121, P2012, DOI 10.1161/CIRCULATIONAHA.109.906610; Patten DA, 2014, EMBO J, V33, P2676, DOI 10.15252/embj.201488349; Piantadosi CA, 2006, J BIOL CHEM, V281, P324, DOI 10.1074/jbc.M508805200; Piquereau J, 2012, CARDIOVASC RES, V94, P408, DOI 10.1093/cvr/cvs117; Preti SC, 2005, BASIC CLIN PHARMACOL, V97, P29, DOI 10.1111/j.1742-7843.2005.pto_97105.x; Puddu P, 2007, CLIN EXP HYPERTENS, V29, P427, DOI 10.1080/10641960701613852; Retailleau K, 2010, HYPERTENSION, V55, P339, DOI 10.1161/HYPERTENSIONAHA.109.140236; RIBEIRO MO, 1992, HYPERTENSION, V20, P298, DOI 10.1161/01.HYP.20.3.298; Sarzi E, 2012, BRAIN, V135, P3599, DOI 10.1093/brain/aws303; Sun Y, 2005, HYPERTENSION, V46, P1355, DOI 10.1161/01.HYP.0000192651.06674.3f; Tang S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004492; Tang Y, 2014, CARDIOVASC PATHOL, V23, P101, DOI 10.1016/j.carpath.2013.11.002; Touyz RM, 2004, HISTOCHEM CELL BIOL, V122, P339, DOI 10.1007/s00418-004-0696-7; Vishnyakova PA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32410; Wei BR, 2011, AM J HYPERTENS, V24, P976, DOI 10.1038/ajh.2011.88; Wilde E, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.116.005204; Yarosh W, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040006	55	6	6	3	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21678	10.1096/fj.202000238RRR	http://dx.doi.org/10.1096/fj.202000238RRR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34133045	Green Published			2022-12-26	WOS:000667814100039
J	Weems, JC; Slaughter, BD; Unruh, JR; Weaver, KJ; Miller, BD; Delventhal, KM; Conaway, JW; Conaway, RC				Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Weaver, Kyle J.; Miller, Brandon D.; Delventhal, Kym M.; Conaway, Joan W.; Conaway, Ronald C.			A role for the Cockayne Syndrome B (CSB)-Elongin ubiquitin ligase complex in signal-dependent RNA polymerase II transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED REPAIR; DNA-DAMAGE; CUL5-RBX2 MODULES; ALPHA-AMANITIN; FACTOR-SIII; ELONGIN; ELONGATION; PROTEIN; DEGRADATION; RECRUITMENT	The Elongin complex was originally identified as an RNA polymerase II (RNAPII) elongation factor and subsequently as the substrate recognition component of a Cullin-RING E3 ubiquitin ligase. More recent evidence indicates that the Elongin ubiquitin ligase assembles with the Cockayne syndrome B helicase (CSB) in response to DNA damage and can target stalled polymerases for ubiquitylation and removal from the genome. In this report, we present evidence that the CSB-Elongin ubiquitin ligase pathway has roles beyond the DNA damage response in the activation of RNAPII-mediated transcription. We observed that assembly of the CSB-Elongin ubiquitin ligase is induced not just by DNA damage, but also by a variety of signals that activate RNAPII-mediated transcription, including endoplasmic reticulum (ER) stress, amino acid starvation, retinoic acid, glucocorticoids, and doxycycline treatment of cells carrying several copies of a doxycycline-inducible reporter. Using glucocorticoid receptor (GR)-regulated genes as a model, we showed that glucocorticoid-induced transcription is accompanied by rapid recruitment of CSB and the Elongin ubiquitin ligase to target genes in a step that depends upon the presence of transcribing RNAPII on those genes. Consistent with the idea that the CSB-Elongin pathway plays a direct role in GR-regulated transcription, mouse cells lacking the Elongin subunit Elongin A exhibit delays in both RNAPII accumulation on and dismissal from target genes following glucocorticoid addition and withdrawal, respectively. Taken together, our findings bring to light a new role for the CSB-Elongin pathway in RNAPII-mediated transcription.	[Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Weaver, Kyle J.; Miller, Brandon D.; Delventhal, Kym M.; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Conaway, JW; Conaway, RC (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.; Conaway, JW; Conaway, RC (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA.	Joan.Conaway@UTSouthwestern.edu; rcc@stowers.org		Conaway, Joan/0000-0002-2786-0663; Weaver, Kyle/0000-0002-3960-9177	Stowers Institute for Medical Research; Helen Nelson Medical Research Fund at the Greater Kansas City Community Fund	Stowers Institute for Medical Research; Helen Nelson Medical Research Fund at the Greater Kansas City Community Fund	This work was supported by funds from the Stowers Institute for Medical Research and a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Fund.	Ardehali MB, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015877; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Boetefuer EL, 2018, NUCLEIC ACIDS RES, V46, P7471, DOI 10.1093/nar/gky660; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; CHAFIN DR, 1995, J BIOL CHEM, V270, P19114, DOI 10.1074/jbc.270.32.19114; Connelly JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40896-w; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Gressel S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11536-8; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Lightman SL, 2006, BIOCHEM SOC T, V34, P1117, DOI 10.1042/BST0341117; Lightman S. L., 2002, Archives of Physiology and Biochemistry, V110, P90, DOI 10.1076/apab.110.1.90.899; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Gonzalez MN, 2021, NAT REV MOL CELL BIO, V22, P3, DOI 10.1038/s41580-020-00308-8; Presman DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001813; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Rodriguez J, 2020, ANNU REV BIOCHEM, V89, P189, DOI 10.1146/annurev-biochem-011520-105250; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Stevnsner T, 2008, MECH AGEING DEV, V129, P441, DOI 10.1016/j.mad.2008.04.009; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Tunnacliffe E, 2020, TRENDS GENET, V36, P288, DOI 10.1016/j.tig.2020.01.003; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Wang YT, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015876; Wang YM, 2014, P NATL ACAD SCI USA, V111, P14454, DOI 10.1073/pnas.1412569111; Weems JC, 2019, METHODS, V159, P157, DOI 10.1016/j.ymeth.2019.02.015; Weems JC, 2017, J BIOL CHEM, V292, P6431, DOI 10.1074/jbc.C117.777946; Weems JC, 2015, J BIOL CHEM, V290, P15030, DOI 10.1074/jbc.M114.632794; Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249; Young EA, 2004, FRONT NEUROENDOCRIN, V25, P69, DOI 10.1016/j.yfrne.2004.07.001	46	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100862	10.1016/j.jbc.2021.100862	http://dx.doi.org/10.1016/j.jbc.2021.100862			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34116057	Green Published, gold			2022-12-26	WOS:000678068400062
J	da Silva, SA; da Rosa, R; Milanezi-Aguiar, RC; Nascimento, CC; Machado, ACZ				da Silva, Santino Aleandro; da Rosa, Renata; Milanezi-Aguiar, Rachel Colauto; Nascimento, Cristianne Cordeiro; Zamboni Machado, Andressa Cristina			Morus alba: Host reaction for Meloidogyne javanica, biological nematicides assessment and study of these relationships with yield and quality of leaves, cocoon and health of the silkworm	PLOS ONE			English	Article							NEMATODE	Root-knot nematodes cause damage to several crops and the importance of each species can vary according with the crop and the agricultural region. In Brazil, Meloidogyne javanica is one of the most important nematode species parasitizing mulberry. To define management strategies, it is important to know if the crop species is damaged by the parasitism of the nematode and the best choices for control, as the use of nematicides. Biological nematicides have been extensively used in Brazil, but no information regarding its efficiency to control M. javanica in mulberry is available. Besides, it is not known if biological nematicides could improve the quality of leaves or if they alter the nutrient composition of leaves, which could interfere in the development of the silkworms that are feed with these leaves or in the quality of the silk produced. With the aim to address these questions, we propose a study that will start in the phenotyping of the main Brazilian mulberry cultivars to Meloidogyne species, passing through the test of efficiency of biological nematicides in the control of M. javanica in mulberry cultivar Miura, evaluation of the amount and quality of leaves produced and, using these leaves to feed silkworms, in the analyzes of the impact of these diet in the health of silkworms, and in the production and quality of the silk.	[da Silva, Santino Aleandro; da Rosa, Renata; Milanezi-Aguiar, Rachel Colauto] Univ Estadual Londrina UEL, Ctr Ciencias Biol, Londrina, Parana, Brazil; [da Silva, Santino Aleandro; Zamboni Machado, Andressa Cristina] Inst Desenvolvimento Rural Parana IAPAR EMATER, Dept Plant Pathol, Londrina, Parana, Brazil; [Nascimento, Cristianne Cordeiro] Univ Estadual Londrina UEL, Ctr Educ Comunicacao & Artes, Londrina, Parana, Brazil	Universidade Estadual de Londrina; Universidade Estadual de Londrina	Machado, ACZ (corresponding author), Inst Desenvolvimento Rural Parana IAPAR EMATER, Dept Plant Pathol, Londrina, Parana, Brazil.	andressa_machado@idr.pr.gov.br		Milanezi-Aguiar, Rachel/0000-0002-1153-7503; Machado, Andressa/0000-0003-4383-2221	Governo do Estado do Parana (Unidade Gestora do Fundo Parana) [TC 055/2018]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [302770/2017-8, 308814/2018-5]; Fiacao de Seda Bratac S.A.	Governo do Estado do Parana (Unidade Gestora do Fundo Parana); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fiacao de Seda Bratac S.A.	Initials: RdR -grant number: TC 055/2018 -Funder: Governo do Estado do Parana (Unidade Gestora do Fundo Parana). Initials: RdR Funder: Fiacao de Seda Bratac S.A. Initials: RdR grant number: 302770/2017-8-Funder: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) Initials: ACZM -grant number: 308814/2018-5 -Funder: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq).	BIRD AF, 1974, ANNU REV PHYTOPATHOL, V12, P69, DOI 10.1146/annurev.py.12.090174.000441; Boneti JI, 1981, FITOPATOL BRAS, V6, P533; Cirio GM., 2018, INOVACOES SERICICULT INOVACOES SERICICULT, V103, pIL; Cirio GM., 2018, SERICICULTURA NO EST; Fang SM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1287-9; Ferreira EB, 2013, EXPDES EXPT DESIGNS; Hussey RS., 1998, PLANT NEMATODE INTER; Jari Oksanen F, 2017, [vegan: Community Ecology Package, R package version 2.4-3]; Juliatto ST., 1985, AMOREIRA HIBRIDOS MA AMOREIRA HIBRIDOS MA; Machado ACZ., 2018, INOVACOES SERICICULT INOVACOES SERICICULT, V103, pIL; Munhoz R., 2013, OPEN J ANIM SCI, V3, P343, DOI [10.4236/ojas.2013.34051, DOI 10.4236/OJAS.2013.34051]; Naik V. N., 2008, International Journal of Industrial Entomology, V16, P49; Oostenbrink M., 1966, MENDELINGEN LANDBOUW, V66, P1; Paes-TakahashiI VD, 2015, CIENC RURAL, V45, P757, DOI 10.1590/0103-8478cr20130350; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Polycarpo GD, 2012, CIENC RURAL, V42, P1669, DOI 10.1590/S0103-84782012000900024; R Core Team, 2020, R LANG ENV STAT COMP; SAHA SS, 1983, NEMATOLOGICA, V29, P463, DOI 10.1163/187529283X00339; Takahashi R., 2009, SERICICULTURA PROMIS, V2; Tinoco STJ., 1992, MANUAL SERICICULTURA; TOIDA Y, 1991, JARQ-JPN AGR RES Q, V24, P300; Venables WN, 2002, MODERN APPL STAT S, V4th, P211, DOI [10.1007/978-0-387-21706-2_8, DOI 10.1007/978-0-387-21706-2]; Zhang P, 2020, J NEMATOL, V52, DOI 10.21307/jofnem-2020-004	24	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252987	10.1371/journal.pone.0252987	http://dx.doi.org/10.1371/journal.pone.0252987			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133425	Green Published, gold			2022-12-26	WOS:000671682700004
J	Luo, JQ; Zhou, LY; Feng, YY; Li, B; Guo, SJ				Luo, Jiaqing; Zhou, Lingyun; Feng, Yunyu; Li, Bo; Guo, Shujin			The selection of indicators from initial blood routine test results to improve the accuracy of early prediction of COVID-19 severity	PLOS ONE			English	Article							CLINICAL CHARACTERISTICS; PNEUMONIA; MORTALITY; DIAGNOSIS; RISK	The global pandemic of COVID-19 poses a huge threat to the health and lives of people all over the world, and brings unprecedented pressure to the medical system. We need to establish a practical method to improve the efficiency of treatment and optimize the allocation of medical resources. Due to the influx of a large number of patients into the hospital and the running of medical resources, blood routine test became the only possible check while COVID-19 patients first go to a fever clinic in a community hospital. This study aims to establish an efficient method to identify key indicators from initial blood routine test results for COVID-19 severity prediction. We determined that age is a key indicator for severity predicting of COVID-19, with an accuracy of 0.77 and an AUC of 0.92. In order to improve the accuracy of prediction, we proposed a Multi Criteria Decision Making (MCDM) algorithm, which combines the Technique for Order of Preference by Similarity to Ideal Solution (TOPSIS) and Naive Bayes (NB) classifier, to further select effective indicators from patients' initial blood test results. The MCDM algorithm selected 3 dominant feature subsets: {Age, WBC, LYMC, NEUT} with a selection rate of 44%, {Age, NEUT, LYMC} with a selection rate of 38%, and {Age, WBC, LYMC} with a selection rate of 9%. Using these feature subsets, the optimized prediction model could achieve an accuracy of 0.82 and an AUC of 0.93. These results indicated that Age, WBC, LYMC, NEUT were the key factors for COVID-19 severity prediction. Using age and the indicators selected by the MCDM algorithm from initial blood routine test results can effectively predict the severity of COVID-19. Our research could not only help medical workers identify patients with severe COVID-19 at an early stage, but also help doctors understand the pathogenesis of COVID-19 through key indicators.	[Luo, Jiaqing; Zhou, Lingyun; Guo, Shujin] Univ Elect Sci & Technol China, Sch Comp Sci & Engn, Chengdu, Peoples R China; [Zhou, Lingyun] West China Hosp Sichuan Univ, Ctr Infect Dis, Chengdu, Peoples R China; [Feng, Yunyu] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr, State Key Lab Biotherapy & Canc Ctr, Chengdu, Peoples R China; [Li, Bo] Sichuan Univ, West China Hosp, Head & Neck Surg, Dept Otorhinolaryngol, Chengdu, Peoples R China; [Guo, Shujin] Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Geriatr Resp Dept, Chengdu, Peoples R China	University of Electronic Science & Technology of China; Sichuan University; Sichuan University; Sichuan University; Sichuan Provincial People's Hospital; University of Electronic Science & Technology of China	Zhou, LY (corresponding author), West China Hosp Sichuan Univ, Ctr Infect Dis, Chengdu, Peoples R China.; Guo, SJ (corresponding author), Univ Elect Sci & Technol China, Sichuan Prov Peoples Hosp, Geriatr Resp Dept, Chengdu, Peoples R China.	4423925@qq.com; shujinguo@126.com		Zhou, Lingyun/0000-0002-6756-6725	Natural Science Foundation of China [81802468, 81700044]; Sichuan Science and Technology Program [2019YFS0207, 2020YFS0113]; China Postdoctoral Science Foundation [2020M670062ZX]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Sichuan Science and Technology Program; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	This work was funded by Natural Science Foundation of China 81802468, Sichuan Science and Technology Program 2019YFS0207 and China Postdoctoral Science Foundation 2020M670062ZX to Dr. Lingyun Zhou; Grant 81700044 from Natural Science Foundation of China to Dr. Shujin Guo; Sichuan Science and Technology Program 2020YFS0113 to Dr. Bo Li. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Waisy AS, 2021, CMC-COMPUT MATER CON, V67, P2409, DOI 10.32604/cmc.2021.012955; Albahri OS, 2020, COMPUT METH PROG BIO, V196, DOI 10.1016/j.cmpb.2020.105617; Alizadeh R, 2020, RENEW SUST ENERG REV, V134, DOI 10.1016/j.rser.2020.110326; Alizadeh R, 2020, ENERG POLICY, V137, DOI 10.1016/j.enpol.2019.111174; Beiragh RG, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12030789; Braithwaite J, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-330; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Chen RC, 2020, CHEST, V158, P97, DOI 10.1016/j.chest.2020.04.010; COVER TM, 1974, IEEE T SYST MAN CYB, VSMC4, P116, DOI 10.1109/TSMC.1974.5408535; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Ganji A, 2020, BLOOD CELL MOL DIS, V83, DOI 10.1016/j.bcmd.2020.102437; Guagliardo Mark F, 2004, Int J Health Geogr, V3, P3; Guagliardo MF, 2004, HEALTH PLACE, V10, P273, DOI 10.1016/j.healthplace.2003.01.001; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Guan WJ, 2020, NEW ENGL J MED, V382, P1861, DOI 10.1056/NEJMc2005203; Guo LX, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02752; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Ibanez-Samaniego L, 2020, J INFECT DIS, V222, P726, DOI 10.1093/infdis/jiaa355; Imam Z, 2020, J INTERN MED, V288, P469, DOI 10.1111/joim.13119; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Kristensen M, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0458-x; Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924; Lin L, 2020, Zhonghua Yi Xue Za Zhi, V100, pE001, DOI 10.3760/cma.j.issn.0376-2491.2020.0001; Lippi G, 2020, CLIN CHIM ACTA, V505, P190, DOI 10.1016/j.cca.2020.03.004; Ma Y, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01761-0; Majumder P, 2020, ELECTRON J GEN MED, V17, DOI 10.29333/ejgm/7904; Majumder P, 2018, INT J PHARM SCI RES, V9, P3732, DOI 10.13040/IJPSR.0975-8232.9(9).3732-42; Marin BG, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2146; Mathew D, 2020, SCIENCE, V369, P1209, DOI 10.1126/science.abc8511; Miller JM, 2018, CLIN INFECT DIS, V67, pE1, DOI 10.1093/cid/ciy381; Mo P., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa270, DOI 10.1093/CID/CIAA270]; Mobley Lee R, 2006, Int J Health Geogr, V5, P19, DOI 10.1186/1476-072X-5-19; Mohammed MA, 2021, CMC-COMPUT MATER CON, V66, P3289, DOI 10.32604/cmc.2021.012874; Mohammed MA, 2020, IEEE ACCESS, V8, P99115, DOI 10.1109/ACCESS.2020.2995597; Pallotto C, 2020, INFECT DIS-NOR, V52, P675, DOI 10.1080/23744235.2020.1778178; Piano S, 2020, LIVER INT, V40, P2394, DOI 10.1111/liv.14565; Sayan M, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/1560250; Stawicki SP, 2020, J GLOB INFECT DIS, V12, P47, DOI 10.4103/jgid.jgid_86_20; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang F, 2020, J INFECT DIS, V221, P1762, DOI 10.1093/infdis/jiaa150; World Health O., 2020, WHONCOVCLINICAL20203, P2020; World Health Organization, 2020, 64 WHO; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xu Youyao, 2020, Glob Health Med, V2, P66, DOI 10.35772/ghm.2020.01015; Yang XB, 2020, LANCET RESP MED, V8, P475, DOI 10.1016/S2213-2600(20)30079-5; Zhang XN, 2020, NATURE, V583, P437, DOI [10.1038/s41586-020-2355-0, 10.1007/s00521-020-05117-w]; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	50	9	9	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253329	10.1371/journal.pone.0253329	http://dx.doi.org/10.1371/journal.pone.0253329			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129653	Green Submitted, Green Published, gold			2022-12-26	WOS:000665475100045
J	Hagos, DG; Kebede, Y; Abdulkader, M; Nigus, E; Arefaine, ZG; Nega, G; Schallig, HDF; Wolday, D				Hagos, Dawit Gebreegzabher; Kebede, Yazezew; Abdulkader, Mahmud; Nigus, Etsay; Arefaine, Zekarias Gessesse; Nega, Gebreab; Schallig, Henk D. F.; Wolday, Dawit			Effect of rK39 testing in guiding treatment initiation and outcome in patients with visceral leishmaniasis in Ethiopia: A prospective cohort study	PLOS ONE			English	Article							DIRECT AGGLUTINATION-TEST; PARASITOLOGICAL METHODS; DIAGNOSTIC-TESTS; FIELD-EVALUATION; EPIDEMIC SITE; KALA-AZAR; COINFECTION; DIPSTICK; KATEX; SUDAN	Background The rapid diagnostic test (RDT) rK39 is currently being used for routine diagnosis of visceral leishmaniasis (VL) in East Africa. However, continuous monitoring of the performance of the assay, in particular its impact on the clinical decision in initiating anti-leishmanial treatment and outcomes remains needed as there are concerns about the diagnostic performance of this test. Methods VL patients prospectively enrolled in a diagnostic trial and with rK39 RDT were included. We evaluated the effect of rK39 testing in guiding treatment initiation and outcome. On the basis of rK39 RDT test result as well as clinical case definition for VL and microscopy examination, the clinicians decide whether to initiate VL therapy or not. Poisson regression models were used to identify factors associated with a decision to initiate VL therapy. In addition, treatment outcomes of those who received VL therapy were compared to those who received non-VL treatment. Results Of 324 VL suspects enrolled, 184 (56.8%) were rK39+ and 140 (43.2%) were rK39. In addition, microscopy exam was done on tissue aspirates from a sub-population (140 individuals), which is 43.2% of the suspected cases, comprising of 117 (63.6%) rK39+ and only 23 (16.4%) rK39 cases. Of those with microscopy examination, only 87 (62.1%) were found positive. Among 184 (56.8%) patients without microscopy, 67 (36.4%) were rK39+, of whom 83 (65.9%) were positive by microscopy, 21 (16.7%) were negative by microscopy and 22 (17.5%) had no microscopy results. On the other hand, of those who did not receive VL treatment 58/189 (30.7%) were rK39+ and 131 (69.3%) were rK39. Of the rK39+ cases who did not receive VL therapy, only 1 (1.7%) patient was microscopy positive, 12 (20.7%) were negative and 45 (77.6%) patients had no microscopy result. Of the rK39 cases (n = 131) who did not receive VL treatment, 16 were microscopy negative and 115 without microscopy exams. Whereas positive rK39 result [adjusted Relative Risk (aRR) 0.69; 95% CI: 0.49-0.96, p = 0.029] and positive microscopy results (aRR 0.03; 95% CI: 0.00-0.24, p = 0.001) were independently associated with VL treatment, having confirmed diagnosis other than VL (aRR 1.64; 95% CI: 1.09-2.46, p = 0.018) was independently associated with initiation of non-VL therapy. The proportion of rK39+ patients who received non-VL treatment with no improvement outcome was significantly higher when compared to those who received VL treatment (24.1%, 95% CI: 14.62-37.16 vs. 11.9%, 95%CI: 7.26-18.93; p<0.0001). Conclusion The study shows that a significant proportion of patients with rK39+ results were undertreated. Failure to do microscopy was associated with lack of improved clinical outcome. Including an additional simple point-of-care assay in the diagnostic work-up is urgently needed to correctly identify VL cases and to prevent morbidity and mortality associated with the disease.	[Hagos, Dawit Gebreegzabher; Kebede, Yazezew; Abdulkader, Mahmud; Nigus, Etsay; Arefaine, Zekarias Gessesse; Nega, Gebreab; Wolday, Dawit] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia; [Hagos, Dawit Gebreegzabher; Schallig, Henk D. F.] Univ Amsterdam, Med Ctr, Dept Med Microbiol, Parasitol Unit, Amsterdam, Netherlands	Mekelle University; University of Amsterdam	Wolday, D (corresponding author), Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia.	dawwol@gmail.com		Kiros, Yazezew Kebede/0000-0003-1618-7247; Mahmud, Mahmud Abdulkader/0000-0002-7509-5695	European Developing Countries Clinical Trial Partnership (EDCTP), The Hague, The Netherlands [TMA2016SF-1437]	European Developing Countries Clinical Trial Partnership (EDCTP), The Hague, The Netherlands(Netherlands Government)	The project was supported by the European Developing Countries Clinical Trial Partnership (EDCTP), The Hague, The Netherlands (Project ID#: TMA2016SF-1437). The funder has no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abass E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116408; Alvar J, 2008, CLIN MICROBIOL REV, V21, P334, DOI 10.1128/CMR.00061-07; [Anonymous], 2015, VISCERAL LEISHMANIAS; [Anonymous], 2016, LEISHMANIASIS HIGH B; Babiker ZOE, 2007, AM J TROP MED HYG, V76, P689, DOI 10.4269/ajtmh.2007.76.689; Bashaye S, 2009, AM J TROP MED HYG, V81, P34, DOI 10.4269/ajtmh.2009.81.34; Bezuneh A, 2014, AM J TROP MED HYG, V91, P1109, DOI [10.4269/ajtmh.14-0759, 10.4269/ajtmh.13-0759]; Bhattacharyya T, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002675; Bhattacharyya T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002057; Boelaert M, 2008, T ROY SOC TROP MED H, V102, P32, DOI 10.1016/j.trstmh.2007.09.003; Boelaert M, 2004, AM J TROP MED HYG, V70, P72, DOI 10.4269/ajtmh.2004.70.72; Boelaert M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009135.pub2; Canavate C, 2011, AM J TROP MED HYG, V84, P102, DOI 10.4269/ajtmh.2011.10-0229; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cota GF, 2013, AM J TROP MED HYG, V89, P570, DOI 10.4269/ajtmh.13-0239; de Ruiter CM, 2014, J CLIN MICROBIOL, V52, P3147, DOI 10.1128/JCM.00372-14; Deribe K, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-240; Diro E, 2007, T ROY SOC TROP MED H, V101, P908, DOI 10.1016/j.trstmh.2007.05.002; Diro E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003738; Diro E, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002869; Gadisa E, 2012, AM J TROP MED HYG, V86, P792, DOI 10.4269/ajtmh.2012.11-0196; Gidwani K, 2011, CLIN VACCINE IMMUNOL, V18, P346, DOI 10.1128/CVI.00473-10; Herrero M, 2009, AM J TROP MED HYG, V81, P373, DOI 10.4269/ajtmh.2009.81.373; Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x; Kassa M, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008963; Kiros Yazezew Kebede, 2017, BMC Res Notes, V10, P169, DOI 10.1186/s13104-017-2490-3; Leta S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003131; Ministry of Health, 2013, GUID DIAGN TREATM PR, V2; Ministry of Health, 2018, NAT GUID US ANT DRUG; Mohebali M, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4935-x; Teixeira AIP, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760180452; Reiter-Owona I, 2016, PARASITOL RES, V115, P761, DOI 10.1007/s00436-015-4801-8; SIDDIG M, 1988, T ROY SOC TROP MED H, V82, P66, DOI 10.1016/0035-9203(88)90265-9; Sundar S, 2002, CLIN DIAGN LAB IMMUN, V9, P951, DOI 10.1128/CDLI.9.5.951-958.2002; Sundar S, 2008, TROP MED INT HEALTH, V13, P2, DOI 10.1111/j.1365-3156.2007.01974.x; Sundar S, 2018, MOL DIAGN THER, V22, P443, DOI 10.1007/s40291-018-0343-y; ter Horst R, 2009, AM J TROP MED HYG, V80, P929, DOI 10.4269/ajtmh.2009.80.929; WHO, 2010, WORKING TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: FIRST WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1; Wolday D, 2001, MED MICROBIOL IMMUN, V190, P65, DOI 10.1007/s004300100082; ZIJLSTRA EE, 1992, T ROY SOC TROP MED H, V86, P505, DOI 10.1016/0035-9203(92)90086-R; Zijlstra EE, 2001, T ROY SOC TROP MED H, V95, pS27, DOI 10.1016/S0035-9203(01)90218-4	41	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0253303	10.1371/journal.pone.0253303	http://dx.doi.org/10.1371/journal.pone.0253303			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125865	gold, Green Published			2022-12-26	WOS:000664643500032
J	Morris, ERA; Boyle, AG; Riihimaki, M; Aspan, A; Anis, E; Hillhouse, AE; Ivanov, I; Bordin, AI; Pringle, J; Cohen, ND				Morris, Ellen Ruth A.; Boyle, Ashley G.; Riihimaeki, Miia; Aspan, Anna; Anis, Eman; Hillhouse, Andrew E.; Ivanov, Ivan; Bordin, Angela I.; Pringle, John; Cohen, Noah D.			Differences in the genome, methylome, and transcriptome do not differentiate isolates of Streptococcus equi subsp. equi from horses with acute clinical signs from isolates of inapparent carriers	PLOS ONE			English	Article							GENE-EXPRESSION; SILENT CARRIERS; DNA METHYLATION; STRANGLES; INFECTION; CULTURE; PERSISTENT; PATHOGEN; OUTBREAK; BACTERIA	Streptococcus equi subsp. equi (SEE) is a host-restricted bacterium that causes the common infectious upper respiratory disease known as strangles in horses. Perpetuation of SEE infection appears attributable to inapparent carrier horses because it neither persists long-term in the environment nor infects other host mammals or vectors, and infection results in short-lived immunity. Whether pathogen factors enable SEE to remain in horses without causing clinical signs remains poorly understood. Thus, our objective was to use next-generation sequencing technologies to characterize the genome, methylome, and transcriptome of isolates of SEE from horses with acute clinical strangles and inapparent carrier horses-including isolates recovered from individual horses sampled repeatedly-to assess pathogen-associated changes that might reflect specific adaptions of SEE to the host that contribute to inapparent carriage. The accessory genome elements and methylome of SEE isolates from Sweden and Pennsylvania revealed no significant or consistent differences between acute clinical and inapparent carrier isolates of SEE. RNA sequencing of SEE isolates from Pennsylvania demonstrated no genes that were differentially expressed between acute clinical and inapparent carrier isolates of SEE. The absence of specific, consistent changes in the accessory genomes, methylomes, and transcriptomes of acute clinical and inapparent carrier isolates of SEE indicates that adaptations of SEE to the host are unlikely to explain the carrier state of SEE. Efforts to understand the carrier state of SEE should instead focus on host factors.	[Morris, Ellen Ruth A.; Bordin, Angela I.; Cohen, Noah D.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA; [Boyle, Ashley G.] Univ Penn, Sch Vet Med, Dept Clin Studies, New Bolton Ctr, Kennett Sq, PA 19348 USA; [Riihimaeki, Miia; Aspan, Anna; Pringle, John] Swedish Univ Agr Sci, Dept Clin Sci, Uppsala, Sweden; [Anis, Eman] Univ Penn, New Bolton Ctr, Sch Vet Med, Dept Pathobiol, Kennett Sq, PA 19348 USA; [Hillhouse, Andrew E.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, College Stn, TX USA; [Hillhouse, Andrew E.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Texas A&M Inst Genome Sci & Soc, College Stn, TX USA; [Ivanov, Ivan] Texas A&M Univ, Dept Vet Physiol & Pharmacol, Coll Vet Med & Biomed Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University of Pennsylvania; Swedish University of Agricultural Sciences; University of Pennsylvania; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Cohen, ND (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Large Anim Clin Sci, College Stn, TX 77843 USA.	ncohen@cvm.tamu.edu	Pringle, John/E-8332-2019	Pringle, John/0000-0003-4013-0363; Cohen, Noah/0000-0002-0384-2903; Ivanov, Ivan/0000-0002-5323-8325; Alexander Morris, Ellen Ruth/0000-0002-7957-4642; Aspan, Anna/0000-0001-6374-1154	Link Equine Research Endowment, College of Veterinary Medicine & Biomedical Sciences, Texas AM University; Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Science, Texas AM University; Patsy Link Chair in Equine Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) [221-2013-606]	Link Equine Research Endowment, College of Veterinary Medicine & Biomedical Sciences, Texas AM University; Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Science, Texas AM University; Patsy Link Chair in Equine Research; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas)	Funding for the whole genome sequencing of the isolates was provided by the Link Equine Research Endowment, College of Veterinary Medicine & Biomedical Sciences, Texas A&M University. Funding for the RNA-Seq portion of the study was provided by a grant from the Department of Large Animal Clinical Sciences, College of Veterinary Medicine & Biomedical Science, Texas A&M University. Dr. Cohen is supported by the Patsy Link Chair in Equine Research. Funding for the Swedish contribution to this work was provided by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) grant #221-2013-606. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blow MJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005854; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boyle AG, 2018, J VET INTERN MED, V32, P633, DOI 10.1111/jvim.15043; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Casselli T, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00395-18; Chanter N, 2000, MICROBIOL-UK, V146, P1361, DOI 10.1099/00221287-146-6-1361; Davis JJ, 2020, NUCLEIC ACIDS RES, V48, pD606, DOI 10.1093/nar/gkz943; Durham AE, 2018, EQUINE VET J, V50, P861, DOI 10.1111/evj.12840; Durham AE, 2021, EQUINE VET J, V53, P38, DOI 10.1111/evj.13276; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Flusberg BA, 2010, NAT METHODS, V7, P461, DOI [10.1038/NMETH.1459, 10.1038/nmeth.1459]; Gomez-Gonzalez PJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41692-2; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Harris SR, 2015, GENOME RES, V25, P1360, DOI 10.1101/gr.189803.115; Heather Z, 2008, MOL MICROBIOL, V70, P1274, DOI 10.1111/j.1365-2958.2008.06481.x; Holden MTG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000346; Jolley KA, 2012, MICROBIOL-SGM, V158, P1005, DOI 10.1099/mic.0.055459-0; Kelly C, 2006, J CLIN MICROBIOL, V44, P480, DOI 10.1128/JCM.44.2.480-486.2006; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Morris ERA, 2020, VET MICROBIOL, V243, DOI 10.1016/j.vetmic.2020.108638; Newton JR, 2000, EQUINE VET J, V32, P515, DOI 10.2746/042516400777584721; Newton JR, 1997, VET REC, V140, P84, DOI 10.1136/vr.140.4.84; Nye TM, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007841; Ozer EA, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2154-x; Ozer EA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-737; Paillot R, 2017, EQUINE VET J, V49, P141, DOI 10.1111/evj.12659; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pringle J, 2019, VET J, V246, P66, DOI 10.1016/j.tvjl.2019.02.003; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Riihimaki M, 2018, VET MICROBIOL, V223, P107, DOI 10.1016/j.vetmic.2018.07.016; Roberts RJ, 2015, NUCLEIC ACIDS RES, V43, pD298, DOI 10.1093/nar/gku1046; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Roosaare M, 2017, PEERJ, V5, DOI 10.7717/peerj.3353; Sanchez-Romero MA, 2015, CURR OPIN MICROBIOL, V25, P9, DOI 10.1016/j.mib.2015.03.004; Segerman B, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00116; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Slater JD, 2003, EQUINE VET J, V35, P118, DOI 10.2746/042516403776114252; Steward KF, 2016, MOL BIOSYST, V12, P1194, DOI 10.1039/c5mb00780a; Sweeney CR, 2005, J VET INTERN MED, V19, P123, DOI 10.1892/0891-6640(2005)19&lt;123:SEIIHG&gt;2.0.CO;2; Verheyen K, 2000, EQUINE VET J, V32, P527, DOI 10.2746/042516400777584703; Waller AS, 2011, J MED MICROBIOL, V60, P1231, DOI 10.1099/jmm.0.028233-0; Webb K, 2008, MICROBIOL-SGM, V154, P3016, DOI 10.1099/mic.0.2008/018911-0; Weese JS, 2009, CAN VET J, V50, P968	45	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252804	10.1371/journal.pone.0252804	http://dx.doi.org/10.1371/journal.pone.0252804			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125848	gold, Green Published			2022-12-26	WOS:000664643500016
J	Rozario, LT; Sharker, T; Nila, TA				Rozario, Liza Teresa; Sharker, Tanima; Nila, Tasnin Akter			In silico analysis of deleterious SNPs of human MTUS1 gene and their impacts on subsequent protein structure and function	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MUTATIONS; CANCER; IDENTIFICATION; EXPRESSION; STABILITY; VARIANTS; SEQUENCE; SERVER; WEB	The mitochondrial tumor suppressor 1 (MTUS1) gene acts as a crucial tumor suppressor by inhibiting growth and proliferation of eukaryotic cells including tumor cell lines. Down regulation of MTUS1 gene has been implicated in a wide range of cancers as well as various human diseases. Alteration through nsSNPs can potentially damage the structure and/or function of the protein. As characterization of functional SNPs in such disease linked genes is a major challenge, it is feasible to analyze putative functional SNPs prior to performing larger population studies. Hence, in this in silico study we differentiated the potentially harmful nsSNPs of the MTUS1 gene from the neutral ones by using various sequence and structure based bioinformatic tools. In a total of 215 nsSNPs, 9 were found to be most likely to exert deleterious effect using 7 prediction tools. From which, 5nsSNPs (S1259L, E960K, P503T, L1084V and L1143Q) were selected as potentially damaging due to their presence in the highly conserved region and ability to decrease protein stability. In fact, 2 nsSNPs (S1259L and E960K) among these 5 were found to be individually associated with two distinctive cancers named Stomach adenocarcinoma and Uterine corpus endometrial carcinoma. As this is the first comprehensive study analyzing the functional nsSNPs of MTUS1, the results of the current study would certainly be helpful in future prospects concerning large population-based studies as well as drug discovery, especially developing individualized medicine.	[Rozario, Liza Teresa; Sharker, Tanima] Noakhali Sci & Technol Univ, Dept Biochem & Mol Biol, Noakhali, Bangladesh; [Nila, Tasnin Akter] Univ Dhaka, Dept Biochem & Mol Biol, Dhaka, Bangladesh	Noakhali Science & Technology University (NSTU); University of Dhaka	Rozario, LT (corresponding author), Noakhali Sci & Technol Univ, Dept Biochem & Mol Biol, Noakhali, Bangladesh.	teresa.bmb@nstu.edu.bd						Adiba Maisha, 2021, Informatics in Medicine Unlocked, V24, DOI 10.1016/j.imu.2021.100556; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Bromberg Y, 2008, BIOINFORMATICS, V24, P2397, DOI 10.1093/bioinformatics/btn435; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; Clark TG, 2003, BRIT J CANCER, V89, P232, DOI 10.1038/sj.bjc.6601118; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Dakal TC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06575-4; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Deller MC, 2016, ACTA CRYSTALLOGR F, V72, P72, DOI 10.1107/S2053230X15024619; Di Benedetto M, 2006, GENE, V380, P127, DOI 10.1016/j.gene.2006.05.021; Di Benedetto M, 2006, MOL CELL ENDOCRINOL, V252, P207, DOI 10.1016/j.mce.2006.03.014; Ding XQ, 2012, MOL ONCOL, V6, P73, DOI 10.1016/j.molonc.2011.11.002; Doss CGP, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-10; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Guo Li-Li, 2005, Yichuan, V27, P523; Guo XE, 2014, CURR DRUG TARGETS, V15, P2, DOI 10.2174/1389450114666140106095151; Hossain A.B.M.A, 2018, J BIOL SCI, V18, P178, DOI [10.3923/jbs.2018.178.191, DOI 10.3923/JBS.2018.178.191]; Hossain MS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71457-1; IKEGAKI N, 1989, EMBO J, V8, P1793, DOI 10.1002/j.1460-2075.1989.tb03573.x; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Jin Q, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.87; Kamaraj B, 2013, J MOL MODEL, V19, P5587, DOI 10.1007/s00894-013-2044-0; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mitsopoulos C, 2021, NUCLEIC ACIDS RES, V49, pD1074, DOI 10.1093/nar/gkaa1059; Nagy A, 2021, INT J CANCER, V148, P502, DOI 10.1002/ijc.33283; Nouet S, 2004, J BIOL CHEM, V279, P28989, DOI 10.1074/jbc.M403880200; Petersen B, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-51; Ping H, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317713389; Rodrigues-Ferreira S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007239; Seibold S, 2003, FASEB J, V17, P1180, DOI 10.1096/fj.02-0934fje; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Strub Caroline, 2004, BMC Biochemistry, V5, P9, DOI 10.1186/1471-2091-5-9; Surget S, 2014, ONCOTARGETS THER, V7, P57, DOI 10.2147/OTT.S53876; Tang HM, 2016, BIOINFORMATICS, V32, P2230, DOI 10.1093/bioinformatics/btw222; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang Li-Hui, 2018, Cell Physiol Biochem, V51, P2647, DOI 10.1159/000495956; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Wu T, 2010, J BIOL CHEM, V285, P18291, DOI 10.1074/jbc.M110.106575; Yang F, 2008, J CELL BIOL, V180, P673, DOI 10.1083/jcb.200709057; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yin JH, 2004, HUM MOL GENET, V13, P2421, DOI 10.1093/hmg/ddh269; Yue P, 2006, J MOL BIOL, V356, P1263, DOI 10.1016/j.jmb.2005.12.025; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zindy PJ, 2006, HEPATOLOGY, V44, P1296, DOI 10.1002/hep.21367	56	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252932	10.1371/journal.pone.0252932	http://dx.doi.org/10.1371/journal.pone.0252932			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125870	Green Published, gold			2022-12-26	WOS:000664643500017
J	Walter, SS; Lorbeer, R; Hefferman, G; Schlett, CL; Peters, A; Rospleszcz, S; Nikolaou, K; Bamberg, F; Notohamiprodjo, M; Maurer, E				Walter, Sven S.; Lorbeer, Roberto; Hefferman, Gerald; Schlett, Christopher L.; Peters, Anette; Rospleszcz, Susanne; Nikolaou, Konstantin; Bamberg, Fabian; Notohamiprodjo, Mike; Maurer, Elke			Correlation between thoracolumbar disc degeneration and anatomical spinopelvic parameters in supine position on MRI	PLOS ONE			English	Article							LOW-BACK-PAIN; SAGITTAL ALIGNMENT; LUMBAR LORDOSIS; SPINE; POPULATION; PELVIS; ASSOCIATION; BALANCE; ATHEROSCLEROSIS; CLASSIFICATION	Objective This study aims to investigate the correlation between spinopelvic parameters in supine position (pelvic incidence (PI), sacral slope (SS), pelvic tilt (PT), lumbar lordosis (LL)), disc degeneration and herniation of the thoracolumbar spine, as well as cardiovascular risk factors and back pain in a southern German cohort from the general population. Methods This study is a cross-sectional, case-control study drawn from a prospective cohort of the "Cooperative Health Research in the Region of Augsburg/Kooperative Gesundheitsforschung in der Region Augsburg" study (KORA). In total, 374 participants (mean age 56.4 9.2 years; 57.8% male) from the whole-body MRI cohort (FF4) were included. All participants underwent a standardized whole-body MRI on which disc degeneration of the thoracic and lumbar spine was evaluated using a sequence adapted Pfirrmann score. PI, PT, SS and LL were measured according to the description in the literature, using sagittal imaging. Furthermore, disc bulging and protrusion were assessed. Correlations were estimated by logistic regression models providing odds ratios. Results Mean PI was 54.0 degrees +/- 11.1 degrees, PT 13.0 degrees +/- 5.8 degrees, SS 40.2 degrees +/- 8.8 degrees and LL 36.2 degrees +/- 9.6 degrees. SS was greater in men (p<0.05) and lumbar lordosis in women (p<0.001). PT increased by 0.09 degrees per age-year with rising age. Age was not associated with PI, SS and LL. Neither BMI, hypertension, cholesterol, lipid levels, nor physical activity were associated with PI, PT, SS or LL. Diabetes mellitus negatively correlated with SS (beta = -4.19; 95%CI -7.31-1.06, p<0.01). Smaller spinopelvic parameters (PI, SS and LL) where significantly (p<0.05) correlated with an increased frequency of disc bulging, as well as a local clustering in the lumbar, but not the thoracic spine. Conclusion In conclusion, spinopelvic parameters, measured in supine position, are significantly correlated with disc bulging alone; there is no significant correlation between supine spinopelvic parameters and disc degeneration, back pain or cardiovascular risk factors.	[Walter, Sven S.; Nikolaou, Konstantin; Notohamiprodjo, Mike] Eberhard Karls Univ Tuebingen, Univ Hosp Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Lorbeer, Roberto] Ludwig Maximilian Univ Hosp, Dept Radiol, Munich, Germany; [Hefferman, Gerald] Brigham & Womens Hosp, Dept Radiol, 75 Francis St, Boston, MA 02115 USA; [Hefferman, Gerald] Harvard Med Sch, Boston, MA 02115 USA; [Schlett, Christopher L.; Bamberg, Fabian] Univ Freiburg, Med Ctr, Dept Diagnost & Intervent Radiol, Freiburg, Germany; [Peters, Anette; Rospleszcz, Susanne] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol, Neuherberg, Germany; [Peters, Anette; Rospleszcz, Susanne] Ludwig Maximilians Univ Munchen, Med Fac, Inst Med Informat Proc Biometry & Epidemiol, Munich, Germany; [Peters, Anette] German Ctr Diabet Res DZD, Partner Site Neuherberg, Neuherberg, Germany; [Notohamiprodjo, Mike] Die Radiol, Munich, Germany; [Maurer, Elke] Eberhard Karls Univ Tuebingen, BG Unfallklin Tuebingen, Dept Trauma & Reconstruct Surg, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Freiburg; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Notohamiprodjo, M (corresponding author), Eberhard Karls Univ Tuebingen, Univ Hosp Tuebingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany.; Notohamiprodjo, M (corresponding author), Die Radiol, Munich, Germany.	mike.notohamiprodjo@uni-tuebingen.de	Hefferman, Gerald/AAI-1568-2020; Rospleszcz, Susanne/AGF-1630-2022	Hefferman, Gerald/0000-0002-5135-3282; Rospleszcz, Susanne/0000-0002-4788-2341				Asai Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178697; Bamberg F, 2017, DIABETES, V66, P158, DOI 10.2337/db16-0630; Barrey C, 2007, EUR SPINE J, V16, P1459, DOI 10.1007/s00586-006-0294-6; Boulay C, 2006, EUR SPINE J, V15, P415, DOI 10.1007/s00586-005-0984-5; Chevillotte T, 2018, ORTHOP TRAUMATOL-SUR, V104, P565, DOI 10.1016/j.otsr.2018.06.005; Chun SW, 2017, SPINE J, V17, P1180, DOI 10.1016/j.spinee.2017.04.034; DURING J, 1985, SPINE, V10, P83, DOI 10.1097/00007632-198501000-00013; DUVALBEAUPERE G, 1992, ANN BIOMED ENG, V20, P451, DOI 10.1007/BF02368136; Habibi Z, 2014, ASIAN SPINE J, V8, P813, DOI 10.4184/asj.2014.8.6.813; Hangai M, 2008, SPINE J, V8, P732, DOI 10.1016/j.spinee.2007.07.392; Holle R, 2005, GESUNDHEITSWESEN, V67, pS19, DOI 10.1055/s-2005-858235; Izumi Y, 2001, EUR J ORTHOP SURG TR, V11, P9; Jackson RP, 1998, SPINE, V23, P1750, DOI 10.1097/00007632-199808150-00008; Kauppila LI, 2009, EUR J VASC ENDOVASC, V37, P661, DOI 10.1016/j.ejvs.2009.02.006; Kumar MN, 2001, EUR SPINE J, V10, P314, DOI 10.1007/s005860000239; Le Huec J C, 2011, Eur Spine J, V20 Suppl 5, P564, DOI 10.1007/s00586-011-1940-1; Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038; Andreasen ML, 2007, J MANIP PHYSIOL THER, V30, P26, DOI 10.1016/j.jmpt.2006.11.009; Longo UG, 2011, EUR SPINE J, V20, P1658, DOI 10.1007/s00586-011-1737-2; Maurer E., 2020, SPINE J; Maurer E, 2022, ACTA RADIOL, V63, P750, DOI 10.1177/02841851211010391; Mehta VA, 2012, NEUROSURGERY, V70, P707, DOI 10.1227/NEU.0b013e31823262ea; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; POWELL MC, 1986, LANCET, V2, P1366; Romero-Vargas S, 2013, EUR SPINE J, V22, P878, DOI 10.1007/s00586-012-2560-0; Roussouly P, 2003, REV CHIR ORTHOP, V89, P632; Roussouly P., 2011, EUR SPINE J, V20, P609, DOI 10.1007/s00586-011-1928-x; Shcherbina A, 2017, PM&R, V9, P1144, DOI 10.1016/j.pmrj.2017.04.007; Takatalo J, 2017, SCAND J MED SCI SPOR, V27, P1993, DOI 10.1111/sms.12840; Takatalo J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056244; Teraguchi M, 2014, OSTEOARTHR CARTILAGE, V22, P104, DOI 10.1016/j.joca.2013.10.019; Teraguchi M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147565; Urrutia J, 2016, EUR SPINE J, V25, P2728, DOI 10.1007/s00586-016-4438-z; Vaz G, 2002, EUR SPINE J, V11, P80, DOI 10.1007/s005860000224; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043; Vollner F, 2019, ORTHOPADE, V48, P44, DOI 10.1007/s00132-018-03673-7; Wang Q, 2019, J ORTHOP SURG RES, V14, DOI 10.1186/s13018-019-1156-3; Yang X, 2014, EUR SPINE J, V23, P569, DOI 10.1007/s00586-013-3067-z; Zarate-Kalfopulos B, 2019, WORLD NEUROSURG, V126, pE417, DOI 10.1016/j.wneu.2019.02.067; Zawojska K, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55100627; Zhang YD, 2016, LIPIDS HEALTH DIS, V15, DOI 10.1186/s12944-016-0248-x	41	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252385	10.1371/journal.pone.0252385	http://dx.doi.org/10.1371/journal.pone.0252385			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106962	Green Published, gold			2022-12-26	WOS:000664642200046
J	McDonald, TS; Kumar, V; Fung, JN; Woodruff, TM; Lee, JD				McDonald, Tanya S.; Kumar, Vinod; Fung, Jenny N.; Woodruff, Trent M.; Lee, John D.			Glucose clearance and uptake is increased in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis through an insulin-independent mechanism	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis; glucagon; glucose tolerance; glycogen; insulin; liver metabolism	BODY-MASS INDEX; CARBOHYDRATE-METABOLISM; FDG-PET; ALS; MUSCLE; SIGNATURES; TOLERANCE; PATHOLOGY; GLUCAGON	Metabolic disturbances are associated with the progression of the neurodegenerative disorder, amyotrophic lateral sclerosis (ALS). However, the molecular events that drive energy imbalances in ALS are not completely understood. In this study, we aimed to elucidate deficits in energy homeostasis in the SOD1(G93A) mouse model of ALS. SOD1(G93A) mice and their wild-type littermates underwent indirect calorimetry and intraperitoneal glucose/insulin tolerance tests at both the onset and mid-symptomatic stages of the disease. Glucose uptake and the plasma glucoregulatory hormone profiles were analyzed. Pancreatic islet cell mass and function were assessed by measuring hormone concentrations and secretion in isolated islets, and pancreatic alpha- and beta-cell immunoreactive areas. Finally, we profiled liver glycogen metabolism by measuring glucagon concentrations and liver metabolic gene expressions. We identified that mid-symptomatic SOD1(G93A) mice have increased oxygen consumption and faster exogenous glucose uptake, despite presenting with normal insulin tolerance. The capacity for pancreatic islets to secrete insulin appears intact, however, islet cell insulin concentrations and beta-cell mass were reduced. Fasting glucose homeostasis was also disturbed, along with increased liver glycogen stores, despite elevated circulating glucagon, suggesting that glucagon signaling is impaired. Metabolic gene expression profiling of livers indicated that glucose cannot be utilized efficiently in SOD1(G93A) mice. Overall, we demonstrate that glucose homeostasis and uptake are altered in SOD1(G93A) mice, which is linked to an increase in insulin-independent glucose uptake, and a loss of beta-cells, insulin production, and glucagon sensitivity. This suggests that the hormonal regulation of glucose concentrations may contribute to the progression of disease in this ALS mouse model.	[McDonald, Tanya S.; Kumar, Vinod; Fung, Jenny N.; Woodruff, Trent M.; Lee, John D.] Univ Queensland, Sch Biomed Sci, Skerman Bldg, Brisbane, Qld 4072, Australia; [Woodruff, Trent M.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Lee, JD (corresponding author), Univ Queensland, Sch Biomed Sci, Skerman Bldg, Brisbane, Qld 4072, Australia.	j.lee9@uq.edu.au	Kumar, Vinod/ABC-4866-2020; Woodruff, Trent M/B-4861-2009; Lee, John/Y-2066-2018	Kumar, Vinod/0000-0002-2775-6049; Woodruff, Trent M/0000-0003-1382-911X; McDonald, Tanya/0000-0003-4325-3537; Lee, John/0000-0002-9976-7396	Motor Neuron Disease Research Australia (MNDRA) Postdoctoral Fellowship [PDF1604]; National Health and Medical Research Council (NHMRC) [APP1082271]; MNDRA [IG1930]	Motor Neuron Disease Research Australia (MNDRA) Postdoctoral Fellowship; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); MNDRA	JDL was supported by Motor Neuron Disease Research Australia (MNDRA) Postdoctoral Fellowship (PDF1604), and the research was funded by grants from the National Health and Medical Research Council (NHMRC; Project grant APP1082271) and MNDRA (IG1930)	Ahmed RM, 2014, J NEUROL, V261, P1774, DOI 10.1007/s00415-014-7416-6; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1038/nrdp.2017.85, 10.1056/NEJMra1603471, 10.1056/NEJMc1710379, 10.1016/S0140-6736(17)31287-4, 10.1016/S0140-6736(10)61156-7, 10.1038/nrdp.2017.71]; Browne SE, 2006, NEUROBIOL DIS, V22, P599, DOI 10.1016/j.nbd.2006.01.001; Cistaro A, 2012, EUR J NUCL MED MOL I, V39, P251, DOI 10.1007/s00259-011-1979-6; Desseille C, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00332; Dodge JC, 2013, P NATL ACAD SCI USA, V110, P10812, DOI 10.1073/pnas.1308421110; Dupuis L, 2004, P NATL ACAD SCI USA, V101, P11159, DOI 10.1073/pnas.0402026101; Dupuis L, 2010, CURR DRUG TARGETS, V11, P1250, DOI 10.2174/1389450111007011250; Genton L, 2011, CLIN NUTR, V30, P553, DOI 10.1016/j.clnu.2011.06.004; GOTOH F, 1972, J NEUROL SCI, V16, P201, DOI 10.1016/0022-510X(72)90089-5; Grad LI, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024117; Graham KL, 2016, BIOPROTOC, V6, P1840, DOI [10.21769/BioProtoc.1840, DOI 10.21769/BIOPROTOC.1840, 10.21769/ BioProtoc.1840]; Han HS, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2015.122; HARNO K, 1984, ACTA NEUROL SCAND, V70, P451; HARRIS MD, 1986, J CLIN ENDOCR METAB, V63, P41; HUBBARD RW, 1992, NEUROLOGY, V42, P1532, DOI 10.1212/WNL.42.8.1532; KARPATI G, 1979, CAN J NEUROL SCI, V6, P105, DOI 10.1017/S0317167100119481; Kasarskis EJ, 1996, AM J CLIN NUTR, V63, P130, DOI 10.1093/ajcn/63.1.130; Kioumourtzoglou MA, 2015, JAMA NEUROL, V72, P905, DOI 10.1001/jamaneurol.2015.0910; Lee JD, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1435-2; Lee JD, 2017, BRIT J PHARMACOL, V174, P689, DOI 10.1111/bph.13730; Lee JD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-119; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lutz C, 2018, BRAIN RES, V1693, P1, DOI 10.1016/j.brainres.2018.03.024; Mariosa D, 2015, EUR J NEUROL, V22, P1436, DOI 10.1111/ene.12632; Ngo ST, 2015, J NEUROL SCI, V357, P22, DOI 10.1016/j.jns.2015.06.053; Okuno T, 2015, BIOACTIVE LIPID MEDI, P331, DOI [10.1007/978-4-431-55669-5_23, DOI 10.1007/978-4-431-55669-5_23]; Pagani M, 2014, NEUROLOGY, V83, P1067, DOI 10.1212/WNL.0000000000000792; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Palamiuc L, 2015, EMBO MOL MED, V7, P526, DOI 10.15252/emmm.201404433; Poulton K R, 1993, Funct Neurol, V8, P33; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; REYES ET, 1984, J NEUROL SCI, V63, P317, DOI 10.1016/0022-510X(84)90154-0; SAFFER D, 1977, J NEUROL NEUROSUR PS, V40, P533, DOI 10.1136/jnnp.40.6.533; Scaricamazza S, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101087; Smittkamp SE, 2014, NEURODEGENER DIS, V13, P29, DOI 10.1159/000351606; Spiers JG, 2017, STRESS, V20, P59, DOI 10.1080/10253890.2016.1276898; Stallings NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071793; Sun Y, 2015, J EPIDEMIOL, V25, P445, DOI 10.2188/jea.JE20140176; Szelechowski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22318-5; Tefera TW, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00611; Valbuena GN, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01276; Vandoorne T, 2018, ACTA NEUROPATHOL, V135, P489, DOI 10.1007/s00401-018-1835-x; Wang HTA, 2017, SKELET MUSCLE, V7, DOI 10.1186/s13395-017-0128-8; Zarei Sara, 2015, Surg Neurol Int, V6, P171, DOI 10.4103/2152-7806.169561; Zeng MF, 2018, J CHROMATOGR B, V1083, P137, DOI 10.1016/j.jchromb.2018.02.040	48	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21707	10.1096/fj.202002450R	http://dx.doi.org/10.1096/fj.202002450R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118098	Green Submitted			2022-12-26	WOS:000667814100018
J	Zeleke, S; Kassaw, A; Eshetie, Y				Zeleke, Shegaw; Kassaw, Amare; Eshetie, Yeshambaw			Non-pharmacological pain management practice and barriers among nurses working in Debre Tabor Comprehensive Specialized Hospital, Ethiopia	PLOS ONE			English	Article							KNOWLEDGE; ATTITUDE; CARE	Background Pain is an unpleasant sensory and emotional experience associated with or resembling that actual or potential tissue damage. Different study findings show that about 55% to 78.6% of inpatients experience moderate-to-severe pain. Nurses are one of the health professional who may hear of pain suffered by the patients and who can manage patient suffering by themselves. Therefore, their correct skill is very important in non- pharmacology and pharmacology pain management methods. Objective To assess non-pharmacological pain management practice and barriers among nurses working in Debre Tabor Comprehensive Specialized Hospital, Ethiopia. Methods Data were collected using structured observational check list with interviewer administered questionnaires that measure nurses' practice on non-pharmacological pain management. Data were entered using Epi Data version 3.1 and analyzed using SPSS (Stastical Package for Social Sciences) version 23. Bivariable and multivariable analysis were conducted to examine the association between independent and outcome variables. Results A total of 169 nurses participated in the study, with a response rate of 100%. Among the study participants 94 (55.6%) were females, and the mean age of nurses were 34.9(SD = 5.7) years. Only 44(26%) of nurses had good practice on non- pharmacology pain management methods. About 130(77.55%), 125(74.0%), and 123(72.8%) of nurses reported that inadequate cooperation of physicians, multiple responsibilities of nurses and insufficient number of nurses per patient ratio as barriers for practice of non -pharmacology pain management respectively. Conclusion Majority of nurses didn't apply non-pharmacological pain management practices for their patients in pain and the overall practice level of nurses was very poor. The major identified obstacle factors for the poor practice of non-pharmacological pain management methods were nurses' fatigue, inadequate cooperation of physicians, heavy workload, multiple responsibilities of nurses, and insufficient number of nurses per patient ratio and unfavorable attitude of nurse on non-pharmacology pain management. Even if nurses experiences different challenges, they shall use non-pharmacological pain management methods complementary to pharmacological treatment of pain as they are low cost and safe. And also boosting nurse's attitude towards the effect of non-pharmacological pain management methods is crucial.	[Zeleke, Shegaw; Eshetie, Yeshambaw] Debre Tabor Univ, Coll Hlth Sci, Dept Adult Hlth Nursing, Debre Tabor, Ethiopia; [Kassaw, Amare] Debre Tabor Univ, Coll Hlth Sci, Dept Pediat, Debre Tabor, Ethiopia; [Kassaw, Amare] Debre Tabor Univ, Coll Hlth Sci, Dept Child Hlth Nursing, Debre Tabor, Ethiopia		Zeleke, S (corresponding author), Debre Tabor Univ, Coll Hlth Sci, Dept Adult Hlth Nursing, Debre Tabor, Ethiopia.	shegawzn@gmail.com	Zeleke, Shegaw/AHA-7554-2022	Zeleke, Shegaw/0000-0002-3555-0147				Ali H.S., 2013, LIFE SCI J, V2; Ali NS, 2015, EGYPTIAN J NURSING, V10; Alzghoul Bashar I, 2015, Glob J Health Sci, V8, P154, DOI 10.5539/gjhs.v8n6p154; Benimana O., 2017, KNOWLEDGE ATTITUDES, DOI [10.4155/fmc-2017-0001, DOI 10.4155/FMC-2017-0001]; Bicek E, 2004, NURSES ATTITUDES KNO; Callister LC, 2003, HOME HLTH CARE MANAG, V15, P207, DOI [DOI 10.1177/1084822302250687, 10.1177/1084822302250687]; Craig KD, 2009, CAN PSYCHOL, V50, P22, DOI 10.1037/a0014772; Dukes IM., 2018, INCREASING PATIENT S; El Geziry A., 2018, PAIN MANAGEMENT SPEC, P1, DOI [10.5772/intechopen.79689, DOI 10.5772/INTECHOPEN.79689]; Fosnocht D., 2005, ANN EMERG MED, V3, P49; Fosnocht DE, 2004, AM J EMERG MED, V22, P286, DOI 10.1016/j.ajem.2004.04.011; Hossain MS., 2010, NURSES KNOWLEDGE ATT; Jira L, 2020, J PAIN RES, V13, P2917, DOI 10.2147/JPR.S265544; Khallil NS, 2018, APPL NURS RES, V44, P33, DOI 10.1016/j.apnr.2018.09.001; Kia Z, 2021, COMPLEMENT THER MED, V58, DOI 10.1016/j.ctim.2021.102705; Kumar S, 2013, CURR OPIN SUPPORT PA, V7, P216, DOI 10.1097/SPC.0b013e3283610255; Kwekkeboom K L, 2001, Crit Care Nurs Clin North Am, V13, P181; Lakha SF, 2016, MED PRIN PRACT, V25, P29, DOI 10.1159/000442526; Linton SJ, 2011, PHYS THER, V91, P700, DOI 10.2522/ptj.20100330; Liyew B, 2020, PAIN RES MANAG, V2020, DOI 10.1155/2020/6036575; Lui LYY, 2008, J CLIN NURS, V17, P2014, DOI 10.1111/j.1365-2702.2007.02183.x; Manwere A., 2015, HLTH SCI J, V9, P1; Moceri JT, 2014, J EMERG NURS, V40, P6, DOI 10.1016/j.jen.2012.04.014; Raja SN, 2020, PAIN, V161, P1976, DOI 10.1097/j.pain.0000000000001939; Rawlinson F., 2014, ECANCERMEDICALSCIENC, P8; Snell K., PALLIATIVE CARE CURR; Snyder JS., 2019, PHARM NURSING PROCES; Woldehaimanot TE, 2014, EUR J THER, V20, P254, DOI 10.5455/GMJ-30-157196	28	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253086	10.1371/journal.pone.0253086	http://dx.doi.org/10.1371/journal.pone.0253086			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129616	gold, Green Published			2022-12-26	WOS:000665475100023
J	Ramirez-Soto, MC; Arroyo-Hernandez, H; Ortega-Caceres, G				Carlos Ramirez-Soto, Max; Arroyo-Hernandez, Hugo; Ortega-Caceres, Gutia			Sex differences in the incidence, mortality, and fatality of COVID-19 in Peru	PLOS ONE			English	Article								Background There is a worrying lack of epidemiological data on the sex differential in COVID-19 infection and death rates between the regions of Peru. Methods Using cases and death data from the national population-based surveillance system of Peru, we estimated incidence, mortality and fatality, stratified by sex, age and geographic distribution (per 100,000 habitants) from March 16 to November 27, 2020. At the same time, we calculated the risk of COVID-19 death. Results During the study period, 961894 cases and 35913 deaths were reported in Peru. Men had a twofold higher risk of COVID-19 death within the overall population of Peru (odds ratio (OR), 2.11; confidence interval (CI) 95%; 2.06-2.16; p<0.00001), as well as 20 regions of Peru, compared to women (p<0.05). There were variations in incidence, mortality and fatality rates stratified by sex, age, and region. The incidence rate was higher among men than among women (3079 vs. 2819 per 100,000 habitants, respectively). The mortality rate was two times higher in males than in females (153 vs. 68 per 100,000 habitants, respectively). The mortality rates increased with age, and were high in men 60 years of age or older. The fatality rate was two times higher in men than in women (4.96% vs. 2.41%, respectively), and was high in men 50 years of age or older. Conclusions These findings show the higher incidence, mortality and fatality rates among men than among women from Peru. These rates vary widely by region, and men are at greater risk of COVID-19 death. In addition, the mortality and fatality rates increased with age, and were most predominant in men 50 years of age or older.	[Carlos Ramirez-Soto, Max] Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru; [Carlos Ramirez-Soto, Max] Univ Tecnol Peru, Fac Ciencias Salud, Lima, Peru; [Arroyo-Hernandez, Hugo] Inst Nacl Salud, Oficina Gen Informac & Sistemas, Lima, Peru; [Ortega-Caceres, Gutia] Univ Ricardo Palma, Escuela Posgrad, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Tecnologica del Peru; Instituto Nacional de Salud - Peru; Universidad Ricardo Palma	Ramirez-Soto, MC (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth & Adm, Lima, Peru.; Ramirez-Soto, MC (corresponding author), Univ Tecnol Peru, Fac Ciencias Salud, Lima, Peru.	maxcrs22@gmail.com	Ramírez-Soto, Max Carlos BSc, MPH, FRSPH, MACE/O-7824-2018; Arroyo-Hernandez, Hugo/AAY-1858-2021	Ramírez-Soto, Max Carlos BSc, MPH, FRSPH, MACE/0000-0003-0471-6746; Arroyo-Hernandez, Hugo/0000-0001-5128-7820; Ortega-Caceres, Gutia/0000-0002-3564-5357				Abate BB, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-040129; Anca PS, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13666; Bhopal SS, 2020, LANCET, V396, P532, DOI 10.1016/S0140-6736(20)31748-7; Bouman A, 2005, HUM REPROD UPDATE, V11, P411, DOI 10.1093/humupd/dmi008; Chakravarty D, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1088-9; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Garg S, 2020, MMWR-MORBID MORTAL W, V69, P458, DOI 10.15585/mmwr.mm6915e3; Gebhard C, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00304-9; Global Health 50/50, COVID 19 DAT DIS AG; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Instituto Nacional de Estadistica e Informatica (INEI), 2017, SIT SAL POBL AD MAYO; Klein SL, 2015, T ROY SOC TROP MED H, V109, P9, DOI 10.1093/trstmh/tru167; Kopel J, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00418; Leow MKS, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03097-w; Ministerio de Salud, 2021, SAL SIT COVID 19 PER; Munayco C, 2020, AGING-US, V12, P13869, DOI 10.18632/aging.103687; Muus C, 2021, NAT MED, V27, P546, DOI 10.1038/s41591-020-01227-z; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Penna C, 2020, BRIT J PHARMACOL, V177, P4375, DOI 10.1111/bph.15207; Pradhan A, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00330-7; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; Shi SB, 2020, JAMA CARDIOL, V5, P802, DOI 10.1001/jamacardio.2020.0950; Takahashi T, 2020, NATURE, V588, DOI 10.1038/s41586-020-2700-3; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Zeng FF, 2020, J MED VIROL, V92, P2050, DOI 10.1002/jmv.25989; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	26	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0253193	10.1371/journal.pone.0253193	http://dx.doi.org/10.1371/journal.pone.0253193			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125851	gold, Green Published			2022-12-26	WOS:000664643500026
J	Chuan, MW; Wong, KL; Riyadi, MA; Hamzah, A; Rusli, S; Alias, NE; Lim, CS; Tan, MLP				Chuan, Mu Wen; Wong, Kien Liong; Riyadi, Munawar Agus; Hamzah, Afiq; Rusli, Shahrizal; Alias, Nurul Ezaila; Lim, Cheng Siong; Tan, Michael Loong Peng			Semi-analytical modelling and evaluation of uniformly doped silicene nanotransistors for digital logic gates	PLOS ONE			English	Article							FIELD-EFFECT TRANSISTOR; PERFORMANCE ANALYSIS; BAND-GAP; CARBON; CIRCUITS; SURFACE; DEVICE	Silicene has attracted remarkable attention in the semiconductor research community due to its silicon (Si) nature. It is predicted as one of the most promising candidates for the next generation nanoelectronic devices. In this paper, an efficient non-iterative technique is employed to create the SPICE models for p-type and n-type uniformly doped silicene field-effect transistors (FETs). The current-voltage characteristics show that the proposed silicene FET models exhibit high on-to-off current ratio under ballistic transport. In order to obtain practical digital logic timing diagrams, a parasitic load capacitance, which is dependent on the interconnect length, is attached at the output terminal of the logic circuits. Furthermore, the key circuit performance metrics, including the propagation delay, average power, power-delay product and energy-delay product of the proposed silicene-based logic gates are extracted and benchmarked with published results. The effects of the interconnect length to the propagation delay and average power are also investigated. The results of this work further envisage the uniformly doped silicene as a promising candidate for future nanoelectronic applications.	[Chuan, Mu Wen; Wong, Kien Liong; Hamzah, Afiq; Rusli, Shahrizal; Alias, Nurul Ezaila; Lim, Cheng Siong; Tan, Michael Loong Peng] Univ Teknol Malaysia, Sch Elect Engn, Fac Engn, Skudai, Johor, Malaysia; [Riyadi, Munawar Agus] Diponegoro Univ, Dept Elect Engn, Semarang, Indonesia	Universiti Teknologi Malaysia; Diponegoro University	Tan, MLP (corresponding author), Univ Teknol Malaysia, Sch Elect Engn, Fac Engn, Skudai, Johor, Malaysia.	michael@utm.my	Riyadi, Munawar/G-4039-2011; CHUAN, MU WEN/AAT-6365-2020; Tan, Michael/E-6219-2010	CHUAN, MU WEN/0000-0002-9362-2778; , Afiq Hamzah/0000-0003-0026-9133; Riyadi, Munawar/0000-0003-1407-7116; Tan, Michael/0000-0003-4210-9293	World Class Research Universitas Diponegoro (WCRU) [118-16/UN7.6.1/PP/2021]; UTM Fundamental Research (UTMFR) [Q. J130000.2551.21H51]	World Class Research Universitas Diponegoro (WCRU); UTM Fundamental Research (UTMFR)	1.) Munawar Agus Riyadi -World Class Research Universitas Diponegoro (WCRU) 2021 Grant no. 118-16/UN7.6.1/PP/2021; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. 2.) Michael Tan Loong Peng -UTM Fundamental Research (UTMFR) Vote no.: Q. J130000.2551.21H51; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, INT ROADMAP DEVICES; Borowik P, 2016, SEMICOND SCI TECH, V31, DOI 10.1088/0268-1242/31/11/115004; Celis A, 2016, J PHYS D APPL PHYS, V49, DOI 10.1088/0022-3727/49/14/143001; Chen XC, 2014, MICROELECTRON RELIAB, V54, P1103, DOI 10.1016/j.microrel.2013.12.009; Chien AA, 2013, COMPUTER, V46, P48, DOI 10.1109/MC.2013.431; Chin HC, 2014, J NANOMATER, V2014, DOI 10.1155/2014/879813; Chuan MW, 2021, ADV NANO RES, V10, P91, DOI 10.12989/anr.2021.10.1.091; Chuan MW, 2020, ADV NANO RES, V9, P105, DOI 10.12989/anr.2020.9.2.105; Chuan MW, 2020, SUPERLATTICE MICROST, V140, DOI 10.1016/j.spmi.2020.106429; Chuan MW, 2020, CURR NANOSCI, V16, P595, DOI 10.2174/1573413715666190709120019; Chuan MW, 2020, PHYSICA E, V116, DOI 10.1016/j.physe.2019.113731; Ding Y, 2013, J PHYS CHEM C, V117, P18266, DOI 10.1021/jp407666m; Ding Y, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3211968; Eshkalak MA, 2015, PHYSICA E, V66, P133, DOI 10.1016/j.physe.2014.10.021; Goudarzi K, 2016, OPT LASER TECHNOL, V78, P139, DOI 10.1016/j.optlastec.2015.10.013; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Hills G, 2019, NATURE, V572, P595, DOI 10.1038/s41586-019-1493-8; Hsu HC, 2018, SEMICOND SCI TECH, V33, DOI 10.1088/1361-6641/aaad88; Huang L, 2017, NANO LETT, V17, P1161, DOI 10.1021/acs.nanolett.6b04804; Jiang YD, 2018, NANOARCH'18: PROCEEDINGS OF THE 14TH IEEE/ACM INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURES, P51, DOI 10.1145/3232195.3232199; Kazmierski TJ, 2007, 2007 IEEE INTERNATIONAL SYMPOSIUM ON NANOSCALE ARCHITECTURE, P33, DOI 10.1109/NANOARCH.2007.4400855; Kazmierski TJ, 2010, IEEE T NANOTECHNOL, V9, P99, DOI 10.1109/TNANO.2009.2017019; Kharadi MA, 2020, ECS J SOLID STATE SC, V9, DOI 10.1149/2162-8777/abd09a; Kim R., 2008, NOTES FERMI DIRAC IN; Lam KT, 2014, IEEE ELECTR DEVICE L, V35, P963, DOI 10.1109/LED.2014.2333368; Lim WH, 2017, SUPERLATTICE MICROST, V112, P328, DOI 10.1016/j.spmi.2017.09.040; Liu CC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.076802; Lopez-Bezanilla A, 2014, J PHYS CHEM C, V118, P18788, DOI 10.1021/jp5060809; Ma L, 2013, CHEMPHYSCHEM, V14, P47, DOI 10.1002/cphc.201200253; Moaiyeri MH, 2017, J COMPUT ELECTRON, V16, P240, DOI 10.1007/s10825-017-0980-0; Ni ZY, 2014, NANOSCALE, V6, P7609, DOI 10.1039/c4nr00028e; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Peng LM, 2014, MATER TODAY, V17, P433, DOI 10.1016/j.mattod.2014.07.008; Pirzadi M, 2016, IEEE PHOTONIC TECH L, V28, P2387, DOI 10.1109/LPT.2016.2596580; Poljak M, 2020, IEEE T ELECTRON DEV, V67, P4705, DOI 10.1109/TED.2020.3017465; Rahman A, 2003, IEEE T ELECTRON DEV, V50, P1853, DOI 10.1109/TED.2003.815366; Safina I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232670; Schwierz F, 2015, NANOSCALE, V7, P8261, DOI 10.1039/c5nr01052g; Shulaker MM, 2013, NATURE, V501, P526, DOI 10.1038/nature12502; Siuti P, 2013, NAT BIOTECHNOL, V31, P448, DOI 10.1038/nbt.2510; Stepniak-Dybala A, 2019, ADV FUNCT MATER, V29, DOI 10.1002/adfm.201906053; Stepniak-Dybala A, 2019, J PHYS CHEM C, V123, P17019, DOI 10.1021/acs.jpcc.9b04343; Tan MLP, 2012, NANOSCALE RES LETT, V7, DOI 10.1186/1556-276X-7-467; Tao L, 2015, NAT NANOTECHNOL, V10, P227, DOI [10.1038/NNANO.2014.325, 10.1038/nnano.2014.325]; Waldrop MM, 2016, NATURE, V530, P144, DOI 10.1038/530144a; Yu B, 2002, INTERNATIONAL ELECTRON DEVICES 2002 MEETING, TECHNICAL DIGEST, P251, DOI 10.1109/IEDM.2002.1175825; Zhang GL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218370; Zhang JM, 2014, COMP MATER SCI, V95, P429, DOI 10.1016/j.commatsci.2014.08.019; Zhao JJ, 2016, PROG MATER SCI, V83, P24, DOI 10.1016/j.pmatsci.2016.04.001	49	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0253289	10.1371/journal.pone.0253289	http://dx.doi.org/10.1371/journal.pone.0253289			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125874	gold, Green Published			2022-12-26	WOS:000664643500031
J	Benitez, VL; Saffran, JR				Benitez, Viridiana L.; Saffran, Jenny R.			Two for the price of one: Concurrent learning of words and phonotactic regularities from continuous speech	PLOS ONE			English	Article							INFANTS SENSITIVITY; NATIVE LANGUAGE; SEGMENTATION; CUES; PATTERNS; VOWELS; SOUND; COMPREHENSION; DEPENDENCIES; COMPUTATIONS	To acquire the words of their language, learners face the challenge of tracking regularities at multiple levels of abstraction from continuous speech. In the current study, we examined adults' ability to track two types of regularities from a continuous artificial speech stream: the individual words in the speech stream (token level information), and a phonotactic pattern shared by a subset of those words (type level information). We additionally manipulated exposure time to the language to examine the relationship between the acquisition of these two regularities. Using a ratings test procedure, we found that adults can extract both the words in the language and their phonotactic patterns from continuous speech in as little as 3.5 minutes of listening time. Results from a 2AFC testing method provide converging evidence that adults rapidly learn both words and their phonotactic patterns. Together, the findings suggest that adults are capable of concurrently tracking regularities at multiple levels of abstraction from brief exposures to a continuous stream of speech.	[Benitez, Viridiana L.] Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA; [Saffran, Jenny R.] Univ Wisconsin, Waisman Ctr, Madison, WI USA	Arizona State University; Arizona State University-Tempe; University of Wisconsin System; University of Wisconsin Madison	Benitez, VL (corresponding author), Arizona State Univ, Dept Psychol, Tempe, AZ 85287 USA.	viridiana.benitez@asu.edu		Benitez, Viridiana/0000-0003-3082-6287	National Science Foundation SBE Postdoctoral Research Fellowship [1513834]; National Institute of Child Health and Human Development [R37HD037466]; James S. McDonnell Foundation; Waisman Center [U54 HD090256]	National Science Foundation SBE Postdoctoral Research Fellowship; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); James S. McDonnell Foundation; Waisman Center	This research was supported by the National Science Foundation SBE Postdoctoral Research Fellowship (https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=504810) 1513834 awarded to VLB, grants from the National Institute of Child Health and Human Development (https://www.nichd.nih.gov/) to JRS (R37HD037466) and the Waisman Center (U54 HD090256), and by a grant from the James S. McDonnell Foundation (https://www.jsmf.org/) to JRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaans F, 2010, J MEM LANG, V62, P311, DOI 10.1016/j.jml.2009.11.007; Antovich DM, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12548; Aslin RN, 1998, PSYCHOL SCI, V9, P321, DOI 10.1111/1467-9280.00063; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Batterink LJ, 2017, PSYCHOL SCI, V28, P921, DOI 10.1177/0956797617698226; Benavides-Varela S, 2015, CHILD DEV, V86, P209, DOI 10.1111/cdev.12291; Benitez VL, 2020, DEVELOPMENTAL SCI, V23, DOI 10.1111/desc.12896; Bergelson E, 2012, P NATL ACAD SCI USA, V109, P3253, DOI 10.1073/pnas.1113380109; Boersma P., 2014, OXFORD HDB CORPUS PH, P342, DOI DOI 10.1093/OXFORDHB/9780199571932.013.016; Bolker Ben, 2020, CRAN; Bonatti LL, 2005, PSYCHOL SCI, V16, P451, DOI 10.1111/j.0956-7976.2005.01556.x; Bonatti LL, 2007, PSYCHOL SCI, V18, P924, DOI 10.1111/j.1467-9280.2007.02002.x; Brady TF, 2008, PSYCHOL SCI, V19, P678, DOI 10.1111/j.1467-9280.2008.02142.x; Breen E, 2019, J SPEECH LANG HEAR R, V62, P1923, DOI 10.1044/2019_JSLHR-L-18-0131; Chambers KE, 2003, COGNITION, V87, pB69, DOI 10.1016/S0010-0277(02)00233-0; Chambers KE, 2011, LANG LEARN DEV, V7, P287, DOI 10.1080/15475441.2011.580447; Emberson LL, 2016, COGNITION, V153, P63, DOI 10.1016/j.cognition.2016.04.010; Endress AD, 2007, COGNITION, V105, P247, DOI 10.1016/j.cognition.2006.09.010; Estes KG, 2007, PSYCHOL SCI, V18, P254, DOI 10.1111/j.1467-9280.2007.01885.x; Estes KG, 2016, J EXP CHILD PSYCHOL, V146, P34, DOI 10.1016/j.jecp.2016.01.012; FRIEDERICI AD, 1993, PERCEPT PSYCHOPHYS, V54, P287, DOI 10.3758/BF03205263; Frost RLA, 2016, COGNITION, V147, P70, DOI 10.1016/j.cognition.2015.11.010; Gomez R, 2005, INFANCY, V7, P183, DOI 10.1207/s15327078in0702_4; Gomez RL, 1999, COGNITION, V70, P109, DOI 10.1016/S0010-0277(99)00003-7; Gomez RL, 2002, PSYCHOL SCI, V13, P431, DOI 10.1111/1467-9280.00476; Gonzalez-Gomez N, 2012, INFANCY, V17, P498, DOI 10.1111/j.1532-7078.2011.00104.x; Johnson EK, 2001, J MEM LANG, V44, P548, DOI 10.1006/jmla.2000.2755; Jusczyk PW, 1999, J MEM LANG, V40, P62, DOI 10.1006/jmla.1998.2605; JUSCZYK PW, 1993, J MEM LANG, V32, P402, DOI 10.1006/jmla.1993.1022; JUSCZYK PW, 1994, J MEM LANG, V33, P630, DOI 10.1006/jmla.1994.1030; Kam CLH, 2009, COGNITIVE PSYCHOL, V59, P30, DOI 10.1016/j.cogpsych.2009.01.001; Kidd E, 2016, CHILD DEV, V87, P184, DOI 10.1111/cdev.12461; Krogh L, 2012, FRONT PSYCHOL, V3, DOI [10.3389/fpsyg.2012.00048, 10.3389/fpsyg.2012.00598]; Lew-Williams C, 2012, COGNITION, V122, P241, DOI 10.1016/j.cognition.2011.10.007; Marcus GF, 1999, SCIENCE, V283, P77, DOI 10.1126/science.283.5398.77; Mattys SL, 1999, COGNITIVE PSYCHOL, V38, P465, DOI 10.1006/cogp.1999.0721; Mattys SL, 2005, J EXP PSYCHOL GEN, V134, P477, DOI 10.1037/0096-3445.134.4.477; Mattys SL, 2001, COGNITION, V78, P91, DOI 10.1016/S0010-0277(00)00109-8; Mattys SL, 2007, J ACOUST SOC AM, V122, P554, DOI 10.1121/1.2735105; McQueen JM, 1998, J MEM LANG, V39, P21, DOI 10.1006/jmla.1998.2568; Newport EL, 2004, COGNITIVE PSYCHOL, V48, P127, DOI 10.1016/S0010-0285(03)00128-2; Onishi KH, 2002, COGNITION, V83, pB13, DOI 10.1016/S0010-0277(01)00165-2; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Pena M, 2002, SCIENCE, V298, P604, DOI 10.1126/science.1072901; Reeder PA, 2013, COGNITIVE PSYCHOL, V66, P30, DOI 10.1016/j.cogpsych.2012.09.001; Romberg AR, 2013, COGNITIVE SCI, V37, P1290, DOI 10.1111/cogs.12050; Romberg AR, 2010, WIRES COGN SCI, V1, P906, DOI 10.1002/wcs.78; Saffran JR, 2006, ADV CHILD DEV BEHAV, V34, P1, DOI 10.1016/S0065-2407(06)80003-0; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Saffran JR, 1997, PSYCHOL SCI, V8, P101, DOI 10.1111/j.1467-9280.1997.tb00690.x; Saffran JR, 2003, INFANCY, V4, P273, DOI 10.1207/S15327078IN0402_07; Saffran JR, 2003, DEV PSYCHOL, V39, P484, DOI 10.1037/0012-1649.39.3.484; Saffran JR., 2006, HDB CHILD DEV; Sahni SD, 2010, CHILD DEV, V81, P727, DOI 10.1111/j.1467-8624.2010.01430.x; Siegelman N, 2019, COGNITION, V192, DOI 10.1016/j.cognition.2019.06.014; Siegelman N, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0059; Siegelman N, 2015, J MEM LANG, V81, P105, DOI 10.1016/j.jml.2015.02.001; Sundara M., 2020, 45 BOST U C LANG DEV; Thiessen ED, 2007, LANG LEARN DEV, V3, P73, DOI 10.1080/15475440709337001; Thiessen ED, 2013, PSYCHOL BULL, V139, P792, DOI 10.1037/a0030801; Thiessen ED, 2013, CURR DIR PSYCHOL SCI, V22, P239, DOI 10.1177/0963721413476035; Tincoff R, 1999, PSYCHOL SCI, V10, P172, DOI 10.1111/1467-9280.00127; Toro JM, 2008, PSYCHOL SCI, V19, P137, DOI 10.1111/j.1467-9280.2008.02059.x; Vuong LC, 2016, LANG LEARN, V66, P8, DOI 10.1111/lang.12137; Wang YY, 2015, LANG LEARN DEV, V11, P1, DOI 10.1080/15475441.2013.876270; Weiss DJ, 2010, LANG COGNITIVE PROC, V25, P402, DOI 10.1080/01690960903212254; Wu R, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00498	68	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253039	10.1371/journal.pone.0253039	http://dx.doi.org/10.1371/journal.pone.0253039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SD	34115799	Green Published, gold			2022-12-26	WOS:000664643000043
J	Chen, YG; Li, YJ; Feng, S; Man, XM; Long, YQ				Chen, Yanguang; Li, Yajing; Feng, Shuo; Man, Xiaoming; Long, Yuqing			Gravitational scaling analysis on spatial diffusion of COVID-19 in Hubei Province, China	PLOS ONE			English	Article							URBAN; ENTROPY	The spatial diffusion of epidemic disease follows distance decay law in geography and social physics, but the mathematical models of distance decay depend on concrete spatio-temporal conditions. This paper is devoted to modeling spatial diffusion patterns of COVID-19 stemming from Wuhan city to Hubei province, China. The modeling approach is to integrate analytical method and experimental method. The local gravity model is derived from allometric scaling and global gravity model, and then the parameters of the local gravity model are estimated by observational data and least squares calculation. The main results are as below. The local gravity model based on power law decay can effectively describe the diffusion patterns and process of COVID-19 in Hubei Province, and the goodness of fit of the gravity model based on negative exponential decay to the observational data is not satisfactory. Further, the goodness of fit of the model to data entirely became better and better over time, the size elasticity coefficient increases first and then decreases, and the distance attenuation exponent decreases first and then increases. Moreover, the significance of spatial autoregressive coefficient in the model is low, and the confidence level is less than 80%. The conclusions can be reached as follows. (1) The spatial diffusion of COVID-19 of Hubei bears long range effect, and the size of a city and the distance of the city to Wuhan affect the total number of confirmed cases. (2) Wuhan direct transmission is the main process in the spatial diffusion of COVID-19 in Hubei at the early stage, and the horizontal transmission between regions is not significant. (3) The effect of spatial lockdown and isolation measures taken by Chinese government against the transmission of COVID-19 is obvious. This study suggests that the role of urban gravity (size and distance) should be taken into account to prevent and control epidemic disease.	[Chen, Yanguang; Li, Yajing; Feng, Shuo; Man, Xiaoming; Long, Yuqing] Peking Univ, Dept Geog, Coll Urban & Environm Sci, Beijing, Peoples R China	Peking University	Chen, YG (corresponding author), Peking Univ, Dept Geog, Coll Urban & Environm Sci, Beijing, Peoples R China.	chenyg@pku.edu.cn		Chen, Yanguang/0000-0002-7804-9993	National Natural Science Foundation of China [41671167]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was sponsored by the National Natural Science Foundation of China (Grant No. 41671167).	Allen PM., 1997, CITIES REGIONS SELF; Arbesman S, 2012, HALF LIFE FACTS WHY; Banks R.B., 1994, GROWTH DIFFUSION PHE; Barabasi AL, 2003, SCI AM, V288, P60, DOI 10.1038/scientificamerican0503-60; Batty M., 2005, CITIES COMPLEXITY UN; Batty M., 1976, URBAN MODELLING ALGO; Batty M, 1991, FRACTALS CHAOS, P43; Batty M., 1994, FRACTAL CITIES; Batty M, 2010, GEOGR ANAL, V42, P395, DOI 10.1111/j.1538-4632.2010.00800.x; Berry BJL., 1972, MAN SPACE ENV CONCEP, P340; Chen Y., 2019, MATH URBAN MORPHOLOG, P21; Chen Y., 2005, ECON GEOGR, V6, P817; Chen Y.G., 2008, FRACTAL URBAN SYSTEM; Chen YG, 2017, PHYSICA A, V465, P673, DOI 10.1016/j.physa.2016.08.008; Chen YG, 2015, CHAOS SOLITON FRACT, V77, P174, DOI 10.1016/j.chaos.2015.05.022; Chen YG, 2014, CHAOS SOLITON FRACT, V65, P65, DOI 10.1016/j.chaos.2014.04.017; Chen Yanguang, 2009, Acta Scientiarum Naturalium Universitatis Pekinensis, V45, P333; Chen YG., 2020, COMPLEXITY, V2020; Dittmar JE, 2011, Q J ECON, V126, P1133, DOI 10.1093/qje/qjr035; Domenech-Carbo A, 2021, PHYSICA A, V568, DOI 10.1016/j.physa.2021.125752; Fotheringham A.S., 1989, SPATIAL INTERACTION; Fotheringham AS, 2000, QUANTITATIVE GEOGRAP; Haggett P., 1977, LOCATIONAL ANAL HUMA; Hgerstrand T., 1962, READINGS CULTURAL GE, P355; Holland JH., 1998, EMERGENCE CHAOS ORDE; KAC M, 1969, SCIENCE, V166, P695, DOI 10.1126/science.166.3906.695; Lee KB, 2020, PHYSICA A, V559, DOI 10.1016/j.physa.2020.125090; Liu J.S., 2000, SCI GEOGRAPHICA SINI, V20, P528; Mackay JR., 1958, CAN GEOGR, V3, P1; Mandal M, 2020, CHAOS SOLITON FRACT, V136, DOI 10.1016/j.chaos.2020.109889; Morrill R., 1988, SPATIAL DIFFUSION; Northam RM., 1979, URBAN GEOGR; Portugali J, 2011, UNDERST COMPLEX SYST, P1, DOI 10.1007/978-3-642-19451-1; Reza F M, 1961, INTRO INFORM THEORY; Shi X, 2012, ANN ASSOC AM GEOGR, V102, P1125, DOI 10.1080/00045608.2012.657498; Silviu G., 1977, INFORM THEORY APPL; Su M.K., 1988, PRINCIPLE APPL SYSTE; Taylor PJ., 1983, QUANTITATIVE METHODS; Taylor PJ., 1975, DISTANCE DECAY MODEL, P23; Tuite AR, 2020, CAN MED ASSOC J, V192, pE497, DOI 10.1503/cmaj.200476; VONNEUMANN J, 1961, COLLECTED WORKS; West G., 2017, SCALE UNIVERSAL LAWS; Wilson A., 2000, COMPLEX SPATIAL SYST; Wilson A. G., 1970, ENTROPY URBAN REGION; WILSON AG, 1968, NATURE, V220, P963, DOI 10.1038/220963a0; Wilson A, 2010, GEOGR ANAL, V42, P364, DOI 10.1111/j.1538-4632.2010.00799.x; Zhao C.Y., 1991, FDN CONTROL THEORY; Zhou Y, 1995, URBAN GEOGR	49	2	3	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252889	10.1371/journal.pone.0252889	http://dx.doi.org/10.1371/journal.pone.0252889			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115791	Green Published, gold, Green Submitted			2022-12-26	WOS:000664643000037
J	Teshome, A; Shegaze, M; Glagn, M; Getie, A; Tekabe, B; Getahun, D; Kanko, T; Getachew, T; Yenesew, N; Meskele, S; Tolosie, K; Temtem, Z; Yirgu, T				Teshome, Abinet; Shegaze, Mulugeta; Glagn, Mustefa; Getie, Asmare; Tekabe, Beemnet; Getahun, Dinkalem; Kanko, Tesfaye; Getachew, Tamiru; Yenesew, Nuhamin; Meskele, Simeon; Tolosie, Kabtamu; Temtem, Zebene; Yirgu, Teshome			Perceived stress and associated factors among health care professionals working in the context of COVID-19 pandemic in public health institutions of southern Ethiopia 2020	PLOS ONE			English	Article								Introduction Health care professionals are at higher risk of developing stress-related problems during outbreaks, due to the overwhelming clinical workload, fear of contagion, and inadequate protective gears. So, in order to monitoring mental health issues and to understand the factors evidence-based interventions is important. Therefore, this study was aimed to assess perceived stress and associated factors among health care professionals working in the context of COVID-19, Southern Ethiopia. Methods Institution based cross-sectional study was conducted among 798 health care professionals from the 1(st) May to 1(st) June 2020. The study participants were selected using simple random sampling technique after allocating a proportion to each health institute based on the size of health care professionals. A pre-tested and structured interviewer-administered questionnaire using KOBO collect survey tool was used to collect data. A total score of >20 points was considered as the cut off for experiencing perceived stress based on perceived stress scale. Both bivariable and multivariable logistic regression analysis were performed to identify associated factors. The level of statistical significance was set at a p-value of less than 0.05 in multivariable logistic regression. Result Nearly two-thirds 61.8% (95% CI: 58.4%, 65.2%) of HCPs had perceived stress. Not having COVID-19 updated information (AOR = 2.41, 95% CI: 1.31, 4.43), not at all confident on coping with stress (AOR = 9.94, 95% CI:3.74, 26.41), somewhat confident in coping with stress (AOR = 4.69, 95% CI:2.81, 7.84), moderately confident on coping with stress (AOR = 2.36, 95% CI: 1.46, 3.82), and not getting along well with people (AOR = 4.88, 95% CI: 1.42, 16.72) were positively association with perceived stress. However, feeling overwhelmed by the demand of everyday life (AOR = 0.52 95% CI: 0.35, 0.77) and worrying about what other people think about them (AOR = 0.48, 95% CI: 0.24, 0.81) were negatively associated with perceived stress. Conclusion COVID-19 update, confidence in coping with stress, getting along with people, worrying about what other people think about them, and feeling overwhelmed by the demand of everyday life were factors significantly associated with perceived stress. The provision of COVID-19 update to HCPs along with wider strategies to support their psychological wellbeing is vital.	[Teshome, Abinet; Kanko, Tesfaye] Arba Minch Univ, Dept Biomed Sci, Arba Minch, Ethiopia; [Shegaze, Mulugeta; Glagn, Mustefa; Tekabe, Beemnet] Arba Minch Univ, Sch Publ Hlth, Arba Minch, Ethiopia; [Getie, Asmare; Getahun, Dinkalem] Arba Minch Univ, Sch Nursing, Arba Minch, Ethiopia; [Getachew, Tamiru; Meskele, Simeon] Arba Minch Univ, Dept Anat, Arba Minch, Ethiopia; [Yenesew, Nuhamin; Temtem, Zebene] Arba Minch Univ, Dept Psychol, Arba Minch, Ethiopia; [Tolosie, Kabtamu] Arba Minch Univ, Dept Stat, Arba Minch, Ethiopia; [Yirgu, Teshome] Arba Minch Univ, Dept Geog, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University; Arba Minch University; Arba Minch University; Arba Minch University; Arba Minch University; Arba Minch University	Getie, A (corresponding author), Arba Minch Univ, Sch Nursing, Arba Minch, Ethiopia.	asmaregetie2017@gmail.com	Kanko, Tesfaye/AGX-6462-2022	Kanko, Tesfaye/0000-0001-8111-2538; Getie, Asmare/0000-0002-4078-0078; Shimbre, Mulugeta Shegaze/0000-0001-5633-1309				Abdulah DM, 2020, ROM J INTERN MED, V58, P219, DOI 10.2478/rjim-2020-0020; Afulani P., 2020, MEDRXIV; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Busch IM, 2020, J PATIENT SAF, V16, pE61, DOI 10.1097/PTS.0000000000000589; Chekole YA, 2020, ADV PUBLIC HLTH, V2020, DOI 10.1155/2020/5036861; Huang YE, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112954; Khalid I, 2016, CLIN MED RES, V14, P7, DOI 10.3121/cmr.2016.1303; Krishnamoorthya Yuvaraj., 2020, PSYCHIAT RES, P293; Li DJ, 2020, PSYCHIAT CLIN NEUROS, V74, P608, DOI 10.1111/pcn.13128; Madebo Wubshet Estifanos., 2016, ASSESSMENT PERCEIVED; Mulu GB, 2020, INFECT DRUG RESIST, V13, P3171, DOI 10.2147/IDR.S265829; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Que JY, 2020, GEN PSYCHIAT, V33, DOI 10.1136/gpsych-2020-100259; Spoorthy MS, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102119; Tang CSK, 2005, J AGING HEALTH, V17, P490, DOI 10.1177/0898264305277966; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Zhang LW, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8010064	17	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252809	10.1371/journal.pone.0252809	http://dx.doi.org/10.1371/journal.pone.0252809			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111170	Green Published, gold			2022-12-26	WOS:000664642700046
J	Urquhart, AS; Elliott, CE; Zeng, W; Idnurm, A				Urquhart, Andrew S.; Elliott, Candace E.; Zeng, Wei; Idnurm, Alexander			Constitutive expression of transcription factor SirZ blocks pathogenicity in Leptosphaeria maculans independently of sirodesmin production	PLOS ONE			English	Article							BIOSYNTHETIC GENE-CLUSTER; PL; PATHWAY; GLIOTOXIN; PROTEIN; METABOLISM; ACTIVATION; PHYTOTOXIN; INFECTION; SELECTION	Sirodesmin, the major secondary metabolite produced by the plant pathogenic fungus Leptosphaeria maculans in vitro, has been linked to disease on Brassica species since the 1970s, and yet its role has remained ambiguous. Re-examination of gene expression data revealed that all previously described genes and two newly identified genes within the sir gene cluster in the genome are down-regulated during the crucial early establishment stages of blackleg disease on Brassica napus. To test if this is a strategy employed by the fungus to avoid damage to and then detection by the host plant during the L. maculans asymptomatic biotrophic phase, sirodesmin was produced constitutively by overexpressing the sirZ gene encoding the transcription factor that coordinates the regulation of the other genes in the sir cluster. The sirZ over-expression strains had a major reduction in pathogenicity. Mutation of the over-expression construct restored pathogenicity. However, mutation of two genes, sirP and sirG, required for specific steps in the sirodesmin biosynthesis pathway, in the sirZ over-expression background resulted in strains that were unable to synthesize sirodesmin, yet were still non-pathogenic. Elucidating the basis for this pathogenicity defect or finding ways to overexpress sirZ during disease may provide new strategies for the control of blackleg disease.	[Urquhart, Andrew S.; Elliott, Candace E.; Zeng, Wei; Idnurm, Alexander] Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia; [Urquhart, Andrew S.] Macquarie Univ, Appl BioSci, Macquarie Pk, NSW, Australia; [Elliott, Candace E.] Post Entry Quarantine, Dept Agr Water & Environm, Biosecur Operat Div, Mickleham, Vic, Australia; [Zeng, Wei] Zhejiang A&F Univ, Sino Australia Plant Cell Wall Res Ctr, State Key Lab Subtrop Silviculture, Hangzhou, Peoples R China	University of Melbourne; Macquarie University; Zhejiang A&F University	Idnurm, A (corresponding author), Univ Melbourne, Sch BioSci, Melbourne, Vic, Australia.	alexander.idnurm@unimelb.edu.au	Zeng, Wei/AAZ-7073-2021	Urquhart, Andrew/0000-0002-6687-9965	Australian Research Council [FT130100146]; Grains Research and Development Corporation [UM00050, GRS11006]; ARC; GRDC	Australian Research Council(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp); ARC(Australian Research Council); GRDC	This work was supported by funding to A. I. from the Australian Research Council (FT130100146) and Grains Research and Development Corporation (UM00050), and to A.S. U. from the Grains Research and Development Corporation (GRS11006). ARC: www.arc.gov.au GRDC: https://grdc.com.au/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADAWY HMA, 1989, J PHYTOPATHOL, V127, P137, DOI 10.1111/j.1439-0434.1989.tb01122.x; Becker MG, 2017, PLANT J, V90, P573, DOI 10.1111/tpj.13514; Bergmann S, 2010, APPL ENVIRON MICROB, V76, P8143, DOI 10.1128/AEM.00683-10; BOUDART G, 1989, APPL ENVIRON MICROB, V55, P1555, DOI 10.1128/AEM.55.6.1555-1559.1989; Davis C, 2011, CHEM BIOL, V18, P542, DOI 10.1016/j.chembiol.2010.12.022; Elliott CE, 2007, MOL PLANT PATHOL, V8, P791, DOI [10.1111/j.1364-3703.2007.00433.x, 10.1111/J.1364-3703.2007.00433.X]; Elliott CE, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-169; Fitt BDL, 2006, EUR J PLANT PATHOL, V114, P3, DOI 10.1007/s10658-005-2233-5; Fox EM, 2008, FUNGAL GENET BIOL, V45, P671, DOI 10.1016/j.fgb.2007.10.005; Gallagher L, 2012, EUKARYOT CELL, V11, P1226, DOI 10.1128/EC.00113-12; Gardiner DM, 2005, FUNGAL GENET BIOL, V42, P257, DOI 10.1016/j.fgb.2004.12.001; Gardiner DM, 2004, CURR GENET, V45, P249, DOI 10.1007/s00294-004-0488-6; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Gardiner DM, 2004, MOL MICROBIOL, V53, P1307, DOI 10.1111/j.1365-2958.2004.04215.x; Gay EJ, 2021, BMC BIOL, V19, DOI 10.1186/s12915-021-00989-3; Grigoriev IV, 2014, NUCLEIC ACIDS RES, V42, pD699, DOI 10.1093/nar/gkt1183; HAMMOND KE, 1985, PLANT PATHOL, V34, P557, DOI 10.1111/j.1365-3059.1985.tb01407.x; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; Huang XNA, 2020, ANGEW CHEM INT EDIT, V59, P4349, DOI 10.1002/anie.201915514; Idnurm Alexander, 2017, Fungal Biol Biotechnol, V4, P12, DOI 10.1186/s40694-017-0043-0; Keller NP, 2019, NAT REV MICROBIOL, V17, P167, DOI 10.1038/s41579-018-0121-1; Kremer A, 2010, MICROBIOL-SGM, V156, P278, DOI 10.1099/mic.0.033886-0; Lowe RGT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103098; Netzker T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00299; Pedras MSC, 2012, PHYTOCHEMISTRY, V77, P129, DOI 10.1016/j.phytochem.2012.02.010; ROUXEL T, 1988, PLANT SCI, V57, P45, DOI 10.1016/0168-9452(88)90140-9; Rouxel T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1189; Scharf DH, 2016, ENVIRON MICROBIOL, V18, P1096, DOI 10.1111/1462-2920.13080; Sock J, 1999, J PHYTOPATHOL, V147, P169, DOI 10.1046/j.1439-0434.1999.147003169.x; Sonah H, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01784; Urquhart AS, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz080; Urquhart AS, 2017, CURR MICROBIOL, V74, P1438, DOI 10.1007/s00284-017-1338-3; Vargas WA, 2014, MICROBIOL-SGM, V160, P2319, DOI 10.1099/mic.0.079210-0; Welch TR, 2014, NAT PROD REP, V31, P1376, DOI 10.1039/c3np70097f; Wiemann P, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00530; Wiemann P, 2013, P NATL ACAD SCI USA, V110, P17065, DOI 10.1073/pnas.1313258110; Yin WB, 2012, MOL MICROBIOL, V83, P1024, DOI 10.1111/j.1365-2958.2012.07986.x	37	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252333	10.1371/journal.pone.0252333	http://dx.doi.org/10.1371/journal.pone.0252333			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111151	gold, Green Published			2022-12-26	WOS:000664642700024
J	Koenig, KA; Beall, EB; Sakaie, KE; Ontaneda, D; Stone, L; Rao, SM; Nakamura, K; Jones, SE; Lowe, MJ				Koenig, Katherine A.; Beall, Erik B.; Sakaie, Ken E.; Ontaneda, Daniel; Stone, Lael; Rao, Stephen M.; Nakamura, Kunio; Jones, Stephen E.; Lowe, Mark J.			Evaluation of a connectivity-based imaging metric that reflects functional decline in Multiple Sclerosis	PLOS ONE			English	Article							QUALITY-OF-LIFE; DIFFUSION TENSOR; MACAQUE MONKEY; PARAHIPPOCAMPAL CORTICES; COGNITIVE DYSFUNCTION; ALZHEIMERS-DISEASE; EPISODIC MEMORY; NORMATIVE DATA; BRAIN; MOTION	Cognitive impairment is a common symptom in individuals with Multiple Sclerosis (MS), but meaningful, reliable biomarkers relating to cognitive decline have been elusive, making evaluation of the impact of therapeutics on cognitive function difficult. Here, we combine pathway-based MRI measures of structural and functional connectivity to construct a metric of functional decline in MS. The Structural and Functional Connectivity Index (SFCI) is proposed as a simple, z-scored metric of structural and functional connectivity, where changes in the metric have a simple statistical interpretation and may be suitable for use in clinical trials. Using data collected at six time points from a 2-year longitudinal study of 20 participants with MS and 9 age- and sex-matched healthy controls, we probe two common symptomatic domains, motor and cognitive function, by measuring structural and functional connectivity in the transcallosal motor pathway and posterior cingulum bundle. The SFCI is significantly lower in participants with MS compared to controls (p = 0.009) and shows a significant decrease over time in MS (p = 0.012). The change in SFCI over two years performed favorably compared to measures of brain parenchymal fraction and lesion volume, relating to follow-up measures of processing speed (r = 0.60, p = 0.005), verbal fluency (r = 0.57, p = 0.009), and score on the Multiple Sclerosis Functional Composite (r = 0.67, p = 0.003). These initial results show that the SFCI is a suitable metric for longitudinal evaluation of functional decline in MS.	[Koenig, Katherine A.; Beall, Erik B.; Sakaie, Ken E.; Jones, Stephen E.; Lowe, Mark J.] Cleveland Clin, Imaging Sci, Imaging Inst, Cleveland, OH 44106 USA; [Ontaneda, Daniel; Stone, Lael] Cleveland Clin, Mellen Ctr, Neurol Inst, Cleveland, OH 44106 USA; [Rao, Stephen M.] Cleveland Clin, Schey Ctr Cognit Neuroimaging, Neurol Inst, Cleveland, OH 44106 USA; [Nakamura, Kunio] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Koenig, KA (corresponding author), Cleveland Clin, Imaging Sci, Imaging Inst, Cleveland, OH 44106 USA.	koenigk@ccf.org		Beall, Erik/0000-0001-5837-8485; Koenig, Katherine/0000-0002-1504-7130; Nakamura, Kunio/0000-0002-7833-8138	National Multiple Sclerosis Society [RG4931A1]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	This work was supported by grant number RG4931A1, awarded to M.J.L., from the National Multiple Sclerosis Society (nationalmssociety.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato MP, 2006, J NEUROL SCI, V245, P41, DOI 10.1016/j.jns.2005.08.019; Amato MP, 2001, ARCH NEUROL-CHICAGO, V58, P1602, DOI 10.1001/archneur.58.10.1602; [Anonymous], 1994, ASSESSMENT CLIN MANU; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beall EB, 2007, NEUROIMAGE, V37, P1286, DOI 10.1016/j.neuroimage.2007.07.004; Beall EB, 2014, NEUROIMAGE, V101, P21, DOI 10.1016/j.neuroimage.2014.06.038; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 2006, J INT NEUROPSYCH SOC, V12, P549, DOI 10.1017/S1355617706060723; Benjamini Y, 2000, J EDUC BEHAV STAT, V25, P60, DOI 10.3102/10769986025001060; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bobholz JA, 2006, NEUROLOGY, V67, P1640, DOI 10.1212/01.wnl.0000242885.71725.76; Buckner RL, 2005, J NEUROSCI, V25, P7709, DOI 10.1523/JNEUROSCI.2177-05.2005; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Contentti EC, 2017, CLIN NEUROL NEUROSUR, V163, P149, DOI 10.1016/j.clineuro.2017.10.032; Chen NK, 2009, BRAIN STRUCT FUNCT, V213, P571, DOI 10.1007/s00429-009-0218-4; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis SW, 2012, CEREB CORTEX, V22, P232, DOI 10.1093/cercor/bhr123; Delis DC, 2001, DELIS KAPLAN EXECUTI; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Dineen RA, 2009, BRAIN, V132, P239, DOI 10.1093/brain/awn275; Drake AS, 2010, MULT SCLER J, V16, P228, DOI 10.1177/1352458509354552; Fisher E., 1997, MED IMAGING; Fjell AM, 2017, HUM BRAIN MAPP, V38, P561, DOI 10.1002/hbm.23403; Fling BW, 2012, NEUROBIOL AGING, V33, P2521, DOI 10.1016/j.neurobiolaging.2011.11.018; Glanz BI, 2010, J NEUROL SCI, V290, P75, DOI 10.1016/j.jns.2009.11.004; Glover GH, 2000, MAGNET RESON MED, V44, P162, DOI 10.1002/1522-2594(200007)44:1<162::AID-MRM23>3.0.CO;2-E; Greicius MD, 2004, P NATL ACAD SCI USA, V101, P4637, DOI 10.1073/pnas.0308627101; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; GRONWALL DMA, 1977, PERCEPT MOTOR SKILL, V44, P367, DOI 10.2466/pms.1977.44.2.367; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Hohenfeld C, 2018, NEUROIMAGE-CLIN, V18, P849, DOI 10.1016/j.nicl.2018.03.013; Jacobsen C, 2021, MULT SCLER J-EXP TRA, V7, DOI 10.1177/2055217321992394; Johnston JM, 2008, J NEUROSCI, V28, P6453, DOI 10.1523/JNEUROSCI.0573-08.2008; Kobayashi Y, 2003, J COMP NEUROL, V466, P48, DOI 10.1002/cne.10883; Koenig KA, 2016, 5 BIENN INT C RES ST; Koenig KA, 2015, MULT SCLER J, V21, P1794, DOI 10.1177/1352458515576983; Koenig KA, 2013, MAGN RESON IMAGING, V31, P695, DOI 10.1016/j.mri.2012.10.030; Lavenex P, 2002, J COMP NEUROL, V447, P394, DOI 10.1002/cne.10243; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lowe M., 1997, HUM BRAIN MAPP, V5, pS194; Lowe MJ, 2008, HUM BRAIN MAPP, V29, P818, DOI 10.1002/hbm.20576; Lowe MJ, 2006, NEUROIMAGE, V32, P1127, DOI 10.1016/j.neuroimage.2006.04.208; Lowe MJ, 2014, BRAIN CONNECT, V4, P558, DOI 10.1089/brain.2014.0265; Lowe MJ, 2002, RADIOLOGY, V224, P184, DOI 10.1148/radiol.2241011005; Lowe MJ, 1999, J COMPUT ASSIST TOMO, V23, P463, DOI 10.1097/00004728-199905000-00025; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Lowe MJ, 1997, MAGNET RESON MED, V37, P723, DOI 10.1002/mrm.1910370514; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; Morris R, 1999, EUR J NEUROSCI, V11, P2506, DOI 10.1046/j.1460-9568.1999.00672.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Quigley M, 2001, AM J NEURORADIOL, V22, P294; Ranganath C, 2005, HIPPOCAMPUS, V15, P997, DOI 10.1002/hipo.20141; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Riccitelli GC, 2019, MULT SCLER J, V25, P204, DOI 10.1177/1352458517743091; Rovaris M, 2006, BRAIN, V129, P2628, DOI 10.1093/brain/awl222; Ruano L, 2017, MULT SCLER J, V23, P1258, DOI 10.1177/1352458516674367; Rudick RA, 1999, NEUROLOGY, V53, P1698, DOI 10.1212/WNL.53.8.1698; Saad ZS, 2009, NEUROIMAGE, V44, P839, DOI 10.1016/j.neuroimage.2008.09.037; Sakaie KE, 2010, MAGN RESON IMAGING, V28, P290, DOI 10.1016/j.mri.2009.07.004; Sakaie KE, 2007, NEUROIMAGE, V34, P169, DOI 10.1016/j.neuroimage.2006.08.034; Schott BH, 2013, HUM BRAIN MAPP, V34, P407, DOI 10.1002/hbm.21435; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Smith A., 1982, SYMBOL DIGIT MODALIT; SUZUKI WA, 1994, J COMP NEUROL, V350, P497, DOI 10.1002/cne.903500402; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Uitdehaag BMJ, 2018, CNS DRUGS, V32, P543, DOI 10.1007/s40263-018-0530-8; van den Heuvel M, 2008, J NEUROSCI, V28, P10844, DOI 10.1523/JNEUROSCI.2964-08.2008; Van Schependom J, 2014, J NEUROL SCI, V336, P116, DOI 10.1016/j.jns.2013.10.020; Zhang M, 2013, IEEE T MED IMAGING, V32, P1397, DOI 10.1109/TMI.2013.2257179	72	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0251338	10.1371/journal.pone.0251338	http://dx.doi.org/10.1371/journal.pone.0251338			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101741	gold, Green Published			2022-12-26	WOS:000664641500003
J	Terab, AMA; Abdel Wahab, GEA; Ishag, HZA; Khalil, NAH; El Tigani-Asil, ETA; Hashem, FM; Khalafalla, AI; Shah, AAM; Al Muhairi, SSM				Terab, Abdelnasir Mohammed Adam; Wahab, Ghada El Derdiri Abdel; Ishag, Hassan Zackaria Ali; Khalil, Nasereldien Altaib Hussein; El Tigani-Asil, El Tigani Ahmed; Hashem, Farouk Mohamed; Khalafalla, Abdelmalik Ibrahim; Shah, Asma Abdi Mohamed; Al Muhairi, Salama Suhail Mohammed			Pathology, bacteriology and molecular studies on caseous lymphadenitis in Camelus dromedarius in the Emirate of Abu Dhabi, UAE, 2015-2020	PLOS ONE			English	Article							CORYNEBACTERIUM-PSEUDOTUBERCULOSIS; GOATS; SHEEP; LIVER; CLASSIFICATION; INFECTION; ABSCESSES; OVINE	Caseous lymphadenitis (CLA) or pseudotuberculosis is a chronic zoonotic bacterial disease caused by Corynebacterium pseudotuberculosis, which affects livestock and humans. This study aimed to describe the pathology, bacteriology and confirm the identity of the pathogen by 16S rRNA gene sequencing in Camelus dromedarius. A total of 12 camels with suspected CLA in three regions of Abu Dhabi Emirate (Abu Dhabi, Al Ain and Al Dhafra), United Arab Emirate (UAE) were subjected to clinical and postmortem examinations from January 2015 to December 2020. Clinically, camels were emaciated and showed the presence of external caseous abscesses suggestive of CLA. Postmortem examination showed multiple abscesses of variable sizes with caseous material encapsulated by fibrous tissue in the liver, lungs, muscle, and lymph nodes. Following clinical and postmortem examination, blood, pus and different tissue samples were collected for subsequent analysis. Histopathological examination of all organs stained with Hematoxylin and Eosin (H&E) indicated a central caseo-necrotic core that was admixed with bacterial colonies and infiltration of chronic inflammatory cells, surrounded by a pyogenic membrane, and an outer fibrous connective tissue capsule. Bacterial culture identified the isolates of Corynebacterium pseudotuberculosis biotype ovis strain, and these isolates were shown to be sensitive to all antibiotics tested (penicillin, ampicillin, Co-trimoxazole, enrofloxacin and tetracycline). Moreover, the identity of the isolates was confirmed by partial sequencing of the 16S rRNA gene which showed a 100% identity to Corynebacterium pseudotuberculosis. Phylogenetic analysis based on 16S rRNA gene sequence clearly differentiates Corynebacterium pseudotuberculosis from other species of Corynebacterium. Briefly, this study provided the basic information for infection of Corynebacterium pseudotuberculosis in Camels and will help in controlling of this pathogen in the region.	[Terab, Abdelnasir Mohammed Adam; Wahab, Ghada El Derdiri Abdel; Ishag, Hassan Zackaria Ali; Khalil, Nasereldien Altaib Hussein; El Tigani-Asil, El Tigani Ahmed; Hashem, Farouk Mohamed; Khalafalla, Abdelmalik Ibrahim; Shah, Asma Abdi Mohamed; Al Muhairi, Salama Suhail Mohammed] Abu Dhabi Agr & Food Safety Author ADAFSA, Vet Labs, Anim Wealth Sect, Abu Dhabi, U Arab Emirates		Ishag, HZA; Al Muhairi, SSM (corresponding author), Abu Dhabi Agr & Food Safety Author ADAFSA, Vet Labs, Anim Wealth Sect, Abu Dhabi, U Arab Emirates.	hassan.ishag@adafsa.gov.ae; salama.almuhairi@adafsa.gov.ae	Khalafalla, Abdelmalik Ibrahim/GLT-3730-2022	Khalafalla, Abdelmalik Ibrahim/0000-0001-9156-1361	Abu Dhabi Agriculture and Food Safety Authority (ADAFSA)	Abu Dhabi Agriculture and Food Safety Authority (ADAFSA)	This work is funded by Abu Dhabi Agriculture and Food Safety Authority (ADAFSA) as part of its annual operational budget to fulfill its mandate in protecting animal health.	Abubakr MI, 1999, J CAMEL PRACT RES, V6, P107; Al-Gaabary MH, 2010, SMALL RUMINANT RES, V94, P117, DOI 10.1016/j.smallrumres.2010.07.011; Aljameel MA, 2014, OPEN VET J, V4, P118; Aljameel MA., 2013, U K J VET MED ANIM P, V4, P39; [Anonymous], 2018, VET08ED42018 CLSI S; [Anonymous], 2012, J CLIN CELL IMMUNOL; ASHFAQ MK, 1979, VET MED SM ANIM CLIN, V74, P1161; Bancroft JD., 2019, BANCROFTS THEORY PRA, V8th; Borham M., 2017, Alexandria Journal of Veterinary Sciences, V55, P52, DOI 10.5455/ajvs.282343; Cetinkaya B, 2002, VET MICROBIOL, V88, P75, DOI 10.1016/S0378-1135(02)00089-5; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Connor KM, 2007, VET RES, V38, P613, DOI 10.1051/vetres:2007013; Nassar Alessandra Figueiredo de Castro, 2015, Arq. Inst. Biol., V82, P00215, DOI 10.1590/1808-1657000692013; Dercksen DP, 2000, VET MICROBIOL, V75, P167, DOI 10.1016/S0378-1135(00)00217-0; Dorneles EMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098758; ESTERABADI AH, 1975, ARCH I RAZI, V27, P61, DOI DOI 10.22092/ARI.1975.108778; Fettweis JM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S17; Fontaine MC, 2008, SMALL RUMINANT RES, V76, P42, DOI 10.1016/j.smallrumres.2007.12.025; Hassan SS, 2012, J BACTERIOL, V194, P5718, DOI 10.1128/JB.01373-12; Hawari AD., 2008, AM J AM VET SCI, V3, P68, DOI [10.3844/ajavsp.2008.68.72, DOI 10.3844/AJAVSP.2008.68.72]; HUSBAND AJ, 1977, RES VET SCI, V22, P105, DOI 10.1016/S0034-5288(18)33322-8; Ismail A. A., 1972, Journal of the Egyptian Veterinary Medical Association, V32, P195; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Li HX, 2018, SMALL RUMINANT RES, V168, P69, DOI 10.1016/j.smallrumres.2018.09.015; Moustafa A M, 1994, Rev Elev Med Vet Pays Trop, V47, P313; Muyzer G, 1998, ANTON LEEUW INT J G, V73, P127, DOI 10.1023/A:1000669317571; Newton ILG, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-221; Nourani H, 2013, J CAMEL PRACT RES, V20, P97; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Osman AY., 2018, J VET MED RES, V5; Peel MM, 1997, CLIN INFECT DIS, V24, P185, DOI 10.1093/clinids/24.2.185; Plummer P.J., 2012, SHEEP GOAT MED, V2nd, P126; RADWAN AI, 1989, TROP ANIM HEALTH PRO, V21, P229, DOI 10.1007/BF02261094; Soares SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053818; Songer JG., 2004, VET MICROBIOLOGY BAC, V1st ed; Sprake P, 2012, CAN VET J, V53, P387; Takahashi T, 1997, MICROBIOL IMMUNOL, V41, P649, DOI 10.1111/j.1348-0421.1997.tb01907.x; Tarazi YH, 2016, J INFECT DEV COUNTR, V10, P506, DOI 10.3855/jidc.7023; Ted Valli VEO., 2016, JUBB KENNEDY PALMERS, V3, P202; Tejedor MT, 2004, TROP ANIM HEALTH PRO, V36, P459, DOI 10.1023/B:TROP.0000035012.63821.12; Tejedor MT, 2000, CAN VET J, V41, P126; Tejedor-Junco MT, 2008, TROP ANIM HEALTH PRO, V40, P165, DOI 10.1007/s11250-007-9077-2; Guerrero JAV, 2018, MICROB PATHOGENESIS, V117, P304, DOI 10.1016/j.micpath.2018.02.031; Wernery U, 2012, J CAMEL PRACT RES, V19, P21; Wernery U., 2014, CAMELID INFECT DISOR, P163; Wernery U., 2016, AUSTIN J VET SCI ANI, V3, P1; Williamson LH, 2001, VET CLIN N AM-FOOD A, V17, P359, DOI 10.1016/S0749-0720(15)30033-5; Zavoshti Fereydon Rezazadeh, 2012, Comp Clin Path, V21, P667, DOI 10.1007/s00580-010-1154-7; Zidan K H, 2013, 1 INT SCI C PATH DEP, V47, P59	51	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252893	10.1371/journal.pone.0252893	http://dx.doi.org/10.1371/journal.pone.0252893			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101753	gold, Green Published			2022-12-26	WOS:000664641500028
J	Maksimowski, NA; Scholey, JW; Williams, VR				Maksimowski, Nicholas A.; Scholey, James W.; Williams, Vanessa R.		Nephrotic Syndrome	Sex and kidney ACE2 expression in primary focal segmental glomerulosclerosis: A NEPTUNE study	PLOS ONE			English	Article							NEPHROTIC SYNDROME; RENAL ACE2; ANGIOTENSIN-(1-7); COVID-19; RECEPTOR; INFLAMMATION; INHIBITION; PROGNOSIS; PATHOLOGY; INJURY	Background Angiotensin-converting enzyme 2 (ACE2) has been implicated in the pathogenesis of experimental kidney disease. ACE2 is on the X chromosome, and in mice, deletion of ACE2 leads to the development of focal segmental glomerulosclerosis (FSGS). The relationship between sex and renal ACE2 expression in humans with kidney disease is a gap in current knowledge. Methods We studied renal tubulointerstitial microarray data and clinical variables from subjects with FSGS enrolled in the Nephrotic Syndrome Study Network (NEPTUNE) study. We compared relationships between ACE2 expression and age, estimated glomerular filtration rate (eGFR), urinary albumin to creatinine ratio (UACR), interstitial fibrosis, tubular atrophy, and genes implicated in inflammation and fibrosis in male and female subjects. Results ACE2 mRNA expression was lower in the tubulointerstitium of males compared to females (P = 0.0026). Multiple linear regression analysis showed that ACE2 expression was related to sex and eGFR but not to age or treatment with renin angiotensin system blockade. ACE2 expression is also related to interstitial fibrosis, and tubular atrophy, in males but not in females. Genes involved in inflammation (CCL2 and TNF) correlated with ACE2 expression in males (TNF: r = -0.65, P < 0.0001; CCL2: r = -0.60, P < 0.0001) but not in females. TGFB1, a gene implicated in fibrosis correlated with ACE2 in both sexes. Conclusions Sex is an important determinant of ACE2 expression in the tubulointerstitium of the kidney in FSGS. Sex also influences the relationships between ACE2, kidney fibrosis, and expression of genes involved in kidney inflammation.	[Maksimowski, Nicholas A.; Scholey, James W.; Williams, Vanessa R.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Scholey, James W.] Univ Toronto, Dept Physiol, Toronto, ON, Canada; [Scholey, James W.] Univ Hlth Network, Div Nephrol, Toronto, ON, Canada; [Williams, Vanessa R.] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Maksimowski, NA (corresponding author), Univ Toronto, Inst Med Sci, Toronto, ON, Canada.	nicholas.maksimowski@mail.utoronto.ca			National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN) [U54-DK-083912]; University of Michigan; NephCure Kidney International; Halpin Foundation	National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); NephCure Kidney International; Halpin Foundation	The Nephrotic Syndrome Study Network Consortium (NEPTUNE), U54-DK-083912, is a part of the National Institutes of Health (NIH) Rare Disease Clinical Research Network (RDCRN), supported through a collaboration between the Office of Rare Diseases Research, National Center for Advancing Translational Sciences and the National Institute of Diabetes, Digestive, and Kidney Diseases. Additional funding and/or programmatic support for this project has also been provided by the University of Michigan, the NephCure Kidney International and the Halpin Foundation.	Alhenc-Gelas F, 2020, KIDNEY INT, V97, P1091, DOI 10.1016/j.kint.2020.04.009; Aoki T, 2020, INTERNAL MED, V59, P2237, DOI 10.2169/internalmedicine.4243-19; Bae EH, 2017, KIDNEY INT, V91, P1347, DOI 10.1016/j.kint.2016.12.022; Bae EH, 2015, AM J PATHOL, V185, P1423, DOI 10.1016/j.ajpath.2015.01.021; Barisoni L, 2013, CLIN J AM SOC NEPHRO, V8, P1449, DOI 10.2215/CJN.08370812; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Batlle D, 2020, J AM SOC NEPHROL, V31, P1380, DOI 10.1681/ASN.2020040419; Bourgonje AR, 2020, J PATHOL, V251, P228, DOI 10.1002/path.5471; Cahova M, 2021, KIDNEY BLOOD PRESS R, V46, P245, DOI 10.1159/000513710; Carrero JJ, 2018, NAT REV NEPHROL, V14, P151, DOI 10.1038/nrneph.2017.181; Cattran DC, 2008, NEPHROL DIAL TRANSPL, V23, P2247, DOI 10.1093/ndt/gfm919; Chanana N, 2020, AM J PHYSIOL-ENDOC M, V319, pE562, DOI 10.1152/ajpendo.00295.2020; Danser AHJ, 2020, HYPERTENSION, V75, P1382, DOI 10.1161/HYPERTENSIONAHA.120.15082; Dart AB, 2020, PEDIATR DIABETES, V21, P1102, DOI 10.1111/pedi.13081; Donoghue M, 2000, CIRC RES, V87, pE1, DOI 10.1161/01.res.87.5.e1; Gagliardi MC, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0276-1; Gallagher PE, 2008, AM J PHYSIOL-HEART C, V295, pH2373, DOI 10.1152/ajpheart.00426.2008; Gan R, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110024; Gheblawi M, 2020, CIRC RES, V126, P1456, DOI 10.1161/CIRCRESAHA.120.317015; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hikmet F, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20209610; Hirsch JS, 2020, KIDNEY INT, V98, P209, DOI 10.1016/j.kint.2020.05.006; Hussain AN, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110287; Ji H, 2008, EXP PHYSIOL, V93, P648, DOI 10.1113/expphysiol.2007.041392; Kant S, 2020, BMC NEPHROL, V21, DOI 10.1186/s12882-020-02112-0; Klein SL, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00301-y; Komatsu T, 2002, DNA SEQUENCE, V13, P217, DOI 10.1080/1042517021000021608; Lai JY, 2015, J AM SOC NEPHROL, V26, P805, DOI 10.1681/ASN.2013121274; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lely AT, 2004, J PATHOL, V204, P587, DOI 10.1002/path.1670; Liu Jun, 2010, Biol Sex Differ, V1, P6, DOI 10.1186/2042-6410-1-6; Lynch Matthew R, 2020, R I Med J (2013), V103, P24; Maksimowski N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241534; Matsusaka T, 2012, J AM SOC NEPHROL, V23, P1181, DOI 10.1681/ASN.2011121159; Miller JA, 2006, J AM SOC NEPHROL, V17, P2554, DOI 10.1681/ASN.2005101095; Mizuiri S, 2008, AM J KIDNEY DIS, V51, P613, DOI 10.1053/j.ajkd.2007.11.022; Mizuiri S, 2011, NEPHRON CLIN PRACT, V117, pC57, DOI 10.1159/000319648; Ng JH, 2021, AM J KIDNEY DIS, V77, P204, DOI 10.1053/j.ajkd.2020.09.002; Ogna VF, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0275-x; Oudit GY, 2006, AM J PATHOL, V168, P1808, DOI 10.2353/ajpath.2006.051091; Oudit GY, 2010, DIABETES, V59, P529, DOI 10.2337/db09-1218; Park MD, 2020, NAT REV IMMUNOL, DOI 10.1038/s41577-020-0378-2; Parmar MS, 2021, NEPHROLOGY, V26, P239, DOI 10.1111/nep.13814; Pei GC, 2020, J AM SOC NEPHROL, V31, P1157, DOI 10.1681/ASN.2020030276; Puelles VG, 2020, NEW ENGL J MED, V383, P590, DOI [10.1056/NEJMc2013400, 10.1056/NEJMc2011400]; Reich HN, 2008, KIDNEY INT, V74, P1610, DOI 10.1038/ki.2008.497; Ruggenenti P, 1999, LANCET, V354, P359, DOI 10.1016/S0140-6736(98)10363-X; Schelling JR, 2016, PEDIATR NEPHROL, V31, P693, DOI 10.1007/s00467-015-3169-4; Schmid H, 2006, DIABETES, V55, P2993, DOI 10.2337/db06-0477; Serfozo P, 2020, HYPERTENSION, V75, P173, DOI 10.1161/HYPERTENSIONAHA.119.14071; Silva ACSE, 2013, BRIT J PHARMACOL, V169, P477, DOI 10.1111/bph.12159; Silva ACSE, 2016, PHARMACOL RES, V107, P154, DOI 10.1016/j.phrs.2016.03.018; Smith AR, 2020, KIDNEY MED, V2, P407, DOI 10.1016/j.xkme.2020.03.006; Troost JP, 2020, CLIN KIDNEY J, V13, P597, DOI 10.1093/ckj/sfz092; Troyanov S, 2005, J AM SOC NEPHROL, V16, P1061, DOI 10.1681/ASN.2004070593; Tukiainen T, 2017, NATURE, V550, P244, DOI 10.1038/nature24265; Vickers C, 2002, J BIOL CHEM, V277, P14838, DOI 10.1074/jbc.M200581200; Viveiros A, 2021, AM J PHYSIOL-HEART C, V320, pH296, DOI 10.1152/ajpheart.00755.2020; Wang G, 2011, KIDNEY BLOOD PRESS R, V34, P141, DOI 10.1159/000324521; Webster AC, 2017, LANCET, V389, P1238, DOI 10.1016/S0140-6736(16)32064-5; WEHRMANN M, 1990, CLIN NEPHROL, V33, P115; Wong DW, 2007, AM J PATHOL, V171, P438, DOI 10.2353/ajpath.2007.060977; Wysocki J, 2020, J AM SOC NEPHROL, V31, P1941, DOI 10.1681/ASN.2020050667; Yamaleyeva LM, 2012, AM J PHYSIOL-RENAL, V302, pF1374, DOI 10.1152/ajprenal.00656.2011; ZATZ R, 1986, J CLIN INVEST, V77, P1925, DOI 10.1172/JCI112521; Zhong JC, 2011, HYPERTENSION, V57, P314, DOI 10.1161/HYPERTENSIONAHA.110.164244	66	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252758	10.1371/journal.pone.0252758	http://dx.doi.org/10.1371/journal.pone.0252758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097714	Green Published, gold			2022-12-26	WOS:000664640700016
J	Schmidbauer, C; Schwarz, M; Schutz, A; Schubert, R; Schwanke, C; Gutic, E; Pirker, R; Lang, T; Reiberger, T; Haltmayer, H; Gschwantler, M				Schmidbauer, Caroline; Schwarz, Michael; Schuetz, Angelika; Schubert, Raphael; Schwanke, Cornelia; Gutic, Enisa; Pirker, Roxana; Lang, Tobias; Reiberger, Thomas; Haltmayer, Hans; Gschwantler, Michael			Directly observed therapy at opioid substitution facilities using sofosbuvir/velpatasvir results in excellent SVR12 rates in PWIDs at high risk for non-adherence to DAA therapy	PLOS ONE			English	Article							DIRECT-ACTING ANTIVIRALS; CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; HCV TREATMENT; ELIMINATION; VIRUS; INITIATION; INCREASE; FIBROSIS; ERA	Background & aims We evaluated the effectiveness of sofosbuvir/velpatasvir (SOF/VEL) in difficult-to-treat PWIDs with presumed high risk for non-adherence to antiviral therapy using an innovative concept involving their opioid agonist therapy (OAT) facility. Methods N = 221 patients (m/f: 168/53; median age: 44.7 years (IQR 16.9); HCV-genotype 3: 45.2%; cirrhosis: 33.9%) treated with SOF/VEL were included. PWIDs at high risk for non-adherence to DAA therapy (n = 122) received HCV treatment alongside OAT under the supervision of medical staff ("directly observed therapy", DOT). These patients were compared to patients with presumed excellent drug compliance, who were treated in a "standard setting" (SS) of SOF/VEL prescription at a tertiary care center (n = 99). Results DOT-patients (n = 122/221; 55.2%) were younger than SS-patients (median age: 41.3 vs. 53.0 years), all had psychiatric comorbidities and most had a poor socioeconomic status. 83/122 (68.0%) reported ongoing intravenous drug use. Within the DOT-group, SVR12 was achieved in 99.1% (95% CI: 95.0-100; n = 109/110) with one patient experiencing treatment failure, while n = 12/122 (9.8%) patients were excluded due to loss of follow-up (FU). 5 patients showed HCV reinfection after achieving SVR12. SS-patients achieved SVR in 96.6% (95% CI: 90.3-99.3%; n = 84/87) after exclusion of 10/99 (10.1%) patients who were lost to FU and 2 patients who died prior to SVR12 due to reasons not related to DAA therapy. Conclusions SOF/VEL given as DOT along with OAT in PWIDs at high risk of non-adherence to antiviral therapy including those with ongoing intravenous drug use resulted in excellent SVR rates similar to patients with presumed "excellent compliance" under standard drug intake.	[Schmidbauer, Caroline; Schwarz, Michael; Pirker, Roxana; Lang, Tobias; Gschwantler, Michael] Klin Ottakring, Dept Internal Med 4, Vienna, Austria; [Schmidbauer, Caroline; Schwarz, Michael; Reiberger, Thomas] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria; [Schmidbauer, Caroline; Schwarz, Michael; Reiberger, Thomas] Vienna HIV & Liver Study Grp, Vienna, Austria; [Schuetz, Angelika; Schubert, Raphael; Schwanke, Cornelia; Haltmayer, Hans] Suchthilfe Wien gGmbH, Ambulatorium Suchthilfe Wien, Vienna, Austria; [Gschwantler, Michael] Sigmund Freud Univ, Vienna, Austria	Medical University of Vienna	Gschwantler, M (corresponding author), Klin Ottakring, Dept Internal Med 4, Vienna, Austria.; Gschwantler, M (corresponding author), Sigmund Freud Univ, Vienna, Austria.	michael.gschwantler@gesundheitsverbund.at	Reiberger, Thomas/H-7613-2019	Reiberger, Thomas/0000-0002-4590-3583; Schwarz, Caroline/0000-0001-7762-7483; Schwarz, Michael/0000-0002-2587-1385	City of Vienna; Austrian Ministry of Health	City of Vienna; Austrian Ministry of Health	There was no specific funding for this study. However, the following authors are employed by Suchthilfe Wien gGmbH: Raphael Schubert Angelika Schutz Cornelia Schwanke Hans Haltmayer. Suchthilfe Wien gGmbH represents a governmental non-profit organization financed by the City of Vienna and the Austrian Ministry of Health. Suchthilfe Wien gGmbH did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries. The specific roles of these authors are articulated in the `author contributions' section.	Ahmed A, 2017, HEPATOLOGY, V66, P46, DOI 10.1002/hep.29137; Ayoub HH, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026600; Barror S, 2019, J ANTIMICROB CHEMOTH, V74, pV39, DOI 10.1093/jac/dkz455; Baumert TF, 2019, GASTROENTEROLOGY, V156, P431, DOI 10.1053/j.gastro.2018.10.024; Berenguer J, 2018, HEPATOLOGY, V68, P32, DOI 10.1002/hep.29814; Berg KM, 2011, DRUG ALCOHOL DEPEN, V113, P192, DOI 10.1016/j.drugalcdep.2010.07.025; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Boyle A, 2020, J VIRAL HEPATITIS, V27, P371, DOI 10.1111/jvh.13239; Butt AA, 2019, GASTROENTEROLOGY, V156, P987, DOI 10.1053/j.gastro.2018.11.022; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Charatcharoenwitthaya P, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01196-0; Chromy D, 2019, UNITED EUR GASTROENT, V7, P507, DOI 10.1177/2050640619835394; Chromy D, 2018, WIEN KLIN WOCHENSCHR, V130, P105, DOI 10.1007/s00508-017-1231-x; Cousien A, 2018, J VIRAL HEPATITIS, V25, P1197, DOI 10.1111/jvh.12919; Cunningham EB., 2019, CLIN INFECT DIS PUBL; Feld JJ, 2020, J HEPATOL, V72, P601, DOI 10.1016/j.jhep.2020.01.002; Fiore V, 2021, INT J DRUG POLICY, V90, DOI 10.1016/j.drugpo.2020.103055; Fiore V, 2021, LIVER INT, V41, P271, DOI 10.1111/liv.14745; Flemming JA, 2017, HEPATOLOGY, V65, P804, DOI 10.1002/hep.28923; Foster GR, 2019, DRUG ALCOHOL DEPEN, V194, P487, DOI 10.1016/j.drugalcdep.2018.11.007; Hajarizadeh B, 2020, J HEPATOL, V72, P643, DOI 10.1016/j.jhep.2019.11.012; Heffernan A, 2019, LANCET, V393, P1319, DOI 10.1016/S0140-6736(18)32277-3; Horvath I., 2018, GESUNDHEIT OSTERREIC; Ioannou GN, 2019, GASTROENTEROLOGY, V156, P446, DOI 10.1053/j.gastro.2018.10.033; Kinoshita MN, 2019, J HEPATOL, V70, P78, DOI 10.1016/j.jhep.2018.09.029; Krauth C, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4524-z; Kronfli N, 2018, INT J DRUG POLICY, V57, P95, DOI 10.1016/j.drugpo.2018.04.003; Macias J., 2019, J HEPATOL; Macias J, 2019, J HEPATOL, V71, P45, DOI 10.1016/j.jhep.2019.02.018; Mandorfer M, 2016, HEPATOL INT, V10, P424, DOI 10.1007/s12072-015-9691-4; Mandorfer M, 2016, AIDS, V30, P1039, DOI 10.1097/QAD.0000000000001020; Mangia A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223287; Marshall AD, 2018, J HEPATOL, V69, P1188, DOI 10.1016/j.jhep.2018.06.016; Martin NK, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25062; Moser S, 2016, DIGEST LIVER DIS, V48, P970, DOI 10.1016/j.dld.2016.05.004; Nijmeijer BM, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25348; Norton BL, 2018, INFECT DIS CLIN N AM, V32, P347, DOI 10.1016/j.idc.2018.02.001; Park H, 2019, HEPATOLOGY, V69, P1032, DOI 10.1002/hep.30303; Pontali E, 2018, INT J DRUG POLICY, V59, P50, DOI 10.1016/j.drugpo.2018.06.017; Ponziani FR, 2017, WORLD J HEPATOL, V9, P352, DOI 10.4254/wjh.v9.i7.352; Razavi H, 2017, LANCET GASTROENTEROL, V2, P325, DOI 10.1016/S2468-1253(17)30045-6; Rosenthal ES, 2020, CLIN INFECT DIS, V71, P1715, DOI 10.1093/cid/ciaa105; Safreed-Harmon K, 2019, CLIN INFECT DIS, V69, P2218, DOI 10.1093/cid/ciz714; Scheiner B, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004061; Schmidbauer C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229239; Schmidbauer C, 2020, LIVER INT, V40, P787, DOI 10.1111/liv.14399; Schutz A, 2018, J VIRAL HEPATITIS, V25, P870, DOI 10.1111/jvh.12857; Schutz A, 2016, AM J GASTROENTEROL, V111, P903, DOI 10.1038/ajg.2016.119; Schwabl P, 2015, LIVER INT, V35, P381, DOI 10.1111/liv.12623; Shiha G., 2020, J VIRAL HEPAT; Stover H, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6357-x; Stone J, 2018, LANCET INFECT DIS, V18, P1397, DOI 10.1016/S1473-3099(18)30469-9; Thomas DL, 2019, NEW ENGL J MED, V380, P2041, DOI 10.1056/NEJMra1810477; United Nations, 2015, TRANSF OUR WORLD 203; Wilton J, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa055; World Health Organization, 2016, COMB HEP B C REACH E	56	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252274	10.1371/journal.pone.0252274	http://dx.doi.org/10.1371/journal.pone.0252274			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086708	gold, Green Published			2022-12-26	WOS:000664640100043
J	Escobar, FB; Velasco, C; Motoki, K; Byrne, DV; Wang, QJ				Barbosa Escobar, Francisco; Velasco, Carlos; Motoki, Kosuke; Byrne, Derek Victor; Wang, Qian Janice			The temperature of emotions	PLOS ONE			English	Article							AMBIENT-TEMPERATURE; COLOR-EMOTION; WARMTH; WEATHER; TESTS; EXPERIENCE; UNIVERSAL; COGNITION; PACKAGE; ANGER	Emotions and temperature are closely related through embodied processes, and people seem to associate temperature concepts with emotions. While this relationship is often evidenced by everyday language (e.g., cold and warm feelings), what remains missing to date is a systematic study that holistically analyzes how and why people associate specific temperatures with emotions. The present research aimed to investigate the associations between temperature concepts and emotion adjectives on both explicit and implicit levels. In Experiment 1, we evaluated explicit associations between twelve pairs of emotion adjectives derived from the circumplex model of affect, and five different temperature concepts ranging from 0 degrees C to 40 degrees C, based on responses from 403 native speakers of four different languages (English, Spanish, Japanese, Chinese). The results of Experiment 1 revealed that, across languages, the temperatures were associated with different regions of the circumplex model. The 0 degrees C and 10 degrees C were associated with negative-valanced, low-arousal emotions, while 20 degrees C was associated with positive-valanced, low-to-medium-arousal emotions. Moreover, 30 degrees C was associated with positive-valanced, high-arousal emotions; and 40 degrees C was associated with high-arousal and either positive- or negative-valanced emotions. In Experiment 2 (N = 102), we explored whether these temperature-emotion associations were also present at the implicit level, by conducting Implicit Association Tests (IATs) with temperature words (cold and hot) and opposing pairs of emotional adjectives for each dimension of valence (Unhappy/Dissatisfied vs. Happy/Satisfied) and arousal (Passive/Quiet vs. Active/Alert) on native English speakers. The results of Experiment 2 revealed that participants held implicit associations between the word hot and positive-valanced and high-arousal emotions. Additionally, the word cold was associated with negative-valanced and low-arousal emotions. These findings provide evidence for the existence of temperature-emotion associations at both explicit and implicit levels across languages.	[Barbosa Escobar, Francisco; Byrne, Derek Victor; Wang, Qian Janice] Aarhus Univ, Fac Sci & Technol, Dept Food Sci, Aarhus, Denmark; [Velasco, Carlos] BI Norwegian Business Sch, Ctr Multisensory Mkt, Dept Mkt, Oslo, Norway; [Motoki, Kosuke] Miyagi Univ, Dept Food Sci & Business, Sendai, Miyagi, Japan	Aarhus University; BI Norwegian Business School; Miyagi University	Escobar, FB (corresponding author), Aarhus Univ, Fac Sci & Technol, Dept Food Sci, Aarhus, Denmark.	francisco.barbosa@food.au.dk	Motoki, Kosuke/S-9469-2019; Barbosa Escobar, Francisco/AAC-7064-2021	Motoki, Kosuke/0000-0001-7803-2713; Barbosa Escobar, Francisco/0000-0003-1784-451X; Wang, Qian Janice/0000-0001-7054-2137	Carlsberg Foundation Young Researcher Fellowship [CF19-0587]	Carlsberg Foundation Young Researcher Fellowship	This study was partially supported by a Carlsberg Foundation Young Researcher Fellowship (CF19-0587) awarded to QJW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAKER DA, 1986, J CONSUM RES, V12, P365, DOI 10.1086/208524; ADAMS FM, 1973, J CROSS CULT PSYCHOL, V4, P135, DOI 10.1177/002202217300400201; ANDERSON CA, 1995, PERS SOC PSYCHOL B, V21, P434, DOI 10.1177/0146167295215002; Anderson CA, 2000, ADV EXP SOC PSYCHOL, V32, P63, DOI 10.1016/S0065-2601(00)80004-0; Anwyl-Irvine A, 2021, BEHAV RES METHODS, V53, P1407, DOI 10.3758/s13428-020-01501-5; Balters S, 2017, J INTELL MANUF, V28, P1585, DOI 10.1007/s10845-015-1145-2; BARON RA, 1976, J PERS SOC PSYCHOL, V33, P245, DOI 10.1037/0022-3514.33.3.245; BARON RA, 1972, J PERS SOC PSYCHOL, V21, P183, DOI 10.1037/h0032892; Barrett L. F, 2017, EMOTIONS ARE MADE SE; Barrett LF, 2006, PERS SOC PSYCHOL REV, V10, P20, DOI 10.1207/s15327957pspr1001_2; Barsalou LW, 2008, ANNU REV PSYCHOL, V59, P617, DOI 10.1146/annurev.psych.59.103006.093639; Barsalou LW, 2010, TOP COGN SCI, V2, P716, DOI 10.1111/j.1756-8765.2010.01115.x; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Bathke AC, 2009, AM STAT, V63, P239, DOI 10.1198/tast.2009.08187; Baylis P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195750; Bergman P, 2015, COGN NEUROSCI-UK, V6, P24, DOI 10.1080/17588928.2014.988132; Bosacki SL, 2004, SEX ROLES, V50, P659, DOI 10.1023/B:SERS.0000027568.26966.27; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Bridges D, 2020, PEERJ, V8, DOI 10.7717/peerj.9414; Bruno P, 2017, INT J RES MARK, V34, P302, DOI 10.1016/j.ijresmar.2016.08.005; Buchanan TW, 2000, COGNITIVE BRAIN RES, V9, P227, DOI 10.1016/S0926-6410(99)00060-9; Cavanaugh LA, 2016, COGNITION EMOTION, V30, P1430, DOI 10.1080/02699931.2015.1070119; Chen N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116954; Cliff N, 1996, MULTIVAR BEHAV RES, V31, P331, DOI 10.1207/s15327906mbr3103_4; Crisinel AS, 2010, PERCEPTION, V39, P417, DOI 10.1068/p6574; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; Erceg-Hurn DM, 2008, AM PSYCHOL, V63, P591, DOI 10.1037/0003-066X.63.7.591; Ermatinger FA, 2019, PHYSIOL BEHAV, V211, DOI 10.1016/j.physbeh.2019.112672; Fetterman AK, 2018, SOC PSYCHOL PERS SCI, V9, P560, DOI 10.1177/1948550617712032; Fischer R, 2011, PERS SOC PSYCHOL B, V37, P1031, DOI 10.1177/0146167211407075; Fugate JMB, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00206; Gergen Kenneth J., 2001, SOCIAL CONSTRUCTION; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Gueguen N, 2013, J NONVERBAL BEHAV, V37, P51, DOI 10.1007/s10919-012-0140-y; Hahn AC, 2012, BIOL LETTERS, V8, P864, DOI 10.1098/rsbl.2012.0338; Halekoh U, 2014, J STAT SOFTW, V59, P1; Howe PD, 2014, CLIMATIC CHANGE, V127, P381, DOI 10.1007/s10584-014-1253-6; Huang X, 2014, J CONSUM PSYCHOL, V24, P241, DOI 10.1016/j.jcps.2013.09.009; IJzerman H, 2009, PSYCHOL SCI, V20, P1214, DOI 10.1111/j.1467-9280.2009.02434.x; International Organization for Standardization, 2016, GEOMETRICAL PRODUCT; Ioannou Stephanos, 2017, Front Hum Neurosci, V11, P525, DOI 10.3389/fnhum.2017.00525; Jackson JC, 2019, SCIENCE, V366, P1517, DOI 10.1126/science.aaw8160; Jager G, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.189; Jaeger SR, 2021, FOOD QUAL PREFER, V90, DOI 10.1016/j.foodqual.2020.104172; Jaeger SR, 2020, FOOD QUAL PREFER, V83, DOI 10.1016/j.foodqual.2019.103805; Jaeger SR, 2019, FOOD QUAL PREFER, V73, P117, DOI 10.1016/j.foodqual.2018.11.015; Jonauskaite D, 2020, PSYCHOL SCI, V31, P1245, DOI 10.1177/0956797620948810; Jonauskaite D, 2019, J ENVIRON PSYCHOL, V66, DOI 10.1016/j.jenvp.2019.101350; Keller MC, 2005, PSYCHOL SCI, V16, P724, DOI 10.1111/j.1467-9280.2005.01602.x; Kistler A, 1998, INT J PSYCHOPHYSIOL, V29, P35, DOI 10.1016/S0167-8760(97)00087-1; Kitayama Shinobu, 1995, P439; Knez I, 2008, BUILD ENVIRON, V43, P1483, DOI 10.1016/j.buildenv.2007.08.002; Kosonogov V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183592; Kovecses Z, 2020, EXTENDED CONCEPTUAL METAPHOR THEORY, P1, DOI 10.1017/9781108859127; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lakoff George, 2003, METAPHOR WE LIVE BY; Lee WK, 2020, J ENVIRON PSYCHOL, V70, DOI 10.1016/j.jenvp.2020.101458; Levenson RW, 2011, EMOT REV, V3, P379, DOI 10.1177/1754073911410743; Levenson RW, 2003, ANN NY ACAD SCI, V1000, P348, DOI 10.1196/annals.1280.016; Levenson RW, 1999, COGNITION EMOTION, V13, P481, DOI 10.1080/026999399379159; Lindquist KA, 2017, CURR OPIN PSYCHOL, V17, P135, DOI 10.1016/j.copsyc.2017.07.006; Lindquist KA, 2013, EMOT REV, V5, P356, DOI 10.1177/1754073913489750; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; Marks L.E., 1996, METAPHOR SYMBOL, V11, P39, DOI [DOI 10.1207/S15327868MS1101_3, 10.1207/s15327868ms1101_3]; MESQUITA B, 1992, PSYCHOL BULL, V112, P179, DOI 10.1037/0033-2909.112.2.179; Motoki K, 2019, FOOD QUAL PREFER, V72, P45, DOI 10.1016/j.foodqual.2018.09.004; Noelke C, 2016, ENVIRON RES, V151, P124, DOI 10.1016/j.envres.2016.06.045; Noguchi K, 2012, J STAT SOFTW, V50, P1, DOI 10.18637/jss.v050.i12; Ogarkova A., 2013, COMPONENTS EMOTIONAL, P46, DOI DOI 10.1093/ACPROF:OSO/9780199592746.003.0004; Or Calvin K. L., 2007, Occupational Ergonomics, V7, P83; Ou LC, 2018, COLOR RES APPL, V43, P736, DOI 10.1002/col.22243; Parker PM, 2000, INT J RES MARK, V17, P33, DOI 10.1016/S0167-8116(00)00006-9; Pavlidis I, 2002, IEEE ENG MED BIOL, V21, P56, DOI 10.1109/MEMB.2002.1175139; Perlovsky LI, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00084; Perlovsky LI, 2006, IEEE IJCNN, P1570; Pham MT, 2013, INT J RES MARK, V30, P383, DOI 10.1016/j.ijresmar.2013.04.004; Pramudya RC, 2018, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.02264; Richetin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129601; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Russell JA, 2017, EMOTIONS AND AFFECT IN HUMAN FACTORS AND HUMAN-COMPUTER INTERACTION, P123, DOI 10.1016/B978-0-12-801851-4.00004-5; Salazar-Lopez E, 2015, CONSCIOUS COGN, V34, P149, DOI 10.1016/j.concog.2015.04.003; Shadmehr R, 2018, CURR BIOL, V28, pR793, DOI 10.1016/j.cub.2018.05.071; Sieyers B, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0513; Soto JA, 2005, EMOTION, V5, P154, DOI 10.1037/1528-3542.5.2.154; Specker E, 2018, ACTA PSYCHOL, V186, P47, DOI 10.1016/j.actpsy.2018.04.007; Spence C, 2020, MULTISENS RES, V33, P645, DOI 10.1163/22134808-20191494; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; Stevens HR, 2021, ENVIRON BEHAV, V53, P787, DOI 10.1177/0013916520937455; Stokes CN, 2016, INT J FOOD SCI TECH, V51, P2041, DOI 10.1111/ijfs.13176; Torchiano M., 2020, EFFSIZE EFFICIENT EF; Tsai JL, 2006, J PERS SOC PSYCHOL, V90, P288, DOI 10.1037/0022-3514.90.2.288; Van de Vliert E, 2004, J ENVIRON PSYCHOL, V24, P17, DOI 10.1016/S0272-4944(03)00021-5; VANDENABEELE P, 1994, J CONSUM RES, V20, P586; Velasco C, 2013, J SENS STUD, V28, P335, DOI 10.1111/joss.12052; Waggoner JE, 2010, PSYCHOL REP, V106, P233, DOI 10.2466/PR0.106.1.233-245; Wang HY, 2020, ENERG BUILDINGS, V211, DOI 10.1016/j.enbuild.2020.109789; Wang Q, 2017, MULTISENS RES, V30, P307, DOI 10.1163/22134808-00002564; Whorf BL., 1997, SOCIOLOINGUISTICS MO, P35; Wilkowski BM, 2009, EMOTION, V9, P464, DOI 10.1037/a0015764; Wilson-Mendenhall CD, 2013, PSYCHOL SCI, V24, P947, DOI 10.1177/0956797612464242; Woods AT, 2015, PEERJ, V3, DOI 10.7717/peerj.1058; Younan D, 2018, AM J EPIDEMIOL, V187, P1931, DOI 10.1093/aje/kwy104; Zhou XY, 2012, EMOTION, V12, P678, DOI 10.1037/a0027236; Zimmerman DW, 2000, J GEN PSYCHOL, V127, P354, DOI 10.1080/00221300009598589; Zwebner Y, 2014, J CONSUM PSYCHOL, V24, P251, DOI 10.1016/j.jcps.2013.11.003	106	6	6	7	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252408	10.1371/journal.pone.0252408	http://dx.doi.org/10.1371/journal.pone.0252408			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6QS	34081750	Green Published, gold			2022-12-26	WOS:000664639200017
J	Chaudhury, S; Hutter, J; Bolton, JS; Hakre, S; Mose, E; Wooten, A; O'Connell, W; Hudak, J; Krebs, SJ; Darden, JM; Regules, JA; Murray, CK; Modjarrad, K; Scott, P; Peel, S; Bergmann-Leitner, ES				Chaudhury, Sidhartha; Hutter, Jack; Bolton, Jessica S.; Hakre, Shilpa; Mose, Evelyn; Wooten, Amy; O'Connell, William; Hudak, Joseph; Krebs, Shelly J.; Darden, Janice M.; Regules, Jason A.; Murray, Clinton K.; Modjarrad, Kayvon; Scott, Paul; Peel, Sheila; Bergmann-Leitner, Elke S.			Serological profiles of pan-coronavirus-specific responses in COVID-19 patients using a multiplexed electro-chemiluminescence-based testing platform	PLOS ONE			English	Article							ANTIBODIES; SARS-COV-2; INFECTION	Serological assessment of SARS-CoV-2 specific responses are an essential tool for determining the prevalence of past SARS-CoV-2 infections in the population especially when testing occurs after symptoms have developed and limited contact tracing is in place. The goal of our study was to test a new 10-plex electro-chemiluminescence-based assay to measure IgM and IgG responses to the spike proteins from multiple human coronaviruses including SARS-CoV-2, assess the epitope specificity of the SARS-CoV-2 antibody response against full-length spike protein, receptor-binding domain and N-terminal domain of the spike protein, and the nucleocapsid protein. We carried out the assay on samples collected from three sample groups: subjects diagnosed with COVID-19 from the U.S. Army hospital at Camp Humphreys in Pyeongtaek, South Korea; healthcare administrators from the same hospital but with no reported diagnosis of COVID-19; and pre-pandemic samples. We found that the new CoV-specific multiplex assay was highly sensitive allowing plasma samples to be diluted 1:30,000 with a robust signal. The reactivity of IgG responses to SARS-CoV-2 nucleocapsid protein and IgM responses to SARS-CoV-2 spike protein could distinguish COVID-19 samples from non-COVID-19 and pre-pandemic samples. The data from the three sample groups also revealed a unique pattern of cross-reactivity between SARS-CoV-2 and SARS-CoV-1, MERS-CoV, and seasonal coronaviruses HKU1 and OC43. Our findings show that the CoV-2 IgM response is highly specific while the CoV-2 IgG response is more cross-reactive across a range of human CoVs and also showed that IgM and IgG responses show distinct patterns of epitope specificity. In summary, this multiplex assay was able to distinguish samples by COVID-19 status and characterize distinct trends in terms of cross-reactivity and fine-specificity in antibody responses, underscoring its potential value in diagnostic or serosurveillance efforts.	[Chaudhury, Sidhartha] Walter Reed Army Inst Res, Ctr Enabling Capabil, Silver Spring, MD USA; [Hutter, Jack] Walter Reed Army Inst Res, Clin Trials Ctr, Silver Spring, MD USA; [Bolton, Jessica S.; Regules, Jason A.; Bergmann-Leitner, Elke S.] Walter Reed Army Inst Res, Immunol Core, Malaria Biol Branch, Silver Spring, MD 20910 USA; [Bolton, Jessica S.; Darden, Janice M.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Hakre, Shilpa; Krebs, Shelly J.; Modjarrad, Kayvon; Scott, Paul] Walter Reed Army Inst Res, Emerging Infect Dis Branch, Silver Spring, MD USA; [Mose, Evelyn; Wooten, Amy; O'Connell, William; Hudak, Joseph] Brian D Allgood Army Community Hosp, Camp Humphreys, Pyeongtaek, South Korea; [Peel, Sheila] Walter Reed Army Inst Res, Diagnost & Countermeasures Branch, Silver Spring, MD USA	United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR)	Bergmann-Leitner, ES (corresponding author), Walter Reed Army Inst Res, Immunol Core, Malaria Biol Branch, Silver Spring, MD 20910 USA.	elke.s.bergmann-leitner.civ@mail.mil	Bergmann-Leitner, Elke S./B-3548-2011	Bergmann-Leitner, Elke S./0000-0002-8571-8956	Military Infectious Disease Research program (MIDRP)	Military Infectious Disease Research program (MIDRP)	The work was funded by the Military Infectious Disease Research program (MIDRP), which was not in the online database of funders. The funders did not have any influence on this study and the experimental plan.	Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1101/2020.03.17.20037713, 10.1038/s41591-020-0913-5]; Bolke E, 2020, NEW ENGL J MED, V383, P1694, DOI 10.1056/NEJMc2027051; Bolton JS, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03225-5; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Cao WCC, 2007, NEW ENGL J MED, V357, P1162, DOI 10.1056/NEJMc070348; Chaudhury S., 2020, VACCINE; Hsueh PR, 2004, CLIN MICROBIOL INFEC, V10, P1062, DOI 10.1111/j.1469-0691.2004.01009.x; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Jacofsky D, 2020, J ARTHROPLASTY, V35, pS74, DOI 10.1016/j.arth.2020.04.055; Krammer F, 2020, SCIENCE, V368, P1060, DOI 10.1126/science.abc1227; Liu T, 2020, PREVALENCE IGG ANTIB, DOI [DOI 10.1101/2020.06.13.20130252, 10.1101/2020.06.13.20130252]; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Mo HY, 2006, RESPIROLOGY, V11, P49, DOI 10.1111/j.1440-1843.2006.00783.x; Ng KW, 2020, SCIENCE, V370, P1339, DOI 10.1126/science.abe1107; Oh MD, 2018, KOREAN J INTERN MED, V33, P233, DOI 10.3904/kjim.2018.031; Seow J., 2020, LONGITUDINAL EVALUAT, DOI [10.1101/2020.07.09.20148429, DOI 10.1038/S41564-020-00813-8, 10.1038/s41564-020-00813-8]; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Wajnberg A., 2020, HUMORAL IMMUNE RESPO, DOI [10.1101/2020.04.30.20085613, DOI 10.1101/2020.04.30.20085613]; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Weisberg SP, 2021, NAT IMMUNOL, V22, P25, DOI 10.1038/s41590-020-00826-9; Weiss S, 2020, J INFECT DIS, V222, P1629, DOI [10.1093/infdis/jiaa531, 10.1101/2020.04.14.20059501]; Whitman JD, 2020, NAT BIOTECHNOL, V38, P1174, DOI [10.1038/s41587-020-0659-0, 10.1101/2020.04.25.20074856]; Xiang F, 2020, CLIN INFECT DIS, V71, P1930, DOI 10.1093/cid/ciaa461	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252628	10.1371/journal.pone.0252628	http://dx.doi.org/10.1371/journal.pone.0252628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081747	Green Published, gold, Green Submitted			2022-12-26	WOS:000664639200033
J	Denisov, SS; Ippel, JH; Castoldi, E; Mans, B; Hackeng, TM; Dijkgraaf, I				Denisov, Stepan S.; Ippel, Johannes H.; Castoldi, Elisabetta; Mans, Ben J.; Hackeng, Tilman M.; Dijkgraaf, Ingrid			Molecular basis of anticoagulant and anticomplement activity of the tick salivary protein Salp14 and its homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; LECTIN PATHWAY; FACTOR-V; ORNITHODOROS-SAVIGNYI; BORNE DISEASES; C-TERMINUS; XPLOR-NIH; INHIBITOR; ACTIVATION; SEQUENCE	During feeding, a tick's mouthpart penetrates the host's skin and damages tissues and small blood vessels, triggering the extrinsic coagulation and lectin complement pathways. To elude these defense mechanisms, ticks secrete multiple anticoagulant proteins and complement system inhibitors in their saliva. Here, we characterized the inhibitory activities of the homologous tick salivary proteins tick salivary lectin pathway inhibitor, Salp14, and Salp9Pac from Ixodes scapularis in the coagulation cascade and the lectin complement pathway. All three proteins inhibited binding ofmannan-binding lectin to the polysaccharide mannan, preventing the activation of the lectin complement pathway. In contrast, only Salp14 showed an appreciable effect on coagulation by prolonging the lag timeof thrombin generation. We found that the anticoagulant properties of Salp14 are governed by its basic tail region, which resembles the C terminus of tissue factor pathway inhibitor alpha and blocks the assembly and/or activity of the prothrombinase complex in the same way. Moreover, the Salp14 protein tail contributes to the inhibition of the lectin complement pathway via interaction with mannan binding lectin-associated serine proteases. Furthermore, we identified BaSO4-adsorbing protein 1 isolated from the tick Ornithodoros savignyi as a distant homolog of tick salivary lectin pathway inhibitor/Salp14 proteins and showed that it inhibits the lectin complement pathway but not coagulation. The structure of BaSO4-adsorbing protein 1, solved here usingNMR spectroscopy, indicated that this protein adopts a noncanonical epidermal growth factor domain-like structural fold, the first such report for tick salivary proteins. These data support a mechanism by which tick saliva proteins simultaneously inhibit both the host coagulation cascade and the lectin complement pathway.	[Denisov, Stepan S.; Ippel, Johannes H.; Castoldi, Elisabetta; Hackeng, Tilman M.; Dijkgraaf, Ingrid] Univ Maastricht, Cardiovasc Res Inst Maastricht CARIM, Dept Biochem, Maastricht, Netherlands; [Mans, Ben J.] Agr Res Council, Onderstepoort Vet Inst, Epidemiol Parasites & Vectors, Onderstepoort, South Africa; [Mans, Ben J.] Univ South Africa, Dept Life & Consumer Sci, Pretoria, South Africa; [Mans, Ben J.] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa	Maastricht University; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of South Africa; University of Pretoria	Dijkgraaf, I (corresponding author), Univ Maastricht, Cardiovasc Res Inst Maastricht CARIM, Dept Biochem, Maastricht, Netherlands.	i.dijkgraaf@maastrichtuniversity.nl	Mans, Ben J./M-2427-2017	Mans, Ben J./0000-0002-0177-0029; Ippel, Hans/0000-0001-6589-6678; Denisov, Stepan S./0000-0001-5460-940X; Hackeng, Tilman/0000-0003-0142-0843; Dijkgraaf, Ingrid/0000-0003-4586-3646	Netherlands Organisation for Scientific Research [Aspasia 015.010.005, ECHO 711.018.005]; Maastricht UMC+ Kootstra Talent Fellowship	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Maastricht UMC+ Kootstra Talent Fellowship	This work was supported by the Netherlands Organisation for Scientific Research grant Aspasia 015.010.005 and ECHO 711.018.005 to I. D. and Maastricht UMC+ Kootstra Talent Fellowship to S. S. D.	Assumpcao TC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22780-1; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bersch B, 1998, BIOCHEMISTRY-US, V37, P1204, DOI 10.1021/bi971851v; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bhattacharya S, 2020, ADV PROTEIN CHEM STR, V119, P1, DOI 10.1016/bs.apcsb.2019.09.003; Bunce MW, 2013, J BIOL CHEM, V288, P30151, DOI 10.1074/jbc.M113.506840; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Denisov SS, 2019, J BIOL CHEM, V294, P12370, DOI 10.1074/jbc.RA119.008902; Denisov SS, 2019, CHEM COMMUN, V55, P1374, DOI 10.1039/c8cc08777f; Dzik S, 2019, TRANSFUS MED REV, V33, P199, DOI 10.1016/j.tmrv.2019.08.004; Ehebauer MT, 2002, EXP PARASITOL, V101, P138, DOI 10.1016/S0014-4894(02)00102-9; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Gingras AR, 2011, STRUCTURE, V19, P1635, DOI 10.1016/j.str.2011.08.014; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Horak IG, 2002, EXP APPL ACAROL, V28, P27, DOI 10.1023/A:1025381712339; KARCZEWSKI J, 1994, J BIOL CHEM, V269, P6702; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Keizer MP, 2015, EUR J IMMUNOL, V45, P544, DOI 10.1002/eji.201445070; Kjaer TR, 2013, MOL IMMUNOL, V56, P413, DOI 10.1016/j.molimm.2013.05.007; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; Mans BJ, 2002, J BIOL CHEM, V277, P21371, DOI 10.1074/jbc.M112060200; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Narasimhan S, 2002, INSECT MOL BIOL, V11, P641, DOI 10.1046/j.1365-2583.2002.00375.x; Nijhof AM, 2010, INT J PARASITOL, V40, P1587, DOI 10.1016/j.ijpara.2010.06.003; Ogden NH, 2016, TRENDS PARASITOL, V32, P646, DOI 10.1016/j.pt.2016.04.015; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Reichhardt MP, 2020, P NATL ACAD SCI USA, V117, P362, DOI 10.1073/pnas.1909973116; Ribeiro J. M. C, 2020, FRONT CELL INFECT MI, V10, P1; Schuijt TJ, 2013, CIRCULATION, V128, P254, DOI 10.1161/CIRCULATIONAHA.113.003191; Schuijt TJ, 2011, CELL HOST MICROBE, V10, P136, DOI 10.1016/j.chom.2011.06.010; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tian Y, 2017, J BIOMOL NMR, V67, P35, DOI 10.1007/s10858-016-0082-5; Tirloni L, 2020, J PROTEOMICS, V229, DOI 10.1016/j.jprot.2020.103899; Tombling BJ, 2020, ANGEW CHEM INT EDIT, V59, P11218, DOI 10.1002/anie.201913809; van Doorn P, 2017, J THROMB HAEMOST, V15, P140, DOI 10.1111/jth.13559; van Doorn P, 2020, THROMB HAEMOSTASIS, V120, P55, DOI 10.1055/s-0039-1700516; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110	43	3	3	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100865	10.1016/j.jbc.2021.100865	http://dx.doi.org/10.1016/j.jbc.2021.100865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34118237	Green Published, gold			2022-12-26	WOS:000678068400065
J	Yoshihisa, Y; Rehman, MU; Andoh, T; Tabuchi, Y; Makino, T; Shimizu, T				Yoshihisa, Yoko; Rehman, Mati Ur; Andoh, Tsugunobu; Tabuchi, Yoshiaki; Makino, Teruhiko; Shimizu, Tadamichi			Overexpression of D-dopachrome tautomerase increases ultraviolet B irradiation-induced skin tumorigenesis in mice	FASEB JOURNAL			English	Article						apoptosis; cancer; carcinogenesis; D-dopachrome tautomerase; macrophage migration inhibitory factor; p53; skin; ultraviolet	MIGRATION INHIBITORY FACTOR; FACTOR MIF; EXPRESSION; HOMOLOG; CELLS; GENE; CYTOKINE; DAMAGE; LIGHT; IL-6	Ultraviolet irradiation (UV) exposure is the leading factor underlying the development of skin malignancies. D-dopachrome tautomerase (D-DT), a functional homolog of macrophage migration inhibitory factor (MIF), has functional similarities to MIF. However, its role, unlike the role of MIF in photocarcinogenesis, is unknown. We therefore explored the role of D-DT in photocarcinogenesis by developing D-DT transgenic (D-DT Tg) mice and provided a research model for future studies targeting D-DT. Chronic UVB exposure accelerated tumor development in D-DT Tg mice compared with wild-type (WT) mice, with a higher incidence of tumors observed in D-DT Tg mice than in WT mice. In D-DT Tg irradiated mouse keratinocytes, the p53, PUMA, and Bax expression was lower than that in WT mice. These results indicate that D-DT Tg overexpression confers prevention against UVB-induced apoptosis in keratinocytes. Taken together, these findings support D-DT as a functionally important cytokine in photocarcinogenesis and potential therapeutic target for the prevention of photocarcinogenesis.	[Yoshihisa, Yoko; Makino, Teruhiko; Shimizu, Tadamichi] Univ Toyama, Acad Assembly, Fac Med, Dept Dermatol, Sugitani 2630, Toyama 9300194, Japan; [Rehman, Mati Ur] Univ Toyama, Acad Assembly, Fac Med, Dept Radiol, Toyama, Japan; [Andoh, Tsugunobu] Kinjo Gakuin Univ, Coll Pharm, Dept Pharmacol & Pathophysiol, Nagoya, Aichi, Japan; [Tabuchi, Yoshiaki] Univ Toyama, Acad Assembly, Fac Med, Life Sci Res Ctr,Div Mol Genet Res, Toyama, Japan	University of Toyama; University of Toyama; University of Toyama	Shimizu, T (corresponding author), Univ Toyama, Acad Assembly, Fac Med, Dept Dermatol, Sugitani 2630, Toyama 9300194, Japan.	shimizut@med.u-toyama.ac.jp		Shimizu, Tadamichi/0000-0002-3231-0279; Makino, Teruhiko/0000-0002-0536-1679; Tabuchi, Yoshiaki/0000-0002-6007-6176	Japan Society for the Promotion of Science [20K08686]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science, Grant/Award Number: 20K08686	Akagi Y, 1997, KIDNEY INT, V51, P1265, DOI 10.1038/ki.1997.172; ANSEL JC, 1988, J IMMUNOL, V140, P2274; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Brock SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099795; Brock SE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378299; Cadet J, 2018, PHOTOCH PHOTOBIO SCI, V17, P1816, DOI 10.1039/c7pp00395a; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; Cavalli E, 2020, MOLECULES, V25, DOI 10.3390/molecules25051194; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Faurschou A, 2010, DAN MED BULL, V57; Gunther S, 2019, DRUG DISCOV TODAY, V24, P428, DOI 10.1016/j.drudis.2018.11.003; Guo DW, 2016, INT J CANCER, V139, P2056, DOI 10.1002/ijc.30278; Harris J, 2019, TRENDS IMMUNOL, V40, P447, DOI 10.1016/j.it.2019.03.002; Honda A, 2008, J DERMATOL SCI, V49, P63, DOI 10.1016/j.jdermsci.2007.09.007; Honda A, 2009, CARCINOGENESIS, V30, P1597, DOI 10.1093/carcin/bgp160; Ishimoto K, 2012, CYTOKINE, V60, P772, DOI 10.1016/j.cyto.2012.07.037; Kang I, 2019, NAT REV RHEUMATOL, V15, P427, DOI 10.1038/s41584-019-0238-2; Kim BS, 2016, BURNS, V42, P1265, DOI 10.1016/j.burns.2016.02.005; KIRNBAUER R, 1991, J INVEST DERMATOL, V96, P484, DOI 10.1111/1523-1747.ep12470181; Kobold S, 2014, ONCOTARGET, V5, P103, DOI 10.18632/oncotarget.1560; KUPPER TS, 1987, J CLIN INVEST, V80, P430, DOI 10.1172/JCI113090; Lan CCE, 2019, EXP DERMATOL, V28, P23, DOI 10.1111/exd.13818; Lang T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04581-2; Martin J, 2009, FASEB J, V23, P720, DOI 10.1096/fj.08-119628; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Naka T, 2002, ARTHRITIS RES THER, V4, pS233, DOI 10.1186/ar565; Pasupuleti V, 2014, J BIOL CHEM, V289, P3713, DOI 10.1074/jbc.M113.500694; Pohl J, 2017, J CRIT CARE, V40, P52, DOI 10.1016/j.jcrc.2017.03.012; PONTEN F, 1995, J INVEST DERMATOL, V105, P402, DOI 10.1111/1523-1747.ep12321071; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Rajasekaran D, 2014, FASEB J, V28, P4961, DOI 10.1096/fj.14-256636; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shimizu T, 1999, J INVEST DERMATOL, V112, P210, DOI 10.1046/j.1523-1747.1999.00486.x; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Shimizu T, 1999, J ALLERGY CLIN IMMUN, V104, P659, DOI 10.1016/S0091-6749(99)70339-8; Shimizu T, 1997, BIOCHEM BIOPH RES CO, V240, P173, DOI 10.1006/bbrc.1997.7633; Shimizu T, 1996, FEBS LETT, V381, P199, DOI 10.1016/0014-5793(96)00120-2; Sonesson B, 2003, EXP DERMATOL, V12, P278, DOI 10.1034/j.1600-0625.2003.120307.x; Stenback F, 1998, EUR J CANCER, V34, P1415, DOI 10.1016/S0959-8049(98)00062-8; Stoppe C, 2015, ANTIOXID REDOX SIGN, V23, P865, DOI 10.1089/ars.2014.6243; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Xin D, 2010, MOL CANCER RES, V8, P1601, DOI 10.1158/1541-7786.MCR-10-0101	43	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21671	10.1096/fj.202002631RRR	http://dx.doi.org/10.1096/fj.202002631RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105803				2022-12-26	WOS:000667814100026
J	Dyduch, W; Chudzinski, P; Cyfert, S; Zastempowski, M				Dyduch, Wojciech; Chudzinski, Pawel; Cyfert, Szymon; Zastempowski, Maciej			Dynamic capabilities, value creation and value capture: Evidence from SMEs under Covid-19 lockdown in Poland	PLOS ONE			English	Article							FIRM INNOVATION CAPABILITY; TECHNOLOGICAL-INNOVATION; PERFORMANCE; STRATEGY; MANAGEMENT; KNOWLEDGE; ORGANIZATIONS; ORIENTATION; INFORMATION; LEADERSHIP	Dynamic capabilities, resulting from activities that allow conscious and skillful modification of a firm's strategic potential, are seen as one of the key drivers of a firm's value creation, competitive advantage and above-average performance in changing environments. However, little is known about how dynamic capabilities can shape business survival and performance during crises. The research objective of this paper is twofold. First, through a literature review, we seek to identify which first-order dynamic capabilities-managerial decisions under uncertainty-are vital for rapid response to a crisis. Second, we present the results of research carried out among 151 small and medium-sized companies in Poland immediately after the beginning of the economic lockdown (April 2020). The survey that we developed identifies which dynamic capabilities were essential for businesses to survive during this unexpected black swan event. We also present dependence and regression analyses showing the links between the identified dynamic capabilities and value creation, understood as retaining employees and production levels, as well as value capture, understood as maintaining cash flow and current revenues.	[Dyduch, Wojciech] Univ Econ Katowice, Coll Management, Katowice, Poland; [Chudzinski, Pawel] Poznan Univ Econ & Business, Poznan, Poland; [Cyfert, Szymon] Poznan Univ Econ & Business, Inst Management, Poznan, Poland; [Zastempowski, Maciej] Nicolaus Copernicus Univ, Dept Enterprise Management, Torun, Poland	University of Economics in Katowice; Poznan University of Economics & Business; Poznan University of Economics & Business; Nicolaus Copernicus University	Dyduch, W (corresponding author), Univ Econ Katowice, Coll Management, Katowice, Poland.	wojciech.dyduch@ue.katowice.pl	Zastempowski, Maciej/E-7792-2014	Zastempowski, Maciej/0000-0001-8196-3236; Dyduch, Wojciech/0000-0003-1090-5690; Cyfert, Szymon/0000-0002-5563-1403	National Science Centre Poland	National Science Centre Poland(National Science Centre, Poland)	This research was funded by the National Science Centre Poland, grant number grant no 2015/17/B/HS4/00935. https://www.ncn.gov.pl/The funders -National Science Centre Poland -had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akman G, 2008, INT J INNOV MANAG, V12, P69, DOI 10.1142/S1363919608001923; Akpan I.J., 2022, J SMALL BUS ENTREP, V34, P123, DOI [10.1080/08276331.2020.1820185, DOI 10.1080/08276331.2020.1820185]; Alves AC, 2017, RAE-REV ADMIN EMPRES, V57, P232, DOI [10.1590/s0034-759020170304, 10.1590/S0034-759020170304]; Amit R, 2017, STRATEG ENTREP J, V11, P228, DOI 10.1002/sej.1256; Ando M, 2012, ASIAN ECON J, V26, P261, DOI 10.1111/j.1467-8381.2012.02085.x; Arend RJ, 2014, SMALL BUS ECON, V42, P33, DOI 10.1007/s11187-012-9461-9; Ronda-Pupo GA, 2012, STRATEGIC MANAGE J, V33, P162, DOI 10.1002/smj.948; Arrfelt M, 2015, STRATEGIC MANAGE J, V36, P1017, DOI 10.1002/smj.2264; Augier M, 2009, ORGAN SCI, V20, P410, DOI 10.1287/orsc.1090.0424; Barney J.B., 2006, BLACKWELL HDB STRATE, V124188, P123, DOI 10.1111/b.9780631218616.2006.00006.x; Barney JB, 2018, STRATEGIC MANAGE J, V39, P1325, DOI 10.1002/smj.2768; Battisti M, 2017, INT SMALL BUS J, V35, P78, DOI 10.1177/0266242615611471; Bessiere Veronique, 2017, International Journal of Entrepreneurship and Innovation Management, V21, P318; Bigler W., 2016, MANAG ACCOUNT Q, V17, P10; Blyler M, 2003, STRATEGIC MANAGE J, V24, P677, DOI 10.1002/smj.327; Brahm T, 2012, J MANAGE PSYCHOL, V27, P595, DOI 10.1108/02683941211252446; Calantone RJ, 2002, IND MARKET MANAG, V31, P515, DOI 10.1016/S0019-8501(01)00203-6; Chatterji A, 2014, ACAD MANAGE PERSPECT, V28, P395, DOI 10.5465/amp.2013.0111; Cheng C, 2017, J BUS RES, V81, P107, DOI 10.1016/j.jbusres.2017.08.019; Cooper R.G., 2011, WINNING NEW PRODUCTS; Dalic N., 2018, JITA J INF TECHNOL A, P14, DOI [10.7251/jit1702108dj, DOI 10.7251/JIT1702108DJ]; Dattee B, 2018, ACAD MANAGE J, V61, P466, DOI 10.5465/amj.2015.0869; de la Fuente A, 2020, J AFR ECON, V29, P454, DOI 10.1093/jae/ejaa002; Delmar F, 2008, ENTREP THEORY PRACT, V32, P437, DOI 10.1111/j.1540-6520.2008.00235.x; Desai D., 2007, VIKALPA, V32, P45, DOI [DOI 10.1177/0256090920070404, 10.1177/0256090920070404]; Dirani KM, 2020, HUM RESOUR DEV INT, V23, P380, DOI 10.1080/13678868.2020.1780078; Drnevich PL, 2011, STRATEGIC MANAGE J, V32, P254, DOI 10.1002/smj.882; Durand T, 2005, CONTRIB MANAG SCI, P317; Dziallas M, 2019, TECHNOVATION, V80-81, P3, DOI 10.1016/j.technovation.2018.05.005; Eisenhardt KM, 2000, STRATEGIC MANAGE J, V21, P1105, DOI 10.1002/1097-0266(200010/11)21:10/11<1105::AID-SMJ133>3.0.CO;2-E; Fath B, 2021, CRIT PERSPECT INT BU, V17, P359, DOI 10.1108/cpoib-05-2020-0061; Felin T, 2016, CALIF MANAGE REV, V58, P78, DOI 10.1525/cmr.2016.58.4.78; Figueiredo PN, 2018, RESOUR POLICY, V58, P21, DOI 10.1016/j.resourpol.2017.10.012; Forsman H, 2011, RES POLICY, V40, P739, DOI 10.1016/j.respol.2011.02.003; Ghapanchi AH, 2012, INT J PROJ MANAG, V30, P407, DOI 10.1016/j.ijproman.2011.10.002; Gourinchas P.-O., 2020, NBER WORKING PAPERS, V27877, DOI [10.3386/w27877, DOI 10.3386/W27877]; Green SD, 2008, CONSTR MANAG ECON, V26, P63, DOI 10.1080/01446190701656174; Guan J, 2003, TECHNOVATION, V23, P737, DOI 10.1016/S0166-4972(02)00013-5; Guo H, 2020, FRONT BUS RES CHINA, V14, DOI 10.1186/s11782-020-00087-1; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hansen A.O., 2014, CONT CHALLENGES RISK, P91, DOI 10.1057/9781137447623_5; Harreld JB, 2007, CALIF MANAGE REV, V49, P21, DOI 10.2307/41166404; Holzweber M, 2012, SERV IND J, V32, P531, DOI 10.1080/02642069.2011.596530; Jones S., 2016, EFFECTIVE EXECUTIVE, V19, P12; Ju KJ, 2016, MANAG PROD ENG REV, V7, P6, DOI 10.1515/mper-2016-0031; Kalman J, 2018, INF TECHNOL INT DEV, V14, P81; Karim S., 2015, RECONFIGURATION ADDI; Karna A, 2016, STRATEGIC MANAGE J, V37, P1154, DOI 10.1002/smj.2379; Khatri N, 2010, INT J HUM RESOUR MAN, V21, P2889, DOI 10.1080/09585192.2010.528672; Kim G, 2011, J ASSOC INF SYST, V12, P487; Klein KJ, 2006, ADMIN SCI QUART, V51, P590, DOI 10.2189/asqu.51.4.590; Kraus S, 2020, INT J ENTREP BEHAV R, DOI 10.1108/IJEBR-04-2020-0214; Kylaheiko K, 2007, J MANUF TECHNOL MANA, V18, P966, DOI 10.1108/17410380710828280; Lawless M, 2014, POLICY STUD-UK, V35, P435, DOI 10.1080/01442872.2014.886681; Lawson B., 2001, INT J INNOV MANAG, V5, P377, DOI [10.1142/s1363919601000427, 10.1142/S1363919601000427]; Lee N, 2015, RES POLICY, V44, P370, DOI 10.1016/j.respol.2014.09.008; Leoncini R, 2019, SMALL BUS ECON, V52, P891, DOI 10.1007/s11187-017-9939-6; Liguori E.W., 2020, J INT COUNCIL SMALL, V1, P106, DOI [DOI 10.1080/26437015.2020.1779538, 10.1080/26437015.2020.1779538]; Lin HF, 2007, INT J MANPOWER, V28, P315, DOI 10.1108/01437720710755272; Lin YN, 2014, J BUS RES, V67, P407, DOI 10.1016/j.jbusres.2012.12.019; Lu Y, 2020, ENVIRON HAZARDS-UK, V19, P323, DOI 10.1080/17477891.2020.1763902; Maijanen P., 2018, ACAD MANAG P, V2018, P12319, DOI [10.5465/ambpp.2018.12319abstract, DOI 10.5465/AMBPP.2018.12319ABSTRACT]; Maritan CA, 2001, ACAD MANAGE J, V44, P513, DOI 10.2307/3069367; Marsh SJ, 2003, J PROD INNOVAT MANAG, V20, P136, DOI 10.1111/1540-5885.2002006; Martinez-Roman JA, 2017, REV MANAG SCI, V11, P543, DOI 10.1007/s11846-016-0196-x; Martinez-Roman JA, 2017, J ENG TECHNOL MANAGE, V43, P19, DOI 10.1016/j.jengtecman.2016.11.002; Martinez-Roman JA, 2011, TECHNOVATION, V31, P459, DOI 10.1016/j.technovation.2011.05.005; Mazzucchelli A, 2021, J BUS RES, V128, P742, DOI 10.1016/j.jbusres.2019.05.034; Messersmith JG, 2010, HUM RESOUR MANAGE-US, V49, P241, DOI 10.1002/hrm.20342; Mitrega M., 2017, HANDEL WEWNETRZNY, V6, P236; Monalisa M, 2008, RES TECHNOL MANAGE, V51, P48, DOI 10.1080/08956308.2008.11657514; Morrow JL, 2007, STRATEGIC MANAGE J, V28, P271, DOI 10.1002/smj.579; Mukherjee D, 2012, MANAGE DECIS, V50, P273, DOI 10.1108/00251741211203560; Nassimbeni G, 2001, RES POLICY, V30, P245, DOI 10.1016/S0048-7333(99)00114-6; O'Connor GC, 2008, INT J TECHNOL MANAGE, V44, P179, DOI 10.1504/IJTM.2008.020704; Ojha D, 2020, INT J PROD ECON, V222, DOI 10.1016/j.ijpe.2019.09.030; Oliver C, 2008, ACAD MANAGE REV, V33, P496; Papadopoulos T, 2020, INT J INFORM MANAGE, V55, DOI 10.1016/j.ijinfomgt.2020.102192; Pedauga L, 2022, SMALL BUS ECON, V58, P665, DOI 10.1007/s11187-021-00476-7; Popadiuk Silvio, 2018, Rev. adm. contemp., V22, P639, DOI 10.1590/1982-7849rac2018180135; Castro MP, 2021, J ENTREP EMERG ECON, V13, P721, DOI 10.1108/JEEE-07-2020-0246; Radford K., 2015, COMP YOUNGER OLDER A, V41, P58; Razumovskaia E., 2020, J OPEN INNOV-TECHNOL, V6, P160, DOI [10.3390/joitmc6040160, DOI 10.3390/JOITMC6040160]; Rizan M., 2019, ACAD STRATEG MANAG J, P18; Romijn H, 2002, RES POLICY, V31, P1053, DOI 10.1016/S0048-7333(01)00176-7; S A R Mortazavi, 2020, J Biomed Phys Eng, V10, P383, DOI 10.31661/jbpe.v0i0.2004-1106; Sachitra V, 2018, COMPET REV, V28, P478, DOI 10.1108/CR-01-2017-0004; Salvato C, 2018, STRATEGIC MANAGE J, V39, P1728, DOI 10.1002/smj.2703; Schilke O, 2018, ACAD MANAG ANN, V12, P390, DOI 10.5465/annals.2016.0014; Schumpeter J., 2013, THEORIE WIRTSCHAFTLI, DOI [10.3790/978-3-428-47725-8, DOI 10.3790/978-3-428-47725-8]; Schwarz Jan Oliver, 2020, Futures & Foresight Science, V2, DOI 10.1002/ffo2.28; Sharma GD, 2020, J PUBLIC AFF, V20, DOI 10.1002/pa.2206; Sommer SA, 2016, GROUP ORGAN MANAGE, V41, P172, DOI 10.1177/1059601115578027; Song J, 2016, CALIF MANAGE REV, V58, P118, DOI 10.1525/cmr.2016.58.4.118; Subramaniam M, 2005, ACAD MANAGE J, V48, P450, DOI 10.2307/20159670; Susanto YB., 2019, GATR J MANAG MARK RE, V4, P157, DOI [10.35609/jmmr.2019.4.3(1), DOI 10.35609/JMMR.2019.4.3(1)]; Syriopoulos K., 2020, J INT ACAD CASE STUD; Takahashi Adriana Roseli Wünsch, 2017, BBR, Braz. Bus. Rev., V14, P466, DOI 10.15728/bbr.2017.14.5.1; Teece D.J., 2009, KNOWL STRATEGY, V18, P77, DOI [10.1142/9789812796929_0004, DOI 10.1142/9789812796929_0004]; Teece D, 2016, CALIF MANAGE REV, V58, P13, DOI 10.1525/cmr.2016.58.4.13; Teece DJ, 2007, STRATEGIC MANAGE J, V28, P1319, DOI 10.1002/smj.640; Teece DJ, 2018, LONG RANGE PLANN, V51, P40, DOI 10.1016/j.lrp.2017.06.007; Teece DJ, 2016, EUR ECON REV, V86, P202, DOI 10.1016/j.euroecorev.2015.11.006; Teece DJ, 2014, J INT BUS STUD, V45, P8, DOI 10.1057/jibs.2013.54; Tondolo VAG., 2014, BRAZ BUS REV, V11, P122, DOI 10.15728/bbr.2014.11.5.6; Townsend DM, 2015, J BUS VENTURING, V30, P292, DOI 10.1016/j.jbusvent.2014.07.008; Uhlaner LM, 2013, SMALL BUS ECON, V41, P581, DOI 10.1007/s11187-012-9455-7; Vargo SL, 2004, J MARKETING, V68, P1, DOI 10.1509/jmkg.68.1.1.24036; Vorhies DW, 2009, STRATEGIC MANAGE J, V30, P1310, DOI 10.1002/smj.798; Wadsworth MB, 2015, COMPUT HUM BEHAV, V44, P386, DOI 10.1016/j.chb.2014.11.026; Wamba SF, 2020, INT J PROD ECON, V222, DOI 10.1016/j.ijpe.2019.09.019; Wang ETG, 2013, INFORM MANAGE-AMSTER, V50, P336, DOI 10.1016/j.im.2013.04.007; Wang WK, 2019, COMPUT HUM BEHAV, V95, P284, DOI 10.1016/j.chb.2018.06.029; Wilden R, 2016, ACAD MANAG ANN, V10, P997, DOI 10.1080/19416520.2016.1161966; Winter SG, 2003, STRATEGIC MANAGE J, V24, P991, DOI 10.1002/smj.318; Wohlgemuth V, 2019, EUR MANAG J, V37, P760, DOI 10.1016/j.emj.2019.02.005; Yam RCM., 2011, RES POLICY, V40, P391, DOI [10.1016/j.respol.2010.10.013, DOI 10.1016/j.respol.2010.10.013, DOI 10.1016/J.RESPOL.2010.10.013]; Yoshikuni AC, 2017, RAE-REV ADMIN EMPRES, V57, P215, DOI [10.1590/S0034-759020170303, 10.1590/s0034-759020170303]; Zagelmeyer S, 2013, INT J MANPOWER, V34, P271, DOI 10.1108/IJM-04-2013-0082; Zhang G., 2016, ACAD MANAG P, V2016, P11201, DOI [10.5465/ambpp.2016.11201abstract, DOI 10.5465/AMBPP.2016.11201ABSTRACT]; Zhang M.J., 2007, J BUS MANAG, V13, P57; Zhang M, 2020, INT BUS REV, V29, DOI 10.1016/j.ibusrev.2019.101638; Zhu ZC, 2010, ORGAN STUD, V31, P1752	124	21	21	3	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0252423	10.1371/journal.pone.0252423	http://dx.doi.org/10.1371/journal.pone.0252423			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SX8VJ	34129597	Green Published, gold			2022-12-26	WOS:000665475100007
J	Alzaabi, AH; Ahmed, LA; Rabooy, AE; Al Zaabi, A; Alkaabi, M; AlMahmoud, F; Hamed, MF; Bashaeb, KO; Bakhsh, AR; Adil, S; Elmajed, N; Abousalha, AN; Uwaydah, AK; Al Mazrouei, K				Alzaabi, Ashraf Hassan; Ahmed, Luai A.; Rabooy, Abdulla E.; Al Zaabi, Ali; Alkaabi, Mohammed; AlMahmoud, Falah; Hamed, Mai Farouk; Bashaeb, Khalid Omar; Bakhsh, Abdul Rahim; Adil, Suha; Elmajed, Nadeen; Abousalha, Ahmed Nigm; Uwaydah, Ahmad Kanaan; Al Mazrouei, Khulood			Longitudinal changes in IgG levels among COVID-19 recovered patients: A prospective cohort study	PLOS ONE			English	Article								Objectives To quantify SARS-CoV2 IgG antibody titers over time and assess the longevity of the immune response in a multi-ethnic population setting. Setting This prospective study was conducted in a tertiary hospital in Abu Dhabi city, UAE, among COVID-19 confirmed patients. The virus-specific IgG were measured quantitatively in serum samples from the patients during three visits over a period of 6 months. Serum IgG levels >= 15 AU/ml was used to define a positive response. Participants 113 patients were analyzed at first visit, with a mean (SD) age of participants of 45.9 (11.8) years 87.5% of the patients were men. 63 and 27 participants had data available for visits 2 and 3, respectively. Primary outcome Change in SARS-CoV2 IgG antibody titers over the visits. Results No mortality or re-infection were reported. 69% of the patients developed positive IgG response within the first month after the onset of symptoms. The levels of IgG showed a consistent increase during the first three months with a peak level during the third month. Increasing trend in the levels of IgG were observed in 82.5%, 55.6% and 70.4% of patients between visit 1 to visit 2, visit 2 to visit 3, and from visit 1 to visit 3, respectively. Furthermore, about 64.3% of the patients showed sustained increase in IgG response for more than 120 days. Conclusions Our study indicates a sustained and prolonged positive immune response in COVID-19 recovered patients. The consistent rise in antibody and positive levels of IgG titers within the first 5 months suggest that immunization is possible, and the chances of reinfection minimal.	[Alzaabi, Ashraf Hassan; Al Mazrouei, Khulood] Zayed Mil Hosp, Pulmonol Dept, Abu Dhabi, U Arab Emirates; [Ahmed, Luai A.] United Arab Emirates Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates; [Ahmed, Luai A.] United Arab Emirates Univ, Zayed Ctr Hlth Sci, Al Ain, U Arab Emirates; [Rabooy, Abdulla E.; AlMahmoud, Falah; Bashaeb, Khalid Omar] Zayed Mil Hosp, Radiol Dept, Abu Dhabi, U Arab Emirates; [Al Zaabi, Ali] Zayed Mil Hosp, Pathol & Lab Dept, Abu Dhabi, U Arab Emirates; [Alkaabi, Mohammed] Zayed Mil Hosp, Microbiol Dept, Abu Dhabi, U Arab Emirates; [Hamed, Mai Farouk] Zayed Mil Hosp, Lab Dept, Abu Dhabi, U Arab Emirates; [Bakhsh, Abdul Rahim; Adil, Suha; Elmajed, Nadeen; Abousalha, Ahmed Nigm] Zayed Mil Hosp, Internal Med Dept, Abu Dhabi, U Arab Emirates; [Uwaydah, Ahmad Kanaan] Zayed Mil Hosp, Infect Dis Dept, Abu Dhabi, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Alzaabi, AH (corresponding author), Zayed Mil Hosp, Pulmonol Dept, Abu Dhabi, U Arab Emirates.	ashrafalzaabi@hotmail.com	Ahmed, Luai A./J-7225-2013	Ahmed, Luai A./0000-0001-5292-8212	Zayed military hospital	Zayed military hospital	This study was funded by unrestricted educational grant from Zayed military hospital (No grant number).	Chen YZ, 2020, CELL, V183, P1496, DOI 10.1016/j.cell.2020.10.051; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gidari A, 2021, EUR J CLIN MICROBIOL, V40, P1, DOI 10.1007/s10096-020-04057-6; Grzelak L., 2020, SEX DIFFERENCES DECL, DOI [10.1101/2020.11.12.20230466, DOI 10.1101/2020.11.12.20230466]; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; Harvala H, 2021, TRANSFUSION MED, V31, P167, DOI 10.1111/tme.12746; Hou HY, 2020, CLIN TRANSL IMMUNOL, V9, DOI 10.1002/cti2.1136; Isho B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abe5511; Iyer Anita S, 2020, medRxiv, DOI 10.1101/2020.07.18.20155374; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Ma H, 2020, CELL MOL IMMUNOL, V17, P773, DOI 10.1038/s41423-020-0474-z; Pan D, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100404; Pradenas E, 2021, MED-CAMBRIDGE, V2, P313, DOI 10.1016/j.medj.2021.01.005; Ripperger TJ, 2020, IMMUNITY, V53, P925, DOI 10.1016/j.immuni.2020.10.004; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Tan Y, 2020, FRONT MED-PRC, V14, P746, DOI 10.1007/s11684-020-0822-5; Tsitsilonis OE, 2020, LIFE-BASEL, V10, DOI 10.3390/life10090214; Wu J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22034-1; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2951-z, 10.1038/s41586-020-2012-7]	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0251159	10.1371/journal.pone.0251159	http://dx.doi.org/10.1371/journal.pone.0251159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115768	gold, Green Published			2022-12-26	WOS:000664643000009
J	Maksimova, V; Shalginskikh, N; Vlasova, O; Usalka, O; Beizer, A; Bugaeva, P; Fedorov, D; Lizogub, O; Lesovaya, E; Katz, R; Belitsky, G; Kirsanov, K; Yakubovskaya, M				Maksimova, Varvara; Shalginskikh, Natalya; Vlasova, Olga; Usalka, Olga; Beizer, Anastasia; Bugaeva, Polina; Fedorov, Dmitry; Lizogub, Olga; Lesovaya, Ekaterina; Katz, Richard; Belitsky, Gennady; Kirsanov, Kirill; Yakubovskaya, Marianna			HeLa TI cell-based assay as a new approach to screen for chemicals able to reactivate the expression of epigenetically silenced genes	PLOS ONE			English	Article							METABOLIC-ACTIVATION; AROMATIC-HYDROCARBONS; TRANSPOSABLE ELEMENTS; DNA METHYLATION; TOXICITY; IDENTIFICATION; GENOTOXICITY; REPRESSION; INHIBITORS; UTILITY	Chemicals reactivating epigenetically silenced genes target diverse classes of enzymes, including DNMTs, HDACs, HMTs and BET protein family members. They can strongly influence the expression of genes and endogenous retroviral elements with concomitant dsRNA synthesis and massive transcription of LTRs. Chemicals reactivating gene expression may cause both beneficial effects in cancer cells and may be hazardous by promoting carcinogenesis. Among chemicals used in medicine and commerce, only a small fraction has been studied with respect to their influence on epigenetic silencing. Screening of chemicals reactivating silent genes requires adequate systems mimicking whole-genome processes. We used a HeLa TSA-inducible cell population (HeLa TI cells) obtained by retroviral infection of a GFP-containing vector followed by several rounds of cell sorting for screening purposes. Previously, the details of GFP epigenetic silencing in HeLa TI cells were thoroughly described. Herein, we show that the epigenetically repressed gene GFP is reactivated by 15 agents, including HDAC inhibitors-vorinostat, sodium butyrate, valproic acid, depsipeptide, pomiferin, and entinostat; DNMT inhibitors-decitabine, 5-azacytidine, RG108; HMT inhibitors-UNC0638, BIX01294, DZNep; a chromatin remodeler-curaxin CBL0137; and BET inhibitors-JQ-1 and JQ-35. We demonstrate that combinations of epigenetic modulators caused a significant increase in cell number with reactivated GFP compared to the individual effects of each agent. HeLa TI cells are competent to metabolize xenobiotics and possess constitutively expressed and inducible cytochrome P450 mono-oxygenases involved in xenobiotic biotransformation. Thus, HeLa TI cells may be used as an adequate test system for the extensive screening of chemicals, including those that must be metabolically activated. Studying the additional metabolic activation of xenobiotics, we surprisingly found that the rat liver S9 fraction, which has been widely used for xenobiotic activation in genotoxicity tests, reactivated epigenetically silenced genes. Applying the HeLa TI system, we show that N-nitrosodiphenylamine and N-nitrosodimethylamine reactivate epigenetically silenced genes, probably by affecting DNA methylation.	[Maksimova, Varvara; Shalginskikh, Natalya; Vlasova, Olga; Usalka, Olga; Beizer, Anastasia; Fedorov, Dmitry; Lizogub, Olga; Lesovaya, Ekaterina; Belitsky, Gennady; Kirsanov, Kirill; Yakubovskaya, Marianna] NN Blokhin Natl Med Res Ctr Oncol, Inst Carcinogenesis, Dept Chem Carcinogenesis, Moscow, Russia; [Shalginskikh, Natalya; Katz, Richard] Temple Univ, Fox Chase Canc Ctr, Philadelphia, PA 19122 USA; [Usalka, Olga; Lizogub, Olga] Sechenov Univ, Int Sch Med Future, Moscow, Russia; [Bugaeva, Polina] Julius Maximilians Univ Wurzburg, Dept Translat Neurobiol, Wurzburg, Germany; [Fedorov, Dmitry] AV Vishnevsky Natl Med Res Ctr Surg, Dept Urol, Moscow, Russia; [Lesovaya, Ekaterina] Ryazan State Med Univ, Dept Oncol, Ryazan, Russia; [Kirsanov, Kirill] Peoples Friendship Univ Russia, Med Inst, Dept Gen & Med Practice, Moscow, Russia	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Sechenov First Moscow State Medical University; University of Wurzburg; Ryazan State Medical University; Peoples Friendship University of Russia	Maksimova, V (corresponding author), NN Blokhin Natl Med Res Ctr Oncol, Inst Carcinogenesis, Dept Chem Carcinogenesis, Moscow, Russia.	lavarvar@gmail.com		Maksimova, Varvara/0000-0003-0896-2952; Usalka, Olga/0000-0001-9525-0771	Russian Science Foundation [18-75-00115, 17-15-01526]	Russian Science Foundation(Russian Science Foundation (RSF))	This research was supported by the Russian Science Foundation grant. 18-75-00115 (studies of the activity of biotransformation enzymes in HeLa TI cells, reactivation of GFP after treatment with epigenetic modulators, N-nitroso compounds, and S9 mixture) and grant. 17-15-01526 (studies of the effects of combinations of epigenetic modulators on GFP reactivation and analysis of DNA methylation).	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Angrish MM, 2018, ENVIRON HEALTH PERSP, V126, DOI 10.1289/EHP2322; Arima Y, 2006, TOXICOL SCI, V91, P382, DOI 10.1093/toxsci/kfj161; Audebert M, 2010, TOXICOL LETT, V199, P182, DOI 10.1016/j.toxlet.2010.08.022; Baba Y, 2019, ANAL LETT, V52, P754, DOI 10.1080/00032719.2018.1494739; Banerjee C, 2012, J LEUKOCYTE BIOL, V92, P1147, DOI 10.1189/jlb.0312165; Bijlsma N, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020181; Bonasio R, 2015, J EXP BIOL, V218, P114, DOI 10.1242/jeb.110809; Brocks D, 2017, NAT GENET, V49, P1052, DOI 10.1038/ng.3889; Campa CC, 2019, NAT METHODS, V16, P887, DOI 10.1038/s41592-019-0508-6; Casabar RCT, 2006, DRUG METAB DISPOS, V34, P1779, DOI 10.1124/dmd.106.010199; Cavalli G, 2019, NATURE, V571, P489, DOI 10.1038/s41586-019-1411-0; Chen ZW, 2020, ALTEX-ALTERN ANIM EX, V37, P623, DOI 10.14573/altex.2002291; Chung FFL, 2020, ENVIRON HEALTH PERSP, V128, DOI 10.1289/EHP6104; Coecke S, 2006, ATLA-ALTERN LAB ANIM, V34, P49, DOI 10.1177/026119290603400113; Cote Ila L., 2017, Current Opinion in Toxicology, V6, P71, DOI 10.1016/j.cotox.2017.09.002; Cox JA, 2016, MUTAGENESIS, V31, P117, DOI 10.1093/mutage/gev082; Daskalakis M, 2018, CELL CYCLE, V17, P811, DOI 10.1080/15384101.2018.1442623; Dearfield KL, 2017, ENVIRON MOL MUTAGEN, V58, P264, DOI 10.1002/em.22045; Ding X, 2019, CRISPR J, V2, P51, DOI 10.1089/crispr.2018.0036; Dolinoy DC, 2008, NUTR REV, V66, pS7, DOI 10.1111/j.1753-4887.2008.00056.x; Ellis J, 2005, CURR GENE THER, V5, P367, DOI 10.2174/1566523054546233; Fang H, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00219; Feng CY, 2018, INT J GENOMICS, V2018, DOI 10.1155/2018/8260652; GARRIGUES P, 1995, TRAC-TREND ANAL CHEM, V14, P231, DOI 10.1016/0165-9936(95)91376-4; Hakk H, 2009, TOXICOL APPL PHARM, V241, P119, DOI 10.1016/j.taap.2009.08.009; Han WG, 2013, EPIGENETICS-US, V8, P1176, DOI 10.4161/epi.26195; Herceg Z, 2013, CARCINOGENESIS, V34, P1955, DOI 10.1093/carcin/bgt212; Hoffmann MF, 2014, NUCLEIC ACIDS RES, V42, pD1113, DOI 10.1093/nar/gkt1246; Hrebackova Jana, 2009, Interdiscip Toxicol, V2, P205, DOI 10.2478/v10102-009-0019-x; Hubbard S. A., 1985, COMP GENETIC TOXICOL, V16, P413, DOI [10.1007/978-1-349-07901-8_50, DOI 10.1007/978-1-349-07901-8_50]; Hurst TP, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060130; Iwanari M, 2002, ARCH TOXICOL, V76, P287, DOI 10.1007/s00204-002-0340-z; Johnson RL, 2008, ANAL BIOCHEM, V375, P237, DOI 10.1016/j.ab.2007.12.028; Kamataki T, 2002, DRUG METAB REV, V34, P667, DOI 10.1081/DMR-120005668; Katsura Y, 2019, AM J MED SCI, V358, P384, DOI 10.1016/j.amjms.2019.09.007; Katz RA, 2007, J VIROL, V81, P2592, DOI 10.1128/JVI.01643-06; LaRocca Jessica, 2017, Current Opinion in Toxicology, V6, P87, DOI 10.1016/j.cotox.2017.11.004; Leonova K, 2018, ELIFE, V7, DOI 10.7554/eLife.30842; Makovec T, 2019, RADIOL ONCOL, V53, P148, DOI 10.2478/raon-2019-0018; Maksimova V., 2019, ADV MOL ONCOLOGY, V6, P8, DOI [10.17650/2313-805X-2019-6-3-8-27, DOI 10.17650/2313-805X-2019-6-3-8-27]; Marczylo EL, 2016, CRIT REV TOXICOL, V46, P676, DOI 10.1080/10408444.2016.1175417; Martinez ED., 2006, Measuring Biological Responses with Automated Microscopy, P21, DOI 10.1016/S0076-6879%2806%2914002-1; Martinez ED, 2006, METHOD ENZYMOL, V414, P21, DOI 10.1016/S0076-6879(06)14002-1; Michalowicz J, 2014, ENVIRON TOXICOL PHAR, V37, P738, DOI 10.1016/j.etap.2014.02.003; Michieletto D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08333-8; MILLER EC, 1981, CANCER-AM CANCER SOC, V47, P2327, DOI 10.1002/1097-0142(19810515)47:10<2327::AID-CNCR2820471003>3.0.CO;2-Z; Misiak B, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00580; Moreno FS, 2016, NUTR CANCER, V68, P719, DOI 10.1080/01635581.2016.1180410; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OECD, 2018, OECD SER TEST ASS, V286; Parfett CL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061179; Perera Bambarendage P. U., 2019, Current Opinion in Toxicology, V18, P27, DOI 10.1016/j.cotox.2019.02.008; Piotrowska H, 2013, MOL CELL BIOCHEM, V383, P95, DOI 10.1007/s11010-013-1758-8; Plazar J, 2007, TOXICOL IN VITRO, V21, P1134, DOI 10.1016/j.tiv.2007.02.012; Poleshko A, 2008, J VIROL, V82, P2313, DOI 10.1128/JVI.01882-07; Poleshko A, 2010, J BIOL CHEM, V285, P422, DOI 10.1074/jbc.M109.064667; Rappaport SM, 2010, CHEM-BIOL INTERACT, V184, P189, DOI 10.1016/j.cbi.2009.12.017; Rey O, 2016, TRENDS ECOL EVOL, V31, P514, DOI 10.1016/j.tree.2016.03.013; [Шалгинских Н.А. Shalginskikh N.A.], 2013, [Молекулярная медицина, Molekulyarnaya meditsina], P43; Shalginskikh N, 2013, J VIROL, V87, P2137, DOI 10.1128/JVI.02026-12; Shiverick KT, 2011, REPRODUCTIVE AND DEVELOPMENTAL TOXICOLOGY, P319, DOI 10.1016/B978-0-12-382032-7.10024-4; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Sotero-Caio CG, 2017, GENOME BIOL EVOL, V9, P161, DOI 10.1093/gbe/evw264; Stewart-Morgan KR, 2020, NAT CELL BIOL, V22, P361, DOI 10.1038/s41556-020-0487-y; Straif K, 2000, OCCUP ENVIRON MED, V57, P180, DOI 10.1136/oem.57.3.180; Tang XJ, 2015, CURR DRUG METAB, V16, P86, DOI 10.2174/138920021602150713114159; Tate MJ, 2017, MUTAGENESIS, V32, P491, DOI 10.1093/mutage/gex017; Wang T, 2018, NAT BIOTECHNOL, V36, P225, DOI 10.1038/nbt.4099; Wang TH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061210; Winter HK, 2008, MUTAT RES-GEN TOX EN, V657, P133, DOI 10.1016/j.mrgentox.2008.08.012; WOOD AW, 1978, CANCER RES, V38, P3398; Yoshida W, 2016, ANAL CHEM, V88, P9264, DOI 10.1021/acs.analchem.6b02565; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007	74	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252504	10.1371/journal.pone.0252504	http://dx.doi.org/10.1371/journal.pone.0252504			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115770	gold, Green Published			2022-12-26	WOS:000664643000021
J	Papasideris, M; Leatherdale, ST; Battista, K; Hall, PA				Papasideris, Mia; Leatherdale, Scott T.; Battista, Kate; Hall, Peter A.			An examination of the prospective association between physical activity and academic achievement in youth at the population level	PLOS ONE			English	Article							COGNITIVE FUNCTION; AEROBIC FITNESS; EXERCISE; PARTICIPATION; CHILDREN; ADULTS; SCHOOL; BRAIN; SPORT; METAANALYSIS	Exercise has significant benefits for brain health and this may have downstream learning benefits for youth. However existing studies looking at links between physical activity and academic achievement are limited by relatively small sample sizes and/or cross-sectional designs. The objective of this study is to determine the direction and magnitude of the association between physical activity and academic achievement in a large prospective sample of adolescents. Linear mixed models with random intercepts and multinomial ordinal generalized estimating equations were employed to analyze the prospective relationship between measures of physical activity and academic achievement from the COMPASS study (N = 9,898 linked participant data cases from year 2 (2013-2014) to year 4 (2015-2016)). The linear relationships between minutes of moderate to vigorous physical activity and academic achievement (English: r = -.047, p < .000; Math: r = -.026, p = .008) as well as meeting the national physical activity guidelines and academic achievement (English: est = -.052, p = .004; Math: est = -.052, p = .028) were negative and trivial in magnitude. Organized sport participation showed slight positive associations with academic achievement indices, but these were also of trivial magnitude. In conclusion, the relationship between physical activity and academic achievement was effectively null in this population sample. Advocacy for physical activity programming for adolescent populations may best be undertaken with reference to lack of net academic achievement cost, rather than presence of benefit, or simply with reference to the many other physical and mental health benefits for youth.	[Papasideris, Mia; Leatherdale, Scott T.; Battista, Kate; Hall, Peter A.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada	University of Waterloo	Hall, PA (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.	pahall@uwaterloo.ca	Leatherdale, Scott Thomas/AAE-4515-2022		CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) [OOP-110788]; CIHR Institute of Population and Public Health (IPPH) [MOP-114875]; CIHR [PJT-148562, PJT-159693, PJT-149092]; Health Canada [1617-HQ-000012]	CIHR Institute of Nutrition, Metabolism and Diabetes (INMD)(Canadian Institutes of Health Research (CIHR)); CIHR Institute of Population and Public Health (IPPH)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); Health Canada	The COMPASS study has been supported by a bridge grant from the CIHR Institute of Nutrition, Metabolism and Diabetes (INMD) through the "Obesity -Interventions to Prevent or Treat" priority funding awards (OOP-110788; awarded to SL; https://cihr-irsc.gc.ca/e/193.html), an operating grant from the CIHR Institute of Population and Public Health (IPPH) (MOP-114875; awarded to SL), a CIHR project grant (PJT-148562; awarded to SL), a CIHR bridge grant (PJT-149092; awarded to KP/SL), a CIHR project grant (PJT-159693; awarded to KP), and by a research funding arrangement with Health Canada (#1617-HQ-000012; contract awarded to SL; https://www.canada.ca/en/health-canada.html).	Aberg MAI, 2009, P NATL ACAD SCI USA, V106, P20906, DOI 10.1073/pnas.0905307106; Alvarez-Bueno C, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-1498; Amrhein V, 2019, NATURE, V567, P305, DOI 10.1038/d41586-019-00857-9; Bailey AP, 2018, PSYCHOL MED, V48, P1068, DOI 10.1017/S0033291717002653; Bredin, 2015, ASSESSING LONGITUDIN, P1; Broh BA, 2002, SOCIOL EDUC, V75, P69, DOI 10.2307/3090254; Carlson SA, 2008, AM J PUBLIC HEALTH, V98, P721, DOI 10.2105/AJPH.2007.117176; Davis CL, 2011, HEALTH PSYCHOL, V30, P91, DOI 10.1037/a0021766; Donnelly JE, 2016, MED SCI SPORT EXER, V48, P1197, DOI 10.1249/MSS.0000000000000901; Dyer AM, 2017, AM J HEALTH BEHAV, V41, P179, DOI [10.5993/ajhb.41.2.9, 10.5993/AJHB.41.2.9]; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Erickson KI, 2011, P NATL ACAD SCI USA, V108, P3017, DOI 10.1073/pnas.1015950108; Faught EL, 2019, PREV MED, V125, P24, DOI 10.1016/j.ypmed.2019.05.007; Faulkner, 2014, RELIABILITY VALIDITY, P1; Gordon BR, 2017, SPORTS MED, V47, P2521, DOI 10.1007/s40279-017-0769-0; Groot C, 2016, AGEING RES REV, V25, P13, DOI 10.1016/j.arr.2015.11.005; Hall, 2020, EXAMINING RELATIONSH; Hansen DM, 2014, MED SCI SPORT EXER, V46, P2279, DOI 10.1249/MSS.0000000000000362; Hillman CH, 2009, NEUROSCIENCE, V159, P1044, DOI 10.1016/j.neuroscience.2009.01.057; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Hillman CH, 2014, PEDIATRICS, V134, pE1063, DOI 10.1542/peds.2013-3219; Institute of Medicine of the National Academies, 2013, ED STUD BOD TAK PHYS; Jaakkola T, 2015, J SPORT SCI, V33, P1719, DOI 10.1080/02640414.2015.1004640; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kari JT, 2017, MED SCI SPORT EXER, V49, P2158, DOI 10.1249/MSS.0000000000001351; Knight CJ, 2018, PSYCHOL SPORT EXERC, V38, P137, DOI 10.1016/j.psychsport.2018.06.007; Kramer AF, 2007, TRENDS COGN SCI, V11, P342, DOI 10.1016/j.tics.2007.06.009; Kramer AF, 2018, PERSPECT PSYCHOL SCI, V13, P213, DOI 10.1177/1745691617707316; Lear SA, 2017, LANCET, V390, P2643, DOI 10.1016/S0140-6736(17)31634-3; Leatherdale, 2014, DEV COMPASS STUDENT; Leatherdale ST, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-331; Lent, 2005, CAREER DEV COUNSELIN, P542; Lima RA, 2019, J PHYS ACT HEALTH, V16, P177, DOI 10.1123/jpah.2017-0587; Negru-Subtirica O, 2016, J VOCAT BEHAV, V93, P163, DOI 10.1016/j.jvb.2016.02.006; Reverdito RS, 2017, PERCEPT MOTOR SKILL, V124, P569, DOI 10.1177/0031512517697069; Singh AS, 2019, BRIT J SPORT MED, V53, P640, DOI [10.1186/s12870-018-1476-1, 10.1136/bjsports-2017-098136]; Smith PJ, 2010, PSYCHOSOM MED, V72, P239, DOI 10.1097/PSY.0b013e3181d14633; Suchert V, 2016, J SCHOOL HEALTH, V86, P734, DOI 10.1111/josh.12424; Verburgh L, 2014, BRIT J SPORT MED, V48, P973, DOI 10.1136/bjsports-2012-091441; Watson A, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0569-9; Westfall DR, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01298; Wittberg RA, 2012, AM J PUBLIC HEALTH, V102, P2303, DOI 10.2105/AJPH.2011.300515; Zahl T, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-1711; Zhang, 2013, HINDAWI, DOI DOI 10.1155/2013/431979	44	3	3	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253142	10.1371/journal.pone.0253142	http://dx.doi.org/10.1371/journal.pone.0253142			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SD	34115814	gold, Green Published			2022-12-26	WOS:000664643000049
J	de Araujo, LML; Lopes, MVD; de Arruda, RS; Martins, RR; Oliveira, AG				Lima de Araujo, Lorena Maria; de Moura Lopes, Maria Vivyanne; de Arruda, Rafael Silva; Martins, Rand Randall; Oliveira, Antonio Gouveia			Proton pump inhibitor and community pharmacies: Usage profile and factors associated with long-term use	PLOS ONE			English	Article							MEDICATION; SAMPLE; RISKS	Aim To characterize the usage profile and the factors associated with the prolonged use of proton pump inhibitor drugs in a community pharmacy. Methodology This is a cross-sectional, prospective and observational study involving interviews with 410 patients who acquired PPI for their own use from community pharmacies. To characterize the factors associated with the prolonged use of PPI, a multivariate logistic regression model was used. Results Pantoprazole (42.7%) and omeprazole (31%) were the most acquired PPIs, prescribed mainly by gastroenterologists (49.5%). They are used in the morning, especially for gastrointestinal symptoms, however, they had been consumed for more than 5 years in 30% of cases. The factors associated with prolonged use are old age (OR 1.03 CI95% 1.01-1.05), body mass index (OR 1.07 CI95% 1.01-1.12), use of non-steroidal anti-inflammatories (OR 3.18 CI95% 1.20-8.43) and selective serotonin reuptake inhibitors (OR 3.5 95% CI 1.39-8.88). Conclusion PPIs are adequate in terms of indication and form of use, however, prolonged use associated with old age, being overweight and use of anti-inflammatories and antidepressants is frequent.	[Lima de Araujo, Lorena Maria; Martins, Rand Randall; Oliveira, Antonio Gouveia] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Postgrad Program Pharmaceut Sci, Natal, RN, Brazil; [Lima de Araujo, Lorena Maria; de Moura Lopes, Maria Vivyanne; de Arruda, Rafael Silva; Martins, Rand Randall; Oliveira, Antonio Gouveia] Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Pharm Dept, Natal, RN, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Martins, RR (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Postgrad Program Pharmaceut Sci, Natal, RN, Brazil.; Martins, RR (corresponding author), Univ Fed Rio Grande do Norte, Hlth Sci Ctr, Pharm Dept, Natal, RN, Brazil.	rand.martins@ufrn.br	Martins, Rand Randall/X-8188-2019	Martins, Rand Randall/0000-0001-9668-0482	Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES) [001]	Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	We declare that this study was financed by the Coordination for the Improvement of Higher Education Personnel - Brazil (CAPES) - Finance Code 001. There was no additional external funding received for this study.	Abbas MK, 2019, CUREUS, V11, DOI 10.7759/cureus.5563; Alhossan A, 2019, SAUDI PHARM J, V27, P225, DOI 10.1016/j.jsps.2018.11.002; Aljadhey H, 2015, SAUDI MED J, V36, P328, DOI 10.15537/smj.2015.3.10523; Almubark RA, 2020, DRUGS-REAL WOR OUTC, V7, P161, DOI 10.1007/s40801-020-00186-8; Association of the European Self-Care Industry (AESGP), 2017, OTC; Boardman HF, 2015, INT J CLIN PHARM-NET, V37, P709, DOI 10.1007/s11096-015-0150-z; Bomba LA., 2018, REV ESP SALUD PUBLIC, V92, P1; Euromonitor International, 2014, GLOBAL OPPORTUNITIES; Eusebi LH, 2017, J GASTROEN HEPATOL, V32, P1295, DOI 10.1111/jgh.13737; Fossmark R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205203; Freedberg DE, 2017, GASTROENTEROLOGY, V152, P706, DOI 10.1053/j.gastro.2017.01.031; Holmberg D, 2019, ALIMENT PHARM THER, V50, P159, DOI 10.1111/apt.15274; Ladd AM, 2014, AM J MED SCI, V347, P446, DOI 10.1097/MAJ.0b013e31829f87d5; Lundell L, 2015, ALIMENT PHARM THER, V42, P649, DOI 10.1111/apt.13324; Mahrous MS, 2018, INT J HEALTH SCI-IJH, V12, P3; Mares-Garcia E, 2017, CURR MED RES OPIN, V33, P1725, DOI 10.1080/03007995.2017.1308921; McCoul ED, 2020, LARYNGOSCOPE, V130, P2114, DOI 10.1002/lary.28366; OMahony L, 2019, Ir Med J, V112, P932; Pasina L, 2016, J CLIN PHARM THER, V41, P220, DOI 10.1111/jcpt.12371; World Health Organization (WHO), 2002, FINANC MANAGE	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252785	10.1371/journal.pone.0252785	http://dx.doi.org/10.1371/journal.pone.0252785			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111166	Green Published, gold			2022-12-26	WOS:000664642700043
J	Sylverken, AA; Kwarteng, A; Twumasi-Ankrah, S; Owusu, M; Arthur, RA; Dumevi, RM; Adu-Amoah, L; Addofoh, N; Okyere, PB; Dzata, F; Bonsu, F; Adusi-Poku, Y; Kranzer, K; Siroka, A; van Gemert, W; Dean, A; Owusu-Dabo, E				Sylverken, Augustina Angelina; Kwarteng, Alexander; Twumasi-Ankrah, Sampson; Owusu, Michael; Arthur, Rejoice Agyeiwaa; Dumevi, Rexford Mawunyo; Adu-Amoah, Louis; Addofoh, Nicholas; Okyere, Portia Boakye; Dzata, Francisca; Bonsu, Frank; Adusi-Poku, Yaw; Kranzer, Katharina; Siroka, Andrew; van Gemert, Wayne; Dean, Anna; Owusu-Dabo, Ellis			The burden of drug resistance tuberculosis in Ghana; results of the First National Survey	PLOS ONE			English	Article							RISK-FACTORS; BURKINA-FASO; TB	Resistance to Tuberculosis drugs has become a major threat to the control of tuberculosis (TB) globally. We conducted the first nation-wide drug resistance survey to investigate the level and pattern of resistance to first-line TB drugs among newly and previously treated sputum smear-positive TB cases. We also evaluated associations between potential risk factors and TB drug resistance. Using the World Health Organization (WHO) guidelines on conducting national TB surveys, we selected study participants from 33 health facilities from across the country, grouped into 29 clusters, and included them into the survey. Between April 2016 and June 2017, a total of 927 patients (859 new and 68 previously treated) were enrolled in the survey. Mycobacterium tuberculosis complex (MTBC) isolates were successfully cultured from 598 (65.5%) patient samples and underwent DST, 550 from newly diagnosed and 48 from previously treated patients. The proportion of patients who showed resistance to any of the TB drugs tested was 25.2% (95% CI; 21.8-28.9). The most frequent resistance was to Streptomycin (STR) (12.3%), followed by Isoniazid (INH) (10.4%), with Rifampicin (RIF), showing the least resistance of 2.4%. Resistance to Isoniazid and Rifampicin (multi-drug resistance) was found in 19 (3.2%; 95% CI: 1.9-4.9) isolates. Prevalence of multidrug resistance was 7 (1.3%; 95% CI: 0.5-2.6) among newly diagnosed and 12 (25.0%; 95% CI: 13.6-39.6) among previously treated patients. At both univariate and multivariate analysis, MDR-TB was positively associated with previous history of TB treatment (OR = 5.09, 95% CI: 1.75-14.75, p = 0.003); (OR = 5.41, 95% CI: 1.69-17.30, p = 0.004). The higher levels of MDR-TB and overall resistance to any TB drug among previously treated patients raises concerns about adherence to treatment. This calls for strengthening existing TB programme measures to ensure a system for adequately testing and monitoring TB drug resistance.	[Sylverken, Augustina Angelina] Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana; [Sylverken, Augustina Angelina; Kwarteng, Alexander; Twumasi-Ankrah, Sampson; Arthur, Rejoice Agyeiwaa; Dumevi, Rexford Mawunyo; Adu-Amoah, Louis; Addofoh, Nicholas; Okyere, Portia Boakye; Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana; [Kwarteng, Alexander] Kwame Nkrumah Univ Sci & Technol, Dept Biochem & Biotechnol, Kumasi, Ghana; [Twumasi-Ankrah, Sampson] Kwame Nkrumah Univ Sci & Technol, Dept Stat & Actuarial Sci, Kumasi, Ghana; [Owusu, Michael] Kwame Nkrumah Univ Sci & Technol, Dept Med Lab Technol, Kumasi, Ghana; [Dzata, Francisca; Bonsu, Frank; Adusi-Poku, Yaw] Ghana Hlth Serv, Natl TB Control Programme, Accra, Ghana; [Kranzer, Katharina] Supranat Reference Mycobacterium Lab, Borstel, Germany; [Siroka, Andrew; van Gemert, Wayne; Dean, Anna] WHO, Global TB Programme, Geneva, Switzerland; [Owusu-Dabo, Ellis] Kwame Nkrumah Univ Sci & Technol, Sch Publ Hlth, Dept Global & Int Hlth, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Ghana Health Service; World Health Organization; Kwame Nkrumah University Science & Technology	Sylverken, AA (corresponding author), Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana.; Sylverken, AA (corresponding author), Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res Trop Med, Kumasi, Ghana.	asylverken@knust.edu.gh	; Kranzer, Katharina/O-8845-2014	Dumevi, Rexford/0000-0002-7135-2754; Kranzer, Katharina/0000-0001-5691-7270; SYLVERKEN, AUGUSTINA/0000-0002-7691-914X	(Ghana National Tuberculosis Control Programme) Global Fund Round 5	(Ghana National Tuberculosis Control Programme) Global Fund Round 5	FB (Ghana National Tuberculosis Control Programme) Global Fund Round 5 https://www.theglobalfund.org/en/ The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo KK, 2018, J TUBERC RES, V6, P135; Asante-Poku A, 2015, INT J TUBERC LUNG D, V19, P954, DOI 10.5588/ijtld.14.0864; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P301; Chonde TM, 2010, INT J TUBERC LUNG D, V14, P967; Demile B, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3167-9; Diande S, 2019, EUR J MICROBIOL IMMU, V9, P23, DOI 10.1556/1886.2018.00029; Diande S, 2009, MICROB DRUG RESIST, V15, P217, DOI 10.1089/mdr.2009.0906; Espinal MA, 2005, LANCET, V365, P1206, DOI 10.1016/S0140-6736(05)74788-7; Faustini A, 2006, THORAX, V61, P158, DOI 10.1136/thx.2005.045963; Forson A., 2010, GHANA MED J, V44; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Holtz TH, 2006, INT J TUBERC LUNG D, V10, P649; Kim JY, 2005, SOC SCI MED, V61, P847, DOI 10.1016/j.socscimed.2004.08.046; Kuyinu YA, 2018, J NATL MED ASSOC, V110, P88, DOI 10.1016/j.jnma.2017.04.007; Lawn S D, 2001, West Afr J Med, V20, P92; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Lukoye D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070763; Menzies D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000146; Musa BM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185105; N'Guessan K, 2018, EUR J MICROBIOL IMMU, V8, P91, DOI 10.1556/1886.2018.00001; Newman M J, 2007, West Afr J Med, V26, P131; Organization W.H., 2019, WHO GLOB TASK FORC T; Osei-Wusu S, 2018, INFECT DRUG RESIST, V11, P239, DOI 10.2147/IDR.S152720; Otchere ID, 2016, TUBERCULOSIS, V99, P147, DOI 10.1016/j.tube.2016.05.014; Owusu-Dabo Ellis, 2006, Emerg Infect Dis, V12, P1171; Pablos-Mendez A, 2002, B WORLD HEALTH ORGAN, V80, P489; Siddiqi SH., 2006, MGIT PROCEDURE MANUA, V307; Sindani I., 2013, MULTIDRUG RESISTANT, V19, P1, DOI [10.3201/eid1903.121287, DOI 10.3201/EID1903.121287]; Sitienei Joseph., 2017, J HEAL SCI, V5, P282, DOI [10.17265/2328-7136/2017.06.002, DOI 10.17265/2328-7136/2017.06.002]; Sylverken AA., 2019, AAS OPEN RES, V2, DOI [10.12688/aasopenres.12920.2, DOI 10.12688/AASOPENRES.12920.2]; VANDERWERF TS, 1989, TUBERCLE, V70, P249, DOI 10.1016/0041-3879(89)90019-6; Weyer K., 1998, LABORATORY SERVICES; Weyer K, 2013, EUR RESPIR J, V42, P252, DOI 10.1183/09031936.00157212; WHO, 2018, GLOBAL TUBERCULOSIS; WHO, 2009, WHOHTMTB2009422; World Health Organization, 2008, WORLD HEAL ORGAN, P12; World Health Organization (WHO), 2014, COMP HDB; Yeboah-Manu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021906	38	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252819	10.1371/journal.pone.0252819	http://dx.doi.org/10.1371/journal.pone.0252819			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111159	Green Published, gold			2022-12-26	WOS:000664642700048
J	Takamatsu, Y; Aiba, I				Takamatsu, Yasuyuki; Aiba, Ikuko			Skeletal muscle loss and body composition in progressive supranuclear palsy: A retrospective cross-sectional study	PLOS ONE			English	Article							OLDER MEN; SARCOPENIA; MORTALITY; CONSENSUS; FRAILTY	Introduction Skeletal muscle mass loss has been associated with decreased physical performance; however, the body composition characteristics in progressive supranuclear palsy (PSP) are not well understood. We investigated body composition parameters, focusing on skeletal muscle mass, in patients with PSP and compared them with those of healthy older adults. Methods This retrospective cross-sectional study included 39 patients with PSP and 30 healthy older adults (control group). Using a multi-frequency bioelectrical impedance analysis, we measured the skeletal mass index (SMI), basal metabolism, extracellular water/total body water ratio (ECW/TBW), and body fat percentage and examined the relationship between SMI and age, body mass index (BMI) and other body composition parameters. Results The PSP group had a higher rate of low muscle mass (56.4%) than the control group (10.0%), although the ages and BMIs were similar. The leg SMI was lower for the PSP group, while the ECW/TBW was higher for the PSP group. The basal metabolism was lower for the PSP group than for the controls but only in the women. The basal metabolism and BMI showed a significant correlation with SMI in the PSP group. There was a significant correlation between SMI and age, ECW/TBW, and body fat percentage in the PSP group but only in the women. Conclusion This study is the first to show that a high proportion of patients with PSP have low muscle mass. We showed differences in terms of sex in muscle mass loss in women with PSP, which was associated with inactivity and aging.	[Takamatsu, Yasuyuki] Hokkaido Univ, Fac Hlth Sci, Dept Rehabil Sci, Sapporo, Hokkaido, Japan; [Aiba, Ikuko] Higashinagoya Natl Hosp, Natl Hosp Org, Dept Neurol, Nagoya, Aichi, Japan	Hokkaido University	Aiba, I (corresponding author), Higashinagoya Natl Hosp, Natl Hosp Org, Dept Neurol, Nagoya, Aichi, Japan.	ikukoaiba0401@gmail.com		Aiba, Ikuko/0000-0001-9312-5707; Takamatsu, Yasuyuki/0000-0002-1671-6674	Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants; Ministry of Health, Labour and Welfare, Japan [20FC1049]	Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants; Ministry of Health, Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by Grants-in Aid from the Research Committee of CNS Degenerative Diseases, Research on Policy Planning and Evaluation for Rare and Intractable Diseases, Health, Labour and Welfare Sciences Research Grants, the Ministry of Health, Labour and Welfare, Japan (20FC1049, to I.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akima H, 2017, ARCH GERONTOL GERIAT, V70, P105, DOI 10.1016/j.archger.2017.01.014; Azzolino D, 2019, AGING CLIN EXP RES, V31, P799, DOI 10.1007/s40520-019-01128-3; Barichella M, 2016, J AM MED DIR ASSOC, V17, P640, DOI 10.1016/j.jamda.2016.03.016; Batsis JA, 2018, NAT REV ENDOCRINOL, V14, P513, DOI 10.1038/s41574-018-0062-9; Booth FW, 2017, PHYSIOL REV, V97, P1351, DOI 10.1152/physrev.00019.2016; Buckinx F, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0510-9; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Cruz-Jentoft AJ, 2017, AGING CLIN EXP RES, V29, P43, DOI 10.1007/s40520-016-0709-0; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Grimm MJ, 2019, MOVEMENT DISORD, V34, P1228, DOI 10.1002/mds.27666; Hirani V, 2017, AGE AGEING, V46, P413, DOI 10.1093/ageing/afw214; Hoglinger GU, 2017, MOVEMENT DISORD, V32, P853, DOI 10.1002/mds.26987; Jayanama K, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/4537623; Landi F, 2012, J AM MED DIR ASSOC, V13, P121, DOI 10.1016/j.jamda.2011.07.004; Lanza E, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232371; Lee SY, 2018, J AM MED DIR ASSOC, V19, P378, DOI 10.1016/j.jamda.2018.02.003; Naseeb MA, 2017, NUTR RES, V40, P1, DOI 10.1016/j.nutres.2017.01.001; Oka M, 2001, ACTA NEUROL SCAND, V104, P1, DOI 10.1034/j.1600-0404.2001.00262.x; Park I, 2020, CLIN NUTR, V39, P1826, DOI 10.1016/j.clnu.2019.07.022; Rizzoli R, 2013, CALCIFIED TISSUE INT, V93, P101, DOI 10.1007/s00223-013-9758-y; Steele JC, 2014, SEMIN NEUROL, V34, P129, DOI 10.1055/s-0034-1377058; Steffl M, 2017, CLIN INTERV AGING, V12, P835, DOI 10.2147/CIA.S132940; Tan AH, 2018, PARKINSONISM RELAT D, V56, P58, DOI 10.1016/j.parkreldis.2018.06.020; VANSWIETEN JC, 1988, STROKE, V19, P604, DOI 10.1161/01.STR.19.5.604; Zhao WT, 2018, J NUTR HEALTH AGING, V22, P1003, DOI 10.1007/s12603-018-1055-z	25	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0253079	10.1371/journal.pone.0253079	http://dx.doi.org/10.1371/journal.pone.0253079			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111224	Green Published, gold			2022-12-26	WOS:000664642700094
J	Jung, HO; Han, SW				Jung, Hyun-Ok; Han, Seung-Woo			Implementing psychological first aid ontology	PLOS ONE			English	Article								Background This study develops an ontology of Psychological First Aid (PFA) by extracting relevant knowledge from a review of PFA literature. Materials and methods This study was conducted using the PFA ontology development 101 method. This review processes previously-developed PFA studies by consulting Google Scholar, CINHL, PUBMED, and MEDLINE. Protege 5.0 program was used to integrate with ontology development. The developed PFA ontology consisted of eight super classes: Action agenda, Assessment, Concrete method, Disaster type, Disaster disposition, Purpose, Qualification and Skill, Reaction. In total, 166 terms were collected. Results The eight super classes were divided into 72 classes and 64 subclasses. The composition yielded in a total of 166 axioms (85 logical axioms; 81 declaration axioms). Conclusions This study provides basic data to guide development and composition of PFA arbitration programs.	[Jung, Hyun-Ok] Kyungpook Natl Univ, Coll Nursing, Daegu, South Korea; [Han, Seung-Woo] Kyungil Univ, Dept Emergency Med Technol, Gyongsan, South Korea	Kyungpook National University; Kyungil University	Han, SW (corresponding author), Kyungil Univ, Dept Emergency Med Technol, Gyongsan, South Korea.	swhan@kiu.ac.kr						[Anonymous], 2015, PHILIPPINE J PSYCHOL; Brymer M., 2006, PSYCHOL 1 AID FIELD, V2nd; Kang SH., 2016, DISASTER MENNTAL HLT, V2th ed; Kim HS., 2015, DAEGU DISASTER PSYCH, V1th ed; Kwon JH., 2014, PSYCHOL 1 AID DISAST, V2th ed; McCabe OL., 2008, INT J EMERG MENT HLT, V9, P181; McGuinness Deborah L, 2001, ONTOLOGY DEV; O Bodenreider A., 2005, MED INFORM; Park HA, 2018, KOR J I COMMUNICATIO, V35, P85; Ruzek J.I., 2007, J MENTAL HLTH COUNS, V29, P17, DOI [DOI 10.17744/MEHC.29.1.5RACQXJUEAFABGWP, https://doi.org/10.17744/mehc.29.1.5racqxjueafabgwp]; Sakuma A, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0440-y; SMITH Barry., 2012, FURNITURE WORLD; Strawbridge WJ, 1997, AM J PUBLIC HEALTH, V87, P957, DOI 10.2105/AJPH.87.6.957; Veenema TG., 2016, READYRN E BOOK HDB D; WHO CBM World Vision UNICEF, 2014, FAC MAN PSYCH 1 AID; WHO Team Mental Health and Substance Use, 2011, PSYCHOL 1 AID GUIDE	16	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252891	10.1371/journal.pone.0252891	http://dx.doi.org/10.1371/journal.pone.0252891			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106955	Green Published			2022-12-26	WOS:000664642200062
J	Moreira, PVS; Falco, C; Menegaldo, LL; Goethel, MF; de Paula, LV; Goncalves, M				Sarmet Moreira, Pedro Vieira; Falco, Coral; Menegaldo, Luciano Luporini; Goethel, Marcio Fagundes; de Paula, Leandro Vinhas; Goncalves, Mauro			Are isokinetic leg torques and kick velocity reliable predictors of competitive level in taekwondo athletes?	PLOS ONE			English	Article							ROUNDHOUSE KICK; MUSCLE STRENGTH; IMPACT FORCE; PERFORMANCE; HIP; COORDINATION; DYNAMICS; DISTANCE	The aim of this study is to analyze how isokinetic knee and hip peak torques and roundhouse kick velocities are related to expertise level (elite vs. sub-elite) in taekwondo athletes. Seven elite and seven sub-elite athletes were tested for kick-specific variables (KSV, composed of kinematic variables and power of impact) and for concentric isokinetic peak torque (PT) at 60 degrees /s and 240 degrees /s. First, KSVs and PTs were compared between groups, then PTs were correlated with KSVs. Parametric variables with larger effect sizes (Cohen's d) were entered in a stepwise linear discriminant analysis (LDA), generating an equation to estimate competitive level. Between-group differences were found in hip flexors (p = 0.04, d = 0.92) and extensors (p = 0.04, d = 0.96) with PT at 240 degrees /s. Hip flexion PT at 60 degrees /s and 240 degrees /s correlated negatively with kick time (R = -0.46, p = 0.0499 and R = -0.62, p = 0.01 respectively). Hip flexion torque at 60 degrees /s correlated positively (R = 0.52, p = 0.03) with peak linear velocity of the foot (LVF) and power of impact (R = 0.51, p = 0.03). Peak torque of hip extension at 60 degrees /s and hip abduction at 240 degrees /s also correlated with LVF (R = 0.56, p = 0.02 and R = 0.46, p = 0.0499). Hip extension at 60 degrees /s correlated positively with peak linear velocity of the knee (R = 0.48, p = 0.04). The LDA showed an accuracy of 85.7% (p = 0.003) in predicting expertise level based on hip flexion and extension torques at 240 degrees /s and on knee extension velocity during the kick. The study demonstrates that hip muscle strength is probably the dominant muscular factor for determining kick performance. Knee angular velocity combined with hip torques is the best discriminator for competitive level in taekwondo athletes.	[Sarmet Moreira, Pedro Vieira; Menegaldo, Luciano Luporini] Univ Fed Rio de Janeiro, Biomed Engn Program, COPPE, Rio De Janeiro, RJ, Brazil; [Sarmet Moreira, Pedro Vieira; Goethel, Marcio Fagundes; Goncalves, Mauro] Sao Paulo State Univ UNESP, Lab Biomech, Rio Claro, SP, Brazil; [Sarmet Moreira, Pedro Vieira] Tech4Fight Sports Technol, Rio De Janeiro, RJ, Brazil; [Falco, Coral] Western Norway Univ Appl Sci, Dept Sport Food & Nat Sci, Bergen, Norway; [de Paula, Leandro Vinhas] Univ Fed Minas Gerais, Lab Biomech, Belo Horizonte, MG, Brazil	Universidade Federal do Rio de Janeiro; Universidade Estadual Paulista; Western Norway University of Applied Sciences; Universidade Federal de Minas Gerais	Falco, C (corresponding author), Western Norway Univ Appl Sci, Dept Sport Food & Nat Sci, Bergen, Norway.	coral.falco@hvl.no	Menegaldo, Luciano L/J-3645-2016; Menegaldo, Luciano/AAM-3561-2021; Moreira, Pedro/F-9276-2015; Goethel, Marcio/C-5693-2013	Menegaldo, Luciano L/0000-0002-5855-4650; Menegaldo, Luciano/0000-0002-5855-4650; Moreira, Pedro/0000-0001-6919-0904; Goethel, Marcio/0000-0003-4382-0159	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/19093-6]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES) [001]; Research Support Foundation of the State of Rio de Janeiro (FAPERJ) [2020.01759.2]; Western Norway University of Applied Sciences	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Research Support Foundation of the State of Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Western Norway University of Applied Sciences	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP: http://www.fapesp.br/) under a PhD. Grant for Moreira, PVS through the grant number: #2012/19093-6. This study was financed in part by the Post Doctoral Grant for Moreira, PVS, by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES, https://www.capes.gov.br/), Finance Code 001 and partially with the aid of the grant from the Research Support Foundation of the State of Rio de Janeiro (FAPERJ), through the edital 17/2019 "Doctor Enterpreneur Program: Transforming Knowledge in Innnovation" under the grant number: 2020.01759.2. Its publication was also financed by the Western Norway University of Applied Sciences.	Aagaard P, 2002, J APPL PHYSIOL, V93, P1318, DOI 10.1152/japplphysiol.00283.2002; Abdelmohsen AM, 2019, J CHIROPR MED, V18, P27, DOI 10.1016/j.jcm.2018.03.009; BELL GJ, 1992, SPORTS MED, V13, P234, DOI 10.2165/00007256-199213040-00002; Beunen GP., 2014, OPEN SPORTS SCI J, V3, P58; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; Ervilha UF, 2020, SPORT BIOMECH, V19, P665, DOI 10.1080/14763141.2018.1515244; Estevan I, 2013, J SPORT SCI, V31, P1815, DOI 10.1080/02640414.2013.803590; Estevan I, 2011, J STRENGTH COND RES, V25, P2851, DOI 10.1519/JSC.0b013e318207ef72; Falco C, 2012, SCI RES, V2, P28, DOI [10.4236/ape.2012.21005, DOI 10.4236/APE.2012.21005]; Fong SSM, 2012, HONG KONG PHYSIOTHER, V30, P25, DOI 10.1016/j.hkpj.2011.11.004; Fong SSM, 2011, PHYS THER SPORT, V12, P100, DOI 10.1016/j.ptsp.2010.07.001; Gaines J M, 1999, Biol Res Nurs, V1, P57, DOI 10.1177/109980049900100108; Gautrey CN, 2013, INT J SPORTS MED, V34, P623, DOI 10.1055/s-0032-1327662; Gavagan CJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182645; Hammami N, 2014, SCI SPORT, V29, P150, DOI 10.1016/j.scispo.2013.07.013; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Ho J, 2019, NAT METHODS, V16, P565, DOI 10.1038/s41592-019-0470-3; Jones N, 2016, BIOL SPORT, V33, P117, DOI 10.5604/20831862.1198210; Kellis E, 2007, J SPORT SCI MED, V6, P154; Kim JW, 2010, SPORT BIOMECH, V9, P98, DOI 10.1080/14763141003799459; Kim YK, 2011, J SPORT SCI MED, V10, P31; Kinoshita M., 2014, 32 INT C BIOM SPORTS; Kreighbaum E., 1990, BIOMECHANICS QUALITA, V3rd, P63; Li PW, 2018, EUR J SPORT SCI, V18, P550, DOI 10.1080/17461391.2018.1439104; Lust KR, 2009, J SPORT REHABIL, V18, P407, DOI 10.1123/jsr.18.3.407; Menescardi C, 2015, J STRENGTH COND RES, V29, P466, DOI 10.1519/JSC.0000000000000645; Moreira P., 2017, J ATHLETIC ENHANCEME, V1, P1, DOI 10.4172/2324-9080.1000250; Moreira PVS., 2018, J MECH ENG BIOMECHAN, V3, P33; O'Donovan O, 2006, J SPORT SCI MED, V5, P5; O'Sullivan D, 2009, J SPORT SCI MED, V8, P13; PIETER W, 1989, J HUM MOVEMENT STUD, V16, P17; PUTNAM CA, 1993, J BIOMECH, V26, P125, DOI 10.1016/0021-9290(93)90084-R; Quinzi F, 2015, EUR J APPL PHYSIOL, V115, P47, DOI 10.1007/s00421-014-2990-y; Quinzi F, 2014, HUM MOVEMENT SCI, V33, P108, DOI 10.1016/j.humov.2013.07.021; Quinzi F, 2013, J ELECTROMYOGR KINES, V23, P140, DOI 10.1016/j.jelekin.2012.09.006; Moreira PVS, 2018, ARCH BUDO, V14, P59; Moreira PVS, 2016, J ELECTROMYOGR KINES, V30, P55, DOI 10.1016/j.jelekin.2016.06.001; Moreira PVS, 2015, ARCH BUDO, V11, P271; Sbriccoli P, 2010, EUR J APPL PHYSIOL, V108, P1269, DOI 10.1007/s00421-009-1338-5; Seo MW, 2015, J EXERC REHABIL, V11, P101, DOI 10.12965/jer.150196; Sheng SJ., 2016, ALTHEA MED J, V3, P392; Singh A, 2015, SPORT EXERC MED OPEN, V1, P42, DOI [10.17140/SEMOJ-1-107, DOI 10.17140/SEMOJ-1-107]; Sorensen H, 1996, J SPORT SCI, V14, P483, DOI 10.1080/02640419608727735; Systems VM, 2018, PLUG IN GAIT REFEREN; Tasika N., 2013, J HUM SPORT EXERC, V8, pS622, DOI [DOI 10.4100/JHSE.2013.8.PROC3.08, https://doi.org/10.4100/JHSE.2013.8.PROC3.08]; Teng WM., 2008, INT J SPORTSCI ENG, V2, P111; Thibordee S, 2014, J ELECTROMYOGR KINES, V24, P353, DOI 10.1016/j.jelekin.2014.02.002; Tucker R, 2012, BRIT J SPORT MED, V46, P555, DOI 10.1136/bjsports-2011-090548; Vagner M, 2019, J HUM KINET, V68, P145, DOI 10.2478/hukin-2019-0063; Weiss LD., 2015, EASY EMG E BOOK GUID	51	4	4	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0235582	10.1371/journal.pone.0235582	http://dx.doi.org/10.1371/journal.pone.0235582			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106936	Green Published, gold			2022-12-26	WOS:000664642200001
J	Vasiukov, G; Menshikh, A; Owens, P; Novitskaya, T; Hurley, P; Blackwell, T; Feoktistov, I; Novitskiy, SV				Vasiukov, Georgii; Menshikh, Anna; Owens, Philip; Novitskaya, Tatiana; Hurley, Paula; Blackwell, Timothy; Feoktistov, Igor; Novitskiy, Sergey V.			Adenosine/TGF beta axis in regulation of mammary fibroblast functions	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SMOOTH MUSCLE ACTIN; CANCER-ASSOCIATED FIBROBLASTS; E3 UBIQUITIN LIGASES; TGF-BETA; EXTRACELLULAR-MATRIX; MYELOID CELLS; COLLAGEN; RECEPTOR; MICROENVIRONMENT	Cancer associated fibroblasts (CAF) play a key role in cancer progression and metastasis. Diminished TGF beta response on CAF correlates with poor outcome and recurrence in cancer patients. Mechanisms behind lost TGF beta signaling on CAF are poorly understood, but, utilizing MMTV-PyMT mouse model, we have previously demonstrated that in tumor microenvironment myeloid cells, producing adenosine, contribute to downregulated TGF beta signaling on CAFs. In the current work, we performed serial in vitro studies to investigate the role of adenosine/TGF beta axis in mouse mammary fibroblast functions, i.e., proliferation, protein expression, migration, and contractility. We found that adenosine analog NECA diminished TGF beta -induced CCL5 and MMP9 expression. Additionally, we discovered that NECA completely inhibited effect of TGF beta to upregulate alpha SMA, key protein of cytoskeletal rearrangements, necessary for migration and contractility of fibroblasts. Our results show that TGF beta increases contractility of mouse mammary fibroblasts and human fibroblast cell lines, and NECA attenuates theses effects. Using pharmacological approach and genetically modified animals, we determined that NECA effects on TGF beta pathway occur via A(2A)/A(2B) adenosine receptor-AC-PKA dependent manner. Using isolated CD11b(+) cells from tumor tissue of CD73-KO and CD39-KO animals in co-culture experiments with ATP and AMP, we confirmed that myeloid cells can affect functions of mammary fibroblasts through adenosine signaling. Our data suggest a novel mechanism of interaction between adenosine and TGF beta signaling pathways that can impact phenotype of fibroblasts in a tumor microenvironment.	[Vasiukov, Georgii; Blackwell, Timothy; Novitskiy, Sergey V.] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm Crit Care Med, Nashville, TN 37232 USA; [Menshikh, Anna] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN USA; [Owens, Philip] Univ Colorado Boulder, Dept Pathol, Denver, CO USA; [Novitskaya, Tatiana] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Hurley, Paula] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN USA; [Feoktistov, Igor] Vanderbilt Univ, Med Ctr, Dept Med, Div Cardiovasc Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; University of Colorado System; University of Colorado Boulder; Vanderbilt University; Vanderbilt University; Vanderbilt University	Novitskiy, SV (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm Crit Care Med, Nashville, TN 37232 USA.	sergey.v.novitskiy@vumc.org			NIH [R01CA200681]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant R01CA200681 (S.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhavan A, 2012, CANCER RES, V72, P2578, DOI 10.1158/0008-5472.CAN-11-3732; Aldinucci D, 2020, CANCERS, V12, DOI 10.3390/cancers12071765; Aldinucci D, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/292376; Allard B, 2016, CURR OPIN PHARMACOL, V29, P7, DOI 10.1016/j.coph.2016.04.001; An GL, 2019, ONCOL REP, V42, P2499, DOI 10.3892/or.2019.7344; Annes JP, 2003, J CELL SCI, V116, P217, DOI 10.1242/jcs.00229; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Asano Y, 2004, J IMMUNOL, V172, P7123, DOI 10.4049/jimmunol.172.11.7123; Augsten M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00062; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Bellam N, 2010, CANCER TREAT RES, V155, P85, DOI 10.1007/978-1-4419-6033-7_5; Beyer TA, 2013, BBA-GEN SUBJECTS, V1830, P2268, DOI 10.1016/j.bbagen.2012.08.025; Bhat R, 2014, WIRES DEV BIOL, V3, P147, DOI 10.1002/wdev.130; Bierie B, 2006, NAT REV CANCER, V6, P506, DOI 10.1038/nrc1926; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Boison D, 2019, CANCER CELL, V36, P582, DOI 10.1016/j.ccell.2019.10.007; Bowser JL, 2017, J APPL PHYSIOL, V123, P1303, DOI 10.1152/japplphysiol.00101.2017; Cheng N, 2005, ONCOGENE, V24, P5053, DOI 10.1038/sj.onc.1208685; Cheng N, 2008, MOL CANCER RES, V6, P1521, DOI 10.1158/1541-7786.MCR-07-2203; Cho A, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00245; Colak S, 2017, TRENDS CANCER, V3, P56, DOI 10.1016/j.trecan.2016.11.008; Conery AR, 2004, NAT CELL BIOL, V6, P366, DOI 10.1038/ncb1117; David D, 2013, BBA-REV CANCER, V1835, P119, DOI 10.1016/j.bbcan.2012.11.003; Di Virgilio F, 2018, NAT REV CANCER, V18, P601, DOI 10.1038/s41568-018-0037-0; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Falzoni S, 2013, INTERFACE FOCUS, V3, DOI 10.1098/rsfs.2012.0101; Fang WB, 2011, CLIN EXP METASTAS, V28, P351, DOI 10.1007/s10585-011-9373-0; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Gilkes DM, 2014, NAT REV CANCER, V14, P430, DOI 10.1038/nrc3726; Giuliani AL, 2019, IMMUNOL LETT, V205, P16, DOI 10.1016/j.imlet.2018.11.006; Gkretsi V, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00145; Grasset EM, 2018, CANCER RES, V78, P5229, DOI 10.1158/0008-5472.CAN-18-0601; Guo X, 2009, CELL RES, V19, P71, DOI 10.1038/cr.2008.302; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; Hinz B, 2001, MOL BIOL CELL, V12, P2730, DOI 10.1091/mbc.12.9.2730; Huang H, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103249; Jolly LA, 2016, CANCER RES, V76, P1804, DOI 10.1158/0008-5472.CAN-15-2351; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; KOBAYASHI H, 1993, GYNECOL ONCOL, V48, P308, DOI 10.1006/gyno.1993.1054; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liu H, 2015, J APPL PHYSIOL, V119, P1173, DOI 10.1152/japplphysiol.00350.2015; Liu TY, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00060; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; Liu XQ, 2005, J PHARMACOL EXP THER, V315, P678, DOI 10.1124/jpet.105.090324; Liu XQ, 2004, AM J PHYSIOL-CELL PH, V286, pC1089, DOI 10.1152/ajpcell.00461.2003; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; McKenzie AJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25589-0; Meng WF, 2018, GENE, V641, P105, DOI 10.1016/j.gene.2017.10.015; Neuzillet C, 2015, PHARMACOL THERAPEUT, V147, P22, DOI 10.1016/j.pharmthera.2014.11.001; Novitskiy SV, 2008, BLOOD, V112, P1822, DOI 10.1182/blood-2008-02-136325; Novitskiy SV, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0425-7; Novitskiy SV, 2012, J LEUKOCYTE BIOL, V92, P641, DOI 10.1189/jlb.1211639; Novitskiy SV, 2011, CANCER DISCOV, V1, P430, DOI 10.1158/2159-8290.CD-11-0100; Novitskiy SV, 2010, J THORAC ONCOL, V5, P1410, DOI 10.1097/JTO.0b013e3181e59c24; Ohta A, 2006, P NATL ACAD SCI USA, V103, P13132, DOI 10.1073/pnas.0605251103; Ohta A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00109; Otranto M, 2012, CELL ADHES MIGR, V6, P203, DOI 10.4161/cam.20377; Owens P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067533; Oyanagi J, 2014, EXP CELL RES, V326, P267, DOI 10.1016/j.yexcr.2014.04.009; Pang YL, 2013, CANCER DISCOV, V3, P936, DOI 10.1158/2159-8290.CD-12-0527; Pathak R, 2008, J RECEPT SIG TRANSD, V28, P505, DOI 10.1080/10799890802539559; Peng ZW, 2017, HEPATOL COMMUN, V1, P957, DOI 10.1002/hep4.1084; Perrot I, 2019, CELL REP, V27, P2411, DOI 10.1016/j.celrep.2019.04.091; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Pray TR, 2002, DRUG RESIST UPDATE, V5, P249, DOI 10.1016/S1368-7646(02)00121-8; RonnovJessen L, 1996, J CELL BIOL, V134, P67, DOI 10.1083/jcb.134.1.67; Ryzhov S, 2014, PURINERG SIGNAL, V10, P477, DOI 10.1007/s11302-014-9410-y; Ryzhov S, 2011, J IMMUNOL, V187, P6120, DOI 10.4049/jimmunol.1101225; Ryzhov SV, 2014, J IMMUNOL, V193, P3155, DOI 10.4049/jimmunol.1400578; Sapudom J, 2017, BIOMATER SCI-UK, V5, P1858, DOI 10.1039/c7bm00286f; Schiller M, 2003, ONCOGENE, V22, P8881, DOI 10.1038/sj.onc.1206871; Shaw AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117908; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shinde AV, 2017, BBA-MOL BASIS DIS, V1863, P298, DOI 10.1016/j.bbadis.2016.11.006; Song KY, 2006, EMBO J, V25, P58, DOI 10.1038/sj.emboj.7600917; Vasiukov G, 2020, CANCER RES, V80, P2628, DOI 10.1158/0008-5472.CAN-19-3954; Walker C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103028; Ween MP, 2011, INT J MOL SCI, V12, P1009, DOI 10.3390/ijms12021009; Wipff PJ, 2007, J CELL BIOL, V179, P1311, DOI 10.1083/jcb.200704042; Xiao Q, 2012, CANCER MICROENVIRON, V5, P261, DOI 10.1007/s12307-012-0105-z; Xu SS, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2058-1; Young A, 2014, CANCER DISCOV, V4, P879, DOI 10.1158/2159-8290.CD-14-0341; Zhang LZ, 2004, MOL CELL BIOL, V24, P2169, DOI 10.1128/MCB.24.5.2169-2180.2004	84	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252424	10.1371/journal.pone.0252424	http://dx.doi.org/10.1371/journal.pone.0252424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101732	gold, Green Published			2022-12-26	WOS:000664641500014
J	Aigbedion-Atalor, PO; Idemudia, I; Adom, M; Forchibe, EE; Tossou, H; Wilson, DD; Day, MD				Aigbedion-Atalor, Pascal O.; Idemudia, Itohan; Adom, Medetissi; Forchibe, Ethelyn E.; Tossou, Hospice; Wilson, David D.; Day, Michael D.			Marching across and beyond West Africa: First record of the stem-galling fly Cecidochares connexa (Diptera: Tephritidae) in Central Africa and the implications for biological control of Chromolaena odorata (Asteraceae)	PLOS ONE			English	Article							MACQUART DIPTERA; COMMUNITIES; INVASION; IMPACTS; AGENT	The Neotropical invasive plant Chromolaena odorata R.M. King and H. Robinson (Asteraceae) is a serious weed in West and Central Africa and two biological control agents that have been introduced into West Africa to help reduce its impacts on agriculture and biodiversity, have established. The stem-galling fly, Cecidochares connexa (Macquart) (Diptera: Tephritidae), has spread widely across West Africa since its release in only Cote d'Ivoire, occurring in six countries. This study aimed to investigate whether the gall fly had spread further across West Africa and into Central Africa. Here, we surveyed C. odorata for C. connexa galls in Cameroon between October 2018 and October 2020, along roadsides, on farms, residential areas, and abandoned plots, encompassing various vegetation types. Additional surveys were conducted across four countries (Ghana, Togo, Benin Republic and Nigeria) in West Africa that we considered the probable pathway for the spread of the gall fly into Central Africa. Cecidochares connexa was present at five of the six locations surveyed in Cameroon, albeit in varying abundance. In Africa, these findings represent the first-ever report of C. connexa outside of West Africa. In West Africa, we recorded significant expansion in the geographic range of C. connexa, as reflected in the absent-present record of C. connexa in two locations in Nigeria and one in Ghana, as well as its occurrence in all locations surveyed in Benin Republic and Togo. Clearly, Ghana, Togo, Benin Republic and Nigeria served as the dispersal pathway of C. connexa from the release sites in Cote d'Ivoire into Cameroon, covering over 2,300 km. Following the spread and establishment of C. connexa into Cameroon, we anticipate that it will continue to spread further into other parts of Central Africa which are climatically suitable. Cecidochares connexa is currently the only biological control agent for C. odorata in Central Africa. Given that it has significantly reduced populations of C. odorata in other countries where it has established, it is expected to have a similar impact in Central Africa.	[Aigbedion-Atalor, Pascal O.] Rhodes Univ, Dept Zool & Entomol, Ctr Biol Control, Grahamstown, South Africa; [Aigbedion-Atalor, Pascal O.; Idemudia, Itohan; Adom, Medetissi; Forchibe, Ethelyn E.; Tossou, Hospice; Wilson, David D.] Univ Ghana, African Reg Postgrad Programme Insect Sci, Legon, Ghana; [Day, Michael D.] Dept Agr & Fisheries, Brisbane, Qld, Australia	Rhodes University; University of Ghana	Aigbedion-Atalor, PO (corresponding author), Rhodes Univ, Dept Zool & Entomol, Ctr Biol Control, Grahamstown, South Africa.; Aigbedion-Atalor, PO (corresponding author), Univ Ghana, African Reg Postgrad Programme Insect Sci, Legon, Ghana.	pascalatalor1@yahoo.com	TOSSOU, Hospice/GZA-5794-2022	Day, Michael/0000-0001-5856-1685; Aigbedion-Atalor, Pascal Osa/0000-0001-7210-0885				Aigbedion-Atalor PO, 2018, AFR ENTOMOL, V26, P471, DOI 10.4001/003.026.0471; Aigbedion-Atalor PO, 2018, BIOCONTROL SCI TECHN, V28, P805, DOI 10.1080/09583157.2018.1493722; Aigbedion-Atalor PO, 2019, BIOCONTROL SCI TECHN, V29, P1215, DOI 10.1080/09583157.2019.1670782; Aigbedion-Atalor PO, 2019, J PLANT DIS PROTECT, V126, P93, DOI 10.1007/s41348-018-0189-x; Aigbedion-Atalor PO, 2019, BIOCONTROL, V64, P103, DOI 10.1007/s10526-018-09917-x; Blackburn TM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001850; Catarino L, 2019, BIOINVASIONS REC, V8, P190, DOI 10.3391/bir.2019.8.1.20; COCK MJW, 1982, B ENTOMOL RES, V72, P193, DOI 10.1017/S000748530001049X; Colombari F, 2016, BIOCONTROL, V61, P127, DOI 10.1007/s10526-015-9712-1; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Cruz ZT, 2006, ANN ENTOMOL SOC AM, V99, P845, DOI 10.1603/0013-8746(2006)99[845:EOCCDT]2.0.CO;2; Day M. D., 2013, Proceedings of the Eighth International Workshop on Biological Control and Management of Chromolaena odorata and Other Eupatorieae, 1-2 November 2010, Nairobi, Kenya, P134; Day M. D., 2013, Proceedings of the XIII International Symposium on Biological Control of Weeds, Waikoloa, Hawaii, USA, 11-16 September, 2011, P400; Day M.D., 2020, BIOL CONTROL WEEDS W; FARRELL G, 1997, BIOL CONTROL WEEDS T, P105; Furlong MJ, 2017, CURR OPIN INSECT SCI, V20, P39, DOI 10.1016/j.cois.2017.03.006; Gautier Laurent, 1992, Candollea, V47, P645; Hoevers R., 1996, P 3 INT WORKSH BIOL, P1; IVENS G W, 1974, PANS (PEST ARTIC NEWS SUMM), V20, P76; McFadyen REC, 2003, AUST J ENTOMOL, V42, P294, DOI 10.1046/j.1440-6055.2003.00360.x; McNeely J, 2001, LAND USE WATER RESOU, V1, P1, DOI [10.22004/ag.econ.47850, DOI 10.22004/AG.ECON.47850]; Muniappan R, 2005, INVASIVE PLANTS: ECOLOGICAL AND AGRICULTURAL ASPECTS, P223, DOI 10.1007/3-7643-7380-6_14; Ngobo M, 2004, ECOL SOC, V9; Parker I.M., 1999, Biological Invasions, V1, P3, DOI 10.1023/A:1010034312781; Paterson ID., 2014, CHROMOLAENA ODORATA, V19, P1; R Core Team, 2020, R LANG ENV STAT COMP; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Tchiengue B., 2013, Scripta Botanica Belgica, V50, P121; Timbilla J. A., 2000, Proceedings of the X International Symposium on Biological Control of Weeds, Bozeman, Montana, USA, 4-14 July, 1999, P105; Timbilla JA., 1998, P 4 INT WORKSH BIOL, P97; Timbilla JA., 1996, P 3 INT WORKSH BIOL, P5; Zachariades C., 2013, Proceedings of the Eighth International Workshop on Biological Control and Management of Chromolaena odorata and Other Eupatorieae, 1-2 November 2010, Nairobi, Kenya, P20; Zachariades C, 2009, BIOLOGICAL CONTROL OF TROPICAL WEEDS USING ARTHROPODS, P130, DOI 10.1017/CBO9780511576348.008	33	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252770	10.1371/journal.pone.0252770	http://dx.doi.org/10.1371/journal.pone.0252770			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086801	Green Published, gold, Green Accepted			2022-12-26	WOS:000664640100129
J	Avramidis, P; Bekiari, V				Avramidis, Pavlos; Bekiari, Vlasoula			Application of a catalytic oxidation method for the simultaneous determination of total organic carbon and total nitrogen in marine sediments and soils	PLOS ONE			English	Article							ZAKYNTHOS ISLAND; TITRATION METHOD; LAGOON; MATTER; IGNITION; QUALITY; ROCKS; LAKE	This study presents the application of a simultaneous method for the determination of total organic carbon (TOC) and total nitrogen (TN) in marine sediments and soils, using a data set of 206 samples collected from coastal lagoonal/marine sedimentary environments and certified reference materials (CRMs). TOC and TN were determined using the high temperature (720 degrees C) catalytic (Pt/Al2O3) oxidation method and the detection of TOC and TN was performed using an infrared or a chemiluminescence detector, respectively. Results from the abovementioned TOC method were compared with the results from the widely used Wakley-Black titration method, while TN results with these from elemental analysis. Analytical quality control experiments were performed using CRM samples. Method characteristics such as range of measurement, calibration, method detection limit (MDL), limit of quantification (LOQ), repeatability and reproducibility, were calculated. The precision and the accuracy of the methods are also discussed. Comparison of the two TOC methods of 206 data set yields a regression line of correlation coefficient with R-2 = 0.985. Additional different levels of TOC concentrations of low <1%, moderate 1-5% and high 5-40% level were examined indicating very good correlations. The lowest correlation coefficient was observed in low concentrations TOC<1% (R-2 0.825), mainly as a result of the limitation of titration method. The evaluation of TN results indicated that the catalytic oxidation method and the elemental analysishave a significant good correlation with R-2 = 0.977. The results of precision and accuracy, as well as the calculated MDL and LOQ show that this is a reliable method. Moreover, it requires a small amount of the analyzed sample and the total analysis time is 10 min. Therefore, it can be easily applied for the fast and precise simultaneous determination of TOC and TN in sediment and soil samples.	[Avramidis, Pavlos] Univ Patras, Dept Geol, Rion, Greece; [Bekiari, Vlasoula] Univ Patras, Dept Crop Sci, Mesolongion, Greece	University of Patras; University of Patras	Avramidis, P (corresponding author), Univ Patras, Dept Geol, Rion, Greece.	p.avramidis@upatras.gr	Bekiari, Vlasoula/ABA-8386-2020; Avramidis, Pavlos/AAA-3097-2021	Avramidis, Pavlos/0000-0002-8204-970X; Bekiari, Vlasoula/0000-0002-7115-9866				Andrade A, 2011, CLIM RES, V48, P247, DOI 10.3354/cr00992; [Anonymous], 2009, 15936 DIN EN; APHA- American Public Health Association, 2005, AM PUBL HLTH ASS STA, V21; Arnade A., 2011, CLIM RES, V48, P247; ASTM, 2008, D517608 ASTM; ASTM Designation: D 7348-08, 2008, STANDARD TEST METHOD; Avramidis P, 2017, QUATERN INT, V439, P37, DOI 10.1016/j.quaint.2016.12.014; Avramidis P, 2013, QUATERN INT, V293, P184, DOI 10.1016/j.quaint.2012.04.026; Avramidis P, 2019, GEOSCIENCES, V9, DOI 10.3390/geosciences9060267; Avramidis P, 2015, AGRIC AGRIC SCI PROC, V4, P425, DOI 10.1016/j.aaspro.2015.03.048; Bakacsi Z, 2020, STUD AGRIC ECON, V122, P86, DOI 10.7896/j.2037; Beaudoin A, 2003, J PALEOLIMNOL, V29, P387, DOI 10.1023/A:1023972116573; Behera P, 2020, SCI TOTAL ENVIRON, V706, DOI 10.1016/j.scitotenv.2019.135709; Bekiari V, 2015, AGRIC AGRIC SCI PROC, V4, P445, DOI 10.1016/j.aaspro.2015.03.051; Bekiari V, 2014, INT J ENVIRON AN CH, V94, P65, DOI 10.1080/03067319.2013.763940; Bengtsson G, 2003, SOIL BIOL BIOCHEM, V35, P143, DOI 10.1016/S0038-0717(02)00248-1; Bengtsson L, 1986, HDB HOLOCENE PALAEOE, P423, DOI DOI 10.1016/0277-3791(85)90013-7; Cheng YW, 2021, J CLEAN PROD, V280, DOI 10.1016/j.jclepro.2020.124346; DEAN WE, 1974, J SEDIMENT PETROL, V44, P242; DITORO DM, 1991, ENVIRON TOXICOL CHEM, V10, P1541, DOI 10.1002/etc.5620101203; Emmanouilidis A, 2018, QUATERN INT, V476, P46, DOI 10.1016/j.quaint.2018.03.005; Erlbeck L, 2018, BREW SCI, V71, P56, DOI 10.23763/BrSc18-08erlbeck; ESPITALIE J, 1977, REV I FR PETROL, V32, P23, DOI 10.2516/ogst:1977002; FROELICH PN, 1979, GEOCHIM COSMOCHIM AC, V43, P1075, DOI 10.1016/0016-7037(79)90095-4; GAUDETTE HE, 1974, J SEDIMENT PETROL, V44, P249; Hartnett HE, 1998, NATURE, V391, P572, DOI 10.1038/35351; Heiri O, 2001, J PALEOLIMNOL, V25, P101, DOI 10.1023/A:1008119611481; ISHIWATARI R, 1987, GEOCHIM COSMOCHIM AC, V51, P321, DOI 10.1016/0016-7037(87)90244-4; Karakas G, 2019, CATAL TODAY, V323, P159, DOI 10.1016/j.cattod.2018.04.058; Katsaros D, 2017, FRESEN ENVIRON BULL, V26, P6093; Lee HS, 2020, J ENVIRON SCI, V90, P20, DOI 10.1016/j.jes.2019.11.010; Meyers PA, 2003, ORG GEOCHEM, V34, P261, DOI 10.1016/S0146-6380(02)00168-7; Michelsen TC., 1992, WASHINGTON DEP ECOLO, V390, P10; Moritsuka N, 2020, AGRONOMY-BASEL, V10, DOI 10.3390/agronomy10010040; Panagiotaras D, 2012, GEOL J, V47, P372, DOI 10.1002/gj.1339; Paul NC, 2017, FOOD MICROBIOL, V64, P202, DOI 10.1016/j.fm.2017.01.004; Robinson WO, 1927, J AGRIC RES, V34, P0339; ROY WR, 1985, ENVIRON GEOL WATER S, V7, P241, DOI 10.1007/BF02509925; Rumpel C, 1998, GEODERMA, V86, P123, DOI 10.1016/S0016-7061(98)00036-6; Schumacher B., 2002, SOILS SEDIMENTS; Tsagdi A, 2020, MOLECULES, V25, DOI 10.3390/molecules25071678; Walkley A, 1934, SOIL SCI, V37, P29, DOI 10.1097/00010694-193401000-00003; Wang DL, 1998, COMMUN SOIL SCI PLAN, V29, P15, DOI 10.1080/00103629809369925; Wang XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044334; Xu XM, 2018, J OCEANOL LIMNOL, V36, P105, DOI 10.1007/s00343-017-6229-8; Xue K, 2016, NAT CLIM CHANGE, V6, P595, DOI [10.1038/NCLIMATE2940, 10.1038/nclimate2940]	46	2	2	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252308	10.1371/journal.pone.0252308	http://dx.doi.org/10.1371/journal.pone.0252308			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086719	Green Published, gold			2022-12-26	WOS:000664640100044
J	Barata, F; Fidalgo, P; Figueiredo, S; Tonin, FS; Duarte-Ramos, F				Barata, Fernando; Fidalgo, Paula; Figueiredo, Sara; Tonin, Fernanda S.; Duarte-Ramos, Filipa			Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis	PLOS ONE			English	Article							MULTIDISCIPLINARY; BARRIERS; CARE	Background We aimed to identify the perception of physicians on the limitations and delays for diagnosing, staging and treatment of lung cancer in Portugal. Methods Portuguese physicians were invited to participate an electronic survey (Feb-Apr-2020). Descriptive statistical analyses were performed, with categorical variables reported as absolute and relative frequencies, and continuous variables with non-normal distribution as median and interquartile range (IQR). The association between categorical variables was assessed through Pearson's chi-square test. Mann-Whitney test was used to compare categorical and continuous variables (Stata v.15.0). Results Sixty-one physicians participated in the study (45 pulmonologists, 16 oncologists), with n = 26 exclusively assisting lung cancer patients. Most experts work in public hospitals (90.16%) in Lisbon (36.07%). During the last semester of 2019, responders performed a median of 85 (IQR 55-140) diagnoses of lung cancer. Factors preventing faster referral to the specialty included poor articulation between services (60.0%) and patients low economic/cultural level (44.26%). Obtaining National Drugs Authority authorization was one of the main reasons (75.41%) for delaying the begin of treatment. The cumulative lag-time from patients' admission until treatment ranged from 42-61 days. Experts believe that the time to diagnosis could be optimized in around 11.05 days [IQR 9.61-12.50]. Most physicians (88.52%) started treatment before biomarkers results motivated by performance status deterioration (65.57%) or high tumor burden (52.46%). Clinicians exclusively assisting lung cancer cases reported fewer delays for obtaining authorization for biomarkers analysis (p = 0.023). Higher waiting times for surgery (p = 0.001), radiotherapy (p = 0.004), immunotherapy (p = 0.003) were reported by professionals from public hospitals. Conclusions Physicians believe that is possible to reduce delays in all stages of lung cancer diagnosis with further efforts from multidisciplinary teams and hospital administration.	[Barata, Fernando] Ctr Hosp & Univ Coimbra, Coimbra, Portugal; [Fidalgo, Paula] Ctr Hosp Porto, Porto, Portugal; [Figueiredo, Sara] AstraZeneca Portugal, Oncol Med Dept, Porto, Portugal; [Tonin, Fernanda S.] Univ Fed Parana, Pharmaceut Sci Postgrad Program, Curitiba, Parana, Brazil; [Duarte-Ramos, Filipa] Univ Lisbon, Dept Social Pharm, Fac Pharm, Lisbon, Portugal; [Duarte-Ramos, Filipa] Univ Porto, EPIUnit, Inst Saude Publ, Porto, Portugal	Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Universidade Federal do Parana; Universidade de Lisboa; Universidade do Porto	Tonin, FS (corresponding author), Univ Fed Parana, Pharmaceut Sci Postgrad Program, Curitiba, Parana, Brazil.	stumpf.tonin@ufpr.br	Duarte-Ramos, Filipa/P-5976-2016; Tonin, Fernanda S./AAE-3435-2022; Figueiredo, Sara/G-5809-2013	Duarte-Ramos, Filipa/0000-0001-6632-2553; Tonin, Fernanda S./0000-0003-4262-8608; Figueiredo, Sara/0000-0002-3350-4059; Fidalgo, Paula/0000-0002-6045-7059	AstraZeneca	AstraZeneca(AstraZeneca)	This work was supported by AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1998, Thorax, V53 Suppl 1, pS1; Baldwin DR, 2017, THORAX, V72, P393, DOI 10.1136/thoraxjnl-2016-209591; Barata F, 2018, CANCRO PULMAO NUMERO; Barros João Adriano, 2006, J. bras. pneumol., V32, P221, DOI 10.1590/S1806-37132006000300008; Barta JA, 2019, ANN GLOB HEALTH, V85, DOI 10.5334/aogh.2419; Borges M, 2014, VALUE HEALTH, V17, pA626, DOI 10.1016/j.jval.2014.08.2228; Car LT, 2016, J GLOB HEALTH, V6, DOI 10.7189/jogh.06.020901; Cassim S, 2019, BMC CANCER, V19, DOI 10.1186/s12885-018-5169-9; Diaconescu R, 2011, J THORAC ONCOL, V6, P1254, DOI 10.1097/JTO.0b013e318217b623; Dunn J, 2017, SUPPORT CARE CANCER, V25, P497, DOI 10.1007/s00520-016-3428-3; Eberth Jan M, 2018, Prev Med Rep, V11, P93, DOI 10.1016/j.pmedr.2018.05.013; Field JK, 2019, ESMO OPEN, V4, DOI 10.1136/esmoopen-2019-000577; Forrest LF, 2015, THORAX, V70, P138, DOI 10.1136/thoraxjnl-2014-205517; Garcia Sofia F, 2010, J Support Oncol, V8, P64; Gill RR, 2013, J AM COLL RADIOL, V10, P931, DOI 10.1016/j.jacr.2013.09.013; Gopal Ramesh, 2005, J Support Oncol, V3, P248; Hermens RPMG, 2006, LUNG CANCER, V54, P117, DOI 10.1016/j.lungcan.2006.07.001; Jacobsen MM, 2017, LUNG CANCER, V112, P156, DOI 10.1016/j.lungcan.2017.08.011; Ju F, 2018, J MED SYST, V42, DOI 10.1007/s10916-017-0873-6; Kedia SK, 2015, TRANSL LUNG CANCER R, V4, P456, DOI 10.3978/j.issn.2218-6751.2015.07.10; Kerr KM, 2014, ANN ONCOL, V25, P1681, DOI 10.1093/annonc/mdu145; Labbe C, 2017, CURR ONCOL, V24, P367, DOI 10.3747/co.24.3655; Leiro-Fernandez V, 2019, THORAC CANCER, V10, P296, DOI 10.1111/1759-7714.12950; Maklouf-Quiros A, 2021, SUPPORT CARE CANCER, V29, P751, DOI 10.1007/s00520-020-05532-8; Malalasekera A, 2021, ASIA-PAC J CLIN ONCO, V17, pE77, DOI 10.1111/ajco.13335; Malalasekera A, 2018, J ONCOL PRACT, V14, P611, DOI 10.1200/JOP.18.00125; Malalasekera A, 2018, EUR RESPIR REV, V27, DOI 10.1183/16000617.0045-2018; Menon U, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025895; Moyer VA, 2014, ANN INTERN MED, V160, P330, DOI 10.7326/M13-2771; Mueller J, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6336; Oudkerk M, 2017, LANCET ONCOL, V18, pE754, DOI [10.1016/S1470-2045(17)30861-6, 10.1016/s1470-2045(17)30861-6]; Parekh AD, 2020, AM J CLIN ONCOL-CANC, V43, P229, DOI 10.1097/COC.0000000000000665; Postmus PE, 2017, ANN ONCOL, V28, P1, DOI 10.1093/annonc/mdx222; Santucci C., 2020, EUR J CANCER PREV; Sharma M., 2019, J CLIN ONCOL, V37; Statistics Portugal, 2019, I NAC EST HOSP SECT; SUDMAN S, 1973, J AM STAT ASSOC, V68, P805, DOI 10.2307/2284504; Tanoue LT, 2015, AM J RESP CRIT CARE, V191, P19, DOI 10.1164/rccm.201410-1777CI; The Global Cancer Observatory, 2019, PORT GLOB 2018; Veljovic M, 2015, J CLIN ONCOL, V33, DOI 10.1200/jco.2015.33.15_suppl.e17698; Vidaver RM, 2016, J ONCOL PRACT, V12, P553, DOI 10.1200/JOP.2015.009605; Vinas F, 2016, CLIN RESPIR J, V10, P267, DOI 10.1111/crj.12217; Zulueta JJ, 2015, AM J RESP CRIT CARE, V191, P1209, DOI 10.1164/rccm.201502-0345LE	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252529	10.1371/journal.pone.0252529	http://dx.doi.org/10.1371/journal.pone.0252529			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086757	gold, Green Published			2022-12-26	WOS:000664640100079
J	Habuchi, H; Izumi, M; Dan, JP; Ushida, T; Ikeuchi, M; Takeuchi, K; Habuchi, O				Habuchi, Hiroko; Izumi, Masashi; Dan, Junpei; Ushida, Takahiro; Ikeuchi, Masahiko; Takeuchi, Kosei; Habuchi, Osami			Bone marrow derived mast cells injected into the osteoarthritic knee joints of mice induced by sodium monoiodoacetate enhanced spontaneous pain through activation of PAR2 and action of extracellular ATP	PLOS ONE			English	Article							CONNECTIVE-TISSUE-TYPE; SUBCHONDRAL BONE; SYNOVIAL-FLUID; ADENOSINE-TRIPHOSPHATE; RHEUMATOID-ARTHRITIS; P2X RECEPTORS; EXPRESSION; INFLAMMATION; TRYPTASE; MODEL	Conditions that resemble osteoarthritis (OA) were produced by injection of sodium monoiodoacetate (MIA) into the knee joints of mice. Bone marrow derived mast cells (BMMCs) injected into the OA knee joints enhanced spontaneous pain. Since no spontaneous pain was observed when BMMCs were injected into the knee joints of control mice that had not been treated with MIA, BMMCs should be activated within the OA knee joints and release some pain-inducible factors. Protease activated receptor-2 (PAR2) antagonist (FSLLRY-NH2) almost abolished the pain-enhancing effects of BMMCs injected into the OA knee joints, suggesting that tryptase, a mast cell protease that is capable of activating PAR2, should be released from the injected BMMCs and enhance pain through activation of PAR2. When PAR2 agonist (SLIGKV-NH2) instead of BMMCs was injected into the OA knee joints, it was also enhanced pain. Apyrase, an ATP degrading enzyme, injected into the OA knee joints before BMMCs suppressed the pain enhanced by BMMCs. We showed that purinoceptors (P2X4 and P2X7) were expressed in BMMCs and that extracellular ATP stimulated the release of tryptase from BMMCs. These observations suggest that ATP may stimulate degranulation of BMMCs and thereby enhanced pain. BMMCs injected into the OA knee joints stimulated expression of IL-1 beta, IL-6, TNF-alpha, CCL2, and MMP9 genes in the infrapatellar fat pads, and PAR2 antagonist suppressed the stimulatory effects of BMMCs. Our study suggests that intermittent pain frequently observed in OA knee joints may be due, at least partly, to mast cells through activation of PAR2 and action of ATP, and that intraarticular injection of BMMCs into the OA knee joints may provide a useful experimental system for investigating molecular mechanisms by which pain is induced in OA knee joints.	[Habuchi, Hiroko; Ushida, Takahiro; Habuchi, Osami] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi, Japan; [Izumi, Masashi; Dan, Junpei; Ikeuchi, Masahiko] Kochi Univ, Kochi Med Sch, Dept Orthoped Surg, Nankoku, Kochi, Japan; [Takeuchi, Kosei] Aichi Med Univ, Sch Med, Dept Med Cell Biol, Nagakute, Aichi, Japan	Aichi Medical University; Kochi University; Aichi Medical University	Habuchi, O (corresponding author), Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi, Japan.	ohabuchi@aichi-med-u.ac.jp	Takeuchi, Kosei/AAV-3577-2021	Takeuchi, Kosei/0000-0001-6397-2243	JSPS [JP16K08999]; Nakatomi Foundation	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nakatomi Foundation	This work was supported by JSPS Grantin-Aid for Scientific Research JP16K08999 (https://www.jsps.go.jp/) (2016) to O.H. and Research Grant from Nakatomi Foundation (2017). (https://www.nakatomi.or.jp/) to M.I. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiable N, 2011, J RHEUMATOL, V38, P911, DOI 10.3899/jrheum.100710; Anower-E-Khuda MF, 2013, J BIOL CHEM, V288, P3705, DOI 10.1074/jbc.M112.416651; Aso K, 2016, OSTEOARTHR CARTILAGE, V24, P1596, DOI 10.1016/j.joca.2016.04.009; Barr AJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0735-x; Belluzzi E, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/6390182; Buckley MG, 1997, CLIN SCI, V93, P363, DOI 10.1042/cs0930363; Chen ZM, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/9647072; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; Cordaro M, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-2048-y; de Lange-Brokaar BJE, 2016, OSTEOARTHR CARTILAGE, V24, P664, DOI 10.1016/j.joca.2015.11.011; de Lange-Brokaar BJE, 2012, OSTEOARTHR CARTILAGE, V20, P1484, DOI 10.1016/j.joca.2012.08.027; DEAN G, 1993, BRIT J RHEUMATOL, V32, P671; DELUCA M, 1964, BIOCHEMISTRY-US, V3, P935, DOI 10.1021/bi00895a015; DENBURG J L, 1970, Archives of Biochemistry and Biophysics, V141, P668, DOI 10.1016/0003-9861(70)90187-6; Dowd E, 1998, BRIT J PHARMACOL, V125, P341, DOI 10.1038/sj.bjp.0702080; Fusco M, 2017, PAIN PRACT, V17, P522, DOI 10.1111/papr.12551; Guingamp C, 1997, ARTHRITIS RHEUM, V40, P1670, DOI 10.1002/art.1780400917; Guzman RE, 2003, TOXICOL PATHOL, V31, P619, DOI 10.1080/01926230390241800; Huesa C, 2016, ANN RHEUM DIS, V75, P1989, DOI 10.1136/annrheumdis-2015-208268; Ioan-Facsinay A, 2018, OSTEOARTHR CARTILAGE, V26, P1, DOI 10.1016/j.joca.2017.10.005; Jackson MT, 2014, ARTHRITIS RHEUMATOL, V66, P3337, DOI 10.1002/art.38876; Janusz MJ, 2001, OSTEOARTHR CARTILAGE, V9, P751, DOI 10.1053/joca.2001.0472; Kaczmarek-Hajek K, 2012, PURINERG SIGNAL, V8, P375, DOI 10.1007/s11302-012-9314-7; Kumahashi N, 2011, KNEE, V18, P160, DOI 10.1016/j.knee.2010.04.013; Lee H, 2013, ARTHRITIS RHEUM-US, V65, P109, DOI 10.1002/art.37741; Leitao JMM, 2010, J PHOTOCH PHOTOBIO B, V101, P1, DOI 10.1016/j.jphotobiol.2010.06.015; LEVISCHAFFER F, 1986, P NATL ACAD SCI USA, V83, P6485, DOI 10.1073/pnas.83.17.6485; Li JP, 2016, IJC METAB ENDOCR, V10, P16, DOI 10.1016/j.ijcme.2015.11.003; McCloskey MA, 1999, J IMMUNOL, V163, P970; Miller HRP, 1999, BLOOD, V93, P3473, DOI 10.1182/blood.V93.10.3473.410k01_3473_3486; Moormann C, 2006, J INVEST DERMATOL, V126, P746, DOI 10.1038/sj.jid.5700169; Mrozkova P, 2016, PHYSIOL RES, V65, P357, DOI 10.33549/physiolres.933269; Nakano S, 2007, CLIN RHEUMATOL, V26, P1284, DOI 10.1007/s10067-006-0495-8; NAKANO T, 1985, J EXP MED, V162, P1025, DOI 10.1084/jem.162.3.1025; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Nurkhametova D, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00045; O'Neill TW, 2018, CURR OSTEOPOROS REP, V16, P611, DOI 10.1007/s11914-018-0477-1; Ogbonna AC, 2013, EUR J PAIN, V17, P514, DOI 10.1002/j.1532-2149.2012.00223.x; Ohtake-Niimi S, 2010, J BIOL CHEM, V285, P20793, DOI 10.1074/jbc.M109.084749; RAZIN E, 1984, J IMMUNOL, V132, P1479; Steinhoff M, 2005, ENDOCR REV, V26, P1, DOI 10.1210/er.2003-0025; Takano H, 2008, FEBS LETT, V582, P1444, DOI 10.1016/j.febslet.2008.03.033; Torres BT, 2016, VET COMP ORTHOPAED, V29, P344, DOI 10.3415/VCOT-15-06-0111; Valente JD, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00974; Wang Q, 2019, ELIFE, V8, DOI 10.7554/eLife.39905; Yoshida K, 2020, J IMMUNOL, V204, P3077, DOI 10.4049/jimmunol.1900954; Yoshida K, 2017, INT IMMUNOPHARMACOL, V43, P99, DOI 10.1016/j.intimp.2016.12.014; Zhang YQ, 2011, ARTHRITIS RHEUM-US, V63, P691, DOI 10.1002/art.30148	49	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252590	10.1371/journal.pone.0252590	http://dx.doi.org/10.1371/journal.pone.0252590			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086763	gold, Green Published			2022-12-26	WOS:000664640100090
J	Marrero, MG; Dado-Senn, B; Field, SL; Yang, G; Driver, JP; Laporta, J				Marrero, Marcela G.; Dado-Senn, Bethany; Field, Sena L.; Yang, Guan; Driver, John P.; Laporta, Jimena			Chronic heat stress delays immune system development and alters serotonin signaling in pre-weaned dairy calves	PLOS ONE			English	Article							LATE-GESTATION; DENDRITIC CELLS; HUMAN MONOCYTES; SHOCK PROTEINS; RECEPTORS; BLOOD; 5-HYDROXYTRYPTAMINE; ACTIVATION; CYTOKINE; INVOLVEMENT	Exposure to heat stress can alter the development and immune system function in dairy calves. Serotonin is an immunomodulatory biogenic amine that functions as a neurotransmitter and as a stress-response mediator. Our objectives were to characterize the patterns of serum serotonin concentrations and the pattern of serotonin-related genes expressed by immune cells of calves exposed to chronic heat stress or heat stress abatement during early life, and to explore whether these might relate to immune system development. Dairy calves were exposed to chronic heat stress (HS; n = 6) or heat stress abatement (cooling, CL; n = 6) across the prenatal (late gestation, last 46 d) and postnatal (from birth to weaning, 56 d) developmental windows. Blood samples were collected to harvest serum (weekly, from d 1 to 49), to isolate of circulating leukocyte mRNA (at 1, 21 and 42 d of age) and characterize immune cell populations by flow cytometry (at 21 and 47 d of age). Calves exposed to chronic heat stress pre- and postnatally had lower red blood cell counts and lower circulating serotonin, immunoglobulin G, and B-lymphocytes compared to CL calves. Circulating blood leukocyte mRNA expression of serotonin receptors -1A, -1F, -4 and -5 was greater, while heat shock protein 70 and immune-related genes (i.e., TBX21, TLR4, and TGF beta) were lower in HS relative to CL calves. Peripheral blood leukocytes from all calves secreted serotonin and interleukin-6 after in-vitro lipopolysaccharide stimulation. However, the HS calves produced more serotonin and less interleukin-6 than CL calves when activated in-vitro. Together, our data suggest that providing heat stress abatement to dairy calves across prenatal and postnatal developmental windows might modulate the serotonin synthesis pathway in ways that may benefit humoral immunity against microbial pathogens.	[Marrero, Marcela G.; Yang, Guan; Driver, John P.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Dado-Senn, Bethany; Field, Sena L.; Laporta, Jimena] Univ Wisconsin, Dept Anim & Dairy Sci, Madison, WI 53706 USA	State University System of Florida; University of Florida; University of Wisconsin System; University of Wisconsin Madison	Laporta, J (corresponding author), Univ Wisconsin, Dept Anim & Dairy Sci, Madison, WI 53706 USA.	jlaporta@wisc.edu	Laporta, Jimena/AAX-3093-2021	YANG, Guan/0000-0002-2131-8435; Marrero, Marcela G./0000-0002-1301-0772	Southeast Milk Check-Off	Southeast Milk Check-Off	We would like to thank Lizbeth Vega Acosta and Mariela Torres Rivera for their assistance with data recording and blood collection, Veronique Ouellette for her help with data analysis, and Southeast Milk Check-Off for supporting this research.	Afanas'eva M A, 2009, Dokl Biol Sci, V427, P319; Ahern GP, 2011, CURR OPIN PHARMACOL, V11, P29, DOI 10.1016/j.coph.2011.02.004; Akatsu S, 2015, NEUROSCI RES, V101, P15, DOI 10.1016/j.neures.2015.07.002; Amireault P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083010; Amireault P, 2011, P NATL ACAD SCI USA, V108, P13141, DOI 10.1073/pnas.1103964108; Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; AUNE TM, 1994, J IMMUNOL, V153, P489; Berger M, 2009, ANNU REV MED, V60, P355, DOI 10.1146/annurev.med.60.042307.110802; Bernabucci U, 2010, ANIMAL, V4, P1167, DOI 10.1017/S175173111000090X; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Chaouloff F, 1999, NEUROPSYCHOPHARMACOL, V21, pS28, DOI 10.1016/S0893-133X(99)00008-1; Cloez-Tayarani I, 2003, INT IMMUNOL, V15, P233, DOI 10.1093/intimm/dxg027; Collier R J, 2006, J Anim Sci, V84 Suppl, pE1; Dado-Senn B, 2020, J DAIRY SCI, V103, P4822, DOI 10.3168/jds.2019-17926; Dahl GE, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00116; Diez-Fraile A, 2003, VET RES, V34, P57, DOI 10.1051/vetres:2002053; Duerschmied D, 2013, BLOOD, V121, P1008, DOI 10.1182/blood-2012-06-437392; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Eggesbo JB, 1996, CYTOKINE, V8, P152, DOI 10.1006/cyto.1996.0022; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Ghazi A, 2015, CURR BIOL, V25, pR71, DOI 10.1016/j.cub.2014.11.055; Godden S, 2008, VET CLIN N AM-FOOD A, V24, P19, DOI 10.1016/j.cvfa.2007.10.005; Gray JA, 2001, BRAIN RES BULL, V56, P441, DOI 10.1016/S0361-9230(01)00623-2; Herr N, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00048; Horowitz M, 2002, COMP BIOCHEM PHYS A, V131, P475, DOI 10.1016/S1095-6433(01)00500-1; Idzko M, 2004, J IMMUNOL, V172, P6011, DOI 10.4049/jimmunol.172.10.6011; IKEN K, 1995, CELL IMMUNOL, V163, P1, DOI 10.1006/cimm.1995.1092; Inoue M, 2011, INT IMMUNOPHARMACOL, V11, P67, DOI 10.1016/j.intimp.2010.10.007; Kampen AH, 2006, VET IMMUNOL IMMUNOP, V113, P53, DOI 10.1016/j.vetimm.2006.04.001; KELLEY KW, 1982, J DAIRY SCI, V65, P1514, DOI 10.3168/jds.S0022-0302(82)82376-X; Koch L, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/283126; Krishnamoorthy S, 2010, BASIC CLIN PHARMACOL, V107, P830, DOI 10.1111/j.1742-7843.2010.00586.x; Kubera M, 2005, PSYCHIAT RES, V134, P251, DOI 10.1016/j.psychres.2004.01.014; Leon-Ponte M, 2007, BLOOD, V109, P3139, DOI 10.1182/blood-2006-10-052787; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marrero MG, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66326-w; Marrero MG, 2019, DOMEST ANIM ENDOCRIN, V69, P42, DOI 10.1016/j.domaniend.2019.04.007; MOHAMED MI, 1982, COMP BIOCHEM PHYS C, V73, P313, DOI 10.1016/0306-4492(82)90127-7; Monteiro APA, 2014, J DAIRY SCI, V97, P6426, DOI 10.3168/jds.2013-7891; Mota CMD, 2017, BRAIN BEHAV IMMUN, V66, P372, DOI 10.1016/j.bbi.2017.07.010; Murphy K., 2016, JANEWAYS IMMUNOLOGY, DOI 10.1201/9781315533247; Natarajan R, 2017, J NEUROSCI, V37, P6214, DOI 10.1523/JNEUROSCI.3781-16.2017; Natarajan R, 2015, STRESS, V18, P668, DOI 10.3109/10253890.2015.1087502; Nau F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075426; Nonnecke BJ, 2012, J DAIRY SCI, V95, P221, DOI 10.3168/jds.2011-4712; O'Connell PJ, 2006, BLOOD, V107, P1010, DOI 10.1182/blood-2005-07-2903; Puglisi-Allegra S, 2015, BEHAV BRAIN RES, V277, P58, DOI 10.1016/j.bbr.2014.07.052; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; SHARMA HS, 1992, NEUROSCIENCE, V50, P445, DOI 10.1016/0306-4522(92)90436-6; Sladek Z, 2009, RES VET SCI, V86, P235, DOI 10.1016/j.rvsc.2008.07.016; Soga F, 2007, J INVEST DERMATOL, V127, P1947, DOI 10.1038/sj.jid.5700824; Strong RA, 2015, J DAIRY SCI, V98, P7771, DOI 10.3168/jds.2015-9591; Sweeney BC, 2010, J DAIRY SCI, V93, P148, DOI 10.3168/jds.2009-2427; Tao S, 2012, J DAIRY SCI, V95, P7128, DOI 10.3168/jds.2012-5697; Tatum MC, 2015, CURR BIOL, V25, P163, DOI 10.1016/j.cub.2014.11.040; Van Riel E, 2003, NEUROSCIENCE, V120, P649, DOI 10.1016/S0306-4522(03)00355-5; Watanabe H, 2010, ENDOCRINOLOGY, V151, P4776, DOI 10.1210/en.2009-1349; Waters WR, 2003, INFECT IMMUN, V71, P317, DOI 10.1128/IAI.71.1.317-326.2003; Wyler SC, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00277; Yokota S, 2010, MICROBIOL IMMUNOL, V54, P299, DOI 10.1111/j.1348-0421.2010.00214.x; Zhang G, 2011, NEUROSCI LETT, V490, P68, DOI 10.1016/j.neulet.2010.12.028	61	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252474	10.1371/journal.pone.0252474	http://dx.doi.org/10.1371/journal.pone.0252474			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086766	gold, Green Published			2022-12-26	WOS:000664640100072
J	Patel, AP; Mehta, SS; White, AJ; Niehoff, NM; Arroyave, WD; Wang, A; Lunn, RM				Patel, Achal P.; Mehta, Suril S.; White, Alexandra J.; Niehoff, Nicole M.; Arroyave, Whitney D.; Wang, Amy; Lunn, Ruth M.			Urinary polycyclic aromatic hydrocarbon metabolites and mortality in the United States: A prospective analysis	PLOS ONE			English	Article							OXIDATIVE STRESS; LUNG-CANCER; RISK-ASSESSMENT; BREAST-CANCER; US POPULATION; EXPOSURE; BIOMARKERS; PAHS; RECEPTOR; EXTRACTION	Background Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous organic compounds associated with chronic disease in epidemiologic studies, though the contribution of PAH exposure on fatal outcomes in the U.S. is largely unknown. Objectives We investigated urinary hydroxylated PAH metabolites (OH-PAHs) with all-cause and cause-specific mortality in a representative sample of the U.S. population. Methods Study participants were >= 20 years old from the National Health and Nutrition Examination Survey 2001-2014. Concentrations (nmol/L) of eight OH-PAHs from four parent PAHs (naphthalene, fluorene, phenanthrene, pyrene) were measured in spot urine samples at examination. We identified all-cause, cancer-specific, and cardiovascular-specific deaths through 2015 using the National Death Index. We used Cox proportional hazards regression to estimate adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between Sigma OH-PAHs and mortality endpoints. We assessed potential heterogeneity by age, gender, smoking status, poverty, and race/ethnicity. Additionally, we examined the overall mixture effect using quantile g-computation. Results In 9,739 eligible participants, there were 934 all-cause deaths, 159 cancer-specific deaths, and 108 cardiovascular-specific deaths (median 6.75 years follow-up). A log(10) increase in Sigma OH-PAHs was associated with higher all-cause mortality (HRadj = 1.39 [95%CI: 1.21, 1.61]), and possibly cancer-specific mortality (HRadj = 1.15 [95%CI: 0.79, 1.69]), and cardiovascular-specific mortality (HRadj = 1.49 [95%CI: 0.94, 2.33]). We observed substantial effect modification by age, smoking status, gender, and race/ethnicity across mortality endpoints. Risk of cardiovascular mortality was higher for non-Hispanic blacks and those in poverty, indicating potential disparities. Quantile g-computation joint associations for a simultaneous quartile increase in OH-PAHs were HRadj = 1.15 [95%CI: 1.02, 1.31], HRadj = 1.41 [95%CI: 1.05, 1.90], and HRadj = 0.98 [95%CI: 0.66, 1.47] for all-cause, cancer-specific, and cardiovascular-specific mortalities, respectively. Discussion Our results support a role for total PAH exposure in all-cause and cause-specific mortality in the U.S. population.	[Patel, Achal P.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Mehta, Suril S.; Wang, Amy; Lunn, Ruth M.] NIEHS, Div Natl Toxicol Program, Off Report Carcinogens, POB 12233, Res Triangle Pk, NC 27709 USA; [White, Alexandra J.; Niehoff, Nicole M.] NIEHS, Epidemiol Branch, Res Triangle Pk, NC 27709 USA; [Arroyave, Whitney D.] Integrated Syst Lab, Morrisville, NC USA	University of North Carolina; University of North Carolina Chapel Hill; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Mehta, SS (corresponding author), NIEHS, Div Natl Toxicol Program, Off Report Carcinogens, POB 12233, Res Triangle Pk, NC 27709 USA.	suril.mehta@nih.gov	White, Alexandra J/D-9687-2019	White, Alexandra J/0000-0003-2455-2945; Mehta, Suril/0000-0003-0939-0255	National Institute of Environmental Health Sciences, Intramural Research Program [ES-103317-05]; National Institute of Environmental Health Sciences [T32 ES007018]	National Institute of Environmental Health Sciences, Intramural Research Program; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	S.S.M., A.W., R.M.L., National Institute of Environmental Health Sciences, Intramural Research Program Project ES-103317-05, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. A.P.P., National Institute of Environmental Health Sciences, Training Grant T32 ES007018, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamdow A, 2019, TOXICOL SCI, V171, P235, DOI 10.1093/toxsci/kfz142; Alhamdow A, 2019, CARCINOGENESIS, V40, P771, DOI 10.1093/carcin/bgz022; Alshaarawy O, 2016, ENVIRON INT, V89-90, P174, DOI 10.1016/j.envint.2016.02.006; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; BERTRAND JP, 1987, BRIT J IND MED, V44, P559; Bostrom CE, 2002, ENVIRON HEALTH PERSP, V110, P451, DOI 10.1289/ehp.02110s3451; Burstyn I, 2005, EPIDEMIOLOGY, V16, P744, DOI 10.1097/01.ede.0000181310.65043.2f; Burstyn I, 2003, AM J EPIDEMIOL, V158, P468, DOI 10.1093/aje/kwg180; Cakmak S, 2017, ENVIRON POLLUT, V228, P1, DOI 10.1016/j.envpol.2017.05.013; Carreira VS, 2015, TOXICOL SCI, V147, P425, DOI 10.1093/toxsci/kfv138; Castano-Vinyals G, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2003.008375; Chen YY, 2021, ENVIRON GEOCHEM HLTH, V43, P37, DOI 10.1007/s10653-020-00663-7; Choi H, 2010, POLYCYCL AROMAT COMP; Dobraca D, 2018, ENVIRON RES, V165, P46, DOI 10.1016/j.envres.2017.11.011; Duru OK, 2012, J NATL MED ASSOC, V104, P89, DOI 10.1016/S0027-9684(15)30120-6; Eckers A, 2011, ARCH BIOCHEM BIOPHYS, V516, P138, DOI 10.1016/j.abb.2011.10.006; Eom SY, 2013, ANTICANCER RES, V33, P3089; Gammon MD, 2004, ARCH ENVIRON HEALTH, V59, P640, DOI 10.1080/00039890409602948; Godschalk RWL, 2000, CARCINOGENESIS, V21, P87, DOI 10.1093/carcin/21.1.87; Greenland S, 1999, EPIDEMIOLOGY, V10, P37, DOI 10.1097/00001648-199901000-00008; Guo H, 2014, ENVIRON MOL MUTAGEN, V55, P472, DOI 10.1002/em.21866; Hogstedt C, 2013, AM J PUBLIC HEALTH, V103, P1708, DOI 10.2105/AJPH.2012.300860; Holme JA, 2019, ENVIRON HEALTH-GLOB, V18, DOI 10.1186/s12940-019-0514-2; Hoyert Donna L, 2012, Natl Vital Stat Rep, V61, P1; Hu C, 2018, ENVIRON POLLUT, V233, P45, DOI 10.1016/j.envpol.2017.10.042; Hudson-Hanley B, 2021, CHEMOSPHERE, V276, DOI 10.1016/j.chemosphere.2021.130211; IARC, 2010, SOM NONH POL AR HYDR, P1017; Kato M, 2004, CANCER EPIDEM BIOMAR, V13, P1005; Keil AP, 2020, ENVIRON HEALTH PERSP, V128, DOI 10.1289/EHP5838; Kim KH, 2013, ENVIRON INT, V60, P71, DOI 10.1016/j.envint.2013.07.019; Lee KH, 2010, CANCER EPIDEM BIOMAR, V19, P877, DOI 10.1158/1055-9965.EPI-09-1098; Li Z, 2008, ENVIRON RES, V107, P320, DOI 10.1016/j.envres.2008.01.013; Li Z, 2006, ANAL CHEM, V78, P5744, DOI 10.1021/ac0606094; Li Z, 2016, J EXPO SCI ENV EPID, V26, P241, DOI 10.1038/jes.2014.94; Li Z, 2014, ANAL BIOANAL CHEM, V406, P3119, DOI 10.1007/s00216-014-7676-0; Li Z, 2010, J EXPO SCI ENV EPID, V20, P526, DOI 10.1038/jes.2009.41; Li Z, 2010, J ENVIRON MONITOR, V12, P1110, DOI 10.1039/c000689k; Merlo F, 1998, CANCER EPIDEM BIOMAR, V7, P147; Miller BG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-962; Moorthy B, 2015, TOXICOL SCI, V145, P5, DOI 10.1093/toxsci/kfv040; Nadler DL., 2014, ADV EPIDEMIOL, V2014, P1, DOI [10.1155/2014/746769, DOI 10.1155/2014/746769]; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Nethery E, 2012, J EXPO SCI ENV EPID, V22, P70, DOI 10.1038/jes.2011.32; NTP (National Toxicology Program), 2016, REP CARC 14 ED; Pavanello S, 2014, BIOMARKERS IN TOXICOLOGY, P785, DOI 10.1016/B978-0-12-404630-6.00047-6; Pratt MM, 2011, INT J ENV RES PUB HE, V8, P2675, DOI 10.3390/ijerph8072675; Ramesh A, 2004, INT J TOXICOL, V23, P301, DOI 10.1080/10915810490517063; REDMOND CK, 1983, ENVIRON HEALTH PERSP, V52, P67, DOI 10.2307/3429652; Romanoff LC, 2006, J CHROMATOGR B, V835, P47, DOI 10.1016/j.jchromb.2006.03.004; Shen J, 2017, BRIT J CANCER, V116, P1229, DOI 10.1038/bjc.2017.81; Srogi K, 2007, ENVIRON CHEM LETT, V5, P169, DOI 10.1007/s10311-007-0095-0; St Helen G, 2012, CHEM RES TOXICOL, V25, P952, DOI 10.1021/tx300043k; Tsay JJ, 2013, ANTICANCER RES, V33, P1247; Van Dyke M, 2018, MMWR SURVEILL SUMM, V67, P1, DOI 10.15585/mmwr.ss6705a1; Vatcheva Kristina P, 2016, Epidemiology (Sunnyvale), V6; Vimercati L, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072199; Wang YS, 2017, ANAL BIOANAL CHEM, V409, P931, DOI 10.1007/s00216-016-9933-x; Weinberg CR, 2019, EPIDEMIOLOGY, V30, P768, DOI 10.1097/EDE.0000000000001053; Weir CB., 2020, STATPEARLS INTERNET, V2020; White AJ, 2016, ENVIRON INT, V89-90, P185, DOI 10.1016/j.envint.2016.02.009; Xu XH, 2010, SCI TOTAL ENVIRON, V408, P4943, DOI 10.1016/j.scitotenv.2010.07.034; Zhang Nan, 2011, J Cardiovasc Dis Res, V2, P91, DOI 10.4103/0975-3583.83033; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P21063, DOI 10.1073/pnas.0905756106; Zhou Y, 2016, AM J RESP CRIT CARE, V193, P835, DOI 10.1164/rccm.201412-2279OC	64	9	9	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252719	10.1371/journal.pone.0252719	http://dx.doi.org/10.1371/journal.pone.0252719			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086784	gold, Green Published			2022-12-26	WOS:000664640100117
J	Hatano, S; Matsuda, S; Okanobu, A; Furutama, D; Memida, T; Kajiya, M; Ouhara, K; Fujita, T; Mizuno, N; Kurihara, H				Hatano, Saki; Matsuda, Shinji; Okanobu, Ai; Furutama, Daisuke; Memida, Takumi; Kajiya, Mikihito; Ouhara, Kazuhisa; Fujita, Tsuyoshi; Mizuno, Noriyoshi; Kurihara, Hidemi			The role of nuclear receptor 4A1 (NR4A1) in drug-induced gingival overgrowth	FASEB JOURNAL			English	Article						cytosolic calcium; DIGO; NFATc3	NF-KAPPA-B; CYCLOSPORINE-A; CREVICULAR FLUID; TGF-BETA; NUR77; TACROLIMUS; EXPRESSION; ENLARGEMENT; CONVERSION; DISEASE	Drug-induced gingival overgrowth (DIGO) is a side effect of cyclosporine A (CsA), nifedipine (NIF), and phenytoin (PHT). Nuclear receptor 4A1 (NR4A1) plays a role in fibrosis in multiple organs. However, the relationship between NR4A1 and DIGO remains unclear. We herein investigated the involvement of NR4A1 in DIGO. In the DIGO mouse model, CsA inhibited the up-regulation of Nr4a1 expression induced by periodontal disease (PD) in gingival tissue, but not that of Col1a1 and Pai1. We detected gingival overgrowth (GO) in Nr4a1 knock out (KO) mice with PD. A NR4A1 agonist inhibited the development of GO in DIGO model mice. TGF-beta increased Col1a1 and Pai1 expression levels in KO mouse gingival fibroblasts (mGF) than in wild-type mice, while the overexpression of NR4A1 in KO mGF suppressed the levels. NR4A1 expression levels in gingival tissue were significantly lower in DIGO patients than in PD patients. We also investigated the relationship between nuclear factor of activated T cells (NFAT) and NR4A1. NFATc3 siRNA suppressed the TGF-beta-induced up-regulation of NR4A1 mRNA expression in human gingival fibroblasts (hGF). CsA suppressed the TGF-beta-induced translocation of NFATc3 into the nuclei of hGF. Furthermore, NIF and PHT also decreased NR4A1 mRNA expression levels and suppressed the translocation of NFATc3 in hGF. We confirmed that CsA, NIF, and PHT reduced cytosolic calcium levels increased by TGF-beta, while CaCl2 enhanced the TGF-beta-up-regulated NR4A1 expression. We propose that the suppression of the calcium-NFATc3-NR4A1 cascade by these three drugs plays a role in the development of DIGO.	[Hatano, Saki; Matsuda, Shinji; Okanobu, Ai; Furutama, Daisuke; Memida, Takumi; Kajiya, Mikihito; Ouhara, Kazuhisa; Fujita, Tsuyoshi; Mizuno, Noriyoshi; Kurihara, Hidemi] Hiroshima Univ, Dept Periodontal Med, Grad Sch Biomed & Hlth Sci, Hiroshima, Japan; [Hatano, Saki; Matsuda, Shinji; Okanobu, Ai; Furutama, Daisuke; Memida, Takumi; Kajiya, Mikihito; Ouhara, Kazuhisa; Fujita, Tsuyoshi; Mizuno, Noriyoshi; Kurihara, Hidemi] Hiroshima Univ, Dept Periodontal Med, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan	Hiroshima University; Hiroshima University	Matsuda, S (corresponding author), Hiroshima Univ, Dept Periodontal Med, Grad Sch Biomed & Hlth Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	matsudas@hiroshima-u.ac.jp	Matsuda, Shinji/AAB-7387-2019; Kajiya, Mikihito/A-4288-2018	Matsuda, Shinji/0000-0002-4281-3216; Kajiya, Mikihito/0000-0001-6652-0007; Ouhara, Kazuhisa/0000-0001-6796-884X	JSPS [16K11830, 18K17070, 19K10130]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	JSPS, Grant/Award Number: 16K11830, 18K17070 and 19K10130	Al-Hamilly NS, 2016, ARCH ORAL BIOL, V66, P38, DOI 10.1016/j.archoralbio.2016.02.006; Alshargabi R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66660-z; Assaggaf MA, 2015, AM J PATHOL, V185, P1588, DOI 10.1016/j.ajpath.2015.02.004; Bader G, 1998, J PERIODONTOL, V69, P729, DOI 10.1902/jop.1998.69.6.729; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Chang JH, 2015, J DENT RES, V94, P1439, DOI 10.1177/0022034515594117; Diatchenko L, 2005, J LEUKOCYTE BIOL, V78, P1366, DOI 10.1189/jlb.0405211; Gao H, 2012, J MOL CELL CARDIOL, V53, P657, DOI 10.1016/j.yjmcc.2012.08.005; Gaur Sumit, 2018, J Clin Exp Dent, V10, pe610, DOI 10.4317/jced.54715; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Gong Y, 2014, J PERIODONTAL RES, V49, P448, DOI 10.1111/jre.12123; Hedrick E, 2018, MOL CANCER RES, V16, P1991, DOI 10.1158/1541-7786.MCR-18-0366; Hedrick E, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00306-17; Hernandez G, 2003, J PERIODONTOL, V74, P1816, DOI 10.1902/jop.2003.74.12.1816; Hiwatashi N, 2017, LARYNGOSCOPE, V127, pE317, DOI 10.1002/lary.26678; Khalaf H, 2014, CYTOKINE, V67, P29, DOI 10.1016/j.cyto.2014.02.007; Khocht A, 1997, J PERIODONTOL, V68, P1140, DOI 10.1902/jop.1997.68.11.1140; Li L, 2015, NAT CHEM BIOL, V11, P339, DOI [10.1038/NCHEMBIO.1788, 10.1038/nchembio.1788]; Li N, 2013, BIOL CELL, V105, P261, DOI 10.1111/boc.201200064; Li XX, 2015, ELIFE, V4, DOI 10.7554/eLife.07217; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LIU J, 1993, TRENDS PHARMACOL SCI, V14, P182, DOI 10.1016/0165-6147(93)90206-Y; Livada R, 2014, J HUM HYPERTENS, V28, P10, DOI 10.1038/jhh.2013.47; Matsuda S, 2019, CLIN ORAL INVEST, V23, P4099, DOI 10.1007/s00784-019-02846-8; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Miranda J, 2001, J PERIODONTOL, V72, P605, DOI 10.1902/jop.2001.72.5.605; Molkentin JD, 2000, CIRC RES, V87, P731, DOI 10.1161/01.RES.87.9.731; Okanobu A, 2017, J IMMUNOL METHODS, V445, P31, DOI 10.1016/j.jim.2017.03.003; Paixao CG, 2011, J PERIODONTOL, V82, P251, DOI 10.1902/jop.2010.100368; Palumbo-Zerr K, 2015, NAT MED, V21, P150, DOI 10.1038/nm.3777; Park YJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00195; PERNU HE, 1993, J PERIODONTOL, V64, P1098, DOI 10.1902/jop.1993.64.11.1098; Rodriguez-Calvo R, 2017, EXPERT OPIN THER TAR, V21, P291, DOI 10.1080/14728222.2017.1279146; Sadeghi L, 2018, DARU, V26, P191, DOI 10.1007/s40199-018-0224-2; Samaniego M, 2006, NAT CLIN PRACT NEPHR, V2, P688, DOI 10.1038/ncpneph0343; Sattari M, 2011, IRAN J IMMUNOL, V8, P20, DOI IJIv8i1A3; Sekiguchi RT, 2007, J CLIN PERIODONTOL, V34, P545, DOI 10.1111/j.1600-051X.2007.01074.x; Seymour RA, 2000, J CLIN PERIODONTOL, V27, P217, DOI 10.1034/j.1600-051x.2000.027004217.x; Sheng JQ, 2018, CELL PHYSIOL BIOCHEM, V48, P1675, DOI 10.1159/000492292; Smolyaninova LV, 2017, CELL CALCIUM, V68, P5, DOI 10.1016/j.ceca.2017.10.002; Takeda K, 2011, TISSUE ENG PT A, V17, P955, DOI [10.1089/ten.tea.2010.0070, 10.1089/ten.TEA.2010.0070]; Trackman PC, 2015, J DENT RES, V94, P540, DOI 10.1177/0022034515571265; Trackman PC, 2004, CRIT REV ORAL BIOL M, V15, P165, DOI 10.1177/154411130401500305; WORONICZ JD, 1995, MOL CELL BIOL, V15, P6364; Wu H, 2016, J PATHOL, V238, P457, DOI 10.1002/path.4670; Wu H, 2011, FASEB J, V25, P192, DOI 10.1096/fj.10-166462; Xiong Y, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00158; Yan GJ, 2015, MOL CELL BIOL, V35, P3312, DOI 10.1128/MCB.00229-15; Zeng XL, 2018, CELL PHYSIOL BIOCHEM, V46, P1078, DOI 10.1159/000488838; Zhou FF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4388; Zhou H, 2019, SIGNAL TRANSDUCT TAR, V4, DOI 10.1038/s41392-019-0094-1	51	0	0	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21693	10.1096/fj.202100032R	http://dx.doi.org/10.1096/fj.202100032R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34109683				2022-12-26	WOS:000667814100071
J	Theilacker, C; Sprenger, R; Leverkus, F; Walker, J; Hackl, D; von Eiff, C; Schiffner-Rohe, J				Theilacker, Christian; Sprenger, Ralf; Leverkus, Friedhelm; Walker, Jochen; Haeckl, Dennis; von Eiff, Christof; Schiffner-Rohe, Julia			Population-based incidence and mortality of community-acquired pneumonia in Germany	PLOS ONE			English	Article							SHORT-TERM MORTALITY; OLDER-ADULTS; COMPUTED-TOMOGRAPHY; BURDEN; RISK; RATES; CODES	Background Little information on the current burden of community-acquired pneumonia (CAP) in adults in Germany is available. Methods We conducted a retrospective cohort study using a representative healthcare claims database of approx. 4 million adults to estimate the incidence rates (IR) and associated mortality of CAP in 2015. IR and mortality were stratified by treatment setting, age group, and risk group status. A pneumonia coded in the primary diagnosis position or in the second diagnosis position with another pneumonia-related condition coded in the primary position was used as the base cases definition for the study. Sensitivity analyses using broader and more restrictive case definitions were also performed. Results The overall IR of CAP in adults >= 18 years was 1,054 cases per 100,000 person-years of observation. In adults aged 16 to 59 years, IR for overall CAP, hospitalized CAP and outpatient CAP was 551, 96 and 466 (with a hospitalization rate of 17%). In adults aged >= 60 years, the respective IR were 2,032, 1,061 and 1,053 (with a hospitalization rate of 52%). If any pneumonia coded in the primary or secondary diagnosis position was considered for hospitalized patients, the IR increased 1.5-fold to 1,560 in the elderly >= 60 years. The incidence of CAP hospitalizations was substantially higher in adults >= 18 years with at-risk conditions and high-risk conditions (IR of 608 and 1,552, respectively), compared to adults without underlying risk conditions (IR 108). High mortality of hospitalized CAP in adults >= 18 was observed in-hospital (18.5%), at 30 days (22.9%) and at one-year (44.5%) after CAP onset. Mortality was more than double in older adults in comparison to younger patients. Conclusion CAP burden in older adults and individuals with underlying risk conditions was high. Maximizing uptake of existing vaccines for respiratory diseases may help to mitigate the disease burden, especially in times of strained healthcare resources.	[Theilacker, Christian; Sprenger, Ralf; von Eiff, Christof] Pfizer Pharma GmbH, Berlin, Germany; [Leverkus, Friedhelm; Schiffner-Rohe, Julia] Pfizer Deutschland GmbH, Berlin, Germany; [Walker, Jochen] InGef Inst Appl Hlth Res Berlin, Berlin, Germany; [Haeckl, Dennis] WIG2 GmbH, Leipzig, Germany	Pfizer; Pfizer	Theilacker, C (corresponding author), Pfizer Pharma GmbH, Berlin, Germany.	christian.theilacker@pfizer.com		Sprenger, Ralf/0000-0003-2721-110X; Theilacker, Christian/0000-0003-0821-9202	Pfizer Deutschland GmbH	Pfizer Deutschland GmbH	This study was supported by an unrestricted research grant from Pfizer Deutschland GmbH. The funder provided support in the form of salaries for authors [RS, CT, J SR, CvE, FL], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersohn F, 2016, PHARMACOEPIDEM DR S, V25, P106, DOI 10.1002/pds.3895; Bornheimer R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184877; Brown JD, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0787-2; Cilloniz C, 2020, EUR RESPIR REV, V29, DOI 10.1183/16000617.0126-2019; Claessens YE, 2015, AM J RESP CRIT CARE, V192, P974, DOI 10.1164/rccm.201501-0017OC; Corrales-Medina VF, 2009, MEDICINE, V88, P154, DOI 10.1097/MD.0b013e3181a692f0; Ewig S, 2009, THORAX, V64, P1062, DOI 10.1136/thx.2008.109785; Gessner BD, 2019, VACCINE, V37, P5777, DOI 10.1016/j.vaccine.2018.05.097; IQTIG-Institut fur Qualitatssicherung und Transparenz im Gesundheitswesen B, BUND ERF 2018 AMB ER; Janssens JP, 2004, LANCET INFECT DIS, V4, P112, DOI 10.1016/S1473-3099(04)00931-4; Kolditz M, 2016, RESP MED, V121, P32, DOI 10.1016/j.rmed.2016.10.015; Krone CL, 2014, LANCET RESP MED, V2, P141, DOI 10.1016/S2213-2600(13)70165-6; McLaughlin JM, 2020, VACCINE, V38, P741, DOI 10.1016/j.vaccine.2019.10.101; Musher DM, 2007, CLIN INFECT DIS, V45, P158, DOI 10.1086/518849; Musher DM, 2019, NEW ENGL J MED, V380, P171, DOI 10.1056/NEJMra1808137; Pelton SI, 2019, J ASTHMA ALLERGY, V12, P95, DOI 10.2147/JAA.S200492; Pelton SI, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1162-y; Peyrani P, 2020, CHEST, V157, P34, DOI 10.1016/j.chest.2019.09.022; Pflug MA, 2015, POSTGRAD MED J, V91, P77, DOI 10.1136/postgradmedj-2014-132802; Poethko-Muller C, 2013, BUNDESGESUNDHEITSBLA, V56, P845, DOI 10.1007/s00103-013-1693-6; Restrepo MI, 2013, CURR OPIN INFECT DIS, V26, P151, DOI 10.1097/QCO.0b013e32835ebc6d; Schmedt N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220848; Schmedt N, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-018-3861-8; Schnoor M, 2007, J INFECTION, V55, P233, DOI 10.1016/j.jinf.2007.04.355; Self WH, 2013, AM J EMERG MED, V31, P401, DOI 10.1016/j.ajem.2012.08.041; Shea KM, 2014, OPEN FORUM INFECT DI, V1, DOI 10.1093/ofid/ofu024; Shi T, 2019, J INFECT DIS, DOI 10.1093/infdis/jiy662; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564; Standige Impfkommission (STIKO) am Robert-Koch-Institut, 2016, EPIDEMIOLOGISCHES B, P34; Standing Committee on Vaccination (STIKO) at the Robert Koch Institute, 2017, REC STAND COMM VACC; Thindwa D, 2020, VACCINE, V38, P5398, DOI 10.1016/j.vaccine.2020.06.047; Torres A, 2018, RESP MED, V137, P6, DOI 10.1016/j.rmed.2018.02.007; van De Garde EMW, 2007, J CLIN EPIDEMIOL, V60, P834, DOI 10.1016/j.jclinepi.2006.10.018; van Vugt SF, 2013, EUR RESPIR J, V42, P1076, DOI 10.1183/09031936.00111012; Violi F, 2017, CLIN INFECT DIS, V64, P1486, DOI 10.1093/cid/cix164; Watt JP, 2010, EPIDEMIOL INFECT, V138, P1146, DOI 10.1017/S0950268809991464; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Wesemann T, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0730-x; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	39	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253118	10.1371/journal.pone.0253118	http://dx.doi.org/10.1371/journal.pone.0253118			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129632	Green Published, gold			2022-12-26	WOS:000665475100026
J	Wang, XL; Zhang, L; Song, YF; Jiang, Y; Zhang, D; Wang, R; Hu, TH; Han, S				Wang, Xiaoliang; Zhang, Li; Song, Yifu; Jiang, Yang; Zhang, Di; Wang, Run; Hu, Tianhao; Han, Sheng			MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors	ONCOGENE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; FUNCTIONAL-CHARACTERIZATION; COMPLEX; EXPRESSION; CANCER; ACTIVATION; PROGNOSIS; FAMILY; CDC6	Mini-chromosome maintenance (MCM) proteins are critical components of DNA-replication-licensing factors. MCM8 is an MCM protein that exhibits oncogenic functions in several human malignancies. However, the role of MCM8 in glioblastomas (GBMs) has remained unclear. In the present study, we investigated the biological functions and mechanisms of MCM8 in glioma stem cells (GSCs). The clinical relevance of MCM8 mRNA expression was explored via TCGA and REMBRANDT datasets. The effects of MCM8 on the self-renewal and tumorigenicity of GSCs were examined both in vitro and in vivo. The regulation of MCM8 expression and its interacting proteins were also evaluated. We found that the expression of MCM8 was elevated in high-grade gliomas and classical molecular subtypes and was inversely correlated with patient prognosis. GSCs had a significantly higher expression of MCM8 compared with that in normal glioma cells. Silencing of MCM8 induced G0/G1 arrest and apoptosis, as well as inhibited the proliferation and self-renewal of GSCs. Forced expression of MCM8 enhanced clonogenicity of GSCs both in vitro and in vivo. MCM8 expression was regulated by EGFR signaling, which was mediated by NF-kappa B (p65). MCM8 interacted with DNA-replication-initiating factors-including EZH2, CDC6, and CDCA2-and influenced these factors to associate with chromatin. In addition, MCM8 knockdown increased the sensitivity of GSCs to radiation and TMZ treatments. Our findings suggest that MCM8, regulated by the EGFR pathway, maintains the clonogenic and tumorigenic potential of GSCs through interaction with DNA-replication-initiating factors; hence, MCM8 may represent a novel therapeutic target in GBMs.	[Wang, Xiaoliang; Zhang, Li; Song, Yifu; Jiang, Yang; Wang, Run; Hu, Tianhao; Han, Sheng] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China; [Jiang, Yang] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 1, Dept Neurosurg, Sch Med, Shanghai, Peoples R China; [Zhang, Di] China Med Univ, Dept Pathol, Shenyang, Peoples R China	China Medical University; Shanghai Jiao Tong University; China Medical University	Han, S (corresponding author), China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Peoples R China.	hansheng2001_x@aliyun.com		Han, Sheng/0000-0001-6991-0529; song, yi fu/0000-0002-5096-5949	LiaoNing Revitalization Talents Program [XLYC1807253]; National Natural Science Foundation of China [81772653, 81402045]	LiaoNing Revitalization Talents Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Qingchang Li from the Department of Pathology at China Medical University for technological support and assistance with statistical analyses. This work was supported by the LiaoNing Revitalization Talents Program (No. XLYC1807253) and the National Natural Science Foundation of China (No. 81772653 and 81402045)	Azzarelli R, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.162693; Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247; Cai HQ, 2018, HUM PATHOL, V78, P182, DOI 10.1016/j.humpath.2018.04.024; Cai LL, 2015, INT J CLIN EXP PATHO, V8, P14180; De Ruysscher D, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0064-5; Erkan EP, 2014, ONCOGENE, V33, P4778, DOI 10.1038/onc.2013.423; Freeman A, 1999, CLIN CANCER RES, V5, P2121; Friedman HS, 2000, CLIN CANCER RES, V6, P2585; Gozuacik D, 2003, NUCLEIC ACIDS RES, V31, P570, DOI 10.1093/nar/gkg136; Greenall SA, 2019, NEURO-ONCOLOGY, V21, P1016, DOI 10.1093/neuonc/noz073; Guo SY, 2021, THERANOSTICS, V11, P4316, DOI 10.7150/thno.51745; Han S, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0552-y; Han S, 2015, J NEURO-ONCOL, V124, P45, DOI 10.1007/s11060-015-1818-x; He DM, 2017, ONCOGENE, V36, P3629, DOI 10.1038/onc.2017.123; Honeycutt KA, 2006, ONCOGENE, V25, P4027, DOI 10.1038/sj.onc.1209435; Hua C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-526; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Ishimi Y, 2018, GENES GENET SYST, V93, P125, DOI 10.1266/ggs.18-00026; Jiang Y, 2019, CANCER RES, V79, P2593, DOI 10.1158/0008-5472.CAN-18-3297; Jin X, 2017, NAT MED, V23, P1352, DOI 10.1038/nm.4415; Labib K, 2001, MOL BIOL CELL, V12, P3658, DOI 10.1091/mbc.12.11.3658; Lee KY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8744; Li XJ, 2018, MOL CELL, V72, P650, DOI 10.1016/j.molcel.2018.09.007; Liu YQ, 2017, J MOL CELL BIOL, V9, P178, DOI 10.1093/jmcb/mjx013; Liu ZK, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4056-8; Matson JP, 2017, ELIFE, V6, DOI 10.7554/eLife.30473; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Mukherjee S, 2018, CELL REP, V23, P1651, DOI 10.1016/j.celrep.2018.04.016; Nishimura K, 2012, MOL CELL, V47, P511, DOI 10.1016/j.molcel.2012.05.047; Park J, 2013, MOL CELL BIOL, V33, P1632, DOI 10.1128/MCB.01503-12; Peng YP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164150; Song YF, 2019, THERANOSTICS, V9, P6019, DOI 10.7150/thno.35747; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Volkening M, 2005, MOL CELL BIOL, V25, P1560, DOI 10.1128/MCB.25.4.1560-1568.2005; Wang QY, 2018, CLIN CANCER RES, V24, P950, DOI 10.1158/1078-0432.CCR-17-1475; Wang YF, 2020, BBA-REV CANCER, V1874, DOI 10.1016/j.bbcan.2020.188415; Weller M, 2017, LANCET ONCOL, V18, pE315, DOI 10.1016/S1470-2045(17)30194-8; Yang WW, 2012, MOL CELL, V48, P771, DOI 10.1016/j.molcel.2012.09.028; Zhang X, 2014, MOL CANCER RES, V12, P1535, DOI 10.1158/1541-7786.MCR-13-0641	41	2	2	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2021	40	27					4615	4624		10.1038/s41388-021-01888-1	http://dx.doi.org/10.1038/s41388-021-01888-1		JUN 2021	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TG4PV	34131285				2022-12-26	WOS:000661812800002
J	Borse, S; Joshi, M; Saggam, A; Bhat, V; Walia, S; Marathe, A; Sagar, S; Chavan-Gautam, P; Girme, A; Hingorani, L; Tillu, G				Borse, Swapnil; Joshi, Manali; Saggam, Akash; Bhat, Vedika; Walia, Safal; Marathe, Aniket; Sagar, Sneha; Chavan-Gautam, Preeti; Girme, Aboli; Hingorani, Lal; Tillu, Girish			Ayurveda botanicals in COVID-19 management: An in silico multi-target approach	PLOS ONE			English	Article							IMMUNOMODULATORY ACTIVITY; ASPARAGUS-RACEMOSUS; EXTRACT; PROTEIN; LIGAND; CORONAVIRUS; INHIBITION; WITHAFERIN; PATHWAYS; ADJUVANT	The Coronavirus disease (COVID-19) caused by the virus SARS-CoV-2 has become a global pandemic in a very short time span. Currently, there is no specific treatment or vaccine to counter this highly contagious disease. There is an urgent need to find a specific cure for the disease and global efforts are directed at developing SARS-CoV-2 specific antivirals and immunomodulators. Ayurvedic Rasayana therapy has been traditionally used in India for its immunomodulatory and adaptogenic effects, and more recently has been included as therapeutic adjuvant for several maladies. Amongst several others, Withania somnifera (Ashwagandha), Tinospora cordifolia (Guduchi) and Asparagus racemosus (Shatavari) play an important role in Rasayana therapy. The objective of this study was to explore the immunomodulatory and anti SARS-CoV2 potential of phytoconstituents from Ashwagandha, Guduchi and Shatavari using network pharmacology and docking. The plant extracts were prepared as per ayurvedic procedures and a total of 31 phytoconstituents were identified using UHPLC-PDA and mass spectrometry studies. To assess the immunomodulatory potential of these phytoconstituents an in-silico network pharmacology model was constructed. The model predicts that the phytoconstituents possess the potential to modulate several targets in immune pathways potentially providing a protective role. To explore if these phytoconstituents also possess antiviral activity, docking was performed with the Spike protein, Main Protease and RNA dependent RNA polymerase of the virus. Interestingly, several phytoconstituents are predicted to possess good affinity for the three targets, suggesting their application for the termination of viral life cycle. Further, predictive tools indicate that there would not be adverse herb-drug pharmacokinetic-pharmacodynamic interactions with concomitantly administered drug therapy. We thus make a compelling case to evaluate the potential of these Rasayana botanicals as therapeutic adjuvants in the management of COVID-19 following rigorous experimental validation.	[Borse, Swapnil; Saggam, Akash; Bhat, Vedika; Chavan-Gautam, Preeti; Tillu, Girish] Savitribai Phule Pune Univ, Interdisciplinary Sch Hlth Sci, Ctr Complementary & Integrat Hlth, AYUSH Ctr Excellence, Pune, Maharashtra, India; [Joshi, Manali; Walia, Safal; Marathe, Aniket] Savitribai Phule Pune Univ, Bioinformat Ctr, Pune, Maharashtra, India; [Saggam, Akash] Serum Inst India Pvt Ltd, Pune, Maharashtra, India; [Sagar, Sneha] LJ Inst Pharm, Dept Pharmaceut Chem, Ahmadabad, Gujarat, India; [Girme, Aboli; Hingorani, Lal] Pharmanza Herbal Pvt Ltd, Anand, Gujarat, India	Savitribai Phule Pune University; Savitribai Phule Pune University; Serum Institute of India	Chavan-Gautam, P (corresponding author), Savitribai Phule Pune Univ, Interdisciplinary Sch Hlth Sci, Ctr Complementary & Integrat Hlth, AYUSH Ctr Excellence, Pune, Maharashtra, India.; Joshi, M (corresponding author), Savitribai Phule Pune Univ, Bioinformat Ctr, Pune, Maharashtra, India.	manalijoshi@unipune.ac.in; chavanpriti@gmail.com	Saggam, Akash/R-3604-2017; Sagar, Sneha/AAE-9740-2019	Saggam, Akash/0000-0003-1845-9226; Chavan-Gautam, Preeti/0000-0001-8514-3171; Marathe, Aniket/0000-0001-8229-1603; Girme, Aboli/0000-0002-1536-1656	Ministry of AYUSH, Govt. of India [Z 15015/07/2017-COE]	Ministry of AYUSH, Govt. of India	The work was funded by the Ministry of AYUSH, Govt. of India (Grant no. Z 15015/07/2017-COE; Dt. 27/11/2017). The funder provided support in the form of salaries/fellowship for authors [SB, AS, VB], but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. Pharmanza Herbals Pvt. Ltd provided support in the form of salaries for authors [AG, LH] and supplied the herbal extracts as a gift, but did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of authors are provided in the author contributions section.	Agarwal R, 1999, J ETHNOPHARMACOL, V67, P27, DOI 10.1016/S0378-8741(99)00065-3; Ahmad M, 2017, SUSTAINED ENERGY FOR ENHANCED HUMAN FUNCTIONS AND ACTIVITY, P137, DOI 10.1016/B978-0-12-805413-0.00008-9; Ahmed SM, 2006, J CHROMATOGR SCI, V44, P504, DOI 10.1093/chromsci/44.8.504; Anchi P, 2017, PHYTOTHER RES, V31, P591, DOI 10.1002/ptr.5792; [Anonymous], BJGMC PUNE PROTOCOL, V19, P1; Balasubramani SP, 2011, CHIN J INTEGR MED, V17, P88, DOI 10.1007/s11655-011-0659-5; Bani S, 2006, J ETHNOPHARMACOL, V107, P107, DOI 10.1016/j.jep.2006.02.016; Bartels K, 2013, P NATL ACAD SCI USA, V110, P18351, DOI 10.1073/pnas.1318345110; Bhushan Patwardhan RC., 2016, INNOVATIVE APPROACHE; Borse Swapnil P, 2019, Porto Biomed J, V4, pe15, DOI 10.1016/j.pbj.0000000000000015; Borse SP, 2015, J INTEGR MED-JIM, V13, P165, DOI 10.1016/S2095-4964(15)60173-X; Braciale TJ, 2013, IMMUNOL REV, V255, P5, DOI 10.1111/imr.12109; Cascella M, 2020, STATPEARLS; Chaguturu R., 2016, DRUG DISCOVERY WORLD, V17, P45; Chandran, 2015, NISCAIR ONLINE PERIO; Chandran U, 2017, J ETHNOPHARMACOL, V197, P250, DOI 10.1016/j.jep.2016.07.080; Chaudhary A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53568-6; Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7; Cheng W, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/3769879; Chopra, AYURVEDA RASAYANA PR, V19, P1; Chow KC, 2004, AM J CLIN PATHOL, V121, P574, DOI 10.1309/C0EDU0RAQBTXBHCE; Chow N, 2020, MMWR-MORBID MORTAL W, V69, P382, DOI 10.15585/mmwr.mm6913e2; Conti Bruno, 2016, Temperature (Austin), V3, P25, DOI 10.1080/23328940.2015.1130520; Coomes EA, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2141; Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117; Diseases, 2020, GALIDESIVIR BIOCRYST; Driver S BK, STOCKLEYS HERBAL MED; Du LY, 2009, NAT REV MICROBIOL, V7, P226, DOI 10.1038/nrmicro2090; Duan Kai, 2020, Proc Natl Acad Sci U S A, V117, P9490, DOI 10.1073/pnas.2004168117; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Fung M, 2021, CLIN INFECT DIS, V72, P340, DOI 10.1093/cid/ciaa863; GAO Y, 2020, SCI 80, DOI DOI 10.1126/SCIENCE.ABB7498; Garcia-Cremades M, 2020, CLIN PHARMACOL THER, V108, P253, DOI 10.1002/cpt.1856; Gautam M, 2009, J ETHNOPHARMACOL, V121, P41, DOI 10.1016/j.jep.2008.10.028; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Girme A, 2020, ACS OMEGA, V5, P27933, DOI 10.1021/acsomega.0c03266; Girme A, 2020, J PHARMACEUT BIOMED, V191, DOI 10.1016/j.jpba.2020.113603; Guo JY, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.016219; Hopkins AL, 2014, NAT REV DRUG DISCOV, V13, P105, DOI 10.1038/nrd4163; Hualan L., 2020, COVID 19 ATTACKS 1 B, DOI [10.26434/CHEMRXIV.11938173.V6, DOI 10.26434/CHEMRXIV.11938173.V6]; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; JIN Y, 2020, VIRUSES, P12; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORIS I, 1972, VIRCHOWS ARCH B, V12, P73; Joshi M, 2016, CHEM BIOL DRUG DES, V88, P5, DOI 10.1111/cbdd.12741; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kaur G, 2015, PHARM BIOL, V53, P147, DOI 10.3109/13880209.2014.912240; Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033; Kulkarni, 2019, SCI REP-UK, P9, DOI [10.1038/s41598-018-36956-2, DOI 10.1038/S41598-018-36956-2]; Lee EYP, 2020, LANCET INFECT DIS, V20, P384, DOI 10.1016/S1473-3099(20)30134-1; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Michot JM, 2020, ANN ONCOL, V31, P961, DOI 10.1016/j.annonc.2020.03.300; Min KJ, 2011, INT IMMUNOPHARMACOL, V11, P1137, DOI 10.1016/j.intimp.2011.02.029; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mukherjee P.K., 2018, SYNERGY, V7, P30, DOI [10.1016/j.synres.2018.10.003, DOI 10.1016/J.SYNRES.2018.10.003]; OBOYLE NM, 2011, J CHEMINFORMATICS, V3, DOI [DOI 10.1186/1758-2946-3-33, 10.1186/1758-2946-3-33]; Ostermann G, 2002, NAT IMMUNOL, V3, P151, DOI 10.1038/ni755; Ostrand-Rosenberg, 2013, J IMMUNOL, P190; Patgiri Biswajyoti, 2014, Ayu, V35, P108, DOI 10.4103/0974-8520.141958; Paul D, 2014, J AOAC INT, V97, P1497, DOI 10.5740/jaoacint.13-382; Patil D, 2014, INTEGR CANCER THER, V13, P167, DOI 10.1177/1534735413503551; Patwardhan, 2020, PUBLIC HLTH APPROACH, V10, P1, DOI [10.1089/acm.2020.0129, DOI 10.1089/ACM.2020.0129]; Patwardhan B, 2005, DRUG DISCOV TODAY, V10, P495, DOI 10.1016/S1359-6446(04)03357-4; Patwardhan B., 2008, CURR BIOACT COMPD, V4, P201, DOI [10.2174/157340708786847870, DOI 10.2174/157340708786847870]; Patwardhan B, 2012, CURR SCI INDIA, V102, P1406; Patwardhan B, 2010, INDIAN J EXP BIOL, V48, P220; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Rahul Chulet, 2009, Pharmacognosy Reviews, V3, P229; Rege NN, 1999, PHYTOTHER RES, V13, P275, DOI 10.1002/(SICI)1099-1573(199906)13:4&lt;275::AID-PTR510&gt;3.0.CO;2-S; RO GP, 1992, PHARM RES-DORDR, V9, P663, DOI DOI 10.1023/A:1015810312465; Russell B, 2020, ECANCERMEDICALSCIENC, V14, P1, DOI 10.3332/ecancer.2020.1022; Saggam A, 2020, J ETHNOPHARMACOL, V255, DOI 10.1016/j.jep.2020.112759; Saha Sanjib, 2013, In Silico Pharmacol, V1, P11, DOI 10.1186/2193-9616-1-11; Saha S, 2012, ANC SCI LIFE, V31, P151, DOI 10.4103/0257-7941.107344; Sanders JM, 2020, JAMA-J AM MED ASSOC, V323, P1824, DOI 10.1001/jama.2020.6019; Sciences, 2020, REMDESIVIR GILEAD SC; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma U, 2012, J ETHNOPHARMACOL, V141, P918, DOI 10.1016/j.jep.2012.03.027; Sikandan A, 2018, INT J MOL MED, V42, P425, DOI 10.3892/ijmm.2018.3608; Srivastava DN., 1993, J APPL ANIM RES, V3, P129, DOI [10.1080/09712119.1993.9705964, DOI 10.1080/09712119.1993.9705964]; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Tillu G, 2020, J ALTERN COMPLEM MED, V26, P360, DOI 10.1089/acm.2020.0129; Tiwari M, 2014, J ETHNOPHARMACOL, V153, P326, DOI 10.1016/j.jep.2014.01.031; Tiwari N, 2017, BIOMED PHARMACOTHER, V86, P555, DOI 10.1016/j.biopha.2016.11.087; Varshney A, 2020, PREPRINT; Varshney A., 2020, VIROLOGY J, DOI [DOI 10.21203/RS.3.RS-17806/V1, 10.21203/rs.3.rs-17806/v1]; Wadhwa R., 2017, SCI ASHWAGANDHA PREV, P149, DOI 10.1007/978-3-319-59192-6; Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005; WHO, 2020, SOL CLIN TRIAL COVID; Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yazdany J, 2020, ANN INTERN MED, V172, P754, DOI 10.7326/M20-1334; YUAN H, 2017, MOL MDPI AG, DOI DOI 10.3390/MOLECULES22071135; Zaim S, 2020, CURR PROB CARDIOLOGY, V45, DOI 10.1016/j.cpcardiol.2020.100618; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zhang C, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105954	100	25	25	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0248479	10.1371/journal.pone.0248479	http://dx.doi.org/10.1371/journal.pone.0248479			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115763	gold, Green Published, Green Submitted			2022-12-26	WOS:000664643000004
J	Casado-Rey, P; Vazquez-Iglesias, L; Botana-Rial, M; Andrade-Olivie, MA; Ferreiro-Fernandez, L; Capilla, ES; Nunez-Ares, A; de Miguel, EB; Pajares-Ruiz, V; Fernandez-Villar, A				Casado-Rey, Pedro; Vazquez-Iglesias, Lorena; Botana-Rial, Maribel; Amalia Andrade-Olivie, Maria; Ferreiro-Fernandez, Lucia; San Jose Capilla, Esther; Nunez-Ares, Ana; Bollo de Miguel, Elena; Pajares-Ruiz, Virginia; Fernandez-Villar, Alberto			A rapid calprotectin test for the diagnosis of pleural effusion	PLOS ONE			English	Article							BIOMARKERS; AGREEMENT; CANCER; FLUID	In previous studies, measuring the levels of calprotectin in patients with pleural effusion (PE) was an exceptionally accurate way to predict malignancy. Here, we evaluated a rapid method for the measurement of calprotectin levels as a useful parameter in the diagnosis of malignant pleural effusion (MPE) in order to minimise invasive diagnostic tests. Calprotectin levels were measured with Quantum Blue((R)) sCAL (QB((R))sCAL) and compared with the gold standard reference ELISA method. Calprotectin levels in patients with benign pleural effusion (BPE) were significantly higher (p < 0.0001) than for MPE patients. We measured the sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and positive and negative likelihood ratios (LRs) for a cut-off value of <less than or equal to> 14,150 ng/mL; the diagnostic accuracy was 64%. The odds ratio for PE calprotectin levels was 10.938 (95% CI [4.133 - 28.947]). The diagnostic performance of calprotectin concentration was better for predicting MPE compared to other individual parameters. Comparison of two assays showed a slope of 1.084, an intercept of 329.7, and a Pearson correlation coefficient of 0.798. The Bland-Altman test showed a positive bias for the QB((R))sCAL method compared to ELISA fCAL((R)). Clinical concordance between both these methods was 88.5% with a Cohen kappa index of 0.76 (95% CI [0.68 - 0.84]). We concluded that QB((R))sCAL is a fast, reliable, and non-invasive diagnostic tool for diagnosing MPE and represents an alternative to ELISA that could be implemented in medical emergencies.	[Casado-Rey, Pedro; Amalia Andrade-Olivie, Maria] Hosp Alvaro Cunqueiro, Clin Chem Dept, EOXI Vigo, Vigo, Spain; [Vazquez-Iglesias, Lorena] Univ Vigo, CINBIO, Vigo, Spain; [Vazquez-Iglesias, Lorena; Fernandez-Villar, Alberto] SERGAS UVIGO, Inst Invest Sanitaria Galicia Sur IIS Galicia Sur, Grp Invest Quim Coloidal, Vigo, Spain; [Botana-Rial, Maribel] Hosp Alvaro Cunqueiro, PneumoVigol Res Grp, Hlth Res Inst Galicia Sur IIS Galicia Sur, Pulm Dept,EOXI Vigo, Vigo, Spain; [Ferreiro-Fernandez, Lucia] Univ Hosp Complex Santiago, Pulm Dept, EOXI Santiago, Santiago, Spain; [Ferreiro-Fernandez, Lucia] Hlth Res Inst Santiago IDIS, Santiago De Compostela, Spain; [San Jose Capilla, Esther] Univ Hosp Complex Santiago, Clin Chem Dept, EOXI Santiago, Santiago, Spain; [Nunez-Ares, Ana] Univ Hosp Complex Albacete, Pulm Dept, Albacete, Spain; [Bollo de Miguel, Elena] Univ Hosp Complex Leon, Pulm Dept, Leon, Spain; [Pajares-Ruiz, Virginia] Hosp Santa Creu & Sant Pau Barcelona, Pulm Dept, Barcelona, Spain	Universidade de Vigo; CINBIO	Vazquez-Iglesias, L (corresponding author), Univ Vigo, CINBIO, Vigo, Spain.; Vazquez-Iglesias, L (corresponding author), SERGAS UVIGO, Inst Invest Sanitaria Galicia Sur IIS Galicia Sur, Grp Invest Quim Coloidal, Vigo, Spain.	lorena.vazquez@uvigo.es	; Vazquez-Iglesias, Lorena/M-1837-2014	Pajares, Virginia/0000-0002-0916-527X; , IIS Galicia Sur/0000-0003-3812-7413; Vazquez-Iglesias, Lorena/0000-0002-0203-3514; Ferreiro, Lucia/0000-0002-9023-0429	Xunta de Galicia [PI13/01538]; grant of societies AEER (2015), SOGAPAR (2014) [CN/2014]; Fundacion Biomedica Galicia Sur; In-tegrated research programs of SEPAR (PII Neumologia Intervencionista 2015)	Xunta de Galicia(Xunta de GaliciaEuropean Commission); grant of societies AEER (2015), SOGAPAR (2014); Fundacion Biomedica Galicia Sur; In-tegrated research programs of SEPAR (PII Neumologia Intervencionista 2015)	Project PI13/01538 (FIS-FEDER), Xunta de Galicia (CN/2014), grant of societies AEER (2015), SOGAPAR (2014). Lorena Vazquez was supported by Fundacion Biomedica Galicia Sur with In-tegrated research programs of SEPAR (PII Neumologia Intervencionista 2015).	Botana-Rial M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62388-y; Burri E, 2013, WORLD J GASTROENTERO, V19, P2028, DOI 10.3748/wjg.v19.i13.2028; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Coorevits L, 2013, CLIN CHEM LAB MED, V51, P825, DOI 10.1515/cclm-2012-0386; Drago L, 2018, CLIN CHEM LAB MED, V56, P19, DOI 10.1515/cclm-2017-0041; Feller-Kopman D, 2018, NEW ENGL J MED, V378, P1754, DOI 10.1056/NEJMc1803858; Florkowski C, 2017, CRIT REV CL LAB SCI, V54, P471, DOI 10.1080/10408363.2017.1399336; Guardiola J, 2018, GASTROENT HEPAT-BARC, V41, P514, DOI 10.1016/j.gastrohep.2018.05.029; Klimiuk J, 2015, ADV EXP MED BIOL, V873, P53, DOI 10.1007/5584_2015_156; Labaere D, 2014, UNITED EUR GASTROENT, V2, P30, DOI 10.1177/2050640613518201; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Li CY, 2018, COMPUT METH PROG BIO, V153, P211, DOI 10.1016/j.cmpb.2017.10.022; Oliver Saez P., 2016, REV LABORATORIO CLIN, V9, P60; Roberts ME, 2010, THORAX, V65, P32, DOI 10.1136/thx.2010.136994; Rodriguez-Pineiro AM, 2010, J PROTEOMICS, V73, P1511, DOI 10.1016/j.jprot.2010.03.005; Sahn SA, 2012, RESPIROLOGY, V17, P270, DOI 10.1111/j.1440-1843.2011.02100.x; Sanchez-Otero N, 2012, BRIT J CANCER, V107, P1876, DOI 10.1038/bjc.2012.478; Shu CC, 2015, RESPIROLOGY, V20, P147, DOI 10.1111/resp.12414; Sriram KB, 2011, FUTURE ONCOL, V7, P737, DOI [10.2217/fon.11.45, 10.2217/FON.11.45]; Valdes L, 2013, LUNG, V191, P633, DOI 10.1007/s00408-013-9512-2; Vazquez-Iglesias L, 2017, CLIN CHEM LAB MED, V55, pE172, DOI 10.1515/cclm-2016-0884; Garrido VV, 2014, ARCH BRONCONEUMOL, V50, P235, DOI 10.1016/j.arbres.2014.01.016; Wang YX, 2015, TRANSL CANCER RES, V4, P270, DOI 10.3978/j.issn.2218-676X.2015.06.02; Wouthuyzen-Bakker M, 2018, J ARTHROPLASTY, V33, P1149, DOI 10.1016/j.arth.2017.11.006	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252714	10.1371/journal.pone.0252714	http://dx.doi.org/10.1371/journal.pone.0252714			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111153	Green Published, gold			2022-12-26	WOS:000664642700038
J	Abdur Rehman, N; Counts, S				Abdur Rehman, Nabeel; Counts, Scott			Neighborhood level chronic respiratory disease prevalence estimation using search query data	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-POLLUTION; HEALTH; ASTHMA; RISK; COPD; SMOKING	Estimation of disease prevalence at sub-city neighborhood scale allows early and targeted interventions that can help save lives and reduce public health burdens. However, the cost-prohibitive nature of highly localized data collection and sparsity of representative signals, has made it challenging to identify neighborhood scale prevalence of disease. To overcome this challenge, we utilize alternative data sources, which are both less sparse and representative of localized disease prevalence: using query data from a large commercial search engine, we identify the prevalence of respiratory illness in the United States, localized to census tract geographic granularity. Focusing on asthma and Chronic Obstructive Pulmonary Disease (COPD), we construct a set of features based on searches for symptoms, medications, and disease-related information, and use these to identify illness rates in more than 23 thousand tracts in 500 cities across the United States. Out of sample model estimates from search data alone correlate with ground truth illness rate estimates from the CDC at 0.69 to 0.76, with simple additions to these models raising those correlations to as high as 0.84. We then show that in practice search query data can be added to other relevant data such as census or land cover data to boost results, with models that incorporate all data sources correlating with ground truth data at 0.91 for asthma and 0.88 for COPD.	[Abdur Rehman, Nabeel] NYU, New York, NY USA; [Counts, Scott] Microsoft Res, Redmond, WA 98052 USA	New York University; Microsoft	Counts, S (corresponding author), Microsoft Res, Redmond, WA 98052 USA.	counts@microsoft.com			Microsoft Research	Microsoft Research(Microsoft)	Microsoft Research provided support in the form of salary for author SC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	500 Cities, 2020, 500 CITIES PROJECT L; Ads Management for Facebook, 2021, FAC BUS; [Anonymous], 2002, Bull World Health Organ, V80, P983; Beelen R, 2008, ENVIRON HEALTH PERSP, V116, P196, DOI 10.1289/ehp.10767; Berry CE, 2010, COPD, V7, P375, DOI 10.3109/15412555.2010.510160; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Census gov, 2020, CENS TRACTS; Chan EH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001206; Desai R, 2012, CLIN INFECT DIS, V55, pE75, DOI 10.1093/cid/cis579; FCC, 2020, MOR CENS TRACTS; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Google, 2020, GOOGL EARTH PRO 7 3; Haustein KO, 2006, EUR J CARDIOV PREV R, V13, P312, DOI 10.1097/00149831-200606000-00004; Jacobs W, 2017, COGENT SOC SCI, V3, DOI 10.1080/23311886.2017.1302785; Jean N, 2016, SCIENCE, V353, P790, DOI 10.1126/science.aaf7894; Kurmi OP, 2010, THORAX, V65, P221, DOI 10.1136/thx.2009.124644; Leas EC, 2019, JAMA INTERN MED, V179, P442, DOI 10.1001/jamainternmed.2018.5990; Maharana A, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.1535; Mikolov T., 2013, P ICLR WORKSH POST S; [MRLC] Multi-Resolution Land Characteristics Consortium, 2020, NLCD 2016 LAND COV C; National Center for Health Statistics, 2016, HLTH US 2015 SPEC 20; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Peacock JL, 2011, THORAX, V66, P591, DOI 10.1136/thx.2010.155358; Rehman NA, 2018, 26TH ACM SIGSPATIAL INTERNATIONAL CONFERENCE ON ADVANCES IN GEOGRAPHIC INFORMATION SYSTEMS (ACM SIGSPATIAL GIS 2018), P379, DOI 10.1145/3274895.3274982; Rehman NA, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501215; Rehman Nabeel Abdur, 2019, P IEEE C COMP VIS PA, P44; Ritz T, 2006, PSYCHOSOM MED, V68, P956, DOI 10.1097/01.psy.0000248898.59557.74; Rodriguez MA, 2002, ARCH PEDIAT ADOL MED, V156, P269, DOI 10.1001/archpedi.156.3.269; Salje H, 2012, P NATL ACAD SCI USA, V109, P9535, DOI 10.1073/pnas.1120621109; Seifter A, 2010, GEOSPATIAL HEALTH, V4, P135, DOI 10.4081/gh.2010.195; Smit HA, 2015, LANCET RESP MED, V3, P973, DOI 10.1016/S2213-2600(15)00428-2; Stang P, 2000, CHEST, V117, p354S, DOI 10.1378/chest.117.5_suppl_2.354S; U S GAO, 2020, US GAO 2020 CENS; Wheaton AG, 2015, MMWR-MORBID MORTAL W, V64, P289; Willard SD, 2013, UROLOGY, V81, P37, DOI 10.1016/j.urology.2011.04.024; Zhang XY, 2014, AM J EPIDEMIOL, V179, P1025, DOI 10.1093/aje/kwu018	36	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252383	10.1371/journal.pone.0252383	http://dx.doi.org/10.1371/journal.pone.0252383			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106982	Green Published, gold			2022-12-26	WOS:000664642200045
J	Xi, SY; Cai, HP; Lu, JB; Zhang, Y; Yu, YJ; Chen, FR; Huang, QT; Wang, F; Chen, ZP				Xi, Shaoyan; Cai, Haiping; Lu, Jiabin; Zhang, Yu; Yu, Yanjiao; Chen, Furong; Huang, Qitao; Wang, Fang; Chen, Zhongping			The pseudogene PRELID1P6 promotes glioma progression via the hnHNPH1-Akt/mTOR axis	ONCOGENE			English	Article							NONCODING RNA; PROTEINS; CANCER; RECOGNITION; DYSFUNCTION; EXPRESSION; CARCINOMA; APOPTOSIS; UBIQUITIN; PATHWAYS	Research over the past decade has suggested important roles for pseudogenes in glioma. This study aimed to show that pseudogene PRELI domain-containing 1 pseudogene 6 (PRELID1P6) promotes glioma progression. Aberrant expression of genes was screened using The Cancer Genome Atlas database. We found that mRNA level of PRELID1P6 was highly upregulated in glioma and was associated with a shorter survival time. Functional studies showed that the knockdown of PRELID1P6 decreased cell proliferation, sphere formation, and clone formation ability and blocked the cell cycle transition at G0/G1, while overexpression of PRELID1P6 had the opposite effects. Mechanistically, knockdown of PRELID1P6 changed the cellular localization of heterogeneous nuclear ribonucleoprotein H1 (hnRNPH1) from nucleus to cytoplasm, which promoted ubiquitin-mediated degradation of hnRNPH1. RNA-sequence and gene set enrichment analysis suggested that knockdown of PRELID1P6 regulates the apoptosis signaling pathway. Western blotting showed that PRELID1P6 increased TRF2 expression by hnRNPH1-mediated alternative splicing effect and activated the Akt/mTOR pathway. Furthermore, Akt inhibitor MK2206 treatment reversed the oncogenic function of PRELID1P6. PRELID1P6 was also found to be negatively regulated by miR-1825. Our result showed that PRELID1P6 promotes glioma progression through the hnHNPH1-Akt/mTOR pathway. These findings shed new light on the important role of PRELID1P6 as a novel oncogene for glioma.	[Xi, Shaoyan; Lu, Jiabin; Zhang, Yu; Huang, Qitao] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Pathol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China; [Cai, Haiping; Yu, Yanjiao; Chen, Furong; Chen, Zhongping] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Neurosurg Neurooncol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China; [Wang, Fang] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Mol Diagnost, Canc Ctr, Guangzhou, Peoples R China	State Key Lab Oncology South China; Sun Yat Sen University; State Key Lab Oncology South China; Sun Yat Sen University; Sun Yat Sen University	Chen, ZP (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Neurosurg Neurooncol, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China.; Wang, F (corresponding author), Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Dept Mol Diagnost, Canc Ctr, Guangzhou, Peoples R China.	wangfang@sysucc.org.cn; chenzhp@sysucc.org.cn	wang, fang/GYD-4295-2022	chen, zhongping/0000-0002-6226-5771	National Natural Science Foundation of China (NSFC) [81902536]; Medical Scientific Research Foundation of Guangdong Province of China [20181030153136778]; Fundamental Research Funds for the Central Universities [20ykpy173, 17ykpy84]; National Basic Research Program of China (973) [2015CB755505]; NSFC [81872059]; National High Technology Research and Development Program of China (863) [2012AA02A508]; Guangzhou Science, Technology and Innovation Project [201508020125]; Science and Technology Planning Project [2016A020213004]; Natural Science Foundation of Guangdong Province [S2013040012894]; Guangdong Natural Science Foundation [2017A030310192]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Foundation of Guangdong Province of China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Basic Research Program of China (973)(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China (863)(National High Technology Research and Development Program of China); Guangzhou Science, Technology and Innovation Project; Science and Technology Planning Project; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	The study was approved by the Ethics Committee of Sun Yat-sen University Cancer Center with a no. of GZR2019-053. The authors thank Qi Zhao for the work of bioinformatics. This study was supported by grants from National Natural Science Foundation of China (NSFC; 81902536) and Medical Scientific Research Foundation of Guangdong Province of China (20181030153136778) and Fundamental Research Funds for the Central Universities (20ykpy173) to SX; National Basic Research Program of China (973; 2015CB755505), NSFC (81872059), the National High Technology Research and Development Program of China (863; 2012AA02A508), Guangzhou Science, Technology and Innovation Project (201508020125), Science and Technology Planning Project (2016A020213004) and Natural Science Foundation of Guangdong Province (S2013040012894) to ZC; and Guangdong Natural Science Foundation (2017A030310192) and the Fundamental Research Funds for the Central Universities (17ykpy84) for FW.	Aboudehen K, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2019.194449; Barth RF, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0280-5; Bracken CP, 2016, NAT REV GENET, V17, P719, DOI 10.1038/nrg.2016.134; Chen CL, 2015, BIOMATERIALS, V44, P71, DOI 10.1016/j.biomaterials.2014.12.023; Chen X, 2012, TRENDS BIOCHEM SCI, V37, P457, DOI 10.1016/j.tibs.2012.08.005; Chen X, 2020, THERANOSTICS, V10, P1479, DOI 10.7150/thno.40659; da Silva MR, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/150514; Deng JM, 2016, MOL NEUROBIOL, V53, P1132, DOI 10.1007/s12035-014-9080-3; Edwards LA, 2005, ONCOGENE, V24, P3596, DOI 10.1038/sj.onc.1208427; Gautrey H, 2015, RNA BIOL, V12, P1139, DOI 10.1080/15476286.2015.1076610; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Grammatikakis I, 2016, CELL CYCLE, V15, P3026, DOI 10.1080/15384101.2016.1222339; Grammatikakis I, 2016, CELL REP, V15, P926, DOI 10.1016/j.celrep.2016.03.080; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Hu XL, 2018, CANCERS, V10, DOI 10.3390/cancers10080256; JACQ C, 1977, CELL, V12, P109, DOI 10.1016/0092-8674(77)90189-1; Karreth FA, 2015, CELL, V161, P319, DOI 10.1016/j.cell.2015.02.043; Kedzierska H, 2017, CANCER LETT, V396, P53, DOI 10.1016/j.canlet.2017.03.013; Kerscher O, 2006, ANNU REV CELL DEV BI, V22, P159, DOI 10.1146/annurev.cellbio.22.010605.093503; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Li XM, 2016, ONCOTARGET, V7, P33440, DOI [10.18632/oncotarget.7961, 10.18632/oncotarget.6497]; Lian YF, 2018, CANCER COMMUN, V38, DOI 10.1186/s40880-018-0333-9; Lu XJ, 2015, J MED GENET, V52, P17, DOI 10.1136/jmedgenet-2014-102785; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Ostrom QT, 2018, NEURO-ONCOLOGY, V20, P1, DOI 10.1093/neuonc/noy131; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rynkeviciene R, 2019, CANCERS, V11, DOI 10.3390/cancers11010017; Sarkar S, 2013, BIOCHEM SOC T, V41, P1103, DOI 10.1042/BST20130134; Shan K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.145; Shan YJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0759-7; Shen D, 2015, ONCOL REP, V34, P2715, DOI 10.3892/or.2015.4232; Sizoo EM, 2010, NEURO-ONCOLOGY, V12, P1162, DOI 10.1093/neuonc/nop045; Wang F, 2018, ORL J OTO-RHINO-LARY, V80, P227, DOI 10.1159/000489461; Wang L, 2013, CARCINOGENESIS, V34, P1773, DOI 10.1093/carcin/bgt139; Werner C, 2008, J AM COLL CARDIOL, V52, P470, DOI 10.1016/j.jacc.2008.04.034; Xing WL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317705339; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Xu WL, 2017, ONCOTARGET, V8, P51758, DOI 10.18632/oncotarget.17401; Yang N, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.358; Zhang YQ, 2018, MOL MED REP, V18, P4239, DOI 10.3892/mmr.2018.9491	43	7	7	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2021	40	26					4453	4467		10.1038/s41388-021-01854-x	http://dx.doi.org/10.1038/s41388-021-01854-x		JUN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TC8LA	34108621	hybrid, Green Published			2022-12-26	WOS:000659470200005
J	Busari, LO; Ojurongbe, O; Adeleke, MA; Surakat, OA; Akindele, AA				Busari, Lateef O.; Ojurongbe, Olusola; Adeleke, Monsuru A.; Surakat, Olabanji A.; Akindele, Akeem A.			Biting behaviour and infectivity of Simulium damnosum complex with Onchocerca parasite in Alabameta, Osun State, Southwestern, Nigeria	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; VOLVULUS INFECTION; SENSU-LATO; TRANSMISSION; PREVALENCE; DIPTERA; RIVER; AREA	A longitudinal study was carried out to investigate species composition, seasonal abundance, parity and transmission potential of Simulium damnosum complex in Alabameta community in Osun State, Southwestern, Nigeria. Adult Simulium damnosum complex were collected along Owena River, Alabameta, by two dark complexioned vector collectors from 07:00hr to 18:00hr weekly using collecting tubes from November 2014 to April 2015. The flies were morphologically identified and dissected for the purpose of detecting Onchocerca parasite using dissecting microscope. The Monthly Biting Rate (MBR) of flies was determined using World Health Organization standard formula. A total of four hundred and forty flies were collected during the study period with all of them identified as forest species of Simulium damnosum complex. There was significant variation in monthly collection of the flies with the month of November having the highest number of flies (194) (44%) while the month of April recorded the lowest number of flies (31) (7%) (p<0.05). The morning biting peak (09hr - 11hr) (137) was higher than the evening biting peak (15hr -17hr) (64) (p<0.05) while nulliparous flies (294) (67%) were more abundant than the parous flies (146) (33%) (p<0.05). There was absence of infection (zero infectivity) of the flies (p<0.05). The zero infectivity in the flies may plausibly indicate the possibility of zero transmission of Onchocerca parasite in the community which if sustained over a period of time may signify the possibility of onchocerciasis elimination. Also, the presence of forest species of the flies reduces the risk of resident's intense exposure to blinding savannah strain of onchocerciasis.	[Busari, Lateef O.; Adeleke, Monsuru A.; Surakat, Olabanji A.] Osun State Univ, Dept Zool, Osogbo, Osun State, Nigeria; [Ojurongbe, Olusola; Akindele, Akeem A.] Ladoke Akintola Univ Technol, Dept Med Microbiol & Parasitol, Ogbomosho, Oyo State, Nigeria		Busari, LO (corresponding author), Osun State Univ, Dept Zool, Osogbo, Osun State, Nigeria.	lateef.busari@pgc.uniosun.edu.ng		Busari, Lateef/0000-0002-1600-591X; Adeleke, Monsuru/0000-0001-7447-3220				Adeleke M.A., 2010, ACTA ENTOMOL SINICA, V53, P1319; Adeleke MA, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-93; Adewale B, 1999, West Afr J Med, V18, P257; [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Crosskey RW., 1990, NATURAL HIST BLACK F, P110; Dent A.E., 2011, NELSON TXB PEDIAT; Ekpo U.F., 2011, BIOECOLOGY SIMULIUM; FRYAUFF DJ, 1986, AM J TROP MED HYG, V35, P1218, DOI 10.4269/ajtmh.1986.35.1218; GARMS R, 1973, Z TROPENMED PARASIT, V24, P358; Garms R., 1982, Z ANGEW ZOOLOGIE, V69, P219; Ibeh OO, 2006, AFR J BIOTECHNOL, V5, P1813; KATHOLI CR, 1995, J INFECT DIS, V172, P1414, DOI 10.1093/infdis/172.5.1414; KURTAK DC, 1981, T ROY SOC TROP MED H, V75, P126, DOI 10.1016/0035-9203(81)90034-1; Mafiana C. F, 1988, THESIS U BENIN; Mafuyai HB, 1996, TROP MED INT HEALTH, V1, P779; Ojurongbe O, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003633; Okolo CG., 2004, NIG J ENT, V21, P84; Opara KN, 2005, AM J TROP MED HYG, V73, P371, DOI 10.4269/ajtmh.2005.73.371; Opara KN., 2008, J VECTOR DIS, V45, P225; Opoku A.A., 2006, W AFRICA J APPL ECOL, VVolume 9; Oyibo W A, 2003, Rural Remote Health, V3, P211; Rodriguez-Perez MA, 1999, PARASITOLOGY, V119, P613, DOI 10.1017/S0031182099005107; Sam-Wobo SO, 2013, INT J TROP INSECT SC, V33, P2, DOI 10.1017/S1742758412000434; Toe L, 1997, LANCET, V349, P163, DOI 10.1016/S0140-6736(96)05265-8; Usip LPE, 2006, MEM I OSWALDO CRUZ, V101, P201, DOI 10.1590/S0074-02762006000200012; WILSON MD, 1993, ANN TROP MED PARASIT, V87, P65, DOI 10.1080/00034983.1993.11812739; World Health Organization, 1976, TECH REP SER; World Health Organization, 1975, WHO TECHN REP SER, V597; World Health Organization, 1995, TECHN REP SER, V852; Yameogo L, 1999, AM J TROP MED HYG, V60, P124, DOI 10.4269/ajtmh.1999.60.124	30	1	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252652	10.1371/journal.pone.0252652	http://dx.doi.org/10.1371/journal.pone.0252652			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086811	gold, Green Published			2022-12-26	WOS:000664640100103
J	Dill, V; Pfaff, F; Zimmer, A; Beer, M; Eschbaumer, M				Dill, Veronika; Pfaff, Florian; Zimmer, Aline; Beer, Martin; Eschbaumer, Michael			Adherent and suspension baby hamster kidney cells have a different cytoskeleton and surface receptor repertoire	PLOS ONE			English	Article							MOUTH-DISEASE VIRUS; BHK CELLS; INTEGRIN; ADAPTATION; CULTURE; PROTEIN; BINDING; GROWTH; LINE	Animal cell culture, with single cells growing in suspension, ideally in a chemically defined environment, is a mainstay of biopharmaceutical production. The synthetic environment lacks exogenous growth factors and usually requires a time-consuming adaptation process to select cell clones that proliferate in suspension to high cell numbers. The molecular mechanisms that facilitate the adaptation and that take place inside the cell are largely unknown. Especially for cell lines that are used for virus antigen production such as baby hamster kidney (BHK) cells, the restriction of virus growth through the evolution of undesired cell characteristics is highly unwanted. The comparison between adherently growing BHK cells and suspension cells with different susceptibility to foot-and-mouth disease virus revealed differences in the expression of cellular receptors such as integrins and heparan sulfates, and in the organization of the actin cytoskeleton. Transcriptome analyses and growth kinetics demonstrated the diversity of BHK cell lines and confirmed the importance of well-characterized parental cell clones and mindful screening to make sure that essential cellular features do not get lost during adaptation.	[Dill, Veronika; Pfaff, Florian; Beer, Martin; Eschbaumer, Michael] Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Insel Riems, Germany; [Zimmer, Aline] Merck KGaA, Upstream R&D, Merck Life Sci, Darmstadt, Germany	Friedrich Loeffler Institute; Merck KGaA	Eschbaumer, M (corresponding author), Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Insel Riems, Germany.	michael.eschbaumer@fli.de		Zimmer, Aline/0000-0003-0279-4863; Eschbaumer, Michael/0000-0002-1104-0695; Pfaff, Florian/0000-0003-0178-6183				Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; Basiouni S., 2012, BIOTECHNIQUES, V53, P1, DOI DOI 10.2144/000113914; BEDOWS E, 1983, MOL CELL BIOL, V3, P712, DOI 10.1128/MCB.3.4.712; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; BOLWELL C, 1989, J GEN VIROL, V70, P45, DOI 10.1099/0022-1317-70-1-45; Carrillo C, 2005, J VIROL, V79, P6487, DOI 10.1128/JVI.79.10.6487-6504.2005; CLARKE JB, 1980, ARCH VIROL, V63, P1, DOI 10.1007/BF01320756; CLARKE JB, 1983, VET MICROBIOL, V8, P259, DOI 10.1016/0378-1135(83)90078-0; Costa AR, 2013, NEW BIOTECHNOL, V30, P563, DOI 10.1016/j.nbt.2012.12.002; Cruz HJ, 1998, CYTOTECHNOLOGY, V26, P59, DOI 10.1023/A:1007951813755; Dill V, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9080231; Dingermann Theo, 2008, Biotechnology Journal, V3, P90, DOI 10.1002/biot.200700214; Genzel Y, 2006, VACCINE, V24, P3261, DOI 10.1016/j.vaccine.2006.01.019; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; GUSKEY LE, 1975, APPL MICROBIOL, V30, P433, DOI 10.1128/AEM.30.3.433-438.1975; Han SC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19294; Hernandez Raquel, 2010, Curr Protoc Microbiol, VChapter 4, p4H, DOI 10.1002/9780471729259.mca04hs17; Jackson T, 2004, J VIROL, V78, P4533, DOI 10.1128/JVI.78.9.4533-4540.2004; Jackson T, 2002, J VIROL, V76, P935, DOI 10.1128/JVI.76.3.935-941.2002; Jackson T, 1997, J VIROL, V71, P8357, DOI 10.1128/JVI.71.11.8357-8361.1997; Jackson T, 1996, J VIROL, V70, P5282, DOI 10.1128/JVI.70.8.5282-5287.1996; Jackson T, 2000, J VIROL, V74, P4949, DOI 10.1128/JVI.74.11.4949-4956.2000; Kluge S, 2015, VACCINE, V33, P4269, DOI 10.1016/j.vaccine.2015.02.077; Kumar CC, 1998, ONCOGENE, V17, P1365, DOI 10.1038/sj.onc.1202172; Lawrence P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MACPHERSON I, 1962, VIROLOGY, V16, P147, DOI 10.1016/0042-6822(62)90290-8; Malm M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76137-8; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Merten O W, 2002, Dev Biol (Basel), V111, P233; Merten OW, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0040; O'Donnell V, 2009, J COMP PATHOL, V141, P98, DOI 10.1016/j.jcpa.2008.09.008; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Rourou S, 2007, VACCINE, V25, P3879, DOI 10.1016/j.vaccine.2007.01.086; SaCarvalho D, 1997, J VIROL, V71, P5115, DOI 10.1128/JVI.71.7.5115-5123.1997; Srivastava A, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02151-8; Stewart PL, 2007, TRENDS MICROBIOL, V15, P500, DOI 10.1016/j.tim.2007.10.001; Syusyukin A.A., 1976, VETERINARIYA MOSCOW, V51, P46; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walther CG, 2016, APPL BIOCHEM BIOTECH, V178, P1286, DOI 10.1007/s12010-015-1945-z; Wiesner S, 2005, CELL MOL LIFE SCI, V62, P1081, DOI 10.1007/s00018-005-4522-8; Zhao L, 2017, BIOTECHNOL BIOENG, V114, P1583, DOI 10.1002/bit.26272; Zhu AQ, 2019, BIOINFORMATICS, V35, P2084, DOI 10.1093/bioinformatics/bty895	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0246610	10.1371/journal.pone.0246610	http://dx.doi.org/10.1371/journal.pone.0246610			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086711	Green Submitted, Green Published, gold			2022-12-26	WOS:000664640100007
J	Hoshiko, H; Feskens, EJM; Oosterink, E; Ariens, RMC; Mes, JJ; de Wit, NJW				Hoshiko, Hiroyuki; Feskens, Edith J. M.; Oosterink, Els; Ariens, Renata M. C.; Mes, Jurriaan J.; de Wit, Nicole J. W.			Identification of leaky gut-related markers as indicators of metabolic health in Dutch adults: The Nutrition Questionnaires plus (NQplus) study	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; LIVER; LBP; ENDOTOXEMIA; MICROBIOTA; PROTEIN; LPS	Background and aim Chronic inflammation is a primary risk factor for chronic metabolic disease and may be triggered by a "leaky gut." Several biomarkers have been recognized to indicate intestinal permeability (i.e., leaky gut) and bacterial translocation. Nonetheless, which of these biomarkers exhibit the highest correlation with metabolic health parameters remains unclear. Hence, this study aimed to explore the correlation between leaky gut-related markers and metabolic health. Methods Based on waist circumference, plasma fasting glucose, plasma gamma-glutamyl transpeptidase (GGT), and plasma LDL cholesterol, two groups of 40 subjects with the most extreme metabolic health profiles were selected from the NQplus cohort study (n = 2048), which was previously conducted by the Wageningen University's Division of Human Nutrition. Eight potential leaky gut-related markers were selected from the literature and measured in serum or EDTA plasma samples of these selected individuals. These samples were also obtained from the NQplus cohort study. Results From the leaky gut markers, levels of zonulin, lipopolysaccharide-binding protein, soluble CD14, bactericidal/permeability-increasing protein, and peptidoglycan were significantly higher in individuals with unhealthy metabolic profiles (p<0.05). No differences in EndoCAb IgM, EndoCAb IgA, and EndoCAb IgG were observed between healthy and unhealthy individuals. Stepwise regression analysis revealed that zonulin was substantially associated with metabolic health parameters such as BMI, blood glucose, triglyceride, GGT, and C-reactive protein levels. C-reactive protein, an inflammation marker, showed the most pronounced association with zonulin. Conclusions Biomarkers that link a leaky gut and subsequent bacterial translocation to metabolic health were identified in this study. Especially zonulin may aid in monitoring a leaky gut and detecting individuals at risk for developing chronic metabolic diseases.	[Hoshiko, Hiroyuki] Suntory MONOZUKURI Expert Ltd, HE Ctr, Kyoto, Japan; [Feskens, Edith J. M.] Wageningen Univ, Human Nutr & Hlth, Wageningen, Netherlands; [Oosterink, Els; Ariens, Renata M. C.; Mes, Jurriaan J.; de Wit, Nicole J. W.] Wageningen Univ Res, Wageningen Food & Biobased Res, Wageningen, Netherlands	Suntory Holdings Ltd; Wageningen University & Research; Wageningen University & Research	Hoshiko, H (corresponding author), Suntory MONOZUKURI Expert Ltd, HE Ctr, Kyoto, Japan.	Hiroyuki_Hoshiko@suntory.co.jp		Hoshiko, Hiroyuki/0000-0002-4449-6808; Ariens, Renata M.C./0000-0001-9846-4257	Suntory Global Innovation Center Ltd.; Suntory Holdings Ltd.; ZonMw [91110030]; Wageningen University	Suntory Global Innovation Center Ltd.; Suntory Holdings Ltd.; ZonMw(Netherlands Organization for Health Research and Development); Wageningen University(European Commission)	This study was supported by Suntory Global Innovation Center Ltd., a company affiliated with Suntory Holdings Ltd. HH is an employee of Suntory MONOZUKURI Expert Ltd. (SME), a company affiliated to Suntory Holdings Ltd. SME financially provides the salary of HH. The specific roles of these authors are articulated in the 'author contributions' section. The funder had no role in study design, data collection, analysis, decision to publish, or manuscript preparation. NQplus study was funded by ZonMw (ZonMw, Grant 91110030) and Wageningen University.	Alexander S, 2004, BLOOD, V103, P93, DOI 10.1182/blood-2003-02-0660; Moreira APB, 2012, BRIT J NUTR, V108, P801, DOI 10.1017/S0007114512001213; Brouwer-Brolsma EM, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-020228; Devaraj S, 2009, CURR OPIN LIPIDOL, V20, P182, DOI 10.1097/MOL.0b013e32832ac03e; Gosiewski T, 2017, EUR J CLIN MICROBIOL, V36, P329, DOI 10.1007/s10096-016-2805-7; Gummesson A, 2011, OBESITY, V19, P2280, DOI 10.1038/oby.2011.251; Hemert S, 2013, ADV MICROBIOL, V3, P212, DOI [DOI 10.4236/AIM.2013.32032, 10.4236/aim.2013.32032]; Ilan Y, 2012, WORLD J GASTROENTERO, V18, P2609, DOI 10.3748/wjg.v18.i21.2609; International Diabetes Federation (IDF), 2006, IDF CONS WORLDW DEF; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Jiang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114589; Kim SJ, 2017, BMB REP, V50, P55, DOI 10.5483/BMBRep.2017.50.2.011; Laugerette F, 2014, MOL NUTR FOOD RES, V58, P1513, DOI 10.1002/mnfr.201400044; Leclercq S, 2012, BRAIN BEHAV IMMUN, V26, P911, DOI 10.1016/j.bbi.2012.04.001; Llorente C, 2015, CELL MOL GASTROENTER, V1, P275, DOI 10.1016/j.jcmgh.2015.04.003; Moreno-Navarrete JM, 2012, INT J OBESITY, V36, P1442, DOI 10.1038/ijo.2011.256; Obika M, 2012, EXP DIABETES RES, DOI 10.1155/2012/145754; Ohlsson B, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030582; Scarpellini E, 2014, REV RECENT CLIN TRIA, V9, P141, DOI 10.2174/1574887109666141216104334; Shen W, 2006, OBESITY, V14, P727, DOI 10.1038/oby.2006.83; Stevens J, 2010, EUR J CLIN NUTR, V64, P6, DOI 10.1038/ejcn.2009.101; Uhde M, 2016, GUT, V65, P1930, DOI 10.1136/gutjnl-2016-311964	22	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252936	10.1371/journal.pone.0252936	http://dx.doi.org/10.1371/journal.pone.0252936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086828	Green Published, gold			2022-12-26	WOS:000664640100155
J	Huang, Y; Mu, RP; Wen, D; Grimsby, JS; Liang, MN; Rosenbaum, AI				Huang, Yue; Mu, Ruipeng; Wen, David; Grimsby, Joseph S.; Liang, Meina; Rosenbaum, Anton I.			Differences in levels of phosphatidylinositols in healthy and stable Coronary Artery Disease subjects revealed by HILIC-MRM method with SERRF normalization	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; HYDROPHILIC INTERACTION; MASS-SPECTROMETRY; PHOSPHOINOSITIDES; LIPIDS; QUANTIFICATION; BIOMARKERS; SEPARATION; PHOSPHOLIPIDS; METABOLISM	Quantification of endogenous biomarkers in clinical studies requires careful evaluation of a number of assay performance parameters. Comparisons of absolute values from several clinical studies can enable retrospective analyses further elucidating the biology of a given biomarker across various study populations. We characterized the performance of a highly multiplex bioanalytical method for quantification of phosphatidylinositols (PI). Hydrophilic interaction chromatography (HILIC) and multiple reaction monitoring (MRM) were employed for targeted multiplex quantification. Odd-chain PI species that are not normally present in human plasma were utilized as surrogate analytes (SA) to assess various assay performance parameters and establish a definitive dynamic linear range for PI lipids. To correct for batch effects, Systematic Error Removal using Random Forest (SERRF) normalization algorithm was employed and used to bridge raw values between two clinical studies, enabling quantitative comparison of their absolute values. A high throughput method was developed, qualified, transferred to an automation platform and applied to sample testing in two clinical trials in healthy volunteers (NCT03001297) and stable Coronary Artery Disease (CAD, NCT03351738) subjects. The method demonstrated acceptable precision and accuracy (+/- 30%) over linear range of 1-1000 nM for SA and 8-fold dilutional linearity for endogenous PI. We determined that mean-adjusted average QC performed best for normalization using SERRF. The comparison of two studies revealed that healthy subject levels of PI are consistently higher across PI species compared to CAD subjects identifying a potential lipid biomarker to be explored in future studies.	[Huang, Yue; Mu, Ruipeng; Wen, David; Liang, Meina; Rosenbaum, Anton I.] AstraZeneca, Clin Pharmacol & Safety Sci, Integrated Bioanal Clin Pharmacol & Quantitat Pha, R&D, San Francisco, CA 94080 USA; [Grimsby, Joseph S.] AstraZeneca, Res & Early Dev, Cardiovasc Renal & Metab CVRM, BioPharmaceut R&D, Gaithersburg, MD USA	AstraZeneca; AstraZeneca	Rosenbaum, AI (corresponding author), AstraZeneca, Clin Pharmacol & Safety Sci, Integrated Bioanal Clin Pharmacol & Quantitat Pha, R&D, San Francisco, CA 94080 USA.	anton.rosenbaum@astrazeneca.com		Rosenbaum, Anton/0000-0003-1939-951X; Huang, Yue/0000-0003-2788-0856; Grimsby, Joseph/0000-0002-0388-1427				Beger RD, 2006, METABOLOMICS, V2, P125, DOI 10.1007/s11306-006-0026-2; Berkecz R, 2018, J PHARMACEUT BIOMED, V149, P308, DOI 10.1016/j.jpba.2017.10.043; Brugger B, 1997, P NATL ACAD SCI USA, V94, P2339, DOI 10.1073/pnas.94.6.2339; Burgess JW, 2005, J LIPID RES, V46, P350, DOI 10.1194/jlr.M400438-JLR200; Cai XM, 2016, SCI REP-UK, V6, DOI 10.1038/srep36490; (CHMP) CfMPfHU, 2011, GUIDELINE BIOANALYTI; Cifkova E, 2016, J CHROMATOGR A, V1439, P65, DOI 10.1016/j.chroma.2016.01.064; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Fan SL, 2019, ANAL CHEM, V91, P3590, DOI 10.1021/acs.analchem.8b05592; Food Drug Administration CfDEaRC Center for Veterinary Medicine (CVM), 2018, BIOAN METH VAL GUID; Granafei S, 2016, J CHROMATOGR A, V1477, P47, DOI 10.1016/j.chroma.2016.11.048; Grimsby J., 2019, ABSTRACT 14373 EFFEC, V140; Hartmann T, 2014, J ALZHEIMERS DIS, V41, P715, DOI 10.3233/JAD-141137; Hodge AM, 2007, NUTR METAB CARDIOVAS, V17, P415, DOI 10.1016/j.numecd.2006.04.005; Irino Y, 2012, J LIPID RES, V53, P810, DOI 10.1194/jlr.D019547; Khaw KT, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001255; Kielkowska Anna, 2014, Advances in Biological Regulation, V54, P131, DOI 10.1016/j.jbior.2013.09.001; Koivusalo M, 2001, J LIPID RES, V42, P663; Kontush A, 2013, J LIPID RES, V54, P2950, DOI 10.1194/jlr.R036095; Lazar DF, 2006, NAT REV DRUG DISCOV, V5, P333, DOI 10.1038/nrd2007; Le Lay JE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abb0602; Lofgren L, 2012, J LIPID RES, V53, P1690, DOI 10.1194/jlr.D023036; Ma DWL, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.27; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; Pastural E, 2009, PROSTAG LEUKOTR ESS, V81, P253, DOI 10.1016/j.plefa.2009.06.003; Pettitt TR, 2006, J LIPID RES, V47, P1588, DOI 10.1194/jlr.D600004-JLR200; PHILLIPS GB, 1967, J LIPID RES, V8, P676; Reis A, 2013, J LIPID RES, V54, P1812, DOI 10.1194/jlr.M034330; Ruff CT., 2019, ABSTRACT 12342 LE S1, V140; Sandra K, 2010, J CHROMATOGR A, V1217, P4087, DOI 10.1016/j.chroma.2010.02.039; Schwalbe-Herrmann M, 2010, J CHROMATOGR A, V1217, P5179, DOI 10.1016/j.chroma.2010.05.014; Silversand C, 1997, J CHROMATOGR B, V703, P7, DOI 10.1016/S0378-4347(97)00385-X; Steffen BT, 2012, EUR J CLIN NUTR, V66, P600, DOI 10.1038/ejcn.2011.215; Tiemeier H, 2003, AM J CLIN NUTR, V78, P40, DOI 10.1093/ajcn/78.1.40; Vicinanza M, 2008, EMBO J, V27, P2457, DOI 10.1038/emboj.2008.169; Wang C, 2005, ANAL CHEM, V77, P4108, DOI 10.1021/ac0481001; Wurtman R, 2015, METABOLISM, V64, pS47, DOI 10.1016/j.metabol.2014.10.034; Zahradnickova H, 2014, J SEP SCI, V37, P2062, DOI 10.1002/jssc.201400113; Zheng JS, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0968-4; Zhou XC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048889	40	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252426	10.1371/journal.pone.0252426	http://dx.doi.org/10.1371/journal.pone.0252426			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086718	gold, Green Published			2022-12-26	WOS:000664640100062
J	Lightner, JS; Rajabiun, S; Cabral, HJ; Flaherty, J; Shank, J; Brooks, R				Lightner, Joseph S.; Rajabiun, Serena; Cabral, Howard J.; Flaherty, Jessica; Shank, Jamie; Brooks, Ronald			Associations of internalized and anticipated HIV stigma with returning to work for persons living with HIV	PLOS ONE			English	Article							BARRIERS; EMPLOYMENT	Introduction Employment is particularly beneficial for persons living with HIV (PLWH). However, PLWH experiencing internalized stigma or anticipating that they may experience stigma may be less likely to seek employment due to additional barriers associated with HIV. The purpose of this study was to understand the associations between internalized and anticipated stigma and employment barriers for PLWH. Methods Participants (N = 712) from 12 sites across the United States were recruited and interviewed about barriers to employment, HIV stigma, and several other factors related to health. A series of unadjusted and adjusted linear regression models were conducted using cross-sectional data. Results Adjusted models suggest that greater anticipated stigma was related to increased employment barriers (beta = 0.12, p = 0.04). Mental and physical health functioning also positively predicted employment barriers (beta = -0.18, p <0.001; <beta> = -0.40, p <0.001, respectively). Discussion Employment among PLWH has beneficial impacts on HIV-related health outcomes. This study suggests that anticipated stigma may limit and individual's willingness to seek out employment, or may cause them to leave employment. Internalized stigma may not play as large of a role in employment as anticipated stigma for PLWH. HIV-related stigma reduction interventions focused on community-level and employers are essential to improve employment opportunities for PLWH.	[Lightner, Joseph S.] Univ Missouri, Sch Nursing & Hlth Studies, Kansas City, MO 64110 USA; [Lightner, Joseph S.; Shank, Jamie] Kansas City Hlth Dept, HIV Serv, Kansas City, MO 64108 USA; [Rajabiun, Serena] Univ Massachusetts, Dept Publ Hlth, Zuckerberg Coll Hlth Sci, Lowell, MA USA; [Cabral, Howard J.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Flaherty, Jessica] Boston Univ, Sch Social Work, Boston, MA 02215 USA; [Brooks, Ronald] Univ Calif Los Angeles, Ctr HIV Identificat Prevent & Treatment Serv, Los Angeles, CA USA	University of Missouri System; University of Missouri Kansas City; University of Massachusetts System; University of Massachusetts Lowell; Boston University; Boston University; University of California System; University of California Los Angeles	Lightner, JS (corresponding author), Univ Missouri, Sch Nursing & Hlth Studies, Kansas City, MO 64110 USA.; Lightner, JS (corresponding author), Kansas City Hlth Dept, HIV Serv, Kansas City, MO 64108 USA.	Lightnerj@umkc.edu		Lightner, Joseph/0000-0002-8536-0085	Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) [H89HA00028, U90HA31449]	Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS)	This project was supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant numbers H89HA00028 and U90HA31449, Special Projects of National Significance (SPNS) Initiative, Improving Health Outcomes through the Coordination of Supportive Employment & Housing Services, awarded to the City of Kansas City, MO and Boston University, respectively. No percentage of this project was financed with non-governmental sources. This information or content and conclusions are those of the authors and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.	Ali R, 2002, ADDICTION, V97, P1183; [Anonymous], SPSS STAT WIND VERS; Blalock AC, 2002, PSYCHOSOMATICS, V43, P400, DOI 10.1176/appi.psy.43.5.400; Blumberg SJ, 1999, AM J PUBLIC HEALTH, V89, P1231, DOI 10.2105/AJPH.89.8.1231; Brooks RA, 2004, AIDS CARE, V16, P756, DOI 10.1080/09540120412331269594; Centers for Disease Control and Prevention, 2020, BEH CLIN CHAR PERS D; Coduti WA, 2018, WORK, V61, P225, DOI 10.3233/WOR-182794; Dabaghzadeh Fatemeh, 2015, Iran J Psychiatry, V10, P185; Denning P., 2019, COMMUNITIES CRISIS I; Denning Paul H., 2011, Morbidity and Mortality Weekly Report, V60, P1045; Earnshaw VA, 2013, AIDS BEHAV, V17, P1785, DOI 10.1007/s10461-013-0437-9; Gueler A, 2017, AIDS, V31, P427, DOI 10.1097/QAD.0000000000001335; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; HIV/AIDS Bureau, 2017, IMPR HIV HLTH OUTC C; Kazis LE, 2006, J AMBUL CARE MANAG, V29, P310, DOI 10.1097/00004479-200610000-00007; Kucukalic S, 2017, PSYCHIAT DANUB, V29, pS895; Lazar M, 2018, J COMMUN HEALTH NURS, V35, P28, DOI 10.1080/07370016.2018.1404832; Liu Y, 2012, AIDS CARE, V24, P129, DOI 10.1080/09540121.2011.596512; Maulsby CH, 2020, AIDS BEHAV, V24, P2942, DOI 10.1007/s10461-020-02845-x; National Institute for Drug Abuse, DAT HARM SEEK TEST T; Nunnally J., 1978, PSYCHOMETRIC THEORY; Pellowski JA, 2013, AM PSYCHOL, V68, P197, DOI 10.1037/a0032694; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Rice WS, 2017, JAIDS-J ACQ IMM DEF, V76, P482, DOI [10.1097/qai.0000000000001543, 10.1097/QAI.0000000000001543]; Rodger AJ, 2010, OCCUP MED-OXFORD, V60, P423, DOI 10.1093/occmed/kqq077; Schnur Schnurr P., BRIEF TRAUMA QUESTIO; Sweeney SM, 2016, AIDS BEHAV, V20, P29, DOI 10.1007/s10461-015-1164-1; Turan B, 2017, AIDS BEHAV, V21, P283, DOI 10.1007/s10461-016-1451-5; U.S. Department of Health and Human Services, 2020, HIV NAT STRAT PLAN U; Waddell G., 2006, IS WORK GOOD YOUR HL	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252783	10.1371/journal.pone.0252783	http://dx.doi.org/10.1371/journal.pone.0252783			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086826	gold, Green Published			2022-12-26	WOS:000664640100131
J	Teixeira, GCM; Prado, RD; Oliveira, KS; Buchelt, AC; Rocha, AMS; Santos, MD				Marques Teixeira, Gelza Carliane; Prado, Renato de Mello; Oliveira, Kamilla Silva; Buchelt, Antonio Carlos; Souza Rocha, Antonio Marcio; Santos, Michelle de Souza			Nutritional deficiency in scarlet eggplant limits its growth by modifying the absorption and use efficiency of macronutrients	PLOS ONE			English	Article							PLANTS; RESPONSES; SULFUR	The intensity damages caused by nutritional deficiency in growing plants can vary with nutrients. The effects caused by nutrient omission in the plant nutritional efficiency in relation to the absorption and use of the missing nutrient, and the reasons why these damages reflect in other nutrients have not yet been reported in the culture of scarlet eggplant. A better understanding of the nutritional mechanisms involved may clarify why certain nutrients cause greater limitations than other during plants growth. Thus, this study was designed with the aim of evaluating the damages caused by macronutrients deficiency in the culture of scarlet eggplant in the accumulation of these nutrients, nutritional deficiency, plants growth and in visual symptoms. The experiment was carried out in a controlled environment where plants were cultivated in a hydroponic system. Treatments consisted of supplying a complete Hoagland and Arnon solution (CS), and other nutrient solutions with individual omissions of nitrogen (-N), phosphorus (-P), potassium (-K), calcium (-Ca), magnesium (-Mg) and sulphur (-S). When a nutrient deficiency arose, nutritional analyses, growth and visual symptoms were analyzed. The omissions of N, S and K in the nutrient solution resulted in lower accumulation of all macronutrients in both the above and below ground biomass. Individual omissions resulted in nutritional imbalances with reflexes in the absorption efficiencies and use of the missing nutrient, as well as of other nutrients, revealing that the metabolism involves multiple nutritional interactions. Losses of nutritional efficiencies of macronutrients caused detrimental effects on plants growth, with reduced height, stem diameter, number of leaves, leaf area, and biomass production in above ground and below ground. From the losses in production in above ground biomass, the order of macronutrients limitation was N, S, K, Ca, Mg, and P, with reductions of 99, 96, 94, 76, 51 and 46%, respectively, in comparison to plants cultivated in CS. The most limiting nutrients were N, S, and K, seen that its deficiencies affected the metabolism of all other nutrients. This study demonstrates the importance of an adequate nutritional management of N, S, and K in the cultivation of scarlet eggplant.	[Marques Teixeira, Gelza Carliane; Prado, Renato de Mello; Oliveira, Kamilla Silva; Santos, Michelle de Souza] Sao Paulo State Univ UNESP, Dept Agr Sci, Jaboticabal, SP, Brazil; [Buchelt, Antonio Carlos] Mato Grosso State Univ UNEMAT, Dept Agron, Alta Floresta, MG, Brazil; [Souza Rocha, Antonio Marcio] Sao Paulo State Univ UNESP, Dept Technol, Jaboticabal, SP, Brazil	Universidade Estadual Paulista; Universidade do Estado de Mato Grosso; Universidade Estadual Paulista	Teixeira, GCM (corresponding author), Sao Paulo State Univ UNESP, Dept Agr Sci, Jaboticabal, SP, Brazil.	gelzacarliane@hotmail.com	Teixeira, Gelza Carliane Marques/ABG-9313-2020; Oliveira, Kamilla Silva/AAR-4496-2021	Teixeira, Gelza Carliane Marques/0000-0002-8062-482X; Oliveira, Kamilla Silva/0000-0002-8715-2685; de Souza Santos, Michelle/0000-0002-1687-1236	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) (Authors benefited GCMT and RMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bataglia OC., 1983, METODOS ANALISE QU; Beshir H. M., 2015, African Journal of Agricultural Research, V10, P3157; Bianco MS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123500; Cakmak I., 2010, Better Crops with Plant Food, V94, P23; Campos CNS, 2021, J PLANT NUTR, V44, P2609, DOI 10.1080/01904167.2021.1921205; Cavalcante VS, 2019, HORTSCIENCE, V54, P738, DOI 10.21273/HORTSCI13807-18; CONROY JP, 1986, PLANT PHYSIOL, V81, P423, DOI 10.1104/pp.81.2.423; de Bang TC, 2021, NEW PHYTOL, V229, P2446, DOI 10.1111/nph.17074; Osorio CRWD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234512; Fageria NK, 2005, ADV AGRON, V88, P97, DOI 10.1016/S0065-2113(05)88004-6; FAGERIA NK, 1983, PLANT SOIL, V70, P309, DOI 10.1007/BF02374887; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; Guo WL, 2017, PLANT MACRONUTRIENT USE EFFICIENCY: MOLECULAR AND GENOMIC PERSPECTIVES IN CROP PLANTS, P197, DOI 10.1016/B978-0-12-811308-0.00011-9; Haag HP., 1978, ESC SUPER AGR LUIZ Q, V25, P327; Hawkesford M., 2011, MARSCHNERS MINERAL N, VThird, P135, DOI [10.1016/B978-0-12-384905-2.00006%26%23x2013%3B6, DOI 10.1016/B978-0-12-384905-2.00006%26%23X2013%3B6]; Hepler PK, 2010, J INTEGR PLANT BIOL, V52, P147, DOI 10.1111/j.1744-7909.2010.00923.x; Hermans C, 2006, TRENDS PLANT SCI, V11, P610, DOI 10.1016/j.tplants.2006.10.007; Hoagland D.R., 1950, 347 CAL AGR EXP STAT; IBGE, 2018, CENS AGR; Imsande J, 1998, PHYSIOL PLANTARUM, V103, P139, DOI 10.1034/j.1399-3054.1998.1030117.x; Kellermeier F, 2014, PLANT CELL, V26, P1480, DOI 10.1105/tpc.113.122101; Miamoto JDM, 2020, J APPL RES MED AROMA, V16, DOI 10.1016/j.jarmap.2019.100238; Mak M, 2014, ENVIRON EXP BOT, V98, P1, DOI 10.1016/j.envexpbot.2013.10.003; Prado R de M., 2020, NUTRICAO PLANTAS; Ragel P, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00281; Reich M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00541; Rietra RPJJ, 2017, COMMUN SOIL SCI PLAN, V48, P1895, DOI 10.1080/00103624.2017.1407429; Salim BBM, 2019, ANN AGR SCI-CAIRO, V64, P244, DOI 10.1016/j.aoas.2019.12.008; Santos KR, 2015, AQUAT BOT, V122, P47, DOI 10.1016/j.aquabot.2015.01.007; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; Teixeira GCM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240847; Verbruggen N, 2013, PLANT SOIL, V368, P87, DOI 10.1007/s11104-013-1589-0; Xie KL, 2021, CROP J, V9, P249, DOI 10.1016/j.cj.2020.10.005; Yuan LX, 2007, PLANT CELL, V19, P2636, DOI 10.1105/tpc.107.052134; Zhang XC, 2013, PHOTOSYNTHETICA, V51, P593, DOI 10.1007/s11099-013-0059-5	36	0	0	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252866	10.1371/journal.pone.0252866	http://dx.doi.org/10.1371/journal.pone.0252866			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086839	gold, Green Published			2022-12-26	WOS:000664640100150
J	Melki, J; Tamim, H; Hadid, D; Makki, M; El Amine, J; Hitti, E				Melki, Jad; Tamim, Hani; Hadid, Dima; Makki, Maha; El Amine, Jana; Hitti, Eveline			Mitigating infodemics: The relationship between news exposure and trust and belief in COVID-19 fake news and social media spreading	PLOS ONE			English	Article							SELECTIVE EXPOSURE; PUBLIC-HEALTH; GENDER-GAP; INFLUENZA; LITERACY; COMMUNICATION; CRISIS; INTERVENTIONS; CREDIBILITY; INFORMATION	Introduction Misinformation surrounding COVID-19 poses a global public health problem that adversely affects governments' abilities to mitigate the disease and causes accidental deaths and self-harm due to false beliefs about the virus, prevention measures, vaccines and cures. We aim to examine the relationship between exposure to and trust in COVID-19 news (from Television, social media, interpersonal communication) and information sources (healthcare experts, government, clerics) and belief in COVID-19 myths and false information, as well as critical verification practices before posting on social media. Methods We use a cross-sectional researcher-administered phone survey of adults living in Lebanon between March 27 and April 23, 2020. Results The sample included 56.1% men and 43.9% women, 37.9% with a university degree, 63.0% older than 30, and 7% with media literacy training. Those who trust COVID-19 news from social media [95%CI:(1.05-1.52)] and interpersonal communication [95%CI:(1.25-1.82)], and those who trust information from clerics [95%CI:(1.25-1.82)] were more likely to believe in COVID-19 myths and false information. University graduates [95%CI:(0.25-0.51)] and those who trust information from government [95%CI:(0.65-0.89] were less likely to believe in myths and false information. Those who believe in COVID-19 myths and false information [95%CI:(0.25-0.70)] were less likely to engage in critical social media posting practices. Only those who underwent media literacy training [95%CI:(1.24-6.55)] were more likely to engage in critical social media posting practices. Conclusion Higher education and trust in information from government contributed to decreasing belief in COVID-19 myths and false information. Trust in news from social media, interpersonal communication and clerics contributed to increasing belief in COVID-19 myths and false information, which in turn contributed to less critical social media posting practices, thereby exacerbated the infodemic. Media literacy training contributed to increasing critical social media posting practices, thereby played a role in mitigating the infodemic.	[Melki, Jad; El Amine, Jana] Lebanese Amer Univ, Inst Media Res & Training, Dept Commun Arts, Beirut, Lebanon; [Tamim, Hani; Makki, Maha] Amer Univ Beirut, Med Ctr, Dept Internal Med, Beirut, Lebanon; [Hadid, Dima; Hitti, Eveline] Amer Univ Beirut, Med Ctr, Dept Emergency Med, Beirut, Lebanon	Lebanese American University; American University of Beirut; American University of Beirut	Hitti, E (corresponding author), Amer Univ Beirut, Med Ctr, Dept Emergency Med, Beirut, Lebanon.	eh16@aub.edu.lb			German Academic Exchange Service (DAAD) through the Arab-European Association for Media and Communication Researchers (AREACORE)	German Academic Exchange Service (DAAD) through the Arab-European Association for Media and Communication Researchers (AREACORE)(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported in part by the German Academic Exchange Service (DAAD) through the Arab-European Association for Media and Communication Researchers (AREACORE). The funding source had no involvement in the study. There was no additional external funding received for this study.	Abbasi M-A, 2013, INT C SOC COMP BEH C; Anhang R, 2004, CANCER-AM CANCER SOC, V100, P308, DOI 10.1002/cncr.20006; [Anonymous], 2020, LETS FLATT INF CURV; [Anonymous], 2020, IMM PUBL MIS; [Anonymous], 2021, THE ECONOMIST 0417; Baltes MM, 1996, HEALTH COMMUN, V8, P217, DOI 10.1207/s15327027hc0803_3; Bardus M, 2020, J MED INTERNET RES, V22, DOI 10.2196/15607; Benesch C, 2012, J MEDIA ECON, V25, P147, DOI 10.1080/08997764.2012.700976; Bessi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118093; Boyle J., 2020, CASES INCREASE AM TR; Cropley L, 2004, HEALTH PROMOT INT, V19, P445, DOI 10.1093/heapro/dah406; Davidson AE, 2004, J HEALTH COMMUN, V9, P111, DOI 10.1080/10810730490425268; De Abreu Belinha S., 2017, INT HDB MEDIA LITERA; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Dutton B., 2017, WORLD EC FORUM BLOG; Elledge BL, 2008, HEALTH PROMOT PRACT, V9, p54S, DOI 10.1177/1524839908319089; Evenagea S., 2020, CORNELL ALLIANCE SCI; Festinger L., 1964, CONFLICT DECISION DI; Flaxman S, 2016, PUBLIC OPIN QUART, V80, P298, DOI 10.1093/poq/nfw006; FOLKMAN S, 1980, J HEALTH SOC BEHAV, V21, P219, DOI 10.2307/2136617; Halliwell E, 2011, BRIT J HEALTH PSYCH, V16, P396, DOI 10.1348/135910710X515714; Hart W, 2009, PSYCHOL BULL, V135, P555, DOI 10.1037/a0015701; Irving LM, 2001, PSYCHOL WOMEN QUART, V25, P103, DOI 10.1111/1471-6402.00012; Jeong M, 2018, HEALTH COMMUN, V33, P988, DOI 10.1080/10410236.2017.1331184; Jeong SH, 2012, J COMMUN, V62, DOI 10.1111/j.1460-2466.2012.01643.x; Jhummon-Mahadnac Namrata Devi, 2012, BMC Res Notes, V5, P377, DOI 10.1186/1756-0500-5-377; Johnson TJ, 2013, COMPUT HUM BEHAV, V29, P1862, DOI 10.1016/j.chb.2013.02.011; Keating J, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-313; Khoury P, 2020, JAMA-J AM MED ASSOC, V324, P548, DOI 10.1001/jama.2020.12695; Kim S, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12239904; Knobloch-Westerwick S, 2015, J COMPUT-MEDIAT COMM, V20, P171, DOI 10.1111/jcc4.12105; Knobloch-Westerwick S, 2009, COMMUN RES, V36, P426, DOI 10.1177/0093650209333030; Lazer DMJ, 2018, SCIENCE, V359, P1094, DOI 10.1126/science.aao2998; Liu BF, 2011, PUBLIC RELAT REV, V37, P233, DOI 10.1016/j.pubrev.2011.03.005; Melki J., JOURNAL PRACT, V2020, P1; Melki J., 2020, EUROPEAN JOURNALISM; Melki J, 2021, INT J PRESS/POLIT, V26, P907, DOI 10.1177/1940161220972892; Melki JP., 2013, MEDIA LITERACY ED AC, P77; Messing S, 2014, COMMUN RES, V41, P1042, DOI 10.1177/0093650212466406; Metzger M., 2015, COMMUN RES; Mian A, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01556-3; Mihailidis P, 2008, CYNICISM MEDIA LITER; Nahas M, 2018, COMPUT HUM BEHAV, V87, P348, DOI 10.1016/j.chb.2018.06.009; News U., 2020, NEWS U; Pratt CB, 2002, J COMMUN, V52, P889, DOI 10.1093/joc/52.4.889; Pulido CM, 2020, INT SOCIOL, V35, P377, DOI 10.1177/0268580920914755; Ratzan SC, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp3022010; Reynolds B, 2008, HEALTH PROMOT PRACT, V9, p13S, DOI 10.1177/1524839908325267; Ricard J., 2020, HARVARD KENNEDY SCH; Smith S, 2009, BOSTON GLOBE; Swire B, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.160802; Taha SA, 2013, J HEALTH COMMUN, V18, P278, DOI 10.1080/10810730.2012.727960; Taylor J, 2020, GUARDIAN; Toff B, 2019, JOURNALISM STUD, V20, P1563, DOI 10.1080/1461670X.2018.1528882; Tsfati Y, 2005, MEDIA PSYCHOL, V7, P251, DOI 10.1207/S1532785XMEP0703_2; Vigdor N, 2020, NEW YORK TIMES MAR, P24; Watson Rebecca, 2006, Eat Disord, V14, P385, DOI 10.1080/10640260600952530; Westerwick A, 2013, J COMMUN, V63, P432, DOI 10.1111/jcom.12028; Yates B. L., 1999, J HLTH ED, V30, P180, DOI DOI 10.1080/10556699.1999.10603399; Zhang Ll, 2015, ATL J COMMUN, V23, P67, DOI 10.1080/15456870.2015.1013101; Zimmer F, 2019, 8 ANN ARTS HUM SOC S	62	30	30	11	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252830	10.1371/journal.pone.0252830	http://dx.doi.org/10.1371/journal.pone.0252830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086813	Green Published, gold			2022-12-26	WOS:000664640100144
J	Nakura, Y; Wu, HN; Okamoto, Y; Takeuchi, M; Suzuki, K; Tamura, Y; Oba, Y; Nishiumi, F; Hatori, N; Fujiwara, S; Yasukawa, K; Ida, S; Yanagihara, I				Nakura, Yukiko; Wu, Heng Ning; Okamoto, Yuya; Takeuchi, Muneyuki; Suzuki, Koichiro; Tamura, Yoshitaka; Oba, Yuichiro; Nishiumi, Fumiko; Hatori, Nobuaki; Fujiwara, Shinsuke; Yasukawa, Kiyoshi; Ida, Shinobu; Yanagihara, Itaru			Development of an efficient one-step real-time reverse transcription polymerase chain reaction method for severe acute respiratory syndrome-coronavirus-2 detection	PLOS ONE			English	Article							BACTERIAL FAMILY; DNA-POLYMERASE	The general methods to detect the RNA of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) in clinical diagnostic testing involve reverse transcriptases and thermostable DNA polymerases. In this study, we compared the detection of SARS-CoV-2 by a one-step real-time RT-PCR method using a heat-resistant reverse transcriptase variant MM4 from Moloney murine leukemia virus, two thermostable DNA polymerase variants with reverse transcriptase activity from Thermotoga petrophila K4 and Thermococcus kodakarensis KOD1, or a wild-type DNA polymerase from Thermus thermophilus M1. The highest performance was achieved by combining MM4 with the thermostable DNA polymerase from T. thermophilus M1. These enzymes efficiently amplified specific RNA using uracil-DNA glycosylase (UNG) to remove contamination and human RNase P RNA amplification as an internal control. The standard curve was obtained from 5 to 10(5) copies of synthetic RNA. The one-step real-time RT-PCR method's sensitivity and specificity were 99.44% and 100%, respectively (n = 213), compared to those of a commercially available diagnostic kit. Therefore, our method will be useful for the accurate detection and quantification of SARS-CoV-2.	[Nakura, Yukiko; Wu, Heng Ning; Nishiumi, Fumiko; Yanagihara, Itaru] Osaka Womens & Childrens Hosp, Dept Dev Med, Res Inst, Izumi, Osaka, Japan; [Okamoto, Yuya; Ida, Shinobu; Yanagihara, Itaru] Osaka Womens & Childrens Hosp, Dept Lab Med, Izumi, Osaka, Japan; [Takeuchi, Muneyuki] Osaka Womens & Childrens Hosp, Dept Intens Care Med, Izumi, Osaka, Japan; [Suzuki, Koichiro; Hatori, Nobuaki] Osaka Univ, Res Fdn Microbial Dis, Suita, Osaka, Japan; [Tamura, Yoshitaka] Osaka Habikino Med Ctr, Dept Clin Lab, Habikino, Osaka, Japan; [Oba, Yuichiro] Osaka Gen Med Ctr, Dept Gen Med, Osaka, Osaka, Japan; [Fujiwara, Shinsuke] Kwansei Gakuin Univ, Sch Biol & Environm Sci, Dept Biosci, Sanda City, Hyogo, Japan; [Yasukawa, Kiyoshi] Kyoto Univ, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto, Kyoto, Japan	Osaka University; Kwansei Gakuin University; Kyoto University	Yanagihara, I (corresponding author), Osaka Womens & Childrens Hosp, Dept Dev Med, Res Inst, Izumi, Osaka, Japan.; Yanagihara, I (corresponding author), Osaka Womens & Childrens Hosp, Dept Lab Med, Izumi, Osaka, Japan.	itaruy@wch.opho.jp	Fujiwara, Shinsuke/CAE-9955-2022	Nishiumi, Fumiko/0000-0003-0383-1179	JSPS KAKENHI [JP20H03564]; AMED [JP20fk0108143]; Nakatani Foundation for Advanced of Measuring Technologies in Biomedical Engineering [2018T006]; Research Foundation for Microbial Diseases, Osaka University (BIKEN); Osaka Prefectural Hospital Organization's Research Support Fund; Osaka Prefectural Government	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); AMED; Nakatani Foundation for Advanced of Measuring Technologies in Biomedical Engineering; Research Foundation for Microbial Diseases, Osaka University (BIKEN); Osaka Prefectural Hospital Organization's Research Support Fund; Osaka Prefectural Government	This work was supported by research grants from the JSPS KAKENHI (JP20H03564 to IY), AMED (JP20fk0108143 to IY), Grant Program for Biomedical Engineering Research from Nakatani Foundation for Advanced of Measuring Technologies in Biomedical Engineering (2018T006) (IY, KY, FS), The Research Foundation for Microbial Diseases, Osaka University (BIKEN) 2021 (IY, KY, FS), Osaka Prefectural Hospital Organization's Research Support Fund (IY), and Osaka Prefectural Government for supporting diagnostic equipment for SARS-CoV-2 (IY). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ellefson JW, 2016, SCIENCE, V352, P1590, DOI 10.1126/science.aaf5409; MYERS TW, 1991, BIOCHEMISTRY-US, V30, P7661, DOI 10.1021/bi00245a001; Okano H, 2018, J BIOSCI BIOENG, V125, P275, DOI 10.1016/j.jbiosc.2017.10.004; Sano S, 2012, J BIOSCI BIOENG, V113, P315, DOI 10.1016/j.jbiosc.2011.11.001; Surkova E, 2020, LANCET RESP MED, V8, P1167, DOI 10.1016/S2213-2600(20)30453-7; UDAYKUMAR, 1993, NUCLEIC ACIDS RES, V21, P3917, DOI 10.1093/nar/21.16.3917; Woloshin S, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2015897; Yasukawa K, 2012, BIOCHEM BIOPH RES CO, V427, P654, DOI 10.1016/j.bbrc.2012.09.116; Yasukawa K, 2010, J BIOTECHNOL, V150, P299, DOI 10.1016/j.jbiotec.2010.09.961	9	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252789	10.1371/journal.pone.0252789	http://dx.doi.org/10.1371/journal.pone.0252789			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086827	Green Published, gold			2022-12-26	WOS:000664640100133
J	Dos Santos, GRRM; Leite, ACR; Lander, N; Chiurillo, MA; Vercesi, AE; Docampo, R				Dos Santos, Guilherme Rodrigo R. M.; Rezende Leite, Ana Catarina; Lander, Noelia; Chiurillo, Miguel Angel; Vercesi, Anibal Eugenio; Docampo, Roberto			Trypanosoma cruzi Letm1 is involved in mitochondrial Ca2+ transport, and is essential for replication, differentiation, and host cell invasion	FASEB JOURNAL			English	Article						calcium signaling; cell bioenergetics; Letm1; mitochondria; Trypanosoma cruzi	ESSENTIAL COMPONENT; CA-2+ TRANSPORT; CANDIDATE GENE; PROTEIN; MEMBRANE; TOPOLOGY; BIOENERGETICS; METABOLISM; PREDICTION; AUTOPHAGY	Leucine zipper-EF-hand containing transmembrane protein 1 (Letm1) is a mitochondrial inner membrane protein involved in Ca2+ and K+ homeostasis in mammalian cells. Here, we demonstrate that the Letm1 orthologue of Trypanosoma cruzi, the etiologic agent of Chagas disease, is important for mitochondrial Ca2+ uptake and release. The results show that both mitochondrial Ca2+ influx and efflux are reduced in TcLetm1 knockdown (TcLetm1-KD) cells and increased in TcLetm1 overexpressing cells, without alterations in the mitochondrial membrane potential. Remarkably, TcLetm1 knockdown or overexpression increases or does not affect mitochondrial Ca2+ levels in epimastigotes, respectively. TcLetm1-KD epimastigotes have reduced growth, and both overexpression and knockdown of TcLetm1 cause a defect in metacyclogenesis. TcLetm1-KD also affected mitochondrial bioenergetics. Invasion of host cells by TcLetm1-KD trypomastigotes and their intracellular replication is greatly impaired. Taken together, our findings indicate that TcLetm1 is important for Ca2+ homeostasis and cell viability in T cruzi.	[Dos Santos, Guilherme Rodrigo R. M.; Vercesi, Anibal Eugenio; Docampo, Roberto] Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, Rua Cinco de Junho 350,Cidade Univ, BR-13083877 Campinas, SP, Brazil; [Rezende Leite, Ana Catarina] Univ Fed Alagoas, Inst Quim & Biotecnol, Lab Bioenerget, Maceio, Alagoas, Brazil; [Lander, Noelia; Chiurillo, Miguel Angel; Docampo, Roberto] Univ Georgia, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Docampo, Roberto] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH USA; [Lander, Noelia; Chiurillo, Miguel Angel] Univ Georgia, Dept Cellular Biol, Athens, GA 30602 USA	Universidade Estadual de Campinas; Universidade Federal de Alagoas; University System of Georgia; University of Georgia; University System of Ohio; University of Cincinnati; University System of Georgia; University of Georgia	Vercesi, AE (corresponding author), Univ Estadual Campinas, Fac Ciencias Med, Dept Patol Clin, Rua Cinco de Junho 350,Cidade Univ, BR-13083877 Campinas, SP, Brazil.; Docampo, R (corresponding author), Univ Georgia, Paul D Coverdell Ctr, Dept Cellular Biol, 500 DW Brooks Dr, Athens, GA 30602 USA.; Docampo, R (corresponding author), Univ Georgia, Paul D Coverdell Ctr, Ctr Trop & Emerging Global Dis, 500 DW Brooks Dr, Athens, GA 30602 USA.	anibal@unicamp.br; rdocampo@uga.edu	Leite, Ana C. R./K-8340-2014; dos Santos, Guilherme Rodrigo Reis M/D-8868-2018	Leite, Ana C. R./0000-0002-3426-3357; dos Santos, Guilherme Rodrigo Reis M/0000-0001-8680-869X; Vercesi, Anibal Eugenio/0000-0001-6671-7125; Docampo, Roberto/0000-0003-4229-8784; Lander, Noelia/0000-0003-2178-381X	Sao Paulo Research Foundation (FAPESP) [2013/50624--0, 2018/04559--6]; CNPq [405909/2015--2]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [K99AI137322, AI108222]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Sao Paulo Research Foundation (FAPESP), Grant/Award Number: 2013/50624--0 and 2018/04559--6; CNPq, Grant/Award Number: 405909/2015--2; National Institute of Allergy and Infectious Diseases of the National Institutes of Health, Grant/Award Number: K99AI137322 and AI108222	Alvarez VE, 2008, J BIOL CHEM, V283, P3454, DOI 10.1074/jbc.M708474200; [Anonymous], 2001, BIOENERGETICS; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; Austin S, 2019, TRENDS BIOCHEM SCI, V44, P648, DOI 10.1016/j.tibs.2019.04.002; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; BONE GJ, 1956, NATURE, V178, P308, DOI 10.1038/178308a0; Brennand Ana, 2012, Cells, V1, P346, DOI 10.3390/cells1030346; CARAFOLI E, 1970, BIOCHIM BIOPHYS ACTA, V205, P18, DOI 10.1016/0005-2728(70)90057-5; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chang L, 2019, ACTA BIOCH BIOPH SIN, V51, P78, DOI 10.1093/abbs/gmy138; Chiurillo MA, 2017, MBIO, V8, DOI [10.1128/mBio.00574-17, 10.1128/mbio.00574-17]; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; DOCAMPO R, 1989, J BIOL CHEM, V264, P108; DOCAMPO R, 1989, ARCH BIOCHEM BIOPHYS, V272, P122, DOI 10.1016/0003-9861(89)90202-6; Docampo R, 2012, TRENDS PARASITOL, V28, P31, DOI 10.1016/j.pt.2011.10.007; Doonan PJ, 2014, FASEB J, V28, P4936, DOI 10.1096/fj.14-256453; Endele S, 1999, GENOMICS, V60, P218, DOI 10.1006/geno.1999.5881; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Figueira TR, 2012, METHODS MOL BIOL, V810, P103, DOI 10.1007/978-1-61779-382-0_7; Gao P, 2020, DIABETES, V69, P165, DOI 10.2337/db19-0526; Hasegawa A, 2007, HUM MOL GENET, V16, P2061, DOI 10.1093/hmg/ddm154; Hashimi H, 2013, J BIOL CHEM, V288, P26914, DOI 10.1074/jbc.M113.495119; Huang GZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3865; Jiang DW, 2013, P NATL ACAD SCI USA, V110, pE2249, DOI 10.1073/pnas.1308558110; Jiang DW, 2009, SCIENCE, V326, P144, DOI 10.1126/science.1175145; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lander N, 2019, METHODS MOL BIOL, V1955, P61, DOI 10.1007/978-1-4939-9148-8_5; Lander N, 2018, J BIOL CHEM, V293, P17402, DOI [10.1074/jbc.RA118.004498, 10.1074/jbc.ra118.004498]; Lander N, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2299; Lander N, 2015, MBIO, V6, DOI 10.1128/mBio.01012-15; Lander N, 2013, J BIOL CHEM, V288, P34205, DOI 10.1074/jbc.M113.518993; Lander N, 2010, INFECT IMMUN, V78, P231, DOI 10.1128/IAI.00780-09; Li FJ, 2017, AUTOPHAGY, V13, P715, DOI 10.1080/15548627.2017.1280218; Liu JC, 2016, CELL REP, V16, P1561, DOI 10.1016/j.celrep.2016.07.011; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; McQuibban AG, 2010, HUM MOL GENET, V19, P987, DOI 10.1093/hmg/ddp563; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Nakamura S, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0832-5; Negreiros RS, 2021, MBIO, V12, DOI 10.1128/mBio.00540-21; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Palty R, 2012, J BIOL CHEM, V287, P31650, DOI 10.1074/jbc.R112.355867; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santulli G, 2015, P NATL ACAD SCI USA, V112, P11389, DOI 10.1073/pnas.1513047112; Smaili SS, 2013, CURR MOL MED, V13, P252; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Tang GF, 2018, MOL PLANT PATHOL, V19, P1595, DOI 10.1111/mpp.12633; Tsai MF, 2014, J GEN PHYSIOL, V143, P67, DOI 10.1085/jgp.201311096; Turner JD, 2010, CIRC RES, V106, P730, DOI 10.1161/CIRCRESAHA.109.206631; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; Tusnady GE, 1998, J MOL BIOL, V283, P489, DOI 10.1006/jmbi.1998.2107; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; VERCESI AE, 1992, BIOCHEM J, V284, P463, DOI 10.1042/bj2840463; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041	62	5	5	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21685	10.1096/fj.202100120RR	http://dx.doi.org/10.1096/fj.202100120RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34085343				2022-12-26	WOS:000667814100056
J	Matsumoto, N; Nemoto-Sasaki, Y; Oka, S; Arai, S; Wada, I; Yamashita, A				Matsumoto, Naoki; Nemoto-Sasaki, Yoko; Oka, Saori; Arai, Seisuke; Wada, Ikuo; Yamashita, Atsushi			Phosphorylation of human phospholipase A1 DDHD1 at newly identified phosphosites affects its subcellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SEC23P-INTERACTING PROTEIN; HEREDITARY SPASTIC PARAPARESIS; ACID; A(1); LYSOPHOSPHATIDYLINOSITOL; METABOLISM; MUTATIONS; KINASE; BRAIN; PURIFICATION	Phospholipase A1 (PLA1) hydrolyzes the fatty acids of glycerophospholipids, which are structural components of the cellular membrane. Genetic mutations in DDHD1, an intracellular PLA1, result in hereditary spastic paraplegia (HSP) in humans. However, the regulation of DDHD1 activity has not yet been elucidated in detail. In the present study, we examined the phosphorylation of DDHD1 and identified the responsible protein kinases. We performed MALDI-TOF MS/MS analysis and Phos-tag SDS-PAGE in alanine-substitution mutants in HEK293 cells and revealed multiple phosphorylation sites in human DDHD1, primarily Ser8, Ser11, Ser723, and Ser727. The treatment of cells with a protein phosphatase inhibitor induced the hyperphosphorylation of DDHD1, suggesting that multisite phosphorylation occurred not only at these major, but also at minor sites. Site-specific kinase-substrate prediction algorithms and in vitro kinase analyses indicated that cyclin-dependent kinase CDK1/cyclin A2 phosphorylated Ser8, Ser11, and Ser727 in DDHD1 with a preference for Ser11 and that CDK5/p35 also phosphorylated Ser11 and Ser727 with a preference for Ser11. In addition, casein kinase CK2a1 was found to phosphorylate Ser104, although this was not a major phosphorylation site in cultivated HEK293 cells. The evaluation of the effects of phosphorylation revealed that the phosphorylation mimic mutants S11/727E exhibit only 20% reduction in PLA1 activity. However, the phosphorylation mimics were mainly localized to focal adhesions, whereas the phosphorylation-resistant mutants S11/727A were not. This suggested that phosphorylation alters the subcellular localization of DDHD1 without greatly affecting its PLA1 activity.	[Matsumoto, Naoki; Nemoto-Sasaki, Yoko; Oka, Saori; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Tokyo, Japan; [Arai, Seisuke; Wada, Ikuo] Fukushima Med Univ, Inst Biomed Sci, Dept Cell Sci, Sch Med, Fukushima, Fukushima, Japan	Teikyo University; Fukushima Medical University	Yamashita, A (corresponding author), Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Tokyo, Japan.	ayamashi@pharm.teikyo-u.ac.jp		Yamashita, Atsushi/0000-0002-2544-2134	Japan Society for the Promotion of Science [15K07946, 19K07088, 17K07311]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grants-in-Aid for Scientific Research (15K07946 (A. Y.), 19K07088 (A. Y.), and 17K07311 (I. W.)) from the Japan Society for the Promotion of Science.	Aoki J, 2007, BIOCHIMIE, V89, P197, DOI 10.1016/j.biochi.2006.09.021; Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921; Breitkopf S. B., 2012, CURR PROTOC MOL BIOL, V98; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dard R, 2017, EUR J MED GENET, V60, P639, DOI 10.1016/j.ejmg.2017.08.015; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Gao J, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020025; Gotzke H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12301-7; Han MH, 2001, J BIOL CHEM, V276, P27698, DOI 10.1074/jbc.M101983200; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Higgs HN, 1996, J BIOL CHEM, V271, P10874, DOI 10.1074/jbc.271.18.10874; HIGGS HN, 1994, P NATL ACAD SCI USA, V91, P9574, DOI 10.1073/pnas.91.20.9574; Hiramatsu T, 2003, J BIOL CHEM, V278, P49438, DOI 10.1074/jbc.M213018200; Inoue N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9858; Kato A, 2007, BIOPOLYMERS, V85, P12, DOI 10.1002/bip.20596; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Lev S, 2004, EXP CELL RES, V297, P1, DOI 10.1016/j.yexcr.2004.02.033; Liguori R, 2014, J NEUROL, V261, P1789, DOI 10.1007/s00415-014-7418-4; Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011; Mazaki Y, 1998, J BIOL CHEM, V273, P22435, DOI 10.1074/jbc.273.35.22435; McNiven MA, 2013, TRENDS CELL BIOL, V23, P16, DOI 10.1016/j.tcb.2012.08.009; Mignarri A, 2016, J NEUROL SCI, V362, P287, DOI 10.1016/j.jns.2016.02.007; Miura S, 2016, EUR J MED GENET, V59, P413, DOI 10.1016/j.ejmg.2016.05.010; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2010, J BIOCHEM, V147, P671, DOI 10.1093/jb/mvp208; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; PETE MJ, 1994, J BIOL CHEM, V269, P19494; Richter KN, 2018, EMBO J, V37, P139, DOI 10.15252/embj.201695709; Sato T, 1997, J BIOL CHEM, V272, P2192; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037551; Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Waite M., 1987, PHOSPHOLIPASES HDB L, V5, P1; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yamashita A, 2013, PROSTAG OTH LIPID M, V107, P103, DOI 10.1016/j.prostaglandins.2013.05.004; Yamashita A, 2010, BBA-MOL CELL BIOL L, V1801, P711, DOI 10.1016/j.bbalip.2010.03.012	43	5	5	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100851	10.1016/j.jbc.2021.100851	http://dx.doi.org/10.1016/j.jbc.2021.100851			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34089703	Green Published, gold			2022-12-26	WOS:000678068400051
J	Conen, K; Guthrie, DM; Stevens, T; Winemaker, S; Seow, H				Conen, Katrin; Guthrie, Dawn M.; Stevens, Tara; Winemaker, Samantha; Seow, Hsien			Symptom trajectories of non-cancer patients in the last six months of life: Identifying needs in a population-based home care cohort	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; EARLY PALLIATIVE CARE; COGNITIVE IMPAIRMENT; PAIN MANAGEMENT; ADVANCED CANCER; SCALE; END; BREATHLESSNESS; DIAGNOSIS; ILLNESS	Introduction The end-of-life symptom prevalence of non-cancer patients have been described mostly in hospital and institutional settings. This study aims to describe the average symptom trajectories among non-cancer patients who are community-dwelling and used home care services at the end of life. Materials and methods This is a retrospective, population-based cohort study of non-cancer patients who used home care services in the last 6 months of life in Ontario, Canada, between 2007 and 2014. We linked the Resident Assessment Instrument for Home Care (RAI-HC) (standardized home care assessment tool) and the Discharge Abstract Databases (for hospital deaths). Patients were grouped into four non-cancer disease groups: cardiovascular, neurological, respiratory, and renal (not mutually exclusive). Our outcomes were the average prevalence of these outcomes, each week, across the last 6 months of life: uncontrolled moderate-severe pain as per the Pain Scale, presence of shortness of breath, mild-severe cognitive impairment as per the Cognitive Performance Scale, and presence of caregiver distress. We conducted a multivariate logistic regression to identify factors associated with having each outcome respectively, in the last 6 months. Results A total of 20,773 non-cancer patient were included in our study, which were analyzed by disease groups: cardiovascular (n = 12,923); neurological (n = 6,935); respiratory (n = 6,357); and renal (n = 3,062). Roughly 80% of patients were > 75 years and half were female. In the last 6 months of life, moderate to severe pain was frequent in the cardiovascular (57.2%), neurological (42.7%), renal (61.0%) and respiratory (58.3%) patients. Patients with renal disease had significantly higher odds for reporting uncontrolled moderate to severe pain (odds ratio [OR] = 1.21; 95% CI: 1.08 to 1.34) than those who did not. Patients with respiratory disease reported significantly higher odds for shortness of breath (5.37; 95% CI, 5.00 to 5.80) versus those who did not. Patients with neurological disease compared to those without were 9.65 times more likely to experience impaired cognitive performance and had 56% higher odds of caregiver distress (OR = 1.56; 95% CI: 1.43 to 1.71). Discussion In our cohort of non-cancer patients dying in the community, pain, shortness of breath, impaired cognitive function and caregiver distress are important symptoms to manage near the end of life even in non-institutional settings.	[Conen, Katrin] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Conen, Katrin; Winemaker, Samantha; Seow, Hsien] McMaster Univ, Div Palliat Care, Dept Family Med, Hamilton, ON, Canada; [Guthrie, Dawn M.; Stevens, Tara] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON, Canada; [Guthrie, Dawn M.] Wilfrid Laurier Univ, Dept Hlth Sci, Waterloo, ON, Canada; [Seow, Hsien] McMaster Univ, Dept Oncol, Hamilton, ON, Canada	McMaster University; McMaster University; Wilfrid Laurier University; Wilfrid Laurier University; McMaster University	Conen, K (corresponding author), McMaster Univ, Dept Med, Hamilton, ON, Canada.; Conen, K (corresponding author), McMaster Univ, Div Palliat Care, Dept Family Med, Hamilton, ON, Canada.	conenk@mcmaster.ca	Seow, Hsien/AAQ-1438-2021	Seow, Hsien/0000-0001-6701-1714; Conen, Katrin/0000-0002-6438-7414	Canadian Centre for Applied Research in Cancer Control (ARCC); Canadian Cancer Society Research Institute [2015-703549]; Canada Research Chairs program	Canadian Centre for Applied Research in Cancer Control (ARCC); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Canada Research Chairs program(Canada Research Chairs)	This work is funded by the Canadian Centre for Applied Research in Cancer Control (ARCC). ARCC receives core funding from the Canadian Cancer Society Research Institute (grant #2015-703549). The senior author is also supported by the Canada Research Chairs program. Authors otherwise did not receive funding for this work.	Amblas-Novellas J, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012340; Bausewein C, 2007, RESP MED, V101, P399, DOI 10.1016/j.rmed.2006.07.003; Bausewein C, 2010, J PALLIAT MED, V13, P1109, DOI 10.1089/jpm.2010.0068; Bostwick D, 2017, J PAIN SYMPTOM MANAG, V53, P1079, DOI 10.1016/j.jpainsymman.2017.02.014; Brumley Richard D, 2003, J Palliat Med, V6, P715, DOI 10.1089/109662103322515220; Cantin B, 2009, J PALLIAT CARE, V25, P92, DOI 10.1177/082585970902500203; Cook RJ, 2013, ARCH PHYS MED REHAB, V94, P1038, DOI 10.1016/j.apmr.2012.12.024; Dalkin SM, 2016, PALLIATIVE MED, V30, P690, DOI 10.1177/0269216315626352; Dirikkan F, 2018, TURK KARDIYOL DERN A, V46, P692, DOI [10.5543/tkda.2018.10.5543/tkda.2018.69057, 10.5543/tkda.2018.69057]; Ellershaw J, 2001, J PAIN SYMPTOM MANAG, V21, P12, DOI 10.1016/S0885-3924(00)00240-2; Fassbender K, 2015, ANN PALLIAT MED, V4, P135, DOI 10.3978/j.issn.2224-5820.2015.06.01; Fries BE, 2001, GERONTOLOGIST, V41, P173, DOI 10.1093/geront/41.2.173; Gomes B, 2013, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007760.pub2, 10.1590/1516-3180.20161341T2]; Hawes C, 2007, GERONTOLOGIST, V47, P378, DOI 10.1093/geront/47.3.378; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Horton R, 2013, J PALLIAT MED, V16, P67, DOI 10.1089/jpm.2012.0285; Hui D, 2013, CANCER-AM CANCER SOC, V119, P1098, DOI 10.1002/cncr.27854; Jansen WJJ, 2015, J PALLIAT MED, V18, P67, DOI 10.1089/jpm.2013.0645; Kim H, 2015, GERIATR GERONTOL INT, V15, P220, DOI 10.1111/ggi.12330; Kite S, 1999, PALLIATIVE MED, V13, P477, DOI 10.1191/026921699670359259; Koncicki HM, 2017, AM J KIDNEY DIS, V69, P451, DOI 10.1053/j.ajkd.2016.08.039; Lorenz Karl, 2006, Evid Rep Technol Assess (Full Rep), P1; Lorenz KA, 2006, J CLIN ONCOL, V24, P4933, DOI 10.1200/JCO.2006.06.8650; Luddington L, 2001, Int J Palliat Nurs, V7, P221; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Martin L, 2008, AGE AGEING, V37, P51, DOI 10.1093/ageing/afm162; Mavounza C, 2020, AGING MENT HEALTH, V24, P423, DOI 10.1080/13607863.2018.1544208; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; Morris JN, 1999, RAI HOME CARE RAI HC; Morris JN, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-128; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2005, BRIT MED J, V330, P671, DOI 10.1136/bmj.330.7492.671-a; Ponikowski Piotr, 2016, Rev Esp Cardiol (Engl Ed), V69, P1167, DOI 10.1016/j.rec.2016.11.005; Quinn KL, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0677; Quinn KL, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2257; Romem A, 2015, PALLIATIVE MED, V29, P464, DOI 10.1177/0269216315570411; Seow H, 2021, PSYCHO-ONCOLOGY, V30, P103, DOI 10.1002/pon.5559; Seow H, 2020, J PALLIAT MED, V23, P1644, DOI 10.1089/jpm.2019.0416; Seow H, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021147; Seow H, 2011, J CLIN ONCOL, V29, P1151, DOI 10.1200/JCO.2010.30.7173; Sevilla-Cazes J, 2018, J GEN INTERN MED, V33, P1700, DOI 10.1007/s11606-018-4542-3; Solano JP, 2006, J PAIN SYMPTOM MANAG, V31, P58, DOI 10.1016/j.jpainsymman.2005.06.007; Soto-Rubio A, 2017, ARCH GERONTOL GERIAT, V73, P113, DOI 10.1016/j.archger.2017.07.024; Steinhauser KE, 2011, J PAIN SYMPTOM MANAG, V42, P331, DOI 10.1016/j.jpainsymman.2010.11.006; Szeto JYY, 2016, J PARKINSON DIS, V6, P589, DOI 10.3233/JPD-160823; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678; Vogelmeier CF, 2017, AM J RESP CRIT CARE, V195, P557, DOI 10.1164/rccm.201701-0218PP; Zimmermann C, 2014, LANCET, V383, P1721, DOI 10.1016/S0140-6736(13)62416-2	49	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0252814	10.1371/journal.pone.0252814	http://dx.doi.org/10.1371/journal.pone.0252814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129643	Green Published, gold			2022-12-26	WOS:000665475100012
J	Jakovljevic, T; Jankovic, MM; Savic, AM; Soldatovic, I; Macuzic, I; Jakulin, TJ; Papa, G; Kovic, V				Jakovljevic, Tamara; Jankovic, Milica M.; Savic, Andrej M.; Soldatovic, Ivan; Macuzic, Ivan; Jakulin, Tadeja Jere; Papa, Gregor; Kovic, Vanja			The effect of colour on reading performance in children, measured by a sensor hub: From the perspective of gender	PLOS ONE			English	Article							SEX-DIFFERENCES; EEG; AGE; SIMILARITIES; VARIABILITY; REACTIVITY	In recent decades reported findings regarding gender differences in reading achievement, cognitive abilities and maturation process in boys and girls are conflicting. As reading is one of the most important processes in the maturation of an individual, the aim of the study was to better understand gender differences between primary school students. The study evaluates differences in Heart Rate Variability (HRV), Electroencephalography (EEG), Electrodermal Activities (EDA) and eye movement of participants during the reading task. Taking into account that colour may affect reading skills, in that it affects the emotional and physiological state of the body, the research attempts to provide a better understanding of gender differences in reading through examining the effect of colour, as applied to reading content. The physiological responses of 50 children (25 boys and 25 girls) to 12 different background and overlay colours of reading content were measured and summarised during the reading process. Our findings show that boys have shorter reading duration scores and a longer Saccade Count, Saccade Duration Total, and Saccade Duration Average when reading on a coloured background, especially purple, which could be caused by their motivation and by the type of reading task. Also, the boys had higher values for the Delta band and the Whole Range of EEG measurements in comparison to the girls when reading on coloured backgrounds, which could reflect the faster maturation of the girls. Regarding EDA measurements we did not find systematic differences between groups either on white or on coloured/overlay background. We found the most significant differences arose in the HRV parameters, namely (SDNN (ms), STD HR (beats/min), RMSSD (ms), NN50 (beats), pNN50 (%), CVRR) when children read the text on coloured/overlay backgrounds, where the girls showed systematically higher values on HRV measurements in comparison to the boys, mostly with yellow, red, and orange overlay colours.	[Jakovljevic, Tamara] Jozef Stefan Int Postgrad Sch, Sensor Technol, Ljubljana, Slovenia; [Jankovic, Milica M.; Savic, Andrej M.] Univ Belgrade, Sch Elect Engn, Belgrade, Serbia; [Soldatovic, Ivan] Univ Belgrade, Inst Med Stat & Informat, Fac Med, Belgrade, Serbia; [Macuzic, Ivan] Univ Kragujevac, Fac Engn, Kragujevac, Serbia; [Jakulin, Tadeja Jere] FTS Turist UP, Portoroz, Slovenia; [Papa, Gregor] Jozef Stefan Inst, Ljubljana, Slovenia; [Kovic, Vanja] Univ Belgrade, Fac Philosophy, Lab Neurocognit & Appl Cognit, Belgrade, Serbia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Belgrade; University of Belgrade; University of Kragujevac; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Belgrade	Jakovljevic, T (corresponding author), Jozef Stefan Int Postgrad Sch, Sensor Technol, Ljubljana, Slovenia.	tamara.jakovljevic@hotmail.com	Jankovic, Milica/AAX-4707-2021; Macuzic, Ivan/GXZ-6435-2022; Papa, Gregor/C-3958-2013; Kovic, Vanja/O-9504-2016	(Jakovljevic) Papic, Tamara/0000-0002-9666-7824; Papa, Gregor/0000-0002-0623-0865; Kovic, Vanja/0000-0002-3954-1125; Jankovic, Milica/0000-0002-7506-4995	Slovenian Research Agency [P2-0098]; AD Futura Fund (Public Scholarship, Development, Disability and Maintenance Fund of the Republic of Slovenia); AD Futura Fund (Ministry of Education, Science and Technological Development of the Republic of Serbia)	Slovenian Research Agency(Slovenian Research Agency - Slovenia); AD Futura Fund (Public Scholarship, Development, Disability and Maintenance Fund of the Republic of Slovenia); AD Futura Fund (Ministry of Education, Science and Technological Development of the Republic of Serbia)	The Authors work were supported through the Slovenian Research Agency (research core funding No. P2-0098), AD Futura Fund (Public Scholarship, Development, Disability and Maintenance Fund of the Republic of Slovenia, and the Ministry of Education, Science and Technological Development of the Republic of Serbia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], KUBIOS HRV PREMIUMKU; [Anonymous], PSYCHOL SEX DIFFEREN; [Anonymous], 1985, ELECTROENCEPHALOGRAP, V60, DOI [10.1016/0013-4694%2885%2991013-2, DOI 10.1016/0013-4694%2885%2991013-2]; [Anonymous], SEX COGNITION; Ardila A, 2011, DEV PSYCHOL, V47, P984, DOI 10.1037/a0023819; Bobkowski W, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00311; Clarke AR, 2001, CLIN NEUROPHYSIOL, V112, P806, DOI 10.1016/S1388-2457(01)00488-6; COHN NB, 1985, ELECTROEN CLIN NEURO, V62, P399, DOI 10.1016/0168-5597(85)90049-8; Conway ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163326; Conway ML., 2014, FRONTIERS PSYCHOL, V5, P9; CORSICABRERA M, 1993, INT J NEUROSCI, V72, P257, DOI 10.3109/00207459309024114; de Jong P.F., 2002, SCI STUD READ, V6, P51, DOI [10.1207/S1532799XSSR0601_03, DOI 10.1207/S1532799XSSR0601_03]; Denton TF, 2016, BEHAV ANAL PRACT, V9, P191, DOI 10.1007/s40617-015-0079-7; Devetak I, 2010, INT J SCI EDUC, V32, P1561, DOI 10.1080/09500690903150609; EEGOLOFSSON O, 1971, NEUROPADIATRIE, V2, P375, DOI 10.1055/s-0028-1091791; Ehri L. C., 1995, J RES READ, V18, P116, DOI [10.1111/j.14679817.1995.tb00077.x, DOI 10.1111/J.14679817.1995.TB00077.X, 10.1111/j.1467-9817.1995.tb00077.x, DOI 10.1111/J.1467-9817.1995.TB00077.X]; Eilers S, 2019, SCI STUD READ, V23, P509, DOI 10.1080/10888438.2019.1617293; El-Sheikh M, 2007, DEV PSYCHOBIOL, V49, P180, DOI 10.1002/dev.20171; El-Sheikh M, 2010, BIOL PSYCHOL, V83, P116, DOI 10.1016/j.biopsycho.2009.11.009; Estevez-Baez M, 2019, ADV EXP MED BIOL, V1133, P19, DOI 10.1007/5584_2018_292; Etchell A, 2018, NEUROPSYCHOLOGIA, V114, P19, DOI 10.1016/j.neuropsychologia.2018.04.011; Evans BE, 2016, BIOL PSYCHOL, V117, P67, DOI 10.1016/j.biopsycho.2016.03.002; GASSER T, 1988, ELECTROEN CLIN NEURO, V69, P91, DOI 10.1016/0013-4694(88)90204-0; Giagloglou E, 2019, INT J OCCUP SAF ERGO, V25, P296, DOI 10.1080/10803548.2017.1370231; Halpern DF, 2011, SEX ROLES, V64, P336, DOI 10.1007/s11199-010-9891-2; Harris P, 1988, CHILD LANGUAGE TEACH, V4, P230, DOI [10.1177/026565908800400212, DOI 10.1177/026565908800400212]; HEDGES LV, 1995, SCIENCE, V269, P41, DOI 10.1126/science.7604277; Hyde JS, 2016, CURR OPIN NEUROBIOL, V38, P53, DOI 10.1016/j.conb.2016.02.007; Hyde JS, 2014, ANNU REV PSYCHOL, V65, P373, DOI 10.1146/annurev-psych-010213-115057; HYDE JS, 1988, PSYCHOL BULL, V104, P53, DOI 10.1037/0033-2909.104.1.53; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Jakovljevic T., 2020, SENSOR HUB DETECTING; Joel D, 2015, P NATL ACAD SCI USA, V112, P15468, DOI 10.1073/pnas.1509654112; Kivikangas JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100318; Korneev A. A., 2018, Human Physiology, V44, P183, DOI 10.1134/S036211971802010X; Langrova J, 2012, PHYSIOL RES, V61, pS119, DOI 10.33549/physiolres.932421; Lerkkanen MK, 2004, LEARN INSTR, V14, P111, DOI 10.1016/j.learninstruc.2004.01.006; Lindberg SM, 2010, PSYCHOL BULL, V136, P1123, DOI 10.1037/a0021276; Lindsley DB, 1939, PEDAGOG SEMIN J GEN, V55, P197; Lobier M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058097; Logan S, 2010, EDUC REV, V62, P175, DOI 10.1080/00131911003637006; Lynn R, 2009, TRAMES-J HUMANIT SOC, V13, P3, DOI 10.3176/tr.2009.1.01; Maccoby E.E., 1966, DEV SEX DIFFERENCES; Marcuse LV, 2008, CLIN NEUROPHYSIOL, V119, P1778, DOI 10.1016/j.clinph.2008.02.023; Martinovic Z, 1998, NEUROPHYSIOL CLIN, V28, P231, DOI 10.1016/S0987-7053(98)80114-7; Matousek M., 1973, AUTOMATION CLIN ELEC, P75102; McCarthy MM, 2005, FRONT NEUROENDOCRIN, V26, P85, DOI 10.1016/j.yfrne.2005.06.001; McManis MH, 2001, PSYCHOPHYSIOLOGY, V38, P222, DOI 10.1111/1469-8986.3820222; McTigue EM., 2020, J ED PSYCHOL; Miller DI, 2014, TRENDS COGN SCI, V18, P37, DOI 10.1016/j.tics.2013.10.011; Moodithaya Shailaja, 2012, J Aging Res, V2012, P679345, DOI 10.1155/2012/679345; Penolazzi B, 2008, PSYCHOPHYSIOLOGY, V45, P1025, DOI 10.1111/j.1469-8986.2008.00709.x; Pinna B, 2018, I-PERCEPTION, V9, DOI 10.1177/2041669518779098; Rayner K, 2013, EXP PSYCHOL, V60, P354, DOI 10.1027/1618-3169/a000207; Reilly D, 2019, AM PSYCHOL, V74, P445, DOI 10.1037/amp0000356; Reilly D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039904; Sachin S., 2010, IJCSE INT J COMPUTER; Sargezeh BA, 2019, PHYSIOL BEHAV, V206, P43, DOI 10.1016/j.physbeh.2019.03.023; Segalowitz SJ, 2010, BRAIN COGNITION, V72, P86, DOI 10.1016/j.bandc.2009.10.003; Shaffer F, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00258; Smith JR, 1938, PEDAGOG SEMIN J GEN, V53, P455; Somsen RJM, 1997, BIOL PSYCHOL, V44, P187, DOI 10.1016/S0301-0511(96)05218-0; Spironelli C, 2010, DEV NEUROPSYCHOL, V35, P357, DOI 10.1080/87565641.2010.480913; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Tolga Dogru M., 2010, TURK KARDIYOL DERN A, V38; van Bommel W. J. M., 2004, Lighting Research & Technology, V36, P255, DOI 10.1191/1365782804li122oa; Veszeli J, 2019, VISION RES, V156, P73, DOI 10.1016/j.visres.2019.01.006; Vlachos F, 2015, COGENT PSYCHOL, V2, DOI 10.1080/23311908.2015.1045224; Voyer D, 2014, PSYCHOL BULL, V140, P1174, DOI 10.1037/a0036620; Wass SV, 2016, RES METH DEV PSYCHOL, P24; Weiss EM, 2003, PERS INDIV DIFFER, V35, P863, DOI 10.1016/S0191-8869(02)00288-X; Wilkins AJ, 2010, APPL ERGON, V41, P509, DOI 10.1016/j.apergo.2009.01.011; Wolf T, 2018, PSYCHOSOM MED, V80, P452, DOI 10.1097/PSY.0000000000000582; Zell E, 2015, AM PSYCHOL, V70, P10, DOI 10.1037/a0038208; Zhan ZH, 2020, INTERACT TECHNOL SMA, V17, P267, DOI 10.1108/ITSE-12-2019-0082; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3	77	0	0	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252622	10.1371/journal.pone.0252622	http://dx.doi.org/10.1371/journal.pone.0252622			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125863	Green Published, gold			2022-12-26	WOS:000664643500009
J	Hellem, MNN; Vinther-Jensen, T; Anderberg, L; Budtz-Jorgensen, E; Hjermind, LE; Larsen, VA; Nielsen, JE; Law, I				Hellem, Marie N. N.; Vinther-Jensen, Tua; Anderberg, Lasse; Budtz-Jorgensen, Esben; Hjermind, Lena E.; Larsen, Vibeke Andree; Nielsen, Jorgen E.; Law, Ian			Hybrid 2-[F-18] FDG PET/MRI in premanifest Huntington's disease gene-expansion carriers: The significance of partial volume correction	PLOS ONE			English	Article							PET; METABOLISM; BIOMARKERS; BIAS; HD	Background Huntington's disease (HD) is an inherited, progressive neurodegenerative disease that has no cure. Striatal atrophy and hypometabolism has been described in HD as far as 15 years before clinical onset and therefore structural and functional imaging biomarkers are the most applied biomarker modalities which call for these to be exact; however, most studies are not considering the partial volume effect and thereby tend to overestimate metabolic reductions, which may bias imaging outcome measures of interventions. Objective Evaluation of partial volume effects in a cohort of premanifest HD gene-expansion carriers (HDGECs). Methods 21 HDGECs and 17 controls had a hybrid 2-[F-18]FDG PET/MRI scan performed. Volume measurements and striatal metabolism, both corrected and uncorrected for partial volume effect were correlated to an estimate of disease burden, the CAG age product scaled (CAP(S)). Results We found significantly reduced striatal metabolism in HDGECs, but not in striatal volume. There was a negative correlation between the CAP(S) and striatal metabolism, both corrected and uncorrected for the partial volume effect. The partial volume effect was largest in the smallest structures and increased the difference in metabolism between the HDGEC with high and low CAP(S) scores. Statistical parametric mapping confirmed the results. Conclusions A hybrid 2-[F-18]FDG PET/MRI scan provides simultaneous information on structure and metabolism. Using this approach for the first time on HDGECs, we highlight the importance of partial volume effect correction in order not to underestimate the standardized uptake value and thereby the risk of overestimating the metabolic effect on the striatal structures, which potentially could bias studies determining imaging outcome measures of interventions in HDGECs and probably also symptomatic HD.	[Hellem, Marie N. N.; Vinther-Jensen, Tua; Hjermind, Lena E.; Nielsen, Jorgen E.] Univ Copenhagen, Rigshosp, Danish Dementia Res Ctr, Neurogenet Clin, Copenhagen, Denmark; [Anderberg, Lasse; Law, Ian] Univ Copenhagen, Rigshosp, Dept Clin Physiol Nucl Med & PET, Copenhagen, Denmark; [Budtz-Jorgensen, Esben] Univ Copenhagen, Dept Publ Hlth, Sect Biostat, Copenhagen, Denmark; [Larsen, Vibeke Andree] Univ Copenhagen, Rigshosp, Dept Radiol, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Hellem, MNN (corresponding author), Univ Copenhagen, Rigshosp, Danish Dementia Res Ctr, Neurogenet Clin, Copenhagen, Denmark.	marie.nathalie.nickelsen.hellem@regionh.dk		Hellem, Marie/0000-0002-9026-1073; Budtz-Jorgensen, Esben/0000-0002-5551-0724	Danish Huntington's Disease Association Resaerch Foundation; Research Board at Rigshospitalet; A.P. Moller Foundation; Novo Nordisk Foundation	Danish Huntington's Disease Association Resaerch Foundation; Research Board at Rigshospitalet; A.P. Moller Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	MNNH received funds from Danish Huntington's Disease Association Resaerch Foundation, http://huntingtons.dk/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MNNH received funding from The Research Board at Rigshospitalet, https://www.rigshospitalet.dk/english/Pages/default.aspx.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MNNH received funding from A.P. Moller Foundation, https://www.apmollerfonde.dk/om-fonden/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MNNH received funding from The Soren Segel & Johanne Wiibro Segel's Research Fund, https://www.legatbogen.dk/lge-sren-segel-og-hustru-johannewiibroe-segel-forskningsfond.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. JEN received funding from The Novo Nordisk Foundation, https://novonordiskfonden.dk/en/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen FL, 2014, NEUROIMAGE, V84, P206, DOI 10.1016/j.neuroimage.2013.08.042; Ciarmiello A, 2006, J NUCL MED, V47, P215; Ciarmiello A, 2012, EUR J NUCL MED MOL I, V39, P1030, DOI 10.1007/s00259-012-2114-z; Cysouw MCF, 2017, EUR J NUCL MED MOL I, V44, P2105, DOI 10.1007/s00259-017-3775-4; Delso G, 2011, J NUCL MED, V52, P1914, DOI 10.2967/jnumed.111.092726; Feigin A, 2007, BRAIN, V130, P2858, DOI 10.1093/brain/awm217; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Georgiou-Karistianis N, 2013, NEUROSCI BIOBEHAV R, V37, P480, DOI 10.1016/j.neubiorev.2013.01.022; Greve DN, 2016, NEUROIMAGE, V132, P334, DOI 10.1016/j.neuroimage.2016.02.042; Greve DN, 2014, NEUROIMAGE, V92, P225, DOI 10.1016/j.neuroimage.2013.12.021; HAYDEN MR, 1986, NEUROLOGY, V36, P888, DOI 10.1212/WNL.36.7.888; Henriksen OM, 2016, PET CLIN, V11, P441, DOI 10.1016/j.cpet.2016.05.003; KUHL DE, 1982, ANN NEUROL, V12, P425, DOI 10.1002/ana.410120504; L JL., 1997, NEUROIMAGE, V5; Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8; Malone IB, 2015, NEUROIMAGE, V104, P366, DOI 10.1016/j.neuroimage.2014.09.034; Niccolini F, 2018, J NEUROL NEUROSUR PS, V89, P185, DOI 10.1136/jnnp-2017-316633; Pagano G, 2016, EUR J NUCL MED MOL I, V43, P1171, DOI 10.1007/s00259-016-3324-6; Paulsen JS, 2010, BRAIN RES BULL, V82, P201, DOI 10.1016/j.brainresbull.2010.04.003; Rees EM, 2013, J HUNTINGTONS DIS, V2, P21, DOI 10.3233/JHD-120030; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Rodrigues FB, 2018, J HUNTINGTONS DIS, V7, P279, DOI 10.3233/JHD-189003; Roos RAC, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-40; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Rub U, 2013, BRAIN PATHOL, V23, P165, DOI 10.1111/j.1750-3639.2012.00629.x; Sattarivand M, 2012, PHYS MED BIOL, V57, P7101, DOI 10.1088/0031-9155/57/21/7101; Tabrizi SJ, 2012, LANCET NEUROL, V11, P42, DOI 10.1016/S1474-4422(11)70263-0; van Oostrom JCH, 2005, NEUROLOGY, V65, P941, DOI 10.1212/01.wnl.0000176071.08694.cc; Vinther-Jensen T, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0114-8; Zhang Y, 2011, AM J MED GENET B, V156B, P751, DOI 10.1002/ajmg.b.31232	31	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252683	10.1371/journal.pone.0252683	http://dx.doi.org/10.1371/journal.pone.0252683			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115782	Green Published, gold			2022-12-26	WOS:000664643000027
J	Sherazi, SWA; Bae, JW; Lee, JY				Sherazi, Syed Waseem Abbas; Bae, Jang-Whan; Lee, Jong Yun			A soft voting ensemble classifier for early prediction and diagnosis of occurrences of major adverse cardiovascular events for STEMI and NSTEMI during 2-year follow-up in patients with acute coronary syndrome	PLOS ONE			English	Article							ISCHEMIC-HEART-DISEASE; 2018 KOREAN SOCIETY; EPIDEMIOLOGY; PREVENTION; GUIDELINES; MANAGEMENT; MORTALITY	Objective Some researchers have studied about early prediction and diagnosis of major adverse cardiovascular events (MACE), but their accuracies were not high. Therefore, this paper proposes a soft voting ensemble classifier (SVE) using machine learning (ML) algorithms. Methods We used the Korea Acute Myocardial Infarction Registry dataset and selected 11,189 subjects among 13,104 with the 2-year follow-up. It was subdivided into two groups (ST-segment elevation myocardial infarction (STEMI), non ST-segment elevation myocardial infarction NSTEMI), and then subdivided into training (70%) and test dataset (30%). Third, we selected the ranges of hyper-parameters to find the best prediction model from random forest (RF), extra tree (ET), gradient boosting machine (GBM), and SVE. We generated each ML-based model with the best hyper-parameters, evaluated by 5-fold stratified cross-validation, and then verified by test dataset. Lastly, we compared the performance in the area under the ROC curve (AUC), accuracy, precision, recall, and F-score. Results The accuracies for RF, ET, GBM, and SVE were (88.85%, 88.94%, 87.84%, 90.93%) for complete dataset, (84.81%, 85.00%, 83.70%, 89.07%) STEMI, (88.81%, 88.05%, 91.23%, 91.38%) NSTEMI. The AUC values in RF were (98.96%, 98.15%, 98.81%), ET (99.54%, 99.02%, 99.00%), GBM (98.92%, 99.33%, 99.41%), and SVE (99.61%, 99.49%, 99.42%) for complete dataset, STEMI, and NSTEMI, respectively. Consequently, the accuracy and AUC in SVE outperformed other ML models. Conclusions The performance of our SVE was significantly higher than other machine learning models (RF, ET, GBM) and its major prognostic factors were different. This paper will lead to the development of early risk prediction and diagnosis tool of MACE in ACS patients.	[Sherazi, Syed Waseem Abbas; Lee, Jong Yun] Chungbuk Natl Univ, Dept Comp Sci, Cheongju, Chungbuk, South Korea; [Bae, Jang-Whan] Chungbuk Natl Univ, Coll Med, Dept Internal Med, Cheongju, Chungbuk, South Korea	Chungbuk National University; Chungbuk National University	Lee, JY (corresponding author), Chungbuk Natl Univ, Dept Comp Sci, Cheongju, Chungbuk, South Korea.	jongyun@chungbuk.ac.kr		LEE, Jong Yun/0000-0001-5526-946X	KIAT (Korea Institute for Advancement of Technology) grant - Korea Government (MOTIE: Ministry of Trade Industry and Energy) [N0002429]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2017R1D1A1A02018718]	KIAT (Korea Institute for Advancement of Technology) grant - Korea Government (MOTIE: Ministry of Trade Industry and Energy)(Ministry of Trade, Industry & Energy (MOTIE), Republic of Korea); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	This research was supported by the KIAT (Korea Institute for Advancement of Technology) grant funded by the Korea Government (MOTIE: Ministry of Trade Industry and Energy) (No. N0002429). It was also supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2017R1D1A1A02018718).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Almuhaideb S, 2016, FRONT COMPUT SCI-CHI, V10, P1082, DOI 10.1007/s11704-016-5203-5; Ang Q, 2010, 2010 2 IEEE INT C IN; [Anonymous], KOREA ACUTE MYOCARDI; Antman EM, 2000, JAMA-J AM MED ASSOC, V284, P835, DOI 10.1001/jama.284.7.835; Armstrong EJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000062; Bedetti G, 2010, AM J CARDIOL, V106, P1709, DOI 10.1016/j.amjcard.2010.08.024; Benhar H., 2018, WORLD C INF SYST TEC; Bonnell J.A., 2011, IMPLEMENTATION NEW S; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cha M, 2009, J KOREAN SOC HYPERTE, V15, P37; Denil M, 2014, PR MACH LEARN RES, V32; Dimopoulos AC, 2018, BMC MED RES METHODOL, V18, DOI 10.1186/s12874-018-0644-1; FRAWLEY WJ, 1992, AI MAG, V13, P57; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; HARRINGTON PD, 1993, ANAL CHEM, V65, P2167, DOI 10.1021/ac00063a042; Hoque N, 2014, EXPERT SYST APPL, V41, P6371, DOI 10.1016/j.eswa.2014.04.019; Huang MW, 2016, EXPERT SYST, V33, P432, DOI 10.1111/exsy.12155; Jhee JH, 2018, J CLIN MED, V7, DOI 10.3390/jcm7110463; Johnson KW, 2018, J AM COLL CARDIOL, V71, P2668, DOI 10.1016/j.jacc.2018.03.521; Jupyter.org, 2019, PROJECT JUPYTER; Kannel W.B., 1970, FRAMINGHAM STUDY EPI; Kim HC, 2019, CLIN HYPERTENS, V25, DOI 10.1186/s40885-019-0121-0; Kim J.K., 2017, J GINSENG RES, P2017; Kim Jin Q., 1997, Journal of Korean Medical Science, V12, P17; Lee SY, 2019, KOREAN J INTERN MED, V34, P353, DOI 10.3904/kjim.2016.285; Li X, 2017, STUD HEALTH TECHNOL, V245, P476, DOI 10.3233/978-1-61499-830-3-476; Miaoa Kathleen H., 2018, International Journal of Advanced Computer Science and Applications, V9, P1; Miranda E, 2016, HEALTHC INFORM RES, V22, P196, DOI 10.4258/hir.2016.22.3.196; Pai C., 2017, INT J COMPUT APPL, V175, P7, DOI DOI 10.5120/IJCA2017915495; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Poolsawad N., 2012, 2012 9 INT C FUZZ SY; Poolsawad N, 2014, INT J AUTOM COMPUT, V11, P162, DOI 10.1007/s11633-014-0778-5; Rahimi K, 2015, J EPIDEMIOL COMMUN H, V69, P1000, DOI 10.1136/jech-2015-205689; Rahm E., 2000, IEEE DATA ENG B, V23, P3; Ridker PM, 2001, CIRCULATION, V103, P1813, DOI 10.1161/01.CIR.103.13.1813; Saqlain M, 2019, IEEE T SEMICONDUCT M, V32, P171, DOI 10.1109/TSM.2019.2904306; Seo MH, 2019, J OBES METAB SYNDR, V28, P40, DOI 10.7570/jomes.2019.28.1.40; Sherazi SWA, 2020, HEALTH INFORM J, V26, P1289, DOI 10.1177/1460458219871780; Ton VK, 2013, CLIN CARDIOL, V36, pE1, DOI 10.1002/clc.22079; Ultsch A., 1993, INF CLASSIF, P307, DOI [10.1007/978-3-642-50974-231, DOI 10.1007/978-3-642-50974-231, DOI 10.1007/978-3-642-50974-2_31]; Uma K., 2017, INT J SCI ENG RES, V8, P1131; Weng SF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174944	45	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0249338	10.1371/journal.pone.0249338	http://dx.doi.org/10.1371/journal.pone.0249338			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115750	Green Published, gold			2022-12-26	WOS:000664643000006
J	Yeboah, I; Kwankye, SO; Frempong-Ainguah, F				Yeboah, Isaac; Kwankye, Stephen Owusu; Frempong-Ainguah, Faustina			Predictors of underachieved and overachieved fertility among women with completed fertility in Ghana	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; UNITED-STATES; PREFERENCES; INTENTIONS; REALIZATION; TRANSITION; CONTEXT; DESIRES; IDEAL	Background A woman's ability to achieve her preferred family size is critical in addressing issues of high fertility in sub-Saharan Africa. The socio-cultural context in sub-Saharan Africa presents some difficulty for the attainment of preferred fertility for many women. Few studies in sub-Saharan Africa have examined the extent to which women are unable to achieve their preferred family sizes. This study, therefore, examines the factors that are associated with the non-attainment of women's preferred fertility by the end of their reproductive years. Data and methods The study analyzed pooled cross-sectional data with a sub-sample of 1,888 currently married women aged 45-49 years from five rounds of the Ghana Demographic and Health Survey, 1993 to 2014. Test of associations and multinomial logistic regression analysis were used to examine the predictors of underachieved and overachieved fertility relative to achieved fertility. Results The results indicate that 44 per cent of the women recorded overachieved fertility while about 36 per cent underachieved their fertility. Partner wants more, experiencing child loss and married more than once were significantly associated with overachieved fertility. Nonetheless, increased years of a woman's education and delaying her at first birth were negatively associated with overachieved fertility. On the other hand, underachieved fertility was significantly associated with having a partner with fewer fertility preference, being of the Islamic faith and ever use of modern contraception. Conclusion Partner's fertility preference, child loss experience, marrying more than once and ever use of modern contraception were important predictors of a woman's inability to achieve her fertility preference. Policies to regulate men's fertility behaviour, delaying age at first birth, use of modern contraception, encouraging longer years of education, and reducing infant and child mortality are important strategies to achieve fertility preference in Ghana.	[Yeboah, Isaac] Univ Profess Studies, Inst Work Employment & Soc, Accra, Ghana; [Yeboah, Isaac; Kwankye, Stephen Owusu; Frempong-Ainguah, Faustina] Univ Profess Studies, Reg Inst Populat Studies, Accra, Ghana		Yeboah, I (corresponding author), Univ Profess Studies, Inst Work Employment & Soc, Accra, Ghana.; Yeboah, I (corresponding author), Univ Profess Studies, Reg Inst Populat Studies, Accra, Ghana.	isaac.yeboah@upsamail.edu.gh		yeboah, isaac/0000-0001-6795-4405				Adsera A., 2006, REV ECON HOUSEHOLD, V4, P75, DOI [10.1007/s11150-005-6698-y, DOI 10.1007/S11150-005-6698-Y]; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; [Anonymous], 1989, GHAN DEM HLTH SURV 1, VCalverton; [Anonymous], 1999, GHAN DEM HLTH SURV 1; [Anonymous], 2009, GHAN DEM HLTH SURV 2; [Anonymous], 2004, GHAN DEM HLTH SURV 2; Atake EH, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0747-9; Bachan L., 2013, DECLINE NONNUM UNPUB; Baizan P, 2016, EUR J POPUL, V32, P1, DOI 10.1007/s10680-015-9356-y; Balbo, 2011, VIENNA YB POPULATION, V9, P179, DOI [10.1553/populationyearbook2011s187, DOI 10.1553/POPULATIONYEARBOOK2011S179]; Bankole Akinrinola, 2007, Afr J Reprod Health, V11, P197, DOI 10.2307/25549740; BECK N, 1995, AM POLIT SCI REV, V89, P634, DOI 10.2307/2082979; Behrman JA, 2015, DEMOGRAPHY, V52, P787, DOI 10.1007/s13524-015-0392-3; Berrington A, 2014, ADV LIFE COURSE RES, V21, P10, DOI 10.1016/j.alcr.2013.12.003; Bethlehem J., 2011, ENCY SURVEY RES METH, P958; Bhrolchain MN, 2019, SPRINGER SER DEMOGR, V47, P27, DOI 10.1007/978-3-319-93227-9_3; Bongaarts J, 2013, POPUL DEV REV, V38, P153, DOI 10.1111/j.1728-4457.2013.00557.x; CALDWELL JC, 1987, POPUL DEV REV, V13, P409, DOI 10.2307/1973133; Casterline JB, 2017, DEMOGR RES, V36, P427, DOI 10.4054/DemRes.2017.36.14; Channon MD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219736; de Carvalho AA, 2016, REV LATINOAM POBLAC, V10, P83; DeRose LF, 2005, POP STUD-J DEMOG, V59, P197, DOI 10.1080/00324720500099496; Dewi RK, 2018, DEV POLICY REV, V36, pO552, DOI 10.1111/dpr.12310; Dibaba B., 2016, J WOMENS HLTH CARE, V5, P4; Dodoo F. N., 1996, African Studies Review, V39, P29, DOI 10.2307/524942; DODOO FN, 1994, SOCIOL QUART, V35, P507, DOI 10.1111/j.1533-8525.1994.tb01742.x; Dommermuth L, 2015, ADV LIFE COURSE RES, V24, P34, DOI 10.1016/j.alcr.2015.02.001; Feyisetan B, 2000, INT FAM PLAN PERSPEC, V26, P100, DOI 10.2307/2648298; Ghana Statistical Service Ghana Health Service and ICF International, 2015, GHAN DEM HLTH SURV 2; Govindasamy P., 2000, DECADE UNMET NEED CO, DOI [10.1107/s0108270199009257, DOI 10.1107/S0108270199009257]; Gunther I., 2013, COURANT RES CENT POV, V144, P1; Gyimah SO., 2002, PSC DISCUSSION PAPER, V16, P1; Gyimah SO., 2004, CAN STUD POPUL, V31, P33, DOI [10.25336/P64G7Q, DOI 10.25336/P64G7Q]; Hagewen KJ, 2005, POPUL DEV REV, V31, P507, DOI 10.1111/j.1728-4457.2005.00081.x; Hayford SR, 2019, DEMOGRAPHY, V56, P573, DOI 10.1007/s13524-018-0754-8; HECKHAUSEN J, 1995, PSYCHOL REV, V102, P284, DOI 10.1037/0033-295X.102.2.284; Ibisomi L, 2011, J BIOSOC SCI, V43, P233, DOI 10.1017/S0021932010000684; Johnson-Hanks J, 2005, CURR ANTHROPOL, V46, P363, DOI 10.1086/428799; Khatun T., 2011, THESIS; Klomegah R, 1999, INT REV MOD SOCIOL, V29, P17; Kravdal O, 2002, DEMOGRAPHY, V39, P233, DOI 10.2307/3088337; Kuhnt AK, 2016, ADV LIFE COURSE RES, V27, P16, DOI 10.1016/j.alcr.2015.10.002; Liefbroer AC, 2009, EUR J POPUL, V25, P363, DOI 10.1007/s10680-008-9173-7; Muhoza DN., 2014, INT J POPUL RES, V2014, P1, DOI [DOI 10.1155/2014/486079, 10.1155/2014/486079]; Nyarko SH., 2019, GENUS, V75, P22, DOI DOI 10.1186/S41118-019-0069-7; Philipov D, 2011, COMP POPUL STUD, V36, P495, DOI 10.4232/10.CPoS-2011-14en; Raffalovich LE, 2014, INT J CONFL VIOLENCE, V8, P209; Reda A Alex, 2014, Etude Popul Afr, V28, P1157; Reher DS, 2017, DEMOGRAPHY, V54, P3, DOI 10.1007/s13524-016-0536-0; Thomson E., 2004, DEMOGR RES, V3, P117, DOI [10.4054/DemRes.2004.S3.5, DOI 10.4054/DEMRES.2004.S3.5]; Thomson E, 2014, DEMOGRAPHY, V51, P485, DOI 10.1007/s13524-013-0273-6; Tilson D, 2000, J BIOSOC SCI, V32, P355, DOI 10.1017/S0021932000003552; Trinitapoli J, 2018, POPUL DEV REV, V44, P87, DOI 10.1111/padr.12114; World Bank, 2015, AFR POP BOOM WILL IT; Wulifan JK, 2019, CONTRACEP REPROD MED, V4, DOI 10.1186/s40834-018-0083-8	55	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0250881	10.1371/journal.pone.0250881	http://dx.doi.org/10.1371/journal.pone.0250881			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115779	Green Published, gold			2022-12-26	WOS:000664643000008
J	Grassi, T; Harris, FR; Smadbeck, JB; Murphy, SJ; Block, MS; Multinu, F; Klein, JLS; Zhang, PY; Karagouga, G; Liu, MC; Larish, A; Lemens, MA; Sommerfield, MKS; Cappuccio, S; Cheville, JC; Vasmatzis, G; Mariani, A				Grassi, Tommaso; Harris, Faye R.; Smadbeck, James B.; Murphy, Stephen J.; Block, Matthew S.; Multinu, Francesco; Klein, Janet L. Schaefer; Zhang, Piyan; Karagouga, Giannoula; Liu, Minetta C.; Larish, Alyssa; Lemens, Maureen A.; Sommerfield, Marla Kay S.; Cappuccio, Serena; Cheville, John C.; Vasmatzis, George; Mariani, Andrea			Personalized tumor-specific DNA junctions to detect circulating tumor in patients with endometrial cancer	PLOS ONE			English	Article							CELL-FREE DNA; CHROMOSOMAL REARRANGEMENTS; GENOME	Introduction There are no reliable blood biomarkers for monitoring endometrial cancer patients in the current clinical practice. Circulating tumor DNA (ctDNA) is emerging as a promising non-invasive method to measure tumor burden, define prognosis and monitor disease status in many solid cancers. In this pilot study, we investigated if unique tumor-specific DNA junctions can be used to detect ctDNA levels in patients with endometrial cancer. Methods Chromosomal rearrangements in primary tumors of eleven patients with high-grade or advanced stage endometrial cancer were determined by whole-genome Mate-Pair sequencing. Identified unique tumor-specific junctions were evaluated in pre- and six-week post-surgery patient plasma using individualized quantitative polymerase chain reaction (qPCR) assays. The relationship between clinicopathological features and detection of ctDNA was investigated. Results CtDNA was detected in 60% (6/10) of cases pre-surgery and in 27% (3/11) post-surgery. The detection of ctDNA pre-surgery was consistent with clinical indicators of aggressive disease such as advanced stage (80% - 4/5), lymphatic spread of disease (100% - 3/3), serous histology (80% - 4/5), deep myometrial invasion (100% - 3/3), lympho-vascular space invasion (75% - 3/4). All patients in which ctDNA was detected post-surgically had type II endometrial cancer. Discussion This pilot study demonstrates the feasibility of using personalized tumor-specific junction panels for detecting ctDNA in the plasma of endometrial cancer patients. Larger studies and longer follow-up are needed to validate the potential association between pre-surgical ctDNA detection and the presence of cancers with aggressive pathologic tumor characteristics or advanced stage observed in this study.	[Grassi, Tommaso; Multinu, Francesco; Larish, Alyssa; Lemens, Maureen A.; Sommerfield, Marla Kay S.; Cappuccio, Serena; Mariani, Andrea] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN USA; [Grassi, Tommaso] Univ Milano Bicocca, San Gerardo Hosp, Clin Obstet & Gynecol, Monza, Italy; [Harris, Faye R.; Smadbeck, James B.; Murphy, Stephen J.; Klein, Janet L. Schaefer; Zhang, Piyan; Karagouga, Giannoula; Vasmatzis, George] Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA; [Block, Matthew S.; Liu, Minetta C.] Mayo Clin, Dept Oncol, Rochester, MN USA; [Multinu, Francesco] IRCCS, European Inst Oncol, IEO, Dept Gynecol, Milan, Italy; [Cappuccio, Serena] Univ Cattolica Sacro Cuore, Dept Women & Child Hlth, Rome, Italy; [Cheville, John C.] Mayo Clin, Lab Med & Pathol, Rochester, MN USA	Mayo Clinic; San Gerardo Hospital; University of Milano-Bicocca; Mayo Clinic; Mayo Clinic; IRCCS European Institute of Oncology (IEO); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Mayo Clinic	Vasmatzis, G (corresponding author), Mayo Clin, Ctr Individualized Med, Rochester, MN 55905 USA.	Vasmatzis.george@mayo.edu	cappuccio, serena/AAC-5427-2022	Grassi, Tommaso/0000-0001-9404-0596	Center for Individualized Medicine of Mayo Clinic; Biomarker Discovery Program within the Center for Individualized Medicine of Mayo Clinic	Center for Individualized Medicine of Mayo Clinic; Biomarker Discovery Program within the Center for Individualized Medicine of Mayo Clinic	This work was supported by the Center for Individualized Medicine, and the Biomarker Discovery Program within the Center for Individualized Medicine, both of Mayo Clinic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink K., 2018, TUMOUR BIOL, V40, p1010428318757103, DOI [10.1177/1010428318757103, DOI 10.1177/1010428318757103]; Bolivar AM, 2019, MODERN PATHOL, V32, P405, DOI 10.1038/s41379-018-0158-8; Casas-Arozamena C, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020585; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Devonshire AS, 2014, ANAL BIOANAL CHEM, V406, P6499, DOI 10.1007/s00216-014-7835-3; Drucker TM, 2014, BIOINFORMATICS, V30, P1627, DOI 10.1093/bioinformatics/btu078; Gaitatzes A, 2018, BIOINFORMATICS, V34, P1629, DOI 10.1093/bioinformatics/btx829; Garcia-Murillas I, 2015, SCI TRANSL MED, V7, DOI [10.1126/scitranslmed.aab0021, 10.1126/scitranslmed.aac7551]; Harris FR, 2016, SCI REP-UK, V6, DOI 10.1038/srep29831; Iijima Y, 2017, EUR J CANCER, V86, P349, DOI 10.1016/j.ejca.2017.09.004; Iwahashi N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47030-w; Jemal A, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djx030; Johnson SH, 2018, CANCER GENET-NY, V221, P1, DOI 10.1016/j.cancergen.2017.11.009; Kurman RJ., 2014, WHO CLASSIFICATION T; Moss EL, 2020, CANCERS, V12, DOI 10.3390/cancers12082231; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Pereira E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145754; Shigemizu D, 2013, SCI REP-UK, V3, DOI 10.1038/srep02161; Shintani D, 2020, INT J GYNECOL CANCER, V30, P1340, DOI 10.1136/ijgc-2019-001053; Silveira AB, 2020, CLIN CHEM, V66, P606, DOI 10.1093/clinchem/hvaa013; Smadbeck JB, 2018, GENE CHROMOSOME CANC, V57, P459, DOI 10.1002/gcc.5; Tanaka H, 2012, INT J GYNECOL CANCER, V22, P82, DOI 10.1097/IGC.0b013e3182328c94; Tie J, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6219; Vizza E, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0688-4; Yost KJ, 2014, OBSTET GYNECOL, V124, P307, DOI 10.1097/AOG.0000000000000372	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252390	10.1371/journal.pone.0252390	http://dx.doi.org/10.1371/journal.pone.0252390			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111149	gold, Green Published			2022-12-26	WOS:000664642700026
J	Nahi, SL; Shetty, AA; Tanna, SD; Leventhal, JR				Nahi, Skylar L.; Shetty, Aneesha A.; Tanna, Sajal D.; Leventhal, Joseph R.			Renal allograft function in kidney transplant recipients infected with SARS-CoV 2: An academic single center experience	PLOS ONE			English	Article								Background Kidney transplant recipients are a unique cohort in regard to SARS-CoV 2 susceptibility and clinical course, owing to their immunosuppressed state and propensity for kidney injury. The primary purpose of this study is to ascertain if, in kidney transplant recipients, SARS-CoV 2 infection impacts long term renal allograft function. Methods This retrospective, single-center study reviewed 53 kidney transplant recipients with a positive SARS-CoV-2 PCR at NMH from January 1, 2020 to June 30, 2020. Results Change in eGFR from baseline kidney function prior to infection to 90 days after the first positive SARS-CoV 2 test was +1.76%, -17.5% and -23.16% the mild, moderate and severe disease groups respectively. There was a significant decline in kidney function in the moderate and severe disease cohorts as compared to the mild disease cohort, with respective p values of p = 0.0002 and p = 0.021. Relative to the mild disease cohort, the moderate and severe disease cohorts also demonstrated significantly increased risk of developing AKI (66%, 85%), both with p values of P = 0.0001. Conclusions Clinically severe SARS-CoV 2 infection is associated with greater risk of acute kidney injury and greater decline in renal allograft function at 90 days post infection, compared to mild disease.	[Nahi, Skylar L.; Leventhal, Joseph R.] Northwestern Univ, Dept Surg Organ Transplantat, Chicago, IL 60611 USA; [Shetty, Aneesha A.] Northwestern Univ, Dept Nephrol & Hypertens, Chicago, IL 60611 USA; [Tanna, Sajal D.] Northwestern Univ, Dept Infect Dis, Chicago, IL 60611 USA	Northwestern University; Northwestern University; Northwestern University	Leventhal, JR (corresponding author), Northwestern Univ, Dept Surg Organ Transplantat, Chicago, IL 60611 USA.	jleventh@nm.org		Nahi, Skylar/0000-0001-7208-1266				Alberici F, 2020, KIDNEY INT REP, V5, P580, DOI 10.1016/j.ekir.2020.04.001; Banas B, 2020, TRANSPL P, V52, P102, DOI 10.1016/j.transproceed.2019.11.003; Cajamarca-Baron Jairo, 2021, Reumatol Clin (Engl Ed), V17, P408, DOI 10.1016/j.reumae.2020.08.001; D'Antiga L, 2020, LIVER TRANSPLANT, V26, P832, DOI 10.1002/lt.25756; Florescu DF, 2019, CURR OPIN INFECT DIS, V32, P300, DOI 10.1097/QCO.0000000000000558; Francois H, 2020, AM J TRANSPLANT; Gabarre P, 2020, INTENS CARE MED, V46, P1339, DOI 10.1007/s00134-020-06153-9; Gagliardi I, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082506; Hui DS, 2018, LANCET INFECT DIS, V18, pE217, DOI 10.1016/S1473-3099(18)30127-0; Johnson KM, 2020, PHARMACOTHERAPY, V40, P517, DOI 10.1002/phar.2410; Michalakis K, 2020, DIABETES METAB SYND, V14, P469, DOI 10.1016/j.dsx.2020.04.033; Mucha Krzysztof, 2019, Pol Arch Intern Med, V129, P1, DOI 10.20452/pamw.15012; Perico L, 2020, NEPHRON, V144, P213, DOI 10.1159/000507305; Ronco C, 2020, LANCET RESP MED, V8, P738, DOI 10.1016/S2213-2600(20)30229-0; Shetty AA, 2021, J AM SOC NEPHROL, V32, P33, DOI 10.1681/ASN.2020060804; Stockman LJ, 2007, PEDIATR INFECT DIS J, V26, P68, DOI 10.1097/01.inf.0000247136.28950.41; Vahidy FS, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039849; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017	18	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252979	10.1371/journal.pone.0252979	http://dx.doi.org/10.1371/journal.pone.0252979			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111211	gold, Green Published			2022-12-26	WOS:000664642700078
J	Jeremiah, K; Lyimo, E; Ritz, C; PrayGod, G; Rutkowski, KT; Korsholm, KS; Ruhwald, M; Tait, D; Grewal, HMS; Faurholt-Jepsen, D				Jeremiah, Kidola; Lyimo, Eric; Ritz, Christian; PrayGod, George; Rutkowski, Kathryn Tucker; Korsholm, Karen Smith; Ruhwald, Morten; Tait, Dereck; Grewal, Harleen M. S.; Faurholt-Jepsen, Daniel			Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania	PLOS ONE			English	Article							HIV EPIDEMIC; ANNUAL RISK; VACCINE; TRANSMISSION; COMMUNITY; CHILDREN; DISEASE; TRIAL; KENYA; AGE	Background The prevalence of latent tuberculosis infection (LTBI) is vastly higher than that of tuberculosis (TB) disease and this enormous reservoir of individuals with LTBI impacts the global TB control strategy. Adolescents are at greatest risk of TB infection and are thus an ideal target population for a potential effective TB vaccine to be added to the current BCG programme as it could reduce the number of latent infections and consequently the number of adults with TB disease. However, LTBI rates are often unknown for this population. This study aims to estimate the magnitude of LTBI and to determine if Tanzanian adolescents would be a good population for a prevention of TB infection trial. Methods This was a descriptive cross-sectional study that recruited 193 adolescents aged 12 and 16 years from government schools and directly from the community in Mwanza Region, Tanzania. Socio-demographic characteristics were collected for all enrolled participants. Blood was drawn and tested using QuantiFERON-TB Gold In-Tube (QFT-GIT), and Early Secretory Antigenic Target-6-Free Interferon-gamma Release Assay (ESAT-6 free IGRA). Concordance between QFT-GIT and ESAT-6 free IGRA was evaluated using the McNemar's test. Results Overall estimates of LTBI prevalence were 19.2% [95%CI, 14.1; 25.2] and 18.6% [95%CI, 13.6; 24.6] as measured by QFT-GIT IGRA and ESAT-6 free IGRA, respectively. The 16-year-old cohort had a higher LTBI prevalence (23.7% [95%CI, 16.1; 32.9]) as compared to 12-year-old cohort (14.6% [95%CI, 8.6; 22.7]) as measured by QFT-GIT IGRA. When measured by ESAT-6 Free IGRA, LTBI prevalence was 24.7% (95%CI, 16.9; 34.0) for the 16-year-old cohort and 12.5% (95%CI, 7.0; 20.3) among the 12-year-old cohort. According to both tests the prevalence of TB infection and the corresponding annual risk of tuberculosis infection (ARTI) and force of infection were high and increased with age. Of all enrolled participants, 97.4% had concordant results for QFT-GIT IGRA and ESAT-6 free IGRA (p = 0.65). Conclusions The prevalence of LTBI and the associated ARTI and force of infection among adolescents is high and increases with age in Mwanza Region. There was a high concordance between the QFT-GIT and the novel ESAT-6 free IGRA assays. These findings suggest Mwanza is a promising area to conduct novel TB vaccine research prevention of infection (POI) studies targeting adolescents.	[Jeremiah, Kidola; Lyimo, Eric; PrayGod, George] Mwanza Res Ctr, Natl Inst Med Res, Mwanza, Tanzania; [Ritz, Christian] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Rutkowski, Kathryn Tucker] Int AIDS Vaccine Initiat IAVI, New York, NY USA; [Rutkowski, Kathryn Tucker; Korsholm, Karen Smith] Statens Serum Inst SSI, Ctr Vaccine Res, Dept Infect Immunol, Copenhagen, Denmark; [Korsholm, Karen Smith; Ruhwald, Morten] Statens Serum Inst SSI, Ctr Vaccine Res, Dept Vaccine Dev, Copenhagen, Denmark; [Ruhwald, Morten] Fdn Innovat New Diagnost, Geneva, Switzerland; [Tait, Dereck] Int AIDS Vaccine Initiat IAVI NPC, Cape Town, South Africa; [Grewal, Harleen M. S.] Univ Bergen, Fac Med, BIDS Grp, Dept Clin Sci, Bergen, Norway; [Grewal, Harleen M. S.] Haukeland Hosp, Dept Microbiol, Bergen, Norway; [Faurholt-Jepsen, Daniel] Rigshosp, Dept Infect Dis, Copenhagen, Denmark	National Institute of Medical Research; University of Copenhagen; International AIDS Vaccine Initiative; Statens Serum Institut; Statens Serum Institut; Foundation For Innovative New Diagnostics; University of Bergen; University of Bergen; Haukeland University Hospital; Rigshospitalet; University of Copenhagen	Jeremiah, K (corresponding author), Mwanza Res Ctr, Natl Inst Med Res, Mwanza, Tanzania.	jkidola@gmail.com	Faurholt-Jepsen, Daniel/M-6324-2019; Ritz, Christian/P-6159-2014	Faurholt-Jepsen, Daniel/0000-0001-8561-0155; Lyimo, Eric/0000-0002-1904-7410; Ritz, Christian/0000-0002-5095-0624; Jeremiah, Kidola/0000-0001-7900-9689	Research Council of Norway, Global Health and Vaccination Research (GLOBVAC) project [248042]; Statens Serum Institut; European Union; IAVI South Africa NPC	Research Council of Norway, Global Health and Vaccination Research (GLOBVAC) project(Research Council of Norway); Statens Serum Institut; European Union(European Commission); IAVI South Africa NPC	This study was funded jointly by the Research Council of Norway, Global Health and Vaccination Research (GLOBVAC) project (248042), Statens Serum Institut and Aeras Global TB Vaccine Foundation NPC, (currently IAVI South Africa NPC). The project is also part of the EDCTP 2 programme supported by the European Union. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funders. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; [Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; [Anonymous], 2020, GLOBAL TUBERCULOSIS; Cellestis, 2015, QUANTIFERON TB GOLD; Dodd PJ, 2016, AM J EPIDEMIOL, V183, P156, DOI 10.1093/aje/kwv160; Dye C, 2000, INT J TUBERC LUNG D, V4, pS146; Dye C, 2008, J R SOC INTERFACE, V5, P653, DOI 10.1098/rsif.2007.1138; Egwaga SA, 2006, AIDS, V20, P915, DOI 10.1097/01.aids.0000218557.44284.83; Ellis RD, 2015, TUBERCULOSIS, V95, P352, DOI 10.1016/j.tube.2015.02.036; Evans TG, 2013, VACCINE, V31, pB223, DOI 10.1016/j.vaccine.2012.11.081; Fan WC, 2014, LUNG CANCER, V85, P472, DOI 10.1016/j.lungcan.2014.07.001; Getahun H, 2015, NEW ENGL J MED, V372, P2127, DOI 10.1056/NEJMra1405427; Jensen AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064008; Khoshnood S, 2018, INT J BIOL MACROMOL, V120, P180, DOI 10.1016/j.ijbiomac.2018.08.037; Kifai EJ., 2009, TANZANIA E AFR J PUB, V6, P211, DOI [10.4314/eajph.v6i2.51786, DOI 10.4314/EAJPH.V6I2.51786]; Luabeya AKK, 2015, VACCINE, V33, P4130, DOI 10.1016/j.vaccine.2015.06.051; Machingaidze S, 2012, AM J RESP CRIT CARE, V186, P1051, DOI 10.1164/rccm.201206-1134OC; Mahomed H, 2011, INT J TUBERC LUNG D, V15, P331; Mahomed H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059652; Mahomed H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017984; McNerney R, 2012, J INFECT DIS, V205, pS147, DOI 10.1093/infdis/jir860; Middelkoop K, 2008, CLIN INFECT DIS, V47, P349, DOI 10.1086/589750; Middelkoop K, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-156; MIGLIORI GB, 1994, EUR RESPIR J, V7, P946; Nduba V, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4314-7; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/NEJMoa1714021, 10.1056/nejmoa1714021]; Nemes E, 2019, CLIN INFECT DIS, V69, P1724, DOI 10.1093/cid/ciz034; Odhiambo JA, 1999, AM J PUBLIC HEALTH, V89, P1078, DOI 10.2105/AJPH.89.7.1078; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Ruhwald M, 2017, SCI REP-UK, V7, DOI 10.1038/srep45969; Statistics TNBo, 2012, 2012 CENS DAT; TB/COVID-19 Global Study Group, 2022, EUR RESPIR J, V59, P2102538, DOI [10.1183/13993003.02538-2021, DOI 10.1183/13993003.02538-2021]; Triasih R, 2015, TROP MED INT HEALTH, V20, P737, DOI 10.1111/tmi.12484; Wood R, 2010, INT J TUBERC LUNG D, V14, P406	34	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252808	10.1371/journal.pone.0252808	http://dx.doi.org/10.1371/journal.pone.0252808			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097715	Green Published, gold			2022-12-26	WOS:000664640700018
J	Galal, TM; Hassan, LM; Ahmed, DA; Alamri, SAM; Alrumman, SA; Eid, EM				Galal, Tarek M.; Hassan, Loutfy M.; Ahmed, Dalia A.; Alamri, Saad A. M.; Alrumman, Sulaiman A.; Eid, Ebrahem M.			Heavy metals uptake by the global economic crop (Pisum sativum L.) grown in contaminated soils and its associated health risks	PLOS ONE			English	Article							SEWAGE IRRIGATION; VEGETABLES; CADMIUM; QUALITY; STRESS; FRUITS; WATER; LEAD	The aim of the present investigation was to determine the concentration of heavy metals in the different organs of Pisum sativum L. (garden pea) grown in contaminated soils in comparison to nonpolluted soils in the South Cairo and Giza provinces, Egypt, and their effect on consumers' health. To collect soil and plant samples from two nonpolluted and two polluted farms, five quadrats, each of 1 m(2), were collected per each farm and used for growth measurement and chemical analysis. The daily intake of metals (DIM) and its associated health risks (health risk index (HRI) were also assessed. The investigated heavy metals were cadmium (Cd), arsenic (As), chromium (Cr), copper (Cu), nickel (Ni), iron (Fe), manganese (Mn), zinc (Zn), silver (Ag), cobalt (Co) and vanadium (V). Significant differences in soil heavy metals, except As, between nonpolluted and polluted sites were recorded. Fresh and dry phytomass, photosynthetic pigments, fruit production, and organic and inorganic nutrients were reduced in the polluted sites, where there was a high concentration of heavy metals in the fruit. The bioaccumulation factor for all studied heavy metals exceeded 1 in the polluted sites and only Pb, Cu and Mn exceeded 1 in the nonpolluted sites. Except for Fe, the DIM of the studied heavy metals in both sites did not exceed 1 in either children or adults. However, the HRI of Pb, Cd, Fe, and Mn in the polluted plants and Pb in the nonpolluted ones exceeded 1, indicating significant potential health risks to consumers. The authors recommend not to eat garden peas grown in the polluted sites, and farmers should carefully grow heavy metals non-accumulating food crops or non-edible plants for other purposes such as animal forages.	[Galal, Tarek M.; Hassan, Loutfy M.] Helwan Univ, Dept Bot & Microbiol, Fac Sci, Cairo, Egypt; [Galal, Tarek M.] Taif Univ, Dept Biol, Coll Sci, At Taif, Saudi Arabia; [Ahmed, Dalia A.] Tanta Univ, Dept Bot, Fac Sci, Tanta, Egypt; [Alamri, Saad A. M.; Alrumman, Sulaiman A.; Eid, Ebrahem M.] King Khalid Univ, Coll Sci, Dept Biol, Abha, Saudi Arabia; [Eid, Ebrahem M.] Kafrelsheikh Univ, Dept Bot, Fac Sci, Kafr Al Sheikh, Egypt	Egyptian Knowledge Bank (EKB); Helwan University; Taif University; Egyptian Knowledge Bank (EKB); Tanta University; King Khalid University; Egyptian Knowledge Bank (EKB); Kafrelsheikh University	Galal, TM (corresponding author), Helwan Univ, Dept Bot & Microbiol, Fac Sci, Cairo, Egypt.; Galal, TM (corresponding author), Taif Univ, Dept Biol, Coll Sci, At Taif, Saudi Arabia.	tarekhelwan@yahoo.com	Alamri, Saad/AGM-5459-2022; Ahmed, Dalia/AAJ-7366-2020	Ahmed, Dalia/0000-0001-7115-9375; Galal, Tarek/0000-0001-9847-1051; Eid, Ebrahem/0000-0003-2452-4469	Scientific Research Deanship at King Khalid University; Ministry of Education in Saudi Arabia [IFP-KKU-2020/3]	Scientific Research Deanship at King Khalid University; Ministry of Education in Saudi Arabia	The authors extend their appreciation to the Scientific Research Deanship at King Khalid University and the Ministry of Education in Saudi Arabia for funding this research work through the project number IFP-KKU-2020/3.	Ahmad Parvaiz, 2006, Physiology and Molecular Biology of Plants, V12, P59; ALI MHH, 2012, EGYPT J AQUATIC RES, V38, P31, DOI DOI 10.1016/j.ejar.2012.08.002; Allen SE, 1989, CHEM ANAL ECOLOGICAL; [Anonymous], 2000, METHODS INORGANIC PO; Asgari K, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4565-8; Aydinalp C, 2003, POL J ENVIRON STUD, V12, P629; Bakht J, 2016, SAINS MALAYS, V45, P167; Borah M., 2012, INT J ADV BIOL RES, V2, P314; Chen Y, 2014, SCI AGR, V71, P126, DOI 10.1590/S0103-90162014000200006; Chibuike G.U., 2014, APPL ENVIRON SOIL SC, DOI [10.1155/2014/752708, DOI 10.1155/2014/752708, 10.1155/ 2014/752708]; Chowdhury M. A. H., 2019, Journal of the Bangladesh Agricultural University, V17, P288, DOI 10.3329/jbau.v17i3.43198; Dan A, 2017, SCI TOTAL ENVIRON, V584, P742, DOI 10.1016/j.scitotenv.2017.01.112; Dong Q, 2019, ENVIRON POLLUT, V252, P1406, DOI 10.1016/j.envpol.2019.06.079; Eid EM, 2020, J SOIL SCI PLANT NUT, V20, P149, DOI 10.1007/s42729-019-00113-z; Eid EM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41807-9; El-Sherbiny AE., 2014, 4 INT C RAD SCI APPL; Elkhatib HA, 2007, J AGRI ENV SCI ALEX, V6, P218; FAOSTAT, CROPS; Galal TM, 2019, INT J PHYTOREMEDIAT, V21, P1397, DOI 10.1080/15226514.2018.1524842; Galal TM, 2018, INT J PHYTOREMEDIAT, V20, P1007, DOI 10.1080/15226514.2018.1452186; Galal TM, 2016, ENVIRON MONIT ASSESS, V188, DOI 10.1007/s10661-016-5448-3; Guerra F, 2012, SCI AGR, V69, P54, DOI 10.1590/S0103-90162012000100008; HARE L, 1992, CRIT REV TOXICOL, V22, P327, DOI 10.3109/10408449209146312; Horiguchi H, 2004, ENVIRON RES, V95, P20, DOI 10.1016/S0013-9351(03)00142-7; Horler D. N. H., 1980, International Journal of Remote Sensing, V1, P121, DOI 10.1080/01431168008547550; Hu S, 2020, J CLEAN PROD, V266, DOI 10.1016/j.jclepro.2020.121991; Hu WY, 2017, CHEMOSPHERE, V170, P183, DOI 10.1016/j.chemosphere.2016.12.047; Iglesias-Garcia R, 2017, CROP PASTURE SCI, V68, P915, DOI [10.1071/CP16423, 10.1071/cp16423]; Jhamaria C, 2015, INT J ENV ECOL FAM U, V5, P1; John R, 2008, PLANT SOIL ENVIRON, V54, P262, DOI 10.17221/2787-PSE; Kumar Vinod, 2012, Journal of Stress Physiology & Biochemistry, V8, P203; Lionetto MG, 2016, REND LINCEI-SCI FIS, V27, P105, DOI 10.1007/s12210-015-0486-2; Liu WH, 2005, ENVIRON INT, V31, P805, DOI 10.1016/j.envint.2005.05.042; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mahurpawar M., 2015, INT J RESEACRH GRANT, V3, P1, DOI [10.29121/granthaalayah.v3.i9se.2015.3282, DOI 10.29121/GRANTHAALAYAH.V3.I9SE.2015.3282]; Mansur U. D., 2010, Bayero Journal of Pure and Applied Sciences, V3, P255; METZNER H, 1965, PLANTA, V65, P186, DOI 10.1007/BF00384998; Oteef MDY, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4905-8; Palma JM, 2002, PLANT PHYSIOL BIOCH, V40, P521, DOI 10.1016/S0981-9428(02)01404-3; Radwan MA, 2006, FOOD CHEM TOXICOL, V44, P1273, DOI 10.1016/j.fct.2006.02.004; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; Sajjad Khan, 2009, World Applied Sciences Journal, V6, P1602; Shehata HS, 2020, J CONSUM PROT FOOD S, V15, P205, DOI 10.1007/s00003-020-01284-z; Singh S, 2012, J ENV CHEM ECOTOXICO, V24, P170; Singh S, 2010, TROP GRASSLANDS, V44, P55; Sobukola OP, 2007, FOOD SCI TECHNOL INT, V13, P35, DOI 10.1177/1082013207075953; Sonil Nanda, 2013, African Journal of Biotechnology, V12, P3099; SPSS, 2006, SPSS BAS 150 US GUID; Toth G, 2016, ENVIRON INT, V88, P299, DOI 10.1016/j.envint.2015.12.017; Udita Gubrelay, 2013, International Journal of Agriculture and Crop Sciences (IJACS), V5, P2743; Umbriet W. W., 1959, MONOMETRIC TECHNIQUE, P239; United States Environmental Protection Agency (USEPA), 2010, RISK BASED CONCENTRA; US-EPA (United States Environmental Protection Agency), 2012, 1A US EPA IRIS; US-EPA (United States Environmental Protection Agency), 2013, 1A UA EPA IRIS; Wang YC, 2012, J ENVIRON SCI, V24, P690, DOI 10.1016/S1001-0742(11)60833-4; WHO, 1996, WATER QUALITY WASTE, V2nd; WHO/FAO (World Health Organization Food and Agriculture Organization of the United Nations), 2004, 61 REPORT JOINT FAO; WHO/FAO (World Health Organization Food and Agriculture Organization of the United Nations), 2013, GUIDELINES SAFE USE; Xiao Q, 2015, ECOTOX ENVIRON SAFE, V120, P377, DOI 10.1016/j.ecoenv.2015.06.019; Zeid I. M., 2013, International Journal of Agronomy and Plant Production, V4, P984; Zeng XF, 2015, ECOTOXICOLOGY, V24, P2115, DOI 10.1007/s10646-015-1547-0	61	8	8	9	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252229	10.1371/journal.pone.0252229	http://dx.doi.org/10.1371/journal.pone.0252229			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086714	gold, Green Published			2022-12-26	WOS:000664640100038
J	Larson, J; Perkins, E; Oldfather, T; Zabala, M				Larson, Jacob; Perkins, Edmon; Oldfather, Taylor; Zabala, Michael			Local dynamic stability of the lower-limb as a means of post-hoc injury classification	PLOS ONE			English	Article							LARGEST LYAPUNOV EXPONENT; JOINT COORDINATE SYSTEM; PART 1; KNEE; KINEMATICS; MOTION; RISK; GAIT; HIP; RECONSTRUCTION	Since most sporting injuries occur at the lower extremity (50% to 66%) and many of those injuries occur at the knee (30% to 45%), it is important to have robust metrics to measure risk of knee injury. Dynamic measures of knee stability are not commonly used in existing metrics but could provide important context to knee health and improve injury screening effectiveness. This study used the Local Dynamic Stability (LDS) of knee kinematics during a repetitive vertical jump to perform a post-hoc previous injury classification of participants. This study analyzed the kinematics from twenty-seven female collegiate division 1 (D1) soccer, D1 basketball, and club soccer athletes from Auburn University (height = 171 +/- 8.9cm, weight = 66.3 +/- 8.6kg, age = 19.8 +/- 1.9yr), with 7 subjects having sustained previous knee injury requiring surgery and 20 subjects with no history of injury. This study showed that LDS correctly identified 84% of previously injured and uninjured subjects using a multivariate logistic regression during a fatigue jump task. Findings showed no statistical difference in kinematic position at maximum knee flexion during all jumps between previously injured and uninjured subjects. Additionally, kinematic positioning at maximum knee flexion was not indicative of LDS values, which would indicate that future studies should look specifically at LDS with respect to injury prevention as it cannot be effectively inferred from kinematics. These points suggest that the LDS preserves information about subtle changes in movement patterns that traditional screening methods do not, and this information could allow for more effective injury screening tests in the future.	[Larson, Jacob; Oldfather, Taylor; Zabala, Michael] Auburn Univ, Dept Mech Engn, Auburn, AL 36849 USA; [Perkins, Edmon] North Carolina State Univ, Dept Mech & Aerosp Engn, Raleigh, NC USA	Auburn University System; Auburn University; University of North Carolina; North Carolina State University	Larson, J (corresponding author), Auburn Univ, Dept Mech Engn, Auburn, AL 36849 USA.	jsl0043@auburn.edu		Larson, Jacob/0000-0002-2154-0239; Perkins, Edmon/0000-0003-1988-5075				Andriacchi TP, 1998, J BIOMECH ENG-T ASME, V120, P743, DOI 10.1115/1.2834888; Arai T, 2013, CLIN BIOMECH, V28, P642, DOI 10.1016/j.clinbiomech.2013.05.003; Bahr R, 2016, BRIT J SPORT MED, V50, P776, DOI 10.1136/bjsports-2016-096256; Bulgheroni P, 1997, Knee Surg Sports Traumatol Arthrosc, V5, P14, DOI 10.1007/s001670050018; Cesar GM, 2016, SPORT BIOMECH, V15, P440, DOI 10.1080/14763141.2016.1174286; Chakraborty S, 2020, J BIOMECH, V104, DOI 10.1016/j.jbiomech.2020.109718; Dingenen B, 2015, CLIN BIOMECH, V30, P781, DOI 10.1016/j.clinbiomech.2015.06.013; Graci V, 2012, GAIT POSTURE, V36, P461, DOI 10.1016/j.gaitpost.2012.04.006; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Hamill J, 1999, CLIN BIOMECH, V14, P297, DOI 10.1016/S0268-0033(98)90092-4; Herzog MM, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116684776; Hewett TE, 2006, AM J SPORT MED, V34, P299, DOI 10.1177/0363546505284183; Hewett TE, 2005, AM J SPORT MED, V33, P492, DOI 10.1177/0363546504269591; Howard JS, 2011, J ATHL TRAINING, V46, P376; Hurd WI, 2007, J ORTHOP RES, V25, P1369, DOI 10.1002/jor.20440; Ishida T, 2014, KNEE, V21, P563, DOI 10.1016/j.knee.2012.12.002; Lam KC, 2017, J ATHL TRAINING, V52, P534, DOI 10.4085/1062-6050-50.5.01; Lie MM, 2019, BRIT J SPORT MED, V53, P1162, DOI 10.1136/bjsports-2018-099751; Lockhart T, 2008, ERGONOMICS, V51, P1860, DOI 10.1080/00140130802567079; Look N, 2013, CHAOS, V23, DOI 10.1063/1.4837095; Mehdizadeh S, 2018, GAIT POSTURE, V60, P241, DOI 10.1016/j.gaitpost.2017.12.016; Myer GD, 2005, J ELECTROMYOGR KINES, V15, P181, DOI 10.1016/j.jelekin.2004.08.006; Nayfeh A.H., 2004, APPL NONLINEAR DYNAM; Nessler JA, 2011, GAIT POSTURE, V34, P285, DOI 10.1016/j.gaitpost.2011.04.003; O'Kane JW, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967117733963; Padua DA, 2009, AM J SPORT MED, V37, P1996, DOI 10.1177/0363546509343200; Palsis JA, 2018, J BONE JOINT SURG AM, V100, P326, DOI 10.2106/JBJS.17.00161; Perc M, 2005, EUR J PHYS, V26, P525, DOI 10.1088/0143-0807/26/3/017; Raffalt PC, 2019, ANN BIOMED ENG, V47, P913, DOI 10.1007/s10439-019-02216-1; ROSENSTEIN MT, 1993, PHYSICA D, V65, P117, DOI 10.1016/0167-2789(93)90009-P; Sloot LH, 2011, ANN BIOMED ENG, V39, P1563, DOI 10.1007/s10439-010-0240-y; Tamura A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179810; Turner C, 2018, PHYS THER SPORT, V31, P1, DOI 10.1016/j.ptsp.2017.12.002; Ursei ME, 2020, ORTHOP TRAUMATOL-SUR, V106, P179, DOI 10.1016/j.otsr.2019.07.009; van Emmerik REA, 2016, J SPORT HEALTH SCI, V5, P3, DOI 10.1016/j.jshs.2016.01.013; van Schooten KS, 2013, J BIOMECH, V46, P137, DOI 10.1016/j.jbiomech.2012.10.032; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Xiang LL, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10051893; Ying J., 2021, PHYS ACTIVITY HLTH, V5; Yu B, 1999, J APPL BIOMECH, V15, P318, DOI 10.1123/jab.15.3.318	41	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252839	10.1371/journal.pone.0252839	http://dx.doi.org/10.1371/journal.pone.0252839			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086814	gold, Green Published			2022-12-26	WOS:000664640100148
J	Suay-Corredera, C; Pricolo, MR; Herrero-Galan, E; Velazquez-Carreras, D; Sanchez-Ortiz, D; Garcia-Giustiniani, D; Delgado, J; Galano-Frutos, JJ; Garcia-Cebollada, H; Vilches, S; Dominguez, F; Molina, MS; Barriales-Villa, R; Frisso, G; Sancho, J; Serrano, L; Garcia-Pavia, P; Monserrat, L; Alegre-Cebollada, J				Suay-Corredera, Carmen; Rosaria Pricolo, Maria; Herrero-Galan, Elias; Velazquez-Carreras, Diana; Sanchez-Ortiz, David; Garcia-Giustiniani, Diego; Delgado, Javier; Jose Galano-Frutos, Juan; Garcia-Cebollada, Helena; Vilches, Silvia; Dominguez, Fernando; Sabater Molina, Maria; Barriales-Villa, Roberto; Frisso, Giulia; Sancho, Javier; Serrano, Luis; Garcia-Pavia, Pablo; Monserrat, Lorenzo; Alegre-Cebollada, Jorge			Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-BINDING; CARDIAC MYOSIN; C GENE; MOLECULAR DIAGNOSIS; CIRCULAR-DICHROISM; SEQUENCE VARIANTS; SITE MUTATION; DOMAIN; IDENTIFICATION; GUIDELINES	Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. Variants in MYBPC3, the gene encoding cardiac myosin-binding protein C (cMyBP-C), are the leading cause of HCM. However, the pathogenicity status of hundreds of MYBPC3 variants found in patients remains unknown, as a consequence of our incomplete understanding of the pathomechanisms triggered by HCM-causing variants. Here, we examined 44 nontruncating MYBPC3 variants that we classified as HCM-linked or nonpathogenic according to cosegregation and population genetics criteria. We found that around half of the HCM-linked variants showed alterations in RNA splicing or protein stability, both of which can lead to cMyBP-C haploinsufficiency. These protein haploinsufficiency drivers associated with HCM pathogenicity with 100% and 94% specificity, respectively. Furthermore, we uncovered that 11% of nontruncating MYBPC3 variants currently classified as of uncertain significance in ClinVar induced one of these molecular phenotypes. Our strategy, which can be applied to other conditions induced by protein loss of function, supports the idea that cMyBP-C haploinsufficiency is a fundamental pathomechanism in HCM.	[Suay-Corredera, Carmen; Rosaria Pricolo, Maria; Herrero-Galan, Elias; Velazquez-Carreras, Diana; Sanchez-Ortiz, David; Dominguez, Fernando; Alegre-Cebollada, Jorge] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain; [Rosaria Pricolo, Maria; Frisso, Giulia] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Garcia-Giustiniani, Diego; Monserrat, Lorenzo] Hlth Code A, La Coruna, Spain; [Delgado, Javier; Serrano, Luis] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Jose Galano-Frutos, Juan; Garcia-Cebollada, Helena; Sancho, Javier] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Fac Ciencias, Zaragoza, Spain; [Jose Galano-Frutos, Juan; Garcia-Cebollada, Helena; Sancho, Javier] Univ Zaragoza, Biocomputat & Complex Syst Phys Inst BIFI, Joint Units BIFI IQFR CSIC & GBs CSIC, Madrid, Spain; [Vilches, Silvia; Dominguez, Fernando; Garcia-Pavia, Pablo] Hosp Univ Puerta Hierro, Dept Cardiol, Heart Failure & Inherited Cardiac Dis Unit, Madrid, Spain; [Vilches, Silvia; Dominguez, Fernando; Sabater Molina, Maria; Garcia-Pavia, Pablo] European Reference Network Rare & Low Prevalence, Murcia, Spain; [Dominguez, Fernando; Barriales-Villa, Roberto; Garcia-Pavia, Pablo] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Sabater Molina, Maria] Hosp C Univ Virgen Arrixaca, Murcia, Spain; [Barriales-Villa, Roberto] Univ A Coruna, Serv Galego Saude SERGAS, Unidad Cardiopatias Familiares,Serv Galego Saude, Inst Invest Biomed Coruna INIBIC,Complexo Hosp Un, La Coruna, Spain; [Frisso, Giulia] Scarl, CEINGE Biotecnol Avanzate, Zaragoza, Spain; [Sancho, Javier] Aragon Hlth Res Inst IIS Aragon, Zaragoza, Spain; [Serrano, Luis] Inst Catalana Recerca & Estudis Avancats ICREA, Madrid, Spain; [Serrano, Luis] Univ Pompeu Fabra UPF, Barcelona, Spain; [Garcia-Pavia, Pablo] Univ Francisco Vitoria UFV, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Naples Federico II; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Zaragoza; University of Zaragoza; Hospital Puerta de Hierro-Majadahonda; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); ICREA; Pompeu Fabra University; Universidad Francisco de Vitoria	Alegre-Cebollada, J (corresponding author), Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain.	jalegre@cnic.es	Pricolo, Maria Rosaria/T-9200-2019; Galano-Frutos, Juan José/J-4337-2015; Alegre-Cebollada, Jorge/I-4301-2014; Herrero-Galán, Elías/L-1207-2014; Sancho, javier/AAA-1225-2019; Frisso, Giulia/A-5675-2014; Sabater-Molina, Maria/I-2722-2015	Pricolo, Maria Rosaria/0000-0002-6362-780X; Galano-Frutos, Juan José/0000-0002-1896-7805; Alegre-Cebollada, Jorge/0000-0003-0542-0170; Herrero-Galán, Elías/0000-0003-1916-6185; Sancho, javier/0000-0002-2879-9200; Garcia-Cebollada, Helena/0000-0002-9590-7371; Vilches-Soria, Silvia/0000-0001-8080-3329; Barriales-Villa, Roberto/0000-0002-6721-3487; Velazquez Carreras, Diana/0000-0002-0671-2549; Monserrat, Lorenzo/0000-0001-5776-0623; Sanchez-Ortiz, David/0000-0002-3551-6416; Sabater-Molina, Maria/0000-0003-1352-1748; Suay-Corredera, Carmen/0000-0003-2100-4847; Dominguez, Fernando/0000-0001-8408-363X	Ministerio de Ciencia e Innovacion (MCIN) [BIO2014-54768-P, BIO2017-83640-P, EIN2019-102966, RYC-2014-16604]; European Research Area Network on Cardiovascular Diseases (ERA-CVD/ISCIII, Spain MINOTAUR) [AC16/00045]; Comunidad de Madrid [S2018/NMT-4443]; ISCIII; Pro CNIC Foundation; Severo Ochoa Center of Excellence [SEV2015-0505]; ISCIII to the Centro de Investigacion Biomedica en Red [CB16/11/00425]; MCIN [BFU2015-63571-P, FPU16/04232]; Gobierno de Aragon [E45_17R]; ERDF-InterregV-A POCTEFA, Spain [PIREPREDEFA086/15, BES-2016-076638]; Italian Ministry of Education, Universities and Research, Italy; AEI [PID2019-107293GB-I00]	Ministerio de Ciencia e Innovacion (MCIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Area Network on Cardiovascular Diseases (ERA-CVD/ISCIII, Spain MINOTAUR); Comunidad de Madrid(Comunidad de Madrid); ISCIII(Instituto de Salud Carlos III); Pro CNIC Foundation; Severo Ochoa Center of Excellence(Spanish Government); ISCIII to the Centro de Investigacion Biomedica en Red; MCIN; Gobierno de Aragon(Gobierno de Aragon); ERDF-InterregV-A POCTEFA, Spain; Italian Ministry of Education, Universities and Research, Italy; AEI	J. A.-C. acknowledges funding from the Ministerio de Ciencia e Innovacion (MCIN) through grants BIO2014-54768-P; BIO2017-83640-P/MINECO/AEI/FEDER, UE; EIN2019-102966 and RYC-2014-16604, the European Research Area Network on Cardiovascular Diseases (ERA-CVD/ISCIII, Spain MINOTAUR, AC16/00045), and the Comunidad de Madrid (consortium Tec4Bio-CM, S2018/NMT-4443, FEDER). The CNIC is supported by the ISCIII, MCIN, and the Pro CNIC Foundation and was a Severo Ochoa Center of Excellence (SEV2015-0505). We acknowledge funding from ISCIII to the Centro de Investigacion Biomedica en Red (CB16/11/00425). L. S. acknowledges funding from MCIN (BFU2015-63571-P). J. S. acknowledges funding from AEI (PID2019-107293GB-I00), Gobierno de Aragon (E45_17R), and ERDF-InterregV-A POCTEFA, Spain (PIREPREDEFA086/15). C. S.-C. is the recipient of an FPI-SO predoctoral fellowship BES-2016-076638. M. R. P. was the recipient of a PhD fellowship from the Italian Ministry of Education, Universities and Research, Italy. H. G.-C. is the recipient of an FPU16/04232 doctoral contract from MCIN.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Alegre-Cebollada J, 2020, NANOMECHANICAL PHENO NANOMECHANICAL PHENO; Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Amato F, 2012, J MOL DIAGN, V14, P81, DOI 10.1016/j.jmoldx.2011.09.001; Andersen PS, 2004, EUR J HUM GENET, V12, P673, DOI 10.1038/sj.ejhg.5201190; Ashley EA, 2018, J AM COLL CARDIOL, V72, P430, DOI 10.1016/j.jacc.2018.05.029; Bagnall RD, 2018, J AM COLL CARDIOL, V72, P419, DOI 10.1016/j.jacc.2018.04.078; Bali V, 2015, INT J BIOCHEM CELL B, V64, P58, DOI 10.1016/j.biocel.2015.03.011; Bezold KL, 2013, J BIOL CHEM, V288, P21496, DOI 10.1074/jbc.M113.474346; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Braunwald E., 2015, HYPERTROPHIC CARDIOM, P1; Carrier L, 1997, CIRC RES, V80, P427, DOI 10.1161/01.res.0000435859.24609.b3; Cerny J., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/716945; Crehalet H, 2012, CARDIOGENETICS, V2, P26, DOI 10.4081/cardiogenetics.2012.e6; D'Argenio V, 2014, J MOL DIAGN, V16, P32, DOI 10.1016/j.jmoldx.2013.07.008; Da'as SI, 2018, BIOCHEM J, V475, P3933, DOI 10.1042/BCJ20180685; Doh CY, 2019, BBA-MOL BASIS DIS, V1865, P661, DOI 10.1016/j.bbadis.2019.01.007; Erdmann J, 2001, J AM COLL CARDIOL, V38, P322, DOI 10.1016/S0735-1097(01)01387-0; Frisso G, 2009, CLIN GENET, V76, P91, DOI 10.1111/j.1399-0004.2009.01190.x; Frisso G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111883; Galano-Frutos JJ, 2021, BRIEF BIOINFORM, V22, P3, DOI 10.1093/bib/bbz146; Glazier AA, 2019, PFLUG ARCH EUR J PHY, V471, P781, DOI 10.1007/s00424-018-2226-9; Glazier AA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99319; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Harper AR, 2021, NAT GENET, V53, P135, DOI 10.1038/s41588-020-00764-0; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Helms AS, 2020, CIRC-GENOM PRECIS ME, V13, P396, DOI 10.1161/CIRCGEN.120.002929; Helms AS, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133782; Helms AS, 2014, CIRC-CARDIOVASC GENE, V7, P434, DOI 10.1161/CIRCGENETICS.113.000448; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Holliday M., 2021, CIRC-GENOM PRECIS ME, V14; Homburger JR, 2016, P NATL ACAD SCI USA, V113, P6701, DOI 10.1073/pnas.1606950113; Houdayer C, 2012, HUM MUTAT, V33, P1228, DOI 10.1002/humu.22101; Ito K, 2017, P NATL ACAD SCI USA, V114, P7689, DOI 10.1073/pnas.1707741114; Jaaskelainen P, 2002, J MOL MED-JMM, V80, P412, DOI 10.1007/s00109-002-0323-9; Jordan DM, 2011, AM J HUM GENET, V88, P183, DOI 10.1016/j.ajhg.2011.01.011; Galano-Frutos JJ, 2019, J CHEM INF MODEL, V59, P4350, DOI 10.1021/acs.jcim.9b00430; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kobayashi Y, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0403-7; Lappalainen T, 2019, CELL, V177, P70, DOI 10.1016/j.cell.2019.02.032; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Lin J, 2010, CAN J CARDIOL, V26, P518, DOI 10.1016/S0828-282X(10)70464-5; Lopes LR, 2020, CIRC-GENOM PRECIS ME, V13, P165, DOI 10.1161/CIRCGEN.120.002905; Lv WJ, 2018, CIRCULATION, V138, P2852, DOI 10.1161/CIRCULATIONAHA.118.035028; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Marston S, 2012, J MUSCLE RES CELL M, V33, P75, DOI 10.1007/s10974-011-9268-3; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; McNally EM, 2015, TRENDS CARDIOVAS MED, V25, P646, DOI 10.1016/j.tcm.2015.02.013; Moolman-Smook J, 2002, CIRC RES, V91, P704, DOI 10.1161/01.RES.0000036750.81083.83; Nag S, 2021, ELIFE, V10, DOI 10.7554/eLife.63703; O'Leary TS, 2019, J MOL CELL CARDIOL, V127, P165, DOI 10.1016/j.yjmcc.2018.12.003; Page SP, 2012, CIRC-CARDIOVASC GENE, V5, P156, DOI 10.1161/CIRCGENETICS.111.960831; Pimenta-Lopes C, 2019, COMMUN PHYS-UK, V2, DOI 10.1038/s42005-019-0192-y; Porebski BT, 2015, PROTEIN ENG DES SEL, V28, P67, DOI 10.1093/protein/gzv002; Pricolo MR, 2020, J CARDIOVASC TRANSL, V13, P867, DOI 10.1007/s12265-020-09959-6; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Redwood CS, 1999, CARDIOVASC RES, V44, P20, DOI 10.1016/S0008-6363(99)00213-8; Rees M, 2021, ACTA NEUROPATHOL, V141, P431, DOI 10.1007/s00401-020-02257-0; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Rottbauer W, 1997, J CLIN INVEST, V100, P475, DOI 10.1172/JCI119555; Sadayappan S, 2014, PFLUG ARCH EUR J PHY, V466, P195, DOI 10.1007/s00424-013-1396-8; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Schuldt M, 2021, CIRC-HEART FAIL, V14, P39, DOI 10.1161/CIRCHEARTFAILURE.120.007022; Semsarian C., 2015, HYPERTROPHIC CARDIOM; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Singer ES, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.118.002368; Smelter DF, 2018, AM J PHYSIOL-HEART C, V314, pH1179, DOI 10.1152/ajpheart.00686.2017; Thompson A. D., 2021, GENET MED; van der Velden J, 2015, CARDIOVASC RES, V105, P449, DOI 10.1093/cvr/cvv019; van Dijk SJ, 2016, ARCH BIOCHEM BIOPHYS, V601, P133, DOI 10.1016/j.abb.2016.01.006; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Vignier N, 2009, CIRC RES, V105, P239, DOI 10.1161/CIRCRESAHA.109.201251; Walsh R, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0616-z; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yang LL, 2017, PEERJ, V5, DOI 10.7717/peerj.3550; Yotti R, 2019, ANNU REV GENOM HUM G, V20, P129, DOI 10.1146/annurev-genom-083118-015306; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhang MZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33340; Zhang XL, 2014, BIOCHEMISTRY-US, V53, P5332, DOI 10.1021/bi500784g	86	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100854	10.1016/j.jbc.2021.100854	http://dx.doi.org/10.1016/j.jbc.2021.100854			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097875	gold, Green Published			2022-12-26	WOS:000678068400054
J	Kim, MC; Kweon, OJ; Lim, YK; Choi, SH; Chung, JW; Lee, MK				Kim, Min-Chul; Kweon, Oh Joo; Lim, Yong Kwan; Choi, Seong-Ho; Chung, Jin-Won; Lee, Mi-Kyung			Impact of social distancing on the spread of common respiratory viruses during the coronavirus disease outbreak	PLOS ONE			English	Article							ADULT PATIENTS; RHINOVIRUSES	During the coronavirus disease (COVID-19) pandemic, social distancing was effective in controlling disease spread across South Korea. The impact of national social distancing on the spread of common respiratory virus infections has rarely been investigated. We evaluated the weekly proportion of negative respiratory virus polymerase chain reaction (PCR) test results and weekly positive rates of each respiratory virus during the social distancing period (10th-41st weeks of 2020) and the corresponding period in different years, utilizing the national respiratory virus surveillance dataset reported by the Korean Center for Disease Control and Prevention. The proportions of negative respiratory virus PCR test results increased up to 87.8% and 86.1% during level 3 and level 2 of the social distancing period, respectively. The higher the level of social distancing, the higher the proportion of negative respiratory virus PCR test results. During the social distancing period, the mean weekly positive rates for parainfluenza virus, influenza virus, human coronavirus, and human metapneumovirus were significantly lower than those during the same period in 2015-2019 (0.1% vs. 9.3%, P <0.001; 0.1% vs. 7.2%, P <0.001; 0.4% vs. 2.3%, P <0.001; and 0.2% vs. 5.3%, P <0.001, respectively). The mean positive rate for rhinovirus/enterovirus during level 3 social distancing was lower than that in the same period in 2015-2019 (8.5% vs. 19.0%, P <0.001), but the rate during level 1 social distancing was higher than that in the same period in 2015-2019 (38.3% vs. 19.4%, P <0.001). The national application of social distancing reduced the spread of common respiratory virus infections during the COVID-19 pandemic.	[Kim, Min-Chul; Choi, Seong-Ho; Chung, Jin-Won] Chung Ang Univ, Chung Ang Univ Hosp, Coll Med, Div Infect Dis,Dept Internal Med, Seoul, South Korea; [Kweon, Oh Joo; Lim, Yong Kwan; Lee, Mi-Kyung] Chung Ang Univ, Chung Ang Univ Hosp, Coll Med, Dept Lab Med, Seoul, South Korea	Chung Ang University; Chung Ang University Hospital; Chung Ang University; Chung Ang University Hospital	Choi, SH (corresponding author), Chung Ang Univ, Chung Ang Univ Hosp, Coll Med, Div Infect Dis,Dept Internal Med, Seoul, South Korea.	tobeservant@cau.ac.kr	Lim, Yong Kwan/AAD-9243-2022	Choi, Seong-Ho/0000-0001-8108-2412; Lim, Yong Kwan/0000-0002-4300-8964; Kweon, Oh Joo/0000-0003-4751-7384	National Research Foundation of Korea - Korean Government [2019R1C1C006417]	National Research Foundation of Korea - Korean Government(National Research Foundation of KoreaKorean Government)	This work was supported by a National Research Foundation of Korea grant funded by the Korean Government (2019R1C1C006417). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Broderick MP, 2008, J INFECT DIS, V198, P1420, DOI 10.1086/592711; Cho EB, 2018, J MED VIROL, V90, P1304, DOI [10.1002/jmv.25199, 10.1002/jmv.25091]; Choi SH, 2015, J CLIN MICROBIOL, V53, P1172, DOI 10.1128/JCM.03298-14; Choi SH, 2015, J CLIN VIROL, V63, P70, DOI 10.1016/j.jcv.2014.12.016; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Ganime AC, 2014, J MED VIROL, V86, P2065, DOI 10.1002/jmv.23907; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; L'Huillier AG, 2015, CLIN MICROBIOL INFEC, V21, P381, DOI 10.1016/j.cmi.2014.12.002; Lai SJ, 2020, NATURE, V585, P410, DOI [10.1101/2020.03.03.20029843, 10.1038/s41586-020-2293-x]; Lee H, 2021, CLIN INFECT DIS, V73, pE132, DOI 10.1093/cid/ciaa672; Lu N, 2020, AM J INFECT CONTROL, V48, P851, DOI 10.1016/j.ajic.2020.04.021; Nascimento-Carvalho CM, 2016, PEDIATR INFECT DIS J, V35, P338, DOI 10.1097/INF.0000000000001032; Noh JY, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e182; Peck KR, 2020, CLIN MICROBIOL INFEC, V26, P805, DOI 10.1016/j.cmi.2020.04.025; Self WH, 2016, J INFECT DIS, V213, P584, DOI 10.1093/infdis/jiv323; World Health Organization, WHO DIR GEN OP REM M	16	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252963	10.1371/journal.pone.0252963	http://dx.doi.org/10.1371/journal.pone.0252963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125839	Green Published, gold			2022-12-26	WOS:000664643500019
J	Zhang, Z; Min, L; Li, HC; Chen, L; Zhao, Y; Liu, S; Guo, QD; Zhu, ST; Li, P; Zhang, ST				Zhang, Zheng; Min, Li; Li, Hengcun; Chen, Lei; Zhao, Yu; Liu, Si; Guo, Qingdong; Zhu, Shengtao; Li, Peng; Zhang, Shutian			Asporin represses gastric cancer apoptosis via activating LEF1-mediated gene transcription independent of beta-catenin	ONCOGENE			English	Article							TUMOR MICROENVIRONMENT; BORRMANN TYPE; WNT; SUSCEPTIBILITY; COACTIVATOR; PROTEINS; PROTECTS; INVASION; PATHWAY; TARGET	Asporin (ASPN) presents in the tumor microenvironment and exhibits a cancer-promoting effect as a stroma protein. Even though ASPN has already been observed inside cancer cells, the functions of intracellular ASPN and its underlying mechanisms remain unknown. Here we reported that ASPN was upregulated in different stages of gastric cancer (GC), and associated with a poor prognosis. Moreover, we found that ASPN markedly inhibited GC cell apoptosis and promoted cell growth in vitro and in vivo. Further mechanism investigations revealed that ASPN directly binding to lymphoid enhancer-binding factor 1 (LEF1) and promoted LEF1-mediated gene transcription independent of beta-catenin, the classic co-factor in the Wnt/LEF1 pathway. We also demonstrated that ASPN selectively facilitated LEF1 binding to and activating the promoters of PTGS2, IL6, and WISP1 to promote their transcription. The suppression of cell apoptosis by ASPN overexpression could be attenuated by LEF1 knockdown or 100 mu M aspirin (PTGS2 inhibitor), and siASPN mediated apoptosis could be rescued by LEF1 ectopic expression or adding recombinant IL6. Therefore, we concluded that ASPN repressed GC cell apoptosis via activating LEF1-mediated gene transcription independent of beta-catenin, which could serve as a potential prognostic biomarker in GC patients.	[Zhang, Zheng; Min, Li; Li, Hengcun; Chen, Lei; Zhao, Yu; Liu, Si; Guo, Qingdong; Zhu, Shengtao; Li, Peng; Zhang, Shutian] Capital Med Univ, Beijing Key Lab Precancerous Lesion Digest Dis, Natl Clin Res Ctr Digest Dis, Dept Gastroenterol,Beijing Friendship Hosp,Beijin, Beijing, Peoples R China	Capital Medical University	Li, P; Zhang, ST (corresponding author), Capital Med Univ, Beijing Key Lab Precancerous Lesion Digest Dis, Natl Clin Res Ctr Digest Dis, Dept Gastroenterol,Beijing Friendship Hosp,Beijin, Beijing, Peoples R China.	lipeng@ccmu.edu.cn; zhangshutian@ccmu.edu.cn	; Min, Li/T-8107-2018	Li, Peng/0000-0003-2927-2758; Min, Li/0000-0001-9595-5536; Zhang, Zheng/0000-0002-0822-7985	National Natural Science Foundation of China [81570507, 81702314]; National Key Research and Development Program of China [2017YFC0113600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China	This study was supported by National Natural Science Foundation of China (81570507, 81702314) and National Key Research and Development Program of China (2017YFC0113600).	Acebron SP, 2016, TRENDS CELL BIOL, V26, P956, DOI 10.1016/j.tcb.2016.07.009; An JY, 2008, J GASTROINTEST SURG, V12, P1364, DOI 10.1007/s11605-008-0516-9; Badgwell B, 2016, LANCET ONCOL, V17, P1628, DOI 10.1016/S1470-2045(16)30521-6; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Castellana B, 2012, J CANCER, V3, P175, DOI 10.7150/jca.4120; Chiurillo MA, 2015, WORLD J EXP MED, V5, P84, DOI [10.5493/wjem.v5.i2.84, DOI 10.5493/wjem.v5.i2.84, DOI 10.5493/WJEM.V5.I2.84]; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Cottini F, 2014, NAT MED, V20, P599, DOI 10.1038/nm.3562; Cristescu R, 2015, NAT MED, V21, P449, DOI 10.1038/nm.3850; Cui JA, 2011, NUCLEIC ACIDS RES, V39, P1197, DOI 10.1093/nar/gkq960; D'Errico M, 2009, EUR J CANCER, V45, P461, DOI 10.1016/j.ejca.2008.10.032; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Hrckulak D, 2016, CANCERS, V8, DOI 10.3390/cancers8070070; Hughes RM, 2019, CANCER RES, V79, P3636, DOI 10.1158/0008-5472.CAN-18-2931; Hurley PJ, 2016, CLIN CANCER RES, V22, P448, DOI 10.1158/1078-0432.CCR-15-0256; Ikegawa S, 2008, CURR MED CHEM, V15, P724, DOI 10.2174/092986708783885237; Ikeguchi M, 2004, IN VIVO, V18, P577; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kessler M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9989; Kim HK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016694; Kizawa H, 2005, NAT GENET, V37, P138, DOI 10.1038/ng1496; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Lee HH, 2018, ANN SURG ONCOL, V25, P778, DOI 10.1245/s10434-018-7051-z; Li C, 2009, ONCOLOGY-BASEL, V77, P197, DOI 10.1159/000236018; Li HC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1376-9; Longo KA, 2002, J BIOL CHEM, V277, P38239, DOI 10.1074/jbc.M206402200; Lordick F, 2014, CANCER TREAT REV, V40, P692, DOI 10.1016/j.ctrv.2014.03.002; Lorenzo P, 2001, J BIOL CHEM, V276, P12201, DOI 10.1074/jbc.M010932200; Luehders K, 2015, DEVELOPMENT, V142, P3351, DOI 10.1242/dev.124438; Luo JW, 2019, TRANSL ONCOL, V12, P475, DOI 10.1016/j.tranon.2018.11.010; Maris P, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001871; Moon Randall T, 2004, Nat Rev Genet, V5, P691, DOI 10.1038/nrg1427; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Ooi CH, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000676; Packham S, 2015, ONCOGENE, V34, P2227, DOI 10.1038/onc.2014.165; Park JH, 2018, MOL CELLS, V41, P290, DOI 10.14348/molcells.2018.2167; Perez-Garijo A, 2015, DEVELOPMENT, V142, P3253, DOI 10.1242/dev.127878; Pinto M, 2003, J PATHOL, V200, P32, DOI 10.1002/path.1327; Rodriguez-Lopez J, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1920; Santiago L, 2017, AM J CANCER RES, V7, P1389; Satoyoshi R, 2015, ONCOGENE, V34, P650, DOI 10.1038/onc.2013.584; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simkova D, 2016, BIOMED PAP, V160, P467, DOI 10.5507/bp.2016.037; Song YJ, 2017, BRIT J CANCER, V116, P973, DOI 10.1038/bjc.2017.54; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; STEWART D, 2014, JNCI-J NATL CANCER I, V106; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Uhlen M, 2016, NAT METHODS, V13, P823, DOI [10.1038/nmeth.3995, 10.1038/NMETH.3995]; Uka R, 2020, ONCOGENE, V39, P4132, DOI 10.1038/s41388-020-1267-7; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Wang L, 2018, ANN ONCOL, V29, P352, DOI 10.1093/annonc/mdx689; Wang LL, 2017, CANCER LETT, V398, P24, DOI 10.1016/j.canlet.2017.04.001; Warsito D, 2012, EMBO REP, V13, P244, DOI 10.1038/embor.2011.251; Wenzel J, 2020, ONCOGENE, V39, P3893, DOI 10.1038/s41388-020-1259-7; Wu H, 2016, ONCOTARGET, V7, P73402, DOI 10.18632/oncotarget.12336	55	2	2	0	4	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2021	40	27					4552	4566		10.1038/s41388-021-01858-7	http://dx.doi.org/10.1038/s41388-021-01858-7		JUN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TG4PV	34127813				2022-12-26	WOS:000661408100001
J	Cao, G; Gonzalez, J; Fragola, JPO; Muller, A; Tumarkin, M; Moriondo, M; Azzato, F; Blanco, MV; Milei, J				Cao, Gabriel; Gonzalez, Julian; Ortiz Fragola, Juan P.; Muller, Angelica; Tumarkin, Mariano; Moriondo, Marisa; Azzato, Francisco; Vazquez Blanco, Manuel; Milei, Jose			Structural changes in endocrine pancreas of male Wistar rats due to chronic cola drink consumption. Role of PDX-1	PLOS ONE			English	Article							SUGAR-SWEETENED BEVERAGES; NUCLEUS-ACCUMBENS SHELL; INSULIN-RESISTANCE; GLUCAGON-SECRETION; OXIDATIVE STRESS; WEIGHT-GAIN; SOFT DRINK; GLUCOSE; FRUCTOSE; SUCROSE	Aim: The objective of this work was to analyze the structural changes of the pancreatic islets in rats, after 6 month consuming regular and light cola for 6 months. Also, we have analyzed the possible role of PDX-1 in that process. Finally, with the available knowledge, we propose a general working hypothesis that explains the succession of phenomena observed. Previously, we reported evidence showing that chronic cola consumption in rats impairs pancreatic metabolism of insulin and glucagon and produces some alterations typically observed in the metabolic syndrome, with an increase in oxidative stress. Of note It is worth mentioning that no apoptosis nor proliferation of islet cells could be demonstrated. In the present study, 36 male Wistar rats were divided into three groups to and given free access to freely drink regular cola (C), light cola (L), or water (W, control). We assessed the impact of the three different beverages in on glucose tolerance, lipid levels, creatinine levels and immunohistochemical changes addressed for the expression of insulin, glucagon, PDX-1 and NGN3 in islet cells, to evaluate the possible participation of PDX-1 in the changes observed in alpha and beta cells after 6 months of treatment. Moreover, we assessed by stereological methods, the mean volume of islets (Vi) and three important variables: the fractional beta -cell area, the cross-sectional area of alpha (A alpha-cell) and beta cells (A beta-cell), and the number of beta and alpha cell per body weight. Data were analyzed by two-way ANOVA followed by Bonferroni's multiple t-test or by Kruskal-Wallis test, then followed by Dunn's test (depending on distribution). Statistical significance was set at p<0.05. Cola drinking caused impaired glucose tolerance as well as fasting hyperglycemia (mean:148; CI:137-153; p<0.05 vs W) and an increase of in insulin immunolabeling (27.3 +/- 19.7; p<0.05 vs W and L). Immunohistochemical expression for PDX-1 was significantly high in C group compared to W (0.79 +/- 0.71; p<0.05). In this case, we observed cytoplasmatic and nuclear localization. Likewise, a mild but significant decrease of in Vi was detected after 6 months in C compared to W group (8.2 +/- 2.5; p<0.05). Also, we observed a significant decrease of in the fractional beta cell area (78.2 +/- 30.9; p<0.05) compared to W. Accordingly, a reduced mean value of islet alpha and beta cell number per body weight (0.05 +/- 0.02 and 0.08 +/- 0.04 respectively; both p<0.05) compared to W was detected. Interestingly, consumption of light cola increased the Vi (10.7 +/- 3.6; p<0.05) compared to W. In line with this, a decreased cross-sectional area of beta-cells was observed after chronic consumption of both, regular (78.2 +/- 30.9; p<0.05) and light cola (110.5 +/- 24.3; p<0.05), compared to W. As for, NGN3, it was negative in all three groups. Our results support the idea that PDX-1 plays a key role in the dynamics of the pancreatic islets after chronic consumption of sweetened beverages. In this experimental model, the loss of islets cells might be attributed to autophagy, favored by the local metabolic conditions and oxidative stress.	[Cao, Gabriel] Univ Abierta Interamer, Ctr Altos Estudios Ciencias Humanas & Salud CAECI, Buenos Aires, DF, Argentina; [Gonzalez, Julian; Ortiz Fragola, Juan P.; Muller, Angelica; Tumarkin, Mariano; Moriondo, Marisa; Milei, Jose] Consejo Nacl Invest Cient & Tecn, Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Azzato, Francisco; Vazquez Blanco, Manuel; Milei, Jose] Univ Buenos Aires, CONICET, Fac Med, Inst Alberto C Taquini Invest Med Traslac IATIMET, Buenos Aires, DF, Argentina; Hosp Clin Buenos Aires, Fac Med, Sexta Catedra Med, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Cao, G (corresponding author), Univ Abierta Interamer, Ctr Altos Estudios Ciencias Humanas & Salud CAECI, Buenos Aires, DF, Argentina.	gabrielcao@fibertel.com.ar			University of Buenos Aires, Argentina [UBACYT 20020150100027BA]	University of Buenos Aires, Argentina(University of Buenos Aires)	The author JM, received specific funding for this work from University of Buenos Aires, Argentina, UBACYT 20020150100027BA.	Ahmed S, 2014, NEUROCHEM RES, V39, P815, DOI 10.1007/s11064-014-1274-6; Al-Bari MAA, 2020, ANN NY ACAD SCI, V1467, P3, DOI 10.1111/nyas.14305; ANDREWS SS, 1975, METABOLISM, V24, P35, DOI 10.1016/0026-0495(75)90005-0; Botezelli JD, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-43; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Brown RJ, 2012, DIABETES CARE, V35, P959, DOI 10.2337/dc11-2424; Brown RJ, 2009, DIABETES CARE, V32, P2184, DOI 10.2337/dc09-1185; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Canadian Council on Animal Care, GUIDE CARE USE EXPT, V1, P1993; Cao G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152461; Castro DC, 2014, J NEUROSCI, V34, P4239, DOI 10.1523/JNEUROSCI.4458-13.2014; Clark KS, 2019, CLIN EXP PHARMACOL P, V46, P475, DOI 10.1111/1440-1681.13065; Colley DL, 2015, PHYSIOL BEHAV, V139, P202, DOI 10.1016/j.physbeh.2014.11.025; Collin LJ, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3121; Cong WN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070257; de Araujo IE, 2008, NEURON, V57, P930, DOI 10.1016/j.neuron.2008.01.032; DeFronzo RA, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.19; Di Chiara G, 2002, BEHAV BRAIN RES, V137, P75, DOI 10.1016/S0166-4328(02)00286-3; Elliott SS, 2002, AM J CLIN NUTR, V76, P911, DOI 10.1093/ajcn/76.5.911; Ferretti F, 2019, GLOBALIZATION HEALTH, V15, DOI 10.1186/s12992-019-0474-x; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Gao T, 2014, CELL METAB, V19, P259, DOI 10.1016/j.cmet.2013.12.002; Gaysinskaya VA, 2011, PHARMACOL BIOCHEM BE, V97, P521, DOI 10.1016/j.pbb.2010.10.008; GERICH JE, 1974, J CLIN INVEST, V54, P833, DOI 10.1172/JCI107823; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Hu FB, 2010, PHYSIOL BEHAV, V100, P47, DOI 10.1016/j.physbeh.2010.01.036; KANAREK RB, 1982, J NUTR, V112, P1546, DOI 10.1093/jn/112.8.1546; Kaneto Hideaki, 2005, Am J Ther, V12, P529, DOI 10.1097/01.mjt.0000178773.31525.c2; Kaneto H, 2015, INT J MOL SCI, V16, P6281, DOI 10.3390/ijms16036281; Kaplan A., 1979, CLIN CHEM INTERPRETA; Kawamori D, 2003, DIABETES, V52, P2896, DOI 10.2337/diabetes.52.12.2896; Lebda MA, 2017, NUTR RES, V41, P47, DOI 10.1016/j.nutres.2017.04.002; Lim JS, 2010, NAT REV GASTRO HEPAT, V7, P251, DOI 10.1038/nrgastro.2010.41; Lindqvist A, 2005, REGUL PEPTIDES, V130, P123, DOI 10.1016/j.regpep.2005.05.002; Lindqvist A, 2008, REGUL PEPTIDES, V150, P26, DOI 10.1016/j.regpep.2008.06.008; MacDonald PE, 2007, PLOS BIOL, V5, P1236, DOI 10.1371/journal.pbio.0050143; Malik VS, 2013, NAT REV ENDOCRINOL, V9, P13, DOI 10.1038/nrendo.2012.199; Matteucci E, 2008, J ETHNOPHARMACOL, V115, P163, DOI 10.1016/j.jep.2007.08.040; Meier JJ, 2012, DIABETOLOGIA, V55, P1346, DOI 10.1007/s00125-012-2466-8; Milei J, 2011, WORLD J CARDIOL, V3, P111, DOI 10.4330/wjc.v3.i4.111; Montanya E, 2000, DIABETES, V49, P1341, DOI 10.2337/diabetes.49.8.1341; Nauck MA, 2018, DIABETES OBES METAB, V20, P5, DOI 10.1111/dom.13129; Ostlund SB, 2013, PSYCHOPHARMACOLOGY, V229, P105, DOI 10.1007/s00213-013-3077-x; Otero-Losada M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155630; Otero-Losada M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118700; Otero-Losada M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089838; Otero-Losada ME, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-57; Otero-Losada ME, 2011, INT J CARDIOL, V146, P106, DOI 10.1016/j.ijcard.2010.09.066; Pepino MY, 2011, CURR OPIN CLIN NUTR, V14, P391, DOI 10.1097/MCO.0b013e3283468e7e; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; Rukstalis JM, 2009, ISLETS, V1, P177, DOI 10.4161/isl.1.3.9877; Sachdeva MM, 2009, P NATL ACAD SCI USA, V106, P19090, DOI 10.1073/pnas.0904849106; Saisho Y, 2010, DIABETOLOGIA, V53, P111, DOI 10.1007/s00125-009-1552-z; Salehi A, 2006, DIABETES, V55, P2318, DOI 10.2337/db06-0080; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Sheludiakova A, 2012, EUR J NUTR, V51, P445, DOI 10.1007/s00394-011-0228-x; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; WEIBEL ER, 1963, LAB INVEST, V12, P131; Welsh JA, 2011, AM J CLIN NUTR, V94, P726, DOI 10.3945/ajcn.111.018366; Zatroch KK, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-0982-y	60	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0243340	10.1371/journal.pone.0243340	http://dx.doi.org/10.1371/journal.pone.0243340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115756	gold, Green Published			2022-12-26	WOS:000664643000002
J	Lee, D; Son, T				Lee, Dongha; Son, Taekwon			Structural connectivity differs between males and females in the brain object manipulation network	PLOS ONE			English	Article							SEX-DIFFERENCES; PARIETAL CORTEX; MOTOR IMAGERY; REPRESENTATIONS; PARCELLATION; CONNECTOME; ORGANIZATION; TRACTOGRAPHY; STABILITY; IDENTITY	Object control skills are one of the most important abilities in daily life. Knowledge of object manipulation is an essential factor in improving object control skills. Although males and females equally try to use object manipulation knowledge, their object control abilities often differ. To explain this difference, we investigated how structural brain networks in males and females are differentially organized in the tool-preferring areas of the object manipulation network. The structural connectivity between the primary motor and premotor regions and between the inferior parietal regions in males was significantly higher than that in females. However, females showed greater structural connectivity in various regions of the object manipulation network, including the paracentral lobule, inferior parietal regions, superior parietal cortices, MT+ complex and neighboring visual areas, and dorsal stream visual cortex. The global node strength found in the female parietal network was significantly higher than that in males but not for the entire object manipulation, ventral temporal, and motor networks. These findings indicated that the parietal network in females has greater inter-regional structural connectivity to retrieve manipulation knowledge than that in males. This study suggests that differential structural networks in males and females might influence object manipulation knowledge retrieval.	[Lee, Dongha] Korea Brain Res Inst, Cognit Sci Res Grp, Daegu, South Korea; [Son, Taekwon] Korea Brain Res Inst, Korea Brain Bank, Daegu, South Korea	Korea Brain Research Institute (KBRI); Korea Brain Research Institute (KBRI)	Lee, D (corresponding author), Korea Brain Res Inst, Cognit Sci Res Grp, Daegu, South Korea.	donghalee@kbri.re.kr		Son, Taekwon/0000-0002-6096-2231; LEE, DONGHA/0000-0001-8316-2141	KBRI basic research program through Korea Brain Research Institute - Ministry of Science and ICT [21-BR-05-01]	KBRI basic research program through Korea Brain Research Institute - Ministry of Science and ICT	This research was supported by KBRI basic research program through Korea Brain Research Institute funded by Ministry of Science and ICT(21-BR-05-01).	Ahrenfeldt LJ, 2019, EUR J PUBLIC HEALTH, V29, P667, DOI 10.1093/eurpub/cky266; Almeida J, 2013, CORTEX, V49, P2334, DOI 10.1016/j.cortex.2013.05.004; Andrews TJ, 2004, NEUROIMAGE, V23, P905, DOI 10.1016/j.neuroimage.2004.07.060; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Booth MCA, 1998, CEREB CORTEX, V8, P510, DOI 10.1093/cercor/8.6.510; Bracci S, 2017, CEREB CORTEX, V27, P310, DOI 10.1093/cercor/bhw419; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buxbaum LJ, 2014, BRAIN, V137, P1971, DOI 10.1093/brain/awu111; Cadieu CF, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003963; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Chen QJ, 2016, CEREB CORTEX, V26, P1609, DOI 10.1093/cercor/bhu328; Choi HJ, 2006, J COMP NEUROL, V495, P53, DOI 10.1002/cne.20849; Daducci A, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00247; Deco G, 2015, NAT REV NEUROSCI, V16, P430, DOI 10.1038/nrn3963; Deco G, 2011, NAT REV NEUROSCI, V12, P43, DOI 10.1038/nrn2961; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Ehrsson HH, 2003, J NEUROPHYSIOL, V90, P2978, DOI 10.1152/jn.00958.2002; Feng J, 2007, PSYCHOL SCI, V18, P850, DOI 10.1111/j.1467-9280.2007.01990.x; FRIED I, 1991, J NEUROSCI, V11, P3656; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Garcea FE, 2018, BRAIN STRUCT FUNCT, V223, P2589, DOI 10.1007/s00429-018-1641-1; Garcea FE, 2014, NEUROPSYCHOLOGIA, V60, P131, DOI 10.1016/j.neuropsychologia.2014.05.018; Gershon RC, 2010, LANCET NEUROL, V9, P138, DOI 10.1016/S1474-4422(09)70335-7; Geyer S, 2004, Adv Anat Embryol Cell Biol, V174, pI; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Grafton ST, 1997, NEUROIMAGE, V6, P231, DOI 10.1006/nimg.1997.0293; Grefkes C, 2001, NEUROIMAGE, V14, P617, DOI 10.1006/nimg.2001.0858; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Guclu U, 2015, J NEUROSCI, V35, P10005, DOI 10.1523/JNEUROSCI.5023-14.2015; Hausmann M, 2009, PSYCHONEUROENDOCRINO, V34, P389, DOI 10.1016/j.psyneuen.2008.09.019; Hiramatsu Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138506; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Ingalhalikar M, 2014, P NATL ACAD SCI USA, V111, P823, DOI 10.1073/pnas.1316909110; ITO M, 1995, J NEUROPHYSIOL, V73, P218, DOI 10.1152/jn.1995.73.1.218; Jbabdi S, 2011, BRAIN CONNECT, V1, P169, DOI 10.1089/brain.2011.0033; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Khaligh-Razavi SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003915; Knickmeyer RC, 2014, CEREB CORTEX, V24, P2721, DOI 10.1093/cercor/bht125; Kravitz DJ, 2013, TRENDS COGN SCI, V17, P26, DOI 10.1016/j.tics.2012.10.011; Kroliczak G, 2016, NEUROPSYCHOLOGIA, V93, P501, DOI 10.1016/j.neuropsychologia.2016.03.023; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Lee D, 2021, CORTEX, V137, P282, DOI 10.1016/j.cortex.2020.12.026; Lee D, 2019, CORTEX, V117, P157, DOI 10.1016/j.cortex.2019.02.018; Lee D, 2019, NEUROIMAGE, V188, P680, DOI 10.1016/j.neuroimage.2018.12.055; Lee D, 2017, HUM BRAIN MAPP, V38, P5292, DOI 10.1002/hbm.23738; LOGOTHETIS NK, 1995, CURR BIOL, V5, P552, DOI 10.1016/S0960-9822(95)00108-4; Luders E, 2009, J NEUROSCI, V29, P14265, DOI 10.1523/JNEUROSCI.2261-09.2009; Mahon BZ, 2007, NEURON, V55, P507, DOI 10.1016/j.neuron.2007.07.011; Matousek RH, 2010, HORM BEHAV, V57, P352, DOI 10.1016/j.yhbeh.2010.01.004; McGivern RF, 1997, BRAIN COGNITION, V34, P323, DOI 10.1006/brcg.1997.0872; McGivern RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032238; Mechelli A, 2005, J NEUROSCI, V25, P8303, DOI 10.1523/JNEUROSCI.0357-05.2005; Miller DI, 2014, TRENDS COGN SCI, V18, P37, DOI 10.1016/j.tics.2013.10.011; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Peelen MV, 2012, J COGNITIVE NEUROSCI, V24, P2096, DOI 10.1162/jocn_a_00257; Pilgramm S, 2016, HUM BRAIN MAPP, V37, P81, DOI 10.1002/hbm.23015; Poldrack RA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002707; Reuben DB, 2013, NEUROLOGY, V80, pS65, DOI 10.1212/WNL.0b013e3182872e01; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Smith RE, 2015, NEUROIMAGE, V104, P253, DOI 10.1016/j.neuroimage.2014.10.004; Smith RE, 2013, NEUROIMAGE, V67, P298, DOI 10.1016/j.neuroimage.2012.11.049; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Szameitat AJ, 2007, NEUROIMAGE, V34, P702, DOI 10.1016/j.neuroimage.2006.09.033; Szameitat AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038506; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Vanston JE, 2017, J NEUROSCI RES, V95, P617, DOI 10.1002/jnr.23895; Vogt BA, 2003, J CHEM NEUROANAT, V26, P301, DOI 10.1016/j.jchemneu.2003.09.004; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839; Wang JJ, 1999, HUM BRAIN MAPP, V8, P170, DOI 10.1002/(SICI)1097-0193(1999)8:4<170::AID-HBM2>3.3.CO;2-N; Wen HG, 2018, CEREB CORTEX, V28, P4136, DOI 10.1093/cercor/bhx268; Yarkoni T, 2011, NAT METHODS, V8, P665, DOI [10.1038/NMETH.1635, 10.1038/nmeth.1635]; Yeh CH, 2016, NEUROIMAGE, V142, P150, DOI 10.1016/j.neuroimage.2016.05.047	79	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253273	10.1371/journal.pone.0253273	http://dx.doi.org/10.1371/journal.pone.0253273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SD	34115811	Green Published, gold			2022-12-26	WOS:000664643000062
J	Wu, J; Li, L; Zhang, HB; Zhao, YQ; Zhang, HH; Wu, SY; Xu, B				Wu, Jie; Li, Lan; Zhang, Huibo; Zhao, Yaqi; Zhang, Haohan; Wu, Siyi; Xu, Bin			A risk model developed based on tumor microenvironment predicts overall survival and associates with tumor immunity of patients with lung adenocarcinoma	ONCOGENE			English	Article							PROGNOSTIC VALUE; MUTATIONS; IMMUNOTHERAPY; MACROPHAGE; LANDSCAPE; CELLS	Tumor microenvironment (TME) has been reported to exhibit a crucial effect in lung cancer. Therefore, this study was aimed to investigate the genes associated with TME and develop a risk score to predict the overall survival (OS) of patients with lung adenocarcinoma (LUAD) based on these genes. The immune and stromal scores were generated by the ESTIMATE algorithm for LUAD patients in The Cancer Genome Atlas (TCGA) database. Differentially expressed gene and weighted gene co-expression network analyses were used to derive immune- and stromal-related genes. The Least Absolute Shrinkage and Selection Operator (LASSO)-Cox regression was applied for further selection and the selected genes were inputted into stepwise regression to develop TME-related risk score (TMErisk) which was further validated in Gene Expression Omnibus (GEO) datasets. TMErisk-related biological phenotypes were analyzed in function enrichment, tumor immune signature, and tumor mutation signature. The patient's response to immunotherapy was inferred by the tumor immune dysfunction and exclusion (TIDE) score and immunophenoscore (IPS). According to our results, TMErisk was developed based on SERPINE1, CX3CR1, CD200R1, GBP1, IRF1, STAP1, LOX, and OR7E47P. Furthermore, high TMErisk was identified as a poor factor for OS in TCGA and GEO datasets, as well as in subgroup analysis with different gender, smoking status, age, race, anatomic site, therapies, and tumor-node-metastasis (TNM) stages. Higher TMErisk is also associated negatively with the abundance of B cells, CD4+ T cells, CD8+ T cells, neutrophils, macrophages, and other stromal or immune cells. Several genes of the human leukocyte antigen (HLA) family and immune checkpoints were less expressed in the high-TMErisk group. Mutations of 19 genes occurred more frequently in the high-TMErisk group. These mutations may be associated with TME change and indicate patients' response to immunotherapy. According to our analyses, a lower TMErisk score may indicate better response and OS outcome of immunotherapy.	[Wu, Jie; Li, Lan; Zhang, Huibo; Zhao, Yaqi; Zhang, Haohan; Wu, Siyi; Xu, Bin] Wuhan Univ, Renmin Hosp, Canc Ctr, Wuhan, Peoples R China	Wuhan University	Xu, B (corresponding author), Wuhan Univ, Renmin Hosp, Canc Ctr, Wuhan, Peoples R China.	xubin_oneology@whu.edu.cn	Wu, Jie/ABG-2502-2021	Wu, Jie/0000-0003-0935-342X; Zhang, Huibo/0000-0001-7312-6841	Wuhan University Medical Faculty Innovation Seed Fund Cultivation Project [TFZZ2018025]; Chen xiao-ping foundation for the development of science and technology of Hubei province [CXPJJH12000001-2020313]; National Natural Science Foundation of China [81670123, 81670144]	Wuhan University Medical Faculty Innovation Seed Fund Cultivation Project; Chen xiao-ping foundation for the development of science and technology of Hubei province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from Wuhan University Medical Faculty Innovation Seed Fund Cultivation Project (grant no. TFZZ2018025), Chen xiao-ping foundation for the development of science and technology of Hubei province (grant no. CXPJJH12000001-2020313), and the National Natural Science Foundation of China (grant nos. 81670123 and 81670144).	Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Aran D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9971; Assoun S, 2019, LUNG CANCER, V132, P65, DOI 10.1016/j.lungcan.2019.04.005; Barker HE, 2012, NAT REV CANCER, V12, P540, DOI 10.1038/nrc3319; Bender E, 2014, NATURE, V513, pS2, DOI 10.1038/513S2a; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Camidge DR, 2019, NAT REV CLIN ONCOL, V16, P341, DOI 10.1038/s41571-019-0173-9; Carter BW, 2016, J THORAC IMAG, V31, P201, DOI 10.1097/RTI.0000000000000213; Choi H, 2018, THERANOSTICS, V8, P1956, DOI 10.7150/thno.23767; Conroy MJ, 2020, ADV EXP MED BIOL, V1231, P1, DOI 10.1007/978-3-030-36667-4_1; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Denton AE, 2018, ADV EXP MED BIOL, V1060, P99, DOI 10.1007/978-3-319-78127-3_6; Duffy MJ, 2004, CURR PHARM DESIGN, V10, P39, DOI 10.2174/1381612043453559; Erin N, 2015, ONCOGENE, V34, P3860, DOI 10.1038/onc.2014.317; Frankel T, 2017, ADV EXP MED BIOL, V1036, P51, DOI 10.1007/978-3-319-67577-0_4; Garg N, 2010, J THROMB HAEMOST, V8, P1847, DOI 10.1111/j.1538-7836.2010.03907.x; Gibney GT, 2016, LANCET ONCOL, V17, pE542, DOI 10.1016/S1470-2045(16)30406-5; Giraldo NA, 2017, CLIN CANCER RES, V23, P4416, DOI 10.1158/1078-0432.CCR-16-2848; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Hellmann MD, 2018, CANCER CELL, V33, P853, DOI 10.1016/j.ccell.2018.04.001; Jamal-Hanjani M, 2015, CLIN CANCER RES, V21, P1258, DOI 10.1158/1078-0432.CCR-14-1429; Jia D, 2018, AGING-US, V10, P592, DOI 10.18632/aging.101415; Johnston RJ, 2019, NATURE, V574, P565, DOI 10.1038/s41586-019-1674-5; Kinoshita T, 2016, ANN ONCOL, V27, P2117, DOI 10.1093/annonc/mdw319; Li B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1028-7; Marinelli D, 2020, ANN ONCOL, V31, P1746, DOI 10.1016/j.annonc.2020.08.2105; Martinez-Terroba E, 2018, J PATHOL, V245, P421, DOI 10.1002/path.5096; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Ohri CM, 2009, EUR RESPIR J, V33, P118, DOI 10.1183/09031936.00065708; Rakaee M, 2019, NEOPLASIA, V21, P282, DOI 10.1016/j.neo.2019.01.005; Schmall A, 2015, AM J RESP CRIT CARE, V191, P437, DOI 10.1164/rccm.201406-1137OC; Sun H, 2020, EBIOMEDICINE, V60, DOI 10.1016/j.ebiom.2020.102990; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Travis WD, 2013, J CLIN ONCOL, V31, P992, DOI 10.1200/JCO.2012.46.9270; Wang H, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01212; Wang SX, 2019, ELIFE, V8, DOI 10.7554/eLife.49020; Wojas-Krawczyk K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081915; Wu T, 2017, CANCER LETT, V387, P61, DOI 10.1016/j.canlet.2016.01.043; Xu WH, 2019, AGING-US, V11, P6999, DOI 10.18632/aging.102233; Yan HM, 2019, CANCER IMMUNOL IMMUN, V68, P1971, DOI 10.1007/s00262-019-02408-7; Yang S, 2020, J CELL PHYSIOL, V235, P1025, DOI 10.1002/jcp.29018; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zeng DQ, 2019, CANCER IMMUNOL RES, V7, P737, DOI 10.1158/2326-6066.CIR-18-0436; Zhang YT, 2020, CANCER BIOL MED, V17, P32, DOI 10.20892/j.issn.2095-3941.2019.0372; Zhao LQ, 2020, AGING-US, V12, P14556, DOI 10.18632/aging.103502	49	58	58	13	65	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2021	40	26					4413	4424		10.1038/s41388-021-01853-y	http://dx.doi.org/10.1038/s41388-021-01853-y		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TC8LA	34108619				2022-12-26	WOS:000659470200004
J	Dong, R; Leung, C; Naert, MN; Naanyu, V; Kiptoo, P; Matelong, W; Matini, E; Orango, V; Bloomfield, GS; Edelman, D; Fuster, V; Manyara, S; Menya, D; Pastakia, SD; Valente, T; Kamano, J; Horowitz, CR; Vedanthan, R				Dong, Rae; Leung, Claudia; Naert, Mackenzie N.; Naanyu, Violet; Kiptoo, Peninah; Matelong, Winnie; Matini, Esther; Orango, Vitalis; Bloomfield, Gerald S.; Edelman, David; Fuster, Valentin; Manyara, Simon; Menya, Diana; Pastakia, Sonak D.; Valente, Tom; Kamano, Jemima; Horowitz, Carol R.; Vedanthan, Rajesh			Chronic disease stigma, skepticism of the health system, and socio-economic fragility: Qualitative assessment of factors impacting receptiveness to group medical visits and microfinance for non-communicable disease care in rural Kenya	PLOS ONE			English	Article							BRIDGING INCOME GENERATION; GROUP INTEGRATED CARE; HYPERTENSION	Background Non-communicable diseases (NCDs) are the leading cause of mortality in the world, and innovative approaches to NCD care delivery are being actively developed and evaluated. Combining the group-based experience of microfinance and group medical visits is a novel approach to NCD care delivery. However, the contextual factors, facilitators, and barriers impacting wide-scale implementation of these approaches within a low- and middle-income country setting are not well known. Methods Two types of qualitative group discussion were conducted: 1) mabaraza (singular, baraza), a traditional East African community gathering used to discuss and exchange information in large group settings; and 2) focus group discussions (FGDs) among rural clinicians, community health workers, microfinance group members, and patients with NCDs. Trained research staff members led the discussions using structured question guides. Content analysis was performed with NVivo using deductive and inductive codes that were then grouped into themes. Results We conducted 5 mabaraza and 16 FGDs. A total of 205 individuals (113 men and 92 women) participated in the mabaraza, while 162 individuals (57 men and 105 women) participated in the FGDs. In the context of poverty and previous experiences with the health system, participants described challenges to NCD care across three themes: 1) stigma of chronic disease, 2) earned skepticism of the health system, and 3) socio-economic fragility. However, they also outlined windows of opportunity and facilitators of group medical visits and microfinance to address those challenges. Discussion Our qualitative study revealed actionable factors that could impact the success of implementation of group medical visits and microfinance initiatives for NCD care. While several challenges were highlighted, participants also described opportunities to address and mitigate the impact of these factors. We anticipate that our approach and analysis provides new insights and methodological techniques that will be relevant to other low-resource settings worldwide.	[Dong, Rae; Naert, Mackenzie N.; Fuster, Valentin; Horowitz, Carol R.] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Leung, Claudia] Duke Univ, Med Ctr, Durham, NC USA; [Naanyu, Violet] Moi Univ, Sch Arts & Social Sci, Eldoret, Kenya; [Naanyu, Violet; Kiptoo, Peninah; Matelong, Winnie; Matini, Esther; Orango, Vitalis; Manyara, Simon] Acad Model Providing Access Healthcare, Eldoret, Kenya; [Bloomfield, Gerald S.; Edelman, David] Duke Univ, Sch Med, Durham, NC USA; [Menya, Diana] Moi Univ, Sch Publ Hlth, Eldoret, Kenya; [Pastakia, Sonak D.] Purdue Univ, Coll Pharm, Ctr Hlth Equ & Innovat, W Lafayette, IN 47907 USA; [Valente, Tom] USC, Keck Sch Med, Los Angeles, CA USA; [Kamano, Jemima] Moi Univ, Coll Hlth Sci, Eldoret, Kenya; [Vedanthan, Rajesh] NYU Grossman Sch Med, New York, NY 10016 USA	Icahn School of Medicine at Mount Sinai; Duke University; Moi University; Duke University; Moi University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Southern California; University of Southern California Keck Hospital; Moi University	Vedanthan, R (corresponding author), NYU Grossman Sch Med, New York, NY 10016 USA.	rajesh.vedanthan@nyulangone.org	Naanyu, Violet/GNM-8783-2022	Naanyu, Violet/0000-0003-0182-1719; Naert, Mackenzie/0000-0002-2726-5864; Leung, Claudia/0000-0003-3389-9115; Edelman, David/0000-0001-7112-6151; Vedanthan, Rajesh/0000-0001-7138-2382	National Heart, Lung, and Blood Institute of the National Institutes of Health	National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under award number R01HL125487.The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler NE, 2002, HEALTH AFFAIR, V21, P60, DOI 10.1377/hlthaff.21.2.60; [Anonymous], 2017, LEAV NO ON STRENGTH; Association SEWs, 2009, SEW SERV; Berendes S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000433; Earnshaw VA, 2012, J HEALTH PSYCHOL, V17, P157, DOI 10.1177/1359105311414952; Edelman D., 2012, VA EVIDENCE BASED SY; Einterz RM, 2007, ACAD MED, V82, P812, DOI 10.1097/ACM.0b013e3180cc29f1; Fiscella K, 1998, MED CARE, V36, P180, DOI 10.1097/00005650-199802000-00007; Genberg B., 2019, HLTH SYSTEM FACTORS, V18; Gertler P, 2009, HEALTH ECON, V18, P257, DOI 10.1002/hec.1372; Graham JL, 2015, AIDS PATIENT CARE ST, V29, P661, DOI 10.1089/apc.2015.0156; Gurewich D, 2020, J GEN INTERN MED, V35, P1571, DOI 10.1007/s11606-020-05720-6; Gutierrez M., 2009, MICROFINANZAS SISTEM; Haywood C, 2014, J PAIN SYMPTOM MANAG, V48, P934, DOI 10.1016/j.jpainsymman.2014.02.002; Jaber R, 2006, J AM BOARD FAM MED, V19, P276, DOI 10.3122/jabfm.19.3.276; Kim J, 2009, B WORLD HEALTH ORGAN, V87, P824, DOI 10.2471/BLT.08.056580; Kruk ME, 2018, LANCET, V392, P2203, DOI [10.1016/S0140-6736(18)31668-4, 10.1016/s0140-6736(18)31668-4]; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Leung CL, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05199-1; Lorenzetti LMJ, 2017, HEALTH POLICY PLANN, V32, P732, DOI 10.1093/heapol/czw170; Mahajan AP, 2008, AIDS, V22, pS67, DOI 10.1097/01.aids.0000327438.13291.62; Naanyu V, 2011, QUAL HEALTH RES, V21, P14, DOI 10.1177/1049732310367498; National Academies of Sciences Engineering and Medicine., 2019, INT SOC CAR DEL HLTH, P194; Pastakia SD, 2017, J GEN INTERN MED, V32, P540, DOI 10.1007/s11606-016-3918-5; Pastakia Sonak D, 2015, Clin Diabetes, V33, P136, DOI 10.2337/diaclin.33.3.136; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Salari P, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001809; Sayles JN, 2009, J GEN INTERN MED, V24, P1101, DOI 10.1007/s11606-009-1068-8; Sommer I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2227-y; Vedanthan R, 2019, J AM COLL CARDIOL, V74, P1897, DOI 10.1016/j.jacc.2019.08.003; Vedanthan R, 2017, AM HEART J, V188, P175, DOI 10.1016/j.ahj.2017.03.012; Vedanthan R, 2016, ETHNIC DIS, V26, P315, DOI 10.18865/ed.26.3.315	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0248496	10.1371/journal.pone.0248496	http://dx.doi.org/10.1371/journal.pone.0248496			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RH	34097700	gold, Green Submitted, Green Published			2022-12-26	WOS:000664640700001
J	Sulot, D; Alonso-Caneiro, D; Ksieniewicz, P; Krzyzanowska-Berkowska, P; Iskander, DR				Sulot, Dominika; Alonso-Caneiro, David; Ksieniewicz, Pawel; Krzyzanowska-Berkowska, Patrycja; Iskander, D. Robert			Glaucoma classification based on scanning laser ophthalmoscopic images using a deep learning ensemble method	PLOS ONE			English	Article							AUTOMATIC SEGMENTATION; CLASSIFIERS	This study aimed to assess the utility of optic nerve head (onh) en-face images, captured with scanning laser ophthalmoscopy (slo) during standard optical coherence tomography (oct) imaging of the posterior segment, and demonstrate the potential of deep learning (dl) ensemble method that operates in a low data regime to differentiate glaucoma patients from healthy controls. The two groups of subjects were initially categorized based on a range of clinical tests including measurements of intraocular pressure, visual fields, oct derived retinal nerve fiber layer (rnfl) thickness and dilated stereoscopic examination of onh. 227 slo images of 227 subjects (105 glaucoma patients and 122 controls) were used. A new task-specific convolutional neural network architecture was developed for slo image-based classification. To benchmark the results of the proposed method, a range of classifiers were tested including five machine learning methods to classify glaucoma based on rnfl thickness-a well-known biomarker in glaucoma diagnostics, ensemble classifier based on inception v3 architecture, and classifiers based on features extracted from the image. The study shows that cross-validation dl ensemble based on slo images achieved a good discrimination performance with up to 0.962 of balanced accuracy, outperforming all of the other tested classifiers.	[Sulot, Dominika; Iskander, D. Robert] Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland; [Alonso-Caneiro, David] Queensland Univ Technol, Sch Optometry & Vis Sci, Ctr Vis & Eye Res, Contact Lens & Visual Opt Lab, Brisbane, Qld, Australia; [Ksieniewicz, Pawel] Wroclaw Univ Sci & Technol, Dept Syst & Comp Networks, Wroclaw, Poland; [Krzyzanowska-Berkowska, Patrycja] Wroclaw Med Univ, Dept Ophthalmol, Wroclaw, Poland	Wroclaw University of Science & Technology; Queensland University of Technology (QUT); Wroclaw University of Science & Technology; Wroclaw Medical University	Sulot, D (corresponding author), Wroclaw Univ Sci & Technol, Dept Biomed Engn, Wroclaw, Poland.	dominika.sulot@pwr.edu.pl	Ksieniewicz, Paweł/AAD-3318-2019	Ksieniewicz, Paweł/0000-0001-9578-8395; Krzyzanowska-Berkowska, Patrycja/0000-0001-8034-2534; Sulot, Dominika/0000-0002-0246-3223; Alonso-Caneiro, David/0000-0002-7754-6592	InterDok - Interdisciplinary Doctoral Studies Projects at Wroclaw University of Science and Technology; National Science Centre, Poland within the OPUS grant [2018/29/B/ST7/02451]; Rebecca L. Cooper 2018 Project Grant; National Health & Medical Research Council [APP1186915]; Department of Systems and Computer Networks, Wroclaw University of Science and Technology; European Union under the European Social Fund	InterDok - Interdisciplinary Doctoral Studies Projects at Wroclaw University of Science and Technology; National Science Centre, Poland within the OPUS grant; Rebecca L. Cooper 2018 Project Grant; National Health & Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Department of Systems and Computer Networks, Wroclaw University of Science and Technology; European Union under the European Social Fund	The work of D. S. was supported by InterDok - Interdisciplinary Doctoral Studies Projects at Wroclaw University of Science and Technology, a project co-financed by the European Union under the European Social Fund, D.R. I.was supported by the National Science Centre, Poland within the OPUS grant [2018/29/B/ST7/02451], D.A.-C. was supported by Rebecca L. Cooper 2018 Project Grant and the National Health & Medical Research Council Ideas Grant (APP1186915), while P. K., by the statutory funds of the Department of Systems and Computer Networks, Wroclaw University of Science and Technology.	Abadi M., 2016, TENSORFLOW LARGE SCA; Al-Jarrah OY, 2015, BIG DATA RES, V2, P87, DOI 10.1016/j.bdr.2015.04.001; Alpaydin E., 2009, ADAPT COMPUT MACH LE, P511; Asaoka R, 2019, AM J OPHTHALMOL, V198, P136, DOI 10.1016/j.ajo.2018.10.007; Bowd C, 2008, OPTOMETRY VISION SCI, V85, P396, DOI 10.1097/OPX.0b013e3181783ab6; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Chan KL, 2002, IEEE T BIO-MED ENG, V49, P963, DOI 10.1109/TBME.2002.802012; Chollet F, 2016, KERAS, DOI DOI 10.1038/NATURE083580; Christopher M, 2020, OPHTHALMOLOGY, V127, P346, DOI 10.1016/j.ophtha.2019.09.036; Cunefare D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07103-0; Fang LY, 2017, BIOMED OPT EXPRESS, V8, P2732, DOI 10.1364/BOE.8.002732; Geoffrey E Hinton, 2012, ARXIV; Glorot X., 2010, P 13 INT C ARTIFICIA, V9, P249, DOI DOI 10.1.1/207.2059; Greenfield DS, 2008, AM J OPHTHALMOL, V145, P598, DOI 10.1016/j.ajo.2007.12.018; Haleem MS, 2016, J MED SYST, V40, DOI 10.1007/s10916-016-0482-9; Hamwood J, 2018, BIOMED OPT EXPRESS, V9, P3049, DOI 10.1364/BOE.9.003049; He XX, 2020, NEUROCOMPUTING, V405, P37, DOI 10.1016/j.neucom.2020.04.044; Hogarty DT, 2019, CLIN EXP OPHTHALMOL, V47, P128, DOI 10.1111/ceo.13381; Kim SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177726; Kingma DP., 2014, ADAM METHOD STOCHAST; Kugelman J, 2019, 2019 DIG IM COMP TEC, P1; Li L, 2020, IEEE T MED IMAGING, V39, P413, DOI 10.1109/TMI.2019.2927226; Li XC, 2019, NEUROCOMPUTING, V369, P134, DOI 10.1016/j.neucom.2019.08.079; Liu TYA, 2020, J NEURO-OPHTHALMOL, V40, P178, DOI 10.1097/WNO.0000000000000827; Masumoto H, 2018, J GLAUCOMA, V27, P647, DOI 10.1097/IJG.0000000000000988; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perez L, 2017, ARXIV171204621; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Qummar S, 2019, IEEE ACCESS, V7, P150530, DOI 10.1109/ACCESS.2019.2947484; Rahimy E, 2018, CURR OPIN OPHTHALMOL, V29, P254, DOI 10.1097/ICU.0000000000000470; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Shen DG, 2017, ANNU REV BIOMED ENG, V19, P221, DOI 10.1146/annurev-bioeng-071516-044442; Sugimoto K, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003114; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tatham AJ, 2015, PROG BRAIN RES, V221, P103, DOI 10.1016/bs.pbr.2015.03.001; Wang PY, 2019, OPHTHALMOL GLAUCOMA, V2, P422, DOI 10.1016/j.ogla.2019.08.004; Wollstein G, 1998, OPHTHALMOLOGY, V105, P1557, DOI 10.1016/S0161-6420(98)98047-2; Woniak M, 2014, INFOR FUSION, V16	39	5	5	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252339	10.1371/journal.pone.0252339	http://dx.doi.org/10.1371/journal.pone.0252339			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086716	gold, Green Published			2022-12-26	WOS:000664640100048
J	van de Bunte, W; Weerman, J; Hof, AR				van de Bunte, Wiene; Weerman, Janno; Hof, Anouschka R.			Potential effects of GPS collars on the behaviour of two red pandas (Ailurus fulgens) in Rotterdam Zoo	PLOS ONE			English	Article							WOLONG RESERVE; ECOLOGY; MAMMALS; WEIGHT	GPS collars are frequently used to study the (behavioural) ecology of species. However, such collars can cause behavioural changes and can have negative physiological effects on the individuals wearing them. A pilot study to obtain data on behavioural and physiological effects of GPS collars on the target species would therefore be recommended, especially when it concerns rare or endangered species. The red panda (Ailurus fulgens) is a small carnivore endemic to the mountains of Central Asia that is currently classified as endangered. There is a lack in knowledge on the species ecology which could be enhanced by a study using GPS-technology. As a pilot study, the two adult red pandas in Rotterdam Zoo were observed before and after fitting a GPS-collar, to determine possible behavioural effects of wearing a collar. Although the study did not take place under ideal circumstances, indications of both behavioural, e.g. increased shaking behaviour, and physical, e.g. abrasions, effects of the collar were found. Even though our results were only based on two individuals, our findings stress the need for pilot studies in controlled environments before GPS collars to ensure safety of the study species and validity of the collected data.	[van de Bunte, Wiene; Hof, Anouschka R.] Wageningen Univ, Wildlife Ecol & Conservat Grp, Wageningen, Netherlands; [Weerman, Janno] Royal Rotterdam Zool & Bot Gardens, Rotterdam, Netherlands; [Hof, Anouschka R.] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, Umea, Sweden	Wageningen University & Research; Swedish University of Agricultural Sciences	Weerman, J (corresponding author), Royal Rotterdam Zool & Bot Gardens, Rotterdam, Netherlands.	j.weerman@diergaardeblijdorp.nl		Weerman, Janno/0000-0003-2156-3227	Rotterdam Zoo	Rotterdam Zoo	Rotterdam Zoo, the employer of Janno Weerman, provided funds for the GPS collars, we did not receive any other specific funding for this work. Rotterdam Zoo, other than Janno Weerman, Linda Bruins-van Sonsbeek who provided medical assistance during the research, and the red panda keepers who enabled checking the physical effects of the collar on the red pandas, had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bista D, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11040921; Brooks C, 2008, J WILDLIFE MANAGE, V72, P527, DOI 10.2193/2007-061; Bruholt S., 2018, THESIS NORWEGIAN U L; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Calero G., 1998, RED LESSER PANDA STU, P14; Conservation Planning Specialist Group, 2021, ON PLAN APPR CONS; Cypher BL, 1997, J WILDLIFE MANAGE, V61, P1412, DOI 10.2307/3802145; Fornelino MM., 1995, RED LESSER PANDA STU, P31; Gebauer A, 2011, RED PANDA: BIOLOGY AND CONSERVATION OF THE FIRST PANDA, P157, DOI 10.1016/B978-1-4377-7813-7.00010-0; Glatston A., 2015, IUCN RED LIST THREAT; Glatston AR., 1980, RED LESSER PANDA STU; Gursky S, 1998, AM J PRIMATOL, V46, P145, DOI 10.1002/(SICI)1098-2345(1998)46:2<145::AID-AJP4>3.0.CO;2-W; HAMLEY JM, 1975, CAN J ZOOL, V53, P1476, DOI 10.1139/z75-179; Hart BL, 2018, PHILOS T R SOC B, V373, DOI 10.1098/rstb.2017.0205; Hebblewhite M, 2010, PHILOS T R SOC B, V365, P2303, DOI 10.1098/rstb.2010.0087; JOHNSON KG, 1988, J MAMMAL, V69, P552, DOI 10.2307/1381347; Jule KR., 2008, THESIS U EXETER; Keller R., 1980, RED PANDA LESSER PAN, P39; Krausman PR, 2004, WILDLIFE SOC B, V32, P987, DOI 10.2193/0091-7648(2004)032[0987:FTFNLI]2.0.CO;2; Manning JK, 2017, APPL ANIM BEHAV SCI, V187, P54, DOI 10.1016/j.applanim.2016.11.013; Matthews A, 2013, AUST MAMMAL, V35, P65, DOI 10.1071/AM12021; McNab B.K., 1989, P73; Merchan M., 1998, REPTILIA UK, P30, DOI 10.1523/JNEUROSCI.18-24-10603.1998; REID DG, 1991, J ZOOL, V225, P347, DOI 10.1111/j.1469-7998.1991.tb03821.x; Robert Leander, 2019, KNMI UURG WEER NED; Salesa MJ, 2011, RED PANDA: BIOLOGY AND CONSERVATION OF THE FIRST PANDA, P27, DOI 10.1016/B978-1-4377-7813-7.00003-3; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Stabach JA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0221843; Stevenson M., 1989, P103; TANAKA I, 1993, ANTHROPOL SCI, V101, P187, DOI 10.1537/ase.101.187; The R Foundation for Statistical Computing, 2019, R VERS 3 6 1 2019 07; Weber J.-M., 1992, P698; WEBSTER AB, 1980, CAN J ZOOL, V58, P997, DOI 10.1139/z80-139; Yonzon P.B., 1989, P1; Zhang ZJ, 2009, ACTA THERIOL, V54, P225, DOI 10.4098/j.at.0001-7051.017.2008	35	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252456	10.1371/journal.pone.0252456	http://dx.doi.org/10.1371/journal.pone.0252456			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086742	gold, Green Published			2022-12-26	WOS:000664640100070
J	Wysocka-Mincewicz, M; Golebiewska, J; Baszynska-Wilk, M; Olechowski, A; Byczynska, A; Mazur, M; Nowacka-Gotowiec, M				Wysocka-Mincewicz, Marta; Golebiewska, Joanna; Baszynska-Wilk, Marta; Olechowski, Andrzej; Byczynska, Aleksandra; Mazur, Maria; Nowacka-Gotowiec, Monika			Associations of nerve conduction parameters and OCT angiography results in adolescents with type 1 diabetes	PLOS ONE			English	Article							GANGLION-CELL COMPLEX; RETINAL THICKNESS; NEUROPATHY; RETINOPATHY; MELLITUS; CHILDREN; POLYNEUROPATHY; COMPLICATIONS; ONSET	Aim To evaluate dependence of abnormalities in peripheral nerves and retina in children with type 1 diabetes (T1D) using optical coherence tomography angiography (OCTA) and nerve conduction studies (NCS). Material and methods 50 adolescents with T1D without any signs and symptoms of diabetic retinopathy and neuropathy (mean age 16.921.6 years, diabetes duration 6.88 4.34years) were included. In OCTA capillary plexuses superficial (SCP) and deep (DCP) vessel density: whole, foveal and parafoveal, ganglion cell complex (GCC), loss volume focal (FLV) and global loss volume (GLV) were analyzed in relation to NCS parameters (motor nerves median and tibial potential amplitude (CMAP), velocity (CV), distal latency (DML) and F wave and sensory nerves median and sural potential amplitude (SNAP), CV and distal latency (DSL). Results We detected the correlations between median sensory SNAP and GCC (r = -0.3, p <0.04), motor nerves tibial DML and CV and FLV (respectively r = -0.53, p<0.001, and r = -0.34, p<0.05), and median DML and GLV (r = 0.47, p<0.001). Vessel densities were related to changes in motor nerves tibial velocity (whole SCP r = 0.43, p <0.01, parafoveal SCP r = 0.41, p <0.01), CMAP (parafoveal SCP r = -0.35, p<0.03), median DML (whole DC r = 0.36, p<0.03, foveal DCP r = 0.37, p<0.02) and in sensory median SNAP (whole SCP r = -0.31, p<0.05). Conclusions In adolescents with T1D without diabetic neuropathy and retinopathy we detected associations between NCS and OCT and OCTA parameters, regarding decreased GCC and density of superficial and deep vessel plexuses in relation to DML and CV and amplitudes of sensory and motor potential.	[Wysocka-Mincewicz, Marta; Baszynska-Wilk, Marta; Byczynska, Aleksandra; Mazur, Maria] Childrens Mem Hlth Inst, Clin Endocrinol & Diabetol, Warsaw, Poland; [Golebiewska, Joanna; Olechowski, Andrzej] Childrens Mem Hlth Inst, Dept Ophthalmol, Warsaw, Poland; [Golebiewska, Joanna] Lazarski Univ, Fac Med, Warsaw, Poland; [Olechowski, Andrzej] James Cook Univ Hosp, Ophthalmol Dept, Middlesbrough, Cleveland, England; [Nowacka-Gotowiec, Monika] Childrens Mem Hlth Inst, Electromyog & Evoked Potential Lab, Warsaw, Poland	Children's Memorial Health Institute; Children's Memorial Health Institute; Uczelnia Lazarskiego w Warszawie; James Cook University Hospital; Children's Memorial Health Institute	Golebiewska, J (corresponding author), Childrens Mem Hlth Inst, Dept Ophthalmol, Warsaw, Poland.; Golebiewska, J (corresponding author), Lazarski Univ, Fac Med, Warsaw, Poland.	joanna.golebiewska@wp.pl	Gołębiewska, Joanna/GMW-5071-2022; Gołębiewska, Joanna/ABF-6966-2021	Gołębiewska, Joanna/0000-0002-3013-4363; Nowacka-Gotowiec, Monika/0000-0002-8183-8360; Olechowski, Andrzej/0000-0003-2089-4518				Barber AJ, 2003, PROG NEURO-PSYCHOPH, V27, P283, DOI 10.1016/S0278-5846(03)00023-X; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Biallosterski C, 2007, BRIT J OPHTHALMOL, V91, P1135, DOI 10.1136/bjo.2006.111534; Cameron NE, 2001, DIABETOLOGIA, V44, P1973, DOI 10.1007/s001250100001; Cho YH, 2014, PEDIATR DIABETES, V15, P18, DOI 10.1111/pedi.12112; El-Fayoumi D, 2016, INVEST OPHTH VIS SCI, V57, P5355, DOI 10.1167/iovs.16-19988; GIANNINI C, 1995, ANN NEUROL, V37, P498, DOI 10.1002/ana.410370412; Girach A, 2006, INT J CLIN PRACT, V60, P1471, DOI 10.1111/j.1742-1241.2006.01175.x; Golebiewska J, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/5458015; Golebiewska J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186479; HANSEN S, 1977, J NEUROL NEUROSUR PS, V40, P555, DOI 10.1136/jnnp.40.6.555; Holl RW, 1998, J PEDIATR-US, V132, P790, DOI 10.1016/S0022-3476(98)70305-1; Jia YL, 2012, OPT EXPRESS, V20, P4710, DOI 10.1364/OE.20.004710; Karsidag S, 2005, DIABETES RES CLIN PR, V67, P211, DOI 10.1016/j.diabres.2004.07.017; Lee SS, 2010, PEDIATR DIABETES, V11, P521, DOI 10.1111/j.1399-5448.2009.00636.x; Matanovic D, 2013, CENT EUR J MED, V8, P503, DOI 10.2478/s11536-013-0181-6; Meijer JWG, 2002, DIABETIC MED, V19, P962, DOI 10.1046/j.1464-5491.2002.00819.x; Nathan DM, 1996, ANN INTERN MED, V124, P86, DOI 10.7326/0003-4819-124-1_Part_2-199601011-00002; PARANO E, 1993, J CHILD NEUROL, V8, P336, DOI 10.1177/088307389300800408; Shahidi AM, 2012, DIABETIC MED, V29, pE106, DOI 10.1111/j.1464-5491.2012.03588.x; Srinivasan S, 2016, CLIN EXP OPTOM, V99, P526, DOI 10.1111/cxo.12379; Srinivasan S, 2016, CURR EYE RES, V41, P1359, DOI 10.3109/02713683.2015.1119855; Srinivasan S, 2016, OPHTHAL PHYSL OPT, V36, P158, DOI 10.1111/opo.12263; van Dijk HW, 2012, INVEST OPHTH VIS SCI, V53, P2715, DOI 10.1167/iovs.11-8997; Vujosevic S, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/905058; YOUNG MJ, 1993, DIABETOLOGIA, V36, P150, DOI 10.1007/BF00400697	26	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252588	10.1371/journal.pone.0252588	http://dx.doi.org/10.1371/journal.pone.0252588			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086761	Green Published, gold			2022-12-26	WOS:000664640100089
J	Gifford, CC; Lian, F; Tang, JQ; Costello, A; Goldschmeding, R; Samarakoon, R; Higgins, PJ				Gifford, Cody C.; Lian, Fei; Tang, Jiaqi; Costello, Angelica; Goldschmeding, Roel; Samarakoon, Rohan; Higgins, Paul J.			PAI-1 induction during kidney injury promotes fibrotic epithelial dysfunction via deregulation of klotho, p53, and TGF-beta 1-receptor signaling	FASEB JOURNAL			English	Article						cell cycle arrest; chronic kidney disease; epithelial dysfunction; klotho; obstructive nephropathy; p53; PAI-1; renal fibrosis; TGF-beta 1	PLASMINOGEN-ACTIVATOR INHIBITOR-1; CELL-CYCLE ARREST; TGF-BETA; TARGET GENES; FIBROSIS; DISEASE; SENESCENCE; EXPRESSION; MECHANISMS	Renal fibrosis leads to chronic kidney disease, which affects over 15% of the U.S. population. PAI-1 is highly upregulated in the tubulointerstitial compartment in several common nephropathies and PAI-1 global ablation affords protection from fibrogenesis in mice. The precise contribution of renal tubular PAI-1 induction to disease progression, however, is unknown and surprisingly, appears to be independent of uPA inhibition. Human renal epithelial (HK-2) cells engineered to stably overexpress PAI-1 underwent dedifferentiation (E-cadherin loss, gain of vimentin), G2/M growth arrest (increased p-Histone3, p21), and robust induction of fibronectin, collagen-1, and CCN2. These cells are also susceptible to apoptosis (elevated cleaved caspase-3, annexin-V positivity) compared to vector controls, demonstrating a previously unknown role for PAI-1 in tubular dysfunction. Persistent PAI-1 expression results in a loss of klotho expression, p53 upregulation, and increases in TGF-beta RI/II levels and SMAD3 phosphorylation. Ectopic restoration of klotho in PAI-1-transductants attenuated fibrogenesis and reversed the proliferative defects, implicating PAI-1 in klotho loss in renal disease. Genetic suppression of p53 reversed the PA1-1-driven maladaptive repair, moreover, confirming a pathogenic role for p53 upregulation in this context and uncovering a novel role for PAI-1 in promoting renal p53 signaling. TGF-beta RI inhibition also attenuated PAI-1-initiated epithelial dysfunction, independent of TGF-beta 1 ligand synthesis. Thus, PAI-1 promotes tubular dysfunction via klotho reduction, p53 upregulation, and activation of the TGF-beta RI-SMAD3 axis. Since klotho is an upstream regulator of both PAI-1-mediated p53 induction and SMAD3 signaling, targeting tubular PAI-1 expression may provide a novel, multi-level approach to the therapy of CKD.	[Gifford, Cody C.; Tang, Jiaqi; Costello, Angelica; Samarakoon, Rohan; Higgins, Paul J.] Albany Med Coll, Dept Regenerat & Canc Cell Biol, MC 165,47 New Scotland Ave, Albany, NY 12208 USA; [Lian, Fei; Higgins, Paul J.] Albany Med Coll, Div Urol, Albany, NY 12208 USA; [Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands	Albany Medical College; Albany Medical College; Utrecht University; Utrecht University Medical Center	Samarakoon, R; Higgins, PJ (corresponding author), Albany Med Coll, Dept Regenerat & Canc Cell Biol, MC 165,47 New Scotland Ave, Albany, NY 12208 USA.	samarar@amc.edu; higginp@amc.edu		Tang, Jiaqi/0000-0002-3544-3456	NIH [GM057242]; Capital District Medical Research Institute; Friedman Family Research Fund; Charlotte Graver Foundation; John Faunce & Alicia Tracy Roach Fund; Edith Dickstein & Sylvan Kessler Estate Foundation; Butler Family Mesothelioma Research Fund; Mueller Family Cancer Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Capital District Medical Research Institute; Friedman Family Research Fund; Charlotte Graver Foundation; John Faunce & Alicia Tracy Roach Fund; Edith Dickstein & Sylvan Kessler Estate Foundation; Butler Family Mesothelioma Research Fund; Mueller Family Cancer Foundation	This study was supported by NIH Grant GM057242 to PJH, a Capital District Medical Research Institute Grant to RS, the Friedman Family Research Fund, the Charlotte Graver Foundation, the John Faunce & Alicia Tracy Roach Fund, the Edith Dickstein & Sylvan Kessler Estate Foundation, the Butler Family Mesothelioma Research Fund, and TMueller Family Cancer Foundation	Adijiang A, 2011, J RENAL NUTR, V21, P105, DOI 10.1053/j.jrn.2010.10.020; Anorga S, 2018, FASEB J, V32, P2644, DOI 10.1096/fj.201700722R; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Chen JC, 2012, J AM SOC NEPHROL, V23, P215, DOI 10.1681/ASN.2011070645; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; de Oliveira RM, 2006, FEBS LETT, V580, P5753, DOI 10.1016/j.febslet.2006.09.036; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Eddy AA, 2006, J AM SOC NEPHROL, V17, P2999, DOI 10.1681/ASN.2006050503; Eren M, 2014, SEMIN THROMB HEMOST, V40, P645, DOI 10.1055/s-0034-1387883; ERICKSON LA, 1984, J CLIN INVEST, V74, P1465, DOI 10.1172/JCI111559; Ferenbach DA, 2015, NAT REV NEPHROL, V11, P264, DOI 10.1038/nrneph.2015.3; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Guan X, 2014, J PATHOL, V234, P560, DOI 10.1002/path.4420; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Krag S, 2005, KIDNEY INT, V68, P2651, DOI 10.1111/j.1523-1755.2005.00737.x; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Lindberg K, 2014, J AM SOC NEPHROL, V25, P2169, DOI 10.1681/ASN.2013111209; Liu Y, 2019, MOL THER, V27, P1051, DOI 10.1016/j.ymthe.2019.02.009; Lovisa S, 2015, NAT MED, V21, P998, DOI 10.1038/nm.3902; Ma J, 2006, KIDNEY INT, V69, P1064, DOI 10.1038/sj.ki.5000201; Matsuo S, 2005, KIDNEY INT, V67, P2221, DOI 10.1111/j.1523-1755.2005.00327.x; Meng XM, 2016, NAT REV NEPHROL, V12, P325, DOI 10.1038/nrneph.2016.48; Nicholas SB, 2005, KIDNEY INT, V67, P1297, DOI 10.1111/j.1523-1755.2005.00207.x; Oda T, 2001, KIDNEY INT, V60, P587, DOI 10.1046/j.1523-1755.2001.030002587.x; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Overstreet JM, 2014, CELL SIGNAL, V26, P1427, DOI 10.1016/j.cellsig.2014.02.017; Patel S, 2019, FASEB J, V33, P9797, DOI 10.1096/fj.201802489RR; Perico N, 2012, NEPHROL DIAL TRANSPL, V27, P19, DOI 10.1093/ndt/gfs284; Samarakoon R, 2008, J MOL CELL CARDIOL, V44, P527, DOI 10.1016/j.yjmcc.2007.12.006; Samarakoon R, 2016, FASEB J, V30, P3308, DOI 10.1096/fj.201500105R; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Samarakoon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022896; Sedeek M, 2013, CLIN SCI, V124, P191, DOI 10.1042/CS20120330; Sugiura H, 2005, NEPHROL DIAL TRANSPL, V20, P2636, DOI 10.1093/ndt/gfi165; Yamaguchi I, 2007, AM J PHYSIOL-RENAL, V293, pF12, DOI 10.1152/ajprenal.00380.2006; Yan YL, 2016, KIDNEY INT, V89, P68, DOI 10.1038/ki.2015.293; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang RH, 2017, SCI REP-UK, V7, DOI 10.1038/srep43409; Yao L, 2019, NEPHROL DIAL TRANSPL, V34, P2042, DOI 10.1093/ndt/gfz050; Yin SS, 2017, BBA-MOL CELL RES, V1864, P1207, DOI 10.1016/j.bbamcr.2017.03.002; Ying Y, 2014, J AM SOC NEPHROL, V25, P2707, DOI 10.1681/ASN.2013121270; Zhang DS, 2014, J AM SOC NEPHROL, V25, P2278, DOI 10.1681/ASN.2013080902; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865	50	5	5	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21725	10.1096/fj.202002652RR	http://dx.doi.org/10.1096/fj.202002652RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110636	Green Accepted			2022-12-26	WOS:000667814100057
J	Yoon, JH; Basu, D; Choudhury, JR; Prakash, S; Prakash, L				Yoon, Jung-Hoon; Basu, Debashree; Choudhury, Jayati Roy; Prakash, Satya; Prakash, Louise			DNA polymerase lambda promotes error-free replication through Watson-Crick impairing N1-methyl-deoxyadenosine adduct in conjunction with DNA polymerase zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; DAMAGE TOLERANCE; THYMINE DIMER; BYPASS; ETA; IOTA; DUPLEX; YEAST; PHOTOPRODUCT	In a previous study, we showed that replication through the N1-methyl-deoxyadenosine (1-MeA) adduct in human cells is mediated via three different Pol tau/Pol theta, Pol zeta, and Pol.-dependent pathways. Based on biochemical studies with these Pols, in the Pol tau/Pol theta pathway, we inferred a role for Pol theta in the insertion of a nucleotide (nt) opposite 1-MeA and of Pol theta in extension of synthesis from the inserted nt; in the Pol eta pathway, we inferred that this Pol alone would replicate through 1-MeA; in the Pol zeta pathway, however, the Pol required for inserting an nt opposite 1-MeA had remained unidentified. In this study, we provide biochemical and genetic evidence for a role for Pol lambda in inserting the correct nt T opposite 1-MeA, from which Pol zeta would extend synthesis. The high proficiency of purified Pol lambda for inserting a T opposite 1-MeA implicates a role for Pol lambda-which normally uses W-C base pairing for DNA synthesis-in accommodating 1-MeA in a syn confirmation and forming a Hoogsteen base pair with T. The potential of Pol. to replicate through DNA lesions by Hoogsteen base pairing adds another novel aspect to Pol lambda's role in translesion synthesis in addition to its role as a scaffolding component of Pol zeta. We discuss how the action mechanisms of Pol lambda and Pol lambda could be restrained to inserting a T opposite 1-MeA and extending synthesis thereafter, respectively.	[Yoon, Jung-Hoon; Basu, Debashree; Choudhury, Jayati Roy; Prakash, Satya; Prakash, Louise] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, L (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	loprakash@utmb.edu		Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444	National Institutes of Health [R01 GM126087]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (R01 GM126087). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Baynton K, 1998, MOL CELL BIOL, V18, P960, DOI 10.1128/MCB.18.2.960; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Conde J, 2015, J BIOL CHEM, V290, P29794, DOI 10.1074/jbc.M115.693010; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Jain RK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43904; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P12359, DOI 10.1073/pnas.0504380102; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; KEMMINK J, 1987, NUCLEIC ACIDS RES, V15, P4645, DOI 10.1093/nar/15.11.4645; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; Lee JH, 1999, P NATL ACAD SCI USA, V96, P6632, DOI 10.1073/pnas.96.12.6632; Malik R, 2020, NAT STRUCT MOL BIOL, V27, P913, DOI 10.1038/s41594-020-0476-7; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Ummat A, 2012, NAT STRUCT MOL BIOL, V19, P628, DOI 10.1038/nsmb.2295; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Yoon JH, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000900; Yoon JH, 2019, GENE DEV, V33, P282, DOI 10.1101/gad.320531.118; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Yoon JH, 2018, J BIOL CHEM, V293, P2949, DOI 10.1074/jbc.RA117.000962; Yoon JH, 2017, J BIOL CHEM, V292, P18682, DOI 10.1074/jbc.M117.808659; Yoon JH, 2015, GENE DEV, V29, P2588, DOI 10.1101/gad.272229.115; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	41	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100868	10.1016/j.jbc.2021.100868	http://dx.doi.org/10.1016/j.jbc.2021.100868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34119520	Green Published, gold			2022-12-26	WOS:000678068400068
J	Yu, F; Yu, N; Peng, J; Zhao, Y; Zhang, L; Wang, XH; Xu, XN; Zhou, J; Wang, F				Yu, Fang; Yu, Nan; Peng, Jie; Zhao, Yan; Zhang, Lei; Wang, Xiaohui; Xu, Xiaona; Zhou, Jian; Wang, Feng			Emodin inhibits lipid accumulation and inflammation in adipose tissue of high-fat diet-fed mice by inducing M2 polarization of adipose tissue macrophages	FASEB JOURNAL			English	Article						adipose tissue macrophages; emodin; M2 macrophage; obesity; TREM2	11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; AIRWAY INFLAMMATION; CANCER-CELLS; IN-VITRO; OBESITY; PROTECTS; LIVER; AMPK; ATTENUATION; DISEASE	Adipose tissue macrophages (ATMs) represent the most abundant leukocytes in adipose tissue (AT). An increase in number and a phenotypical switch of ATMs during the development of obesity contribute to chronic inflammation and metabolic disorders, which have been regarded as potential therapeutic targets to restore AT homeostasis. Emodin has been shown to exert strong anti-inflammatory property via acting on macrophages in a range of disease models. However, whether emodin exerts a beneficial effect on obesity via modulating ATMs has not been reported. In high-fat diet (HFD)-induced obese mice, emodin significantly inhibited the increase of body weight and lipid accumulation in ATs. Emodin apparently reduced glucose and insulin levels and ameliorated serum lipid profiles in HFD-fed mice. Moreover, the local and systemic inflammation was dramatically alleviated by emodin. We next discovered that M2 macrophage percentage was greatly increased by emodin although total ATMs was not altered, which resulted in a net increase of M2 macrophages in AT. In vitro studies confirmed that emodin promoted the polarization of macrophages towards M2. Gene ontology (GO) analysis showed that myeloid leukocyte differentiation and activation were among the most significant biological processes in emodin-treated ATMs. We further identified that TREM2 was the most dramatically upregulated molecule by emodin and emodin-induced M2 macrophage polarization was dependent on TREM2. Furthermore, silencing TREM2 apparently abrogated the effect of emodin on AT inflammation and adipogenesis. We, for the first time, disclosed that emodin inhibited obesity by promoting M2 macrophage polarization via TREM2, suggesting that emodin may be explored as a clinical and translational candidate in preventing obesity and its related metabolic diseases.	[Yu, Fang; Zhang, Lei; Wang, Xiaohui; Xu, Xiaona; Zhou, Jian; Wang, Feng] Air Force Med Univ, Dept Nutr & Food Hyg, 169 Changle West Rd, Xian 710032, Peoples R China; [Yu, Fang; Zhang, Lei; Wang, Xiaohui; Xu, Xiaona; Zhou, Jian; Wang, Feng] Air Force Med Univ, Dept Hlth Educ & Hlth Management, Minist Educ, Key Lab Hazard Assessment & Control Special Opera, Xian, Peoples R China; [Yu, Nan] Changzhi Med Coll, Dept Ophthalmol, Heping Hosp, Changzhi, Peoples R China; [Peng, Jie] Air Force Med Univ, Dept Toxicol, Xian, Peoples R China; [Zhao, Yan] Air Force Med Univ, Dept Pharmacogen, State Key Lab Canc Biol, Xian, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Changzhi Medical College; Air Force Military Medical University; Air Force Military Medical University	Yu, F; Wang, F (corresponding author), Air Force Med Univ, Dept Nutr & Food Hyg, 169 Changle West Rd, Xian 710032, Peoples R China.	yufang@fmmu.edu.cn; wfeng@fmmu.edu.cn			Shaanxi Science and Technology Innovation Team [2018TD-001]; Key Research and Development Plan of Shaanxi Province [2018SF-342]; Logistics Research Project of China [AWS17J014, BWS18J011]; Medical Science and Technology Youth Training Project of Ministry of Health [14QNP093]	Shaanxi Science and Technology Innovation Team; Key Research and Development Plan of Shaanxi Province; Logistics Research Project of China; Medical Science and Technology Youth Training Project of Ministry of Health	Shaanxi Science and Technology Innovation Team, Grant/Award Number: 2018TD-001; Key Research and Development Plan of Shaanxi Province, Grant/Award Number: 2018SF-342; Logistics Research Project of China, Grant/Award Number: AWS17J014 and BWS18J011; Medical Science and Technology Youth Training Project of Ministry of Health, Grant/Award Number: 14QNP093	Bluher M, 2016, CLIN SCI, V130, P1603, DOI 10.1042/CS20160005; Caslin HL, 2020, IMMUNOL REV, V295, P101, DOI 10.1111/imr.12853; Castoldi A, 2016, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00637; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Chen ZF, 2012, J CELL BIOCHEM, V113, P3547, DOI 10.1002/jcb.24232; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Fang L, 2019, INT IMMUNOPHARMACOL, V75, DOI 10.1016/j.intimp.2019.105763; Feng Y, 2010, BRIT J PHARMACOL, V161, P113, DOI 10.1111/j.1476-5381.2010.00826.x; Genua M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0293-z; Haase J, 2014, DIABETOLOGIA, V57, P562, DOI 10.1007/s00125-013-3139-y; Hamerman JA, 2006, J IMMUNOL, V177, P2051, DOI 10.4049/jimmunol.177.4.2051; Han JW, 2015, INT J MOL SCI, V16, P8102, DOI 10.3390/ijms16048102; Herrada AA, 2021, OBES REV, V22, DOI 10.1111/obr.13200; Hua S, 2019, MED SCI MONITOR, V25, P5621, DOI 10.12659/MSM.915080; Iwanowycz S, 2016, MOL CANCER THER, V15, P1931, DOI 10.1158/1535-7163.MCT-15-0987; Iwanowycz S, 2016, J BIOL CHEM, V291, P11491, DOI 10.1074/jbc.M115.702092; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jia XM, 2014, BREAST CANCER RES TR, V148, P291, DOI 10.1007/s10549-014-3164-7; Jia XM, 2014, EXP BIOL MED, V239, P1025, DOI 10.1177/1535370214530247; Kober DL, 2017, J MOL BIOL, V429, P1607, DOI 10.1016/j.jmb.2017.04.004; Lee EH, 2020, PHARM BIOL, V58, P333, DOI 10.1080/13880209.2020.1750658; Li JM, 2016, EUR J PHARMACOL, V770, P99, DOI 10.1016/j.ejphar.2015.11.045; Liu C, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-2050-9; Liu DL, 2012, INT J ONCOL, V40, P1049, DOI 10.3892/ijo.2011.1285; Lu Y, 2011, BIOCHEM PHARMACOL, V82, P1700, DOI 10.1016/j.bcp.2011.08.022; Makki Kassem, 2013, ISRN Inflamm, V2013, P139239, DOI 10.1155/2013/139239; Shang Xiao-yu, 2002, Yaoxue Xuebao, V37, P798; Shrimali D, 2013, CANCER LETT, V341, P139, DOI 10.1016/j.canlet.2013.08.023; Song YD, 2018, ACTA PHARMACOL SIN, V39, P1317, DOI 10.1038/aps.2017.147; Subramanian S, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1187-7; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Tong HF, 2011, ANAT REC, V294, P445, DOI 10.1002/ar.21352; Tzeng TF, 2012, PLANTA MED, V78, P943, DOI 10.1055/s-0031-1298626; Vieira-Potter VJ, 2014, CELL MICROBIOL, V16, P1484, DOI 10.1111/cmi.12336; Wang YJ, 2012, ACTA PHARMACOL SIN, V33, P1195, DOI 10.1038/aps.2012.87; Xue JF, 2010, FITOTERAPIA, V81, P173, DOI 10.1016/j.fitote.2009.08.020; Xue JH, 2015, CELL PHYSIOL BIOCHEM, V35, P1557, DOI 10.1159/000373971; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Yu LY, 2020, DRUG DES DEV THER, V14, P1493, DOI 10.2147/DDDT.S243893; Zhang XB, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/9340610; Zhang Yin-Huan, 2019, Zhongguo Zhong Yao Za Zhi, V44, P2820, DOI 10.19540/j.cnki.cjcmm.20190321.401; Zhao JY, 2019, J ASIAN NAT PROD RES, V21, P186, DOI 10.1080/10286020.2017.1408594; Zhou Y, 2015, CELL METAB, V22, P1045, DOI 10.1016/j.cmet.2015.09.013; Zhu SY, 2014, PHARM BIOL, V52, P51, DOI 10.3109/13880209.2013.810648	45	6	6	3	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21730	10.1096/fj.202100157RR	http://dx.doi.org/10.1096/fj.202100157RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110631				2022-12-26	WOS:000667814100077
J	Jo, HH; Min, C; Kyoung, DS; Park, MA; Kim, SG; Kim, YS; Chang, Y; Jeong, SW; Jang, JY; Lee, SH; Kim, HS; Jun, BG; Kim, YD; Cheon, GJ; Yoo, JJ				Jo, Hyun Ho; Min, Changwook; Kyoung, Dae-Sung; Park, Min-Ae; Kim, Sang Gyune; Kim, Young Seok; Chang, Young; Jeong, Soung Won; Jang, Jae Young; Lee, Sae Hwan; Kim, Hong Soo; Jun, Baek Gyu; Kim, Young Don; Cheon, Gab Jin; Yoo, Jeong-Ju			Adverse outcomes after surgeries in patients with liver cirrhosis among Korean population: A population-based study	PLOS ONE			English	Article							RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; INTRAABDOMINAL SURGERY; CARDIAC-SURGERY; MORTALITY; DISEASE; MORBIDITY; EMERGENCY	Background Patients with liver cirrhosis have an increased risk of in-hospital mortality or postoperative complication after surgery. However, large-scale studies on the prognosis of these patients after surgery are lacking. The aim of the study was to investigate the adverse outcomes of patients with liver cirrhosis after surgery over five years. Methods and findings We used the Health Insurance Review and Assessment Service-National Inpatient Samples (HIRA-NIS) between 2012 and 2016. In-hospital mortality and hospital stay were analyzed using the data. Mortality rates according to the surgical department were also analyzed. Of the 1,662,887 patients who underwent surgery, 16,174 (1.0%) patients had cirrhosis. The in-hospital mortality (8.0% vs. 1.0%) and postoperative complications such as respiratory (6.0% vs. 5.3%) or infections (2.8% vs. 2.4%) was significantly higher in patients with cirrhosis than in those without cirrhosis. In addition, the total hospitalization period and use of the intensive care unit were significantly higher in patients with liver cirrhosis. In propensity score matching analysis, liver cirrhosis increased the risk of adverse outcome significantly [adjusted OR (aOR) 1.67, 95% CI 1.56-1.79, P<0.001], especially in-hospital mortality. In liver cirrhosis group, presence of decompensation or varices showed significantly increased postoperative complication or mortality. Adverse outcomes in patients with cirrhosis was the highest in patients who underwent otorhinolaryngology surgery (aOR 1.86), followed by neurosurgery (aOR 1.72), thoracic and cardiovascular surgery (aOR 1.56), and plastic surgery (aOR 1.36). Conclusion The adverse outcomes of patients with cirrhosis is significantly high after surgery, despite advances in cirrhosis treatment.	[Jo, Hyun Ho; Min, Changwook; Kim, Sang Gyune; Kim, Young Seok; Yoo, Jeong-Ju] Soonchunhyang Univ, Sch Med, Dept Gastroenterol & Hepatol, Seoul, South Korea; [Kyoung, Dae-Sung; Park, Min-Ae] Hanmi Pharm Co Ltd, Data Sci Team, Seoul, South Korea; [Chang, Young; Jeong, Soung Won; Jang, Jae Young] Soonchunhyang Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Seoul, South Korea; [Lee, Sae Hwan; Kim, Hong Soo] Soonchunhyang Univ, Sch Med, Dept Internal Med, Div Gastroenterol & Hepatol, Cheonan, South Korea; [Jun, Baek Gyu; Kim, Young Don; Cheon, Gab Jin] Univ Ulsan, Gangneung Asan Hosp, Coll Med, Dept Internal Med, Seoul, South Korea	Soonchunhyang University; Hanmi Pharmaceutical; Soonchunhyang University; Soonchunhyang University; University of Ulsan	Yoo, JJ (corresponding author), Soonchunhyang Univ, Sch Med, Dept Gastroenterol & Hepatol, Seoul, South Korea.	puby17@naver.com		KYOUNG, Dae-Sung/0000-0003-3993-716X; Yoo, Jeong-Ju/0000-0002-7802-0381; Kim, Young Seok/0000-0002-7113-3623	Soonchunhyang University research fund	Soonchunhyang University research fund	This work was supported by the Soonchunhyang University research fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The data science team of Hanmi Pharm. Co provided support for authors [DSK, MAP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Andraus W, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0052-y; ARANHA GV, 1986, ARCH SURG-CHICAGO, V121, P275; Befeler AS, 2005, ARCH SURG-CHICAGO, V140, P650, DOI 10.1001/archsurg.140.7.650; Bizouarn P, 1999, ANN THORAC SURG, V67, P1334, DOI 10.1016/S0003-4975(99)00226-X; Bohnen JD, 2016, J TRAUMA ACUTE CARE, V81, P122, DOI 10.1097/TA.0000000000001015; Brusselaers N, 2017, METHOD INFORM MED, V56, P401, DOI 10.3414/ME17-01-0051; Chen CC, 2012, J NEUROSURG, V117, P348, DOI 10.3171/2012.4.JNS111338; Choi J, 2019, JAMA ONCOL, V5, P30, DOI 10.1001/jamaoncol.2018.4070; Chou AH, 2017, CIRC J, V81, P476, DOI 10.1253/circj.CJ-16-0849; Cramer JD, 2017, LARYNGOSCOPE, V127, P102, DOI 10.1002/lary.26044; Friedman LS, 1999, HEPATOLOGY, V29, P1617, DOI 10.1002/hep.510290639; GARRISON RN, 1984, ANN SURG, V199, P648, DOI 10.1097/00000658-198406000-00003; Hanje J, 2007, NAT CLIN PRACT GASTR, V4, P266, DOI 10.1038/ncpgasthep0794; Huang YF, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-1163-1; Lin CS, 2013, BRIT J SURG, V100, P1784, DOI 10.1002/bjs.9312; Marcus JL, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa044; Mellinger JL, 2018, HEPATOLOGY, V68, P872, DOI 10.1002/hep.29887; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Mullen MG, 2017, JAMA SURG, V152, P768, DOI 10.1001/jamasurg.2017.0918; Neeff H, 2011, J GASTROINTEST SURG, V15, P1, DOI 10.1007/s11605-010-1366-9; Newman KL, 2020, CLIN GASTROENTEROL H, V18, P2398, DOI 10.1016/j.cgh.2019.07.051; Northup PG, 2019, CLIN GASTROENTEROL H, V17, P595, DOI 10.1016/j.cgh.2018.09.043; Northup PG, 2005, ANN SURG, V242, P244, DOI 10.1097/01.sla.0000171327.29262.e0; Perumpail BJ, 2017, WORLD J GASTROENTERO, V23, P8263, DOI 10.3748/wjg.v23.i47.8263; Roderburg C, 2016, VISC MED, V32, P121, DOI 10.1159/000444990; Ryu S, 2011, METABOLISM, V60, P860, DOI 10.1016/j.metabol.2010.08.005; Shaheen AAM, 2009, LIVER INT, V29, P1141, DOI 10.1111/j.1478-3231.2009.02058.x; Storesund A, 2019, BRIT J SURG, V106, P236, DOI 10.1002/bjs.10985; Teh SH, 2007, GASTROENTEROLOGY, V132, P1261, DOI 10.1053/j.gastro.2007.01.040; Telem DA, 2010, CLIN GASTROENTEROL H, V8, P451, DOI 10.1016/j.cgh.2009.12.015; Wong MCS, 2018, HEPATOL INT, V12, P201, DOI 10.1007/s12072-018-9865-y; Xu HW, 2018, SURG ENDOSC, V32, P712, DOI 10.1007/s00464-017-5727-2; Ziser A, 1999, ANESTHESIOLOGY, V90, P42, DOI 10.1097/00000542-199901000-00008	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0253165	10.1371/journal.pone.0253165	http://dx.doi.org/10.1371/journal.pone.0253165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125860	gold, Green Published			2022-12-26	WOS:000664643500024
J	Kuwabara, S; Tanimoto, Y; Okutani, M; Jie, M; Haseda, Y; Kinugasa-Katayama, Y; Aoshi, T				Kuwabara, Soichiro; Tanimoto, Yoshihiko; Okutani, Mie; Jie, Meng; Haseda, Yasunari; Kinugasa-Katayama, Yumi; Aoshi, Taiki			Microfluidics sorting enables the isolation of an intact cellular pair complex of CD8(+) T cells and antigen-presenting cells in a cognate antigen recognition-dependent manner	PLOS ONE			English	Article							ALLELIC EXCLUSION; DENDRITIC CELL; TCR-ALPHA; CLASS-I; IDENTIFICATION; EPITOPES; CHAINS; LEVEL	Adaptive immune responses begin with cognate antigen presentation-dependent specific interaction between T cells and antigen-presenting cells. However, there have been limited reports on the isolation and analysis of these cellular complexes of T cell-antigen-presenting cell (T/APC). In this study, we successfully isolated intact antigen-specific cellular complexes of CD8(+) T/APC by utilizing a microfluidics cell sorter. Using ovalbumin (OVA) model antigen and OT-I-derived OVA-specific CD8(+) T cells, we analyzed the formation of antigen-specific and antigen-non-specific T/APC cellular complexes and revealed that the antigen-specific T/APC cellular complex was highly stable than the non-specific one, and that the intact antigen-specific T/APC complex can be retrieved as well as enriched using a microfluidics sorter, but not a conventional cell sorter. The single T/APC cellular complex obtained can be further analyzed for the sequences of T cell receptor V alpha and V beta genes as well as cognate antigen information simultaneously. These results suggested that this approach can be applied for other antigen and CD8(+) T cells of mice and possibly those of humans. We believe that this microfluidics sorting method of the T/APC complex will provide useful information for future T cell immunology research.	[Kuwabara, Soichiro; Tanimoto, Yoshihiko; Okutani, Mie; Haseda, Yasunari] Osaka Univ, Res Inst Microbial Dis RIMD, Vaccine Dynam Project, BIKEN Innovat Vaccine Res Alliance Labs, Suita, Osaka, Japan; [Jie, Meng; Kinugasa-Katayama, Yumi; Aoshi, Taiki] Osaka Univ, Dept Cellular Immunol, RIMD, Suita, Osaka, Japan	Osaka University; Osaka University	Aoshi, T (corresponding author), Osaka Univ, Dept Cellular Immunol, RIMD, Suita, Osaka, Japan.	aoshi@biken.osaka-u.ac.jp	Tanimoto, Yoshihiko/AFV-1606-2022	Tanimoto, Yoshihiko/0000-0002-6371-1331	Research Foundation for Microbial Diseases of Osaka University	Research Foundation for Microbial Diseases of Osaka University	This research was supported by the Research Foundation for Microbial Diseases of Osaka University. The Research Foundation for Microbial Diseases of the Osaka University had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Alanio C, 2010, BLOOD, V115, P3718, DOI 10.1182/blood-2009-10-251124; Aoshi T, 2005, J IMMUNOL METHODS, V298, P21, DOI 10.1016/j.jim.2004.12.015; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Bentzen AK, 2018, NAT BIOTECHNOL, V36, P1191, DOI 10.1038/nbt.4303; Bentzen AK, 2016, NAT BIOTECHNOL, V34, P1037, DOI 10.1038/nbt.3662; Border EC, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1532759; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; Dornmair K, 2003, AM J PATHOL, V163, P1215, DOI 10.1016/S0002-9440(10)63481-5; Dura B, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6940; Gascoigne NRJ, 1999, SEMIN IMMUNOL, V11, P337, DOI 10.1006/smim.1999.0190; Gerard A., 2013, BIO-PROTOCOL, V3, P933, DOI [10.21769/BioProtoc.933, DOI 10.21769/BIOPROTOC.933]; Gerner MY, 2017, J EXP MED, V214, P3105, DOI 10.1084/jem.20170335; Gilbert SC, 2012, IMMUNOLOGY, V135, P19, DOI 10.1111/j.1365-2567.2011.03517.x; Grebe Kristie M, 2002, Sci STKE, V2002, ppl14, DOI 10.1126/stke.2002.149.pl14; Gurevich I, 2017, EUR J IMMUNOL, V47, P1802, DOI 10.1002/eji.201747042; Hoffmann HJ, 2017, ALLERGY, V72, P1022, DOI 10.1111/all.13135; Hor JL, 2015, IMMUNITY, V43, P615, DOI 10.1016/j.immuni.2015.08.018; Ikeda H, 2016, INT IMMUNOL, V28, P349, DOI 10.1093/intimm/dxw022; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; KELLY JM, 1993, EUR J IMMUNOL, V23, P3318, DOI 10.1002/eji.1830231239; Kondo Y, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3305-6; Latorre D, 2018, NATURE, V562, P63, DOI 10.1038/s41586-018-0540-1; Lim TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045185; Linnemann C, 2013, NAT MED, V19, P1534, DOI 10.1038/nm.3359; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Nagamata S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40372-5; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; O'Reilly RJ, 2016, BONE MARROW TRANSPL, V51, P1163, DOI 10.1038/bmt.2016.17; Ozga AJ, 2016, J EXP MED, V213, P2811, DOI 10.1084/jem.20160206; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Sadelain M, 2017, NATURE, V545, P423, DOI 10.1038/nature22395; Segaliny AI, 2018, LAB CHIP, V18, P3733, DOI 10.1039/c8lc00818c; Shen ZH, 1997, J IMMUNOL, V158, P2723; Siewert K, 2012, NAT MED, V18, P824, DOI 10.1038/nm.2720; Stadhouders R, 2018, J AUTOIMMUN, V87, P1, DOI 10.1016/j.jaut.2017.12.007; Takeda K., 2011, CYTOMETRY RES, V21, P43; Wang ZF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7833; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Yoshimoto N, 2013, SCI REP-UK, V3, DOI 10.1038/srep01191; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657; Zhao LJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02250	42	1	1	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252666	10.1371/journal.pone.0252666	http://dx.doi.org/10.1371/journal.pone.0252666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125844	gold, Green Published			2022-12-26	WOS:000664643500011
J	Antwi, K; Wiesner, P; Merkle, EM; Zech, CJ; Boll, DT; Wild, D; Christ, E; Heye, T				Antwi, Kwadwo; Wiesner, Patricia; Merkle, Elmar M.; Zech, Christoph J.; Boll, Daniel T.; Wild, Damian; Christ, Emanuel; Heye, Tobias			Investigating difficult to detect pancreatic lesions: Characterization of benign pancreatic islet cell tumors using multiparametric pancreatic 3-T MRI	PLOS ONE			English	Article							GA-68-DOTA-EXENDIN-4 PET/CT; LOCALIZATION; INSULINOMAS; CT	Introduction Pancreatic islet-cell tumors (PICT) often present with atypical signal-characteristics and are often missed on preoperative imaging. The aim of this study is to provide a multiparametric PICT characterization and investigate factors impeding PICT detection. Material and methods This is a detailed MRI analysis of a prospective, monocenter study, including 49 consecutive patients (37 female, 12 male; median age 50) with symptoms due to endogenous hyperinsulinemic hypoglycemia (EHH) and mostly negative prior-imaging. All patients received a 3-T MRI and a Ga-68-DOTA-exendin-4-PET/CT. Pooled accuracy, sensitivity, specificity and inter-reader agreement were calculated. Reference-standard was histopathology and Ga-68-DOTA-Exendin-4-PET/CT in one patient who refused surgery. For PICT analyses, 34 patients with 49 PICTs (48 histologically proven; one Ga-68-DOTA-exendin-4-PET/CT positive) were assessed. Dynamic contrast-enhanced (DCE) Magnetic Resonance Images (MRI) with Golden-Angle-Radial-Sparse-Parallel (GRASP) reconstruction, enabling imaging at high spatial and temporal resolution, was used to assess enhancement-patterns of PICTs. Tumor-to-background (T2B) ratio for each sequence and the employed quantitative threshold for conspicuity of PICTs were analyzed in regard to prediction of true-positive PICTs. Results Evaluation of 49 patients revealed a pooled lesion-based accuracy, sensitivity and specificity of 70.3%, 72.9% and 62.5%, respectively. Mean PICT size was 12.95.3mm for detected, 9.0 +/- 2.9mm for undetected PICTs (p-value 0.0112). In-phase T1w detected the most PICT (67.3%). Depending on the sequence, PICTs were isointense and poorly visible in 29-68%. Only 2/41(4.9%) PICTs showed typical signal-characteristics across T1w, T2w, DWI and ceT1w combined. 66.6% of PICTs enhanced simultaneously to the parenchyma, 17.8% early and 15.6% late. Predictor screening analysis showed number of sequences detecting a PICT, lesion size and in-phase T1w T2B ratio had the highest contribution for detecting a true-positive PICT. Conclusion The majority of PICTs enhance simultaneously to surrounding parenchyma, present with atypical signal-characteristics and thus are poorly visible. In non-enhancing PICTs, radiologists should search for small lesions most likely conspicuous on unenhanced T1w or DWI.	[Antwi, Kwadwo; Wiesner, Patricia; Merkle, Elmar M.; Zech, Christoph J.; Boll, Daniel T.; Wild, Damian; Heye, Tobias] Univ Hosp Basel, Dept Radiol, Basel, Switzerland; [Wild, Damian; Christ, Emanuel] Univ Hosp Basel, Ctr Neuroendocrine & Endocrine Tumors, Basel, Switzerland; [Christ, Emanuel] Univ Hosp Basel, Div Endocrinol Diabetol & Metab, Basel, Switzerland	University of Basel; University of Basel; University of Basel	Antwi, K (corresponding author), Univ Hosp Basel, Dept Radiol, Basel, Switzerland.	EKwadwo.Antwi@usb.ch		Antwi, Kwadwo/0000-0002-1840-1780	Swiss National Science Foundation [320030-152938]; Desiree & Niels Yde's Foundation [389-12]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Desiree & Niels Yde's Foundation	The study was funded by the Swiss National Science Foundation (grant number 320030-152938) and Desiree & Niels Yde's Foundation (grant number 389-12).	Antwi K, 2019, J CLIN ENDOCR METAB, V104, P5843, DOI 10.1210/jc.2018-02754; Antwi K, 2018, EUR J NUCL MED MOL I, V45, P2318, DOI 10.1007/s00259-018-4101-5; Antwi K, 2015, J NUCL MED, V56, P1075, DOI 10.2967/jnumed.115.157768; Barral M, 2015, RADIOLOGY, V274, P45, DOI 10.1148/radiol.14130778; Brenner R, 2012, EUR J RADIOL, V81, pE746, DOI 10.1016/j.ejrad.2012.01.032; BUETOW PC, 1995, AM J ROENTGENOL, V165, P1175, DOI 10.2214/ajr.165.5.7572498; Christ E, 2015, ENDOCRINE, V50, P821, DOI 10.1007/s12020-015-0633-7; Christ E, 2013, LANCET DIABETES ENDO, V1, P115, DOI 10.1016/S2213-8587(13)70049-4; Cuthbertson DJ, 2016, CLIN ENDOCRINOL, V84, P789, DOI 10.1111/cen.12973; Daneshvar K, 2011, PANCREATOLOGY, V11, P487, DOI 10.1159/000330208; Feng L, 2014, MAGN RESON MED, V72, P707, DOI 10.1002/mrm.24980; Fidler JL, 2003, AM J ROENTGENOL, V181, P775, DOI 10.2214/ajr.181.3.1810775; Grant CS, 2005, BEST PRACT RES CL GA, V19, P783, DOI 10.1016/j.bpg.2005.05.008; Hackert T, 2011, LANGENBECK ARCH SURG, V396, P1197, DOI 10.1007/s00423-011-0801-z; Herwick Steven, 2006, AJR Am J Roentgenol, V187, pW472, DOI 10.2214/AJR.05.0809; Humphrey PE, 2015, ABDOM IMAGING, V40, P2398, DOI 10.1007/s00261-015-0458-0; Ichikawa T, 2000, RADIOLOGY, V216, P163, DOI 10.1148/radiology.216.1.r00jl26163; Jeon SK, 2017, RADIOLOGY, V284, P77, DOI 10.1148/radiol.2016160586; LANDIS JR, 1977, BIOMETRICS, V33, P363, DOI 10.2307/2529786; Lewis RB, 2010, RADIOGRAPHICS, V30, P1445, DOI 10.1148/rg.306105523; Mehrabi A, 2014, PANCREAS, V43, P675, DOI 10.1097/MPA.0000000000000110; Thoeni RF, 2000, RADIOLOGY, V214, P483, DOI 10.1148/radiology.214.2.r00fe32483; Wenning AS, 2015, PATIENT SAF SURG, V9, DOI 10.1186/s13037-015-0064-7; Zhu L, 2017, J MAGN RESON IMAGING, V46, P1648, DOI 10.1002/jmri.25709	24	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253078	10.1371/journal.pone.0253078	http://dx.doi.org/10.1371/journal.pone.0253078			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115803	gold, Green Published			2022-12-26	WOS:000664643000048
J	Doyen, V; Corazza, F; Thi, HN; Chi, TL; Truyens, C; Nagant, C; Mong, HTT; Fils, JF; Huynh, PTN; Michel, O				Doyen, Virginie; Corazza, Francis; Hoa Nhu Thi; Thanh Le Chi; Truyens, Carine; Nagant, Carole; Hiep Tran Thi Mong; Fils, Jean-Francois; Phuong Thi Ngoc Huynh; Michel, Olivier			Hookworm treatment induces a decrease of suppressive regulatory T cell associated with a Th2 inflammatory response	PLOS ONE			English	Article							CYTOKINE PRODUCTION; ANTIBODY-RESPONSES; DENDRITIC CELLS; INFECTION; ACTIVATION; GENERATION; EXPANSION; IL-6; AREA	Background Like other helminths, hookworms (HW) induce a regulatory immune response able to modulate and dampen reactivity of the host to antigens. No data about the evolution of the immune response after treatment are available. We aim to phenotype the regulatory immune response during natural HW infection and its evolution after treatment. Methodology Twenty hookworm infected (HW+) and 14 non-infected subjects HW-from endemic area in the periphery of Ho Chi Minh City were included. Blood and feces samples were obtained before, 2 and 4 weeks after treatment with Albendazole 400mg. Additional samples were obtained at 3 and 12 months in the HW+ group. Hematological parameters, Treg (CD4+CD25(hi)FoxP3(hi)) and surface molecules (CD39, CD62L, ICOS, PD-1, CD45RA) were measured as well as inflammatory and lymphocytes differentiation cytokines such as IL-1 beta, IL-6, IFN gamma, IL-4, IL-17, IL-10, IL-2 and TGF beta. Results HW+ subjects showed higher Treg, TregICOS+, Treg PD1-, TregCD62L+ and CD45RA+FoxP3(lo) resting Treg (rTreg). CD45RA-FoxP3(lo) non-suppressive Treg cells were also increased. No preferential Th1/Th2 orientation was observed, nor difference for IL-10 between two groups. After treatment, Treg, TregICOS+, TregCD62L+, Treg PD1- and rTreg decreased while IL-4 and IL-6 cytokines increased. Conclusion During HW infection, Treg are increased and characterized by a heterogeneous population: a highly suppressive as well as a non-suppressive T cells phenotype. After treatment, Treg with immune-suppressive phenotype exhibited a decrease parallel to an inflammatory Th2 response.	[Doyen, Virginie; Corazza, Francis; Nagant, Carole] Univ Libre Bruxelles ULB, CHU Brugmann, ULB223, Lab Translat Res, Brussels, Belgium; [Doyen, Virginie; Michel, Olivier] ULB, CHU Brugmann, Clin Immunoallergol, Brussels, Belgium; [Corazza, Francis; Nagant, Carole] ULB, LHUB, Immunol Lab, Brussels, Belgium; [Hoa Nhu Thi] Pham Ngoc Thach Univ Med, Parasitol & Mycol Dept, Ho Chi Minh, Vietnam; [Thanh Le Chi] Inst Pasteur, Immunol Lab, Ho Chi Minh, Vietnam; [Truyens, Carine] Univ Libre Bruxelles, ULB Ctr Res Immunol U CRI, Parasitol Lab, Brussels, Belgium; [Hiep Tran Thi Mong] Pham Ngoc Thach Univ Med, Dept Family Med, Ho Chi Minh, Vietnam; [Fils, Jean-Francois] Ars Statist SPRL, Blvd Archers, Nivelles, Belgium; [Phuong Thi Ngoc Huynh] ULB, Bordet Inst, Dept Hematol, Brussels, Belgium; [Doyen, Virginie] CHU Brugmann, Clin Immunoallergol, Pl Gehuchten, Brussels, Belgium; [Corazza, Francis] CHU Brugmann, Serv Immunol LHUB, Pl Gehuchten, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Institut Jules Bordet; Universite Libre de Bruxelles	Doyen, V (corresponding author), Univ Libre Bruxelles ULB, CHU Brugmann, ULB223, Lab Translat Res, Brussels, Belgium.; Doyen, V (corresponding author), ULB, CHU Brugmann, Clin Immunoallergol, Brussels, Belgium.; Doyen, V (corresponding author), CHU Brugmann, Clin Immunoallergol, Pl Gehuchten, Brussels, Belgium.	doyenv@yahoo.fr		Doyen, Virginie/0000-0001-6083-2931	Academie de recherche et d'enseignement superieur (ARESCUD); Brugmann Foundation	Academie de recherche et d'enseignement superieur (ARESCUD); Brugmann Foundation	This study was supported by Academie de recherche et d'enseignement superieur (ARESCUD) in the form of a grant awarded to OM (PIC O MICHEL 2012-2016), the Brugmann Foundation in the form of a grant awarded to VD (Grant 2014), and Ars Statistica in the form of a salary for JFF. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Amoani B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222382; Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; Brooker S, 2007, T ROY SOC TROP MED H, V101, P146, DOI 10.1016/j.trstmh.2006.05.012; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; Busse M, 2012, J IMMUNOL, V189, P1975, DOI 10.4049/jimmunol.1103581; Chami GF, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004193; Chang LY, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1040215; Chevalier MF, 2015, J INFECT DIS, V211, P769, DOI 10.1093/infdis/jiu549; Clay BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007525; Cop N, 2018, CYTOM PART B-CLIN CY, V94, P405, DOI 10.1002/cyto.b.21547; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Flohr C, 2010, CLIN EXP ALLERGY, V40, P131, DOI 10.1111/j.1365-2222.2009.03346.x; Forrer A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003486; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; Gaze S, 2014, PARASITE IMMUNOL, V36, P358, DOI 10.1111/pim.12088; Geiger SM, 2007, PARASITE IMMUNOL, V29, P347, DOI 10.1111/j.1365-3024.2007.00950.x; Geiger SM, 2004, CLIN EXP IMMUNOL, V136, P334, DOI 10.1111/j.1365-2249.2004.02449.x; Geiger Stefan Michael, 2011, J Parasitol Res, V2011, P512154, DOI 10.1155/2011/512154; Giacomin P, 2015, SCI REP-UK, V5, DOI 10.1038/srep13797; Gubernatorova EO, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02718; Hung BK, 2016, KOREAN J PARASITOL, V54, P471, DOI 10.3347/kjp.2016.54.4.471; Insiripong S., 2013, TROP MED SURG, V1, P3; Jaiswal S, 2018, BIOL BLOOD MARROW TR, V24, pS83; Klion AD, 2004, J ALLERGY CLIN IMMUN, V113, P30, DOI 10.1016/j.jaci.2003.10.050; Lange C, 2011, BRAIN BEHAV IMMUN, V25, P120, DOI 10.1016/j.bbi.2010.09.004; Li DY, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02104; Lima NF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006327; Loukas A, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.88; Lu SY, 2011, CLIN EXP IMMUNOL, V165, P264, DOI 10.1111/j.1365-2249.2011.04418.x; Maizels RM, 2016, J ALLERGY CLIN IMMUN, V138, P666, DOI 10.1016/j.jaci.2016.07.007; Maizels RM, 2011, ADV IMMUNOL, V112, P73, DOI 10.1016/B978-0-12-387827-4.00003-6; McKay DM, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1283385; Metenou S, 2014, EUR J IMMUNOL, V44, P2036, DOI 10.1002/eji.201444452; Mihrshahi S, 2009, INT J PARASITOL, V39, P1037, DOI 10.1016/j.ijpara.2009.01.013; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Montresor A., 1998, WORLD HLTH ORG; Nafady-Hego H, 2010, TRANSPLANTATION, V90, P1547, DOI 10.1097/TP.0b013e3181f9960d; Navarro S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8807; Plitas G, 2016, CANCER IMMUNOL RES, V4, P721, DOI 10.1158/2326-6066.CIR-16-0193; PRITCHARD DI, 1992, PARASITE IMMUNOL, V14, P617, DOI 10.1111/j.1365-3024.1992.tb00034.x; QUINNELL RJ, 1995, PARASITE IMMUNOL, V17, P313, DOI 10.1111/j.1365-3024.1995.tb00897.x; Raimondi G, 2006, J IMMUNOL, V176, P2808, DOI 10.4049/jimmunol.176.5.2808; Redpath SA, 2013, EUR J IMMUNOL, V43, P705, DOI 10.1002/eji.201242794; Ricci ND, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001383; Nunez CR, 2013, SCI WORLD J, DOI 10.1155/2013/572089; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Silver ZA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006153; Simonetta F, 2012, J INFECT DIS, V205, P1510, DOI 10.1093/infdis/jis235; Takenaka MC, 2016, TRENDS IMMUNOL, V37, P427, DOI 10.1016/j.it.2016.04.009; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Nguyen T, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1780-2; Verbeke G., 2000, SPRINGER SERIES STAT; Vieira PL, 2004, EUR J IMMUNOL, V34, P1282, DOI 10.1002/eji.200324417; Vocanson M, 2010, J ALLERGY CLIN IMMUN, V126, P280, DOI 10.1016/j.jaci.2010.05.022; WHO, 2002, WHO TECH REP SER, V912, P1; Zaiss MM, 2016, PARASITE IMMUNOL, V38, P5, DOI 10.1111/pim.12274	59	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252921	10.1371/journal.pone.0252921	http://dx.doi.org/10.1371/journal.pone.0252921			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111180	Green Published, gold			2022-12-26	WOS:000664642700064
J	Ischer, M; Coppin, G; De Marles, A; Essellier, M; Porcherot, C; Cayeux, I; Margot, C; Sander, D; Delplanque, S				Ischer, Matthieu; Coppin, Geraldine; De Marles, Axel; Essellier, Myriam; Porcherot, Christelle; Cayeux, Isabelle; Margot, Christian; Sander, David; Delplanque, Sylvain			Exogenous capture of visual spatial attention by olfactory-trigeminal stimuli	PLOS ONE			English	Article							CHEMICAL-STIMULATION; POTENTIALS; RESPONSES; FASTER; REWARD; ODORS; BIAS	The extent to which a nasal whiff of scent can exogenously orient visual spatial attention remains poorly understood in humans. In a series of seven studies, we investigated the existence of an exogenous capture of visual spatial attention by purely trigeminal (i.e., CO2) and both olfactory and trigeminal stimuli (i.e., eucalyptol). We chose these stimuli because they activate the trigeminal system which can be considered as an alert system and are thus supposedly relevant for the individual, and thus prone to capture attention. We used them as lateralized cues in a variant of a visual spatial cueing paradigm. In valid trials, trigeminal cues and visual targets were presented on the same side whereas in invalid trials they were presented on opposite sides. To characterize the dynamics of the cross-modal attentional capture, we manipulated the interval between the onset of the trigeminal cues and the visual targets (from 580 to 1870 ms). Reaction times in trigeminal valid trials were shorter than all other trials, but only when this interval was around 680 or 1170 ms for CO2 and around 610 ms for eucalyptol. This result reflects that both pure trigeminal and olfactory-trigeminal stimuli can exogenously capture humans' spatial visual attention. We discuss the importance of considering the dynamics of this cross-modal attentional capture.	[Ischer, Matthieu; Coppin, Geraldine; De Marles, Axel; Essellier, Myriam; Sander, David; Delplanque, Sylvain] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Ischer, Matthieu; Coppin, Geraldine; Essellier, Myriam; Sander, David; Delplanque, Sylvain] Univ Geneva, Dept Psychol, Geneva, Switzerland; [Coppin, Geraldine] Swiss Distance Univ Inst UniDistance FernUni, Brig, Switzerland; [Porcherot, Christelle; Cayeux, Isabelle; Margot, Christian] Firmenich Co, Geneva, Switzerland	University of Geneva; University of Geneva; Firmenich	Delplanque, S (corresponding author), Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland.; Delplanque, S (corresponding author), Univ Geneva, Dept Psychol, Geneva, Switzerland.	sylvain.delplanque@unige.ch		Delplanque, Sylvain/0000-0002-9025-4754	National Center of Competence in Research (NCCR) for the Affective Sciences from the Swiss National Science Foundation; Firmenich, SA	National Center of Competence in Research (NCCR) for the Affective Sciences from the Swiss National Science Foundation; Firmenich, SA	This research was supported by the National Center of Competence in Research (NCCR) for the Affective Sciences, financed by a grant from the Swiss National Science Foundation hosted by the University of Geneva, and was also supported by a research grant from Firmenich, SA, to David Sander and Patrik Vuilleumier. The funder provided support in the form of salaries for author MI and provided material to conduct the experiments but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Haim Y, 2007, PSYCHOL BULL, V133, P1, DOI 10.1037/0033-2909.133.1.1; Bensafi M, 2002, NEUROSCI LETT, V328, P309, DOI 10.1016/S0304-3940(02)00548-7; Boesveldt S, 2010, BIOL PSYCHOL, V84, P313, DOI 10.1016/j.biopsycho.2010.03.006; Chen KP, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1729; Chica AB, 2014, NEUROSCI BIOBEHAV R, V40, P35, DOI 10.1016/j.neubiorev.2014.01.002; Cousineau D, 2005, TUTOR QUANT METHODS, V1, P42, DOI 10.20982/tqmp.01.1.p042; Croy I, 2015, CHEM SENSES, V40, P351, DOI 10.1093/chemse/bjv020; Croy I, 2014, NEUROIMAGE, V98, P289, DOI 10.1016/j.neuroimage.2014.05.004; DeBose JL, 2008, J CHEM ECOL, V34, P867, DOI 10.1007/s10886-008-9493-4; Dematte ML, 2009, CHEM SENSES, V34, P103, DOI 10.1093/chemse/bjn055; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Filiou RP, 2015, CHEM SENSES, V40, P61, DOI 10.1093/chemse/bju064; Frasnelli J, 2005, ENVIRON TOXICOL PHAR, V19, P575, DOI 10.1016/j.etap.2004.12.022; Frasnelli J, 2004, NEUROSCI LETT, V362, P65, DOI 10.1016/j.neulet.2004.02.059; Frasnelli J, 2017, SPRINGER HBK, P881; Furr RM, 2003, PSYCHOL METHODS, V8, P275, DOI 10.1037/1082-989X.8.3.275; Gagliardo A, 2013, J EXP BIOL, V216, P2165, DOI 10.1242/jeb.070250; Gire DH, 2016, CURR BIOL, V26, P1261, DOI 10.1016/j.cub.2016.03.040; Hoskison EE, 2013, J LARYNGOL OTOL, V127, P1156, DOI 10.1017/S0022215113002545; Hummel T, 2003, TOXICOL LETT, V140, P273, DOI 10.1016/S0378-4274(03)00078-X; HUMMEL T, 1994, ELECTROEN CLIN NEURO, V92, P426, DOI 10.1016/0168-5597(94)90020-5; Iannilli E, 2013, NEUROIMAGE, V77, P254, DOI 10.1016/j.neuroimage.2012.12.057; Ischer M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00736; Jacobs LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129387; Johnson BN, 2006, CHEM SENSES, V31, P795, DOI 10.1093/chemse/bjl021; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; KOBAL G, 1989, EXPERIENTIA, V45, P130, DOI 10.1007/BF01954845; KOBAL G, 1988, ELECTROEN CLIN NEURO, V71, P241, DOI 10.1016/0168-5597(88)90023-8; La Buissonniere-Ariza V, 2012, NEUROSCI LETT, V506, P188, DOI 10.1016/j.neulet.2011.11.002; Lambrou-Louca A., 2018, ENCY EVOLUTIONARY PS, P1, DOI [10.1007/978-3-319-16999-6_1018-1, DOI 10.1007/978-3-319-16999-6_1018-1]; McDonald J., 2011, NEURAL BASEMULTISE, V20111651, P509, DOI [10.1201/9781439812174-33, DOI 10.1201/9781439812174-33]; McDonald JJ, 2000, NATURE, V407, P906, DOI 10.1038/35038085; Moessnang C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029614; Muller S, 2016, Q J EXP PSYCHOL, V69, P752, DOI 10.1080/17470218.2015.1049624; Noto T, 2018, CHEM SENSES, V43, P583, DOI 10.1093/chemse/bjy045; Olofsson JK, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00033; Pause BM, 1996, PSYCHOPHYSIOLOGY, V33, P376, DOI 10.1111/j.1469-8986.1996.tb01062.x; Pinto Jayant M, 2011, Proc Am Thorac Soc, V8, P46, DOI 10.1513/pats.201005-035RN; Pool E, 2016, PSYCHOL BULL, V142, P79, DOI 10.1037/bul0000026; Pool E, 2015, J EXP PSYCHOL-ANIM L, V41, P128, DOI 10.1037/xan0000052; Pool E, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00158; Pool E, 2014, COGNITION, V130, P348, DOI 10.1016/j.cognition.2013.12.002; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Richter M, 2010, BIOL PSYCHOL, V84, P279, DOI 10.1016/j.biopsycho.2010.02.014; Rosenthal Robert., 1985, CONTRAST ANAL FOCUSE; Sanz LRD, 2018, NEUROPSYCHOLOGIA, V120, P105, DOI 10.1016/j.neuropsychologia.2018.10.014; Scheibe M, 2008, LARYNGOSCOPE, V118, P152, DOI 10.1097/MLG.0b013e318156599d; Sela L, 2010, EXP BRAIN RES, V205, P13, DOI 10.1007/s00221-010-2348-6; Sharvit G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17487; SHULMAN GL, 1979, J EXP PSYCHOL HUMAN, V5, P522, DOI 10.1037/0096-1523.5.3.522; Spence C, 1997, PERCEPT PSYCHOPHYS, V59, P1, DOI 10.3758/BF03206843; Spence C, 2001, Q J EXP PSYCHOL-A, V54, P775, DOI 10.1080/02724980042000480; Spence C, 2001, EXP BRAIN RES, V141, P324, DOI 10.1007/s002210100883; Spence C, 2010, ANN NY ACAD SCI, V1191, P182, DOI 10.1111/j.1749-6632.2010.05440.x; Spence C, 2009, HEARING RES, V258, P134, DOI 10.1016/j.heares.2009.04.015; Steck K, 2012, CURR OPIN NEUROBIOL, V22, P231, DOI 10.1016/j.conb.2011.10.011; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; THESEN A, 1993, J EXP BIOL, V180, P247; Townsend J.T., 1978, COGNITIVE THEORY, V3, P200; Van der Stoep N, 2015, ACTA PSYCHOL, V162, P20, DOI 10.1016/j.actpsy.2015.09.010; VONBEKESY G, 1964, J APPL PHYSIOL, V19, P369, DOI 10.1152/jappl.1964.19.3.369; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Wudarczyk OA, 2016, J EXP PSYCHOL HUMAN, V42, P1780, DOI 10.1037/xhp0000261; Wysocki CJ, 2003, PERCEPT PSYCHOPHYS, V65, P115, DOI 10.3758/BF03194788	67	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252943	10.1371/journal.pone.0252943	http://dx.doi.org/10.1371/journal.pone.0252943			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111171	Green Published, gold			2022-12-26	WOS:000664642700069
J	Pokora, R; Kutschbach, S; Weigl, M; Braun, D; Epple, A; Lorenz, E; Grund, S; Hecht, J; Hollich, H; Rietschel, P; Schneider, F; Sohmen, R; Taylor, K; Dienstbuehl, I				Pokora, Roman; Kutschbach, Susan; Weigl, Matthias; Braun, Detlef; Epple, Annegret; Lorenz, Eva; Grund, Stefan; Hecht, Juergen; Hollich, Helmut; Rietschel, Peter; Schneider, Frank; Sohmen, Roland; Taylor, Katherine; Dienstbuehl, Isabel			Investigation of superspreading COVID-19 outbreak events in meat and poultry processing plants in Germany: A cross-sectional study	PLOS ONE			English	Article								Since May 2020, several COVID-19 outbreaks have occurred in the German meat industry despite various protective measures, and temperature and ventilation conditions were considered as possible high-risk factors. This cross-sectional study examined meat and poultry plants to assess possible risk factors. Companies completed a self-administered questionnaire on the work environment and protective measures taken to prevent SARS-CoV-2 infection. Multivariable logistic regression analysis adjusted for the possibility to distance at least 1.5 meters, break rules, and employment status was performed to identify risk factors associated with COVID-19 cases. Twenty-two meat and poultry plants with 19,072 employees participated. The prevalence of COVID-19 in the seven plants with more than 10 cases was 12.1% and was highest in the deboning and meat cutting area with 16.1%. A subsample analysis where information on maximal ventilation rate per employee was available revealed an association with the ventilation rate (adjusted odds ratio (AOR) 0.996, 95% CI 0.993-0.999). When including temperature as an interaction term in the working area, the association with the ventilation rate did not change. When room temperatures increased, the chance of testing positive for COVID-19 (AOR 0.90 95% CI 0.82-0.99) decreased, and the chance for testing positive for COVID-19for the interaction term (AOR 1.001, 95% CI 1.000-1.003) increased. Employees who work where a minimum distance of less than 1.5 m between workers was the norm had a higher chance of testing positive (AOR 3.61; 95% CI 2.83-4.6). Our results further indicate that climate conditions and low outdoor air flow are factors that can promote the spread of SARS-CoV-2 aerosols. A possible requirement for pandemic mitigation strategies in industrial workplace settings is to increase the ventilation rate.	[Pokora, Roman; Kutschbach, Susan; Weigl, Matthias; Braun, Detlef; Epple, Annegret; Grund, Stefan; Hecht, Juergen; Hollich, Helmut; Rietschel, Peter; Schneider, Frank; Sohmen, Roland; Dienstbuehl, Isabel] Berufsgenossenschaft Nahrungsmittel & Gastgewerbe, Div Prevent, Mainz, Germany; [Pokora, Roman; Lorenz, Eva; Taylor, Katherine] Johannes Gutenberg Univ Mainz, Univ Hosp, Inst Med Biostat Epidemiol & Informat, Mainz, Germany; [Lorenz, Eva] Bernhard Nocht Inst Trop Med, Infect Dis Epidemiol, Hamburg, Germany; [Lorenz, Eva] German Ctr Infect Res (DZIF), Hamburg, Germany	Johannes Gutenberg University of Mainz; University Hospital Mainz; Bernhard Nocht Institut fur Tropenmedizin; German Center for Infection Research	Pokora, R (corresponding author), Berufsgenossenschaft Nahrungsmittel & Gastgewerbe, Div Prevent, Mainz, Germany.; Pokora, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Hosp, Inst Med Biostat Epidemiol & Informat, Mainz, Germany.	pokora@uni-mainz.de	Pokora, Roman/AFK-6503-2022; Pokora, Roman/AAG-4753-2022	Lorenz, Eva/0000-0002-6057-0078; Pokora, Roman/0000-0002-7862-1187				[Anonymous], 2020, AV SPREAD COR VIR IN; Asher E., 2020, ARXIV200709607V2; Atrubin D, 2020, MMWR-MORBID MORTAL W, V69, P1492, DOI 10.15585/mmwr.mm6941a4; Chong K., 2020, ARXIV PREPRINT ARXIV, DOI 10.1101/2020.08.04.20168468; Donaldson AI, 2020, VET REC, V187, DOI 10.1136/vr.m2702; Durand-Moreau Q, 2020, WHAT EXPLAINS HIGH R; Dyal JW, 2020, MMWR-MORBID MORTAL W, V69, P557, DOI 10.15585/mmwr.mm6918e3; Gunther T., 2020, INVESTIGATION SUPERS, DOI [10.2139/SSRN.3654517, DOI 10.2139/SSRN.3654517]; Kamps BS., 2020, COVID REFERENCE ENG, P92; Ma YL, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138226; Marinaccio A, 2020, OCCUP ENVIRON MED, V77, P818, DOI 10.1136/oemed-2020-106844; Matson MJ, 2020, EMERG INFECT DIS, V26, P2276, DOI 10.3201/eid2609.202267; Middleton J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2716; Morawska L, 2020, ENVIRON INT, V142, DOI 10.1016/j.envint.2020.105832; Notari A, 2021, SCI TOTAL ENVIRON, V763, DOI 10.1016/j.scitotenv.2020.144390; Notari Alessio, 2020, ARXIV PREPRINT ARXIV, DOI [10.1101/2020.05.08.20095063, 10.1101/2020.05.08.20095083]; Robert Koch-Institut, 2020, RKIS DAIL SIT REP CO; Somsen GA, 2020, LANCET RESP MED, V8, P658, DOI 10.1016/S2213-2600(20)30245-9; Steinberg J, 2020, MMWR-MORBID MORTAL W, V69, P1015, DOI 10.15585/mmwr.mm6931a2; Waltenburg MA, 2020, MMWR-MORBID MORTAL W, V69, P887, DOI 10.15585/mmwr.mm6927e2; Xie JG, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138201; Yao Y, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00517-2020	22	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0242456	10.1371/journal.pone.0242456	http://dx.doi.org/10.1371/journal.pone.0242456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111143	Green Submitted, Green Published, gold			2022-12-26	WOS:000664642700001
J	Jefferson, TA; Smultea, MA; Ward, EJ; Berejikian, B				Jefferson, Thomas A.; Smultea, Mari A.; Ward, Eric J.; Berejikian, Barry			Estimating the stock size of harbor seals (Phoca vitulina richardii) in the inland waters of Washington State using line-transect methods	PLOS ONE			English	Article							MARINE MAMMAL DISTRIBUTION; BRITISH-COLUMBIA; KILLER WHALES; ABUNDANCE; SALMON; RECOVERY; BEHAVIOR; DENSITY; ICE	Harbor seals (Phoca vitulina richardii) in the inland waters of Washington were reduced by predator control programs in the twentieth century, but stocks have rebounded since being protected in the 1970s. Three management stocks are recognized, but there is little information on their current abundance. We conducted 38,431 km of aerial line-transect surveys throughout the range of these stocks in 2013-2016, sighting a total of 4,678 groups of harbor seals. Line-transect analysis with Beaufort sea state as a covariate provided estimates of the number of seals in the water. We then incorporated tagging data from 15 instrumented seals to develop correction factors, both for seals missed in the water while diving, and those that were on shore. Tagging data were modeled with generalized linear mixed models to provide estimates of the proportions diving and hauled out. After applying these correction factors, we estimated that the Hood Canal stock contained 1,368 seals (CV = 16.8%), the Southern Puget Sound stock contained 1,976 seals (CV = 20.5%), and the Washington Northern Inland Waters stock contained 7,513 seals (CV = 11.5%). This study presents a non-traditional approach to estimating the size of Washington inland waters harbor seal stocks, which may also be applicable to other species for which survey and tagging data are available.	[Jefferson, Thomas A.] Clymene Enterprises, Lakeside, CA 92040 USA; [Smultea, Mari A.] Smultea Environm Sci, Preston, WA USA; [Ward, Eric J.] NOAA, Conservat Biol Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Seattle, WA USA; [Berejikian, Barry] NOAA, Environm & Fisheries Sci Div, Northwest Fisheries Sci Ctr, Natl Marine Fisheries Serv, Port Orchard, WA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Jefferson, TA (corresponding author), Clymene Enterprises, Lakeside, CA 92040 USA.	sclymene@aol.com		Berejikian, Barry/0000-0003-2933-7806	US National Marine Mammal Laboratory (NMML)/NMFS; Puget Sound Partnership; Long Live the Kings; US Navy	US National Marine Mammal Laboratory (NMML)/NMFS; Puget Sound Partnership; Long Live the Kings; US Navy(United States Department of Defense)	Funding for the aerial surveys was provided by the US Navy and US National Marine Mammal Laboratory (NMML)/NMFS. Additional analysis funds were provided by the Puget Sound Partnership and Long Live the Kings. We are rateful also to HDR, Inc. and especially to K. Ampela for assistance in funding surveys. The funders provided support in the form of salaries for authors [TAJ, MAS], but did not have any additional role in the data collection and analysis, or preparation of the manuscript. They only had a very minor role in study design suggestions, and decision to publish. The specific roles of these authors are articulated in the 'author contributions' section.	Acevedo-Gutierrez A, 2011, AQUAT MAMM, V37, P167, DOI 10.1578/AM.37.2.2011.167; Aerts LAM, 2013, CONT SHELF RES, V67, P116, DOI 10.1016/j.csr.2013.04.020; Allegue H, 2020, MAR ECOL PROG SER, V647, P211, DOI 10.3354/meps13389; Ampela K., 2021, J WILDL MANAGE, V2021, P1, DOI [10.1002/jwmg22019, DOI 10.1002/JWMG22019]; Ashley EA., 2020, FRONT MAR SCI, V7, DOI [10.3389/fmars, DOI 10.3389/FMARS]; Barlow J., 1995, NOAA TECHNICAL MEMOR, V6, P73; Bengtson JL, 2011, DEEP-SEA RES PT II, V58, P1261, DOI 10.1016/j.dsr2.2010.10.037; Berejikian BA, 2016, MAR ECOL PROG SER, V543, P21, DOI 10.3354/meps11579; Best Benjamin D., 2015, Journal of Cetacean Research and Management, V15, P9; Borchers DL, 2013, BIOMETRICS, V69, P703, DOI 10.1111/biom.12049; Brooks ME, 2017, R J, V9, P378, DOI 10.32614/RJ-2017-066; Brown RF., 1988, NWAFC PROCESSED REPO, V88; Buckland S. T., 1993, Distance sampling: estimating abundance of biological populations.; Buckland S.T., 1993, International North Pacific Fisheries Commission Bulletin, V53, P387; Buckland ST., 2004, ADV DISTANCE SAMPLIN; Buckland ST, 2018, ENCYCLOPEDIA OF MARINE MAMMALS, 3RD EDITION, P1, DOI 10.1016/B978-0-12-804327-1.00001-7; Calambokidis J., 1985, NOAA TECHNICAL MEMOR, V18, P159; Calambokidis J.A., 1979, Murrelet, V60, P110, DOI 10.2307/3534278; Carretta JV., 2020, NOAA T MEMO SWFSC, V629, P380; Carretta JV., 2000, SW FISHERIES SCI CTR, VLJ-00-02; Chambellant M., 2009, CANADIAN SCI ADVISOR; Chasco B, 2017, CAN J FISH AQUAT SCI, V74, P1173, DOI 10.1139/cjfas-2016-0203; Daniel RG, 2003, MAR MAMMAL SCI, V19, P128, DOI 10.1111/j.1748-7692.2003.tb01097.x; Deagle BE, 2019, MOL ECOL, V28, P391, DOI 10.1111/mec.14734; Department of Fisheries and Oceans, 2010, CAN SCI ADVIS SECR S; Duguid WDP, 2019, DEEP-SEA RES PT II, V159, P22, DOI 10.1016/j.dsr2.2018.05.018; Ford JKB, 1998, CAN J ZOOL, V76, P1456, DOI 10.1139/cjz-76-8-1456; Gaydos Joseph K., 2011, Northwestern Naturalist, V92, P79; Gearin P., 1986, WASHINGTON DEP GAME, V86; Gelatt TS, 1999, WILDLIFE SOC B, V27, P330; Hammond PS, 1995, DEV MAR BIO, V4, P3; Hardee SE., 2008, THESIS W WASHINGTON; Herr H, 2009, MAR BIOL, V156, P811, DOI 10.1007/s00227-008-1105-x; Hoef JMV, 2014, STAT METHODOL, V17, P46, DOI 10.1016/j.stamet.2013.03.001; Houghton J, 2015, NORTHWEST SCI, V89, P154, DOI 10.3955/046.089.0207; Huber HR, 2012, CAN J ZOOL, V90, P1361, DOI 10.1139/cjz-2012-0047; Huber HR, 2010, CAN J ZOOL, V88, P280, DOI 10.1139/Z09-141; Huber HR, 2001, MAR MAMMAL SCI, V17, P276, DOI 10.1111/j.1748-7692.2001.tb01271.x; Jefferson TA, 2016, CAN J ZOOL, V94, P505, DOI 10.1139/cjz-2015-0236; Jefferson Thomas A., 2014, Journal of Marine Animals and their Ecology, V7, P14; Jeffries S, 2003, J WILDLIFE MANAGE, V67, P207, DOI 10.2307/3803076; Jeffries SJ., 2000, ATLAS SEA SEA LION H; Jeffries SJ, 1985, MARINE MAMMALS THEIR, P85; Lance MM, 2012, MAR ECOL PROG SER, V464, P257, DOI 10.3354/meps09880; London JM., 2006, THESIS U WASHINGTON; London JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038180; Lowry MS, 2005, FISH B-NOAA, V103, P331; Lunn NJ, 1997, CAN J FISH AQUAT SCI, V54, P914, DOI 10.1139/cjfas-54-4-914; Marques FFC, 2003, BIOMETRICS, V59, P924, DOI 10.1111/j.0006-341X.2003.00107.x; Marques FFC, 2004, ADVANCED DISTANCE SAMPLING: ESTIMATING ABUNDANCE OF BIOLOGICAL POPULATIONS, P31; Marshall KN, 2016, CONSERV LETT, V9, P70, DOI 10.1111/conl.12186; Mizuno AW, 2002, ECOL RES, V17, P79, DOI 10.1046/j.1440-1703.2002.00464.x; Moore ME, 2021, MAR ECOL PROG SER, V662, P139, DOI 10.3354/meps13606; Nelson BW, 2019, CAN J FISH AQUAT SCI, V76, P447, DOI 10.1139/cjfas-2017-0481; Patterson Jessie, 2008, Northwestern Naturalist, V89, P17, DOI 10.1898/1051-1733(2008)89[17:TIOTHB]2.0.CO;2; Scheffer Victor B., 1944, AMER MIDLAND NAT, V32, P373, DOI 10.2307/2421307; Shields MW, 2018, PEERJ, V6, DOI 10.7717/peerj.6062; Shields MW., 2019, STATUS TRENDS W COAS; Smultea MA, N6247015D8006 US PAC; Sobocinski KL., PROG OCEANOGR; Southwell C, 2004, MAR MAMMAL SCI, V20, P602, DOI 10.1111/j.1748-7692.2004.tb01182.x; Colin S, 2007, J AGR BIOL ENVIR ST, V12, P41, DOI 10.1198/108571107X162920; Suryan RM, 1998, MAR MAMMAL SCI, V14, P361, DOI 10.1111/j.1748-7692.1998.tb00728.x; Temte JL., 1986, THESIS OREGON STATE; Thomas AC, 2017, CAN J FISH AQUAT SCI, V74, P907, DOI 10.1139/cjfas-2015-0558; Thomas AC, 2011, MAR ECOL PROG SER, V441, P225, DOI 10.3354/meps09370; Thomas L, 2010, J APPL ECOL, V47, P5, DOI 10.1111/j.1365-2664.2009.01737.x; Williams Rob, 2007, Journal of Cetacean Research and Management, V9, P15; Wilson K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092838; Zier J., 2014, HARBOR SEAL SPECIES, P1	70	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0241254	10.1371/journal.pone.0241254	http://dx.doi.org/10.1371/journal.pone.0241254			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106950	Green Published, gold			2022-12-26	WOS:000664642200003
J	Roghmann, MC; Lydecker, AD; Shardell, M; DeBoy, RT; Johnson, JK; Zhao, LC; Hittle, LL; Mongodin, EF				Roghmann, Mary-Claire; Lydecker, Alison D.; Shardell, Michelle; DeBoy, Robert T.; Johnson, J. Kristie; Zhao, LiCheng; Hittle, Lauren L.; Mongodin, Emmanuel F.			Effect of mupirocin for Staphylococcus aureus decolonization on the microbiome of the nose and throat in community and nursing home dwelling adults	PLOS ONE			English	Article							DOUBLE-BLIND; CARRIAGE	Objective To characterize the microbial communities of the anterior nares (nose) and posterior pharynx (throat) of adults dwelling in the community and in nursing homes before and after treatment with intranasal mupirocin. MethodsStaphylococcus aureus-colonized adults were recruited from the community (n = 25) and from nursing homes (n = 7). S. aureus colonization was confirmed using cultures. Participants had specimens taken from nose and throat for S. aureus quantitation using quantitative PCR for the nuc gene and bacterial profiling using 16S rRNA gene sequencing over 12 weeks. After two baseline study visits 4 weeks apart, participants received intranasal mupirocin for 5 days with 3 further visits over a 8 week follow-up period. Results We found a decrease in the absolute abundance of S. aureus in the nose for 8 weeks after mupirocin (1693 vs 141 fg/ul, p = 0.047). Mupirocin caused a statistically significant disruption in bacterial communities of the nose and throat after 1 week, which was no longer detected after 8 weeks. Bacterial community profiling demonstrated that there was a decrease in the relative abundance of S. aureus (8% vs 0.3%, p<0.01) 8 weeks after mupirocin and a transient decrease in the relative abundance of Staphylococcus epidermidis in the nose (21% vs 5%, p<0.01) 1 week after mupirocin. Conclusions Decolonization with mupirocin leads to a sustained effect on absolute and relative abundance of S. aureus but not for other bacteria in the nose. This demonstrates that a short course of mupirocin selectively decreases S. aureus in the nose for up to 8 weeks.	[Roghmann, Mary-Claire] VA Maryland Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Baltimore, MD 21218 USA; [Roghmann, Mary-Claire; Lydecker, Alison D.; Shardell, Michelle; DeBoy, Robert T.; Johnson, J. Kristie] Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Shardell, Michelle; Hittle, Lauren L.; Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Shardell, Michelle; Hittle, Lauren L.; Mongodin, Emmanuel F.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Johnson, J. Kristie; Zhao, LiCheng] Univ Maryland, Sch Med, Dept Pathol, Baltimore, MD 21201 USA	Geriatric Research Education & Clinical Center; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Roghmann, MC (corresponding author), VA Maryland Hlth Care Syst, Geriatr Res Educ & Clin Ctr, Baltimore, MD 21218 USA.; Roghmann, MC (corresponding author), Univ Maryland, Sch Med, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA.	mroghmann@som.umaryland.edu		Roghmann, Mary-Claire/0000-0003-1063-9257	United States (U.S.) Department of Veterans Affairs Clinical Sciences Research and Development Service [I01 CX000491-01A1]; National Institute of Allergy and Infectious Diseases [1R01AI087865-01A1]; University of Maryland Institute for Clinical Translational Science; University of Maryland General Clinical Research Center	United States (U.S.) Department of Veterans Affairs Clinical Sciences Research and Development Service; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Maryland Institute for Clinical Translational Science; University of Maryland General Clinical Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by the United States (U.S.) Department of Veterans Affairs Clinical Sciences Research and Development Service (I01 CX000491-01A1) (MCR, JKJ, EFM); and the National Institute of Allergy and Infectious Diseases (1R01AI087865-01A1) (MCR, JKJ, EFM). The contents do not represent the views of the U.S. Department of Veterans Affairs or the United States Government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Allergy and Infectious Diseases or the National Institutes of Health. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.; This work supported by the University of Maryland Institute for Clinical Translational Science and the University of Maryland General Clinical Research Center.	Abramovici A, 2015, AM J PERINAT, V32, P1119, DOI 10.1055/s-0035-1549294; Ammerlaan HSM, 2009, CLIN INFECT DIS, V48, P922, DOI 10.1086/597291; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Centers for Medicare & Medicaid Services, HOSP COMP; CLSI, 2011, PERFORMANCE STANDARD; Conlan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047075; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fadrosh DW, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-6; Harbarth S, 1999, ANTIMICROB AGENTS CH, V43, P1412, DOI 10.1128/AAC.43.6.1412; Hauser LJ, 2016, INT FORUM ALLERGY RH, V6, P34, DOI 10.1002/alr.21630; Holm JB, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00029-19; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Jackson HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095414; Khamash DF, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz062; Liu CM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400216; Louca S, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0420-9; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Merkley MA, 2015, INT FORUM ALLERGY RH, V5, P884, DOI 10.1002/alr.21591; Mody L, 2003, CLIN INFECT DIS, V37, P1467, DOI 10.1086/379325; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Oksanen J., 2007, VEGAN PACKAGE COMMUN, V10, P631; Paulson JN, 2013, NAT METHODS, V10, P1200, DOI [10.1038/NMETH.2658, 10.1038/nmeth.2658]; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Price LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008422; Redel H, 2013, J INFECT DIS, V207, P1105, DOI 10.1093/infdis/jit005; Roghmann MC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00210-17; Roghmann MC, 2017, DIAGN MICR INFEC DIS, V88, P53, DOI 10.1016/j.diagmicrobio.2017.02.005; SanMiguel AJ, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00774-17; Seitz V, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv694; SUTHERLAND R, 1985, ANTIMICROB AGENTS CH, V27, P495, DOI 10.1128/AAC.27.4.495; van Rijen M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006216.pub2; Walker AW, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0087-4; Warnes GR, 2009, R PACKAGE VERSION; Weber SG, 2007, INFECT CONT HOSP EP, V28, P249, DOI 10.1086/512261; Zipperer A, 2016, NATURE, V535, P511, DOI 10.1038/nature18634; Zupancic ML, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043052	39	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252004	10.1371/journal.pone.0252004	http://dx.doi.org/10.1371/journal.pone.0252004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101737	gold, Green Published			2022-12-26	WOS:000664641500007
J	Nakamori, M; Ishikawa, K; Imamura, E; Yamamoto, H; Kimura, K; Ayukawa, T; Mizoue, T; Wakabayashi, S				Nakamori, Masahiro; Ishikawa, Kenichi; Imamura, Eiji; Yamamoto, Haruna; Kimura, Keiko; Ayukawa, Tomoko; Mizoue, Tatsuya; Wakabayashi, Shinichi			Relationship between tongue pressure and dysphagia diet in patients with acute stroke	PLOS ONE			English	Article							RELIABILITY	A dysphagia diet is important for patients with stroke to help manage their nutritional state and prevent aspiration pneumonia. Tongue pressure measurement is a simple, non-invasive, and objective method for diagnosing dysphagia. We hypothesized that tongue pressure may be useful in making a choice of diet for patients with acute stroke. Using balloon-type equipment, tongue pressure was measured in 80 patients with acute stroke. On admission, a multidisciplinary swallowing team including doctors, nurses, speech therapists, and management dietitians evaluated and decided on the possibility of oral intake and diet form; the tongue pressure was unknown to the team. Diet form was defined and classified as dysphagia diet Codes 0 to 4 and normal form (Code 5 in this study) according to the 2013 Japanese Dysphagia Diet Criteria. In multivariate analysis, only tongue pressure was significantly associated with the dysphagia diet form (p<0.001). Receiver operating characteristic analyses revealed that the optimal cutoff tongue pressure for predicting diet Codes 1, 2, 3, 4, and 5 was 3.6 (p<0.001, area under the curve [AUC] = 0.997), 9.6 (p<0.001, AUC = 0.973), 12.8 (p<0.001, AUC = 0.963), 16.5 (p<0.001, AUC = 0.979), and 17.3 kPa (p<0.001, AUC = 0.982), respectively. Tongue pressure is one of the sensitive indicators for choosing dysphagia diet forms in patients with acute stroke. A combination of simple modalities will increase the accuracy of the swallowing assessment and choice of the diet form.	[Nakamori, Masahiro; Ishikawa, Kenichi] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan; [Nakamori, Masahiro; Ishikawa, Kenichi; Imamura, Eiji] Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan; [Yamamoto, Haruna; Kimura, Keiko] Suiseikai Kajikawa Hosp, Dept Nursing, Hiroshima, Japan; [Ayukawa, Tomoko] Suiseikai Kajikawa Hosp, Dept Rehabil, Hiroshima, Japan; [Mizoue, Tatsuya; Wakabayashi, Shinichi] Suiseikai Kajikawa Hosp, Dept Neurosurg, Hiroshima, Japan	Hiroshima University	Nakamori, M (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Clin Neurosci & Therapeut, Hiroshima, Japan.; Nakamori, M (corresponding author), Suiseikai Kajikawa Hosp, Dept Neurol, Hiroshima, Japan.	mnakamori1@gmail.com		Nakamori, Masahiro/0000-0002-0944-5538				ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Aoki S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154608; Harms H, 2012, J NEUROL NEUROSUR PS, V83, P1225, DOI 10.1136/jnnp-2012-302194; Hayashi R, 2002, INT J PROSTHODONT, V15, P385; Hinds NP, 1998, QJM-MON J ASSOC PHYS, V91, P829, DOI 10.1093/qjmed/91.12.829; Hiraoka A, 2017, DYSPHAGIA, V32, P542, DOI 10.1007/s00455-017-9797-z; Hirota N, 2010, STROKE, V41, P2982, DOI 10.1161/STROKEAHA.110.594960; Kunieda K, 2013, J PAIN SYMPTOM MANAG, V46, P201, DOI 10.1016/j.jpainsymman.2012.07.020; LYDEN P, 1994, STROKE, V25, P2220, DOI 10.1161/01.STR.25.11.2220; Nakamori M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239590; Nakamori M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165837; Nakamori M, 2016, CLIN NEUROPHYSIOL, V127, P1669, DOI 10.1016/j.clinph.2015.07.032; Nilsson H, 1998, DYSPHAGIA, V13, P32, DOI 10.1007/PL00009547; Ono T, 2007, GERODONTOLOGY, V24, P143, DOI 10.1111/j.1741-2358.2007.00172.x; Persson E, 2019, DYSPHAGIA, V34, P271, DOI 10.1007/s00455-018-9937-0; Shaker R, 1988, Dysphagia, V3, P79, DOI 10.1007/BF02412424; Smithard DG, 1996, STROKE, V27, P1200, DOI 10.1161/01.STR.27.7.1200; Tddcot JSoDR, 2013, JPN J DYSPHAGIA REHA, V17, P255; Tohara H, 2003, DYSPHAGIA, V18, P126, DOI 10.1007/s00455-002-0095-y; Tsuga K, 2011, J ORAL REHABIL, V38, P680, DOI 10.1111/j.1365-2842.2011.02202.x; Tsuga K, 2012, GERODONTOLOGY, V29, pE1078, DOI 10.1111/j.1741-2358.2011.00615.x; Utanohara Y, 2008, DYSPHAGIA, V23, P286, DOI 10.1007/s00455-007-9142-z; Yoshida M, 2006, DYSPHAGIA, V21, P61, DOI 10.1007/s00455-005-9011-6; Yoshikawa M, 2005, J GERONTOL A-BIOL, V60, P506, DOI 10.1093/gerona/60.4.506; Yoshikawa M, 2011, DYSPHAGIA, V26, P232, DOI 10.1007/s00455-010-9291-3	25	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252837	10.1371/journal.pone.0252837	http://dx.doi.org/10.1371/journal.pone.0252837			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086830	gold, Green Published			2022-12-26	WOS:000664640100147
J	Prahm, KP; Hogdall, CK; Karlsen, MA; Christensen, IJ; Novotny, GW; Hogdall, E				Prahm, Kira Philipsen; Hogdall, Claus Kim; Karlsen, Mona Aarenstrup; Christensen, Ib Jarle; Novotny, Guy Wayne; Hogdall, Estrid			MicroRNA characteristics in epithelial ovarian cancer	PLOS ONE			English	Article							PRIMARY CYTOREDUCTIVE SURGERY; NEOADJUVANT CHEMOTHERAPY; TUMOR-SUPPRESSOR; SEROUS CARCINOMA; DOWN-REGULATION; EARLY RELAPSE; UP-REGULATION; EXPRESSION; GENE; PREDICTION	The purpose of the current study was to clarify differences in microRNA expression according to clinicopathological characteristics, and to investigate if miRNA profiles could predict cytoreductive outcome in patients with FIGO stage IIIC and IV ovarian cancer. Patients enrolled in the Pelvic Mass study between 2004 and 2010, diagnosed and surgically treated for epithelial ovarian cancer, were used for investigation. MicroRNA was profiled from tumour tissue with global microRNA microarray analysis. Differences in miRNA expression profiles were analysed according to histologic subtype, FIGO stage, tumour grade, type I or II tumours and result of primary cytoreductive surgery. One microRNA, miR-130a, which was found to be associated with serous histology and advanced FIGO stage, was also validated using data from external cohorts. Another seven microRNAs (miR-34a, miR-455-3p, miR-595, miR-1301, miR-146-5p, 193a-5p, miR-939) were found to be significantly associated with the clinicopathological characteristics (p <= 0.001), in our data, but mere not similarly significant when tested against external cohorts. Further validation in comparable cohorts, with microRNA profiled using newest and similar methods are warranted.	[Prahm, Kira Philipsen; Karlsen, Mona Aarenstrup; Christensen, Ib Jarle; Novotny, Guy Wayne; Hogdall, Estrid] Herlev Univ Hosp, Dept Pathol, Mol Unit, Danish Canc Biobank, Herlev, Denmark; [Prahm, Kira Philipsen; Hogdall, Claus Kim; Karlsen, Mona Aarenstrup] Copenhagen Univ Hosp, Dept Gynecol, Rigshosp, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen	Prahm, KP (corresponding author), Herlev Univ Hosp, Dept Pathol, Mol Unit, Danish Canc Biobank, Herlev, Denmark.; Prahm, KP (corresponding author), Copenhagen Univ Hosp, Dept Gynecol, Rigshosp, Copenhagen, Denmark.	kira@prahm.dk	Karlsen, Mona/AAT-6331-2021	Karlsen, Mona/0000-0002-2631-5516; Hogdall, Claus/0000-0002-5959-8874; Philipsen Prahm, Kira/0000-0002-8567-6338	Mermaid Project; Danish Cancer Research Foundation; Herlev Hospital Research Council	Mermaid Project; Danish Cancer Research Foundation; Herlev Hospital Research Council	Funding the study was supported by: The Mermaid Project, awarded to CH and EH, https://www.mermaidprojektet.dk/en/frontpage/.Danish Cancer Research Foundation, awarded to KPP, https://www.dansk-kraeftforsknings-fond.dk/.Herlev Hospital Research Council, awarded to EH, https://www.herlevhospital.dk/forskning.The funders had no role in study design, data collection and analysis, decisions to publish, or preparation of the manuscript. Medical Prognosis Institute A/S (MPI), https://medical-prognosis.com/, performed the microarray analyses and provided study reagents for the analyses. MPI was not engaged in any other part of the scientific content of this paper, or in the decision to submit the manuscript for publication. Their participation does not alter our adherence to PLOS ONE policies on sharing data and materials.	Abdallah R, 2015, INT J GYNECOL CANCER, V25, P1000, DOI 10.1097/IGC.0000000000000449; Alessi A, 2016, TUMORI, V102, P103, DOI 10.5301/tj.5000396; [Anonymous], 2017, FLASHTAG BIOTIN HSR; [Anonymous], 2011, RECOVERALL TOTAL NUC; [Anonymous], 2017, ANN REP 2016 2017; Bagnoli M, 2016, LANCET ONCOL, V17, P1137, DOI 10.1016/S1470-2045(16)30108-5; Bagnoli M, 2011, ONCOTARGET, V2, P1265, DOI 10.18632/oncotarget.401; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartels CL, 2009, CLIN CHEM, V55, P623, DOI 10.1373/clinchem.2008.112805; Bell DA, 2005, MODERN PATHOL, V18, pS19, DOI 10.1038/modpathol.3800306; Berchuck A, 2004, AM J OBSTET GYNECOL, V190, P910, DOI 10.1016/j.ajog.2004.02.005; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Bristow RE, 2000, CANCER, V89, P1532, DOI 10.1002/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO;2-A; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2006, CANCER RES, V66, P7390, DOI 10.1158/0008-5472.CAN-06-0800; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Danish Gynecologic Cancer Database, 2011, NAT WID CLIN DAT CAN; Danish Gynecologic Cancer Database, NAT WID CLIN DAT CAN; DGCG, 2015, ANN REP 2014 2015; du Bois A, 2009, CANCER-AM CANCER SOC, V115, P1234, DOI 10.1002/cncr.24149; Elattar A, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007565.pub2, 10.1002/14651858.CD007565]; Fago-Olsen CL, 2014, GYNECOL ONCOL, V132, P292, DOI 10.1016/j.ygyno.2013.11.035; Fagotti A, 2006, ANN SURG ONCOL, V13, P1156, DOI 10.1245/ASO.2006.08.021; Fanfani F, 2003, ONCOLOGY-BASEL, V65, P316, DOI 10.1159/000074644; Glasgow MA, 2013, J SURG ONCOL, V107, P195, DOI 10.1002/jso.23171; Guo J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200716; Hayes J, 2014, TRENDS MOL MED, V20, P460, DOI 10.1016/j.molmed.2014.06.005; Hentze JL, 2017, CONT CLIN TRIAL COMM, V8, P167, DOI 10.1016/j.conctc.2017.10.003; Hermeking H, 2010, CELL DEATH DIFFER, V17, P193, DOI 10.1038/cdd.2009.56; HOSKINS WJ, 1994, AM J OBSTET GYNECOL, V170, P974, DOI 10.1016/S0002-9378(94)70090-7; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Hynninen J, 2013, GYNECOL ONCOL, V131, P389, DOI 10.1016/j.ygyno.2013.08.023; Ibeanu OA, 2010, INT J GYNECOL CANCER, V20, pS1, DOI 10.1111/IGC.0b013e3181cff38b; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2009, J CLIN ONCOL, V27, P5848, DOI 10.1200/JCO.2009.24.0317; Karlsen MA, 2016, TUMOR BIOL, V37, P12619, DOI 10.1007/s13277-016-5166-z; Kehoe S, 2015, LANCET, V386, P249, DOI 10.1016/S0140-6736(14)62223-6; Kim TH, 2010, HISTOPATHOLOGY, V57, P734, DOI 10.1111/j.1365-2559.2010.03686.x; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Kurman RJ, 2016, AM J PATHOL, V186, P733, DOI 10.1016/j.ajpath.2015.11.011; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Ledermann JA, 2013, ANN ONCOL, V24, P24, DOI 10.1093/annonc/mdt333; Lee H, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-174; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Li YJ, 2016, CELL BIOL INT, V40, P621, DOI 10.1002/cbin.10584; Lin MS, 2011, ONCOL REP, V25, P739, DOI 10.3892/or.2010.1112; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Liu JC, 2016, GENE, V592, P308, DOI 10.1016/j.gene.2016.07.034; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Malpica A, 2004, AM J SURG PATHOL, V28, P496, DOI 10.1097/00000478-200404000-00009; Michielsen K, 2014, EUR RADIOL, V24, P889, DOI 10.1007/s00330-013-3083-8; Millstein J, 2020, ANN ONCOL, V31, P1240, DOI 10.1016/j.annonc.2020.05.019; Nagel R, 2008, CANCER RES, V68, P5795, DOI 10.1158/0008-5472.CAN-08-0951; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Pavlik EJ, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10020056; Piek JMJ, 2004, AM J OBSTET GYNECOL, V191, P718, DOI 10.1016/j.ajog.2004.02.067; Pignata S, 2011, J CLIN ONCOL, V29, P3628, DOI 10.1200/JCO.2010.33.8566; Pradervand S, 2009, RNA, V15, P493, DOI 10.1261/rna.1295509; Prahm KP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207319; Prahm KP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174300; Prahm KP, 2015, GYNECOL ONCOL, V136, P205, DOI 10.1016/j.ygyno.2014.12.029; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Qin L, 2016, ONCOL REP, V36, P3325, DOI 10.3892/or.2016.5139; Riester M, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju048; Rutten MJ, 2017, J CLIN ONCOL, V35, P613, DOI 10.1200/JCO.2016.69.2962; Rutten MJ, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009786.pub2; Rutten MJ, 2015, INT J GYNECOL CANCER, V25, P407, DOI 10.1097/IGC.0000000000000368; Schmid G, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2135-2; Shen Y, 2016, TUMOR BIOL, V37, P14765, DOI 10.1007/s13277-016-5335-0; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sorensen SM, 2016, CLIN EPIDEMIOL, V8, P485, DOI 10.2147/CLEP.S99479; Sorrentino A, 2008, GYNECOL ONCOL, V111, P478, DOI 10.1016/j.ygyno.2008.08.017; Szafranska AE, 2008, J MOL DIAGN, V10, P415, DOI 10.2353/jmoldx.2008.080018; Tarasov V, 2007, CELL CYCLE, V6, P1586, DOI 10.4161/cc.6.13.4436; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Wang SS, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0681-x; Wang XC, 2010, AM J MED SCI, V340, P385, DOI 10.1097/MAJ.0b013e3181e892a0; Wright AA, 2016, GYNECOL ONCOL, V143, P3, DOI 10.1016/j.ygyno.2016.05.022; Xiong Y, 2015, BIOMED PHARMACOTHER, V71, P64, DOI 10.1016/j.biopha.2015.02.020; Xu LX, 2017, MOL MED REP, V16, P9777, DOI 10.3892/mmr.2017.7790; Yang D, 2013, CANCER CELL, V23, P186, DOI 10.1016/j.ccr.2012.12.020; Yang LY, 2012, ONCOL REP, V28, P592, DOI 10.3892/or.2012.1823; Zhang HD, 2017, BREAST CANCER-TOKYO, V24, P521, DOI 10.1007/s12282-017-0776-x; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zhang X, 2013, ACTA BIOCH BIOPH SIN, V45, P995, DOI 10.1093/abbs/gmt113; Zuberi M, 2015, CLIN TRANSL ONCOL, V17, P779, DOI 10.1007/s12094-015-1303-1	89	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252401	10.1371/journal.pone.0252401	http://dx.doi.org/10.1371/journal.pone.0252401			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086724	gold, Green Published			2022-12-26	WOS:000664640100059
J	Myint, K; Jacobs, K; Myint, AM; Lam, SK; Henden, L; Hoe, SZ; Guillemin, GJ				Myint, Kyaimon; Jacobs, Kelly; Myint, Aye Mu; Lam, Sau Kuen; Henden, Lyndal; Hoe, See Ziau; Guillemin, Gilles J.			Effects of stress associated with academic examination on the kynurenine pathway profile in healthy students	PLOS ONE			English	Article							QUINOLINIC ACID; NEUROTROPHIC FACTOR; INDOLEAMINE 2,3-DIOXYGENASE; UNDERGRADUATE STUDENTS; CENTRAL MECHANISMS; MEDICAL-STUDENTS; MAMMALIAN BRAIN; HUMAN MICROGLIA; MESSENGER-RNA; EXPRESSION	The effects of stress on the neuroendocrine, central nervous and immune systems are extremely complex. The kynurenine pathway (KP) of the tryptophan metabolism is recognised as a cross-link between the neuroendocrine- and immune systems. However, the effects of acute stress from everyday life on KP activation have not yet been studied. This study aims to investigate changes in the levels of the KP neuroactive metabolites and cytokines in response to stress triggered by academic examinations. Ninety-two healthy first year medical students benevolently participated in the study. Parameters were measured pre- examination, which is considered to be a high-stress period, and post-examination, as a low-stress period. Stress induced by academic examinations significantly increases the perceived stress scores (p<0.001), serum cortisol levels (p<0.001) and brain-derived neurotrophic factor (BDNF) levels (p<0.01). It decreased IL-10 levels (p<0.05) but had no effect on IL-6 and TNF-alpha levels. Only the KP neuroactive metabolite, 3-hydroxykynurenine (3-HK) significantly increased (p<0.01) in the post-examination period. In addition, the stress scores positively correlated with the levels of cortisol (r(2) = 0.297, p<0.01) at post examination. Acute stress triggered by academic examinations increases cortisol and BDNF production and suppresses the anti-inflammatory cytokine, IL-10, but did not increase significantly the levels of other pro-inflammatory cytokines, tryptophan, kynurenine and downstream KP metabolites. The concomitant increased levels of BDNF under the duress of acute examination stress appear to limit the levels pro-inflammatory markers, which may attenuate the action of cortisol and the neuroinflammatory branch of the KP.	[Myint, Kyaimon; Hoe, See Ziau] Univ Malaya, Dept Physiol, Fac Med, Kuala Lumpur, Malaysia; [Jacobs, Kelly; Guillemin, Gilles J.] Macquarie Univ, Dept Biomed Sci, Neuroinflammat Grp, Fac Med & Hlth Sci, Sydney, NSW, Australia; [Myint, Aye Mu] European Collaborat Project, Psychoneuroimmunol Res Grp, Munich, Germany; [Lam, Sau Kuen] Univ Tunku Abdul Rahman, Dept Preclin Sci, Fac Med & Hlth Sci, Bandar Sungai Long, Kajang, Malaysia; [Henden, Lyndal] Macquarie Univ, Dept Biomed Sci, Genom & Bioinformat Grp, Fac Med & Hlth Sci, Sydney, NSW, Australia	Universiti Malaya; Macquarie University; Universiti Tunku Abdul Rahman (UTAR); Macquarie University	Hoe, SZ (corresponding author), Univ Malaya, Dept Physiol, Fac Med, Kuala Lumpur, Malaysia.; Guillemin, GJ (corresponding author), Macquarie Univ, Dept Biomed Sci, Neuroinflammat Grp, Fac Med & Hlth Sci, Sydney, NSW, Australia.	hoesz@ummc.edu.my; gilles.guillemin@mq.edu.au	Guillemin, Gilles J/C-3878-2015; HOE, SEE ZIAU/B-8637-2010; KYAIMON, MYINT/B-8822-2010	Guillemin, Gilles J/0000-0001-8105-4470; HOE, SEE ZIAU/0000-0001-6138-1271; Henden, Lyndal/0000-0001-5541-7637; Jacobs, Kelly/0000-0002-2595-6426	University of Malaya Research Grant Health and Translational Medicine Cluster [RG266/10HTM]; National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); Macquarie University	University of Malaya Research Grant Health and Translational Medicine Cluster; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Macquarie University	This study was funded by grants (RG266/10HTM) from the University of Malaya Research Grant Health and Translational Medicine Cluster to KM. GJG was supported by the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC) and Macquarie University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ayadhi LY, 2005, ANN SAUDI MED, V25, P36, DOI 10.5144/0256-4947.2005.36; Assaf AM, 2017, SAUDI PHARM J, V25, P1237, DOI 10.1016/j.jsps.2017.09.009; Badawy AAB, 2016, INT J TRYPTOPHAN RES, V9, P31, DOI [10.4137/ijtr.s38189, 10.4137/IJTR.S38189]; Bessede A, 2014, NATURE, V511, P184, DOI 10.1038/nature13323; Bjorkholm C, 2016, NEUROPHARMACOLOGY, V102, P72, DOI 10.1016/j.neuropharm.2015.10.034; Calabrese F, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00430; Cervenka I, 2017, SCIENCE, V357, DOI 10.1126/science.aaf9794; Charmandari E, 2005, ANNU REV PHYSIOL, V67, P259, DOI 10.1146/annurev.physiol.67.040403.120816; Chen YQ, 2009, INT J TRYPTOPHAN RES, V2, P1; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Clark SM, 2019, CYTOKINE, V113, P256, DOI 10.1016/j.cyto.2018.07.015; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Fan D, 2016, MOL NEUROBIOL, V53, P344, DOI 10.1007/s12035-014-9013-1; Fatokun AA, 2013, AMINO ACIDS, V45, P1319, DOI 10.1007/s00726-013-1602-1; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; GLASER R, 1987, Brain Behavior and Immunity, V1, P7, DOI 10.1016/0889-1591(87)90002-X; Gobaille S, 2008, J NEUROCHEM, V105, P982, DOI 10.1111/j.1471-4159.2008.05219.x; Guillemin GJ, 2007, J NEUROSCI, V27, P12884, DOI 10.1523/JNEUROSCI.4101-07.2007; Guillemin GJ, 2012, FEBS J, V279, P1355, DOI 10.1111/j.1742-4658.2012.08493.x; Guillemin GJ, 2005, GLIA, V49, P15, DOI 10.1002/glia.20090; Guillemin GJ, 2003, ADV EXP MED BIOL, V527, P105; Hakansson K, 2017, J ALZHEIMERS DIS, V55, P645, DOI 10.3233/JAD-160593; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Holsen LM, 2011, J AFFECT DISORDERS, V131, P379, DOI 10.1016/j.jad.2010.11.024; Hritcu L, 2014, PROG NEURO-PSYCHOPH, V51, P126, DOI 10.1016/j.pnpbp.2014.01.016; Hufner K, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10060322; Iqbal S, 2015, INDIAN J MED RES, V141, P354; JHAMANDAS K, 1990, BRAIN RES, V529, P185, DOI 10.1016/0006-8993(90)90826-W; Jones SP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131389; Kulsoom B, 2015, NEUROPSYCH DIS TREAT, V11, P1713, DOI 10.2147/NDT.S83577; Lacey K, 2000, PSYCHONEUROENDOCRINO, V25, P339, DOI 10.1016/S0306-4530(99)00059-1; Colin-Gonzalez AL, 2013, NEUROTOXICOLOGY, V34, P189, DOI 10.1016/j.neuro.2012.11.007; Ledreux A, 2019, J ALZHEIMERS DIS, V71, P1245, DOI 10.3233/JAD-190756; Lee WS, 2013, INT IMMUNOPHARMACOL, V17, P721, DOI 10.1016/j.intimp.2013.08.018; Lim CK, 2017, PROG NEUROBIOL, V155, P76, DOI 10.1016/j.pneurobio.2015.12.009; Loft P, 2007, PSYCHONEUROENDOCRINO, V32, P367, DOI 10.1016/j.psyneuen.2007.02.004; Lovelace MD, 2017, NEUROPHARMACOLOGY, V112, P373, DOI 10.1016/j.neuropharm.2016.03.024; Lovibond SH., 2004, MANUAL DEPRESSION AN, V4th; Ludwig AB, 2015, BMC MED EDUC, V15, DOI 10.1186/s12909-015-0425-z; Maduka IC, 2015, AFR HEALTH SCI, V15, P131, DOI 10.4314/ahs.v15i1.18; Maes M, 2011, PROG NEURO-PSYCHOPH, V35, P702, DOI 10.1016/j.pnpbp.2010.12.017; Marmigere F, 2003, HIPPOCAMPUS, V13, P646, DOI 10.1002/hipo.10109; Marshall GD, 1998, BRAIN BEHAV IMMUN, V12, P297, DOI 10.1006/brbi.1998.0537; Martin-Hernandez D, 2019, MOL NEUROBIOL, V56, P490, DOI 10.1007/s12035-018-1096-7; Myint AM, 2003, MED HYPOTHESES, V61, P519, DOI 10.1016/S0306-9877(03)00207-X; Myint AM, 2012, FEBS J, V279, P1375, DOI 10.1111/j.1742-4658.2012.08551.x; Myint AM, 2014, PROG NEURO-PSYCHOPH, V48, P304, DOI 10.1016/j.pnpbp.2013.08.008; Myint K, 2011, BIOMED RES-INDIA, V22; Neeley EW, 2011, PHYSIOL BEHAV, V104, P334, DOI 10.1016/j.physbeh.2011.02.032; Numakawa T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112312; O'Farrell K, 2017, NEUROPHARMACOLOGY, V112, P307, DOI 10.1016/j.neuropharm.2015.12.004; Oxenkrug GF, 2010, ISR J PSYCHIATR REL, V47, P56; Park SW, 2011, NEUROSCI RES, V71, P335, DOI 10.1016/j.neures.2011.08.010; Parrott JM, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00116; Pfau ML, 2015, NEUROBIOL STRESS, V1, P66, DOI 10.1016/j.ynstr.2014.09.004; Phillips C, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/7260130; Al-Dubai SAR, 2011, MALAYS J MED SCI, V18, P57; SALTER M, 1985, BIOCHEM J, V229, P499, DOI 10.1042/bj2290499; Sathyasaikumar KV, 2017, NEUROSCIENCE, V367, P85, DOI 10.1016/j.neuroscience.2017.10.006; Schmitt K, 2016, ANN MED, V48, P42, DOI 10.3109/07853890.2015.1131327; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Shaikh Babar T, 2004, Educ Health (Abingdon), V17, P346; Shanmugan S, 2014, HUM BRAIN MAPP, V35, P847, DOI 10.1002/hbm.22218; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; SPECIALE C, 1993, J NEUROCHEM, V60, P212, DOI 10.1111/j.1471-4159.1993.tb05840.x; Sundaram G, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0204-5; Takatsuji K, 2008, BIOMED RES-TOKYO, V29, P221, DOI 10.2220/biomedres.29.221; WETMORE C, 1990, EXP NEUROL, V109, P141, DOI 10.1016/0014-4886(90)90068-4; Yusoff MSB, 2010, MALAYS J MED SCI, V17, P30; Zhang XY, 2016, BRAIN BEHAV IMMUN, V51, P169, DOI 10.1016/j.bbi.2015.09.014; Zhong L, 2009, NEUROL RES, V31, P707, DOI 10.1179/174313209X380856	74	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252668	10.1371/journal.pone.0252668	http://dx.doi.org/10.1371/journal.pone.0252668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081742	Green Published, gold			2022-12-26	WOS:000664639200042
J	Alves, CRR; Eichelberger, EJ; das Neves, W; Ribeiro, MAC; Bechara, LRG; Voltarelli, VA; de Almeida, NR; Hagen, L; Sharma, A; Ferreira, JCB; Swoboda, KJ; Slupphaug, G; Brum, PC				Alves, Christiano R. R.; Eichelberger, Eric J.; das Neves, Willian; Ribeiro, Marcio A. C.; Bechara, Luiz R. G.; Voltarelli, Vanessa A.; de Almeida, Ney R.; Hagen, Lars; Sharma, Animesh; Ferreira, Julio C. B.; Swoboda, Kathryn J.; Slupphaug, Geir; Brum, Patricia C.			Cancer-induced muscle atrophy is determined by intrinsic muscle oxidative capacity	FASEB JOURNAL			English	Article						aerobic metabolism; atrophy; cancer cachexia; fiber type; muscle wasting	SKELETAL-MUSCLE; HEART-FAILURE; REDOX REGULATION; MECHANISMS; CACHEXIA; PROTEOME; GLUTATHIONYLATION; INHIBITION; PATHWAY; DAMAGE	We tested the hypothesis that cancer cachexia progression would induce oxidative post-translational modifications (Ox-PTMs) associated with skeletal muscle wasting, with different responses in muscles with the prevalence of glycolytic and oxidative fibers. We used cysteine-specific isotopic coded affinity tags (OxICAT) and gel-free mass spectrometry analysis to investigate the cysteine Ox-PTMs profile in the proteome of both plantaris (glycolytic) and soleus (oxidative) muscles in tumor-bearing and control rats. Histological analysis revealed muscle atrophy in type II fibers in plantaris muscle, with no changes in plantaris type I fibers and no differences in both soleus type I and II fibers in tumor-bearing rats when compared to healthy controls. Tumor progression altered the Ox-PTMs profile in both plantaris and soleus. However, pathway analysis including the differentially oxidized proteins revealed tricarboxylic acid cycle and oxidative phosphorylation as main affected pathways in plantaris muscle from tumor-bearing rats, while the same analysis did not show main metabolic pathways affected in the soleus muscle. In addition, cancer progression affected several metabolic parameters such as ATP levels and markers of oxidative stress associated with muscle atrophy in plantaris muscle, but not in soleus. However, isolated soleus from tumor-bearing rats had a reduced force production capacity when compared to controls. These novel findings demonstrate that tumor-bearing rats have severe muscle atrophy exclusively in glycolytic fibers. Cancer progression is associated with cysteine Ox-PTMs in the skeletal muscle, but these modifications affect different pathways in a glycolytic muscle compared to an oxidative muscle, indicating that intrinsic muscle oxidative capacity determines the response to cancer cachectic effects.	[Alves, Christiano R. R.; das Neves, Willian; Voltarelli, Vanessa A.; de Almeida, Ney R.; Brum, Patricia C.] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil; [Alves, Christiano R. R.; Eichelberger, Eric J.; Swoboda, Kathryn J.] Massachusetts Gen Hosp, Ctr Genom Med, Boston, MA 02114 USA; [Ribeiro, Marcio A. C.; Bechara, Luiz R. G.; Ferreira, Julio C. B.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil; [Hagen, Lars; Sharma, Animesh; Slupphaug, Geir] NTNU Norwegian Univ Sci & Technol, Dept Clin & Mol Med, Trondheim, Norway; [Hagen, Lars; Sharma, Animesh; Slupphaug, Geir] NTNU, PROMEC Prote & Mod Expt Core, Trondheim, Norway; [Hagen, Lars; Sharma, Animesh; Slupphaug, Geir] Cent Norway Reg Hlth Author, Trondheim, Norway	Universidade de Sao Paulo; Harvard University; Massachusetts General Hospital; Universidade de Sao Paulo; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Alves, CRR; Brum, PC (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, Brazil.	calves2@mgh.harvard.edu; pcbrum@usp.br	Brum, Patricia C/E-6605-2011; Ferreira, Julio Cesar Batista/AEU-0494-2022; Ferreira, Julio/L-4687-2019; Ferreira, Julio Cesar Batista/I-3177-2012; Bechara, Luiz R G/K-4095-2012; Voltarelli, Vanessa Azevedo/J-3419-2015; Alves, Christiano RR/C-5912-2013	Brum, Patricia C/0000-0002-4750-6506; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Ferreira, Julio Cesar Batista/0000-0003-2694-239X; Voltarelli, Vanessa Azevedo/0000-0003-0087-646X; Alves, Christiano RR/0000-0002-2646-9689; das Neves Silva, Willian/0000-0002-8796-0025; Ribeiro, Marcio/0000-0002-8431-4968; Bechara, Luiz/0000-0002-1642-1008	FAPESP [2015/22814-5, 2016/01478-0, 2014/03016-8, 2012/25240-1, 2012/02528-0, Sprint 16/50336-3, 2016/20187-6]; Conselho Nacional de Pesquisa e Desenvolvimento [CNPq 306261/2016-2]; NICHD [R01HD054599]; Biogen; Cure SMA	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa e Desenvolvimento(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Biogen(Biogen); Cure SMA	FAPESP, Grant/Award Number: 2015/22814-5, 2016/01478-0, 2014/03016-8, 2012/25240-1, 2012/02528-0, Sprint 16/50336-3 and 2016/20187-6; Conselho Nacional de Pesquisa e Desenvolvimento, Grant/Award Number: CNPq 306261/2016-2; NICHD, Grant/Award Number: R01HD054599; Biogen; Cure SMA;	Abrigo J, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2063179; Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004; Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Alves CRR, 2020, MOL METAB, V39, DOI 10.1016/j.molmet.2020.101012; Alves CRR, 2018, LIFE SCI, V206, P29, DOI 10.1016/j.lfs.2018.05.030; Applegate MAB, 2008, BIOCHEMISTRY-US, V47, P473, DOI 10.1021/bi7017464; Bacurau AVN, 2016, INT J CARDIOL, V214, P137, DOI 10.1016/j.ijcard.2016.03.071; Bacurau AVN, 2009, J APPL PHYSIOL, V106, P1631, DOI 10.1152/japplphysiol.91067.2008; Bechara LRG, 2014, INT J CARDIOL, V175, P499, DOI 10.1016/j.ijcard.2014.06.046; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Blackwell TA, 2018, PHYSIOL GENOMICS, V50, P1071, DOI 10.1152/physiolgenomics.00061.2018; Brown JL, 2017, J CACHEXIA SARCOPENI, V8, P926, DOI 10.1002/jcsm.12232; Bueno CR, 2010, J APPL PHYSIOL, V109, P702, DOI 10.1152/japplphysiol.00281.2010; Byrne DP, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax2713; Chiappetta G, 2010, METHOD ENZYMOL, V473, P199, DOI 10.1016/S0076-6879(10)73010-X; Chung HS, 2013, CIRC RES, V112, P382, DOI 10.1161/CIRCRESAHA.112.268680; Correia JC, 2020, SCIENCE, V368, P470, DOI 10.1126/science.abb4116; Cunha TF, 2017, J APPL PHYSIOL, V122, P817, DOI 10.1152/japplphysiol.00182.2016; Cunha TF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041701; Dalle-Donne I, 2007, FREE RADICAL BIO MED, V43, P883, DOI 10.1016/j.freeradbiomed.2007.06.014; das Neves W, 2016, LIFE SCI, V163, P11, DOI 10.1016/j.lfs.2016.08.025; Fearon K, 2013, NAT REV CLIN ONCOL, V10, P90, DOI 10.1038/nrclinonc.2012.209; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fu CX, 2008, J PROTEOME RES, V7, P3789, DOI 10.1021/pr800233r; Fukawa T, 2016, NAT MED, V22, P666, DOI 10.1038/nm.4093; Gutierrez VP, 2008, EUR J PHARMACOL, V594, P84, DOI 10.1016/j.ejphar.2008.07.053; HARRINGTON GM, 1983, BEHAV GENET, V13, P91, DOI 10.1007/BF01071746; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; HSIEH ST, 1994, J NEUROSCI, V14, P6392; Hyltander A, 2000, EUR J CANCER, V36, P330, DOI 10.1016/S0959-8049(99)00273-7; Jannig PR, 2017, LIFE SCI, V191, P46, DOI 10.1016/j.lfs.2017.10.012; Kimura M, 2015, SUPPORT CARE CANCER, V23, P1699, DOI 10.1007/s00520-014-2534-3; Kriegenburg F, 2011, ANTIOXID REDOX SIGN, V15, P2265, DOI 10.1089/ars.2010.3590; Leichert LI, 2008, P NATL ACAD SCI USA, V105, P8197, DOI 10.1073/pnas.0707723105; Li P, 2007, AM J PATHOL, V170, P599, DOI 10.2353/ajpath.2007.060505; Mailloux RJ, 2014, REDOX BIOL, V2, P123, DOI 10.1016/j.redox.2013.12.011; Mallis RJ, 2000, FEBS LETT, V482, P237, DOI 10.1016/S0014-5793(00)02022-6; Margaritelis NV, 2020, REDOX BIOL, V35, DOI 10.1016/j.redox.2020.101499; McDonagh B, 2014, J PROTEOME RES, V13, P5008, DOI 10.1021/pr5006394; Milzani A, 1997, FASEB J, V11, P261, DOI 10.1096/fasebj.11.4.9068615; Moreira JBN, 2013, J APPL PHYSIOL, V114, P1029, DOI 10.1152/japplphysiol.00760.2012; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Piccirillo R, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00287; Poole LB, 2008, CURR OPIN CHEM BIOL, V12, P18, DOI 10.1016/j.cbpa.2008.01.021; Quiros Pedro M, 2017, Curr Protoc Mouse Biol, V7, P47, DOI 10.1002/cpmo.21; Rees MD, 2008, FREE RADICAL BIO MED, V44, P1973, DOI 10.1016/j.freeradbiomed.2008.03.016; Roos G, 2011, FREE RADICAL BIO MED, V51, P314, DOI 10.1016/j.freeradbiomed.2011.04.031; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Souza RWA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35728-2; Springer J, 2012, INT J CANCER, V131, P2187, DOI 10.1002/ijc.27494; Stanford KI, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a029801; von Haehling S, 2010, J CACHEXIA SARCOPENI, V1, P129, DOI 10.1007/s13539-010-0014-2; Xiao HP, 2020, CELL, V180, P968, DOI 10.1016/j.cell.2020.02.012; Xiong Y, 2011, ANTIOXID REDOX SIGN, V15, P233, DOI 10.1089/ars.2010.3540	54	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21714	10.1096/fj.202100263R	http://dx.doi.org/10.1096/fj.202100263R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118107				2022-12-26	WOS:000667814100033
J	Garaventa, JM; Parker, VT				Garaventa, Joanna M.; Parker, V. Thomas			Extended seed rain period of Adenostoma fasciculatum impacts diverse seed predators	PLOS ONE			English	Article							LIFE-HISTORY; DISPERSAL; BANK; FIRE; CALIFORNIA; GERMINATION; EVOLUTIONARY; ANTS; RESTORATION; DENDROMECON	Aims The principal chaparral species in California, Adenostoma fasciculatum, an evergreen, sclerophyllous shrub, is broadly distributed and provides habitat and food resources for a large and diverse animal community. The effects of climate change, including elevated temperatures, fire frequency and severity, along with increased urban encroachment, have placed pressure on chaparral habitats in California. Our goal is to investigate aspects of reproductive ecology as a measure of the potential resiliency of A. fasciculatum. We focus on seed rain (all seed falling into the seed traps regardless of origin) and seed banks in the context of plant-animal interactions and regeneration. Methods Stand recovery following disturbance is achieved through both resprouting and germination from established persistent soil seed banks. In this study we focus on seed ecology using a series of experiments to document the length and quantity of seed rain, seed predation, parsing the importance of the community of granivores, and evaluating the connection between stand age and germination rate from soil seed banks. Important findings Our research documented an 8-month seed rain duration with over 1 million seeds per m(2), multiple seed predators including passerines (songbirds) and rodents, and points to the possibility of native ants playing a role in the seed dispersal process. This is important given the recent advancement of the invasive Argentine ant (Linepthema humile) into Californian chaparral. This research demonstrates a clear relationship between A. fasciculatum and both resident and migratory granivores in the chaparral. We documented that a 39-year-old stand had higher germination rates than those which were 16, 20, 41 and 71 years old and how seed banks play a major role in assuring resiliency following fire. These findings are important for wildland managers to assure the continued resiliency of A. fasciculatum.	[Garaventa, Joanna M.; Parker, V. Thomas] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Garaventa, Joanna M.] Garaventa Consulting & Res, Concord, CA 94519 USA	California State University System; San Francisco State University	Garaventa, JM (corresponding author), San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA.; Garaventa, JM (corresponding author), Garaventa Consulting & Res, Concord, CA 94519 USA.	jgaraventa@sbcglobal.net		Parker, V. Thomas/0000-0002-6149-7140				Abatatzoglou JT, 2017, B AM METEOROL SOC, V98, P1815, DOI 10.1175/BAMS-D-16-0193.1; Alexander JM, 2003, RESTOR ECOL, V11, P185, DOI 10.1046/j.1526-100X.2003.00169.x; Aslan C, 2019, AOB PLANTS, V11, DOI 10.1093/aobpla/plz006; Bakker JP, 1996, ACTA BOT NEERL, V45, P461; Baldwin BG, 2014, ANNU REV ECOL EVOL S, V45, P347, DOI 10.1146/annurev-ecolsys-110512-135847; BEATTIE AJ, 1982, NATURE, V297, P627, DOI 10.1038/297627a0; Beckman NG, 2019, AOB PLANTS, V12, DOI 10.1093/aobpla/plz048; Bekker R. M., 2003, Aspects of Applied Biology, P1; BERG RY, 1966, AM J BOT, V53, P61, DOI 10.2307/2439925; Bogdziewicz M, 2016, OIKOS, V125, P300, DOI 10.1111/oik.03012; Bossuyt B, 2008, J VEG SCI, V19, P875, DOI 10.3170/2008-8-18462; Boyd RS, 2001, AM J BOT, V88, P234, DOI 10.2307/2657014; BROWN JH, 1979, ANNU REV ECOL SYST, V10, P201, DOI 10.1146/annurev.es.10.110179.001221; BROWN JS, 1986, AM NAT, V127, P31, DOI 10.1086/284465; BULLOCK SH, 1989, AM J BOT, V76, P1506, DOI 10.2307/2444438; Carney SE, 2003, OECOLOGIA, V135, P576, DOI 10.1007/s00442-003-1200-0; Cayan DR, 2008, CLIMATIC CHANGE, V87, pS21, DOI 10.1007/s10584-007-9377-6; Chick MP, 2016, INT J WILDLAND FIRE, V25, P849, DOI 10.1071/WF15013; Childs DZ, 2010, P ROY SOC B-BIOL SCI, V277, P3055, DOI 10.1098/rspb.2010.0707; COHEN D, 1966, J THEOR BIOL, V12, P119, DOI 10.1016/0022-5193(66)90188-3; Crawley M. J., 2000, Seeds: the ecology of regeneration in plant communities, P167, DOI 10.1079/9780851994321.0167; Detrain C, 2000, NATURWISSENSCHAFTEN, V87, P373, DOI 10.1007/s001140050744; Dettinger M., 2016, SAN FRANC ESTUARY WA, V14, DOI 10.15447/sfews.2016v14iss3art5; El-Keblawy AA, 2015, J ARID ENVIRON, V117, P10, DOI 10.1016/j.jaridenv.2015.02.001; Garwood N.C., 1989, ECOLOGY SOIL SEED BA, V1, P149, DOI DOI 10.1016/B978-0-12-440405-2.50014-2; Gioria M, 2019, BIOL INVASIONS, V21, P2313, DOI 10.1007/s10530-019-01978-y; GRIFFIN JR, 1971, ECOLOGY, V52, P862, DOI 10.2307/1936034; GUTTERMAN Y, 1994, BOT REV, V60, P373, DOI 10.1007/BF02857924; GUTTERMAN Y, 1967, ISRAEL J BOT, V16, P213; HANES TL, 1971, ECOL MONOGR, V41, P27, DOI 10.2307/1942434; Harper J. L., 1977, Population biology of plants.; Holway DA, 1995, CONSERV BIOL, V9, P1634, DOI 10.1046/j.1523-1739.1995.09061634.x; JANZEN DH, 1969, EVOLUTION, V23, P1, DOI [10.2307/2406478, 10.1111/j.1558-5646.1969.tb03489.x]; Keeley J.E., 1999, J MEDITERR ECOL, V1, P41; KEELEY JE, 1991, BOT REV, V57, P81, DOI 10.1007/BF02858766; KEELEY JE, 1987, ECOLOGY, V68, P434, DOI 10.2307/1939275; Keeley JE, 1993, JAN, V1, P1; Keeley JE, 2018, INT J WILDLAND FIRE, V27, P781, DOI 10.1071/WF18026; Keeley JE, 2016, ECOSYSTEMS OF CALIFORNIA, P27; KELLY VR, 1990, AM MIDL NAT, V124, P114, DOI 10.2307/2426084; Kemp P.R., 1989, ECOLOGY SOIL SEED BA, P257, DOI DOI 10.1016/B978-0-12-440405-2.50017-8; KERLEY GIH, 1991, J ARID ENVIRON, V20, P63, DOI 10.1016/S0140-1963(18)30775-4; Lawrence VD., 2014, CABI SEEDS; Merritt DJ, 2011, SCIENCE, V332, P424, DOI 10.1126/science.1203083; Miller TEX, 2006, AM NAT, V168, P608, DOI 10.1086/509610; ODOWD DJ, 1984, ECOLOGY, V65, P1052, DOI 10.2307/1938313; Parker V.T., 1989, ECOLOGY SOIL SEED BA, P231, DOI [10.1016/b978-0-12-440405-2.50016-6, DOI 10.1016/B978-0-12-440405-2.50016-6]; Parker V. Thomas, 2015, Ecologia Mediterranea, V41, P5; Parker VT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132625; PARMENTER RR, 1984, J ARID ENVIRON, V7, P75, DOI 10.1016/S0140-1963(18)31403-4; Pausas JG, 2016, NEW PHYTOL, V209, P945, DOI 10.1111/nph.13644; Penn HJ, 2018, ECOL EVOL, V8, P9122, DOI 10.1002/ece3.4377; Peterson NB, 2016, ECOL EVOL, V6, P4298, DOI 10.1002/ece3.2156; Pratt RB, 2014, GLOBAL CHANGE BIOL, V20, P893, DOI 10.1111/gcb.12477; Saatkamp A, 2019, NEW PHYTOL, V221, P1764, DOI 10.1111/nph.15502; STONE EDWARD C, 1953, CALIFORNIA AGRIC, V7, P13; Vander Wall SB, 2005, ECOLOGY, V86, P801, DOI 10.1890/04-0847; Vander Wall SB, 2005, OECOLOGIA, V145, P282, DOI 10.1007/s00442-005-0125-1; Venable DL, 2007, ECOLOGY, V88, P1086, DOI 10.1890/06-1495; VENABLE DL, 1988, AM NAT, V131, P360, DOI 10.1086/284795; Venturas MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159145; Wagtendonk J. W. van, 2008, Fire Ecology, V4, P34; Warzecha B, 2014, PLANT ECOL, V215, P1313, DOI 10.1007/s11258-014-0389-9; Willis CG, 2014, NEW PHYTOL, V203, P300, DOI 10.1111/nph.12782; Willson M. F., 2000, Seeds: the ecology of regeneration in plant communities, P85, DOI 10.1079/9780851994321.0085; Wolff A, 1999, OIKOS, V84, P443, DOI 10.2307/3546423; ZAMMIT C, 1994, VEGETATIO, V111, P1; ZAMMIT CA, 1988, VEGETATIO, V75, P175; ZEDLER PH, 1983, ECOLOGY, V64, P809, DOI 10.2307/1937204	69	0	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0250290	10.1371/journal.pone.0250290	http://dx.doi.org/10.1371/journal.pone.0250290			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129603	gold, Green Published			2022-12-26	WOS:000665475100002
J	Doke, M; Pendyala, G; Samikkannu, T				Doke, Mayur; Pendyala, Gurudutt; Samikkannu, Thangavel			Psychostimulants and opioids differentially influence the epigenetic modification of histone acetyltransferase and histone deacetylase in astrocytes	PLOS ONE			English	Article							COCAINE-INDUCED PLASTICITY; NUCLEUS-ACCUMBENS; SYNAPTIC PLASTICITY; UP-REGULATION; ACETYLATION; EXPRESSION; MEMORY; GENE; PHOSPHORYLATION; METHYLATION	Illicit drugs are known to affect central nervous system (CNS). Majorly psychostimulants such as cocaine, methamphetamine (METH) and opioids such as morphine are known to induce epigenetic changes of histone modifications and chromatin remodeling which are mediated by histone acetyltransferase (HAT) and histone deacetylase (HDAC). Aberrant changes in histone acetylation-deacetylation process further exacerbate dysregulation of gene expression and protein modification which has been linked with neuronal impairments including memory formation and synaptic plasticity. In CNS, astrocytes play a pivotal role in cellular homeostasis. However, the impact of psychostimulants and opioid mediated epigenetic changes of HAT/HADCs in astrocytes has not yet been fully elucidated. Therefore, we have investigated the effects of the psychostimulants and opioid on the acetylation-regulating enzymes- HAT and HDACs role in astrocytes. In this study, Class I and II HDACs and HATs gene expression, protein changes and global level changes of acetylation of H3 histones at specific lysines were analyzed. In addition, we have explored the neuroprotective "nootropic" drug piracetam were exposed with or without psychostimulants and opioid in the human primary astrocytes. Results revealed that psychostimulants and opioid upregulated HDAC1, HDAC4 and p300 expression, while HDAC5 and GCN5 expression were downregulated. These effects were reversed by piracetam coexposure. Psychostimulants and opioid exposure upregulated global acetylation levels of all H3Ks, except H3K14. These results suggest that psychostimulants and opioids differentially influence HATs and HDACs.	[Doke, Mayur; Samikkannu, Thangavel] Texas A&M Univ, Dept Pharmaceut Sci, Irma Lerma Rangel Coll Pharm, Kingsville, TX USA; [Pendyala, Gurudutt] Univ Nebraska Med Ctr, Dept Anesthesiol, Omaha, NE USA	Texas A&M University System; Texas A&M University Kingsville; University of Nebraska System; University of Nebraska Medical Center	Samikkannu, T (corresponding author), Texas A&M Univ, Dept Pharmaceut Sci, Irma Lerma Rangel Coll Pharm, Kingsville, TX USA.	thangavel@tamu.edu	DOKE, MAYUR/ABA-8020-2022	DOKE, MAYUR/0000-0002-7761-1251; Samikkannu, Thangavel/0000-0001-5071-056X	National Institute of Health (NIH)/National Institute of Drug Abuse (NIDA) [R01 DA044872]	National Institute of Health (NIH)/National Institute of Drug Abuse (NIDA)	The present study was supported by grants from National Institute of Health (NIH)/National Institute of Drug Abuse (NIDA): R01 DA044872 to S. Thangavel.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Altaf M, 2007, MUTAT RES-FUND MOL M, V618, P81, DOI 10.1016/j.mrfmmm.2006.09.009; Belanger Mireille, 2009, Dialogues Clin Neurosci, V11, P281; Cadet JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-545; Carlezon WA, 2005, TRENDS NEUROSCI, V28, P436, DOI 10.1016/j.tins.2005.06.005; Chen WS, 2016, BRAIN RES, V1652, P151, DOI 10.1016/j.brainres.2016.10.007; Dietrich JB, 2012, SYNAPSE, V66, P61, DOI 10.1002/syn.20988; Doke M, 2021, EPIGENETICS-US, V16, P980, DOI 10.1080/15592294.2020.1834919; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Egervari G, 2017, BIOL PSYCHIAT, V81, P585, DOI 10.1016/j.biopsych.2016.09.015; Fernandes S, 2015, TOXICOL LETT, V234, P131, DOI 10.1016/j.toxlet.2015.02.011; GIURGEA CE, 1982, DRUG DEVELOP RES, V2, P441, DOI 10.1002/ddr.430020505; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Herz HM, 2013, TRENDS BIOCHEM SCI, V38, P621, DOI 10.1016/j.tibs.2013.09.004; Hu XL, 2012, PROTEIN CELL, V3, P278, DOI 10.1007/s13238-012-2916-6; Jochems J, 2014, NEUROPSYCHOPHARMACOL, V39, P389, DOI 10.1038/npp.2013.207; Kennedy PJ, 2013, NAT NEUROSCI, V16, P434, DOI 10.1038/nn.3354; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Kim MS, 2012, J NEUROSCI, V32, P10879, DOI 10.1523/JNEUROSCI.2089-12.2012; Korzus E, 2004, NEURON, V42, P961, DOI 10.1016/j.neuron.2004.06.002; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Koyama Y, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00261; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Kurdistani SK, 2004, CELL, V117, P721, DOI 10.1016/j.cell.2004.05.023; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; LaPlant Q, 2011, HORM BEHAV, V59, P321, DOI 10.1016/j.yhbeh.2010.05.015; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Malvaez M, 2011, J NEUROSCI, V31, P16941, DOI 10.1523/JNEUROSCI.2747-11.2011; Martin TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034236; Mashayekhi FJ, 2012, NEUROCHEM RES, V37, P1517, DOI 10.1007/s11064-012-0746-9; Maze I, 2013, NEUROPSYCHOPHARMACOL, V38, P3, DOI 10.1038/npp.2012.124; Montagud-Romero S, 2016, PROG NEURO-PSYCHOPH, V70, P39, DOI 10.1016/j.pnpbp.2016.04.016; Nestler EJ, 2014, NEUROPHARMACOLOGY, V76, P259, DOI 10.1016/j.neuropharm.2013.04.004; Niedzielska E., 2014, HDB NEUROTOXICITY, P455, DOI [10.1007/978-1-4614-5836-4%5F179, DOI 10.1007/978-1-4614-5836-4%5F179]; Omonijo O, 2014, NEUROTOXICOLOGY, V45, P178, DOI 10.1016/j.neuro.2014.10.008; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Penrod RD, 2018, ADDICT BIOL, V23, P653, DOI 10.1111/adb.12522; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Quello Susan B, 2005, Sci Pract Perspect, V3, P13; Renthal W, 2008, TRENDS MOL MED, V14, P341, DOI 10.1016/j.molmed.2008.06.004; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Rivieccio MA, 2009, P NATL ACAD SCI USA, V106, P19599, DOI 10.1073/pnas.0907935106; Rogge GA, 2013, NEUROPSYCHOPHARMACOL, V38, P94, DOI 10.1038/npp.2012.154; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Samikkannu T, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00614; Sando R, 2012, CELL, V151, P821, DOI 10.1016/j.cell.2012.09.037; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt HD, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012047; Sheng J, 2011, NEUROREPORT, V22, P575, DOI 10.1097/WNR.0b013e328348e6aa; Shibasaki M, 2011, J NEUROCHEM, V118, P1056, DOI 10.1111/j.1471-4159.2011.07387.x; Sivalingam K, 2021, MOL NEUROBIOL, V58, P490, DOI 10.1007/s12035-020-02131-w; Sivalingam K, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10090611; Sleiman SF, 2009, EXPERT OPIN INV DRUG, V18, P573, DOI [10.1517/13543780902810345, 10.1517/13543780902810345 ]; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Timmermann S, 2001, CELL MOL LIFE SCI, V58, P728, DOI 10.1007/PL00000896; Torres OV, 2016, NEUROTOX RES, V30, P32, DOI 10.1007/s12640-015-9591-3; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; UNITED NATIONS, 2016, UN OFF DRUGS CRIM; Walker CD, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020297; Walker Deena M, 2018, Handb Clin Neurol, V148, P747, DOI 10.1016/B978-0-444-64076-5.00048-X; Wang YP, 2015, J MOL NEUROSCI, V55, P269, DOI 10.1007/s12031-014-0317-4; Wang ZW, 2014, EUR J PHARMACOL, V732, P123, DOI 10.1016/j.ejphar.2014.03.040; Wei L, 2016, BRAIN RES, V1646, P418, DOI 10.1016/j.brainres.2016.06.019; Winblad B, 2005, CNS DRUG REV, V11, P169; Xu WT, 1998, MOL CELL BIOL, V18, P5659, DOI 10.1128/MCB.18.10.5659; Zhang K, 2005, J CELL BIOCHEM, V96, P1137, DOI 10.1002/jcb.20615; Zhu YC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11409-0; Zhu YJ, 2017, J NEUROSCI, V37, P7547, DOI 10.1523/JNEUROSCI.3000-16.2017	71	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252895	10.1371/journal.pone.0252895	http://dx.doi.org/10.1371/journal.pone.0252895			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115777	gold, Green Published			2022-12-26	WOS:000664643000038
J	Inouye, S; Sumida, Y; Tomabechi, Y; Taguchi, J; Shirouzu, M; Hosoya, T				Inouye, Satoshi; Sumida, Yuto; Tomabechi, Yuri; Taguchi, Jumpei; Shirouzu, Mikako; Hosoya, Takamitsu			Chiral deaza-coelenterazine analogs for probing a substrate-binding site in the Ca2+-binding photoprotein aequorin	PLOS ONE			English	Article							BLUE FLUORESCENT PROTEIN; BIOLUMINESCENCE; APOAEQUORIN; REGENERATION; LUCIFERASE; OXIDATION	The Ca2+-binding photoprotein aequorin is a complex of apoAequorin (apoprotein) and (S)-2-peroxycoelenterazine. Aequorin can be regenerated by the incubation of apoAequorin with coelenterazine and molecular oxygen (O-2). In this study, to investigate the molecular recognition of apoAequorin for coelenterazine using chemical probes, the chiral deaza-analogs of (S)- and (R)-deaza-CTZ (daCTZ) for coelenterazine and of (S)-2- and (R)-2-hydroxymethyl-deaza-CTZ (HM-daCTZ) for 2-peroxycoelenterazine were efficiently prepared by the improvement method. The chiral deaza-analogs of (S)-daCTZ and (S)-HM-daCTZ selectively inhibited the regeneration step to aequorin by binding the catalytic site of coelenterazine in the apoAequorin molecule. The crystal structures of the apoAequorin complexes with (S)-daCTZ and (S)-HM-daCTZ were determined, suggesting that the hydroxy moiety at the C6-hydroxyphenyl group and the carbonyl moiety of the imidazopyrazinone ring in coelenterazine are essential to bind the apoAequorin molecule through hydrogen bonding. Therefore, the chiral deaza-analogs of coelenterazine can be used as a probe to study the interaction between coelenterazine and the related proteins including photoprotein, luciferase, and coelenterazine-binding protein.	[Inouye, Satoshi] JNC Co, Yokohama Res Ctr, Yokohama, Kanagawa, Japan; [Sumida, Yuto; Hosoya, Takamitsu] RIKEN, Ctr Biosyst Dynam Res BDR, Lab Chem Biol, Kobe, Hyogo, Japan; [Tomabechi, Yuri; Shirouzu, Mikako] RIKEN, Ctr Biosyst Dynam Res BDR, Lab Prot Funct & Struct Biol, Yokohama, Kanagawa, Japan; [Taguchi, Jumpei; Hosoya, Takamitsu] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Lab Chem Biosci, Tokyo, Japan; [Sumida, Yuto] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kanazawa, Ishikawa, Japan	RIKEN; RIKEN; Tokyo Medical & Dental University (TMDU); Kanazawa University	Inouye, S (corresponding author), JNC Co, Yokohama Res Ctr, Yokohama, Kanagawa, Japan.; Hosoya, T (corresponding author), RIKEN, Ctr Biosyst Dynam Res BDR, Lab Chem Biol, Kobe, Hyogo, Japan.; Hosoya, T (corresponding author), Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Lab Chem Biosci, Tokyo, Japan.	sinouye@jnc-corp.co.jp; thosoya.cb@tmd.ac.jp	Hosoya, Takamitsu/N-7762-2015	Hosoya, Takamitsu/0000-0002-7270-351X; Inouye, Satoshi/0000-0001-8732-7839; Tomabechi, Yuri/0000-0001-5208-163X; Taguchi, Jumpei/0000-0003-2337-9132				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Burakova LP, 2016, J PHOTOCH PHOTOBIO B, V162, P286, DOI 10.1016/j.jphotobiol.2016.06.054; Ding BW, 2017, J AM CHEM SOC, V139, P1106, DOI 10.1021/jacs.6b09119; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GOTO T, 1968, Pure and Applied Chemistry, V17, P421, DOI 10.1351/pac196817030421; Head JF, 2000, NATURE, V405, P372, DOI 10.1038/35012659; INOUYE S, 1985, P NATL ACAD SCI USA, V82, P3154, DOI 10.1073/pnas.82.10.3154; Inouye S, 2000, METHOD ENZYMOL, V326, P165; Inouye S, 2006, FEBS LETT, V580, P1977, DOI 10.1016/j.febslet.2006.02.065; Inouye S, 2004, FEBS LETT, V577, P105, DOI 10.1016/j.febslet.2004.09.078; Inouye S, 1997, BIOCHEM BIOPH RES CO, V233, P349, DOI 10.1006/bbrc.1997.6452; INOUYE S, 1986, BIOCHEMISTRY-US, V25, P8425, DOI 10.1021/bi00374a015; Inouye S, 2018, J BIOCHEM, V164, P247, DOI 10.1093/jb/mvy049; Inouye S, 2010, ANAL BIOCHEM, V407, P247, DOI 10.1016/j.ab.2010.08.025; Inouye S, 2009, BIOCHEM BIOPH RES CO, V386, P617, DOI 10.1016/j.bbrc.2009.06.094; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Liu ZJ, 2003, BIOCHEM BIOPH RES CO, V311, P433, DOI 10.1016/j.bbrc.2003.09.231; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nakamura H, 2001, J AM CHEM SOC, V123, P1523, DOI 10.1021/ja005663v; Nakamura H, 1997, TETRAHEDRON LETT, V38, P6405, DOI 10.1016/S0040-4039(97)01438-X; RIZZUTO R, 1992, NATURE, V358, P325, DOI 10.1038/358325a0; SHIMOMURA O, 1993, BIOCHEM J, V296, P549, DOI 10.1042/bj2960549; Shimomura O, 1999, PROTEIN EXPRES PURIF, V16, P91, DOI 10.1006/prep.1999.1049; SHIMOMURA O, 1975, NATURE, V256, P236, DOI 10.1038/256236a0; SHIMOMURA O, 1970, NATURE, V227, P1356, DOI 10.1038/2271356a0; Shimomura O, 2006, BIOLUMINESCENCE: CHEMICAL PRINCIPLES AND METHODS, P159, DOI 10.1142/9789812773647_0005; Titushin MS, 2010, J BIOL CHEM, V285, P40891, DOI 10.1074/jbc.M110.133843; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Wu C, 2001, TETRAHEDRON, V57, P9575, DOI 10.1016/S0040-4020(01)00980-2; Wu C, 2001, TETRAHEDRON LETT, V42, P2997, DOI 10.1016/S0040-4039(01)00340-9	30	2	2	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0251743	10.1371/journal.pone.0251743	http://dx.doi.org/10.1371/journal.pone.0251743			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115795	gold, Green Published			2022-12-26	WOS:000664643000013
J	Kimura, H; Sada, R; Takada, N; Harada, A; Doki, Y; Eguchi, H; Yamamoto, H; Kikuchi, A				Kimura, Hirokazu; Sada, Ryota; Takada, Naoki; Harada, Akikazu; Doki, Yuichiro; Eguchi, Hidetoshi; Yamamoto, Hideki; Kikuchi, Akira			The Dickkopf1 and FOXM1 positive feedback loop promotes tumor growth in pancreatic and esophageal cancers	ONCOGENE			English	Article							TRANSCRIPTION FACTOR; WNT; DKK1; LUNG; TARGET; GENE; CONTRIBUTES; SPECIFICITY; EXPRESSION; REGULATOR	Dickkopf1 (DKK1) is overexpressed in various cancers and promotes cancer cell proliferation by binding to cytoskeleton-associated protein 4 (CKAP4). However, the mechanisms underlying DKK1 expression are poorly understood. RNA sequence analysis revealed that expression of the transcription factor forkhead box M1 (FOXM1) and its target genes concordantly fluctuated with expression of DKK1 in pancreatic ductal adenocarcinoma (PDAC) cells. DKK1 knockdown decreased FOXM1 expression and vice versa in PDAC and esophageal squamous cell carcinoma (ESCC) cells. Inhibition of either the DKK1-CKAP4-AKT pathway or the ERK pathway suppressed FOXM1 expression, and simultaneous inhibition of both pathways showed synergistic effects. A FOXM1 binding site was identified in the 5MODIFIER LETTER PRIME-untranslated region of the DKK1 gene, and its depletion decreased DKK1 expression and cancer cell proliferation. Clinicopathological and database analysis revealed that PDAC and ESCC patients who simultaneously express DKK1 and FOXM1 have a poorer prognosis. Multivariate analysis demonstrated that expression of both DKK1 and FOXM1 is the independent prognostic factor in ESCC patients. Although it has been reported that FOXM1 enhances Wnt signaling, FOXM1 induced DKK1 expression independently of Wnt signaling in PDAC and ESCC cells. These results suggest that DKK1 and FOXM1 create a positive feedback loop to promote cancer cell proliferation.	[Kimura, Hirokazu; Sada, Ryota; Takada, Naoki; Harada, Akikazu; Yamamoto, Hideki; Kikuchi, Akira] Osaka Univ, Grad Sch Med, Dept Mol Biol & Biochem, Suita, Osaka, Japan; [Doki, Yuichiro; Eguchi, Hidetoshi] Osaka Univ, Grad Sch Med, Dept Gastroenterol Surg, Suita, Osaka, Japan	Osaka University; Osaka University	Kikuchi, A (corresponding author), Osaka Univ, Grad Sch Med, Dept Mol Biol & Biochem, Suita, Osaka, Japan.	akikuchi@molbiobc.med.osaka-u.ac.jp		Sada, Ryota/0000-0003-3403-0542; Kikuchi, Akira/0000-0003-3378-9522	Ministry of Education, Culture, Sports, Science and Technology of Japan [16H06374, 16H06944, 18K15064, 20K16330, 20K07311]; Japan Agency for Medical Research and development, AMED [18cm0106132h0001, 20cm0106152h0002]; Yasuda Memorial Foundation; Ichiro Kanehara Foundation of the Promotion of Medical Science Medical Care; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and development, AMED(Japan Agency for Medical Research and Development (AMED)); Yasuda Memorial Foundation; Ichiro Kanehara Foundation of the Promotion of Medical Science Medical Care; Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University	This work was supported by Grants-in-Aid for Scientific Research (2016-2021) (No. 16H06374) to AK, for Young Scientists (Start-up) (2016-2017) (No. 16H06944) to HK, for Early-Career Scientists (2018-2019) (No. 18K15064) to HK, for Early-Career Scientists (2020-2021) (No. 20K16330) to RS, for Scientific Research (C) (2020-2022) (No. 20K07311) to HY from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and also supported by the Project for Cancer Research And Therapeutic Evolution (P-CREATE) (2018) (18cm0106132h0001) and (2019-2021) (20cm0106152h0002) to AK from the Japan Agency for Medical Research and development, AMED, and by grants to AK from the Yasuda Memorial Foundation, the Ichiro Kanehara Foundation of the Promotion of Medical Science & Medical Care, and by Integrated Frontier Research for Medical Science Division, Institute for Open and Transdisciplinary Research Initiatives, Osaka University to AK.	Aguilera O, 2006, ONCOGENE, V25, P4116, DOI 10.1038/sj.onc.1209439; Aoyagi K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018196; Arensman MD, 2014, ONCOGENE, V33, P899, DOI 10.1038/onc.2013.23; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Eisinger-Mathason TSK, 2015, P NATL ACAD SCI USA, V112, pE3402, DOI 10.1073/pnas.1420005112; Gartel AL, 2017, CANCER RES, V77, P3135, DOI 10.1158/0008-5472.CAN-16-3566; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Golson ML, 2016, DEVELOPMENT, V143, P4558, DOI 10.1242/dev.112672; Haeberle L, 2019, TRANSL GASTROENT HEP, V4, DOI 10.21037/tgh.2019.06.02; Han SX, 2015, ONCOTARGET, V6, P19907, DOI 10.18632/oncotarget.4529; Haniu M, 2011, PROTEIN SCI, V20, P1802, DOI 10.1002/pro.705; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hussain M, 2009, CANCER RES, V69, P3570, DOI 10.1158/0008-5472.CAN-08-2807; Jiang XM, 2013, P NATL ACAD SCI USA, V110, P12649, DOI 10.1073/pnas.1307218110; Kagey MH, 2017, BRIT J PHARMACOL, V174, P4637, DOI 10.1111/bph.13894; Kajiwara C, 2018, CANCER RES, V78, P6107, DOI 10.1158/0008-5472.CAN-18-1749; Kikuchi A, 2017, BRIT J PHARMACOL, V174, P4651, DOI 10.1111/bph.13863; Kimura H, 2019, CLIN CANCER RES, V25, P1936, DOI 10.1158/1078-0432.CCR-18-2124; Kimura H, 2016, J CLIN INVEST, V126, P2689, DOI 10.1172/JCI84658; Korver W, 1997, NUCLEIC ACIDS RES, V25, P1715, DOI 10.1093/nar/25.9.1715; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Ma RYM, 2005, J CELL SCI, V118, P795, DOI 10.1242/jcs.01657; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mikheev AM, 2008, BREAST CANCER RES TR, V112, P263, DOI 10.1007/s10549-007-9867-2; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Park HJ, 2009, EMBO J, V28, P2908, DOI 10.1038/emboj.2009.239; Peters CJ, 2010, GASTROENTEROLOGY, V139, P1995, DOI 10.1053/j.gastro.2010.05.080; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Renz BW, 2018, CANCER CELL, V33, P75, DOI 10.1016/j.ccell.2017.11.007; Rustgi AK, 2014, NEW ENGL J MED, V371, P2499, DOI 10.1056/NEJMra1314530; Sada R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aat9519; Sakane H, 2010, J CELL SCI, V123, P360, DOI 10.1242/jcs.058008; Shinno N, 2018, ONCOGENE, V37, P3471, DOI 10.1038/s41388-018-0179-2; Suzuki R, 2007, BRIT J HAEMATOL, V138, P624, DOI 10.1111/j.1365-2141.2007.06702.x; Wang IC, 2014, ONCOGENE, V33, P5391, DOI 10.1038/onc.2013.475; Yamabuki T, 2007, CANCER RES, V67, P2517, DOI 10.1158/0008-5472.CAN-06-3369; Yamamoto H, 2008, DEV CELL, V15, P37, DOI 10.1016/j.devcel.2008.04.015; Yoshida Y, 2007, GASTROENTEROLOGY, V132, P1420, DOI 10.1053/j.gastro.2007.01.036; Zhang H, 2016, TUMOR BIOL, V37, P11321, DOI 10.1007/s13277-016-4995-0; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhang YQ, 2013, CANCER RES, V73, P4909, DOI 10.1158/0008-5472.CAN-12-4384	45	7	7	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2021	40	26					4486	4502		10.1038/s41388-021-01860-z	http://dx.doi.org/10.1038/s41388-021-01860-z		JUN 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TC8LA	34117362	Green Published, hybrid			2022-12-26	WOS:000660409400002
J	Gyasi, RM; Frimpong, S; Amoako, GK; Adam, AM				Gyasi, Razak M.; Frimpong, Siaw; Amoako, Gilbert Kwabena; Adam, Anokye M.			Financial inclusion and physical health functioning among aging adults in the sub-Saharan African context: Exploring social networks and gender roles	PLOS ONE			English	Article							SELF-RATED HEALTH; IMPACT; EMPOWERMENT; IMPAIRMENT; BENEFITS; SERVICES	Background It remains poorly understood how financial inclusion influences physical health functioning in later life in sub-Saharan African context and whether the association differs by gender and social relationships. We aim 1) to examine the associations of financial inclusion with functional impairment during older age in Ghana; and 2) to evaluate whether gender and social networks modify this association. Methods The cross-sectional analyses are based on a sample (N = 1,201) of study participants aged 50 years and over (M = 66.5 years, SD = 11.9, 63.3% female) deriving from the 2016-2017 AgeHeaPsyWel-HeaSeeB Study. Ordinary least squares (OLS) regression analyses with interactions were performed to estimate the link between financial inclusion and functional health and how the association is modified by gender and older age social networks. Results The mean financial inclusion score was 1.66 (SD = 1.74) in women and 2.33 (SD = 1.82) in men whilst mean activities of daily living (ADL) score was 13.03 (SD = 4.99) and 14.85 (SD = 5.06) in women and men respectively. We found that financial inclusion was associated with decreases in ADL (total sample: beta = -.548, p < .001; women: <beta> = -.582, p < .001; men: <beta> = -1.082 p < .001) and instrumental ADL (IADL) (total sample: <beta> = -.359, p = .034; women: beta = -.445, p = .026 but not in men). Social networks significantly moderated the association of financial inclusion with ADL such that the financially included who were embedded in a stronger constellation of social networks were 6% less likely to report ADL impairment compared to those with weaker social networks (beta = -.062, p = .025). Conclusions The study provides empirical evidence for a better understanding of the association between financial inclusion and physical health functioning in the context of later life social networks. Interventions for functional health through financial inclusion in sub-Saharan Africa should include improving interpersonal and social networks for older adult and also through gender lenses.	[Gyasi, Razak M.] African Populat & Hlth Res Ctr APHRC, Nairobi, Kenya; [Frimpong, Siaw; Adam, Anokye M.] Univ Cape Coast, Sch Business, Dept Finance, Cape Coast, Ghana; [Amoako, Gilbert Kwabena] Kumasi Tech Univ, Dept Accountancy & Accounting Informat Syst, Kumasi, Ghana	African Population & Health Research Centre; University of Cape Coast	Gyasi, RM (corresponding author), African Populat & Hlth Res Ctr APHRC, Nairobi, Kenya.	RGyasi@aphrc.org	Frimpong, Siaw/AEO-6397-2022; Gyasi, Razak M/V-2309-2018; Adam, Anokye Mohammed/L-5818-2019	Gyasi, Razak M/0000-0002-6733-1539; Adam, Anokye Mohammed/0000-0003-3830-1186; Amoako, Dr Gilbert Kwabena/0000-0002-8428-5212	Lingnan University, Hong Kong [RPG 1129310]	Lingnan University, Hong Kong	This work was supported by Lingnan University, Hong Kong [RPG 1129310] to RMG (https://www.ln.edu.hk/about-lu/introducinglingnan).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott S, 2006, HEALTH SOC CARE COMM, V14, P1, DOI 10.1111/j.1365-2524.2005.00582.x; Agrigoroaei S, 2017, RES AGING, V39, P1075, DOI 10.1177/0164027516658502; Aguila E, 2016, ECON LETT, V144, P41, DOI 10.1016/j.econlet.2016.04.013; Aguila E, 2015, P NATL ACAD SCI USA, V112, P70, DOI 10.1073/pnas.1414453112; Allmark P, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1589-5; Allmark P, 2013, HEALTH SOC CARE COMM, V21, P59, DOI 10.1111/j.1365-2524.2012.01087.x; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P33; Atkinson A., 2008, EVIDENCE IMPACT OVER; Babych Y, 2018, 849 ADBI; Bank World., 2016, GHAN ACC FIN NOT; Das PJ, 2022, EDUC PRIM CARE, DOI 10.1080/14739879.2022.2137856; Demirguc-Kunt A., 2018, GLOBAL FINDEX DATABA; Duvendack M, 2019, CAMPBELL SYST REV, V15, DOI 10.4073/csr.2019.2; Finkelstein A, 2012, Q J ECON, V127, P1057, DOI 10.1093/qje/qjs020; GEIGER M., 2019, ARXIV190608034; Grohmann A, 2018, WORLD DEV, V111, P84, DOI 10.1016/j.worlddev.2018.06.020; Gyasi R. M, 2018, THESIS LINGNAN U; Gyasi RM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229840; Gyasi RM, 2021, J APPL GERONTOL, V40, P189, DOI 10.1177/0733464820907441; Gyasi RM, 2020, GERONTOLOGIST, V60, P416, DOI 10.1093/geront/gnz052; Gyasi RM, 2019, RES AGING, V41, P794, DOI 10.1177/0164027519846604; Gyasi RM, 2019, WOMEN HEALTH, V59, P1089, DOI 10.1080/03630242.2019.1587666; Gyasi RM, 2018, ARCH GERONTOL GERIAT, V77, P174, DOI 10.1016/j.archger.2018.05.010; Hageman SA, 2019, SOC WORK PUBLIC HLTH, V34, P176, DOI 10.1080/19371918.2019.1575310; Hajek A, 2017, AGE AGEING, V46, P813, DOI 10.1093/ageing/afx012; Hamad R, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0194-7; Han SH, 2021, J GERONTOL B-PSYCHOL, V76, P360, DOI 10.1093/geronb/gbz161; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kim YD, 2017, INT J STROKE, V12, P869, DOI 10.1177/1747493017694389; Krause N, 2011, J GERONTOL B-PSYCHOL, V66, P207, DOI 10.1093/geronb/gbq086; Lwanga S.K., 1991, SIZE ESTIMATION HLTH; McCracken K, 2017, GLOBALIZATION HEALTH, V2nd; Morrow-Howell N, 2014, FINANCIAL CAPABILITY; Nussbaum M.C., 2011, CREATING CAPABILITIE; Orton L, 2016, B WORLD HEALTH ORGAN, V94, P694, DOI 10.2471/BLT.15.168252; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; Pearlin LI, 1996, GERONTOLOGIST, V36, P239, DOI 10.1093/geront/36.2.239; Raj A, 2018, SOC SCI MED, V196, P197, DOI 10.1016/j.socscimed.2017.11.042; Sarma M, 2011, J INT DEV, V23, P613, DOI 10.1002/jid.1698; Schneekloth U, 1993, POTENTIALS LIMITATIO; Shankar A, 2013, PSYCHOSOM MED, V75, P161, DOI 10.1097/PSY.0b013e31827f09cd; Stoeckel KJ, 2016, INT PSYCHOGERIATR, V28, P39, DOI 10.1017/S1041610215000538; Taylor M., 2009, OCCASIONAL PAPERS SE; Tevfik Bedirhan., 2010, MEASURING HLTH DISAB; Tomas MT, 2018, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00244; United Nations, 2015, TRANSF OUR WORLD 203; UNSGSA, 2019, UNSGSA ANN REP 2019; World Bank, 2018, FINANCIAL INCLUSION	48	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252007	10.1371/journal.pone.0252007	http://dx.doi.org/10.1371/journal.pone.0252007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111127	Green Published, gold			2022-12-26	WOS:000664642700016
J	Wakai, E; Ikemura, K; Kato, C; Okuda, M				Wakai, Eri; Ikemura, Kenji; Kato, Chika; Okuda, Masahiro			Effect of number of medications and complexity of regimens on medication adherence and blood pressure management in hospitalized patients with hypertension	PLOS ONE			English	Article							RISK-FACTORS; POLYPHARMACY; JAPAN	Introduction Good adherence of antihypertensives is recommended for the accomplishment of hypertension therapy. The number of medications and characteristics contributing to medication regimen complexity, such as dosage forms and dosing frequency, are known to influence medication adherence. However, the effect of medication regimen complexity on the therapeutic efficacy of medicines remains to be clarified. In the present study, we retrospectively investigated the effect of number of medications and medication regimen complexity on medication adherence and therapeutic efficacy in patients with hypertension. Methods According to the inclusion and exclusion criteria, 1,057 patients, who were on medications including antihypertensives on admission at the Mie University Hospital between July 2018 and December 2018, were enrolled in this study. Poor blood pressure management was defined if the systolic or diastolic blood pressure were >= 140 mmHg or >= 90 mmHg. Medication regimen complexity was quantified using the medication regimen complexity index (MRCI) score. Results Among 1,057 patients, 164 and 893 patients were categorized into poor and good adherence groups, respectively. The multivariate analyses revealed that age >= 71 years and oral MRCI score >= 19.5 but not number of oral medications were extracted as risk factors for poor medication adherence. Medication adherence and blood pressure management were poor in the group with oral MRCI score >= 19.5, regardless of the age. The rate of readmission was similar. Conclusion Our study is the first to demonstrate that medication regimen complexity rather than number of medications is closely related to medication adherence and blood pressure management. Hence, physicians and/or pharmacists should consider the complexity of medication regimens while modifying them.	[Wakai, Eri] Mie Univ, Grad Sch Med, Dept Integrat Pharmacol, Tsu, Mie, Japan; [Ikemura, Kenji; Okuda, Masahiro] Osaka Univ Hosp, Dept Pharm, Suita, Osaka, Japan; [Kato, Chika] Mie Univ Hosp, Dept Pharm, Tsu, Mie, Japan	Mie University; Osaka University; Mie University	Ikemura, K (corresponding author), Osaka Univ Hosp, Dept Pharm, Suita, Osaka, Japan.	ikemurak@hp-drug.med.osaka-u.ac.jp		Ikemura, Kenji/0000-0003-1870-9571	Japan Society for the Promotion of Science [20H01033]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by a Grant-inAid for Encouragement of Scientists [Grant 20H01033] from the Japan Society for the Promotion of Science.	Abou-Karam N, 2016, SAGE OPEN MED, V4, DOI 10.1177/2050312116632426; Alves-Conceicao V, 2018, ANN PHARMACOTHER, V52, P1117, DOI 10.1177/1060028018773691; Appel LJ, 2017, CARDIOL CLIN, V35, P197, DOI 10.1016/j.ccl.2016.12.002; Briasoulis A, 2012, J CLIN HYPERTENS, V14, P792, DOI 10.1111/jch.12008; Burnier M, 2019, CIRC RES, V124, P1124, DOI 10.1161/CIRCRESAHA.118.313220; Cobretti MR, 2017, CLIN INTERV AGING, V12, P679, DOI 10.2147/CIA.S130832; Curtin D, 2019, EUR J CLIN PHARMACOL, V75, P427, DOI 10.1007/s00228-018-2598-y; Formica M, 2018, BLOOD PURIFICAT, V46, P332, DOI 10.1159/000492149; Garcia-Perez L, 2011, QJM-INT J MED, V104, P639, DOI 10.1093/qjmed/hcr070; George J, 2004, ANN PHARMACOTHER, V38, P1369, DOI 10.1345/aph.1D479; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Huai PC, 2013, HYPERTENSION, V62, P1021, DOI 10.1161/HYPERTENSIONAHA.113.01965; Kim J, 2017, NURS CLIN N AM, V52, P457, DOI 10.1016/j.cnur.2017.04.007; Kojima T, 2016, GERIATR GERONTOL INT, V16, P983, DOI 10.1111/ggi.12890; Kojima T, 2012, GERIATR GERONTOL INT, V12, P425, DOI 10.1111/j.1447-0594.2011.00783.x; Kose Eiji, 2016, J Aging Res, V2016, P7957825, DOI 10.1155/2016/7957825; Mansur N, 2012, AM J GERIATR PHARMAC, V10, P223, DOI 10.1016/j.amjopharm.2012.06.002; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Moraes-Silva IC, 2017, ADV EXP MED BIOL, V1000, P65, DOI 10.1007/978-981-10-4304-8_5; Nyamdorj R, 2008, OBESITY, V16, P1622, DOI 10.1038/oby.2008.73; Ohkubo T, 2004, HYPERTENS RES, V27, P755, DOI 10.1291/hypres.27.755; Parker K, 2019, HEMODIAL INT, V23, P333, DOI 10.1111/hdi.12739; Toba K, 1999, Nihon Ronen Igakkai Zasshi, V36, P181; Umemura S, 2019, HYPERTENS RES, V42, P1235, DOI 10.1038/s41440-019-0284-9; Wetzels GEC, 2004, J HYPERTENS, V22, P1849, DOI 10.1097/00004872-200410000-00002; Yukawa E, 1999, Am J Ther, V6, P71, DOI 10.1097/00045391-199903000-00003	26	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252944	10.1371/journal.pone.0252944	http://dx.doi.org/10.1371/journal.pone.0252944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111189	Green Published, gold			2022-12-26	WOS:000664642700070
J	Bebi, C; Turetti, M; Lievore, E; Ripa, F; Rocchini, L; Spinelli, MG; De Lorenzis, E; Albo, G; Longo, F; Gadda, F; Dell'Orto, PG; Salonia, A; Montanari, E; Boeri, L				Bebi, Carolina; Turetti, Matteo; Lievore, Elena; Ripa, Francesco; Rocchini, Lorenzo; Spinelli, Matteo Giulio; De Lorenzis, Elisa; Albo, Giancarlo; Longo, Fabrizio; Gadda, Franco; Dell'Orto, Paolo Guido; Salonia, Andrea; Montanari, Emanuele; Boeri, Luca			Bipolar Transurethral Enucleation of the Prostate: Is it a size-independent endoscopic treatment option for symptomatic benign prostatic hyperplasia?	PLOS ONE			English	Article							HOLMIUM LASER ENUCLEATION; PLASMAKINETIC ENUCLEATION; HYPERTROPHY TREATMENT; PLASMA ENUCLEATION; LEARNING-CURVE; OUTCOMES; MORBIDITY; RESECTION; TERM	Background Bipolar Transurethral Enucleation of the Prostate (B-TUEP) is recommended as a first-choice treatment for benign prostatic obstruction in prostates >80 ml. Differently, B-TUEP is only considered as an alternative option after TURP for smaller prostates (30-80 ml). The aim of our study is to assess the relation between prostate size and surgical outcomes after B-TUEP. Methods We performed a retrospective analysis of data collected from 172 patients submitted to B-TUEP. Patients were segregated according to tertiles of prostate volume (PV) (<= 60 ml, 61-110 ml, >110 ml). For each group we evaluated enucleation efficacy (enucleated weight/enucleation time), complication rates, urinary and sexual function parameters. Functional and sexual parameters were compared between groups at baseline, 1 and 3 months follow up. Descriptive statistics and linear and logistic regression models tested the association between PV and postoperative complications/outcomes. Results Operative time and weight of enucleated adenomas increased along with prostate volumes (all p <= 0.01). Enucleation efficacy was higher in men with PV >110 ml compared to other groups (p <= 0.001). Length of hospital stay, catheterization time and rates of postoperative complications, such as transfusion and clot evacuation rates and bladder neck/urethral strictures, were comparable between groups. Urinary symptoms improved at 1-and 3-months in each group as compared to baseline evaluation (all p<0.01) but they did not differ according to PV. In each group maximum urinary flow and post-void residual volume significantly improved at 3 months compared to baseline (all p<less than or equal to>0.01), without differences according to PV. Sexual symptoms were similar between groups at each follow up assessment. At multivariable linear and logistic regression analysis, prostate volume was not associated with postoperative functional outcomes and complications. Conversely, patient's comorbid status and antiplatelet/anticoagulation use were independently associated with postoperative complications. Conclusion According to our findings, B-TUEP should be considered a "size independent procedure" as it can provide symptom relief in men with prostates of all sizes with the same efficacy and safety profile.	[Bebi, Carolina; Turetti, Matteo; Lievore, Elena; Ripa, Francesco; Rocchini, Lorenzo; Spinelli, Matteo Giulio; De Lorenzis, Elisa; Albo, Giancarlo; Longo, Fabrizio; Gadda, Franco; Dell'Orto, Paolo Guido; Montanari, Emanuele; Boeri, Luca] Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Dept Urol, Milan, Italy; [De Lorenzis, Elisa; Montanari, Emanuele] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Salonia, Andrea] IRCCS Osped San Raffaele, Div Expt Oncol, Unit Urol, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Boeri, L (corresponding author), Univ Milan, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Dept Urol, Milan, Italy.	dr.lucaboeri@gmail.com	Boeri, Luca/AAC-4848-2022; MONTANARI, EMANUELE/I-8034-2015	MONTANARI, EMANUELE/0000-0002-3586-666X; de lorenzis, elisa/0000-0002-5961-9874				Badia X, 1997, EUR UROL, V31, P129; Bebi C, 2022, INT J IMPOT RES, V34, P71, DOI 10.1038/s41443-020-00366-8; Boeri L, 2020, EUR UROL FOCUS, V6, P720, DOI 10.1016/j.euf.2019.03.002; Briganti A, 2006, J UROLOGY, V175, P1817, DOI 10.1016/S0022-5347(05)00983-3; Capogrosso P, 2016, INT J IMPOT RES, V28, P189, DOI 10.1038/ijir.2016.29; Carmignani L, 2015, ASIAN J ANDROL, V17, P802, DOI 10.4103/1008-682X.139255; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SS, 2018, KAOHSIUNG J MED SCI, V34, P576, DOI 10.1016/j.kjms.2018.03.001; Chen SS, 2014, EUR UROL, V66, P284, DOI 10.1016/j.eururo.2014.01.010; D'Elia Carolina, 2012, Arch Ital Urol Androl, V84, P197; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Geavlete B, 2013, BJU INT, V111, P793, DOI 10.1111/j.1464-410X.2012.11730.x; Giulianelli R, 2019, J ENDOUROL, V33, P396, DOI 10.1089/end.2019.0050; Giulianelli R, 2017, UROLOGY, V107, P190, DOI 10.1016/j.urology.2017.05.021; Giulianelli R, 2015, UROLOGY, V86, P407, DOI 10.1016/j.urology.2015.03.045; Hirasawa Y, 2017, J ENDOUROL, V31, P679, DOI 10.1089/end.2017.0092; Humphreys MR, 2008, J UROLOGY, V180, P2431, DOI 10.1016/j.juro.2008.08.019; Jeong CW, 2012, INT BRAZ J UROL, V38, P362, DOI 10.1590/S1677-55382012000300009; Kim M, 2013, KOREAN J UROL, V54, P570, DOI 10.4111/kju.2013.54.9.570; Kuntz RM, 2004, J ENDOUROL, V18, P183, DOI 10.1089/089277904322959842; Mallikarjuna C, 2018, INDIAN J UROL, V34, P219, DOI 10.4103/iju.IJU_71_16; Mu XN, 2017, ASIAN J ANDROL, V19, P608, DOI 10.4103/1008-682X.178484; Netsch C, 2014, UROL INT, V93, P22, DOI 10.1159/000355105; Professionals S-O, EAU GUIDELINES MANAG; Reich O, 2008, J UROLOGY, V180, P246, DOI 10.1016/j.juro.2008.03.058; Seki N, 2007, J ENDOUROL, V21, P192, DOI 10.1089/end.2006.0123; Shah HN, 2008, BJU INT, V101, P1536, DOI 10.1111/j.1464-410X.2007.07434.x; Tubaro A, 2006, BJU INT, V97, P101, DOI 10.1111/j.1464-410X.2006.05885.x; Uchida T, 1999, UROLOGY, V53, P98, DOI 10.1016/S0090-4295(98)00524-X; Ugolini V., 2005, GIMSER, V12, P215; Yalcin S, 2020, TURK J UROL, V46, P219, DOI 10.5152/tud.2020.19235; Zhu LF, 2013, J UROLOGY, V189, P1427, DOI 10.1016/j.juro.2012.10.117	32	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0253083	10.1371/journal.pone.0253083	http://dx.doi.org/10.1371/journal.pone.0253083			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106986	Green Published, gold			2022-12-26	WOS:000664642200071
J	Kumakamba, C; Niama, FR; Muyembe, F; Mombouli, JV; Kingebeni, PM; Nina, RA; Lukusa, IN; Bounga, G; N'Kawa, F; Nkoua, CG; Losoma, JA; Mulembakani, P; Makuwa, M; Tamufe, U; Gillis, A; LeBreton, M; Olson, SH; Cameron, K; Reed, P; Ondzie, A; Tremeau-Bravard, A; Smith, BR; Pante, J; Schneider, BS; McIver, DJ; Ayukekbong, JA; Hoff, NA; Rimoin, AW; Laudisoit, A; Monagin, C; Goldstein, T; Joly, DO; Saylors, K; Wolfe, ND; Rubin, EM; MPassi, RB; Tamfum, JJM; Lange, CE				Kumakamba, Charles; Niama, Fabien R.; Muyembe, Francisca; Mombouli, Jean-Vivien; Kingebeni, Placide Mbala; Nina, Rock Aime; Lukusa, Ipos Ngay; Bounga, Gerard; N'Kawa, Frida; Nkoua, Cynthia Goma; Losoma, Joseph Atibu; Mulembakani, Prime; Makuwa, Maria; Tamufe, Ubald; Gillis, Amethyst; LeBreton, Matthew; Olson, Sarah H.; Cameron, Kenneth; Reed, Patricia; Ondzie, Alain; Tremeau-Bravard, Alex; Smith, Brett R.; Pante, Jasmine; Schneider, Bradley S.; McIver, David J.; Ayukekbong, James A.; Hoff, Nicole A.; Rimoin, Anne W.; Laudisoit, Anne; Monagin, Corina; Goldstein, Tracey; Joly, Damien O.; Saylors, Karen; Wolfe, Nathan D.; Rubin, Edward M.; MPassi, Romain Bagamboula; Tamfum, Jean J. Muyembe; Lange, Christian E.			Coronavirus surveillance in wildlife from two Congo basin countries detects RNA of multiple species circulating in bats and rodents	PLOS ONE			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; FRUIT BAT; SARS-LIKE; IDENTIFICATION; TRANSMISSION; PNEUMONIA; OUTBREAK; MARKET; VIRUS	Coronaviruses play an important role as pathogens of humans and animals, and the emergence of epidemics like SARS, MERS and COVID-19 is closely linked to zoonotic transmission events primarily from wild animals. Bats have been found to be an important source of coronaviruses with some of them having the potential to infect humans, with other animals serving as intermediate or alternate hosts or reservoirs. Host diversity may be an important contributor to viral diversity and thus the potential for zoonotic events. To date, limited research has been done in Africa on this topic, in particular in the Congo Basin despite frequent contact between humans and wildlife in this region. We sampled and, using consensus coronavirus PCR-primers, tested 3,561 wild animals for coronavirus RNA. The focus was on bats (38%), rodents (38%), and primates (23%) that posed an elevated risk for contact with people, and we found coronavirus RNA in 121 animals, of which all but two were bats. Depending on the taxonomic family, bats were significantly more likely to be coronavirus RNA-positive when sampled either in the wet (Pteropodidae and Rhinolophidae) or dry season (Hipposideridae, Miniopteridae, Molossidae, and Vespertilionidae). The detected RNA sequences correspond to 15 alpha- and 6 betacoronaviruses, with some of them being very similar (>95% nucleotide identities) to known coronaviruses and others being more unique and potentially representing novel viruses. In seven of the bats, we detected RNA most closely related to sequences of the human common cold coronaviruses 229E or NL63 (>80% nucleotide identities). The findings highlight the potential for coronavirus spillover, especially in regions with a high diversity of bats and close human contact, and reinforces the need for ongoing surveillance.	[Kumakamba, Charles; Muyembe, Francisca; Kingebeni, Placide Mbala; Lukusa, Ipos Ngay; N'Kawa, Frida; Losoma, Joseph Atibu; Mulembakani, Prime; Makuwa, Maria] Metabiota Inc, Kinshasa, DEM REP CONGO; [Niama, Fabien R.; Mombouli, Jean-Vivien; Nkoua, Cynthia Goma] Natl Lab Publ Hlth, Brazzaville, Rep Congo; [Nina, Rock Aime] Minist Agr & Livestock, Brazzaville, Rep Congo; [Bounga, Gerard; Olson, Sarah H.; Cameron, Kenneth; Reed, Patricia; Ondzie, Alain; Joly, Damien O.] Wildlife Conversat Soc, Bronx, NY USA; [Makuwa, Maria; Saylors, Karen; Lange, Christian E.] Labyringth Global Hlth, St Petersburg, FL 33704 USA; [Tamufe, Ubald] Metabiota Cameroon Ltd, Yaounde, Centre, Cameroon; [Gillis, Amethyst; Schneider, Bradley S.; Monagin, Corina; Saylors, Karen; Wolfe, Nathan D.; Rubin, Edward M.] Metabiota Inc, San Francisco, CA USA; [LeBreton, Matthew] Mosaic, Yaounde, Centre, Cameroon; [Tremeau-Bravard, Alex; Smith, Brett R.; Pante, Jasmine; Monagin, Corina; Goldstein, Tracey] Univ Calif Davis, Sch Vet Med, One Hlth Inst, Davis, CA 95616 USA; [McIver, David J.; Ayukekbong, James A.; Joly, Damien O.; Lange, Christian E.] Metabiota Inc, Nanaimo, BC, Canada; [Hoff, Nicole A.; Rimoin, Anne W.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Laudisoit, Anne] EcoHlth Alliance, New York, NY USA; [MPassi, Romain Bagamboula] Minist Natl Def, Brazzaville, Rep Congo; [Tamfum, Jean J. Muyembe] Inst Natl Rech Biomed, Kinshasa, DEM REP CONGO; [Gillis, Amethyst] Dev Alternat Inc, Washington, DC USA; [Cameron, Kenneth] US Fish & Wildlife Serv, Baileys Crossroads, VA USA; [Schneider, Bradley S.] Etiologic, Oakland, CA USA; [Schneider, Bradley S.] Pinpoint Sci, San Francisco, CA USA; [McIver, David J.] Univ Calif San Francisco, Inst Global Hlth Sci, San Francisco, CA 94143 USA; [Ayukekbong, James A.] Southbridge Care, Cambridge, ON, Canada; [Joly, Damien O.] British Columbia Minist Environm & Climate Change, Victoria, BC, Canada	University of California System; University of California Davis; University of California System; University of California Los Angeles; EcoHealth Alliance; Institute Nacional de Recherche Biomedical; United States Department of the Interior; US Fish & Wildlife Service; University of California System; University of California San Francisco	Lange, CE (corresponding author), Labyringth Global Hlth, St Petersburg, FL 33704 USA.; Lange, CE (corresponding author), Metabiota Inc, Nanaimo, BC, Canada.	clange_virology@gmx.de	Hoff, Nicole/ABE-9171-2021; LAUDISOIT, Anne/G-8040-2016	LAUDISOIT, Anne/0000-0001-7626-9426	United States Agency for International Development [GHN-A-OO-09-00010-00, AID-OAA-A-14-00102]	United States Agency for International Development(United States Agency for International Development (USAID))	The PREDICT Consortium (https://ohi.vetmed.ucdavis.edu/programs-projects/predictproject/authorship) received awards GHN-A-OO-09-00010-00 and AID-OAA-A-14-00102 from the United States Agency for International Development (https://www.usaid.gov).The contributions to/work on this manuscript of all listed authors were/was funded exclusively through these awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akem ES, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08460-8; Allen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00923-8; Anthony SJ, 2017, VIRUS EVOL, V3, DOI 10.1093/ve/vex012; Ayukekbong JA., 2020, WORLD J CLIN INFECT, V10, P1, DOI [10.5495/wjcid.v10.i1.1, DOI 10.5495/WJCID.V10.I1.1]; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Corman VM, 2015, J VIROL, V89, P11858, DOI 10.1128/JVI.01755-15; Corman VM, 2014, J VIROL, V88, P11297, DOI 10.1128/JVI.01498-14; Crossley BM, 2012, VIRUSES-BASEL, V4, P3689, DOI 10.3390/v4123689; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; FAYENUWO JO, 1974, J MAMMAL, V55, P453, DOI 10.2307/1379016; Geldenhuys M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194527; Geldenhuys M, 2013, VECTOR-BORNE ZOONOT, V13, P516, DOI 10.1089/vbz.2012.1101; Huynh J, 2012, J VIROL, V86, P12816, DOI 10.1128/JVI.00906-12; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kamins AO, 2011, BIOL CONSERV, V144, P3000, DOI 10.1016/j.biocon.2011.09.003; Kan B, 2005, J VIROL, V79, P11892, DOI 10.1128/JVI.79.18.11892-11900.2005; King A. M., 2012, VIRUS TAXONOMY CLASS; Kingdon J, 2005, KINGDON FIELD GUIDE; Lau SKP, 2012, J VIROL, V86, P11906, DOI 10.1128/JVI.01305-12; Leopardi S, 2018, INFECT GENET EVOL, V58, P279, DOI 10.1016/j.meegid.2018.01.012; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; Maganga GD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64159-1; Markotter W, 2019, TROP MED INFECT DIS, V4, DOI 10.3390/tropicalmed4030099; Masters P, 2013, FIELDS VIROLOGY, P825; Monadjem A., 2015, RODENTS SUBSAHARAN A; Monadjem A., 2010, BATS CENTRAL SO AFRI; Montecino-Latorre D, 2020, ONE HEALTH OUTLOOK, V2, DOI 10.1186/s42522-019-0008-8; Nziza J, 2020, ECOHEALTH, V17, P152, DOI 10.1007/s10393-019-01458-8; Patrono LV, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0121-2; Pfefferle S, 2009, EMERG INFECT DIS, V15, P1377, DOI 10.3201/eid1509.090224; Quan PL, 2010, MBIO, V1, DOI 10.1128/mBio.00208-10; Razanajatovo NH, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0271-y; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sabir JSM, 2016, SCIENCE, V351, P81, DOI 10.1126/science.aac8608; Seimon TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118543; Tao Y, 2012, VIRUS RES, V167, P67, DOI 10.1016/j.virusres.2012.04.007; Tong SX, 2009, EMERG INFECT DIS, V15, P482, DOI 10.3201/eid1503.081013; van Vliet N, 2017, ECOL SOC, V22, DOI [10.5751/ES-09780-220435, 10.5751/es-09780-220435]; van Vliet N, 2012, ORYX, V46, P196, DOI 10.1017/S0030605311000202; Voigt CC., 2016, ROLES TAXONOMY SYSTE; Wang N, 2018, VIROL SIN, V33, P104, DOI 10.1007/s12250-018-0012-7; Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Yip CW, 2009, INFECT GENET EVOL, V9, P1185, DOI 10.1016/j.meegid.2009.09.015; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	48	5	5	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0236971	10.1371/journal.pone.0236971	http://dx.doi.org/10.1371/journal.pone.0236971			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106949	gold, Green Published			2022-12-26	WOS:000664642200002
J	Liu, WB; Huang, YS; Wang, DD; Han, F; Chen, HQ; Chen, JP; Jiang, X; Cao, J; Liu, JY				Liu, Wenbin; Huang, Yongsheng; Wang, Dandan; Han, Fei; Chen, Hongqiang; Chen, Jianping; Jiang, Xiao; Cao, Jia; Liu, Jinyi			MPDZ as a novel epigenetic silenced tumor suppressor inhibits growth and progression of lung cancer through the Hippo-YAP pathway	ONCOGENE			English	Article							DNA METHYLATION; BREAST-CANCER; YAP/TAZ; MUPP1; PROTEIN; HYPERMETHYLATION; INACTIVATION; ANGIOMOTIN; DIAGNOSIS; PROGNOSIS	MPDZ also named MUPP1 is involved in signal transduction mediated by the formation of protein complexes. However, the expression regulation, clinical significance, potential function, and mechanism of this gene in lung cancer remain unclear. Methylation status of MPDZ was measured by methylation-specific PCR and bisulfite genomic sequencing. Kaplan-Meier and Cox regression analyses were performed to identify the prognostic value of MPDZ. The tumor suppressing effects of MPDZ were determined in vitro and in vivo. The target molecules and signaling pathway that mediated the function of MPDZ were also identified. MPDZ methylation was identified in 61.2% of primary lung cancer tissues and most lung cancer cell lines but not in normal lung tissues. MPDZ expression was significantly downregulated in lung cancer tissues and negatively associated with DNA hypermethylation, and attenuated MPDZ expression predicted a poor outcome. Furthermore, MPDZ overexpression prominently dampened cell growth, migration, and invasion of tumor cells. Conversely, MPDZ knockdown promoted cell proliferation, migration, and invasion in vitro and in vivo. Moreover, MPDZ deficiency promotes tumor metastasis and reduces the survival of MPDZ knockout mice. Importantly, MPDZ promotes tumor suppressor ability that depends on the Hippo pathway-mediated repression of YAP. MPDZ activates the phosphorylation of YAP (Ser127) and inhibits YAP expression through stabilizing MST1 and interaction with LATS1. We first identified and validated that MPDZ methylation and expression could be a good diagnostic marker and independent prognostic factor for lung cancer. MPDZ functions as a tumor suppressor by inhibiting cell proliferation, migration, and invasion through regulating the Hippo-YAP signaling pathway.	[Liu, Wenbin; Huang, Yongsheng; Wang, Dandan; Han, Fei; Chen, Hongqiang; Chen, Jianping; Jiang, Xiao; Cao, Jia; Liu, Jinyi] Third Mil Med Univ, Army Med Univ, Coll Prevent Med, Inst Toxicol, Chongqing, Peoples R China	Army Medical University	Liu, WB; Cao, J; Liu, JY (corresponding author), Third Mil Med Univ, Army Med Univ, Coll Prevent Med, Inst Toxicol, Chongqing, Peoples R China.	liuwenbin@tmmu.edu.cn; caojia1962@126.com; jinyiliutmmu@163.com	liu, wen/HGE-3071-2022; Han, Fei/AAG-9260-2020	Han, Fei/0000-0002-0265-5487; liu, jin-yi/0000-0003-1803-7752; Huang, Yongsheng/0000-0002-8449-7522	National Natural Science Foundation of China [81573179]; Natural Science Foundation Project of Chongqing CSTC of China [cstc2018jcyjAX0233]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation Project of Chongqing CSTC of China	This work was supported by grants from the National Natural Science Foundation of China (No. 81573179) and the Natural Science Foundation Project of Chongqing CSTC of China (No. cstc2018jcyjAX0233). The authors sincerely thank Yajing Li for technical help.	Belinsky SA, 2015, ANNU REV PHYSIOL, V77, P453, DOI 10.1146/annurev-physiol-021014-072018; Berger AH, 2016, CANCER CELL, V30, P214, DOI 10.1016/j.ccell.2016.06.022; Coyne CB, 2004, J BIOL CHEM, V279, P48079, DOI 10.1074/jbc.M409061200; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feldner A, 2017, EMBO MOL MED, V9, P890, DOI 10.15252/emmm.201606430; Guillaume JL, 2008, J BIOL CHEM, V283, P16762, DOI 10.1074/jbc.M802069200; Han F, 2015, ONCOGENE, V34, P4391, DOI 10.1038/onc.2014.370; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hsu YL, 2015, ONCOGENE, V34, P4056, DOI 10.1038/onc.2014.333; Hubers AJ, 2015, BRIT J CANCER, V112, P1105, DOI 10.1038/bjc.2014.636; Ishiuchi T, 2009, J CELL BIOL, V185, P959, DOI 10.1083/jcb.200811030; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Krapivinsky G, 2004, NEURON, V43, P563, DOI 10.1016/j.neuron.2004.08.003; Lanaspa MA, 2008, P NATL ACAD SCI USA, V105, P15797, DOI 10.1073/pnas.0805761105; Lanaspa MA, 2007, P NATL ACAD SCI USA, V104, P13672, DOI 10.1073/pnas.0702752104; Lee YS, 2013, CANCER CELL, V24, P603, DOI 10.1016/j.ccr.2013.10.003; Li E, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a019133; Liu JL, 2018, J PATHOL, V244, P71, DOI 10.1002/path.4995; Liu W, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.65; Liu WB, 2015, ONCOTARGET, V6, P21225, DOI 10.18632/oncotarget.4237; Liu WB, 2015, MOL CARCINOGEN, V54, P312, DOI 10.1002/mc.22101; Liu WB, 2014, INT J CANCER, V134, P1311, DOI 10.1002/ijc.28472; Liu Y, 2003, CARCINOGENESIS, V24, P1897, DOI 10.1093/carcin/bgg169; Martin TA, 2004, EUR J CANCER, V40, P2717, DOI 10.1016/j.ejca.2004.08.008; Massimi P, 2004, ONCOGENE, V23, P8033, DOI 10.1038/sj.onc.1207977; Mohammad HP, 2015, CANCER CELL, V28, P57, DOI 10.1016/j.ccell.2015.06.002; Nawaz I, 2014, EPIGENETICS-US, V9, P1138, DOI 10.4161/epi.29499; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Rodriguez-Paredes M, 2011, NAT MED, V17, P330, DOI 10.1038/nm.2305; Sheu JJC, 2009, CANCER EPIDEM BIOMAR, V18, P2709, DOI 10.1158/1055-9965.EPI-09-0349; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tetzlaff F, 2018, ELIFE, V7, DOI 10.7554/eLife.32860; Ullmer C, 1998, FEBS LETT, V424, P63, DOI 10.1016/S0014-5793(98)00141-0; Walko G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14744; Wang J, 2016, J BIOL CHEM, V291, P17988, DOI 10.1074/jbc.M115.711275; Wen XL, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0170-6; Wrangle J, 2014, CLIN CANCER RES, V20, P1856, DOI 10.1158/1078-0432.CCR-13-2109; Yang JN, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809540; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yuan S, 2016, ONCOGENE, V35, P6120, DOI 10.1038/onc.2016.149; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang X, 2011, ONCOGENE, V30, P2810, DOI 10.1038/onc.2011.8; Zhang YL, 2018, CANCER RES, V78, P2305, DOI 10.1158/0008-5472.CAN-17-2867; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2012, GENE DEV, V26, P54, DOI 10.1101/gad.173435.111; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhu HB, 2013, HEPATOLOGY, V58, P2012, DOI 10.1002/hep.26587	49	5	5	2	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2021	40	26					4468	4485		10.1038/s41388-021-01857-8	http://dx.doi.org/10.1038/s41388-021-01857-8		JUN 2021	18	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TC8LA	34108620				2022-12-26	WOS:000659470200001
J	Nagano, Y; Kimura, K; Kobayashi, G; Kawamura, Y				Nagano, Yukio; Kimura, Kei; Kobayashi, Genta; Kawamura, Yoshio			Genomic diversity of 39 samples of Pyropia species grown in Japan	PLOS ONE			English	Article							BLADED BANGIALES RHODOPHYTA; YEZOENSIS BANGIALES; GENETIC DIVERSITY; PORPHYRA BANGIALES; SIGNALING PATHWAY; SEQUENCE; ALIGNMENT; POPULATION; BIOGEOGRAPHY; PERFORMANCE	Some Pyropia species, such as nori (P. yezoensis), are important marine crops. We conducted a phylogenetic analysis of 39 samples of Pyropia species grown in Japan using organellar genome sequences. A comparison of the chloroplast DNA sequences with those from China showed a clear genetic separation between Japanese and Chinese P. yezoensis. Conversely, comparing the mitochondrial DNA sequences did not separate Japanese and Chinese P. yezoensis. Analysis of organellar genomes showed that the genetic diversity of Japanese P. yezoensis used in this study is lower than that of Chinese wild P. yezoensis. To analyze the genetic relationships between samples of Japanese Pyropia, we used whole-genome resequencing to analyze their nuclear genomes. In the offspring resulting from cross-breeding between P. yezoensis and P. tenera, nearly 90% of the genotypes analyzed by mapping were explained by the presence of different chromosomes originating from two different parental species. Although the genetic diversity of Japanese P. yezoensis is low, analysis of nuclear genomes genetically separated each sample. Samples isolated from the sea were often genetically similar to those being farmed. Study of genetic heterogeneity of samples within a single aquaculture strain of P. yezoensis showed that samples were divided into two groups and the samples with frequent abnormal budding formed a single, genetically similar group. The results of this study will be useful for breeding and the conservation of Pyropia species.	[Nagano, Yukio] Saga Univ, Analyt Res Ctr Expt Sci, Saga, Japan; [Kimura, Kei; Kobayashi, Genta; Kawamura, Yoshio] Saga Univ, Fac Agr, Saga, Japan	Saga University; Saga University	Nagano, Y (corresponding author), Saga Univ, Analyt Res Ctr Expt Sci, Saga, Japan.	nagano@cc.saga-u.ac.jp	Nagano, Yukio/H-8734-2019	Nagano, Yukio/0000-0001-5030-676X	"Projects for sophistication of production and utilisation technology supporting local agriculture and marine industry" from Saga University; KAKENHI from the Japan Society for the Promotion of Science [18K19235]	"Projects for sophistication of production and utilisation technology supporting local agriculture and marine industry" from Saga University; KAKENHI from the Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the "Projects for sophistication of production and utilisation technology supporting local agriculture and marine industry" from Saga University (http://www.saga-u.ac.jp/) (to YN, KK, GK, YK) and KAKENHI (18K19235) from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/) (to KK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2013, J APPL PHYCOL, V25, P225, DOI 10.1007/s10811-012-9856-7; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bi YH, 2014, BIOCHEM SYST ECOL, V54, P307, DOI 10.1016/j.bse.2014.02.010; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cao J, 2016, J MED FOOD, V19, P111, DOI 10.1089/jmf.2015.3426; Cao Y, 2018, BOT MAR, V61, P141, DOI 10.1515/bot-2017-0073; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chifman J, 2014, BIOINFORMATICS, V30, P3317, DOI 10.1093/bioinformatics/btu530; Choi SJ, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11120220; Cook DE, 2017, BIOINFORMATICS, V33, P1581, DOI 10.1093/bioinformatics/btx011; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Darriba D, 2020, MOL BIOL EVOL, V37, P291, DOI 10.1093/molbev/msz189; Dumilag RV, 2018, J APPL PHYCOL, V30, P173, DOI 10.1007/s10811-017-1201-8; Dumilag RV, 2017, EUR J PHYCOL, V52, P104, DOI 10.1080/09670262.2016.1230786; Dumilag RV, 2016, PHYTOTAXA, V255, P83, DOI 10.11646/phytotaxa.255.1.8; Ramirez ME, 2014, PHYTOTAXA, V158, P133, DOI 10.11646/phytotaxa.158.2.2; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; FAO, 2020, STAT WORLD FISH AQ 2, DOI [10.4060/ca9229-n, 10.4060/ca9229en]; Fisher R, 2013, BRIT J CANCER, V108, P479, DOI 10.1038/bjc.2012.581; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Garrison E., 2012, VCFLIB C LIB PARSING; Guillemin ML, 2016, MOL PHYLOGENET EVOL, V94, P814, DOI 10.1016/j.ympev.2015.09.027; Harden LK, 2016, MITOCHONDRIAL DNA A, V27, P3058, DOI 10.3109/19401736.2015.1063137; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hwang IK, 2018, ALGAE-SEOUL, V33, P49, DOI 10.4490/algae.2018.33.2.20; Jin JJ, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02154-5; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kavale MG, 2015, PHYTOTAXA, V224, P45, DOI 10.11646/phytotaxa.224.1.3; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Koh YH, 2018, J APPL PHYCOL, V30, P3425, DOI 10.1007/s10811-018-1529-8; Kovaka S, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1910-1; Kucera H, 2012, J PHYCOL, V48, P869, DOI 10.1111/j.1529-8817.2012.01193.x; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2015, BIOINFORMATICS, V31, P3694, DOI 10.1093/bioinformatics/btv440; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lindstrom SC, 2018, MAR POLLUT BULL, V132, P70, DOI 10.1016/j.marpolbul.2017.07.016; Milstein D, 2015, EUR J PHYCOL, V50, P37, DOI 10.1080/09670262.2014.982202; Mumford TF., 1988, ALGAE HUMAN AFFAIRS, P87; Niwa K, 2004, PHYCOL RES, V52, P180, DOI 10.1111/j.1440-183.2004.00339.x; Niwa K, 2008, J APPL PHYCOL, V20, P261, DOI 10.1007/s10811-007-9242-z; Niwa K, 2010, J PHYCOL, V46, P1097, DOI 10.1111/j.1529-8817.2010.00897.x; Niwa K, 2010, J PHYCOL, V46, P693, DOI 10.1111/j.1529-8817.2010.00853.x; NODA H, 1993, J APPL PHYCOL, V5, P255, DOI 10.1007/BF00004027; Ogata E., 1970, B JAP SOC PHYCOL, V18, P171; OHME M, 1986, Japanese Journal of Phycology, V34, P101; Park SJ, 2015, ONCOL REP, V33, P19, DOI 10.3892/or.2014.3557; Park SJ, 2014, INT J ONCOL, V45, P1011, DOI 10.3892/ijo.2014.2509; Poplin R, 2018, NAT BIOTECHNOL, V36, P983, DOI 10.1038/nbt.4235; Reith M, 1995, PLANT MOL BIOL REP, V13, P333, DOI 10.1007/BF02669187; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Shorthouse DP, 2010, SIMPLEMAPPR ONLINE T; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sutherland JE, 2011, J PHYCOL, V47, P1131, DOI 10.1111/j.1529-8817.2011.01052.x; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Swofford DL. PAUP, 2020, PHYLOGENETIC ANAL US; Verges A, 2013, PHYCOLOGIA, V52, P121, DOI 10.2216/12-003.1; Verges A, 2013, BOT MAR, V56, P229, DOI 10.1515/bot-2013-0003; Wang DM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17689-1; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065902; Xie ZY, 2015, BOT MAR, V58, P189, DOI 10.1515/bot-2014-0063; Xu KP, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00756; Xu Y, 2016, AQUACULTURE, V452, P351, DOI 10.1016/j.aquaculture.2015.11.016; Yanagita T, 2020, ARCH BIOCHEM BIOPHYS, V691, DOI 10.1016/j.abb.2020.108486; Yang LE, 2018, MOL PHYLOGENET EVOL, V120, P94, DOI 10.1016/j.ympev.2017.11.009; Yun T, 2020, BIOINFORMATICS, V36, P5582, DOI 10.1093/bioinformatics/btaa1081; Zheng XW, 2012, BIOINFORMATICS, V28, P3326, DOI 10.1093/bioinformatics/bts606	70	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252207	10.1371/journal.pone.0252207	http://dx.doi.org/10.1371/journal.pone.0252207			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106965	gold, Green Published, Green Submitted			2022-12-26	WOS:000664642200032
J	Shamu, T; Chimbetete, C; Egger, M; Mudzviti, T				Shamu, Tinei; Chimbetete, Cleophas; Egger, Matthias; Mudzviti, Tinashe			Treatment outcomes in HIV infected patients older than 50 years attending an HIV clinic in Harare, Zimbabwe: A cohort study	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; PERIPHERAL NEUROPATHY; BURDEN; COUNTRIES; DISEASE; ADULTS; CARE	There is a growing number of older people living with HIV (OPLHIV). While a significant proportion of this population are adults growing into old age with HIV, there are also new infections among OPLHIV. There is a lack of data describing the outcomes of OPLHIV who commenced antiretroviral therapy (ART) after the age of 50 years in sub-Saharan Africa. We conducted a cohort study of patients who enrolled in care at Newlands Clinic in Harare, Zimbabwe, at ages >= 50 years between February 2004 and March 2020. We examined demographic characteristics, attrition, viral suppression, immunological and clinical outcomes. Specifically, we described prevalent and incident HIV-related communicable and non-communicable comorbidities. We calculated frequencies, medians, interquartile ranges (IQR), and proportions; and used Cox proportional hazards models to identify risk factors associated with death. We included 420 (57% female) who commenced ART and were followed up for a median of 5.6 years (IQR 2.4-9.9). Most of the men were married (n = 152/179, 85%) whereas women were mostly widowed (n = 125/241, 51.9%). Forty per cent (n = 167) had WHO stage 3 or 4 conditions at ART baseline. Hypertension prevalence was 15% (n = 61) at baseline, and a further 27% (n = 112) had incident hypertension during follow-up. During follow-up, 300 (71%) were retained in care, 88 (21%) died, 17 (4%) were lost to follow-up, and 15 (4%) were transferred out. Of those in care, 283 (94%) had viral loads <50 copies/ml, and 10 had viral loads >1000 copies/ml. Seven patients (1.7%) were switched to second line ART during follow-up and none were switched to third-line. Higher baseline CD4 T-cell counts were protective against mortality (p = 0.001) while male sex (aHR: 2.29, 95%CI: 1.21-4.33), being unmarried (aHR: 2.06, 95%CI: 1.13-3.78), and being unemployed (aHR: 2.01, 95%CI: 1.2-3.37) were independent independent risk factors of mortality. There was high retention in care and virologic suppression in this cohort of OPLHIV. Hypertension was a common comorbidity. Being unmarried or unemployed were significant predictors of mortality highlighting the importance of sociologic factors among OPLHIV, while better immune competence at ART commencement was protective against mortality.	[Shamu, Tinei; Chimbetete, Cleophas; Mudzviti, Tinashe] Newlands Clin, Harare, Zimbabwe; [Shamu, Tinei; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Shamu, Tinei] Univ Bern, Grad Sch Hlth Sci, Bern, Switzerland; [Egger, Matthias] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, Rondebosch, Western Cape, South Africa; [Egger, Matthias] Univ Bristol, Bristol Med Sch, Populat Hlth Sci, Bristol, Avon, England; [Mudzviti, Tinashe] Univ Zimbabwe, Coll Hlth Sci, Sch Pharm, Harare, Zimbabwe	University of Bern; University of Bern; University of Cape Town; University of Bristol; University of Zimbabwe	Shamu, T (corresponding author), Newlands Clin, Harare, Zimbabwe.; Shamu, T (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.; Shamu, T (corresponding author), Univ Bern, Grad Sch Hlth Sci, Bern, Switzerland.	tineis@newlandsclinic.co.zw	Shamu, Tinei/E-8255-2016	Shamu, Tinei/0000-0001-8931-4484				Achwoka D, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6716-2; Agaba PA, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx031; Anderegg N, 2018, CLIN INFECT DIS, V66, P893, DOI 10.1093/cid/cix915; Auld AF, 2015, MMWR-MORBID MORTAL W, V64, P1281, DOI 10.15585/mmwr.mm6446a2; Autenrieth CS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207005; Burgess MJ, 2015, HIV AIDS-RES PALLIAT, V7, P251, DOI 10.2147/HIV.S39655; Castelnuovo B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142722; Chammartin F, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035246; Chimbetete C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237904; Choi H, 2011, J AGING HEALTH, V23, P714, DOI 10.1177/0898264310393339; Cornell M, 2015, LANCET HIV, V2, pE368, DOI 10.1016/S2352-3018(15)00113-7; Crimmins EM, 2019, CLIN CHEM, V65, P135, DOI 10.1373/clinchem.2018.288332; Desai M, 2015, CLIN INFECT DIS, V61, P445, DOI 10.1093/cid/civ316; Dovel K, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25517; Egger M, 2012, INT J EPIDEMIOL, V41, P1256, DOI 10.1093/ije/dyr080; Fatti G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100273; Ford N, 2017, CURR OPIN HIV AIDS, V12, P123, DOI 10.1097/COH.0000000000000348; Franzese O, 2018, CHEMOTHERAPY, V63, P64, DOI 10.1159/000487534; Ghidei L, 2013, DRUG AGING, V30, P809, DOI 10.1007/s40266-013-0107-7; Gouda HN, 2019, LANCET GLOB HEALTH, V7, pE1375, DOI 10.1016/S2214-109X(19)30374-2; Greene M, 2020, HIV INFECT OLDER ADU; Greig J., 2012, AIDS, P26, DOI [10.1097/QAD.0b013e3283558446 22781173, DOI 10.1097/QAD.0B013E328355844622781173]; Grimsrud A, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25526; Haas AD, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25084; Heestermans T, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000125; Hegdahl HK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148502; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hontelez JAC, 2011, AIDS, V25, P1665, DOI 10.1097/QAD.0b013e32834982ea; Islam FM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-234; Kiplagat J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194047; Kiwuwa-Muyingo S, 2014, AIDS, V28, P2579, DOI 10.1097/QAD.0000000000000447; Lopman B, 2007, AIDS, V21, pS57, DOI 10.1097/01.aids.0000300536.82354.52; Magadi MA, 2011, SOCIOL HEALTH ILL, V33, P522, DOI 10.1111/j.1467-9566.2010.01304.x; Makurumidze R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0222309; Mpondo Bonaventura C T, 2016, J Aging Res, V2016, P2404857, DOI 10.1155/2016/2404857; Mutevedzi PC, 2011, FUTURE VIROL, V6, P755, DOI 10.2217/FVL.11.43; Mutowo M, 2015, INT J PUBLIC HEALTH, V60, P1, DOI 10.1007/s00038-014-0626-y; Mutowo MP, 2015, WORLD J META-ANAL, V3, P54, DOI 10.13105/wjma.v3.i1.54; Osler M, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25530; Ramsay ID., 2014, SIDE EFFECTS DRUGS A, P401, DOI [10.1016/B978-0-444-63407-8.00029%26%23x2013%3B0, DOI 10.1016/B978-0-444-63407-8.00029%26%23X2013%3B0]; Saylor D, 2017, NEUROLOGY, V89, P485, DOI 10.1212/WNL.0000000000004136; Shamu T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186726; Sia D, 2020, PUBLIC HEALTH, V182, P56, DOI 10.1016/j.puhe.2020.01.014; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Sokoya T, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/6825493; Takarinda KC, 2016, PUBLIC HEALTH ACTION, V6, P3, DOI 10.5588/pha.15.0072; Thomas F., 2008, Gender and Development, V16, P73, DOI 10.1080/13552070701876235	47	4	4	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0253000	10.1371/journal.pone.0253000	http://dx.doi.org/10.1371/journal.pone.0253000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RW	34106989	Green Published, gold			2022-12-26	WOS:000664642200069
J	Chou, MSH; Ting, NCH; El-Turk, N; Harrington, Z; Dobler, CC				Chou, Michael S. H.; Ting, Natasha C. H.; El-Turk, Nicole; Harrington, Zinta; Dobler, Claudia C.			Treatment burden experienced by patients with obstructive sleep apnoea using continuous positive airway pressure therapy	PLOS ONE			English	Article							CPAP ADHERENCE; BARRIERS; EXERCISE; ACCEPTANCE	Background Little is known about the treatment burden experienced by patients with obstructive sleep apnoea (OSA) who use continuous positive airway pressure (CPAP) therapy. Participants 18 patients (33.3% males, mean age 59.711.8 years) with OSA who use CPAP therapy were interviewed. Methods Patients treated with CPAP for OSA at a tertiary hospital outpatient clinic in Sydney, Australia, were invited to participate in an interview in person or via phone. Semi-structured interviews were used to explore the treatment burden associated with using CPAP. The interviews were recorded, transcribed, and analysed using NVivo 12 qualitative analysis software. Results Four categories of OSA-specific treatment burden were identified: healthcare tasks, consequences of healthcare tasks, exacerbating and alleviating factors of treatment burden. Participants reported a significant burden associated with using CPAP, independently of how frequently they used their device. Common sources of their treatment burden included attending healthcare appointments, the financial cost of treatment, lifestyle changes, treatment-related side effects and general discomfort. Conclusions This study demonstrated that there is a significant treatment burden associated with the use of CPAP, and that treatment non-adherence is not the only consequence of treatment burden. Other consequences include relationship burden, stigma and financial burden. It is important for physicians to identify other negative impacts of treatment burden in order to optimise the patient experience.	[Chou, Michael S. H.; Ting, Natasha C. H.; El-Turk, Nicole; Harrington, Zinta; Dobler, Claudia C.] Liverpool Hosp, Dept Resp & Sleep Med, Sydney, NSW, Australia; [Chou, Michael S. H.; Ting, Natasha C. H.; El-Turk, Nicole; Harrington, Zinta; Dobler, Claudia C.] Univ New South Wales UNSW, South Western Sydney Clin Sch, Sydney, NSW, Australia; [Dobler, Claudia C.] Bond Univ, Inst Evidence Based Healthcare, Gold Coast, Qld, Australia; [Dobler, Claudia C.] Gold Coast Univ Hosp, Gold Coast, Qld, Australia	Liverpool Hospital; University of New South Wales Sydney; Bond University; Gold Coast University Hospital	Chou, MSH (corresponding author), Liverpool Hosp, Dept Resp & Sleep Med, Sydney, NSW, Australia.; Chou, MSH (corresponding author), Univ New South Wales UNSW, South Western Sydney Clin Sch, Sydney, NSW, Australia.	michaelcsh1718@gmail.com		El-Turk, Nicole/0000-0003-1112-9670; Chou, Michael/0000-0002-1537-4289; Dobler, Claudia/0000-0002-5460-0189	South Western Sydney Local Health District (SWSLHD)	South Western Sydney Local Health District (SWSLHD)	Claudia C. Dobler was supported by an award from the South Western Sydney Local Health District (SWSLHD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FR, 2013, SLEEP BREATH, V17, P659, DOI 10.1007/s11325-012-0739-6; Baron KG, 2012, J CLIN SLEEP MED, V8, P147, DOI 10.5664/jcsm.1766; Brostrom A, 2010, SLEEP MED, V11, P126, DOI 10.1016/j.sleep.2009.04.010; Butner Katrina L, 2013, N Am J Med Sci, V5, P362, DOI 10.4103/1947-2714.114168; Dempsey JA, 2010, PHYSIOL REV, V90, P47, DOI 10.1152/physrev.00043.2008; Dobler CC, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4065; EnableNSW, HOM RESP PROGR; Eton DT, 2015, PATIENT-RELAT OUTCOM, V6, P117, DOI 10.2147/PROM.S78955; Flemons WW, 1999, SLEEP, V22, P667, DOI 10.1093/sleep/22.5.667; Galetke W, 2011, RESPIRATION, V82, P155, DOI 10.1159/000322838; Gallacher K, 2011, ANN FAM MED, V9, P235, DOI 10.1370/afm.1249; Harb N., 2015, INT J CHRONIC OBSTR, P1641, DOI [10.2147/COPD.S83596, DOI 10.2147/COPD.S83596]; Irvine A, 2013, QUAL RES, V13, P87, DOI 10.1177/1468794112439086; Justine M, 2013, SINGAP MED J, V54, P581, DOI 10.11622/smedj.2013203; KRIBBS NB, 1993, AM REV RESPIR DIS, V147, P887, DOI 10.1164/ajrccm/147.4.887; Lee CHK, 2017, SLEEP SCI, V10, P57, DOI 10.5935/1984-0063.20170010; Li YY, 2016, INT J PSYCHIAT MED, V51, P554, DOI 10.1177/0091217417696737; Luyster FS, 2016, BEHAV SLEEP MED, V14, P67, DOI 10.1080/15402002.2014.946597; Mair FS, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6680; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Parthasarathy S, 2013, J CLIN SLEEP MED, V9, P543, DOI 10.5664/jcsm.2744; Pepin JL, 2012, THORAX, V67, P1025, DOI 10.1136/thoraxjnl-2012-202807; Pires FS, 2013, SLEEP BREATH, V17, P993, DOI 10.1007/s11325-012-0789-9; Quadri F, 2017, RESP PHYSIOL NEUROBI, V236, P51, DOI 10.1016/j.resp.2016.11.004; Rezaie L, 2018, PATIENT PREFER ADHER, V12, P1299, DOI 10.2147/PPA.S165905; Rotenberg BW, 2016, J OTOLARYNGOL-HEAD N, V45, DOI 10.1186/s40463-016-0156-0; Rueda AD., 2009, SLEEP SCI, V2, P8; Sav A, 2013, HEALTH SOC CARE COMM, V21, P665, DOI 10.1111/hsc.12052; Sawyer AM, 2010, QUAL HEALTH RES, V20, P873, DOI 10.1177/1049732310365502; Schutzer KA, 2004, PREV MED, V39, P1056, DOI 10.1016/j.ypmed.2004.04.003; Senaratna CV, 2017, SLEEP MED REV, V34, P70, DOI 10.1016/j.smrv.2016.07.002; Sjors C, 2014, INTERACT J MED RES, V3, P2, DOI 10.2196/ijmr.3191; Tan B, 2018, AM J OTOLARYNG, V39, P501, DOI 10.1016/j.amjoto.2018.05.012; Tietjens JR, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010440; Tran VT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0356-x; Troxel WM, 2007, SLEEP MED REV, V11, P389, DOI 10.1016/j.smrv.2007.05.002; Weaver TE, 2012, AM J RESP CRIT CARE, V186, P677, DOI 10.1164/rccm.201202-0200OC; Ye LC, 2017, SLEEP HEALTH, V3, P362, DOI 10.1016/j.sleh.2017.07.003; Zhao YY, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx040	39	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252915	10.1371/journal.pone.0252915	http://dx.doi.org/10.1371/journal.pone.0252915			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097721	gold, Green Published			2022-12-26	WOS:000664640700022
J	Shah, SU; Loo, EXL; Chua, CE; Kew, GS; Demutska, A; Quek, S; Wong, S; Lau, HX; Low, EXS; Loh, TL; Lung, OS; Hung, ECW; Rahman, MM; Ghoshal, UC; Wong, SH; Cheung, CKY; Syam, AF; Tan, N; Xiao, YL; Liu, JS; Lu, F; Chen, CL; Lee, YY; Maralit, RM; Kim, YS; Oshima, T; Miwa, H; Siah, KTH; Pang, JX				Shah, Shimoni Urvish; Loo, Evelyn Xiu Ling; Chua, Chun En; Kew, Guan Sen; Demutska, Alla; Quek, Sabrina; Wong, Scott; Lau, Hui Xing; Low, En Xian Sarah; Loh, Tze Liang; Lung, Ooi Shien; Hung, Emily C. W.; Rahman, M. Masudur; Ghoshal, Uday C.; Wong, Sunny H.; Cheung, Cynthia K. Y.; Syam, Ari F.; Tan, Niandi; Xiao, Yinglian; Liu, Jin-Song; Lu, Fang; Chen, Chien-Lin; Lee, Yeong Yeh; Maralit, Ruter M.; Kim, Yong-Sung; Oshima, Tadayuki; Miwa, Hiroto; Siah, Kewin Tien Ho; Pang, Junxiong			Association between well-being and compliance with COVID-19 preventive measures by healthcare professionals: A cross-sectional study	PLOS ONE			English	Article							FORM MHC-SF; MENTAL-HEALTH; NATIONAL-SURVEY; HAND HYGIENE; CONTINUUM; POPULATION; KNOWLEDGE; INFLUENZA; ATTITUDE; WORKERS	Importance Knowledge and attitude influence compliance and individuals' practices. The risk and protective factors associated with high compliance to these preventive measures are critical to enhancing pandemic preparedness. Objective This survey aims to assess differences in mental health, knowledge, attitudes, and practices (KAP) of preventive measures for COVID-19 amongst healthcare professionals (HCP) and non-healthcare professionals. Design Multi-national cross-sectional study was carried out using electronic surveys between May-June 2020. Setting Multi-national survey was distributed across 36 countries through social media, word-of-mouth, and electronic mail. Participants Participants >= 21 years working in healthcare and non-healthcare related professions. Main outcome Risk factors determining the difference in KAP towards personal hygiene and social distancing measures during COVID-19 amongst HCP and non-HCP. Results HCP were significantly more knowledgeable on personal hygiene (AdjOR 1.45, 95% CI -1.14 to 1.83) and social distancing (AdjOR 1.31, 95% CI -1.06 to 1.61) compared to non-HCP. They were more likely to have a positive attitude towards personal hygiene and 1.5 times more willing to participate in the contact tracing app. There was high compliance towards personal hygiene and social distancing measures amongst HCP. HCP with high compliance were 1.8 times more likely to flourish and more likely to have a high sense of emotional (AdjOR 1.94, 95% CI (1.44 to 2.61), social (AdjOR 2.07, 95% CI -1.55 to 2.78), and psychological (AdjOR 2.13, 95% CI (1.59-2.85) well-being. Conclusion and relevance While healthcare professionals were more knowledgeable, had more positive attitudes, their higher sense of total well-being was seen to be more critical to enhance compliance. Therefore, focusing on the well-being of the general population would help to enhance their compliance towards the preventive measures for COVID-19.	[Shah, Shimoni Urvish; Pang, Junxiong] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Shah, Shimoni Urvish; Pang, Junxiong] Natl Univ Hlth Syst, Singapore, Singapore; [Shah, Shimoni Urvish; Pang, Junxiong] Natl Univ Singapore, Ctr Infect Dis Epidemiol & Res, Singapore, Singapore; [Loo, Evelyn Xiu Ling] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Paediat, Singapore, Singapore; [Loo, Evelyn Xiu Ling; Lau, Hui Xing; Siah, Kewin Tien Ho] ASTAR, Singapore Inst Clin Sci SICS, Singapore, Singapore; [Chua, Chun En; Kew, Guan Sen; Quek, Sabrina; Siah, Kewin Tien Ho] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Kew, Guan Sen] Natl Univ Singapore Hosp, Dept Med, Div Gastroenterol & Hepatol, Singapore, Singapore; [Demutska, Alla] James Cook Univ, Dept Clin Psychol, Singapore, Singapore; [Wong, Scott; Low, En Xian Sarah] Ng Teng Fong Gen Hosp, Dept Med, Singapore, Singapore; [Loh, Tze Liang] Univ Putra Malaysia, Dept Otorhinolarygol Head & Neck Surg, Serdang, Malaysia; [Lung, Ooi Shien] Columbia Asia Hosp, Dept Anaesthesiol, Sarawak, Malaysia; [Hung, Emily C. W.] Cambridge Paediat, Shatin, Hong Kong, Peoples R China; [Rahman, M. Masudur] Sheikh Russel Natl Gastroliver Inst & Hosp, Dept Gastroenterol, Dhaka, Bangladesh; [Ghoshal, Uday C.] Sanjay Gandhi Postgrad Inst Med Sci, Dept Gastroenterol, Lucknow, Uttar Pradesh, India; [Wong, Sunny H.] Chinese Univ Hong Kong, Fac Med, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Cheung, Cynthia K. Y.] Univ Hong Kong, Pharmaceut Biotechnol, State Key Lab, Dept Med, Hong Kong, Peoples R China; [Syam, Ari F.] Univ Indonesia, Fac Med, Dept Internal Med, Div Gastroenterol, Jakarta, Indonesia; [Tan, Niandi; Xiao, Yinglian] Sun Yat Sen Univ, Dept Gastroenterol, Affiliated Hosp 1, Guangzhou, Peoples R China; [Tan, Niandi; Xiao, Yinglian] Sun Yat Sen Univ, Dept Hepatol, Affiliated Hosp 1, Guangzhou, Peoples R China; [Liu, Jin-Song] Huazhong Univ Sci & Technol, Wuhan Union Hosp, Dept Gastroenterol, Wuhan, Hubei, Peoples R China; [Lu, Fang] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing, Peoples R China; [Chen, Chien-Lin] Buddhist Tzu Chi Hosp & Univ, Sch Med, Dept Med, Hualien, Taiwan; [Lee, Yeong Yeh] Univ New South Wales, St George & Sutherland Clin Sch, Sydney, NSW, Australia; [Lee, Yeong Yeh] Univ Kebangsaan Malaysia, Fac Med, Gut Res Grp, Kuala Lumpur, Malaysia; [Maralit, Ruter M.] Med City, Manila, Philippines; [Kim, Yong-Sung] Wonkwang Univ, Sch Med, Gut & Food Hlthcare, Wonkwang Digest Dis Res Inst, Iksan, South Korea; [Oshima, Tadayuki; Miwa, Hiroto] Hyogo Coll Med, Dept Internal Med, Div Gastroenterol & Hepatol, Nishinomiya, Hyogo, Japan	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore; Universiti Putra Malaysia; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Chinese University of Hong Kong; University of Hong Kong; University of Indonesia; Sun Yat Sen University; Sun Yat Sen University; Huazhong University of Science & Technology; China Academy of Chinese Medical Sciences; Xiyuan Hospital, CACMS; Buddhist Tzu Chi General Hospital; University of New South Wales Sydney; Universiti Kebangsaan Malaysia; Wonkwang University; Hyogo College of Medicine	Pang, JX (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore.; Pang, JX (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.; Pang, JX (corresponding author), Natl Univ Singapore, Ctr Infect Dis Epidemiol & Res, Singapore, Singapore.	pangv@hotmail.com	Syam, Ari Fahrial/ABI-4994-2020; Wong, Sunny H/N-3754-2015; Lee, Yeong Yeh/G-2470-2010; Kim, Yong Sung/GMW-8652-2022; Demutska, Alla/ABC-2177-2021	Wong, Sunny H/0000-0002-3354-9310; Lee, Yeong Yeh/0000-0002-6486-7717; Kim, Yong Sung/0000-0001-8836-4818; Shah, Shimoni/0000-0003-0991-5138; Pang, Junxiong, Vincent/0000-0002-9788-701X; Wong, Scott/0000-0001-5191-154X; Lau, Hui Xing/0000-0002-7154-2881; Quek, Sabrina/0000-0001-5377-1528; Loh, Tze Liang/0000-0002-7363-4958; Loo, Evelyn Xiu Ling/0000-0001-7690-3191	NUS COVID-19 RESEARCH SEED FUNDING [NUSCOVID19RG-43]; Lloyd's Register Foundation Institute for the Public Understanding of Risk [IPUR_FY2020_RES_02_PANG]	NUS COVID-19 RESEARCH SEED FUNDING; Lloyd's Register Foundation Institute for the Public Understanding of Risk	JP -1) NUS COVID-19 RESEARCH SEED FUNDING (NUSCOVID19RG-43) 2) Lloyd's Register Foundation Institute for the Public Understanding of Risk (IPUR_FY2020_RES_02_PANG) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, Bull World Health Organ, V80, P983; Bellato Alessio, 2020, Soc Sci Humanit Open, V2, P100062, DOI 10.1016/j.ssaho.2020.100062; Bin Ibrahim MA, 2018, AM J INFECT CONTROL, V46, P253, DOI 10.1016/j.ajic.2017.09.014; Brienen NCJ, 2010, RISK ANAL, V30, P1210, DOI 10.1111/j.1539-6924.2010.01428.x; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P106; Coroiu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239795; Costa MF, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002494; de Bruin WB, 2020, AM J PREV MED, V59, P157, DOI 10.1016/j.amepre.2020.05.001; Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041; Guner R, 2020, TURK J MED SCI, V50, P571, DOI 10.3906/sag-2004-146; Guo C, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0394-2; Herrera-Diestra JL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225576; Iqbal MR, 2020, INT J SURG, V79, P156, DOI 10.1016/j.ijsu.2020.05.042; Kebede Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233744; Keyes CLM, 2005, J CONSULT CLIN PSYCH, V73, P539, DOI 10.1037/0022-006X.73.3.539; Keyes CLM, 2002, J HEALTH SOC BEHAV, V43, P207, DOI 10.2307/3090197; Keyes CLM, 2008, CLIN PSYCHOL PSYCHOT, V15, P181, DOI 10.1002/cpp.572; Lai J., 2020, JAMA NETW OPEN, V3, P1, DOI [10.1001/jamanetworkopen.2020.3976, DOI 10.1001/JAMANETWORKOPEN.2020.3976]; Mathur Purva, 2011, Indian J Med Res, V134, P611, DOI 10.4103/0971-5916.90985; McEachan R, 2016, ANN BEHAV MED, V50, P592, DOI 10.1007/s12160-016-9798-4; Moncion K, 2019, Can Commun Dis Rep, V45, P12, DOI 10.14745/ccdr.v45i01a02; Perugini MLL, 2017, EUR J PSYCHOL, V13, P93, DOI 10.5964/ejop.v13i1.1163; Picco L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178359; Qualls N, 2017, MMWR RECOMM REP, V66, P1, DOI 10.15585/mmwr.rr6601a1; Saladino V, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.577684; Seale H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235112; Sheth K., 2020, REV ECON HOUSEHOLD, P1; Simione L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02166; Srivastava N., 2020, CORONAVIRUS DIS, P127, DOI [10.1007/978-981-15-4814-7_11, DOI 10.1007/978-981-15-4814-7_11]; Szilagyi L, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-249; Tamang N, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-10025-8; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Williams N., 2020, OCCUP MED LOND; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001; Yang C, 2020, GRAEF ARCH CLIN EXP, V258, P1133, DOI 10.1007/s00417-020-04652-5; Zhang M, 2020, J HOSP INFECT, V105, P183, DOI 10.1016/j.jhin.2020.04.012; Zhao SZ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186692	39	2	2	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252835	10.1371/journal.pone.0252835	http://dx.doi.org/10.1371/journal.pone.0252835			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RH	34097719	Green Published, gold, Green Accepted			2022-12-26	WOS:000664640700020
J	Campbell, RM; Vinas, G; Henneberg, M				Campbell, Ryan M.; Vinas, Gabriel; Henneberg, Maciej			Towards the restoration of ancient hominid craniofacial anatomy: Chimpanzee morphology reveals covariation between craniometrics and facial soft tissue thickness	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; AUSTRALOPITHECUS-AFRICANUS; LATE PLEISTOCENE; MOUTH-WIDTH; STS 5; RECONSTRUCTION; APPROXIMATION; PREDICTION; POSITION; STERKFONTEIN	In modern humans, facial soft tissue thicknesses have been shown to covary with craniometric dimensions. However, to date it has not been confirmed whether these relationships are shared with non-human apes. In this study, we analyze these relationships in chimpanzees (Pan troglodytes) with the aim of producing regression models for approximating facial soft tissue thicknesses in Plio-Pleistocene hominids. Using CT scans of 19 subjects, 637 soft tissue, and 349 craniometric measurements, statistically significant multiple regression models were established for 26 points on the face and head. Examination of regression model validity resulted in minimal differences between observed and predicted soft tissue thickness values. Assessment of interspecies compatibility using a bonobo (Pan paniscus) and modern human subject resulted in minimal differences for the bonobo but large differences for the modern human. These results clearly show that (1) soft tissue thicknesses covary with craniometric dimensions in P. troglodytes, (2) confirms that such covariation is uniformly present in both extant Homo and Pan species, and (3) suggests that chimp-derived regression models have interspecies compatibility with hominids who have similar craniometric dimensions to P. troglodytes. As the craniometric dimensions of early hominids, such as South African australopithecines, are more similar to P. troglodytes than those of H. sapiens, chimpanzee-derived regression models may be used for approximating their craniofacial anatomy. It is hoped that the results of the present study and the reference dataset for facial soft tissue thicknesses of chimpanzees it provides will encourage further research into this topic.	[Campbell, Ryan M.; Henneberg, Maciej] Univ Adelaide, Adelaide Med Sch, Biol Anthropol & Comparat Anat Res Unit, Adelaide, SA, Australia; [Vinas, Gabriel] Arizona State Univ, Herberger Inst Design & Arts, Sculpture Dept, Tempe, AZ USA; [Henneberg, Maciej] Univ Zurich, Inst Evolutionary Med, Fac Med, Zurich, Switzerland	University of Adelaide; Arizona State University; Arizona State University-Tempe; University of Geneva; University of Zurich	Campbell, RM (corresponding author), Univ Adelaide, Adelaide Med Sch, Biol Anthropol & Comparat Anat Res Unit, Adelaide, SA, Australia.	ryan.campbell@adelaide.edu.au		Henneberg, Maciej/0000-0003-1941-2286; Campbell, Ryan/0000-0003-2630-1701				Aiello L, 1990, INTRO HUMAN EVOLUTIO; Alemseged Z, 2006, NATURE, V443, P296, DOI 10.1038/nature05047; Anderson K, 2011, THESIS U ADELAIDE AD; Balter M, 2009, SCIENCE, V325, P136, DOI 10.1126/science.325_136; Basu RN, 1941, U CALCUTTA ANTHR PAP, V6, P59; Benazzi S, 2013, AM J PHYS ANTHROPOL, V150, P324, DOI 10.1002/ajpa.22225; Benazzi S, 2011, J HUM EVOL, V61, P75, DOI 10.1016/j.jhevol.2011.02.005; Bonmati A, 2008, ANAT REC, V291, P1707, DOI 10.1002/ar.20795; Brassey CA, 2018, J HUM EVOL, V115, P47, DOI 10.1016/j.jhevol.2017.07.014; Briers N, 2015, FORENSIC SCI INT, V252, DOI 10.1016/j.forsciint.2015.04.015; BROADBENT T R, 1957, Plast Reconstr Surg (1946), V20, P1, DOI 10.1097/00006534-195707000-00001; BROOM R, 1947, NATURE, V159, P672, DOI 10.1038/159672a0; BROWN F, 1985, NATURE, V316, P788, DOI 10.1038/316788a0; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Campbell RM, 2021, FRONT ECOL EVOL, V9, DOI 10.3389/fevo.2021.639048; Caple J, 2016, INT J LEGAL MED, V130, P863, DOI 10.1007/s00414-015-1292-1; Clarke RJ, 2019, J HUM EVOL, V134, DOI 10.1016/j.jhevol.2019.06.005; Cofran Z, 2019, J HUM EVOL, V130, P72, DOI 10.1016/j.jhevol.2019.02.006; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; De Greef S, 2006, FORENSIC SCI INT, V159, pS126, DOI 10.1016/j.forsciint.2006.02.034; de Waal Frans B. M., 1997, BONOBO FORGOTTEN APE; Diogo Potau JM, 2013, PHOTOGRAPHIC DESCRIP; Diogo R., 2013, PHOTOGRAPHIC DESCRIP; Diogo R., 2010, PHOTOGRAPHIC DESCRIP; Diogo R., 2017, PHOTOGRAPHIC DESCRIP; Diogo R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00548-3; Fedosyutkin BA, 1993, FORENSIC ANAL SKULL; GEORGE RM, 1987, J FORENSIC SCI, V32, P1305; Gerasimov M., 1971, THE FACE FINDER; Gerasimov M., 1955, RECONSTRUCTION FACE; Gunz P, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4729; Gurche J, 2013, SHAPING HUMANITY SCI; Guyomarc'h P, 2012, J FORENSIC SCI, V57, P1427, DOI 10.1111/j.1556-4029.2012.02181.x; Guyomarc'h P, 2012, J FORENSIC SCI, V57, P1271, DOI 10.1111/j.1556-4029.2012.02075.x; Hanebrink JR, 2006, THESIS LOUISIANA STA; Hayes S, 2013, J ARCHAEOL SCI, V40, P4400, DOI 10.1016/j.jas.2013.06.028; Iscan M.Y., 2013, HUMAN SKELETON FOREN, V3rd, P493; Kern MW., 2012, THESIS U WISCONSIN M; Keyser AW, 2000, S AFR J SCI, V96, P189; Kimbel WH, 2017, J HUM EVOL, V107, P94, DOI 10.1016/j.jhevol.2017.03.011; Kimbel WH, 2010, PHILOS T R SOC B, V365, P3365, DOI 10.1098/rstb.2010.0070; KOLLMANN J, 1898, ARCH ANTHR, V25, P329; LEAKEY LSB, 1959, NATURE, V184, P491, DOI 10.1038/184491a0; Lockwood CA, 1999, AM J PHYS ANTHROPOL, V108, P97, DOI 10.1002/(SICI)1096-8644(199901)108:1<97::AID-AJPA6>3.0.CO;2-O; MACHO GA, 1986, J FORENSIC SCI, V31, P1391; McKinnon MR, 2018, J FORENSIC SCI, V63, P1641, DOI 10.1111/1556-4029.13768; Montagu MFA., 1947, TECHNOL REV, V49, P345; Morwood MJ, 2005, NATURE, V437, P1012, DOI 10.1038/nature04022; OESTREICHER JH, 1990, OPHTHALMIC SURG LAS, V21, P245; OHIGGINS P, 1993, J HUM EVOL, V24, P183, DOI 10.1006/jhev.1993.1014; Partridge T. C., 2005, Transactions of the Royal Society of South Africa, V60, P107; Potze S, 2010, J HUM EVOL, V58, P533, DOI 10.1016/j.jhevol.2009.11.005; Prag J., 1997, MAKING FACES USING F; Prokopec M., 2002, FORENSIC SCI COMMUNI, V4, P1; Dinh QH, 2011, STUD COMPUT INTELL, V351, P117; Rak Y., 1983, AUSTRALOPITHECINE FA, DOI [10.1016/B978-0-12-576280-9.50006-7, DOI 10.1016/B978-0-12-576280-9.50006-7]; Roberts A., 2018, EVOLUTION HUMAN STOR; Rosset A, 2004, J DIGIT IMAGING, V17, P205, DOI 10.1007/s10278-004-1014-6; Rynn C, 2006, AM J PHYS ANTHROPOL, V130, P364, DOI 10.1002/ajpa.20337; Saccenti E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57247-4; Schaefer K, 2004, ANN ANAT, V186, P471, DOI 10.1016/S0940-9602(04)80086-4; Simpson E, 2002, AM J PHYS ANTHROPOL, V118, P121, DOI 10.1002/ajpa.10073; Song WC, 2007, PLAST RECONSTR SURG, V120, P1343, DOI 10.1097/01.prs.0000279558.86727.5a; Stephan CN, 2019, FORENSIC SCI INT, V304, DOI 10.1016/j.forsciint.2019.109965; Stephan C N, 2008, J Forensic Odontostomatol, V26, P2; Stephan CN, 2008, J FORENSIC SCI, V53, P1257, DOI 10.1111/j.1556-4029.2008.00852.x; Stephan CN, 2018, FORENSIC SCI INT, V286, P128, DOI 10.1016/j.forsciint.2018.03.011; Stephan CN, 2017, FORENSIC SCI INT, V280, P113, DOI 10.1016/j.forsciint.2017.09.016; Stephan CN, 2005, J FORENSIC SCI, V50, P513; Stephan CN, 2003, AM J PHYS ANTHROPOL, V122, P240, DOI 10.1002/ajpa.10300; Stephan CN, 2003, J FORENSIC SCI, V48, P725; Stephan CN, 2003, AM J PHYS ANTHROPOL, V121, P48, DOI 10.1002/ajpa.10166; Stephan CN, 2002, FORENSIC SCI INT, V130, P29, DOI 10.1016/S0379-0738(02)00279-7; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; SUTTON PRN, 1969, AM J PHYS ANTHROPOL, V30, P303, DOI 10.1002/ajpa.1330300215; Tawane GM, 2018, S AFR J SCI, V114, DOI 10.17159/sajs.2018/a0249; Ullrich H, 2016, ANTHROPOL-INT J HUM, V54, P97; van Vugt JLA, 2017, J CACHEXIA SARCOPENI, V8, P285, DOI 10.1002/jcsm.12158; Walker M, 2019, ECOL EVOL, V9, P4289, DOI 10.1002/ece3.5050; Welcker H, 1883, SCHILLERS SCH DEL TO; Wilkinson C., 2004, FORENSIC FACIAL RECO	81	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0245760	10.1371/journal.pone.0245760	http://dx.doi.org/10.1371/journal.pone.0245760			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086683	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000664640100006
J	Dhounchak, S; Popp, SK; Brown, DJ; Laybutt, DR; Biden, TJ; Bornstein, SR; Parish, CR; Simeonovic, CJ				Dhounchak, Sarita; Popp, Sarah K.; Brown, Debra J.; Laybutt, D. Ross; Biden, Trevor J.; Bornstein, Stefan R.; Parish, Christopher R.; Simeonovic, Charmaine J.			Heparan sulfate proteoglycans in beta cells provide a critical link between endoplasmic reticulum stress, oxidative stress and type 2 diabetes	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENZYME GENE-EXPRESSION; MOUSE MODEL; INSULIN-SECRETION; BASEMENT-MEMBRANE; CD44 ISOFORMS; ER STRESS; ISLETS; DYSFUNCTION; FAILURE	Heparan sulfate proteoglycans (HSPGs) consist of a core protein with side chains of the glycosaminoglycan heparan sulfate (HS). We have previously identified (i) the HSPGs syndecan-1 (SDC1), and collagen type XVIII (COL18) inside mouse and human islet beta cells, and (ii) a critical role for HS in beta cell survival and protection from reactive oxygen species (ROS). The objective of this study was to investigate whether endoplasmic reticulum (ER) stress contributes to oxidative stress and type 2 diabetes (T2D) by depleting beta cell HSPGs/HS. A rapid loss of intra-islet/beta cell HSPGs, HS and heparanase (HPSE, an HS-degrading enzyme) accompanied upregulation of islet ER stress gene expression in both young T2D-prone db/db and Akita Ins2(WT/C96Y) mice. In MIN6 beta cells, HSPGs, HS and HPSE were reduced following treatment with pharmacological inducers of ER stress (thapsigargin or tunicamycin). Treatment of young db/db mice with Tauroursodeoxycholic acid (TUDCA), a chemical protein folding chaperone that relieves ER stress, improved glycemic control and increased intra-islet HSPG/HS. In vitro, HS replacement with heparin (a highly sulfated HS analogue) significantly increased the survival of wild-type and db/db beta cells and restored their resistance to hydrogen peroxide-induced death. We conclude that ER stress inhibits the synthesis/maturation of HSPG core proteins which are essential for HS assembly, thereby exacerbating oxidative stress and promoting beta cell failure. Diminished intracellular HSPGs/HS represent a previously unrecognized critical link bridging ER stress, oxidative stress and beta cell failure in T2D.	[Dhounchak, Sarita; Popp, Sarah K.; Brown, Debra J.; Simeonovic, Charmaine J.] Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia; [Laybutt, D. Ross; Biden, Trevor J.] Univ NSW, St Vincents Clin Sch, Garvan Inst Med Res, Sydney, NSW, Australia; [Bornstein, Stefan R.] Tech Univ Dresden, Carl Gustav Carus Med Sch, Dept Internal Med 3, Dresden, Germany; [Parish, Christopher R.] Australian Natl Univ, John Curtin Sch Med Res, ACRF Dept Canc Biol & Therapeut, Canberra, ACT, Australia	Australian National University; John Curtin School of Medical Research; Garvan Institute of Medical Research; University of New South Wales Sydney; Technische Universitat Dresden; Australian National University; John Curtin School of Medical Research	Simeonovic, CJ (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Dept Immunol & Infect Dis, Canberra, ACT, Australia.	Charmaine.Simeonovic@anu.edu.au	Biden, Trevor/AAW-2829-2021	Parish, Christopher/0000-0001-7740-0430	National Health and Medical Research Council of Australia (NHMRC) [1065068]; Diabetes Australia Research Trust	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Trust	This work was supported by grants from The National Health and Medical Research Council of Australia (NHMRC; www.nhmrc.gov.au< http://www.nhmrc.gov.au>), #1065068, to CJS and SRB and the Diabetes Australia Research Trust (www.diabetesaustralia.com.au/research-advocacy/research/< http://www.diabetesaustralia.com.au/research-advocacy/research/>) to CJS. PI-88 compound for in vitro studies was a gift from Progen Pharrmaceuticals Limited (Brisbane, Queensland, Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin A, 2012, J PATHOL, V227, P165, DOI 10.1002/path.3960; BEAVAN LA, 1989, ARCH BIOCHEM BIOPHYS, V269, P576, DOI 10.1016/0003-9861(89)90143-4; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; Bensellam M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49289-5; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Biden TJ, 2014, TRENDS ENDOCRIN MET, V25, P389, DOI 10.1016/j.tem.2014.02.003; Chan JY, 2015, MOL CELL ENDOCRINOL, V413, P189, DOI 10.1016/j.mce.2015.06.025; Chan JY, 2013, DIABETES, V62, P1557, DOI 10.2337/db12-0701; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Choong FJ, 2015, AM J TRANSPLANT, V15, P2851, DOI 10.1111/ajt.13366; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; DAVID G, 1992, J CELL BIOL, V119, P961, DOI 10.1083/jcb.119.4.961; Davis DAS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00470; Dennissen MABA, 2002, J BIOL CHEM, V277, P10982, DOI 10.1074/jbc.M104852200; Dreyfuss JL, 2009, AN ACAD BRAS CIENC, V81, P409, DOI 10.1590/S0001-37652009000300007; Eizirik DL, 2013, DIABETOLOGIA, V56, P234, DOI 10.1007/s00125-012-2762-3; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Eizirik DL, 2020, NAT REV ENDOCRINOL, V16, P349, DOI 10.1038/s41574-020-0355-7; Engin F, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006534; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Gazda LS, 1997, J AUTOIMMUN, V10, P261, DOI 10.1006/jaut.1997.0138; Gerber PA, 2017, ANTIOXID REDOX SIGN, V26, P501, DOI 10.1089/ars.2016.6755; Harmon JS, 2009, ENDOCRINOLOGY, V150, P4855, DOI 10.1210/en.2009-0708; Hasnain SZ, 2016, J MOL ENDOCRINOL, V56, pR33, DOI 10.1530/JME-15-0232; Hasnain SZ, 2014, NAT MED, V20, P1417, DOI 10.1038/nm.3705; Herbert TP, 2016, DIABETES, V65, P1472, DOI 10.2337/db15-1633; Iozzo RV, 2001, J CLIN INVEST, V108, P165, DOI 10.1172/JCI13560; Izumi T, 2003, DIABETES, V52, P409, DOI 10.2337/diabetes.52.2.409; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kjorholt C, 2005, DIABETES, V54, P2755, DOI 10.2337/diabetes.54.9.2755; Korpos E, 2013, DIABETES, V62, P531, DOI 10.2337/db12-0432; Krisko A, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.180249; Kurup S, 2007, J BIOL CHEM, V282, P21032, DOI 10.1074/jbc.M702073200; LATIF ZA, 1988, TRANSPLANTATION, V45, P827; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Li N, 2012, DIABETES, V61, P2842, DOI 10.2337/db12-0009; Liu Z, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.183; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marhfour I, 2012, DIABETOLOGIA, V55, P2417, DOI 10.1007/s00125-012-2604-3; Martegani MP, 1999, AM J PATHOL, V154, P291, DOI 10.1016/S0002-9440(10)65275-3; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oyadomari S, 2001, P NATL ACAD SCI USA, V98, P10845, DOI 10.1073/pnas.191207498; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Raats CJI, 1997, J BIOL CHEM, V272, P26734, DOI 10.1074/jbc.272.42.26734; Riemer J, 2009, SCIENCE, V324, P1284, DOI 10.1126/science.1170653; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Rops ALWMM, 2004, KIDNEY INT, V65, P768, DOI 10.1111/j.1523-1755.2004.00451.x; Rota C, 2005, ANAL BIOCHEM, V344, P193, DOI 10.1016/j.ab.2005.06.043; Sarrazin S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004952; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Shewade YM, 1999, TRANSPL P, V31, P1721, DOI 10.1016/S0041-1345(99)00077-9; Simeonovic CJ, 2020, ADV EXP MED BIOL, V1221, P607, DOI 10.1007/978-3-030-34521-1_24; Simeonovic CJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191360; Simeonovic CJ., 1998, ORGANTRANSPLANTATION, P167, DOI 10.1111/j.1399-3089.1998.tb00004.x; Song BB, 2008, J CLIN INVEST, V118, P3378, DOI 10.1172/JCI34587; Takahashi I, 2018, MOL CELL ENDOCRINOL, V470, P142, DOI 10.1016/j.mce.2017.10.008; Takahashi I, 2012, J DIABETES INVEST, V3, P362, DOI 10.1111/j.2040-1124.2012.00205.x; Takahashi I, 2009, BIOCHEM BIOPH RES CO, V383, P113, DOI 10.1016/j.bbrc.2009.03.140; Theodoraki A, 2015, MOL CELL ENDOCRINOL, V399, P296, DOI 10.1016/j.mce.2014.09.011; Tiedge M, 1997, DIABETES, V46, P1733, DOI 10.2337/diabetes.46.11.1733; van den Born J, 2005, J BIOL CHEM, V280, P20516, DOI 10.1074/jbc.M502065200; Wang J, 1999, J CLIN INVEST, V103, P27, DOI 10.1172/JCI4431; Yi XQ, 2020, MOL MED REP, V21, P2041, DOI 10.3892/mmr.2020.11013; Zhang J, 2016, NUTRIENTS, V8, DOI 10.3390/nu8100589; Ziolkowski AF, 2012, J CLIN INVEST, V122, P132, DOI 10.1172/JCI46177	71	6	6	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252607	10.1371/journal.pone.0252607	http://dx.doi.org/10.1371/journal.pone.0252607			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086738	Green Published, gold, Green Accepted			2022-12-26	WOS:000664640100095
J	Abdulkareem, NM; Bhat, R; Qin, LF; Vasaikar, S; Gopinathan, A; Mitchell, T; Shea, MJ; Nanda, S; Thangavel, H; Zhang, B; De Angelis, C; Schiff, R; Trivedi, MV				Abdulkareem, Noor Mazin; Bhat, Raksha; Qin, Lanfang; Vasaikar, Suhas; Gopinathan, Ambily; Mitchell, Tamika; Shea, Martin J.; Nanda, Sarmistha; Thangavel, Hariprasad; Zhang, Bing; De Angelis, Carmine; Schiff, Rachel; Trivedi, Meghana, V			A novel role of ADGRF1 (GPR110) in promoting cellular quiescence and chemoresistance in human epidermal growth factor receptor 2-positive breast cancer	FASEB JOURNAL			English	Article						ADGRF1; breast cancer; chemoresistance; GPR110; HER2; quiescence; tumorigenesis	PROTEIN-COUPLED RECEPTORS; ADHESION GPCRS; EXPRESSION; CELLS; GPR56/ADGRG1; ENCYCLOPEDIA; METASTASIS; ACTIVATION; DIVERSE; TRENDS	While G protein-coupled receptors (GPCRs) are known to be excellent drug targets, the second largest family of adhesion-GPCRs is less explored for their role in health and disease. ADGRF1 (GPR110) is an adhesion-GPCR and has an important function in neurodevelopment and cancer. Despite serving as a poor predictor of survival, ADGRF1's coupling to G proteins and downstream pathways remain unknown in cancer. We evaluated the effects of ADGRF1 overexpression on tumorigenesis and signaling pathways using two human epidermal growth factor receptor-2-positive (HER2+) breast cancer (BC) cell-line models. We also interrogated publicly available clinical datasets to determine the expression of ADGRF1 in various BC subtypes and its impact on BC-specific survival (BCSS) and overall survival (OS) in patients. ADGRF1 overexpression in HER2+ BC cells increased secondary mammosphere formation, soft agar colony formation, and % of Aldefluor-positive tumorigenic population in vitro and promoted tumor growth in vivo. ADGRF1 co-immunoprecipitated with both G alpha s and G alpha q proteins and increased cAMP and IP1 when overexpressed. However, inhibition of only the G alpha s pathway by SQ22536 reversed the pro-tumorigenic effects of ADGRF1 overexpression. RNA-sequencing and RPPA analysis revealed inhibition of cell cycle pathways with ADGRF1 overexpression, suggesting cellular quiescence, as also evidenced by cell cycle arrest at the G0/1 phase and resistance to chemotherapy in HER2+ BC. ADGRF1 was significantly overexpressed in the HER2-enriched BC compared to luminal A and B subtypes and predicted worse BCSS and OS in these patients. Therefore, ADGRF1 represents a novel drug target in HER2+ BC, warranting discovery of novel ADGRF1 antagonists.	[Abdulkareem, Noor Mazin; Bhat, Raksha; Trivedi, Meghana, V] Univ Houston, Coll Pharm, Dept Pharmacol & Pharmaceut Sci, Houston, TX 77204 USA; [Bhat, Raksha; Gopinathan, Ambily; Thangavel, Hariprasad; Trivedi, Meghana, V] Univ Houston, Coll Pharm, Dept Pharm Practice & Translat Res, Houston, TX 77204 USA; [Qin, Lanfang; Vasaikar, Suhas; Mitchell, Tamika; Shea, Martin J.; Nanda, Sarmistha; Zhang, Bing; De Angelis, Carmine; Schiff, Rachel; Trivedi, Meghana, V] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Zhang, Bing] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [De Angelis, Carmine] Univ Naples Federico II, Dept Clin Med & Surg, Naples, Italy; [Schiff, Rachel] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX USA; [Schiff, Rachel; Trivedi, Meghana, V] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Baylor College of Medicine; Baylor College of Medicine; University of Naples Federico II; Baylor College of Medicine; Baylor College of Medicine	Trivedi, MV (corresponding author), Univ Houston, Dept Pharm Practice & Translat Res, Hlth 2,4849 Calhoun Rd, Houston, TX 77204 USA.	mtrivedi@central.uh.edu	Bhat, Raksha/GNW-3971-2022	Bhat, Raksha/0000-0002-0026-1118; DE ANGELIS, CARMINE/0000-0003-1158-4630; Trivedi, Meghana V/0000-0002-0585-5580	Department of Defense BCRP [W81XWH-14-1-0340, W81XWH-14-1-0341]; Breast Cancer Research Foundation [BCRF-18-145, 19-145]; NIH [CA125123, P50 CA058183, CA186784-01]	Department of Defense BCRP(United States Department of Defense); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in parts by Department of Defense BCRP grants W81XWH-14-1-0340 and W81XWH-14-1-0341; Breast Cancer Research Foundation (BCRF-18-145 and 19-145 grants); and NIH grants CA125123, P50 CA058183, and CA186784-01. None of the funding agencies had any role in the design, analysis, or reporting of the analyses. The authors thank Joe Gray and Thomas Westbrook labs for providing SKBR3 cells and lentiviral vector (pHAGE-ind-ubc-DEST) containing a c-terminal HA tag, respectively. We also thank Dr. Shixia Huang from the Antibody-based Proteomics Core/Shared Resource and Dr. Preethi Gunaratne, Dr. Kimberly Holloway, and Mr. Brandon Mistretta from the UH Seq-N-Edit Core for their excellent technical assistant in performing RPPA and RNA-Seq studies, respectively.	Almeida MQ, 2011, MOL CELL ENDOCRINOL, V336, P162, DOI 10.1016/j.mce.2010.11.018; Ariazi EA, 2006, J STEROID BIOCHEM, V102, P128, DOI 10.1016/j.jsbmb.2006.09.003; Arpino G, 2007, JNCI-J NATL CANCER I, V99, P694, DOI 10.1093/jnci/djk151; Aust G, 2016, HANDB EXP PHARMACOL, V234, P369, DOI 10.1007/978-3-319-41523-9_17; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Beristain AG, 2015, ONCOGENE, V34, P1160, DOI 10.1038/onc.2014.41; Bhat RR, 2018, BREAST CANCER RES TR, V170, P279, DOI 10.1007/s10549-018-4751-9; Brown JA, 2017, CELL STEM CELL, V21, P650, DOI 10.1016/j.stem.2017.10.001; Caretta Antonio, 2011, Cancers (Basel), V3, P913, DOI 10.3390/cancers3010913; Chen W, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/1740936; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; De Angelis ML, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00626; Demberg LM, 2017, J BIOL CHEM, V292, P4383, DOI 10.1074/jbc.M116.763656; Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069; Gad AA, 2020, ACS PHARMACOL TRANSL, V3, P29, DOI 10.1021/acsptsci.9b00093; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Hasan AN, 2015, BIOINFORMATION, V11, P229, DOI 10.6026/97320630011229; Hauser AS, 2017, NAT REV DRUG DISCOV, V16, P829, DOI 10.1038/nrd.2017.178; Huang BX, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0831-6; Huang C, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2936; Jiang P, 2009, CANCER LETT, V284, P122, DOI 10.1016/j.canlet.2009.02.034; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kishore A, 2016, HANDB EXP PHARMACOL, V234, P127, DOI 10.1007/978-3-319-41523-9_7; Knapp B, 2016, HANDB EXP PHARMACOL, V234, P147, DOI 10.1007/978-3-319-41523-9_8; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lee JW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13123; Lee SH, 2020, STEM CELL REV REP, V16, P1185, DOI 10.1007/s12015-020-10031-8; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Liu ZQ, 2018, MED SCI MONITOR, V24, P5216, DOI 10.12659/MSM.909555; Lum AM, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-40; Ma BT, 2017, AM J CANCER RES, V7, P433; McKenzie AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026552; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Moreno M, 2017, CELL REP, V21, P2183, DOI 10.1016/j.celrep.2017.10.083; Nair A, 2018, NAT MED, V24, P505, DOI 10.1038/nm.4507; Nardone A, 2019, BRIT J CANCER, V120, P331, DOI 10.1038/s41416-018-0354-9; Parish AJ, 2018, CANCER-AM CANCER SOC, V124, P4080, DOI 10.1002/cncr.31724; Park T, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1621-2; Peeters MC, 2015, CELL SIGNAL, V27, P2579, DOI 10.1016/j.cellsig.2015.08.015; Pereira B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11479; Rask-Andersen M, 2011, NAT REV DRUG DISCOV, V10, P579, DOI 10.1038/nrd3478; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Schioth HB, 2005, GEN COMP ENDOCR, V142, P94, DOI 10.1016/j.ygcen.2004.12.018; Scholz N, 2019, ANN NY ACAD SCI, V1456, P80, DOI 10.1111/nyas.14192; Sethunath V, 2019, MOL CANCER RES, V17, P2318, DOI 10.1158/1541-7786.MCR-19-0756; Shi HP, 2017, BIOCHEM BIOPH RES CO, V491, P349, DOI 10.1016/j.bbrc.2017.07.097; Stoveken HM, 2018, MOL PHARMACOL, V93, P477, DOI 10.1124/mol.117.111476; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Tang XL, 2013, CANCER RES, V73, P6206, DOI 10.1158/0008-5472.CAN-13-1049; Thangavel H, 2019, J CLIN MED, V8, DOI 10.3390/jcm8111772; Valtcheva N, 2013, J BIOL CHEM, V288, P35736, DOI 10.1074/jbc.M113.512954; van Oirschot BA, 2001, J BIOL CHEM, V276, P33854, DOI 10.1074/jbc.M104395200; Vasaikar SV, 2018, NUCLEIC ACIDS RES, V46, pD956, DOI 10.1093/nar/gkx1090; Vizurraga A, 2020, J BIOL CHEM, V295, P14065, DOI 10.1074/jbc.REV120.007423; Wang YC, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3067; Ward Y, 2018, CELL REP, V23, P808, DOI 10.1016/j.celrep.2018.03.092; Yona S, 2008, FASEB J, V22, P741, DOI 10.1096/fj.07-9435com; Zambon AC, 2005, P NATL ACAD SCI USA, V102, P8561, DOI 10.1073/pnas.0503363102; Zhang XM, 2013, CANCER RES, V73, P4885, DOI 10.1158/0008-5472.CAN-12-4081; Zhu XL, 2019, PATHOL RES PRACT, V215, P539, DOI 10.1016/j.prp.2018.12.004	61	4	4	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21719	10.1096/fj.202100070R	http://dx.doi.org/10.1096/fj.202100070R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110646	Green Accepted			2022-12-26	WOS:000667814100046
J	Esendir, E; Burtscher, V; Coleman, JA; Zhu, R; Gouaux, E; Freissmuth, M; Sandtner, W				Esendir, Eray; Burtscher, Verena; Coleman, Jonathan A.; Zhu, Rong; Gouaux, Eric; Freissmuth, Michael; Sandtner, Walter			Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; INDUCED FIT; IBOGAINE; ANTIDEPRESSANTS; INHIBITION; MECHANISM; DOPAMINE; STATE	The serotonin transporter (SERT) shapes serotonergic neurotransmission by retrieving its eponymous substrate from the synaptic cleft. Ligands that discriminate between SERT and its close relative, the dopamine transporter DAT, differ in their association rate constant rather than their dissociation rate. The structural basis for this phenomenon is not known. Here we examined the hypothesis that the extracellular loops 2 (EL2) and 4 (EL4) limit access to the ligand-binding site of SERT. We employed an antibody directed against EL4 (residues 388-400) and the antibody fragments 8B6 scFv (directed against EL2 and EL4) and 15B8 Fab (directed against EL2) and analyzed their effects on the transport cycle of and inhibitor binding to SERT. Electrophysiological recordings showed that the EL4 antibody and 8B6 scFv impeded the initial substrate-induced transition from the outward to the inward-facing conformation but not the forward cycling mode of SERT. In contrast, binding of radiolabeled inhibitors to SERT was enhanced by either EL4or EL2-directed antibodies. We confirmed this observation by determining the association and dissociation rate of the DAT-selective inhibitor methylphenidate via electrophysiological recordings; occupancy of EL2 with 15B8 Fab enhanced the affinity of SERT for methylphenidate by accelerating its binding. Based on these observations, we conclude that (i) EL4 undergoes a major movement during the transition from the outward to the inward-facing state, and (ii) EL2 and EL4 limit access of inhibitors to the binding of SERT, thus acting as a selectivity filter. This insight has repercussions for drug development.	[Esendir, Eray; Burtscher, Verena; Freissmuth, Michael; Sandtner, Walter] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria; [Esendir, Eray; Burtscher, Verena; Freissmuth, Michael; Sandtner, Walter] Med Univ Vienna, Ctr Physiol & Pharmacol, Gaston H Glock Res Labs Exploratory Drug Dev, Vienna, Austria; [Coleman, Jonathan A.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Zhu, Rong] Johannes Kepler Univ Linz, Inst Biophys, Linz, Austria; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA; [Coleman, Jonathan A.] Univ Pittsburgh, Dept Struct Biol, Pittsburgh, PA USA	Medical University of Vienna; Medical University of Vienna; Oregon Health & Science University; Johannes Kepler University Linz; Howard Hughes Medical Institute; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Freissmuth, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria.; Freissmuth, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Gaston H Glock Res Labs Exploratory Drug Dev, Vienna, Austria.	michael.freissmuth@meduniwien.ac.at		Sandtner, Walter/0000-0003-3637-260X; Burtscher, Verena/0000-0002-0464-0799	doctoral program CCHD (Cell Communication In Health and Disease) - Austrian Science Fund/FWF [W1205]; Medical University of Vienna; Vienna Science and Technology Fund/WWTF [LSC17-026]; Austrian Science Fund/FWF [P31599]; National Institutes of Health [5R37MH070039]	doctoral program CCHD (Cell Communication In Health and Disease) - Austrian Science Fund/FWF; Medical University of Vienna; Vienna Science and Technology Fund/WWTF; Austrian Science Fund/FWF(Austrian Science Fund (FWF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the doctoral program CCHD (Cell Communication In Health and Disease) funded by a grant from the Austrian Science Fund/FWF (W1205) and by the Medical University of Vienna, by grants from the Vienna Science and Technology Fund/WWTF (LSC17-026 to M. F.), from the Austrian Science Fund/FWF (P31599 to W. S. and R. Z.), and from the National Institutes of Health (5R37MH070039 to E. G.). E. G. is an investigator with the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bhat S, 2019, BIOCHEM SOC T, V47, P861, DOI 10.1042/BST20180512; Bhat S, 2017, J BIOL CHEM, V292, P16773, DOI 10.1074/jbc.M117.794081; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Burtscher V., 2019, BIO-PROTOCOL, V9, P1; Burtscher V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215365; Burtscher V, 2018, ELIFE, V7, DOI 10.7554/eLife.34944; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chakraborty P, 2017, BIOCHEMISTRY-US, V56, P2853, DOI 10.1021/acs.biochem.7b00340; Coleman JA, 2020, ELIFE, V9, DOI 10.7554/eLife.56427; Coleman JA, 2019, NATURE, V569, P141, DOI 10.1038/s41586-019-1135-1; Coleman JA, 2018, NAT STRUCT MOL BIOL, V25, P170, DOI 10.1038/s41594-018-0026-8; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Freissmuth M, 2018, HANDB EXP PHARMACOL, V245, P249, DOI 10.1007/164_2017_71; Hasenhuetl PS, 2018, J GEN PHYSIOL, V150, P431, DOI 10.1085/jgp.201711915; Hasenhuetl PS, 2016, J BIOL CHEM, V291, P25864, DOI 10.1074/jbc.M116.753319; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; KOSHLAND DE, 1959, J CELL COMPAR PHYSL, V54, P245, DOI 10.1002/jcp.1030540420; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Navratna V, 2019, CURR OPIN STRUC BIOL, V54, P161, DOI 10.1016/j.sbi.2019.03.011; PLENGE P, 1991, EUR J PHARM-MOLEC PH, V206, P243, DOI 10.1016/S0922-4106(05)80025-2; Plenge P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15292-y; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Rannversson H, 2015, J BIOL CHEM, V290, P14582, DOI 10.1074/jbc.M114.629071; Rothman RB, 2012, J PHARMACOL EXP THER, V341, P251, DOI 10.1124/jpet.111.188946; Sandtner W, 2016, MOL PHARMACOL, V89, P165, DOI 10.1124/mol.115.101394; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhu R, 2016, ANGEW CHEM INT EDIT, V55, P1719, DOI 10.1002/anie.201508755	36	3	3	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100863	10.1016/j.jbc.2021.100863	http://dx.doi.org/10.1016/j.jbc.2021.100863			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34118233	Green Published, gold			2022-12-26	WOS:000678068400063
J	Mishra, S; Sharma, G; Das, MK; Pande, V; Singh, OP				Mishra, Shobhna; Sharma, Gunjan; Das, Manoj K.; Pande, Veena; Singh, Om P.			Intragenomic sequence variations in the second internal transcribed spacer (ITS2) ribosomal DNA of the malaria vector Anopheles stephensi	PLOS ONE			English	Article							CULICIFACIES COMPLEX; SPECIES COMPLEX; PHYLOGENETIC ANALYSIS; 1ST RECORD; DIPTERA; MEMBERS; RDNA; MOSQUITOS; DIFFERENTIATION; IDENTIFICATION	Second Internal Transcribed Spacer (ITS2) ribosomal DNA (rDNA) sequence is a widely used molecular marker for species-identification or -delimitation due to observed concerted evolution which is believed to homogenize rDNA copies in an interbreeding population. However, intra-specific differences in ITS2 of Anopheles stephensi have been reported. This study reports the presence of intragenomic sequence variation in the ITS2-rDNA of An. stephensi and hypothesizes that observed intra-specific differences in this species may have resulted due to ambiguous DNA sequence-chromatogram resulting from intragenomic heterogeneity. Anopheles stephensi collected from different parts of India were sequenced for complete ITS2 and the variable region of 28S-rDNA (d1-d3 domains). Intragenomic variations were found in ITS2 region of all An. stephensi sequenced, but no such variation was observed in d1 to d3 domains of 28S-rDNA. Cloning and sequencing of ITS2 through the d3 domain of the 28S region of rDNA from representative samples from northern, central, and southern India confirmed the presence of intragenomic variation in ITS2 due to transitions at three loci and two bp indel in a di-nucleotide microsatellite locus. Multiple haplotypes were observed in ITS2 raised from such variations. Due to the absence of detectable intragenomic sequence variation in the d1 to d3 domain of 28S rDNA of An. stephensi, this region can serve as an ideal reference sequence for taxonomic and phylogenetic studies. The presence of intragenomic variation in rDNA should be carefully examined before using this as a molecular marker for species delimitation or phylogenetic analyses.	[Mishra, Shobhna; Sharma, Gunjan; Singh, Om P.] Natl Inst Malaria Res, New Delhi, India; [Das, Manoj K.] Natl Inst Malaria Res, Field Unit, Ranchi, Bihar, India; [Pande, Veena] Kumaun Univ, Dept Biotechnol, Naini Tal, Uttarakhand, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Kumaun University	Singh, OP (corresponding author), Natl Inst Malaria Res, New Delhi, India.	dr.opsingh@gmail.com	Singh, Om/B-7958-2011	Singh, Om/0000-0001-5135-6654	Department of Science & Technology, India; ICMR-Senior Research Fellowship	Department of Science & Technology, India(Department of Science & Technology (India)); ICMR-Senior Research Fellowship	This research was supported by the Department of Science & Technology, India, https://dst.gov.in/(OPS) and ICMR-Senior Research Fellowship (SM and GS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adak T, 1999, T ROY SOC TROP MED H, V93, P573, DOI 10.1016/S0035-9203(99)90052-4; Alam MT, 2008, PARASITOL RES, V103, P75, DOI 10.1007/s00436-008-0930-7; Alam MT, 2007, T ROY SOC TROP MED H, V101, P239, DOI 10.1016/j.trstmh.2006.03.007; Balkew M, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-3904-y; Beebe NW, 2018, PARASITOLOGY, V145, P622, DOI 10.1017/S0031182018000343; BEEBE NW, 1995, AM J TROP MED HYG, V53, P478, DOI 10.4269/ajtmh.1995.53.478; Bezzhonova OV, 2008, J MED ENTOMOL, V45, P337, DOI 10.1603/0022-2585(2008)45[337:IHORIT]2.0.CO;2; Bhinder Preety, 2012, Toxicol Int, V19, P201, DOI 10.4103/0971-6580.97223; Campbell B.C., 1993, Insect Molecular Biology, V2, P225; Carter TE, 2018, ACTA TROP, V188, P180, DOI 10.1016/j.actatropica.2018.09.001; Christophers SR, 1933, DIPTERA FAMILY CULIC, VVol IV, P371; Dash AP, 2007, CURR SCI INDIA, V92, P1571; De Santi VP, 2021, EMERG INFECT DIS, V27, P1697, DOI 10.3201/eid2706.204557; Dharmasiri AGG, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1977-7; Djadid ND, 2006, ACTA TROP, V97, P65, DOI 10.1016/j.actatropica.2005.08.003; DOVER G, 1981, NATURE, V290, P731, DOI 10.1038/290731a0; Fairley TL, 2005, J MED ENTOMOL, V42, P795, DOI 10.1603/0022-2585(2005)042[0795:IHOITS]2.0.CO;2; Faulde MK, 2014, ACTA TROP, V139, P39, DOI 10.1016/j.actatropica.2014.06.016; Firooziyan S, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2523-y; Gholizadeh S, 2015, ACTA TROP, V146, P101, DOI 10.1016/j.actatropica.2015.03.012; Goldman ASH, 1996, GENETICS, V144, P43; Ironside JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055878; Jiang XF, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0459-2; Kaur S, 2000, J PARASITOL, V86, P1345, DOI 10.1645/0022-3395(2000)086[1345:SOSABA]2.0.CO;2; Keller I, 2006, GENETICS, V174, P863, DOI 10.1534/genetics.106.061341; Li C, 2007, J HERED, V98, P51, DOI 10.1093/jhered/esl037; LITVAITIS MK, 1994, MAR BIOL, V120, P437, DOI 10.1007/BF00680218; LIVAK KJ, 1984, GENETICS, V107, P611; Munawar K, 2020, ACTA TROP, V207, DOI 10.1016/j.actatropica.2020.105494; Onyabe DY, 1999, INSECT MOL BIOL, V8, P435, DOI 10.1046/j.1365-2583.1999.00134.x; Polanco C, 1998, GENETICS, V149, P243; Raghavendra K, 2009, INFECT GENET EVOL, V9, P271, DOI 10.1016/j.meegid.2008.12.007; Seyfarth M, 2019, PARASITOL RES, V118, P725, DOI 10.1007/s00436-019-06213-0; Sharma D, 2016, PARASITOL RES, V115, P323, DOI 10.1007/s00436-015-4750-2; Sharma S. K., 2001, Dengue Bulletin, V25, P88; Sharma VP, 2012, CURR SCI INDIA, V102, P678; Sharpe RG, 1999, MED VET ENTOMOL, V13, P265, DOI 10.1046/j.1365-2915.1999.00178.x; Sindhania A, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03492-2; Singh OP, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03172-1; Singh OP, 2004, J BIOSCIENCES, V29, P275, DOI 10.1007/BF02702609; Singh OP, 2004, AM J TROP MED HYG, V70, P27, DOI 10.4269/ajtmh.2004.70.27; Surendran SN, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00053; Surendran SN, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2601-y; Tadesse FG, 2021, EMERG INFECT DIS, V27, P603, DOI 10.3201/eid2702.200019; Whang IJ, 2002, MOL CELLS, V14, P158; WHO, 2019, VECT AL AN STEPH INV; Zhang W, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176395	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0253173	10.1371/journal.pone.0253173	http://dx.doi.org/10.1371/journal.pone.0253173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125861	gold, Green Published, Green Submitted			2022-12-26	WOS:000664643500025
J	Erram, J; Bari, M; Domingo, A; Cannon, DT				Erram, Jyotika; Bari, Monica; Domingo, Antoinette; Cannon, Daniel T.			Pulmonary function with expiratory resistive loading in healthy volunteers	PLOS ONE			English	Article							LIMB MUSCLE DYSFUNCTION; LUNG-FUNCTION CHANGES; FLOW-VOLUME CURVES; EXERCISE; HYPERINFLATION; LIMITATION; COPD; DYNAMICS; DYSPNEA	Expiratory flow limitation is a key characteristic in obstructive pulmonary diseases. To study abnormal lung mechanics isolated from heterogeneities of obstructive disease, we measured pulmonary function in healthy adults with expiratory loading. Thirty-seven volunteers (25 +/- 5 yr) completed spirometry and body plethysmography under control and threshold expiratory loading of 7, 11 cmH(2)O, and a subset at 20 cmH(2)O (n = 11). We analyzed the shape of the flow-volume relationship with rectangular area ratio (RAR; Ma et al., Respir Med 2010). Airway resistance was increased (p<0.0001) with 7 and 11 cmH(2)O loading vs control (9.20<plus/minus>1.02 and 11.76 +/- 1.68 vs. 2.53 +/- 0.80 cmH(2)O/L/s). RAR was reduced (p = 0.0319) in loading vs control (0.45 +/- 0.07 and 0.47 +/- 0.09L vs. 0.48 +/- 0.08). FEV1 was reduced (p<0.0001) in loading vs control (3.24<plus/minus>0.81 and 3.23 +/- 0.80 vs. 4.04 +/- 1.05 L). FVC was reduced (p<0.0001) in loading vs control (4.11<plus/minus>1.01 and 4.14 +/- 1.03 vs. 5.03 +/- 1.34 L). Peak expiratory flow (PEF) was reduced (p<0.0001) in loading vs control (6.03<plus/minus>1.67 and 6.02 +/- 1.84 vs. 8.50 +/- 2.81 L/s). FEV1/FVC (p<0.0068) was not clinically significant and FRC (p = 0.4) was not different in loading vs control. Supra-physiologic loading at 20 cmH(2)O did not result in further limitation. Expiratory loading reduced FEV1, FVC, PEF, but there were no clinically meaningful differences in FEV1/FVC, FRC, or RAR. Imposed expiratory loading likely leads to high airway pressures that resist dynamic airway compression. Thus, a concave expiratory flow-volume relationship was consistently absent-a key limitation for model comparison with pulmonary function in COPD. Threshold loading may be a useful strategy to increase work of breathing or induce dynamic hyperinflation.	[Erram, Jyotika; Bari, Monica; Domingo, Antoinette; Cannon, Daniel T.] San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA	California State University System; San Diego State University	Cannon, DT (corresponding author), San Diego State Univ, Sch Exercise & Nutr Sci, San Diego, CA 92182 USA.	dcannon@sdsu.edu						Aliverti A, 2002, J APPL PHYSIOL, V92, P1953, DOI 10.1152/japplphysiol.01222.2000; Aliverti A, 2007, RESPIROLOGY, V12, P478, DOI 10.1111/j.1440-1843.2007.01106.x; Barreiro E, 2015, COPD, V12, P413, DOI 10.3109/15412555.2014.974737; Bellamy David, 2006, Prim Care Respir J, V15, P48, DOI 10.1016/j.pcrj.2005.11.003; BLACK LF, 1969, AM REV RESPIR DIS, V99, P696; Bretonneau Q, 2020, MULTIDISCIP RESP MED, V15, DOI 10.4081/mrm.2020.702; Cooper CB, 2009, RESP MED, V103, P325, DOI 10.1016/j.rmed.2008.10.026; Eberlein Michael, 2014, Ann Am Thorac Soc, V11, P1258, DOI 10.1513/AnnalsATS.201312-465OI; Eltayara L, 1996, AM J RESP CRIT CARE, V154, P1726, DOI 10.1164/ajrccm.154.6.8970362; Iandelli I, 2002, J APPL PHYSIOL, V92, P1943, DOI 10.1152/japplphysiol.00393.2000; Katajisto M, 2012, INT J CHRONIC OBSTR, V7, P743, DOI 10.2147/COPD.S35497; KOULOURIS NG, 1995, EUR RESPIR J, V8, P306, DOI 10.1183/09031936.95.08020306; Langer D, 2014, EXPERT REV RESP MED, V8, P731, DOI 10.1586/17476348.2014.949676; Lee J, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0182-8; Ma SY, 2010, RESP MED, V104, P389, DOI 10.1016/j.rmed.2009.10.014; Makarevich AE, 2014, ADV CLIN EXP MED, V23, P381, DOI 10.17219/acem/37129; Maltais F, 2014, AM J RESP CRIT CARE, V189, P1121, DOI 10.1164/rccrn.201402-0373ST; Melissant CF, 1998, EUR RESPIR J, V11, P1369, DOI 10.1183/09031936.98.11061369; MUELLER RE, 1970, J APPL PHYSIOL, V28, P784, DOI 10.1152/jappl.1970.28.6.784; Nussbaumer-Ochsner Y, 2011, CHEST, V139, P165, DOI 10.1378/chest.10-1252; O'Donnell Denis E, 2006, Proc Am Thorac Soc, V3, P180, DOI 10.1513/pats.200508-093DO; O'Donnell DE, 2014, CLIN CHEST MED, V35, P51, DOI 10.1016/j.ccm.2013.09.008; ODONNELL DE, 1987, AM REV RESPIR DIS, V135, P912, DOI 10.1164/arrd.1987.135.4.912; Porszasz J, 2018, RESP PHYSIOL NEUROBI, V251, P8, DOI 10.1016/j.resp.2018.02.006; Ranu Harpreet, 2011, Ulster Med J, V80, P84; Spahija JA, 1996, J APPL PHYSIOL, V80, P1772, DOI 10.1152/jappl.1996.80.5.1772; Terzano C, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-8; THOMAN RL, 1966, AM REV RESPIR DIS, V93, P100; Urban MH, 2021, EXP PHYSIOL, V106, P532, DOI 10.1113/EP088439; van den Bemt L, 2008, RESP MED, V102, P633, DOI 10.1016/j.rmed.2007.12.014; Varga J, 2016, RESP PHYSIOL NEUROBI, V234, P79, DOI 10.1016/j.resp.2016.08.005; WASSERMANN K, 1995, RESPIRATION, V62, P177	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252916	10.1371/journal.pone.0252916	http://dx.doi.org/10.1371/journal.pone.0252916			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115812	Green Published, gold			2022-12-26	WOS:000664643000040
J	Kuruppath, P; Belluscio, L				Kuruppath, Praveen; Belluscio, Leonardo			The influence of stimulus duration on olfactory perception	PLOS ONE			English	Article								The duration of a stimulus plays an important role in the coding of sensory information. The role of stimulus duration is extensively studied in the tactile, visual, and auditory system. In the olfactory system, temporal properties of the stimulus are key for obtaining information when an odor is released in the environment. However, how the stimulus duration influences the odor perception is not well understood. To test this, we activated the olfactory bulbs with blue light in mice expressing channelrhodopsin in the olfactory sensory neurons (OSNs) and assessed the relevance of stimulus duration on olfactory perception using foot shock associated active avoidance behavioral task on a "two-arms maze". Our behavior data demonstrate that the stimulus duration plays an important role in olfactory perception and the associated behavioral responses.	[Kuruppath, Praveen; Belluscio, Leonardo] NINDS, Dev Neural Plast Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Kuruppath, Praveen] Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA; [Belluscio, Leonardo] Howard Hughes Med Inst, Chevy Chase, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Colorado System; University of Colorado Anschutz Medical Campus; Howard Hughes Medical Institute	Kuruppath, P (corresponding author), NINDS, Dev Neural Plast Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.; Kuruppath, P (corresponding author), Univ Colorado, Sch Med, Dept Physiol & Biophys, Aurora, CO 80045 USA.	praveen.kuruppath@cuanschutz.edu			Intramural Research Program of the National Institutes of Health-National Institute of Neurological Disorders and Stroke [1ZIANS003116-01]	Intramural Research Program of the National Institutes of Health-National Institute of Neurological Disorders and Stroke	This work was supported by the Intramural Research Program of the National Institutes of Health-National Institute of Neurological Disorders and Stroke (1ZIANS003116-01). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Abraham NM, 2004, NEURON, V44, P865, DOI 10.1016/j.neuron.2004.11.017; Arzi A, 2010, CURR BIOL, V20, pR563, DOI 10.1016/j.cub.2010.04.048; Bathellier B., 2009, NEUROBIOLOGY OLFACTI; Blankenship ML, 2019, CURR BIOL, V29, P62, DOI 10.1016/j.cub.2018.11.011; Boie SD, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006275; Bolding KA, 2017, ELIFE, V6, DOI 10.7554/eLife.22630; Busch NA, 2004, CLIN NEUROPHYSIOL, V115, P1810, DOI 10.1016/j.clinph.2004.03.015; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; Catania KC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2444; Celani A, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.041015; Cheetham CEJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10729; Christensen TA, 1997, J NEUROPHYSIOL, V77, P775, DOI 10.1152/jn.1997.77.2.775; Denman D., 2017, MOUSE HUE WAVELENGTH, DOI [10.1101/174631, DOI 10.1101/174631]; Denman DJ, 2018, ELIFE, V7, DOI 10.7554/eLife.31209; Erofeev A, 2019, APPL SCI-BASEL, V9, DOI 10.3390/app9183673; Finelli CM, 1999, LIMNOL OCEANOGR, V44, P1056, DOI 10.4319/lo.1999.44.4.1056; Frasnelli J, 2006, INT J PSYCHOPHYSIOL, V62, P24, DOI 10.1016/j.ijpsycho.2005.11.006; Gupta P, 2015, NAT NEUROSCI, V18, P272, DOI 10.1038/nn.3913; Heinbockel T., 1999, J COMP NEUROL; Jordan R, 2018, NEURON, V98, P1214, DOI 10.1016/j.neuron.2018.05.016; Kakutani Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07285-7; Klink KB, 2004, J COMP PHYSIOL A, V190, P1039, DOI 10.1007/s00359-004-0561-0; Li A, 2014, J NEUROSCI, V34, P16058, DOI 10.1523/JNEUROSCI.3382-14.2014; Lin JY, 2012, PROG BRAIN RES, V196, P29, DOI 10.1016/B978-0-444-59426-6.00002-1; Lin JY, 2011, EXP PHYSIOL, V96, P19, DOI 10.1113/expphysiol.2009.051961; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Lin JY, 2012, EXP PHYSIOL; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; Masek P, 2008, P NATL ACAD SCI USA, V105, P15985, DOI 10.1073/pnas.0804086105; McDonald JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116357; Oka Y, 2009, J NEUROSCI, V29, P12070, DOI 10.1523/JNEUROSCI.1415-09.2009; Pannunzi M, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01428; Paoli M, 2018, J NEUROSCI, V38, P9240, DOI 10.1523/JNEUROSCI.0453-18.2018; Parabucki A, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0396-18.2019; Park IM, 2014, J NEUROSCI, V34, P941, DOI 10.1523/JNEUROSCI.2204-13.2014; Peirson SN, 2018, J NEUROSCI METH, V300, P26, DOI 10.1016/j.jneumeth.2017.04.007; Plewan T, 2012, EXP BRAIN RES, V223, P367, DOI 10.1007/s00221-012-3265-7; Porter J, 2005, NEURON, V47, P581, DOI 10.1016/j.neuron.2005.06.028; Quinlan MAL, 2019, FRONT SYST NEUROSCI, V12, DOI 10.3389/fnsys.2018.00067; Rajan R, 2006, SCIENCE, V311, P666, DOI 10.1126/science.1122096; Reddy G., 2017, ANTAGONISM OLFACTORY, DOI [10.1101/204354, DOI 10.1101/204354]; Schoenfeld TA, 2005, TRENDS NEUROSCI, V28, P620, DOI 10.1016/j.tins.2005.09.005; Scott JW, 2014, J NEUROSCI, V34, P2025, DOI 10.1523/JNEUROSCI.3736-13.2014; Shusterman R, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0149-18.2018; Sirotin YB, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0083-15.2015; Smear M, 2013, NAT NEUROSCI, V16, P1687, DOI 10.1038/nn.3519; Smear M, 2011, NATURE, V479, P397, DOI 10.1038/nature10521; Sparta DR, 2012, NAT PROTOC, V7, P12, DOI 10.1038/nprot.2011.413; Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011; Szyszka P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036096; Ung K, 2012, JOVE-J VIS EXP, DOI 10.3791/50004; Vergassola M, 2007, NATURE, V445, P406, DOI 10.1038/nature05464; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; Wachowiak M, 2011, NEURON, V71, P962, DOI 10.1016/j.neuron.2011.08.030; Wilson CD, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01432-4; Wright GA, 2009, BEHAV NEUROSCI, V123, P36, DOI 10.1037/a0014040; Zak JD, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17124-5	57	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252931	10.1371/journal.pone.0252931	http://dx.doi.org/10.1371/journal.pone.0252931			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111206	Green Published, gold			2022-12-26	WOS:000664642700065
J	Li, XC; Tao, F; Fan, SH; Li, HY; Yang, JR; Gao, LQ				Li, Xiancheng; Tao, Fei; Fan, Sanhong; Li, Haiyuan; Yang, Jiarong; Gao, Liqiang			Genetic diversity of Venturia inaequalis isolates (Apple scab) in China and UK determined by SSR markers	PLOS ONE			English	Article							LEAF-LITTER; POPULATIONS; RESISTANCE	Apple scab caused by Venturia inaequalis is a serious disease of cultivated apple worldwide. In this study, we collected 132 V. inaequalis isolates from Shaanxi, Gansu, Xinjiang, and the U.K. and analyzed their genetic diversity by using 13 microsatellite markers. Cluster analysis based on population structure and genetic distances suggested high similarity among the four regions. Population differentiation values ranged from 0.044 to 0.155, indicating there is a high level of kinship among the four regions. All isolates could be divided into 5 lineages with a 0.76 similarity coefficient. Among the four regions, Shaanxi had only one lineage, Group II; Gansu had four lineages, Group I, Group II, Group IV, and Group V; Xinjiang had all five lineages, Group I, Group II, Group III, Group IV, and Group V; and the U.K. had three lineages, Group I, Group II and Group IV. High molecular variance was detected for populations in the four regions, with 91% of the variance occurring within the populations and 9% among the populations. Structure analysis there are three common ancestors of these four regions. The results of the present study shed light on the genetic diversity of V. inaequalis in Shaanxi, Gansu and Xinjiang, which will lead to the development of more effective management strategies and new resistant apple cultivars through molecular marker-assisted selection.	[Li, Xiancheng; Li, Haiyuan; Yang, Jiarong; Gao, Liqiang] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China; [Tao, Fei] Gansu Agr Univ, Coll Plant Protect, Lanzhou, Gansu, Peoples R China; [Fan, Sanhong] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Gansu Agricultural University; Northwest A&F University - China	Yang, JR (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	yjrong@nwsuaf.edu.cn			"111"Project from Education Ministry of China [B07049]; Shaanxi Provincial Science and Technology Project [2015TTC-N-10-5]	"111"Project from Education Ministry of China(Ministry of Education, China - 111 Project); Shaanxi Provincial Science and Technology Project	This research was supported by"111"Project from Education Ministry of China (B07049) and Shaanxi Provincial Science and Technology Project (2015TTC-N-10-5).	[Anonymous], 1997, MOL BIOL BIOTECHNOLO; Beckerman J., 2009, PURDUE EXTENSION B; Bessho H, 2009, J AM POMOL SOC, V63, P2; Boehm EWA, 2003, PHYTOPARASITICA, V31, P236, DOI 10.1007/BF02980833; Bowen JK, 2011, MOL PLANT PATHOL, V12, P105, DOI 10.1111/j.1364-3703.2010.00656.x; [张恒涛 Zhang Hengtao], 2020, [果树学报, Journal of Fruit Science], V37, P1779; Celik A, 2019, ERWERBS-OBSTBAU, V61, P263, DOI 10.1007/s10341-019-00426-4; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ebrahimi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160737; Fu J., 2010, Acta mycologica Sinica, V2, P303; Gladieux P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001455; Gomez C, 2007, AGR ECOSYST ENVIRON, V118, P249, DOI 10.1016/j.agee.2006.05.025; Guerin F, 2004, MOL ECOL NOTES, V4, P268, DOI 10.1111/j.1471-8286.2004.00637.x; Hu XiaoPing, 2008, Acta Phytopathologica Sinica, V38, P329; Jha G, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/680160; KIMURA M, 1964, GENETICS, V49, P725; Koopman TA, 2017, PHYTOPATHOLOGY, V107, P455, DOI 10.1094/PHYTO-07-16-0279-R; Lewontin R.C., 1972, EVOL BIOL, P381, DOI [10.1007/978-1-4684-9063-3_14, DOI 10.1007/978-1-4684-9063-3_14]; Lichtner FJ, 2020, PHYTOPATHOLOGY, V110, P544, DOI 10.1094/PHYTO-06-19-0222-A; MacHardy W.E, 1996, APPLE SCAB BIOL EPID; MacHardy WE, 2001, PLANT DIS, V85, P1036, DOI 10.1094/PDIS.2001.85.10.1036; Mansoor S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224300; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Papp D, 2020, PLANT DIS, V104, P649, DOI 10.1094/PDIS-10-19-2082-RE; PARISI L, 1993, PHYTOPATHOLOGY, V83, P533, DOI 10.1094/Phyto-83-533; Passey TAJ, 2017, PLANT PATHOL, V66, P1445, DOI 10.1111/ppa.12686; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Sitther V, 2018, FOREST PATHOL, V48, DOI 10.1111/efp.12405; Sutton DK, 2000, PLANT DIS, V84, P1319, DOI 10.1094/PDIS.2000.84.12.1319; Tenzer I, 1997, EUR J PLANT PATHOL, V103, P565, DOI 10.1023/A:1008636913211; Tenzer I, 1999, EUR J PLANT PATHOL, V105, P545, DOI 10.1023/A:1008775900736; Weir B.S., 1997, TRENDS GENET, V13, P379, DOI DOI 10.1016/S0168-; Wilson EE, 1928, PHYTOPATHOLOGY, V18, P375; Xu XM, 2008, PLANT DIS, V92, P247, DOI 10.1094/PDIS-92-2-0247; Xu Xiangming, 2009, BMC Res Notes, V2, P163, DOI 10.1186/1756-0500-2-163	36	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252865	10.1371/journal.pone.0252865	http://dx.doi.org/10.1371/journal.pone.0252865			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111167	Green Published, gold			2022-12-26	WOS:000664642700054
J	Kim, HG; Yang, SY; Han, YD; Cho, MS; Min, BS; Lee, KY; Kim, NK; Hur, H				Kim, Han-Gil; Yang, Seung Yoon; Han, Yoon Dae; Cho, Min Soo; Min, Byung Soh; Lee, Kang Young; Kim, Nam Kyu; Hur, Hyuk			Association of perioperative serum carcinoembryonic antigen level and recurrence in low-risk stage IIA colon cancer	PLOS ONE			English	Article							COLORECTAL-CANCER; TUMOR-MARKERS; CEA; SMOKING; DIAGNOSIS; SURVIVAL; AGE	Background The purpose is to investigate prognosis according to serum CEA levels before and after surgery in patients with stage IIA colon cancer who do not show high-risk features. Methods Among the patients diagnosed with colon adenocarcinoma between April 2011 and December 2017, 462 patients were confirmed as low-risk stage IIA after surgery and enrolled. The ROC curve was used to determine cut-off values of pre- and postoperative CEA. Patients were classified into three groups using these new cut-off values. Results All recurrence occurred in 52 of 463 patients (11.2%). However, recurrence in group H was 15.9%, which was slightly higher than the other two groups (P = 0.04). Group L and M showed 10.5% and 12.8% overall survival, group H was higher at 21.0% (P = 0.005). Recurrence was the only risk factor in group H was significantly higher in group L (HR 2.008, 95% CI, 1.123-3.589, P = 0.019). Mortality was similar to recurrence (HR 1.975, 95% CI 1.091-3.523, P = 0.044). Conclusion Among patients with low-risk stage IIA colon cancer, recurrence and mortality rates were higher when perioperative serum CEA levels were above a certain level. Therefore, high CEA level should be considered a high-risk feature and adjuvant chemotherapy should be performed.	[Kim, Han-Gil; Yang, Seung Yoon; Han, Yoon Dae; Cho, Min Soo; Min, Byung Soh; Lee, Kang Young; Kim, Nam Kyu; Hur, Hyuk] Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea; [Kim, Han-Gil] Gyeongsang Natl Univ, Coll Med, Gyeongsang Natl Univ Hosp, Dept Surg, Jinju, Gyeongsangnam D, South Korea; [Hur, Hyuk] Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Gyeongsang National University; Gyeongsang National University Hospital; Yonsei University; Yonsei University Health System	Hur, H (corresponding author), Yonsei Univ, Coll Med, Severance Hosp, Dept Surg, Seoul, South Korea.; Hur, H (corresponding author), Yonsei Univ, Coll Med, Yongin Severance Hosp, Dept Surg, Seoul, South Korea.	HHYUK@yuhs.ac		Kim, Han-Gil/0000-0002-6394-942X; Yang, Seung Yoon/0000-0001-8129-7712; Kim, Nam-Kyu/0000-0003-0639-5632; Han, Yoondae/0000-0002-2136-3578; Hur, Hyuk/0000-0002-9864-7229				ALEXANDER JC, 1976, JAMA-J AM MED ASSOC, V235, P1975; Baqar AR, 2019, INT J SURG, V64, P10, DOI 10.1016/j.ijsu.2019.02.014; Benson AB, 2005, SEMIN ONCOL, V32, pS74, DOI 10.1053/j.seminoncol.2005.4.016; Benson AB, 2018, J NATL COMPR CANC NE, V16, P359, DOI 10.6004/jnccn.2018.0021; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; CULLEN KJ, 1976, AUST NZ J MED, V6, P279, DOI 10.1111/imj.1976.6.4.279; De Rosa M, 2015, ONCOL REP, V34, P1087, DOI 10.3892/or.2015.4108; Duffy MJ, 2007, EUR J CANCER, V43, P1348, DOI 10.1016/j.ejca.2007.03.021; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Gao YF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21048-y; Kannarkatt J, 2017, J ONCOL PRACT, V13, P233, DOI 10.1200/JOP.2016.017210; Kashiwabara K, 2001, CLIN CHIM ACTA, V303, P25, DOI 10.1016/S0009-8981(00)00341-7; Kim CW, 2013, ANN SURG ONCOL, V20, P2914, DOI 10.1245/s10434-013-2919-4; Kim JY, 2009, ANN SURG ONCOL, V16, P2771, DOI 10.1245/s10434-009-0651-x; Konishi T, 2018, JAMA ONCOL, V4, P309, DOI 10.1001/jamaoncol.2017.4420; Lin JK, 2011, INT J COLORECTAL DIS, V26, P1135, DOI 10.1007/s00384-011-1209-5; Litvak A, 2014, J NATL COMPR CANC NE, V12, P907, DOI 10.6004/jnccn.2014.0085; Locker GY, 2006, J CLIN ONCOL, V24, P5313, DOI 10.1200/JCO.2006.08.2644; Moreno CC, 2016, CLIN COLORECTAL CANC, V15, P67, DOI 10.1016/j.clcc.2015.07.004; Potosky AL, 2002, J CLIN ONCOL, V20, P1192, DOI 10.1200/JCO.20.5.1192; Tsai HL, 2016, WORLD J SURG, V40, P1002, DOI 10.1007/s00268-015-3331-y; Vatandoost N, 2016, J CANCER RES CLIN, V142, P341, DOI 10.1007/s00432-015-1928-z; Verberne CJ, 2017, BRIT J SURG, V104, P1069, DOI 10.1002/bjs.10535; Wichmann MW, 2000, LANGENBECK ARCH SURG, V385, P271, DOI 10.1007/s004230000136	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252566	10.1371/journal.pone.0252566	http://dx.doi.org/10.1371/journal.pone.0252566			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106954	Green Published, gold			2022-12-26	WOS:000664642200052
J	Kong, JD; Tekwa, EW; Gignoux-Wolfsohn, SA				Kong, Jude Dzevela; Tekwa, Edward W.; Gignoux-Wolfsohn, Sarah A.			Social, economic, and environmental factors influencing the basic reproduction number of COVID-19 across countries	PLOS ONE			English	Article							AMBIENT AIR-POLLUTION; EPIDEMIC GROWTH; PUBLIC-HEALTH; TRANSMISSION; SPREAD; IMPACT; ASSOCIATION; MEDIA; VARIABLES; CLIMATE	Objective To assess whether the basic reproduction number (R-0) of COVID-19 is different across countries and what national-level demographic, social, and environmental factors other than interventions characterize initial vulnerability to the virus. Methods We fit logistic growth curves to reported daily case numbers, up to the first epidemic peak, for 58 countries for which 16 explanatory covariates are available. This fitting has been shown to robustly estimate R-0 from the specified period. We then use a generalized additive model (GAM) to discern both linear and nonlinear effects, and include 5 random effect covariates to account for potential differences in testing and reporting that can bias the estimated R-0. Findings We found that the mean R0 is 1.70 (S.D. 0.57), with a range between 1.10 (Ghana) and 3.52 (South Korea). We identified four factors-population between 20-34 years old (youth), population residing in urban agglomerates over 1 million (city), social media use to organize offline action (social media), and GINI income inequality-as having strong relationships with R-0, across countries. An intermediate level of youth and GINI inequality are associated with high R-0, (n-shape relationships), while high city population and high social media use are associated with high R-0. Pollution, temperature, and humidity did not have strong relationships with R-0 but were positive. Conclusion Countries have different characteristics that predispose them to greater intrinsic vulnerability to COVID-19. Studies that aim to measure the effectiveness of interventions across locations should account for these baseline differences in social and demographic characteristics.	[Kong, Jude Dzevela] York Univ, Ctr Dis Modeling CDM, Toronto, ON, Canada; [Kong, Jude Dzevela] York Univ, Dept Math & Stat, Toronto, ON, Canada; [Tekwa, Edward W.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ USA; [Tekwa, Edward W.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Tekwa, Edward W.] Univ British Columbia, Dept Zool, Vancouver, BC, Canada; [Gignoux-Wolfsohn, Sarah A.] Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA	York University - Canada; York University - Canada; Rutgers State University New Brunswick; Princeton University; University of British Columbia; Smithsonian Institution; Smithsonian Environmental Research Center	Kong, JD (corresponding author), York Univ, Ctr Dis Modeling CDM, Toronto, ON, Canada.; Kong, JD (corresponding author), York Univ, Dept Math & Stat, Toronto, ON, Canada.	jdkong@yorku.ca		Tekwa, E.W./0000-0003-2971-6128; Gignoux-Wolfsohn, Sarah/0000-0002-9037-1088	Canada's International Development Research Centre (IDRC) [109559-001]	Canada's International Development Research Centre (IDRC)	This research is funded by Canada's International Development Research Centre (IDRC) : https://www.idrc.ca/en (Grant No. 109559-001 (J. D.K)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114047; [Anonymous], 2020, DOWNL TOD DAT GEOGR; Azuma K, 2020, ENVIRON RES, V190, DOI 10.1016/j.envres.2020.110042; Boehmer TK, 2020, MMWR-MORBID MORTAL W, V69, P1404, DOI 10.15585/mmwr.mm6939e1; Central Intelligence Agency, 2017, WORLD FACTBOOK; Chan MPS, 2018, SOC SCI MED, V212, P50, DOI 10.1016/j.socscimed.2018.07.007; Chaudhry R, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100464; Comunian S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124487; Copiello S, 2020, SCI TOTAL ENVIRON, V744, DOI 10.1016/j.scitotenv.2020.141028; Cowling BJ, 2020, LANCET PUBLIC HEALTH, V5, pE279, DOI 10.1016/S2468-2667(20)30090-6; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Davies NG, 2020, NAT MED, V26, P1205, DOI 10.1038/s41591-020-0962-9; Demongeot J, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9050094; Diop BZ, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002699; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Du ZW, 2020, EMERG INFECT DIS, V26, P1341, DOI [10.3201/eid2606.200357, 10.1101/2020.02.19.20025452]; Duhon J, 2021, SCI TOTAL ENVIRON, V760, DOI 10.1016/j.scitotenv.2020.144325; Fattorini D, 2020, ENVIRON POLLUT, V264, DOI 10.1016/j.envpol.2020.114732; Frontera A, 2020, J INFECTION, V81, P339, DOI 10.1016/j.jinf.2020.03.045; Gangemi Sebastiano, 2020, Clin Mol Allergy, V18, P12, DOI 10.1186/s12948-020-00127-4; Gargiulo C, 2020, TEMA, P189, DOI 10.6092/1970-9870/6864; Geneva World Health Organization, 2016, GLOB HLTH EST 2015 D; Ghosh D, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.020348; Haque SE, 2020, ENVIRON SCI POLICY, V114, P253, DOI 10.1016/j.envsci.2020.08.012; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hilton J, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008031; Islam MS, 2020, AM J TROP MED HYG, V103, P1621, DOI 10.4269/ajtmh.20-0812; Islam N, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110355; Jiang Y, 2020, INFECT CONT HOSP EP, V41, P1011, DOI 10.1017/ice.2020.222; Kissler SM, 2020, SCIENCE, V368, P860, DOI 10.1126/science.abb5793; Kong JD., 2020, DATA CODE SOCIAL EC; Kreutz R, 2020, CARDIOVASC RES, V116, P1688, DOI 10.1093/cvr/cvaa097; Krkosek M, 2021, FACETS, V6, P180, DOI 10.1139/facets-2020-0055; Li H, 2020, INT J INFECT DIS, V97, P278, DOI 10.1016/j.ijid.2020.05.076; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Li Y, 2021, LANCET INFECT DIS, V21, P193, DOI 10.1016/S1473-3099(20)30785-4; Lolli S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73197-8; Ma JL, 2014, B MATH BIOL, V76, P245, DOI 10.1007/s11538-013-9918-2; Martins LD, 2020, ENVIRON RES, V191, DOI 10.1016/j.envres.2020.110184; Matrajt L, 2020, EMERG INFECT DIS, V26, P1740, DOI 10.3201/eid2608.201093; Morris DH, 2021, ELIFE, V10, DOI 10.7554/eLife.65902; Nakada LYK, 2021, ENVIRON SCI POLLUT R, V28, P40322, DOI 10.1007/s11356-020-10930-w; Niehus Rene, 2020, medRxiv, DOI 10.1101/2020.02.13.20022707; Nuclear Threat Initiative Johns Hopkins Center for Health Security The Economist Intelligence Unit, 2019, GHS INDEX; Oronce CI, 2020, J GEN INTERN MED, V35, P2791, DOI 10.1007/s11606-020-05971-3; Park M, 2020, J CLIN MED, V9, DOI 10.3390/jcm9040967; Pequeno P, 2020, PEERJ, V8, DOI 10.7717/peerj.9322; Rader B, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1104-0; Ran JJ, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01253-2020; Raza A, 2021, ENVIRON SCI POLLUT R, V28, P40378, DOI 10.1007/s11356-020-11203-2; Ridenhour B, 2014, AM J PUBLIC HEALTH, V104, pE32, DOI 10.2105/AJPH.2013.301704; Roser M., 2020, CORONAVIRUS DIS COVI; Russell TW, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01790-9; Russell Timothy W, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.12.2000256; Sajadi MM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11834; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Scarpone C, 2020, INT J HEALTH GEOGR, V19, DOI 10.1186/s12942-020-00225-1; Shaw J., 2020, HARVARD MAG; Singh O, 2021, ENVIRON DEV SUSTAIN, V23, P9514, DOI 10.1007/s10668-020-01003-6; Sobral MFF, 2020, SCI TOTAL ENVIRON, V729, DOI 10.1016/j.scitotenv.2020.138997; Sooknanan J, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00757-4; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; The World Bank, 2011, CLIM DAT API; Tuite AR, 2020, CAN MED ASSOC J, V192, pE497, DOI 10.1503/cmaj.200476; V-Dem Institute, 2020, **DATA OBJECT**; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Vosoughi S, 2018, SCIENCE, V359, P1146, DOI 10.1126/science.aap9559; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; Wang BM, 2020, AM J PHYSIOL-LUNG C, V319, pL416, DOI 10.1152/ajplung.00244.2020; Wei JT, 2020, INT J HYG ENVIR HEAL, V230, DOI 10.1016/j.ijheh.2020.113610; World Bank, 2020, WORLD DEV IND; Wu K, 2020, NONLINEAR DYNAM, V101, P1561, DOI 10.1007/s11071-020-05862-6; Yao Y, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00517-2020; Zhang ZB, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140244; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050	75	20	20	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252373	10.1371/journal.pone.0252373	http://dx.doi.org/10.1371/journal.pone.0252373			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RW	34106993	gold, Green Submitted, Green Published			2022-12-26	WOS:000664642200043
J	Li, X; Feng, LY				Li, Xia; Feng, Linyan			Impact of donors' financial fairness perception on donation intention in nonprofit organizations after COVID-19 outbreak	PLOS ONE			English	Article								Based on the investigation of financial fairness perception and donation intention of individual donors in non-profit organizations (NPOs), this paper uses structural equation model to analyze the impact of individual donors' financial fairness perception on donation intention. The results show that individual donors' perceptions on financial result fairness, financial procedure fairness and financial information fairness all have positive impact on donation intention; among which the perception on financial result fairness only has direct impact on individual donation intention, while the perceptions on financial procedure fairness and financial information fairness have direct and indirect impact on individual donation intention.	[Li, Xia] Anhui Univ Finance & Econ, Accounting Sch, Bengbu, Anhui, Peoples R China; [Feng, Linyan] Anhui Univ Finance & Econ, Coll Business Adm, Bengbu, Anhui, Peoples R China	Anhui University of Finance & Economics; Anhui University of Finance & Economics	Li, X (corresponding author), Anhui Univ Finance & Econ, Accounting Sch, Bengbu, Anhui, Peoples R China.	15955203990@163.com			Humanities and social sciences research key project of Anhui province [SK2019A0470]	Humanities and social sciences research key project of Anhui province	This paper is supported by the following fund projects: Humanities and social sciences research key project of Anhui province "research on factors influencing the financial performance of non-profit organizations and their action mechanism from the perspective of interest conflict" (SK2019A0470).	Ackermann K, 2019, NONPROF VOLUNT SEC Q, V48, P1119, DOI 10.1177/0899764019848484; Albouy J, 2019, NONPROF VOLUNT SEC Q, V48, P1250, DOI 10.1177/0899764019843341; Andorfer VA, 2013, NONPROF VOLUNT SEC Q, V42, P657, DOI 10.1177/0899764012440180; Bies R. J., 1986, RES NEGOTIATION ORG, V1, P43, DOI [DOI 10.1037/0021-9010.86.3.425, DOI 10.1111/J.1559-1816.2004.TB02581.X]; Brooks A. C., 2006, WHO REALLY CARES SUR; Colquitt JA, 2001, J APPL PSYCHOL, V86, P386, DOI 10.1037//0021-9010.86.3.386; Du L.Y., 2012, RES ATTRACTIVENESS I, V4, P182; Goenka S, 2019, J CONSUM RES, V46, P774, DOI 10.1093/jcr/ucz012; Gottfried M.A., 2006, INT J ED ADV, V6, P268, DOI [10.1057/palgrave.ijea.2150034, DOI 10.1057/PALGRAVE.IJEA.2150034]; Grant AM, 2010, J PERS SOC PSYCHOL, V98, P946, DOI 10.1037/a0017935; Kottasz R., 2004, INT J NONPROFIT VOLU, V9, P9, DOI [10.1002/nvsm.230, DOI 10.1002/NVSM.230]; Leventhal G., 1976, ADV EXP SOC PSYCHOL, P91, DOI DOI 10.1016/S0065-2601(08)60059-3; Li X., 2017, J SHANGHAI U FINANCE, V19, P40; Reed A, 2007, J MARKETING, V71, P178, DOI 10.1509/jmkg.71.1.178; SHAPIRO DL, 1994, ORGAN BEHAV HUM DEC, V58, P346, DOI 10.1006/obhd.1994.1041; Thibaut J., 1975, PROCEDURAL JUSTICE P; Trussel JM, 2007, ADV ACCOUNT, V23, P263, DOI 10.1016/S0882-6110(07)23010-X; Willis, 1980, SOCIAL EXCHANGE ADV, P27, DOI [10.1007/978-1-4613-3087-5_2, DOI 10.1007/978-1-4613-3087-5_2]; Zhao F.F., 2016, TECHNOLOGY MANAGEMEN, V2, P36	19	2	2	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0251991	10.1371/journal.pone.0251991	http://dx.doi.org/10.1371/journal.pone.0251991			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106946	gold, Green Published			2022-12-26	WOS:000664642200025
J	Oscar-Berman, M; Ruiz, SM; Marinkovic, K; Valmas, MM; Harris, GJ; Sawyer, KS				Oscar-Berman, Marlene; Ruiz, Susan Mosher; Marinkovic, Ksenija; Valmas, Mary M.; Harris, Gordon J.; Sawyer, Kayle S.			Brain responsivity to emotional faces differs in men and women with and without a history of alcohol use disorder	PLOS ONE			English	Article							FACIAL EXPRESSION; DRINKING HISTORY; RECOGNITION; MEMORY; ASSOCIATIONS; ATTENTION; DEFICITS; STIMULI; SYSTEM; TERM	Inclusion of women in research on Alcohol Use Disorder (AUD) has shown that gender differences contribute to unique profiles of cognitive, emotional, and neuropsychological dysfunction. We employed functional magnetic resonance imaging (fMRI) of abstinent individuals with a history of AUD (21 women [AUDw], 21 men [AUDm]) and demographically similar non-AUD control (NC) participants without AUD (21 women [NCw], 21 men [NCm]) to explore how gender and AUD interact to influence brain responses during emotional processing and memory. Participants completed a delayed match-to-sample emotional face memory fMRI task, and brain activation contrasts between a fixation stimulus and pictures of emotional face elicited a similar overall pattern of activation for all four groups. Significant Group by Gender interactions revealed two activation clusters. A cluster in an anterior portion of the middle and superior temporal gyrus, elicited lower activation to the fixation stimulus than to faces for the AUDw as compared to the NCw; that abnormality was more pronounced than the one observed for men. Another cluster in the medial portion of the superior frontal cortex elicited higher activation to the faces by AUDm than NCm, a difference that was more evident than the one observed for women. Together, these findings have added new evidence of AUD-related gender differences in neural responses to facial expressions of emotion.	[Oscar-Berman, Marlene; Ruiz, Susan Mosher; Valmas, Mary M.; Sawyer, Kayle S.] VA Boston Healthcare Syst, Psychol Res Serv, Boston, MA 02130 USA; [Oscar-Berman, Marlene; Ruiz, Susan Mosher; Valmas, Mary M.; Sawyer, Kayle S.] Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA; [Oscar-Berman, Marlene; Valmas, Mary M.; Harris, Gordon J.; Sawyer, Kayle S.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Marinkovic, Ksenija] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Sawyer, Kayle S.] Sawyer Sci LLC, Boston, MA 02108 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Harvard University; Massachusetts General Hospital; California State University System; San Diego State University	Sawyer, KS (corresponding author), VA Boston Healthcare Syst, Psychol Res Serv, Boston, MA 02130 USA.; Sawyer, KS (corresponding author), Boston Univ, Sch Med, Dept Anat & Neurobiol, Boston, MA 02118 USA.; Sawyer, KS (corresponding author), Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA.; Sawyer, KS (corresponding author), Sawyer Sci LLC, Boston, MA 02108 USA.	kslays@bu.edu	Sawyer, Kayle S./H-2724-2019	Sawyer, Kayle S./0000-0001-7767-5688; Berman, Marlene Oscar/0000-0003-0100-8883	National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health US Department of Health and Human Services [R01AA007112, K05AA00219, R01AA016624, K01AA13402]; US Department of Veterans Affairs Clinical Science Research and Development [I01CX000326]; National Center for Advancing Translational Sciences of the National Institutes of Health US Department of Health and Human Services [1S10RR023401, 1S10RR019307, 1S10RR023043, 1UL1TR001430]	National Institute on Alcohol Abuse and Alcoholism (NIAAA) of the National Institutes of Health US Department of Health and Human Services; US Department of Veterans Affairs Clinical Science Research and Development; National Center for Advancing Translational Sciences of the National Institutes of Health US Department of Health and Human Services	This work was supported by funds from the National Institute on Alcohol Abuse and Alcoholism (NIAAA; https://www.niaaa.nih.gov/) of the National Institutes of Health US Department of Health and Human Services under Award Numbers R01AA007112 and K05AA00219 awarded to M.O. B., as well as R01AA016624 and K01AA13402 awarded to K.M.; US Department of Veterans Affairs Clinical Science Research and Development (https://www.research.va.gov/services/csrd/) grant I01CX000326 awarded to M.O.B.; National Center for Advancing Translational Sciences of the National Institutes of Health US Department of Health and Human Services under Award Numbers 1S10RR023401, 1S10RR019307, 1S10RR023043, and 1UL1TR001430. K.S.S. is an employee of Sawyer Scientific, LLC. The funders provided support in the form of salaries for authors M.O.B., S.M.R., K.M., M.M.V., G.J.H., and K.S.S., but did not have any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the U.S. Department of Veterans Affairs, or the United States Government.	Andrews TJ, 2004, NEUROIMAGE, V23, P905, DOI 10.1016/j.neuroimage.2004.07.060; BRIGGS G G, 1975, Cortex, V11, P230; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cahalan D., 1969, CTR ALCOHOL STUDIES; Clark US, 2007, NEUROPSYCHOLOGY, V21, P346, DOI 10.1037/0894-4105.21.3.346; Cotto JH, 2010, GENDER MED, V7, P402, DOI 10.1016/j.genm.2010.09.004; Cowan N, 2011, NEUROPSYCHOLOGIA, V49, P1401, DOI 10.1016/j.neuropsychologia.2011.01.035; Dale A, 1999, NEUROIMAGE, V9, pS33; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dolcos F, 2006, J NEUROSCI, V26, P2072, DOI 10.1523/JNEUROSCI.5042-05.2006; Druzgal TJ, 2003, J COGNITIVE NEUROSCI, V15, P771, DOI 10.1162/089892903322370708; Durazzo TC, 2013, ALCOHOL CLIN EXP RES, V37, P1794, DOI 10.1111/acer.12140; Engell AD, 2007, NEUROPSYCHOLOGIA, V45, P3234, DOI 10.1016/j.neuropsychologia.2007.06.022; Fama R, 2020, ALCOHOL RES-CURR REV, V40, DOI 10.35946/arcr.v40.2.03; Fein G, 2015, ALCOHOL RES-CURR REV, V37, P125; Fine JG, 2009, BEHAV BRAIN RES, V201, P137, DOI 10.1016/j.bbr.2009.02.009; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Foisy ML, 2005, J STUD ALCOHOL, V66, P673, DOI 10.15288/jsa.2005.66.673; Fox HC, 2009, HARVARD REV PSYCHIAT, V17, P103, DOI 10.1080/10673220902899680; Fusar-Poli P, 2009, J PSYCHIATR NEUROSCI, V34, P418; Grant BF, 2015, JAMA PSYCHIAT, V72, P757, DOI 10.1001/jamapsychiatry.2015.0584; Greve DN, 2018, NEUROIMAGE, V171, P6, DOI 10.1016/j.neuroimage.2017.12.072; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hoffman LA, 2019, ALCOHOL CLIN EXP RES, V43, P1928, DOI 10.1111/acer.14152; Kauschke C, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01654; Keightley ML, 2011, SOC COGN AFFECT NEUR, V6, P24, DOI 10.1093/scan/nsq003; Kesler ML, 2001, COGNITIVE BRAIN RES, V11, P213, DOI 10.1016/S0926-6410(00)00073-2; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Kornreich C, 2001, J STUD ALCOHOL, V62, P533, DOI 10.15288/jsa.2001.62.533; Kret ME, 2012, NEUROPSYCHOLOGIA, V50, P1211, DOI 10.1016/j.neuropsychologia.2011.12.022; Kuntsche E, 2006, ADDICT BEHAV, V31, P1844, DOI 10.1016/j.addbeh.2005.12.028; LoPresti ML, 2008, J NEUROSCI, V28, P3718, DOI 10.1523/JNEUROSCI.0464-08.2008; Luhar RB, 2013, NEUROPSYCH DIS TREAT, V9, P1767, DOI 10.2147/NDT.S52298; Majerus S, 2007, NEUROIMAGE, V35, P353, DOI 10.1016/j.neuroimage.2006.12.008; Marinkovic K, 2009, ALCOHOL CLIN EXP RES, V33, P1880, DOI 10.1111/j.1530-0277.2009.01026.x; Mosher Ruiz S., 2015, SAGE ENCY ALCOHOL 2, V2, P586; Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207; Narumoto J, 2001, COGNITIVE BRAIN RES, V12, P225, DOI 10.1016/S0926-6410(01)00053-2; Nixon Sara Jo, 2014, Handb Clin Neurol, V125, P253, DOI 10.1016/B978-0-444-62619-6.00016-1; Nolen-Hoeksema S, 2012, ANNU REV CLIN PSYCHO, V8, P161, DOI 10.1146/annurev-clinpsy-032511-143109; Nutt DJ, 2010, LANCET, V376, P1558, DOI 10.1016/S0140-6736(10)61462-6; Oscar-Berman M, 2003, ALCOHOL RES HEALTH, V27, P125; Oscar-Berman M, 2007, NEUROPSYCHOL REV, V17, P239, DOI 10.1007/s11065-007-9038-6; Oscar-Berman Marlene, 2014, Handb Clin Neurol, V125, P183, DOI 10.1016/B978-0-444-62619-6.00012-4; OSCARBERMAN M, 1990, ALCOHOL CLIN EXP RES, V14, P383, DOI 10.1111/j.1530-0277.1990.tb00491.x; Padula CB, 2015, ALCOHOL CLIN EXP RES, V39, P272, DOI 10.1111/acer.12626; Philippi CL, 2009, J NEUROSCI, V29, P15089, DOI 10.1523/JNEUROSCI.0796-09.2009; Philippot P, 1999, ALCOHOL CLIN EXP RES, V23, P1031, DOI 10.1097/00000374-199906000-00010; Pleis John R, 2010, Vital Health Stat 10, P1; Rivas-Grajales AM, 2018, NEUROIMAGE-CLIN, V19, P98, DOI 10.1016/j.nicl.2018.03.025; Robins LN, 2000, COMPUTERIZED DIAGNOS; Ruiz SM, 2013, J ALCOHOL DRUG DEPEN, V1, P106, DOI [10.4172/2329-6488.1000e106, DOI 10.4172/2329-6488.1000E106]; Ruiz SM, 2017, ALCOHOL ALCOHOLISM, V52, P496, DOI 10.1093/alcalc/agx016; Ruiz SM, 2013, ALCOHOL CLIN EXP RES, V37, P110, DOI 10.1111/j.1530-0277.2012.01862.x; Said CP, 2011, PHILOS T R SOC B, V366, P1660, DOI 10.1098/rstb.2010.0351; Satterthwaite TD, 2009, HUM BRAIN MAPP, V30, P3748, DOI 10.1002/hbm.20803; Sawyer KS, 2019, ELIFE, V8, DOI 10.7554/eLife.41723; Sawyer KS, 2018, NEUROPSYCHOPHARMACOL, V43, P1876, DOI 10.1038/s41386-018-0089-6; Sawyer KS, 2017, PSYCHIAT RES-NEUROIM, V263, P15, DOI 10.1016/j.pscychresns.2017.03.001; Sawyer KS, 2016, ALCOHOL CLIN EXP RES, V40, P1262, DOI 10.1111/acer.13074; Sawyer KS, 2015, PEERJ, V3, DOI 10.7717/peerj.941; Seitz J, 2017, BRAIN IMAGING BEHAV, V11, P1006, DOI 10.1007/s11682-016-9579-5; Sprengelmeyer R, 1998, P ROY SOC B-BIOL SCI, V265, P1927, DOI 10.1098/rspb.1998.0522; Thesen S, 2000, MAGNET RESON MED, V44, P457, DOI 10.1002/1522-2594(200009)44:3<457::AID-MRM17>3.0.CO;2-R; Townshend JM, 2003, NEUROPSYCHOLOGIA, V41, P773, DOI 10.1016/S0028-3932(02)00284-1; Uekermann J, 2005, CORTEX, V41, P189, DOI 10.1016/S0010-9452(08)70893-1; Valmas MM, 2014, ALCOHOL CLIN EXP RES, V38, P2998, DOI 10.1111/acer.12566; Verplaetse TL, 2021, J NEUROSCI RES, V99, P309, DOI 10.1002/jnr.24625; Versace F, 2012, ADDICT BIOL, V17, P991, DOI 10.1111/j.1369-1600.2011.00372.x; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Wechsler D., 2010, WAIS 4 WECHSLER ADUL; Wechsler D., 1997, TECHNICAL MANUAL, VThird, P426; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004; Woo CW, 2014, NEUROIMAGE, V91, P412, DOI 10.1016/j.neuroimage.2013.12.058; World Health Organization, 2018, AIR POLL CHILD HLTH; Wrase J, 2003, NEUROSCI LETT, V348, P41, DOI 10.1016/S0304-3940(03)00565-2; Zou XW, 2018, ALCOHOL CLIN EXP RES, V42, P1062, DOI 10.1111/acer.13757	82	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0248831	10.1371/journal.pone.0248831	http://dx.doi.org/10.1371/journal.pone.0248831			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106934	Green Published, gold			2022-12-26	WOS:000664642200009
J	Shimai, H; Setoguchi, H; Roberts, DL; Sun, M				Shimai, Hiro; Setoguchi, Hiroaki; Roberts, David L.; Sun, Miao			Biogeographical patterns and speciation of the genus Pinguicula (Lentibulariaceae) inferred by phylogenetic analyses	PLOS ONE			English	Article							NUCLEAR RDNA; L. LENTIBULARIACEAE; MOLECULAR PHYLOGENY; CARNIVOROUS PLANT; EVOLUTION; DIVERSIFICATION; HYBRIDIZATION; INCONGRUENCE; MORPHOLOGY; ASTERACEAE	Earlier phylogenetic studies in the genus Pinguicua (Lentibulariaceae) suggested that the species within a geographical region was rather monophyletic, although the sampling was limited or was restricted to specific regions. Those results conflicted with the floral morphology-based classification, which has been widely accepted to date. In the current study, one nuclear ribosomal DNA (internal transcribed spacer; ITS) and two regions of chloroplast DNA (matK and rpl32-trnL), from up to ca. 80% of the taxa in the genus Pinguicula, covering all three subgenera, were sequenced to demonstrate the inconsistency and explore a possible evolutionary history of the genus. Some incongruence was observed between nuclear and chloroplast topologies and the results from each of the three DNA analyses conflicted with the morphology-based subgeneric divisions. Both the ITS tree and network, however, corresponded with the biogeographical patterns of the genus supported by life-forms (winter rosette or hibernaculum formation) and basic chromosome numbers (haploidy). The dormant strategy evolved in a specific geographical region is a phylogenetic constraint and a synapomorphic characteristic within a lineage. Therefore, the results denied the idea that the Mexican group, morphologically divided into the three subgenera, independently acquired winter rosette formations. Topological incongruence among the trees or reticulations, indicated by parallel edges in phylogenetic networks, implied that some taxa originated by introgressive hybridisation. Although there are exceptions, species within the same geographical region arose from a common ancestor. Therefore, the classification by the floral characteristics is rather unreliable. The results obtained from this study suggest that evolution within the genus Pinguicula has involved; 1) ancient expansions to geographical regions with gene flow and subsequent vicariance with genetic drift, 2) acquirement of a common dormant strategy within a specific lineage to adapt a local climate (i.e., synapomorphic characteristic), 3) recent speciation in a short time span linked to introgressive hybridisation or multiplying the ploidy level (i.e., divergence), and 4) parallel evolution in floral traits among lineages found in different geographical regions (i.e., convergence). As such, the floral morphology masks and obscures the phylogenetic relationships among species in the genus.	[Shimai, Hiro; Roberts, David L.] Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England; [Setoguchi, Hiroaki] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto, Japan; [Sun, Miao] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA; [Shimai, Hiro] Tokyo Metropolitan Board Educ, Shinjuku Ku, Tokyo, Japan; [Setoguchi, Hiroaki] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto, Japan; [Sun, Miao] Aarhus Univ, Dept Biol Ecoinformat & Biodivers, Aarhus C, Denmark	University of Kent; Kyoto University; State University System of Florida; University of Florida; Kyoto University; Aarhus University	Shimai, H (corresponding author), Univ Kent, Durrell Inst Conservat & Ecol, Sch Anthropol & Conservat, Canterbury, Kent, England.; Shimai, H (corresponding author), Tokyo Metropolitan Board Educ, Shinjuku Ku, Tokyo, Japan.	shimaihiro@gmail.com	; Sun, Miao/A-6128-2018	Shimai, Hiro/0000-0003-2429-0543; Sun, Miao/0000-0001-5701-0478; Roberts, David/0000-0001-6788-2691				Alm T, 2000, POLARFLOKKEN, V24, P193; [Anonymous], 1966, BIBLIOTHECA BOT; Barnhart JH., 1916, MEM NY BOT GARD, V6, P39; Beck Stephan G., 2008, Willdenowia, V38, P201, DOI 10.3372/wi.38.38115; Bell CD, 2010, AM J BOT, V97, P1296, DOI 10.3732/ajb.0900346; Birky CW, 2008, CURR BIOL, V18, pR692, DOI 10.1016/j.cub.2008.06.049; Blanca G, 1999, FOLIA GEOBOT, V34, P337, DOI 10.1007/BF02912819; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Casper SJ, 2009, PLANT SYST EVOL, V277, P21, DOI 10.1007/s00606-008-0097-9; Casper SJ., 2003, WILLDENOWIA, V33, P167, DOI [10.3372/wi.33.33116, DOI 10.3372/WI.33.33116]; Casper SJ., 1962, FEDDES REPERT, V66, P1; Casper SJ., 2001, WULFENIA, V8, P27; Casper SJ., 1972, FLORA EUROPEAE, V3, P294; Cheek Martin, 1994, Kew Bulletin, V49, P813, DOI 10.2307/4118077; Cieslak T, 2005, AM J BOT, V92, P1723, DOI 10.3732/ajb.92.10.1723; Contandriopoulos J., 1962, ANN FACULTE SCI MARS, V32, P1; Conti F, 2006, ANN BOT FENN, V43, P321; Darwin C., 1875, INSECTIVOROUS PLANTS; Degtjareva GV, 2006, PLANT BIOLOGY, V8, P778, DOI 10.1055/s-2006-924560; Douzery EJP, 1999, AM J BOT, V86, P887, DOI 10.2307/2656709; Fior S, 2006, AM J BOT, V93, P399, DOI 10.3732/ajb.93.3.399; Fleischmann A, 2018, CARNIVOROUS PLANTS: PHYSIOLOGY, ECOLOGY, AND EVOLUTION, P70, DOI 10.1093/oso/9780198779841.003.0006; Givnish T.J., 1989, P243; Hall B.G., 2016, PHYLOGENETIC TREES M; Heslop-Harrison Y, 2004, J ECOL, V92, P1071, DOI 10.1111/j.0022-0477.2004.00942.x; Heslop-Harrison Y., 1962, P ROYAL IRISH ACAD B, V62, P23; Hidalgo O, 2004, ANN BOT-LONDON, V93, P283, DOI 10.1093/aob/mch042; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Huxley AJ., 1992, NEW ROYAL HORTICULTU, V3, P581; IMAI HT, 1986, AM NAT, V128, P900, DOI 10.1086/284612; International Plant Names Index, 2020, DAT; Jobson RW, 2004, P NATL ACAD SCI USA, V101, P18064, DOI 10.1073/pnas.0408092101; Juniper B. E., 1989, CARNIVOROUS PLANTS; Kondo Katsuhiko, 2006, APG Acta Phytotaxonomica et Geobotanica, V57, P155; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Ledig FT, 1997, EVOLUTION, V51, P1815, DOI [10.2307/2411004, 10.1111/j.1558-5646.1997.tb05105.x]; Legendre L, 2000, ACTA BOT GALLICA, V147, P77, DOI 10.1080/12538078.2000.10515837; Lloyd F.E., 1942, CARNIVOROUS PLANTS; Lozano-Garcia S, 2005, HOLOCENE, V15, P329, DOI 10.1191/0959683605hl814rp; Luhrs Hans, 1995, Phytologia, V79, P114; Magny M, 2002, PALAEOGEOGR PALAEOCL, V186, P47, DOI 10.1016/S0031-0182(02)00442-X; Malcomber ST, 2002, EVOLUTION, V56, P42, DOI 10.1111/j.0014-3820.2002.tb00848.x; Mallet J, 2005, TRENDS ECOL EVOL, V20, P229, DOI 10.1016/j.tree.2005.02.010; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; MASON HERBERT L., 1954, MADRONO, V12, P161; Metcalfe SE, 2000, QUATERNARY SCI REV, V19, P699, DOI 10.1016/S0277-3791(99)00022-0; Mitsui Y, 2008, ANN BOT-LONDON, V101, P111, DOI 10.1093/aob/mcm267; Muller K, 2004, PLANT BIOLOGY, V6, P477, DOI 10.1055/s-2004-817909; Neubig KM, 2015, BOT J LINN SOC, V179, P421, DOI 10.1111/boj.12330; Nie ZL, 2008, MOL PHYLOGENET EVOL, V48, P1027, DOI 10.1016/j.ympev.2008.06.004; Nomura N, 2010, ANN BOT-LONDON, V106, P467, DOI 10.1093/aob/mcq139; Okuyama Y, 2005, MOL BIOL EVOL, V22, P285, DOI 10.1093/molbev/msi016; Ortega-Rosas CI, 2008, REV PALAEOBOT PALYNO, V151, P1, DOI 10.1016/j.revpalbo.2008.01.008; Pennington W., 1969, HIST BRIT VEGETATION; Piperno DR, 2007, P NATL ACAD SCI USA, V104, P11874, DOI 10.1073/pnas.0703442104; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Schubert I, 2007, CURR OPIN PLANT BIOL, V10, P109, DOI 10.1016/j.pbi.2007.01.001; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shim H, 2016, CHEM LETT, V45, P51, DOI 10.1246/cl.150910; Shimai H., 2017, THESIS U KENT; Shimai H., 2007, CHROMOSOME BOT, V2, P67, DOI 10.3199/iscb.2.67; Slack A., 1986, INSECT EATING PLANTS; Smith JF, 2017, MOL PHYLOGENET EVOL, V106, P228, DOI 10.1016/j.ympev.2016.10.001; SOLTIS DE, 1991, AM J BOT, V78, P1091, DOI 10.2307/2444898; Soltis PS, 2015, CURR OPIN GENET DEV, V35, P119, DOI 10.1016/j.gde.2015.11.003; Soltis PS, 2009, ANNU REV PLANT BIOL, V60, P561, DOI 10.1146/annurev.arplant.043008.092039; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Sun M, 2015, MOL PHYLOGENET EVOL, V83, P156, DOI 10.1016/j.ympev.2014.11.003; TAMMARO F, 1987, Informatore Botanico Italiano, V19, P429; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turesson G, 1927, HEREDITAS, V9, P81; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; Whitfield JB, 2007, TRENDS ECOL EVOL, V22, P258, DOI 10.1016/j.tree.2007.01.012; YAMANAKA T., 1953, JOUR JAPANESE BOT, V28, P30; ZAMORA R, 1995, OIKOS, V73, P309, DOI 10.2307/3545955; Zamora R, 1996, PLANT SYST EVOL, V200, P41, DOI 10.1007/BF00984747; Zamudio S., 1986, PHYTOLOGIA, V60, P255; Zamudio S., 2000, ACTA BOT MEX, V53, P67; Zamudio S., 2005, FLORA BAJIO REGIONES, V136, P1; Zamudio S., 1999, ACTA BOT MEX, V47, P15; Zamudio S, 1997, ACTA BOT MEX, V39, P61; Zamudio S., 2005, ACTA BOT MEX, V70, P69, DOI DOI 10.21829/ABM70.2005.988; Zamudio S., 1997, ACTA BOT MEX, V40, P65; Zamudio S, 2001, THESIS U NACL AUTONO; Zamudio S., 1991, ACTA BOTANICA MEXICA, V14, P23; Zamudio S, 1998, ACTA BOT MEX, V42, P7; Zamudio S., 2006, FLORA VALLE TEHUACAN, V45, P1; Zamudio S., 1988, ACTA BOT MEX, V3, P21	89	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252581	10.1371/journal.pone.0252581	http://dx.doi.org/10.1371/journal.pone.0252581			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097720	Green Published, Green Accepted, gold			2022-12-26	WOS:000664640700012
J	Ibe, T; Wada, H; Sakakura, K; Ugata, Y; Maki, H; Yamamoto, K; Seguchi, M; Taniguchi, Y; Jinnouchi, H; Fujita, H				Ibe, Tatsuro; Wada, Hiroshi; Sakakura, Kenichi; Ugata, Yusuke; Maki, Hisataka; Yamamoto, Kei; Seguchi, Masaru; Taniguchi, Yousuke; Jinnouchi, Hiroyuki; Fujita, Hideo			Cardiac index predicts long-term outcomes in patients with heart failure	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; SIDED FILLING PRESSURES; PROGNOSTIC IMPACT; MEDICAL THERAPY; MORTALITY; CATHETERIZATION; ASSOCIATION; CARDIOLOGY; MORBIDITY; DISEASE	Background The role of cardiac index (CI) and right atrial pressure (RAP) for predicting long-term outcomes of heart failure has not been well established. The aim of this study was to investigate long-term cardiac outcomes in patients with heart failure having various combinations of CI and RAP. Methods A total of 787 heart failure patients who underwent right-heart catheterization were retrospectively categorized into the following four groups: Preserved CI (>= 2.5 L/min/m(2)) and Low RAP (<8 mmHg) (PRE-CI/L-RAP; n = 285); Preserved CI (<greater than or equal to>2.5 L/min/m(2)) and High RAP (>= 8 mmHg) (PRE-CI/H-RAP; n = 242); Reduced CI (<2.5 L/min/m(2)) and Low RAP (<8 mmHg) (RED-CI/L-RAP; n = 123); and Reduced CI (<2.5 L/min/m(2)) and High RAP (<greater than or equal to>8 mmHg) (RED-CI/H-RAP; n = 137). Survival analysis was applied to investigate which groups were associated with major adverse cardiovascular events (MACE). Results The RED-CI/L-RAP and RED-CI/H-RAP groups were significantly associated with MACE as compared with the PRE-CI/L-RAP and PRE-CI/H-RAP groups after adjustment for confounding factors (RED-CI/L-RAP vs. PRE-CI/L-RAP: HR 2.11 [95% CI 1.33-3.37], p = 0.002; RED-CI/H-RAP vs. PRE-CI/L-RAP: HR 2.18 [95% CI 1.37-3.49], p = 0.001; RED-CI/L-RAP vs. PRE-CI/H-RAP: HR 1.86 [95% CI 1.16-3.00], p = 0.01; RED-CI/H-RAP vs. PRE-CI/H-RAP: HR 1.92 [95% CI 1.26-2.92], p = 0.002), whereas the difference between the RED-CI/H-RAP and RED-CI/L-RAP groups was not significant (HR 1.03 [95% CI 0.64-1.66], p = 0.89). Conclusions The hemodynamic severity categorized by CI and RAP levels provided clear risk stratification in patients with symptomatic heart failure. Low CI was an independent predictor of long-term cardiac outcomes.	[Ibe, Tatsuro; Wada, Hiroshi; Sakakura, Kenichi; Ugata, Yusuke; Maki, Hisataka; Yamamoto, Kei; Seguchi, Masaru; Taniguchi, Yousuke; Jinnouchi, Hiroyuki; Fujita, Hideo] Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Saitama, Japan	Jichi Medical University	Wada, H (corresponding author), Jichi Med Univ, Saitama Med Ctr, Div Cardiovasc Med, Saitama, Japan.	wadahiro@jichi.ac.jp	Sakakura, Kenichi/AAK-4564-2020; Ibe, Tatsuro/AAD-7941-2022; FUJITA, HIDEO/AHC-6839-2022	Sakakura, Kenichi/0000-0003-3566-0394; Fujita, Hideo/0000-0002-4901-3502; Ibe, Tatsuro/0000-0002-8162-4004				Altaie S, 2018, ESC HEART FAIL, V5, P1008, DOI 10.1002/ehf2.12353; Anker SD, 2003, CIRCULATION, V107, P1991, DOI 10.1161/01.CIR.0000065637.10517.A0; Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Boucly A, 2017, EUR RESPIR J, V50, DOI 10.1183/13993003.00889-2017; Cho JH, 2019, CIRC J, V83, P347, DOI 10.1253/circj.CJ-18-0543; Cooper LB, 2016, J CARD FAIL, V22, P182, DOI 10.1016/j.cardfail.2015.11.012; Damman K, 2007, EUR J HEART FAIL, V9, P872, DOI 10.1016/j.ejheart.2007.05.010; Drazner MH, 2012, J HEART LUNG TRANSPL, V31, P67, DOI 10.1016/j.healun.2011.09.003; Drazner MH, 1999, J HEART LUNG TRANSPL, V18, P1126, DOI 10.1016/S1053-2498(99)00070-4; FORRESTER JS, 1976, NEW ENGL J MED, V295, P1404, DOI 10.1056/NEJM197612162952505; FORRESTER JS, 1976, NEW ENGL J MED, V295, P1356, DOI 10.1056/NEJM197612092952406; Galie N, 2016, EUR HEART J, V37, P67, DOI 10.1093/eurheartj/ehv317; Gardner RS, 2005, J HEART LUNG TRANSPL, V24, P303, DOI 10.1016/j.healun.2004.01.010; Groenveld HF, 2008, J AM COLL CARDIOL, V52, P818, DOI 10.1016/j.jacc.2008.04.061; Hamaguchi S, 2011, CIRC J, V75, P2403, DOI 10.1253/circj.CJ-11-0267; HO KKL, 1993, J AM COLL CARDIOL, V22, pA6, DOI 10.1016/0735-1097(93)90455-A; Ibe T, 2016, J CARDIOL, V67, P555, DOI 10.1016/j.jjcc.2015.07.015; Imai E, 2007, AM J KIDNEY DIS, V50, P927, DOI 10.1053/j.ajkd.2007.09.004; JACOB R, 1992, EUR HEART J, V13, P7, DOI 10.1093/eurheartj/13.suppl_E.7; Kenchaiah S, 2007, CIRCULATION, V116, P627, DOI 10.1161/CIRCULATIONAHA.106.679779; Kovacs G, 2014, AM J RESP CRIT CARE, V190, P252, DOI 10.1164/rccm.201402-0269PP; Lauritsen J, 2018, ESC HEART FAIL, V5, P685, DOI 10.1002/ehf2.12283; McAlister FA, 2004, CIRCULATION, V109, P1004, DOI 10.1161/01.CIR.0000116764.53225.A9; Miura M, 2016, CIRC J, V80, P1396, DOI 10.1253/circj.CJ-16-0216; Nickel N, 2012, EUR RESPIR J, V39, P589, DOI 10.1183/09031936.00092311; Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7; Nutritional anaemias, 1968, WHO TECH REP SER, V405, P5; Padang R, 2020, EUR HEART J, V41, P1273, DOI 10.1093/eurheartj/ehaa037; Patel CB, 2014, AM J CARDIOL, V114, P1059, DOI 10.1016/j.amjcard.2014.07.022; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Rudski LG, 2010, J AM SOC ECHOCARDIOG, V23, P685, DOI 10.1016/j.echo.2010.05.010; Sakakura K, 2010, HYPERTENSION, V55, P422, DOI 10.1161/HYPERTENSIONAHA.109.143131; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Vedin O, 2017, CIRC-HEART FAIL, V10, DOI 10.1161/CIRCHEARTFAILURE.117.003875; Yamanaka H, 2011, NUCLEOS NUCLEOT NUCL, V30, P1018, DOI 10.1080/15257770.2011.596496; Yamauchi T, 2017, CIRC J, V81, P185, DOI 10.1253/circj.CJ-16-0759	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252833	10.1371/journal.pone.0252833	http://dx.doi.org/10.1371/journal.pone.0252833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086818	Green Published, gold			2022-12-26	WOS:000664640100146
J	Armbrust, F; Bickenbach, K; Koudelka, T; Tholey, A; Pietrzik, C; Becker-Pauly, C				Armbrust, Fred; Bickenbach, Kira; Koudelka, Tomas; Tholey, Andreas; Pietrzik, Claus; Becker-Pauly, Christoph			Phosphorylation of meprin beta controls its cell surface abundance and subsequently diminishes ectodomain shedding	FASEB JOURNAL			English	Article						APP; IL6-R; meprin beta; metalloprotease; phosphorylation; PKC	AMYLOID PRECURSOR PROTEIN; METALLOPROTEASE MEPRIN; ALZHEIMERS-DISEASE; ALPHA; PKC; INTERNALIZATION; ACTIVATION; RELEASE; CASCADE; ADAM10	Meprin beta is a zinc-dependent metalloprotease exhibiting a unique cleavage specificity with strong preference for acidic amino acids at the cleavage site. Proteomic studies revealed a diverse substrate pool of meprin beta including the interleukin-6 receptor (IL-6R) and the amyloid precursor protein (APP). Dysregulation of meprin beta is often associated with pathological conditions such as chronic inflammation, fibrosis, or Alzheimer's disease (AD). The extracellular regulation of meprin beta including interactors, sheddases, and activators has been intensively investigated while intracellular regulation has been barely addressed in the literature. This study aimed to analyze C-terminal phosphorylation of meprin beta with regard to cell surface expression and proteolytic activity. By immunoprecipitation of endogenous meprin beta from the colon cancer cell line Colo320 and subsequent LC-MS analysis, we identified several phosphorylation sites in its C-terminal region. Here, T694 in the C-terminus of meprin beta was the most preferred residue after phorbol 12-myristate 13-acetate (PMA) stimulation. We further demonstrated the role of protein kinase C (PKC) isoforms for meprin beta phosphorylation and identified the involvement of PKC-alpha and PKC-beta. As a result of phosphorylation, the meprin beta activity at the cell surface is reduced and, consequently, the extent of substrate cleavage is diminished. Our data indicate that this decrease of the surface activity is caused by the internalization and degradation of meprin beta.	[Armbrust, Fred; Bickenbach, Kira; Becker-Pauly, Christoph] Univ Kiel, Biochem Inst, Unit Degrad Protease Web, Otto Hahn Pl 9, D-24118 Kiel, Germany; [Koudelka, Tomas; Tholey, Andreas] Univ Kiel, Inst Expt Med, Systemat Prote & Bioanalyt, Kiel, Germany; [Pietrzik, Claus] Johannes Gutenberg Univ Mainz, Inst Pathobiochem, Univ Med Ctr, Mainz, Germany	University of Kiel; University of Kiel; Johannes Gutenberg University of Mainz	Becker-Pauly, C (corresponding author), Univ Kiel, Biochem Inst, Unit Degrad Protease Web, Otto Hahn Pl 9, D-24118 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de	Becker-Pauly, Christoph/B-7569-2011	Bickenbach, Kira/0000-0001-5079-0512; Armbrust, Fred/0000-0002-3331-5522	Deutsche Forschungsgemeinschaft (DFG) [125440785 SFB 877]; Alzheimer Forschungsinitiative e.V. (AFI) project [18007]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Alzheimer Forschungsinitiative e.V. (AFI) project	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) Project-number 125440785 SFB 877 (Proteolysis as a Regulatory Event in Pathophysiology, Projects A9 (to C.B.-P.), A15 (to C.B.-P. and C.U.P.), and Z2 (to T.K and A.T.), and by the Alzheimer Forschungsinitiative e.V. (AFI) project 18007 (to C.B.-P. and C.U.P.)	Amin ARMR, 2003, INT J ONCOL, V23, P1727; Arnold P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44053; Becker-Pauly C, 2007, J INVEST DERMATOL, V127, P1115, DOI 10.1038/sj.jid.5700675; Becker-Pauly C, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00159; Bedau T, 2017, FASEB J, V31, P1226, DOI 10.1096/fj.201601113R; Berner DK, 2020, FASEB J, V34, P6675, DOI 10.1096/fj.201902183R; Bertenshaw GP, 2003, J BIOL CHEM, V278, P2522, DOI 10.1074/jbc.M208808200; Bian JW, 2018, VASC PHARMACOL, V103, P1, DOI 10.1016/j.vph.2018.01.008; Biasin V, 2017, SCI REP-UK, V7, DOI 10.1038/srep39969; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Broder C, 2013, BIOCHEM J, V450, P253, DOI 10.1042/BJ20121751; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Choi DS, 2006, P NATL ACAD SCI USA, V103, P8215, DOI 10.1073/pnas.0509725103; Etcheberrigaray R, 2004, P NATL ACAD SCI USA, V101, P11141, DOI 10.1073/pnas.0403921101; Filippova N, 1999, J PHYSIOL-LONDON, V518, P385, DOI 10.1111/j.1469-7793.1999.0385p.x; Hahn D, 2003, J BIOL CHEM, V278, P42829, DOI 10.1074/jbc.M211169200; Herzog C, 2014, J BIOL CHEM, V289, P13308, DOI 10.1074/jbc.M114.559088; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Jackle F, 2015, BIOCHEM J, V470, P91, DOI 10.1042/BJ20141417; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Ji LN, 2010, J ALZHEIMERS DIS, V19, P829, DOI 10.3233/JAD-2010-1281; JOHNSON GD, 1992, J BIOL CHEM, V267, P13505; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Ohler A, 2010, BIOL CHEM, V391, P455, DOI 10.1515/BC.2010.023; Peters F, 2019, FASEB J, V33, P7490, DOI 10.1096/fj.201802391R; Prox J, 2015, MATRIX BIOL, V44-46, P7, DOI 10.1016/j.matbio.2015.01.010; Rust HL, 2011, ACS CHEM BIOL, V6, P881, DOI 10.1021/cb200171d; Sammel M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153677; Scharfenberg F, 2019, CELL MOL LIFE SCI, V76, P3193, DOI 10.1007/s00018-019-03179-1; Schlenzig D, 2018, J ALZHEIMERS DIS, V66, P359, DOI 10.3233/JAD-171183; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Serge A, 2011, INTEGR BIOL-UK, V3, P675, DOI 10.1039/c0ib00121j; Skowyra D, 1997, CELL, V91, P209, DOI 10.1016/S0092-8674(00)80403-1; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Talman V, 2016, BASIC CLIN PHARMACOL, V119, P149, DOI 10.1111/bcpt.12581; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Varedi SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014029; Webb BLJ, 2000, BRIT J PHARMACOL, V130, P1433, DOI 10.1038/sj.bjp.0703452; Wichert R, 2017, CELL REP, V21, P2090, DOI 10.1016/j.celrep.2017.10.087; Zemoura K, 2019, MOL NEUROBIOL, V56, P1293, DOI 10.1007/s12035-018-1142-5	45	4	4	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21677	10.1096/fj.202100271R	http://dx.doi.org/10.1096/fj.202100271R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34125978	hybrid			2022-12-26	WOS:000667814100029
J	Kritsiligkou, P; Shen, TK; Dick, TP				Kritsiligkou, Paraskevi; Shen, Tzu Keng; Dick, Tobias P.			A comparison of Prx- and OxyR-based H2O2 probes expressed in S. cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; INDICATOR	Genetically encoded fluorescent H2O2 probes continue to advance the field of redox biology. Here, we compare the previously established peroxiredoxin-based H2O2 probe roGFP2-Tsa2 Delta CR with the newly described OxyR-based H2O2 probe HyPer7, using yeast as the model system. Although not as sensitive as roGFP2-Tsa2 Delta CR, HyPer7 is much improved relative to earlier HyPer versions, most notably by ratiometric pH stability. The most striking difference between the two probes is the dynamics of intracellular probe reduction. HyPer7 is rapidly reduced, predominantly by the thioredoxin system, whereas roGFP2-Tsa2 Delta CR is reduced more slowly, predominantly by the glutathione system. We discuss the pros and cons of each probe and suggest that future side-by-side measurements with both probes may provide information on the relative activity of the two major cellular reducing systems.	[Kritsiligkou, Paraskevi; Shen, Tzu Keng; Dick, Tobias P.] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Dick, Tobias P.] Heidelberg Univ, Fac Biosci, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Dick, TP (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Heidelberg, Germany.; Dick, TP (corresponding author), Heidelberg Univ, Fac Biosci, Heidelberg, Germany.	t.dick@dkfz.de	Kritsiligkou, Paraskevi/W-9399-2019	Kritsiligkou, Paraskevi/0000-0003-2452-141X; SHEN, TZU-KENG/0000-0001-5026-4600	CNV Foundation; European Commission	CNV Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	P. K. acknowledges support by the CNV Foundation. This work has been supported by the European Commission (to T. P. D.).	Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bilan DS, 2013, ACS CHEM BIOL, V8, P535, DOI 10.1021/cb300625g; Breckwoldt MO, 2016, SCI REP-UK, V6, DOI 10.1038/srep23251; Carmona M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12475-0; Dalla Tiezza M, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101540; de Cubas L, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10050731; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Domenech A, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0523-6; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Ezerina D, 2014, J MOL CELL CARDIOL, V73, P43, DOI 10.1016/j.yjmcc.2013.12.023; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Kostyuk AI, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218164; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Markvicheva KN, 2011, BIOORGAN MED CHEM, V19, P1079, DOI 10.1016/j.bmc.2010.07.014; Matlashov ME, 2015, BBA-GEN SUBJECTS, V1850, P2318, DOI 10.1016/j.bbagen.2015.08.002; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Morgan B, 2016, NAT CHEM BIOL, V12, P437, DOI [10.1038/NCHEMBIO.2067, 10.1038/nchembio.2067]; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pak VV, 2020, CELL METAB, V31, P642, DOI 10.1016/j.cmet.2020.02.003; Pastor-Flores D, 2020, P NATL ACAD SCI USA, V117, P16313, DOI 10.1073/pnas.1915275117; Pedre B, 2018, P NATL ACAD SCI USA, V115, pE11623, DOI 10.1073/pnas.1807954115; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Roma LP, 2018, ANTIOXID REDOX SIGN, V29, P552, DOI 10.1089/ars.2017.7449; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schwarzlander M, 2016, ANTIOXID REDOX SIGN, V24, P680, DOI 10.1089/ars.2015.6266; Schwarzlander M, 2014, NATURE, V514, pE12, DOI 10.1038/nature13858; Ugalde J. M., 2021, PLANT PHYSIOL; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	31	4	4	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100866	10.1016/j.jbc.2021.100866	http://dx.doi.org/10.1016/j.jbc.2021.100866			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34118234	gold, Green Published			2022-12-26	WOS:000678068400066
J	Li, B; Zhang, L; Zhu, L; Cao, YQ; Dou, ZM; Yu, Q				Li, Bin; Zhang, Lei; Zhu, Lei; Cao, Yongqiang; Dou, Zhimin; Yu, Qin			HDAC5 promotes intestinal sepsis via the Ghrelin/E2F1/NF-kappa B axis	FASEB JOURNAL			English	Article						Ghrelin; HDAC5; intestinal dysfunction; intestinal sepsis; NF-kappa B	NF-KAPPA-B; GHRELIN; INFLAMMATION; APOPTOSIS; E2F1; DIAGNOSIS; PROTECTS; PATHWAY; BARRIER; INJURY	In the current study, we sought to determine the roles of histone deacetylase 5 (HDAC5) on the promotion of intestinal sepsis in a mouse model. Dual luciferase reporter gene assay was used to determine the binding relationship between HDAC5 and Ghrelin. Cecal ligation and puncture (CLP) was used as an animal model of intestinal sepsis. The roles of HDAC5 on intestinal sepsis were determined by HDAC5 knockdown, overexpression, and inhibitor (LMK-235) in vivo. Mice intestinal permeability and intestinal epithelial damage were evaluated, and HE staining was used to evaluate the intestinal mucosal injury index. Lipopolysaccharide (LPS)-treated intestinal-derived macrophages served as a cell model of sepsis, followed by the loss-of-function and gain-of-function assays. ELISA was used to determine the levels of inflammatory factors, and TUNEL staining was used to detect intestinal cell apoptosis. HDAC5 was upregulated in the intestine of sepsis patients. This increased HDAC5 expression was positively correlated with the expression of inflammatory factors TNF-alpha, IL-1 beta, IL-6, and HMGB1, as well as the intestinal dysfunction-related factors IFABP. In sepsis mice, the expression of inflammatory factors was reduced by HDAC5 knockdown. HDAC5 knockdown also improved survival, morphology of intestinal tissue, intestinal permeability, and epithelial damage. Ghrelin was bound and inhibited by HDAC5, but E2F1 expression was increased by Ghrelin overexpression, leading to inhibition of the NF-kappa B pathway. Ghrelin and E2F1 expression were increased by the treatment with HDAC5 inhibitor LMK-235, which inhibited the NF-kappa B pathway to improve intestinal dysfunction in the sepsis model. In conclusion, HDAC5 inhibits Ghrelin to reduce E2F1 and thus activate the NF-kappa B pathway, thereby promoting intestinal sepsis.	[Li, Bin; Zhang, Lei; Zhu, Lei; Cao, Yongqiang; Dou, Zhimin] Lanzhou Univ, Hosp 1, Dept Crit Med, Lanzhou, Peoples R China; [Yu, Qin] Lanzhou Univ, Hosp 1, Sch Clin Med 1, Dept Resp, 1 West Donggang Rd, Lanzhou 730000, Gansu, Peoples R China	Lanzhou University; Lanzhou University	Yu, Q (corresponding author), Lanzhou Univ, Hosp 1, Sch Clin Med 1, Dept Resp, 1 West Donggang Rd, Lanzhou 730000, Gansu, Peoples R China.	yuqin@lzu.edu.cn						Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2; Cheyuo C, 2012, AM J PHYSIOL-ENDOC M, V302, pE265, DOI 10.1152/ajpendo.00508.2011; Chung H, 2016, J ENDOCRINOL, V230, P239, DOI 10.1530/JOE-16-0126; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Cummins EP, 2013, LAB INVEST, V93, P378, DOI 10.1038/labinvest.2013.9; Di Giorgio E, 2016, EPIGENOMICS-UK, V8, P251, DOI 10.2217/epi.15.106; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; Hsing CH, 2012, AM J PHYSIOL-RENAL, V303, pF1443, DOI 10.1152/ajprenal.00143.2012; Jacob A, 2010, HEPATIC MED-EVID RES, V2, P33; Jain S, 2018, AM J MED SCI, V356, P277, DOI 10.1016/j.amjms.2018.06.012; Ji ZR, 2019, INFLAMMATION, V42, P731, DOI 10.1007/s10753-018-0931-3; Jiang C, 2020, J ETHNOPHARMACOL, V251, DOI 10.1016/j.jep.2019.112501; Jiang LY, 2010, WORLD J EMERG MED, V1, P138; Joe Y, 2020, CELL REP, V30, P1063, DOI 10.1016/j.celrep.2019.12.090; Kauppinen A, 2013, CELL SIGNAL, V25, P1939, DOI 10.1016/j.cellsig.2013.06.007; Kempker JA, 2016, CLIN CHEST MED, V37, P165, DOI 10.1016/j.ccm.2016.01.002; Kockara A, 2013, RENAL FAILURE, V35, P291, DOI 10.3109/0886022X.2012.744040; Lee HJ, 2009, BIOCHEM J, V420, P403, DOI 10.1042/BJ20081850; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Lu HJ, 2018, LIFE SCI, V199, P167, DOI 10.1016/j.lfs.2018.02.016; Ma L, 2017, NEUROSCI LETT, V644, P55, DOI 10.1016/j.neulet.2017.02.038; Ma LX, 2015, MOL ENDOCRINOL, V29, P1571, DOI 10.1210/me.2015-1184; Miksa M, 2005, FRONT BIOSCI-LANDMRK, V10, P2217, DOI 10.2741/1691; Muller TD, 2015, MOL METAB, V4, P437, DOI 10.1016/j.molmet.2015.03.005; Ouyang Lin, 2015, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V40, P464, DOI 10.11817/j.issn.1672-7347.2015.05.002; Palomer X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019724; Sun SC, 2017, NAT REV IMMUNOL, V17, P545, DOI 10.1038/nri.2017.52; Tanaka H, 2002, MOL CELL, V9, P1017, DOI 10.1016/S1097-2765(02)00522-1; Tian R, 2019, BBA-MOL BASIS DIS, V1865, P1701, DOI 10.1016/j.bbadis.2019.04.009; Verdonk F, 2017, CURR OPIN ANESTHESIO, V30, P200, DOI 10.1097/ACO.0000000000000446; von Knethen A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20020346; Wu RQ, 2009, CRIT CARE MED, V37, P2421, DOI 10.1097/CCM.0b013e3181a557a2; Wu XW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04231-5; Yang BC, 2017, J SURG RES, V211, P70, DOI 10.1016/j.jss.2016.11.061; Yang D, 2018, INT J MOL MED, V41, P43, DOI 10.3892/ijmm.2017.3212	35	6	6	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21368	10.1096/fj.202001584R	http://dx.doi.org/10.1096/fj.202001584R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34125448				2022-12-26	WOS:000667814100051
J	Doyle, D; McDonald, G; Pratt, C; Rehan, Z; Benteau, T; Phillips, J; Daley, P				Doyle, Daniel; McDonald, Gerald; Pratt, Claire; Rehan, Zahra; Benteau, Tammy; Phillips, Jennifer; Daley, Peter			Impact of a mobile decision support tool on antimicrobial stewardship indicators in St. John's, Canada	PLOS ONE			English	Article								Objectives Inappropriate antibiotic use contributes to antimicrobial resistance. The Spectrum(TM) app provides antibiotic decision support, based on local antimicrobial resistance rates. We determined the impact of regional implementation of the app on inpatient antimicrobial appropriateness, inpatient antimicrobial usage (AMU), population-based Clostridioides difficile infection (CDI) rates and cost, using a retrospective, before and after quasi-experimental design, including a one-year study period. Methods The Spectrum(TM) app was released to prescribers in February, 2019. We performed two one-day inpatient point prevalence surveys using the National Antimicrobial Prescribing Survey tool, six months before (June 25, 2018) and six months after (June 25, 2019) app dissemination. Inpatient AMU in Defined Daily Dose/1000 patient days and CDI incidence were compared, before and after app dissemination. Results The pre-survey included 184 prescriptions, and the post-survey included 197 prescriptions. Appropriateness was 97/176 (55.1%) pre, and 126/192 (65.6%) post (+10.5%, p = 0.051). Inpatient AMU declined by 6.6 DDD/1000 patient days per month, and CDI declined by 0.3 cases per month. Cost savings associated with reduced AMU were $403.98/bed/year and associated with reduced CDI were $82,078/year. Conclusion We observed improvement in antimicrobial stewardship indicators following Spectrum(TM) implementation. We cannot determine the cause of these improvements.	[Doyle, Daniel; Pratt, Claire; Rehan, Zahra; Daley, Peter] Mem Univ Newfoundland, St John, NF, Canada; [McDonald, Gerald; Phillips, Jennifer; Daley, Peter] Eastern Hlth Reg, St John, NF, Canada; [Benteau, Tammy] Choosing Wisely Newfoundland & Labrador, St John, NF, Canada	Memorial University Newfoundland	Daley, P (corresponding author), Mem Univ Newfoundland, St John, NF, Canada.; Daley, P (corresponding author), Eastern Hlth Reg, St John, NF, Canada.	pkd336@mun.ca						[Anonymous], 2020, ESSENTIAL MED HLTH P; [Anonymous], 2018, SUMMARY REPORT ANTIM; [Anonymous], 2016, NATL ANTIMICROBIAL P; [Anonymous], 2020, ANN POPULATION CENSU; [Anonymous], 2018, HOSP NAPS APPROPRIAT; Canadian NAPS, 2018, PIL IN US GUID; Curtis CE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183062; Daley P, 2015, CAN J INFECT DIS MED, V26, P133, DOI 10.1155/2015/830415; Davey P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003543.pub3; Hofer F, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0811-2; Levy AR, 2015, OPEN FORUM INFECT DI, V2, DOI 10.1093/ofid/ofv076; Ostrowsky B, 2018, CLIN INFECT DIS, V66, P995, DOI 10.1093/cid/cix1093; Park Chan Ho, 2017, Hip Pelvis, V29, P30, DOI 10.5371/hp.2017.29.1.30; Parvizi Javad, 2019, Hip Pelvis, V31, P1, DOI 10.5371/hp.2019.31.1.1; Paul M, 2006, J ANTIMICROB CHEMOTH, V58, P1238, DOI 10.1093/jac/dkl372; Peermohamed S., 2020, NOVEL MOBILE APP HEL; Ridgway JP., 2020, CLIN INFECT DIS, V72; Versporten A, 2018, LANCET GLOB HEALTH, V6, pE619, DOI [10.1016/S2214-109X(18)30186-4, 10.1016/s2214-109x(18)30186-4]; Yoon CH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211157; Zander J, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1255-z	20	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252407	10.1371/journal.pone.0252407	http://dx.doi.org/10.1371/journal.pone.0252407			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133424	gold, Green Published			2022-12-26	WOS:000671682700008
J	Guo, YJ; Duan, XG; Wang, CY; Guo, HQ				Guo, Yanjun; Duan, Xingguang; Wang, Chengyi; Guo, Huiqin			Segmentation and recognition of breast ultrasound images based on an expanded U-Net	PLOS ONE			English	Article								This paper establishes a fully automatic real-time image segmentation and recognition system for breast ultrasound intervention robots. It adopts the basic architecture of a U-shaped convolutional network (U-Net), analyses the actual application scenarios of semantic segmentation of breast ultrasound images, and adds dropout layers to the U-Net architecture to reduce the redundancy in texture details and prevent overfitting. The main innovation of this paper is proposing an expanded training approach to obtain an expanded of U-Net. The output map of the expanded U-Net can retain texture details and edge features of breast tumours. Using the grey-level probability labels to train the U-Net is faster than using ordinary labels. The average Dice coefficient (standard deviation) and the average IOU coefficient (standard deviation) are 90.5% (+/- 0.02) and 82.7% (+/- 0.02), respectively, when using the expanded training approach. The Dice coefficient of the expanded U-Net is 7.6 larger than that of a general U-Net, and the IOU coefficient of the expanded U-Net is 11 larger than that of the general U-Net. The context of breast ultrasound images can be extracted, and texture details and edge features of tumours can be retained by the expanded U-Net. Using an expanded U-Net can quickly and automatically achieve precise segmentation and multi-class recognition of breast ultrasound images.	[Guo, Yanjun; Duan, Xingguang] Beijing Inst Technol, Sch Mechatron Engn, Beijing, Peoples R China; [Wang, Chengyi] Chinese Acad Sci, Inst Remote Sensing & Digital Earth, Beijing, Peoples R China; [Guo, Huiqin] Chengcheng Cty Hosp, UItrason Diag Dept, Weinan, Shanxi, Peoples R China	Beijing Institute of Technology; Chinese Academy of Sciences; The Institute of Remote Sensing & Digital Earth, CAS	Guo, YJ (corresponding author), Beijing Inst Technol, Sch Mechatron Engn, Beijing, Peoples R China.	gmy63000@126.com			National Natural Science Foundation of China [61603043]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China [Grant number 61603043].	Abbas S, 2021, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.390; Bhattacharya S, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102589; Cheng JZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24454; Du GT, 2020, J IMAGING SCI TECHN, V64, DOI 10.2352/J.ImagingSci.Technol.2020.64.2.020508; Feiqian W, 2019, BIOINFORMATICS BIOME; Gadekallu TR, 2021, COMPLEX INTELL SYST, V7, P1855, DOI 10.1007/s40747-021-00324-x; Huang QH, 2017, INT J COMPUT ASS RAD, V12, P493, DOI 10.1007/s11548-016-1513-1; Javed AR, 2020, HUM-CENT COMPUT INFO, V10, DOI 10.1186/s13673-020-00245-7; Krizhevsky A, 2017, COMMUN ACM, V60, P84, DOI 10.1145/3065386; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Meiburger KM, 2018, COMPUT BIOL MED, V92, P210, DOI 10.1016/j.compbiomed.2017.11.018; Milletari F, 2016, INT CONF 3D VISION, P565, DOI 10.1109/3DV.2016.79; Qian CJ, 2014, LECT NOTES COMPUT SC, V8679, P314, DOI 10.1007/978-3-319-10581-9_39; Reddy GT, 2022, MULTIMED TOOLS APPL, V81, P41429, DOI 10.1007/s11042-020-09988-y; Ronneberger Olaf, 2015, arXiv; Salehi SSM, 2017, IEEE T MED IMAGING, V36, P2319, DOI 10.1109/TMI.2017.2721362; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Tan CQ, 2018, LECT NOTES COMPUT SC, V11141, P270, DOI 10.1007/978-3-030-01424-7_27; Xian M, 2015, PATTERN RECOGN, V48, P485, DOI 10.1016/j.patcog.2014.07.026; Xu Y, 2019, ULTRASONICS, V91, P1, DOI 10.1016/j.ultras.2018.07.006; Yan ZN, 2017, ELS MIC SOC BOOK SER, P83, DOI 10.1016/B978-0-12-810408-8.00006-7; Zeng Y, 2018, P SPIE, V11069	22	4	4	10	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253202	10.1371/journal.pone.0253202	http://dx.doi.org/10.1371/journal.pone.0253202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129619	Green Published, gold			2022-12-26	WOS:000665475100032
J	Bigler, MR; Seiler, C				Bigler, Marius Reto; Seiler, Christian			Detection of myocardial ischemia by intracoronary ECG using convolutional neural networks	PLOS ONE			English	Article							CORONARY; ELECTROCARDIOGRAM; CLASSIFICATION	Introduction The electrocardiogram (ECG) is a valuable tool for the diagnosis of myocardial ischemia as it presents distinctive ischemic patterns. Deep learning methods such as convolutional neural networks (CNN) are employed to extract data-derived features and to recognize natural patterns. Hence, CNN enable an unbiased view on well-known clinical phenomenon, e.g., myocardial ischemia. This study tested a novel, hypothesis-generating approach using pre-trained CNN to determine the optimal ischemic parameter as obtained from the highly susceptible intracoronary ECG (icECG). Method This was a retrospective observational study in 228 patients with chronic coronary syndrome. Each patient had participated in clinical trials with icECG recording and ST-segment shift measurement at the beginning (i.e., non-ischemic) and the end (i.e., ischemic) of a one-minute proximal coronary artery balloon occlusion establishing the reference. Using these data (893 icECGs in total), two pre-trained, open-access CNN (GoogLeNet/ResNet101) were trained to recognize ischemia. The best performing CNN during training were compared with the icECG ST-segment shift for diagnostic accuracy in the detection of artificially induced myocardial ischemia. Results Using coronary patency or occlusion as reference for absent or present myocardial ischemia, receiver-operating-characteristics (ROC)-analysis of manually obtained icECG ST-segment shift (mV) showed an area under the ROC-curve (AUC) of 0.9030.043 (p<0.0001, sensitivity 80%, specificity 92% at a cut-off of 0.279mV). The best performing CNN showed an AUC of 0.924 (sensitivity 93%, specificity 92%). DeLong-Test of the ROC-curves showed no significant difference between the AUCs. The underlying morphology responsible for the network prediction differed between the trained networks but was focused on the ST-segment and the T-wave for myocardial ischemia detection. Conclusions When tested in an experimental setting with artificially induced coronary artery occlusion, quantitative icECG ST-segment shift and CNN using pathophysiologic prediction criteria detect myocardial ischemia with similarly high accuracy.	[Bigler, Marius Reto; Seiler, Christian] Univ Bern, Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland	University of Bern; University Hospital of Bern	Bigler, MR (corresponding author), Univ Bern, Bern Univ Hosp, Inselspital, Dept Cardiol, Bern, Switzerland.	mariusreto.bigler@insel.ch		Bigler, Marius Reto/0000-0002-3199-4664				Acharya UR, 2017, INFORM SCIENCES, V405, P81, DOI 10.1016/j.ins.2017.04.012; Anguelov D, 2014, CORRABS14094842; Attia ZI, 2019, LANCET, V394, P861, DOI 10.1016/S0140-6736(19)31721-0; Ba J, 2014, CORRARXIV14126980; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Bigler MR, 2020, AM HEART J, V230, P1, DOI 10.1016/j.ahj.2020.09.006; Bigler MR, 2021, J ELECTROCARDIOL, V64, P50, DOI 10.1016/j.jelectrocard.2020.11.018; Cohen-Shelly M, 2021, EUR HEART J, V42, P2885, DOI 10.1093/eurheartj/ehab153; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; He K., 2016, CVPR, P770; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Iwendi C, 2020, COMPUT COMMUN, V161, P160, DOI 10.1016/j.comcom.2020.07.032; Javed AR, 2021, IEEE T NETW SCI ENG, V8, P1456, DOI 10.1109/TNSE.2021.3059881; Javed AR, 2021, IEEE T INTELL TRANSP, V22, P4291, DOI 10.1109/TITS.2020.3025875; Jo Y-Y., 2021, EUROPEAN HEART J DIG, DOI [10.1093/ehjdh/ztab025, DOI 10.1093/EHJDH/ZTAB025]; Kiranyaz S, 2016, IEEE T BIO-MED ENG, V63, P664, DOI 10.1109/TBME.2015.2468589; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lundervold AS, 2019, Z MED PHYS, V29, P102, DOI 10.1016/j.zemedi.2018.11.002; Makimoto H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65105-x; MEIER B, 1985, CIRCULATION, V71, P557, DOI 10.1161/01.CIR.71.3.557; Muschelli J, 2020, J CLASSIF, V37, P696, DOI 10.1007/s00357-019-09345-1; PANDE AK, 1992, AM HEART J, V124, P337, DOI 10.1016/0002-8703(92)90595-M; Polyak B. T, 1964, USSR COMP MATH MATH, V4, P1, DOI [10.1016/0041-5553(64)90137-5, DOI 10.1016/0041-5553(64)90137-5]; Ribeiro AH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15432-4; Rusk N, 2016, NAT METHODS, V13, P35, DOI 10.1038/nmeth.3707; Sagar R, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9010097; Seiler C, 1998, J AM COLL CARDIOL, V32, P1272, DOI 10.1016/S0735-1097(98)00384-2; Seiler C, 2013, HEART, V99, P1408, DOI 10.1136/heartjnl-2013-304369; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Srivastava N, 2014, J MACH LEARN RES, V15, P1929; Stoller M, 2017, CIRC-CARDIOVASC INTE, V10, DOI 10.1161/CIRCINTERVENTIONS.116.004990; Trask AW., 2020, NEURONALE NETZE DEEP; Tschannen, FUNCTIONAL ASSESSMEN; van de Leur RR, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015138; Vogel R, 2006, EUR HEART J, V27, P157, DOI 10.1093/eurheartj/ehi585; Vranken JF, 2021, EUR HEART J DIGIT HL, DOI [10.1093/ehjdh/ztab045, DOI 10.1093/EHJDH/ZTAB045]; Yan GX, 2003, J AM COLL CARDIOL, V42, P401, DOI 10.1016/S0735-1097(03)00713-7; Zhou Bolei, 2016, IEEE CVF C COMP VIS, DOI DOI 10.1109/CVPR.2016.319	41	3	3	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0253200	10.1371/journal.pone.0253200	http://dx.doi.org/10.1371/journal.pone.0253200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125855	gold, Green Published			2022-12-26	WOS:000664643500027
J	Jiang, X; Howard, JH; Rebeck, GW; Turner, RS				Jiang, Xiong; Howard, James H.; Rebeck, G. William; Turner, Raymond Scott			Spatial inhibition of return is impaired in mild cognitive impairment and mild Alzheimer's disease	PLOS ONE			English	Article							VISUOSPATIAL ATTENTION; RESPONSES; DEMENTIA; DEFICITS	Spatial inhibition of return (IOR) refers to the phenomenon by which individuals are slower to respond to stimuli appearing at a previously cued location compared to un-cued locations. Here with a group of older adults (n = 56, 58-80 (67.9 +/- 5.2) year old, 31 females, 18.7 +/- 3.6 years of education), we provide evidence supporting the notion that spatial IOR is mildly impaired in individuals with mild cognitive impairment (MCI) or mild Alzheimer's disease (AD), and the impairment is detectable using a double cue paradigm. Furthermore, reduced spatial IOR in high-risk healthy older individuals is associated with reduced memory and other neurocognitive task performance, suggesting that the double cue spatial IOR paradigm may be useful in detecting MCI and early AD.	[Jiang, Xiong; Rebeck, G. William] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA; [Howard, James H.] Catholic Univ Amer, Dept Psychol, Washington, DC 20064 USA; [Turner, Raymond Scott] Georgetown Univ, Med Ctr, Dept Neurol, Washington, DC 20007 USA	Georgetown University; Catholic University of America; Georgetown University	Jiang, X (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20007 USA.	Xiong.Jiang@Georgetown.Edu	Turner, Raymond Scott/G-2263-2011	Turner, Raymond Scott/0000-0001-7534-2935	Alzheimer's Drug Discovery Foundation [20130805]	Alzheimer's Drug Discovery Foundation	The work was supported by the Alzheimer's Drug Discovery Foundation in the form of a grant awarded to XJ (20130805).	Almubark I., 2019, IEEE BIGDATA 2019 C; Amieva H, 2004, BRAIN, V127, P949, DOI 10.1093/brain/awh045; Bao Y, 2011, NEUROSCI LETT, V500, P47, DOI 10.1016/j.neulet.2011.06.003; Bayer A, 2014, J ALZHEIMERS DIS, V40, P177, DOI 10.3233/JAD-131934; Besson FL, 2015, J NEUROSCI, V35, P10402, DOI 10.1523/JNEUROSCI.0150-15.2015; Briand KA, 2001, NEUROPSYCHOLOGIA, V39, P1240, DOI 10.1016/S0028-3932(01)00045-8; Briand KA, 2000, PERCEPT PSYCHOPHYS, V62, P1512, DOI 10.3758/BF03212152; Chiotis K, 2018, MOL PSYCHIATR, V23, P1666, DOI 10.1038/mp.2017.108; Danckert J, 1998, NEUROPSYCHOLOGY, V12, P225, DOI 10.1037/0894-4105.12.2.225; Dukewich KR, 2008, NEUROSCI LETT, V448, P231, DOI 10.1016/j.neulet.2008.10.063; Faust ME, 1997, NEUROPSYCHOLOGY, V11, P13, DOI 10.1037/0894-4105.11.1.13; Gauggel S, 2004, J NEUROL NEUROSUR PS, V75, P539; Hartley AA, 1995, PSYCHOL AGING, V10, P670, DOI 10.1037/0882-7974.10.4.670; Howard JH, 2008, J EXP PSYCHOL LEARN, V34, P1139, DOI 10.1037/a0012797; Klein RM, 2000, TRENDS COGN SCI, V4, P138, DOI 10.1016/S1364-6613(00)01452-2; Levinson AJ, 2010, BIOL PSYCHIAT, V67, P458, DOI 10.1016/j.biopsych.2009.09.025; Li TN, 2020, J GERONTOL B-PSYCHOL, V75, P753, DOI 10.1093/geronb/gby070; MacInnes WJ, 2017, NEURAL COMPUT, V29, P804, DOI 10.1162/NECO_a_00904; Malkinson TS, 2018, CORTEX, V102, P176, DOI 10.1016/j.cortex.2017.11.005; Pagani M, 2017, EUR J NUCL MED MOL I, V44, P2042, DOI 10.1007/s00259-017-3761-x; Pantsiou K, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00330; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Pratt J, 1999, PERCEPT PSYCHOPHYS, V61, P756, DOI 10.3758/BF03205543; Redden RS, 2021, CORTEX, V135, P30, DOI 10.1016/j.cortex.2020.11.009; Richards E, 2021, NEUROPSYCHOLOGIA, V155, DOI 10.1016/j.neuropsychologia.2021.107794; Satel Jason, 2019, Vision (Basel), V3, DOI 10.3390/vision3040058; Spence C, 2000, EXP BRAIN RES, V134, P42, DOI 10.1007/s002210000442; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Tales A, 2005, NEUROCASE, V11, P85, DOI 10.1080/13554790490896983; Tales A, 2011, CORTEX, V47, P180, DOI 10.1016/j.cortex.2009.09.007; Visser TAW, 2009, ATTEN PERCEPT PSYCHO, V71, P392, DOI 10.3758/APP.71.2.392	32	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252958	10.1371/journal.pone.0252958	http://dx.doi.org/10.1371/journal.pone.0252958			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125847	Green Published, Green Submitted, gold			2022-12-26	WOS:000664643500018
J	Fan, R; Dong, LJ; Li, P; Wang, XM; Chen, XW				Fan, Rong; Dong, Lijin; Li, Ping; Wang, Xiaoming; Chen, Xuewei			Integrated bioinformatics analysis and screening of hub genes in papillary thyroid carcinoma	PLOS ONE			English	Article							ACTIVATABLE FIBRINOLYSIS INHIBITOR; LYSOPHOSPHATIDIC ACID RECEPTOR; FACTOR PATHWAY INHIBITOR; BREAST-CANCER; EXPRESSION; TFPI; SURVIVAL; CELLS	Background With the increasing incidence of papillary thyroid carcinoma (PTC), PTC continues to garner attention worldwide; however its pathogenesis remains to be elucidated. The purpose of this study was to explore key biomarkers and potential new therapeutic targets for, PTC. Methods GEO2R and Venn online software were used for screening of differentially expressed genes. Hub genes were screened via STRING and Cytoscape, followed by Gene Ontology and KEGG enrichment analysis. Finally, survival analysis and expression validation were performed using the UALCAN online software and immunohistochemistry. Results We identified 334 consistently differentially expressed genes (DEGs) comprising 136 upregulated and 198 downregulated genes. Gene Ontology enrichment analysis results suggested that the DEGs were mainly enriched in cancer-related pathways and functions. PPI network visualization was performed and 17 upregulated and 13 downregulated DEGs were selected. Finally, the expression verification and overall survival analysis conducted using the Gene Expression Profiling Interactive Analysis Tool (GEPIA) and UALCAN showed that LPAR5, TFPI, and ENTPD1 were associated with the development of PTC and the prognosis of PTC patients, and the expression of LPAR5, TFPI and ENTPD1 was verified using a tissue chip. Conclusions In summary, the hub genes and pathways identified in the present study not only provide information for the development of new biomarkers for PTC but will also be useful for elucidation of the pathogenesis of PTC.	[Fan, Rong] Tianjin Xiqing Hosp, Cent Lab, Tianjin, Peoples R China; [Dong, Lijin] Logist Univ Chinese Peoples Armed Police Force, Educ & Res Secur Ctr, Editorial Dept, Tianjin, Peoples R China; [Li, Ping] Southwest Med Univ, Luzhou City, Sichuan, Peoples R China; [Li, Ping; Wang, Xiaoming; Chen, Xuewei] Tianjin Inst Environm & Operat Med, Dept Operat Med, Tianjin, Peoples R China	Southwest Medical University	Wang, XM; Chen, XW (corresponding author), Tianjin Inst Environm & Operat Med, Dept Operat Med, Tianjin, Peoples R China.	sisuo55123@sina.com; chenxuewei11@sina.com			National Natural Science Foundation of China [81201757]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (No.81201757).	Allard B, 2017, IMMUNOL REV, V276, P121, DOI 10.1111/imr.12528; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; [Anonymous], 2019, CA-CANCER J CLIN, DOI [DOI 10.3322/CAAC.21551, DOI 10.3322/caac.21551]; Cai B, 2017, PROSTATE, V77, P1057, DOI 10.1002/pros.23361; Cai XY, 2016, ONCOL LETT, V12, P4080, DOI 10.3892/ol.2016.5189; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Erem C, 2009, ENDOCRINE, V35, P75, DOI 10.1007/s12020-008-9116-4; Fukushima K, 2018, BIOCHEM BIOPH RES CO, V496, P225, DOI 10.1016/j.bbrc.2018.01.030; Furui T, 1999, CLIN CANCER RES, V5, P4308; Gao XR, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181441; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; La Vecchia C, 2015, INT J CANCER, V136, P2187, DOI 10.1002/ijc.29251; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Liu L, 2019, J CELL PHYSIOL, V234, P23647, DOI 10.1002/jcp.28932; Mandapathil M, 2018, ACTA OTO-LARYNGOL, V138, P428, DOI 10.1080/00016489.2017.1405278; Mosaad Zaki Eman, 2019, Hematol Oncol Stem Cell Ther, V12, P26, DOI 10.1016/j.hemonc.2018.09.002; Ravindranath TM, 2007, CLIN APPL THROMB-HEM, V13, P362, DOI 10.1177/1076029607305580; Schlumberger M, 2012, EUR J ENDOCRINOL, V166, P5, DOI 10.1530/EJE-11-0631; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Stavik B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-357; Stavik B, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-5; Sun C., 2019, GENE EXPRESSION PROF, V39; Sun XF, 2013, HEPATOLOGY, V57, P205, DOI 10.1002/hep.25989; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Tang JN, 2018, PEERJ, V6, DOI 10.7717/peerj.4674; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Tinholt M, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0548-5; Tuttle RM, 2010, J NATL COMPR CANC NE, V8, P1228, DOI 10.6004/jnccn.2010.0093; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang T, 2014, P NATL ACAD SCI USA, V111, pE3234, DOI 10.1073/pnas.1410041111; Zarychta E, 2018, J PHYSIOL PHARMACOL, V69, P921, DOI 10.26402/jpp.2018.6.06; Zhang SL, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190083; Zhao P, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/164087	34	0	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0251962	10.1371/journal.pone.0251962	http://dx.doi.org/10.1371/journal.pone.0251962			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115774	gold, Green Published			2022-12-26	WOS:000664643000015
J	Hasley, JAR; Navet, N; Tian, MY				Hasley, Jeremieh Abram R.; Navet, Natasha; Tian, Miaoying			CRISPR/Cas9-mediated mutagenesis of sweet basil candidate susceptibility gene ObDMR6 enhances downy mildew resistance	PLOS ONE			English	Article							PERONOSPORA-BELBAHRII; IMPROVEMENT; ENCODES; TOMATO	Sweet basil (Ocimum basilicum) is an economically important allotetraploid (2n = 4x = 48) herb whose global production is threatened by downy mildew disease caused by the obligate biotrophic oomycete, Peronospora belbahrii. Generation of disease resistant cultivars by mutagenesis of susceptibility (S) genes via CRISPR/Cas9 is currently one of the most promising strategies to maintain favored traits while improving disease resistance. Previous studies have identified Arabidopsis DMR6 (Downy Mildew Resistance 6) as an S gene required for pathogenesis of the downy mildew-causing oomycete pathogen Hyaloperonospora arabidopsidis. In this study, a sweet basil homolog of DMR6, designated ObDMR6, was identified in the popular sweet basil cultivar Genoveser and found to exist with a high copy number in the genome with polymorphisms among the variants. Two CRISPR/Cas9 constructs expressing one or two single guide RNAs (sgRNAs) targeting the conserved regions of ObDMR6 variants were generated and used to transform Genoveser via Agrobacterium-mediated transformation. 56 T0 lines were generated, and mutations of ObDMR6 were detected by analyzing the Sanger sequencing chromatograms of an ObDMR6 fragment using the Interference of CRISPR Edits (ICE) software. Among 54 lines containing mutations in the targeted sites, 13 had an indel percentage greater than 96% suggesting a near-complete knockout (KO) of ObDMR6. Three representative transgene-free lines with near-complete KO of ObDMR6 determined by ICE were identified in the T1 segregating populations derived from three independent T0 lines. The mutations were further confirmed using amplicon deep sequencing. Disease assays conducted on T2 seedlings of the above T1 lines showed a reduction in production of sporangia by 61-68% compared to the wild-type plants and 69-93% reduction in relative pathogen biomass determined by quantitative PCR (qPCR). This study not only has generated transgene-free sweet basil varieties with improved downy mildew resistance, but also contributed to our understanding of the molecular interactions of sweet basil-P. belbahrii.	[Hasley, Jeremieh Abram R.; Navet, Natasha; Tian, Miaoying] Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA; [Navet, Natasha] Oregon State Univ, Bot & Plant Pathol Dept, Corvallis, OR 97331 USA	University of Hawaii System; University of Hawaii Manoa; Oregon State University	Tian, MY (corresponding author), Univ Hawaii Manoa, Dept Plant & Environm Protect Sci, Honolulu, HI 96822 USA.	mtian@hawaii.edu			NIFA HATCH [1003536, 1020611]; USDA-ARS [58-5320-4020]	NIFA HATCH; USDA-ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was supported by the NIFA HATCH (Accession No. 1003536 and 1020611) and the USDA-ARS Agreement No. 58-5320-4020, entitled, "Control of Pests and Diseases and Adding Value to Specialty Crops," managed by the College of Tropical Agriculture and Human Resource, University of Hawaii at Manoa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben-Naim Y, 2018, PHYTOPATHOLOGY, V108, P114, DOI 10.1094/PHYTO-06-17-0207-R; Cohen Y, 2017, PHYTOPATHOLOGY, V107, P1149, DOI [10.1094/PHYTO-01-17-0017-FI, 10.1094/PHYTO-01-17-0017-F1]; Cohen Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155330; Cohen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126103; Cohen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081282; Dong OX, 2019, PLANT PHYSIOL, V180, P26, DOI 10.1104/pp.18.01224; Farahani-Kofoet RD, 2014, SCI HORTIC-AMSTERDAM, V179, P248, DOI 10.1016/j.scienta.2014.09.036; Fratianni F, 2017, FOOD CHEM, V229, P752, DOI 10.1016/j.foodchem.2017.02.137; Haque E, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00617; Hsiau T, 2018, BIORXIV, DOI [10.1101/251082, DOI 10.1101/251082]; Jaganathan D, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00985; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Langner T, 2018, ANNU REV PHYTOPATHOL, V56, P479, DOI 10.1146/annurev-phyto-080417-050158; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Low YC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67006-5; Mushtaq M, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00550; Navet N, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3828; Navet N, 2020, PLANT DIRECT, V4, DOI 10.1002/pld3.233; Nekrasov V, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00578-x; Pan CT, 2016, SCI REP-UK, V6, DOI 10.1038/srep24765; Paula de Toledo Thomazella D., 2016, BIORXIV, P064824, DOI [10.1101/064824., DOI 10.1101/064824, 10.1101/064824]; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; Peng D, 2015, MICROB GENOMICS, V1, DOI 10.1099/mgen.0.000033; Pintore I, 2016, PHYTOPARASITICA, V44, P563, DOI 10.1007/s12600-016-0538-x; Pyne R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184319; Pyne RM, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1284-7; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Shao DD, 2018, CURR PLANT BIOL, V15, P2, DOI 10.1016/j.cpb.2018.09.003; Simon JE, 2020, SCIENTIA, DOI [10.33548/SCIENTIA540, DOI 10.33548/SCIENTIA540]; Sun K, 2016, TRANSGENIC RES, V25, P731, DOI 10.1007/s11248-016-9964-2; Torre S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160370; van Damme M, 2008, PLANT J, V54, P785, DOI 10.1111/j.1365-313X.2008.03427.x; van Schie CCN, 2014, ANNU REV PHYTOPATHOL, V52, P551, DOI 10.1146/annurev-phyto-102313-045854; Vieira RF, 2000, ECON BOT, V54, P207, DOI 10.1007/BF02907824; Volpe V, 2018, COLLOID SURFACE A, V546, P285, DOI 10.1016/j.colsurfa.2018.02.070; Wang FJ, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0159436, 10.1371/journal.pone.0154027]; Wyenandt CA, 2015, PHYTOPATHOLOGY, V105, P885, DOI 10.1094/PHYTO-02-15-0032-FI; Xing HL, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0327-y; Zaidi SSEA, 2018, TRENDS BIOTECHNOL, V36, P898, DOI 10.1016/j.tibtech.2018.04.005; Zhang GR, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01117; Zhang YJ, 2017, PLANT PHYSIOL, V175, P1082, DOI 10.1104/pp.17.00695	42	11	11	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0253245	10.1371/journal.pone.0253245	http://dx.doi.org/10.1371/journal.pone.0253245			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111225	gold, Green Published			2022-12-26	WOS:000664642700098
J	Powdthavee, N; Riyanto, YE; Wong, ECL; Yeo, JXW; Chan, QY				Powdthavee, Nattavudh; Riyanto, Yohanes E.; Wong, Erwin C. L.; Yeo, Jonathan X. W.; Chan, Qi Yu			When face masks signal social identity: Explaining the deep face-mask divide during the COVID-19 pandemic	PLOS ONE			English	Article							COOPERATION	With the COVID-19 pandemic still raging and the vaccination program still rolling out, there continues to be an immediate need for public health officials to better understand the mechanisms behind the deep and perpetual divide over face masks in America. Using a random sample of Americans (N = 615), following a pre-registered experimental design and analysis plan, we first demonstrated that mask wearers were not innately more cooperative as individuals than non-mask wearers in the Prisoners' Dilemma (PD) game when information about their own and the other person's mask usage was not salient. However, we found strong evidence of in-group favouritism among both mask and non-mask wearers when information about the other partner's mask usage was known. Non-mask wearers were 23 percentage points less likely to cooperate than mask wearers when facing a mask-wearing partner, and 26 percentage points more likely to cooperate than mask wearers when facing a non-mask-wearing partner. Our analysis suggests social identity effects as the primary reason behind people's decision whether to wear face masks during the pandemic.	[Powdthavee, Nattavudh] Warwick Business Sch, Coventry, W Midlands, England; [Riyanto, Yohanes E.; Wong, Erwin C. L.; Yeo, Jonathan X. W.; Chan, Qi Yu] Nanyang Technol Univ, Singapore, Singapore	University of Warwick; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Powdthavee, N (corresponding author), Warwick Business Sch, Coventry, W Midlands, England.	Nattavudh.powdthavee@wbs.ac.uk			Nanyang Technological University; Warwick University	Nanyang Technological University(Nanyang Technological University); Warwick University	Nattavudh Powdthavee received funding from Warwick University's and Yohanes E. Riyanto and Jonathan W.X. Yeo received funding from Nanyang Technological University's personal research budgets for this work.	Akerlof GA, 2000, Q J ECON, V115, P715, DOI 10.1162/003355300554881; Alam M, 2020, J STAT MECH-THEORY E, V2020, DOI 10.1088/1742-5468/ab75ea; [Anonymous], 2021, CDC GUIDANCE WEARING; Aratani L, 2020, THE GUARDIAN 0629; Arefin M.R., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Arefin MR, 2020, P ROY SOC A-MATH PHY, V476, DOI 10.1098/rspa.2020.0327; Bohnet I, 2008, AM ECON REV, V98, P294, DOI 10.1257/aer.98.1.294; de Bruin WB, 2020, J RISK UNCERTAINTY, V61, P177, DOI 10.1007/s11166-020-09336-3; Burton-Chellew MN, 2016, P NATL ACAD SCI USA, V113, P1291, DOI 10.1073/pnas.1509740113; Chan EY, 2021, PERS INDIV DIFFER, V171, DOI 10.1016/j.paid.2020.110463; Chen Y, 2009, AM ECON REV, V99, P431, DOI 10.1257/aer.99.1.431; Ebbs S, 2020, ABC NEWS 1214; Faciani M, 2020, CONVERSATION 0909; Fodjo JNS, 2020, J INFECTION, V81, pE1, DOI 10.1016/j.jinf.2020.07.015; Gandhi M, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2026913; Goette L, 2006, AM ECON REV, V96, P212, DOI 10.1257/000282806777211658; Habib MDA, 2020, EVERGREEN, V7, P7; Huddy L., 2017, OXFORD RES ENCY POLI, DOI [10. 1093/acrefore/9780190228637. 013. 250, DOI 10.1093/ACREFORE/9780190228637.013.250]; Kabir KMA, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201095; Keshtkar-Jahromi M, 2020, AM J TROP MED HYG, V102, P1160, DOI 10.4269/ajtmh.20-0305; Korn L, 2020, P NATL ACAD SCI USA, V117, P14890, DOI 10.1073/pnas.1919666117; Li SX, 2020, HDB LABOR HUMAN RESO, P1; Maclean J.C., 2019, NATL BUREAU EC RES N, DOI [10.3386/w25632, DOI 10.3386/W25632]; McKelvey T., 2020, BBC 0720; Meer J, 2011, J PUBLIC ECON, V95, P926, DOI 10.1016/j.jpubeco.2010.11.026; Richter F, 2021, MAJORITY AM WEAR MAS; Rojas R., 2020, NEW YORK TIMES 0504; Rothgerber H., 2020, POLITICIZING COVID 1, DOI [10.31234/osf.io/k23cv, DOI 10.31234/OSF.IO/K23CV]; Scolforo M., 2021, ASS PRESS NEWS 0403; Smith A., 2021, NBC NEWS 0406; Stewart AJ, 2012, P NATL ACAD SCI USA, V109, P10134, DOI 10.1073/pnas.1208087109; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Tang S, 2017, ORGAN BEHAV HUM DEC, V140, P1, DOI 10.1016/j.obhdp.2017.02.001; Tanimoto J., 2021, SOCIOPHYSICS APPROAC; Wedekind C, 1996, P NATL ACAD SCI USA, V93, P2686, DOI 10.1073/pnas.93.7.2686; Weisel O, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026745118; Worby CJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17922-x; World Health Organization, 2020, COR DIS COVID 19 ADV; Yeung N., ARXIV PREPRINT ARXIV; YouGov Poll, 2020, PERS MEAS TAK AV COV	42	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0253195	10.1371/journal.pone.0253195	http://dx.doi.org/10.1371/journal.pone.0253195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111233	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000664642700097
J	Emery, BF; Niles, MT; Danforth, CM; Dodds, PS				Emery, Benjamin Freixas; Niles, Meredith T.; Danforth, Christopher M.; Dodds, Peter Sheridan			Local information sources received the most attention from Puerto Ricans during the aftermath of Hurricane Maria	PLOS ONE			English	Article							HAPPINESS	In September 2017, Hurricane Maria made landfall across the Caribbean region as a category 4 storm. In the aftermath, many residents of Puerto Rico were without power or clean running water for nearly a year. Using both English and Spanish tweets from September 16 to October 15 2017, we investigate discussion of Maria both on and off the island, constructing a proxy for the temporal network of communication between victims of the hurricane and others. We use information theoretic tools to compare the lexical divergence of different subgroups within the network. Lastly, we quantify temporal changes in user prominence throughout the event. We find at the global level that Spanish tweets more often contained messages of hope and a focus on those helping. At the local level, we find that information propagating among Puerto Ricans most often originated from sources local to the island, such as journalists and politicians. Critically, content from these accounts overshadows content from celebrities, global news networks, and the like for the large majority of the time period studied. Our findings reveal insight into ways social media campaigns could be deployed to disseminate relief information during similar events in the future.	[Emery, Benjamin Freixas; Danforth, Christopher M.; Dodds, Peter Sheridan] Univ Vermont, Dept Math & Stat, Computat Story Lab, Vermont Complex Syst Ctr,Vermont Adv Comp Core, Burlington, VT 05405 USA; [Niles, Meredith T.] Univ Vermont, Dept Nutr & Food Sci, Burlington, VT USA	University of Vermont; University of Vermont	Emery, BF (corresponding author), Univ Vermont, Dept Math & Stat, Computat Story Lab, Vermont Complex Syst Ctr,Vermont Adv Comp Core, Burlington, VT 05405 USA.	bfemery@uvm.edu		Emery, Benjamin/0000-0002-7639-7898				Abdullah NA, 2017, PROCEEDINGS OF THE 50TH ANNUAL HAWAII INTERNATIONAL CONFERENCE ON SYSTEM SCIENCES, P432; Allen G., 2015, POWER PROBLEMS PUERT; Allyn Bobby, 2019, NATL PUBLIC RADIO; Andrade E., 2018, ASCERTAINMENT ESTIMA; Bailey M., 2019, ADA J GENDER NEW MED, DOI [10.5399/uo/ada.2019.15.6, DOI 10.5399/UO/ADA.2019.15.6]; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Cha M, 2010, P INT AAAI C WEB SOC, V4; Chang A., 2018, VOX; Chu HR, 2020, DISASTERS, V44, P726, DOI 10.1111/disa.12388; Cody EM, 2016, ARXIV PREPRINT ARXIV; Dodds PS, 2015, P NATL ACAD SCI USA, V112, P2389, DOI 10.1073/pnas.1411678112; Dodds PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026752; FitzGerald D, 2017, WEEK MARIAS STRIKE P; Fountain N, 2017, NATL PUBLIC RADIO; Frank MR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02625; Gallagher RJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195644; Garcia D, 2015, P NATL ACAD SCI USA, V112, pE2983, DOI 10.1073/pnas.1502909112; Guan XY, 2014, NAT HAZARDS, V74, P837, DOI 10.1007/s11069-014-1217-1; Irfan U, 2018, ITS BEEN MORE 100 DA; Jackson SJ, 2015, J COMMUN, V65, P932, DOI 10.1111/jcom.12185; Jackson SJ, 2016, INFORM COMMUN SOC, V19, P397, DOI 10.1080/1369118X.2015.1106571; Kishore N, 2018, NEW ENGL J MED, V379, P162, DOI [10.1056/NEJMsa1803972, 10.1056/nejmsa1803972]; Kryvasheyeu Y, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500779; Kumar R, 2010, LINK MINING: MODELS, ALGORITHMS, AND APPLICATIONS, P337, DOI 10.1007/978-1-4419-6515-8_13; Mazzei P., 2017, NO CELL SERVICE PUER; Meyer R, 2017, WHATS HAPPENING RELI; Mitchell L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064417; Narang Kanika, 2013, Advances in Information Retrieval. 35th European Conference on IR Research, ECIR 2013. Proceedings, P545, DOI 10.1007/978-3-642-36973-5_46; Niles MT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210484; Olteanu A, 2018, WSDM'18: PROCEEDINGS OF THE ELEVENTH ACM INTERNATIONAL CONFERENCE ON WEB SEARCH AND DATA MINING, P785, DOI 10.1145/3159652.3162004; Padro Ocasio B, 2019, RI ROSSELLO PUERTO R; Reagan AJ, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0093-1; Reece AG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12961-9; Singh JP, 2019, ANN OPER RES, V283, P737, DOI 10.1007/s10479-017-2522-3; Sullivan E, 2018, NEARLY YEAR MARIA PU; Sullivan L., 2018, FEMA REPORT ACKNOWLE; Sutton Jeannette, 2013, International Journal of Information Systems for Crisis Response and Management, V5, P58, DOI 10.4018/jiscrm.2013010104; Wikipedia contributors, 2019, NTR; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	39	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0251704	10.1371/journal.pone.0251704	http://dx.doi.org/10.1371/journal.pone.0251704			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106937	Green Submitted, Green Published			2022-12-26	WOS:000664642200017
J	Epule, TE; Chehbouni, A; Dhiba, D; Etongo, D; Driouech, F; Brouziyne, Y; Peng, C				Epule, Terence Epule; Chehbouni, Abdelghani; Dhiba, Driss; Etongo, Daniel; Driouech, Fatima; Brouziyne, Youssef; Peng, Changhui			Vulnerability of maize, millet, and rice yields to growing season precipitation and socio-economic proxies in Cameroon	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CLIMATE-CHANGE; CROP PRODUCTION; RESILIENCE; DROUGHT; VARIABILITY; POVERTY; TRENDS	In sub-Saharan Africa growing season precipitation is affected by climate change. Due to this, in Cameroon, it is uncertain how some crops are vulnerable to growing season precipitation. Here, an assessment of the vulnerability of maize, millet, and rice to growing season precipitation is carried out at a national scale and validated at four sub-national scales/sites. The data collected were historical yield, precipitation, and adaptive capacity data for the period 1961-2019 for the national scale analysis and 1991-2016 for the sub-national scale analysis. The crop yield data were collected for maize, millet, and rice from FAOSTAT and the global yield gap atlas to assess the sensitivity both nationally and sub-nationally. Historical data on mean crop growing season and mean annul precipitation were collected from a collaborative database of UNDP/Oxford University and the climate portal of the World Bank to assess the exposure both nationally and sub-nationally. To assess adaptive capacity, literacy, and poverty rate proxies for both the national and regional scales were collected from KNOEMA and the African Development Bank. These data were analyzed using a vulnerability index that is based on sensitivity, exposure, and adaptive capacity. The national scale results show that millet has the lowest vulnerability index while rice has the highest. An inverse relationship between vulnerability and adaptive capacity is observed. Rice has the lowest adaptive capacity and the highest vulnerability index. Sub-nationally, this work has shown that northern maize is the most vulnerable crop followed by western highland rice. This work underscores the fact that at different scales, crops are differentially vulnerable due to variations in precipitation, temperature, soils, access to farm inputs, exposure to crop pest and variations in literacy and poverty rates. Therefore, caution should be taken when transitioning from one scale to another to avoid generalization. Despite these differences, in the sub-national scale, western highland rice is observed as the second most vulnerable crop, an observation similar to the national scale observation.	[Epule, Terence Epule; Chehbouni, Abdelghani; Dhiba, Driss; Driouech, Fatima; Brouziyne, Youssef] Mohammed VI Polytech Univ UM6P, Int Water Res Inst IWRI, Benguerir, Morocco; [Epule, Terence Epule] McGill Univ, Dept Geog, Montreal, PQ, Canada; [Chehbouni, Abdelghani] Mohammed VI Polytech Univ UM6P, Ctr Remote Sensing Applicat CRSA, Benguerir, Morocco; [Etongo, Daniel] Univ Seychelles, James Michel Blue Econ Res Inst, Anse Royale, Seychelles; [Etongo, Daniel] Univ Seychelles, Dept Environm Sci, Anse Royale, Seychelles; [Peng, Changhui] Univ Quebec Montreal UQAM, Dept Biol Sci, Montreal, PQ, Canada; [Peng, Changhui] North East A&F Univ, Ctr Ecol Forecasting & Global Change, Yangling, Shaanxi, Peoples R China	Mohammed VI Polytechnic University; McGill University; Mohammed VI Polytechnic University; University of Quebec; University of Quebec Montreal	Epule, TE (corresponding author), Mohammed VI Polytech Univ UM6P, Int Water Res Inst IWRI, Benguerir, Morocco.; Epule, TE (corresponding author), McGill Univ, Dept Geog, Montreal, PQ, Canada.	epule.terence@um6p.ma	Driouech, Fatima/AIF-4406-2022	Driouech, Fatima/0000-0002-0830-1831; Epule, Terence Epule/0000-0002-5756-382X	Mohamed VI Polytechnic University	Mohamed VI Polytechnic University	This work was supported by a research grant from Mohamed VI Polytechnic University to T.E under the auspices of the research grant to new professors under grant number UM6P. The link to the funder's website is: https://www.um6p.ma/en.The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adger WN., 2004, NEW INDICATORS VULNE, P1; African Development Bank Group (AfDB), 2020, CAM EC OUTL; Albizua A, 2019, REG ENVIRON CHANGE, V19, P1147, DOI 10.1007/s10113-019-01462-2; Antwi-Agyei P, 2012, APPL GEOGR, V32, P324, DOI 10.1016/j.apgeog.2011.06.010; Benson T, 2005, FOOD POLICY, V30, P532, DOI 10.1016/j.foodpol.2005.09.004; Challinor A, 2009, ENVIRON SCI POLICY, V12, P453, DOI 10.1016/j.envsci.2008.09.008; Challinor AJ, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/3/034012; Chen C., 2015, U NOTRE DAME GLOBAL; Cooper PJM, 2008, AGR ECOSYST ENVIRON, V126, P24, DOI 10.1016/j.agee.2008.01.007; Easterling W, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P273; Epule E. T., 2011, Journal of Sustainable Development, V4, P188; Epule TE, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-0912-7; Epule TE, 2017, WATER-SUI, V9, DOI 10.3390/w9030181; Epule TE, 2015, GEOJOURNAL, V80, P79, DOI 10.1007/s10708-014-9528-z; Epule TE, 2015, SUSTAINABILITY-BASEL, V7, P384, DOI 10.3390/su7010384; Eriksen S.H., 2007, MITIG ADAPT STRATEG, V12, P495, DOI [10.1007/s11027-006-3460-6, DOI 10.1007/S11027-006-3460-6]; Fonjong LN., 2007, J INT WOMENS STUDIES, V8, P133; Food and Agriculture Organization of the United Nations (FAO), FAOSTAT; Ford JD, 2013, ANN ASSOC AM GEOGR, V103, P1193, DOI 10.1080/00045608.2013.776880; Ford JD, 2010, WIRES CLIM CHANGE, V1, P374, DOI 10.1002/wcc.48; Giannini A, 2008, CLIMATIC CHANGE, V90, P359, DOI [10.1007/s10584-008-9396-y, 10.1007/s10584-008-9396-v]; Global Yield Gap Atlas (GYGA)., 2013, FAO CROP CAL MAIZ SO; Gollin D., 2014, SMALLHOLDER AGR AFRI; Gollin D, 2014, Q J ECON, V129, P939, DOI 10.1093/qje/qjt056; Goufo P., 2008, Research Journal of Agriculture and Biological Sciences, V4, P745; Goufo P., 2008, Research Journal of Agriculture and Biological Sciences, V4, P734; Hahn MB, 2009, GLOBAL ENVIRON CHANG, V19, P74, DOI 10.1016/j.gloenvcha.2008.11.002; Jassogne L, 2013, BANANA SYSTEMS IN THE HUMID HIGHLANDS OF SUB-SAHARAN AFRICA: ENHANCING RESILIENCE AND PRODUCTIVITY, P144, DOI 10.1079/9781780642314.0144; Kamali B, 2018, GLOBAL PLANET CHANGE, V162, P266, DOI 10.1016/j.gloplacha.2018.01.011; Kamali B, 2018, EUR J AGRON, V93, P57, DOI 10.1016/j.eja.2017.10.012; KNOEMA, CAM AD LIT RAT; Lobell DB, 2007, CLIMATIC CHANGE, V81, P187, DOI 10.1007/s10584-006-9141-3; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2010, AGR FOREST METEOROL, V150, P1443, DOI 10.1016/j.agrformet.2010.07.008; Luers AL, 2003, GLOBAL ENVIRON CHANG, V13, P255, DOI 10.1016/S0959-3780(03)00054-2; McSweeney C, 2010, B AM METEOROL SOC, V91, P157, DOI 10.1175/2009BAMS2826.1; McSweeney C., 2010, UNDP CLIMATE CHANGE; Minot NM., 2006, 145 INT FOOD POL RES; Mishra AK, 2010, J HYDROL, V391, P204, DOI 10.1016/j.jhydrol.2010.07.012; Mishra AK, 2011, J HYDROL, V403, P157, DOI 10.1016/j.jhydrol.2011.03.049; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; Mwaura F. M., 2014, Journal of Sustainable Development, V7, P159; Nelson DR, 2007, ANNU REV ENV RESOUR, V32, P395, DOI 10.1146/annurev.energy.32.051807.090348; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Sacks WJ, 2010, GLOBAL ECOL BIOGEOGR, V19, P607, DOI 10.1111/j.1466-8238.2010.00551.x; Sharma J, 2019, ENVIRON RES COMMUN, V1, DOI 10.1088/2515-7620/ab24ed; Sherman M, 2016, FOOD SECUR, V8, P551, DOI 10.1007/s12571-016-0583-9; Sherman M, 2013, GLOB FOOD SECUR-AGR, V2, P144, DOI 10.1016/j.gfs.2013.08.003; Shi WJ, 2014, FOOD SECUR, V6, P471, DOI 10.1007/s12571-014-0370-4; Shiferaw B, 2014, WEATHER CLIM EXTREME, V3, P67, DOI 10.1016/j.wace.2014.04.004; Simelton E, 2009, ENVIRON SCI POLICY, V12, P438, DOI 10.1016/j.envsci.2008.11.005; Sivakumar MVK, 2005, CLIMATIC CHANGE, V70, P31, DOI 10.1007/s10584-005-5937-9; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; Sullivan C, 2002, WORLD DEV, V30, P1195, DOI 10.1016/S0305-750X(02)00035-9; Ward P, 2009, DOWNSCALED CLIMATE C; WASSMANN R, 1993, CHEMOSPHERE, V26, P201, DOI 10.1016/0045-6535(93)90422-2; World Bank Group (WB), 2021, POP TOT CAM; World Bank Group (WB), 2021, CLIM CHANG KNOWL POR; Yengoh GT, 2014, AMBIO, V43, P175, DOI 10.1007/s13280-013-0428-0; Zou JW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002401	61	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252335	10.1371/journal.pone.0252335	http://dx.doi.org/10.1371/journal.pone.0252335			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RW	34106980	Green Published, gold			2022-12-26	WOS:000664642200040
J	Wan, NN; Li, L; Wu, XZ; Fan, JC				Wan, Nana; Li, Li; Wu, Xiaozhi; Fan, Jianchang			Coordination of a fresh agricultural product supply chain with option contract under cost and loss disruptions	PLOS ONE			English	Article							PRODUCTION DECISIONS; DEMAND; MANAGEMENT; CHANNEL	This paper analyzes the option coordination problem of a fresh agricultural product supply chain under two supply chain structures, when the production cost and the loss rate are disrupted simultaneously. This paper provides the explicit option coordination conditions for the disrupted supply chain under two supply chain structures, and then explores the effects of the disruptions and supply chain structure on the option coordination conditions. The results suggest that it is unfavorable to apply the original coordinating contracts without disruptions to coordinate the disrupted supply chain. The coordination of the disrupted supply chain can be achieved with knowledge of the distribution of demand. In two coordinating contracts for the disrupted supply chain, the exercise price is still at the original level without disruptions while the option price deviates from the original level without disruptions. Moreover, the relationships of the coordination conditions in two supply chain structures depend on the value of the profit allocation coefficient. When the profit allocation coefficient exceeds (falls behind) a certain threshold, the option price is set at a higher (lower) value in the supplier-led supply chain structure than in the distributor-led supply chain structure, while the exercise price is set at a lower (higher) value in the supplier-led supply chain structure than in the distributor-led supply chain structure. Finally, the disrupted supply chain with any supply chain structure will perform better in the modified coordinating contracts than in the original coordinating contracts without disruptions.	[Wan, Nana; Li, Li] Southwest Univ Sci & Technol, Sch Econ & Management, Mianyang, Sichuan, Peoples R China; [Wu, Xiaozhi] Univ Elect Sci & Technol China, Zhongshan Inst, Zhongshan, Peoples R China; [Fan, Jianchang] Nanjing Univ Finance & Econ, Sch Mkt & Logist Management, Nanjing, Peoples R China	Southwest University of Science & Technology - China; University of Electronic Science & Technology of China; Nanjing University of Finance & Economics	Wan, NN (corresponding author), Southwest Univ Sci & Technol, Sch Econ & Management, Mianyang, Sichuan, Peoples R China.; Wu, XZ (corresponding author), Univ Elect Sci & Technol China, Zhongshan Inst, Zhongshan, Peoples R China.; Fan, JC (corresponding author), Nanjing Univ Finance & Econ, Sch Mkt & Logist Management, Nanjing, Peoples R China.	wannana850417@163.com; fjfzwxz@163.com; fanjianchang@outlook.com	Fan, Jianchang/AHC-1021-2022		National Natural Science Foundation of China [71802168, 71972136, 72002094]; Humanities and Social Science Foundation of Ministry of Education of China [18YJC630165, 19YJC630185, 20YJC630020]; Foundation of Educational Commission of Guangdong Province of China [2018WTSCX199]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Humanities and Social Science Foundation of Ministry of Education of China(Ministry of Education, China); Foundation of Educational Commission of Guangdong Province of China	The paper is partially supported by National Natural Science Foundation of China (71802168, 71972136, 72002094), Humanities and Social Science Foundation of Ministry of Education of China (18YJC630165, 19YJC630185, 20YJC630020), and Foundation of Educational Commission of Guangdong Province of China (2018WTSCX199).	Behzadi G, 2017, INT J PROD ECON, V191, P207, DOI 10.1016/j.ijpe.2017.06.018; Cai XQ, 2013, OMEGA-INT J MANAGE S, V41, P752, DOI 10.1016/j.omega.2012.09.004; Cao EB, 2013, INT J PROD ECON, V141, P425, DOI 10.1016/j.ijpe.2012.09.009; Fu Q, 2012, PROD OPER MANAG, V21, P361, DOI 10.1111/j.1937-5956.2011.01255.x; Ghalebeigi A., 2015, OPTION CONTRACTS SUP; Han XH, 2017, INT J PROD RES, V55, P1147, DOI 10.1080/00207543.2016.1230684; Hou XY, 2017, J OPER RES SOC, V68, P566, DOI 10.1057/s41274-016-0025-2; Hu F, 2014, APPL MATH COMPUT, V232, P1225, DOI 10.1016/j.amc.2014.01.149; Huang HF, 2018, J CLEAN PROD, V180, P280, DOI 10.1016/j.jclepro.2018.01.152; Huang YT, 2018, J CLEAN PROD, V191, P248, DOI 10.1016/j.jclepro.2018.04.221; Jeuland AP, 2008, MARKET SCI, V27, P52, DOI 10.1287/mksc.1070.0332; Liu WH, 2016, INT J PROD ECON, V179, P59, DOI 10.1016/j.ijpe.2016.05.022; Liu X, 2016, J OPER RES SOC, V67, P187, DOI 10.1057/jors.2014.133; Liu ZY, 2020, INT J PROD ECON, V223, DOI 10.1016/j.ijpe.2019.107518; MacKenzie CA, 2017, INT J LOGIST MANAG, V28, P656, DOI 10.1108/IJLM-04-2016-0097; Qian GX, 2013, J INTEGR AGR, V12, P2300, DOI 10.1016/S2095-3119(13)60585-7; Qin YY, 2014, INT J PROD ECON, V152, P42, DOI 10.1016/j.ijpe.2014.01.005; Rahmani K, 2019, COMPUT IND ENG, V127, P493, DOI 10.1016/j.cie.2018.10.039; Robson I., 2001, SUPPLY CHAIN MANAG, V6, P39, DOI DOI 10.1108/13598540110384279; Sharma A, 2019, COMPUT IND ENG, V137, DOI 10.1016/j.cie.2019.106096; Sun GH, 2013, DISCRETE DYN NAT SOC, V2013, DOI 10.1155/2013/416790; Tao Y, 2017, COMPUT IND ENG, V110, P560, DOI 10.1016/j.cie.2017.04.029; Turvey C. G., 2001, Review of Agricultural Economics, V23, P333, DOI 10.1111/1467-9353.00065; Wan NN, 2022, J IND MANAG OPTIM, V18, P2827, DOI 10.3934/jimo.2021093; Wang C, 2017, ANN OPER RES, V248, P471, DOI 10.1007/s10479-016-2167-7; Wang M, 2018, INT J PROD RES, V56, P4207, DOI 10.1080/00207543.2018.1430904; Wu Q, 2015, INT J PROD ECON, V160, P94, DOI 10.1016/j.ijpe.2014.10.007; Xiao YB, 2012, DECISION SCI, V43, P785, DOI 10.1111/j.1540-5915.2012.00375.x; Yan B., 2020, ASIA PAC J OPER RES; Yan B, 2020, COMPUT OPER RES, V123, DOI 10.1016/j.cor.2020.105038; Yan B, 2020, CENT EUR J OPER RES, V28, P1343, DOI 10.1007/s10100-019-00657-6; Yan B, 2017, IND MANAGE DATA SYST, V117, P1842, DOI 10.1108/IMDS-06-2016-0245; Yang L, 2019, TRANSPORT RES E-LOG, V125, P425, DOI 10.1016/j.tre.2019.03.020; Yang L, 2017, APPL MATH MODEL, V47, P1, DOI 10.1016/j.apm.2017.03.002; Ye F, 2020, OPER RES-GER, V20, P369, DOI 10.1007/s12351-017-0328-3; Yu YL, 2017, COMPUT IND ENG, V111, P56, DOI 10.1016/j.cie.2017.07.001; Zhang LM, 2019, ASIA PAC J OPER RES, V36, DOI 10.1142/S0217595919500088; Zhang P, 2015, INT J PROD RES, V53, P3141, DOI 10.1080/00207543.2014.975853; Zhao TY, 2020, TRANSPORT RES E-LOG, V134, DOI 10.1016/j.tre.2020.101838; Zhao YX, 2010, EUR J OPER RES, V207, P668, DOI 10.1016/j.ejor.2010.05.017; Zheng Q, 2017, IND MANAGE DATA SYST, V117, P538, DOI 10.1108/IMDS-04-2016-0139; Zhou LN, 2019, KYBERNETES, V48, P1134, DOI 10.1108/K-08-2017-0291	42	6	6	24	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252960	10.1371/journal.pone.0252960	http://dx.doi.org/10.1371/journal.pone.0252960			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106997	Green Published, gold			2022-12-26	WOS:000664642200067
J	Fu, XX; Richards, JE				Fu, Xiaoxue; Richards, John E.			Age-related changes in diffuse optical tomography sensitivity profiles in infancy	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; PHOTON MIGRATION; BRAIN; DISTANCE; TEMPLATES; CHANNELS; SYSTEMS	Diffuse optical tomography uses near-infrared light spectroscopy to measure changes in cerebral hemoglobin concentration. Anatomical interpretations of the location that generates the hemodynamic signal requires accurate descriptions of diffuse optical tomography sensitivity to the underlying cortical structures. Such information is limited for pediatric populations because they undergo rapid head and brain development. The present study used photon propagation simulation methods to examine diffuse optical tomography sensitivity profiles in realistic head models among infants ranging from 2 weeks to 24 months with narrow age bins, children (4 and 12 years) and adults (20 to 24 years). The sensitivity profiles changed systematically with the source-detector separation distance. The peak of the sensitivity function in the head was largest at the smallest separation distance and decreased as separation distance increased. The fluence value dissipated more quickly with sampling depth at the shorter source-detector separations than the longer separation distances. There were age-related differences in the shape and variance of sensitivity profiles across a wide range of source-detector separation distances. Our findings have important implications in the design of sensor placement and diffuse optical tomography image reconstruction in (functional) near-infrared light spectroscopy research. Age-appropriate realistic head models should be used to provide anatomical guidance for standalone near-infrared light spectroscopy data in infants.	[Fu, Xiaoxue; Richards, John E.] Univ South Carolina, Dept Psychol, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Fu, XX (corresponding author), Univ South Carolina, Dept Psychol, Columbia, SC 29208 USA.	xiaoxuef@mailbox.sc.edu			National Institute of Child Health and Human Development [NICHD-R01-HD18942, NIHCD-R03-HD091464]	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	JER: NICHD-R01-HD18942 JER: NICHD-R01-HD18942 JER: NIHCD-R03-HD091464 National Institute of Child Health and Human Development https://www.nichd.nih.gov/The funder did not play any role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Aasted CM, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.020801; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Brigadoi S, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.3.035010; Brigadoi S, 2015, NEUROPHOTONICS, V2, DOI 10.1117/1.NPh.2.2.025005; Brigadoi S, 2014, NEUROIMAGE, V100, P385, DOI 10.1016/j.neuroimage.2014.06.028; Bulgarelli C, 2020, HUM BRAIN MAPP, V41, P2717, DOI 10.1002/hbm.24974; Bulgarelli C, 2019, DEV COGN NEUROS-NETH, V38, DOI 10.1016/j.dcn.2019.100676; Cooper RJ, 2012, NEUROIMAGE, V62, P1999, DOI 10.1016/j.neuroimage.2012.05.031; Culver JP, 2003, OPT LETT, V28, P2061, DOI 10.1364/OL.28.002061; Custo A, 2010, NEUROIMAGE, V49, P561, DOI 10.1016/j.neuroimage.2009.07.033; Dehaes M, 2013, HUM BRAIN MAPP, V34, P878, DOI 10.1002/hbm.21483; Dehaes M, 2011, BIOMED OPT EXPRESS, V2, P552, DOI 10.1364/BOE.2.000552; Dehghani H, 2009, COMMUN NUMER METH EN, V25, P711, DOI 10.1002/cnm.1162; Ding XP, 2014, NEUROIMAGE, V85, P335, DOI 10.1016/j.neuroimage.2013.07.051; Douaud G, 2007, BRAIN, V130, P2375, DOI 10.1093/brain/awm184; Emberson LL, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.3.031406; Fang QQ, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.11.115002; Fang QQ, 2010, BIOMED OPT EXPRESS, V1, P165, DOI 10.1364/BOE.1.000165; Fang QQ, 2009, OPT EXPRESS, V17, P20178, DOI 10.1364/OE.17.020178; Fang QQ, 2009, I S BIOMED IMAGING, P1142, DOI 10.1109/ISBI.2009.5193259; Fillmore PT, 2015, DEV NEUROSCI-BASEL, V37, P515, DOI 10.1159/000438749; Fillmore PT, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00044; Fu X., INVESTIGATING DEV CH; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Gervain J, 2011, DEV COGN NEUROS-NETH, V1, P22, DOI 10.1016/j.dcn.2010.07.004; Gilmore JH, 2012, CEREB CORTEX, V22, P2478, DOI 10.1093/cercor/bhr327; Huppert TJ, 2009, FRONT NEUROSCI, P393; Jacques S.L., 1995, OPTICAL THERMAL RESP, DOI 10.1007/978-1-4757-6092-7; Jenkinson M, 2005, 11 ANN M ORG HUM BRA; Jurcak V, 2007, NEUROIMAGE, V34, P1600, DOI 10.1016/j.neuroimage.2006.09.024; Lloyd-Fox S, 2010, NEUROSCI BIOBEHAV R, V34, P269, DOI 10.1016/j.neubiorev.2009.07.008; Makropoulos A, 2016, NEUROIMAGE, V125, P456, DOI 10.1016/j.neuroimage.2015.10.047; Mansouri C, 2010, LASER MED SCI, V25, P431, DOI 10.1007/s10103-010-0754-4; Perdue KL, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12839; Perdue KL, 2012, PHYS MED BIOL, V57, P2857, DOI 10.1088/0031-9155/57/10/2857; Perlman SB, 2014, NEUROIMAGE, V85, P326, DOI 10.1016/j.neuroimage.2013.04.057; Pinti P, 2020, ANN NY ACAD SCI, V1464, P5, DOI 10.1111/nyas.13948; Reddy ANK, 2015, PRAMANA-J PHYS, V84, P117, DOI 10.1007/s12043-014-0828-0; Reyes LD, 2020, NEUROIMAGE, V219, DOI 10.1016/j.neuroimage.2020.116971; Richards J.E., 2020, BRAIN DEV INFANTS ST; Richards JE, UPDATING NEURODEVELO; Richards JE, 2016, NEUROIMAGE, V124, P1254, DOI 10.1016/j.neuroimage.2015.04.055; Richards JE, 2015, ADV CHILD DEV BEHAV, V48, P1, DOI 10.1016/bs.acdb.2014.11.001; Richards JE, 2015, BRAIN TOPOGR, V28, P70, DOI 10.1007/s10548-014-0400-8; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Rorden C., 2012, MRICROGL; Sanchez CE, 2012, DEV PSYCHOBIOL, V54, P474, DOI 10.1002/dev.21018; Sanchez CE, 2012, DEV NEUROPSYCHOL, V37, P379, DOI 10.1080/87565641.2012.688900; Schweiger M, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.040801; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Strangman G, 2003, NEUROIMAGE, V18, P865, DOI 10.1016/S1053-8119(03)00021-1; Strangman GE, 2014, NEUROIMAGE, V85, P136, DOI 10.1016/j.neuroimage.2013.04.090; Strangman GE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066319; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wang L, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201900175; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Wheelock MD, 2019, REV SCI INSTRUM, V90, DOI 10.1063/1.5086809; Whiteman AC, 2018, NEUROPHOTONICS, V5, DOI 10.1117/1.NPh.5.1.011009; Wijeakumar S, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12822; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Morais GAZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21716-z	62	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252036	10.1371/journal.pone.0252036	http://dx.doi.org/10.1371/journal.pone.0252036			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101747	gold, Green Published, Green Submitted			2022-12-26	WOS:000664641500008
J	Suzuki, A; Matsui, M; Tung, R; Iwamoto, A				Suzuki, Ayako; Matsui, Mitsuaki; Tung, Rathavy; Iwamoto, Azusa			"Why did our baby die soon after birth?"-Lessons on neonatal death in rural Cambodia from the perspective of caregivers	PLOS ONE			English	Article							VERBAL AUTOPSY; MORTALITY; DETERMINANTS; WALK; CARE	Introduction Neonatal deaths represent around half the deaths of children less than five-years old in Cambodia. The process from live birth to neonatal death has not been well described. This study aimed to identify problems in health care service which hamper the reduction of preventable neonatal deaths in rural Cambodia. Methods This study adopted a method of qualitative case study design using narrative data from the verbal autopsy standard. Eighty and forty villages were randomly selected from Kampong Cham and Svay Rieng provinces, respectively. All households in the target villages were visited between January and February 2017. Family caregivers were asked to describe their experiences on births and neonatal deaths between 2015 and 2016. Information on the process from birth to death was extracted with open coding, categorized, and summarized into several groups which represent potential problems in health services. Results Among a total of 4,142 children born in 2015 and 2016, 35 neonatal deaths were identified. Of these deaths, 74% occurred within one week of birth, and 57% were due to low-birth weight. Narrative data showed that three factors should be improved, 1) the unavailability of a health-care professional, 2) barriers in the referral system, and 3) lack of knowledge and skill to manage major causes of neonatal deaths. Conclusion The current health system has limitations to achieve further reduction of neonatal deaths in rural Cambodia. The mere deployment of midwives at fixed service points such as health centers could not solve the problems occurring in rural communities. Community engagement revisiting the principle of primary health care, as well as health system transformation, is the key to the solution and potential breakthrough for the future.	[Suzuki, Ayako; Matsui, Mitsuaki; Tung, Rathavy; Iwamoto, Azusa] Japan Int Cooperat Agcy, Project Improving Continuum Care Focus Intrapartu, Phnom Penh, Cambodia; [Matsui, Mitsuaki] Nagasaki Univ, Sch Trop Med & Global Hlth, Dept Global Hlth, Nagasaki, Japan; [Tung, Rathavy] Natl Maternal & Child Hlth Ctr, Phnom Penh, Cambodia; [Iwamoto, Azusa] Natl Ctr Global Hlth & Med, Bur Int Hlth Cooperat, Tokyo, Japan	Nagasaki University; National Center for Global Health & Medicine - Japan	Iwamoto, A (corresponding author), Japan Int Cooperat Agcy, Project Improving Continuum Care Focus Intrapartu, Phnom Penh, Cambodia.; Iwamoto, A (corresponding author), Natl Ctr Global Hlth & Med, Bur Int Hlth Cooperat, Tokyo, Japan.	iwamoto@it.ncgm.go.jp		MATSUI, MITSUAKI/0000-0003-4075-1266	Japan Intranational Cooperation Agency; Nagasaki University	Japan Intranational Cooperation Agency; Nagasaki University	The study was funded by the Japan Intranational Cooperation Agency to the Project for Improving Continuum of Care with focus on Intrapartum and Neonatal Care in Cambodia; and by core funding from Nagasaki University to MM. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akseer N, 2015, INT J GYNECOL OBSTET, V131, pS43, DOI 10.1016/j.ijgo.2015.03.017; Akshaya KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183739; Annear P., 2015, KINGDOM CAMBODIA HLT, V5; [Anonymous], 1978, PRIM HLTH CAR REP IN; [Anonymous], 2000, CIRCULATION, V102, pI343, DOI [10.1161/circ.102.suppl%5F1.I-343, DOI 10.1161/CIRC.102.SUPPL%5F1.I-343]; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS51, DOI 10.1038/sj.jp.7211274; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS92, DOI 10.1038/sj.jp.7211277; Bang Abhay T, 2005, J Perinatol, V25 Suppl 1, pS82, DOI 10.1038/sj.jp.7211275; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Creswell JW., 2013, 5 QUALITATIVE APPROA, V3rd ed, P97; D'Ambruoso L, 2017, LANCET GLOB HEALTH, V5, pE20, DOI 10.1016/S2214-109X(16)30332-1; Division P, 2011, TECHNICAL PAPER SERI; Gabrysch S, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-34; Gouda HN, 2017, SOC SCI MED, V184, P65, DOI 10.1016/j.socscimed.2017.05.002; Gupta N, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6282-z; Jacobs B, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0803-3; Jeblee S, 2019, BMC MED INFORM DECIS, V19, DOI 10.1186/s12911-019-0841-9; Johnston LC, 2016, SEMIN PERINATOL, V40, P419, DOI 10.1053/j.semperi.2016.08.001; Korachais C, 2019, HEALTH POLICY PLANN, V34, P740, DOI 10.1093/heapol/czz095; Maredza M, 2016, COST EFFECT RESOUR A, V14, DOI 10.1186/s12962-015-0049-5; Meessen B., 2009, REMOVING USER FEES H; Meessen B, 2011, HEALTH POLICY PLANN, V26, pII1, DOI 10.1093/heapol/czr071; Ministry of Health Cambodia, 2016, FAST TRACK IN ROAD M; Ministry of Health Cambodia, 2017, NAT STRAT REPR SEX H; Ministry of Health Cambodia, 2015, 5 YEAR ACT PLAN NEWB; Ministry of Interior Cambodia, 2016, NAT BAS CIV REG VIT; National Institute of Statistics Directorate General for Health & ICF International, 2015, CAMB DEM HLTH SURV 2; Pariyo GW, 2011, BMC INT HEALTH HUM R, V11, DOI 10.1186/1472-698X-11-S1-S10; Partnering to Save Lives, COMM HLTH VOL BRIDG; Patel S, 2016, GLOB HEALTH-SCI PRAC, V4, P552, DOI 10.9745/GHSP-D-16-00253; Pittalis C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223328; Roro EM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5757-2; Singhal N, 2012, RESUSCITATION, V83, P90, DOI 10.1016/j.resuscitation.2011.07.010; Sivanandan S, 2017, SEMIN FETAL NEONAT M, V22, P260, DOI 10.1016/j.siny.2017.04.004; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; The Royal Government of Cambodia, 2016, NAT STRAT PLAN ID 20; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UNICEF, 2018, EV CHILD AL URG NEED; United Nations Children's Fund (UNICEF), 2020, MOT BOD BOD REF SYST; United Nations Inter-agency Group for Child Mortality Estimation (UN IGME), 2019, ESTIMATES DEV INTERA; World Health Organization, 2018, DEFINITION SKILLED H; World Health Organization, 2007, VERB AUT STAND ASC A; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; Yameogo WME, 2016, INT J GYNECOL OBSTET, V135, pS27, DOI 10.1016/j.ijgo.2016.08.003	44	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252663	10.1371/journal.pone.0252663	http://dx.doi.org/10.1371/journal.pone.0252663			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RH	34097710	gold, Green Published			2022-12-26	WOS:000664640700014
J	Adisasmita, A; Izati, Y; Choirunisa, S; Pratomo, H; Adriyanti, L				Adisasmita, Asri; Izati, Yulia; Choirunisa, Septyana; Pratomo, Hadi; Adriyanti, Luzy			Kangaroo mother care knowledge, attitude, and practice among nursing staff in a hospital in Jakarta, Indonesia	PLOS ONE			English	Article							IMPLEMENTATION; BIRTH; INFANTS; SKIN	Background Kangaroo mother care (KMC) has been proven to decrease rates of morbidity and mortality among premature and low-birth-weight infants. Thus, this study aimed to obtain baseline data regarding KMC knowledge, attitudes, and practices (KAP) among nursing staff caring for mothers and newborns in a hospital in Indonesia. Methods This cross-sectional study included 65 participants from three hospital wards at Koja District Hospital, North Jakarta. Participants included 29 perinatal ward nurses, 21 postnatal ward nurses and midwives, and 15 labor ward midwives. Data on KAP of KMC were collected using a self-administered questionnaire with closed-ended questions. Each questionnaire can be completed in approximately 1 hour. Results Among the included nursing staff, 12.3% (8/65) were determined to have received specific training on KMC, whereas 21.5% (14/65) had received more general training that included KMC content. About 46.2% of the nursing staff had good knowledge concerning KMC, 98.5% had good knowledge of KMC benefits, and 100% had a positive attitude toward KMC. All perinatal ward nurses had some experience assisting and implementing KMC. Some KAP that were observed among the nursing staff included lack of knowledge about the eligible infant weight for KMC and weight gain of infants receiving KMC, lack of education/training about KMC, and concerns regarding necessary equipment in KMC wards. Conclusions This study identified several issues that need to be addressed, including knowledge of feeding and weight gain, workload, incubator use, and the need for well-equipped KMC wards. We recommend that hospitals improve their nursing staff's knowledge of KMC and establish well-equipped KMC wards.	[Adisasmita, Asri] Univ Indonesia, Dept Epidemiol, Fac Publ Hlth, Depok, Indonesia; [Adisasmita, Asri; Izati, Yulia; Choirunisa, Septyana; Pratomo, Hadi] Univ Indonesia, Kangaroo Mother Care Res Project, Fac Publ Hlth, Depok, Indonesia; [Pratomo, Hadi] Univ Indonesia, Dept Hlth Educ & Behav Sci, Fac Publ Hlth, Depok, Indonesia; [Adriyanti, Luzy] Koja Dist Gen Hosp, North Jakarta, Jakarta Provinc, Indonesia	University of Indonesia; University of Indonesia; University of Indonesia	Adisasmita, A (corresponding author), Univ Indonesia, Dept Epidemiol, Fac Publ Hlth, Depok, Indonesia.; Adisasmita, A (corresponding author), Univ Indonesia, Kangaroo Mother Care Res Project, Fac Publ Hlth, Depok, Indonesia.	aadsmt237@gmail.com		Choirunisa, Septyana/0000-0001-5756-8957	PEER (Partnerships for Enhanced Engagement in Research) Program; USAID; Universitas Indonesia [2019: PENG-1/UN2. R3.1/PPM.00/2019];  [AID-OAA-A-11-00012]	PEER (Partnerships for Enhanced Engagement in Research) Program; USAID(United States Agency for International Development (USAID)); Universitas Indonesia(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); 	This study was made possible by the generous support of the American people through the PEER (Partnerships for Enhanced Engagement in Research) Program. The program is supported by USAID and implemented by the U.S. National Academies of Sciences. HP (as the principal investigator of this study) received funding under Sponsor Grant Award Number: AID-OAA-A-11-00012. NAS URL: http://www.nasonline.org/USAID PEER Program https://www.usaid.gov/what-we-do/GlobalDevLab/international-researchscience-programs/peer The contents of this study are the sole responsibility of the authors and do not necessarily reflect the views of the USAID or the United States Government. The publication of this study was made possible by support of Universitas Indonesia (UI research grant 2019: PENG-1/UN2. R3.1/PPM.00/2019) including funding for publication. The funders had no role in the study design; data collection and analysis, decision to publish, or preparation of the manuscript.	ACCESS and USAID, 2009, KANG MOTH CAR FAC GU; Bergh AM, 2003, ACTA PAEDIATR, V92, P709, DOI 10.1080/08035250310002399; Bergh AM., 2007, RETROSPECTIVE EVALUA; Bergh AM, 2012, S AFR J CHILD HEALTH, V6, P38; Cattaneo A, 1998, ACTA PAEDIATR, V87, P976, DOI 10.1080/080352598750031653; Chan G, 2017, HEALTH POLICY PLANN, V32, P1466, DOI 10.1093/heapol/czx098; Chan GJ, 2016, B WORLD HEALTH ORGAN, V94, P130, DOI 10.2471/BLT.15.157818; Charpak N, 1997, PEDIATRICS, V100, P682, DOI 10.1542/peds.100.4.682; Charpak N, 2006, ACTA PAEDIATR, V95, P529, DOI 10.1080/08035250600599735; Chawanpaiboon S, 2019, LANCET GLOB HEALTH, V7, pE37, DOI 10.1016/S2214-109X(18)30451-0; Chia P, 2006, AUST J ADV NURS, V23, P20; Conde-Agudelo A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub2; Conde-Agudelo A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002771.pub4; Desai RP., 2013, NHL J MED SCI, V2, P2319; DiMenna L, 2006, NEONATAL NETW, V25, P405, DOI 10.1891/0730-0832.25.6.405; El-Nagar S., 2013, Journal of Natural Sciences Research, V3, P175; Engler Arthur J, 2002, MCN Am J Matern Child Nurs, V27, P146, DOI 10.1097/00005721-200205000-00004; Hendricks-Munoz KD, 2010, AM J PERINAT, V27, P193, DOI 10.1055/s-0029-1234039; Johnson AN, 2007, MCN-AM J MATERN-CHIL, V32, P25; JSI Research & Training Institute, 2010, HLTH SERV PROGR HSP; KMC (Kangaroo Mother Care) research team PEER (Partnership of Engaging and Enhancement Research) USAID, 2016, KANG MOTH CAR BAS RE; Kristoffersen L, 2016, JOGNN-J OBST GYN NEO, V45, P339, DOI 10.1016/j.jogn.2016.02.007; Lawn JE, 2010, INT J EPIDEMIOL, V39, P144, DOI 10.1093/ije/dyq031; Lee HC, 2012, BREASTFEED MED, V7, P79, DOI 10.1089/bfm.2011.0004; Lipato T, 2012, EVALUATION KANGAROO; Mallet I, 2007, ARCH PEDIATRIE, V14, P881, DOI 10.1016/j.arcped.2007.01.017; McMaster P, 2000, TROP DOCT, V30, P136, DOI 10.1177/004947550003000307; Moore ER, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub3; Nyqvist KH, 2011, THESIS UPPSALA U UPP; Pratomo Hadi, 2020, Clin Exp Pediatr, V63, P433, DOI 10.3345/cep.2018.06506; Seidman G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125643; Solomons N, 2012, S AFR J CLIN NUTR, V25, P33; Vidya G. S., 2015, International Journal of Health and Allied Sciences, V4, P230; WHO, 2016, EARL IN BREASTF; WHO Immediate KMC Study Group, 2020, BMC TRIALS, V21, P280, DOI [10.1186/s13063-020-4101-1, DOI 10.1186/S13063-020-4101-1]; Zhang Y, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-021740	36	1	1	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252704	10.1371/journal.pone.0252704	http://dx.doi.org/10.1371/journal.pone.0252704			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086791	Green Published, gold			2022-12-26	WOS:000664640100110
J	Alhabib, KF; Al-Rasadi, K; Almigbal, TH; Batais, MA; Al-Zakwani, I; Al-Allaf, FA; Al-Waili, K; Zadjali, F; Alghamdi, M; Alnouri, F; Awan, Z; Kinsara, AJ; AlQudaimi, A; Almahmeed, W; Sabbour, H; Traina, M; Atallah, B; Al-Jarallah, M; AlSarraf, A; AlSayed, N; Amin, H; Altaradi, H				Alhabib, Khalid F.; Al-Rasadi, Khalid; Almigbal, Turky H.; Batais, Mohammed A.; Al-Zakwani, Ibrahim; Al-Allaf, Faisal A.; Al-Waili, Khalid; Zadjali, Fahad; Alghamdi, Mohammad; Alnouri, Fahad; Awan, Zuhier; Kinsara, Abdulhalim J.; AlQudaimi, Ahmed; Almahmeed, Wael; Sabbour, Hani; Traina, Mahmoud; Atallah, Bassam; Al-Jarallah, Mohammed; AlSarraf, Ahmad; AlSayed, Nasreen; Amin, Haitham; Altaradi, Hani			Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry	PLOS ONE			English	Article							PREVALENCE; THERAPY; STATIN; ATHEROSCLEROSIS; CONSANGUINITY; GUIDELINES; MORTALITY; DIAGNOSIS; GUIDANCE; INSIGHTS	Background and aims Familial hypercholesterolemia (FH) is a common autosomal dominant disorder that can result in premature atherosclerotic cardiovascular disease (ASCVD). Limited data are available worldwide about the prevalence and management of FH. Here, we aimed to estimate the prevalence and management of patients with FH in five Arabian Gulf countries (Saudi Arabia, Oman, United Arab Emirates, Kuwait, and Bahrain). Methods The multicentre, multinational Gulf FH registry included adults (>= 18 years old) recruited from outpatient clinics in 14 tertiary-care centres across five Arabian Gulf countries over the last five years. The Gulf FH registry had four phases: 1- screening, 2- classification based on the Dutch Lipid Clinic Network, 3- genetic testing, and 4- follow-up. Results Among 34,366 screened patient records, 3713 patients had suspected FH (mean age: 4915 years; 52% women) and 306 patients had definite or probable FH. Thus, the estimated FH prevalence was 0.9% (1:112). Treatments included high-intensity statin therapy (34%), ezetimibe (10%), and proprotein convertase subtilisin/kexin type 9 inhibitors (0.4%). Targets for low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol were achieved by 12% and 30%, respectively, of patients at high ASCVD risk, and by 3% and 6%, respectively, of patients at very high ASCVD risk (p <0.001; for both comparisons). Conclusions This snap-shot study was the first to show the high estimated prevalence of FH in the Arabian Gulf region (about 3-fold the estimated prevalence worldwide), and is a "call-to-action" for further confirmation in future population studies. The small proportions of patients that achieved target LDL-C values implied that health care policies need to implement nation-wide screening, raise FH awareness, and improve management strategies for FH.	[Alhabib, Khalid F.; Altaradi, Hani] King Saud Univ, Dept Cardiac Sci, Coll Med, Riyadh, Saudi Arabia; [Al-Rasadi, Khalid] Sultan Qaboos Univ, Med Res Ctr, Muscat, Oman; [Al-Rasadi, Khalid; Zadjali, Fahad] Sultan Qaboos Univ, Dept Biochem, Coll Med & Hlth Sci, Muscat, Oman; [Almigbal, Turky H.; Batais, Mohammed A.] King Saud Univ, Dept Family & Community Med, Coll Med, Riyadh, Saudi Arabia; [Almigbal, Turky H.] Alfarabi Coll, Alfarabi Coll Med, Riyadh, Saudi Arabia; [Al-Zakwani, Ibrahim] Sultan Qaboos Univ, Dept Pharmacol & Clin Pharm, Coll Med & Hlth Sci, Muscat, Oman; [Al-Zakwani, Ibrahim] Gulf Hlth Res, Muscat, Oman; [Al-Allaf, Faisal A.] Umm Al Qura Univ, Dept Med Genet, Fac Med, Mecca, Saudi Arabia; [Al-Waili, Khalid] Sultan Qaboos Univ Hosp, Dept Clin Biochem, Muscat, Oman; [Alghamdi, Mohammad] Natl Guard Hosp, Riyadh, Saudi Arabia; [Alnouri, Fahad] Prince Sultan Cardiac Ctr, Cardiovasc Prevent Unit, Riyadh, Saudi Arabia; [Awan, Zuhier] King Abdulaziz Univ, Dept Clin Biochem, Fac Med, Jeddah, Saudi Arabia; [Kinsara, Abdulhalim J.] King Saud Bin Abdulaziz Univ Hlth Sci, Minist Natl Guard Hlth Affair, COM WR, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [AlQudaimi, Ahmed] Saud Al Babtain Cardiac Ctr, Dammam, Saudi Arabia; [Almahmeed, Wael; Sabbour, Hani; Traina, Mahmoud] Cleveland Clin Abu Dhabi, Inst Heart & Vasc, Abu Dhabi, U Arab Emirates; [Atallah, Bassam] Cleveland Clin Abu Dhabi, Dept Pharm, Abu Dhabi, U Arab Emirates; [Atallah, Bassam] Case Western Reserve Univ, Cleveland Clin, Lerner Coll Med, Cleveland, OH 44106 USA; [Al-Jarallah, Mohammed; AlSarraf, Ahmad] Sabah Al Ahmed Cardiac Ctr, Dept Med, Kuwait, Kuwait; [AlSayed, Nasreen] Gulf Med & Diabet Ctr, Manama, Bahrain; [Amin, Haitham] Bahrain Def Force Hosp, Riffa, Bahrain	King Saud University; Sultan Qaboos University; Sultan Qaboos University; King Saud University; Sultan Qaboos University; Umm Al Qura University; Sultan Qaboos University; Prince Sultan Cardiac Center; King Abdulaziz University; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Alhabib, KF (corresponding author), King Saud Univ, Dept Cardiac Sci, Coll Med, Riyadh, Saudi Arabia.	khalidalhabib13@hotmail.com		ALNOURI, FAHAD/0000-0002-2315-8367; Alhabib, Khalid/0000-0002-6692-3874; Al-Zakwani, Ibrahim/0000-0002-3626-4230	SanofiAventis Groupe [DIREGL08183]	SanofiAventis Groupe	This study received support from SanofiAventis Groupe (https://www.sanofi.com) in the form of a grant (number DIREGL08183) awarded to KFA, KA, FA, WA, MA, and NA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Akioyamen LE, 2018, J PSYCHOSOM RES, V109, P32, DOI 10.1016/j.jpsychores.2018.03.170; Al-Allaf FA, 2017, ACTA BIOCHIM POL, V64, P75, DOI 10.18388/abp.2016_1283; Al-Nozha MM, 2007, SAUDI MED J, V28, P77; Al-Nozha MM, 2009, J SAUDI HEART ASSOC, V21, P169, DOI 10.1016/j.jsha.2009.06.007; Al-Nozha MM, 2004, SAUDI MED J, V25, P1603; Al-Rasadi K, 2020, CURR VASC PHARMACOL, V18, P57, DOI 10.2174/1570161116666181005125459; ALAWADI SA, 1985, CLIN GENET, V27, P483; AlGazali LI, 1997, J BIOSOC SCI, V29, P491, DOI 10.1017/S0021932097004914; Alhababi D, 2018, ATHEROSCLEROSIS, V279, P62, DOI 10.1016/j.atherosclerosis.2018.10.022; Allard MD, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-65; Alnouri F, 2020, GLOB HEART, V15, DOI 10.5334/gh.759; Alnouri F, 2018, ATHEROSCLEROSIS, V277, P425, DOI 10.1016/j.atherosclerosis.2018.06.878; Alonso R, 2018, EUR CARDIOL REV, V13, P14, DOI 10.15420/ecr.2018:10:2; Austin MA, 2004, AM J EPIDEMIOL, V160, P407, DOI 10.1093/aje/kwh236; Batais MA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183494; Beheshti SO, 2020, J AM COLL CARDIOL, V75, P2553, DOI 10.1016/j.jacc.2020.03.057; Beliard S, 2018, PRESSE MED, V47, P159, DOI 10.1016/j.lpm.2018.01.025; Benn M, 2012, J CLIN ENDOCR METAB, V97, P3956, DOI 10.1210/jc.2012-1563; Berg AO, 2009, ANN INTERN MED, V151, P872, DOI [10.7326/0000605-200912150-00165, 10.7326/0003-4819-151-12-200912150-00165]; Besseling J, 2015, JAMA-J AM MED ASSOC, V313, P1029, DOI 10.1001/jama.2015.1206; Catapano AL, 2016, ATHEROSCLEROSIS, V253, P281, DOI 10.1016/j.atherosclerosis.2016.08.018; Civeira F, 2004, ATHEROSCLEROSIS, V173, P55, DOI 10.1016/j.atherosclerosis.2003.11.010; Cuchel M, 2014, EUR HEART J, V35, P2146, DOI 10.1093/eurheartj/ehu274; deGoma EM, 2016, CIRC-CARDIOVASC GENE, V9, P240, DOI 10.1161/CIRCGENETICS.116.001381; ELHAZMI MAF, 1995, J MED GENET, V32, P623, DOI 10.1136/jmg.32.8.623; Hamilton-Craig I, 2010, VASC HEALTH RISK MAN, V6, P1023, DOI 10.2147/VHRM.S13496; Hu PW, 2020, CIRCULATION, V141, P1742, DOI 10.1161/CIRCULATIONAHA.119.044795; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; KANE JP, 1990, JAMA-J AM MED ASSOC, V264, P3007, DOI 10.1001/jama.264.23.3007; Kastelein JJP, 2015, EUR HEART J, V36, P2996, DOI 10.1093/eurheartj/ehv370; Kazi DS, 2016, JAMA-J AM MED ASSOC, V316, P743, DOI 10.1001/jama.2016.11004; Krogh HW, 2016, EUR HEART J, V37, P1398, DOI 10.1093/eurheartj/ehv602; Mach F, 2020, EUR HEART J, V41, P111, DOI [10.15829/1560-4071-2020-3826, 10.1093/eurheartj/ehz455]; Migliara G, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00252; Neil A, 2008, EUR HEART J, V29, P2625, DOI 10.1093/eurheartj/ehn422; Neil HAW, 2004, HEART, V90, P1431, DOI 10.1136/hrt.2003.022764; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Parihar Ravi Kumar, 2012, Indian J Endocrinol Metab, V16, P643, DOI 10.4103/2230-8210.98032; Patel RS., 2017, CONTINUING CHALLENGE; Pijlman AH, 2010, ATHEROSCLEROSIS, V209, P189, DOI 10.1016/j.atherosclerosis.2009.09.014; Raal FJ, 2015, LANCET, V385, P331, DOI 10.1016/S0140-6736(14)61399-4; Raal FJ, 2011, CIRCULATION, V124, P2202, DOI 10.1161/CIRCULATIONAHA.111.042523; Rader DJ, 2003, J CLIN INVEST, V111, P1795, DOI 10.1172/JCI200318925; RUBINSZTEIN DC, 1994, S AFR MED J, V84, P339; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sjouke B, 2014, J AM COLL CARDIOL, V63, pA2050, DOI 10.1016/S0735-1097(14)62053-2; Ungar Leo, 2018, Front Cardiovasc Med, V5, P116, DOI 10.3389/fcvm.2018.00116; Vallejo-Vaz AJ, 2015, ATHEROSCLEROSIS, V243, P257, DOI 10.1016/j.atherosclerosis.2015.09.021; Versmissen J, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2423	49	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251560	10.1371/journal.pone.0251560	http://dx.doi.org/10.1371/journal.pone.0251560			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086694	Green Published, gold			2022-12-26	WOS:000664640100018
J	Suh, KJ; Kim, JW; Kim, JE; Sung, JH; Koh, J; Kim, KJ; Kim, JW; Ahn, SH; Park, DJ; Kim, HH; Lee, HS; Lee, KW				Suh, Koung Jin; Kim, Jin Won; Kim, Ji Eun; Sung, Ji Hea; Koh, Jiwon; Kim, Kui-Jin; Kim, Ji-Won; Ahn, Sang-Hoon; Park, Do Joong; Kim, Hyung-Ho; Lee, Hye Seung; Lee, Keun-Wook			Correlation between tumor infiltrating immune cells and peripheral regulatory T cell determined using methylation analyses and its prognostic significance in resected gastric cancer	PLOS ONE			English	Article							LUNG-CANCER; ADVERSE PROGNOSIS; LYMPHOCYTES; RECURRENCE; RATIO	Peripheral regulatory T cells (pTregs) are a highly immunosuppressive fraction of CD4+ T cells. We aimed to evaluate the clinical significance of pTregs in patients with gastric cancer and to determine the correlation between pTregs and immune cell infiltration in tumor microenvironment. pTregs status was determined by assessing the pTreg/total T-cell ratio (ratio of Foxp3 Treg-specific demethylated region (TSDR) to CD3G/CD3D demethylation, so-called Cellular Ratio of Immune Tolerance "ImmunoCRIT") using methylation analyses in 433 patients with gastric cancer who received curative surgery. Among 422 evaluable patients, 230 (54.5%) had high ImmunoCRIT (> 21.0). Patients with high ImmunoCRIT had significantly shorter disease-free survival (DFS) and overall survival (OS) than those with high ImmunoCRIT (p = 0.030, p = 0.008, respectively). In multivariate analysis, high ImmunoCRIT kept a prognostic role for shorter OS (hazard ratio [HR] 1.9, 95% confidence interval [CI] 1.4-2.9; p = 0.005). CD3+ cell density and CD4+ cell density was significantly higher within the tumor in high ImmunoCRIT group than those in low ImmunoCRIT group (CD3+ cell, 202.12/mm(2)vs. 172.2/mm(2), p = 0.029; CD4+ cell, 56.5/mm(2)vs. 43.5/mm(2), p = 0.007). In conclusion, the peripheral ImmunoCRIT determined by epigenetic methylation analysis provides prognostic information in resected gastric tumors.	[Suh, Koung Jin; Kim, Jin Won; Kim, Ji Eun; Sung, Ji Hea; Kim, Ji-Won; Lee, Keun-Wook] Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Coll Med, Seongnam, South Korea; [Kim, Ji Eun] Yonsei Univ, Yonsei Biomed Res Inst, Coll Med, Seoul, South Korea; [Koh, Jiwon] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Pathol, Seoul, South Korea; [Kim, Kui-Jin] Seoul Natl Univ, Bundang Hosp, Biomed Res Inst, Seongnam, South Korea; [Ahn, Sang-Hoon; Park, Do Joong; Kim, Hyung-Ho] Seoul Natl Univ, Bundang Hosp, Dept Surg, Coll Med, Seongnam, South Korea; [Park, Do Joong] Seoul Natl Univ, Coll Med, Dept Surg, Seoul Natl Univ Hosp, Seoul, South Korea; [Lee, Hye Seung] Seoul Natl Univ, Coll Med, Dept Pathol, Bundang Hosp, Seongnam, South Korea	Seoul National University (SNU); Yonsei University; Yonsei University Health System; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Kim, JW (corresponding author), Seoul Natl Univ, Dept Internal Med, Bundang Hosp, Coll Med, Seongnam, South Korea.	jwkim@snubh.org	Lee, Hye Seung/G-6419-2011	Lee, Hye Seung/0000-0002-1667-7986; Suh, Koung Jin/0000-0002-1881-8738	SNUBH research fund [14-2014-009]	SNUBH research fund	This study was supported by grant no. 14-2014-009 from the SNUBH research fund.	Alsibai KD., 2018, HISTOPATHOL UPDATE, P11, DOI [10.5772/INTECHOPEN.72648, DOI 10.5772/INTECHOPEN.72648]; Anraku M, 2008, J THORAC CARDIOV SUR, V135, P823, DOI 10.1016/j.jtcvs.2007.10.026; Barth SD, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv224; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Choi Y, 2017, GASTRIC CANCER, V20, P602, DOI 10.1007/s10120-016-0642-0; Ibrahim EM, 2014, BREAST CANCER RES TR, V148, P467, DOI 10.1007/s10549-014-3185-2; Jimenez-Sanchez A, 2017, CELL, V170, P927, DOI 10.1016/j.cell.2017.07.025; Kim HI, 2011, J SURG ONCOL, V104, P728, DOI 10.1002/jso.22038; Koh J, 2017, ONCOTARGET, V8, P26356, DOI 10.18632/oncotarget.15465; Kotsakis A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39247; Meyer C, 2014, CANCER IMMUNOL IMMUN, V63, P247, DOI 10.1007/s00262-013-1508-5; Perrone G, 2008, EUR J CANCER, V44, P1875, DOI 10.1016/j.ejca.2008.05.017; Schatton T, 2014, METHODS MOL BIOL, V1102, P287, DOI 10.1007/978-1-62703-727-3_16; Sehouli J, 2011, EPIGENETICS-US, V6, P236, DOI 10.4161/epi.6.2.13755; Shang B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15179; Shen ZB, 2010, J CANCER RES CLIN, V136, P1585, DOI 10.1007/s00432-010-0816-9; Shimizu K, 2010, J THORAC ONCOL, V5, P585, DOI 10.1097/JTO.0b013e3181d60fd7; Sun KY, 2014, J CANCER RES CLIN, V140, P1537, DOI 10.1007/s00432-014-1714-3; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Turbachova I, 2013, EPIGENETICS-US, V8, P1226, DOI 10.4161/epi.26334; Uryvaev A, 2018, MED ONCOL, V35, DOI 10.1007/s12032-018-1080-0; Voo KS, 2014, INT J CANCER, V135, P2834, DOI 10.1002/ijc.28937; Wieczorek G, 2009, CANCER RES, V69, P599, DOI 10.1158/0008-5472.CAN-08-2361; Williams BA, 2006, FINDING OPTIMAL CUTP; Woo EY, 2001, CANCER RES, V61, P4766; Zhuo CH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-153	26	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252480	10.1371/journal.pone.0252480	http://dx.doi.org/10.1371/journal.pone.0252480			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086741	gold, Green Published			2022-12-26	WOS:000664640100074
J	Tun, MMN; Kyaw, AK; Nabeshima, T; Soe, AM; Nwe, KM; Htet, KKK; Aung, TH; Htwe, TT; Aung, T; Myaing, SS; Mar, TT; Lwin, EP; Thu, HM; Thant, KZ; Morita, K				Tun, Mya Myat Ngwe; Kyaw, Aung Kyaw; Nabeshima, Takeshi; Soe, Aung Min; Nwe, Khine Mya; Htet, Kyaw Ko Ko; Aung, Thet Htoo; Htwe, Thein Thein; Aung, Thidar; Myaing, Su Su; Mar, Tu Tu; Lwin, Ei Phyu; Thu, Hlaing Myat; Thant, Kyaw Zin; Morita, Kouichi			Detection of genotype-1 of dengue virus serotype 3 for the first time and complete genome analysis of dengue viruses during the 2018 epidemic in Mandalay, Upper Myanmar	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS; HEMORRHAGIC-FEVER; VIRAL LOAD; OUTBREAK; CHINA; PERFORMANCE; INFECTIONS; ALIGNMENT; TYPE-1; BORDER	Background Dengue (DEN) is a neglected tropical disease, and surveillance of dengue virus (DENV) serotypes and genotypes is critical for the early detection of outbreaks. Risk factors for outbreaks include the emergence of new genotypes and serotype shifting. Methodology and principal findings To understand the genomic and viral characteristics of DENV-infected patients, we conducted a cross-sectional descriptive study among pediatric patients admitted at the 550-bedded Mandalay Children Hospital during the 2018 DEN endemic season. We conducted virus isolation, serological tests, viremia level measurement, and whole-genome sequencing. Among the 202 serum samples, we detected 85 samples with DENV (46 DENV-1, 10 DENV-3, 26 DENV-4 and three multiple serotype co-infections) via reverse transcription quantitative/real-time PCR (RT-qPCR), and we obtained 49 DENV isolates (31 DENV-1, 10 DENV-3 and 8 DEN-4). We did not detect DENV-2 in this study. The viral genome levels in serum did not differ significantly among virus serotypes, infection status (primary versus secondary) and disease severity. Based on the phylogenetic analysis, we identified DENV-1 genotype-1, DENV-4 genotype-1 and DENV-3 genotype-3 and genotype-1 which was detected for the first time. Next-generation sequencing analysis revealed greater frequencies of nonsynonymous and synonymous mutations per gene in the nonstructural genes. Moreover, mutation rates were also higher among DENV-1. Conclusion/Significance In conclusion, there was an increasing trend of DENV-3 cases during DENV endemic season in 2018 with the first detection of the genotype 1. However, DENV-1 has remained the predominant serotype in this study area since 2013, and we identified stop codon mutations in the DENV-1 genome. This report is the first to feature a complete genome analysis of the strains of DENV-3 and DENV-4 circulating among pediatric patients in Myanmar. This study highlighted the importance of annual surveillance for a better understanding of the molecular epidemiology of DENVs.	[Tun, Mya Myat Ngwe; Nabeshima, Takeshi; Soe, Aung Min; Nwe, Khine Mya; Morita, Kouichi] Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki, Japan; [Kyaw, Aung Kyaw; Soe, Aung Min; Htet, Kyaw Ko Ko; Aung, Thet Htoo; Htwe, Thein Thein; Aung, Thidar; Myaing, Su Su; Mar, Tu Tu; Thu, Hlaing Myat] Minist Hlth & Sports, Dept Med Res, Yangon, Myanmar; [Lwin, Ei Phyu] Minist Hlth & Sports, 550 Bedded Children Hosp Mandalay, Dept Med Serv, Mandalay, Myanmar; [Thant, Kyaw Zin] Myanmar Acad Med Sci, Yangon, Myanmar	Nagasaki University	Tun, MMN; Morita, K (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Virol, Nagasaki, Japan.	myamyat@tm.nagasaki-u.ac.jp; moritak@nagasaki-u.ac.jp	KYAW, Aung KYAW/R-7376-2017; Htet, Kyaw Ko Ko/AAW-2957-2021	KYAW, Aung KYAW/0000-0002-1384-8030; HTET, KYAW KO KO/0000-0001-7853-7308	Japan Agency of Medical Research and Development (AMED) [JP21wm0125006]; Institute of Tropical Medicine, Nagasaki University, Japan [2020-Ippan-25]; Department of Medical Research, Ministry of Health and Sports, Myanmar [2020-Ippan-25]	Japan Agency of Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Institute of Tropical Medicine, Nagasaki University, Japan; Department of Medical Research, Ministry of Health and Sports, Myanmar	This study was supported by Japan Agency of Medical Research and Development (AMED) under grant number JP21wm0125006 (Japan program for Infectious Diseases Research and Infrastructure), and Joint research of Department of Medical Research, Ministry of Health and Sports, Myanmar and Institute of Tropical Medicine, Nagasaki University, Japan (2020-Ippan-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaskov J, 2006, SCIENCE, V311, P236, DOI 10.1126/science.1115030; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; BUNDO K, 1985, J VIROL METHODS, V11, P15, DOI 10.1016/0166-0934(85)90120-X; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hu TS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2401-1; IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531; Inoue S, 2010, VECTOR-BORNE ZOONOT, V10, P143, DOI 10.1089/vbz.2008.0153; Ito M, 2004, J CLIN MICROBIOL, V42, P5935, DOI 10.1128/JCM.42.12.5935-5937.2004; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; KUBERSKI T, 1977, AM J TROP MED HYG, V26, P775, DOI 10.4269/ajtmh.1977.26.775; Kyaw AK, 2017, EPIDEMIOL INFECT, V145, P1886, DOI 10.1017/S0950268817000735; Kyaw AK, 2020, T ROY SOC TROP MED H, V114, P57, DOI 10.1093/trstmh/trz071; Kyaw AK, 2019, J VIROL METHODS, V273, DOI 10.1016/j.jviromet.2019.113724; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lao M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115569; Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026; Li DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019447; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; MORITA K, 1991, J CLIN MICROBIOL, V29, P2107, DOI 10.1128/JCM.29.10.2107-2110.1991; Tun MMN, 2016, INFECT GENET EVOL, V43, P31, DOI 10.1016/j.meegid.2016.04.025; Tun MMN, 2013, J MED VIROL, V85, P1258, DOI 10.1002/jmv.23577; Suzuki K, 2019, INFECT GENET EVOL, V75, DOI 10.1016/j.meegid.2019.103977; Thant Kyaw Zin, 2015, Trop Med Health, V43, P21, DOI 10.2149/tmh.2014-27; Thu HM, 2005, VIROLOGY, V336, P163, DOI 10.1016/j.virol.2005.03.018; Thu HM, 2004, EMERG INFECT DIS, V10, P593, DOI 10.3201/eid1004.030216; Tripathi SK, 2013, IRAN J MICROBIOL, V5, P68; Tun MMN, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234508; Tun MMN, 2020, J CLIN VIROL, V125, DOI 10.1016/j.jcv.2020.104304; Vignuzzi M, 2019, NAT MICROBIOL, V4, P1075, DOI 10.1038/s41564-019-0465-y; Wang BH, 2018, EMERG INFECT DIS, V24, P1756, DOI 10.3201/eid2409.180252; Wang WK, 2006, CLIN INFECT DIS, V43, P1023, DOI 10.1086/507635; Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704; Wen SJ, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00148; WHO. World Health Organization, 2009, DENG GUID DIAGN TREA; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Yang CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006773	42	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251314	10.1371/journal.pone.0251314	http://dx.doi.org/10.1371/journal.pone.0251314			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086703	Green Published, gold			2022-12-26	WOS:000664640100014
J	Yang, H; Wen, R; Zhao, H; Guo, M; Zhang, L; Chen, Y				Yang, Hao; Wen, Ran; Zhao, Heng; Guo, Men; Zhang, Lu; Chen, Yu			Study on ageing characteristics and evaluation methods of RTV silicone rubber in high humidity area	PLOS ONE			English	Article							INSULATORS	Due to high humidity, the ageing of room temperature vulcanized silicone rubber (RTV) has been a serious problem in Southwestern China. In order to solve the problem of RTV life prediction, the aging classification method was established by analyzing the microtopography of RTV samples in this paper. Besides, the comprehensive analysis of RTV element content, partial element content ratio, and major chemical groups of RTV samples in each aging level were conducted. It is found that as the ageing level increases, the element contents of C, Si, O, Al change accordingly and the ratio of C:Si drops from 2.39 to 1.54, and absorption peaks of the chemical groups of Si-(CH3)(2), Si-O-Si, Si-CH3 and C-H in CH3 decrease. This work can enrich the investigation of RTV, and may provide useful reference for performance evaluation and replacement of RTV in substations.	[Yang, Hao; Wen, Ran; Zhao, Heng] Xian Polytech Univ, Sch Elect & Informat, Xian, Peoples R China; [Guo, Men] Xi An Jiao Tong Univ, State Key Lab Elect Insulat & Power Equipment, Xian, Peoples R China; [Zhang, Lu; Chen, Yu] State Grid Shaanxi Elect Power Co Xian, Elect Power Res Inst, Xian, Peoples R China	Xi'an Polytechnic University; Xi'an Jiaotong University	Yang, H (corresponding author), Xian Polytech Univ, Sch Elect & Informat, Xian, Peoples R China.	yanghao@xpu.edu.cn		Yang, Hao/0000-0002-6997-6963	Electric Power Research Institute, State Grid Shaanxi Electric Power Company	Electric Power Research Institute, State Grid Shaanxi Electric Power Company	This work was supported by Electric Power Research Institute, State Grid Shaanxi Electric Power Company in the form of salaries for LZ and YC. The specific roles of these authors are articulated in the `author contributions' section. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbasi A, 2014, IEEE T DIELECT EL IN, V21, P721, DOI 10.1109/TDEI.2013.003990; Ahmad F, 2021, ARAB J SCI ENG, V46, P1103, DOI 10.1007/s13369-020-04938-0; Akbar M, 2019, MATER RES EXPRESS, V6, DOI 10.1088/2053-1591/ab3f0d; Akbar M, 2020, J ELECTRON MATER, V49, P5399, DOI 10.1007/s11664-020-08265-w; Akbar M, 2020, ENG FAIL ANAL, V110, DOI 10.1016/j.engfailanal.2020.104449; Ehsani M, 2004, EUR POLYM J, V40, P2495, DOI 10.1016/j.eurpolymj.2004.03.014; Jia Boyan, 2019, High Voltage Apparatus, V55, P126, DOI 10.13296/j.1001-1609.hva.2019.09.017; Kumagai S, 2004, IEEE T DIELECT EL IN, V11, P681, DOI 10.1109/TDEI.2004.1324357; Liang Y, 2008, THESIS N CHINA ELECT; Ma B, 2011, IEEE T DIELECT EL IN, V18, P1984, DOI 10.1109/TDEI.2011.6118636; Ma B, 2010, IEEE T DIELECT EL IN, V17, P555, DOI 10.1109/TDEI.2010.5448112; Mehmood B, 2020, ENG FAIL ANAL, V118, DOI 10.1016/j.engfailanal.2020.104870; Plesa I, 2016, POLYMERS-BASEL, V8, DOI 10.3390/polym8050173; Sun W, 2018, THESIS XIAN JIAOTON; Ullah R., 2020, CSEE J POWER ENERGY, P1, DOI [10.17775/CSEEJPES.2019.02990, DOI 10.17775/CSEEJPES.2019.02990]; Ullah R, 2020, APPL NANOSCI, V10, P2101, DOI 10.1007/s13204-020-01381-3; Verma AR, 2018, POLYM TEST, V68, P185, DOI 10.1016/j.polymertesting.2018.04.014; Wen XS, 2017, ENERGIES, V10, DOI 10.3390/en10071054; Xia Yanwei, 2019, High Voltage Apparatus, V55, P163, DOI 10.13296/j.1001-1609.hva.2019.09.022; Yang H, 2015, IEEE T DIELECT EL IN, V22, P3226, DOI 10.1109/TDEI.2015.005058; Zeng L, 2019, THESIS S CHINA U TEC; Zhong R, 2018, STUDY AGING PROPERTI	22	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251092	10.1371/journal.pone.0251092	http://dx.doi.org/10.1371/journal.pone.0251092			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086712	Green Published, gold			2022-12-26	WOS:000664640100013
J	Ehrencrona, E; van der Post, S; Gallego, P; Recktenwald, CV; Rodriguez-Pineiro, AM; Garcia-Bonete, MJ; Trillo-Muyo, S; Backstrom, M; Hansson, GC; Johansson, MEV				Ehrencrona, Erik; van der Post, Sjoerd; Gallego, Pablo; Recktenwald, Christian, V; Rodriguez-Pineiro, Ana M.; Garcia-Bonete, Maria-Jose; Trillo-Muyo, Sergio; Backstrom, Malin; Hansson, Gunnar C.; Johansson, Malin E., V			The IgGFc-binding protein FCGBP is secreted with all GDPH sequences cleaved but maintained by interfragment disulfide bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-ALPHA-INHIBITOR; COVALENTLY CROSS-LINKS; VON-WILLEBRAND-FACTOR; MUC2 MUCIN; HEAVY-CHAIN; AUTOCATALYTIC CLEAVAGE; LOW PH; IDENTIFICATION; LAYERS; CELLS	Mucus forms an important protective barrier that minimizes bacterial contact with the colonic epithelium. Intestinal mucus is organized in a complex network with several specific proteins, including the mucin-2 (MUC2) and the abundant IgGFc-binding protein, FCGBP. FCGBP is expressed in all intestinal goblet cells and is secreted into the mucus. It is comprised of repeated von Willebrand D (vWD) domain assemblies, most of which have a GDPH amino acid sequence that can be autocatalytically cleaved, as previously observed in the mucins MUC2 and mucin-5AC. However, the functions of FCGBP in the mucus are not understood. We show that all vWD domains of FCGBP with a GDPH sequence are cleaved and that these cleavages occur early during biosynthesis in the endoplasmic reticulum. All cleaved fragments, however, remain connected via a disulfide bond within each vWD domain. This cleavage generates a C-terminal-reactive Asp-anhydride that could react with other molecules, such as MUC2, but this was not observed. Quantitative analyses by MS showed that FCGBP was mainly soluble in chaotropic solutions, whereas MUC2 was insoluble, and most of the secreted FCGBP was not covalently bound to MUC2. Although FCGBP has been suggested to bind immunoglobulin G, we were unable to reproduce this binding in vitro using purified proteins. In conclusion, while the function of FCGBP is still unknown, our results suggest that it does not contribute to covalent crosslinking in the mucus, nor incorporate immunoglobulin G into mucus, instead the single disulfide bond linking each fragment could mediate controlled dissociation.	[Ehrencrona, Erik; van der Post, Sjoerd; Gallego, Pablo; Recktenwald, Christian, V; Rodriguez-Pineiro, Ana M.; Garcia-Bonete, Maria-Jose; Trillo-Muyo, Sergio; Backstrom, Malin; Hansson, Gunnar C.; Johansson, Malin E., V] Univ Gothenburg, Inst Biomed, Dept Med Biochem, Gothenburg, Sweden	University of Gothenburg	Johansson, MEV (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem, Gothenburg, Sweden.	malin.johansson@medkem.gu.se	Johansson, Malin E. V./HCH-7451-2022; Garcia-Bonete, Maria Jose/AAE-8902-2021; Hansson, Gunnar C./A-1236-2009	Garcia-Bonete, Maria Jose/0000-0002-8832-4338; Johansson, Malin E. V./0000-0002-4237-6677; van der Post, Sjoerd/0000-0002-7965-5311; Recktenwald, Christian Viktor/0000-0003-1710-1863; Trillo-Muyo, Sergio/0000-0002-3135-9134; Hansson, Gunnar C./0000-0002-1900-1869	Swedish Research Council [201503047, 2017-00958, 2019-01134]; Swedish Cancer Foundation [CAN2016/487, 2017/360]; Knut and Alice Wallenberg Foundation [2017-0028]; National Institute of Allergy and Infectious Diseases [U01AI095473]; European Research Council (ERC) [694181]; IngaBritt and Arne Lundberg Foundation [2015-070, 2018-0117]; Sahlgrenska University Hospital [ALFGBG-724681, ALFGBG-440741]; Sahlgrenska Academy	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Research Council (ERC)(European Research Council (ERC)European Commission); IngaBritt and Arne Lundberg Foundation; Sahlgrenska University Hospital; Sahlgrenska Academy	We thank the Mammalian Protein Expression Core Facility and the Centre for Cellular Imaging at the Sahlgrenska Academy for their assistance. We are thankful for all technical assistance and help from Frida Svensson and Joakim Bergstrom. This work was supported by the Swedish Research Council (201503047, 2017-00958, 2019-01134), the Swedish Cancer Foundation (CAN2016/487, 2017/360), the Knut and Alice Wallenberg Foundation (2017-0028), National Institute of Allergy and Infectious Diseases (U01AI095473), European Research Council (ERC) (694181), IngaBritt and Arne Lundberg Foundation (2015-070, 2018-0117), Sahlgrenska University Hospital (ALFGBG-724681, ALFGBG-440741), and the Sahlgrenska Academy.	Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Albert TK, 2010, J PROTEOME RES, V9, P3108, DOI 10.1021/pr100020c; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Axelsson MAB, 1998, J BIOL CHEM, V273, P18864, DOI 10.1074/jbc.273.30.18864; Bell CH, 2013, SCIENCE, V341, P77, DOI 10.1126/science.1232322; Blom AM, 1997, BIOCHEM J, V328, P185; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dong XC, 2019, BLOOD, V133, P1523, DOI 10.1182/blood-2018-10-876300; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; Erickson NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131991; Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Harada N, 1997, J BIOL CHEM, V272, P15232, DOI 10.1074/jbc.272.24.15232; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; Javitt G, 2020, CELL, V183, P717, DOI 10.1016/j.cell.2020.09.021; Johansson MEV, 2015, CELL HOST MICROBE, V18, P582, DOI 10.1016/j.chom.2015.10.007; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kaczmarczyk A, 2002, J BIOL CHEM, V277, P13578, DOI 10.1074/jbc.M200288200; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; KOBAYASHI K, 1989, J IMMUNOL, V143, P2567; KOBAYASHI K, 1991, J IMMUNOL, V146, P68; Lang TG, 2016, MOL BIOL EVOL, V33, P1921, DOI 10.1093/molbev/msw066; Lidell ME, 2006, BIOCHEM J, V399, P121, DOI 10.1042/BJ20060443; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Lockhart-Cairns MP, 2019, MATRIX BIOL, V77, P73, DOI 10.1016/j.matbio.2018.08.006; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Nystrom EEL, 2018, EBIOMEDICINE, V33, P134, DOI 10.1016/j.ebiom.2018.05.031; Osicka R, 2004, J BIOL CHEM, V279, P24944, DOI 10.1074/jbc.M314013200; Patrick ME, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153814; PISZKIEW.D, 1970, BIOCHEM BIOPH RES CO, V40, P1173, DOI 10.1016/0006-291X(70)90918-6; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Recktenwald CV, 2016, J BIOL CHEM, V291, P13580, DOI 10.1074/jbc.M116.726406; Reese AT, 2018, ELIFE, V7, DOI 10.7554/eLife.35987; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schirrmeister J, 2011, J BACTERIOL, V193, P3733, DOI 10.1128/JB.00437-11; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Schwartz Jacquelyn L, 2014, Open AIDS J, V8, P21, DOI 10.2174/1874613601408010021; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soto P, 2006, J CELL BIOCHEM, V97, P1267, DOI 10.1002/jcb.20718; Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638; Thuveson M, 2000, J BIOL CHEM, V275, P30996, DOI 10.1074/jbc.M002399200; Thuveson M, 1999, J BIOL CHEM, V274, P6741, DOI 10.1074/jbc.274.10.6741; van der Post S, 2019, GUT, V68, P2142, DOI 10.1136/gutjnl-2018-317571; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	54	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100871	10.1016/j.jbc.2021.100871	http://dx.doi.org/10.1016/j.jbc.2021.100871			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34126068	gold, Green Submitted, Green Published			2022-12-26	WOS:000678068400071
J	Hanke-Gogokhia, C; Lehmann, GL; Benedicto, I; de la Fuente-Ortega, E; Arshavsky, VY; Schreiner, R; Rodriguez-Boulan, E				Hanke-Gogokhia, Christin; Lehmann, Guillermo L.; Benedicto, Ignacio; de la Fuente-Ortega, Erwin; Arshavsky, Vadim Y.; Schreiner, Ryan; Rodriguez-Boulan, Enrique			Apical CLC-2 in retinal pigment epithelium is crucial for survival of the outer retina	FASEB JOURNAL			English	Article						CLC-2; photoreceptor degeneration; RPE; subretinal space	TISSUE-SPECIFIC POLARITY; MONOCARBOXYLATE TRANSPORTERS; CHLORIDE CHANNEL; PHOTORECEPTOR DEGENERATION; PLASMA-MEMBRANE; RPE CELLS; EXPRESSION; MUTATION; HYPERPOLARIZATION; MECHANISMS	Knockout of the chloride channel protein 2 (CLC-2; CLCN2) results in fast progressing blindness in mice. Retinal Pigment Epithelium (RPE) and photoreceptors undergo, in parallel, rapid, and profound morphological changes and degeneration. Immunohistochemistry and electron microscopy of the outer retina and electroretinography of the CLC-2 KO mouse demonstrated normal morphology at postnatal day 2, followed by drastic changes in RPE and photoreceptor morphology and loss of vision during the first postnatal month. To investigate whether the RPE or the photoreceptors are the primary cause of the degeneration, we injected lentiviruses carrying HA-tagged CLC-2 with an RPE-specific promotor in the subretinal space of CLC-2-KO mice at the time of eye opening. As expected, CLC-2-HA was expressed exclusively in RPE; strikingly, this procedure rescued the degeneration of both RPE and photoreceptors. Light response in transduced eyes was also recovered. Only a fraction of RPE was transduced with the lentivirus; however, the entire RPE monolayer appears healthy, even the RPE cells not expressing the CLC-2-HA. Surprisingly, in contrast with previous physiological observations that postulate that CLC-2 has a basolateral localization in RPE, our immunofluorescence experiments demonstrated CLC-2 has an apical distribution, facing the subretinal space and the photoreceptor outer segments. Our findings suggest that CLC-2 does not play the postulated role in fluid transport at the basolateral membrane. Rather, they suggest that CLC-2 performs a critical homeostatic role in the subretinal compartment involving a chloride regulatory mechanism that is critical for the survival of both RPE and photoreceptors.	[Hanke-Gogokhia, Christin] Yale Univ, Dept Ophthalmol, New Haven, CT USA; [Lehmann, Guillermo L.] Regeneron Pharmaceut Inc, Tarrytown, NY USA; [Benedicto, Ignacio] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain; [de la Fuente-Ortega, Erwin] Univ Catolica Norte, Fac Med, Dept Ciencias Biomed, Coquimbo, Chile; [Arshavsky, Vadim Y.] Duke Univ, Sch Med, Dept Ophthalmol, Durham, NC USA; [Schreiner, Ryan] Weill Cornell Med, Div Regenerat Med, Ansary Stern Cell Inst Dept Med, New York, NY USA; [Rodriguez-Boulan, Enrique] Weill Cornell Med, Dept Ophthalmol, Margaret Dyson Vis Res Inst, New York, NY USA	Yale University; Regeneron; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad Catolica del Norte; Duke University; Cornell University; Cornell University	Schreiner, R; Rodriguez-Boulan, E (corresponding author), 1300 York Ave, New York, NY 10065 USA.	rps2001@med.cornell.edu; boulan@med.cornell.edu	de la Fuente Ortega, Erwin/S-6513-2019	de la Fuente Ortega, Erwin/0000-0001-8757-571X; Rodriguez-Boulan, Enrique/0000-0003-2033-6233; Schreiner, Ryan/0000-0002-7457-6606	HHS | NIH | National Eye Institute (NEI) [EY08538]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [GM34107]; New York State Stem Cell Science (NYSTEM) [C32596GG]; Comunidad de Madrid [2017-T1/BMD-5247]; MINECO | Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovacion (MICINN); Weill Cornell Medicine [EY005722]	HHS | NIH | National Eye Institute (NEI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); New York State Stem Cell Science (NYSTEM); Comunidad de Madrid(Comunidad de Madrid); MINECO | Instituto de Salud Carlos III (ISCIII)(Spanish Government); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Weill Cornell Medicine	HHS | NIH | National Eye Institute (NEI), Grant/Award Number: EY08538; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: GM34107; New York State Stem Cell Science (NYSTEM), Grant/Award Number: C32596GG; Comunidad de Madrid, Grant/Award Number: 2017-T1/BMD--5247; MINECO | Instituto de Salud Carlos III (ISCIII); Ministerio de Ciencia e Innovacion (MICINN); Weill Cornell Medicine, Grant/Award Number: EY005722	Arreola J, 2003, J PHYSIOL-LONDON, V547, P197, DOI 10.1113/jphysiol.2002.028373; BIALEK S, 1995, J PHYSIOL-LONDON, V484, P53, DOI 10.1113/jphysiol.1995.sp020647; Bonilha VL, 1999, J CELL BIOL, V147, P1533, DOI 10.1083/jcb.147.7.1533; Bosl MR, 2001, EMBO J, V20, P1289, DOI 10.1093/emboj/20.6.1289; Caceres PS, 2020, CURR OPIN CELL BIOL, V62, P37, DOI 10.1016/j.ceb.2019.08.001; Caceres PS, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a027847; Castorino JJ, 2011, TRAFFIC, V12, P483, DOI 10.1111/j.1600-0854.2010.01155.x; de la Fuente-Ortega E, 2015, MOL BIOL CELL, V26, P1728, DOI 10.1091/mbc.E15-01-0047; Deora AA, 2005, P NATL ACAD SCI USA, V102, P16245, DOI 10.1073/pnas.0504419102; Dickson VK, 2014, NATURE, V516, P213, DOI 10.1038/nature13913; Ding JD, 2015, J CELL BIOL, V211, P495, DOI 10.1083/jcb.201508093; Edwards MM, 2010, INVEST OPHTH VIS SCI, V51, P3264, DOI 10.1167/iovs.09-4887; Engevik AC, 2021, CELL MOL GASTROENTER, V12, P59, DOI 10.1016/j.jcmgh.2021.01.022; German OL, 2008, J NEUROSCI RES, V86, P3503, DOI 10.1002/jnr.21813; Goppner C, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016031; GRUNDER S, 1992, NATURE, V360, P759, DOI 10.1038/360759a0; Hamann S, 2002, INT REV CYTOL, V215, P395; Han JYS, 2020, FASEB J, V34, P5401, DOI 10.1096/fj.201902961R; Hu JG, 1996, EXP EYE RES, V62, P443, DOI 10.1006/exer.1996.0049; Hurd TW, 2003, NAT CELL BIOL, V5, P137, DOI 10.1038/ncb923; Jablonski MM, 2000, J NEUROSCI, V20, P7149; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI [10.1080/10409230701829110, 10.1080/10409230701829110 ]; Jentsch TJ, 2005, J AM SOC NEPHROL, V16, P1549, DOI 10.1681/ASN.2005020207; KENNEDY BG, 1990, AM J PHYSIOL, V259, pC29, DOI 10.1152/ajpcell.1990.259.1.C29; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; Lehmann GL, 2014, EXP EYE RES, V126, P5, DOI 10.1016/j.exer.2014.04.021; Lobanova ES, 2008, J NEUROSCI, V28, P3510, DOI 10.1523/JNEUROSCI.0338-08.2008; Lobanova ES, 2010, J NEUROSCI, V30, P6815, DOI 10.1523/JNEUROSCI.0613-10.2010; Lobato-Alvarez JA, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00450; Longbottom R, 2009, P NATL ACAD SCI USA, V106, P18728, DOI 10.1073/pnas.0902593106; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; Mazzoni F, 2014, EXP EYE RES, V126, P51, DOI 10.1016/j.exer.2014.01.010; MILLER SS, 1990, J PHYSIOL-LONDON, V424, P283, DOI 10.1113/jphysiol.1990.sp018067; Nasonkin IO, 2013, DEVELOPMENT, V140, P1330, DOI 10.1242/dev.086603; Nehrke K, 2002, J BIOL CHEM, V277, P23604, DOI 10.1074/jbc.M202900200; Pena-Muzenmayer G, 2005, J CELL SCI, V118, P4243, DOI 10.1242/jcs.02525; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1305, DOI 10.1167/iovs.02-0552; Qiao XX, 2003, VISION RES, V43, P859, DOI 10.1016/S0042-6989(02)00393-0; RAYMOND SM, 1995, CURR BIOL, V5, P1286, DOI 10.1016/S0960-9822(95)00255-7; Rizzolo LJ, 2007, INT REV CYTOL, V258, P195, DOI 10.1016/S0074-7696(07)58004-6; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; Singh RK, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00179; Spencer WJ, 2019, P NATL ACAD SCI USA, V116, P13087, DOI 10.1073/pnas.1906421116; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; THIEMANN A, 1992, NATURE, V356, P57, DOI 10.1038/356057a0; Venkatesh A., 2013, Curr Protoc Microbiol, V28, DOI 10.1002/9780471729259.mc14d04s28; Wang HW, 2017, MOL MED REP, V16, P11, DOI 10.3892/mmr.2017.6600; Zhang KJ, 2014, PROTEIN CELL, V5, P48, DOI 10.1007/s13238-013-0011-2	50	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21689	10.1096/fj.202100349R	http://dx.doi.org/10.1096/fj.202100349R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34085737	Green Published, hybrid			2022-12-26	WOS:000667814100060
J	Roberts, DJ; Nagpal, SK; Forster, AJ; Brandys, T; Murphy, C; Jennings, A; Strauss, SA; Vishnyakova, E; Lawson, J; McIsaac, DI				Roberts, Derek J.; Nagpal, Sudhir K.; Forster, Alan J.; Brandys, Timothy; Murphy, Christine; Jennings, Alison; Strauss, Shira A.; Vishnyakova, Evgeniya; Lawson, Julie; McIsaac, Daniel I.			Disability, pain, and wound-specific concerns self-reported by adults at risk of limb loss: A cross-sectional study using the World Health Organization Disability Assessment Schedule 2.0	PLOS ONE			English	Article							QUALITY-OF-LIFE; WHODAS-II; VALIDATION; RELIABILITY; VALIDITY; OUTCOMES; TRAUMA	Introduction There has been limited study of patient-reported outcomes (PROs) in patients at risk of limb loss. Our primary objective was to estimate the prevalence of disability in this patient population using the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0). Materials and methods We recruited patients referred to a limb-preservation clinic. Patients self-reported their disability status using the 12-domain WHODAS 2.0. Severity of disability in each domain was scored from 1 = none to 5 = extreme and the total normalized to a 100-point scale (total score >= 25 = clinically significant disability). We also asked patients about wound-specific concerns and wound-related discomfort or distress. Results We included 162 patients. Reasons for clinic referral included arterial-insufficient (37.4%), postoperative (25.9%), and mixed etiology (10.8%) wounds. The mean WHODAS 2.0 disability score was 35.0 (standard deviation = 16.0). One-hundred-and-nineteen (73.5%) patients had clinically significant disability. Patients reported they had the greatest difficulty walking a long distance (mean score = 4.2), standing for long periods of time (mean score = 3.6), taking care of household responsibilities (mean score = 2.7), and dealing with the emotional impact of their health problems (mean score = 2.5). In the two-weeks prior to presentation, 87 (52.7%) patients expressed concern over their wound(s) and 90 (55.6%) suffered a moderate amount or great deal of wound-related discomfort or distress. In adjusted ordinary least squares regression models, although WHODAS 2.0 disability scores varied with changes in wound volume (p = 0.03) and total revised photographic wound assessment tool scores (p<0.001), the largest decrease in disability severity was seen in patients with less wound-specific concerns and wound-related discomfort and distress. Discussion The majority of people at risk of limb loss report suffering a substantial burden of disability, pain, and wound-specific concerns. Research is needed to further evaluate the WHODAS 2.0 in a multicenter fashion among these patients and determine whether care and interventions may improve their PROs.	[Roberts, Derek J.; Nagpal, Sudhir K.; Brandys, Timothy; Murphy, Christine; Strauss, Shira A.; Vishnyakova, Evgeniya] Univ Ottawa, Dept Surg, Div Vasc & Endovasc Surg, Ottawa, ON, Canada; [Roberts, Derek J.; Forster, Alan J.; Jennings, Alison; Lawson, Julie; McIsaac, Daniel I.] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Forster, Alan J.; McIsaac, Daniel I.] ICES, Toronto, ON, Canada; [Forster, Alan J.] Univ Ottawa, Dept Med, Ottawa, ON, Canada; [Forster, Alan J.; McIsaac, Daniel I.] Ottawa Hosp, Ottawa, ON, Canada; [Forster, Alan J.; McIsaac, Daniel I.] Univ Ottawa, Fac Med, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada; [McIsaac, Daniel I.] Univ Ottawa, Dept Anesthesiol, Ottawa, ON, Canada; [McIsaac, Daniel I.] Univ Ottawa, Dept Pain Med, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Toronto; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; University of Ottawa	Roberts, DJ (corresponding author), Univ Ottawa, Dept Surg, Div Vasc & Endovasc Surg, Ottawa, ON, Canada.; Roberts, DJ (corresponding author), Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada.	Derek.Roberts01@gmail.com		Strauss, Shira/0000-0002-1614-1911; Roberts, Derek/0000-0001-6111-6291	Department of Surgery, University of Ottawa	Department of Surgery, University of Ottawa	DJR received funding from the Department of Surgery, University of Ottawa to support this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedzadeh-kalahroudi M, 2016, INJURY, V47, P1104, DOI 10.1016/j.injury.2015.11.046; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Alabi O, 2017, J VASC SURG, V65, P571, DOI 10.1016/j.jvs.2016.08.097; Anker SD, 2014, EUR HEART J, V35, P2001, DOI 10.1093/eurheartj/ehu205; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Bosma J, 2013, ANN VASC SURG, V27, P1105, DOI 10.1016/j.avsg.2013.01.010; Brehaut JC, 2010, MED DECIS MAKING, V30, P398, DOI 10.1177/0272989X09344747; Conijn AP, 2015, EUR J VASC ENDOVASC, V49, P316, DOI 10.1016/j.ejvs.2014.12.002; De Wolf AC, 2012, J REHABIL MED, V44, P747, DOI 10.2340/16501977-1016; Garin O, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-51; Hicks CW, 2015, SEMIN VASC SURG, V28, P122, DOI 10.1053/j.semvascsurg.2015.09.006; Houghton P E, 2000, Ostomy Wound Manage, V46, P20; Khunkaew S, 2019, QUAL LIFE RES, V28, P1413, DOI 10.1007/s11136-018-2082-2; Kucukdeveci AA, 2013, DISABIL REHABIL, V35, P214, DOI 10.3109/09638288.2012.690817; Kutlay S, 2011, RHEUMATOL INT, V31, P339, DOI 10.1007/s00296-009-1306-8; Lee HH, 2017, ANN REHABIL MED-ARM, V41, P667, DOI 10.5535/arm.2017.41.4.667; McIsaac DI., 2018, ANN SURG, DOI [10.5770/cgj.21.319, DOI 10.5770/CGJ.21.319]; Nordanstig J, 2014, J VASC SURG, V59, P700, DOI 10.1016/j.jvs.2013.08.099; Olsson M, 2019, WOUND REPAIR REGEN, V27, P114, DOI 10.1111/wrr.12683; Phillips P, 2018, J ADV NURS, V74, P550, DOI 10.1111/jan.13465; Schlote A, 2009, DISABIL REHABIL, V31, P855, DOI 10.1080/09638280802355262; Shulman MA, 2015, ANESTHESIOLOGY, V122, P524, DOI 10.1097/ALN.0000000000000586; Soberg HL, 2012, ARCH PHYS MED REHAB, V93, P765, DOI 10.1016/j.apmr.2011.08.050; Steunenberg SL, 2016, ANN VASC SURG, V36, P310, DOI 10.1016/j.avsg.2016.05.087; Thompson N, 2013, ADV SKIN WOUND CARE, V26, P360, DOI 10.1097/01.ASW.0000431329.50869.6f; Ustun TB, 2010, B WORLD HEALTH ORGAN, V88, P815, DOI 10.2471/BLT.09.067231; Ustun TB., 2010, REHM J MEASURING HLT, P1; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; World Health Organization, 2011, INT CLASS FUNCT DIS, P1	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253288	10.1371/journal.pone.0253288	http://dx.doi.org/10.1371/journal.pone.0253288			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SX8VJ	34129633	gold, Green Published			2022-12-26	WOS:000665475100040
J	Roland, M; Ben Abdelhafidh, L; Deom, V; Vanbiervliet, F; Coppieters, Y; Racape, J				Roland, Michel; Ben Abdelhafidh, Louisa; Deom, Victoria; Vanbiervliet, Frank; Coppieters, Yves; Racape, Judith			SARS-CoV-2 screening among people living in homeless shelters in Brussels, Belgium	PLOS ONE			English	Article							EXPERIENCING HOMELESSNESS; ASYMPTOMATIC PATIENTS; COVID-19; PREVALENCE	Background Subgroups of precarious populations such as homeless people are more exposed to infection and at higher risk of developing severe forms of COVID-19 compared to the general population. Many of the recommended prevention measures, such as social distancing and self-isolation, are not feasible for a population living in shelters characterised by physical proximity and a high population density. The objective of the study was to describe SARS-CoV-2 infection prevalence in homeless shelters in Brussels (Belgium), and to identify risk factors and infection control practices associated with SARS-CoV-2 positivity rates. Methods A total of 1994 adults were tested by quantitative PCR tests in 52 shelters in Brussels (Belgium) between April and June, 2020, in collaboration with Doctors of the World. SARS-CoV-2 prevalence is here described site by site, and we identify risk factors associated with SARS-CoV-2 positivity rates. We also investigate associations between seropositivity and reported symptoms. Results We found an overall prevalence of 4.6% for the period, and a cluster of high rates of SARS-CoV-2 positivity (20-30% in two shelters). Among homeless people, being under 40 years of age (OR (CI95%) 2.3 (1.2-4.4), p = 0.02), having access to urgent medical care (AMU) (OR(CI95%): 2.4 (1.4-4.4)], p = 0.02), and sharing a room with someone who tested positive (OR(CI95%): 5.3 (2.9-9.9), p<0.0001) were factors associated with SARS-CoV-2 positivity rates. 93% of those who tested positive were asymptomatic. Conclusion This study shows high rates of SARS-COV-2 infection positive tests in some shelters, with a high proportion of asymptomatic cases. The survey reveals how important testing and isolation measures are, together with actions taken by medical and social workers during the outbreak.	[Roland, Michel; Ben Abdelhafidh, Louisa; Deom, Victoria] Med Monde, Brussels, Belgium; [Vanbiervliet, Frank] Brusshelp, Brussels, Belgium; [Coppieters, Yves; Racape, Judith] Univ Libre Bruxelles ULB, Sch Publ Hlth, Res Epidemiol Biostat & Clin Res, Brussels, Belgium; [Racape, Judith] Univ Libre Bruxelles ULB, Fac Med, Chair Hlth & Precar, Brussels, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles	Racape, J (corresponding author), Univ Libre Bruxelles ULB, Sch Publ Hlth, Res Epidemiol Biostat & Clin Res, Brussels, Belgium.; Racape, J (corresponding author), Univ Libre Bruxelles ULB, Fac Med, Chair Hlth & Precar, Brussels, Belgium.	jracape@ulb.ac.be			Fonds national de la Recherche Scientifique (FNRS)	Fonds national de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS)	We thank the Fonds national de la Recherche Scientifique (FNRS), Nicolas Horvat (Bruss'help) for encoding the data and Ms Emmanuelle Riviere for editing the manuscript.	Albon D, 2020, CHEST, V158, P477, DOI 10.1016/j.chest.2020.03.057; [Anonymous], KOBOTOOLBOX HARVARD; Baggett TP, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.28195; Baggett TP, 2020, JAMA-J AM MED ASSOC, V323, P2191, DOI 10.1001/jama.2020.6887; Baggett TP, 2018, J AM COLL CARDIOL, V71, P2585, DOI 10.1016/j.jacc.2018.02.077; Dauby N, 2019, INT J INFECT DIS, V81, P52, DOI 10.1016/j.ijid.2019.01.026; Flook M, 2020, LANCET RESP MED, V8, P1160, DOI [10.1016/S2213-2600(20)30446-X, 10.1016/S2213-2600(20)30446-x]; Karb R, 2020, WEST J EMERG MED, V21, P1048, DOI 10.5811/westjem.2020.7.48725; Kronbichler A, 2020, INT J INFECT DIS, V98, P180, DOI 10.1016/j.ijid.2020.06.052; Lewer D, 2020, LANCET RESP MED, V8, P1181, DOI 10.1016/S2213-2600(20)30396-9; Ly TDA., 2020, MEDRXIV, DOI [10.1101/2020.05.05.20091934, DOI 10.1101/2020.05.05.20091934]; Marmot M, 2005, LANCET, V365, P1099, DOI 10.1016/S0140-6736(05)74234-3; Mosites E, 2020, MMWR-MORBID MORTAL W, V69, P521, DOI 10.15585/mmwr.mm6917e1; Perri M, 2020, CAN MED ASSOC J, V192, pE716, DOI 10.1503/cmaj.200834; Ralli M, 2021, INT J INFECT DIS, V103, P243, DOI 10.1016/j.ijid.2020.12.031; Roederer T, 2021, LANCET PUBLIC HEALTH, V6, pE202, DOI 10.1016/S2468-2667(21)00001-3; Rogers JH, 2021, ANN INTERN MED, V174, P42, DOI 10.7326/M20-3799; Schrooyen L, 2021, CLIN MICROBIOL INFEC, V27, P151, DOI 10.1016/j.cmi.2020.08.002; Tobolowsky FA, 2020, MMWR-MORBID MORTAL W, V69, P523, DOI 10.15585/mmwr.mm6917e2; Tsai J, 2020, LANCET PUBLIC HEALTH, V5, pE186, DOI 10.1016/S2468-2667(20)30053-0	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0252886	10.1371/journal.pone.0252886	http://dx.doi.org/10.1371/journal.pone.0252886			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129635	Green Published, gold			2022-12-26	WOS:000665475100016
J	Arkew, M; Yemane, T; Mengistu, Y; Gemechu, K; Tesfaye, G				Arkew, Mesay; Yemane, Tilahun; Mengistu, Yordanos; Gemechu, Kabtamu; Tesfaye, Girum			Hematological parameters of type 2 diabetic adult patients at Debre Berhan Referral Hospital, Northeast Ethiopia: A comparative cross-sectional study	PLOS ONE			English	Article							BLOOD-CELL COUNT; MICROVASCULAR COMPLICATIONS; MELLITUS; PREVALENCE; METABOLISM; INDEXES; ANEMIA; LEVEL; RISK	Background Diabetes is a global public health problem and associated with metabolic, cellular, and blood disturbances. Hematological changes have been reported in diabetes and play a major role in diabetes-associated complications. However, reports are contradicting and data on hematological parameters of type 2 diabetic patients in the study area are scarce. Therefore, the aim of this study was to assess the hematological parameters of type 2 diabetic adult patients at Debre Berhan Referral Hospital, Northeast Ethiopia from May 01 to June 30, 2020. Methods A comparative cross-sectional study was conducted on 268 (134 type 2 diabetic patients and 134 controls) study participants selected by systematic random sampling technique. Socio-demographic, behavioral, and clinical data were collected using a structured questionnaire and checklist. Ethical approval was obtained from Jimma University. All phase of quality assurance was maintained. Hematological parameters and blood glucose levels were determined using UniCel DxH 800 (Beckman Coulter, USA) and Biosystems A25 (Costa Brava, Spain) analyzers, respectively. Independent t-test, Mann-Whitney U-test, correlation, and logistic regression were used during data analysis. P-value <0.05 was considered as statistically significant. Results The current study found that total white blood cell count, absolute counts of neutrophil, lymphocyte, eosinophil, and basophil, red blood cell distribution width, platelet count, and mean platelet volume were significantly higher in type 2 diabetic patients as compared to the control group (P<0.05). On the other hand, the mean hemoglobin was significantly lower in type 2 diabetic patients than the control group (P = 0.007). Anemia was found in 17.9% of type 2 diabetic patients. Longer duration of diabetes (AOR = 3.05, 95% CI = 1.12-8.34) and milk consumption (AOR = 4.60, 95% CI = 1.50-14.00) were significantly associated with anemia. Conclusion This study showed a statistically significant variation in some hematological parameters of type 2 diabetic patients compared to control group. Anemia among type 2 diabetic patients was found to be a mild public health problem. Therefore, routine screening of hematological parameters should be considered for proper management of type 2 diabetic patients. Close attention should also be given to the duration of diabetes and dietary practice.	[Arkew, Mesay; Mengistu, Yordanos; Gemechu, Kabtamu] Haramaya Univ, Coll Hlth & Med Sci, Dept Med Lab Sci, Harar, Ethiopia; [Yemane, Tilahun; Tesfaye, Girum] Jimma Univ, Inst Hlth, Sch Med Lab Sci, Fac Hlth Sci, Jimma, Ethiopia	Haramaya University; Jimma University	Arkew, M (corresponding author), Haramaya Univ, Coll Hlth & Med Sci, Dept Med Lab Sci, Harar, Ethiopia.	mesayarkew12@gmail.com	Tesfaye, Girum/AAB-3547-2022	Tesfaye, Girum/0000-0001-7858-3793; Arkew, Mesay/0000-0002-9009-4586	Jimma University; Haramaya University	Jimma University; Haramaya University	Financial funding was received from Jimma University and Haramaya University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors received a salary from the funders.	Abdel N, 2016, BAOJ DIABET, P1; Agu K, 2018, J INSUL RESIST, V3, P1; Akinsegun A, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.42.3651; Al Salhen KS, 2017, IBNOSINA J MED BIOME, V9, P76, DOI [10.4103/1947-489X.210115, DOI 10.4103/1947-489X.210115]; Alam J., 2015, ADV MED SCI-POLAND, V2, P1; Alba-Loureiro TC, 2007, BRAZ J MED BIOL RES, V40, P1037, DOI 10.1590/S0100-879X2006005000143; Alhadas Kamilla R., 2016, J. Bras. Patol. Med. Lab., V52, P96, DOI 10.5935/1676-2444.20160017; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS81, DOI 10.2337/dc14-S081; American International Health Alliance, 2014, TWINN HELP TRANSF DE; Antwi-Baffour S, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0926-y; Asmah R H, 2015, Clin Diabetes Endocrinol, V1, P7, DOI 10.1186/s40842-015-0008-2; Awofisoye O., 2019, SAHEL MED J, V22, P55; Barbieri J, 2015, ANEMIA, V2015, DOI 10.1155/2015/354737; Bayoumi M., 2018, AM J DIABETES OBES M, V4, P17; Biadgo B, 2016, DIABET METAB SYND OB, V9, P91, DOI 10.2147/DMSO.S97563; Cakir L, 2014, ACTA MEDICA MEDITERR, V30, P425; Cho Young I, 2008, J Diabetes Sci Technol, V2, P1130; Christian M, 2015, ASIAN J MULTIDISCIP, V3, P21; Demirtas L, 2015, INT J CLIN EXP MED, V8, P11420; Ellinger Vivian C.M., 2006, Arq Bras Endocrinol Metab, V50, P114, DOI 10.1590/S0004-27302006000100016; Ethiopian Roads Authority, 2011, CONS SERV DET ENG DE; Feteh VF, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0247-1; Fiseha T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222111; Gauci R, 2017, J DIABETES COMPLICAT, V31, P1169, DOI 10.1016/j.jdiacomp.2017.04.002; Gkrania-Klotsas E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013405; Gundogan K, 2009, METAB SYNDR RELAT D, V7, P427, DOI 10.1089/met.2008.0068; Harish Kumar S, 2017, INT J ADV MED, V4, P1271, DOI [10.18203/2349-3933.ijam20174111, DOI 10.18203/2349-3933.IJAM20174111]; Hillson R, 2015, PRACT DIABETES, V32, P159, DOI 10.1002/pdi.1946; IDF,, 2019, IDF DIABETES ATLAS; Jabeen F, 2013, INT J ADV RES, V1, P322; Jabeen F, 2013, PAK J MED SCI, V29, P152, DOI 10.12669/pjms.291.2592; Jiang H, 2014, INT J ENV RES PUB HE, V11, P5497, DOI 10.3390/ijerph110505497; Kakouros N, 2011, INT J ENDOCRINOL, V2011, DOI 10.1155/2011/742719; Kaur R, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0763-3; Kizilgul M., 2018, DICLE TIP DERGISI, V45, P113; Korniluk A, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/9213074; Kshirsagar R., 2019, PANACEA J MED SCI, V9, P23; Lee RH, 2017, J CLIN INVEST, V127, P2040, DOI 10.1172/JCI94494; Milosevic D, 2019, J MED BIOCHEM, V38, P164, DOI 10.2478/jomb-2018-0021; NHANES, 2014, COMPLETE BLOOD COUNT; Olana C, 2019, INT J BIOMED ADV RES, V10, P1; Osman NA., 2013, MEASUREMENT SOME HAE, P0; Pujani M, 2018, IRAQI J HEMATOL, V7, P72, DOI 10.4103/ijh.ijh_8_18; Randriamboavonjy V, 2015, MECH INVOLVED DIABET; Saad Z., 2017, BIOMED RES THER, V4, P1760; Sahay M, 2017, DIABETES METAB SYND, V11, pS685, DOI 10.1016/j.dsx.2017.04.026; Salvi G., 2014, CRITICAL REV CLIN LA, P1, DOI DOI 10.3109/10408363.2014.992064; Sherif H, 2013, LIFE SCI J, V10, P32; Tavil Y, 2010, PLATELETS, V21, P368, DOI 10.3109/09537101003628421; Vozarova B, 2002, DIABETES, V51, P455, DOI 10.2337/diabetes.51.2.455; Waggiallah H, 2011, N AM J MED SCI, V3, P344, DOI 10.4297/najms.2011.3344; Wang ZS, 2013, VASC HEALTH RISK MAN, V9, P237, DOI 10.2147/VHRM.S43211; World Health Organization, 2011, VITAM MINER NUTR INF, V11, P1; World Health Organization, 2000, GUIDELINES STANDARD, P15	54	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0253286	10.1371/journal.pone.0253286	http://dx.doi.org/10.1371/journal.pone.0253286			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125859	gold, Green Published			2022-12-26	WOS:000664643500029
J	Tiaprapong, K; Sirikul, A; Krajangmek, C; Duangthongkul, N; Pandam, N; Piya-amornphan, N				Tiaprapong, Krueakaew; Sirikul, Achiraporn; Krajangmek, Chamawee; Duangthongkul, Namfon; Pandam, Nichaya; Piya-amornphan, Nitita			Awareness of COVID-19 influences on the wellness of Thai health professional students: An ambulatory assessment during the early "new normal" informing policy	PLOS ONE			English	Article							MENTAL-HEALTH; STROOP COLOR; RESIDENTS; OUTBREAK; BEHAVIOR; VERSION	The COVID-19 global pandemic has had a socioeconomic effect, including many people suffering from stress and mental disorders. Health professional students are at risk of health issues as well when compared to their age-matched counterpart in the population. The present study aimed to find out the impact of COVID-19 awareness on the wellness of Thai health professional students. The awareness of COVID-19 and wellness among Thai health professional students, such as medical, physical therapy, nursing, pharmacy, and medical technology students were surveyed during the early "new normal" informing policy. The participants included 1,001 students, aged 17 to 25 years old, who responded to a Google form questionnaire set by request. The results showed that the prominent health risks among the Thai health professional students included sedentary behavior, obesity, and mental symptoms. A positive rating in attitude towards the COVID-19 epidemic was mostly observed. There was a negative influence on anxiety symptoms (standardized coefficient beta = -0.079, p-value = 0.012), but a positive impact on social well-being (standardized coefficient beta = 0.158, p-value < 0.001) and quality of life (standardized coefficient beta = 0.136, p-value < 0.001) among the students even when the situation was improving. To relieve the domino effect of the COVID-19 pandemic on students' wellness, an updated policy for enhancing awareness and providing updated information is continuously required. Improvements on self and situational awareness may help prevent health risk behaviors and promote health among Thai health professional students.	[Tiaprapong, Krueakaew; Sirikul, Achiraporn; Krajangmek, Chamawee; Duangthongkul, Namfon; Pandam, Nichaya; Piya-amornphan, Nitita] Walailak Univ, Sch Allied Hlth Sci, Dept Phys Therapy, Tha Sala, Nakhon Si Thamm, Thailand	Walailak University	Piya-amornphan, N (corresponding author), Walailak Univ, Sch Allied Hlth Sci, Dept Phys Therapy, Tha Sala, Nakhon Si Thamm, Thailand.	nitita.do@wu.ac.th	Piya-amornphan (Dorkkam), Nitita/GWB-9547-2022	Piya-amornphan (Dorkkam), Nitita/0000-0001-5469-4827	Center for Scientific and Technological Equipment, Walailak University, Thailand	Center for Scientific and Technological Equipment, Walailak University, Thailand	Research grant came from the Center for Scientific and Technological Equipment, Walailak University, Thailand. This funding source had no role in the design of the study and did not have any role in collection, analysis, and interpretation of data or in the writing of the manuscript.	AlFaris E, 2016, BMC MED EDUC, V16, DOI 10.1186/s12909-016-0794-y; American College of Sports Medicine, 2021, UPD PHYS ACT GUID NO; Arsandaux J, 2020, INT J BEHAV MED, V27, P142, DOI 10.1007/s12529-020-09857-w; Biro Eva, 2011, BMC Public Health, V11, P871, DOI 10.1186/1471-2458-11-871; Chow KM, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1119-0; Cuttilan AN, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2016.02.07; Dhiman S, 2020, RES DEV DISABIL, V107, DOI 10.1016/j.ridd.2020.103790; Eurosurveillance Editorial Team, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.5.200131e; GREEN SB, 1991, MULTIVAR BEHAV RES, V26, P499, DOI 10.1207/s15327906mbr2603_7; Hoare E, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0432-4; Homack S, 2004, ARCH CLIN NEUROPSYCH, V19, P725, DOI 10.1016/j.acn.2003.09.003; Li KG, 2009, SOC INDIC RES, V90, P489, DOI 10.1007/s11205-008-9272-1; Lotrakul M, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-46; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Patelarou A, 2021, J MENT HEALTH, V30, P164, DOI 10.1080/09638237.2021.1875420; Pengpid S, 2020, INT J MENT HEALTH SY, V14, DOI 10.1186/s13033-020-00414-2; Rattanawiwatpong P., 2006, J THAI REHABIL, V16, P147; S Professor Emerita E.D., 2011, INT ENCY STAT SCI, P1637, DOI DOI 10.1007/978-3-642-04898-2_98; Scarpina F, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00557; Song YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068599; Soto D, 2014, TRENDS COGN SCI, V18, P520, DOI 10.1016/j.tics.2014.06.005; Stanton NA, 2001, SAFETY SCI, V39, P189, DOI 10.1016/S0925-7535(01)00010-8; Stein T, 2016, NEUROSCI CONSCIOUS, DOI 10.1093/nc/niv011; Stoewen DL, 2017, CAN VET J, V58, P861; Tavolacci MP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194188; Triukose S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246274; Trull TJ, 2013, ANNU REV CLIN PSYCHO, V9, P151, DOI 10.1146/annurev-clinpsy-050212-185510; Unicef Thailand, 2020, SOCIAL IMPACT ASSESS; Veluswamy SK, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-27; von Haaren B, 2015, PSYCHOL SPORT EXERC, V20, P67, DOI 10.1016/j.psychsport.2015.04.004; Waleeprakhon P, 2014, NEUROPSYCH DIS TREAT, V10, P1497, DOI 10.2147/NDT.S67842; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Wongpakaran N, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-6; World Health Organization, 2020, HOM HLTH TOP MENT HL; World Health Organization, 2020, EM COR DIS COVID 19; Yobas PK., 2018, THAI J PHARM SCI, V13, P3; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221; Zhou SJ, 2020, EUR CHILD ADOLES PSY, V29, P749, DOI 10.1007/s00787-020-01541-4	39	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252681	10.1371/journal.pone.0252681	http://dx.doi.org/10.1371/journal.pone.0252681			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SI	34125868	Green Published, gold			2022-12-26	WOS:000664643500012
J	Alnaqbi, A; Shousha, T; AlKetbi, H; Hegazy, FA				Alnaqbi, Arwa; Shousha, Tamer; AlKetbi, Hamda; Hegazy, Fatma A.			Physiotherapists' perspectives on barriers to implementation of direct access of physiotherapy services in the United Arab Emirates: A cross-sectional study	PLOS ONE			English	Article							EPISODES; CARE	Background There are two primary ways of accessing physiotherapy for service users around the world. The direct access, as opposed to the indirect access which requires a referral from a general physician, has several merits including better quality, timeliness, cost effectiveness of treatment and better probability of preventing acute conditions from turning into chronic ailments. Despite these benefits, several countries including the UAE, do not allow direct access to physiotherapists. This study aims to understand the level of awareness among practicing physiotherapists in the United Arab Emirates (UAE) about direct access and to determine whether any of their demographic variables influence the way they perceive the concept. Further, the study sought to explore the perceived barriers and benefits of direct access according to the participating physiotherapists. Subjects and methods An observational cross-sectional study was employed. The questionnaire survey developed by Bury and Stokes in 2013 was adapted and employed in this study. The instrument had six sections with close-ended items using a Likert five-point scale to rate them. Two hundred and sixty-four physiotherapists answered the questionnaire shared with them through a web link. Finally, MANOVA was employed to explore any influence of demographic variables on the opinions of the respondents. Results The findings showed that 70% of participants were aware about direct access while nearly 30% were completely unaware. Younger physiotherapists were more willing to endorse the practice whereas older ones were more apprehensive of the barriers. The main barriers reported were the limited support from the physicians and policy makers, professional autonomy, and the limited scope of practice for the physiotherapists, as well as evidence-based practice. The impact of demographic variables on direct access indicated that physiotherapists under the age of 23 endorsed direct access more strongly than other age groups. Conclusion More efforts are needed to implement direct access in the UAE, considering the benefits of improved professional status, cost savings, patient satisfaction, and higher efficiency. This study recommends leadership support, professional autonomy, and mentorship as possible ways to achieve this goal.	[Alnaqbi, Arwa] Kuwait Hosp, MOHAP, Physiotherapy Deparment, Dubai, U Arab Emirates; [Shousha, Tamer; Hegazy, Fatma A.] Univ Sharjah, Coll Hlth Sci, Dept Physiotherapy, Sharjah, U Arab Emirates; [Shousha, Tamer] Cairo Univ, Fac Phys Therapy, Dept Phys Therapy Musculoskeletal Disordered & It, Giza, Egypt; [AlKetbi, Hamda] Rashid Hosp, DHA, Phys Med & Rehabil Dept, Dubai, U Arab Emirates; [Hegazy, Fatma A.] Cairo Univ, Fac Phys Therapy, Dept Phys Therapy Growth & Dev Disorders Children, Giza, Egypt	University of Sharjah; Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Hegazy, FA (corresponding author), Univ Sharjah, Coll Hlth Sci, Dept Physiotherapy, Sharjah, U Arab Emirates.; Hegazy, FA (corresponding author), Cairo Univ, Fac Phys Therapy, Dept Phys Therapy Growth & Dev Disorders Children, Giza, Egypt.	fhegazy@sharjah.ac.ae	Shousha, Tamer/AAR-1384-2021	Shousha, Tamer/0000-0002-0712-4490; Hegazy, Fatma/0000-0001-7457-083X				Aiken AB, 2008, J INTERPROF CARE, V22, P253, DOI 10.1080/13561820801984134; Al Ghamdi AH, 2019, PHYS MED REHAB KUROR, V29, P26, DOI 10.1055/s-0043-124973; Bishop A, 2021, PHYSIOTHERAPY, V111, P48, DOI 10.1016/j.physio.2020.04.006; Bury TJ, 2013, PHYS THER, V93, P449, DOI 10.2522/ptj.20120060; Demont A, 2021, DISABIL REHABIL, V43, P1637, DOI 10.1080/09638288.2019.1674388; Evans A, APTA REPORT DIRECT A; Garrity BM, 2020, PHYS THER, V100, P107, DOI 10.1093/ptj/pzz152; Goodwin R, 2020, PHYSIOTHERAPY, V108, P29, DOI 10.1016/j.physio.2020.02.003; Holdsworth LK, 2008, PHYSIOTHERAPY, V94, P236, DOI 10.1016/j.physio.2008.01.006; Holdsworth LK., 2004, PHYSIOTHERAPY, V90, DOI [10.1016/j.physio.2004.01.005, DOI 10.1016/J.PHYSIO.2004.01.005]; Igwesi-Chidobe CN., 2020, PHYSIOTHERAPY, DOI [10.1016/j.physio.2020.07.002 33316866, DOI 10.1016/J.PHYSIO.2020.07.00233316866]; Kruger J, 2010, J PHYSIOTHER, V56, P217, DOI 10.1016/S1836-9553(10)70001-1; Laliberte Maude, 2017, Narrat Inq Bioeth, V7, P157, DOI 10.1353/nib.2017.0046; Leemrijse CJ, 2008, PHYS THER, V88, P936, DOI 10.2522/ptj.20070308; Lim A., 2020, EUR J PHYSIOTHER, V21, P1; Mbada CE., 2015, NIGER J MED REHAB, DOI [10.34058/njmr.v18i1.105, DOI 10.34058/NJMR.V18I1.105]; Mitchell JM, 1997, PHYS THER, V77, P10, DOI 10.1093/ptj/77.1.10; Moore JH, 2005, J ORTHOP SPORT PHYS, V35, P67, DOI 10.2519/jospt.2005.35.2.67; Ojha HA, 2014, PHYS THER, V94, P14, DOI 10.2522/ptj.20130096; Papageorgiou G, 2018, INTERACT CARDIOV TH, V27, P153, DOI 10.1093/icvts/ivy102; Piano Leonardo, 2017, J Phys Ther Sci, V29, P1463, DOI 10.1589/jpts.29.1463; Piscitelli D, 2018, CLIN TER, V169, pE249, DOI 10.7417/CT.2018.2087; Schreier M., 2018, SAGE HDB QUALITATIVE, P84, DOI DOI 10.4135/9781526416070.N6; Schrepp M, 2020, J USABILITY STUD, V15, P247; Swinkels IC., 2007, NED TIJDSCHR FYSIOTH, V117, P158; World Physiotherapy. Emirates Physiotherapy Society, WORLD PHYS	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253155	10.1371/journal.pone.0253155	http://dx.doi.org/10.1371/journal.pone.0253155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115810	gold, Green Published			2022-12-26	WOS:000664643000050
J	Geens, M; Stappers, S; Konings, H; De Winter, BY; Specenier, P; Van Meerbeeck, JP; Verpooten, GA; Abrams, S; Janssens, A; Peeters, M; Van de Heyning, P; Vanderveken, OM; Ledeganck, KJ				Geens, Margot; Stappers, Sofie; Konings, Heleen; De Winter, Benedicte Y.; Specenier, Pol; Van Meerbeeck, Jan P.; Verpooten, Gert A.; Abrams, Steven; Janssens, Annelies; Peeters, Marc; Van de Heyning, Paul; Vanderveken, Olivier M.; Ledeganck, Kristien J.			Epidermal growth factor as a potential prognostic and predictive biomarker of response to platinum-based chemotherapy	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; FACTOR RECEPTOR EXPRESSION; NECK-CANCER; SERUM-LEVELS; TGF-ALPHA; HEAD; PROTEIN; PROGRESSION; LUNG; EGFR	In this study, we investigated serum epidermal growth factor (EGF) in an oncological population of head- and neck and pulmonary neoplasms and whether serum EGF could serve as a prognostic marker of survival and as a predictive marker for treatment response to platinum-based chemotherapy. A total of 59 oncological patients and a control group of age- and sex-matched healthy volunteers were included in this study. Pre-treatment serum EGF from both groups was determined. Patient's and tumour characteristics and mortality were recorded during a 5-year follow up period. Baseline serum EGF significantly differed between the oncological patients and the healthy volunteers (p<0.001). Serum EGF was associated with lymph node metastasis (p = 0.004) but not with sex (p = 0.753), age (p = 1.00), TNM stage (p = 0.191) or tumour size (p = 0.077). Neither serum EGF (p = 0.81) nor age (p = 0.55) showed an effect on the patient's survival. Tumour location was significantly associated with overall 5-year survival (p = 0.003). The predictive capacity of serum EGF of response to chemotherapy was limited (AUC = 0.606), a sensitivity of 80% and a specificity of 56% was observed resulting in a likelihood ratio of a positive and negative test equal to 1.81 and 0.36, respectively. In conclusion, serum EGF levels are 5.5 times higher in an oncological population compared to a control group. Within the oncological population, low serum EGF values are associated with the presence of lymph node metastasis. Further investigation is necessary to determine if the serum EGF levels could serve as a diagnostic biomarker.	[Geens, Margot; Stappers, Sofie; Konings, Heleen] Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium; [De Winter, Benedicte Y.; Van Meerbeeck, Jan P.; Verpooten, Gert A.; Ledeganck, Kristien J.] Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium; [De Winter, Benedicte Y.; Van Meerbeeck, Jan P.; Verpooten, Gert A.; Ledeganck, Kristien J.] Univ Antwerp, Infla Med Ctr Excellence, Antwerp, Belgium; [De Winter, Benedicte Y.] Antwerp Univ Hosp, Dept Gastroenterol & Hepatol, Edegem, Belgium; [Specenier, Pol] Antwerp Univ Hosp, Dept Oncol, Edegem, Belgium; [Specenier, Pol; Peeters, Marc] Univ Antwerp, Ctr Oncol Res, Antwerp, Belgium; [Van Meerbeeck, Jan P.] Antwerp Univ Hosp, Dept Pneumol, Edegem, Belgium; [Abrams, Steven] Univ Antwerp, Global Hlth Inst, Family Med & Populat Hlth, Antwerp, Belgium; [Abrams, Steven] UHasselt, Interuniv Inst Biostat & Stat Bioinformat, Data Sci Inst, Diepenbeek, Belgium; [Janssens, Annelies] Antwerp Univ Hosp, Dept Thorac Oncol, Edegem, Belgium; [Peeters, Marc; Vanderveken, Olivier M.] Antwerp Univ Hosp, Multidisciplinary Oncol Ctr Antwerp, Dept Oncol, Edegem, Belgium; [Van de Heyning, Paul] Antwerp Univ Hosp, Dept Otolaryngol Head & Neck Surg, Edegem, Belgium; [Van de Heyning, Paul; Vanderveken, Olivier M.] Univ Antwerp, Dept Translat Neurosci, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp; Hasselt University; University of Antwerp; University of Antwerp; University of Antwerp; University of Antwerp	Ledeganck, KJ (corresponding author), Univ Antwerp, Lab Expt Med & Pediat, Antwerp, Belgium.; Ledeganck, KJ (corresponding author), Univ Antwerp, Infla Med Ctr Excellence, Antwerp, Belgium.	kristien.ledeganck@uantwerp.be	Abrams, Steven/AAC-7351-2022	Abrams, Steven/0000-0001-7353-9304; Peeters, Marc/0000-0003-4969-2303; , Sofie/0000-0003-2703-3219				Adams L, 2008, CANCER PREV RES, V1, P357, DOI 10.1158/1940-6207.CAPR-08-0061; Agha-Hosseini Farzaneh, 2015, Acta Med Iran, V53, P471; Ang KK, 2002, CANCER RES, V62, P7350; [Anonymous], CANC 2018; Ayaz L, 2013, J CANCER RES CLIN, V139, P1499, DOI 10.1007/s00432-013-1469-2; Bansal A, 2016, J CELL BIOCHEM, V117, P1288, DOI 10.1002/jcb.25497; Bernardes VF, 2011, APPL IMMUNOHISTO M M, V19, P1528, DOI 10.1097/PAI.0b013e3182143367; Billeter AT, 2012, SEMIN THORAC CARDIOV, V24, P155, DOI 10.1053/j.semtcvs.2012.06.009; Blanco-Prieto S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127318; Cai Z, 2010, CANCER LETT, V296, P88, DOI 10.1016/j.canlet.2010.03.020; Chaisuparat R, 2013, PATHOL ONCOL RES, V19, P189, DOI 10.1007/s12253-012-9568-y; Cheng J, 2017, BIOCHEM BIOPH RES CO, V486, P781, DOI 10.1016/j.bbrc.2017.03.120; Coca-Pelaz A, 2018, ADV THER, V35, P153, DOI 10.1007/s12325-018-0663-7; Dong SL, 2016, DIS MARKERS, V2016, DOI 10.1155/2016/1857067; Franzmann EJ, 2012, HEAD NECK-J SCI SPEC, V34, P687, DOI 10.1002/hed.21810; Grandis JR, 1998, JNCI-J NATL CANCER I, V90, P824, DOI 10.1093/jnci/90.11.824; Grobe A, 2014, J ORAL PATHOL MED, V43, P205, DOI 10.1111/jop.12111; Guerrero-Preston R, 2011, CANCER PREV RES, V4, P1061, DOI 10.1158/1940-6207.CAPR-11-0006; Gupta A, 2015, BIOCHEM BIOPH RES CO, V467, P248, DOI 10.1016/j.bbrc.2015.09.181; Hao CF, 2018, MINERVA ENDOCRINOL, V43, P253, DOI 10.23736/S0391-1977.17.02721-3; Harper N, 2012, J GASTROINTEST SURG, V16, P946, DOI 10.1007/s11605-011-1778-1; Konings H, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01020; Konturek A, 2005, LANGENBECK ARCH SURG, V390, P216, DOI 10.1007/s00423-004-0529-0; Kriegs M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49885-5; Ledeganck KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057016; Lemos-Gonzalez Y, 2007, BRIT J CANCER, V96, P1569, DOI 10.1038/sj.bjc.6603770; Lin JS, 2018, INT J ORAL MAX SURG, V47, P1236, DOI 10.1016/j.ijom.2018.01.023; Lingen MW, 2010, CANCER PREV RES, V3, P1056, DOI 10.1158/1940-6207.CAPR-10-0173; McMahon GM, 2013, AM J KIDNEY DIS, V62, P165, DOI 10.1053/j.ajkd.2012.12.022; Mehanna H, 2011, CLIN OTOLARYNGOL, V36, P65, DOI 10.1111/j.1749-4486.2010.02231.x; Meybosch S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211212; MOSKAL TL, 1995, CANCER EPIDEM BIOMAR, V4, P127; Ohnishi Y, 2008, ORAL ONCOL, V44, P1155, DOI 10.1016/j.oraloncology.2008.02.015; Pretto G, 2013, DIGEST DIS SCI, V58, P115, DOI 10.1007/s10620-012-2316-z; Ramos TC, 2006, CANCER BIOL THER, V5, P145; Rolke HB, 2007, RESP MED, V101, P1251, DOI 10.1016/j.rmed.2006.10.021; Salomaa ER, 2005, CHEST, V128, P2282, DOI 10.1378/chest.128.4.2282; van Angelen AA, 2013, NEPHROL DIAL TRANSPL, V28, P879, DOI 10.1093/ndt/gfs499; Zeng F, 2014, SEMIN CELL DEV BIOL, V28, P2, DOI 10.1016/j.semcdb.2014.01.011; Zimmermann M, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-11	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252646	10.1371/journal.pone.0252646	http://dx.doi.org/10.1371/journal.pone.0252646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115785	gold, Green Published			2022-12-26	WOS:000664643000025
J	Kron, NS; Fieber, LA				Kron, N. S.; Fieber, L. A.			Co-expression analysis identifies neuro-inflammation as a driver of sensory neuron aging in Aplysia californica	PLOS ONE			English	Article							NF-KAPPA-B; INNATE IMMUNE-RESPONSE; TOLL-LIKE RECEPTORS; MESSENGER-RNA; I INTERFERON; GENE-EXPRESSION; BINDING PROTEIN; RIBOSOMAL-RNA; CATHEPSIN-L; SACCHAROMYCES-CEREVISIAE	Aging of the nervous system is typified by depressed metabolism, compromised proteostasis, and increased inflammation that results in cognitive impairment. Differential expression analysis is a popular technique for exploring the molecular underpinnings of neural aging, but technical drawbacks of the methodology often obscure larger expression patterns. Co-expression analysis offers a robust alternative that allows for identification of networks of genes and their putative central regulators. In an effort to expand upon previous work exploring neural aging in the marine model Aplysia californica, we used weighted gene correlation network analysis to identify co-expression networks in a targeted set of aging sensory neurons in these animals. We identified twelve modules, six of which were strongly positively or negatively associated with aging. Kyoto Encyclopedia of Genes analysis and investigation of central module transcripts identified signatures of metabolic impairment, increased reactive oxygen species, compromised proteostasis, disrupted signaling, and increased inflammation. Although modules with immune character were identified, there was no correlation between genes in Aplysia that increased in expression with aging and the orthologous genes in oyster displaying long-term increases in expression after a virus-like challenge. This suggests anti-viral response is not a driver of Aplysia sensory neuron aging.	[Kron, N. S.; Fieber, L. A.] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA	University of Miami	Kron, NS (corresponding author), Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, Dept Marine Biol & Ecol, 4600 Rickenbacker Causeway, Miami, FL 33149 USA.	n.kron@umiami.edu		Fieber, Lynne/0000-0002-7717-2260; Kron, Nicholas/0000-0002-2274-003X	National Institutes of Health [P40OD010952]; University of California, Irvine [P30CA-062203]; NIH [1S10RR025496-01, 1S10OD010794-01, 1S10OD021718-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California, Irvine(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health Grant (P40OD010952). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was made possible, in part, through access to the Genomics High Throughput Facility Shared Resource of the Cancer Center Support Grant (P30CA-062203) at the University of California, Irvine and NIH shared instrumentation grants 1S10RR025496-01, 1S10OD010794-01, and 1S10OD021718-01.	Abrams TW, 2012, CURR BIOL, V22, pR705, DOI 10.1016/j.cub.2012.08.011; Anderrson JF, 2011, J MOL BIOL, V411, P870, DOI 10.1016/j.jmb.2011.06.016; Antonicka H, 2017, EMBO REP, V18, P28, DOI 10.15252/embr.201643391; Arango D, 2018, CELL, V175, P1872, DOI 10.1016/j.cell.2018.10.030; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Arnold SM, 2000, BIOCHEMISTRY-US, V39, P2149, DOI 10.1021/bi9916473; Arosio P, 2017, IUBMB LIFE, V69, P414, DOI 10.1002/iub.1621; Arroyo JD, 2016, CELL METAB, V24, P875, DOI 10.1016/j.cmet.2016.08.017; Ashida H, 2010, NAT CELL BIOL, V12, P66, DOI 10.1038/ncb2006; AUDESIRK TE, 1979, BIOL BULL, V157, P407, DOI 10.2307/1541026; BAILEY CH, 1983, BEHAV NEURAL BIOL, V38, P70, DOI 10.1016/S0163-1047(83)90399-0; Balastik M, 2008, P NATL ACAD SCI USA, V105, P12016, DOI 10.1073/pnas.0802261105; Balistreri G, 2014, CELL HOST MICROBE, V16, P403, DOI 10.1016/j.chom.2014.08.007; Ban N, 2007, J BIOL CHEM, V282, P9628, DOI 10.1074/jbc.M611767200; Bathige SDNK, 2014, FISH SHELLFISH IMMUN, V39, P263, DOI 10.1016/j.fsi.2014.05.012; Baumas K, 2012, RNA BIOL, V9, DOI [10.4161/rna.9.2.18810, 10.4161/rna.18810]; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Bertrand MJM, 2009, IMMUNITY, V30, P789, DOI 10.1016/j.immuni.2009.04.011; Biswas G, 2005, GENE, V354, P132, DOI 10.1016/j.gene.2005.03.028; Boldin MP, 1996, CELL, V85, P803, DOI 10.1016/S0092-8674(00)81265-9; Bonnin E, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007845; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; Buffenstein R, 2008, AGE, V30, P99, DOI 10.1007/s11357-008-9058-z; Bugarcic A, 2011, TRAFFIC, V12, P1759, DOI 10.1111/j.1600-0854.2011.01284.x; Bundy DL, 1997, J BIOL CHEM, V272, P33132, DOI 10.1074/jbc.272.52.33132; Bushnell B., BBMAP; Cai SY, 2017, BIOCHEM BIOPH RES CO, V483, P624, DOI 10.1016/j.bbrc.2016.12.092; Cambiaghi TD, 2014, BIOCHEM BIOPH RES CO, V443, P592, DOI 10.1016/j.bbrc.2013.12.021; Cao YL, 2017, NATURE, V542, P372, DOI 10.1038/nature21077; Capitanio JS, 2017, ELIFE, V6, DOI 10.7554/eLife.18825; Capo TR, 2003, CONTEMP TOP LAB ANIM, V42, P31; Cardamone MD, 2012, MOL CELL, V46, P91, DOI 10.1016/j.molcel.2012.01.025; Cardamone MD, 2018, MOL CELL, V69, P757, DOI 10.1016/j.molcel.2018.01.037; Carney JP, 1998, CELL, V93, P477, DOI 10.1016/S0092-8674(00)81175-7; CARPENTER K, 1992, BIOCHEM BIOPH RES CO, V183, P443, DOI 10.1016/0006-291X(92)90501-B; Chang ZQ, 2011, PROSTAG OTH LIPID M, V94, P44, DOI 10.1016/j.prostaglandins.2010.12.003; Chen CC, 2017, CARCINOGENESIS, V38, P196, DOI 10.1093/carcin/bgw123; Chen JM, 1998, BIOCHEM J, V335, P111, DOI 10.1042/bj3350111; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Chen M, 2016, AUTOPHAGY, V12, P689, DOI 10.1080/15548627.2016.1151580; Chen YW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00774; CHEN YQ, 1993, HUM MOL GENET, V2, P1841, DOI 10.1093/hmg/2.11.1841; Chi T, 2004, NAT REV IMMUNOL, V4, P965, DOI 10.1038/nri1501; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Ciccia A, 2012, MOL CELL, V47, P396, DOI 10.1016/j.molcel.2012.05.024; CLATWORTHY AL, 1994, J NEUROSCI, V14, P3263; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Currais A, 2015, AGEING RES REV, V21, P30, DOI 10.1016/j.arr.2015.02.001; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; David R, 2013, NAT REV MOL CELL BIO, V14, P266, DOI [10.1038/nrm3573, DOI 10.1038/NRM3573]; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; del Pino J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047272; Deleidi M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00172; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Ding X, 2007, DEV CELL, V12, P863, DOI 10.1016/j.devcel.2007.03.018; Dominissini D, 2018, CELL, V175, P1725, DOI 10.1016/j.cell.2018.11.037; Dowd S, 1998, J CELL SCI, V111, P3389; Duan JJ, 2019, CELL SIGNAL, V58, P44, DOI 10.1016/j.cellsig.2019.03.007; Duguay BA, 2013, J VIROL, V87, P11787, DOI 10.1128/JVI.02306-13; Elrod ND, 2019, MOL CELL, V76, P738, DOI 10.1016/j.molcel.2019.10.034; ERDILE LF, 1990, J BIOL CHEM, V265, P3177; FAIK P, 1988, NATURE, V332, P455, DOI 10.1038/332455a0; Fan RR, 2016, NAT MED, V22, P780, DOI 10.1038/nm.4114; Farr M, 2001, J NEUROBIOL, V46, P89, DOI 10.1002/1097-4695(20010205)46:2<89::AID-NEU20>3.3.CO;2-4; Farr M, 1999, LEARN MEMORY, V6, P331; Feng J, 2014, J VIROL, V88, P7987, DOI 10.1128/JVI.00643-14; Fieber, 2016, FRONT AGING NEUROSCI, P8; Finch AJ, 2011, GENE DEV, V25, P917, DOI 10.1101/gad.623011; Floyd BJ, 2016, MOL CELL, V63, P621, DOI 10.1016/j.molcel.2016.06.033; Fornerod M, 1997, EMBO J, V16, P807, DOI 10.1093/emboj/16.4.807; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; FROLOVA L, 1994, NATURE, V372, P701, DOI 10.1038/372701a0; Fu MG, 2017, NAT REV IMMUNOL, V17, P130, DOI 10.1038/nri.2016.129; Funkelstein L, 2010, NEUROPEPTIDES, V44, P457, DOI 10.1016/j.npep.2010.08.003; Garaschuk O, 2018, AGEING RES REV, V43, P26, DOI 10.1016/j.arr.2018.02.003; Garcia-Oliver E, 2012, BBA-GENE REGUL MECH, V1819, P555, DOI 10.1016/j.bbagrm.2011.11.011; Gaur U, 2003, BIOCHEM PHARMACOL, V66, P1403, DOI 10.1016/S0006-2952(03)00490-8; Gems D, 2013, ANNU REV PHYSIOL, V75, P621, DOI 10.1146/annurev-physiol-030212-183712; Gentleman R, GENEFILTER GENEFILTE; Gerdes R, 2006, J AM ASSOC LAB ANIM, V45, P40; Gijon MA, 2008, J BIOL CHEM, V283, P30235, DOI 10.1074/jbc.M806194200; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Goldshmit Y, 2004, J BIOL CHEM, V279, P16349, DOI 10.1074/jbc.M312873200; Greer JB, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4909-1; Greulich W, 2019, CELL, V179, P1264, DOI 10.1016/j.cell.2019.11.001; Grimm A, 2017, J NEUROCHEM, V143, P418, DOI 10.1111/jnc.14037; Haahr P, 2018, MOL CELL, V70, P165, DOI 10.1016/j.molcel.2018.02.024; Haan S., 2016, FRONT BIOSCI-LANDMRK, V8, P189, DOI DOI 10.2741/E760; Hagele H, 2009, NEPHROL DIAL TRANSPL, V24, P3312, DOI 10.1093/ndt/gfp339; Hamada H, 2019, INT J ONCOL, V55, P896, DOI 10.3892/ijo.2019.4860; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Harz C, 2014, J IMMUNOL, V193, P3146, DOI 10.4049/jimmunol.1303098; Hay RT, 1999, PHILOS T R SOC B, V354, P1601, DOI 10.1098/rstb.1999.0504; HE ZG, 1995, NATURE, V374, P566, DOI 10.1038/374566a0; Heinonen MT, 2015, IMMUNOL CELL BIOL, V93, P158, DOI 10.1038/icb.2014.86; Heraud-Farlow JE, 2013, CELL REP, V5, P1511, DOI 10.1016/j.celrep.2013.11.039; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hu DQ, 2013, MOL CELL, V51, P493, DOI 10.1016/j.molcel.2013.07.003; Hua T, 2012, J BIOL CHEM, V287, P28956, DOI 10.1074/jbc.M112.385351; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; IKEDA Y, 1985, J BIOL CHEM, V260, P1311; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Inuzuka T, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-25; Irudayam JI, 2015, STEM CELL RES, V15, P354, DOI 10.1016/j.scr.2015.08.003; Ishidate T, 2018, MOL CELL, V70, P639, DOI 10.1016/j.molcel.2018.04.009; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Ito S, 2014, J BIOL CHEM, V289, P35724, DOI 10.1074/jbc.C114.602698; Iwata H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12849; Jaillard C, 2012, HUM MOL GENET, V21, P2298, DOI 10.1093/hmg/dds050; James MA, 2006, J VIROL, V80, P5301, DOI 10.1128/JVI.01942-05; Januszyk K, 2011, RNA, V17, P1566, DOI 10.1261/rna.2763111; Jerber J, 2014, HUM MOL GENET, V23, P563, DOI 10.1093/hmg/ddt445; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Jin Y, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113445; Jones RS, 2019, MOL PHARMACOL, V96, P364, DOI 10.1124/mol.119.116731; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Jung DJ, 2002, MOL CELL BIOL, V22, P5203, DOI 10.1128/MCB.22.14.5203-5211.2002; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kadakkuzha BM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-880; Kadoya T, 2005, MOL CELL BIOL, V25, P8619, DOI 10.1128/MCB.25.19.8619-8630.2005; Kaisho T, 2001, ACTA ODONTOL SCAND, V59, P124, DOI 10.1080/000163501750266701; Kaul G, 2011, CELL BIOCHEM FUNCT, V29, P227, DOI 10.1002/cbf.1740; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kazi JU, 2013, MOL ONCOL, V7, P693, DOI 10.1016/j.molonc.2013.02.020; Kemp IK, 2011, FISH SHELLFISH IMMUN, V31, P754, DOI 10.1016/j.fsi.2011.07.010; Kempsell AT, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00173; Kempsell AT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127056; Kempsell AT, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00084; Kim E, 2010, BIOCHEM BIOPH RES CO, V403, P167, DOI 10.1016/j.bbrc.2010.10.121; Kim JS, 2008, INT J CANCER, V122, P672, DOI 10.1002/ijc.23158; Kim KS, 2013, HUM MOL GENET, V22, P4805, DOI 10.1093/hmg/ddt332; Kim YH, 2018, BIOCHEM BIOPH RES CO, V496, P778, DOI 10.1016/j.bbrc.2017.12.014; Kirino Yohei, 2007, Nucleic Acids Symp Ser (Oxf), P417, DOI 10.1093/nass/nrm209; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; KONDO S, 1994, J CELL BIOL, V125, P1095, DOI 10.1083/jcb.125.5.1095; Kondo T, 2013, P NATL ACAD SCI USA, V110, P2969, DOI 10.1073/pnas.1222694110; Korkut C, 2013, NEURON, V77, P1039, DOI 10.1016/j.neuron.2013.01.013; Kozaki T, 2017, P NATL ACAD SCI USA, V114, P2681, DOI 10.1073/pnas.1621508114; KRAEMER D, 1994, P NATL ACAD SCI USA, V91, P1519, DOI 10.1073/pnas.91.4.1519; Krappmann D, 1997, IMMUNOBIOLOGY, V198, P3, DOI 10.1016/S0171-2985(97)80022-8; KretzRemy C, 1996, J CELL BIOL, V133, P1083, DOI 10.1083/jcb.133.5.1083; Kron NS, 2020, FRONT AGING NEUROSCI, V12, DOI 10.3389/fnagi.2020.573764; KWAK EL, 1995, J BIOL CHEM, V270, P15285, DOI 10.1074/jbc.270.25.15285; Lafont M, 2020, MBIO, V11, DOI 10.1128/mBio.02777-19; Lai F, 2015, NATURE, V525, P399, DOI 10.1038/nature14906; Lalaoui N, 2020, NATURE, V577, P103, DOI 10.1038/s41586-019-1828-5; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Le Pen J, 2018, NAT STRUCT MOL BIOL, V25, P778, DOI 10.1038/s41594-018-0106-9; Lee HC, 2008, MOL BIOL CELL, V19, P1174, DOI 10.1091/mbc.E07-09-0893; Leek JT, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku864; Li NX, 1999, FASEB J, V13, P1137, DOI 10.1096/fasebj.13.10.1137; Li Y, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005653; Lim J, 2018, SCIENCE, V361, P701, DOI 10.1126/science.aam5794; Lim J, 2014, CELL, V159, P1365, DOI 10.1016/j.cell.2014.10.055; Lin JX, 2000, ONCOGENE, V19, P2566, DOI 10.1038/sj.onc.1203523; Lin YL, 1998, J BIOL CHEM, V273, P1453, DOI 10.1074/jbc.273.3.1453; Lingappan Krithika, 2018, Current Opinion in Toxicology, V7, P81, DOI 10.1016/j.cotox.2017.11.002; Liu J, 2015, J VIROL, V89, P1925, DOI 10.1128/JVI.02262-14; Liu PP, 2017, PROTEIN CELL, V8, P735, DOI 10.1007/s13238-017-0448-9; Liu XF, 2016, EMBO REP, V17, P349, DOI 10.15252/embr.201540505; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu M, 2007, MOL CELL, V26, P689, DOI 10.1016/j.molcel.2007.05.006; Lubas M, 2013, EMBO J, V32, P1855, DOI 10.1038/emboj.2013.135; Ma L, 2006, CELL DEATH DIFFER, V13, P2079, DOI 10.1038/sj.cdd.4401959; MacPherson L, 2013, NUCLEIC ACIDS RES, V41, P1604, DOI 10.1093/nar/gks1337; Mahoney DJ, 2008, P NATL ACAD SCI USA, V105, P11778, DOI 10.1073/pnas.0711122105; Mahuran DJ, 1998, BBA-LIPID LIPID MET, V1393, P1, DOI 10.1016/S0005-2760(98)00057-5; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; MARTON MJ, 1993, MOL CELL BIOL, V13, P3541, DOI 10.1128/MCB.13.6.3541; Mattson MP, 2018, CELL METAB, V27, P1176, DOI 10.1016/j.cmet.2018.05.011; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Mazur DJ, 2001, J BIOL CHEM, V276, P17022, DOI 10.1074/jbc.M100623200; McCallum KC, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005923; MCCORMACK K, 1995, FEBS LETT, V370, P32, DOI 10.1016/0014-5793(95)00785-8; McCormack RM, 2015, ELIFE, V4, DOI 10.7554/eLife.06508; McNally KE, 2017, NAT CELL BIOL, V19, P1214, DOI 10.1038/ncb3610; Mcnally RS, 2011, J BIOL CHEM, V286, P4098, DOI 10.1074/jbc.M110.147371; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Mellett M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7669; Merveille AC, 2011, NAT GENET, V43, P72, DOI 10.1038/ng.726; Minoda Y, 2006, BIOCHEM BIOPH RES CO, V344, P1023, DOI 10.1016/j.bbrc.2006.04.006; Mitacek RM, 2019, J FOOD SCI, V84, P38, DOI 10.1111/1750-3841.14396; Miyara A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001384; Mogha A, 2013, J NEUROSCI, V33, P17976, DOI 10.1523/JNEUROSCI.1809-13.2013; Morita M, 2012, MOL CELL BIOL, V32, P3585, DOI 10.1128/MCB.00455-12; Moroz LL, 2013, METHODS MOL BIOL, V1048, P323, DOI 10.1007/978-1-62703-556-9_21; Moroz LL, 2011, CURR BIOL, V21, pR60, DOI 10.1016/j.cub.2010.11.028; Moroz LL, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/neuro.24.006.2010; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Muoio DM, 2007, CELL METAB, V5, P412, DOI 10.1016/j.cmet.2007.05.011; Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200; Nam D, 2008, BRIEF BIOINFORM, V9, P189, DOI 10.1093/bib/bbn001; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Niemann A, 2005, J CELL BIOL, V170, P1067, DOI 10.1083/jcb.200507087; Ogami K, 2013, BIOCHEM BIOPH RES CO, V432, P135, DOI 10.1016/j.bbrc.2013.01.072; Ogilvie I, 2005, J CLIN INVEST, V115, P2784, DOI 10.1172/JCI26020; Oldham MC, 2008, NAT NEUROSCI, V11, P1271, DOI 10.1038/nn.2207; Olsen RKJ, 2003, HUM MUTAT, V22, P12, DOI 10.1002/humu.10226; Munoz JP, 2013, EMBO J, V32, P2348, DOI 10.1038/emboj.2013.168; Paclik D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002629; Papa S, 2005, CELL DEATH DIFFER, V12, P1259, DOI 10.1038/sj.cdd.4401694; PAPKA R, 1981, J NEUROBIOL, V12, P455, DOI 10.1002/neu.480120505; Parrish NF, 2015, RNA, V21, P1691, DOI 10.1261/rna.052092.115; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pereira CM, 2005, J BIOL CHEM, V280, P28316, DOI 10.1074/jbc.M408571200; PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992; Poddar J, 2019, J CHEM NEUROANAT, V95, P70, DOI 10.1016/j.jchemneu.2018.04.002; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Qin JZ, 2005, J BIOL CHEM, V280, P25233, DOI 10.1074/jbc.M501363200; Rao RP, 2013, J LIPIDS, V2013, DOI 10.1155/2013/178910; RATTAN KS, 1981, J NEUROBIOL, V12, P469, DOI 10.1002/neu.480120506; Riemer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017037; Rienzo M, 2016, BBA-GENE REGUL MECH, V1859, P1269, DOI 10.1016/j.bbagrm.2016.07.008; Rodriguez CI, 2007, DEV BIOL, V312, P501, DOI 10.1016/j.ydbio.2007.09.053; Roobol A, 2015, BIOCHEM J, V465, P213, DOI 10.1042/BJ20140852; Rorbach J, 2011, NUCLEIC ACIDS RES, V39, P7750, DOI 10.1093/nar/gkr470; Roshanbin S, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0274-7; Ross JL, 2006, NAT CELL BIOL, V8, P562, DOI 10.1038/ncb1421; Rozpedek W, 2016, CURR MOL MED, V16, P533, DOI 10.2174/1566524016666160523143937; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; SAKATSUME M, 1995, J BIOL CHEM, V270, P17528, DOI 10.1074/jbc.270.29.17528; Santel A, 2001, J CELL SCI, V114, P867; Sarute N, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000137; Sasaki K, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0462-y; Sato T, 2012, MOL CELL, V47, P99, DOI 10.1016/j.molcel.2012.04.015; Saunders A, 2010, BLOOD, V115, P3249, DOI 10.1182/blood-2009-08-237586; Schenk G, 2013, COORDIN CHEM REV, V257, P473, DOI 10.1016/j.ccr.2012.03.020; SCHERER DC, 1995, P NATL ACAD SCI USA, V92, P11259, DOI 10.1073/pnas.92.24.11259; Schneider M, 2015, CELL, V162, P1016, DOI 10.1016/j.cell.2015.07.059; Schnell S, 2006, BLOOD, V108, P591, DOI 10.1182/blood-2005-11-4616; Schreiber J, 2015, J CELL BIOL, V211, P569, DOI 10.1083/jcb.201506048; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Serin EAR, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00444; Setty SRG, 2007, MOL BIOL CELL, V18, P768, DOI 10.1091/mbc.E06-12-1066; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Shan JX, 2009, MOL CELL BIOCHEM, V332, P113, DOI 10.1007/s11010-009-0180-8; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Shen JD, 2015, FISH SHELLFISH IMMUN, V47, P986, DOI 10.1016/j.fsi.2015.11.004; Shi YH, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15138; Silva CM, 1996, MOL ENDOCRINOL, V10, P508, DOI 10.1210/me.10.5.508; Simon PS, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1808-6; Singh B, 1997, Prog Cell Cycle Res, V3, P251; Sleeth KM, 2007, J MOL BIOL, V373, P38, DOI 10.1016/j.jmb.2007.07.068; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Song YD, 2019, CANCER MANAG RES, V11, P7455, DOI 10.2147/CMAR.S201177; Stancic M, 2012, GLIA, V60, P919, DOI 10.1002/glia.22324; Staring J, 2017, NATURE, V541, P412, DOI 10.1038/nature21032; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Sun SC, 2019, BRAIN, V142, P2215, DOI 10.1093/brain/awz151; Sundaramoorthy E, 2017, MOL CELL, V65, P751, DOI 10.1016/j.molcel.2016.12.026; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takashima K, 2015, CELL REP, V11, P192, DOI 10.1016/j.celrep.2015.03.027; Takeyama K, 2003, J BIOL CHEM, V278, P21930, DOI 10.1074/jbc.M301157200; Tanaka Y, 2017, HUM MOL GENET, V26, P969, DOI 10.1093/hmg/ddx011; Tang SJ, 2001, NEURON, V32, P463, DOI 10.1016/S0896-6273(01)00493-7; Tatomer DC, 2019, GENE DEV, V33, P1525, DOI 10.1101/gad.330167.119; TIRANTI V, 1995, GENOMICS, V25, P559, DOI 10.1016/0888-7543(95)80058-T; Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923; Torii S, 2004, DEV CELL, V7, P33, DOI 10.1016/j.devcel.2004.05.019; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Ustianenko D, 2013, RNA, V19, P1632, DOI 10.1261/rna.040055.113; Uyama T, 2009, BBA-MOL CELL BIOL L, V1791, P1114, DOI 10.1016/j.bbalip.2009.07.001; Wang GM, 2019, CELL REP, V28, P1961, DOI 10.1016/j.celrep.2019.07.081; Wang MJ, 2019, J CELL PHYSIOL, V234, P20139, DOI 10.1002/jcp.28615; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Wang YR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075702; Wang Y, 2019, NAT CELL BIOL, V21, P1346, DOI 10.1038/s41556-019-0416-0; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Watkins JL, 1998, P NATL ACAD SCI USA, V95, P6779, DOI 10.1073/pnas.95.12.6779; Watts ME, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00216; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Welsby I, 2014, J BIOL CHEM, V289, P26642, DOI 10.1074/jbc.M114.589515; Wendeler M, 2004, EUR J BIOCHEM, V271, P614, DOI 10.1111/j.1432-1033.2003.03964.x; Weon JL, 2018, MOL CELL, V69, P113, DOI 10.1016/j.molcel.2017.11.010; Weston R, 2012, GENE DEV, V26, P1558, DOI 10.1101/gad.193516.112; Widmann B, 2012, MOL BIOL CELL, V23, P22, DOI 10.1091/mbc.E11-07-0639; Wiebe MS, 2007, CELL HOST MICROBE, V1, P187, DOI 10.1016/j.chom.2007.03.007; Wight TN, 2014, MATRIX BIOL, V35, P152, DOI 10.1016/j.matbio.2014.01.015; Williams GD, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00202-20; Woitach JT, 1998, NAT GENET, V19, P371, DOI 10.1038/1258; Wood ER, 2015, J BIOL CHEM, V290, P19681, DOI 10.1074/jbc.M115.653113; Wu YJ, 2005, CELL RES, V15, P483, DOI 10.1038/sj.cr.7290318; Xiao CC, 2005, ADV EXP MED BIOL, V560, P41; Xie XW, 2017, BIOCHEM BIOPH RES CO, V488, P291, DOI 10.1016/j.bbrc.2017.04.161; Xiong F, 2017, HUM MUTAT, V38, P95, DOI 10.1002/humu.23130; Xu SQ, 2018, NEUROBIOL AGING, V62, P159, DOI 10.1016/j.neurobiolaging.2017.09.030; Yamada T, 2016, NAT IMMUNOL, V17, P687, DOI 10.1038/ni.3422; Yamashita A, 2013, GENES CELLS, V18, P161, DOI 10.1111/gtc.12033; Yamashita H, 1999, J BIOL CHEM, V274, P29897, DOI 10.1074/jbc.274.42.29897; Yan LZ, 2005, MOL PHARMACOL, V67, P1513, DOI 10.1124/mol.105.011064; Yan QS, 2009, MOL CELL, V36, P110, DOI 10.1016/j.molcel.2009.08.019; Yankner BA, 2008, ANNU REV PATHOL-MECH, V3, P41, DOI 10.1146/annurev.pathmechdis.2.010506.092044; Yorikawa C, 2005, BIOCHEM J, V387, P17, DOI 10.1042/BJ20041227; Yoshida Y, 2014, IMMUNITY, V40, P187, DOI 10.1016/j.immuni.2013.11.022; Yoshihara M, 2005, SCIENCE, V310, P858, DOI 10.1126/science.1117541; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zampese E, 2011, P NATL ACAD SCI USA, V108, P2777, DOI 10.1073/pnas.1100735108; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang PZ, 2010, J BIOL CHEM, V285, P8869, DOI 10.1074/jbc.M109.063321; ZHANG Q, 1994, MOL CELL BIOL, V14, P3915, DOI 10.1128/MCB.14.6.3915; Zhang XC, 2009, NEURON, V64, P173, DOI 10.1016/j.neuron.2009.08.018; Zhang Y, 2015, NAT IMMUNOL, V16, P1215, DOI 10.1038/ni.3279; Zhdanov DD, 2015, DNA CELL BIOL, V34, P316, DOI 10.1089/dna.2014.2772; Zheng K, 2010, P NATL ACAD SCI USA, V107, P11841, DOI 10.1073/pnas.1003953107	316	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252647	10.1371/journal.pone.0252647	http://dx.doi.org/10.1371/journal.pone.0252647			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34116561	Green Published, gold			2022-12-26	WOS:000664643000026
J	Gravelsins, L; Duncan, K; Einstein, G				Gravelsins, Laura; Duncan, Katherine; Einstein, Gillian			Do oral contraceptives affect young women's memory? Dopamine-dependent working memory is influenced by COMT genotype, but not time of pill ingestion	PLOS ONE			English	Article							COGNITIVE CONTROL; MENSTRUAL-CYCLE; AGE-DIFFERENCES; PERFORMANCE; MECHANISMS; ESTROGEN; OOPHORECTOMY; POLYMORPHISM; DEMENTIA; RISK	Background Despite the widespread use of oral contraceptives (OCs), and the well-documented influence of estrogens, notably 17 beta-estradiol (E2), on cognition, research relating OCs to working memory is limited and mixed. Two factors may contribute to these mixed findings: 1) pharmacokinetics of oral contraceptives, which drive fluctuations in synthetic hormone levels; and 2) genetic polymorphisms related to dopamine degradation and working memory, which interact with E2. This research investigated whether the pharmacokinetics of oral contraceptives, in concert with the single nucleotide polymorphism (Val(158)Met; rs4680) of the catechol-o-methyltransferase gene (COMT), influence working memory performance. Methods University-age women taking and not taking OCs were tested for working memory and genotyped for COMT. If they were not taking OCs (n = 62), sessions occurred in the early follicular (low E2) and late follicular (high E2) phase. If they were taking OCs (n = 52), sessions occurred 1-2 hours after (high ethinyl estradiol, EE) and similar to 24 hours after (low EE) pill ingestion. Working memory was tested using the N-back, AX-CPT, Digit Span, and Digit Ordering Tasks. Data were analyzed using multilevel models with estrogen condition, COMT, and group as predictors, controlling for mood and practice effects. Results For women taking OCs, time of pill ingestion did not influence performance. However, the subgroup with COMT val/val (low dopamine) were less accurate on 2-back lure trials than those with COMT met/met (high dopamine). For women not taking OCs, cycle phase moderated COMT's influence on lure accuracy. When compared, women taking OCs had higher AX-CPT proactive control indices than those not taking OCs. Conclusion These findings suggest that oral contraceptives are not detrimental for young women's working memory and that they may increase proactive control. The more pronounced effects of COMT in women taking OCs suggests that, in women taking OCs, suppressed endogenous E2-not fluctuating EE levels-may be more relevant for working memory. Future studies are needed to differentiate effects of endogenous versus synthetic estrogens on working memory.	[Gravelsins, Laura; Duncan, Katherine; Einstein, Gillian] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Einstein, Gillian] Baycrest Hosp, Rotman Res Inst, Toronto, ON, Canada; [Einstein, Gillian] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Einstein, Gillian] Linkoping Univ, Ctr Med Image Sci CMIV, Linkoping, Ostergotland, Sweden; [Einstein, Gillian] Linkoping Univ, Dept Gender Studies, Linkoping, Ostergotland, Sweden	University of Toronto; University of Toronto; University Toronto Affiliates; Baycrest; University of Toronto; Linkoping University; Linkoping University	Gravelsins, L (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.	laura.gravelsins@mail.utoronto.ca		Einstein, Gillian/0000-0002-0770-5471	Wilfred and Joyce Posluns Chair in Women's Brain Health and Aging from the Posluns Family Foundation; Canadian Institutes of Health Research (CIHR); Ontario Brain Institute; Alzheimer Society of Canada [WJP-150643]; CIHR Masters Award; Jacqueline Ford Gender and Health Fund	Wilfred and Joyce Posluns Chair in Women's Brain Health and Aging from the Posluns Family Foundation; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ontario Brain Institute; Alzheimer Society of Canada; CIHR Masters Award(Canadian Institutes of Health Research (CIHR)); Jacqueline Ford Gender and Health Fund	This work was supported by the Wilfred and Joyce Posluns Chair in Women's Brain Health and Aging from the Posluns Family Foundation, Canadian Institutes of Health Research (CIHR), Ontario Brain Institute, and Alzheimer Society of Canada to GE (grant WJP-150643) and a CIHR Masters Award to LG. CIHR website: https://cihr-irsc.gc.ca/, and Jacqueline Ford Gender and Health Fund to GE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138; Braver TS, 2012, TRENDS COGN SCI, V16, P106, DOI 10.1016/j.tics.2011.12.010; Braver TS, 2009, P NATL ACAD SCI USA, V106, P7351, DOI 10.1073/pnas.0808187106; Braver TS, 2002, NEUROSCI BIOBEHAV R, V26, P809, DOI 10.1016/S0149-7634(02)00067-2; Buckert M, 2012, PSYCHONEUROENDOCRINO, V37, P1810, DOI 10.1016/j.psyneuen.2012.03.014; Colzato LS, 2010, NEUROSCIENCE, V167, P709, DOI 10.1016/j.neuroscience.2010.02.029; Cools R, 2011, BIOL PSYCHIAT, V69, pE113, DOI 10.1016/j.biopsych.2011.03.028; Daniels K, 2018, CURRENT CONTRACEPTIV; DiLiberti CE, 2011, CONTRACEPTION, V83, P55, DOI 10.1016/j.contraception.2010.06.015; Floresco SB, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00062; Galea LAM, 2017, NEUROSCI BIOBEHAV R, V76, P363, DOI 10.1016/j.neubiorev.2016.03.024; Garzon S, 2021, EXPERT OPIN DRUG DEL, V18, P355, DOI 10.1080/17425247.2021.1829589; Gervais NJ, 2020, NEUROBIOL AGING, V94, P1, DOI 10.1016/j.neurobiolaging.2020.04.019; Gogos A, 2014, NEUROCHEM RES, V39, P2288, DOI 10.1007/s11064-014-1444-6; Gravelsins L., 2020, OSF, DOI [10.17605/OSF.IO/35U6H, DOI 10.17605/OSF.IO/35U6H]; Grigorova M, 2006, PSYCHONEUROENDOCRINO, V31, P935, DOI 10.1016/j.psyneuen.2006.05.004; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; HAMPSON E, 1990, BRAIN COGNITION, V14, P26, DOI 10.1016/0278-2626(90)90058-V; Jacobs E, 2011, J NEUROSCI, V31, P5286, DOI 10.1523/JNEUROSCI.6394-10.2011; Jones RK, 2011, BIRTH CONTROL OVERLO; KILLICK SR, 1989, FERTIL STERIL, V52, P580; KIRCHNER WK, 1958, J EXP PSYCHOL, V55, P352, DOI 10.1037/h0043688; Madden T, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.01.051; Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652; MAY CP, 1993, PSYCHOL SCI, V4, P326, DOI 10.1111/j.1467-9280.1993.tb00573.x; MISHELL DR, 1972, AM J OBSTET GYNECOL, V114, P923, DOI 10.1016/0002-9378(72)90098-1; Moustafa AA, 2008, NEUROPSYCHOLOGIA, V46, P3144, DOI 10.1016/j.neuropsychologia.2008.07.011; Papaleo F, 2015, EUR NEUROPSYCHOPHARM, V25, P2349, DOI 10.1016/j.euroneuro.2015.10.005; Peragine D, 2020, PSYCHONEUROENDOCRINO, V115, DOI 10.1016/j.psyneuen.2019.104488; Petersen N, 2014, NEUROIMAGE, V90, P24, DOI 10.1016/j.neuroimage.2013.12.016; PETRIDES M, 1993, P NATL ACAD SCI USA, V90, P878, DOI 10.1073/pnas.90.3.878; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P485, DOI 10.1016/0306-4530(92)90007-T; Pletzer B, 2010, BRAIN RES, V1348, P55, DOI 10.1016/j.brainres.2010.06.019; R Core Team, 2020, R LANG ENV STAT COMP; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; REISBERG D, 1984, J EXP PSYCHOL LEARN, V10, P203; Rocca WA, 2007, NEUROLOGY, V69, P1074, DOI 10.1212/01.wnl.0000276984.19542.e6; Rodriguez-Jimenez R, 2009, BEHAV BRAIN RES, V205, P299, DOI 10.1016/j.bbr.2009.08.022; Rosa EC, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-53; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Rotermann M., 2015, ORAL CONTRACEPTIVE U; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shanmugan S, 2014, HUM BRAIN MAPP, V35, P847, DOI 10.1002/hbm.22218; Skovlund C, 2016, JAMA PSYCHIAT, V73, P1154, DOI 10.1001/jamapsychiatry.2016.2387; Taylor CM, 2021, FRONT NEUROENDOCRIN, V60, DOI 10.1016/j.yfrne.2020.100874; van Heusden AM, 2002, HUM REPROD UPDATE, V8, P345, DOI 10.1093/humupd/8.4.345; Wang Y, 2013, GENES BRAIN BEHAV, V12, P323, DOI 10.1111/gbb.12022; Warren AM, 2014, CONTRACEPTION, V90, P111, DOI 10.1016/j.contraception.2014.03.015; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; Wharton W, 2008, EXP CLIN PSYCHOPHARM, V16, P156, DOI 10.1037/1064-1297.16.2.156	51	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252807	10.1371/journal.pone.0252807	http://dx.doi.org/10.1371/journal.pone.0252807			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111174	gold, Green Published			2022-12-26	WOS:000664642700045
J	Saikia, U; Dodd, MM; Chalmers, J; Dasvarma, G; Schech, S				Saikia, Udoy; Dodd, Melinda M.; Chalmers, James; Dasvarma, Gouranga; Schech, Susanne			COVID-19, individual wellbeing and multi-dimensional poverty in the state of South Australia	PLOS ONE			English	Article								Research efforts in the initial months of the COVID-19 pandemic focused on the actual and potential impacts on societies, economies, sectors, and governments. Less attention was paid to the experiences of individuals and less still to the impact of COVID-19 on an individual's wellbeing. This research addresses this gap by utilising a holistic wellbeing framework to examine the impact of COVID-19 on the overall wellbeing of individuals in the Australian state of South Australia through an online survey. The research framework for the survey comprises six dimensions: psychological and emotional health, physical health, living standards, family and community vitality, governance, and ecological diversity and resilience. The results show that most respondents (71%) were able to maintain overall wellbeing during the pandemic. However, more than a half of the respondents could not maintain wellbeing in psychological and emotional health. Further examination of the drivers of inability to maintain overall wellbeing reveals that low-income individuals, younger respondents (aged 18-24) and women suffer disproportionate hardships. Defining poverty in terms of multi-dimensional deprivations in wellbeing enables a nuanced analysis of the unequal impacts of COVID-19 mitigation policies that can be used to improve policymaking.	[Saikia, Udoy; Dodd, Melinda M.; Chalmers, James; Dasvarma, Gouranga; Schech, Susanne] Flinders Univ S Australia, Coll Humanities Arts & Social Sci, Adelaide, SA, Australia	Flinders University South Australia	Saikia, U (corresponding author), Flinders Univ S Australia, Coll Humanities Arts & Social Sci, Adelaide, SA, Australia.	udoy.saikia@flinders.edu.au		Dasvarma, Gouranga/0000-0002-1784-7967; Saikia, Udoy/0000-0001-5572-3925; Dodd, Melinda/0000-0001-9219-7493	Flinders University, Australia through Flinders University Covid Research Grant 2020; Flinders University Human Research Ethics Committee [2192]	Flinders University, Australia through Flinders University Covid Research Grant 2020; Flinders University Human Research Ethics Committee	The research was funded by Flinders University, Australia (https://flinders.edu.au/) through Flinders University Covid Research Grant 2020 with the approval from Flinders University Human Research Ethics Committee, Project ID: 2192, Project Title: Impact of COVID-19 on the wellbeing of individuals in South Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkire S, 2011, MULTIDIMENSIONAL POV; Alkire S, 2011, J PUBLIC ECON, V95, P476, DOI 10.1016/j.jpubeco.2010.11.006; [Anonymous], 1999, DEV FREEDOM; Australian Bureau of Statistics (ABS), 2016, 2016 CENS QUICKST; Australian Bureau of Statistics (ABS), 2016, SEX GEND DIV 2016 CE; Australian Government, 2020, EMPL PAY LEAV ENT; Australian Government Department of Health, PHYS HLTH; Biddle N, 2020, HARDSHIPS DISTRESS R; Black Dog Institute,, 2020, MENT HLTH RAM COVID; Calder Philip C, 2020, BMJ Nutr Prev Health, V3, P74, DOI 10.1136/bmjnph-2020-000085; Canadian Mental Health Association, CONN MENT PHYS HLTH; Dawel A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.579985; Gates M., 2020, FOREIGN AFF; Gee M., 2020, PC WORLD; Grixti S., 2020, PRESS START; Henriques-Gomes L., 2020, GUARDIAN 0927; Lamu AN, 2016, SOC SCI MED, V152, P176, DOI 10.1016/j.socscimed.2016.01.046; Lynch A, 2020, COVID 19 ITS IMPACT; Melbourne Institute, 2020, JOBL DISTR DISPR EFF; Mlambo-Ngcuka P., 2020, VIOLENCE WOMEN GIRLS; Narayan D., 2000, VOICES POOR CRYING O; OPHI (Oxford Poverty and Human Development Initiative), BHUT GROSS NAT HAPP; Parker K., 2020, HALF LOWER INCOME AM; Parker K., 2020, EC FALLOUT COVID 19; Pash C., 2020, ADNEWS; Rajkumar RP, 2020, ASIAN J PSYCHIATR, V52, DOI 10.1016/j.ajp.2020.102066; Rath T., 2010, EC WELLBEING; Sacco Matteo Antonio, 2020, Med Leg J, V88, P71, DOI 10.1177/0025817220930553; Saikia U., 2018, TIMOR LESTE NATL HUM; Saikia U, 2018, HANDB STAT, V39, P545, DOI 10.1016/bs.host.2018.06.008; Schaeffer K., 2020, EXPERIENCES COVID 19; Stewart F, 2002, UNU WIDER ANN LECT; United Nations Department of Economic and Social Affairs (UN DESA), SOC IMP COVID 19; United Nations Department of Economic and Social Affairs (UN DEST), 2020, ISS BRIEF OLD PERS C; United Nations Department of Economics of Social Affairs (UN DESA), 2020, EV INCL SOC IMP COVI; United Nations Entity for Gender Equality and the Empowerment of Women (UN Women), 2020, COVID 19 END VIOL WO; Waage J, 2010, LANCET, V376, P991, DOI 10.1016/S0140-6736(10)61196-8; World Bank Group, 2020, EC SOC IMP COVID 19; World Health Organisation, 2004, SUMM REP PROM MENT H	39	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252898	10.1371/journal.pone.0252898	http://dx.doi.org/10.1371/journal.pone.0252898			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111173	gold, Green Published			2022-12-26	WOS:000664642700059
J	Schaefer, EJ; Dulipsingh, L; Comite, F; Jimison, J; Grajower, MM; Lebowitz, NE; Lang, M; Geller, AS; Diffenderfer, MR; He, LH; Breton, G; Dansinger, ML; Saida, B; Yuan, C				Schaefer, Ernst J.; Dulipsingh, Latha; Comite, Florence; Jimison, Jessica; Grajower, Martin M.; Lebowitz, Nathan E.; Lang, Maxine; Geller, Andrew S.; Diffenderfer, Margaret R.; He, Lihong; Breton, Gary; Dansinger, Michael L.; Saida, Ben; Yuan, Chong			Corona Virus Disease-19 serology, inflammatory markers, hospitalizations, case finding, and aging	PLOS ONE			English	Article								Most deaths from severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection occur in older subjects. We assessed the utility of serum inflammatory markers interleukin-6 (IL-6), C reactive protein (CRP), and ferritin (Roche, Indianapolis, IN), and SARS-CoV-2 immunoglobulin G (IgG), immunoglobulin M (IgM), and neutralizing antibodies (Diazyme, Poway, CA). In controls, non-hospitalized subjects, and hospitalized subjects assessed for SARS-CoV-2 RNA (n = 278), median IgG levels in arbitrary units (AU)/mL were 0.05 in negative subjects, 14.83 in positive outpatients, and 30.61 in positive hospitalized patients (P<0.0001). Neutralizing antibody levels correlated significantly with IgG (r = 0.875; P<0.0001). Having combined values of IL-6 >= 10 pg/mL and CRP >= 10 mg/L occurred in 97.7% of inpatients versus 1.8% of outpatients (odds ratio 3,861, C statistic 0.976, P = 1.00 x 10(-12)). Antibody or ferritin levels did not add significantly to predicting hospitalization. Antibody testing in family members and contacts of SARS-CoV-2 RNA positive cases (n = 759) was invaluable for case finding. Persistent IgM levels were associated with chronic COVID-19 symptoms. In 81,624 screened subjects, IgG levels were positive (>= 1.0 AU/mL) in 5.21%, while IgM levels were positive in 2.96% of subjects. In positive subjects median IgG levels in AU/mL were 3.14 if <30 years of age, 4.38 if 30-44 years of age, 7.89 if 45-54 years of age, 9.52 if 55-64 years of age, and 10.64 if <greater than or equal to>65 years of age (P = 2.96 x 10(-38)). Our data indicate that: 1) combined IL-6 >= 10 pg/mL and CRP >= 10 mg/L identify SARS-CoV-2 positive subjects requiring hospitalization; 2) IgG levels were significantly correlated with neutralizing antibody levels with a wide range of responses; 3) IgG levels have significant utility for case finding in exposed subjects; 4) persistently elevated IgM levels are associated with chronic symptoms; and 5) IgG levels are significantly higher in positive older subjects than their younger counterparts.	[Schaefer, Ernst J.; Lang, Maxine; Geller, Andrew S.; Diffenderfer, Margaret R.; He, Lihong] Boston Heart Diagnost, Eurofins Sci Network, Lab Div, Framingham, MA 01702 USA; [Schaefer, Ernst J.; Dansinger, Michael L.] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA; [Dulipsingh, Latha] St Francis Hosp & Med Ctr, Trinity Hlth New England, Div Diabet & Endocrinol, Hartford, CT USA; [Dulipsingh, Latha] Univ Connecticut, Sch Med, Dept Med, Farmington, CT USA; [Comite, Florence] Com Ctr Precis Med & Hlth, Clin Care, New York, NY USA; [Comite, Florence] Lenox Hill Hosp Northwell, Dept Internal Med, Endocrinol Metab Diabet, New York, NY USA; [Jimison, Jessica] Atkinson Family Practice, Clin Care, Amherst, MA USA; [Grajower, Martin M.] Albert Einstein Coll Med, Dept Med Endocrinol, Bronx, NY 10467 USA; [Lebowitz, Nathan E.] Adv Cardiol Inst, Clin Care, Ft Lee, NJ USA; [Breton, Gary; Dansinger, Michael L.] Boston Heart Diagnost, Eurofins Sci Network, Clin Affairs Div, Framingham, MA USA; [Saida, Ben; Yuan, Chong] Diazyme Labs Inc, Res Div, Poway, CA USA	Tufts University; Saint Francis Hospital & Medical Center; University of Connecticut; Yeshiva University; Albert Einstein College of Medicine	Schaefer, EJ (corresponding author), Boston Heart Diagnost, Eurofins Sci Network, Lab Div, Framingham, MA 01702 USA.; Schaefer, EJ (corresponding author), Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA.	eschaefer@bostonheartdx.com			Boston Heart Diagnostics, Framingham, MA; Comite Center for Precision Medicine and Health, New York, NY, Atkinson Family Practice, Amherst; St. Francis Hospital, Trinity Health of New England, Hartford, Ct; Comite Center for Precision Medicine and Health, New York, NY; Atkinson Family Practice, Amherst, MA; Advanced Cardiology Institute, Fort Lee, NJ; Diazyme Laboratories, Poway, CA	Boston Heart Diagnostics, Framingham, MA; Comite Center for Precision Medicine and Health, New York, NY, Atkinson Family Practice, Amherst; St. Francis Hospital, Trinity Health of New England, Hartford, Ct; Comite Center for Precision Medicine and Health, New York, NY; Atkinson Family Practice, Amherst, MA; Advanced Cardiology Institute, Fort Lee, NJ; Diazyme Laboratories, Poway, CA	This research was funded by Boston Heart Diagnostics, Framingham, MA, St. Francis Hospital, Trinity Health of New England, Hartford, Ct, Comite Center for Precision Medicine and Health, New York, NY, Atkinson Family Practice, Amherst, MA, Advanced Cardiology Institute, Fort Lee, NJ, and Diazyme Laboratories, Poway, CA. The authors were employees of Boston Heart Diagnostics (EJS, ML, ASG, MRD, LH, GB, MLD, LH, GB, MLD), Trinity Health of New New England (LD) Comite Center for Precision Medicine and Health (FC), Atkinson Family Practice (JJ), Grajower Medical Practice (MMG), Advanced Cardiology Institute (NEL), and Diazyme Laboratories (BS, CY). The funders provided support in the form of salaries for authors but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams Emily R, 2020, Wellcome Open Res, V5, P139, DOI 10.12688/wellcomeopenres.15927.1; Aspinall R, 2003, MICROSC RES TECHNIQ, V62, P508, DOI 10.1002/jemt.10412; Chen G, 2020, J CLIN INVEST, V130, P2620, DOI 10.1172/JCI137244; Deeks JJ, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013652; Dulipsingh L, 2020, TRANSFUS APHER SCI, V59, DOI 10.1016/j.transci.2020.102922; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Havers FP, 2020, JAMA INTERN MED, V180, P1576, DOI 10.1001/jamainternmed.2020.4130; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Herold T, 2020, J ALLERGY CLIN IMMUN, V146, P128, DOI 10.1016/j.jaci.2020.05.008; Ibrahim D, 2020, INFECT DIS THER, V9, P913, DOI 10.1007/s40121-020-00341-2; Juul S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248132; Kleiboeker S, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104439; Lavergne V., 2021, INFECT DIS SOC AM; Leisman DE, 2020, LANCET RESP MED, V8, P1233, DOI 10.1016/S2213-2600(20)30404-5; Li L, 2020, JAMA-J AM MED ASSOC, V324, P460, DOI 10.1001/jama.2020.10044; Lippi G, 2020, CLIN CHEM LAB MED, V58, P1156, DOI 10.1515/cclm-2020-0473; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Muruato Antonio E, 2020, bioRxiv, DOI 10.1101/2020.05.21.109546; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Ren LL, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01526-8; Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Schaefer EJ., 2020, 20172957V2 MEDRXIV, DOI [10.1101/20172957, DOI 10.1101/20172957]; Schaefer EJ., 2021, 21249604V1 MEDRXIV, DOI [10.1101/21249604, DOI 10.1101/21249604]; Shen CG, 2020, JAMA-J AM MED ASSOC, V323, P1582, DOI 10.1001/jama.2020.4783; Suhandynata RT, 2020, J APPL LAB MED, V5, P1324, DOI 10.1093/jalm/jfaa139; Suhandynata RT, 2020, J APPL LAB MED, V5, P908, DOI 10.1093/jalm/jfaa079; Tang MS, 2020, CLIN CHEM, V66, P1538, DOI 10.1093/clinchem/hvaa211; To KKW, 2020, LANCET INFECT DIS, V20, P565, DOI 10.1016/S1473-3099(20)30196-1; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Weitz JS, 2020, NAT MED, V26, P849, DOI 10.1038/s41591-020-0895-3; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wong GCL, 2020, INTERD T GERONT GERI, V43, P36, DOI 10.1159/000504487; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	37	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252818	10.1371/journal.pone.0252818	http://dx.doi.org/10.1371/journal.pone.0252818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111164	gold, Green Published			2022-12-26	WOS:000664642700047
J	Tolossa, T; Wakuma, B; Gebre, DS; Atomssa, EM; Getachew, M; Fetensa, G; Ayala, D; Turi, E				Tolossa, Tadesse; Wakuma, Bizuneh; Gebre, Dejene Seyoum; Atomssa, Emiru Merdassa; Getachew, Motuma; Fetensa, Getahun; Ayala, Diriba; Turi, Ebisa			Time to recovery from COVID-19 and its predictors among patients admitted to treatment center of Wollega University Referral Hospital (WURH), Western Ethiopia: Survival analysis of retrospective cohort study	PLOS ONE			English	Article								Introduction Despite its alarming spread throughout the world, no effective drug and vaccine is discovered for COVID-19 so far. According to WHO, the recovery time from COVID-19 was estimated to be 2 weeks for patients with mild infection, and 3 to 6 weeks for those with serious illnesses. A studies regarding the median recovery time and its predictors are limited globally and specifically in Ethiopia. Therefore, the aim of this study was to estimate the median time to recovery from COVID-19 and its predictors among COVID-19 cases admitted to WURH, Western Ethiopian. Methods This was a hospital-based retrospective cohort study conducted among 263 adult patients admitted with COVID-19 in WURH treatment center from March 29, 2020 through September 30, 2020. Epidata version 3.2 was used for data entry, and STATA version 14 for analysis. A Cox proportional hazard regression model was fitted to determine factors associated with recovery time. A variable with P-value <= 0.25 at bivariable Cox regression analysis were selected for multivariable Cox proportional model. Multivariable Cox regression model with 95% CI and Adjusted Hazard Ratio (AHR) was used to identify a significant predictor of time to recovery from COVID-19 at P-value < 0.05. Results The mean age of patient was 36.8 (SD 10.68) years. At the end of follow up, two hundred twenty seven observations were developed an event (recovered) with median time to recovery of 18 days with IQR of 10-27 days. The overall incidence rate of recovery was of 4.38 per 100 (95% CI: 3.84, 4.99) person-days observations. Being older age (AHR = 1.59, 95% CI: 1.02, 2.49), presence of fever on admission (AHR = 1.78, 95% CI: 1.21, 2.62), and comorbidity (AHR = 0.56, 95% CI, 0.34, 0.90) were found to have statistically significant association with recovery time. Conclusion and recommendations In general, the median recovery time of patients with COVID-19 cases was long, and factors such as older age group, presence of fever, and comorbidity was an independent predictors of delayed recovery from COVID-19. Intervention to further reduce recovery time at treatment center has to focus on patients those shows symptoms and with comorbidities.	[Tolossa, Tadesse; Gebre, Dejene Seyoum; Atomssa, Emiru Merdassa; Getachew, Motuma; Turi, Ebisa] Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia; [Wakuma, Bizuneh; Fetensa, Getahun] Wollega Univ, Inst Hlth Sci, Dept Nursing, Nekemte, Ethiopia; [Ayala, Diriba] Wollega Univ, Inst Hlth Sci, Dept Midwifery, Nekemte, Ethiopia		Tolossa, T (corresponding author), Wollega Univ, Inst Hlth Sci, Dept Publ Hlth, Nekemte, Ethiopia.	yadanotolasa@gmail.com	Hirko, Getahun Fetensa/ABY-0109-2022	Gebre, Dejene Seyoum/0000-0002-5195-1389; Tolasa, Tadesse/0000-0002-7936-9024				Abrahim SA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244269; Bhapkar HR, 2020, J MED SYST, V44, DOI 10.1007/s10916-020-01668-6; Boari GEM, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20203455; Chen XD, 2020, INT J INFECT DIS, V98, P252, DOI 10.1016/j.ijid.2020.06.091; Chinnadurai R, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01803-5; Daniels LB, 2020, AM J CARDIOL, V136, P149, DOI 10.1016/j.amjcard.2020.09.012; Das AK, 2020, PULM MED, V2020, DOI 10.1155/2020/7291698; Du RH, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00524-2020; Hu XW, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138812; Huang C, 2020, LANCET, V395, P496, DOI 10.1016/S0140-6736(20)30252-X; Ioannidis JPA, 2021, B WORLD HEALTH ORGAN, V99, P19, DOI 10.2471/BLT.20.265892; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Leulseged T.W., 2020, MEDRXIV; Organization W.H, 2020, WHO CORONAVIRUS DIS; Ortiz-Prado E, 2020, DIAGN MICR INFEC DIS, V98, DOI 10.1016/j.diagmicrobio.2020.115094; Pamuk S., 2020, TURKISH J EAR NOSE T, V30, P1, DOI DOI 10.5606/TR-ENT.2020.25338; Qi L, 2020, INT J INFECT DIS, V96, P531, DOI 10.1016/j.ijid.2020.05.045; Ruan QR, 2020, INTENS CARE MED, V46, P846, DOI 10.1007/s00134-020-05991-x; Rubini A, 2011, RESP PHYSIOL NEUROBI, V175, P255, DOI 10.1016/j.resp.2010.11.012; Voinsky I, 2020, J INFECTION, V81, pE102, DOI 10.1016/j.jinf.2020.05.026; Wu J, 2020, J INTERN MED, V288, P128, DOI 10.1111/joim.13063; Xie J, 2021, DIABETES CARE, V44, P188, DOI 10.2337/dc20-1714; Xu JQ, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03098-9; Xu KJ, 2020, CLIN INFECT DIS, V71, P799, DOI 10.1093/cid/ciaa351; Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204	26	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252389	10.1371/journal.pone.0252389	http://dx.doi.org/10.1371/journal.pone.0252389			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111146	gold, Green Published			2022-12-26	WOS:000664642700025
J	Udugampolage, N; Caruso, R; Panetta, M; Callus, E; Dellafiore, F; Magon, A; Marelli, S; Pini, A				Udugampolage, Nathasha; Caruso, Rosario; Panetta, Mariangela; Callus, Edward; Dellafiore, Federica; Magon, Arianna; Marelli, Susan; Pini, Alessandro			Is SF-12 a valid and reliable measurement of health-related quality of life among adults with Marfan syndrome? A confirmatory study	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; SF-36	Introduction The structural validity and reliability of the Short-Form Health Survey 12 (SF-12) has not yet been tested in adults with the Marfan syndrome (MFS). This gap could undermine an evidence-grounded practice and research, especially considering that the need to assess health-related quality of life in patients with MFS has increased due to the improved life expectancy of these patients and the need to identify their determinants of quality of life. For this reason, this study aimed to confirm the dimensionality (structural validity) of the SF-12, its concurrent validity, and its reliability (internal consistency). Methods We performed a cross-sectional study in a convenience sample of 111 Italian adults with MFS, collecting anamnestic and socio-demographic information, the SF-12, and short-form Health Survey 36 (SF-36). A confirmatory factor analysis was performed to verify whether the items of SF-12 related to physical restrictions, physical functioning, and bodily pain were retained by the physical summary component of the SF-12. The items referred to the role limitations due to emotional issues, social functioning, and mental health were retained by the mental summary component (MCS12). SF-36 was used to assess the concurrent validity of SF-12, hypothesizing positive correlations among the equivalent summary scores. Results The two-factor structural solution resulted in fitting the sample statistics adequately. The internal consistency was adequate for the two factors. Furthermore, the physical and mental summary scores of the SF-36 were positively correlated with their equivalent summary scores derived from the SF-12. Conclusions This study confirmed the factor structure of the SF-12. Therefore, the use of SF-12 in clinical practice and research for assessing the health-related quality of life among adults with MFS is evidence-grounded. Future research is recommended to determine whether the SF-12 shows measurement invariance in different national contexts and determine eventual demographic variation in the SF-12 scores among patients with MFS.	[Udugampolage, Nathasha; Panetta, Mariangela; Marelli, Susan; Pini, Alessandro] IRCCS Policlin San Donato, Cardiovasc Genet Ctr, San Donato Milanese, Italy; [Caruso, Rosario; Dellafiore, Federica; Magon, Arianna] IRCCS Policlin San Donato, Hlth Profess Res & Dev Unit, San Donato Milanese, Italy; [Callus, Edward] IRCCS Policlin San Donato, Clin Psychol Serv, Milan, Italy; [Callus, Edward] Univ Milan, Dept Biomed Sci Hlth, Milan, Italy	IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; IRCCS Policlinico San Donato; University of Milan	Udugampolage, N (corresponding author), IRCCS Policlin San Donato, Cardiovasc Genet Ctr, San Donato Milanese, Italy.	rosario.caruso@grupposandonato.it	Udugampolage, Nathasha Samali/ABD-6169-2020; Marelli, Susan/AAB-5906-2021; Pini, Alessandro/AAG-2020-2020; Callus, Edward/G-3246-2018	Udugampolage, Nathasha Samali/0000-0002-9013-9326; Pini, Alessandro/0000-0002-8325-6057; Magon, Arianna/0000-0003-0440-6940; Caruso, Rosario/0000-0002-7736-6209; Callus, Edward/0000-0001-9286-1825	`Ricerca Corrente' funds of IRCCS Policlinico San Donato	`Ricerca Corrente' funds of IRCCS Policlinico San Donato	This research was partially supported by `Ricerca Corrente' funds of IRCCS Policlinico San Donato. There was no additional external funding received for this study.	Apolone G, 1998, J CLIN EPIDEMIOL, V51, P1025, DOI 10.1016/S0895-4356(98)00094-8; Cham H, 2017, MULTIVAR BEHAV RES, V52, P12, DOI 10.1080/00273171.2016.1245600; Dellafiore F, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030917; Fleishman JA, 2003, MED CARE, V41, P75, DOI 10.1097/01.MLR.0000076052.42628.CF; Fusar-Poli P, 2008, PSYCHOSOMATICS, V49, P243, DOI 10.1176/appi.psy.49.3.243; Galenkamp H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203483; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Goldfinger JZ, 2017, J AM COLL CARDIOL, V69, P2821, DOI 10.1016/j.jacc.2017.04.026; Jakobsson U, 2012, J EVAL CLIN PRACT, V18, P560, DOI 10.1111/j.1365-2753.2010.01623.x; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Larson CO, 2002, HEALTH SERV RES, V37, P733, DOI 10.1111/1475-6773.00046; Loeys BL, 2010, J MED GENET, V47, P476, DOI 10.1136/jmg.2009.072785; Magon A, 2020, HEALTH QUAL LIFE OUT, V18, DOI 10.1186/s12955-020-01326-y; Maurischat C, 2008, PSYCHOL SCI Q; Maurischat C., 2008, PSYCHOL SCI Q, V50, P7; Montazeri A, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-12; Moon JR, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0488-5; Nielsen C, 2019, J PEDIATR GENET, V8, P109, DOI 10.1055/s-0039-1693663; Okonkwo OC, 2010, QUAL LIFE RES, V19, P1323, DOI 10.1007/s11136-010-9691-8; Pickard AS, 1999, STROKE, V30, P1213, DOI 10.1161/01.STR.30.6.1213; Pyeritz RE, 2000, ANNU REV MED, V51, P481, DOI 10.1146/annurev.med.51.1.481; Ratiu I, 2018, QUAL LIFE RES, V27, P2057, DOI 10.1007/s11136-018-1859-7; Steiger JH, 2007, PERS INDIV DIFFER, V42, P893, DOI 10.1016/j.paid.2006.09.017; Suh Y, 2015, STRUCT EQU MODELING, V22, P568, DOI 10.1080/10705511.2014.937669; Terwee CB, 2007, J CLIN EPIDEMIOL, V60, P34, DOI 10.1016/j.jclinepi.2006.03.012; Vanem TT, 2018, MOL GENET GENOM MED, V6, P1114, DOI 10.1002/mgg3.489; Tucker G, 2010, QUAL LIFE RES, V19, P1069, DOI 10.1007/s11136-010-9658-9; Velvin G, 2015, CLIN GENET, V87, P109, DOI 10.1111/cge.12422; Velvin G, 2016, QUAL LIFE RES, V25, P1779, DOI 10.1007/s11136-015-1214-1; WARE JE, 1994, INT J MENT HEALTH, V23, P49, DOI 10.1080/00207411.1994.11449283; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; White MK, 2018, QUAL LIFE RES, V27, P1757, DOI 10.1007/s11136-018-1851-2; Whittaker TA, 2012, J EXP EDUC, V80, P26, DOI 10.1080/00220973.2010.531299; Wilson D, 2002, SOZ PRAVENTIV MED, V47, P172; Xia Y, 2019, BEHAV RES METHODS, V51, P409, DOI 10.3758/s13428-018-1055-2	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252864	10.1371/journal.pone.0252864	http://dx.doi.org/10.1371/journal.pone.0252864			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106976	gold, Green Published			2022-12-26	WOS:000664642200061
J	Campos-do-Carmo, G; Nobre, AB; Cuzzi, T; Argenziano, G; Ferreira, CG; Thuler, LCS				Campos-do-Carmo, Gabriella; Nobre, Aretha Brito; Cuzzi, Tullia; Argenziano, Giuseppe; Ferreira, Carlos Gil; Santos Thuler, Luiz Claudio			Melanocytic lesions <= 6mm: Prospective series of 481 melanocytic trunk and limb lesions in Brazil	PLOS ONE			English	Article							MICRO-MELANOMA DETECTION; CUTANEOUS MELANOMA; SKIN-LESIONS; DIAMETER; DIAGNOSIS; DERMOSCOPY; BENIGN; SIZE	Early diagnosis when melanoma is still small and thin is essential for improving mortality and morbidity. However, the diagnosis of small size melanoma might be particularly difficult, not only clinically but also dermoscopically. This study aimed to define clinical and dermatoscopic parameters in the diagnosis of suspicious pigmented cutaneous lesions with a diameter of <= 6mm and determine the sensitivity, specificity, positive and negative predictive values as well as the accuracy of each clinical and dermatoscopic criterion. This is a transversal, descriptive and analytical study of dermatoscopic analysis with the gold standard being the pathologic examination obtained from the excisional biopsy of suspicious melanocytic lesions with a diameter of <= 6mm. Trunk and limb lesion data from a public health service and a private clinic were prospectively collected from 2011 to 2017 by a unique observer. In total, 481 melanocytic lesions were included, with 73.8% being <= 4mm in diameter. Overall, 123 were diagnosed as melanoma, 56.0% in situ and 22.0% as thin melanomas (Breslow index 0.1 to 1.0mm). Melanoma presented symmetry in 53.7% of cases, regular borders in 54.5% and a single color in 60.2%. Regarding evolution, 13.8% of melanomas versus 10.9% of benign lesions (p = 0.116) were new by comparing photos from baseline with photos from the follow-up. The majority of melanomas (65%) were found on the limbs compared to 37.2% of the benign lesions at this location (p<0.001). A multiple logistic regression model adjusted for age, gender and location was created. The independent variables associated with the diagnosis of melanoma <less than or equal to> 6mm, adjusted for age, gender and location, were: streaks (adjusted Odds Ratio [aOR] 2.5; 95% CI 1.3-4.7; p = 0.006), and the presence of a structureless area (aOR 2.2, 95% CI 1.2-4.0, p = 0.011). Conversely, a symmetric typical pigment network was a protection variable (aOR 0.4, 95% 0.7-0.9, p = 0.040). In conclusion, dermatoscopic criteria have been identified which help to diagnose cases of small size melanoma. These include streaks and structureless areas that can be taken, particularly in consideration for the diagnosis of this subset of small difficult melanomas.	[Campos-do-Carmo, Gabriella] Gavea Med Ctr, Rio De Janeiro, Brazil; [Nobre, Aretha Brito; Santos Thuler, Luiz Claudio] Natl Canc Inst, Rio De Janeiro, Brazil; [Cuzzi, Tullia] Univ Fed Rio de Janeiro, Rio De Janeiro, Brazil; [Argenziano, Giuseppe] Univ Campania, Dermatol Unit, Caserta, Italy; [Ferreira, Carlos Gil] Oncoclin Inst Res & Educ, Rio De Janeiro, Brazil	National Cancer Institute (Inca); Universidade Federal do Rio de Janeiro; Universita della Campania Vanvitelli	Campos-do-Carmo, G (corresponding author), Gavea Med Ctr, Rio De Janeiro, Brazil.	dragabriellacampos@gmail.com	Ferreira, Carlos Gil/AAD-4104-2020; Thuler, Luiz/C-8581-2016	Ferreira, Carlos Gil/0000-0002-7228-7018; Thuler, Luiz/0000-0003-2550-6537				Abbasi NR, 2008, ARCH DERMATOL, V144, P469, DOI 10.1001/archderm.144.4.469; Abbasi NR, 2004, JAMA-J AM MED ASSOC, V292, P2771, DOI 10.1001/jama.292.22.2771; American Cancer Society, 2018, CANC FACTS FIGURES 2; Annessi G, 2007, J AM ACAD DERMATOL, V56, P759, DOI 10.1016/j.jaad.2007.01.014; Benelli C, 2000, EUR J DERMATOL, V10, P282; Blum A, 2003, J AM ACAD DERMATOL, V48, P672, DOI 10.1067/mjd.2003.282; Bono A, 2006, BRIT J DERMATOL, V155, P570, DOI 10.1111/j.1365-2133.2006.07396.x; Bono A, 2004, TUMORI, V90, P128, DOI 10.1177/030089160409000125; Bono A, 1999, CANCER, V85, P72, DOI 10.1002/(SICI)1097-0142(19990101)85:1<72::AID-CNCR10>3.0.CO;2-Q; Bono A, 1999, MELANOMA RES, V9, P583, DOI 10.1097/00008390-199912000-00007; Bono A, 2008, TUMORI, V94, P11; Bono A, 2011, TUMORI, V97, P35, DOI 10.1177/030089161109700107; Braun-Falco M, 2003, J CLIN PATHOL, V56, P459, DOI 10.1136/jcp.56.6.459; Carli P, 2003, DERMATOLOGY, V206, P292, DOI 10.1159/000069939; de Giorgi V, 2012, MELANOMA RES, V22, P252, DOI 10.1097/CMR.0b013e3283527430; de Oliveira RS, 2015, EINSTEIN-SAO PAULO, V13, P506, DOI 10.1590/S1679-45082015AO3436; Drugge ED, 2018, J AM ACAD DERMATOL, V78, P182, DOI 10.1016/j.jaad.2017.07.049; Fernandez EM, 2004, DERMATOL SURG, V30, P1219, DOI 10.1111/j.1524-4725.2004.30379.x; Ferrara G, 2002, CANCER, V95, P1094, DOI 10.1002/cncr.10768; FRIEDMAN RJ, 1985, CA-CANCER J CLIN, V35, P130, DOI 10.3322/canjclin.35.3.130; Goldsmith SM, 2007, J EUR ACAD DERMATOL, V21, P929, DOI 10.1111/j.1468-3083.2006.02115.x; Gonzalez A, 1996, J CUTAN PATHOL, V23, P126, DOI 10.1111/j.1600-0560.1996.tb01285.x; Grichnik JM, 2001, DERMATOL CLIN, V19, P319, DOI 10.1016/S0733-8635(05)70269-2; Harrington E, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014096; Helsing P, 2004, BRIT J DERMATOL, V151, P1081, DOI 10.1111/j.1365-2133.2004.06248.x; KAMINO H, 1990, J AM ACAD DERMATOL, V22, P1032, DOI 10.1016/0190-9622(90)70147-A; Lallas A, 2018, JAMA DERMATOL, V154, P414, DOI 10.1001/jamadermatol.2017.6447; Pizzichetta MA, 2001, CANCER-AM CANCER SOC, V91, P992, DOI 10.1002/1097-0142(20010301)91:5<992::AID-CNCR1089>3.0.CO;2-I; Pupelli G, 2013, BRIT J DERMATOL, V168, P1027, DOI 10.1111/bjd.12212; Quintella DC, 2017, AN BRAS DERMATOL, V92, P375, DOI 10.1590/abd1806-4841.20175169; Rigel DS, 2010, CA-CANCER J CLIN, V60, P301, DOI 10.3322/caac.20074; Salerni Gabriel, 2015, Dermatol Pract Concept, V5, P31, DOI 10.5826/dpc.0504a08; Seidenari S, 2014, BRIT J DERMATOL, V171, P1006, DOI 10.1111/bjd.12542; Skvara H, 2005, ARCH DERMATOL, V141, P155, DOI 10.1001/archderm.141.2.155; Tognetti L, 2020, J EUR ACAD DERMATOL, V34, P640, DOI 10.1111/jdv.15923; Woltsche N, 2017, J DERMATOL, V44, P499, DOI 10.1111/1346-8138.13808	36	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252162	10.1371/journal.pone.0252162	http://dx.doi.org/10.1371/journal.pone.0252162			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101726	gold, Green Published			2022-12-26	WOS:000664641500010
J	Yin, JW; Julius, AA; Wen, JT				Yin, Jiawei; Julius, A. Agung; Wen, John T.			Optimization of light exposure and sleep schedule for circadian rhythm entrainment	PLOS ONE			English	Article							MELATONIN SUPPRESSION; NOCTURNAL LIGHT; ACTION SPECTRUM; MISTIMED SLEEP; RECOVERY; MODELS; PHASE; DEPRIVATION; SENSITIVITY; MODULATION	The circadian rhythm, called Process C, regulates a wide range of biological processes in humans including sleep, metabolism, body temperature, and hormone secretion. Light is the dominant synchronizer of the circadian rhythm-it has been used to regulate the circadian phase to cope with jet-lag, shift work, and sleep disorder. The homeostatic oscillation of the sleep drive is called Process S. Process C and Process S together determine the sleep-wake cycle in what is known as the two-process model. This paper addresses the regulation of both Process C and Process S by scheduling light exposure and sleep based on numerical simulations of circadian rhythm and sleep mathematical models. This is a significant step beyond the existing literature that only considers the entrainment of Process C. Regulation of the two-process model poses several unique features and challenges: 1. Process S is non-smooth, i.e., the homeostatic dynamics are different in the sleep and wake regimes; 2. Light only indirectly affects Process S through Process C; 3. Light does not affect Process C during sleep. We consider two scenarios: optimizing light intensity as the control input with spontaneous (i.e., unscheduled) sleep/wake times and jointly optimizing the light intensity and the sleep/wake times, which allows limited delayed sleep and early waking as part of the decision variables. We solve the time-optimal entrainment problem for the two-process model for both scenarios using an extension of the gradient descent algorithm to non-smooth systems. To illustrate the efficacy of our time-optimal entrainment strategies, we consider two common use cases: transmeridian travelers and shift workers. For transmeridian travelers, joint optimization of the two-process model avoids the unrealistic long wake duration when only Process C is considered. The entrainment time also decreases when both the light input and the sleep schedule are optimized compared to when only the light input is optimized. For shift workers, we show that the entrainment time is significantly shortened by optimizing the night shift working light.	[Yin, Jiawei] Qilu Univ Technol, Shandong Acad Sci, Inst Oceanog Instrumentat, Qingdao, Peoples R China; [Julius, A. Agung; Wen, John T.] Rensselaer Polytech Inst, Dept Elect Comp & Syst Engn, Troy, NY 12180 USA; [Julius, A. Agung; Wen, John T.] Rensselaer Polytech Inst, Lighting Enabled Syst & Applicat LESA Engn Res Ct, Troy, NY 12180 USA	Qilu University of Technology; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute	Julius, AA (corresponding author), Rensselaer Polytech Inst, Dept Elect Comp & Syst Engn, Troy, NY 12180 USA.; Julius, AA (corresponding author), Rensselaer Polytech Inst, Lighting Enabled Syst & Applicat LESA Engn Res Ct, Troy, NY 12180 USA.	agung@ecse.rpi.edu	Yin, Jiawei/AAT-8712-2021; Wen, John/B-4474-2008	Yin, Jiawei/0000-0003-4227-3448; Wen, John/0000-0002-5123-5411	Army Research Office [W911NF-17-1-0562]; National Science Foundation through an Engineering Research Center [EEC-0812056]	Army Research Office; National Science Foundation through an Engineering Research Center	All authors are supported by the Army Research Office (https://www.arl.army.mil/www/default.cfm?page=29) through grant W911NF-17-1-0562, and the National Science Foundation (https://nsf.gov) through an Engineering Research Center grant EEC-0812056. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHERMANN P, 1994, BIOL CYBERN, V71, P115, DOI 10.1007/BF00197314; Alhola Paula, 2007, Neuropsychiatr Dis Treat, V3, P553; Archer SN, 2015, J SLEEP RES, V24, P476, DOI 10.1111/jsr.12307; Archer SN, 2014, P NATL ACAD SCI USA, V111, pE682, DOI 10.1073/pnas.1316335111; Baehr EK, 2000, J SLEEP RES, V9, P117, DOI 10.1046/j.1365-2869.2000.00196.x; Behn CGD, 2012, SIAM J APPL DYN SYST, V11, P212, DOI 10.1137/110832823; Booth V, 2017, SIAM J APPL DYN SYST, V16, P1089, DOI 10.1137/16M1071328; Booth V, 2014, MATH BIOSCI, V250, P54, DOI 10.1016/j.mbs.2014.01.012; Borbely A A, 1982, Hum Neurobiol, V1, P195; Borbely AA, 1999, J BIOL RHYTHM, V14, P557, DOI 10.1177/074873099129000894; BORBELY AA, 1981, ELECTROEN CLIN NEURO, V51, P483, DOI 10.1016/0013-4694(81)90225-X; Brainard GC, 2001, J NEUROSCI, V21, P6405; DAAN S, 1984, AM J PHYSIOL, V246, pR161, DOI 10.1152/ajpregu.1984.246.2.R161; Daan S., 1984, MATH MODELS CIRCADIA, P129; Daan S., 1984, AM J PHYSIOL, V246, P161; Diekman CO, 2018, J THEOR BIOL, V437, P261, DOI 10.1016/j.jtbi.2017.10.002; Doyle FJ, 2006, COMPUT CHEM ENG, V30, P1700, DOI 10.1016/j.compchemeng.2006.05.029; Ekramian M, 2013, SYST CONTROL LETT, V62, P319, DOI 10.1016/j.sysconle.2013.01.002; Forger DB, 2002, SIAM J APPL MATH, V62, P1281, DOI 10.1137/S0036139900373587; Forger DB, 1999, J BIOL RHYTHM, V14, P532, DOI 10.1177/074873099129000867; Goel N, 2009, SEMIN NEUROL, V29, P320, DOI 10.1055/s-0029-1237117; JEWETT ME, 1991, NATURE, V350, P59, DOI 10.1038/350059a0; Johnson CH, 1999, CHRONOBIOL INT, V16, P711, DOI 10.3109/07420529909016940; Julius AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225988; Julius AA, 2017, P IEEE C DEC CONTR M, P4709; Kayumov L, 2005, J CLIN ENDOCR METAB, V90, P2755, DOI 10.1210/jc.2004-2062; Krauchi K, 2001, NEUROPSYCHOPHARMACOL, V25, pS92, DOI 10.1016/S0893-133X(01)00315-3; Kronauer RE, 1999, J BIOL RHYTHM, V14, P500, DOI 10.1177/074873099129001073; Lockley SW, 2006, SLEEP, V29, P161; Lu ZX, 2016, CHAOS, V26, DOI 10.1063/1.4954275; Pell R, 2017, EARABLE SENSOR MONIT; Piltz SH, 2021, COMMUN NONLINEAR SCI, V96, DOI 10.1016/j.cnsns.2020.105686; Piltz SH, 2020, J THEOR BIOL, V504, DOI 10.1016/j.jtbi.2020.110401; Qiao W, 2017, IEEE T AUTOMAT CONTR, V62, P445, DOI 10.1109/TAC.2016.2555885; Rahman SA, 2011, AM J PHYSIOL-ENDOC M, V300, pE518, DOI 10.1152/ajpendo.00597.2010; Rahman SA, 2008, ENDOCRINOLOGY, V149, P6125, DOI 10.1210/en.2007-1742; Rusterholz T, 2010, SLEEP, V33, P491, DOI 10.1093/sleep/33.4.491; Sacre P, 2014, IEEE CONTR SYST MAG, V34, P50, DOI 10.1109/MCS.2013.2295710; Serkh K, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003523; Skeldon AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103877; Thapan K, 2001, J PHYSIOL-LONDON, V535, P261, DOI 10.1111/j.1469-7793.2001.t01-1-00261.x; Wang YQ, 2011, AUTOMATICA, V47, P1236, DOI 10.1016/j.automatica.2011.01.074; Watson NF, 2015, SLEEP, V38, P1161, DOI 10.5665/sleep.4886; Xu XP, 2004, IEEE T AUTOMAT CONTR, V49, P2, DOI 10.1109/TAC.2003.821417	44	1	1	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0251478	10.1371/journal.pone.0251478	http://dx.doi.org/10.1371/journal.pone.0251478			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101742	gold, Green Published			2022-12-26	WOS:000664641500005
J	Allard, C; Pardo, E; de la Jonquiere, C; Wyniecki, A; Soulier, A; Faddoul, A; Tsai, ES; Bonnet, F; Verdonk, F				Allard, Celine; Pardo, Emmanuel; de la Jonquiere, Christophe; Wyniecki, Anne; Soulier, Anne; Faddoul, Annibal; Tsai, Eileen S.; Bonnet, Francis; Verdonk, Franck			Comparison between femoral block and PENG block in femoral neck fractures: A cohort study	PLOS ONE			English	Article							HIP FRACTURE; NERVE BLOCK; ELDERLY-PEOPLE; FASCIA ILIACA; MORTALITY; LIGAMENT	Background Regional analgesia is worth performing in the multimodal postoperative management of hip fracture (HF) because it reduces hospital morbidity and mortality. The aim of this study is to compare the efficacy and side effects of the recently described "Pericapsular Nerve Group (PENG) Block" with those of the femoral block, which is considered the standard of care for postoperative pain control after femoral neck fracture. Materials and methods We conducted a comparative observational study at a university hospital (Saint Antoine Hospital, Sorbonne University, Paris, France), where the PENG block was introduced in August 2019. We include all patients from June to October 2019, who were coming for femoral neck fractures and who had an analgesic femoral block or PENG block before their surgery. The primary outcome was the comparison of cumulative postoperative morphine consumption 48 hours after surgery. Results Demographics, medical charts, and perioperative data of 42 patients were reviewed: 21 patients before (Femoral group) and 21 patients after the introduction of PENG block (PENG group) in clinical practice. Thirteen total hip arthroplasties (THA) and eight hemi arthroplasties (HA) were included in each group. Demographics were also comparable. The median, postoperative, morphine equivalent consumption at 48 hours was 10 [0-20] mg and 20 [0-50] mg in Femoral and PENG groups respectively (p = 0.458). No statistically significant differences were found in postoperative pain intensity, time to ambulation, incidence of morphine-related side effects, or length of hospital stay. The postoperative muscle strength of the quadriceps was greater in the PENG group than in the Femoral group (5/5 vs. 2/5, p = 0.001). Conclusion In the management of hip fractures, PENG block is not associated in our study with a significant change in postoperative morphine consumption, compared to femoral block. However, it does significantly improve the immediate mobility of the operated limb, making it appropriate for inclusion in enhanced recovery programs after surgery.	[Allard, Celine; Pardo, Emmanuel; de la Jonquiere, Christophe; Wyniecki, Anne; Soulier, Anne; Faddoul, Annibal; Bonnet, Francis; Verdonk, Franck] Hop St Antoine, Assistance Publ Hop Paris, Dept Anesthesiol & Intens Care, Paris, France; [Pardo, Emmanuel; Bonnet, Francis; Verdonk, Franck] Sorbonne Univ, Assistance Publ Hop Paris, GRC 29, DMU DREAM, Paris, France; [Tsai, Eileen S.; Verdonk, Franck] Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Sch Med, Stanford, CA 94305 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Sorbonne Universite; Stanford University	Verdonk, F (corresponding author), Hop St Antoine, Assistance Publ Hop Paris, Dept Anesthesiol & Intens Care, Paris, France.; Verdonk, F (corresponding author), Sorbonne Univ, Assistance Publ Hop Paris, GRC 29, DMU DREAM, Paris, France.; Verdonk, F (corresponding author), Stanford Univ, Dept Anesthesiol Perioperat & Pain Med, Sch Med, Stanford, CA 94305 USA.	fverdonk@stanford.edu		Pardo, Emmanuel/0000-0001-6326-3834				Ahiskalioglu A, 2020, J CLIN ANESTH, V59, P42, DOI 10.1016/j.jclinane.2019.06.021; Alsheikh KA, 2020, ANN SAUDI MED, V40, P298, DOI 10.5144/0256-4947.2020.298; Beaupre LA, 2006, QUAL SAF HEALTH CARE, V15, P375, DOI 10.1136/qshc.2005.017095; Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Da Costa I, 2021, EUR J ANAESTH, V38, pS67, DOI 10.1097/EJA.0000000000001271; Ghodki PS, 2018, J ANAESTH CLIN PHARM, V34, P242, DOI 10.4103/joacp.JOACP_172_17; Giron-Arango L, 2018, REGION ANESTH PAIN M, V43, P859, DOI 10.1097/AAP.0000000000000847; Goldacre MJ, 2002, BRIT MED J, V325, P868, DOI 10.1136/bmj.325.7369.868; Guay J, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001159.pub2; Ketelaars R, 2018, INT J EMERG MED, V11, DOI 10.1186/s12245-018-0173-z; Kukreja P, 2020, CUREUS, V12, DOI 10.7759/cureus.8200; Medical research council of the United Kingdom, 1976, AIDS EX PER NERV SYS; Mistry T, 2019, J CLIN ANESTH, V58, P123, DOI 10.1016/j.jclinane.2019.07.006; Moschinski K, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0446-z; Newman B, 2013, ANAESTHESIA, V68, P899, DOI 10.1111/anae.12321; Orosz GM., 2006, TIMING SURG HIP FRAC, P11; RCP London, 2016, NATL HIP FRACTURE DA; Ritcey B, 2016, CAN J EMERG MED, V18, P37, DOI 10.1017/cem.2015.75; Roche JJW, 2005, BMJ-BRIT MED J, V331, P1374, DOI 10.1136/bmj.38643.663843.55; Schnell S, 2010, GERIATR ORTHOP SURG, V1, P6, DOI 10.1177/2151458510378105; Short AJ, 2018, REGION ANESTH PAIN M, V43, P186, DOI 10.1097/AAP.0000000000000701; Swenson JD, 2015, J CLIN ANESTH, V27, P652, DOI 10.1016/j.jclinane.2015.07.001; Ueshima H, 2018, J CLIN ANESTH, V51, P60, DOI 10.1016/j.jclinane.2018.08.003; Unneby A, 2017, INJURY, V48, P1542, DOI 10.1016/j.injury.2017.04.043	24	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252716	10.1371/journal.pone.0252716	http://dx.doi.org/10.1371/journal.pone.0252716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086782	gold, Green Published			2022-12-26	WOS:000664640100116
J	Damette, O; Mathonnat, C; Goutte, S				Damette, Olivier; Mathonnat, Clement; Goutte, Stephane			Meteorological factors against COVID-19 and the role of human mobility	PLOS ONE			English	Article							HUMIDITY; TRANSMISSION; SURVIVAL; WEATHER	In the vein of recent empirical literature, we reassessed the impact of weather factors on Covid-19 daily cases and fatalities in a panel of 37 OECD countries between 1st January and 27th July 2020. We considered five different meteorological factors. For the first time, we used a dynamic panel model and considered two different kinds of channels between climate and Covid-19 virus: direct/physical factors related to the survival and durability dynamics of the virus on surfaces and outdoors and indirect/social factors through human behaviour and individual mobility, such as walking or driving outdoors, to capture the impact of weather on social distancing and, thus, on Covid-19 cases and fatalities. Our work revealed that temperature, humidity and solar radiation, which has been clearly under considered in previous studies, significantly reduce the number of Covid-19 cases and fatalities. Indirect effects through human behaviour, i.e., correlations between temperature (or solar radiation) and human mobility, were significantly positive and should be considered to correctly assess the effects of climatic factors. Increasing temperature, humidity or solar radiation effects were positively correlated with increasing mobility effects on Covid-19 cases and fatalities. The net effect from weather on the Covid-19 outbreak will, thus, be the result of the physical/direct negative effect of temperature or solar radiation and the mobility/indirect positive effect due to the interaction between human mobility and those meterological variables. Reducing direct effects of temperature and solar radiation on Covid-19 cases and fatalities, when they were significant, were partly and slightly compensated for positive indirect effects through human mobility. Suitable control policies should be implemented to control mobility and social distancing even when the weather is favourable to reduce the spread of the Covid-19 virus.	[Damette, Olivier; Mathonnat, Clement] Univ Lorraine, Fac Droit & Sci Econ, Lorraine, France; [Damette, Olivier; Mathonnat, Clement] Univ Lorraine, BETA, Lorraine, France; [Damette, Olivier] Climate Econ Chair Paris Dauphine, Paris, France; [Goutte, Stephane] Univ Versailles St Quentin Yvelines Paris Saclay, CEMOTEV, Versailles, France	Universite de Lorraine; Universite de Lorraine	Damette, O (corresponding author), Univ Lorraine, Fac Droit & Sci Econ, Lorraine, France.; Damette, O (corresponding author), Univ Lorraine, BETA, Lorraine, France.; Damette, O (corresponding author), Climate Econ Chair Paris Dauphine, Paris, France.	olivier.damette@univ-lorraine.fr		Damette, Olivier/0000-0002-7520-3780				Araujo Miguel B., 2020, SPREAD SARS COV 2 CO, DOI [10.1101/2020.03.12.20034728, DOI 10.1101/2020.03.12.20034728]; Baker RE, 2020, SCIENCE, V369, P315, DOI 10.1126/science.abc2535; Bhoopchand A., 2020, DELVE GLOBAL COVID 1; Carleton T, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2012370118; Casanova LM, 2010, APPL ENVIRON MICROB, V76, P2712, DOI 10.1128/AEM.02291-09; Chan K, 2011, ADV OPTOELECTRON, V2011, DOI [10.1155/2011/734690, 10.1155/2011/196707]; Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3; Dalziel BD, 2018, SCIENCE, V362, P75, DOI 10.1126/science.aat6030; Dbouk T, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0011960; Dell M, 2014, J ECON LIT, V52, P740, DOI 10.1257/jel.52.3.740; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Ficetola G.F., 2020, MEDRXIV, DOI [10.1101/2020.03.23.20040501., DOI 10.1016/j.ijantimicag.2020.105924]; Guo ZD, 2020, EMERG INFECT DIS, V26, P1586, DOI 10.3201/eid2607.200885; Islam N., 2020, TEMPERATURE HUMIDITY; Jamil T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00436; Kampf G, 2020, J HOSP INFECT, V104, P246, DOI 10.1016/j.jhin.2020.01.022; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Livadiotis G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233875; Luo W., ROLE ABSOLUTE HUMIDI, DOI 10.1101/2020.02.12.20022467; Ma YL, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138226; Manski CF, 2021, J ECONOMETRICS, V220, P181, DOI 10.1016/j.jeconom.2020.04.041; Oliveiros B., 2020, ROLE TEMPERATURE HUM, DOI DOI 10.1101/2020.03.05.20031872; Pesaran MH, 2018, OXFORD B ECON STAT, V80, P185, DOI 10.1111/obes.12220; PESARAN MH, 1995, J ECONOMETRICS, V68, P79, DOI 10.1016/0304-4076(94)01644-F; Pesaran MH, 1999, J AM STAT ASSOC, V94, P621, DOI 10.2307/2670182; Qi HC, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138778; Sahin M, 2020, SCI TOTAL ENVIRON, V728, DOI 10.1016/j.scitotenv.2020.138810; Sajadi MM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.11834; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Soucy J. P, ESTIMATING EFFECTS P; Takagi H, 2020, AM J INFECT CONTROL, V48, P1281, DOI 10.1016/j.ajic.2020.06.181; United Nations Environment Programme and International Livestock Research Institute, 2020, PREV NEXT PAND ZOON; Unwin H, STATE LEVEL TRACKING; van Doremalen N, 2013, EUROSURVEILLANCE, V18, P7, DOI 10.2807/1560-7917.ES2013.18.38.20590; Wilson D. J, 2020, FED SAN FRANSISCO WO; Wu Y, SCI TOTAL ENVIRON; Xie JG, 2020, SCI TOTAL ENVIRON, V724, DOI 10.1016/j.scitotenv.2020.138201; Xu R, 2020, MODEST IMPACT WEATHE, DOI 10.2139/ssrn.3593879; Yuan JS, 2006, AM J INFECT CONTROL, V34, P234, DOI 10.1016/j.ajic.2005.12.006	39	10	10	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252405	10.1371/journal.pone.0252405	http://dx.doi.org/10.1371/journal.pone.0252405			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086744	Green Published, gold			2022-12-26	WOS:000664640100060
J	Lansang, MAD; Alejandria, MM; Law, I; Juban, NR; Amarillo, MLE; Sison, OT; Cruz, JRB; Ang, CF; Buensalido, JAL; Canal, JPA; Castillo-Carandang, NT; Cordero, CP; Gaviola, DMG; Ladia, MAJ; Mantaring, JBV; Mendoza, MT; Salamat, MSS; Lam, HY; Tadolini, M; Garfin, AMCG				Lansang, Mary Ann D.; Alejandria, Marissa M.; Law, Irwin; Juban, Noel R.; Amarillo, Maria Lourdes E.; Sison, Olivia T.; Cruz, Jose Rene B.; Ang, Concepcion F.; Buensalido, Joseph Adrian L.; Canal, Johanna Patricia A.; Castillo-Carandang, Nina T.; Cordero, Cynthia P.; Gaviola, Donna Mae G.; Ladia, Mary Ann J.; Mantaring, Jacinto Blas V., III; Mendoza, Myrna T.; Salamat, Maria Sonia S.; Lam, Hilton Y.; Tadolini, Marina; Garfin, Anna Marie Celina G.		Philippine NTPS 2016 Grp	High TB burden and low notification rates in the Philippines: The 2016 national TB prevalence survey	PLOS ONE			English	Article							TUBERCULOSIS	Setting The 3(rd) national tuberculosis (TB) survey in the Philippines in 2007 reported a significant decline in the prevalence of TB. Since then, more significant investments for TB control have been made, yet TB burden estimates from routine surveillance data remain relatively stable. Objective To estimate the prevalence of bacteriologically confirmed pulmonary TB in the Philippines amongst individuals aged >= 15 years in 2016. Design In March-December 2016, we conducted a population-based survey with stratified, multi-stage cluster sampling of residents in 106 clusters aged >= 15 years. Survey participants were screened for TB by symptom-based interview and digital chest X-ray. Those with cough >= 2 weeks and/or haemoptysis and/or chest X-ray suggestive of TB were requested to submit 2 sputum specimens for Xpert MTB/RIF, direct sputum smear microscopy using LED fluorescent microscopy, and mycobacterial solid culture (Ogawa method). Bacteriologically confirmed pulmonary TB was defined as MTB culture positive and/or Xpert positive. Results There were 46,689 individuals interviewed, and 41,444 (88.8%) consented to a chest X-ray. There were 18,597 (39.8%) eligible for sputum examination and 16,242 (87.3%) submitted at least one specimen. Out of 16,058 sputum-eligible participants, 183 (1.1%) were smear-positive. There were 466 bacteriologically confirmed TB cases: 238 (51.1%) Xpert positive, 69 (14.8%) culture positive, and 159 (34.1%) positive by both Xpert and culture. The estimated TB prevalence per 100,000 population aged >= 15 years was 434 (95% CI: 350-518) for smear-positive TB, and 1,159 (95% CI: 1,016-1,301) for bacteriologically confirmed TB. Conclusion This nationally representative survey found that the TB burden in the Philippines in 2016 was higher than estimated from routine TB surveillance data. There was no evidence of a decline in smear and culture positive TB from the 2007 survey despite significant investments in TB control. New strategies for case-finding and patient-centered care must be intensified and expanded.	[Lansang, Mary Ann D.; Alejandria, Marissa M.; Juban, Noel R.; Amarillo, Maria Lourdes E.; Castillo-Carandang, Nina T.; Cordero, Cynthia P.; Mantaring, Jacinto Blas V., III; Lam, Hilton Y.] Univ Philippines, Coll Med, Dept Clin Epidemiol, Manila, Philippines; [Lansang, Mary Ann D.; Alejandria, Marissa M.; Buensalido, Joseph Adrian L.; Mendoza, Myrna T.; Salamat, Maria Sonia S.] Univ Philippines, Philippine Gen Hosp, Div Infect Dis, Dept Med,Coll Med, Manila, Philippines; [Law, Irwin] WHO, Global TB Programme, Geneva, Switzerland; [Sison, Olivia T.; Castillo-Carandang, Nina T.; Ladia, Mary Ann J.] Univ Philippines, Natl Inst Hlth, Inst Clin Epidemiol, Manila, Philippines; [Cruz, Jose Rene B.; Mantaring, Jacinto Blas V., III] Fdn Adv Clin Epidemiol, Manila, Philippines; [Cruz, Jose Rene B.] Univ Philippines, Social Innovat Hlth Initiat, Manila, Philippines; [Ang, Concepcion F.; Mendoza, Myrna T.] Fdn Control Infect Dis, Taft Ave, Manila, Philippines; [Canal, Johanna Patricia A.] Univ Philippines, Coll Med, Dept Radiol, Manila, Philippines; [Canal, Johanna Patricia A.] Philippine Coll Radiol, Quezon City, Philippines; [Gaviola, Donna Mae G.; Garfin, Anna Marie Celina G.] Natl TB Control Program, Dept Hlth, Manila, Philippines; [Lam, Hilton Y.] Univ Philippines, Inst Hlth Policy & Dev Studies, Manila, Philippines; [Tadolini, Marina] IRCCS Azienda Osped Univ Bologna, Infect Dis Unit, Policlin St Orsola, Bologna, Italy; [Tadolini, Marina] Univ Bologna, Dept Med & Surg Sci, Alma Mater Studiorum, Bologna, Italy	University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; World Health Organization; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; University of the Philippines System; University of the Philippines Manila; Philippine Department Health; University of the Philippines System; University of the Philippines Manila; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna	Lansang, MAD (corresponding author), Univ Philippines, Coll Med, Dept Clin Epidemiol, Manila, Philippines.; Lansang, MAD (corresponding author), Univ Philippines, Philippine Gen Hosp, Div Infect Dis, Dept Med,Coll Med, Manila, Philippines.	mlansang@post.upm.edu.ph	Buensalido, Joseph Adrian/GWZ-8214-2022; Gaviola, Donna Mae Geocaniga/GPK-8224-2022	Gaviola, Donna Mae Geocaniga/0000-0003-2393-4343; Law, Irwin/0000-0002-1194-677X; Cruz, Jose Rene Bagani/0000-0001-7539-0144; Alejandria, Marissa/0000-0003-0521-7754; Buensalido, Joseph Adrian/0000-0003-1802-1021; Canal, Johanna Patricia/0000-0001-5407-1478; Lansang, Mary Ann/0000-0002-6606-0466	Philippines' Department of Health from the Department of Science and Technology - Philippine Council for Health Research and Development	Philippines' Department of Health from the Department of Science and Technology - Philippine Council for Health Research and Development	The 2016 NTPS was supported by the Philippines' Department of Health (https://doh.gov.ph/) through a research grant from the Department of Science and Technology - Philippine Council for Health Research and Development (http://pchrd.dost.gov.ph/), as covered by a Memorandum of Understanding dated 11 December 2015. The Department of Health and the Philippine Council for Health Research and Development were involved in the overall design of the survey and the decision to publish the survey results. Anna Marie Celina Garfin, programme manager of the National TB Control Programme of the Department of Health, is a co-author of the paper.	Borgdorff MW, 2004, EMERG INFECT DIS, V10, P1523, DOI 10.3201/eid1009.040349; Dean A., 2011, EPI INFO TM DATABASE, V7.2.3.1; Department of Health Philippines, 2014, JOINT TUB PROGR REV; Department of Health Philippines, 2017, JOINT TUB PROGR REV; Dorman SE, 2018, LANCET INFECT DIS, V18, P76, DOI [10.1016/S1473-3099(17)30691-6, 10.1016/s1473-3099(17)30691-6]; Floyd Sian, 2013, Emerg Themes Epidemiol, V10, P10, DOI 10.1186/1742-7622-10-10; Garfin C, 2017, J INFECT DIS, V216, pS740, DOI 10.1093/infdis/jix391; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Murray CJL, 2018, LANCET INFECT DIS, V18, P261, DOI 10.1016/S1473-3099(17)30703-X; National Institute of Tuberculosis Philippines, 1984, REP NAT TUB PREV SUR; Philippine Statistics Authority, 2016, 201613 PHIL STAT AUT; Philippine Statistics Authority, 2020, 2020092 PHIL STAT AU; Philippines Department of Health, 2020, NAT TUB CONTR PROGR, V6; The World Bank, WORLD DEV IND SUST D; Tropical Disease Foundation and Department of Health, 2008, NAT TUB PREV SURV 20; Tupasi TE, 2009, INT J TUBERC LUNG D, V13, P1224; Tupasi TE, 1999, INT J TUBERC LUNG D, V3, P471; WHO, 2021, WHO CONSOLIDATED GUI; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; World Health Organization,, 2011, TUB PREV SURV HDB, V2nd; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2015, HLTH 2015 MDGS MILL, DOI 10.1007/BF01918387	22	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252240	10.1371/journal.pone.0252240	http://dx.doi.org/10.1371/journal.pone.0252240			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086746	gold, Green Published			2022-12-26	WOS:000664640100039
J	Muller, D; Klamt, T; Gentemann, L; Heisterkamp, A; Kalies, SMK				Mueller, Dominik; Klamt, Thorben; Gentemann, Lara; Heisterkamp, Alexander; Kalies, Stefan Michael Klaus			Evaluation of laser induced sarcomere micro-damage: Role of damage extent and location in cardiomyocytes	PLOS ONE			English	Article							ALPHA-ACTININ; CARDIOMYOPATHY; NANOSURGERY; MECHANISMS; PROTEIN; CELLS; MLP	Whereas it is evident that a well aligned and regular sarcomeric structure in cardiomyocytes is vital for heart function, considerably less is known about the contribution of individual elements to the mechanics of the entire cell. For instance, it is unclear whether altered Z-disc elements are the reason or the outcome of related cardiomyopathies. Therefore, it is crucial to gain more insight into this cellular organization. This study utilizes femtosecond laser-based nanosurgery to better understand sarcomeres and their repair upon damage. We investigated the influence of the extent and the location of the Z-disc damage. A single, three, five or ten Z-disc ablations were performed in neonatal rat cardiomyocytes. We employed image-based analysis using a self-written software together with different already published algorithms. We observed that cardiomyocyte survival associated with the damage extent, but not with the cell area or the total number of Z-discs per cell. The cell survival is independent of the damage position and can be compensated. However, the sarcomere alignment/orientation is changing over time after ablation. The contraction time is also independent of the extent of damage for the tested parameters. Additionally, we observed shortening rates between 6-7% of the initial sarcomere length in laser treated cardiomyocytes. This rate is an important indicator for force generation in myocytes. In conclusion, femtosecond laser-based nanosurgery together with image-based sarcomere tracking is a powerful tool to better understand the Z-disc complex and its force propagation function and role in cellular mechanisms.	[Mueller, Dominik; Klamt, Thorben; Gentemann, Lara; Heisterkamp, Alexander; Kalies, Stefan Michael Klaus] Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany; [Mueller, Dominik; Heisterkamp, Alexander; Kalies, Stefan Michael Klaus] REBIRTH Res Ctr Translat Regenerat Med, Hannover, Germany; [Mueller, Dominik; Klamt, Thorben; Gentemann, Lara; Heisterkamp, Alexander; Kalies, Stefan Michael Klaus] Lower Saxony Ctr Biomed Engn Implant Res & Dev, Hannover, Germany	Leibniz University Hannover	Muller, D (corresponding author), Leibniz Univ Hannover, Inst Quantum Opt, Hannover, Germany.; Muller, D (corresponding author), REBIRTH Res Ctr Translat Regenerat Med, Hannover, Germany.; Muller, D (corresponding author), Lower Saxony Ctr Biomed Engn Implant Res & Dev, Hannover, Germany.	d.mueller@iqo.uni-hannover.de			REBIRTH Research Center for Translational Regenerative Medicine (State of Lower Saxony, Ministry of Science and Culture (Nieders. Vorab)) [ZN3440]	REBIRTH Research Center for Translational Regenerative Medicine (State of Lower Saxony, Ministry of Science and Culture (Nieders. Vorab))	This study was funded by the REBIRTH Research Center for Translational Regenerative Medicine (ZN3440, State of Lower Saxony, Ministry of Science and Culture (Nieders. Vorab)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2018, LANCET, DOI [DOI 10.1016/S0140-6736(18)31310-2, 10.14257/ijgdc.2018.11.9.06]; ARBER S, 1994, CELL, V79, P221, DOI 10.1016/0092-8674(94)90192-9; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; ARMSTRONG RB, 1983, J APPL PHYSIOL, V54, P80, DOI 10.1152/jappl.1983.54.1.80; Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Beussman KM, 2016, METHODS, V94, P43, DOI 10.1016/j.ymeth.2015.09.005; Bildyug N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20205054; Buyandelger B, 2014, PFLUG ARCH EUR J PHY, V466, P1093, DOI 10.1007/s00424-014-1468-4; Chopra A, 2018, DEV CELL, V44, P87, DOI 10.1016/j.devcel.2017.12.012; Ecarnot-Laubriet A, 2000, J MOL CELL CARDIOL, V32, P2385, DOI 10.1006/jmcc.2000.1269; Ehler E, 2016, BBA-MOL CELL RES, V1863, P1857, DOI 10.1016/j.bbamcr.2015.11.006; Florescu C, 2016, ROM J MORPHOL EMBRYO, V57, P1207; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; GORDON AM, 1966, J PHYSIOL-LONDON, V184, P170, DOI 10.1113/jphysiol.1966.sp007909; Hagenah D, 2018, J BIOPHOTONICS, V11, DOI 10.1002/jbio.201700344; Iorga B, 2018, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.01111; Kato T., 2005, J CLIN INVEST, P115, DOI [10.1172/JCI24335, DOI 10.1172/JCI24335]; Knoll R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569628; Kuetemeyer K, 2010, BIOMED OPT EXPRESS, V1, P587, DOI 10.1364/BOE.1.000587; Kung G, 2011, CIRC RES, V108, P1017, DOI 10.1161/CIRCRESAHA.110.225730; Leber Y, 2016, HUM MOL GENET, V25, P2776, DOI 10.1093/hmg/ddw135; Li SJ, 2020, CIRCULATION, V141, P1787, DOI 10.1161/CIRCULATIONAHA.119.043939; Mannhardt I, 2016, STEM CELL REP, V7, P29, DOI 10.1016/j.stemcr.2016.04.011; Matsudaira K, 2019, J MICROMECH MICROENG, V29, DOI 10.1088/1361-6439/ab093d; Melo TG, 2006, PARASITOLOGY, V133, P171, DOI 10.1017/S0031182006000011; Moo EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33658-7; Muller D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40308-z; Orfanos Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep19614; Pecorari I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21165865; Peter AK, 2011, PROG PEDIATR CARDIOL, V31, P83, DOI 10.1016/j.ppedcard.2011.02.003; Prondzynski M, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201911115; Rosado M, 2014, MOL BIOL CELL, V25, P811, DOI 10.1091/mbc.E13-08-0443; Salick MR, 2020, J APPL PHYS, V127, DOI 10.1063/1.5129347; Schambach A, 2006, EXP HEMATOL, V34, P588, DOI 10.1016/j.exphem.2006.02.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Seidman JG, 2001, CELL, V104, P557, DOI 10.1016/S0092-8674(01)00242-2; Sequeira V, 2014, BBA-BIOMEMBRANES, V1838, P700, DOI 10.1016/j.bbamem.2013.07.011; Skwarek-Maruszewska A, 2009, J CELL SCI, V122, P2119, DOI 10.1242/jcs.046805; Tanner K, 2010, BIOPHYS J, V99, P2775, DOI 10.1016/j.bpj.2010.08.071; Toepfer CN, 2019, CIRC RES, V124, P1172, DOI 10.1161/CIRCRESAHA.118.314505; Vikhorev PG, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19082234; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Willingham TB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17579-6; Yu JG, 2005, J HISTOCHEM CYTOCHEM, V53, P839, DOI 10.1369/jhc.4A6608.2005; Zeigler MB, 2009, PHOTOCHEM PHOTOBIOL, V85, P1218, DOI 10.1111/j.1751-1097.2009.00581.x	46	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252346	10.1371/journal.pone.0252346	http://dx.doi.org/10.1371/journal.pone.0252346			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086732	gold, Green Published			2022-12-26	WOS:000664640100051
J	Buonvicino, D; Ranieri, G; Pittelli, M; Lapucci, A; Bragliola, S; Chiarugi, A				Buonvicino, Daniela; Ranieri, Giuseppe; Pittelli, Maria; Lapucci, Andrea; Bragliola, Stefania; Chiarugi, Alberto			SIRT1-dependent restoration of NAD plus homeostasis after increased extracellular NAD plus exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE; CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE; EXOGENOUS NAD; MITOCHONDRIAL; METABOLISM; INHIBITOR; RIBOSIDE; BIOSYNTHESIS; PROTEIN	In the last several years, NAD+ supplementation has emerged as an innovative and safe therapeutic strategy for a wide spectrum of disorders, including diabetes and neuropathy. However, critical questions remain as to how NAD+ and its precursors are taken up by cells, as well as the effects of long-lasting intracellular NAD+ (iNAD+) increases. Here, we investigated the kinetics of iNAD+ levels in different cell types challenged with prolonged exposure to extracellular NAD+ (eNAD+). Surprisingly, we found that after the initial increase, iNAD+ contents decreased back to control levels (iNAD+ resetting). Focusing our attention on HeLa cells, we found that oxygen and ATP consumption occurred with similar temporal kinetics after eNAD+ exposure. Using [H-3]NAD+ and [C-14] NAD+, we determined that NAD+ resetting was not due to increased dinucleotide extrusion but rather due to reduced uptake of cleaved NAD+ products. Indeed, eNAD+ exposure reduced the expression of the ecto-50 -nucleotidase CD73, the nicotinamide adenine mononucleotide transporter solute carrier family 12 member 8, and the nicotinamide riboside kinase. Interestingly, silencing the NAD+-sensor enzyme sirtuin 1 prevented eNAD+-dependent transcriptional repression of ecto-50 -nucleotidase, solute carrier family 12 member 8, and nicotinamide riboside kinase, as well as iNAD+ resetting. Our findings provide the first evidence for a sirtuin 1-mediated homeostatic response aimed at maintaining physiological iNAD+ levels in conditions of excess eNAD+ availability. These data may be of relevance for therapies designed to support the NAD+ metabolome via extracellular supplementation of the dinucleotide or its precursors.	[Buonvicino, Daniela; Ranieri, Giuseppe; Lapucci, Andrea; Bragliola, Stefania; Chiarugi, Alberto] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy; [Pittelli, Maria] Chiesi Farmaceut SpA, Corp Preclin R&D, Parma, Italy	University of Florence; Chiesi Pharmaceuticals Inc	Buonvicino, D (corresponding author), Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy.	aniela.buonvicino@unifi.it	Buonvicino, Daniela/AAC-4978-2022; Ranieri, Giuseppe/AAC-4942-2022	Ranieri, Giuseppe/0000-0001-8875-4250; buonvicino, daniela/0000-0003-0435-8475	AIRC; Fondazione CR Firenze under IG [20451]	AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione CR Firenze under IG	This work was supported by Grant AIRC and Fondazione CR Firenze under IG 2017 - ID. 20451 project (Principal Investigator, A. C.).	Airhart SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186459; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Aleo MF, 2001, J CELL BIOCHEM, V80, P360, DOI 10.1002/1097-4644(20010301)80:3<360::AID-JCB90>3.0.CO;2-X; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Audrito V, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01720; Beauparlant P, 2009, ANTI-CANCER DRUG, V20, P346, DOI 10.1097/CAD.0b013e3283287c20; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Billington RA, 2008, J BIOL CHEM, V283, P6367, DOI 10.1074/jbc.M706204200; Bortell R, 2001, J IMMUNOL, V167, P2049, DOI 10.4049/jimmunol.167.4.2049; Buonvicino D, 2018, PAIN, V159, P1980, DOI 10.1097/j.pain.0000000000001291; Buonvicino D, 2018, CELL CHEM BIOL, V25, P471, DOI 10.1016/j.chembiol.2018.01.012; Buonvicino D, 2013, J BIOL CHEM, V288, P36530, DOI 10.1074/jbc.M113.506378; BURGER RM, 1970, J BIOL CHEM, V245, P6274; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Diguet N, 2018, CIRCULATION, V137, P2256, DOI 10.1161/CIRCULATIONAHA.116.026099; Drevs J, 2003, ANTICANCER RES, V23, P4853; Escande C, 2013, DIABETES, V62, P1084, DOI 10.2337/db12-1139; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Felici R, 2015, MOL PHARMACOL, V87, P965, DOI 10.1124/mol.114.097204; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gardell SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11078-z; Gearing LJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215495; Goldfarb RD, 2002, CRIT CARE MED, V30, P974, DOI 10.1097/00003246-200205000-00004; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Grant R, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00257; Grozio A, 2019, NAT METAB, V1, P47, DOI 10.1038/s42255-018-0009-4; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Heilbronn L., 2019, NUTR HEAL AGING, V5, P71; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kang BE, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13334; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Kulikova V, 2019, METABOLITES, V9, DOI 10.3390/metabo9120293; Lautrup S, 2019, CELL METAB, V30, P630, DOI 10.1016/j.cmet.2019.09.001; Liu L, 2014, FUND CLIN PHARMACOL, V28, P180, DOI 10.1111/fcp.12016; Luongo TS, 2020, NATURE, V588, P174, DOI 10.1038/s41586-020-2741-7; Martens CR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03421-7; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Park JH, 2016, NEUROBIOL DIS, V95, P102, DOI 10.1016/j.nbd.2016.07.018; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Roh E, 2018, METABOLISM, V88, P51, DOI 10.1016/j.metabol.2018.08.005; Ryu D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5504; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Schmidt MS, 2019, NAT METAB, V1, P660, DOI 10.1038/s42255-019-0085-0; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; von Heideman A, 2010, CANCER CHEMOTH PHARM, V65, P1165, DOI 10.1007/s00280-009-1125-3; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; WELTIN D, 1994, ONCOL RES, V6, P399; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	71	4	4	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100855	10.1016/j.jbc.2021.100855	http://dx.doi.org/10.1016/j.jbc.2021.100855			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097876	gold, Green Published			2022-12-26	WOS:000678068400055
J	Kamps, J; Lin, YH; Oliva, R; Bader, V; Winter, R; Winklhofer, KF; Tatzelt, J				Kamps, Janine; Lin, Yu-Hsuan; Oliva, Rosario; Bader, Verian; Winter, Roland; Winklhofer, Konstanze F.; Tatzelt, Joerg			The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the A beta-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COACERVATION; IMPAIRMENT; DISEASE; COPPER; PRPC; PI	Formation of biomolecular condensates through liquid-liquid phase separation (LLPS) has been described for several pathogenic proteins linked to neurodegenerative diseases and is discussed as an early step in the formation of protein aggregates with neurotoxic properties. In prion diseases, neurodegeneration and formation of infectious prions is caused by aberrant folding of the cellular prion protein (PrPC). PrPC is characterized by a large intrinsically disordered N-terminal domain and a structured C-terminal globular domain. A significant fraction of mature PrPC is proteolytically processed in vivo into an entirely unstructured fragment, designated N1, and the corresponding C-terminal fragment C1 harboring the globular domain. Notably, N1 contains a polybasic motif that serves as a binding site for neurotoxic A beta oligomers. PrP can undergo LLPS; however, nothing is known how phase separation of PrP is triggered on a molecular scale. Here, we show that the intrinsically disordered N1 domain is necessary and sufficient for LLPS of PrP. Similar to full-length PrP, the N1 fragment formed highly dynamic liquid-like droplets. Remarkably, a slightly shorter unstructured fragment, designated N2, which lacks the A beta-binding domain and is generated under stress conditions, failed to form liquid-like droplets and instead formed amorphous assemblies of irregular structures. Through a mutational analysis, we identified three positively charged lysines in the postoctarepeat region as essential drivers of condensate formation, presumably largely via cation-pi interactions. These findings provide insights into the molecular basis of LLPS of the mammalian prion protein and reveal a crucial role of the A beta-binding domain in this process.	[Kamps, Janine; Lin, Yu-Hsuan; Tatzelt, Joerg] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Biochem Neurodegenerat Dis, Bochum, Germany; [Kamps, Janine; Winter, Roland; Winklhofer, Konstanze F.; Tatzelt, Joerg] Ruhr Univ Bochum, Cluster Excellence RESOLV, Bochum, Germany; [Oliva, Rosario; Winter, Roland] TU Dortmund Univ, Fac Chem & Chem Biol, Div Phys Chem Biophys Chem 1, Dortmund, Germany; [Bader, Verian; Winklhofer, Konstanze F.] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Mol Cell Biol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Dortmund University of Technology; Ruhr University Bochum	Tatzelt, J (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Biochem Neurodegenerat Dis, Bochum, Germany.; Tatzelt, J (corresponding author), Ruhr Univ Bochum, Cluster Excellence RESOLV, Bochum, Germany.	joerg.Tatzelt@rub.de		Winklhofer, Konstanze/0000-0002-7256-8231; Kamps, Janine/0000-0002-4930-3868; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [2033-390677874-RESOLV, TA 167/6-3, TA 167/11-1, WI/2111-6]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC 2033-390677874-RESOLV; TA 167/6-3 and TA 167/11-1 (to J. T.); and WI/2111-6 (to K. F. W.).	Ahlers J, 2021, BIOPHYS J, V120, P1266, DOI 10.1016/j.bpj.2021.01.019; Alberti S, 2019, ANNU REV GENET, V53, P171, DOI 10.1146/annurev-genet-112618-043527; Altmeppen Hermann C, 2012, Am J Neurodegener Dis, V1, P15; Babinchak WM, 2020, J MOL BIOL, V432, P1910, DOI 10.1016/j.jmb.2020.03.004; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Beland M, 2012, J NEUROCHEM, V120, P853, DOI 10.1111/j.1471-4159.2011.07613.x; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/nphys3532, 10.1038/NPHYS3532]; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Darling AL, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.118984; Darling AL, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700193; Das S, 2020, P NATL ACAD SCI USA, V117, P28795, DOI 10.1073/pnas.2008122117; Eigenbrod S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188989; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Huang JJ, 2020, J MOL BIOL, V432, P828, DOI 10.1016/j.jmb.2019.11.020; Iraci N, 2015, VIRUS RES, V207, P62, DOI 10.1016/j.virusres.2014.10.015; Kang J, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000327; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim S, 2016, P NATL ACAD SCI USA, V113, pE847, DOI 10.1073/pnas.1521521113; Konig A. S., 2021, J BIOL CHEM, V296; Kostylev MA, 2018, MOL CELL, V72, P426, DOI 10.1016/j.molcel.2018.10.009; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin YH, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.178101; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Matos CO, 2020, FASEB J, V34, P365, DOI 10.1096/fj.201901897R; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Nguyen XTA, 2019, MOL NEUROBIOL, V56, P6121, DOI 10.1007/s12035-019-1510-9; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; O'Flynn BG, 2021, CURR OPIN CELL BIOL, V69, P70, DOI 10.1016/j.ceb.2020.12.012; Ondrejcak T, 2018, J NEUROSCI, V38, P10595, DOI 10.1523/JNEUROSCI.1700-18.2018; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Passos YM, 2021, INT J BIOL MACROMOL, V173, P34, DOI 10.1016/j.ijbiomac.2021.01.097; Pierce WK, 2016, J MOL BIOL, V428, P1256, DOI 10.1016/j.jmb.2015.10.002; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purro SA, 2018, BIOL PSYCHIAT, V83, P358, DOI 10.1016/j.biopsych.2017.11.020; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Resenberger UK, 2011, TOP CURR CHEM, V305, P101, DOI 10.1007/128_2011_160; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Sherrill CD, 2013, ACCOUNTS CHEM RES, V46, P1020, DOI 10.1021/ar3001124; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Smith LM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024075; Tange H., 2021, J BIOL CHEM, V296; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; Zbinden A, 2020, DEV CELL, V55, P45, DOI 10.1016/j.devcel.2020.09.014; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	57	8	8	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100860	10.1016/j.jbc.2021.100860	http://dx.doi.org/10.1016/j.jbc.2021.100860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34102212	gold, Green Published			2022-12-26	WOS:000678068400060
J	Suresh, V; Mohanty, V; Avula, K; Ghosh, A; Singh, B; Reddy, RK; Parida, D; Suryawanshi, AR; Raghav, SK; Chattopadhyay, S; Prasad, P; Swain, RK; Dash, R; Parida, A; Syed, GH; Senapati, S				Suresh, Voddu; Mohanty, Varshasnata; Avula, Kiran; Ghosh, Arup; Singh, Bharati; Reddy, Rajendra Kumar; Parida, Deepti; Suryawanshi, Amol Ratnakar; Raghav, Sunil Kumar; Chattopadhyay, Soma; Prasad, Punit; Swain, Rajeeb Kumar; Dash, Rupesh; Parida, Ajay; Syed, Gulam Hussain; Senapati, Shantibhusan			Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity	FASEB JOURNAL			English	Article						COVID-19; differentially expressed proteins; lung proteome; mass spectrometry; Orbitrap; pulmonary surfactant; SARS-CoV-2	IMMUNE-RESPONSES; PROTEIN; SURFACTANT; SERUM; MODEL	Syrian golden hamsters (Mesocricetus auratus) infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) manifests lung pathology. In this study, efforts were made to check the infectivity of a local SARS-CoV-2 isolate in a self-limiting and non-lethal hamster model and evaluate the differential expression of lung proteins during acute infection and convalescence. The findings of this study confirm the infectivity of this isolate in vivo. Analysis of clinical parameters and tissue samples show the pathophysiological manifestation of SARS-CoV-2 infection similar to that reported earlier in COVID-19 patients and hamsters infected with other isolates. However, diffuse alveolar damage (DAD), a common histopathological feature of human COVID-19 was only occasionally noticed. The lung-associated pathological changes were very prominent on the 4th day post-infection (dpi), mostly resolved by 14 dpi. Here, we carried out the quantitative proteomic analysis of the lung tissues from SARS-CoV-2-infected hamsters on day 4 and day 14 post-infection. This resulted in the identification of 1585 proteins of which 68 proteins were significantly altered between both the infected groups. Pathway analysis revealed complement and coagulation cascade, platelet activation, ferroptosis, and focal adhesion as the top enriched pathways. In addition, we also identified altered expression of two pulmonary surfactant-associated proteins (Sftpd and Sftpb), known for their protective role in lung function. Together, these findings will aid in understanding the mechanism(s) involved in SARS-CoV-2 pathogenesis and progression of the disease.	[Suresh, Voddu; Mohanty, Varshasnata; Avula, Kiran; Ghosh, Arup; Singh, Bharati; Reddy, Rajendra Kumar; Parida, Deepti; Suryawanshi, Amol Ratnakar; Raghav, Sunil Kumar; Chattopadhyay, Soma; Prasad, Punit; Swain, Rajeeb Kumar; Dash, Rupesh; Parida, Ajay; Syed, Gulam Hussain; Senapati, Shantibhusan] Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Odisha, India; [Suresh, Voddu; Avula, Kiran; Parida, Deepti] Reg Ctr Biotechnol, Faridabad, India; [Ghosh, Arup; Singh, Bharati] Kalinga Inst Ind Technol, Bhubaneswar, India	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Kalinga Institute of Industrial Technology (KIIT)	Syed, GH; Senapati, S (corresponding author), Inst Life Sci, Nalco Sq, Bhubaneswar 751023, Odisha, India.	gulamsyed@ils.res.in; senapati@ils.res.in		Ghosh, Arup/0000-0003-3259-0124; Syed, Gulam/0000-0001-8540-6162; MOHANTY, VARSHASNATA/0000-0002-1520-7974; Senapati, Shantibhusan/0000-0001-7108-8255; Suresh, Voddu/0000-0001-8533-9465	DBT-BIRAC, India [BT/CS0004/CS/02/20]	DBT-BIRAC, India	DBT-BIRAC, India, Grant/Award Number: BT/CS0004/CS/02/20	Ackermann M, 2020, NEW ENGL J MED, V383, P120, DOI 10.1056/NEJMoa2015432; Bradley BT, 2020, LANCET, V396, P320, DOI 10.1016/S0140-6736(20)31305-2; Chan JFW, 2020, CLIN INFECT DIS, V71, P2139, DOI 10.1093/cid/ciaa644; Chan JFW, 2020, CLIN INFECT DIS, V71, P2428, DOI 10.1093/cid/ciaa325; Chen RC, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05672; Das S, 2014, MOL CANCER RES, V12, P1195, DOI 10.1158/1541-7786.MCR-14-0131; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; Doyle IR, 1997, AM J RESP CRIT CARE, V156, P1217, DOI 10.1164/ajrccm.156.4.9603061; Edeas M, 2020, INT J INFECT DIS, V97, P303, DOI 10.1016/j.ijid.2020.05.110; Ehaideb SN, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03304-8; Fox SE, 2020, LANCET RESP MED, V8, P681, DOI 10.1016/S2213-2600(20)30243-5; Glasser JR, 2012, MICROBES INFECT, V14, P17, DOI 10.1016/j.micinf.2011.08.019; Goldstein AL, 2015, EXPERT OPIN BIOL TH, V15, pS139, DOI 10.1517/14712598.2015.1011617; Goldstein AL, 2012, EXPERT OPIN BIOL TH, V12, P37, DOI 10.1517/14712598.2012.634793; Gomez-Casado C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071730; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; Grasselli G, 2020, LANCET RESP MED, V8, P1201, DOI 10.1016/S2213-2600(20)30370-2; Greene KE, 1999, AM J RESP CRIT CARE, V160, P1843, DOI 10.1164/ajrccm.160.6.9901117; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Hermjakob H, 2006, EXPERT REV PROTEOMIC, V3, P1, DOI 10.1586/14789450.3.1.1; Hong GN, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0950; Hou X, 2020, MOL CELL PROTEOMICS, V19, P1749, DOI 10.1074/mcp.RP120.002128; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Islam AMMK, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76404-8; Ji HL, 2020, PHYSIOL REV, V100, P1065, DOI 10.1152/physrev.00013.2020; Ji YL, 2015, PLATELETS, V26, P138, DOI 10.3109/09537104.2014.888547; Kale K, 2020, AM J REPROD IMMUNOL, V83, DOI 10.1111/aji.13208; Kang R, 2014, MOL ASPECTS MED, V40, P1, DOI 10.1016/j.mam.2014.05.001; Kerget B, 2020, LUNG, V198, P777, DOI 10.1007/s00408-020-00393-8; Kim MS, 2014, NATURE, V509, P575, DOI 10.1038/nature13302; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lee ACY, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100121; Lee CY, 2021, CURR OPIN VIROL, V48, P73, DOI 10.1016/j.coviro.2021.03.009; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Leng L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00355-9; Li C, 2021, CLIN INFECT DIS, V73, pE719, DOI 10.1093/cid/ciab083; Li J, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2298-2; Li Yanchang, 2020, Urine (Amst), V2, P1, DOI 10.1016/j.urine.2021.02.001; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Matsumoto T, 2016, INT J CHRONIC OBSTR, V11, P2321, DOI 10.2147/COPD.S113707; McGonagle D, 2020, LANCET RHEUMATOL, V2, pE437, DOI 10.1016/S2665-9913(20)30121-1; Messner CB, 2020, CELL SYST, V11, P11, DOI 10.1016/j.cels.2020.05.012; Mi HY, 2021, NUCLEIC ACIDS RES, V49, pD394, DOI 10.1093/nar/gkaa1106; Middleton EA, 2016, PHYSIOL REV, V96, P1211, DOI 10.1152/physrev.00038.2015; Mohandas S, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102054; Mukherjee AB, 2007, ENDOCR REV, V28, P707, DOI 10.1210/er.2007-0018; Munoz-Fontela C, 2020, NATURE, V586, P509, DOI 10.1038/s41586-020-2787-6; Nie X, 2021, CELL, V184, P775, DOI 10.1016/j.cell.2021.01.004; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; Park J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-80120-8; Rogan PK, 2020, F1000RESEARCH, V9, P943, DOI [DOI 10.12688/F1000RESEARCH.25390.1, 10.12688/ f1000research.25390.1]; Rosenke Kyle, 2020, bioRxiv, DOI 10.1101/2020.09.25.314070; Sahin, 2020, 2005201420102558 MED, V2005; Shen B, 2020, CELL, V182, P59, DOI 10.1016/j.cell.2020.05.032; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Sia SF, 2020, NATURE, V583, P834, DOI 10.1038/s41586-020-2342-5; Sinha P, 2020, JAMA INTERN MED, V180, P1152, DOI 10.1001/jamainternmed.2020.3313; Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529; Suresh V, 2021, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.579330; Suresh V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51947-7; Surette AP, 2011, BLOOD, V118, P3172, DOI 10.1182/blood-2011-05-353482; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Tostanoski LH, 2020, NAT MED, V26, P1694, DOI 10.1038/s41591-020-1070-6; Tresoldi I, 2020, J MED VIROL, V92, P1741, DOI 10.1002/jmv.25831; Vargas-Vargas M, 2020, REV PANAM SALUD PUBL, V44, DOI 10.26633/RPSP.2020.72; Vinayagam S, 2020, LIFE SCI, V260, DOI 10.1016/j.lfs.2020.118431; Wang N, 2019, J IMMUNOL, V203, P1288, DOI 10.4049/jimmunol.1900427; Wang SZ, 2003, J IMMUNOL, V171, P1051, DOI 10.4049/jimmunol.171.2.1051; Wang YT, 2013, ARCH IMMUNOL THER EX, V61, P309, DOI 10.1007/s00005-013-0230-5; Weisel JW, 2017, SUBCELL BIOCHEM, V82, P405, DOI 10.1007/978-3-319-49674-0_13; Weiskirchen R, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01905; Wu M, 2020, P NATL ACAD SCI USA, V117, P28336, DOI 10.1073/pnas.2018030117; Xu M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.584310; Zeng HL, 2021, FEBS J, V288, P5190, DOI 10.1111/febs.15609	76	7	7	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21713	10.1096/fj.202100431R	http://dx.doi.org/10.1096/fj.202100431R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105201	Green Published, Green Submitted			2022-12-26	WOS:000667814100034
J	Sevim, H; Celik, H; Dusunceli, L; Ceyhan, CS; Molotkova, A; Nakazawa, K; Graham, GT; Petro, JR; Toretsky, JA; Uren, A				Sevim, Handan; Celik, Haydar; Dusunceli, Levent; Ceyhan, Ceyda S.; Molotkova, Anna; Nakazawa, Kay; Graham, Garrett T.; Petro, Jeffrey R.; Toretsky, Jeffrey A.; Uren, Aykut			Clofarabine induces ERK/MSK/CREB activation through inhibiting CD99 on Ewing sarcoma cells	PLOS ONE			English	Article							DEOXYCYTIDINE KINASE; DOSE CYTARABINE; TARGET; EXPRESSION; MECHANISM; ANALOGS; SIGNAL	Clofarabine, an FDA approved purine analog, is used in the treatment of relapsed or refractory acute lymphoblastic leukemia. Clofarabine acts by inhibiting DNA synthesis. We demonstrated that clofarabine may have a novel function though inhibiting CD99, a transmembrane protein highly expressed on Ewing Sarcoma (ES) cells. CD99 is a validated target in ES whose inhibition may lead to a high therapeutic index for patients. Here we present additional data to support the hypothesis that clofarabine acts on CD99 and regulates key signaling pathways in ES. Cellular thermal shift assay indicated a direct interaction between clofarabine and CD99 in ES cell lysates. Clofarabine induced ES cell death does not require clofarabine's conversion to its active form by deoxycytidine kinase. A phosphokinase array screen with clofarabine and a CD99 blocking antibody identified alterations in signaling pathways. CD99 inhibition with clofarabine in ES cells caused rapid and sustained phosphorylation of ERK, MSK, and CREB. However, activation of this pathway did not correlate with clofarabine induced ES cell death. In summary, we demonstrated that clofarabine may activate ERK, MSK, and CREB phosphorylation through CD99 within minutes, however this paradoxical activation and subsequent ES cell death requires additional investigation.	[Sevim, Handan; Celik, Haydar; Dusunceli, Levent; Ceyhan, Ceyda S.; Molotkova, Anna; Nakazawa, Kay; Graham, Garrett T.; Petro, Jeffrey R.; Toretsky, Jeffrey A.; Uren, Aykut] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA; [Sevim, Handan] Hacettepe Univ, Fac Sci, Dept Biol, Ankara, Turkey	Georgetown University; Hacettepe University	Sevim, H; Uren, A (corresponding author), Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.; Sevim, H (corresponding author), Hacettepe Univ, Fac Sci, Dept Biol, Ankara, Turkey.	sevimh@hacettepe.edu.tr; au26@georgetown.edu	SEVIM, HANDAN/N-3245-2019	SEVIM, HANDAN/0000-0002-8511-5258; ceyhan, ceyda seren/0000-0002-5126-612X; Dusunceli, Levent/0000-0002-9301-2259; Graham, Garrett/0000-0002-1097-0962	Children's Cancer Foundation; St. Baldrick's Foundation; Hyundai Hope On Wheels; Alan B. Slifka Foundation	Children's Cancer Foundation; St. Baldrick's Foundation; Hyundai Hope On Wheels; Alan B. Slifka Foundation	We are grateful to Children's Cancer Foundation, St. Baldrick's Foundation, Hyundai Hope On Wheels, Alan B. Slifka Foundation for providing peer reviewed grant support for the studies included in this manuscript.	Adewumi Ifeoluwa, 2019, Advances in Biological Regulation, V71, P147, DOI 10.1016/j.jbior.2018.09.010; Allen LF, 2003, SEMIN ONCOL, V30, P105, DOI 10.1053/j.seminoncol.2003.08.012; Andre N, 2009, PEDIATR BLOOD CANCER, V53, P238, DOI 10.1002/pbc.21940; Bamford MJ, 2005, BIOORG MED CHEM LETT, V15, P3402, DOI 10.1016/j.bmcl.2005.05.021; Bonate PL, 2006, NAT REV DRUG DISCOV, V5, P855, DOI 10.1038/nrd2055; Byun HJ, 2006, J BIOL CHEM, V281, P34833, DOI 10.1074/jbc.M605483200; Cardoso LC., 2017, CD99 PLAYS IMPORTANT; Casey DL, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00537; Celik H, 2018, ONCOGENE, V37, P2181, DOI 10.1038/s41388-017-0080-4; Celik H, 2015, MOL CELL BIOL, V35, P3145, DOI 10.1128/MCB.00332-15; Chang S, 2011, CANCER INVEST, V29, P240, DOI 10.3109/07357907.2010.550594; Cheng F, 2015, J VIROL, V89, P9262, DOI 10.1128/JVI.01098-15; Delaney AM, 2002, MOL CELL BIOL, V22, P7593, DOI 10.1128/MCB.22.21.7593-7602.2002; DuBois SG, 2009, PEDIATR BLOOD CANCER, V52, P324, DOI 10.1002/pbc.21822; El Beaino M, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0668-z; Enein AAA, 2016, CANCER BIOMARK, V17, P117, DOI 10.3233/CBM-160608; ERIKSSON S, 1991, BIOCHEM BIOPH RES CO, V176, P586, DOI 10.1016/S0006-291X(05)80224-4; Franzetti GA, 2013, ONCOGENE, V32, P3915, DOI 10.1038/onc.2012.403; Gollnest T, 2016, ANGEW CHEM INT EDIT, V55, P5255, DOI 10.1002/anie.201511808; Gollnest T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9716; Grunewald TGP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0003-x; Guerzoni C, 2015, CLIN CANCER RES, V21, P146, DOI 10.1158/1078-0432.CCR-14-0492; Hahn MJ, 2000, FEBS LETT, V470, P350, DOI 10.1016/S0014-5793(00)01330-2; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Kim SK, 2016, HUM PATHOL, V55, P91, DOI 10.1016/j.humpath.2016.05.008; Manara MC, 2018, GENES-BASEL, V9, DOI 10.3390/genes9030159; Mansson E, 2003, BIOCHEM PHARMACOL, V65, P237, DOI 10.1016/S0006-2952(02)01484-3; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Pasello M, 2018, J CELL COMMUN SIGNAL, V12, P55, DOI 10.1007/s12079-017-0445-z; Pettitt AR, 2003, BRIT J HAEMATOL, V121, P692, DOI 10.1046/j.1365-2141.2003.04336.x; Reyskens KMSE, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00056; Robak P, 2013, CANCER TREAT REV, V39, P851, DOI 10.1016/j.ctrv.2013.03.006; Rocchi A, 2010, J CLIN INVEST, V120, P668, DOI 10.1172/JCI36667; Salaroglio IC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102505; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scotlandi K, 2007, ONCOGENE, V26, P6604, DOI 10.1038/sj.onc.1210481; Shibuya R, 2014, VIRCHOWS ARCH, V465, P599, DOI 10.1007/s00428-014-1627-1; Stegmaier K, 2007, PLOS MED, V4, P702, DOI 10.1371/journal.pmed.0040122; Vaikari VP, 2020, HAEMATOLOGICA, V105, P999, DOI 10.3324/haematol.2018.207001; Ventura S, 2016, ONCOGENE, V35, P3944, DOI 10.1038/onc.2015.463; Xia YF, 2018, MOL CANCER RES, V16, P825, DOI 10.1158/1541-7786.MCR-17-0576; Zhang CJ, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-1061-1; Zhang Y, 2006, ACTA CRYSTALLOGR D, V62, P133, DOI 10.1107/S0907444905034293; Zhenchuk A, 2009, BIOCHEM PHARMACOL, V78, P1351, DOI 10.1016/j.bcp.2009.06.094; Zhou FC, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108332; Zou JR, 2019, MOL MED REP, V19, P759, DOI 10.3892/mmr.2018.9712	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0253170	10.1371/journal.pone.0253170	http://dx.doi.org/10.1371/journal.pone.0253170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133426	Green Published, gold			2022-12-26	WOS:000671682700031
J	Liang, T; Chen, JR; Xu, GY; Zhang, ZD; Xue, J; Zeng, HP; Jiang, J; Chen, TY; Qin, ZJ; Li, H; Ye, Z; Nie, YF; Liu, C; Zhan, XL				Liang, Tuo; Chen, Jiarui; Xu, GuoYong; Zhang, Zide; Xue, Jiang; Zeng, Haopeng; Jiang, Jie; Chen, Tianyou; Qin, Zhaojie; Li, Hao; Ye, Zhen; Nie, Yunfeng; Liu, Chong; Zhan, Xinli			Immune status changing helps diagnose osteoarticular tuberculosis	PLOS ONE			English	Article							EXTRAPULMONARY TUBERCULOSIS; RISK; LYMPHOCYTES; INFECTION; RESPONSES; MONOCYTES; RATIO	Objective This study is aimed to develop a new nomogram for the clinical diagnosis of osteoarticular tuberculosis (TB). Methods xCell score estimation to obtained the immune cell type abundance scores. We downloaded the expression profile of GSE83456 from GEO and proceed xCell score estimation. The routine blood examinations of 326 patients were collected for further validation. We analyzed univariate and multivariate logistic regression to identified independent predicted factor for developing the nomogram. The performance of the nomogram was assessed using the receiver operating characteristic (ROC) curves. The correlation of ESR with lymphocytes, monocytes, and ML ratio was performed and visualized in osteoarticular TB patients. Results Compared with the healthy control group in the dataset GSE83456, the xCell score of basophils, monocytes, neutrophils, and platelets was higher, while lymphoid was lower in the EPTB group. The clinical data showed that the cell count of monocytes were much higher, while the cell counts of lymphocytes were lower in the osteoarticular TB group. AUCs of the nomogram was 0.798 for the dataset GSE83456, and 0.737 for the clinical data. We identified the ML ratio, BMI, and ESR as the independent predictive factors for osteoarticular TB diagnosis and constructed a nomogram for the clinical diagnosis of osteoarticular TB. AUCs of this nomogram was 0.843. Conclusions We demonstrated a significant change between the ML ratio of the EPTB and non-TB patients. Moreover, we constructed a nomogram for the clinical diagnosis of the osteoarticular TB diagnosis, which works satisfactorily.	[Liang, Tuo; Chen, Jiarui; Xu, GuoYong; Zhang, Zide; Xue, Jiang; Zeng, Haopeng; Jiang, Jie; Chen, Tianyou; Qin, Zhaojie; Li, Hao; Ye, Zhen; Liu, Chong; Zhan, Xinli] Guangxi Med Univ, Affiliated Hosp 1, Spine & Osteopathy Ward, Nanning, Guangxi, Peoples R China; [Nie, Yunfeng] Guangxi Med Univ, Nanning, Guangxi, Peoples R China	Guangxi Medical University; Guangxi Medical University	Zhan, XL (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Spine & Osteopathy Ward, Nanning, Guangxi, Peoples R China.	zhanxinli@stu.gxmu.edu.cn		Zhan, Xinli/0000-0003-3287-4581	National Natural Science Foundation of China [81860393]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was sponsored by the National Natural Science Foundation of China (81560359); National Natural Science Foundation of China (81860393). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran D, 2020, METHODS MOL BIOL, V2120, P263, DOI 10.1007/978-1-0716-0327-7_19; Braverman J, 2017, J IMMUNOL, V199, P1805, DOI 10.4049/jimmunol.1700515; Cliff JM, 2015, IMMUNOL REV, V264, P88, DOI 10.1111/imr.12269; Ding RD, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012177; Furin J, 2019, LANCET, V393, P1642, DOI 10.1016/S0140-6736(19)30308-3; Gaensbauer J, 2019, CURR INFECT DIS REP, V21, DOI 10.1007/s11908-019-0662-0; Gao WW, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05137-w; Habtamu M, 2020, CLIN EXP IMMUNOL, V201, P187, DOI 10.1111/cei.13447; Kim JH, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3349-5; Krakauer T, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/2471215; La Manna MP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171358; Ma JJ, 2014, FASEB J, V28, P3238, DOI 10.1096/fj.13-247056; Ma YF, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4597-8; Meier NR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02476; Mohammed H, 2018, HIV AIDS-RES PALLIAT, V10, P225, DOI 10.2147/HIV.S176587; Moreira-Teixeira L, 2018, J EXP MED, V215, P1273, DOI 10.1084/jem.20180325; Naranbhai V, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0120-7; Naranbhai V, 2014, J INFECT DIS, V209, P500, DOI 10.1093/infdis/jit494; Nasiri MJ, 2019, INFECTION, V47, P353, DOI 10.1007/s15010-019-01285-7; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Pollett S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149372; Qian X, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0106-1; Soyano AE, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0447-2; Suarez I, 2019, DTSCH ARZTEBL INT, V116, P729, DOI 10.3238/arztebl.2019.0729; Tahseen S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232134; Tang JS, 2016, TUBERCULOSIS, V98, P30, DOI 10.1016/j.tube.2016.02.005; Tang Y, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20192134; Wang L, 2020, DIS MARKERS, V2020, DOI 10.1155/2020/2509454; Wassermann R, 2015, CELL HOST MICROBE, V17, P799, DOI 10.1016/j.chom.2015.05.003; Yadav J, 2019, CURR PHARM BIOTECHNO, V20, P446, DOI 10.2174/1389201020666190430114121; Zhang QW, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/2432904	31	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0252875	10.1371/journal.pone.0252875	http://dx.doi.org/10.1371/journal.pone.0252875			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129634	Green Published, gold			2022-12-26	WOS:000665475100015
J	Woo, HG; Chang, Y; Lee, JS; Song, TJ				Woo, Ho Geol; Chang, Yoonkyung; Lee, Ji Sung; Song, Tae-Jin			Tooth loss is associated with an increased risk of hypertension: A nationwide population-based cohort study	PLOS ONE			English	Article							PERIODONTAL-DISEASE; BLOOD-PRESSURE; HEART-FAILURE; ORAL-HEALTH; PREVALENCE; NUTRITION	Tooth loss is closely associated with suboptimal oral care. Suboptimal oral care can facilitate local infections. These can lead to systemic inflammation and endothelial dysfunction, which are important pathological mechanisms of hypertension. The aim of this study was to investigate the link between tooth loss and the risk of hypertension. From the national health insurance system-health screening cohort in Korea, 19,680 participants who underwent three or more health examinations, including blood pressure measurements, between January 2003 and December 2008, without any history or diagnosis of hypertension were included in this study. Hypertension was defined as the diagnosis of hypertension (International Classification of Diseases-10 code "I10-11") accompanied by the prescription of an antihypertensive agent or at least one health examination result of blood pressure of >= 140/90 mmHg. Kaplan-Meier survival curves with the log-rank test were used to evaluate the relationship between oral hygiene indicators and the incidence of hypertension. Cox proportional hazard models were applied to determine the association between oral hygiene indicators and the development of hypertension. During a median follow-up of 7.4 years, 1,853 patients developed hypertension. The estimated incidence of hypertension within seven years was 8.8%. Multivariable analysis confirmed a significant relationship between the number of lost teeth and hypertension (hazard ratio: 2.26; 95% confidence interval [1.24-4.10], p = 0.007, p for trend = 0.005). There was a positive association between the number of lost teeth and the risk of hypertension in a longitudinal research. In conclusion, the number of lost teeth may be associated with the risk of development of hypertension.	[Woo, Ho Geol] Kyung Hee Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Chang, Yoonkyung] Ewha Womans Univ, Mokdong Hosp, Coll Med, Dept Neurol, Seoul, South Korea; [Lee, Ji Sung] Asan Med Ctr, Clin Res Ctr, Seoul, South Korea; [Song, Tae-Jin] Ewha Womans Univ, Seoul Hosp, Coll Med, Dept Neurol, Seoul, South Korea	Kyung Hee University; Ewha Womans University; Samsung; University of Ulsan; Asan Medical Center; Ewha Womans University	Song, TJ (corresponding author), Ewha Womans Univ, Seoul Hosp, Coll Med, Dept Neurol, Seoul, South Korea.	knstar@ewha.ac.kr	Woo, Ho Geol/AAX-4094-2021	Woo, Ho Geol/0000-0001-6489-0100; Chang, Yoonkyung/0000-0002-0345-2278	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [2021R1F1A1048113, 2021R1I1A1A01059868]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea)	This project was supported by grant from the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (2021R1F1A1048113 to T-JS, 2021R1I1A1A01059868 to Y-C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amar S, 2003, ARTERIOSCL THROM VAS, V23, P1245, DOI 10.1161/01.ATV.0000078603.90302.4A; Appel LJ, 1997, NEW ENGL J MED, V336, P1117, DOI 10.1056/NEJM199704173361601; Carey RM, 2018, J AM COLL CARDIOL, V72, P1278, DOI 10.1016/j.jacc.2018.07.008; Caton JG, 2018, J PERIODONTOL, V89, pS1, DOI 10.1002/JPER.18-0157; Chang Y, 2020, EUR J PREV CARDIOL, V27, P1835, DOI 10.1177/2047487319886018; Choi HM, 2015, J PERIODONTOL, V86, P866, DOI 10.1902/jop.2015.150025; Da DX, 2019, BMC ORAL HEALTH, V19, DOI 10.1186/s12903-019-0966-3; Darnaud C, 2015, AM J HYPERTENS, V28, P1257, DOI 10.1093/ajh/hpv025; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Hajishengallis G, 2015, NAT REV IMMUNOL, V15, P30, DOI 10.1038/nri3785; Holt R, 2000, BRIT MED J, V320, P1717, DOI 10.1136/bmj.320.7251.1717; Kinane DF, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.38; Kononen E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8081135; Lee HJ, 2019, J DENT RES, V98, P164, DOI 10.1177/0022034518814829; Lee JH, 2018, J PERIODONTAL IMPLAN, V48, P92, DOI 10.5051/jpis.2018.48.2.92; Lee JH, 2015, MEDICINE, V94, DOI [10.1097/MD.0000000000002075, 10.1097/MD.0000000000001567]; Loesche WJ, 1998, J AM DENT ASSOC, V129, P301, DOI 10.14219/jada.archive.1998.0204; Lowe G, 2003, J CLIN EPIDEMIOL, V56, P694, DOI 10.1016/S0895-4356(03)00086-6; Matthews D C, 2001, J Can Dent Assoc, V67, P207; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Aguilera EM, 2020, CARDIOVASC RES, V116, P28, DOI 10.1093/cvr/cvz201; Nowjack-Raymer RE, 2003, J DENT RES, V82, P123, DOI 10.1177/154405910308200209; Papapanou P N, 1996, Ann Periodontol, V1, P1, DOI 10.1902/annals.1996.1.1.1; Seong SC, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-016640; Shin HS, 2018, J PERIODONTOL, V89, P397, DOI 10.1002/JPER.17-0413; Singh A, 2016, J PUBLIC HEALTH DENT, V76, P198, DOI 10.1111/jphd.12136; Song SO, 2014, DIABETES METAB J, V38, P395, DOI 10.4093/dmj.2014.38.5.395; Stanaway JD, 2018, LANCET, V392, P1923, DOI 10.1016/s0140-6736(18)32225-6; Unger T, 2020, HYPERTENSION, V75, P1334, DOI 10.1161/HYPERTENSIONAHA.120.15026; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339	30	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253257	10.1371/journal.pone.0253257	http://dx.doi.org/10.1371/journal.pone.0253257			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129621	gold, Green Published			2022-12-26	WOS:000665475100038
J	Bedggood, P; Metha, A				Bedggood, Phillip; Metha, Andrew			Towards distortion-free imaging of the eye	PLOS ONE			English	Article							OPTICAL STABILIZATION; OCT; ABERRATIONS	The high power of the eye and optical components used to image it result in "static" distortion, remaining constant across acquired retinal images. In addition, raster-based systems sample points or lines of the image over time, suffering from "dynamic" distortion due to the constant motion of the eye. We recently described an algorithm which corrects for the latter problem but is entirely blind to the former. Here, we describe a new procedure termed "DIOS" (Dewarp Image by Oblique Shift) to remove static distortion of arbitrary type. Much like the dynamic correction method, it relies on locating the same tissue in multiple frames acquired as the eye moves through different gaze positions. Here, the resultant maps of pixel displacement are used to form a sparse system of simultaneous linear equations whose solution gives the common warp seen by all frames. We show that the method successfully handles torsional movement of the eye. We also show that the output of the previously described dynamic correction procedure may be used as input for this new procedure, recovering an image of the tissue that is, in principle, a faithful replica free of any type of distortion. The method could be extended beyond ocular imaging, to any kind of imaging system in which the image can move or be made to move across the detector.	[Bedggood, Phillip; Metha, Andrew] Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia	University of Melbourne	Bedggood, P (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Melbourne, Vic, Australia.	pabedg@unimelb.edu.au	Metha, Andrew/H-2401-2015	Metha, Andrew/0000-0003-2997-4362; Bedggood, Phillip/0000-0001-5144-3694	Australian Research Council [DP180103393]	Australian Research Council(Australian Research Council)	Work supported by Australian Research Council (https://www.arc.gov.au/), Discovery Project DP180103393 (PB, AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akondi V, 2020, OPTICA, V7, P1506, DOI [10.1364/OPTICA.405187, 10.1364/optica.405187]; Azimipour M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206052; Bedggood PA, 2006, OPT EXPRESS, V14, P8019, DOI 10.1364/OE.14.008019; Bedggood P, 2020, OPT LETT, V45, P4320, DOI 10.1364/OL.398168; Bedggood P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174617; Bedggood P, 2010, J OPT SOC AM A, V27, pA37, DOI 10.1364/JOSAA.27.000A37; Bedggood P, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2907211; Bennett TJ, 2009, CLIN EXP OPHTHALMOL, V37, P2, DOI 10.1111/j.1442-9071.2008.01812.x; Bowers NR, 2019, J VISION, V19, DOI 10.1167/19.11.8; Burns SA, 2019, PROG RETIN EYE RES, V68, P1, DOI 10.1016/j.preteyeres.2018.08.002; Carpenter RHS, 1988, MOVEMENTS EYES; Cooper RF, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.5.26; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1757, DOI 10.1364/BOE.2.001757; Escudero-Sanz I, 1999, J OPT SOC AM A, V16, P1881, DOI 10.1364/JOSAA.16.001881; Espuny F, 2011, INT J COMPUT VISION, V91, P131, DOI 10.1007/s11263-010-0335-9; Friberg TR, 2003, OPHTHAL SURG LAS IM, V34, P488; Grossmann E, 2006, 2006 IEEE COMP SOC C; Jonnal RS, 2016, INVEST OPHTH VIS SCI, V57, pOCT51, DOI 10.1167/iovs.16-19103; Kashani AH, 2017, PROG RETIN EYE RES, V60, P66, DOI 10.1016/j.preteyeres.2017.07.002; Kurokawa K, 2021, J BIOMED OPT, V26, DOI 10.1117/1.JBO.26.1.016001; Li ZH, 2020, OPT EXPRESS, V28, P38390, DOI 10.1364/OE.410374; Luo T, 2017, INVEST OPHTH VIS SCI, V58, P2685, DOI 10.1167/iovs.17-21653; Maloney LT, 1989, NEURAL COMPUT, V1, P392, DOI 10.1162/neco.1989.1.3.392; Mece P, 2020, BIOMED OPT EXPRESS, V11, P492, DOI 10.1364/BOE.381398; Nister D, 2005, 10 IEEE INT C COMP V, V1; Ramalingam S, 2010, COMPUT VIS IMAGE UND, V114, P210, DOI 10.1016/j.cviu.2009.07.007; Sakata LM, 2009, CLIN EXP OPHTHALMOL, V37, P90, DOI 10.1111/j.1442-9071.2009.02015.x; Salmon AE, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.2.9; Smith G, 2008, OPTOMETRY VISION SCI, V85, P330, DOI 10.1097/OPX.0b013e31816c4449; Vercauteren T, 2009, NEUROIMAGE, V45, pS61, DOI 10.1016/j.neuroimage.2008.10.040; Vienola KV, 2012, BIOMED OPT EXPRESS, V3, P2950, DOI 10.1364/BOE.3.002950; Vogel CR, 2006, OPT EXPRESS, V14, P487, DOI 10.1364/OPEX.14.000487; Von Gioi RG, 2010, 2010 IEEE INT C IM P; Yang Q, 2014, BIOMED OPT EXPRESS, V5, P3174, DOI 10.1364/BOE.5.003174; Zhang Z., 2016, CAMERA CALIBRATION P; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252876	10.1371/journal.pone.0252876	http://dx.doi.org/10.1371/journal.pone.0252876			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111195	Green Published, gold			2022-12-26	WOS:000664642700055
J	Bell, RL; Withers, GS; Kuypers, FA; Stehr, W; Bhargava, A				Bell, Robert L.; Withers, Ginger S.; Kuypers, Frans A.; Stehr, Wolfgang; Bhargava, Aditi			Stress and corticotropin releasing factor (CRF) promote necrotizing enterocolitis in a formula-fed neonatal rat model	PLOS ONE			English	Article							INTESTINAL BARRIER; NITRIC-OXIDE; GASTROINTESTINAL-TRACT; UROCORTIN 1; PATHOGENESIS; EXPRESSION; TLR4; ACTIVATION; RECEPTORS; CYTOKINES	The etiology of necrotizing enterocolitis (NEC) is not known. Alterations in gut microbiome, mucosal barrier function, immune cell activation, and blood flow are characterized events in its development, with stress as a contributing factor. The hormone corticotropin-releasing factor (CRF) is a key mediator of stress responses and influences these aforementioned processes. CRF signaling is modulated by NEC's main risk factors of prematurity and formula feeding. Using an established neonatal rat model of NEC, we tested hypotheses that: (i) increased CRF levels-as seen during stress-promote NEC in formula-fed (FF) newborn rats, and (ii) antagonism of CRF action ameliorates NEC. Newborn pups were formula-fed to initiate gut inflammation and randomized to: no stress, no stress with subcutaneous CRF administration, stress (acute hypoxia followed by cold exposure-NEC model), or stress after pretreatment with the CRF peptide antagonist Astressin. Dam-fed unstressed and stressed littermates served as controls. NEC incidence and severity in the terminal ileum were determined using a histologic scoring system. Changes in CRF, CRF receptor (CRFRs), and toll-like receptor 4 (TLR4) expression levels were determined by immunofluorescence and immunoblotting, respectively. Stress exposure in FF neonates resulted in 40.0% NEC incidence, whereas exogenous CRF administration resulted in 51.7% NEC incidence compared to 8.7% in FF non-stressed neonates (p<0.001). Astressin prevented development of NEC in FF-stressed neonates (7.7% vs. 40.0%; p = 0.003). CRF and CRFR immunoreactivity increased in the ileum of neonates with NEC compared to dam-fed controls or FF unstressed pups. Immunoblotting confirmed increased TLR4 protein levels in FF stressed (NEC model) animals vs. controls, and Astressin treatment restored TLR4 to control levels. Peripheral CRF may serve as specific pharmacologic target for the prevention and treatment of NEC.	[Bell, Robert L.] Univ Calif San Francisco UCSF, Benioff Childrens Hosp, East Bay Surg Program, Dept Surg, Oakland, CA USA; [Bell, Robert L.; Kuypers, Frans A.; Stehr, Wolfgang] Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA; [Bell, Robert L.] Permanente Med Grp Inc, Dept Surg, Walnut Creek, CA USA; [Withers, Ginger S.] Whitman Coll, Dept Biol, Walla Walla, WA 99362 USA; [Kuypers, Frans A.; Stehr, Wolfgang] UCSF Benioff Childrens Hosp Oakland, Oakland, CA 94609 USA; [Bhargava, Aditi] Univ Calif San Francisco, Ctr Reprod Sci, Dept Obstet & Gynecol, San Francisco, CA 94110 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Children's Hospital Los Angeles; Children's Hospital Oakland Research Institute; Permanente Medical Groups; Whitman College; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; University of California System; University of California San Francisco	Stehr, W (corresponding author), Childrens Hosp, Oakland Res Inst, Oakland, CA 94609 USA.; Stehr, W (corresponding author), UCSF Benioff Childrens Hosp Oakland, Oakland, CA 94609 USA.; Bhargava, A (corresponding author), Univ Calif San Francisco, Ctr Reprod Sci, Dept Obstet & Gynecol, San Francisco, CA 94110 USA.	Aditi.bhargava@ucsf.edu; Aditi.bhargava@ucsf.edu		Bhargava, Aditi/0000-0003-1334-0517	NIH/NIDDK [R01 DK070878]	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by funds from a R01 DK070878 from NIH/NIDDK to Aditi Bhargava. A portion of Dr. Bhargava's salary was supported by this grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other authors received no specific funding for this project.	Aceti A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/7397659; Afrazi A, 2011, PEDIATR RES, V69, P183, DOI 10.1203/PDR.0b013e3182093280; Agelaki S, 2002, INFECT IMMUN, V70, P6068, DOI 10.1128/IAI.70.11.6068-6074.2002; AlFaleh K, 2011, COCHRANE DB SYST REV, DOI [10.1097/AOG.0b013e3181726f2f, 10.1002/14651858.CD005496.pub3]; Anand RJ, 2007, SHOCK, V27, P124, DOI 10.1097/01.shk.0000239774.02904.65; Bale TL, 2004, ANNU REV PHARMACOL, V44, P525, DOI 10.1146/annurev.pharmtox.44.101802.121410; BAUER CR, 1984, PEDIATRICS, V73, P682; Bolt RJ, 2002, CLIN ENDOCRINOL, V56, P207, DOI 10.1046/j.0300-0664.2001.01467.x; Buckinx R, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00054; Caplan Michael S, 2005, Semin Pediatr Surg, V14, P145, DOI 10.1053/j.sempedsurg.2005.05.002; Carlisle EM, 2013, CURR OPIN PEDIATR, V25, P382, DOI 10.1097/MOP.0b013e3283600e91; Carlisle EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018084; Caso JR, 2008, CURR MOL MED, V8, P299, DOI 10.2174/156652408784533751; Cetin S, 2004, J BIOL CHEM, V279, P24592, DOI 10.1074/jbc.M313620200; Chang J, 2007, PEPTIDES, V28, P1453, DOI 10.1016/j.peptides.2007.05.008; Chang J, 2011, AM J PHYSIOL-GASTR L, V300, pG884, DOI 10.1152/ajpgi.00319.2010; Chaniotou Z, 2010, GASTROENTEROLOGY, V139, P2083, DOI 10.1053/j.gastro.2010.08.024; Cong BH, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-43; CROWLEY P, 1990, BRIT J OBSTET GYNAEC, V97, P11, DOI 10.1111/j.1471-0528.1990.tb01711.x; Cureton EL, 2009, ENDOCRINOLOGY, V150, P5428, DOI 10.1210/en.2009-0489; D'Costa S, 2019, J ALLERGY CLIN IMMUN, V143, P1865, DOI 10.1016/j.jaci.2018.08.053; Downard CD, 2011, J PEDIATR SURG, V46, P1023, DOI 10.1016/j.jpedsurg.2011.03.023; DRUGE G, 1989, AM J PHYSIOL, V256, pG214, DOI 10.1152/ajpgi.1989.256.1.G214; Estienne M, 2010, GUT, V59, P744, DOI 10.1136/gut.2009.190728; Ford H, 1997, J PEDIATR SURG, V32, P275, DOI 10.1016/S0022-3468(97)90194-9; Ford HR, 2006, J PEDIATR SURG, V41, P294, DOI 10.1016/j.jpedsurg.2005.11.003; Gareau MG, 2008, CURR MOL MED, V8, P274, DOI 10.2174/156652408784533760; Gougoura S, 2010, FREE RADICAL RES, V44, P803, DOI 10.3109/10715762.2010.485988; Hackam David J, 2005, Semin Pediatr Surg, V14, P49, DOI 10.1053/j.sempedsurg.2004.10.025; Hagiwara S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020101; Hagiwara S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203704; HALAC E, 1990, J PEDIATR-US, V117, P132, DOI 10.1016/S0022-3476(05)72461-6; Halpern MD, 2006, AM J PHYSIOL-GASTR L, V290, pG757, DOI 10.1152/ajpgi.00408.2005; Hasdemir B, 2016, AM J PHYSIOL-REG I, V310, pR1244, DOI 10.1152/ajpregu.00445.2015; Hsueh W, 2003, PEDIATR DEVEL PATHOL, V6, P6, DOI 10.1007/s10024-002-0602-z; Hunter CJ, 2008, PEDIATR RES, V63, P117, DOI 10.1203/PDR.0b013e31815ed64c; Iji TO, 2013, J S AFR VET ASSOC, V84, DOI 10.4102/jsava.v84i1.1083; Ito Y, 2007, PEDIATR RES, V61, P180, DOI 10.1203/pdr.0b013e31802d77db; Jilling T, 2006, J IMMUNOL, V177, P3273, DOI 10.4049/jimmunol.177.5.3273; Jorge E, 2010, NEUROGASTROENT MOTIL, V22, pE241, DOI 10.1111/j.1365-2982.2010.01507.x; Keita A V, 2010, Neurogastroenterol Motil, V22, P770, DOI 10.1111/j.1365-2982.2010.01471.x; Keita AV, 2010, NEUROGASTROENT MOTIL, V22, P718, DOI 10.1111/j.1365-2982.2010.01498.x; Kul M, 2009, J PEDIATR GASTR NUTR, V49, P85, DOI 10.1097/MPG.0b013e318198cd36; la Fleur SE, 2005, P NATL ACAD SCI USA, V102, P7647, DOI 10.1073/pnas.0408531102; Lach G, 2018, NEUROTHERAPEUTICS, V15, P36, DOI 10.1007/s13311-017-0585-0; Larauche M, 2009, J PHYSIOL PHARMACOL, V60, P33; Leaphart CL, 2007, J IMMUNOL, V179, P4808, DOI 10.4049/jimmunol.179.7.4808; Li B, 2017, SCI REP-UK, V7, DOI 10.1038/srep46616; Liu S, 2016, NEUROGASTROENT MOTIL, V28, P281, DOI 10.1111/nmo.12725; Liu SM, 2021, NEUROGASTROENT MOTIL, V33, DOI 10.1111/nmo.14021; Liu YY, 2009, AM J PHYSIOL-GASTR L, V297, pG442, DOI 10.1152/ajpgi.00182.2009; Lutgendorff F, 2008, CURR MOL MED, V8, P282, DOI 10.2174/156652408784533779; McElroy SJ, 2011, AM J PHYSIOL-GASTR L, V301, pG656, DOI 10.1152/ajpgi.00550.2010; Murakami T, 2017, DIGESTION, V95, P55, DOI 10.1159/000452364; Nadler EP, 2000, J SURG RES, V92, P71, DOI 10.1006/jsre.2000.5877; Neu J, 2005, BIOL NEONATE, V87, P97, DOI 10.1159/000081898; Neu Josef, 2005, Semin Pediatr Surg, V14, P137, DOI 10.1053/j.sempedsurg.2005.05.001; Neufeld-Cohen A, 2010, P NATL ACAD SCI USA, V107, P19020, DOI 10.1073/pnas.1013761107; Nino DF, 2016, NAT REV GASTRO HEPAT, V13, P590, DOI 10.1038/nrgastro.2016.119; Nowicki Philip T, 2005, Semin Pediatr Surg, V14, P152, DOI 10.1053/j.sempedsurg.2005.05.003; Nowicki PT, 2005, J PEDIATR-US, V146, P805, DOI 10.1016/j.jpeds.2005.01.046; Petrosyan M, 2009, PEDIATR SURG INT, V25, P309, DOI 10.1007/s00383-009-2344-8; Sharma R, 2007, J PEDIATR SURG, V42, P454, DOI 10.1016/j.jpedsurg.2006.10.038; Soderholm JD, 2002, AM J PHYSIOL-GASTR L, V283, pG1257, DOI 10.1152/ajpgi.00314.2002; Stengel A, 2010, EXP BIOL MED, V235, P1168, DOI 10.1258/ebm.2010.009347; Sun YD, 2013, GASTROENTEROLOGY, V144, P1478, DOI 10.1053/j.gastro.2013.02.038; Tsatsanis C, 2006, J IMMUNOL, V176, P1869, DOI 10.4049/jimmunol.176.3.1869; Vuppaladhadiam L, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040839; Wilbert-Lampen U, 2006, J CARDIOVASC PHARM, V47, P110, DOI 10.1097/01.fjc.0000196240.58641.d3	69	1	1	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0246412	10.1371/journal.pone.0246412	http://dx.doi.org/10.1371/journal.pone.0246412			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111125	Green Published, gold, Green Submitted			2022-12-26	WOS:000664642700004
J	Olney, KC; Gibson, JD; Natri, HM; Underwood, A; Gadau, J; Wilson, MA				Olney, Kimberly C.; Gibson, Joshua D.; Natri, Heini M.; Underwood, Avery; Gadau, Juergen; Wilson, Melissa A.			Lack of parent-of-origin effects in Nasonia jewel wasp: A replication and extension study	PLOS ONE			English	Article							HYBRID BREAKDOWN; SOCIAL INSECTS; GENES; FRAMEWORK; CONFLICT; BEHAVIOR; NUCLEAR; TOOLS; LOCI	In diploid cells, the paternal and maternal alleles are, on average, equally expressed. There are exceptions from this: a small number of genes express the maternal or paternal allele copy exclusively. This phenomenon, known as genomic imprinting, is common among eutherian mammals and some plant species; however, genomic imprinting in species with haplodiploid sex determination is not well characterized. Previous work reported no parent-of-origin effects in the hybrids of closely related haplodiploid Nasonia vitripennis and Nasonia giraulti jewel wasps, suggesting a lack of epigenetic reprogramming during embryogenesis in these species. Here, we replicate the gene expression dataset and observations using different individuals and sequencing technology, as well as reproduce these findings using the previously published RNA sequence data following our data analysis strategy. The major difference from the previous dataset is that they used an introgression strain as one of the parents and we found several loci that resisted introgression in that strain. Our results from both datasets demonstrate a species-of-origin effect, rather than a parent-of-origin effect. We present a reproducible workflow that others may use for replicating the results. Overall, we reproduced the original report of no parent-of-origin effects in the haplodiploid Nasonia using the original data with our new processing and analysis pipeline and replicated these results with our newly generated data.	[Olney, Kimberly C.; Underwood, Avery; Wilson, Melissa A.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Olney, Kimberly C.; Natri, Heini M.; Underwood, Avery; Wilson, Melissa A.] Arizona State Univ, Ctr Evolut & Med, Tempe, AZ 85287 USA; [Gibson, Joshua D.] Georgia Southern Univ, Dept Biol, Statesboro, GA USA; [Gadau, Juergen] Univ Munster, Inst Evolut & Biodivers, Munster, Germany; [Wilson, Melissa A.] Arizona State Univ, Ctr Mech Evolut, Biodesign Inst, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University System of Georgia; Georgia Southern University; University of Munster; Arizona State University; Arizona State University-Tempe	Wilson, MA (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.; Wilson, MA (corresponding author), Arizona State Univ, Ctr Evolut & Med, Tempe, AZ 85287 USA.; Wilson, MA (corresponding author), Arizona State Univ, Ctr Mech Evolut, Biodesign Inst, Tempe, AZ 85287 USA.	mwilsons@asu.edu		Wilson, Melissa/0000-0002-2614-0285; Natri, Heini Maaret/0000-0003-4698-6103; Olney, Kimberly/0000-0002-8578-2069; Gibson, Joshua/0000-0002-0193-2307	ASU Center for Evolution and Medicine postdoctoral fellowship; National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [R35GM124827]; Division of Integrative Organismal Systems (IOS) of the National Science Foundation (NSF) [1145509]; Georgia Southern University; German Research Foundation (DFG) [281125614/GRK2220]; ARCS	ASU Center for Evolution and Medicine postdoctoral fellowship; National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Division of Integrative Organismal Systems (IOS) of the National Science Foundation (NSF); Georgia Southern University; German Research Foundation (DFG)(German Research Foundation (DFG)); ARCS	ARCS Spetzler Scholar additionally supported KCO. https://www.arcsfoundation.org/national-homepage. HMN was supported by an ASU Center for Evolution and Medicine postdoctoral fellowship. https://evmed.asu.edu/ MAW was supported by the National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) grant R35GM124827. https://www.nih.gov/. JDG was supported by the Division of Integrative Organismal Systems (IOS) of the National Science Foundation (NSF) grant 1145509 and by research funds provided by Georgia Southern University. https://www.nsf.gov/. JG was in part supported by a grant from the German Research Foundation (DFG) to N.S. (281125614/GRK2220, Project B7). https://www.dfg.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2009, P NATL ACAD SCI USA, V106, P15400, DOI 10.1073/pnas.0907043106; Andrews S., 2010, FASTQC QUALITY CONTR; Baker M, 2015, NATURE, P533; Baker M, 2016, NATURE, V533, P452, DOI 10.1038/533452a; Baruzzo G, 2017, NAT METHODS, V14, P135, DOI [10.1038/NMETH.4106, 10.1038/nmeth.4106]; Benetta ED., GENOME ELIMINATION M, DOI [10.1101/793273, DOI 10.1101/793273]; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; Burton RS, 2012, MOL ECOL, V21, P4942, DOI 10.1111/mec.12006; Casadevall A, 2010, INFECT IMMUN, V78, P4972, DOI 10.1128/IAI.00908-10; Coordinators NR., 2017, NUCLEIC ACIDS RES, V45, pD12, DOI 10.1093/nar/gkw1071; Del Fabbro C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085024; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Freedman LP, 2014, CANCER RES, V74, P4024, DOI 10.1158/0008-5472.CAN-14-0925; Gadau J, 1999, GENETICS, V153, P1731; Galbraith DA, 2016, P NATL ACAD SCI USA, V113, P1020, DOI 10.1073/pnas.1516636113; Gibson JD, 2013, EVOLUTION, V67, P2124, DOI 10.1111/evo.12080; Gibson JD, 2010, HEREDITY, V104, P310, DOI 10.1038/hdy.2009.172; Gibson JD, 2015, FRONT GENET, V6, DOI [10.3389/fgene.2075.00343, 10.3389/fgene.2015.00343]; HAIG D, 1992, J THEOR BIOL, V156, P401, DOI 10.1016/S0022-5193(05)80683-6; He YY, 2020, GENOMICS, V112, P2291, DOI 10.1016/j.ygeno.2019.12.025; Hunt GJ, 2007, J INSECT PHYSIOL, V53, P399, DOI 10.1016/j.jinsphys.2007.01.010; Hunt GJ, 1998, GENETICS, V148, P1203; Ishida M, 2013, MOL ASPECTS MED, V34, P826, DOI 10.1016/j.mam.2012.06.009; Isles AR, 2006, PHILOS T R SOC B, V361, P2229, DOI 10.1098/rstb.2006.1942; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kocher SD, 2015, G3-GENES GENOM GENET, V5, P1657, DOI 10.1534/g3.115.017814; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lawson HA, 2013, NAT REV GENET, V14, P608, DOI 10.1038/nrg3543; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Marshall H, 2020, EVOL LETT, V4, P479, DOI 10.1002/evl3.197; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; MOORE T, 1991, TRENDS GENET, V7, P45, DOI 10.1016/0168-9525(91)90230-N; Niehuis O, 2008, GENETICS, V178, P413, DOI 10.1534/genetics.107.080523; Niehuis O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008597; Olney KC, 2020, BIOL SEX DIFFER, V11, DOI 10.1186/s13293-020-00312-9; Queller DC, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-15; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schaarschmidt S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051720; Shorter JR, 2012, BEHAV GENET, V42, P663, DOI 10.1007/s10519-012-9530-5; Simoneau J, 2021, BRIEF BIOINFORM, V22, P140, DOI 10.1093/bib/bbz124; Smith NMA, 2020, MOL ECOL, V29, P1523, DOI 10.1111/mec.15419; Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Sylvester JE, 2004, GENET MED, V6, P73, DOI 10.1097/01.GIM.0000117333.21213.17; Tian CH, 2010, J INSECT PHYSIOL, V56, P1857, DOI 10.1016/j.jinsphys.2010.08.004; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang X, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002500; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Yan H, 2015, ANNU REV ENTOMOL, V60, P435, DOI 10.1146/annurev-ento-010814-020803	56	0	0	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252457	10.1371/journal.pone.0252457	http://dx.doi.org/10.1371/journal.pone.0252457			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111141	Green Submitted, Green Published, gold			2022-12-26	WOS:000664642700029
J	Abrams, EA; Burke, VM; Merrill, KG; Frimpong, C; Miti, S; Mwansa, JK; Denison, JA				Abrams, Elizabeth A.; Burke, Virginia M.; Merrill, Katherine G.; Frimpong, Christiana; Miti, Sam; Mwansa, Jonathan K.; Denison, Julie A.			"Adolescents do not only require ARVs and adherence counseling": A qualitative investigation of health care provider experiences with an HIV youth peer mentoring program in Ndola, Zambia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; ANTIRETROVIRAL THERAPY; INFECTION; OUTCOMES	Introduction Adolescents and young adults (AYAs) living with HIV face unique challenges and have poorer health outcomes than adults with HIV. Project YES! was a youth-led initiative to promote HIV self-management and reduce stigma among AYAs in four Ndola, Zambia clinics. Clinic health care providers (HCPs) were involved in multiple intervention aspects, including serving as expert resources during AYA and caregiver group meetings, facilitating resistance test-based AYA antiretroviral drug changes, meeting with participants referred through a safety protocol, and guiding a subset of participants' physical transition from pediatric to adult clinic settings. This study aimed to understand HCP insights on facilitators and barriers to implementing Project YES! and scaling up a clinic-based, youth-focused program. Methods A trained interviewer conducted ten in-depth interviews with participating HCPs from November-December 2018 and analyzed data, identifying key themes. These themes were examined in terms of two implementation science outcomes-acceptability and feasibility-to inform scalability. Results HCPs found peer mentoring valuable for AYAs with HIV and the bimonthly caregiver meetings beneficial to AYA caregivers. HCPs voiced a desire for more involvement in specific processes related to patient clinical care, such as drug changes. HCPs' experiences with the study safety protocol, including referrals for youth experiences of violence, shifted their views of AYAs and informed their understanding of key issues youth face. Considering this, many HCPs requested more resources to support AYAs' varied needs. HCPs noted limited time and clinic space as implementation barriers but felt the program was valuable overall. Conclusions HCPs concluded youth peer mentoring was highly acceptable and feasible, supporting scale-up of youth-led interventions addressing the multi-faceted needs of AYAs living with HIV. Continued provider involvement in resistance test-based antiretroviral drug changes, considered in the context of health system and clinic policy, would enhance long-term success of the program at scale.	[Abrams, Elizabeth A.; Burke, Virginia M.; Merrill, Katherine G.; Denison, Julie A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Frimpong, Christiana; Miti, Sam; Mwansa, Jonathan K.] Arthur Davison Childrens Hosp, Ndola, Zambia	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Abrams, EA (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	eabrams034@gmail.com		Abrams, Elizabeth/0000-0003-4817-3448	Project SOAR; United States President's Emergency Plan for AIDS Relief (PEFPAR) [AID-OAA-A-14-00060]; United States Agency for International Development (USAID); Johns Hopkins University Center for AIDS Research, an NIH [P30AI094189]; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; NIGMS; NIDDK; OAR; Johns Hopkins Center for Global Health Established Field Placement Awards	Project SOAR; United States President's Emergency Plan for AIDS Relief (PEFPAR); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Johns Hopkins University Center for AIDS Research, an NIH; NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OAR; Johns Hopkins Center for Global Health Established Field Placement Awards	This research was funded through Project SOAR. Project SOAR-Supporting Operational AIDS Research (Cooperative Agreement AID-OAA-A-14-00060)-is made possible by the generous support of the American people through the United States President's Emergency Plan for AIDS Relief (PEFPAR) and United States Agency for International Development (USAID). Analysis was also supported by the Johns Hopkins University Center for AIDS Research, an NIH funded program (P30AI094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH,NIA, FIC, NIGMS, NIDDK, and OAR. We also appreciate funding for Ms. Abrams' time and travel from the Johns Hopkins Center for Global Health Established Field Placement Awards (http://hopkinsglobalhealth.org/).Disclaimer: The contents of this paper are the sole responsibility of the authors and do not necessarily reflect the views of PEPFAR, USAID, NIH, or the United States Government.	[Anonymous], 2015, AUST J EMERG MANAG, V30, P9; [Anonymous], 2015, ALL ENDADOLESCENTAID; [Anonymous], PRS COMPENDIUM INTER; Avert, 2018, GLOB INF ED HIV AIDS; Brownson R., 2012, DISSEMINATION IMPLEM, V1st ed; Cluver L, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25176; Denison JA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230703; Denison JA, 2018, AIDS BEHAV, V22, P996, DOI 10.1007/s10461-017-1944-x; Denison JA, 2017, AIDS, V31, pS195, DOI 10.1097/QAD.0000000000001509; Jobanputra K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116144; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Mark D, 2019, CURR HIV-AIDS REP, V16, P467, DOI 10.1007/s11904-019-00470-5; Maughan-Brown B, 2018, AIDS BEHAV, V22, P765, DOI 10.1007/s10461-017-1877-4; Merrill KG, 2021, AIDS BEHAV, V25, P1373, DOI 10.1007/s10461-020-02958-3; Merrill KG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235203; Merrill KG., 2021, GLOB PUBLIC HLTH INT, P1, DOI [10.1080/17441692.2020.1864749, DOI 10.1080/17441692.2020.1864749]; Miti S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236156; Mutambo C, 2019, AIDS RES TREAT, V2019, DOI 10.1155/2019/8056382; Mwamba C, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-001007; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Peters DH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f6753; Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7; Republic of Zambia Ministry of Health, 2020, ZAMBIA CONSOLIDATED; Republic of Zambia Ministry of Health, 2018, ZAMBIA CONSOLIDATED; Shroufi A, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19247; St Clair-Sullivan Natalie, 2019, Mhealth, V5, P45, DOI 10.21037/mhealth.2019.09.02; Tafuma Taurayi A., 2018, South. Afr. j. HIV med. (Online), V19, P1, DOI [10.4102/sajhivmed.v19i1.721, 10.4102/hivmed.v19i1.721]; UNAIDS, 2018, GLOB AIDS UPD 2018 M; Willis N, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6447-4; Winskell K, 2016, CHILD YOUTH SERV REV, V61, P253, DOI 10.1016/j.childyouth.2015.12.017; World Health Organization, 2010, Global recommendations on physical activity for health; World Health Organization (WHO), 2015, GLOB PREV AN 2011, DOI DOI 10.1017/S1368980008002401; Zambia Ministry of Health, 2017, ZAMB POP BAS HIV IMP	34	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252349	10.1371/journal.pone.0252349	http://dx.doi.org/10.1371/journal.pone.0252349			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RW	34106967	Green Published			2022-12-26	WOS:000664642200041
J	Han, CL; Li, MJ; Haihambo, N; Cao, Y; Zhao, XX				Han, Chuanliang; Li, Meijia; Haihambo, Naem; Cao, Yu; Zhao, Xixi			Enlightenment on oscillatory properties of 23 class B notifiable infectious diseases in the mainland of China from 2004 to 2020	PLOS ONE			English	Article							PERIODIC STRUCTURES; TIME-SERIES; EPIDEMICS; VIRUS; VACCINATION; IMPACT	A variety of infectious diseases occur in mainland China every year. Cyclic oscillation is a widespread attribute of most viral human infections. Understanding the outbreak cycle of infectious diseases can be conducive for public health management and disease surveillance. In this study, we collected time-series data for 23 class B notifiable infectious diseases from 2004 to 2020 using public datasets from the National Health Commission of China. Oscillatory properties were explored using power spectrum analysis. We found that the 23 class B diseases from the dataset have obvious oscillatory patterns (seasonal or sporadic), which could be divided into three categories according to their oscillatory power in different frequencies each year. These diseases were found to have different preferred outbreak months and infection selectivity. Diseases that break out in autumn and winter are more selective. Furthermore, we calculated the oscillation power and the average number of infected cases of all 23 diseases in the first eight years (2004 to 2012) and the next eight years (2012 to 2020) since the update of the surveillance system. A strong positive correlation was found between the change of oscillation power and the change in the number of infected cases, which was consistent with the simulation results using a conceptual hybrid model. The establishment of reliable and effective analytical methods contributes to a better understanding of infectious diseases' oscillation cycle characteristics. Our research has certain guiding significance for the effective prevention and control of class B infectious diseases.	[Han, Chuanliang] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China; [Han, Chuanliang] Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China; [Li, Meijia; Haihambo, Naem] Vrije Univ Brussel, Fac Psychol, Brussels, Belgium; [Li, Meijia; Haihambo, Naem] Vrije Univ Brussel, Ctr Neurosci, Brussels, Belgium; [Cao, Yu] Beijing Normal Univ, Coll Life Sci, State Key Lab Earth Surface Proc & Resource Ecol, Beijing, Peoples R China; [Cao, Yu] Beijing Normal Univ, Coll Life Sci, Minist Educ, Key Lab Biodivers Sci & Ecol Engn, Beijing, Peoples R China; [Zhao, Xixi] Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China; [Zhao, Xixi] Capital Med Univ, Beijing Anding Hosp, Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China; [Zhao, Xixi] Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing, Peoples R China; [Zhao, Xixi] Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Beijing Normal University; Beijing Normal University; Capital Medical University; Capital Medical University; Capital Medical University; Capital Medical University	Han, CL (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing, Peoples R China.; Han, CL (corresponding author), Beijing Normal Univ, IDG McGovern Inst Brain Res, Beijing, Peoples R China.; Zhao, XX (corresponding author), Capital Med Univ, Beijing Anding Hosp, Beijing, Peoples R China.; Zhao, XX (corresponding author), Capital Med Univ, Beijing Anding Hosp, Natl Clin Res Ctr Mental Disorders, Beijing, Peoples R China.; Zhao, XX (corresponding author), Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing, Peoples R China.; Zhao, XX (corresponding author), Capital Med Univ, Adv Innovat Ctr Human Brain Protect, Beijing, Peoples R China.	hanchuanliang2014@163.com; zhaoxixi@ccmu.edu.cn		Han, Chuanliang/0000-0002-5734-4790; Li, Meijia/0000-0001-8893-3697	research on prevention and control of major chronic non-communicable diseases in the Ministry of Science and Technology [2016YFC1306100]; Beijing Municipal Hospital Clinical Technology Innovation and Research Plan [XMLX201805]; Beijing Municipal Hospital Research and Development Project [PX2021068]	research on prevention and control of major chronic non-communicable diseases in the Ministry of Science and Technology; Beijing Municipal Hospital Clinical Technology Innovation and Research Plan; Beijing Municipal Hospital Research and Development Project	This study was sponsored by the research on prevention and control of major chronic non-communicable diseases in the Ministry of Science and Technology (2016YFC1306100), Beijing Municipal Hospital Clinical Technology Innovation and Research Plan (XMLX201805), Beijing Municipal Hospital Research and Development Project (PX2021068).	Alter MJ, 2007, WORLD J GASTROENTERO, V13, P2436, DOI 10.3748/wjg.v13.i17.2436; ANDERSON RM, 1984, J HYG-CAMBRIDGE, V93, P587, DOI 10.1017/S0022172400065177; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Bharti N, 2011, SCIENCE, V334, P1424, DOI 10.1126/science.1210554; Bhattacharyya S, 2018, EPIDEMICS-NETH, V23, P64, DOI 10.1016/j.epidem.2017.12.005; Blankson JN, 2005, J INFECT DIS, V191, P1394, DOI 10.1086/428783; Broutin H, 2005, AM J EPIDEMIOL, V161, P1159, DOI 10.1093/aje/kwi141; Buonomo B, 2019, MATH COMPUT SIMULAT, V162, P97, DOI 10.1016/j.matcom.2019.01.005; Carver S, 2015, BIOSCIENCE, V65, P651, DOI 10.1093/biosci/biv047; Chen M., 2018, J BIOSCI MED, V6, P89, DOI [10.4236/jbm.2018.611009, DOI 10.4236/JBM.2018.611009]; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Costa F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003898; de Greeff SC, 2009, EPIDEMIOL INFECT, V137, P1388, DOI 10.1017/S0950268809002489; Donthu N, 2020, J BUS RES, V117, P284, DOI 10.1016/j.jbusres.2020.06.008; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Ferrari MJ, 2008, NATURE, V451, P679, DOI 10.1038/nature06509; FINE PEM, 1986, INT J EPIDEMIOL, V15, P237, DOI 10.1093/ije/15.2.237; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Fisman D, 2012, CLIN MICROBIOL INFEC, V18, P946, DOI 10.1111/j.1469-0691.2012.03968.x; Gossling S, 2021, J SUSTAIN TOUR, V29, P1, DOI 10.1080/09669582.2020.1758708; Greer M, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.191187; Gunning CE, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.1268; Han CL, 2021, NONLINEAR DYNAM, V106, P1169, DOI 10.1007/s11071-021-06371-w; Han CL, 2020, INT J DISAST RISK SC, V11, P497, DOI 10.1007/s13753-020-00294-7; He DH, 2003, P ROY SOC B-BIOL SCI, V270, P1519, DOI 10.1098/rspb.2003.2366; Henrich TJ, 2013, J INFECT DIS, V208, P1189, DOI 10.1093/infdis/jit307; Hitz DA, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05199-w; Hoofnagle JH., 2012, NEW ENGL J MED, P1237, DOI [10.1056/NEJMra1204512, DOI 10.1056/NEJMRA1204512]; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Kamar N., 2012, LANCET, V379, P2477, DOI [10.1016/S0140-6736%2811%2961849-7, DOI 10.1016/S0140-6736%2811%2961849-7]; Keuning MW., 2020, LANCET INFECT DIS, V20, pE173, DOI [10.1016/S1473-3099%2820%2930268-1, DOI 10.1016/S1473-3099%2820%2930268-1]; Koo JR, 2020, LANCET INFECT DIS, V20, P678, DOI 10.1016/S1473-3099(20)30162-6; Li WG, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238710; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Lu Q., 2019, INT J ENV RES PUBLIC, V16, P1, DOI [10.3390/ijerph16020168, DOI 10.3390/IJERPH16020168]; Luo T, 2011, EPIDEMIOL INFECT, V139, P257, DOI 10.1017/S0950268810001056; Ma CF, 2017, J MED VIROL, V89, P1511, DOI 10.1002/jmv.24769; Majander K, 2020, CURR BIOL, V30, P3788, DOI 10.1016/j.cub.2020.07.058; Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467; Ortiz E, 2003, HEALTH SERV RES, V38, pXI, DOI 10.1111/1475-6773.00127; Percival Donald B., 1993, SPECTRAL ANAL PHYS A; Pons-Salort M, 2018, SCIENCE, V361, P800, DOI 10.1126/science.aat6777; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Stella E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72440-6; Suk JE, 2020, EUR J PUBLIC HEALTH, V30, P928, DOI 10.1093/eurpub/ckz111; Sumi A, 2007, MICROBIOL IMMUNOL, V51, P805, DOI 10.1111/j.1348-0421.2007.tb03976.x; Szabo-Solticzky A, 2016, J MATH BIOL, V72, P1153, DOI 10.1007/s00285-015-0902-3; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; Tian HY, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007392; Tian HY, 2017, P NATL ACAD SCI USA, V114, P8041, DOI 10.1073/pnas.1701777114; Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212; Victoriano AFB, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-147; Wearing HJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000647; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Yu XC, 2021, NONLINEAR DYNAM, V106, P1149, DOI 10.1007/s11071-020-05989-6; Zhang XY, 2016, INT J INFECT DIS, V48, P7, DOI 10.1016/j.ijid.2016.04.010; Zhang XY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0088075, 10.1371/journal.pone.0101532]; Zhang YZ, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0769-6	58	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252803	10.1371/journal.pone.0252803	http://dx.doi.org/10.1371/journal.pone.0252803			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106977	gold, Green Published			2022-12-26	WOS:000664642200060
J	Pedrini, S; Stevens, JC; Dixon, KW				Pedrini, Simone; Stevens, Jason C.; Dixon, Kingsley W.			Seed encrusting with salicylic acid: A novel approach to improve establishment of grass species in ecological restoration	PLOS ONE			English	Article							MULTIPLE STRESS TOLERANCE; ECOSYSTEM SERVICES; GERMINATION; INDUCTION	To achieve global ambitions in large scale ecological restoration, there is a need for approaches that improve the efficiency of seed-based interventions, particularly in overcoming the bottleneck in the transition from germination to seedling establishment. In this study, we tested a novel seed-based application of the plant stress modulator compound salicylic acid as a means to reduce seedling losses in the seed-to-seedling phase. Seed coating technology (encrusting) was developed as a precursor for optimising field sowing for three grass species commonly used in restoration programs, Austrostipa scabra, Microlaena stipoides, and Rytidosperma geniculatum. Salicylic acid (SA, 0.1mM) was delivered to seeds via imbibition and seed encrusting. The effects of SA on seed germination were examined under controlled water-limited conditions (drought resilience) in laboratory setting and on seed germination, seedling emergence, seedling growth and plant survival in field conditions. Salicylic acid did not impact germination under water stress in controlled laboratory conditions and did not affect seedling emergence in the field. However, seedling survival and growth were improved in plants grown from SA treated seeds (imbibed and encrusted) under field conditions. When SA delivery methods of imbibing and coating were compared, there was no significant difference in survival and growth, showing that seed coating has potential to deliver SA. Effect of intraspecific competition as a result of seedling density was also considered. Seedling survival over the dry summer season was more than double at low seedling density (40 plants/m(2)) compared to high seedling density (380 plants/m(2)). Overall, adjustment of seeding rate according to expected emergence combined with the use of salicylic acid via coating could improve seed use efficiency in seed-based restoration.	[Pedrini, Simone; Dixon, Kingsley W.] Curtin Univ, Sch Mol & Life Sci, ARC Ctr Mine Site Restorat, Bentley, WA, Australia; [Stevens, Jason C.] Kings Pk Sci Conservat & Attract, Dept Biodivers, Kings Pk, WA, Australia; [Stevens, Jason C.; Dixon, Kingsley W.] Univ Western Australia, Sch Biol Sci, Crawley, WA, Australia	Curtin University; University of Western Australia	Pedrini, S (corresponding author), Curtin Univ, Sch Mol & Life Sci, ARC Ctr Mine Site Restorat, Bentley, WA, Australia.	simone.pedrini@curtin.edu.au	Pedrini, Simone/I-8420-2019; Dixon, Kingsley W/A-8133-2016; Stevens, Jason/G-3810-2010	Pedrini, Simone/0000-0001-9933-2846; Dixon, Kingsley W/0000-0001-5989-2929; Stevens, Jason/0000-0001-5821-9206	Curtin University; Australian Government through the Australian Research Council (ARC) Industrial Transformation Training Centre for Mine Site Restoration [ICI150100041]	Curtin University; Australian Government through the Australian Research Council (ARC) Industrial Transformation Training Centre for Mine Site Restoration	This study was supported by Curtin University in the form of an International Postgraduate Research Scholarship awarded to SP and the Australian Government through the Australian Research Council (ARC) Industrial Transformation Training Centre for Mine Site Restoration in the form of equipment and materials to conduct the study, the publication cost, and a PhD scholarship awarded to SP (Project Number ICI150100041). The views expressed herein are those of the authors and are not necessarily those of the Australian Government or Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BOM, 2018, BUREAU METEOROLOGY; Brown SL, 2017, RANGELAND J, V39, P355, DOI 10.1071/RJ17029; Clarke S., 2010, KINGSTON ACT 2604; Conrad MK, 2011, ECOL ENG, V37, P1149, DOI 10.1016/j.ecoleng.2011.02.010; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cross AT, 2017, PLANT SOIL, V421, P1, DOI 10.1007/s11104-017-3410-y; Dat J. F., 2007, Salicylic acid: a plant hormone, P247, DOI 10.1007/1-4020-5184-0_9; De Vitis M, 2020, RESTOR ECOL, V28, pS249, DOI 10.1111/rec.13174; Gann GD, 2019, RESTOR ECOL, V27, pS3, DOI 10.1111/rec.13035; GUAN LQ, 1995, P NATL ACAD SCI USA, V92, P5930, DOI 10.1073/pnas.92.13.5930; Guan Y., 2014, WORLD J, V2014, P9, DOI [10.1155/2014/75265, DOI 10.1155/2014/75265]; Guan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120695; Gutierrez-Coronado MA, 1998, PLANT PHYSIOL BIOCH, V36, P563, DOI 10.1016/S0981-9428(98)80003-X; Holuigue L., 2007, Salicylic acid: a plant hormone, P197, DOI 10.1007/1-4020-5184-0_8; Horvath E, 2007, J PLANT GROWTH REGUL, V26, P290, DOI 10.1007/s00344-007-9017-4; Hussain S, 2015, SCI REP-UK, V5, DOI 10.1038/srep08101; James JJ, 2019, J APPL ECOL, V56, P2609, DOI 10.1111/1365-2664.13508; James JJ, 2011, J APPL ECOL, V48, P961, DOI 10.1111/j.1365-2664.2011.02009.x; Janda T., 2007, Salicylic acid: a plant hormone, P91, DOI 10.1007/1-4020-5184-0_5; Khan MIR, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00462; Larque-Saavedra A., 2007, Salicylic acid: a plant hormone, P15, DOI 10.1007/1-4020-5184-0_2; Lee S, 2010, PLANT SIGNAL BEHAV, V5, P1534, DOI 10.4161/psb.5.12.13159; Lewandrowski W, 2017, J APPL ECOL, V54, P997, DOI 10.1111/1365-2664.12816; Madsen MD, 2012, J APPL ECOL, V49, P431, DOI 10.1111/j.1365-2664.2012.02118.x; Madsen MD., 2013, P 10 INT S ADJUVANTS, P205; Maruri-Lopez I, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00423; Menz MHM, 2013, SCIENCE, V339, P526, DOI 10.1126/science.1228334; Merritt DJ, 2011, SCIENCE, V332, P424, DOI 10.1126/science.1203083; Nellemann C., 2010, CHALLENGES; Nichols P., 2011, RELIABLE ESTABLISHME; Orrock JL, 2008, ECOLOGY, V89, P1168, DOI 10.1890/07-0223.1; Palmer MA, 2009, SCIENCE, V325, P575, DOI 10.1126/science.1172976; Paparella S, 2015, PLANT CELL REP, V34, P1281, DOI 10.1007/s00299-015-1784-y; Park SW, 2007, SCIENCE, V318, P113, DOI 10.1126/science.1147113; Pearson DE, 2019, RESTOR ECOL, V27, P254, DOI 10.1111/rec.12862; Pedrini S, 2020, RESTOR ECOL, V28, pS266, DOI 10.1111/rec.13184; Pedrini S, 2020, RESTOR ECOL, V28, pS286, DOI 10.1111/rec.13155; Pedrini S, 2018, SEED SCI TECHNOL, V46, P393, DOI 10.15258/sst.2018.46.2.21; Pedrini S, 2017, TRENDS PLANT SCI, V22, P106, DOI 10.1016/j.tplants.2016.11.002; PYKE DA, 1990, OECOLOGIA, V82, P537, DOI 10.1007/BF00319798; R Core Team, 2020, R LANG ENV STAT COMP; RASKIN I, 1990, ANN BOT-LONDON, V66, P369, DOI 10.1093/oxfordjournals.aob.a088037; Ritz C, 2005, J STAT SOFTW, V12, P1; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Senaratna T, 2003, PLANT GROWTH REGUL, V39, P77, DOI 10.1023/A:1021865029762; Senaratna T, 2000, PLANT GROWTH REGUL, V30, P157, DOI 10.1023/A:1006386800974; Sharafizad M., 2013, Journal of Agricultural Science (Toronto), V5, P179; Shaw N, 2020, RESTOR ECOL, V28, pS276, DOI 10.1111/rec.13210; Society for Ecological Restoration International Science & Policy Working Group (SER), 2004, SER INT PRIM EC REST; Stevens J, 2015, SEED SCI TECHNOL, V43, P313, DOI 10.15258/sst.2015.43.2.19; Stevens JC, 2006, AUST J AGR RES, V57, P1279, DOI 10.1071/AR06031; Stevens J, 2006, PLANT GROWTH REGUL, V49, P77, DOI 10.1007/s10725-006-0019-1; Taylor A. G., 1992, HortTechnology, V2, P336; Taylor AG, 1998, SEED SCI RES, V8, P245, DOI 10.1017/S0960258500004141; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Waters C., 2001, GRASSED; Xie Z, 2007, PLANT MOL BIOL, V64, P293, DOI 10.1007/s11103-007-9152-0	58	1	1	6	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0242035	10.1371/journal.pone.0242035	http://dx.doi.org/10.1371/journal.pone.0242035			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106919	Green Submitted, gold, Green Published			2022-12-26	WOS:000664642200004
J	Polinski, NK; Martinez, TN; Gorodinsky, A; Gareus, R; Sasner, M; Herberth, M; Switzer, R; Ahmad, SO; Cosden, M; Kandebo, M; Drolet, RE; Buckett, PD; Shan, W; Chen, Y; Pellegrino, LJ; Ellsworth, GD; Dungan, LB; Hirst, WD; Clark, SW; Dave, KD				Polinski, Nicole K.; Martinez, Terina N.; Gorodinsky, Alexander; Gareus, Ralph; Sasner, Michael; Herberth, Mark; Switzer, Robert; Ahmad, Syed O.; Cosden, Mali; Kandebo, Monika; Drolet, Robert E.; Buckett, Peter D.; Shan, Weisong; Chen, Yi; Pellegrino, Lee J.; Ellsworth, Gregory D.; Dungan, Leo B.; Hirst, Warren D.; Clark, Sean W.; Dave, Kuldip D.			Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model	PLOS ONE			English	Article							GAUCHER-DISEASE; PARKINSON DISEASE; INTRASTRIATAL 6-HYDROXYDOPAMINE; SUBSTANTIA-NIGRA; MUTATIONS; GENE; DEFICIENCY; DOPAMINE; GLUCOSYLSPHINGOSINE; PROGRESSION	Multiple mutations have been described in the human GBA1 gene, which encodes the lysosomal enzyme beta-glucocerebrosidase (GCase) that degrades glucosylceramide and is pivotal in glycosphingolipid substrate metabolism. Depletion of GCase, typically by homozygous mutations in GBA1, is linked to the lysosomal storage disorder Gaucher's disease (GD) and distinct or heterozygous mutations in GBA1 are associated with increased Parkinson's disease (PD) risk. While numerous genes have been linked to heritable PD, GBA1 mutations in aggregate are the single greatest risk factor for development of idiopathic PD. The importance of GCase in PD necessitates preclinical models in which to study GCase-related mechanisms and novel therapeutic approaches, as well as to elucidate the molecular mechanisms leading to enhanced PD risk in GBA1 mutation carriers. The aim of this study was to develop and characterize a novel GBA1 mouse model and to facilitate wide accessibility of the model with phenotypic data. Herein we describe the results of molecular, biochemical, histological, and behavioral phenotyping analyses in a GBA1 D409V knock-in (KI) mouse. This mouse model exhibited significantly decreased GCase activity in liver and brain, with substantial increases in glycosphingolipid substrates in the liver. While no changes in the number of dopamine neurons in the substantia nigra were noted, subtle changes in striatal neurotransmitters were observed in GBA1 D409V KI mice. Alpha-synuclein pathology and inflammation were not observed in the nigrostriatal system of this model. In summary, the GBA1 D409V KI mouse model provides an ideal model for studies aimed at pharmacodynamic assessments of potential therapies aiming to restore GCase.	[Polinski, Nicole K.; Martinez, Terina N.; Dave, Kuldip D.] Michael J Fox Fdn Parkinsons Res, Grand Cent Stn, New York, NY 10163 USA; [Martinez, Terina N.; Gorodinsky, Alexander; Gareus, Ralph] Tacon Biosci, Rensselaer, NY USA; [Gareus, Ralph; Sasner, Michael] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA; [Herberth, Mark] Charles River Labs, Ashland, OH USA; [Switzer, Robert] NeuroSci Associates, Knoxville, TN USA; [Ahmad, Syed O.] St Louis Univ, St Louis, MO 63103 USA; [Cosden, Mali; Kandebo, Monika; Drolet, Robert E.] Merck & Co Inc, Kenilworth, NJ USA; [Buckett, Peter D.; Shan, Weisong; Chen, Yi; Hirst, Warren D.] Pfizer, Cambridge, MA USA; [Pellegrino, Lee J.; Ellsworth, Gregory D.; Dungan, Leo B.; Clark, Sean W.] Amicus Therapeut, Cranbury, NJ USA; [Gorodinsky, Alexander] Monmouth Univ, West Long Branch, NJ USA; [Buckett, Peter D.] Yuman Therapeut, Boston, MA USA; [Shan, Weisong; Chen, Yi] Biogen, Cambridge, MA USA; [Pellegrino, Lee J.] Oncoveda, Hamilton Township, NJ USA; [Clark, Sean W.] SwanBio Therapeut, Bala Cynwyd, PA USA; [Dave, Kuldip D.] ALS Assoc, Arlington, VA USA	Jackson Laboratory; Saint Louis University; Merck & Company; Pfizer; Monmouth University; Biogen	Polinski, NK (corresponding author), Michael J Fox Fdn Parkinsons Res, Grand Cent Stn, New York, NY 10163 USA.	npolinski@michaeljfox.org		Sasner, Michael/0000-0002-6612-6111	Michael J. Fox Foundation for Parkinson's Research [9353, 9353.01, 10305, 10324, 14955, 14954]; Michael J. Fox Foundation for Parkinson's Research; Merck Co; Pfizer; Amicus Therapeutics	Michael J. Fox Foundation for Parkinson's Research; Michael J. Fox Foundation for Parkinson's Research; Merck Co(Merck & Company); Pfizer(Pfizer); Amicus Therapeutics	This work was supported by the following Animal Models Funding Program grants from The Michael J. Fox Foundation for Parkinson's Research: (Grant Nos. 9353, 9353.01) awarded to MS, (Grant No. 10305) awarded to MH and (Grant No. 10324, 14955, and 14954) awarded to RS. The Michael J. Fox Foundation for Parkinson's Research served as the funder for this study and played a role in study design, data analysis, decision to publish, and preparation of the manuscript. Merck & Co provided support in the form of salary to MC, MK, and RED. Pfizer provided support in the form of salary to PDB, WS, YC, and WDH, and Amicus Therapeutics provided support in the form of salaries to LJP, GDE, LBD, and SWC. The specific roles of the authors are articulated in the author contributions' section. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JMFG, 2019, CURR OPIN CHEM BIOL, V53, P204, DOI 10.1016/j.cbpa.2019.10.006; Alcalay RN, 2010, ARCH NEUROL-CHICAGO, V67, P1116, DOI 10.1001/archneurol.2010.194; Bae EJ, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.84; Ballanger B, 2016, J NEUROSCI, V36, P1577, DOI 10.1523/JNEUROSCI.2010-15.2016; Baptista MAS, 2013, DIS MODEL MECH, V6, P1316, DOI 10.1242/dmm.011940; Baris HN, 2014, PEDIATR ENDOCR REV P, V12, P72; Blandini F, 2019, MOVEMENT DISORD, V34, P9, DOI 10.1002/mds.27583; Brundin P, 2017, J NEUROSCI, V37, P9808, DOI 10.1523/JNEUROSCI.1788-16.2017; Burbulla LF, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau6870; Chahine LM, 2013, JAMA NEUROL, V70, P852, DOI 10.1001/jamaneurol.2013.1274; Chao DHM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138107; Chiasserini D, 2015, MOL NEURODEGENER, V10, DOI 10.1186/s13024-015-0010-2; Clarke E, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104502; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Dave KD, 2014, NEUROBIOL DIS, V70, P190, DOI 10.1016/j.nbd.2014.06.009; Dermentzaki G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060674; Dzamko N, 2015, NEUROSCIENCE, V302, P89, DOI 10.1016/j.neuroscience.2014.10.028; Emmanouilidou E, 2016, BRAIN PATHOL, V26, P398, DOI 10.1111/bpa.12373; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; Enquist IB, 2006, P NATL ACAD SCI USA, V103, P13819, DOI 10.1073/pnas.0606016103; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Fishbein I, 2014, BRAIN, V137, P3235, DOI 10.1093/brain/awu291; Gegg ME, 2012, ANN NEUROL, V72, P455, DOI 10.1002/ana.23614; Ginns EI, 2014, MOL GENET METAB, V111, P152, DOI 10.1016/j.ymgme.2013.12.003; Golden JP, 2013, J NEUROSCI, V 33, P17095, DOI 10.1523/JNEUROSCI.0890-13.2013; Hallett PJ, 2018, NEUROBIOL AGING, V67, P189, DOI 10.1016/j.neurobiolaging.2018.02.028; Hamler R, 2017, ANAL CHEM, V89, P8288, DOI 10.1021/acs.analchem.7b01442; Healy-Stoffel M, 2014, BRAIN RES, V1574, P113, DOI 10.1016/j.brainres.2014.05.045; Healy-Stoffel M, 2012, J NEUROSCI METH, V210, P187, DOI 10.1016/j.jneumeth.2012.07.013; IRWIN S, 1968, PSYCHOPHARMACOLOGIA, V13, P222, DOI 10.1007/BF00401402; Kanfer J N, 1982, Prog Clin Biol Res, V95, P627; Klein AD, 2016, CELL REP, V16, P2546, DOI 10.1016/j.celrep.2016.07.085; LATHAM TE, 1991, DNA CELL BIOL, V10, P15, DOI 10.1089/dna.1991.10.15; Liu GQ, 2016, ANN NEUROL, V80, P674, DOI 10.1002/ana.24781; Liu J, 2012, P NATL ACAD SCI USA, V109, P10018, DOI 10.1073/pnas.1200941109; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; Manning-Bog AB, 2009, NEUROTOXICOLOGY, V30, P1127, DOI 10.1016/j.neuro.2009.06.009; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Mirzaian M, 2015, BLOOD CELL MOL DIS, V54, P307, DOI 10.1016/j.bcmd.2015.01.006; Murphy KE, 2014, AUTOPHAGY, V10, P1350, DOI 10.4161/auto.29074; Nichols WC, 2009, NEUROLOGY, V72, P310, DOI 10.1212/01.wnl.0000327823.81237.d1; Papadopoulos VE, 2018, HUM MOL GENET, V27, P1696, DOI 10.1093/hmg/ddy075; Pitcairn C, 2019, NEUROBIOL DIS, V122, P72, DOI 10.1016/j.nbd.2018.03.008; Rocha EM, 2015, ANTIOXID REDOX SIGN, V23, P550, DOI 10.1089/ars.2015.6307; Rocha EM, 2015, ANN CLIN TRANSL NEUR, V2, P433, DOI 10.1002/acn3.177; Sardi SP, 2013, P NATL ACAD SCI USA, V110, P3537, DOI 10.1073/pnas.1220464110; Sardi SP, 2012, NEURODEGENER DIS, V10, P195, DOI 10.1159/000335038; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Schapira AHV, 2017, NAT REV NEUROSCI, V18, P435, DOI 10.1038/nrn.2017.62; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulze H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004804; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Sossi V, 2004, J CEREBR BLOOD F MET, V24, P869, DOI 10.1097/01.WCB.0000126563.85360.75; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Sun Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057560; Tan EK, 2020, NAT REV NEUROL, V16, P303, DOI 10.1038/s41582-020-0344-4; TYBULEWICZ VLJ, 1992, NATURE, V357, P407, DOI 10.1038/357407a0; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Witte MD, 2010, NAT CHEM BIOL, V6, P907, DOI 10.1038/NCHEMBIO.466; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 2008, MOL GENET METAB, V94, P190, DOI 10.1016/j.ymgme.2008.01.013	64	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252325	10.1371/journal.pone.0252325	http://dx.doi.org/10.1371/journal.pone.0252325			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106956	Green Published, gold			2022-12-26	WOS:000664642200039
J	Truong, TH; Benner, EA; Hagen, KM; Temiz, NA; Kerkvliet, CP; Wang, Y; Cortes-Sanchez, E; Yang, CH; Pengo, T; Guillen, KP; Welm, BE; Telang, S; Lange, CA; Ostrander, JH; Trousdell, MC; Camila				Truong, Thu H.; Benner, Elizabeth A.; Hagen, Kyla M.; Temiz, Nuri A.; Kerkvliet, Carlos Perez; Wang, Ying; Cortes-Sanchez, Emilio; Yang, Chieh-Hsiang; Pengo, Thomas; Guillen, Katrin P.; Welm, Bryan E.; Telang, Sucheta; Lange, Carol A.; Ostrander, Julie H.; Trousdell, Marygrace C.; Camila			PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer	ONCOGENE			English	Article							STEM-CELL MARKERS; COACTIVATOR; RECEPTOR; PELP1; AIB1; INHIBITOR; PATHWAY; PFK-158; GROWTH; SRC-3	Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades. Contributing factors to metastatic spread include the maintenance and expansion of breast cancer stem cells (CSCs). Breast CSCs frequently exist as a minority population in therapy resistant tumors. In this study, we show that cytoplasmic complexes composed of steroid receptor (SR) co-activators, PELP1 and SRC-3, modulate breast CSC expansion through upregulation of the HIF-activated metabolic target genes PFKFB3 and PFKFB4. Seahorse metabolic assays demonstrated that cytoplasmic PELP1 influences cellular metabolism by increasing both glycolysis and mitochondrial respiration. PELP1 interacts with PFKFB3 and PFKFB4 proteins, and inhibition of PFKFB3 and PFKFB4 kinase activity blocks PELP1-induced tumorspheres and protein-protein interactions with SRC-3. PFKFB4 knockdown inhibited in vivo emergence of circulating tumor cell (CTC) populations in mammary intraductal (MIND) models. Application of PFKFB inhibitors in combination with ER targeted therapies blocked tumorsphere formation in multiple models of advanced breast cancer including tamoxifen (TamR) and paclitaxel (TaxR) resistant models, murine tumor cells, and ER+ patient-derived organoids (PDxO). Together, our data suggest that PELP1, SRC-3, and PFKFBs cooperate to drive ER+ tumor cell populations that include CSCs and CTCs. Identifying non-ER pharmacological targets offers a useful approach to blocking metastatic escape from standard of care ER/estrogen (E2)-targeted strategies to overcome endocrine and chemotherapy resistance.	[Truong, Thu H.; Benner, Elizabeth A.; Hagen, Kyla M.; Temiz, Nuri A.; Kerkvliet, Carlos Perez; Wang, Ying; Lange, Carol A.; Ostrander, Julie H.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Temiz, Nuri A.] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN USA; [Cortes-Sanchez, Emilio; Yang, Chieh-Hsiang; Guillen, Katrin P.; Welm, Bryan E.] Univ Utah, Dept Oncol Sci, Salt Lake City, UT USA; [Cortes-Sanchez, Emilio; Yang, Chieh-Hsiang; Guillen, Katrin P.; Welm, Bryan E.] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA; [Trousdell, Marygrace C.; Camila] Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA; [Pengo, Thomas] Univ Minnesota, Informat Inst, Minneapolis, MN USA; [Welm, Bryan E.] Univ Utah, Dept Surg, Salt Lake City, UT USA; [Telang, Sucheta] Univ Louisville, Dept Med, James Graham Brown Canc Ctr, Div Med Oncol & Hematol, Louisville, KY 40292 USA; [Lange, Carol A.; Ostrander, Julie H.] Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA; [Lange, Carol A.] Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Cold Spring Harbor Laboratory; University of Minnesota System; University of Minnesota Twin Cities; Utah System of Higher Education; University of Utah; University of Louisville; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lange, CA; Ostrander, JH (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.; Lange, CA; Ostrander, JH (corresponding author), Univ Minnesota, Dept Med, Div Hematol Oncol & Transplantat, Box 736 UMHC, Minneapolis, MN 55455 USA.; Lange, CA (corresponding author), Univ Minnesota, Dept Pharmacol, 3-249 Millard Hall, Minneapolis, MN 55455 USA.	lange047@umn.edu; hans1354@umn.edu	; Pengo, Thomas/D-5867-2013	Truong, Thu/0000-0003-2394-551X; Wang, Ying/0000-0001-9052-0023; Perez, Ph.D., Carlos/0000-0003-2530-840X; Pengo, Thomas/0000-0002-9632-918X; Trousdell, Marygrace/0000-0002-4824-7040	NIH [R01 CA236948, R01 CA229697, F32 CA210340, T32 HL007741, U54 CA224076, R01 CA248158-01, R01 AG069727-01]; ACS Institutional Research Grant [124166-IRG-58-001-52-IRG5]; University of Minnesota Masonic Cancer Center; Tickle Family Land Grant Endowed Chair in Breast Cancer Research; National Center for Advancing Translational Sciences of the NIH [UL1TR000114]; Department of Defense [W81XWH-14-1-0417]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS Institutional Research Grant; University of Minnesota Masonic Cancer Center; Tickle Family Land Grant Endowed Chair in Breast Cancer Research; National Center for Advancing Translational Sciences of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Department of Defense(United States Department of Defense)	This work was supported by NIH grants R01 CA236948 (JHO, CAL), R01 CA229697 (CAL), F32 CA210340 (THT), T32 HL007741 (THT), U54 CA224076 (BEW), R01 CA248158-01 (CODS), and R01 AG069727-01 (CODS). ACS Institutional Research Grant #124166-IRG-58-001-52-IRG5 (JHO), University of Minnesota Masonic Cancer Center (CAL, JHO), the Tickle Family Land Grant Endowed Chair in Breast Cancer Research (CAL), National Center for Advancing Translational Sciences of the NIH Award UL1TR000114 (JHO), and Department of Defense W81XWH-14-1-0417 (BEW). We thank Bruce Lindgren for biostatistics support, and the Masonic Cancer Center Biostatistics and Bioinformatics, Analytical Biochemistry, University Imaging Core (UIC), and Flow Cytometry cores. We also thank Zohar Sachs and Michael Franklin for critical reading of this manuscript.	Anderson TMR, 2018, MOL CANCER RES, V16, P1761, DOI 10.1158/1541-7786.MCR-18-0410; Anderson TMR, 2016, CANCER RES, V76, P1653, DOI 10.1158/0008-5472.CAN-15-2510; Banerjee Arindam, 2018, Oncotarget, V9, P23274, DOI 10.18632/oncotarget.25299; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; Bosco DB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128511; Burandt E, 2013, BREAST CANCER RES TR, V137, P745, DOI 10.1007/s10549-013-2406-4; Chesney J, 2014, ONCOTARGET, V5, P6670, DOI 10.18632/oncotarget.2213; Chu Z., 2021, BREAST CANC PATIENT, DOI [10.1101/2021.02.28.433268, DOI 10.1101/2021]; Dasgupta S, 2018, NATURE, V556, P249, DOI 10.1038/s41586-018-0018-1; Dong CF, 2013, CANCER CELL, V23, P316, DOI 10.1016/j.ccr.2013.01.022; Dwyer AR, 2021, BRIT J CANCER, V124, P217, DOI 10.1038/s41416-020-01094-y; Gao RF, 2018, THERANOSTICS, V8, P6248, DOI 10.7150/thno.28721; Giordano A, 2012, MOL CANCER THER, V11, P2526, DOI 10.1158/1535-7163.MCT-12-0460; Girard BJ, 2017, J BIOL CHEM, V292, P339, DOI 10.1074/jbc.M116.739847; Girard BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121206; Girard BJ, 2014, MOL CELL ENDOCRINOL, V382, P642, DOI 10.1016/j.mce.2013.07.031; Habashy HO, 2010, BREAST CANCER RES TR, V120, P603, DOI 10.1007/s10549-009-0419-9; Imamura Y, 2015, ONCOL REP, V33, P1837, DOI 10.3892/or.2015.3767; Kilgour E, 2020, CANCER CELL, V37, P485, DOI 10.1016/j.ccell.2020.03.012; Kim JW, 2006, CANCER RES, V66, P8927, DOI 10.1158/0008-5472.CAN-06-1501; Kumar R, 2009, CLIN CANCER RES, V15, P4123, DOI 10.1158/1078-0432.CCR-08-2347; Liu Y, 2014, BRIT J CANCER, V110, P2063, DOI 10.1038/bjc.2014.105; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Marotta LLC, 2011, J CLIN INVEST, V121, P2723, DOI 10.1172/JCI44745; Mondal S, 2019, INT J CANCER, V144, P178, DOI 10.1002/ijc.31868; Moore N, 2011, J ONCOL, V2011, DOI 10.1155/2011/396076; Nair BC, 2010, CANCER RES, V70, P7166, DOI 10.1158/0008-5472.CAN-10-0628; O'Neill S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39789-9; Osborne CK, 2003, J NATL CANCER I, V95, P353, DOI 10.1093/jnci/95.5.353; Raj GV, 2017, ELIFE, V6, DOI 10.7554/eLife.26857; Ravindranathan P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2912; Redman R, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-CT206; Rohira AD, 2017, CANCER RES, V77, P4293, DOI 10.1158/0008-5472.CAN-16-2982; Sflomos G, 2016, CANCER CELL, V29, P407, DOI 10.1016/j.ccell.2016.02.002; Shi LL, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.44; Song XZ, 2016, P NATL ACAD SCI USA, V113, P4970, DOI 10.1073/pnas.1604274113; Tasdemir N, 2018, CANCER RES, V78, P6209, DOI 10.1158/0008-5472.CAN-18-1416; Telang S, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.PANCA16-B90; Torres-Arzayus MI, 2006, CANCER RES, V66, P11381, DOI 10.1158/0008-5472.CAN-06-2316; Torres-Arzayus MI, 2004, CANCER CELL, V6, P263, DOI 10.1016/j.ccr.2004.06.027; Truong TH, 2018, MOL CANCER RES, V16, P707, DOI 10.1158/1541-7786.MCR-17-0598; Vadlamudi RK, 2005, CANCER RES, V65, P7724, DOI 10.1158/0008-5472.CAN-05-0614; Vadlamudi RK, 2001, J BIOL CHEM, V276, P38272; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Vlashi E, 2014, BREAST CANCER RES TR, V146, P525, DOI 10.1007/s10549-014-3051-2; Wang XQ, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-77; Wu RC, 2004, MOL CELL, V15, P937, DOI 10.1016/j.molcel.2004.08.019; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yang YZ, 2018, HORM CANCER-US, V9, P371, DOI 10.1007/s12672-018-0343-8; Yao L, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0882-2	50	6	6	3	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2021	40	25					4384	4397		10.1038/s41388-021-01871-w	http://dx.doi.org/10.1038/s41388-021-01871-w		JUN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SY4AZ	34103681	Green Accepted			2022-12-26	WOS:000659032900004
J	Wang, SP; Cao, K; Liao, YT; Zhang, W; Zheng, JH; Li, XC; Huang, MT; Zhong, YH; Hu, X; Chen, D; Wang, YJ				Wang, Shouping; Cao, Kun; Liao, Yuting; Zhang, Wei; Zheng, Jihua; Li, Xiaocui; Huang, Mengting; Zhong, Yonghao; Hu, Xiao; Chen, De; Wang, Yanjie			CDCA2 protects against oxidative stress by promoting BRCA1-NRF2 signaling in hepatocellular carcinoma	ONCOGENE			English	Article							CELL-PROLIFERATION; GENE FAMILY; E3 LIGASE; CANCER; TRANSCRIPTION; NRF2; PATHWAY; EXPRESSION; MUTATIONS; APOPTOSIS	Hepatocellular carcinoma (HCC) patients mostly suffer from poor survival outcomes. It is necessary to identify effective therapeutic targets to improve prognosis for HCC patients. Here, we report a new factor, CDCA2, in promoting HCC development. CDCA2 amplification is an independent risk factor for the recurrence and survival of HCC patients, which is positively correlated with elevated level of alpha-fetoprotein (AFP), high histological grade, large tumor size, advanced TNM stage, and poor prognosis for HCC patients. In HCC cells, CDCA2 promotes cell growth and inhibits apoptosis. Mechanistically, CDCA2's transcription is activated through the binding of E2F2/E2F8 with its promoter. CDCA2 depletion contributes to the suppression of cell proliferation and induction of apoptosis due to reactive oxygen species (ROS)-mediated stress, which can be reversed by antioxidants N-acetyl cysteine (NAC) and glutathione (GSH). Interestingly, we found that CDCA2 triggers the BRCA1-NRF2 cascade, which elevates antioxidant response and attenuates ROS levels. In response to oxidative stress, CDCA2 promotes BRCA1's chromatin relocalization to NRF2, activating NRF2-driven downstream signaling (HO-1, TXNRD1, and NQO1), which then protects HCC cells against oxidative damage. In conclusion, our results reveal that CDCA2 is a prognostic biomarker for HCC patients, and present the E2F2/E2F8-CDCA2-BRCA1-NRF2-ROS signaling axis that have implications for HCC therapeutics.	[Wang, Shouping; Zhang, Wei; Li, Xiaocui; Huang, Mengting; Wang, Yanjie] Guangzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 3, Guangzhou, Peoples R China; [Cao, Kun] Guangdong Med Univ, Inst Aging Res, Guangdong Prov Key Lab Med Mol Diagnost, Dongguan, Peoples R China; [Liao, Yuting; Zheng, Jihua] Gen Hosp Southern Theater Command, Dept Radiotherapy, Guangzhou, Peoples R China; [Zhong, Yonghao] Shenzhen Futian Dist, Dept Surg, Peoples Hosp 2, Shenzhen, Peoples R China; [Hu, Xiao] Second Peoples Hosp Guangdong Prov, Dept Surg, Guangzhou, Peoples R China; [Chen, De; Wang, Yanjie] Guangzhou Med Univ, Biomed Res Ctr, Affiliated Hosp 3, Guangzhou, Peoples R China	Guangzhou Medical University; Guangdong Medical University; Southern Theater Command General Hospital; Guangzhou Medical University	Wang, YJ (corresponding author), Guangzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 3, Guangzhou, Peoples R China.; Chen, D; Wang, YJ (corresponding author), Guangzhou Med Univ, Biomed Res Ctr, Affiliated Hosp 3, Guangzhou, Peoples R China.	drchende@gzhmu.edu.cn; YanjieW@outlook.com			National Natural Science Foundation of China [82002104]; Science and technology project of Guangzhou [201707010379]; Natural Science Youth Project of the Third Affiliated Hospital of Guangzhou Medical University [2019Q07, 2019B06]; Guangdong Basic and Applied Basic Research Foundation [2019A1515110659]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology project of Guangzhou; Natural Science Youth Project of the Third Affiliated Hospital of Guangzhou Medical University; Guangdong Basic and Applied Basic Research Foundation	This work was supported by the National Natural Science Foundation of China (No. 81672393), Science and technology project of Guangzhou (No. 201707010379), Natural Science Youth Project of the Third Affiliated Hospital of Guangzhou Medical University (No. 2019Q07, 2019B06), the National Natural Science Foundation of China (82002104, to KC), Guangdong Basic and Applied Basic Research Foundation (2019A1515110659, to KC).	Bae I, 2004, CANCER RES, V64, P7893, DOI 10.1158/0008-5472.CAN-04-1119; Baiz D, 2014, WORLD J GASTROENTERO, V20, P795, DOI 10.3748/wjg.v20.i3.795; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cao L, 2007, CARCINOGENESIS, V28, P1401, DOI 10.1093/carcin/bgm060; Chen CX, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm.2020.01.99; Chen D, 2020, THERANOSTICS, V10, P8558, DOI 10.7150/thno.44873; Chen WM, 2009, MOL CELL, V34, P663, DOI 10.1016/j.molcel.2009.04.029; Chen XP, 2010, FREE RADICAL RES, V44, P587, DOI 10.3109/10715761003709802; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; El-Daher MT, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0061-y; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Gorbunova V, 2016, CELL, V165, P1312, DOI 10.1016/j.cell.2016.05.061; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Gorrini C, 2013, J EXP MED, V210, P1529, DOI 10.1084/jem.20121337; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hill SJ, 2014, GENE DEV, V28, P1957, DOI 10.1101/gad.241620.114; Huang GQ, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0770-y; Huang JZ, 2017, MOL CELL, V68, P171, DOI 10.1016/j.molcel.2017.09.015; Huang JZ, 2016, J PATHOL, V239, P186, DOI 10.1002/path.4716; Jeong Y, 2017, CANCER DISCOV, V7, P86, DOI 10.1158/2159-8290.CD-16-0127; Kim H, 2005, ONCOGENE, V24, P1252, DOI 10.1038/sj.onc.1208282; Le Gal K, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad3740; Metallo CM, 2013, MOL CELL, V49, P388, DOI 10.1016/j.molcel.2013.01.018; Panieri E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.105; Thang PM, 2016, INT J ONCOL, V49, P1385, DOI 10.3892/ijo.2016.3649; Rezazadeh S, 2019, NUCLEIC ACIDS RES, V47, P7914, DOI 10.1093/nar/gkz528; Saha T, 2009, FEBS LETT, V583, P1535, DOI 10.1016/j.febslet.2009.04.005; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shen ZQ, 2018, ONCOTARGETS THER, V11, P891, DOI 10.2147/OTT.S154754; Shi R, 2017, ONCOTARGET, V8, P19768, DOI 10.18632/oncotarget.15519; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Sugawara S, 2018, J HUM GENET, V63, P657, DOI 10.1038/s10038-018-0437-8; Sun XF, 2016, HEPATOLOGY, V63, P173, DOI 10.1002/hep.28251; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tang ZF, 2019, NUCLEIC ACIDS RES, V47, pW556, DOI 10.1093/nar/gkz430; Teng YQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06586-3; Uchida F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-321; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Vagnarelli P, 2014, ADV EXP MED BIOL, V773, P401, DOI 10.1007/978-1-4899-8032-8_18; Wang H, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6095; Wiel C, 2019, CELL, V178, P330, DOI 10.1016/j.cell.2019.06.005; Wu BW, 2020, J CANCER, V11, P5727, DOI 10.7150/jca.46554; Xanthoulis A, 2013, WORLD J GASTROENTERO, V19, P3189, DOI 10.3748/wjg.v19.i21.3189; Xu IMJ, 2016, P NATL ACAD SCI USA, V113, pE725, DOI 10.1073/pnas.1508779113; Xu YJ, 2018, MOL MED REP, V17, P1507, DOI 10.3892/mmr.2017.8095; Zhan L, 2014, CELL SIGNAL, V26, P1075, DOI 10.1016/j.cellsig.2014.01.008; Zhang YX, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00725; Zou YZ, 2020, AGING-US, V12, P25304, DOI 10.18632/aging.104131	49	5	5	7	17	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUN 24	2021	40	25					4368	4383		10.1038/s41388-021-01855-w	http://dx.doi.org/10.1038/s41388-021-01855-w		JUN 2021	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	SY4AZ	34103686				2022-12-26	WOS:000659032900007
J	Opondo, C; Harrison, S; Alderdice, F; Carson, C; Quigley, MA				Opondo, Charles; Harrison, Sian; Alderdice, Fiona; Carson, Claire; Quigley, Maria A.			Electronic cigarette use (vaping) and patterns of tobacco cigarette smoking in pregnancy-evidence from a population-based maternity survey in England	PLOS ONE			English	Article							NATIONAL SAMPLE; TRENDS; NICOTINE; EXPOSURE; SYSTEMS; RISK	Objectives Exposure to tobacco products during pregnancy presents a potential harm to both mother and baby. This study sought to estimate the prevalence of vaping during pregnancy and to explore the factors and outcomes associated with vaping in pregnancy. Setting England. Participants Women who gave birth between 15(th) and 28(th) October 2017. Methods A cross-sectional population-based postal survey of maternal and infant health, the National Maternity Survey (NMS) 2018. The prevalence of vaping and patterns of cigarette smoking were estimated, and regression analysis was used to explore associations between maternal characteristics and vaping, and between vaping and birth outcomes. Outcome measures Unweighted and weighted prevalence of vaping with 95% confidence intervals, and unadjusted and adjusted relative risks or difference in means for the association of participant characteristics and secondary outcomes with vaping. Secondary outcome measures were: preterm birth, gestational age at birth, birthweight, and initiation and duration of breastfeeding. Results A total of 4,509 women responded to the survey. The prevalence of vaping in pregnancy was 2.8% (95%CI 2.4% to 3.4%). This varied according to the pattern of cigarette smoking in pregnancy: 0.3% in never-smokers; 3.3% in ex-smokers; 7.7% in pregnancy-inspired quitters; 9.5% in temporary quitters; and 17.7% in persistent smokers. Younger women, unmarried women, women with fewer years of formal education, women living with a smoker, and persistent smokers were more likely to vape, although after adjusting for pattern of cigarette smoking and maternal characteristics, persistent smoking was the only risk factor. We did not find any association between vaping and preterm birth, birthweight, or breastfeeding. Conclusions The prevalence of vaping during pregnancy in the NMS 2018 was low overall but much higher in smokers. Smoking was the factor most strongly associated with vaping. Co-occurrence of vaping with persistent smoking has the potential to increase the harms of tobacco exposure in pregnant women and their infants.	[Opondo, Charles; Harrison, Sian; Alderdice, Fiona; Carson, Claire; Quigley, Maria A.] Univ Oxford, Natl Perinatal Epidemiol Unit, NIHR Policy Res Unit Maternal Hlth & Care, Nuffield Dept Populat Hlth, Oxford, England	University of Oxford	Opondo, C (corresponding author), Univ Oxford, Natl Perinatal Epidemiol Unit, NIHR Policy Res Unit Maternal Hlth & Care, Nuffield Dept Populat Hlth, Oxford, England.	charles.opondo@npeu.ox.ac.uk		Opondo, Charles/0000-0001-8155-4117; Alderdice, Fiona/0000-0003-2404-5644	National Institute for Health Research (NIHR) Policy Research Programme [PR-PRU-1217-21202]	National Institute for Health Research (NIHR) Policy Research Programme(National Institute for Health Research (NIHR))	This research is funded by the National Institute for Health Research (NIHR) Policy Research Programme, conducted through the Policy Research Unit in Maternal and Neonatal Health and Care, PR-PRU-1217-21202. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care.	Andres R L, 2000, Semin Neonatol, V5, P231, DOI 10.1053/siny.2000.0025; [Anonymous], 2018, NATL ACAD SCI ENG ME; Arter ZL, 2019, RESPIR MED CASE REP, V27, DOI 10.1016/j.rmcr.2019.100825; Audit Commission for Local Authorities and the National Health Service in England and Wales, 1997, 1 CLASS DEL IMPR MAT; Bilano V, 2015, LANCET, V385, P966, DOI 10.1016/S0140-6736(15)60264-1; Bowker K, 2021, BJOG-INT J OBSTET GY, V128, P984, DOI 10.1111/1471-0528.16553; Brown HK, 2014, J OBSTET GYNAECOL CA, V36, P878, DOI 10.1016/S1701-2163(15)30436-9; Calder R., 2021, NICOTINE TOB RES, P1, DOI [10.1093/ntr/ntaa228, DOI 10.1093/NTR/NTAA228]; Cardenas VM, 2019, TOB INDUC DIS, V17, DOI 10.18332/tid/106089; Cardenas VM, 2020, ANN EPIDEMIOL, V52, P86, DOI 10.1016/j.annepidem.2020.08.002; Christiani DC, 2020, NEW ENGL J MED, V382, P960, DOI 10.1056/NEJMe1912032; Clemens MM, 2019, TOB INDUC DIS, V17, DOI 10.18332/tid/105387; Colman GJ, 2003, AM J PREV MED, V24, P29, DOI 10.1016/S0749-3797(02)00574-3; Cornish D., 2019, AD SMOKING HABITS UK; Fitzpatrick KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153447; Giglia R, 2006, ACTA PAEDIATR, V95, P1370, DOI 10.1080/08035250600771474; Gilbert NL, 2015, J OBSTET GYNAECOL CA, V37, P32, DOI 10.1016/S1701-2163(15)30360-1; Guindon G., 2003, TOB CONTROL; Harrison S.E., 2020, PREVALENCE RISK FACT; Harrison S.E., 2019, YOU YOUR BABY NATL S; Harrison S.E., 2019, YOU YOUR BABY NATL S; Harrison S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242815; Harrison S, 2020, ARCH PUBLIC HEALTH, V78, DOI 10.1186/s13690-020-00427-w; Hartmann-Boyce J, 2016, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD010216.pub3, 10.1002/14651858.CD010216.pub4]; Hawkins SS, 2020, AM J PREV MED, V58, P122, DOI 10.1016/j.amepre.2019.08.031; Horta BL, 2001, AM J PUBLIC HEALTH, V91, P304, DOI 10.2105/AJPH.91.2.304; Jaakkola N, 2001, AM J PUBLIC HEALTH, V91, P284, DOI 10.2105/AJPH.91.2.284; Kalkhoran S, 2016, LANCET RESP MED, V4, P116, DOI 10.1016/S2213-2600(15)00521-4; Kapaya Martha, 2019, MMWR Morb Mortal Wkly Rep, V68, P189, DOI 10.15585/mmwr.mm6808a1; Kim S, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03247-6; Kock L, 2019, ADDICTION, V114, P294, DOI 10.1111/add.14446; Kurti AN, 2020, DRUG ALCOHOL DEPEN, V207, DOI 10.1016/j.drugalcdep.2019.107801; Kurti AN, 2017, PREV MED, V104, P50, DOI 10.1016/j.ypmed.2017.07.030; Layden JE, 2020, NEW ENGL J MED, V382, P903, DOI 10.1056/NEJMoa1911614; Letson G William, 2002, J Hum Lact, V18, P368, DOI 10.1177/089033402237910; Liu BY, 2019, JAMA PEDIATR, V173, P600, DOI 10.1001/jamapediatrics.2019.0658; Liu JH, 2006, AM J PUBLIC HEALTH, V96, P309, DOI 10.2105/AJPH.2004.060798; McAndrew F, 2012, INFANT FEEDING SURVE; McDonnell BP, 2020, BJOG-INT J OBSTET GY, V127, P750, DOI 10.1111/1471-0528.16110; McNeill A, 2015, E CIGARETTES EVIDENC, P111; McNeill AD, 2019, VAPING ENGLAND EVIDE; Miller MD, 2007, PREV MED, V44, P93, DOI 10.1016/j.ypmed.2006.08.015; NHS, US E CIG STOP SMOK; Noble M, 2006, ENVIRON PLANN A, V38, P169, DOI 10.1068/a37168; Office for National Statistics, OP LIF SURV; Owen L, 1998, BRIT MED J, V317, P728, DOI 10.1136/bmj.317.7160.728; Redshaw M., 2010, DELIVERED CARE NATL; Redshaw M., 2007, RECORDED DELIVERY NA; Redshaw M, 2014, SAFELY DELIVERED NAT; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Sanford Zachary, 2014, W V Med J, V110, P10; Shahab L, 2017, ANN INTERN MED, V166, P390, DOI 10.7326/M16-1107; Smith T., 2015, ENGLISH INDICES DEPR; Tikkanen M, 2006, ACTA OBSTET GYN SCAN, V85, P40, DOI 10.1080/00016340500324241; Viswam Darsana, 2018, BMJ Case Rep, V2018, DOI 10.1136/bcr-2018-224350; Wang X, 2020, PREV MED, V134, DOI 10.1016/j.ypmed.2020.106041; World Health Organization, 2012, WHO GLOB REP MORT AT, P392	58	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252817	10.1371/journal.pone.0252817	http://dx.doi.org/10.1371/journal.pone.0252817			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086809	Green Accepted, Green Published, gold			2022-12-26	WOS:000664640100139
J	Tran, L; Jochum, SB; Shaikh, M; Wilber, S; Zhang, LJ; Hayden, DM; Forsyth, CB; Voigt, RM; Bishehsari, F; Keshavarzian, A; Swanson, GR				Tran, Laura; Jochum, Sarah B.; Shaikh, Maliha; Wilber, Sherry; Zhang, Lijuan; Hayden, Dana M.; Forsyth, Christopher B.; Voigt, Robin M.; Bishehsari, Faraz; Keshavarzian, Ali; Swanson, Garth R.			Circadian misalignment by environmental light/dark shifting causes circadian disruption in colon	PLOS ONE			English	Article							INTESTINAL PERMEABILITY; IMMUNE ACTIVATION; IN-VITRO; RHYTHMS; ENDOTOXIN; BARRIER; CELLS; HYPERPERMEABILITY; OSCILLATIONS; MECHANISM	Background Physiological circadian rhythms (CRs) are complex processes with 24-hour oscillations that regulate diverse biological functions. Chronic weekly light/dark (LD) shifting (CR disruption; CRD) in mice results in colonic hyperpermeability. However, the mechanisms behind this phenomenon are incompletely understood. One potential innovative in vitro method to study colonic CRs are colon organoids. The goals of this study were to utilize circadian clock gene Per2 luciferase reporter (Per2::Luc) mice to measure the effects of chronic LD shifting on colonic tissue circadian rhythmicity ex vivo and to determine if organoids made from shifted mice colons recapitulate the in vivo phenotype. Methods Non-shifted (NS) and shifted (S) BL6 Per2::Luc mice were compared after a 22-week experiment. NS mice had a standard 12h light/12h dark LD cycle throughout. S mice alternated 12h LD patterns weekly, with light from 6am-6pm one week followed by shifting light to 6pm-6am the next week for 22 weeks. Mice were tested for intestinal permeability while colon tissue and organoids were examined for CRs of bioluminescence and proteins of barrier function and cell fate. Results There was no absolute difference in NS vs. S 24h circadian period or phase. However, chronic LD shifting caused Per2::Luc S mice colon tissue to exhibit significantly greater variability in both the period and phase of Per2::Luc rhythms than NS mice colon tissue and organoids. Chronic LD shifting also resulted in increased colonic permeability of the Per2::Luc mice as well as decreased protein markers of intestinal permeability in colonic tissue and organoids from shifted Per2:Luc mice. Conclusions Our studies support a model in which chronic central circadian disruption by LD shifting alters the circadian phenotype of the colon tissue and results in colon leakiness and loss of colonic barrier function. These CRD-related changes are stably expressed in colon stem cell derived organoids from CRD mice.	[Tran, Laura; Shaikh, Maliha; Wilber, Sherry; Zhang, Lijuan; Forsyth, Christopher B.; Voigt, Robin M.; Bishehsari, Faraz; Keshavarzian, Ali; Swanson, Garth R.] Rush Univ, Rush Med Coll, Rush Ctr Integrated Microbiome & Chronobiol Res, Med Ctr, Chicago, IL 60612 USA; [Jochum, Sarah B.; Hayden, Dana M.] Rush Univ, Dept Surg, Med Ctr, Chicago, IL 60612 USA; [Forsyth, Christopher B.; Voigt, Robin M.; Bishehsari, Faraz; Keshavarzian, Ali; Swanson, Garth R.] Rush Univ, Dept Med, Med Ctr, Chicago, IL 60612 USA	Rush University; Rush University; Rush University	Swanson, GR (corresponding author), Rush Univ, Rush Med Coll, Rush Ctr Integrated Microbiome & Chronobiol Res, Med Ctr, Chicago, IL 60612 USA.; Swanson, GR (corresponding author), Rush Univ, Dept Med, Med Ctr, Chicago, IL 60612 USA.	garth_swanson@rush.edu		Tran, Laura/0000-0002-4428-053X	National Institute on Alcohol Abuse and Alcoholism [R24AA026801, K23AA025387]	National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	The study was supported by the National Institute on Alcohol Abuse and Alcoholism (R24AA026801, K23AA025387) received by AK and FB. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2006, GUT, V55, DOI 10.1136/gut.2005.085373; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Cornelissen G, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-16; Creely SJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE740, DOI 10.1152/ajpendo.00302.2006; Davidson AJ, 2003, GENES BRAIN BEHAV, V2, P32, DOI 10.1034/j.1601-183X.2003.00005.x; Eckel-Mahan Kristin, 2015, Curr Protoc Mouse Biol, V5, P271, DOI 10.1002/9780470942390.mo140229; Farhadi A, 2008, LIVER INT, V28, P1026, DOI 10.1111/j.1478-3231.2008.01723.x; Forsyth CB, 2017, ALCOHOL CLIN EXP RES, V41, P2100, DOI 10.1111/acer.13519; Forsyth CB, 2013, AM J PHYSIOL-GASTR L, V305, pG185, DOI 10.1152/ajpgi.00354.2012; Forsyth CB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028032; Forsyth CB, 2011, ALCOHOL CLIN EXP RES, V35, P1635, DOI 10.1111/j.1530-0277.2011.01510.x; Guenthner CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087573; Hoogerwerf WA, 2009, REV ENDOCR METAB DIS, V10, P293, DOI 10.1007/s11154-009-9119-3; Izumo M, 2014, ELIFE, V3, DOI 10.7554/eLife.04617; Jung P, 2011, NAT MED, V17, P1225, DOI 10.1038/nm.2470; Karpowicz P, 2013, CELL REP, V3, P996, DOI 10.1016/j.celrep.2013.03.016; Konturek PC, 2011, J PHYSIOL PHARMACOL, V62, P139; Koo BK, 2012, NAT METHODS, V9, P81, DOI [10.1038/NMETH.1802, 10.1038/nmeth.1802]; Lassenius MI, 2011, DIABETES CARE, V34, P1809, DOI 10.2337/dc10-2197; Laukoetter MG, 2006, CURR OPIN GASTROEN, V22, P85, DOI 10.1097/01.mog.0000203864.48255.4f; Leise TL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033334; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Leushacke M, 2014, GUT, V63, P1345, DOI 10.1136/gutjnl-2014-307204; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P117; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; MOORADIAN AD, 1986, DIABETOLOGIA, V29, P221, DOI 10.1007/BF00454879; Moore SR, 2014, DIS MODEL MECH, V7, P1123, DOI 10.1242/dmm.014399; NELSON W, 1979, CHRONOBIOLOGIA, V6, P305; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Niebauer J, 1999, LANCET, V353, P1838, DOI 10.1016/S0140-6736(98)09286-1; Nojkov B, 2010, AM J GASTROENTEROL, V105, P842, DOI 10.1038/ajg.2010.48; Oh-oka K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098016; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Preuss F, 2008, AM J PHYSIOL-REG I, V295, pR2034, DOI 10.1152/ajpregu.00118.2008; Roenneberg Till, 2013, Handb Exp Pharmacol, P311, DOI 10.1007/978-3-642-25950-0_13; Ruben MD, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat8806; Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schernhammer ES, 2003, JNCI-J NATL CANCER I, V95, P825, DOI 10.1093/jnci/95.11.825; Shaikh M, 2015, CLIN CHIM ACTA, V442, P24, DOI 10.1016/j.cca.2014.12.040; Skarke C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17362-6; Spiller RC, 2000, GUT, V47, P804, DOI 10.1136/gut.47.6.804; Stokes K, 2017, CELL MOL GASTROENTER, V4, P95, DOI 10.1016/j.jcmgh.2017.03.011; Summa KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067102; Swanson G, 2011, ALCOHOL CLIN EXP RES, V35, P1305, DOI 10.1111/j.1530-0277.2011.01466.x; Swanson GR, 2016, AM J PHYSIOL-GASTR L, V311, pG192, DOI 10.1152/ajpgi.00087.2016; Thaiss CA, 2014, CELL, V159, P514, DOI 10.1016/j.cell.2014.09.048; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vaile JH, 1999, J RHEUMATOL, V26, P128; Voigt RM, 2019, EXPERT REV GASTROENT, V13, P411, DOI 10.1080/17474124.2019.1595588; Voigt RM, 2016, ALCOHOL CLIN EXP RES, V40, P335, DOI 10.1111/acer.12943; Voigt RM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097500; Xie GX, 2013, J PROTEOME RES, V12, P3297, DOI 10.1021/pr400362z; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zhang R, 2009, J NEUROIMMUNOL, V206, P121, DOI 10.1016/j.jneuroim.2008.09.017; Zielinski T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096462	58	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251604	10.1371/journal.pone.0251604	http://dx.doi.org/10.1371/journal.pone.0251604			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086699	gold, Green Published			2022-12-26	WOS:000664640100019
J	Vasilikos, I; Teixeira, GQ; Seitz, A; Nothelfer, J; Haas, J; Wilke, HJ; Mizaikoff, B; Beck, J; Hubbe, U; Neidlinger-Wilke, C				Vasilikos, Ioannis; Teixeira, Graciosa Q.; Seitz, Andreas; Nothelfer, Julia; Haas, Julian; Wilke, Hans-Joachim; Mizaikoff, Boris; Beck, Juergen; Hubbe, Ulrich; Neidlinger-Wilke, Cornelia			Can UVA-light-activated riboflavin-induced collagen crosslinking be transferred from ophthalmology to spine surgery? A feasibility study on bovine intervertebral disc	PLOS ONE			English	Article							PROGRESSIVE KERATOCONUS; DEGENERATION; ULTRAVIOLET; DISEASE; PROBE; CXL	Background Collagen cross-links contribute to the mechanical resilience of the intervertebral disc (IVD). UVA-light-activated riboflavin-induced collagen crosslinking (UVA-CXL) is a well-established and effective ophthalmological intervention that increases the mechanical rigidity of the collagen-rich corneal matrix in Keratoconus. This study explores the feasibility, safety and efficacy of translating this intervention in reinforcing the IVD. Methods Annulus fibrosus (AF) cells were isolated from bovine IVDs and treated with different combinations of riboflavin (RF) concentrations (0.05-8 mM) and UVA light intensities (0.3-4 mW/cm(2)). Metabolic activity (resazurin assay), cell viability (TUNEL assay), and gene expression of apoptosis regulators C-FOS and PT5 were assessed immediately and 24 hours after treatment. Biomechanical effects of UVA-CXL on IVDs were measured by indentation analysis of changes in the instantaneous modulus and by peel-force delamination strength analysis of the AF prior and after treatment. Results Different intensities of UVA did not impair the metabolic activity of AF cells. However, RF affected metabolic activity (p < 0.001). PT53 expression was similar in all RF conditions tested while C-FOS expression decreased 24 hours after treatment. Twenty-four hours after treatment, no apoptotic cells were observed in any condition tested. Biomechanical characterizations showed a significant increase in the annular peel strength of the UVA-CXL group, when compared to controls of UVA and RF alone (p < 0.05). UVA-CXL treated IVDs showed up to 152% higher (p < 0.001) instantaneous modulus values compared to the untreated control. Conclusion This is the first study on UVA-CXL treatment of IVD. It induced significantly increased delamination strength and instantaneous modulus indentation values in intact IVD samples in a structure-function relationship. RF concentrations and UVA intensities utilized in ophthalmological clinical protocols were well tolerated by the AF cells. Our findings suggest that UVA-CXL may be a promising tool to reinforce the IVD matrix.	[Vasilikos, Ioannis; Beck, Juergen; Hubbe, Ulrich] Univ Freiburg, Dept Neurosurg, Fac Med, Med Ctr, Freiburg, Germany; [Vasilikos, Ioannis; Beck, Juergen; Hubbe, Ulrich] Univ Freiburg, Lab Expt Neurosurgery LENS, Med Ctr, Fac Med, Freiburg, Germany; [Teixeira, Graciosa Q.; Seitz, Andreas; Nothelfer, Julia; Wilke, Hans-Joachim; Neidlinger-Wilke, Cornelia] Univ Ulm, Inst Orthopaed Res & Biomech, Trauma Res Ctr, Ulm, Germany; [Haas, Julian; Mizaikoff, Boris] Univ Ulm, Inst Analyt & Bioanalyt Chem, Ulm, Germany	University of Freiburg; University of Freiburg; Ulm University; Ulm University	Vasilikos, I (corresponding author), Univ Freiburg, Dept Neurosurg, Fac Med, Med Ctr, Freiburg, Germany.; Vasilikos, I (corresponding author), Univ Freiburg, Lab Expt Neurosurgery LENS, Med Ctr, Fac Med, Freiburg, Germany.	ioannisvasilikos@icloud.com	Seitz, Andreas Martin/D-6989-2017; Teixeira, Graciosa Q./AAM-9925-2020; Wilke, Hans-Joachim/M-6440-2014	Seitz, Andreas Martin/0000-0001-8174-8552; Teixeira, Graciosa Q./0000-0003-4206-6326; Wilke, Hans-Joachim/0000-0001-6007-8844; Vasilikos, Ioannis/0000-0001-5820-1110				Adams MA, 2006, SPINE, V31, P2151, DOI 10.1097/01.brs.0000231761.73859.2c; Belviranli S, 2020, EUR J OPHTHALMOL, V30, P1256, DOI 10.1177/1120672119872375; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Bradford SM, 2017, BIOMED OPT EXPRESS, V8, P4788, DOI 10.1364/BOE.8.004788; Bradford SM, 2016, J CATARACT REFR SURG, V42, P1660, DOI 10.1016/j.jcrs.2016.06.040; Brinjikji W, 2015, AM J NEURORADIOL, V36, P2394, DOI 10.3174/ajnr.A4498; Bruehlmann SB, 2002, J ANAT, V201, P159, DOI 10.1046/j.1469-7580.2002.00080.x; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chuang SY, 2007, CLIN BIOMECH, V22, P14, DOI 10.1016/j.clinbiomech.2006.08.001; Duance VC, 1998, SPINE, V23, P2545, DOI 10.1097/00007632-199812010-00009; Elkeles A, 1999, MOL CELL BIOL, V19, P2594; Ferdi AC, 2019, OPHTHALMOLOGY, V126, P935, DOI 10.1016/j.ophtha.2019.02.029; Gregory DE, 2012, EUR SPINE J, V21, P1716, DOI 10.1007/s00586-012-2308-x; Hartvigsen J, 2018, LANCET, V391, P2356, DOI 10.1016/S0140-6736(18)30480-X; HAYES WC, 1972, J BIOMECH, V5, P541, DOI 10.1016/0021-9290(72)90010-3; Hedman TP, 2017, J MED BIOL ENG, V37, P94, DOI 10.1007/s40846-016-0207-z; Hersh PS, 2017, OPHTHALMOLOGY, V124, P1259, DOI [10.1016/j.ophtha.2017.03.052, 10.1016/j.ophtha.2017.05.036]; JURVELIN JS, 1995, J BIOMECH, V28, P231, DOI 10.1016/0021-9290(94)00060-H; Kanellopoulos AJ, 2019, CLIN OPHTHALMOL, V13, P581, DOI 10.2147/OPTH.S188517; Li Y, 2019, EXP THER MED, V17, P1367, DOI 10.3892/etm.2018.7085; Lin HJ, 2015, SPINE, V40, P1572, DOI 10.1097/BRS.0000000000001089; Mazzotta C, 2018, CORNEA, V37, P560, DOI 10.1097/ICO.0000000000001505; McCall AS, 2010, INVEST OPHTH VIS SCI, V51, P129, DOI 10.1167/iovs.09-3738; Melrose J, 2008, EUR SPINE J, V17, P1131, DOI 10.1007/s00586-008-0712-z; Molinos M, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.1191; Pokharna HK, 1998, SPINE, V23, P1645, DOI 10.1097/00007632-199808010-00005; Raj P Prithvi, 2008, Pain Pract, V8, P18, DOI 10.1111/j.1533-2500.2007.00171.x; Saggese T, 2019, EUR SPINE J, V28, P922, DOI 10.1007/s00586-019-05901-w; Schultz KJ, 2014, GYNECOL OBSTET INVES, V77, P100, DOI 10.1159/000357617; Sim S, 2017, J ORTHOP RES, V35, P858, DOI 10.1002/jor.23330; Sorkin N, 2014, OPHTHALMOLOGICA, V232, P10, DOI 10.1159/000357979; Sung HW, 1999, J BIOMAT SCI-POLYM E, V10, P63, DOI 10.1163/156856299X00289; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Vasilikos I, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.202000110; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wuertz K, 2012, EUR CELLS MATER, V23, P103	36	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252672	10.1371/journal.pone.0252672	http://dx.doi.org/10.1371/journal.pone.0252672			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081754	Green Published, gold			2022-12-26	WOS:000664639200043
J	Zhang, YQ; Shen, WJ; Qiu, S; Yang, PL; Dempsey, G; Zhao, L; Zhou, Q; Hao, X; Dong, DC; Stahl, A; Kraemer, FB; Leung, LL; Morser, J				Zhang, Yiqiang; Shen, Wen-Jun; Qiu, Shuo; Yang, Pinglin; Dempsey, Garrett; Zhao, Lei; Zhou, Qin; Hao, Xiao; Dong, Dachuan; Stahl, Andreas; Kraemer, Fredric B.; Leung, Lawrence L.; Morser, John			Chemerin regulates formation and function of brown adipose tissue: Ablation results in increased insulin resistance with high fat challenge and aging	FASEB JOURNAL			English	Article						adipocytes; adipokines; chemerin; energy balance	WHITE; ADIPOGENESIS; ADIPOCYTES; COAGULATION; ACTIVATION; ADIPOKINE; PROTEIN; OBESITY; CELLS	Apart from its role in inflammation and immunity, chemerin is also involved in white adipocyte biology. To study the role of chemerin in adipocyte metabolism, we examined the function of chemerin in brown adipose tissue. Brown and white adipocyte precursors were differentiated into adipocytes in the presence of Chemerin siRNA. Chemerin-deficient (Chem(-/-)) mice were compared to wild-type mice when fed a high-fat diet. Chemerin is expressed during brown adipocyte differentiation and knock down of chemerin mRNA results in decreased brown adipocyte differentiation with reduced fatty acid uptake in brown adipocytes. Chem(-/-) mice are leaner than wild-type mice but gain more weight when challenged with high-fat diet feeding, resulting in a larger increase in fat deposition. Chem(-/-) mice develop insulin resistance when on a high-fat diet or due to age. Brown adipose depots in Chem(-/-) mice weigh more than in wild-type mice, but with decreased mitochondrial content and function. Compared to wild-type mice, male Chem(-/-) mice have decreased oxygen consumption, CO2 production, energy expenditure, and a lower respiratory exchange ratio. Additionally, body temperature of Chem(-/-) mice is lower than that of wild-type mice. These results revealed that chemerin is expressed during brown adipocyte differentiation and has a pivotal role in energy metabolism through brown adipose tissue thermogenesis.	[Zhang, Yiqiang; Shen, Wen-Jun; Qiu, Shuo; Yang, Pinglin; Hao, Xiao; Dong, Dachuan; Kraemer, Fredric B.] Stanford Univ, Dept Med, Div Endocrinol, Sch Med, Stanford, CA 94305 USA; [Zhang, Yiqiang; Shen, Wen-Jun; Qiu, Shuo; Yang, Pinglin; Zhao, Lei; Zhou, Qin; Hao, Xiao; Dong, Dachuan; Kraemer, Fredric B.; Leung, Lawrence L.; Morser, John] Vet Affairs Palo Alto Hlth Care Syst, Bldg 101-4A131,3801 Miranda Ave, Palo Alto, CA 94304 USA; [Zhang, Yiqiang] Changzhi Med Coll, Dept Biochem, Changzhi, Peoples R China; [Yang, Pinglin] Xi An Jiao Tong Univ, Dept Orthoped, Affiliated Hosp 2, Xian, Peoples R China; [Dempsey, Garrett; Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Zhao, Lei; Zhou, Qin; Leung, Lawrence L.; Morser, John] Stanford Univ, Dept Med, Div Hematol, Sch Med, Stanford, CA 94305 USA; [Hao, Xiao] Zhengzhou Univ, Dept Endocrinol, Affiliated Hosp 1, Med Coll, Zhengzhou, Peoples R China	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Changzhi Medical College; Xi'an Jiaotong University; University of California System; University of California Berkeley; Stanford University; Zhengzhou University	Shen, WJ; Morser, J (corresponding author), Vet Affairs Palo Alto Hlth Care Syst, Bldg 101-4A131,3801 Miranda Ave, Palo Alto, CA 94304 USA.	wen-jun@stanford.edu; jmorser@stanford.edu		Kraemer, Fredric/0000-0003-2468-7807	U.S. Department of Veterans Affairs (VA) [I01BX001959, I01BX000398]; SU | School of Medicine, Stanford University (Stanford University School of Medicine); HHS | National Institutes of Health (NIH) [P30DK116074]	U.S. Department of Veterans Affairs (VA)(US Department of Veterans Affairs); SU | School of Medicine, Stanford University (Stanford University School of Medicine); HHS | National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01BX001959; SU | School of Medicine, Stanford University (Stanford University School of Medicine); U.S. Department of Veterans Affairs (VA), Grant/Award Number: I01BX000398; HHS | National Institutes of Health (NIH), Grant/Award Number: P30DK116074	Barzilai N, 2012, DIABETES, V61, P1315, DOI 10.2337/db11-1300; Blaak E, 2001, CURR OPIN CLIN NUTR, V4, P499, DOI 10.1097/00075197-200111000-00006; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chang SS, 2016, OBESITY, V24, P1522, DOI 10.1002/oby.21534; Cinti S, 1997, ENDOCRINOLOGY, V138, P797, DOI 10.1210/en.138.2.797; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; De Henau O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164179; Dubikovskaya E, 2014, METHOD ENZYMOL, V538, P107, DOI 10.1016/B978-0-12-800280-3.00007-4; Ernst MC, 2012, ENDOCRINOLOGY, V153, P672, DOI 10.1210/en.2011-1490; Ernst MC, 2010, TRENDS ENDOCRIN MET, V21, P660, DOI 10.1016/j.tem.2010.08.001; Ernst MC, 2010, ENDOCRINOLOGY, V151, P1998, DOI 10.1210/en.2009-1098; Ge XM, 2018, BLOOD, V131, P353, DOI 10.1182/blood-2017-07-792580; Giordano A, 2014, EUR J ENDOCRINOL, V170, pR159, DOI 10.1530/EJE-13-0945; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Goralski KB, 2007, J BIOL CHEM, V282, P28175, DOI 10.1074/jbc.M700793200; Issa ME, 2012, AM J PHYSIOL-CELL PH, V302, pC1621, DOI 10.1152/ajpcell.00187.2011; Lorincz H, 2014, CLIN ENDOCRINOL, V81, P370, DOI 10.1111/cen.12363; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Muruganandan S, 2010, J BONE MINER RES, V25, P222, DOI 10.1359/jbmr.091106; Niccoli T, 2012, CURR BIOL, V22, pR741, DOI 10.1016/j.cub.2012.07.024; Parlee SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051072; Rhee EJ, 2011, DIABETES METAB J, V35, P216, DOI 10.4093/dmj.2011.35.3.216; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Rourke JL, 2014, J ENDOCRINOL, V222, P201, DOI 10.1530/JOE-14-0069; SBARBATI A, 1991, INT J OBESITY, V15, P581; Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001; Shin HY, 2012, CLIN ENDOCRINOL, V77, P47, DOI 10.1111/j.1365-2265.2011.04217.x; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Strowig T, 2012, NATURE, V481, P278, DOI 10.1038/nature10759; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Vitali A, 2012, J LIPID RES, V53, P619, DOI 10.1194/jlr.M018846; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zhao L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202780; Zhao L, 2018, ARTHRITIS RES THER, V20, DOI 10.1186/s13075-018-1615-y; Zhao L, 2011, J BIOL CHEM, V286, P39520, DOI 10.1074/jbc.M111.258954	38	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21687	10.1096/fj.202100156R	http://dx.doi.org/10.1096/fj.202100156R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34089273	Green Accepted			2022-12-26	WOS:000667814100053
J	Nero, BF				Nero, Bertrand Festus			Structure, composition and diversity of restored forest ecosystems on mine-spoils in South-Western Ghana	PLOS ONE			English	Article							MEASURING BETA-DIVERSITY; SPECIES-ABUNDANCE; LAND; SUCCESSION; EXPANSION; DYNAMICS; ECOLOGY; CANOPY	In response to national policy obligations, many mining companies in Ghana have restored/reclaimed degraded mined out sites through revegetation. The area extent of such restored areas is unknown and there is also paucity of data on success of restoration, species diversity and compositional dynamics of such restored landscapes, particularly using mixed species. This study assessed stand structure, diversity and composition dynamics of sites restored with mixed species and models species abundance distribution on these sites. Three reclaimed and one control site (adjacent natural forest) were inventoried using 27, 30 x 30 m plots on the Hwini-Butre and Benso concession of the Golden Star Wassa Limited. Overall 3057 (per 24 plots) and 150 (per 3 plots) individual trees were recorded in the overstorey of the reclaimed and control sites, respectively. In all, 31 species in 13 families occurred on the reclaimed site while 61 species in 29 families occurred on the control. Species richness, abundance and diversity were significantly lower in the reclaimed sites than the control in the overstorey (p <= 0.018), mid-storey (p <= 0.032), and understorey (p <= 0.031). Species composition of the reclaimed and control sites were mostly dissimilar in the overstorey, midstorey, and understorey. However, the midstorey and overstorey of the reclaimed sites showed high similarity in composition (Jaccard's index = 0.817). Pioneer and shade-tolerant species were most dominant in the understorey of the control while only shade-tolerant species (mostly herbs and grasses) dominated the reclaimed sites. Species abundance distribution of both reclaimed and control sites followed the geometric series model, indicating that both sites are disturbed but at different intensities. It is concluded that reclamation with mixed species does not necessarily lead to rapid restoration of indigenous climax species on mine spoils. Nonetheless, it may lead to accomplishments of short-term goals of stabilizing and protecting landscapes while conditioning the sites for colonisation of the climax species.	[Nero, Bertrand Festus] Kwame Nkrumah Univ Sci & Technol, PMB, FRNR, Dept Forest Resources Technol, Kumasi, Ghana	Kwame Nkrumah University Science & Technology	Nero, BF (corresponding author), Kwame Nkrumah Univ Sci & Technol, PMB, FRNR, Dept Forest Resources Technol, Kumasi, Ghana.	bfn8puo@gmail.com						Alroy J, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500082; Anthony, 2009, AGROFORESTREE DATABA; Asase Alex, 2012, International Journal of Biodiversity Science Ecosystem Services & Management, V8, P217, DOI 10.1080/21513732.2012.707152; Attua E. M., 2013, Journal of Applied Biosciences, V69, P5437; Awotwi A, 2018, LAND DEGRAD DEV, V29, P3331, DOI 10.1002/ldr.3093; Baatuuwie N. B., 2011, Agriculture and Biology Journal of North America, V2, P134, DOI 10.5251/abjna.2011.2.1.134.142; BAZZAZ FA, 1975, ECOLOGY, V56, P485, DOI 10.2307/1934981; Chao A, 2006, BIOMETRICS, V62, P361, DOI 10.1111/j.1541-0420.2005.00489.x; Chave J, 2014, GLOBAL CHANGE BIOL, V20, P3177, DOI 10.1111/gcb.12629; Colwell R.K., 2013, ESTIMATES 910 USER G; Commission European., 2013, SOIL ATLAS AFRICA; Coppin N., 2013, P 8 INT C MIN CLOS, P485, DOI [10.36487/acg%5Frep/1352%5F41%5Fcoppin, DOI 10.36487/ACG%5FREP/1352%5F41%5FCOPPIN]; Davis MA, 2004, RESTOR ECOL, V12, P1, DOI 10.1111/j.1061-2971.2004.0351.x; Doi H, 2013, OIKOS, V122, P179, DOI 10.1111/j.1600-0706.2012.00068.x; Dornelas M, 2009, J APPL ECOL, V46, P666, DOI 10.1111/j.1365-2664.2009.01640.x; EPA E. P. A.,, 2004, RECLAMATION SECURITY; FAO, 1997, ESTIMATING BIOMASS B; Fattorini S, 2005, ACTA OECOL, V28, P199, DOI 10.1016/j.actao.2005.04.003; Ferreira FC, 2008, BRAZ J BIOL, V68, P1003, DOI 10.1590/S1519-69842008000500008; Festin ES, 2019, J FORESTRY RES, V30, P381, DOI 10.1007/s11676-018-0621-x; Forkuor G, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12060911; Forrester DI, 2004, FOREST ECOL MANAG, V193, P81, DOI 10.1016/j.foreco.2004.01.024; Forson S. A. K., 2002, REPORT; Gallery R.E., 2014, ECOL ENV, P1, DOI [10.1007/978-1-4614-7501-9, DOI 10.1007/978-1-4614-7501-9]; Gardner J., 2001, Unasylva (English ed.), V52, P3; Gaspar C.S., 2008, INSECT ECOLOGY CONSE, V661, P1; Gatti RC, 2017, IFOREST, V10, P362, DOI 10.3832/ifor2056-010; Gray JS, 2005, J ANIM ECOL, V74, P1131, DOI 10.1111/j.1365-2656.2005.01011.x; HALL JB, 1976, J ECOL, V64, P913, DOI 10.2307/2258816; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Haudecoeur R, 2018, J ETHNOPHARMACOL, V212, P106, DOI 10.1016/j.jep.2017.10.011; Hawthorne W., 2006, PHOTOGUIDE FOREST TR; Hawthorne W.D., 2006, WOODY PLANTS W AFRIC; Heip Carlo H. R., 1998, Oceanis, V24, P61; Holl KD, 2002, J APPL ECOL, V39, P960, DOI 10.1046/j.1365-2664.2002.00767.x; Koch JM, 2007, RESTOR ECOL, V15, pS26, DOI 10.1111/j.1526-100X.2007.00290.x; Koleff P, 2003, J ANIM ECOL, V72, P367, DOI 10.1046/j.1365-2656.2003.00710.x; Kortatsi B.K., 2004, THESIS U GHANA LEGON; Krebs C. J., 2014, ECOLOGICAL METHDOLOG, P479; Kuter N., 2013, ADV LANDSCAPE ARCHIT, DOI [10.5772/55796., DOI 10.5772/55796]; Macdonald SE, 2015, NEW FOREST, V46, P703, DOI 10.1007/s11056-015-9506-4; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Matthews TJ, 2015, J APPL ECOL, V52, P443, DOI 10.1111/1365-2664.12380; Mensah A. K., 2015, International Journal of Biodiversity and Conservation, V7, P57; Minerals Commission, 2012, 51 2182, V2012; Nero BF, 2019, URBAN ECOSYST, V22, P593, DOI 10.1007/s11252-019-00835-z; Novor S., 2020, OPEN J FOR, V10, P135, DOI [10.4236/ojf.2020.101010, DOI 10.4236/OJF.2020.101010]; Parker A.J.A., 2012, AFRICAN PRIMATES, V7, P175; PARROTTA JA, 1995, J VEG SCI, V6, P627, DOI 10.2307/3236433; Schroeder PJ, 2018, ECOSPHERE, V9, DOI 10.1002/ecs2.2100; SER, 2004, ECOL RESTOR, V2, P206; Snapir B, 2017, INT J APPL EARTH OBS, V58, P225, DOI 10.1016/j.jag.2017.02.009; Suhartoyo H., 2012, BIODIVERSITAS, V13, P13; SWAINE MD, 1983, J ECOL, V71, P601, DOI 10.2307/2259737; SWAINE MD, 1990, VEGETATIO, V88, P31, DOI 10.1007/BF00032601; Tetteh E.N., 2015, J SCI TECHNOL GHANA, V35, P77, DOI [DOI 10.4314/JUST.V35I2.8, 10.4314/just.v35i2.8]; The World Bank,, 2019, LEB EC UPD APR 2019, P1; Tom-Dery Damian, 2011, Journal of the Botanical Research Institute of Texas, V5, P733; Urbaez, 2007, TECHNICAL REPORT 1 T; Vardhan, 2005, MINE SPOIL RESTORATI; Verberk W., 2011, NAT ED KNOWL, V3, P38; von Arx G, 2012, AGR FOREST METEOROL, V166, P144, DOI 10.1016/j.agrformet.2012.07.018; Wali MK, 1999, PLANT SOIL, V213, P195, DOI 10.1023/A:1004475206351; Warburton Toucher M.L., 2017, WATER SCI, V31, P198, DOI [10.1016/j.wsj.2017.06.001, DOI 10.1016/J.WSJ.2017.06.001]; WHITING SN, 2002, MINING ENV MANAGEMEN, V10, P11; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; WILSON MV, 1984, J ECOL, V72, P1055, DOI 10.2307/2259551; Wiryono, 2013, Biodiversitas: Journal of Biological Diversity, V14, P31; Zipper, FOREST RECLAMATION A, V5, P2007	69	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252371	10.1371/journal.pone.0252371	http://dx.doi.org/10.1371/journal.pone.0252371			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125836	Green Published, gold			2022-12-26	WOS:000664643500005
J	Arya, H; Toltesi, R; Eng, M; Garg, D; Merritt, TJS; Rajpurohit, S				Arya, Homica; Toltesi, Regan; Eng, Michelle; Garg, Divita; Merritt, Thomas J. S.; Rajpurohit, Subhash			No water, no mating: Connecting dots from behaviour to pathways	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; DESICCATION RESISTANCE; CORRELATED RESPONSE; CLIMATE-CHANGE; TRADE-OFF; METABOLISM; EXPOSURE; INSECTS; REPRODUCTION; TEMPERATURE	Insects hold considerable ecological and agricultural importance making it vital to understand the factors impacting their reproductive output. Environmental stressors are examples of such factors which have a substantial and significant influence on insect reproductive fitness. Insects are also ectothermic and small in size which makes them even more susceptible to environmental stresses. The present study assesses the consequence of desiccation on the mating latency and copulations duration in tropical Drosophila melanogaster. We tested flies for these reproductive behavioral parameters at varying body water levels and with whole metabolome analysis in order to gain a further understanding of the physiological response to desiccation. Our results showed that the duration of desiccation is positively correlated with mating latency and mating failure, while having no influence on the copulation duration. The metabolomic analysis revealed three biological pathways highly affected by desiccation: starch and sucrose metabolism, galactose metabolism, and phenylalanine, tyrosine and tryptophan biosynthesis. These results are consistent with carbohydrate metabolism providing an energy source in desiccated flies and also suggests that the phenylalanine biosynthesis pathway plays a role in the reproductive fitness of the flies. Desiccation is a common issue with smaller insects, like Drosophila and other tropical insects, and our findings indicate that this lack of ambient water can immediately and drastically affect the insect reproductive behaviour, which becomes more crucial because of unpredictable and dynamic weather conditions.	[Arya, Homica; Garg, Divita; Rajpurohit, Subhash] Ahmedabad Univ, Sch Arts & Sci, Div Biol & Life Sci, Ahmadabad, Gujarat, India; [Toltesi, Regan; Eng, Michelle; Merritt, Thomas J. S.] Laurentian Univ, Dept Chem & Biochem, Sudbury, ON, Canada	Ahmedabad University; Laurentian University	Rajpurohit, S (corresponding author), Ahmedabad Univ, Sch Arts & Sci, Div Biol & Life Sci, Ahmadabad, Gujarat, India.	subhash.rajpurohit@ahduni.edu.in	Rajpurohit, Subhash/O-9912-2018	Rajpurohit, Subhash/0000-0001-9149-391X	Ramanujan Fellowship [SERB-SB/S2/RJN-129/2017]; Ahmedabad University [AU/SUG/DBLS/2017-18/03]; Canadian Natural Sciences and Engineering Research Council Discovery Grant [RGPIN-2018-05551]	Ramanujan Fellowship(Department of Science & Technology (India)); Ahmedabad University; Canadian Natural Sciences and Engineering Research Council Discovery Grant	The financial support for this work was provided through Ramanujan Fellowship (SERB-SB/S2/RJN-129/2017) and Startup Grant from Ahmedabad University (AU/SUG/DBLS/2017-18/03) awarded to S Rajpuroit. TJS Merritt, R Toltesi and M Eng were supported by a Canadian Natural Sciences and Engineering Research Council Discovery Grant (RGPIN-2018-05551). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Bediako A, 2001, J INSECT PHYSIOL, V47, P1377, DOI 10.1016/S0022-1910(01)00128-7; Austin CJ, 2014, EVOL ECOL, V28, P535, DOI 10.1007/s10682-014-9689-8; BASTOCK M., 1955, BEHAVIOR, V8, P85, DOI 10.1163/156853955X00184; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; BENNETCL.HC, 1967, NATURE, V215, P669, DOI 10.1038/215669a0; Billings AC, 2019, BEHAV ECOL, V30, P231, DOI 10.1093/beheco/ary144; Byrne PG, 2006, P ROY SOC B-BIOL SCI, V273, P917, DOI 10.1098/rspb.2005.3372; Carter MJ, 2012, ECOL EVOL, V2, P1414, DOI 10.1002/ece3.247; Chapman RN, 1928, AM NAT, V62, P298, DOI 10.1086/280210; Chong Jasmine, 2019, Curr Protoc Bioinformatics, V68, pe86, DOI 10.1002/cpbi.86; Chown SL, 1999, BIOL REV, V74, P87, DOI 10.1017/S000632319800526X; Coelho AI, 2015, CURR OPIN CLIN NUTR, V18, P422, DOI 10.1097/MCO.0000000000000189; Cox RM, 2010, FUNCT ECOL, V24, P1262, DOI 10.1111/j.1365-2435.2010.01756.x; CROWE JH, 1984, SCIENCE, V223, P701, DOI 10.1126/science.223.4637.701; DANKS HV, 1979, MEM ENTOMOL SOC CAN, P567; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; DIMOND J. B., 1956, CANADIAN ENT, V88, P57; Dus M, 2011, P NATL ACAD SCI USA, V108, P11644, DOI 10.1073/pnas.1017096108; Everman ER, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197822; Fuchs S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084865; Gefen E, 2009, EVOLUTION, V63, P1653, DOI 10.1111/j.1558-5646.2009.00648.x; Gibbs AG, 1997, J EXP BIOL, V200, P1821; Gibbs AG, 2010, INSECT HYDROCARBONS: BIOLOGY, BIOCHEMISTRY, AND CHEMICAL ECOLOGY, P100, DOI 10.1017/CBO9780511711909.007; Gorter JA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19441; Griffin PC, 2017, GENETICS, V205, P871, DOI 10.1534/genetics.116.187104; Hoffmann AA, 1999, HEREDITY, V83, P637, DOI 10.1038/sj.hdy.6886490; Hu XY, 2019, ECOTOX ENVIRON SAFE, V171, P871, DOI 10.1016/j.ecoenv.2019.01.029; Kellermann V, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0048; Klepsatel P, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.202184; KREBS RA, 1994, J EVOLUTION BIOL, V7, P39, DOI 10.1046/j.1420-9101.1994.7010039.x; Li SZ, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003123; Magiafoglou A, 2003, FUNCT ECOL, V17, P664, DOI 10.1046/j.1365-2435.2003.00774.x; Marron MT, 2003, J INSECT PHYSIOL, V49, P261, DOI 10.1016/S0022-1910(02)00287-1; Matsuda H, 2015, J BIOL CHEM, V290, P1244, DOI 10.1074/jbc.M114.619411; Maurya R, 2021, ECOL ENTOMOL, V46, P1093, DOI 10.1111/een.13053; McGeoch MA, 1998, BIOL REV, V73, P181, DOI 10.1017/S000632319700515X; McLay LK, 2017, J INSECT PHYSIOL, V100, P15, DOI 10.1016/j.jinsphys.2017.04.009; Miwa Y, 2018, J NEUROGENET, V32, P353, DOI 10.1080/01677063.2018.1513507; MOLE S, 1993, OECOLOGIA, V93, P121, DOI 10.1007/BF00321201; O'Brien K, 2004, GLOBAL ENVIRON CHANG, V14, P303, DOI 10.1016/j.gloenvcha.2004.01.001; Rajpurohit S, 2018, MOL ECOL, V27, P3525, DOI 10.1111/mec.14814; Razgour O, 2018, DIVERS DISTRIB, V24, P1440, DOI 10.1111/ddi.12773; Reimand J, 2019, NAT PROTOC, V14, P482, DOI 10.1038/s41596-018-0103-9; Torre ARD, 2012, CARBOHYDRATES - COMPREHENSIVE STUDIES ON GLYCOBIOLOGY AND GLYCOTECHNOLOGY, P317, DOI 10.5772/50633; ROSENBERG DM, 1986, ENVIRON MANAGE, V10, P773, DOI 10.1007/BF01867730; Rzezniczak TZ, 2012, G3-GENES GENOM GENET, V2, P1613, DOI 10.1534/g3.112.003715; SCHNEBEL EM, 1984, EVOLUTION, V38, P1296, DOI 10.1111/j.1558-5646.1984.tb05651.x; Schrimpe-Rutledge AC, 2016, J AM SOC MASS SPECTR, V27, P1897, DOI 10.1007/s13361-016-1469-y; Seebacher F, 2015, NAT CLIM CHANGE, V5, P61, DOI 10.1038/NCLIMATE2457; Shenoi VN, 2016, ANIM BEHAV, V120, P183, DOI 10.1016/j.anbehav.2016.08.004; Singh K, 2016, J INSECT PHYSIOL, V91-92, P26, DOI 10.1016/j.jinsphys.2016.06.005; Singh K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153629; Sterkel M, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2607; TUCIC N, 1979, EVOLUTION, V33, P350, DOI 10.1111/j.1558-5646.1979.tb04688.x; Uchida K, 1998, J INSECT PHYSIOL, V44, P525, DOI 10.1016/S0022-1910(98)00033-X; van Heerwaarden B, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0396; Zografou EN, 2001, J APPL ENTOMOL, V125, P365, DOI 10.1046/j.1439-0418.2001.00559.x	58	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252920	10.1371/journal.pone.0252920	http://dx.doi.org/10.1371/journal.pone.0252920			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111165	gold, Green Published			2022-12-26	WOS:000664642700063
J	Fowler, JH; Hill, SJ; Levin, R; Obradovich, N				Fowler, James H.; Hill, Seth J.; Levin, Remy; Obradovich, Nick			Stay-at-home orders associate with subsequent decreases in COVID-19 cases and fatalities in the United States	PLOS ONE			English	Article								Governments issue "stay-at-home" orders to reduce the spread of contagious diseases, but the magnitude of such orders' effectiveness remains uncertain. In the United States these orders were not coordinated at the national level during the coronavirus disease 2019 (COVID-19) pandemic, which creates an opportunity to use spatial and temporal variation to measure the policies' effect. Here, we combine data on the timing of stay-at-home orders with daily confirmed COVID-19 cases and fatalities at the county level during the first seven weeks of the outbreak in the United States. We estimate the association between stay-at-home orders and alterations in COVID-19 cases and fatalities using a difference-in-differences design that accounts for unmeasured local variation in factors like health systems and demographics and for unmeasured temporal variation in factors like national mitigation actions and access to tests. Compared to counties that did not implement stay-at-home orders, the results show that the orders are associated with a 30.2 percent (11.0 to 45.2) average reduction in weekly incident cases after one week, a 40.0 percent (23.4 to 53.0) reduction after two weeks, and a 48.6 percent (31.1 to 61.7) reduction after three weeks. Stay-at-home orders are also associated with a 59.8 percent (18.3 to 80.2) average reduction in weekly fatalities after three weeks. These results suggest that stay-at-home orders might have reduced confirmed cases by 390,000 (170,000 to 680,000) and fatalities by 41,000 (27,000 to 59,000) within the first three weeks in localities that implemented stay-at-home orders.	[Fowler, James H.] Univ Calif San Diego, Infect Dis & Global Publ Hlth Div, San Diego, CA 92103 USA; [Fowler, James H.; Hill, Seth J.] Univ Calif San Diego, Polit Sci Dept, San Diego, CA 92103 USA; [Levin, Remy] Univ Connecticut, Econ Dept, Storrs, CT USA; [Obradovich, Nick] Max Planck Inst Human Dev, Ctr Humans & Machines, Berlin, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of Connecticut; Max Planck Society	Fowler, JH (corresponding author), Univ Calif San Diego, Infect Dis & Global Publ Hlth Div, San Diego, CA 92103 USA.; Fowler, JH (corresponding author), Univ Calif San Diego, Polit Sci Dept, San Diego, CA 92103 USA.; Obradovich, N (corresponding author), Max Planck Inst Human Dev, Ctr Humans & Machines, Berlin, Germany.	fowler@health.ucsd.edu; obradovich@mpib-berlin.mpg.de		Hill, Seth/0000-0002-3785-1533; Obradovich, Nick/0000-0003-1127-2231				[Anonymous], COVID TRACK PROJ; [Anonymous], COV 19 DAT; [Anonymous], 2020, EUR CTR DIS PREV CON; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Barrios JM, 2020, RISK PERCEPTION LENS, DOI [10.2139/ssrn.3568766, DOI 10.2139/SSRN.3568766]; Baud D, 2020, LANCET INFECT DIS, V20, P773, DOI 10.1016/S1473-3099(20)30195-X; Brauner JM, 2021, SCIENCE, V371, P802, DOI 10.1126/science.abd9338; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P465, DOI 10.15585/mmwr.mm6915e4; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Chowell G, 2020, LANCET, V395, P1093, DOI 10.1016/S0140-6736(20)30743-1; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; Dyer O, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1167; Engle S., 2020, STAYING HOME MOBILIT, DOI [10.2139/ssrn.3565703, DOI 10.2139/SSRN.3565703]; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Friedson A. I., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w26992; Ghinai I, 2020, LANCET, V395, P1137, DOI 10.1016/S0140-6736(20)30607-3; Harris J. E., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Jones C, 2021, REV FINANC STUD, V34, P5188, DOI 10.1093/rfs/hhab076; Korinek A, 2020, COVID 19 INFECT EXTE; Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Mervosh S., 2020, NEW YORK TIMES; Reeves A, 2015, LANCET, V386, P274, DOI 10.1016/S0140-6736(15)60574-8; Stanton C.T., 2020, W26989 NAT BUR EC RE, DOI [10.3386/w27422, DOI 10.3386/W26989]; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; Viner RM, 2020, LANCET CHILD ADOLESC, V4, P397, DOI 10.1016/S2352-4642(20)30095-X; WHO & FAO, 2004, WORLD HLTH ORG, VSecond; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	30	30	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0248849	10.1371/journal.pone.0248849	http://dx.doi.org/10.1371/journal.pone.0248849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111123	gold, Green Published			2022-12-26	WOS:000664642700006
J	Bozovic, IB; Maver, A; Leonardis, L; Meznaric, M; Osredkar, D; Peterlin, B				Bozovic, Ivana Babic; Maver, Ales; Leonardis, Lea; Meznaric, Marija; Osredkar, Damjan; Peterlin, Borut			Diagnostic yield of exome sequencing in myopathies: Experience of a Slovenian tertiary centre	PLOS ONE			English	Article							HUMAN PHENOTYPE ONTOLOGY; MUSCULAR-DYSTROPHY; VARIANTS; DISEASE; COHORT	Background Our aim was to present the experience of systematic, routine use of next generation sequencing (NGS) in clinical diagnostics of myopathies. Methods Exome sequencing was performed on patients with high risk for inherited myopathy, which were selected based on the history of the disease, family history, clinical presentation, and diagnostic workup. Exome target capture was performed, followed by sequencing on HiSeq 2500 or MiSeq platforms. Data analysis was performed using internally developed bioinformatic pipeline. Results The study comprised 86 patients, including 22 paediatric cases (26%). The largest group were patients referred with an unspecified myopathy (47%), due to non-specific or incomplete clinical and laboratory findings, followed by congenital myopathies (22%) and muscular dystrophies (22%), congenital myotonias (6%), and mitochondrial myopathies (3%). Altogether, a diagnostic yield was 52%; a high diagnostic rate was present in paediatric patients (64%), while in patients with unspecified myopathies the rate was 35%. We found 51 pathogenic/likely pathogenic variants in 23 genes and two pathogenic copy number variations. Conclusion Our results provide evidence that phenotype driven exome analysis diagnostic approach facilitates the diagnostic rate of complex, heterogeneous disorders, such as myopathies, particularly in paediatric patients and patients with unspecified myopathies.	[Bozovic, Ivana Babic; Maver, Ales; Peterlin, Borut] Univ Med Ctr Ljubljana, Clin Inst Genom Med, Ljubljana, Slovenia; [Leonardis, Lea] Univ Med Ctr Ljubljana, Inst Clin Neurophysiol, Ljubljana, Slovenia; [Leonardis, Lea] Univ Ljubljana, Dept Neurol, Fac Med, Ljubljana, Slovenia; [Meznaric, Marija] Univ Ljubljana, Inst Anat, Fac Med, Ljubljana, Slovenia; [Osredkar, Damjan] Univ Med Ctr Ljubljana, Dept Paediat Neurol, Ljubljana, Slovenia	University Medical Centre Ljubljana; University Medical Centre Ljubljana; University of Ljubljana; University of Ljubljana; University Medical Centre Ljubljana	Peterlin, B (corresponding author), Univ Med Ctr Ljubljana, Clin Inst Genom Med, Ljubljana, Slovenia.	borut.peterlin@guest.arnes.si	Marija, Meznaric/A-5112-2016; Babic Bozovic, Ivana/T-1112-2018; Osredkar, Damjan/B-6293-2011	Marija, Meznaric/0000-0002-5907-6929; Babic Bozovic, Ivana/0000-0002-6071-4430; Osredkar, Damjan/0000-0002-2188-420X	Slovenian Research Agency [J39280];  [739543]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); 	The authors acknowledge the project (J39280) was financially supported by the Slovenian Research Agency.; University Medical Centre Ljubljana is a member of the European Reference Network for Rare Neuromuscular Disease-Project ID No 739543.	Ales M, 2016, GENET MED, V18, P1102, DOI 10.1038/gim.2016.22; Ankala A, 2015, ANN NEUROL, V77, P206, DOI 10.1002/ana.24303; Bartoli M, 2014, MUSCLE NERVE, V50, P1007, DOI 10.1002/mus.24344; Bergant G, 2018, GENET MED, V20, P303, DOI 10.1038/gim.2017.142; Bugiardini E, 2019, NEUROMUSCULAR DISORD, V29, P747, DOI 10.1016/j.nmd.2019.08.003; Dai Y, 2015, NEUROMUSCULAR DISORD, V25, P617, DOI 10.1016/j.nmd.2015.03.002; Dimachkie MM, 2014, NEUROL CLIN, V32, P817, DOI 10.1016/j.ncl.2014.04.004; Eisenberger T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078496; Ellard S., 2020, BEST PRACTICE GUIDEL; Ghaoui R, 2015, JAMA NEUROL, V72, P1424, DOI 10.1001/jamaneurol.2015.2274; Groza T, 2015, AM J HUM GENET, V97, P111, DOI 10.1016/j.ajhg.2015.05.020; Haskell GT, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000212; Kaplan JC, 2017, NEUROMUSCULAR DISORD, V26, P895, DOI [10.1016/j.nmd.2016.11.010, DOI 10.1016/j.nmd.2016.11.010]; Karpati G., 2010, DISORDERS VOLUNTARY; Kohler S, 2017, NUCLEIC ACIDS RES, V45, pD865, DOI 10.1093/nar/gkw1039; Kuhn M, 2016, J NEUROL, V263, P743, DOI 10.1007/s00415-016-8036-0; Nigro V, 2016, CURR OPIN NEUROL, V29, P621, DOI 10.1097/WCO.0000000000000371; O'Grady GL, 2016, ANN NEUROL, V80, P101, DOI 10.1002/ana.24687; Park HJ, 2017, CLIN GENET, V91, P403, DOI 10.1111/cge.12826; Punetha Jaya, 2016, J Neuromuscul Dis, V3, P209; Rehm HL, 2013, NAT REV GENET, V14, P295, DOI 10.1038/nrg3463; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Savarese M, 2016, NEUROLOGY, V87, P71, DOI 10.1212/WNL.0000000000002800; Schofield D, 2017, NPJ GENOM MED, V2, DOI 10.1038/s41525-017-0006-7; Sevy A, 2016, J NEUROL NEUROSUR PS, V87, P340, DOI 10.1136/jnnp-2014-309663; Strom SP, 2014, GENET MED, V16, P510, DOI 10.1038/gim.2013.183; Thuriot F, 2020, NEUROL-GENET, V6, DOI 10.1212/NXG.0000000000000408; Todd EJ, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0364-0; Topf A, 2020, GENET MED, V22, P1478, DOI 10.1038/s41436-020-0840-3; Tsang MHY, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1205; Zenagui R, 2018, J MOL DIAGN, V20, P533, DOI 10.1016/j.jmoldx.2018.04.001	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252953	10.1371/journal.pone.0252953	http://dx.doi.org/10.1371/journal.pone.0252953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106991	gold, Green Published			2022-12-26	WOS:000664642200064
J	McAndrews, KM; Vazquez-Arreguin, K; Kwak, C; Sugimoto, H; Zheng, XF; Li, BR; Kirtley, ML; LeBleu, VS; Kalluri, R				McAndrews, Kathleen M.; Vazquez-Arreguin, Karina; Kwak, Changsoo; Sugimoto, Hikaru; Zheng, Xiaofeng; Li, Bingrui; Kirtley, Michelle L.; LeBleu, Valerie S.; Kalluri, Raghu			alpha SMA(+) fibroblasts suppress Lgr5(+) cancer stem cells and restrain colorectal cancer progression	ONCOGENE			English	Article							CARCINOMA-ASSOCIATED FIBROBLASTS; GROWTH-FACTOR-BETA; MOLECULAR SUBTYPES; GENE-EXPRESSION; TUMOR; METASTASIS; IDENTIFICATION; PHENOTYPE; STROMA; MODEL	The development and progression of solid tumors is dependent on cancer cell autonomous drivers and the tumor microenvironment (TME). Cancer-associated fibroblasts (CAFs) in the TME possess both tumor-promoting and tumor-restraining functions. In the current study, we interrogated the role of alpha SMA(+) CAFs in a genetic mouse model of metastatic colorectal cancer (CRC). Selective depletion of alpha SMA(+) CAFs resulted in increased tumor invasiveness, lymph node metastasis, and reduced overall survival. Depletion of alpha SMA(+) CAFs reduced BMP4 and increased TGF beta 1 secretion from stromal cells, and was associated with increased Lgr5(+) cancer stem-like cells (CSCs) and the generation of an immunosuppressive TME with increased frequency of Foxp3(+) regulatory T cells and suppression of CD8(+) T cells. This study demonstrates that alpha SMA(+) CAFs in CRC exert tumor-restraining functions via BMP4/TGF beta 1 paracrine signaling that serves to suppress Lgr5(+) CSCs and promote anti-tumor immunity, ultimately limiting CRC progression.	[McAndrews, Kathleen M.; Vazquez-Arreguin, Karina; Kwak, Changsoo; Sugimoto, Hikaru; Zheng, Xiaofeng; Li, Bingrui; Kirtley, Michelle L.; LeBleu, Valerie S.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77030 USA; [LeBleu, Valerie S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Kalluri, Raghu] Rice Univ, Dept Bioengn, Houston, TX 77005 USA; [Kalluri, Raghu] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; Northwestern University; Feinberg School of Medicine; Rice University; Baylor College of Medicine	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77030 USA.; Kalluri, R (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77005 USA.; Kalluri, R (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	rkalluri@mdanderson.org	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X; McAndrews, Kathleen/0000-0002-4092-4991	MD Anderson Cancer Center; Ruth L. Kirschstein National Research Service Award [5T32CA186892, CA016672]	MD Anderson Cancer Center; Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by research funds provided by the MD Anderson Cancer Center. KV-A is supported by Ruth L. Kirschstein National Research Service Award 5T32CA186892. We thank Dr. Ronald DePinho for providing the iKAP mouse model and for insightful comments on the manuscript. We thank Dr. Adam Boutin for his generous help with the project, Dr. Krishnan Mahadevan for advice on proliferative index determination, and Patience Kelly for assistance with slide scanning and staining. The Advanced Technology Genomics Core is supported by the core grant CA016672(ATCG).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Becker LM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107701; Blockhuys S, 2017, J BIOMED OPT, V22, DOI 10.1117/1.JBO.22.10.106006; Boutin AT, 2017, GENE DEV, V31, P370, DOI 10.1101/gad.293449.116; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Calon A, 2012, CANCER CELL, V22, P571, DOI 10.1016/j.ccr.2012.08.013; Centers for Disease Control and Prevention, 2019, COL CANC STAT; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; Damaghi M, 2020, EVOL APPL, V13, P2689, DOI 10.1111/eva.13075; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fiori ME, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-0994-2; Fu S, 2004, AM J TRANSPLANT, V4, P1614, DOI 10.1111/j.1600-6143.2004.00566.x; Gascard P, 2016, GENE DEV, V30, P1002, DOI 10.1101/gad.279737.116; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; HAGGITT RC, 1985, GASTROENTEROLOGY, V89, P326; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Kobayashi H, 2021, GASTROENTEROLOGY, V160, P1224, DOI 10.1053/j.gastro.2020.11.011; LeBleu VS, 2020, FASEB J, V34, P3519, DOI 10.1096/fj.201903188R; LeBleu VS, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.029447; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Liu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159947; Lombardo Y, 2011, GASTROENTEROLOGY, V140, P297, DOI 10.1053/j.gastro.2010.10.005; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma HJ, 2014, CANCER LETT, V344, P74, DOI 10.1016/j.canlet.2013.10.017; Marisa L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001453; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Moo-Young TA, 2009, J IMMUNOTHER, V32, P12, DOI 10.1097/CJI.0b013e318189f13c; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Nurmik M, 2020, INT J CANCER, V146, P895, DOI 10.1002/ijc.32193; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Otranto M, 2012, CELL ADHES MIGR, V6, P203, DOI 10.4161/cam.20377; Powell DW, 2011, ANNU REV PHYSIOL, V73, P213, DOI 10.1146/annurev.physiol.70.113006.100646; Qi Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13824; Roulis M, 2020, NATURE, V580, P524, DOI 10.1038/s41586-020-2166-3; Sadanandam A, 2014, CELL CYCLE, V13, P353, DOI 10.4161/cc.27769; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Stzepourginski I, 2017, P NATL ACAD SCI USA, V114, pE506, DOI 10.1073/pnas.1620059114; Vellinga TT, 2016, ONCOGENE, V35, P5263, DOI 10.1038/onc.2016.60; Veschi V, 2020, ONCOGENE, V39, P987, DOI 10.1038/s41388-019-1047-4; WAHL SM, 1994, J EXP MED, V180, P1587, DOI 10.1084/jem.180.5.1587; Wan YY, 2007, IMMUNOL REV, V220, P199, DOI 10.1111/j.1600-065X.2007.00565.x; Woolston A, 2019, CANCER CELL, V36, P35, DOI 10.1016/j.ccell.2019.05.013; Wu XB, 2019, BIOMED PHARMACOTHER, V114, DOI 10.1016/j.biopha.2019.108708; Zhang YC, 2020, ANNU REV PHYSIOL, V82, P251, DOI 10.1146/annurev-physiol-021119-034500; Zhang ZY, 2018, INT J ONCOL, V53, P1869, DOI 10.3892/ijo.2018.4536	53	9	9	3	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2021	40	26					4440	4452		10.1038/s41388-021-01866-7	http://dx.doi.org/10.1038/s41388-021-01866-7		JUN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TC8LA	34108617	Green Accepted			2022-12-26	WOS:000659470200006
J	Batabyal, A; Bhattacharya, A; Thaker, M; Mukherjee, S				Batabyal, Anuradha; Bhattacharya, Anindita; Thaker, Maria; Mukherjee, Shomen			A longitudinal study of perceived stress and cortisol responses in an undergraduate student population from India	PLOS ONE			English	Article							STRATEGIES; COLLEGE; HEALTH	Young adults entering college experience immense shifts in personal and professional environments. Such a potentially stressful event may trigger multiple psychological and physiological effects. In a repeated-measures longitudinal survey (N = 6 time-points) of first year cohort of residential undergraduate students in India, this study evaluates multiple psychological parameters: PSS14 (Perceived Stress Scale), K10 (distress scale) and positive mood measures, along with salivary cortisol levels. We find that compared to women, men showed significantly lower levels of salivary cortisol and also a decrease in perceived stress (PSS14) and distress (K10) with time. By contrast, women reported similar perceived stress and distress levels over time but had higher cortisol levels at the end of the academic year. Academic stress was reported by the students to be the most important stressor. This study highlights notable gender-/sex-differences in psychological and physiological stress responses and adds a valuable longitudinal dataset from the Indian undergraduate student cohort which is lacking in literature.	[Batabyal, Anuradha; Bhattacharya, Anindita; Mukherjee, Shomen] Azim Premji Univ, Bengaluru, India; [Thaker, Maria] Indian Inst Sci, Bengaluru, India; [Batabyal, Anuradha] Univ Calgary, Calgary, AB, Canada	Indian Institute of Science (IISC) - Bangalore; University of Calgary	Bhattacharya, A (corresponding author), Azim Premji Univ, Bengaluru, India.	anindita.bhattacharya@apu.edu.in		Mukherjee, Shomen/0000-0002-2974-4447; Bhattacharya, Anindita/0000-0002-3990-3560	Azim Premji University; DBT-IISc partnership program	Azim Premji University; DBT-IISc partnership program	Azim Premji University provided funding to AB and SM to conduct the study and allowed them to use their facilities. Funding for this research was supported in part by the DBT-IISc partnership program to MT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2016, J AM COLL HEALTH, V64, P362, DOI 10.1080/07448481.2016.1154559; Aparecido De Oliveira Silva R., 2018, AM J ED RES, V6, P1264, DOI [10.12691/education-6-9-4, DOI 10.12691/EDUCATION-6-9-4]; Austin SB, 2018, PSYCHONEUROENDOCRINO, V97, P78, DOI 10.1016/j.psyneuen.2018.07.006; Bolker B., 2012, GETTING STARTED GLMM, V12; Bollini AM, 2004, BIOL PSYCHOL, V67, P245, DOI 10.1016/j.biopsycho.2003.11.002; Britt S., 2016, J FINANCIAL COUNSELI, V27, P172, DOI [10.1891/1052-3073.27.2.172, DOI 10.1891/1052-3073.27.2.172]; Brown GW, 1996, BRIT J PSYCHIAT, V168, P50, DOI 10.1192/S0007125000298413; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Dandona R, 2018, LANCET PUBLIC HEALTH, V3, pE478, DOI 10.1016/S2468-2667(18)30138-5; Dawson MA, 2014, J ATHL TRAINING, V49, P331, DOI 10.4085/1062-6050-49.1.09; Drake EC, 2016, INT J BEHAV DEV, V40, P334, DOI 10.1177/0165025415581914; Dusselier L, 2005, J AM COLL HEALTH, V54, P15, DOI 10.3200/JACH.54.1.15-24; Eaton R.J., 2008, INT J STRESS MANAGE, V15, P94, DOI [10.1037/1072-5245.15.1.94, DOI 10.1037/1072-5245.15.1.94]; Gonzalez-Cabrera J, 2014, STRESS, V17, P149, DOI 10.3109/10253890.2013.876405; Gupta S, 2015, EDUC HEALTH, V28, P92, DOI 10.4103/1357-6283.161924; Halford C., 2012, ROLE SALIVA CORTISOL, P67, DOI DOI 10.2174/978160805342111201010129; Hamaideh SH, 2011, INT J SOC PSYCHIATR, V57, P69, DOI [10.1177/0020764010348442, 10.1177/0020764009348442]; Kadison R., 2004, COLL OVERWHELMED CAM, DOI [10.1002/cne.20086, DOI 10.1002/CNE.20086]; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; Kudielka BM, 2003, PSYCHONEUROENDOCRINO, V28, P35, DOI 10.1016/S0306-4530(02)00008-2; Kudielka BM, 2005, BIOL PSYCHOL, V69, P113, DOI 10.1016/j.biopsycho.2004.11.009; Kumar S, 2009, EUR J DENT EDUC, V13, P39, DOI 10.1111/j.1600-0579.2008.00535.x; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Lopez JF, 1999, BIOL PSYCHIAT, V46, P1461, DOI 10.1016/S0006-3223(99)00266-8; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Morra DJ, 2008, MED TEACH, V30, P313, DOI 10.1080/01421590801953000; Niaz U, 2006, WORLD PSYCHIATRY, V5, P118; Pierceall EA, 2007, COMMUNITY COLL J RES, V31, P703, DOI 10.1080/10668920600866579; Roozendaal B, 2000, Pergamon, P213, DOI 10.1016/S0306-4530%2899%2900058-X; Ross SE., 1999, SOC PSYCHOL-GERMANY, V61, P841; Sapolsky, 1996, Stress, V1, P1, DOI 10.3109/10253899609001092; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Smith JS, 2005, J STUD AFF RES PRACT, V42, P153, DOI 10.2202/1949-6605.1470; Thoma MV, 2017, BRAIN BEHAV IMMUN, V61, P228, DOI 10.1016/j.bbi.2016.11.030; Thompson N, 2000, INT REV PSYCHIATR, V12, P37, DOI 10.1080/09540260074102; Tiwari S., 2012, INDIAN J PHYSIOL PH; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; Wada H, 2007, GEN COMP ENDOCR, V150, P405, DOI 10.1016/j.ygcen.2006.10.002; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063	41	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252579	10.1371/journal.pone.0252579	http://dx.doi.org/10.1371/journal.pone.0252579			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086754	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000664640100087
J	Tanaka, T; Suzuki, K; Ueda, H; Sameshima-Yamashita, Y; Kitamoto, H				Tanaka, Takumi; Suzuki, Ken; Ueda, Hirokazu; Sameshima-Yamashita, Yuka; Kitamoto, Hiroko			Ethanol treatment for sterilization, concentration, and stabilization of a biodegradable plastic-degrading enzyme from Pseudozyma antarctica culture supernatant	PLOS ONE			English	Article							CUTINASE-LIKE ENZYME; TOLERANCE; ACID; PROTEINS	Biodegradable plastics must be sufficiently stable to maintain functionality during use but need to be able to degrade rapidly after use. We previously reported that treatment with an enzyme named PaE, secreted by the basidiomycete yeast Pseudozyma antarctica can speed up this degradation. To facilitate the production of large quantities of PaE, here, we aimed to elucidate the optimal conditions of ethanol treatment for sterilization of the culture supernatant and for concentration and stabilization of PaE. The results showed that Pseudozyma antarctica completely lost its proliferating ability when incubated in >= 20% (v/v) ethanol. When the ethanol concentration was raised to 90% (v/v), PaE formed a precipitate; however, its activity was restored completely when the precipitate was dissolved in water. To reduce ethanol use, PaE was successfully concentrated and recovered by sequential ammonium sulfate precipitation and ethanol precipitation steps. Over 90% of the activity in the original culture supernatant was recovered and the specific activity was increased 3.4-fold. By preparing the enzyme solution at a final concentration of 20% (v/v) ethanol, about 60% of the initial activity was maintained at ambient temperature for over 6 months without growth of microbes. We conclude that ethanol treatment is effective for sterilization, concentration, and stabilization of PaE, and that concentrating PaE by sequential ammonium sulfate precipitation and ethanol precipitation substantially increases the PaE purity and decreases ethanol use.	[Tanaka, Takumi; Suzuki, Ken; Ueda, Hirokazu; Sameshima-Yamashita, Yuka; Kitamoto, Hiroko] Natl Agr & Food Res Org, Inst Agroenvironm Sci NIAES, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan	Kitamoto, H (corresponding author), Natl Agr & Food Res Org, Inst Agroenvironm Sci NIAES, Tsukuba, Ibaraki, Japan.	kitamoto@affrc.go.jp			"Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry" of the Ministry of Agriculture, Forestry and Fisheries (Japan) [25017AB]; "Research Program on Development of Innovative Technology" of the Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization (Japan) [01029C]	"Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry" of the Ministry of Agriculture, Forestry and Fisheries (Japan); "Research Program on Development of Innovative Technology" of the Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization (Japan)	This work was supported by a grant from the "Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry" of the Ministry of Agriculture, Forestry and Fisheries (Japan) (https://www.maff.go.jp/) (grant number, 25017AB; for HK). This work was also supported by the "Research Program on Development of Innovative Technology" of the Bio-oriented Technology Research Advancement Institution, National Agriculture and Food Research Organization (Japan) (http://www.naro.affrc.go.jp/) (grant number, 01029C; for HK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brodhagen M, 2015, APPL MICROBIOL BIOT, V99, P1039, DOI 10.1007/s00253-014-6267-5; Geyer R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700782; Gross M, 2017, CURR BIOL, V27, pR785, DOI 10.1016/j.cub.2017.08.007; Heipieper HJ, 2000, RES MICROBIOL, V151, P777, DOI 10.1016/S0923-2508(00)01143-8; ISMAIL AA, 1971, FOLIA MICROBIOL, V16, P346, DOI 10.1007/BF02875751; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kitamoto HK, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-44; Kliem S, 2020, MATERIALS, V13, DOI 10.3390/ma13204586; KOUKOU AI, 1990, J GEN MICROBIOL, V136, P1271, DOI 10.1099/00221287-136-7-1271; Lambert S, 2017, CHEM SOC REV, V46, P6855, DOI 10.1039/c7cs00149e; Maeda H, 2005, APPL MICROBIOL BIOT, V67, P778, DOI 10.1007/s00253-004-1853-6; Masaki K, 2005, APPL ENVIRON MICROB, V71, P7548, DOI 10.1128/AEM.71.11.7548-7550.2005; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Rai P, 2021, BIORESOURCE TECHNOL, V325, DOI 10.1016/j.biortech.2021.124739; Roohi, 2017, CURR PHARM BIOTECHNO, V18, P429, DOI 10.2174/1389201018666170523165742; Sameshima-Yamashita Y, 2019, BIOSCI BIOTECH BIOCH, V83, P1547, DOI 10.1080/09168451.2019.1571898; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Shinozaki Y, 2013, APPL MICROBIOL BIOT, V97, P2951, DOI 10.1007/s00253-012-4188-8; Tokiwa Y, 2009, INT J MOL SCI, V10, P3722, DOI 10.3390/ijms10093722; Watanabe T, 2016, APPL MICROBIOL BIOT, V100, P3207, DOI 10.1007/s00253-015-7232-7; Watanabe T, 2014, J BIOSCI BIOENG, V117, P325, DOI 10.1016/j.jbiosc.2013.09.002; ZEUTHEN ML, 1988, J GEN MICROBIOL, V134, P1375	22	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252811	10.1371/journal.pone.0252811	http://dx.doi.org/10.1371/journal.pone.0252811			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086819	gold, Green Published			2022-12-26	WOS:000664640100137
J	Bang, MS; Kim, CM; Pyun, SH; Kim, DM; Yun, NR				Bang, Mi Seon; Kim, Choon-Mee; Pyun, Sang-Hyun; Kim, Dong-Min; Yun, Na Ra			Molecular investigation of tick-borne pathogens in ticks removed from tick-bitten humans in the southwestern region of the Republic of Korea	PLOS ONE			English	Article							SPOTTED-FEVER GROUP; BABESIA-MICROTI; RICKETTSIA; ANAPLASMA; IDENTIFICATION; AMBLYOMMA; INFECTION; PROVINCE; COXIELLA	In this study, we investigated the presence of tick-borne pathogens in ticks removed from tick-bitten humans in the southwestern provinces of the Republic of Korea (ROK). We identified 33 ticks from three tick species, namely Amblyomma testudinarium (60.6%), Haemaphysalis longicornis (27.3%), and Ixodes nipponensis (12.1%) in order of occurrence via morphology and 16S rDNA-targeting polymerase chain reaction (PCR). Tick-borne pathogens were detected in 16 ticks using pathogen-specific PCR. From the results, 12 ticks (36.4%) tested positive for spotted fever group (SFG) Rickettsia: Rickettsia monacensis (1/12), R. tamurae (8/12), and Candidatus Rickettsia jingxinensis (3/12). Three ticks (9.1%) were positive for Anaplasma phagocytophilum. In addition, three ticks (9.1%) tested positive for Babesia gibsoni (1/3) and B. microti (2/3). In conclusion, we identified three tick species; the most common species was A. testudinarium, followed by H. longicornis and I. nipponensis. SFG Rickettsia, A. phagocytophilum, and Babesia spp. were the most frequently detected pathogens in ticks removed from tick-bitten humans. To our knowledge, this is the first report of R. tamurae and Ca. R. jingxinensis detection in Korea. The present results will contribute to the understanding of tick-borne infections in animals and humans in the ROK.	[Bang, Mi Seon] Chosun Univ, Coll Med, Dept Med Sci, Gwangju, South Korea; [Kim, Choon-Mee] Chosun Univ, Coll Med, Premed Sci, Gwangju, South Korea; [Pyun, Sang-Hyun] Chosun Univ, Grad Sch, Gwangju, South Korea; [Kim, Dong-Min; Yun, Na Ra] Chosun Univ, Coll Med, Dept Internal Med, Gwangju, South Korea	Chosun University; Chosun University; Chosun University; Chosun University	Kim, DM (corresponding author), Chosun Univ, Coll Med, Dept Internal Med, Gwangju, South Korea.	drongkim@chosun.ac.kr		Kim, Dong-Min/0000-0001-6373-0922	Chosun University Hospital	Chosun University Hospital	We sincerely appreciate the generous help regarding tick collection from the subjects and physicians at Chosun University Hospital.	[Anonymous], GUIDE IDENTIFICATION; Chao LL, 2017, ACTA TROP, V166, P356, DOI 10.1016/j.actatropica.2016.09.022; Cho Shin-Hyeong, 2002, Korean Journal of Parasitology, V40, P33, DOI 10.3347/kjp.2002.40.1.33; de la Fuente J, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00114; Fenollar F, 2004, J CLIN MICROBIOL, V42, P4919, DOI 10.1128/JCM.42.11.4919-4924.2004; Fournier PE, 2006, INT J SYST EVOL MICR, V56, P1673, DOI 10.1099/ijs.0.64134-0; Guedes E, 2011, REV BRAS PARASITOL V, V20, P308, DOI 10.1590/S1984-29612011000400009; Guo WP, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006916; Han JI, 2010, J WILDLIFE DIS, V46, P632, DOI 10.7589/0090-3558-46.2.632; Heo EJ, 2002, J CLIN MICROBIOL, V40, P3082, DOI 10.1128/JCM.40.8.3082-3085.2002; Hong SH, 2017, KOREAN J PARASITOL, V55, P207, DOI 10.3347/kjp.2017.55.2.207; Im JH, 2019, VECTOR-BORNE ZOONOT, V19, P225, DOI 10.1089/vbz.2018.2298; Imaoka K, 2011, CASE REP DERMATOL, V3, P68, DOI 10.1159/000326941; Jahfari S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005042; Jang WJ, 2005, MICROBIOL IMMUNOL, V49, P17, DOI 10.1111/j.1348-0421.2005.tb03635.x; Jang WJ, 2004, J CLIN MICROBIOL, V42, P2310, DOI 10.1128/JCM.42.5.2310-2313.2004; Kang SW, 2013, PARASITOL INT, V62, P276, DOI 10.1016/j.parint.2013.02.002; Kho KL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.4; Kim CM, 2006, APPL ENVIRON MICROB, V72, P5766, DOI 10.1128/AEM.00431-06; Kim JY, 2007, J CLIN MICROBIOL, V45, P2084, DOI 10.1128/JCM.01334-06; Kim KH, 2014, EMERG INFECT DIS, V20, P1708, DOI 10.3201/eid2010.131680; Ko S, 2016, TRANSBOUND EMERG DIS, V63, P56, DOI 10.1111/tbed.12217; Lee KM, 2013, MICROBIOL IMMUNOL, V57, P487, DOI 10.1111/1348-0421.12062; Lee SH, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05522-5; Liu HM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1644-9; Massung RF, 2007, J CLIN MICROBIOL, V45, P2138, DOI 10.1128/JCM.00478-07; 오재영, 2009, Journal of Bacteriology and Virology, V39, P257; Noh Y, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1955-x; Nooroong P, 2018, TICKS TICK-BORNE DIS, V9, P963, DOI 10.1016/j.ttbdis.2018.03.027; Pritt BS., 2011, PUBLIC HEALTH; REGNERY RL, 1991, J BACTERIOL, V173, P1576, DOI 10.1128/jb.173.5.1576-1589.1991; Roh JY., 2014, COINCIDENCE GEOGRAPH, DOI [10.1371/journal.pone.0113193, DOI 10.1371/JOURNAL.PONE.0113193]; Roux V, 1996, J CLIN MICROBIOL, V34, P2058, DOI 10.1128/JCM.34.9.2058-2065.1996; Sapi E, 2013, INT J MED SCI, V10, P362, DOI 10.7150/ijms.5698; Tian ZC, 2011, EXP APPL ACAROL, V54, P165, DOI 10.1007/s10493-010-9423-3; Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018; Wang F, 2020, TRANSBOUND EMERG DIS, V67, P2050, DOI 10.1111/tbed.13548; Yamaguti N., 1971, BRIGHAM YOUNG U SCI	38	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0252992	10.1371/journal.pone.0252992	http://dx.doi.org/10.1371/journal.pone.0252992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129613	gold, Green Published			2022-12-26	WOS:000665475100019
J	Molina-Venegas, R; Rodriguez, MA; Pardo-de-Santayana, M; Mabberley, DJ				Molina-Venegas, Rafael; Rodriguez, Miguel Angel; Pardo-de-Santayana, Manuel; Mabberley, David J.			A global database of plant services for humankind	PLOS ONE			English	Article							BIODIVERSITY; KNOWLEDGE; PEOPLE	Humanity faces the challenge of conserving the attributes of biodiversity that may be essential to secure human wellbeing. Among all the organisms that are beneficial to humans, plants stand out as the most important providers of natural resources. Therefore, identifying plant uses is critical to preserve the beneficial potential of biodiversity and to promote basic and applied research on the relationship between plants and humans. However, much of this information is often uncritical, contradictory, of dubious value or simply not readily accessible to the great majority of scientists and policy makers. Here, we compiled a genus-level dataset of plant-use records for all accepted vascular plant taxa (13489 genera) using the information gathered in the 4(th) Edition of Mabberley's plant-book, the most comprehensive global review of plant classification and their uses published to date. From 1974 to 2017 all the information was systematically gathered, evaluated, and synthesized by David Mabberley, who reviewed over 1000 botanical sources including modern Floras, monographs, periodicals, handbooks, and authoritative websites. Plant uses were arranged across 28 standard categories of use following the Economic Botany Data Collection Standard guidelines, which resulted in a binary classification of 9478 plant-use records pertaining human and animal nutrition, materials, fuels, medicine, poisons, social and environmental uses. Of all the taxa included in the dataset, 33% were assigned to at least one category of use, the most common being "ornamental" (26%), "medicine" (16%), "human food" (13%) and "timber" (8%). In addition to a readily available binary matrix for quantitative analyses, we provide a control text matrix that links the former to the description of the uses in Mabberley's plant-book. We hope this dataset will serve to establish synergies between scientists and policy makers interested in plant-human interactions and to move towards the complete compilation and classification of the nature's contributions to people upon which the wellbeing of future generations may depend.	[Molina-Venegas, Rafael; Rodriguez, Miguel Angel] Univ Alcala, GLOCEE Global Change Ecol & Evolut Grp, Dept Life Sci, Alcala De Henares, Spain; [Pardo-de-Santayana, Manuel] Univ Autonoma Madrid, Dept Biol Bot, Madrid, Spain; [Pardo-de-Santayana, Manuel] UAM, Ctr Invest Biodiversidad & Cambio Global CIBC, Madrid, Spain; [Mabberley, David J.] Univ Oxford, Wadham Coll, Oxford, England; [Mabberley, David J.] Macquarie Univ, Dept Biol Sci, Sydney, NSW, Australia; [Mabberley, David J.] Natl Herbarium New South Wales, Australian Inst Bot Sci, Sydney, NSW, Australia	Universidad de Alcala; Autonomous University of Madrid; Autonomous University of Madrid; University of Oxford; Macquarie University	Molina-Venegas, R (corresponding author), Univ Alcala, GLOCEE Global Change Ecol & Evolut Grp, Dept Life Sci, Alcala De Henares, Spain.	rafmolven@gmail.com	Rodriguez, Miguel A/A-3409-2011; Pardo-de-Santayana, Manuel/A-1123-2012	Rodriguez, Miguel A/0000-0002-4082-2995; Pardo-de-Santayana, Manuel/0000-0001-9406-4758	project "Plant evolutionary history and human wellbeing in a changing world; assessing theoretical foundations using empirical evidence and new phylogenetic tools" by the Regional Government of Madrid (Consejeria de Ciencia, Universidades e Innovacion) [CM/JIN/2019-005]; Universidad de Alcala (Spain); TALENTO fellowship of the Regional Government of Madrid [2018-T2/AMB10332]; Spanish Ministry of Science and Innovation [CGL2017-86926-P]	project "Plant evolutionary history and human wellbeing in a changing world; assessing theoretical foundations using empirical evidence and new phylogenetic tools" by the Regional Government of Madrid (Consejeria de Ciencia, Universidades e Innovacion); Universidad de Alcala (Spain); TALENTO fellowship of the Regional Government of Madrid; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This publication was funded by the project "Plant evolutionary history and human wellbeing in a changing world; assessing theoretical foundations using empirical evidence and new phylogenetic tools" (CM/JIN/2019-005), granted by the Regional Government of Madrid (Consejeria de Ciencia, Universidades e Innovacion) and Universidad de Alcala (Spain) to RM-V. RM-V was supported by a TALENTO fellowship of the Regional Government of Madrid (2018-T2/AMB10332), and MAR by the Spanish Ministry of Science and Innovation (grant CGL2017-86926-P).	Camara-Leret R, 2019, NAT SUSTAIN, V2, P736, DOI 10.1038/s41893-019-0324-0; Camara-Leret R, 2019, P NATL ACAD SCI USA, V116, P9913, DOI 10.1073/pnas.1821843116; Camara-Leret R, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2016.220; CBD (Secretariat of the Convention on Biological Diversity), 2020, GLOBAL BIODIVERSITY; Cook F. E. M., 1995, Economic botany data collection standard.; Cox PA, 2000, SCIENCE, V287, P44, DOI 10.1126/science.287.5450.44; Diaz S, 2020, SCIENCE, V370, P411, DOI 10.1126/science.abe1530; Diaz S, 2018, SCIENCE, V359, P270, DOI 10.1126/science.aap8826; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; Gaston KJ, 2019, PEOPLE NAT, V1, P4, DOI 10.1002/pan3.7; Hiscock SJ, 2019, PLANTS PEOPLE PLANET, V1, P2, DOI 10.1002/ppp3.14; Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services Global, 2018, INF SCOP THEM ASS SU; Kujawska M, 2017, J ETHNOBIOL ETHNOMED, V13, DOI 10.1186/s13002-017-0169-4; Mabberley D.J., 2017, MABBERLEYS PLANT BOO, DOI [10.1017/9781316335581, DOI 10.1017/9781316335581]; Martin-Lopez B, 2018, ECOSYST PEOPLE, V15, P1, DOI 10.1080/26395908.2018.1540160; Molina-Venegas R, 2021, NAT ECOL EVOL, V5, P583, DOI 10.1038/s41559-021-01414-2; Mooers A, 2021, NAT ECOL EVOL, V5, P558, DOI 10.1038/s41559-021-01438-8; Pardo M, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/857270; Phang SC, 2020, BIODIVERS CONSERV, V29, P3061, DOI 10.1007/s10531-020-02009-2; Teixidor-Toneu I, 2018, NAT PLANTS, V4, P754, DOI 10.1038/s41477-018-0226-6; Ulian T, 2020, PLANTS PEOPLE PLANET, V2, P421, DOI 10.1002/ppp3.10145; van Kleunen M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16982-3	22	2	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253069	10.1371/journal.pone.0253069	http://dx.doi.org/10.1371/journal.pone.0253069			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129629	gold, Green Published			2022-12-26	WOS:000665475100022
J	Ronan, P; Kroukamp, O; Liss, SN; Wolfaardt, G				Ronan, Patrick; Kroukamp, Otini; Liss, Steven N.; Wolfaardt, Gideon			Interaction between CO2-consuming autotrophy and CO2-producing heterotrophy in non-axenic phototrophic biofilms	PLOS ONE			English	Article							MUNICIPAL WASTE-WATER; CHLORELLA-VULGARIS; BIODIESEL PRODUCTION; ALGAL BIOMASS; MICROALGAE; GROWTH; CO2; CULTIVATION; NUTRIENTS; BACTERIA	As the effects of climate change become increasingly evident, the need for effective CO2 management is clear. Microalgae are well-suited for CO2 sequestration, given their ability to rapidly uptake and fix CO2. They also readily assimilate inorganic nutrients and produce a biomass with inherent commercial value, leading to a paradigm in which CO2-sequestration, enhanced wastewater treatment, and biomass generation could be effectively combined. Natural non-axenic phototrophic cultures comprising both autotrophic and heterotrophic fractions are particularly attractive in this endeavour, given their increased robustness and innate O-2-CO2 exchange. In this study, the interplay between CO2-consuming autotrophy and CO2-producing heterotrophy in a non-axenic phototrophic biofilm was examined. When the biofilm was cultivated under autotrophic conditions (i.e. no organic carbon), it grew autotrophically and exhibited CO2 uptake. After amending its growth medium with organic carbon (0.25 g/L glucose and 0.28 g/L sodium acetate), the biofilm rapidly toggled from net-autotrophic to net-heterotrophic growth, reaching a CO2 production rate of 60 mu mol/h after 31 hours. When the organic carbon sources were provided at a lower concentration (0.125 g/L glucose and 0.14 g/L sodium acetate), the biofilm exhibited distinct, longitudinally discrete regions of heterotrophic and autotrophic metabolism in the proximal and distal halves of the biofilm respectively, within 4 hours of carbon amendment. Interestingly, this upstream and downstream partitioning of heterotrophic and autotrophic metabolism appeared to be reversible, as the position of these regions began to flip once the direction of medium flow (and hence nutrient availability) was reversed. The insight generated here can inform new and important research questions and contribute to efforts aimed at scaling and industrializing algal growth systems, where the ability to understand, predict, and optimize biofilm growth and activity is critical.	[Ronan, Patrick; Kroukamp, Otini; Liss, Steven N.; Wolfaardt, Gideon] Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada; [Liss, Steven N.; Wolfaardt, Gideon] Stellenbosch Univ, Dept Microbiol, Stellenbosch, South Africa	Toronto Metropolitan University; Stellenbosch University	Wolfaardt, G (corresponding author), Ryerson Univ, Dept Biol & Chem, Toronto, ON, Canada.; Wolfaardt, G (corresponding author), Stellenbosch Univ, Dept Microbiol, Stellenbosch, South Africa.	gmw@sun.ac.za			Natural Sciences and Engineering Research Council of Canada (NSERC)	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) in the form of a Postgraduate Doctoral Scholarship (PR). https://www.nserccrsng.gc.ca/index_eng.asp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jabri H, 2021, WATER-SUI, V13, DOI 10.3390/w13010027; Barranguet C, 2004, AQUAT MICROB ECOL, V34, P1, DOI 10.3354/ame034001; Centre for Disease Control, 2016, GLOB WAT SAN HYG WAS; Chang HX, 2016, BIORESOURCE TECHNOL, V206, P231, DOI 10.1016/j.biortech.2016.01.087; Christenson LB, 2012, BIOTECHNOL BIOENG, V109, P1674, DOI 10.1002/bit.24451; Cole JK, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00109; Das P, 2019, INT J ENVIRON SCI TE, V16, P3355, DOI 10.1007/s13762-018-1867-8; de Assis LR, 2020, J ENVIRON MANAGE, V274, DOI 10.1016/j.jenvman.2020.111183; Ghadakpour M, 2014, MICROB ECOL, V68, P121, DOI 10.1007/s00248-014-0398-1; Gimondo JA, 2019, HORTSCIENCE, V54, P528, DOI 10.21273/HORTSCI13474-18; Golledge NR, 2019, NATURE, V566, P65, DOI 10.1038/s41586-019-0889-9; Goncalves AL, 2017, ALGAL RES, V24, P403, DOI 10.1016/j.algal.2016.11.008; Gupta PL, 2015, WORLD J MICROB BIOT, V31, P1409, DOI 10.1007/s11274-015-1892-4; Guzzon A, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7080252; Halfhide T, 2014, ALGAL RES, V6, P152, DOI 10.1016/j.algal.2014.10.009; Judd S, 2015, WATER RES, V87, P356, DOI 10.1016/j.watres.2015.08.021; Kazamia Elena, 2014, Ind Biotechnol (New Rochelle N Y), V10, P184; Kroukamp O, 2009, APPL ENVIRON MICROB, V75, P4391, DOI 10.1128/AEM.01567-08; Krzeminska I, 2014, BIOPROC BIOSYST ENG, V37, P735, DOI 10.1007/s00449-013-1044-x; Kumar Panga Kiran, 2018, S AFR J CHEM ENG, V25, P133, DOI [10.1016/j.sajce.2018.04.006, DOI 10.1016/J.SAJCE.2018.04.006]; Lawrence JR, 1998, J MICROBIOL METH, V32, P253, DOI 10.1016/S0167-7012(98)00027-X; Le Moal M, 2019, SCI TOTAL ENVIRON, V651, P1, DOI 10.1016/j.scitotenv.2018.09.139; Fuentes JL, 2016, MAR DRUGS, V14, DOI 10.3390/md14050100; Ma XC, 2014, BIORESOURCE TECHNOL, V167, P8, DOI 10.1016/j.biortech.2014.05.087; Molazadeh M, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00042; Mujtaba G, 2015, BIOTECHNOL BIOPROC E, V20, P1114, DOI 10.1007/s12257-015-0421-5; Nawkarkar P, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9896-0; Newton RJ, 2019, CURR OPIN BIOTECH, V57, P145, DOI 10.1016/j.copbio.2019.03.015; Olguin EJ, 2012, BIOTECHNOL ADV, V30, P1031, DOI 10.1016/j.biotechadv.2012.05.001; Paquette AJ, 2020, ALGAL RES, V46, DOI 10.1016/j.algal.2020.101805; Perez-Garcia O, 2011, WATER RES, V45, P11, DOI 10.1016/j.watres.2010.08.037; REVSBECH NP, 1981, LIMNOL OCEANOGR, V26, P717, DOI 10.4319/lo.1981.26.4.0717; Roeselers G, 2008, J APPL PHYCOL, V20, P227, DOI 10.1007/s10811-007-9223-2; Ronan P, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8081163; Ryu BG, 2014, BIOTECHNOL BIOPROC E, V19, P201, DOI 10.1007/s12257-013-0250-3; Schnurr PJ, 2015, RENEW SUST ENERG REV, V52, P418, DOI 10.1016/j.rser.2015.07.090; Seetha N, 2010, BIORESOURCE TECHNOL, V101, P3060, DOI 10.1016/j.biortech.2009.12.055; Sharma J, 2020, BIORESOURCE TECHNOL, V305, DOI 10.1016/j.biortech.2020.123063; Sharp CE, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0769-1; Silva GHR, 2019, ALGAL RES, V44, DOI 10.1016/j.algal.2019.101715; Song CF, 2020, J CLEAN PROD, V268, DOI 10.1016/j.jclepro.2020.122332; Sutherland DL, 2017, ALGAL RES, V25, P496, DOI 10.1016/j.algal.2017.05.023; Tossavainen M, 2019, J APPL PHYCOL, V31, P1753, DOI 10.1007/s10811-018-1689-6; van der Ha D, 2011, WATER RES, V45, P2845, DOI 10.1016/j.watres.2011.03.005; Vu LTK, 2016, BIORESOURCE TECHNOL, V219, P261, DOI 10.1016/j.biortech.2016.07.105; Wang JH, 2017, APPL MICROBIOL BIOT, V101, P2659, DOI 10.1007/s00253-017-8184-x; Wang M, 2018, J ENVIRON MANAGE, V217, P845, DOI 10.1016/j.jenvman.2018.04.021; Yin ZH, 2020, BIORESOURCE TECHNOL, V301, DOI 10.1016/j.biortech.2020.122804; Yu JJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08132; Yuan Q., 2015, OPTIONS IMPROVED NUT	50	0	0	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253224	10.1371/journal.pone.0253224	http://dx.doi.org/10.1371/journal.pone.0253224			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129611	Green Published, gold			2022-12-26	WOS:000665475100035
J	van der Zee, EN; Noordhuis, LM; Epker, JL; van Leeuwen, N; Wijnhoven, BPL; Benoit, DD; Bakker, J; Kompanje, EJO				van der Zee, Esther N.; Noordhuis, Lianne M.; Epker, Jelle L.; van Leeuwen, Nikki; Wijnhoven, Bas P. L.; Benoit, Dominique D.; Bakker, Jan; Kompanje, Erwin J. O.			Assessment of mortality and performance status in critically ill cancer patients: A retrospective cohort study	PLOS ONE			English	Article							STEM-CELL TRANSPLANTATION; LONG-TERM OUTCOMES; QUALITY-OF-LIFE; ANTICANCER TREATMENTS; SURVIVAL; ICU; MALIGNANCIES; ADMISSION; SUPPORT; TRENDS	Introduction Given clinicians' frequent concerns about unfavourable outcomes, Intensive Care Unit (ICU) triage decisions in acutely ill cancer patients can be difficult, as clinicians may have doubts about the appropriateness of an ICU admission. To aid to this decision making, we studied the survival and performance status of cancer patients 2 years following an unplanned ICU admission. Materials and methods This was a retrospective cohort study in a large tertiary referral university hospital in the Netherlands. We categorized all adult patients with an unplanned ICU admission in 2017 into two groups: patients with or without an active malignancy. Descriptive statistics, Pearson's Chi-square tests and the Mann-Whitney U tests were used to evaluate the primary objective 2-year mortality and performance status. A good performance status was defined as ECOG performance status 0 (fully active) or 1 (restricted in physically strenuous activity but ambulatory and able to carry out light work). A multivariable binary logistic regression analysis was used to identify factors associated with 2-year mortality within cancer patients. Results Of the 1046 unplanned ICU admissions, 125 (12%) patients had cancer. The 2-year mortality in patients with cancer was significantly higher than in patients without cancer (72% and 42.5%, P <0.001). The median performance status at 2 years in cancer patients was 1 (IQR 0-2). Only an ECOG performance status of 2 (OR 8.94; 95% CI 1.21-65.89) was independently associated with 2-year mortality. Conclusions In our study, the majority of the survivors have a good performance status 2 years after ICU admission. However, at that point, three-quarter of these cancer patients had died, and mortality in cancer patients was significantly higher than in patients without cancer. ICU admission decisions in acutely ill cancer patients should be based on performance status, severity of illness and long-term prognosis, and this should be communicated in the shared decision making. An ICU admission decision should not solely be based on the presence of a malignancy.	[van der Zee, Esther N.; Noordhuis, Lianne M.; Epker, Jelle L.; Kompanje, Erwin J. O.] Erasmus MC, Dept Intens Care, Rotterdam, Netherlands; [van Leeuwen, Nikki] Erasmus MC, Ctr Med Decis Making, Dept Publ Hlth, Rotterdam, Netherlands; [Wijnhoven, Bas P. L.] Erasmus MC, Dept Surg, Rotterdam, Netherlands; [Benoit, Dominique D.] Ghent Univ Hosp, Dept Intens Care, Ghent, Belgium; [Bakker, Jan] NYU, NYU Langone Med Ctr, Dept Pulmonol & Crit Care, New York, NY USA; [Bakker, Jan] Columbia Univ, Irvine Med Ctr, Dept Pulmonol & Crit Care, New York, NY USA; [Bakker, Jan] Pontificia Univ Catolica Chile, Dept Intens Care, Santiago, Chile	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Ghent University; Ghent University Hospital; New York University; NYU Langone Medical Center; Columbia University; Pontificia Universidad Catolica de Chile	van der Zee, EN (corresponding author), Erasmus MC, Dept Intens Care, Rotterdam, Netherlands.	e.vanderzee@erasmusmc.nl	Bakker, Jan/A-4011-2009	Bakker, Jan/0000-0003-2236-7391; van der Zee, Esther/0000-0003-0431-4659				Allemani C, 2018, LANCET, V391, P1023, DOI 10.1016/S0140-6736(17)33326-3; Atramont A, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.3215; Azoulay E, 2017, INTENS CARE MED, V43, P1366, DOI 10.1007/s00134-017-4884-z; Azoulay E, 2013, J CLIN ONCOL, V31, P2810, DOI 10.1200/JCO.2012.47.2365; Back AL, 2008, CANCER-AM CANCER SOC, V113, P1897, DOI 10.1002/cncr.23653; Baradari Afshin Gholipour, 2016, Mater Sociomed, V28, P343, DOI 10.5455/msm.2016.28.343-347; Benoit DD, 2018, INTENS CARE MED, V44, P1039, DOI 10.1007/s00134-018-5231-8; Borcoman E, 2020, J CRIT CARE, V57, P36, DOI 10.1016/j.jcrc.2020.01.027; Camou F, 2020, SUPPORT CARE CANCER, V28, P1325, DOI 10.1007/s00520-019-04937-4; Palomo YC, 2015, TRANSPL P, V47, P2665, DOI 10.1016/j.transproceed.2015.09.033; Curigliano G, 2016, CA-CANCER J CLIN, V66, P310, DOI 10.3322/caac.21341; Darmon M, 2019, INTENS CARE MED, V45, P977, DOI 10.1007/s00134-019-05653-7; de Groot V, 2003, J CLIN EPIDEMIOL, V56, P221, DOI 10.1016/S0895-4356(02)00585-1; de Vries VA, 2018, BRIT J HAEMATOL, V181, P68, DOI 10.1111/bjh.15140; Egol A, 1999, CRIT CARE MED, V27, P633; Falcao ALE, 2019, ANN INTENSIVE CARE, V9, DOI 10.1186/s13613-019-0488-9; Ferrari S, 2005, ANTI-CANCER DRUG, V16, P733, DOI 10.1097/01.cad.0000168394.89428.11; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fisher R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011363; Gruber PC, 2013, BRIT J ANAESTH, V111, P1026, DOI 10.1093/bja/aet393; Hampshire PA, 2009, CRIT CARE, V13, DOI 10.1186/cc8016; Kasuya G, 2011, ANTICANCER RES, V31, P3527; Lamont EB, 2001, ANN INTERN MED, V134, P1096, DOI 10.7326/0003-4819-134-12-200106190-00009; Lee DS, 2015, CRIT CARE MED, V43, P1439, DOI 10.1097/CCM.0000000000000989; Lopez R, 2019, J GLOB ONCOL, V5, DOI 10.1200/JGO.19.00184; Marta Z., 2018, J CLIN ONCOL, V36; Maruvka YE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083100; Mokart D, 2012, ACTA ANAESTH SCAND, V56, P178, DOI 10.1111/j.1399-6576.2011.02579.x; Mokart D, 2015, J CRIT CARE, V30, P1107, DOI 10.1016/j.jcrc.2015.06.020; Murphy K, 2018, QJM-INT J MED, V111, P379, DOI 10.1093/qjmed/hcy052; Normilio-Silva K, 2016, CRIT CARE MED, V44, P1327, DOI 10.1097/CCM.0000000000001648; Numico G, 2015, CURR OPIN ONCOL, V27, P351, DOI 10.1097/CCO.0000000000000203; Oeyen SG, 2013, INTENS CARE MED, V39, P889, DOI 10.1007/s00134-012-2791-x; Ostermann M, 2017, CRIT CARE MED, V45, P1668, DOI 10.1097/CCM.0000000000002589; Pene F, 2006, J CLIN ONCOL, V24, P643, DOI 10.1200/JCO.2005.03.9073; Puxty K, 2018, JAMA SURG, V153, P834, DOI 10.1001/jamasurg.2018.1571; Puxty K, 2015, JAMA ONCOL, V1, P1078, DOI 10.1001/jamaoncol.2015.2855; Sauer CM, 2019, CANCER RES TREAT, V51, P973, DOI 10.4143/crt.2018.360; Stenehjem JS, 2016, BRIT J CANCER, V115, P178, DOI 10.1038/bjc.2016.180; Taccone FS, 2009, CRIT CARE, V13, DOI 10.1186/cc7713; Tavares M, 2018, J INTENSIVE CARE MED, V33, P415, DOI 10.1177/0885066616664321; Thiery G, 2005, J CLIN ONCOL, V23, P4406, DOI 10.1200/JCO.2005.01.487; Wilkinson D, 2009, THEOR MED BIOETH, V30, P401, DOI 10.1007/s11017-009-9120-6; Xia R, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2242-0; Zampieri FG, 2021, INTENS CARE MED, V47, P170, DOI 10.1007/s00134-020-06184-2	45	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252771	10.1371/journal.pone.0252771	http://dx.doi.org/10.1371/journal.pone.0252771			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115771	Green Published, gold			2022-12-26	WOS:000664643000033
J	Hostetter, NJ; Lunn, NJ; Richardson, ES; Regehr, EV; Converse, SJ				Hostetter, Nathan J.; Lunn, Nicholas J.; Richardson, Evan S.; Regehr, Eric V.; Converse, Sarah J.			Age-structured Jolly-Seber model expands inference and improves parameter estimation from capture-recapture data	PLOS ONE			English	Article							BEARS URSUS-MARITIMUS; POLAR BEARS; SEA-ICE; BAYESIAN-ANALYSIS; MARK-RECAPTURE; BEAUFORT SEA; SURVIVAL; RATES; SIZE; POPULATIONS	Understanding the influence of individual attributes on demographic processes is a key objective of wildlife population studies. Capture-recapture and age data are commonly collected to investigate hypotheses about survival, reproduction, and viability. We present a novel age-structured Jolly-Seber model that incorporates age and capture-recapture data to provide comprehensive information on population dynamics, including abundance, age-dependent survival, recruitment, age structure, and population growth rates. We applied our model to a multi-year capture-recapture study of polar bears (Ursus maritimus) in western Hudson Bay, Canada (2012-2018), where management and conservation require a detailed understanding of how polar bears respond to climate change and other factors. In simulation studies, the age-structured Jolly-Seber model improved precision of survival, recruitment, and annual abundance estimates relative to standard Jolly-Seber models that omit age information. Furthermore, incorporating age information improved precision of population growth rates, increased power to detect trends in abundance, and allowed direct estimation of age-dependent survival and changes in annual age structure. Our case study provided detailed evidence for senescence in polar bear survival. Median survival estimates were lower (<0.95) for individuals aged <5 years, remained high (>0.95) for individuals aged 7-22 years, and subsequently declined to near zero for individuals >30 years. We also detected cascading effects of large recruitment classes on population age structure, which created major shifts in age structure when these classes entered the population and then again when they reached prime breeding ages (10-15 years old). Overall, age-structured Jolly-Seber models provide a flexible means to investigate ecological and evolutionary processes that shape populations (e.g., via senescence, life expectancy, and lifetime reproductive success) while improving our ability to investigate population dynamics and forecast population changes from capture-recapture data.	[Hostetter, Nathan J.] Univ Washington, Washington Cooperat Fish & Wildlife Res Unit, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Lunn, Nicholas J.; Richardson, Evan S.] Environm & Climate Change Canada, Wildlife Res Div, Sci & Technol Branch, Gatineau, PQ, Canada; [Regehr, Eric V.] Univ Washington, Appl Phys Lab, Polar Sci Ctr, Seattle, WA 98195 USA; [Converse, Sarah J.] Univ Washington, US Geol Survey, Washington Cooperat Fish & Wildlife Res Unit, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Converse, Sarah J.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Hostetter, Nathan J.] North Carolina State Univ, North Carolina Cooperat Fish & Wildlife Res Unit, Dept Appl Ecol, US Geol Survey, Raleigh, NC 27695 USA	University of Washington; University of Washington Seattle; Environment & Climate Change Canada; Canadian Wildlife Service; Wildlife Research Division - Environment Canada; University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; United States Department of the Interior; United States Geological Survey; University of North Carolina; North Carolina State University	Hostetter, NJ (corresponding author), Univ Washington, Washington Cooperat Fish & Wildlife Res Unit, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.; Hostetter, NJ (corresponding author), North Carolina State Univ, North Carolina Cooperat Fish & Wildlife Res Unit, Dept Appl Ecol, US Geol Survey, Raleigh, NC 27695 USA.	njhostet@ncsu.edu		Lunn, Nicholas/0000-0003-0189-5494; Hostetter, Nathan/0000-0001-6075-2157	Care for the Wild International; Churchill Northern Studies Centre; Earth Rangers Foundation; Environment and Climate Change Canada; Isdell Family Foundation; Manitoba Sustainable Development; Parks Canada Agency; Prairie Helicopters; Polar Bears International; Schad Foundation; Takla Foundation; University of Alberta; Wildlife Media Inc.; World Wildlife Fund Canada; North Pacific Research Board [1809]; U.S. Fish and Wildlife Service; U.S. Geological Survey (USGS) Patuxent Wildlife Research Center; USGS Washington Cooperative Fish and Wildlife Research Unit; University of Washington	Care for the Wild International; Churchill Northern Studies Centre; Earth Rangers Foundation; Environment and Climate Change Canada; Isdell Family Foundation; Manitoba Sustainable Development; Parks Canada Agency; Prairie Helicopters; Polar Bears International; Schad Foundation; Takla Foundation; University of Alberta(University of Alberta); Wildlife Media Inc.; World Wildlife Fund Canada; North Pacific Research Board; U.S. Fish and Wildlife Service(US Fish & Wildlife Service); U.S. Geological Survey (USGS) Patuxent Wildlife Research Center; USGS Washington Cooperative Fish and Wildlife Research Unit; University of Washington(University of Washington)	Financial and logistical support for field research was provided by Care for the Wild International, the Churchill Northern Studies Centre, Earth Rangers Foundation, Environment and Climate Change Canada, the Isdell Family Foundation, Manitoba Sustainable Development, Parks Canada Agency, Prairie Helicopters, Polar Bears International, the Schad Foundation, the Takla Foundation, the University of Alberta, Wildlife Media Inc., and World Wildlife Fund Canada. Financial and logistical support for data analysis was provided by North Pacific Research Board (Project 1809), U.S. Fish and Wildlife Service, U.S. Geological Survey (USGS) Patuxent Wildlife Research Center, USGS Washington Cooperative Fish and Wildlife Research Unit, and the University of Washington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, TEXTS STAT SCI SERIE; Atwood TC, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1370; Banner KM, 2020, METHODS ECOL EVOL, V11, P882, DOI 10.1111/2041-210X.13407; Boyce MS, 2006, TRENDS ECOL EVOL, V21, P141, DOI 10.1016/j.tree.2005.11.018; Bromaghin JF, 2015, ECOL APPL, V25, P634, DOI 10.1890/14-1129.1; Brooks SP, 2000, BIOMETRICS, V56, P951, DOI 10.1111/j.0006-341X.2000.00951.x; Calvert W, 1998, URSUS-SERIES, V10, P449; Cam E, 2002, AM NAT, V159, P96, DOI 10.1086/324126; Cam E, 2013, OIKOS, V122, P739, DOI 10.1111/j.1600-0706.2012.20532.x; CAUGHLEY G, 1966, ECOLOGY, V47, P906, DOI 10.2307/1935638; Christensen-Dalsgaard SN, 2010, POLAR BIOL, V33, P589, DOI 10.1007/s00300-009-0734-y; Coggins LG, 2006, N AM J FISH MANAGE, V26, P201, DOI 10.1577/M05-133.1; Colchero F, 2012, J ANIM ECOL, V81, P139, DOI 10.1111/j.1365-2656.2011.01898.x; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Derocher AE, 2005, POPUL ECOL, V47, P267, DOI 10.1007/s10144-005-0231-2; Derocher AE, 1996, CAN J ZOOL, V74, P1246, DOI 10.1139/z96-138; EBERHARDT LL, 1990, J WILDLIFE MANAGE, V54, P587, DOI 10.2307/3809353; Folio DM, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0070; Gelman A., 2007, DATA ANAL USING REGR; Glennie R, 2019, BIOMETRICS, V75, P1345, DOI 10.1111/biom.13078; Hoy SR, 2020, FUNCT ECOL, V34, P203, DOI 10.1111/1365-2435.13431; JOLLY GM, 1965, BIOMETRIKA, V52, P225, DOI 10.2307/2333826; Kendall WL, 2002, ECOLOGY, V83, P3276; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Koons DN, 2006, J WILDLIFE MANAGE, V70, P19, DOI 10.2193/0022-541X(2006)70[19:PMIFWM]2.0.CO;2; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lunn NJ, 2016, ECOL APPL, V26, P1302, DOI 10.1890/15-1256; Manly BFJ, 2003, BIOSCIENCE, V53, P666, DOI 10.1641/0006-3568(2003)053[0666:ISEOOA]2.0.CO;2; Matechou E, 2016, ENVIRON ECOL STAT, V23, P531, DOI 10.1007/s10651-016-0352-0; Matechou E, 2013, METHODS ECOL EVOL, V4, P654, DOI 10.1111/2041-210X.12061; McCrea RS, 2013, J R STAT SOC C-APPL, V62, P101, DOI 10.1111/j.1467-9876.2012.01043.x; Morris W. F., 2002, QUANTITATIVE CONSERV; NIMBLE Development Team, 2019, NIMBLE R PACK PROGR; Nussey DH, 2013, AGEING RES REV, V12, P214, DOI 10.1016/j.arr.2012.07.004; Pledger S, 2010, BIOMETRICS, V66, P883, DOI 10.1111/j.1541-0420.2009.01361.x; Pledger S, 2009, ENVIRON ECOL STAT SE, V3, P349, DOI 10.1007/978-0-387-78151-8_15; POLLOCK KH, 1981, BIOMETRICS, V37, P521, DOI 10.2307/2530565; Pradel R, 1996, BIOMETRICS, V52, P703, DOI 10.2307/2532908; R Core Team, 2020, R LANG ENV STAT COMP; RAMSAY MA, 1988, J ZOOL, V214, P601, DOI 10.1111/j.1469-7998.1988.tb03762.x; Regehr EV, 2007, J WILDLIFE MANAGE, V71, P2673, DOI 10.2193/2006-180; Regehr EV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34824-7; Regehr EV, 2017, J APPL ECOL, V54, P1534, DOI 10.1111/1365-2664.12864; Reinke BA, 2020, ECOLOGY, V101, DOI 10.1002/ecy.2877; Richardson ES, 2020, BEHAV ECOL, V31, P1224, DOI 10.1093/beheco/araa074; Ricklefs RE, 2010, P NATL ACAD SCI USA, V107, P10314, DOI 10.1073/pnas.1005862107; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Roach DA, 2014, ANNU REV ECOL EVOL S, V45, P421, DOI 10.1146/annurev-ecolsys-120213-091730; Royle JA, 2009, HIERARCHICAL MODELING AND INFERENCE IN ECOLOGY: THE ANALYSIS OF DATA FROM POPULATIONS, METAPOPULATIONS AND COMMUNITIES, P1; Royle JA, 2014, SPATIAL CAPTURE-RECAPTURE, P1; Schaub M, 2001, ECOLOGY, V82, P852, DOI 10.2307/2680203; Schipper J, 2008, SCIENCE, V322, P225, DOI 10.1126/science.1165115; Schwarz CJ, 1996, BIOMETRICS, V52, P860, DOI 10.2307/2533048; Schwarz CJ, 2001, J AGR BIOL ENVIR ST, V6, P195, DOI 10.1198/108571101750524706; SEBER GAF, 1965, BIOMETRIKA, V52, P249; STIRLING I, 1989, J WILDLIFE DIS, V25, P159, DOI 10.7589/0090-3558-25.2.159; Stirling I, 2011, ECOL APPL, V21, P859, DOI 10.1890/10-0849.1; Williams B. K., 2002, ANAL MANAGEMENT ANIM	58	3	3	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252748	10.1371/journal.pone.0252748	http://dx.doi.org/10.1371/journal.pone.0252748			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106979	gold, Green Published			2022-12-26	WOS:000664642200056
J	Rutherford, JN; Ross, CN; Ziegler, T; Burke, LA; Steffen, AD; Sills, A; Layne Colon, D; deMartelly, VA; Narapareddy, LR; Tardif, SD				Rutherford, Julienne N.; Ross, Corinna N.; Ziegler, Toni; Burke, Larisa A.; Steffen, Alana D.; Sills, Aubrey; Layne Colon, Donna; deMartelly, Victoria A.; Narapareddy, Laren R.; Tardif, Suzette D.			Womb to womb: Maternal litter size and birth weight but not adult characteristics predict early neonatal death of offspring in the common marmoset monkey	PLOS ONE			English	Article							CALLITHRIX-JACCHUS; NONHUMAN PRIMATE; MOTHER-BLAME; RISK-FACTORS; BODY-WEIGHT; INFANT; OBESITY; FETAL; STILLBIRTH; PREGNANCY	A singular focus on maternal health at the time of a pregnancy leaves much about perinatal mortality unexplained, especially when there is growing evidence for maternal early life effects. Further, lumping stillbirth and early neonatal death into a single category of perinatal mortality may obscure different causes and thus different avenues of screening and prevention. The common marmoset monkey (Callithrix jacchus), a litter-bearing nonhuman primate, is an ideal species in which to study the independent effects of a mother's early life and adult phenotypes on pregnancy outcomes. We tested two hypotheses in 59 marmoset pregnancies at the Southwest National Primate Research Center and the Barshop Institute for Longevity and Aging Studies. We explored 1) whether pregnancy outcomes were predicted independently by maternal adult weight versus maternal litter size and birth weight, and 2) whether stillbirth and early neonatal death were differentially predicted by maternal variables. No maternal characteristics predicted stillbirth and no maternal adult characteristics predicted early neonatal death. In univariate Poisson models, triplet-born females had a significantly increased rate of early neonatal death (IRR[se] = 3.00[1.29], p = 0.011), while higher birth weight females had a decreased rate (IRR[se] = 0.89[0.05], p = 0.039). In multivariate Poisson models, maternal litter size remained an independent predictor, explaining 13% of the variance in early neonatal death. We found that the later in the first week those neonates died, the more weight they lost. Together these findings suggest that triplet-born and low birth weight females have distinct developmental trajectories underlying greater rates of infant loss, losses that we suggest may be attributable to developmental disruption of infant feeding and carrying. Our findings of early life contributions to adult pregnancy outcomes in the common marmoset disrupt mother-blaming narratives of pregnancy outcomes in humans. These narratives hold that the pregnant person is solely responsible for pregnancy outcomes and the health of their children, independent of socioecological factors, a moralistic framing that has shaped clinical pregnancy management. It is necessary to differentiate temporal trajectories and causes of perinatal loss and view them as embedded in external processes to develop screening, diagnostic, and treatment tools that consider the full arc of a mother's lived experience, from womb to womb and beyond.	[Rutherford, Julienne N.] Univ Illinois, Dept Human Dev Nursing Sci, Coll Nursing, Chicago, IL 60612 USA; [Ross, Corinna N.; Layne Colon, Donna; Tardif, Suzette D.] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX USA; [Ziegler, Toni] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI USA; [Burke, Larisa A.] Univ Illinois, Coll Nursing, Off Res Facilitat, Chicago, IL USA; [Steffen, Alana D.] Univ Illinois, Dept Populat Hlth Nursing Sci, Coll Nursing, Chicago, IL USA; [Sills, Aubrey] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [deMartelly, Victoria A.] Univ Illinois, Dept Biobehav Hlth Nursing Sci, Coll Nursing, Chicago, IL USA; [Narapareddy, Laren R.] Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Texas Biomedical Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Texas System; University of Texas Health San Antonio; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Emory University	Rutherford, JN (corresponding author), Univ Illinois, Dept Human Dev Nursing Sci, Coll Nursing, Chicago, IL 60612 USA.	ruther4d@uic.edu		Rutherford, Julienne/0000-0001-6536-6888; deMartelly, Victoria/0000-0002-4381-2418	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [R01-HD076018]; Southwest National Primate Research Center grant from the Office of Research Infrastructure Programs, National Institutes of Health [P51-OD011133]	Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Southwest National Primate Research Center grant from the Office of Research Infrastructure Programs, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	JNR: Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health (https://www.nichd.nih.gov/) under award number R01-HD076018 (Rutherford, PI). This investigation used resources that were supported by the Southwest National Primate Research Center grant P51-OD011133 from the Office of Research Infrastructure Programs, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DH, 2003, COMPARATIVE MED, V53, P339; Amark H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206940; [Anonymous], 2011, CHILD MORT MILL DEV; Ash H., 2020, APPL ANIM BEHAV SCI; Avci ME, 2015, J MATERN-FETAL NEO M, V28, P2080, DOI 10.3109/14767058.2014.978279; Barfield WD, 2011, PEDIATRICS, V128, P177, DOI 10.1542/peds.2011-1037; Bartol F., 2014, LACTOCRINE PROGRAMMI; Bassett AMS, 2020, DEV PSYCHOBIOL, V62, P920, DOI 10.1002/dev.21959; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2469, DOI 10.1001/jama.2011.1798; Caldji C, 1998, P NATL ACAD SCI USA, V95, P5335, DOI 10.1073/pnas.95.9.5335; Camp ME, 2014, REPRODUCTION, V148, P441, DOI 10.1530/REP-14-0257; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Da Silva FT, 2016, VACCINE, V34, P6057, DOI 10.1016/j.vaccine.2016.03.044; Dettmer AM, 2012, PSYCHONEUROENDOCRINO, V37, P191, DOI 10.1016/j.psyneuen.2011.06.003; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; Edmond K, 2016, LANCET GLOB HEALTH, V4, pE266, DOI 10.1016/S2214-109X(16)00040-1; Flaherman VJ, 2015, PEDIATRICS, V135, pE16, DOI 10.1542/peds.2014-1532; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Frankshun AL, 2011, REPRODUCTION, V141, P373, DOI 10.1530/REP-10-0401; Frye BM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37723-z; Fuentes A, 2019, AM J PHYS ANTHROPOL, V169, P400, DOI 10.1002/ajpa.23882; Gardosi J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f108; Gubernick D.J., 1981, PARENTAL CARE MAMMAL; Hinde K, 2010, AM J PRIMATOL, V72, P522, DOI 10.1002/ajp.20806; JAQUISH CE, 1991, AM J PHYS ANTHROPOL, V84, P291, DOI 10.1002/ajpa.1330840306; Kuziez D, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23403; Liu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168743; Lumey LH, 1997, AM J PUBLIC HEALTH, V87, P1962, DOI 10.2105/AJPH.87.12.1962; LUNN SF, 1983, FOLIA PRIMATOL, V41, P204, DOI 10.1159/000156132; MEANEY MJ, 1992, NEUROENDOCRINOLOGY, V55, P204, DOI 10.1159/000126116; MEANEY MJ, 1988, SCIENCE, V239, P766, DOI 10.1126/science.3340858; Meaney MJ, 2001, ANNU REV NEUROSCI, V24, P1161, DOI 10.1146/annurev.neuro.24.1.1161; Meehan S, 2014, PEDIATRICS, V133, P863, DOI 10.1542/peds.2013-1480; Mills DA, 2004, PRIMATES, V45, P259, DOI 10.1007/s10329-004-0095-7; Ostendorf ALG, 2013, INT J LEGAL MED, V127, P447, DOI 10.1007/s00414-012-0727-1; Parker G. C., 2018, FRONTIERS SOCIOLOGY, V3, P5; Parker G, 2019, FEM PSYCHOL, V29, P250, DOI 10.1177/0959353519834053; Pittet F, 2017, AM J PHYS ANTHROPOL, V164, P457, DOI 10.1002/ajpa.23286; Price KC, 2000, HUM REPROD, V15, P452, DOI 10.1093/humrep/15.2.452; Pryce CR, 2004, BIOL PSYCHIAT, V56, P72, DOI 10.1016/j.biopsych.2004.05.002; Richardson SS, 2014, NATURE, V512, P131, DOI 10.1038/512131a; Rutherford JN, 2009, PLACENTA, V30, P105, DOI 10.1016/j.placenta.2008.10.010; Rutherford Julienne, 2018, ANTHR FETUS BIOL CUL, P15; Rutherford JN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096845; Rutherford JN, 2009, AM J HUM BIOL, V21, P745, DOI 10.1002/ajhb.20923; Salihu HM, 2011, SEMIN PERINATOL, V35, P340, DOI 10.1053/j.semperi.2011.05.019; Santos CV, 1997, INT J PRIMATOL, V18, P889, DOI 10.1023/A:1026340028851; Scott KA, 2019, J PERINAT NEONAT NUR, V33, P108, DOI 10.1097/JPN.0000000000000394; Sharp GC, 2019, J DEV ORIG HLTH DIS, V10, P509, DOI [10.1017/S2040174419000655, 10.1017/S2040174419000072]; Smith RJ, 2018, AM J PHYS ANTHROPOL, V166, P236, DOI 10.1002/ajpa.23399; Stephansson O, 2001, AM J OBSTET GYNECOL, V184, P463, DOI 10.1067/mob.2001.109591; Tardif SD, 1997, AM J PRIMATOL, V42, P323, DOI 10.1002/(SICI)1098-2345(1997)42:4<323::AID-AJP7>3.0.CO;2-Z; Tardif SD, 2004, AM J PRIMATOL, V62, P83, DOI 10.1002/ajp.20009; Tardif SD, 1998, J MED PRIMATOL, V27, P28, DOI 10.1111/j.1600-0684.1998.tb00065.x; Tardif SD, 2002, ETHOLOGY, V108, P825, DOI 10.1046/j.1439-0310.2002.00815.x; Tardif SD, 2002, J MED PRIMATOL, V31, P147, DOI 10.1034/j.1600-0684.2002.02005.x; Tardif SD, 2008, INTERD T GERONT GERI, V36, P29, DOI 10.1159/000137678; Tardif SD, 2009, OBESITY, V17, P1499, DOI 10.1038/oby.2009.77; Thayer ZM, 2020, EVOL MED PUBLIC HLTH, P14, DOI 10.1093/emph/eoz037; WHO, MAT PER HLTH; Winett LB, 2016, AM J PUBLIC HEALTH, V106, P1369, DOI 10.2105/AJPH.2016.303239	62	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252093	10.1371/journal.pone.0252093	http://dx.doi.org/10.1371/journal.pone.0252093			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106943	gold, Green Published			2022-12-26	WOS:000664642200028
J	Schmidt, S; Benke, C; Pane-Farre, CA				Schmidt, Sebastian; Benke, Christoph; Pane-Farre, Christiane A.			Purchasing under threat: Changes in shopping patterns during the COVID-19 pandemic	PLOS ONE			English	Article							ANXIETY; INTOLERANCE; UNCERTAINTY; FEAR; BEHAVIOR; VERSION; HUMANS	The spreading of COVID-19 has led to panic buying all over the world. In this study, we applied an animal model framework to elucidate changes in human purchasing behavior under COVID-19 pandemic conditions. Purchasing behavior and potential predictors were assessed in an online questionnaire format (N = 813). Multiple regression analyses were used to evaluate the role of individually Perceived Threat of COVID-19, anxiety related personality traits (trait-anxiety, intolerance of uncertainty) and the role of media exposure in predicting quantity and frequency of purchasing behavior. High levels of Perceived Threat of COVID-19 were associated significantly with a reported reduction in purchasing frequency (b = -.24, p < .001) and an increase in the quantity of products bought per purchase (b = .22, p < .001). These results are comparable to observed changes in foraging behavior in rodents under threat conditions. Higher levels of intolerance of uncertainty (b = .19, p < .001) and high extend of media exposure (b = .27, p < .001) were positively associated with Perceived Threat of COVID-19 and an increase in purchasing quantity. This study contributes to our understanding of aberrated human purchasing behavior and aims to link findings from animal research to human behavior beyond experimental investigations.	[Schmidt, Sebastian; Benke, Christoph; Pane-Farre, Christiane A.] Philipps Univ Marburg, Dept Psychol Clin Psychol Expt Psychopathol & Psy, Marburg, Germany; [Pane-Farre, Christiane A.] Philipps Univ Marburg, Ctr Mind Brain & Behav CMBB, Giessen, Germany; [Pane-Farre, Christiane A.] Justus Liebig Univ, Giessen, Germany	Philipps University Marburg; Philipps University Marburg; Justus Liebig University Giessen	Schmidt, S (corresponding author), Philipps Univ Marburg, Dept Psychol Clin Psychol Expt Psychopathol & Psy, Marburg, Germany.	sebastian.schmidt.psychologie@uni-marburg.de	Benke, Christoph/ABA-1394-2020	Benke, Christoph/0000-0002-3595-1258; Schmidt, Sebatian/0000-0001-5324-797X				[Anonymous], 2021, COVID 19 HAS TRANSF; [Anonymous], 2020, RKI COVID 19 GERMANY; Apfelbach R, 2005, NEUROSCI BIOBEHAV R, V29, P1123, DOI 10.1016/j.neubiorev.2005.05.005; Asmundson GJG, 2020, J ANXIETY DISORD, V70, DOI 10.1016/j.janxdis.2020.102196; Bach DR, 2014, CURR BIOL, V24, P541, DOI [10.1016/j.cub.2014.01.046, 10.1016/j.cub.2014.05.051]; Bentall RP, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246339; Betsch C., 2020, PREPRINT, DOI [10.23668/PSYCHARCHIVES.3156, DOI 10.23668/PSYCHARCHIVES.3156]; BLANCHARD RJ, 1989, J COMP PSYCHOL, V103, P70, DOI 10.1037/0735-7036.103.1.70; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Carleton RN, 2007, J ANXIETY DISORD, V21, P105, DOI 10.1016/j.janxdis.2006.03.014; Carleton RN, 2012, EXPERT REV NEUROTHER, V12, P937, DOI 10.1586/ERN.12.82; Carleton RN, 2012, J ANXIETY DISORD, V26, P468, DOI 10.1016/j.janxdis.2012.01.011; Chambers JA, 2004, J ANXIETY DISORD, V18, P587, DOI 10.1016/j.janxdis.2003.09.001; EFRON B, 1981, BIOMETRIKA, V68, P589, DOI 10.1093/biomet/68.3.589; FANSELOW MS, 1994, PSYCHON B REV, V1, P429, DOI 10.3758/BF03210947; FANSELOW MS, 1988, J EXP ANAL BEHAV, V50, P361, DOI 10.1901/jeab.1988.50-361; Garbe L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234232; Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875; Gerlach AL, 2008, Z KL PSYCH PSYCHOTH, V37, P190, DOI 10.1026/1616-3443.37.3.190; GRILLON C, 1991, PSYCHOPHYSIOLOGY, V28, P588, DOI 10.1111/j.1469-8986.1991.tb01999.x; James G., 2014, INTRO STAT LEARNING; Kim DJ, 2015, BEHAV BRAIN RES, V279, P31, DOI 10.1016/j.bbr.2014.10.052; Laato S, 2020, J RETAIL CONSUM SERV, V57, DOI 10.1016/j.jretconser.2020.102224; Laux L., 1981, STAI STATE TRAIT ANG; Leiner DJ., 2019, SOSCI SURVEY VERSION; Leung J, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031127; Mertens G, 2020, J ANXIETY DISORD, V74, DOI 10.1016/j.janxdis.2020.102258; Micalizzi L, 2021, BRIT J HEALTH PSYCH, V26, P535, DOI 10.1111/bjhp.12480; O'Connell M., 2020, PREPARING PANDEMIC S; Our World in Data, 2020, COVID 19 GOV RESP ST; RCore Team, 2020, R LANG ENV STAT COMP; Satow L., 2012, SELBSTDARSTELLUNG SO, V30, P2018; Schmitz A, 2012, NAT PROTOC, V7, P527, DOI 10.1038/nprot.2012.001; Spielberger C. D., 1973, MANUAL STATE TRAIT I; Statista, 2021, COR CONS STOCKP FOOD; Statistisches Bundesamt, 2020, COR KRIS EXP DAT ZEI; Steinmetz H, 2020, ZPID LOCKDOWN MEASUR; Streckmann C, 2020, RP ONLINE; Tull MT, 2020, J ANXIETY DISORD, V75, DOI 10.1016/j.janxdis.2020.102290; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Yuen KF, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103513; Zambetti PR, 2019, ISCIENCE, V16, P442, DOI 10.1016/j.isci.2019.06.011	42	12	12	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0253231	10.1371/journal.pone.0253231	http://dx.doi.org/10.1371/journal.pone.0253231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106996	gold, Green Published			2022-12-26	WOS:000664642200072
J	Fernandes, GA; Junior, APN; Silva, GAE; Feriani, D; Silva, ILAFE; Caruso, P; Curado, MP				Fernandes, Gisele Aparecida; Nassar Junior, Antonio Paulo; Azevedo e Silva, Gulnar; Feriani, Diego; Franca e Silva, Ivan Leonardo Avelino; Caruso, Pedro; Curado, Maria Paula			Excess mortality by specific causes of deaths in the city of SAo Paulo, Brazil, during the COVID-19 pandemic	PLOS ONE			English	Article								Background To investigate the excess of deaths by specific causes, in the first half of 2020 in the city of SAo Paulo-Brazil, during the COVID-19 pandemic. Methods Ecological study conducted from 01/01 to 06/30 of 2019 and 2020. Population and mortality data were obtained from DATASUS. The standardized mortality ratio (SMR) by age was calculated by comparing the standardized mortality rate in 2020 to that of 2019, for overall and specific mortality. The ratio between the standardized mortality rate due to COVID-19 in men as compared to women was calculated for 2020. Crude mortality rates were standardized using the direct method. Results COVID-19 was responsible for 94.4% of the excess deaths in SAo Paulo. In 2020 there was an increase in overall mortality observed among both men (SMR 1.3, 95% CI 1.17-1.42) and women (SMR 1.2, 95% CI 1.06-1.36) as well as a towards reduced mortality for all cancers. Mortality due to COVID-19 was twice as high for men as for women (SMR 2.1, 95% CI 1.67-2.59). There was an excess of deaths observed in men above 45 years of age, and in women from the age group of 60 to 79 years. Conclusion There was an increase in overall mortality during the first six months of 2020 in SAo Paulo, which seems to be related to the COVID-19 pandemic. Chronic health conditions, such as cancer and other non-communicable diseases, should not be disregarded.	[Fernandes, Gisele Aparecida; Curado, Maria Paula] AC Camargo Canc Ctr, Grp Epidemiol & Stat Canc, Sao Paulo, SP, Brazil; [Nassar Junior, Antonio Paulo; Caruso, Pedro] AC Camargo Canc Ctr, Intens Care Unit, Sao Paulo, SP, Brazil; [Azevedo e Silva, Gulnar] Univ Estado Rio de Janeiro, Dept Epidemiol, Rio De Janeiro, RJ, Brazil; [Feriani, Diego; Franca e Silva, Ivan Leonardo Avelino] AC Camargo Canc Ctr, Dept Infect Prevent & Control, Sao Paulo, SP, Brazil	A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; Universidade do Estado do Rio de Janeiro; A.C.Camargo Cancer Center	Curado, MP (corresponding author), AC Camargo Canc Ctr, Grp Epidemiol & Stat Canc, Sao Paulo, SP, Brazil.	mp.curado@accamargo.org.br	Nassar, Antonio P/I-5508-2015; Nassar, Antonio Paulo/AAS-9246-2021; Caruso, Pedro/AAY-8176-2021; Curado, Maria Paula/M-6200-2013	Nassar, Antonio P/0000-0002-0522-7445; Nassar, Antonio Paulo/0000-0002-0522-7445; Curado, Maria Paula/0000-0001-8172-2483; Fernandes, Gisele Aparecida/0000-0002-5978-3279				Alicandro G, 2020, LANCET, V396, pE27, DOI 10.1016/S0140-6736(20)31865-1; [Anonymous], 2020, LANCET, V395, P1168, DOI 10.1016/S0140-6736(20)30823-0; [Anonymous], B DIARIO COVID 19 NO; Silva GAE, 2020, CIENC SAUDE COLETIVA, V25, P3345, DOI 10.1590/1413-81232020259.23642020; Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0; Bhopal SS, 2020, LANCET, V396, P532, DOI 10.1016/S0140-6736(20)31748-7; Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3; Conti S, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00458-2020; da Cunha AR, 2022, ORAL DIS, V28, P925, DOI 10.1111/odi.13620; DOLL R, 1967, INT J CANCER, V2, P269, DOI 10.1002/ijc.2910020310; Informacoes de Saude (TABNET), SIST INF MORT SIM; International Agency for Research on Cancer (IARC), CANC TOD; Kang Y, 2020, HEART, V106, P1132, DOI 10.1136/heartjnl-2020-317056; Krieger N, 2020, LANCET, V395, P1829, DOI 10.1016/S0140-6736(20)31234-4; Lai A., 2020, MEDRXIV, P1; London JW, 2020, JCO CLIN CANCER INFO, V4, P657, DOI 10.1200/CCI.20.00068; Malta DC, 2017, SAO PAULO MED J, V135, P213, DOI 10.1590/1516-3180.2016.0330050117; Ministerio da Saude (BR), DAT DEM SOC; Nogueira PJ, 2020, ACTA MEDICA PORT, V33, P376, DOI 10.20344/amp.13928; OpenEpi, EST EP COD AB SAUD P; Sharma Garima, 2020, JACC Case Rep, V2, P1407, DOI 10.1016/j.jaccas.2020.04.027; Sharpless NE, 2020, SCIENCE, V368, P1290, DOI 10.1126/science.abd3377; Ssentongo P, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238215; Stang A, 2020, J INFECTION, V81, P797, DOI 10.1016/j.jinf.2020.09.012; WHO (World Health Organization), NONC DIS; World Health Organisation, 2020, WHO COR DIS 2019 COV; World Health Organization, 2020, DIR GEN OP REM MED B	27	7	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252238	10.1371/journal.pone.0252238	http://dx.doi.org/10.1371/journal.pone.0252238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097694	gold, Green Published			2022-12-26	WOS:000664640700005
J	Dai, ZH; Trettin, CC; Burton, AJ; Jurgensen, MF; Page-Dumroese, DS; Forschler, BT; Schilling, JS; Lindner, DL				Dai, Zhaohua; Trettin, Carl C.; Burton, Andrew J.; Jurgensen, Martin F.; Page-Dumroese, Deborah S.; Forschler, Brian T.; Schilling, Jonathan S.; Lindner, Daniel L.			Coarse woody debris decomposition assessment tool: Model development and sensitivity analysis	PLOS ONE			English	Article							RETICULITERMES-FLAVIPES ISOPTERA; DISSOLVED ORGANIC-CARBON; SOFT-ROT FUNGI; DECAY-RATES; LITTER DECOMPOSITION; NUTRIENT DYNAMICS; COPTOTERMES-FORMOSANUS; SUBTERRANEAN TERMITES; TROPICAL FORESTS; TEMPERATURE	Coarse woody debris (CWD) is an important component in forests, hosting a variety of organisms that have critical roles in nutrient cycling and carbon (C) storage. We developed a process-based model using literature, field observations, and expert knowledge to assess woody debris decomposition in forests and the movement of wood C into the soil and atmosphere. The sensitivity analysis was conducted against the primary ecological drivers (wood properties and ambient conditions) used as model inputs. The analysis used eighty-nine climate datasets from North America, from tropical (14.2 degrees N) to boreal (65.0 degrees N) zones, with large ranges in annual mean temperature (26.5 degrees C in tropical to -11.8 degrees C in boreal), annual precipitation (6,143 to 181 mm), annual snowfall (0 to 612 kg m(-2)), and altitude (3 to 2,824 m above mean see level). The sensitivity analysis showed that CWD decomposition was strongly affected by climate, geographical location and altitude, which together regulate the activity of both microbial and invertebrate wood-decomposers. CWD decomposition rate increased with increments in temperature and precipitation, but decreased with increases in latitude and altitude. CWD decomposition was also sensitive to wood size, density, position (standing vs downed), and tree species. The sensitivity analysis showed that fungi are the most important decomposers of woody debris, accounting for over 50% mass loss in nearly all climatic zones in North America. The model includes invertebrate decomposers, focusing mostly on termites, which can have an important role in CWD decomposition in tropical and some subtropical regions. The role of termites in woody debris decomposition varied widely, between 0 and 40%, from temperate areas to tropical regions. Woody debris decomposition rates simulated for eighty-nine locations in North America were within the published range of woody debris decomposition rates for regions in northern hemisphere from 1.6 degrees N to 68.3 degrees N and in Australia.	[Dai, Zhaohua; Trettin, Carl C.] US Forest Serv, Ctr Forested Watershed Res, USDA, Cordesville, SC 29434 USA; [Dai, Zhaohua; Burton, Andrew J.; Jurgensen, Martin F.] Michigan Technol Univ, Coll Forest Resources & Environm Sci, Houghton, MI 49931 USA; [Page-Dumroese, Deborah S.] US Forest Serv, Rocky Mt Res Stn, USDA, Moscow, ID USA; [Forschler, Brian T.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Schilling, Jonathan S.] Univ Minnesota, Plant & Microbial Biol, Itasca Biol Stn & Labs, St Paul, MN 55108 USA; [Lindner, Daniel L.] US Forest Serv, Northern Res Stn, USDA, Madison, WI USA	United States Department of Agriculture (USDA); United States Forest Service; Michigan Technological University; United States Department of Agriculture (USDA); United States Forest Service; University System of Georgia; University of Georgia; University of Minnesota System; University of Minnesota Twin Cities; United States Department of Agriculture (USDA); United States Forest Service	Dai, ZH (corresponding author), US Forest Serv, Ctr Forested Watershed Res, USDA, Cordesville, SC 29434 USA.; Dai, ZH (corresponding author), Michigan Technol Univ, Coll Forest Resources & Environm Sci, Houghton, MI 49931 USA.	zhaohuad@mtu.edu		Burton, Andrew/0000-0002-3068-0997	U.S. Dept. of Energy (DOE, USA) [DE-SC0016235]; National Science Foundation (NSF, USA) [DEB 1754603, DEB 1754616]; FWDE	U.S. Dept. of Energy (DOE, USA)(United States Department of Energy (DOE)); National Science Foundation (NSF, USA)(National Science Foundation (NSF)); FWDE	Support of the FWDE and the model development has been provided by U.S. Dept. of Energy (DOE, USA), grant number DE-SC0016235 to CCT and the National Science Foundation (NSF, USA), grant number DEB 1754603 to AJB and grant number DEB 1754616 to JSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGREN GI, 1987, ECOLOGY, V68, P1181, DOI 10.2307/1939202; Agren GI, 2018, SOIL SCI SOC AM J, V82, P1392, DOI 10.2136/sssaj2017.11.0407; Aitkenhead-Peterson J.A., 2000, THESIS; ALBAN DH, 1993, CAN J FOREST RES, V23, P1744, DOI 10.1139/x93-220; Angers VA, 2012, CAN J FOREST RES, V42, P157, DOI [10.1139/X11-167, 10.1139/x11-167]; [Anonymous], 2006, US DEP AGR FOR SERV; [Anonymous], 2002, PSWGTR181 USDA FOR S; Barbosa RI, 2017, FOREST ECOL MANAG, V397, P1, DOI 10.1016/j.foreco.2017.04.026; Beets PN, 2008, FOREST ECOL MANAG, V256, P548, DOI 10.1016/j.foreco.2008.05.036; Blanchette RA, 2004, APPL ENVIRON MICROB, V70, P1328, DOI 10.1128/AEM.70.3.1328-1335.2004; Bond-Lamberty B, 2008, ECOSYSTEMS, V11, P831, DOI 10.1007/s10021-008-9163-y; Borken W, 2003, SOIL SCI SOC AM J, V67, P1888, DOI 10.2136/sssaj2003.1888; Brown KS, 2008, AM MIDL NAT, V159, P21, DOI 10.1674/0003-0031(2008)159[21:CCORFI]2.0.CO;2; Cao RX, 2016, ANN ENTOMOL SOC AM, V109, P64, DOI 10.1093/aesa/sav095; Chambers JQ, 2000, OECOLOGIA, V122, P380, DOI 10.1007/s004420050044; Christ MJ, 1996, SOIL BIOL BIOCHEM, V28, P1191, DOI 10.1016/0038-0717(96)00120-4; CURRAN PMT, 1980, MYCOLOGIA, V72, P350, DOI 10.2307/3759258; Currle W.S., 2003, POTENTIAL US FORESTS; Dai Z. H., 2013, Natural Science, V5, P375, DOI 10.4236/ns.2013.53051; de Boer W, 2008, BR MYCOL SY, V28, P143; Duncan C. G., 1960, WOOD ATTACKING CAPAC; Duncan C.G, 1961, 2218 USDA FOR PROD L; EDMONDS RL, 1986, CAN J FOREST RES, V16, P822, DOI 10.1139/x86-145; FAHEY TJ, 1983, ECOL MONOGR, V53, P51, DOI 10.2307/1942587; Filley TR, 2001, P NATL ACAD SCI USA, V98, P13346, DOI 10.1073/pnas.221299598; Forschler BT, 1996, ENVIRON ENTOMOL, V25, P952, DOI 10.1093/ee/25.5.952; FOSTER JR, 1982, CAN J FOREST RES, V12, P617, DOI 10.1139/x82-094; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Freschet GT, 2012, J ECOL, V100, P161, DOI 10.1111/j.1365-2745.2011.01896.x; Fukasawa Y, 2011, MYCOLOGIA, V103, P474, DOI 10.3852/10-246; Ganjegunte GK, 2004, FOREST ECOL MANAG, V187, P197, DOI 10.1016/S0378-1127(03)00332-3; Gautam BK, 2011, ANN ENTOMOL SOC AM, V104, P459, DOI 10.1603/AN10190; Gonzalez G, 2008, AMBIO, V37, P588, DOI 10.1579/0044-7447-37.7.588; Goodell B., 2008, ACS S SERIES, V982; GREAVES H, 1971, WOOD SCI TECHNOL, V5, P6, DOI 10.1007/BF00363116; GREAVES H, 1969, WOOD SCI TECHNOL, V3, P150, DOI 10.1007/BF00639638; Grube S, 2004, ANN ENTOMOL SOC AM, V97, P466, DOI 10.1603/0013-8746(2004)097[0466:COMAPL]2.0.CO;2; Guo LB, 2006, FOREST ECOL MANAG, V228, P145, DOI 10.1016/j.foreco.2006.02.043; Haagsma KA, 1995, ENVIRON ENTOMOL, V24, P1520, DOI 10.1093/ee/24.6.1520; Hafner SD, 2005, BIOGEOCHEMISTRY, V74, P257, DOI 10.1007/s10533-004-4722-6; Hanula JL, 2012, FORESTS, V3, P317, DOI 10.3390/f3020317; Harmon M.E., 1986, THESIS OREGON STATE; HARMON ME, 1986, ADV ECOL RES, V15, P133, DOI 10.1016/S0065-2504(08)60121-X; HARMON ME, 1995, BIOTROPICA, V27, P305, DOI 10.2307/2388916; Herault B, 2010, OECOLOGIA, V164, P243, DOI 10.1007/s00442-010-1602-8; Herrmann S, 2015, FOR ECOSYST, V2, DOI 10.1186/s40663-015-0052-5; Herrmann S, 2013, SCAND J FOREST RES, V28, P346, DOI 10.1080/02827581.2012.747622; HOWARD RW, 1982, ENVIRON ENTOMOL, V11, P1290, DOI 10.1093/ee/11.6.1290; Idol TW, 2001, FOREST ECOL MANAG, V149, P153, DOI 10.1016/S0378-1127(00)00536-3; Janisch JE, 2005, ECOSCIENCE, V12, P151, DOI 10.2980/i1195-6860-12-2-151.1; Janowiecki MA, 2013, SOCIOBIOLOGY, V60, P441; Johnson CE, 2014, CAN J FOREST RES, V44, P1515, DOI 10.1139/cjfr-2014-0221; Johnston SR, 2016, FEMS MICROBIOL ECOL, V92, DOI 10.1093/femsec/fiw179; Kauffman JB, 1998, OECOLOGIA, V113, P415, DOI 10.1007/s004420050394; Kielak AM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00231; Kim YS, 2000, IAWA J, V21, P135, DOI 10.1163/22941932-90000241; KRANKINA ON, 1995, WATER AIR SOIL POLL, V82, P227, DOI 10.1007/BF01182836; Kruys N, 2002, ECOL APPL, V12, P773; Laiho R, 2004, CAN J FOREST RES, V34, P763, DOI 10.1139/X03-241; LAMBERT RL, 1980, ECOLOGY, V61, P1460, DOI 10.2307/1939054; Li Zhou, 2007, Journal of Forestry Research (Harbin), V18, P48, DOI 10.1007/s11676-007-0009-9; Liski J, 2005, ECOL MODEL, V189, P168, DOI 10.1016/j.ecolmodel.2005.03.005; Lockaby BG, 2002, SOUTHEAST NAT, V1, P339, DOI 10.1656/1528-7092(2002)001[0339:AIDWOT]2.0.CO;2; Mackensen J, 2003, AUST J BOT, V51, P27, DOI 10.1071/BT02014; Mackensen J, 1999, NATL CARBON ACCOUNTI; Magnusson RI, 2016, FOREST ECOL MANAG, V377, P1, DOI 10.1016/j.foreco.2016.06.033; Marcot BG, 2017, PNWRN575 USDA FOR SE; Matsuura K, 2007, POPUL ECOL, V49, P179, DOI 10.1007/s10144-006-0030-4; MATTSON KG, 1987, CAN J FOREST RES, V17, P712, DOI 10.1139/x87-114; Meier CL, 2010, SOIL BIOL BIOCHEM, V42, P1083, DOI 10.1016/j.soilbio.2010.03.005; MOORE TR, 1984, ECOLOGY, V65, P299, DOI 10.2307/1939482; Mori S, 2014, J PLANT ECOL, V7, P356, DOI 10.1093/jpe/rtt041; Muller-Using S, 2009, EUR J FOREST RES, V128, P287, DOI 10.1007/s10342-009-0264-8; Mukhortova L. V., 2012, Folia Forestalia Polonica. Series A, Forestry, V54, P71; Naesset E, 1999, CAN J FOREST RES, V29, P372, DOI 10.1139/cjfr-29-3-372; Noh NJ, 2017, FORESTS, V8, DOI 10.3390/f8060214; OLSON JS, 1963, ECOLOGY, V44, P322, DOI 10.2307/1932179; Palosuo T, 2005, ECOL MODEL, V189, P183, DOI 10.1016/j.ecolmodel.2005.03.006; Pietikainen J, 2005, FEMS MICROBIOL ECOL, V52, P49, DOI 10.1016/j.femsec.2004.10.002; ROSE AK, 2000, THESIS U TENNESSEE K; Russell MB, 2014, ECOSYSTEMS, V17, P765, DOI 10.1007/s10021-014-9757-5; SeigleMurandi F, 1996, APPL ENVIRON MICROB, V62, P2477, DOI 10.1128/AEM.62.7.2477-2481.1996; Shorohova E, 2016, EUR J FOREST RES, V135, P593, DOI 10.1007/s10342-016-0957-8; Singh A. P., 1991, Journal of the Institute of Wood Science, V12, P143; Singh AP, 2019, IAWA J, V40, P845, DOI 10.1163/22941932-40190250; SOLLINS P, 1982, CAN J FOREST RES, V12, P18, DOI 10.1139/x82-003; SPONSLER RC, 1990, ENVIRON ENTOMOL, V19, P15, DOI 10.1093/ee/19.1.15; SU NY, 1984, ANN ENTOMOL SOC AM, V77, P125, DOI 10.1093/aesa/77.2.125; Tarasov M.E., 2001, ECOL B, V49, P137, DOI DOI 10.2307/20113271; Thorne BL, 1999, ETHOL ECOL EVOL, V11, P149, DOI 10.1080/08927014.1999.9522833; Thornton P., 2016, DAYMET DAILY SURFACE; Thybring EE, 2018, IFOREST, V11, P418, DOI 10.3832/ifor2406-011; Tobin B, 2007, FORESTRY, V80, P455, DOI 10.1093/forestry/cpm024; UHL C, 1990, ECOLOGY, V71, P437, DOI 10.2307/1940299; Ulyshen MD, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1910; Ulyshen MD, 2016, BIOL REV, V91, P70, DOI 10.1111/brv.12158; Ulyshen MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101867; Valaskova V, 2009, ISME J, V3, P1218, DOI 10.1038/ismej.2009.64; WIEDER RK, 1982, ECOLOGY, V63, P1636, DOI 10.2307/1940104; Wiltz BA, 2012, SOCIOBIOLOGY, V59, P381; Wu Jia-bing, 2005, Journal of Forestry Research (Harbin), V16, P247, DOI 10.1007/BF02856826; Yang FF, 2010, FOREST ECOL MANAG, V259, P1666, DOI 10.1016/j.foreco.2010.01.046; Yatskov M, 2003, CAN J FOREST RES, V33, P1211, DOI [10.1139/x03-033, 10.1139/X03-033]; Yin XW, 1999, OECOLOGIA, V121, P81, DOI 10.1007/s004420050909; Yuan J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175203; Zell J, 2009, ECOL MODEL, V220, P904, DOI 10.1016/j.ecolmodel.2009.01.020; Zhang DQ, 2008, J PLANT ECOL, V1, P85, DOI 10.1093/jpe/rtn002; Zhang HB, 2008, INT BIODETER BIODEGR, V62, P471, DOI 10.1016/j.ibiod.2008.06.001	108	1	1	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251893	10.1371/journal.pone.0251893	http://dx.doi.org/10.1371/journal.pone.0251893			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086700	Green Published, Green Submitted, gold			2022-12-26	WOS:000664640100026
J	Shahvaroughi-Farahani, A; Linkenauger, SA; Mohler, BJ; Behrens, SC; Giel, KE; Karnath, HO				Shahvaroughi-Farahani, Azam; Linkenauger, Sally A.; Mohler, Betty J.; Behrens, Simone C.; Giel, Katrin E.; Karnath, Hans-Otto			Body size perception in stroke patients with paresis	PLOS ONE			English	Article							NEGLECT; REPRESENTATION; SPACE; DISTORTIONS; ANOSOGNOSIA; HANDEDNESS; DISTANCE; LENGTH; IMAGE	Recent studies have suggested that people's intent and ability to act also can influence their perception of their bodies' peripersonal space. Vice versa one could assume that the inability to reach toward and grasp an object might have an impact on the subject's perception of reaching distance. Here we tested this prediction by investigating body size and action capability perception of neurological patients suffering from arm paresis after stroke, comparing 32 right-brain-damaged patients (13 with left-sided arm paresis without additional spatial neglect, 10 with left-sided arm paresis and additional spatial neglect, 9 patients had neither arm paresis nor neglect) and 27 healthy controls. Nineteen of the group of right hemisphere stroke patients could be re-examined about five months after initial injury. Arm length was estimated in three different methodological approaches: explicit visual, explicit tactile/proprioceptive, and implicit reaching. Results fulfilled the working hypothesis. Patients with an arm paresis indeed perceived their bodies differently. We found a transient overestimation of the length of the contralesional, paretic arm after stroke. Body size and action capability perception for the extremities thus indeed seem to be tightly linked in humans.	[Shahvaroughi-Farahani, Azam; Karnath, Hans-Otto] Univ Tubingen, Div Neuropsychol, Ctr Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Linkenauger, Sally A.] Univ Lancaster, Dept Psychol, Lancaster, England; [Mohler, Betty J.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Behrens, Simone C.; Giel, Katrin E.] Univ Tubingen, Dept Psychosomat Med & Psychotherapy, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Lancaster University; Max Planck Society; Eberhard Karls University of Tubingen	Karnath, HO (corresponding author), Univ Tubingen, Div Neuropsychol, Ctr Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany.	karnath@uni-tuebingen.de		Linkenauger, Sally/0000-0002-6056-0187	Deutsche Forschungsgemeinschaft [KA 1258/231]; Centre for Integrative Neuroscience Tubingen (Pool-Projekt) through the German Excellence Initiative [2014-03, EXC307]; University of Tubingen	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Centre for Integrative Neuroscience Tubingen (Pool-Projekt) through the German Excellence Initiative; University of Tubingen	This work was supported by the Deutsche Forschungsgemeinschaft (KA 1258/231), by the Centre for Integrative Neuroscience Tubingen (Pool-Projekt-2014-03) through the German Excellence Initiative (EXC307), and the Open Access Publishing Fund of University of Tubingen.	Baas U, 2011, NEUROPSYCHOLOGIA, V49, P898, DOI 10.1016/j.neuropsychologia.2011.01.043; Baier B, 2005, J NEUROL NEUROSUR PS, V76, P358, DOI 10.1136/jnnp.2004.036731; Berti A, 2000, J COGNITIVE NEUROSCI, V12, P415, DOI 10.1162/089892900562237; BISIACH E, 1986, NEUROPSYCHOLOGIA, V24, P471, DOI 10.1016/0028-3932(86)90092-8; Coslett HB, 1998, BRAIN COGNITION, V37, P527, DOI 10.1006/brcg.1998.1011; Costantini M, 2014, EXP BRAIN RES, V232, P3233, DOI 10.1007/s00221-014-4012-z; Critchley M., 1953, PARIETAL LOBES; Di Vita A, 2017, APPL NEUROPSYCH-ADUL, V24, P308, DOI 10.1080/23279095.2016.1174866; Ehrsson HH, 2005, PLOS BIOL, V3, P2200, DOI 10.1371/journal.pbio.0030412; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fuentes CT, 2013, J NEUROL NEUROSUR PS, V84, P201, DOI 10.1136/jnnp-2012-304001; GAUTHIER L, 1989, INT J CLIN NEUROPSYC, V11, P49; Gibson JJ, 1950, PERCEPTION VISUAL WO; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Johannsen L, 2004, J CLIN EXP NEUROPSYC, V26, P251, DOI 10.1076/jcen.26.2.251.28085; Linkenauger SA, 2015, J EXP PSYCHOL GEN, V144, P103, DOI 10.1037/xge0000028; Linkenauger SA, 2009, J EXP PSYCHOL HUMAN, V35, P1649, DOI 10.1037/a0016875; Linkenauger SA, 2009, PSYCHOL SCI, V20, P1373, DOI 10.1111/j.1467-9280.2009.02447.x; Moseley GL, 2005, NEUROLOGY, V65, P773, DOI 10.1212/01.wnl.0000174515.07205.11; Nuara A, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00354; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palermo L, 2014, NEUROPSYCHOLOGY, V28, P772, DOI 10.1037/neu0000086; Pegna AJ, 2001, ANN NEUROL, V50, P820, DOI 10.1002/ana.10058; Peltz E, 2011, J PAIN, V12, P1095, DOI 10.1016/j.jpain.2011.05.001; Ramachandran VS, 1998, BRAIN, V121, P1603, DOI 10.1093/brain/121.9.1603; Romano D, 2019, EXP BRAIN RES, V237, P493, DOI 10.1007/s00221-018-5405-1; Rorden C, 2010, NEUROPSYCHOLOGIA, V48, P2758, DOI 10.1016/j.neuropsychologia.2010.04.018; Sadibolova R, 2019, CORTEX, V111, P74, DOI 10.1016/j.cortex.2018.10.016; Sposito A, 2012, NEUROPSYCHOLOGIA, V50, P2187, DOI 10.1016/j.neuropsychologia.2012.05.022; Tosi G, 2018, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00617; Umeki N, 2018, INT J GERONTOL, V12, P310, DOI 10.1016/j.ijge.2018.03.002; Weintraub S., 1985, PRINCIPLES BEHAV NEU, P71; Witt JK, 2010, PERCEPTION, V39, P1341, DOI 10.1068/p6699; Witt JK, 2008, J EXP PSYCHOL HUMAN, V34, P1479, DOI 10.1037/a0010781; Witt JK, 2005, PSYCHOL SCI, V16, P937, DOI 10.1111/j.1467-9280.2005.01640.x; Witt JK, 2005, J EXP PSYCHOL HUMAN, V31, P880, DOI 10.1037/0096-1523.31.5.880	36	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252596	10.1371/journal.pone.0252596	http://dx.doi.org/10.1371/journal.pone.0252596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086777	gold, Green Published			2022-12-26	WOS:000664640100093
J	Garcia-Gonzalez, L; Paumier, JM; Louis, L; Pilat, D; Bernard, A; Stephan, D; Jullien, N; Checler, F; Nivet, E; Khrestchatisky, M; Baranger, K; Rivera, S				Garcia-Gonzalez, Laura; Paumier, Jean-Michel; Louis, Laurence; Pilat, Dominika; Bernard, Anne; Stephan, Delphine; Jullien, Nicolas; Checler, Frederic; Nivet, Emmanuel; Khrestchatisky, Michel; Baranger, Kevin; Rivera, Santiago			MT5-MMP controls APP and beta-CTF/C99 metabolism through proteolytic-dependent and -independent mechanisms relevant for Alzheimer's disease	FASEB JOURNAL			English	Article						amyloid beta precursor protein; endosome; metalloproteinase; proteasome; secretase	AMYLOID PRECURSOR PROTEIN; C-TERMINAL FRAGMENT; MATRIX-METALLOPROTEINASE; BETA-PROTEIN; A-BETA; MEMBRANE; IDENTIFICATION; C99; INHIBITORS; BRAIN	We previously discovered the implication of membrane-type 5-matrix metalloproteinase (MT5-MMP) in Alzheimer's disease (AD) pathogenesis. Here, we shed new light on pathogenic mechanisms by which MT5-MMP controls the processing of amyloid precursor protein (APP) and the fate of amyloid beta peptide (A beta) as well as its precursor C99, and C83. We found in human embryonic kidney cells (HEK) carrying the APP Swedish familial mutation (HEKswe) that deleting the C-terminal non-catalytic domains of MT5-MMP hampered its ability to process APP and release the soluble 95 kDa form (sAPP95). Catalytically inactive MT5-MMP variants increased the levels of A beta and promoted APP/C99 sorting in the endolysosomal system, likely through interactions of the proteinase C-terminal portion with C99. Most interestingly, the deletion of the C-terminal domain of MT5-MMP caused a strong degradation of C99 by the proteasome and prevented A beta accumulation. These discoveries reveal new control of MT5-MMP over APP by proteolytic and non-proteolytic mechanisms driven by the C-terminal domains of the proteinase. The targeting of these non-catalytic domains of MT5-MMP could, therefore, provide new insights into the therapeutic regulation of APP-related pathology in AD.	[Garcia-Gonzalez, Laura; Paumier, Jean-Michel; Louis, Laurence; Pilat, Dominika; Bernard, Anne; Stephan, Delphine; Jullien, Nicolas; Nivet, Emmanuel; Khrestchatisky, Michel; Baranger, Kevin; Rivera, Santiago] Aix Marseille Univ, Inst Neurophysiopathol, INP, CNRS, Marseille, France; [Checler, Frederic] CNRS UCA, IPMC, UMR 7275, Labex DistAlz, Valbonne, France; [Paumier, Jean-Michel] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur; Northwestern University; Feinberg School of Medicine	Baranger, K; Rivera, S (corresponding author), Aix Marseille Univ, Inst Neuropathophysiol INP, UMR 7051, CNRS, Campus Timone,27 Bld Jean Moulin, F-13005 Marseille, France.	kevin.baranger@univ-amu.fr; santiago.rivera@univ-amu.fr	Jullien, Nicolas/O-1947-2015; Checler, Frederic/C-1241-2009	Jullien, Nicolas/0000-0001-8273-2106; Pilat, Dominika/0000-0001-8533-3514; /0000-0001-8875-1877; Checler, Frederic/0000-0003-2098-1750	CNRS; Aix-Marseille Universite; French National Research Agency (ANR); CoEN; Fondation Plan Alzheimer; France Alzheimer; Vaincre l'Alzheimer; Fonds Europeens de Developpement Regional; La fondation NRJ-Institut de France; Fondation pour la Recherche Medicale [FDT201904008423, FDT202001011017]; Conseil General des Alpes Maritimes; LABEX DISTALZ; A*Midex foundation [ANR-17-EURE-0029]; French National Research Agency	CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; French National Research Agency (ANR)(French National Research Agency (ANR)); CoEN; Fondation Plan Alzheimer; France Alzheimer; Vaincre l'Alzheimer; Fonds Europeens de Developpement Regional(European Commission); La fondation NRJ-Institut de France(Fondation de France); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); LABEX DISTALZ; A*Midex foundation(French National Research Agency (ANR)); French National Research Agency(French National Research Agency (ANR))	CNRS; Aix--Marseille Universite; French National Research Agency (ANR); CoEN; Fondation Plan Alzheimer; France Alzheimer; Vaincre l'Alzheimer; Fonds Europeens de Developpement Regional; La fondation NRJ--Institut de France; Fondation pour la Recherche Medicale, Grant/Award Number: FDT201904008423 and FDT202001011017; Conseil General des Alpes Maritimes; LABEX DISTALZ; A*Midex foundation, Grant/Award Number: ANR--17--EURE--0029; French National Research Agency	Ahmad M, 2006, J BIOCHEM, V139, P517, DOI 10.1093/jb/mvj054; Baranger K, 2017, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00163; Baranger K, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0633-4; Baranger K, 2016, CELL MOL LIFE SCI, V73, P217, DOI 10.1007/s00018-015-1992-1; Baranger K, 2014, PROG BRAIN RES, V214, P313, DOI 10.1016/B978-0-444-63486-3.00014-1; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bourgeois A, 2018, NEUROBIOL AGING, V71, P21, DOI 10.1016/j.neurobiolaging.2018.06.038; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Bylander JE, 2007, BIOL CHEM, V388, P1163, DOI 10.1515/BC.2007.156; Caster AH, 2013, J BIOL CHEM, V288, P28567, DOI 10.1074/jbc.M113.481101; Chen AC, 2015, J CELL BIOL, V211, P1157, DOI 10.1083/jcb.201502001; Dive V, 2005, INT J CANCER, V113, P775, DOI 10.1002/ijc.20459; Esler WP, 2002, P NATL ACAD SCI USA, V99, P2720, DOI 10.1073/pnas.052436599; Evrard C, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00435; Flammang B, 2012, J ALZHEIMERS DIS, V30, P145, DOI 10.3233/JAD-2012-112186; Garcia-Gonzalez L, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00244; Gilda JE, 2013, ANAL BIOCHEM, V440, P186, DOI 10.1016/j.ab.2013.05.027; Gueye Y, 2011, GLIA, V59, P750, DOI 10.1002/glia.21146; HAASS C, 1995, NAT MED, V1, P1291, DOI 10.1038/nm1295-1291; Higashi S, 2003, J BIOL CHEM, V278, P14020, DOI 10.1074/jbc.M212264200; Jaworski DM, 2000, BRAIN RES, V860, P174, DOI 10.1016/S0006-8993(00)02035-7; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Jefferson T, 2011, J BIOL CHEM, V286, P27741, DOI 10.1074/jbc.M111.252718; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Jobin PG, 2017, BBA-MOL CELL RES, V1864, P2043, DOI 10.1016/j.bbamcr.2017.05.013; Kwart D, 2019, NEURON, V104, P256, DOI 10.1016/j.neuron.2019.07.010; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lauritzen L, 2019, CURR ALZHEIMER RES, V16, P453, DOI 10.2174/1567205016666190325092841; Letronne F, 2016, EBIOMEDICINE, V9, P278, DOI 10.1016/j.ebiom.2016.06.002; Llano E, 1999, CANCER RES, V59, P2570; Marchant DJ, 2014, NAT MED, V20, P497, DOI 10.1038/nm.3508; Muller UC, 2017, NAT REV NEUROSCI, V18, P281, DOI 10.1038/nrn.2017.29; NEVE RL, 1992, P NATL ACAD SCI USA, V89, P3448, DOI 10.1073/pnas.89.8.3448; Nunan J, 2001, EUR J BIOCHEM, V268, P5329, DOI 10.1046/j.0014-2956.2001.02465.x; Ould-Yahoui A, 2013, CELL TRANSPLANT, V22, P993, DOI 10.3727/096368912X657468; Paumier JM, 2019, FASEB J, V33, P2910, DOI 10.1096/fj.201801076R; Pei DQ, 1999, J BIOL CHEM, V274, P8925, DOI 10.1074/jbc.274.13.8925; Pera M, 2017, EMBO J, V36, P3356, DOI 10.15252/embj.201796797; Perez RG, 1996, J BIOL CHEM, V271, P9100, DOI 10.1074/jbc.271.15.9100; Pulina MV, 2020, ALZHEIMERS DEMENT, V16, P273, DOI 10.1016/j.jalz.2019.09.002; Py NA, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00247, 10.3389/fnagi.2014.00247]; Rice HC, 2019, SCIENCE, V363, P143, DOI 10.1126/science.aao4827; Rivera S, 2019, CELL MOL LIFE SCI, V76, P3167, DOI 10.1007/s00018-019-03178-2; Rivera S, 2010, J NEUROSCI, V30, P15337, DOI 10.1523/JNEUROSCI.3467-10.2010; Sakamoto T, 2009, GENES CELLS, V14, P617, DOI 10.1111/j.1365-2443.2009.01293.x; Sander H, 2019, ANAL BIOCHEM, V575, P44, DOI 10.1016/j.ab.2019.03.010; Sato H, 1996, FEBS LETT, V385, P238, DOI 10.1016/0014-5793(96)00389-4; Sbai O, 2010, GLIA, V58, P344, DOI 10.1002/glia.20927; Sekine-Aizawa Y, 2001, EUR J NEUROSCI, V13, P935, DOI 10.1046/j.0953-816x.2001.01462.x; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Tan JZA, 2019, J BIOL CHEM, V294, P1618, DOI 10.1074/jbc.RA118.005222; Wang P, 2004, J BIOL CHEM, V279, P20461, DOI 10.1074/jbc.M400264200; Wang X, 2001, J BIOL CHEM, V276, P35953, DOI 10.1074/jbc.M103680200; Willem M, 2015, NATURE, V526, P443, DOI 10.1038/nature14864; Zipfel P, 2020, J MED CHEM, V63, P10705, DOI 10.1021/acs.jmedchem.0c00352	57	3	4	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21727	10.1096/fj.202100593R	http://dx.doi.org/10.1096/fj.202100593R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34117802	Green Submitted, Green Published			2022-12-26	WOS:000667814100065
J	Su, ZY; Li, YJ; Lv, H; Cui, XY; Liu, M; Wang, ZY; Zhang, Y; Zhen, JH; Tang, W; Wang, XJ; Yi, F				Su, Zeyu; Li, Yujia; Lv, Hang; Cui, Xiaoyang; Liu, Min; Wang, Ziying; Zhang, Yan; Zhen, Junhui; Tang, Wei; Wang, Xiaojie; Yi, Fan			CLEC14A protects against podocyte injury in mice with adriamycin nephropathy	FASEB JOURNAL			English	Article						C-type lectin receptors; EGR1 signaling; focal segmental glomerular sclerosis; HMGB1; podocyte	HMGB1; RECEPTOR; ACTIVATION; EXPRESSION; ANGIOGENESIS; PATHOGENESIS; INFLAMMATION; PROGRANULIN; TARGET; CELLS	Podocyte injury is a major determinant of focal segmental glomerular sclerosis (FSGS) and the identification of potential therapeutic targets for preventing podocyte injury has clinical importance for the treatment of FSGS. CLEC14A is a single-pass transmembrane glycoprotein belonging to the vascular expressed C-type lectin family. CLEC14A is found to be expressed in vascular endothelial cells during embryogenesis and is also implicated in tumor angiogenesis. However, the current understanding of the biological functions of CLEC14A in podocyte is very limited. In this study, we found that CLEC14A was expressed in podocyte and protected against podocyte injury in mice with Adriamycin (ADR)-induced FSGS. First, we observed that CLEC14A was downregulated in mice with ADR nephropathy and renal biopsies from individuals with FSGS and other forms of podocytopathies. Moreover, CLEC14A deficiency exacerbated podocyte injury and proteinuria in mice with ADR nephropathy accompanied by enhanced inflammatory cell infiltration and inflammatory responses. In vitro, overexpression of CLEC14A in podocyte had pleiotropic protective actions, including anti-inflammatory and anti-apoptosis effects. Mechanistically, CLEC14A inhibited high-mobility group box 1 protein (HMGB1) release, at least in part by directly binding HMGB1, and suppressed HMGB1-mediated signaling, including NF-kappa B signaling and early growth response protein 1 (EGR1) signaling. Taken together, our findings provide new insights into the pivotal role of CLEC14A in maintaining podocyte function, indicating that CLEC14A may be an innovative therapeutic target in FSGS.	[Su, Zeyu; Li, Yujia; Lv, Hang; Cui, Xiaoyang; Liu, Min; Wang, Ziying; Zhang, Yan; Tang, Wei; Wang, Xiaojie; Yi, Fan] Shandong Univ, Sch Basic Med Sci, Dept Pharmacol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China; [Zhen, Junhui] Shandong Univ, Sch Basic Med Sci, Dept Pathol, Jinan, Peoples R China	Shandong University; Shandong University	Wang, XJ; Yi, F (corresponding author), Shandong Univ, Sch Basic Med Sci, Dept Pharmacol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	wangxiaojie@sdu.edu.cn; fanyi@sdu.edu.cn	Tang, Wei/A-6254-2016	Tang, Wei/0000-0002-4573-3502	National Nature Science Foundation of China [82090024, 91949202, 81800645, 81873614, 81770726]; Shandong Provincial Natural Science Foundation, China [ZR2019ZD40, ZR2019MH041]; Key Technology Research and Development Program of Shandong, China [2017GSF218095]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Natural Science Foundation, China(Natural Science Foundation of Shandong Province); Key Technology Research and Development Program of Shandong, China	This study was supported by the National Nature Science Foundation of China (82090024 to FY, 91949202 to FY, 81800645 to ML, 81873614 to ZW, 81770726 to YZ); Shandong Provincial Natural Science Foundation, China (ZR2019ZD40 to FY, ZR2019MH041 to ZW); the Key Technology Research and Development Program of Shandong, China (2017GSF218095 to YZ).	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Brown GD, 2018, NAT REV IMMUNOL, V18, P374, DOI 10.1038/s41577-018-0004-8; Chen QJ, 2016, ACTA PHARM SIN B, V6, P183, DOI 10.1016/j.apsb.2016.02.004; Chen XC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26637-5; Dumitriu IE, 2005, EUR J IMMUNOL, V35, P2184, DOI 10.1002/eji.200526066; Feng D, 2018, AM J PHYSIOL-RENAL, V314, pF921, DOI 10.1152/ajprenal.00641.2017; Fu Y, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.019; Fu Y, 2017, HYPERTENSION, V69, P259, DOI 10.1161/HYPERTENSIONAHA.116.08154; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; Hayashi Y, 2018, BIOCHEM BIOPH RES CO, V495, P634, DOI 10.1016/j.bbrc.2017.11.079; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Inoue K, 2019, J CLIN INVEST, V129, P1295, DOI 10.1172/JCI124030; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Jang J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11118-y; Jefferson JA, 2014, ADV CHRONIC KIDNEY D, V21, P408, DOI 10.1053/j.ackd.2014.05.009; Jin J, 2019, J DIABETES, V11, P826, DOI 10.1111/1753-0407.12914; Khan KA, 2019, FEBS J, V286, P3299, DOI 10.1111/febs.14985; Kim Y, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-1727-6; Lee S, 2017, J CLIN INVEST, V127, P457, DOI 10.1172/JCI85145; Leemans JC, 2014, NAT REV NEPHROL, V10, P398, DOI 10.1038/nrneph.2014.91; Lim BJ, 2016, J PATHOL TRANSL MED, V50, P405, DOI 10.4132/jptm.2016.09.21; Liu M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00498-4; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu B, 2014, P NATL ACAD SCI USA, V111, P3068, DOI 10.1073/pnas.1316925111; Lv B, 2009, THROMB HAEMOSTASIS, V102, P352, DOI 10.1160/TH08-11-0759; Mallipattu SK, 2015, J CLIN INVEST, V125, P1347, DOI 10.1172/JCI77084; Noy PJ, 2015, ONCOGENE, V34, P5821, DOI 10.1038/onc.2015.34; Okabe M, 2019, AM J PHYSIOL-RENAL, V316, pF241, DOI 10.1152/ajprenal.00115.2018; Park JS, 2006, AM J PHYSIOL-CELL PH, V290, pC917, DOI 10.1152/ajpcell.00401.2005; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Priya SK, 2017, INT J CLIN ONCOL, V22, P107, DOI 10.1007/s10147-016-1033-6; Pulskens WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085775; Shang J, 2015, FREE RADICAL BIO MED, V79, P217, DOI 10.1016/j.freeradbiomed.2014.12.013; SUKHATME VP, 1992, KIDNEY INT, V41, P550, DOI 10.1038/ki.1992.79; Tan RJ, 2015, J AM SOC NEPHROL, V26, P2447, DOI 10.1681/ASN.2014060613; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Wang XJ, 2014, KIDNEY INT, V86, P712, DOI 10.1038/ki.2014.111; Wei C, 2008, NAT MED, V14, P55, DOI 10.1038/nm1696; Wei CL, 2011, NAT MED, V17, P952, DOI 10.1038/nm.2411; Wen YM, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00098; Wu C, 2019, EXP CLIN ENDOCR DIAB, V127, P630, DOI 10.1055/s-0044-101601; Yamada K, 2001, KIDNEY INT, V59, P137, DOI 10.1046/j.1523-1755.2001.00474.x; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Yu RC, 2016, KIDNEY BLOOD PRESS R, V41, P55, DOI 10.1159/000368547; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102	46	3	3	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21711	10.1096/fj.202100283R	http://dx.doi.org/10.1096/fj.202100283R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34107098				2022-12-26	WOS:000667814100040
J	Zindel, D; Mensat, P; Vol, C; Homayed, Z; Charrier-Savournin, F; Trinquet, E; Baneres, JL; Pin, JP; Pannequin, J; Roux, T; Dupuis, E; Prezeau, L				Zindel, Diana; Mensat, Patrick; Vol, Claire; Homayed, Zeinab; Charrier-Savournin, Fabienne; Trinquet, Eric; Baneres, Jean-Louis; Pin, Jean-Philippe; Pannequin, Julie; Roux, Thomas; Dupuis, Elodie; Prezeau, Laurent			G protein-coupled receptors can control the Hippo/YAP pathway through Gq signaling	FASEB JOURNAL			English	Article						cellular signaling; constitutive activity; inverse agonist; Ghrelin receptor; Hippo pathway	PROMOTES CELL-PROLIFERATION; GHRELIN RECEPTOR; YAP PATHWAY; INVERSE AGONISM; UVEAL MELANOMA; TAZ; YAP/TAZ; GROWTH; CANCER; ACTIVATION	The Hippo pathway is an evolutionarily conserved kinase cascade involved in the control of tissue homeostasis, cellular differentiation, proliferation, and organ size, and is regulated by cell-cell contact, apical cell polarity, and mechanical signals. Miss-regulation of this pathway can lead to cancer. The Hippo pathway acts through the inhibition of the transcriptional coactivators YAP and TAZ through phosphorylation. Among the various signaling mechanisms controlling the hippo pathway, activation of G12/13 by G protein-coupled receptors (GPCR) recently emerged. Here we show that a GPCR, the ghrelin receptor, that activates several types of G proteins, including G12/13, Gi/o, and Gq, can activate YAP through Gq/11 exclusively, independently of G12/13. We revealed that a strong basal YAP activation results from the high constitutive activity of this receptor, which can be further increased upon agonist activation. Thus, acting on ghrelin receptor allowed to modulate up-and-down YAP activity, as activating the receptor increased YAP activity and blocking constitutive activity reduced YAP activity. Our results demonstrate that GPCRs can be used as molecular switches to finely up- or down-regulate YAP activity through a pure Gq pathway.	[Zindel, Diana; Vol, Claire; Homayed, Zeinab; Pin, Jean-Philippe; Pannequin, Julie; Prezeau, Laurent] Univ Montpellier, Inst Genom Fonct IGF, INSERM, CNRS, 141 Rue Cardonille, F-34094 Montpellier 5, France; [Mensat, Patrick; Charrier-Savournin, Fabienne; Trinquet, Eric; Roux, Thomas; Dupuis, Elodie] Perkin Elmer Cisbio, Codolet, France; [Baneres, Jean-Louis] Univ Montpellier, Inst Biomol Max Mousseron, CNRS, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Ecole nationale superieure de chimie de Montpellier; Universite de Montpellier	Prezeau, L (corresponding author), Univ Montpellier, Inst Genom Fonct IGF, INSERM, CNRS, 141 Rue Cardonille, F-34094 Montpellier 5, France.	laurent.prezeau@igf.cnrs.fr		homayed, Zeinab/0000-0003-4361-3969; Baneres, jean-louis/0000-0001-7078-1285	Labex EpiGenMed, an << Investissements d'avenir >> program of the French government [ANR-10-LABX-12-01]; Fondation Recherche Medicale [FRM DEQ20170336747]; EIDOS Collaborative team IGF-Cisbio (Codolet, France); Region Occitanie (France)	Labex EpiGenMed, an << Investissements d'avenir >> program of the French government(French National Research Agency (ANR)); Fondation Recherche Medicale; EIDOS Collaborative team IGF-Cisbio (Codolet, France); Region Occitanie (France)	This work was supported by the Labex EpiGenMed, an << Investissements d'avenir >> program of the French government (reference ANR-10-LABX-12-01) to JPP, the Fondation Recherche Medicale (FRM DEQ20170336747) to JPP, and by the EIDOS Collaborative team IGF-Cisbio (Codolet, France). DZ was supported by a Grant from the Region Occitanie (France)	Ango F, 1999, NEUROPHARMACOLOGY, V38, P793, DOI 10.1016/S0028-3908(99)00005-2; Bartucci M, 2015, ONCOGENE, V34, P681, DOI 10.1038/onc.2014.5; Brule C, 2014, FASEB J, V28, P5148, DOI 10.1096/fj.14-249771; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; Currow D, 2017, ANN ONCOL, V28, P1949, DOI 10.1093/annonc/mdx192; Damian M, 2015, P NATL ACAD SCI USA, V112, P1601, DOI 10.1073/pnas.1414618112; Damian M, 2012, J BIOL CHEM, V287, P3630, DOI 10.1074/jbc.M111.288324; Davenport AP, 2005, PHARMACOL REV, V57, P541, DOI 10.1124/pr.57.4.1; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Els S, 2012, J MED CHEM, V55, P7437, DOI 10.1021/jm300414b; Feng XD, 2019, CANCER CELL, V35, P457, DOI 10.1016/j.ccell.2019.01.009; Feng XD, 2014, CANCER CELL, V25, P831, DOI 10.1016/j.ccr.2014.04.016; Feng X, 2016, J BIOL CHEM, V291, P18947, DOI 10.1074/jbc.M116.739722; Finch-Edmondson ML, 2015, J BIOL CHEM, V290, P27928, DOI 10.1074/jbc.M115.692285; Gong R, 2015, CELL RES, V25, P985, DOI 10.1038/cr.2015.88; Hansen CG, 2015, TRENDS CELL BIOL, V25, P499, DOI 10.1016/j.tcb.2015.05.002; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hayakawa Y, 2017, CANCER CELL, V31, P21, DOI 10.1016/j.ccell.2016.11.005; Hiemer SE, 2014, J BIOL CHEM, V289, P13461, DOI 10.1074/jbc.M113.529115; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hot B, 2017, CELL SIGNAL, V32, P93, DOI 10.1016/j.cellsig.2017.01.023; Iglesias-Bartolome R, 2015, NAT CELL BIOL, V17, P793, DOI 10.1038/ncb3164; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kim SW, 2005, BONE, V37, P359, DOI 10.1016/j.bone.2005.04.020; Koo JH, 2018, CELL METAB, V28, P196, DOI 10.1016/j.cmet.2018.07.010; Lee JH, 2014, FEBS LETT, V588, P4708, DOI 10.1016/j.febslet.2014.10.044; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Li Z, 2010, GENE DEV, V24, P235, DOI 10.1101/gad.1865810; Lin TC, 2015, J PATHOL, V237, P50, DOI 10.1002/path.4552; Liu HR, 2018, ONCOL REP, V40, P16, DOI 10.3892/or.2018.6423; Luo JQ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050426; M'Kadmi C, 2019, J MED CHEM, V62, P965, DOI 10.1021/acs.jmedchem.8b01644; M'Kadmi C, 2015, J BIOL CHEM, V290, P27021, DOI 10.1074/jbc.M115.659250; Miller E, 2012, CHEM BIOL, V19, P955, DOI 10.1016/j.chembiol.2012.07.005; Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111; Mo JS, 2017, BMB REP, V50, P71, DOI 10.5483/BMBRep.2017.50.2.199; Mo JS, 2014, EMBO REP, V15, P642, DOI 10.15252/embr.201438638; Mo JS, 2012, GENE DEV, V26, P2138, DOI 10.1101/gad.197582.112; Moulin A, 2008, J MED CHEM, V51, P689, DOI 10.1021/jm701292s; Nallet-Staub F, 2014, J INVEST DERMATOL, V134, P123, DOI 10.1038/jid.2013.319; Northrup R, 2013, SUPPORT CARE CANCER, V21, P2409, DOI 10.1007/s00520-013-1800-0; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Schrage R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10156; Soleyman-Jahi S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01014; Spiering D, 2011, CELL ADHES MIGR, V5, P170, DOI 10.4161/cam.5.2.14403; Totaro A, 2018, NAT CELL BIOL, V20, P888, DOI 10.1038/s41556-018-0142-z; Van Raamsdonk CD, 2010, NEW ENGL J MED, V363, P2191, DOI 10.1056/NEJMoa1000584; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Wang J, 2016, J BIOL CHEM, V291, P17988, DOI 10.1074/jbc.M115.711275; Wang LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065539; Wang Q, 2018, CELL PHYSIOL BIOCHEM, V50, P1698, DOI 10.1159/000494789; Waseem T, 2008, PEPTIDES, V29, P1369, DOI 10.1016/j.peptides.2008.03.020; Xia Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109575; Yang CC, 2015, P NATL ACAD SCI USA, V112, P1785, DOI 10.1073/pnas.1420850112; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou X, 2015, J CLIN INVEST, V125, P2123, DOI 10.1172/JCI79573; Zhu HY, 2015, INT J BIOL SCI, V11, P1181, DOI 10.7150/ijbs.12500; Zindel D, 2019, METHODS MOL BIOL, V1893, P153, DOI 10.1007/978-1-4939-8910-2_13	66	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21668	10.1096/fj.202002159R	http://dx.doi.org/10.1096/fj.202002159R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34114695	Green Submitted			2022-12-26	WOS:000667814100014
J	Liu, X; Li, LY; Si, FS; Huang, L; Zhao, YJ; Zhang, CC; Hoft, DF; Peng, GY				Liu, Xia; Li, Lingyun; Si, Fusheng; Huang, Lan; Zhao, Yangjing; Zhang, Chenchen; Hoft, Daniel F.; Peng, Guangyong			NK and NKT cells have distinct properties and functions in cancer	ONCOGENE			English	Article							KILLER T-CELLS; BREAST-CANCER; TUMOR MICROENVIRONMENT; ANTITUMOR-ACTIVITY; SELF-TOLERANCE; ACTIVATION; EXPRESSION; EXHAUSTION; IMMUNITY; DYSFUNCTION	Natural killer (NK) and natural killer T (NKT) cells are two important cell subsets of the innate immune system. NK and NKT cells share many phenotypes and functions for anti-tumor immunity; however, the dynamic changes in phenotypes and functional interactions within the tumor microenvironment during tumor development and progression are unknown. Here we report that NK and NKT cells have distinct properties, metabolic profiles, and functions during tumor development. Using the mouse E0771 breast cancer and B16 melanoma models, we found that both NK and NKT cells are dynamically involved in the immune responses to cancer but have distinct distributions and phenotypic profiles in tumor sites and other peripheral organs during the course of tumor development and progression. In the early stages of tumor development, both NK and NKT cells exhibit effector properties. In the later cancer stages, NK and NKT cells have impaired cytotoxic capacities and dysfunctional states. NK cells become senescent cells, while NKT cells, other than invariant NKT (iNKT) cells, are exhausted in the advanced cancers. In contrast, iNKT cells develop increases in activation and effector function within the breast tumor microenvironment. In addition, senescent NK cells have heightened glucose and lipid metabolism, but exhausted NKT cells display unbalanced metabolism in tumor microenvironments of both breast cancer and melanoma tumor models. These studies provide a better understanding of the dynamic and distinct functional roles of NK and NKT cells in anti-tumor immunity, which may facilitate the development of novel immunotherapies targeting NK and NKT cells for cancer treatment.	[Liu, Xia; Li, Lingyun; Si, Fusheng; Huang, Lan; Zhao, Yangjing; Zhang, Chenchen; Hoft, Daniel F.; Peng, Guangyong] St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, St Louis, MO 63104 USA; [Liu, Xia; Li, Lingyun; Si, Fusheng; Huang, Lan; Zhao, Yangjing; Zhang, Chenchen; Hoft, Daniel F.; Peng, Guangyong] St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA; [Hoft, Daniel F.; Peng, Guangyong] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA	Saint Louis University; Saint Louis University; Saint Louis University	Peng, GY (corresponding author), St Louis Univ, Sch Med, Div Infect Dis Allergy & Immunol, St Louis, MO 63104 USA.; Peng, GY (corresponding author), St Louis Univ, Sch Med, Dept Internal Med, St Louis, MO 63104 USA.; Peng, GY (corresponding author), St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO 63104 USA.	guangyong.peng@health.slu.edu	Zhang, Chenchen/GPW-7947-2022	Zhang, Chenchen/0000-0003-4519-3435	American Cancer Society [RSG10-160-01-LIB]; Melanoma Research Alliance; NIH [CA184379, CA242188, CA237149, AG067441]	American Cancer Society(American Cancer Society); Melanoma Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was partially supported by grants from the American Cancer Society (RSG10-160-01-LIB, to GP), Melanoma Research Alliance (to GP), and the NIH (CA184379, CA242188, CA237149, and AG067441 to GP).	Ardolino M, 2014, J CLIN INVEST, V124, P4781, DOI 10.1172/JCI74337; Baitsch L, 2012, TRENDS IMMUNOL, V33, P364, DOI 10.1016/j.it.2012.02.006; Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Bates JP, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4441-3; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Fourcade J, 2010, J EXP MED, V207, P2175, DOI 10.1084/jem.20100637; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Fu BQ, 2011, IMMUNOLOGY, V133, P350, DOI 10.1111/j.1365-2567.2011.03446.x; Gajewski TF, 2011, CURR OPIN IMMUNOL, V23, P286, DOI 10.1016/j.coi.2010.11.013; Gardiner CM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00367; Gill S, 2012, BLOOD, V119, P5758, DOI 10.1182/blood-2012-03-415364; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Hasmim M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00482; Hsu J, 2018, J CLIN INVEST, V128, P4654, DOI 10.1172/JCI99317; Hu ZSI, 2018, CURR BREAST CANCER R, V10, P35, DOI 10.1007/s12609-018-0274-y; Huang Y, 2015, ONCOTARGET, V6, P17462, DOI 10.18632/oncotarget.3958; Izhak L, 2013, CANCER RES, V73, P1514, DOI 10.1158/0008-5472.CAN-12-2567; Keppel MP, 2015, J IMMUNOL, V194, P1954, DOI 10.4049/jimmunol.1402099; Kim YH, 2017, J IMMUNOL, V199, P3478, DOI 10.4049/jimmunol.1700567; Kobayashi T, 2019, MOL IMMUNOL, V115, P3, DOI [10.1016/J.molimm.2017.11.021, 10.1016/j.molimm.2017.11.021]; Krneta T, 2016, CELL MOL IMMUNOL, V13, P628, DOI 10.1038/cmi.2015.42; Kronenberg M, 2002, NAT REV IMMUNOL, V2, P557, DOI 10.1038/nri854; Liu X, 2020, J CLIN INVEST, V130, P1073, DOI 10.1172/JCI133679; Liu X, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02689-5; Liu Y, 2017, ONCOGENE, V36, P6143, DOI 10.1038/onc.2017.209; Lyons TG, 2018, CURR ONCOL REP, V20, DOI 10.1007/s11912-018-0701-2; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Mah AY, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.95128; Mah AY, 2016, CRIT REV IMMUNOL, V36, P131, DOI 10.1615/CritRevImmunol.2016017387; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; Matsuda JL, 2000, J EXP MED, V192, P741, DOI 10.1084/jem.192.5.741; McEwen-Smith RM, 2015, CANCER IMMUNOL RES, V3, P425, DOI 10.1158/2326-6066.CIR-15-0062; Moretta L, 2014, INT ARCH ALLERGY IMM, V164, P253, DOI 10.1159/000365632; Motohashi S, 2009, J IMMUNOL, V182, P2492, DOI 10.4049/jimmunol.0800126; Muller-Durovic B, 2016, J IMMUNOL, V197, P2891, DOI 10.4049/jimmunol.1600590; O'Konek JJ, 2013, CLIN CANCER RES, V19, P4404, DOI 10.1158/1078-0432.CCR-12-2169; Parekh VV, 2005, J CLIN INVEST, V115, P2572, DOI 10.1172/JCI24762; Pietra G, 2012, CANCER RES, V72, P1407, DOI 10.1158/0008-5472.CAN-11-2544; Polk A, 2018, CANCER TREAT REV, V63, P122, DOI 10.1016/j.ctrv.2017.12.008; Sag D, 2014, J CLIN INVEST, V124, P3725, DOI 10.1172/JCI72308; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schule Jana M, 2004, J Transl Med, V2, P45, DOI 10.1186/1479-5876-2-45; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; Shin JH, 2013, P NATL ACAD SCI USA, V110, P12391, DOI 10.1073/pnas.1302856110; Smyth MJ, 2000, J EXP MED, V191, P661, DOI 10.1084/jem.191.4.661; Stojanovic A, 2014, J IMMUNOL, V192, P4184, DOI 10.4049/jimmunol.1302091; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Ververs FA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01192; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Webb JR, 2010, GYNECOL ONCOL, V118, P228, DOI 10.1016/j.ygyno.2010.05.016; Webb TJ, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw055; Xia LY, 2019, CELL METAB, V29, P103, DOI 10.1016/j.cmet.2018.09.020; Yamasaki K, 2011, CLIN IMMUNOL, V138, P255, DOI 10.1016/j.clim.2010.11.014; Ye J, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.994398; Ye J, 2014, EMBO MOL MED, V6, P1294, DOI 10.15252/emmm.201403918; Ye J, 2013, J IMMUNOL, V190, P2403, DOI 10.4049/jimmunol.1202369; Ye J, 2012, BLOOD, V120, P2021, DOI 10.1182/blood-2012-03-416040; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005; Zhao YJ, 2020, CELL MOL IMMUNOL, V17, P27, DOI 10.1038/s41423-019-0344-8	63	8	8	0	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2021	40	27					4521	4537		10.1038/s41388-021-01880-9	http://dx.doi.org/10.1038/s41388-021-01880-9		JUN 2021	17	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TG4PV	34120141				2022-12-26	WOS:000660811300002
J	Sato, Y; Yamaguchi, K; Ogawa, M; Takekuma, Y; Sugawara, M				Sato, Yuki; Yamaguchi, Kazuki; Ogawa, Mikako; Takekuma, Yoh; Sugawara, Mitsuru			An imaging approach for determining the mechanism of enhancement of intestinal absorption of an L-theanine supplement	PLOS ONE			English	Article							UNIQUE AMINO-ACID; BLOOD-PRESSURE; GAMMA-GLUTAMYLETHYLAMIDE; GREEN TEA; PIPERINE; TRANSPORT; PHARMACOKINETICS; DAIKENCHUTO; METABOLISM; COMPONENTS	Background & objective Theanine (L-glutamylethylamide) contained in green tea is a functional food component that has been attracting attention due to its relaxation effect. It was shown that the ingredients added to the theanine formulations increased the absorption of theanine. If this mechanism can be elucidated, it would be possible to contribute to development of evidence-based formulations. In this study, we investigated the effect of ingredients in the formulations on the absorption of theanine in detail. Main methods After oral administration of a mixture of theanine and additional components to Wistar rats the plasma concentration was determined by an HPLC and the pharmacokinetic parameters were calculated. In addition, a new system for evaluating intestinal blood flow was developed since the involvement of intestinal blood flow was considered as a factor that increased absorption of theanine. Key findings Plasma concentration of theanine increased significantly in the combined use group with eight ingredients containing piperine as compared with theanine only group. Piperine would increase theanine absorption by increased blood flow, not an inhibition of metabolism. We succeeded to develop a visual and quantitative system to evaluate the effect of these ingredients directly including piperine on the intestinal blood flow using indocyanine green while maintaining physiological conditions. Significance Increased intestinal blood flow by these ingredients including piperine enhanced the absorption of theanine. Other mechanisms may also be considered as the mechanism by which theanine absorption is increased in addition to increased blood flow.	[Sato, Yuki; Yamaguchi, Kazuki; Ogawa, Mikako; Sugawara, Mitsuru] Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan; [Ogawa, Mikako; Sugawara, Mitsuru] Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Biosurfaces & Drug Discovery, Sapporo, Hokkaido, Japan; [Takekuma, Yoh; Sugawara, Mitsuru] Hokkaido Univ Hosp, Dept Pharm, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Sugawara, M (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Sapporo, Hokkaido, Japan.; Sugawara, M (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ GI CoRE, Global Stn Biosurfaces & Drug Discovery, Sapporo, Hokkaido, Japan.; Sugawara, M (corresponding author), Hokkaido Univ Hosp, Dept Pharm, Sapporo, Hokkaido, Japan.	msuga@pharm.hokudai.ac.jp	Sugawara, Mitsuru/A-5274-2012; Takekuma, Yoh/F-9723-2012	Sugawara, Mitsuru/0000-0001-5350-2950; Takekuma, Yoh/0000-0002-4325-0785	Northern Advancement Center for Science & Technology of Hokkaido; Japan Society for the Promotion of Science (JSPS) [16K00842, 20K07153]; Hokkaido University, Global Facility Center (GFC), Pharma Science Open Unit (PSOU) - Ministry of Education, Culture, Sports, Science and Technology (MEXT); Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the MEXT; Japan Agency for Medical Research and Development (AMED)	Northern Advancement Center for Science & Technology of Hokkaido; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hokkaido University, Global Facility Center (GFC), Pharma Science Open Unit (PSOU) - Ministry of Education, Culture, Sports, Science and Technology (MEXT); Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the MEXT; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by Grants-in-Aid for Regional R&D Proposal-Based Program from Northern Advancement Center for Science & Technology of Hokkaido and Grants-inAid for Scientific Research (C) (Grant number 16K00842, 20K07153) from the Japan Society for the Promotion of Science (JSPS). This research was partly supported by Hokkaido University, Global Facility Center (GFC), Pharma Science Open Unit (PSOU), funded by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) under "Support Program for Implementation of New Equipment Sharing System." This research was also partially supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics, and Structural Life Science) from the MEXT and Japan Agency for Medical Research and Development (AMED).	ANNAMALAI AR, 1990, INDIAN DRUGS, V27, P595; Bajad S, 2002, J CHROMATOGR B, V776, P245, DOI 10.1016/S1570-0232(02)00352-5; Behrendt FF, 2004, EUR SURG RES, V36, P210, DOI 10.1159/000078855; CHERRICK GR, 1960, J CLIN INVEST, V39, P592, DOI 10.1172/JCI104072; Dai WD, 2017, FOOD RES INT, V96, P40, DOI 10.1016/j.foodres.2017.03.028; Desai MJ, 2005, CHIRALITY, V17, P154, DOI 10.1002/chir.20144; Di X, 2015, J PHARMACEUT BIOMED, V115, P144, DOI 10.1016/j.jpba.2015.06.027; Hironaka T, 2009, PHARM RES-DORDR, V26, P40, DOI 10.1007/s11095-008-9703-3; Izgelov D, 2020, EUR J PHARM SCI, V148, DOI 10.1016/j.ejps.2020.105313; Izgelov D, 2018, MOL PHARMACEUT, V15, P1548, DOI 10.1021/acs.molpharmaceut.7b01090; Juneja LR, 1999, TRENDS FOOD SCI TECH, V10, P199, DOI 10.1016/S0924-2244(99)00044-8; Keenan EK, 2011, FOOD CHEM, V125, P588, DOI 10.1016/j.foodchem.2010.08.071; Khajuria A, 2002, PHYTOMEDICINE, V9, P224, DOI 10.1078/0944-7113-00114; Kono T, 2008, J SURG RES, V150, P78, DOI 10.1016/j.jss.2008.02.057; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu YN, 2011, FOOD CHEM, V125, P277, DOI 10.1016/j.foodchem.2010.09.027; Mitsuoka K, 2009, BIOL PHARM BULL, V32, P1459, DOI 10.1248/bpb.32.1459; Rogers PJ, 2008, PSYCHOPHARMACOLOGY, V195, P569, DOI 10.1007/s00213-007-0938-1; Sakato Y., 1949, NIPPON NOGEIKAGAKU K, V23, P262, DOI DOI 10.1271/NOGEIKAGAKU1924.23.262; Sato Y, 2020, EUR J PHARM SCI, V142, DOI 10.1016/j.ejps.2019.105144; Sato Y, 2018, EUR J PHARM BIOPHARM, V127, P171, DOI 10.1016/j.ejpb.2018.02.013; Sato Y, 2013, J PHARM PHARM SCI, V16, P494, DOI 10.18433/J33K61; Sato Y, 2011, BIOPHARM DRUG DISPOS, V32, P151, DOI 10.1002/bdd.746; Sato Y, 2011, FOOD CHEM, V127, P893, DOI 10.1016/j.foodchem.2011.01.096; Shamsi S, 2017, DRUG METAB DISPOS, V45, P49, DOI 10.1124/dmd.116.073213; Srinivasan K, 2007, CRIT REV FOOD SCI, V47, P735, DOI 10.1080/10408390601062054; Takekawa Y, 2016, BIOL PHARM BULL, V39, P301, DOI 10.1248/bpb.b15-00359; Unno T, 1999, J AGR FOOD CHEM, V47, P1593, DOI 10.1021/jf981113t; Wada T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19550-4; Wang RN, 2019, INT J PHARMACEUT, V561, P9, DOI 10.1016/j.ijpharm.2019.02.027; White DJ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010053; Yamada T, 2009, AMINO ACIDS, V36, P21, DOI 10.1007/s00726-007-0020-7; Yamamoto S, 2012, BIOSCI BIOTECH BIOCH, V76, P2230, DOI 10.1271/bbb.120519; YOKOGOSHI H, 1995, BIOSCI BIOTECH BIOCH, V59, P615, DOI 10.1271/bbb.59.615; Yokogoshi H, 1998, NEUROCHEM RES, V23, P667, DOI 10.1023/A:1022490806093; Yoto A, 2012, J PHYSIOL ANTHROPOL, V31, DOI 10.1186/1880-6805-31-28	36	0	0	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253066	10.1371/journal.pone.0253066	http://dx.doi.org/10.1371/journal.pone.0253066			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115818	gold, Green Published			2022-12-26	WOS:000664643000045
J	Hata, T; Takada, N; Hayakawa, C; Kazama, M; Uchikoba, T; Tachikawa, M; Matsuo, M; Satoh, S; Obokata, J				Hata, Takayuki; Takada, Naoto; Hayakawa, Chihiro; Kazama, Mei; Uchikoba, Tomohiro; Tachikawa, Makoto; Matsuo, Mitsuhiro; Satoh, Soichirou; Obokata, Junichi			De novo activated transcription of inserted foreign coding sequences is inheritable in the plant genome	PLOS ONE			English	Article							GENES; DNA; ORIGIN; METHYLATION; TRANSFORMANTS; INTEGRATION; EVOLUTION; IDENTIFICATION; EXPRESSION; ULTRAFAST	The manner in which inserted foreign coding sequences become transcriptionally activated and fixed in the plant genome is poorly understood. To examine such processes of gene evolution, we performed an artificial evolutionary experiment in Arabidopsis thaliana. As a model of gene-birth events, we introduced a promoterless coding sequence of the firefly luciferase (LUC) gene and established 386 T2-generation transgenic lines. Among them, we determined the individual LUC insertion loci in 76 lines and found that one-third of them were transcribed de novo even in the intergenic or inherently unexpressed regions. In the transcribed lines, transcription-related chromatin marks were detected across the newly activated transcribed regions. These results agreed with our previous findings in A. thaliana cultured cells under a similar experimental scheme. A comparison of the results of the T2-plant and cultured cell experiments revealed that the de novo-activated transcription concomitant with local chromatin remodelling was inheritable. During one-generation inheritance, it seems likely that the transcription activities of the LUC inserts trapped by the endogenous genes/transcripts became stronger, while those of de novo transcription in the intergenic/untranscribed regions became weaker. These findings may offer a clue for the elucidation of the mechanism by which inserted foreign coding sequences become transcriptionally activated and fixed in the plant genome.	[Hata, Takayuki; Takada, Naoto; Hayakawa, Chihiro; Kazama, Mei; Tachikawa, Makoto; Satoh, Soichirou] Kyoto Prefectural Univ, Grad Sch Life & Environfmental Sci, Kyoto, Kyoto, Japan; [Hata, Takayuki; Matsuo, Mitsuhiro; Obokata, Junichi] Setsunan Univ, Fac Agr, Hirakata, Osaka, Japan; [Uchikoba, Tomohiro; Satoh, Soichirou] Kyoto Prefectural Univ, Fac Life & Environm Sci, Kyoto, Kyoto, Japan	Kyoto Prefectural University; Setsunan University; Kyoto Prefectural University	Satoh, S (corresponding author), Kyoto Prefectural Univ, Grad Sch Life & Environfmental Sci, Kyoto, Kyoto, Japan.; Obokata, J (corresponding author), Setsunan Univ, Fac Agr, Hirakata, Osaka, Japan.; Satoh, S (corresponding author), Kyoto Prefectural Univ, Fac Life & Environm Sci, Kyoto, Kyoto, Japan.	s-satoh@kpu.ac.jp; junichi.obokata@setsunan.ac.jp	Hata, Takayuki/AAC-6953-2022	Hata, Takayuki/0000-0001-7313-9263; Obokata, Junichi/0000-0002-2973-0109; Satoh, Soichirou/0000-0002-7622-1868	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant [17J04887, 26660008, 17K19358, 23125512, 23657040, 23117006, 25650131]; Strategic Research Funds at Kyoto Prefectural University	Japan Society for the Promotion of Science (JSPS) KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Strategic Research Funds at Kyoto Prefectural University	This work was supported by the Japan Society for the Promotion of Science (JSPS) KAKENHI Grant Number: 17J04887 to Takayuki Hata, 26660008 to Soichirou Satoh, and 17K19358, 23125512, 23657040, 23117006, and 25650131 to Junichi Obokata, and by the Strategic Research Funds at Kyoto Prefectural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhtar W, 2014, NAT PROTOC, V9, P1255, DOI 10.1038/nprot.2014.072; Akhtar W, 2013, CELL, V154, P914, DOI 10.1016/j.cell.2013.07.018; Andersson R, 2020, NAT REV GENET, V21, P71, DOI 10.1038/s41576-019-0173-8; Berardini TZ, 2015, GENESIS, V53, P474, DOI 10.1002/dvg.22877; Blevins WR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20911-3; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cardoso-Moreira M, 2012, METHODS MOL BIOL, V856, P161, DOI 10.1007/978-1-61779-585-5_7; Carninci P, 1996, GENOMICS, V37, P327, DOI 10.1006/geno.1996.0567; Carvunis AR, 2012, NATURE, V487, P370, DOI 10.1038/nature11184; Cermakova K., BIORXIV PREPRINT, DOI [10.1101/636084v1, DOI 10.1101/636084V1]; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; De Buck S, 2009, PLANT J, V60, P134, DOI 10.1111/j.1365-313X.2009.03942.x; Deal RB, 2007, PLANT CELL, V19, P74, DOI 10.1105/tpc.106.048447; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Durand E, 2019, GENOME RES, V29, P932, DOI 10.1101/gr.239822.118; Erdmann RM, 2015, G3-GENES GENOM GENET, V5, P1, DOI 10.1534/g3.114.014670; ERRAMPALLI D, 1991, PLANT CELL, V3, P149, DOI 10.1105/tpc.3.2.149; Francis KE, 2005, PLANT J, V41, P464, DOI 10.1111/j.1365-313X.2004.02312.x; Gehring M, 2019, NEW PHYTOL, V224, P91, DOI 10.1111/nph.15856; Gomez-Zambrano A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10773-1; Gotea V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057323; Haberle V, 2018, NAT REV MOL CELL BIO, V19, P621, DOI 10.1038/s41580-018-0028-8; Hata T., 2021, MOL BIOL EVOL, DOI [10.1093/molbev/msab069, DOI 10.1093/MOLBEV/MSAB069]; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hirashima M, 2006, J BIOL CHEM, V281, P15385, DOI 10.1074/jbc.M602903200; Ingouff M, 2010, CURR BIOL, V20, P2137, DOI 10.1016/j.cub.2010.11.012; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Jullien PE, 2012, CURR BIOL, V22, P1825, DOI 10.1016/j.cub.2012.07.061; Kaessmann H, 2010, GENOME RES, V20, P1313, DOI 10.1101/gr.101386.109; Kalitsis P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-498; Kawakatsu T, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1251-x; Kim SI, 2007, PLANT J, V51, P779, DOI 10.1111/j.1365-313X.2007.03183.x; Komari T, 1996, PLANT J, V10, P165, DOI 10.1046/j.1365-313X.1996.10010165.x; Kudo H., CRYPTIC PROMOTER ACT, DOI [10.1101/2020.11.28.399337v1, DOI 10.1101/2020.11.28.399337V1]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lashgari A, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx879; Lei BK, 2020, PLANT COMMUN, V1, DOI 10.1016/j.xplc.2019.100015; Li C, 2018, GENOME RES, V28, P676, DOI 10.1101/gr.231449.117; Li ZW, 2016, GENOME BIOL EVOL, V8, P2190, DOI 10.1093/gbe/evw164; Liu Y, 2018, NUCLEIC ACIDS RES, V46, pD1157, DOI 10.1093/nar/gkx919; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Majic P, 2020, MOL BIOL EVOL, V37, P1165, DOI 10.1093/molbev/msz300; MARUYAMA K, 1994, GENE, V138, P171; McLysaght A, 2016, NAT REV GENET, V17, P567, DOI 10.1038/nrg.2016.78; McLysaght A, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0332; Meinke DW, 2020, NEW PHYTOL, V226, P306, DOI 10.1111/nph.16071; Neme R, 2016, ELIFE, V5, DOI 10.7554/eLife.09977; Neme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-117; Palovaara J, 2017, NAT PLANTS, V3, P894, DOI 10.1038/s41477-017-0035-3; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Plessy C, 2010, NAT METHODS, V7, P528, DOI [10.1038/NMETH.1470, 10.1038/nmeth.1470]; Ruiz-Orera J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005721; Ruiz-Orera J, 2014, ELIFE, V3, DOI 10.7554/eLife.03523; Salimullah Md, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5559; Satoh S., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.11.28.401992v2, DOI 10.1101/2020.11.28.401992V2]; Schlotterer C, 2015, TRENDS GENET, V31, P215, DOI 10.1016/j.tig.2015.02.007; Shi DB, 2021, PLANT CELL, V33, P200, DOI 10.1093/plcell/koaa019; Shilo S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006875; Shulse CN, 2019, CELL REP, V27, P2241, DOI 10.1016/j.celrep.2019.04.054; Slane D, 2014, DEVELOPMENT, V141, P4831, DOI 10.1242/dev.116459; Springer PS, 2000, PLANT CELL, V12, P1007, DOI 10.1105/tpc.12.7.1007; Tao Z, 2017, NATURE, V551, P124, DOI 10.1038/nature24300; Teissandier A, 2017, EMBO J, V36, P1471, DOI 10.15252/embj.201796812; Vakirlis N, 2018, MOL BIOL EVOL, V35, P631, DOI 10.1093/molbev/msx315; Van Oss SB, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008160; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Werner MS, 2018, GENOME RES, V28, P1675, DOI 10.1101/gr.234872.118; Wu DD, 2014, GENOME BIOL EVOL, V6, P2822, DOI 10.1093/gbe/evu206; Wu XB, 2013, CELL, V155, P990, DOI 10.1016/j.cell.2013.10.048; Xie C, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002942; Yang HC, 2014, CURR BIOL, V24, P1793, DOI 10.1016/j.cub.2014.06.047; Zhang L, 2019, NAT ECOL EVOL, V3, P679, DOI 10.1038/s41559-019-0822-5; Zhao L, 2014, SCIENCE, V343, P769, DOI 10.1126/science.1248286; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	74	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252674	10.1371/journal.pone.0252674	http://dx.doi.org/10.1371/journal.pone.0252674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111139	gold, Green Submitted, Green Published			2022-12-26	WOS:000664642700037
J	Okwuraiwe, AP; Onwuamah, CK; Shaibu, JO; Amoo, SO; Ige, FA; James, AB; Okoli, LC; Ahmed, A; Ponmak, J; Sokei, JO; Akanmu, S; Salako, BL; Audu, RA				Okwuraiwe, Azuka Patrick; Onwuamah, Chika Kingsley; Shaibu, Joseph Ojonugwa; Amoo, Samuel Olufemi; Ige, Fehintola Anthonia; James, Ayorinde Babatunde; Okoli, Leona Chika; Ahmed, Abul-Rahman; Ponmak, Jamda; Sokei, Judith O.; Akanmu, Sulaimon; Salako, Babatunde Lawal; Audu, Rosemary Ajuma			Low level SARS-CoV-2 RNA detected in plasma samples from a cohort of Nigerians: Implications for blood transfusion	PLOS ONE			English	Article								The present global pandemic triggered by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has lingered for over a year in its devastating effects. Diagnosis of coronavirus disease 2019 (COVID-19) is currently established with a polymerase chain reaction (PCR) test by means of oropharyngeal-, nasopharyngeal-, anal-swabs, sputum and blood plasma. However, oral and nasal swabs are more commonly used. This study, therefore, assessed sensitivity and specificity of plasma as a diagnostic in comparison with a combination of oral and nasal swab samples, and the implications for blood transfusion. Oropharyngeal (OP) and nasopharyngeal (NP) swab samples were obtained from 125 individuals suspected to have COVID-19 and stored in viral transport medium (VTM) tubes. Ten millilitres of blood samples in EDTA were also obtained by venepuncture and spun to obtain plasma. Viral RNA was obtained from both swabs and plasma by manual extraction with Qiagen QIAamp viral RNA Mini Kit. Detection was done using a real time fluorescent RT-qPCR BGI kit, on a QuantStudio 3 real-time PCR instrument. Average age of study participants was 41 years, with 74 (59.2%) being male. Out of the 125 individuals tested for COVID-19, 75 (60%) were positive by OP/NP swab. However, only 6 (4.8%) had a positive plasma result for COVID-19 with median Ct value of 32.4. Sensitivity and specificity of RT-PCR SARS-CoV-2 test using plasma was 8% and 100% respectively. There was no false positive recorded, but 69 (55.2%) false negatives were obtained by plasma. SARS-CoV-2 viral RNA was detected, albeit low (4.8%) in plasma. Plasma is likely not a suitable biological sample to diagnose acute SARS-CoV-2 infection. The implication of transfusing blood in this era of COVID-19 needs further investigations.	[Okwuraiwe, Azuka Patrick; Onwuamah, Chika Kingsley; Shaibu, Joseph Ojonugwa; Amoo, Samuel Olufemi; Ige, Fehintola Anthonia; Okoli, Leona Chika; Ahmed, Abul-Rahman; Ponmak, Jamda; Sokei, Judith O.; Audu, Rosemary Ajuma] Nigerian Inst Med Res, Microbiol Dept, Ctr Human Virol & Genom, Lagos, Nigeria; [James, Ayorinde Babatunde] Nigerian Inst Med Res, Biochem Dept, Lagos, Nigeria; [Ahmed, Abul-Rahman] Univ Lagos, Dept Cell Biol & Genet, Lagos, Nigeria; [Ponmak, Jamda] Fed Coll Vet & Med Lab Technol, Vom, Plateau State, Nigeria; [Akanmu, Sulaimon] Univ Lagos, Dept Haematol, Coll Med, Lagos, Nigeria; [Salako, Babatunde Lawal] Nigerian Inst Med Res, Clin Sci Div, Lagos, Nigeria	University of Lagos; University of Lagos	Okwuraiwe, AP (corresponding author), Nigerian Inst Med Res, Microbiol Dept, Ctr Human Virol & Genom, Lagos, Nigeria.	azukaokwu@yahoo.com	Onwuamah, Chika Kingsley/ABB-9926-2020	Onwuamah, Chika Kingsley/0000-0002-5111-1822; Okwuraiwe, Azuka/0000-0003-2878-0531; Akanmu, Alani Sulaimon/0000-0001-7424-6060; Sokei, Judith/0000-0003-2206-557X				American Association of Blood Banks, UPD IMP 2019 NOV COR; Andersson Monique I, 2020, Wellcome Open Res, V5, P181, DOI [10.12688/wellcomeopenres.16002.2, 10.12688/wellcomeopenres.16002.1]; BGI Europe A/S, REAL TIM FLUR RT PCR; Chan PKS, 2004, EMERG INFECT DIS, V10, P825, DOI 10.3201/eid1005.030682; Chang L, 2020, EMERG INFECT DIS, V26, P1631, DOI 10.3201/eid2607.200839; Chang L, 2020, TRANSFUS MED REV, V34, P75, DOI 10.1016/j.tmrv.2020.02.003; Cho HJ, 2020, J INFECT PUBLIC HEAL, V13, P1678, DOI 10.1016/j.jiph.2020.05.001; Chu DKW, 2020, CLIN CHEM, V66, P549, DOI 10.1093/clinchem/hvaa029; Dodd RY, 2020, TRANSFUS MED REV, V34, P73, DOI 10.1016/j.tmrv.2020.02.004; Druce J, 2012, J CLIN MICROBIOL, V50, P1064, DOI 10.1128/JCM.06551-11; Emery SL, 2004, EMERG INFECT DIS, V10, P311, DOI 10.3201/eid1002.030759; Fauci AS, 2020, NEW ENGL J MED, V382, P1268, DOI 10.1056/NEJMe2002387; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Kim C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021610; Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095; Nijhuis RHT, 2020, J CLIN VIROL, V133, DOI 10.1016/j.jcv.2020.104655; Patel R, 2020, MBIO, V11, DOI 10.1128/mBio.00722-20; Singhal T, 2020, INDIAN J PEDIATR, V87, P281, DOI 10.1007/s12098-020-03263-6; Wang L, 2020, INT J ANTIMICROB AG, V55, DOI DOI 10.1016/J.IJANTIMICAG.2020.105948; Winichakoon P, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00297-20; World Health Organization, 2020, TECHNICAL REPORT; Zhang W, 2020, EMERG MICROBES INFEC, V9, DOI 10.1080/22221751.2020.1729071; Zou LR, 2020, NEW ENGL J MED, V382, P1177, DOI 10.1056/NEJMc2001737	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252611	10.1371/journal.pone.0252611	http://dx.doi.org/10.1371/journal.pone.0252611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111179	gold, Green Published			2022-12-26	WOS:000664642700034
J	Hailu, W; Mohamed, R; Fikre, H; Atnafu, S; Tadesse, A; Diro, E; van Grienvsen, J				Hailu, Workagegnehu; Mohamed, Rezika; Fikre, Helina; Atnafu, Saba; Tadesse, Azeb; Diro, Ermias; van Grienvsen, Johan			Acute kidney injury in patients with Visceral Leishmaniasis in Northwest Ethiopia	PLOS ONE			English	Article							MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; RENAL INVOLVEMENT; KALA-AZAR; HIV	Background Visceral Leishmaniasis (VL) is a neglected tropical disease endemic to several countries including Ethiopia. Outside of Africa, kidney involvement in VL is frequent and associated with increased mortality. There is however limited data on acute kidney injury (AKI) in VL patients in East-Africa, particularly in areas with high rates of HIV co-infection. This study aims to determine the prevalence, characteristics and associated factors of AKI in VL patients in Northwest Ethiopia. Methods A hospital based retrospective patient record analysis was conducted including patients treated for VL from January 2019 to December 2019 at the Leishmaniasis Research and Treatment Center (LRTC), Gondar, Ethiopia. Patients that were enrolled in ongoing clinical trials at the study site and those with significant incomplete data were excluded. Data was analyzed using SPSS version 20. P values were considered significant if < 0.05. Results Among 352 VL patients treated at LRTC during the study period, 298 were included in the study. All were male patients except two; the median age was 23 years (IQR: 20-27). The overall prevalence of AKI among VL patients was 17.4% (confidence interval (CI): 13.6%-22.2%). Pre-renal azotemia (57%) and drug-induced AKI (50%) were the main etiologies of AKI at admission and post-admission respectively. Proteinuria and hematuria occurred in 85% and 42% of AKI patients respectively. Multivariate logistic regression revealed HIV co-infection (adjusted odds ratio (AOR): 6.01 95% CI: 1.99-18.27, p = 0.001) and other concomitant infections (AOR: 3.44 95% CI: 1.37-8.65, p = 0.009) to be independently associated with AKI. Conclusion AKI is a frequent complication in Ethiopian VL patients. Other renal manifestations included proteinuria, hematuria, and pyuria. HIV co-infection and other concomitant infections were significantly associated with AKI. Further studies are needed to quantify proteinuria and evaluate the influence of AKI on the treatment course, morbidity and mortality in VL patients.	[Hailu, Workagegnehu; Mohamed, Rezika; Diro, Ermias] Univ Gondar, Dept Internal Med, Coll Med & Hlth Sci, Gondar, Ethiopia; [Mohamed, Rezika; Fikre, Helina; Atnafu, Saba; Tadesse, Azeb; Diro, Ermias] Univ Gondar, Coll Med & Hlth Sci, Leishmaniasis Res & Treatment Ctr, Gondar, Ethiopia; [van Grienvsen, Johan] Inst Trop Med, Dept Clin Sci, Antwerp, Belgium	University of Gondar; University of Gondar; Institute of Tropical Medicine (ITM)	Hailu, W (corresponding author), Univ Gondar, Dept Internal Med, Coll Med & Hlth Sci, Gondar, Ethiopia.	workhailu@yahoo.com		Hailu, Workagegnehu/0000-0003-0149-4471	Drugs for Neglected Disease Initiative (DNDi); University of Gondar (UoG)	Drugs for Neglected Disease Initiative (DNDi); University of Gondar (UoG)	We thank all LRTC staff members who are actively involved in the management of these patients. Our acknowledgement also goes to the Drugs for Neglected Disease Initiative (DNDi) and University of Gondar (UoG) for supporting the LRTC.	Amann K, 2012, J AM SOC NEPHROL, V23, P586, DOI 10.1681/ASN.2011050472; [Anonymous], 2019, INT M LEISHM NEIGHB; Assefa A, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00723; Clementi A, 2011, CLIN KIDNEY J, V4, P147, DOI 10.1093/ndtplus/sfr008; Clevenbergh P, 2002, SCAND J INFECT DIS, V34, P546, DOI 10.1080/003655402320208857; da Silva GB, 2014, BRAZ J INFECT DIS, V18, P434, DOI 10.1016/j.bjid.2013.11.013; Daher EF, 2008, BRAZ J INFECT DIS, V12, P329, DOI 10.1590/S1413-86702008000400015; de Valliere S, 2009, AM J TROP MED HYG, V81, P209, DOI 10.4269/ajtmh.2009.81.209; DEBRITO T, 1975, AM J TROP MED HYG, V24, P9, DOI 10.4269/ajtmh.1975.24.9; Deray G, 2002, J ANTIMICROB CHEMOTH, V49, P37, DOI 10.1093/jac/49.suppl_1.37; DUARTE MIS, 1983, T ROY SOC TROP MED H, V77, P531, DOI 10.1016/0035-9203(83)90131-1; DUTRA M, 1985, AM J KIDNEY DIS, V6, P22, DOI 10.1016/S0272-6386(85)80034-2; Elnojomi NAA, 2010, SAUDI J KIDNEY DIS T, V21, P872; Enriquez R, 2015, AM J CASE REP, V16, P8, DOI 10.12659/AJCR.892641; Feehally J., 2010, COMPREHENSIVE CLIN N; Gadisa E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0987-y; Hailu A., 2006, EPIDEMIOLOGY ECOLOGY, P556; Hailu W, 2010, T ROY SOC TROP MED H, V104, P706, DOI 10.1016/j.trstmh.2010.07.007; Hurissa Z, 2010, TROP MED INT HEALTH, V15, P848, DOI 10.1111/j.1365-3156.2010.02550.x; ISN, 2012, NEPHRON CLIN PRACT, V2, P3; Kimutai R, 2017, CLIN DRUG INVEST, V37, P259, DOI 10.1007/s40261-016-0481-0; Lyons S, 2003, TROP MED INT HEALTH, V8, P733, DOI 10.1046/j.1365-3156.2003.01088.x; de Oliveira ALL, 2009, TROP DOCT, V39, P180, DOI 10.1258/td.2008.080369; Oliveira MJC, 2010, AM J TROP MED HYG, V82, P449, DOI 10.4269/ajtmh.2010.09-0571; Ortiz M, 2015, CLIN NEPHROL, V83, P370, DOI 10.5414/CN108195; Prakash J., 2006, INTERNET J TROP MED, V4, P1; PRASAD LSN, 1992, INDIAN J MED RES-A, V95, P43; Rai U S, 1994, J Assoc Physicians India, V42, P383; Rocha NA, 2013, PEDIATR INFECT DIS J, V32, pE182, DOI 10.1097/INF.0b013e3182814eae; Salgado Filho Natalino, 2003, Rev. Soc. Bras. Med. Trop., V36, P217, DOI 10.1590/S0037-86822003000200004; Sethi S, 2016, KIDNEY INT REP, V1, P125, DOI 10.1016/j.ekir.2016.06.003; WEISINGER JR, 1978, AM J TROP MED HYG, V27, P357, DOI 10.4269/ajtmh.1978.27.357; WHO, 2020, LEISHM KEY FACTS; WHO, 2017, EP SIT LEISHM	34	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252419	10.1371/journal.pone.0252419	http://dx.doi.org/10.1371/journal.pone.0252419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101727	Green Published, gold			2022-12-26	WOS:000664641500013
J	Yu, WJ; Wang, WH; Yu, XM				Yu, Weijuan; Wang, Weihua; Yu, Xiumei			Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia	PLOS ONE			English	Article							LONG NONCODING RNA; MINIMAL RESIDUAL DISEASE; GENE COEXPRESSION; ANALYSIS REVEALS; EXPRESSION; SURVIVAL; CANCER; PREDICTION; PROGNOSIS; EVOLUTION	ETV6/RUNX1 gene fusion is the most common chromosomal translocation abnormality occurred in pediatric B-cell acute lymphoblastic leukemia (B-ALL). Compared with ETV6-RUNX1-negative patients, ETV6-RUNX1-positive patients possess more improved treatment strategies but higher risk to relapse. In this research, the potential gene interaction networks were constructed intending for elucidating the pathogenesis of B-ALL. We performed the weighted gene co-expression network analysis (WGCNA) to assess the involvement of lncRNA-mRNA pairs in B-ALL patients consisting of 24 ETV6-RUNX1-positive patients and 18 ETV6-RUNX1-negative patients and found a module that was significantly associated with positive/negative trait. Gene Ontology analysis showed that mRNAs in this module were enriched in the positive regulation of MAPK cascade, positive regulation of JNK cascade, and myeloid cell differentiation pathway. To further investigate the relationship between lncRNAs and mRNAs in this significant module, we constructed the lncRNA-mRNA co-expression network. 3 lncRNAs (RP11-170J3.2, RP11-135F9.1 and RP1-151B14.9) were found at the core of the lncRNA-mRNA co-expression network, which had the most co-expression connections with mRNAs. And several related mRNAs (ACTN1, TNFRSF21 and NLRP3) had a significant correlation with the patient survival prediction. Our findings may explicate the pathogenesis of B-ALL, and the disease-associated genes could provide clues to find novel biomarkers for prognosis.	[Yu, Weijuan; Wang, Weihua; Yu, Xiumei] Yantai Yuhuangding Hosp, Dept Hematol Lab, Yantai, Peoples R China		Yu, XM (corresponding author), Yantai Yuhuangding Hosp, Dept Hematol Lab, Yantai, Peoples R China.	yuxiumeiyt@163.com						Almamun M, 2017, LEUKEMIA LYMPHOMA, V58, P2156, DOI 10.1080/10428194.2016.1272683; Bester AC, 2018, CELL, V173, P649, DOI 10.1016/j.cell.2018.03.052; Botia JA, 2017, BMC SYST BIOL, V11, DOI 10.1186/s12918-017-0420-6; Chou WC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-300; Cicenas J, 2018, CANCERS, V10, DOI 10.3390/cancers10010001; Clarke C, 2013, CARCINOGENESIS, V34, P2300, DOI 10.1093/carcin/bgt208; Cuadros M, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0258-9; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Eckert C, 2015, LEUKEMIA, V29, P1648, DOI 10.1038/leu.2015.59; Fernando TR, 2015, MOL CANCER RES, V13, P839, DOI 10.1158/1541-7786.MCR-15-0006-T; Franiak-Pietryga I, 2012, PHARMACOL REP, V64, P412; Garzon R, 2014, P NATL ACAD SCI USA, V111, P18679, DOI 10.1073/pnas.1422050112; Ge J, 2013, BIOMED ENVIRON SCI, V26, P902, DOI 10.3967/bes2013.019; Ghazavi F, 2016, ONCOTARGET, V7, P73769, DOI 10.18632/oncotarget.12063; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Korfi K, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.70; Kuster L, 2011, BLOOD, V117, P2658, DOI 10.1182/blood-2010-03-275347; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li YF, 2013, LUNG CANCER, V80, P91, DOI 10.1016/j.lungcan.2012.12.022; Li ZG, 2009, BLOOD, V114, P4486, DOI 10.1182/blood-2009-04-218123; Liao Q, 2011, NUCLEIC ACIDS RES, V39, P3864, DOI 10.1093/nar/gkq1348; Linabery AM, 2008, CANCER, V112, P416, DOI 10.1002/cncr.23169; Linka Y, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.48; Ma LN, 2015, NUCLEIC ACIDS RES, V43, pD187, DOI 10.1093/nar/gku1167; Cruz-Miranda GM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030735; Mer AS, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0596-2; Mousavian Z, 2017, CELL ONCOL, V40, P33, DOI 10.1007/s13402-016-0303-7; Ribera JM, 2014, J CLIN ONCOL, V32, P1595, DOI 10.1200/JCO.2013.52.2425; Salaro E, 2016, SCI REP-UK, V6, DOI 10.1038/srep26280; Santiago R, 2017, EXPERT OPIN PHARMACO, V18, P1081, DOI 10.1080/14656566.2017.1340938; Smith MA, 2010, J CLIN ONCOL, V28, P2625, DOI 10.1200/JCO.2009.27.0421; Udyavar AR, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-S5-S1; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wang Y, 2018, EUR REV MED PHARMACO, V22, P7364, DOI 10.26355/eurrev_201811_16274; Wang Y, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0541-6; Yamaguchi H, 2017, EUR J CELL BIOL, V96, P685, DOI 10.1016/j.ejcb.2017.07.005; Yang GD, 2014, BBA-GENE REGUL MECH, V1839, P1097, DOI 10.1016/j.bbagrm.2014.08.012; Yasutomi M, 2016, ANN HEMATOL, V95, P141, DOI 10.1007/s00277-015-2517-6; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	41	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0253012	10.1371/journal.pone.0253012	http://dx.doi.org/10.1371/journal.pone.0253012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101758	Green Published, gold			2022-12-26	WOS:000664641500035
J	Fleming, W; Jewell, S; Engelhard, B; Witten, DM; Witten, IB				Fleming, Weston; Jewell, Sean; Engelhard, Ben; Witten, Daniela M.; Witten, Ilana B.			Inferring spikes from calcium imaging in dopamine neurons	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; REWARD PREDICTION; CELLULAR RESOLUTION; TRAIN INFERENCE; SIGNALS; CORTEX; DECONVOLUTION; POPULATIONS; NAVIGATION; DIVERSITY	Calcium imaging has led to discoveries about neural correlates of behavior in subcortical neurons, including dopamine (DA) neurons. However, spike inference methods have not been tested in most populations of subcortical neurons. To address this gap, we simultaneously performed calcium imaging and electrophysiology in DA neurons in brain slices and applied a recently developed spike inference algorithm to the GCaMP fluorescence. This revealed that individual spikes can be inferred accurately in this population. Next, we inferred spikes in vivo from calcium imaging from these neurons during Pavlovian conditioning, as well as during navigation in virtual reality. In both cases, we quantitatively recapitulated previous in vivo electrophysiological observations. Our work provides a validated approach to infer spikes from calcium imaging in DA neurons and implies that aspects of both tonic and phasic spike patterns can be recovered.	[Fleming, Weston; Engelhard, Ben; Witten, Ilana B.] Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA; [Jewell, Sean; Witten, Daniela M.] Univ Washington, Dept Stat & Biostat, Seattle, WA 98195 USA	Princeton University; University of Washington; University of Washington Seattle	Witten, IB (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.; Witten, DM (corresponding author), Univ Washington, Dept Stat & Biostat, Seattle, WA 98195 USA.	dwitten@uw.edu; iwitten@princeton.edu		Fleming, Weston/0000-0002-4792-1929	NYSCF; NSF GRFP; ARO [W911NF1710554]; NIH [R01 EB026908, R01 DA047869, U19 NS104648-01, K99MH122657]; Simons Investigator Award in Mathematical Modeling of Living Systems	NYSCF; NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); ARO; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Investigator Award in Mathematical Modeling of Living Systems	Funding was from NYSCF (IBW); NSF GRFP (WF); ARO W911NF1710554 (IW); NIH grants R01 EB026908 (DMW), R01 DA047869 (DMW & IBW), U19 NS104648-01 (IBW); NIH K99MH122657 (BE); and a Simons Investigator Award in Mathematical Modeling of Living Systems (DMW). IBW is a New York Stem Cell Foundation -Robertson Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronov D, 2014, NEURON, V84, P442, DOI 10.1016/j.neuron.2014.08.042; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Berens P, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006157; Carelli RM, 2004, NEUROPHARMACOLOGY, V47, P180, DOI 10.1016/j.neuropharm.2004.07.017; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Cho J.R., 2020, BIORXIV, DOI [10.1101/2020.07.27.222729v1, DOI 10.1101/2020.07.27.222729V1]; Cohen JY, 2012, NATURE, V482, P85, DOI 10.1038/nature10754; Cox J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10763; da Silva JA, 2018, NATURE, V554, P244, DOI 10.1038/nature25457; Dahan L, 2007, NEUROPSYCHOPHARMACOL, V32, P1232, DOI 10.1038/sj.npp.1301251; Daigle TL, 2018, CELL, V174, P465, DOI 10.1016/j.cell.2018.06.035; de Vries SEJ, 2020, NAT NEUROSCI, V23, P138, DOI 10.1038/s41593-019-0550-9; Deneux T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12190; Dombeck DA, 2007, NEURON, V56, P43, DOI 10.1016/j.neuron.2007.08.003; Donahue CH, 2018, BIORXIV, DOI [DOI 10.1038/nature14066, 10.1101/277855, DOI 10.1101/277855]; Dyer EL, 2013, I IEEE EMBS C NEUR E, P593, DOI 10.1109/NER.2013.6696004; Dyer EL, 2010, LECT NOTES COMPUT SC, V6365, P604, DOI 10.1007/978-3-642-15995-4_75; Engelhard B, 2019, NATURE, V570, P509, DOI 10.1038/s41586-019-1261-9; Eshel N, 2016, NAT NEUROSCI, V19, P479, DOI 10.1038/nn.4239; Eshel N, 2015, NATURE, V525, P243, DOI 10.1038/nature14855; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; Fiorillo CD, 2013, J NEUROSCI, V33, P4693, DOI 10.1523/JNEUROSCI.3886-12.2013; Flagel SB, 2011, NATURE, V469, P53, DOI 10.1038/nature09588; Floresco SB, 2003, NAT NEUROSCI, V6, P968, DOI 10.1038/nn1103; Foehring RC, 2009, J NEUROPHYSIOL, V102, P2326, DOI 10.1152/jn.00038.2009; Friedrich J, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005423; Gore BB, 2014, LEARN MEMORY, V21, P575, DOI 10.1101/lm.036079.114; GRACE AA, 1984, J NEUROSCI, V4, P2877; GRACE AA, 1984, J NEUROSCI, V4, P2866; Greenberg DS, 2008, NAT NEUROSCI, V11, P749, DOI 10.1038/nn.2140; Grewe BF, 2010, NAT METHODS, V7, P399, DOI 10.1038/nmeth.1453; Gritton HJ, 2019, NAT NEUROSCI, V22, P586, DOI 10.1038/s41593-019-0341-3; Guru A., 2020, BIORXIV, DOI [10.1101/2020.05.21.108886v1.abstract, DOI 10.1101/2020.05.21.108886V1.ABSTRACT]; Hamid AA, 2016, NAT NEUROSCI, V19, P117, DOI 10.1038/nn.4173; Harvey CD, 2012, NATURE, V484, P62, DOI 10.1038/nature10918; Houghton C, 2012, NETWORK-COMP NEURAL, V23, P48, DOI 10.3109/0954898X.2012.673048; Howe MW, 2016, NATURE, V535, P505, DOI 10.1038/nature18942; Howe M, 2019, ELIFE, V8, DOI 10.7554/eLife.44903; Howe MW, 2013, NATURE, V500, P575, DOI 10.1038/nature12475; Jewell S, 2018, ANN APPL STAT, V12, P2457, DOI 10.1214/18-AOAS1162; Jewell SW, 2020, BIOSTATISTICS, V21, P709, DOI 10.1093/biostatistics/kxy083; Kim HGR, 2020, CELL, V183, P1600, DOI 10.1016/j.cell.2020.11.013; Lammel S, 2015, NEURON, V85, P429, DOI 10.1016/j.neuron.2014.12.036; Ledochowitsch P., 2019, CORRES ELECT OPTICAL, DOI [10.1101/800102v1.full-text, DOI 10.1101/800102V1.FULL-TEXT]; Low RJ, 2014, P NATL ACAD SCI USA, V111, P18739, DOI 10.1073/pnas.1421753111; Mameli-Engvall M, 2006, NEURON, V50, P911, DOI 10.1016/j.neuron.2006.05.007; Pachitariu M, 2018, J NEUROSCI, V38, P7976, DOI 10.1523/JNEUROSCI.3339-17.2018; Pan PY, 2012, NAT NEUROSCI, V15, P813, DOI 10.1038/nn.3099; Pnevmatikakis EA, 2016, NEURON, V89, P285, DOI 10.1016/j.neuron.2015.11.037; Pnevmatikakis EA, 2013, CONF REC ASILOMAR C, P349, DOI 10.1109/ACSSC.2013.6810293; Puopolo M, 2007, J NEUROSCI, V27, P645, DOI 10.1523/JNEUROSCI.4341-06.2007; Rupprecht P., 2020, BIORXIV, DOI [10.1101/2020.08.31.272450v1.abstract, DOI 10.1101/2020.08.31.272450V1.ABSTRACT]; Sage D, 2003, IEEE SIGNAL PROC MAG, V20, P43, DOI 10.1109/MSP.2003.1253553; Sasaki T, 2008, J NEUROPHYSIOL, V100, P1668, DOI 10.1152/jn.00084.2008; Schmidt H, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00025; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schwaller B, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a035543; Siegle JH., 2020, BIORXIV, DOI [10.1101/2020.08.10.244723v1.abstract, DOI 10.1101/2020.08.10.244723V1.ABSTRACT]; Starkweather CK, 2017, NAT NEUROSCI, V20, P581, DOI 10.1038/nn.4520; Theis L, 2016, NEURON, V90, P471, DOI 10.1016/j.neuron.2016.04.014; Tobler PN, 2005, SCIENCE, V307, P1642, DOI 10.1126/science.1105370; van Rossum MCW, 2001, NEURAL COMPUT, V13, P751, DOI 10.1162/089976601300014321; Vogelstein JT, 2010, J NEUROPHYSIOL, V104, P3691, DOI 10.1152/jn.01073.2009; Vogelstein JT, 2009, BIOPHYS J, V97, P636, DOI 10.1016/j.bpj.2008.08.005; Wei ZQ, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008198; Wilson CJ, 2000, J NEUROPHYSIOL, V83, P3084, DOI 10.1152/jn.2000.83.5.3084; Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874	67	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252345	10.1371/journal.pone.0252345	http://dx.doi.org/10.1371/journal.pone.0252345			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086726	gold, Green Published, Green Submitted			2022-12-26	WOS:000664640100050
J	Govaerts, B; Negra, C; Villa, TCC; Suarez, XC; Espinosa, AD; Fonteyne, S; Gardeazabal, A; Gonzalez, G; Singh, RG; Kommerell, V; Kropff, W; Saavedra, VL; Lopez, GM; Odjo, S; Rojas, NP; Ramirez-Villegas, J; Van Loon, J; Vega, D; Verhulst, N; Woltering, L; Jahn, M; Kropff, M				Govaerts, Bram; Negra, Christine; Camacho Villa, Tania Carolina; Chavez Suarez, Xiomara; Diaz Espinosa, Anabell; Fonteyne, Simon; Gardeazabal, Andrea; Gonzalez, Gabriela; Gopal Singh, Ravi; Kommerell, Victor; Kropff, Wietske; Lopez Saavedra, Victor; Mena Lopez, Georgina; Odjo, Sylvanus; Palacios Rojas, Natalia; Ramirez-Villegas, Julian; Van Loon, Jelle; Vega, Daniela; Verhulst, Nele; Woltering, Lennart; Jahn, Molly; Kropff, Martin			One CGIAR and the Integrated Agri-food Systems Initiative: From short-termism to transformation of the world's food systems	PLOS ONE			English	Article							SECURITY; SCENARIO; AGRICULTURE; ADAPTATION; MITIGATION; PRIORITIES; INNOVATION; VIEWPOINT	Agri-food systems are besieged by malnutrition, yield gaps, and climate vulnerability, but integrated, research-based responses in public policy, agricultural, value chains, and finance are constrained by short-termism and zero sum thinking. As they respond to current and emerging agri-food system challenges, decision makers need new tools that steer toward multi-sector, evidence-based collaboration. To support national agri-food system policy processes, the Integrated Agri-food System Initiative (IASI) methodology was developed and validated through case studies in Mexico and Colombia. This holistic, multi-sector methodology builds on diverse existing data resources and leverages situation analysis, modeled predictions, and scenarios to synchronize public and private action at the national level toward sustainable, equitable, and inclusive agri-food systems. Culminating in collectively agreed strategies and multi-partner tactical plans, the IASI methodology enabled a multi-level systems approach by mobilizing design thinking to foster mindset shifts and stakeholder consensus on sustainable and scalable innovations that respond to real-time dynamics in complex agri-food systems. To build capacity for these types of integrated, context-specific approaches, greater investment is needed in supportive international institutions that function as trusted in-region 'innovation brokers.' This paper calls for a structured global network to advance adaptation and evolution of essential tools like the IASI methodology in support of the One CGIAR mandate and in service of positive agri-food systems transformation.	[Govaerts, Bram; Camacho Villa, Tania Carolina; Chavez Suarez, Xiomara; Diaz Espinosa, Anabell; Fonteyne, Simon; Gardeazabal, Andrea; Gonzalez, Gabriela; Gopal Singh, Ravi; Kommerell, Victor; Lopez Saavedra, Victor; Mena Lopez, Georgina; Odjo, Sylvanus; Palacios Rojas, Natalia; Van Loon, Jelle; Vega, Daniela; Verhulst, Nele; Woltering, Lennart; Kropff, Martin] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico; [Govaerts, Bram] Cornell Univ, Ithaca, NY 14850 USA; [Negra, Christine] Versant Vis LLC, New York, NY 10023 USA; [Kropff, Wietske; Ramirez-Villegas, Julian] Alliance CIAT Biovers, Cali, Colombia; [Jahn, Molly] Univ Wisconsin, Jahn Res Grp, Madison, WI 53706 USA	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Cornell University; University of Wisconsin System; University of Wisconsin Madison	Govaerts, B (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico.; Govaerts, B (corresponding author), Cornell Univ, Ithaca, NY 14850 USA.; Negra, C (corresponding author), Versant Vis LLC, New York, NY 10023 USA.; Jahn, M (corresponding author), Univ Wisconsin, Jahn Res Grp, Madison, WI 53706 USA.	b.govaerts@CGIAR.ORG; Christine@VersantVision.com; molly.jahn@jahnresearchgroup.net	Fonteyne, Simon/AAH-9047-2021	Fonteyne, Simon/0000-0001-9965-5266; Negra, Christine/0000-0003-4336-7243; Gardeazabal, Andrea/0000-0003-1529-4200; Govaerts, Bram/0000-0002-6109-7286; Van Loon, Jelle/0000-0003-1939-6685	Mexican Government through SADER; World Bank; Government of Australia; Government of Belgium; Government of Canada; Government of China; Government of France; Government of India; Government of Japan; Government of Korea; Government of Mexico; Government of Netherlands; Government of New Zealand; Government of Norway; Government of Sweden; Government of Switzerland; Government of U.K.; Government of U.S.	Mexican Government through SADER; World Bank(The World Bank India); Government of Australia; Government of Belgium(CGIAR); Government of Canada(CGIAR); Government of China; Government of France; Government of India; Government of Japan; Government of Korea(Korean Government); Government of Mexico; Government of Netherlands(Netherlands Government); Government of New Zealand; Government of Norway; Government of Sweden; Government of Switzerland; Government of U.K.; Government of U.S.	This work was made possible thanks to the generous support of the Mexican Government through SADER in the frame of MasAgro, Crops for Mexico. The project is part of the CGIAR Research Program on Maize (MAIZE) and Wheat (WHEAT), which is generously supported by W1&W2 donors, including the Governments of Australia, Belgium, Canada, China, France, India, Japan, Korea, Mexico, Netherlands, New Zealand, Norway, Sweden, Switzerland, U.K., U.S., and the World Bank. Any opinions, findings, conclusions, or recommendations expressed in this publication are those of the authors and do not necessarily reflect the view of the donors mentioned previously. The funder provided support in the form of salaries for authors BG, CN, TCCV, XCS, ADE, SF, AG, GG, RGS, VK, VLS, GML, SO, NPR, JR-V, JVL, DV, NV, LW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Alston J., 2020, PAYOFF INVESTING CGI; Anderson WB, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw1976; Andrijevic M, 2020, NAT SUSTAIN, V3, P35, DOI 10.1038/s41893-019-0405-0; [Anonymous], Compact2025 Knowledge and Innovation hub; [Anonymous], Platform for Big Data in Agriculture Communities of Practice; [Anonymous], Knowledge Systems for Sustainability; Babu S., 2021, POLICY MAKERS CALL B; Bernstein J., 2019, IFAD RES SERIES, V38, P86; Bodirsky BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139201; Brondizio E, 2019, SUMMARY POLICYMAKERS; Brouwer ID, 2020, GLOB FOOD SECUR-AGR, V26, DOI 10.1016/j.gfs.2020.100398; Camacho-Villa TC, 2016, J AGRIC EDUC EXT, V22, P455, DOI 10.1080/1389224X.2016.1227091; CGIAR, 2020, CGIAR 2030 RES INN S; CIAT, 2014, CLIM SMART AGR COUNT; Cornell S, 2013, ENVIRON SCI POLICY, V28, P60, DOI 10.1016/j.envsci.2012.11.008; De Pinto A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231764; Dehmer SP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213801; Desa G, 2020, AGR HUM VALUES, V37, P1207, DOI 10.1007/s10460-020-10129-2; Deverell J., 2019, AUSTR NATL OUTLOOK 2; DEWIT CT, 1988, AGR SYST, V26, P211, DOI 10.1016/0308-521X(88)90012-1; Eker S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07811-9; Elven S., 2018, 5 IND SCI PARTN COUN; Fan SG, 2019, GLOB FOOD SECUR-AGR, V22, P33, DOI 10.1016/j.gfs.2019.09.005; Faux Z., 2020, TECH STARTUPS ARE FL; Financiero El., 2020, GOBIERNO APUESTA MAI; Galeano C., 2019, MAIZE COLOMBIA 2030; Gardeazabal A., KNOWL MAN RES PRACT; GLOPAN, 2020, FUT FOOD SYST PEOPL; Govaerts B., 2019, MAIZ MEXICO PLAN EST; Haddad L, 2020, FOOD POLICY, V91, DOI 10.1016/j.foodpol.2020.101824; Hall A., PUBLIC AGR RES ERA T; Hatfield-Dodds S., 2015, AUSTR NATL OUTLOOK 2; Haupt F., 2018, ANAL BRAZILIAN BEEF; Hermans F, 2019, NJAS-WAGEN J LIFE SC, V88, P76, DOI 10.1016/j.njas.2018.10.001; Herrero M, 2021, LANCET PLANET HEALTH, V5, pE50, DOI 10.1016/S2542-5196(20)30277-1; Herrero M, 2020, NAT FOOD, V1, P266, DOI 10.1038/s43016-020-0074-1; IFPRI, 2019, GLOB FOOD POL REP; Jahn M., 2020, NEW SOLUTIONS CHANGI; Kanter DR, 2016, GLOB FOOD SECUR-AGR, V10, P71, DOI 10.1016/j.gfs.2016.08.002; Klapwijk CJ, 2014, CURR OPIN ENV SUST, V6, P110, DOI 10.1016/j.cosust.2013.11.012; Liedtka J., 2017, DESIGN THINKING GREA; Lobell DB, 2020, FOOD POLICY, V91, DOI 10.1016/j.foodpol.2020.101825; Loboguerrero AM, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11051372; Lunt T, 2016, CLIM RISK MANAG, V13, P1, DOI 10.1016/j.crm.2016.05.001; McElwee P, 2020, GLOBAL CHANGE BIOL, V26, P4691, DOI 10.1111/gcb.15219; McGonigle DF, 2020, FRONT SUSTAIN FOOD S, V4, DOI 10.3389/fsufs.2020.00013; Nicholson CF, 2021, AGR SYST, V188, DOI 10.1016/j.agsy.2020.103030; Palazzo A, 2017, GLOBAL ENVIRON CHANG, V45, P227, DOI 10.1016/j.gloenvcha.2016.12.002; Pineiro V, 2020, NAT SUSTAIN, V3, P809, DOI 10.1038/s41893-020-00617-y; Portner H.-O., 2019, SPEC REP OC CRYOSPH; Rabbinge R, 1997, EUR J PLANT PATHOL, V103, P197, DOI 10.1023/A:1008618109374; Reardon T, 2019, AGR SYST, V172, P47, DOI 10.1016/j.agsy.2018.01.022; Reed J, 2019, BIOL CONSERV, V238, DOI 10.1016/j.biocon.2019.108229; Rossi A, 2019, J RURAL STUD, V68, P147, DOI 10.1016/j.jrurstud.2019.01.002; Schils R, 2018, EUR J AGRON, V101, P109, DOI 10.1016/j.eja.2018.09.003; SEARCHINGER T, 2019, CREATING SUSTAINABLE; Smith P, 2020, GLOBAL CHANGE BIOL, V26, P1532, DOI 10.1111/gcb.14878; Solleiro-Rebolledo J. L., 2015, Revista Mexicana de Agronegocios, V19, P1254; SPIA (Standing Panel on Impact Assessment), 2019, DO TAIL INP REC FLEX; Springmann M, 2018, NATURE, V562, P519, DOI 10.1038/s41586-018-0594-0; The Economics of Ecosystems and Biodiversity (TEEB), 2018, MEASURING WHAT MATTE; Turner, 2015, J ENV STUD SCI, V5, P712, DOI [10.1007/s13412-015-0338-5, DOI 10.1007/S13412-015-0338-5]; van Dijk M, 2020, GLOB FOOD SECUR-AGR, V24, DOI 10.1016/j.gfs.2020.100352; van Ittersum MK, 2016, P NATL ACAD SCI USA, V113, P14964, DOI 10.1073/pnas.1610359113; Van Loon J, 2020, AGR SYST, V180, DOI 10.1016/j.agsy.2020.102792; Vervoort JM, 2014, GLOBAL ENVIRON CHANG, V28, P383, DOI 10.1016/j.gloenvcha.2014.03.001; Westermann O, 2018, AGR SYST, V165, P283, DOI 10.1016/j.agsy.2018.07.007; Wiebe K, 2018, ANNU REV ENV RESOUR, V43, P545, DOI 10.1146/annurev-environ-102017-030109; Willett W, 2019, LANCET, V393, P447, DOI 10.1016/S0140-6736(18)31788-4; Woltering L, 2019, AGR SYST, V176, DOI 10.1016/j.agsy.2019.102652	70	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252832	10.1371/journal.pone.0252832	http://dx.doi.org/10.1371/journal.pone.0252832			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086831	gold, Green Published, Green Accepted			2022-12-26	WOS:000664640100145
J	Ahmed, HU; Mohammed, AS; Mohammed, AA; Faraj, RH				Ahmed, Hemn Unis; Mohammed, Ahmed Salih; Mohammed, Azad A.; Faraj, Rabar H.			Systematic multiscale models to predict the compressive strength of fly ash-based geopolymer concrete at various mixture proportions and curing regimes	PLOS ONE			English	Article							MECHANICAL-PROPERTIES; DURABILITY PROPERTIES; ELASTIC-MODULUS; NANO-SILICA; PERFORMANCE; BEHAVIOR; SLAG; MICROSTRUCTURE; RESISTANCE; MORTAR	Geopolymer concrete is an inorganic concrete that uses industrial or agro by-product ashes as the main binder instead of ordinary Portland cement; this leads to the geopolymer concrete being an eco-efficient and environmentally friendly construction material. A variety of ashes used as the binder in geopolymer concrete such as fly ash, ground granulated blast furnace slag, rice husk ash, metakaolin ash, and Palm oil fuel ash, fly ash was commonly consumed to prepare geopolymer concrete composites. The most important mechanical property for all types of concrete composites, including geopolymer concrete, is the compressive strength. However, in the structural design and construction field, the compressive strength of the concrete at 28 days is essential. Therefore, achieving an authoritative model for predicting the compressive strength of geopolymer concrete is necessary regarding saving time, energy, and cost-effectiveness. It gives guidance regarding scheduling the construction process and removal of formworks. In this study, Linear (LR), Non-Linear (NLR), and Multi-logistic (MLR) regression models were used to develop the predictive models for estimating the compressive strength of fly ash-based geopolymer concrete (FA-GPC). In this regard, a comprehensive dataset consists of 510 samples were collected in several academic research studies and analyzed to develop the models. In the modeling process, for the first time, twelve effective variable parameters on the compressive strength of the FA-GPC, including SiO2/Al2O3 (Si/Al) of fly ash binder, alkaline liquid to binder ratio (l/b), fly ash (FA) content, fine aggregate (F) content, coarse aggregate (C) content, sodium hydroxide (SH)content, sodium silicate (SS) content, (SS/SH), molarity (M), curing temperature (T), curing duration inside ovens (CD) and specimen ages (A) were considered as the modeling input parameters. Various statistical assessments such as Root Mean Squared Error (RMSE), Mean Absolute Error (MAE), Scatter Index (SI), OBJ value, and the Coefficient of determination (R-2) were used to evaluate the efficiency of the developed models. The results indicated that the NLR model performed better for predicting the compressive strength of FA-GPC mixtures compared to the other models. Moreover, the sensitivity analysis demonstrated that the curing temperature, alkaline liquid to binder ratio, and sodium silicate content are the most affecting parameter for estimating the compressive strength of the FA-GPC.	[Ahmed, Hemn Unis; Mohammed, Ahmed Salih; Mohammed, Azad A.] Univ Sulaimani, Coll Engn, Dept Civil Engn, Sulaimaniyah, Iraq; [Faraj, Rabar H.] Univ Halabja, Civil Engn Dept, Halabja, Kurdistan Regio, Iraq	University of Sulimanyah	Mohammed, AS (corresponding author), Univ Sulaimani, Coll Engn, Dept Civil Engn, Sulaimaniyah, Iraq.	ahmed.mohammed@univsul.edu.iq	Mohammed, Ahmed Salih/AAE-8528-2022	Mohammed, Ahmed Salih/0000-0003-4306-3274; Ahmed, Hemn Unis/0000-0003-2391-4895				Abdel-Gawwad H. A., 2016, HBRC Journal, V12, P13, DOI 10.1016/j.hbrcj.2014.06.008; Abhilash P, 2016, INT J CHEMTECH RES; Adak D, 2017, CONSTR BUILD MATER, V135, P430, DOI 10.1016/j.conbuildmat.2016.12.111; Albitar M, 2015, KSCE J CIV ENG, V19, P1445, DOI 10.1007/s12205-014-1254-z; Aliabdo AA, 2016, CONSTR BUILD MATER, V121, P694, DOI 10.1016/j.conbuildmat.2016.06.062; Alias M., 2019, INT J ENG TECHNOL, V8, P15; [Anonymous], 2009, EN123903 BS; ASTM C39/C39M, 2017, STANDARD TEST METHOD; ASTM-C618, 1999, STANDARD SPECIFICATI; Barbosa VFF, 2003, MATER RES BULL, V38, P319, DOI 10.1016/S0025-5408(02)01022-X; Behnood A, 2015, CONSTR BUILD MATER, V98, P519, DOI 10.1016/j.conbuildmat.2015.08.124; Behnood A, 2015, CONSTR BUILD MATER, V94, P137, DOI 10.1016/j.conbuildmat.2015.06.055; Bhogayata AC, 2019, J MATER CYCLES WASTE, V21, P1014, DOI 10.1007/s10163-019-00859-9; Cao J, 2021, ENG COMPUT-GERMANY, DOI 10.1007/s00366-020-01241-2; Cevik A, 2018, CERAM INT, V44, P12253, DOI 10.1016/j.ceramint.2018.04.009; Chindaprasirt P, 2014, CONSTR BUILD MATER, V63, P303, DOI 10.1016/j.conbuildmat.2014.04.010; Chithambaram SJ, 2018, STRUCT CONCRETE, V19, P1202, DOI 10.1002/suco.201700235; Criado A, 2005, FUEL, V84, P2048, DOI 10.1016/j.fuel.2005.03.030; Cui YF, 2020, MATERIALS, V13, DOI 10.3390/ma13071651; Das SK, 2020, STRUCT CONCRETE, DOI 10.1002/suco.201900201; Davidovits J., 2008, GEOPOLYMER CHEM APPL; de Vargas AS, 2011, CEMENT CONCRETE COMP, V33, P653, DOI 10.1016/j.cemconcomp.2011.03.006; Diaz EI, 2010, FUEL, V89, P992, DOI 10.1016/j.fuel.2009.09.012; Duxson P, 2007, J MATER SCI, V42, P2917, DOI 10.1007/s10853-006-0637-z; Embong R, 2016, J CLEAN PROD, V112, P816, DOI 10.1016/j.jclepro.2015.06.058; Fang GH, 2018, CONSTR BUILD MATER, V172, P476, DOI 10.1016/j.conbuildmat.2018.04.008; George UA, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-1504-2; Ghafoor M.T., 2020, CONSTR BUILD MATER; Gholampour A, 2020, NEURAL COMPUT APPL, V32, P295, DOI 10.1007/s00521-018-3630-y; Golafshani EM, 2020, CONSTR BUILD MATER, V232, DOI 10.1016/j.conbuildmat.2019.117266; Golafshani EM, 2018, J CLEAN PROD, V176, P1163, DOI 10.1016/j.jclepro.2017.11.186; Gomaa E, 2020, TRANSPORT RES REC, V2674, P430, DOI 10.1177/0361198120915892; Gunasekara C, 2016, CONSTR BUILD MATER, V124, P352, DOI 10.1016/j.conbuildmat.2016.07.121; Guo XL, 2010, CEMENT CONCRETE COMP, V32, P142, DOI 10.1016/j.cemconcomp.2009.11.003; Hardjito D, 2004, ACI MATER J, V101, P467; Hassan A, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-1774-8; Huang JD, 2022, ENG COMPUT-GERMANY, V38, P2209, DOI 10.1007/s00366-020-01207-4; Ibrahim M, 2018, CONSTR BUILD MATER, V173, P573, DOI 10.1016/j.conbuildmat.2018.04.051; Jaydeep S., 2013, INT J ENG TRENDS TEC, V4, P4614; Jindal BB, 2017, T INDIAN CERAM SOC, V76, P258, DOI 10.1080/0371750X.2017.1412837; Joseph B, 2012, SCI IRAN, V19, P1188, DOI 10.1016/j.scient.2012.07.006; Junaid MT, 2017, MATER STRUCT, V50, DOI 10.1617/s11527-016-0877-6; Kumar PD., 2014, INT J SCI ENG TECHNO, V3, P130; Kumaravel S., 2014, J ENG SCI TECHNOLOGY, V7, P116, DOI DOI 10.25103/JESTR; Kurtoglu AE, 2018, ADV CONCR CONSTR, V6, P345, DOI 10.12989/acc.2018.6.4.345; Mahasenan N, 2003, GREENHOUSE GAS CONTROL TECHNOLOGIES, VOLS I AND II, PROCEEDINGS, P995; Mahmood W, 2021, IJST-T CIV ENG, V45, P1657, DOI 10.1007/s40996-020-00522-6; Mehdipour V, 2018, AIR QUAL ATMOS HLTH, V11, P1155, DOI 10.1007/s11869-018-0615-z; Mehta A, 2017, CONSTR BUILD MATER, V146, P136, DOI 10.1016/j.conbuildmat.2017.04.077; Mehta P. K., 2001, CONCRETE INT, V23, P61; Mejeoumov GG., 2007, IMPROVED CEMENT QUAL; Mohammed A. S., 2018, EGYPT J PET, V27, P1265, DOI [10.1016/j.ejpe.2018.07.001, DOI 10.1016/J.EJPE.2018.07.001]; Mohammed A, 2020, J MATER RES TECHNOL, V9, P12416, DOI 10.1016/j.jmrt.2020.08.083; Mohammed A, 2021, J BUILD ENG, V33, DOI 10.1016/j.jobe.2020.101851; Murlidhar B.R., 2020, NAT RESOUR RES, P1; Nagajothi S, 2021, SILICON-NETH, V13, P507, DOI 10.1007/s12633-020-00470-w; Nath P, 2017, CONSTR BUILD MATER, V130, P22, DOI 10.1016/j.conbuildmat.2016.11.034; Neville A.M., 2010, CONCRETE TECHNOLOGY; Nuaklong P, 2020, J CLEAN PROD, V252, DOI 10.1016/j.jclepro.2019.119797; Nuruddin M.N., 2011, IPTEK J TECHNOLOGY S, V22, DOI DOI 10.12962/J20882033.V22I1.54; Okoye FN, 2016, CERAM INT, V42, P3000, DOI 10.1016/j.ceramint.2015.10.084; Okoye FN, 2017, J CLEAN PROD, V149, P1062, DOI 10.1016/j.jclepro.2017.02.176; Olivia M, 2008, P ICCBT2008 A, V46; Omer SA, 2015, CONSTR BUILD MATER, V94, P189, DOI 10.1016/j.conbuildmat.2015.07.006; Parveen, 2018, CONSTR BUILD MATER, V180, P298, DOI 10.1016/j.conbuildmat.2018.05.286; PATANKAR S.V., 2013, INT J ADV TECHNOLOGY, V2, P79; Provis JL, 2015, CEMENT CONCRETE RES, V78, P110, DOI 10.1016/j.cemconres.2015.04.013; Ramujee K, 2017, MATER TODAY-PROC, V4, P2937, DOI 10.1016/j.matpr.2017.02.175; Ravitheja A, 2019, MATER TODAY-PROC, V19, P273, DOI 10.1016/j.matpr.2019.06.761; Sarker PK, 2013, MATER DESIGN, V44, P580, DOI 10.1016/j.matdes.2012.08.005; Sarker PK, 2011, MATER STRUCT, V44, P1021, DOI 10.1617/s11527-010-9683-8; Sarvanan S., 2018, ARPN J ENG APPL SCI, V13, P4028; Sastry KVSGK, 2021, MATER TODAY-PROC, V45, P1017, DOI 10.1016/j.matpr.2020.03.139; Shahmansouri AA, 2021, J CLEAN PROD, V279, DOI 10.1016/j.jclepro.2020.123697; Shahmansouri AA, 2020, J BUILD ENG, V31, DOI 10.1016/j.jobe.2020.101326; Shaikh FUA, 2015, FIRE MATER, V39, P174, DOI 10.1002/fam.2240; Shehab HK, 2016, CONSTR BUILD MATER, V126, P560, DOI 10.1016/j.conbuildmat.2016.09.059; Sihag P, 2018, MODEL EARTH SYST ENV, V4, P61, DOI 10.1007/s40808-017-0410-0; Silva RV, 2014, CONSTR BUILD MATER, V65, P201, DOI 10.1016/j.conbuildmat.2014.04.117; Sumajouw DMJ, 2007, J MATER SCI, V42, P3124, DOI 10.1007/s10853-006-0523-8; Sumesh M, 2017, CONSTR BUILD MATER, V148, P62, DOI 10.1016/j.conbuildmat.2017.04.206; Topark-Ngarm P, 2015, J MATER CIVIL ENG, V27, DOI 10.1061/(ASCE)MT.1943-5533.0001157; Van Chanh N, 2008, 3 ACF INT C ACF VCA, P235; Varaprasad B.S.K.R.J., 2010, INDIAN J SCI TECHNOL, V3; Velay-Lizancos M, 2017, CONSTR BUILD MATER, V144, P195, DOI 10.1016/j.conbuildmat.2017.03.123; Vignesh P., 2015, INT RES J ENG TECHNO, V2, P135; Vijai K, 2010, INT J PHYS SCI, V5, P1419; Vijai K, 2011, EXPT INVESTIGATIONS; Vora PR, 2013, PROCEDIA ENGINEER, V51, P210, DOI 10.1016/j.proeng.2013.01.030; Wallah S., 2010, CIV ENG DIMENSION, V12, DOI DOI 10.9744/CED.12.2.73-78; Wardhono A, 2017, CONSTR BUILD MATER, V143, P272, DOI 10.1016/j.conbuildmat.2017.03.153; Weil M, 2009, WOODHEAD PUBL MATER, P194, DOI 10.1533/9781845696382.2.194; Yildirim G, 2015, J MATER CIVIL ENG, V27, DOI 10.1061/(ASCE)MT.1943-5533.0001145; Yip CK, 2008, CEMENT CONCRETE RES, V38, P554, DOI 10.1016/j.cemconres.2007.11.001; Yu C, 2022, NAT PROD RES, V36, P5484, DOI 10.1080/14786419.2021.2017927; Yu Q.L., 2019, NANOTECHNOL ECO EFFI, P97; Zeng F, 2022, ENG COMPUT-GERMANY, V38, P1755, DOI 10.1007/s00366-021-01374-y; Zeng J, 2021, ENG COMPUT-GERMANY, DOI 10.1007/s00366-020-01225-2; Zhao RD, 2019, CONSTR BUILD MATER, V222, P474, DOI 10.1016/j.conbuildmat.2019.06.166	99	29	29	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0253006	10.1371/journal.pone.0253006	http://dx.doi.org/10.1371/journal.pone.0253006			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125869	Green Published, gold			2022-12-26	WOS:000664643500021
J	Gomez-Rocha, JE; Hernandez-Gress, ES; Rivera-Gomez, H				Emmanuel Gomez-Rocha, Jose; Selene Hernandez-Gress, Eva; Rivera-Gomez, Hector			Production planning of a furniture manufacturing company with random demand and production capacity using stochastic programming	PLOS ONE			English	Article							ROBUST OPTIMIZATION MODEL; SUPPLY CHAIN; AGGREGATE; UNCERTAINTY; MANAGEMENT; IMPACT; COST	In this article two multi-stage stochastic linear programming models are developed, one applying the stochastic programming solver integrated by Lingo 17.0 optimization software that utilizes an approximation using an identical conditional sampling and Latin-hyper-square techniques to reduce the sample variance, associating the probability distributions to normal distributions with defined mean and standard deviation; and a second proposed model with a discrete distribution with 3 values and their respective probabilities of occurrence. In both cases, a scenario tree is generated. The models developed are applied to an aggregate production plan (APP) for a furniture manufacturing company located in the state of Hidalgo, Mexico, which has important clients throughout the country. Production capacity and demand are defined as random variables of the model. The main purpose of this research is to determine a feasible solution to the aggregate production plan in a reasonable computational time. The developed models were compared and analyzed. Moreover, this work was complemented with a sensitivity analysis; varying the percentage of service level, also, varying the stochastic parameters (mean and standard deviation) to test how these variations impact in the solution and decision variables.	[Emmanuel Gomez-Rocha, Jose; Rivera-Gomez, Hector] Univ Autonoma Estado Hidalgo, Engn Acad Area, Pachuca, Hidalgo, Mexico; [Selene Hernandez-Gress, Eva] Tecnol Monterrey, Sch Engn & Sci, Pachuca, Hidalgo, Mexico	Universidad Autonoma del Estado de Hidalgo; Tecnologico de Monterrey	Hernandez-Gress, ES (corresponding author), Tecnol Monterrey, Sch Engn & Sci, Pachuca, Hidalgo, Mexico.	evahgress@tec.mx	Rivera, Hector/AGB-5099-2022; Gómez-Rocha, José Emmanuel/GQR-1456-2022; Hernández -Gress, Eva Selene/AAC-2267-2020	Hernández -Gress, Eva Selene/0000-0001-8720-5997; Gomez Rocha, Jose Emmanuel/0000-0002-0295-3003				Al-e-Hashem SMJM, 2013, EUR J OPER RES, V230, P26, DOI 10.1016/j.ejor.2013.03.033; Al-E-Hashem SMJM, 2011, INT J PROD ECON, V134, P28, DOI 10.1016/j.ijpe.2011.01.027; Al-E-Hashem SMJM, 2012, INT J ADV MANUF TECH, V58, P765, DOI 10.1007/s00170-011-3396-1; Basciftci B, 2021, EUR J OPER RES, V292, P548, DOI 10.1016/j.ejor.2020.11.002; Birge JR, 2011, SPRINGER SER OPER RE, P3, DOI 10.1007/978-1-4614-0237-4; Chen YK, 2003, INT J PROD RES, V41, P3359, DOI 10.1080/0020754031000118107; Dorn W., 1972, NUMERICAL METHODS FO, V1 st; Dowson O, 2021, INFORMS J COMPUT, V33, P27, DOI 10.1287/ijoc.2020.0987; Gomez-Rocha JE, 2020, DYNA-BILBAO, V95, P466, DOI 10.6036/9813; Gangammanavar H, 2021, INFORMS J COMPUT, V33, P51, DOI 10.1287/ijoc.2019.0929; Ghasemi A, 2021, APPL SOFT COMPUT, V106, DOI 10.1016/j.asoc.2021.107309; Ghayour-Baghbani F, 2021, SOC NETW ANAL MIN, V11, DOI 10.1007/s13278-020-00704-0; Hu ZY, 2018, COMPUT IND ENG, V119, P157, DOI 10.1016/j.cie.2018.03.033; Huang JQ, 2021, INFORMS J COMPUT, V33, P352, DOI 10.1287/ijoc.2019.0933; Huang K, MULTISTAGE STOCHASTI; Jamalnia A, 2017, COMPUT IND ENG, V114, P54, DOI 10.1016/j.cie.2017.09.044; Kanyalkar AP, 2010, INT J PROD RES, V48, P635, DOI 10.1080/00207540802471272; Kleywegt AJ, 2001, SIAM J OPTIMIZ, V12, P479, DOI 10.1137/S1052623499363220; Korpeoglu E, 2011, EUR J OPER RES, V213, P166, DOI 10.1016/j.ejor.2011.02.032; Leung SCH, 2004, PROD PLAN CONTROL, V15, P502, DOI 10.1080/09537280410001724287; Lieckens K., 2014, DECISION SUPPORT SYS, DOI [10.2139/ssrn.2419376, DOI 10.2139/SSRN.2419376]; Makui A, 2016, COMPUT IND ENG, V100, P34, DOI 10.1016/j.cie.2016.08.005; Nasiri GR, 2014, COMPUT IND ENG, V77, P35, DOI 10.1016/j.cie.2014.08.005; Nasiri GR, 2010, SUPPLY CHAIN MANAG, V15, P277, DOI 10.1108/13598541011054652; Nasiri GR., SWARM EVOLUTIONARY M, V6466, DOI [10.1007/978-3-642-17563-3%5F58, DOI 10.1007/978-3-642-17563-3%5F58]; Ning YF, 2013, SOFT COMPUT, V17, P617, DOI 10.1007/s00500-012-0931-4; Nowak M, 2013, CROAT OPER RES REV, V4, P247; Pflug GC, 2014, SPRINGER SER OPER RE, P1, DOI 10.1007/978-3-319-08843-3; RAKES TR, 1984, INT J PROD RES, V22, P673, DOI 10.1080/00207548408942487; Ravindran A.R., 2016, SUPPLY CHAIN ENG MOD; Ruszczynski A., 2003, STOCHASTIC PROGRAMMI, V10, DOI [10.1001/archderm.139.12.1614, DOI 10.1001/ARCHDERM.139.12.1614]; SCHULTZ R, 1995, MATH PROGRAM, V70, P73, DOI 10.1007/BF01585929; SCHULTZ R, 1993, MATH OPER RES, V18, P578, DOI 10.1287/moor.18.3.578; Shapiro A, 2000, SIAM J OPTIMIZ, V11, P70, DOI 10.1137/S1052623498349541; Shone R, 2021, EUR J OPER RES, V292, P1, DOI 10.1016/j.ejor.2020.10.039; Tirkolaee EB., ADV MANUFACTURING 2, DOI [10.1007/978-3-030-18789-7%5F8, DOI 10.1007/978-3-030-18789-7%5F8]; Torkaman S, 2017, COMPUT IND ENG, V113, P602, DOI 10.1016/j.cie.2017.09.040; Torres-Rincon S., 2021, RELIABILITY ENG SYST, DOI [10.1016/j.ress.2021.107549, DOI 10.1016/J.RESS.2021.107549]; Verweij B, 2003, COMPUT OPTIM APPL, V24, P289, DOI 10.1023/A:1021814225969; WAGNER HM, 1958, MANAGE SCI, V5, P89, DOI 10.1287/mnsc.5.1.89; Wang ZG, 2021, EXPERT SYST APPL, V173, DOI 10.1016/j.eswa.2021.114635; Zanjani Masoumeh Kazemi, 2013, International Journal of Mathematics in Operational Research, V5, P1; Zhang DL, 2021, EUR J OPER RES, V292, P311, DOI 10.1016/j.ejor.2020.10.026; Zhang J, 2021, EUR J OPER RES, V293, P190, DOI 10.1016/j.ejor.2020.12.023; Zhao H, 2019, EXPERT SYST APPL, V124, P25, DOI 10.1016/j.eswa.2019.01.038	45	1	1	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252801	10.1371/journal.pone.0252801	http://dx.doi.org/10.1371/journal.pone.0252801			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125852	gold, Green Published			2022-12-26	WOS:000664643500015
J	Jain, J; Jadhao, P; Banait, S; Salunkhe, P				Jain, Jyoti; Jadhao, Pooja; Banait, Shashank; Salunkhe, Preetam			Diagnostic accuracy of GeneXpert MTB/RIF assay for detection of tubercular pleural effusion	PLOS ONE			English	Article								India has been engaged in tuberculosis (TB) control activities for over 50 years and yet TB continues to remain India's important public health problem. The present study was conducted to compare the performance of GeneXpert MTB/RIF (GXpert) assay with composite reference standard in diagnosing cases of tubercular pleural effusion (TPE) and to evaluate the reliability of rifampicin resistance. A cross-sectional study was performed in a Department of Medicine of a rural teaching tertiary care hospital in central India. In all consecutive patients with pleural effusion on chest radiograph presenting to Department of Medicine, GXpert assay and composite reference standard was performed to evaluate the diagnostic accuracy of GXpert assay for detecting TPE in comparison to composite reference standard. Standard formulae were used to calculate the sensitivity, specificity, positive predictive values (PPV), negative predictive values (NPV), positive likelihood ratios (LR+) and negative likelihood ratios (LR-). Mc-Nemar's test was applied to compare variables. All comparisons were two-tailed. We considered the difference to be statistically significant if the P value was less than 0.05. The sensitivity of the GXpert assay in diagnosing TPE was 16.6% among 158 study participants, the specificity was 100% and diagnostic accuracy was 52.5% which was statistically significant (p value < 0.05). It had a PPV of 100% (95%CI: 88.3% - 100%) and a NPV of 47.5% (95%CI: 39.3% - 55.7%). The LR+ and LR-were 23.5 (95%CI: 1.43-38.6) and 0.83 (95%CI: 0.76-0.91) respectively. GXpert assay has a very high specificity in diagnosing TPE but has a low sensitivity. In comparison to composite reference standard Thus its clinical utility is limited when used as a standalone test. A physician's clinical acumen in combination with routine pleural fluid analysis should be the key factor in the diagnosis of TPE in clinically and radiologically suspected patients, especially in high TB burden countries.	[Jain, Jyoti; Jadhao, Pooja; Salunkhe, Preetam] Mahatma Gandhi Inst Med Sci, Dept Med, Wardha, Maharashtra, India; [Banait, Shashank] Jawaharlal Nehru Med Coll, Dept Ophthalmol, Wardha, Maharashtra, India	Mahatma Gandhi Institute of Medical Sciences, Sevagram; Datta Meghe Institute of Medical Sciences - Deemed to be University; Jawaharlal Nehru Medical College Wardha	Jain, J (corresponding author), Mahatma Gandhi Inst Med Sci, Dept Med, Wardha, Maharashtra, India.	jyotijain@mgims.ac.in	Jain, Jyoti/ABG-7809-2021; Banait, Dr. Shashank/AAZ-6607-2020	Jain, Jyoti/0000-0001-7631-0791; Banait, Dr. Shashank/0000-0002-6541-4234				[Anonymous], Technical and Operational Guidelines for TB Control in India 2016; D J., 2015, J RES MED SCI, V20, P26; Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814; Friedrich SO, 2011, J CLIN MICROBIOL, V49, P4341, DOI 10.1128/JCM.05454-11; H D., 2010, J CLIN MICROBIOL, V48, P229, DOI [10.1128/JCM.01463-09, DOI 10.1128/JCM.01463-09]; L JK., 2014, PLOS ONE, V9; L SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/fmb.11.84, DOI 10.2217/FMB.11.84]; L Y, 2017, J MED MICROBIOL, V66, P910, DOI [10.1099/jmm.0.000522, DOI 10.1099/JMM.0.000522]; Lee HY, 2013, INT J TUBERC LUNG D, V17, P917, DOI 10.5588/ijtld.12.0885; M R., 2014, BMC PULM MED, V14, P1471; Porcel JM, 2013, INT J TUBERC LUNG D, V17, P1217, DOI 10.5588/ijtld.13.0178; Programme WHOGT, XPERT MTB RIF IMPL M; Programme WHOGT, AUT REAL TIM NUCL AC; R SB., 2015, J CLIN MICROBIOL, V53, P3636, DOI [10.1128/JCM.02182-15, DOI 10.1128/JCM.02182-15]; S IS., 2016, J CLIN MICROBIOL, V54, P1133, DOI [10.1128/JCM.03205-15, DOI 10.1128/JCM.03205-15]; Sharma SK, 2004, INDIAN J MED RES, V120, P316; T A., 2007, SCAND J CLIN LAB INV, V67, P877, DOI [10.1080/00365510701459742, DOI 10.1080/00365510701459742]; Vadwai V, 2011, J CLIN MICROBIOL, V49, P2540, DOI 10.1128/JCM.02319-10	18	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0251618	10.1371/journal.pone.0251618	http://dx.doi.org/10.1371/journal.pone.0251618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125834	Green Published, gold			2022-12-26	WOS:000664643500002
J	Garcia-Navas, R; Liceras-Boillos, P; Gomez, C; Baltanas, FC; Calzada, N; Nuevo-Tapioles, C; Cuezva, JM; Santos, E				Garcia-Navas, Rosula; Liceras-Boillos, Pilar; Gomez, Carmela; Baltanas, Fernando C.; Calzada, Nuria; Nuevo-Tapioles, Cristina; Cuezva, Jose M.; Santos, Eugenio			Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasis	ONCOGENE			English	Article							OXIDATIVE STRESS; CELL-PROLIFERATION; ACTIVATION; FISSION; SUPEROXIDE; INDUCTION; PATHWAYS; CANCER; FUSION; MASS	SOS1 ablation causes specific defective phenotypes in MEFs including increased levels of intracellular ROS. We showed that the mitochondria-targeted antioxidant MitoTEMPO restores normal endogenous ROS levels, suggesting predominant involvement of mitochondria in generation of this defective SOS1-dependent phenotype. The absence of SOS1 caused specific alterations of mitochondrial shape, mass, and dynamics accompanied by higher percentage of dysfunctional mitochondria and lower rates of electron transport in comparison to WT or SOS2-KO counterparts. SOS1-deficient MEFs also exhibited specific alterations of respiratory complexes and their assembly into mitochondrial supercomplexes and consistently reduced rates of respiration, glycolysis, and ATP production, together with distinctive patterns of substrate preference for oxidative energy metabolism and dependence on glucose for survival. RASless cells showed defective respiratory/metabolic phenotypes reminiscent of those of SOS1-deficient MEFs, suggesting that the mitochondrial defects of these cells are mechanistically linked to the absence of SOS1-GEF activity on cellular RAS targets. Our observations provide a direct mechanistic link between SOS1 and control of cellular oxidative stress and suggest that SOS1-mediated RAS activation is required for correct mitochondrial dynamics and function.	[Garcia-Navas, Rosula; Liceras-Boillos, Pilar; Gomez, Carmela; Baltanas, Fernando C.; Calzada, Nuria; Santos, Eugenio] Univ Salamanca, Ctr Invest Canc, Inst Biol Mol & Celular Canc, CSIC, Salamanca, Spain; [Garcia-Navas, Rosula; Liceras-Boillos, Pilar; Gomez, Carmela; Baltanas, Fernando C.; Calzada, Nuria; Santos, Eugenio] Ctr Invest Biomed Red Canc Canc CIBERONC, Madrid, Spain; [Nuevo-Tapioles, Cristina; Cuezva, Jose M.] Univ Autonoma Madrid, Dept Biol Mol, Ctr Biol Mol Severo Ochoa3, CSIC, Madrid, Spain; [Nuevo-Tapioles, Cristina; Cuezva, Jose M.] Ctr Invest Biomed Red Canc Enfermedades Raras CIB, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)	Santos, E (corresponding author), Univ Salamanca, Ctr Invest Canc, Inst Biol Mol & Celular Canc, CSIC, Salamanca, Spain.; Santos, E (corresponding author), Ctr Invest Biomed Red Canc Canc CIBERONC, Madrid, Spain.	esantos@usal.es	Baltanas, Fernando C./D-4756-2018; Nuevo-Tapioles, Cristina/AAT-5772-2021; Nuevo-Tapioles, Cristina/F-5970-2016; Baltanas, Fernando C./AAU-7451-2021	Baltanas, Fernando C./0000-0001-8110-0991; Nuevo-Tapioles, Cristina/0000-0001-5809-2030; Baltanas, Fernando C./0000-0001-8110-0991; Cuezva Marcos, Jose Manuel/0000-0003-1118-248X; Santos, Eugenio/0000-0003-3565-0321	ISCIII-MCUI [FIS PI19/00934, CIBERONC-CB16/12/00352]; Junta de Castilla y Leon [SA264P18-UIC 076]; Ramon Areces Foundation [CIVP19A5942]; FEDER funds	ISCIII-MCUI; Junta de Castilla y Leon(Junta de Castilla y Leon); Ramon Areces Foundation; FEDER funds(European Commission)	This work was supported by grants from ISCIII-MCUI (FIS PI19/00934 and CIBERONC-CB16/12/00352), Junta de Castilla y Leon (SA264P18-UIC 076), and Ramon Areces Foundation (CIVP19A5942). The research was co-financed by FEDER funds.	Amendola CR, 2019, NATURE, V576, P482, DOI 10.1038/s41586-019-1832-9; Amer YO, 2018, BBA-BIOENERGETICS, V1859, P868, DOI 10.1016/j.bbabio.2018.04.005; Enriquez JA, 2016, ANNU REV PHYSIOL, V78, P533, DOI 10.1146/annurev-physiol-021115-105031; Apostolova N, 2010, BRIT J PHARMACOL, V160, P2069, DOI 10.1111/j.1476-5381.2010.00866.x; Azrak SS, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-731; Babu D, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00031; Baker N, 2019, MITOCHONDRION, V49, P259, DOI 10.1016/j.mito.2019.06.003; Baltanas FC, 2020, BBA-REV CANCER, V1874, DOI 10.1016/j.bbcan.2020.188445; Baltanas FC, 2013, MOL CELL BIOL, V33, P4562, DOI 10.1128/MCB.01026-13; Bandaru P, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a031534; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Bartolini D, 2015, FREE RADICAL BIO MED, V88, P466, DOI 10.1016/j.freeradbiomed.2015.06.039; Brand MD, 2004, FREE RADICAL BIO MED, V37, P755, DOI 10.1016/j.freeradbiomed.2004.05.034; Buday L, 2008, BBA-REV CANCER, V1786, P178, DOI 10.1016/j.bbcan.2008.05.001; Byun JK, 2019, EMBO REP, V20, DOI 10.15252/embr.201847451; Caruana NJ, 2020, BIOCHEM SOC T, V48, P621, DOI 10.1042/BST20190930; Chen XL, 2004, CURR PHARM DESIGN, V10, P879, DOI 10.2174/1381612043452901; Cuezva JM, 2002, CANCER RES, V62, P6674; Demine S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080795; Ding S, 2020, BIOGENESIS NDUFS3 LE, DOI 10.22.350587; Dong J, 2008, ANTIOXID REDOX SIGN, V10, P2023, DOI 10.1089/ars.2007.2019; Drose S, 2012, ADV EXP MED BIOL, V748, P145, DOI 10.1007/978-1-4614-3573-0_6; Drosten M, 2014, P NATL ACAD SCI USA, V111, P15155, DOI 10.1073/pnas.1417549111; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Dudkina NV, 2010, BBA-BIOENERGETICS, V1797, P664, DOI 10.1016/j.bbabio.2009.12.013; Esteban LM, 2000, MOL CELL BIOL, V20, P6410, DOI 10.1128/MCB.20.17.6410-6413.2000; Gerboth S, 2018, LEUKEMIA, V32, P820, DOI 10.1038/leu.2017.267; Guo RY, 2018, BIOMED J, V41, P9, DOI 10.1016/j.bj.2017.12.001; Hong YA, 2018, ANTIOXID REDOX SIGN, V28, P1543, DOI 10.1089/ars.2017.7207; Iershov A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09598-9; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Kim H, 1999, J AM CHEM SOC, V121, P4902, DOI 10.1021/ja990190h; Koeberle SC, 2020, REDOX BIOL, V28, DOI 10.1016/j.redox.2019.101388; Kortum RL, 2011, P NATL ACAD SCI USA, V108, P12407, DOI 10.1073/pnas.1104295108; Kunkel GH, 2016, HEART FAIL REV, V21, P499, DOI 10.1007/s10741-016-9561-8; Lee HC, 2002, J BIOMED SCI, V9, P517, DOI 10.1007/BF02254978; Lee YJ, 2004, MOL BIOL CELL, V15, P5001, DOI 10.1091/mbc.E04-04-0294; Lee YK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15061; Liang HL, 2010, FREE RADICAL BIO MED, V49, P1550, DOI 10.1016/j.freeradbiomed.2010.08.018; Liceras-Boillos P, 2016, ONCOGENE, V35, P6389, DOI 10.1038/onc.2016.169; Liceras-Boillos P, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00049-18; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Markevich NI, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.557721; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; Maus M, 2017, CELL METAB, V25, P698, DOI 10.1016/j.cmet.2016.12.021; Mishra P, 2014, CELL METAB, V19, P630, DOI 10.1016/j.cmet.2014.03.011; Monteiro LD, 2020, METHODSX, V7, DOI 10.1016/j.mex.2020.100938; Nagdas S, 2019, CELL REP, V28, P1845, DOI 10.1016/j.celrep.2019.07.031; Nazarewicz RR, 2013, ANTIOXID REDOX SIGN, V19, P344, DOI 10.1089/ars.2013.5185; Ong SB, 2015, EUR J PHARMACOL, V763, P104, DOI 10.1016/j.ejphar.2015.04.056; Peng JY, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002212; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Pierre S, 2011, BIOCHEM PHARMACOL, V82, P1049, DOI 10.1016/j.bcp.2011.07.072; Qian XL, 2000, EMBO J, V19, P642, DOI 10.1093/emboj/19.4.642; Raghunath A, 2018, REDOX BIOL, V17, P297, DOI 10.1016/j.redox.2018.05.002; Ren Y, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2019.101154; Sanchez-Caballero L, 2016, BBA-BIOENERGETICS, V1857, P980, DOI 10.1016/j.bbabio.2016.03.031; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schrepfer E, 2016, MOL CELL, V61, P683, DOI 10.1016/j.molcel.2016.02.022; Semenza GL, 2017, EMBO J, V36, P252, DOI 10.15252/embj.201695204; Seo BJ, 2020, REDOX BIOL, V36, DOI 10.1016/j.redox.2020.101599; Serasinghe MN, 2017, HANDB EXP PHARMACOL, V240, P159, DOI 10.1007/164_2016_38; Seyfried TN, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101761; Son MJ, 2015, CELL DEATH DIFFER, V22, P1957, DOI 10.1038/cdd.2015.43; Suire S, 2019, J LEUKOCYTE BIOL, V106, P815, DOI 10.1002/JLB.2HI0918-359RR; Tan ZQ, 2016, MOL CANCER THER, V15, P774, DOI 10.1158/1535-7163.MCT-15-0621; Tao S, 2014, CANCER RES, V74, P7430, DOI 10.1158/0008-5472.CAN-14-1439; Toma-Fukai S, 2019, MOLECULES, V24, DOI 10.3390/molecules24183308; Valvona CJ, 2016, BRAIN PATHOL, V26, P3, DOI 10.1111/bpa.12299; Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; Wang DW, 2020, J CANCER, V11, P5042, DOI 10.7150/jca.45553; Wang DZM, 1997, GENE DEV, V11, P309, DOI 10.1101/gad.11.3.309; Wong GS, 2018, NAT MED, V24, P968, DOI 10.1038/s41591-018-0022-x; You XN, 2018, BLOOD, V132, P2575, DOI 10.1182/blood-2018-09-874107; Young TW, 2004, CANCER RES, V64, P4577, DOI 10.1158/0008-5472.CAN-04-0222; Zafarullah M, 2003, CELL MOL LIFE SCI, V60, P6, DOI 10.1007/s000180300001; Zanotti F, 2009, BIOCHEM BIOPH RES CO, V384, P43, DOI 10.1016/j.bbrc.2009.04.046; Zarich N, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-018-0111-1; Zhang Z, 2020, BRIT J CANCER, V122, P209, DOI 10.1038/s41416-019-0658-4	80	6	6	0	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2021	40	27					4538	4551		10.1038/s41388-021-01886-3	http://dx.doi.org/10.1038/s41388-021-01886-3		JUN 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TG4PV	34120142	hybrid, Green Published			2022-12-26	WOS:000660811300001
J	Banik, S; Saibire, K; Suryavanshi, S; Johns, G; Chakravorty, S; Kwiatkowski, R; Alland, D; Banada, PP				Banik, Sukalyani; Saibire, Kaheerman; Suryavanshi, Shraddha; Johns, Glenn; Chakravorty, Soumitesh; Kwiatkowski, Robert; Alland, David; Banada, Padmapriya P.			Inactivation of SARS-CoV-2 virus in saliva using a guanidium based transport medium suitable for RT-PCR diagnostic assays	PLOS ONE			English	Article							CORONAVIRUS	Background Upper respiratory samples used to test for SARS-CoV-2 virus may be infectious and present a hazard during transport and testing. A buffer with the ability to inactivate SARS-CoV-2 at the time of sample collection could simplify and expand testing for COVID-19 to non-conventional settings. Methods We evaluated a guanidium thiocyanate-based buffer, eNAT((TM)) (Copan) as a possible transport and inactivation medium for downstream Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) testing to detect SARS-CoV-2. Inactivation of SARS-CoV-2 USA-WA1/2020 in eNAT and in diluted saliva was studied at different incubation times. The stability of viral RNA in eNAT was also evaluated for up to 7 days at room temperature (28 degrees C), refrigerated conditions (4 degrees C) and at 35 degrees C. Results SARS-COV-2 virus spiked directly in eNAT could be inactivated at >5.6 log(10) PFU/ml within a minute of incubation. When saliva was diluted 1:1 in eNAT, no cytopathic effect (CPE) on VeroE6 cells was observed, although SARS-CoV-2 RNA could be detected even after 30 min incubation and after two cell culture passages. A 1:2 (saliva:eNAT) dilution abrogated both CPE and detectable viral RNA after as little as 5 min incubation in eNAT. SARS-CoV-2 RNA from virus spiked at 5X the limit of detection remained positive up to 7 days of incubation in all tested conditions. Conclusion eNAT and similar guanidinium thiocyanate-based media may be of value for transport, stabilization, and processing of clinical samples for RT-PCR based SARS-CoV-2 detection.	[Banik, Sukalyani; Saibire, Kaheerman; Suryavanshi, Shraddha; Alland, David; Banada, Padmapriya P.] Rutgers New Jersey Med Sch, Ctr Emerging Pathogens, Dept Med, Newark, NJ 07103 USA; [Johns, Glenn; Chakravorty, Soumitesh; Kwiatkowski, Robert] Cepheid, Sunnyvale, CA USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Alland, D; Banada, PP (corresponding author), Rutgers New Jersey Med Sch, Ctr Emerging Pathogens, Dept Med, Newark, NJ 07103 USA.	allandda@njms.rutgers.edu; priya.banada@rutgers.edu	Banada, Padmapriya/H-6213-2019	Banada, Padmapriya/0000-0002-5217-6142	National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01 AI131617]; Cepheid LLC; NIH/NIAID; Cepheid -NIH [R01 AI131617]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cepheid LLC; NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cepheid -NIH	This study was funded by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under award number R01 AI131617 and a research grant provided by Cepheid LLC. -DA received the funding from both NIH/NIAID and Cepheid -NIH R01 AI131617. Cepheid supplied the resources including the GeneXpert instrument and the Xpert Xpress SARS-CoV-2 cartridges -National Institute of Allergy and Infectious Diseases of the National Institutes of Health and Cepheid, LLC. -https://www.niaid.nih.gov/about/visitor-information and https://www.cepheid.com/Yes.Cepheid employees GJ, SC and RK were involved in the study design, review of the data and the final draft of the manuscript.	Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065; Banada Padmapriya, 2021, medRxiv, DOI 10.1101/2021.03.03.21251172; Barra GB, 2021, GENES-BASEL, V12, DOI 10.3390/genes12010090; Chan KH, 2020, J HOSP INFECT, V106, P226, DOI 10.1016/j.jhin.2020.07.009; Dewar R, 2020, ARCH PATHOL LAB MED, V144, P916, DOI 10.5858/arpa.2020-0175-LE; Haddock E, 2016, EMERG INFECT DIS, V22, P1292, DOI 10.3201/eid2207.160233; Harcourt J, 2020, EMERG INFECT DIS, V26, P1266, DOI 10.3201/eid2606.200516; Heilingloh Christiane Silke, 2020, Am J Infect Control, V48, P1273, DOI 10.1016/j.ajic.2020.07.031; Herzog P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-138; Kumar-M P, 2020, HEPATOL INT, V14, P711, DOI 10.1007/s12072-020-10071-9; Levett LJ., 2020, EXTRACTION FREE COVI, P1, DOI 10.1101/2020.04.06.028316; Loeffelholz MJ, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00926-20; Pastorino B, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12070735; Pastorino B, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060624; Patterson Edward I, 2020, bioRxiv, DOI [10.1093/infdis/jiaa507, 10.1101/2020.05.21.108035]; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; Richard-Greenblatt M, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00110-21; Scallan MF., 2020, BIORXIV, DOI [10.1101/2020.04.05.026435, DOI 10.1101/2020.04.05.026435]; Sohrabi C, 2020, INT J SURG, V76, P71, DOI 10.1016/j.ijsu.2020.02.034; van Bockel D, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12111208; Welch SR, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01713-20; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	23	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252687	10.1371/journal.pone.0252687	http://dx.doi.org/10.1371/journal.pone.0252687			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115762	Green Published, gold, Green Submitted			2022-12-26	WOS:000664643000028
J	Eckl, DB; Eben, SS; Schottenhaml, L; Eichner, A; Vasold, R; Spath, A; Baumler, W; Huber, H				Eckl, Daniel Bernhard; Eben, Stefanie Susanne; Schottenhaml, Laura; Eichner, Anja; Vasold, Rudolf; Spaeth, Andreas; Baeumler, Wolfgang; Huber, Harald			Interplay of phosphate and carbonate ions with flavin photosensitizers in photodynamic inactivation of bacteria	PLOS ONE			English	Article							SINGLET OXYGEN; METHYLENE-BLUE; WASTE-WATER; FATTY-ACIDS; RIBOFLAVIN; PATHOGENS; THERAPY; PHOTOINACTIVATION; OXIDATION; CURCUMIN	Photodynamic inactivation (PDI) of pathogenic bacteria is a promising technology in different applications. Thereby, a photosensitizer (PS) absorbs visible light and transfers the energy to oxygen yielding reactive oxygen species (ROS). The produced ROS are then capable of killing microorganisms via oxidative damage of cellular constituents. Among other PS, some flavins are capable of producing ROS and cationic flavins are already successfully applied in PDI. When PDI is used for example on tap water, PS like flavins will encounter various ions and other small organic molecules which might hamper the efficacy of PDI. Thus, the impact of carbonate and phosphate ions on PDI using two different cationic flavins (FLASH-02a, FLASH-06a) was investigated using Staphylococcus aureus and Pseudomonas aeruginosa as model organisms. Both were inactivated in vitro at a low light exposure of 0.72 J cm(-)(2). Upon irradiation, FLASH-02a reacts to single substances in the presence of carbonate or phosphate, whereas the photochemical reaction for FLASH-06a was more unspecific. DPBF-assays indicated that carbonate and phosphate ions decreased the generation of singlet oxygen of both flavins. Both microorganisms could be easily inactivated by at least one PS with up to 6 log(10) steps of cell counts in low ion concentrations. Using the constant radiation exposure of 0.72 J cm(-2), the inactivation efficacy decreased somewhat at medium ion concentrations but reached almost zero for high ion concentrations. Depending on the application of PDI, the presence of carbonate and phosphate ions is unavoidable. Only upon light irradiation such ions may attack the PS molecule and reduce the efficacy of PDI. Our results indicate concentrations for carbonate and phosphate, in which PDI can still lead to efficient reduction of bacterial cells when using flavin based PS.	[Eckl, Daniel Bernhard; Eben, Stefanie Susanne; Schottenhaml, Laura; Huber, Harald] Univ Regensburg, Dept Microbiol, Regensburg, Germany; [Eichner, Anja; Baeumler, Wolfgang] Univ Hosp Regensburg, Clin & Polyclin Dermatol, Regensburg, Germany; [Vasold, Rudolf] Univ Regensburg, Dept Organ Chem, Regensburg, Germany; [Spaeth, Andreas] TriOptoTec GmbH, Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Eckl, DB (corresponding author), Univ Regensburg, Dept Microbiol, Regensburg, Germany.	Daniel.eckl@ur.de		Schottenhaml, Laura/0000-0002-7983-1186	German Research Foundation (Deutsche Forschungsgemeinschaft DFG) [415812443]	German Research Foundation (Deutsche Forschungsgemeinschaft DFG)(German Research Foundation (DFG))	HH and WB received a grand (415812443) from the German Research Foundation (Deutsche Forschungsgemeinschaft DFG; www.dfg.de).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. TriOptoTec GmbH provided support in the form of salaries for the author Andreas Spath, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	Ahmad I, 2004, J PHOTOCH PHOTOBIO B, V75, P13, DOI 10.1016/j.jphotobiol.2004.04.001; Ahmad I., 2006, FLAVINS PHOTOCHEMIST, P13, DOI DOI 10.1039/9781847555397-00013; Almeida J, 2014, PHOTOCH PHOTOBIO SCI, V13, P626, DOI 10.1039/c3pp50195g; Baumler W, 2012, PHOTOCH PHOTOBIO SCI, V11, P107, DOI 10.1039/c1pp05142c; Baier J, 2006, BIOPHYS J, V91, P1452, DOI 10.1529/biophysj.106.082388; Bashford CL., 1987, SPECTROPHOTOMETRY SP; Bechert T, 2000, NAT MED, V6, P1053, DOI 10.1038/79568; Berlett BS, 2000, ANAL BIOCHEM, V287, P329, DOI 10.1006/abio.2000.4876; Bhavya ML, 2019, INT J FOOD MICROBIOL, V290, P296, DOI 10.1016/j.ijfoodmicro.2018.10.021; Blyth AW., 1879, J CHEM SOC, V530, P530, DOI [10.1039/CT8793500530, DOI 10.1039/CT8793500530]; Bundesministerium fuar Gesundheit, 1998, VER ZUL ZUS LEB TECH; Carvalho CMB, 2007, J PHOTOCH PHOTOBIO B, V88, P112, DOI 10.1016/j.jphotobiol.2007.04.015; Castano AP, 2004, PHOTODIAGN PHOTODYN, V1, P279, DOI 10.1016/S1572-1000(05)00007-4; CHACON JN, 1988, PHOTOCHEM PHOTOBIOL, V47, P647, DOI 10.1111/j.1751-1097.1988.tb02760.x; Cieplik F, 2013, FREE RADICAL BIO MED, V65, P477, DOI 10.1016/j.freeradbiomed.2013.07.031; Eckl DB, 2020, PHOTOCHEM PHOTOBIOL, V96, P883, DOI 10.1111/php.13229; Eckl DB, 2018, PHOTOCHEM PHOTOBIOL, V94, P165, DOI 10.1111/php.12846; Eichler M, 2005, LASER SURG MED, V37, P314, DOI 10.1002/lsm.20239; Eichner, 2018, BRIT J DERMATOL, V179, pE242, DOI [10.1111/bjd.17287, DOI 10.1111/BJD.17287]; Eichner A, 2020, J HOSP INFECT, V104, P85, DOI 10.1016/j.jhin.2019.07.016; Eichner A, 2015, PHOTOCH PHOTOBIO SCI, V14, P387, DOI 10.1039/c4pp00285g; ENGEBRECHT J, 1983, CELL, V32, P773, DOI 10.1016/0092-8674(83)90063-6; Engelhardt V, 2010, PHOTOCH PHOTOBIO SCI, V9, P365, DOI 10.1039/b9pp00144a; Fabritius M, 2020, MATERIALS, V13, DOI 10.3390/ma13061415; GALLOT S, 1993, FRESEN J ANAL CHEM, V346, P976, DOI 10.1007/BF00322762; GALSTON AW, 1949, P NATL ACAD SCI USA, V35, P10, DOI 10.1073/pnas.35.1.10; Galstyan A, 2019, J PHOTOCH PHOTOBIO B, V197, DOI 10.1016/j.jphotobiol.2019.111554; Glueck M, 2019, PHOTOCH PHOTOBIO SCI, V18, P1700, DOI 10.1039/c9pp00128j; Glueck M, 2017, PHOTOCH PHOTOBIO SCI, V16, P1784, DOI 10.1039/c7pp00165g; Gsponer NS, 2015, PHOTODIAGN PHOTODYN, V12, P67, DOI 10.1016/j.pdpdt.2014.12.004; Hamblin MR, 2002, J ANTIMICROB CHEMOTH, V49, P941, DOI 10.1093/jac/dkf053; Huang LY, 2017, ACS INFECT DIS, V3, P320, DOI 10.1021/acsinfecdis.7b00004; Huang LY, 2012, FREE RADICAL BIO MED, V53, P2062, DOI 10.1016/j.freeradbiomed.2012.09.006; Jemli M, 2002, J ENVIRON MONITOR, V4, P511, DOI 10.1039/b204637g; Jori G, 2011, J ENVIRON PATHOL TOX, V30, P261, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i3.90; Kainz QM, 2012, CHEMISTRYOPEN, V1, P125, DOI 10.1002/open.201200008; Kashiwabuchi RT, 2012, ARQ BRAS OFTALMOL, V75, P423, DOI 10.1590/S0004-27492012000600011; Ke MR, 2020, EMERG MICROBES INFEC, P1, DOI [10.1080/22221751.2019.1699450, DOI 10.1080/22221751.2019.1699450]; Kottke T, 2003, BIOPHYS J, V84, P1192, DOI 10.1016/S0006-3495(03)74933-9; Kuznetsova NA, 2007, J HAZARD MATER, V146, P487, DOI 10.1016/j.jhazmat.2007.04.064; Lambrechts SAG, 2005, ANTIMICROB AGENTS CH, V49, P2026, DOI 10.1128/AAC.49.5.2026-2034.2005; Maisch T, 2007, P NATL ACAD SCI USA, V104, P7223, DOI 10.1073/pnas.0611328104; Maisch T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111792; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; Massey V, 2000, BIOCHEM SOC T, V28, P283, DOI 10.1042/0300-5127:0280283; Morrison PWJ, 2013, MOL PHARMACEUT, V10, P756, DOI 10.1021/mp3005963; Mueller JH, 1941, P SOC EXP BIOL MED, V48, P330, DOI 10.3181/00379727-48-13311; Ohnishi T, 1998, BBA-BIOENERGETICS, V1364, P186, DOI 10.1016/S0005-2728(98)00027-9; Patterson MJ, 2000, EXP PHYSIOL, V85, P869, DOI 10.1017/S0958067000020583; Penzkofer A, 2012, INT J MOL SCI, V13, P9157, DOI 10.3390/ijms13079157; POSTHUMA J, 1960, BIOCHIM BIOPHYS ACTA, V41, P538, DOI 10.1016/0006-3002(60)90058-5; Regensburger J, 2012, EXP DERMATOL, V21, P135, DOI 10.1111/j.1600-0625.2011.01414.x; Remucal CK, 2011, ENVIRON SCI TECHNOL, V45, P5230, DOI 10.1021/es200411a; Roberts, 2013, ENCY BIOPHYSICS, P771; SATO K, 1989, J AM ACAD DERMATOL, V20, P537, DOI 10.1016/S0190-9622(89)70063-3; Schoenen J, 1998, NEUROLOGY, V50, P466, DOI 10.1212/WNL.50.2.466; Song SH, 2007, J PHOTOCH PHOTOBIO B, V87, P37, DOI 10.1016/j.jphotobiol.2006.12.007; Spath A, 2014, J MED CHEM, V57, P5157, DOI 10.1021/jm4019492; Sputh A., 2012, Patent No. [2012/175729 A1, 2012175729]; Sun Y, 2020, INT WOUND J, V17, P285, DOI 10.1111/iwj.13269; TAGLIAFERRI E, 1992, Mitteilungen aus dem Gebiete der Lebensmitteluntersuchung und Hygiene, V83, P435; Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091; Thakuri P S, 2011, Nepal Med Coll J, V13, P281; Thomas O, 2007, TECH INSTRUMENT, V27, P21, DOI 10.1016/S0167-9244(07)80004-7; Tim M, 2015, J PHOTOCH PHOTOBIO B, V150, P2, DOI 10.1016/j.jphotobiol.2015.05.010; Vaid FHM, 2019, J PHOTOCH PHOTOBIO A, V371, P59, DOI 10.1016/j.jphotochem.2018.10.048; Yang MY, 2018, J PHOTOCH PHOTOBIO B, V189, P21, DOI 10.1016/j.jphotobiol.2018.09.021; Yuan LT, 2020, J PHOTOCH PHOTOBIO B, V203, DOI 10.1016/j.jphotobiol.2019.111730	68	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253212	10.1371/journal.pone.0253212	http://dx.doi.org/10.1371/journal.pone.0253212			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115813	Green Published, gold			2022-12-26	WOS:000664643000059
J	Dalby, FR; Hafner, SD; Petersen, SO; Vanderzaag, A; Habtewold, J; Dunfield, K; Chantigny, MH; Sommer, SG				Dalby, Frederik R.; Hafner, Sasha D.; Petersen, Soren O.; Vanderzaag, Andrew; Habtewold, Jemaneh; Dunfield, Kari; Chantigny, Martin H.; Sommer, Sven G.			A mechanistic model of methane emission from animal slurry with a focus on microbial groups	PLOS ONE			English	Article							LIQUID DAIRY MANURE; GREENHOUSE-GAS EMISSIONS; ANAEROBIC-DIGESTION; METHANOGENIC PATHWAY; TEMPERATURE RESPONSE; STORAGE; AMMONIA; OXIDATION; COMMUNITY; ACETATE	Liquid manure (slurry) from livestock releases methane (CH4) that contributes significantly to global warming. Existing models for slurry CH4 production-used for mitigation and inventories-include effects of organic matter loading, temperature, and retention time but cannot predict important effects of management, or adequately capture essential temperature-driven dynamics. Here we present a new model that includes multiple methanogenic groups whose relative abundance shifts in response to changes in temperature or other environmental conditions. By default, the temperature responses of five groups correspond to those of four methanogenic species and one uncultured methanogen, although any number of groups could be defined. We argue that this simple mechanistic approach is able to describe both short- and long-term responses to temperature where other existing approaches fall short. The model is available in the open-source R package ABM (https://github.com/sashahafner/ABM) as a single flexible function that can include effects of slurry management (e.g., removal frequency and treatment methods) and changes in environmental conditions over time. Model simulations suggest that the reduction of CH4 emission by frequent emptying of slurry pits is due to washout of active methanogens. Application of the model to represent a full-scale slurry storage tank showed it can reproduce important trends, including a delayed response to temperature changes. However, the magnitude of predicted emission is uncertain, primarily as a result of sensitivity to the hydrolysis rate constant, due to a wide range in reported values. Results indicated that with additional work-particularly on the magnitude of hydrolysis rate-the model could be a tool for estimation of CH4 emissions for inventories.	[Dalby, Frederik R.; Hafner, Sasha D.; Sommer, Sven G.] Aarhus Univ, Fac Tech Sci, Dept Biotechnol & Chem Engn, Aarhus, Denmark; [Hafner, Sasha D.] Hafner Consulting LLC, Reston, VA USA; [Petersen, Soren O.] Aarhus Univ, Dept Agroecol, Tjele, Denmark; [Vanderzaag, Andrew; Habtewold, Jemaneh] Agr & Agri Food Canada, Ottawa Res & Dev Ctr, Ottawa, ON, Canada; [Dunfield, Kari] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada; [Chantigny, Martin H.] Agr & Agri Food Canada, Quebec Res & Dev Ctr, Quebec City, PQ, Canada	Aarhus University; Aarhus University; Agriculture & Agri Food Canada; University of Guelph; Agriculture & Agri Food Canada	Dalby, FR; Hafner, SD; Sommer, SG (corresponding author), Aarhus Univ, Fac Tech Sci, Dept Biotechnol & Chem Engn, Aarhus, Denmark.; Hafner, SD (corresponding author), Hafner Consulting LLC, Reston, VA USA.	fd@bce.au.dk; sasha@hafnerconsulting.com; sgs@bce.au.dk		Sommer, Sven Gjedde/0000-0002-2673-0162	Danish Agricultural Agency under the Ministry of Environment and Food (Miljo- og Fodevareministeriet) [33010-NIFA-19725]	Danish Agricultural Agency under the Ministry of Environment and Food (Miljo- og Fodevareministeriet)	This work was funded by the Danish Agricultural Agency under the Ministry of Environment and Food (Miljo- og Fodevareministeriet) (grant no. 33010-NIFA-19725). The funder provided support in the form of salaries for authors FRD, SDH, and SGS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Author SDH is employed by a commercial company: Hafner Consulting LLC.	Aguerre MJ, 2012, J DAIRY SCI, V95, P7409, DOI 10.3168/jds.2012-5340; ANGELIDAKI I, 1993, BIOTECHNOL BIOENG, V42, P159, DOI 10.1002/bit.260420203; Angelidaki I, 1999, BIOTECHNOL BIOENG, V63, P363, DOI 10.1002/(SICI)1097-0290(19990505)63:3<363::AID-BIT13>3.0.CO;2-Z; Astals S, 2018, WATER RES, V143, P127, DOI 10.1016/j.watres.2018.06.021; Balde H, 2016, AGR ECOSYST ENVIRON, V230, P261, DOI 10.1016/j.agee.2016.06.016; Baral KR, 2018, AGR SYST, V166, P26, DOI 10.1016/j.agsy.2018.07.009; Barret M, 2013, WATER RES, V47, P737, DOI 10.1016/j.watres.2012.10.047; Batstone D.J., 2002, ANAEROBIC DIGESTION; Batstone DJ, 2015, REV ENVIRON SCI BIO, V14, P595, DOI 10.1007/s11157-015-9376-4; Batstone DJ, 2002, WATER SCI TECHNOL, V45, P65; Chackhiani M, 2004, BIORESOURCE TECHNOL, V93, P227, DOI 10.1016/J.biortech.2003.11.005; CHEN M, 1983, APPL ENVIRON MICROB, V45, P1271, DOI 10.1128/AEM.45.4.1271-1276.1983; Choorit W, 2007, ELECTRON J BIOTECHN, V10, P376, DOI 10.2225/vol10-issue3-fulltext-7; Conrad R, 2020, PEDOSPHERE, V30, P25, DOI 10.1016/S1002-0160(18)60052-9; Dalby FR, 2021, J ENVIRON QUAL, V50, P817, DOI 10.1002/jeq2.20252; Dalby FR, 2020, BIORESOURCE TECHNOL, V307, DOI 10.1016/j.biortech.2020.123171; Dalby FR, 2020, RAPID COMMUN MASS SP, V34, DOI 10.1002/rcm.8628; Demirel Burak, 2008, Reviews in Environmental Science and Bio/Technology, V7, P173, DOI 10.1007/s11157-008-9131-1; Dong H., 2019, 2019 REFINEMENT 2006; Donoso-Bravo A, 2009, WATER SCI TECHNOL, V60, P9, DOI 10.2166/wst.2009.316; ELFERINK SJWH, 1994, FEMS MICROBIOL REV, V15, P119; Elsgaard L, 2016, SCI TOTAL ENVIRON, V539, P78, DOI 10.1016/j.scitotenv.2015.07.145; FAO, 2021, RES GLOB LIV ENV ASS; Fedorovich V, 2003, APPL BIOCHEM BIOTECH, V109, P33, DOI 10.1385/ABAB:109:1-3:33; Fotidis IA, 2013, FEMS MICROBIOL ECOL, V83, P38, DOI 10.1111/j.1574-6941.2012.01456.x; Gomez-Alvarez V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-122; Habtewold J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02806; Habtewold J, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.02830-17; Hafner SD, 2018, SOFTWAREX, V7, P205, DOI 10.1016/j.softx.2018.06.005; Hao LP, 2011, ENVIRON SCI TECHNOL, V45, P508, DOI 10.1021/es102228v; HASHIMOTO AG, 1984, AGR WASTES, V9, P299, DOI 10.1016/0141-4607(84)90088-X; Hattori S, 2008, MICROBES ENVIRON, V23, P118, DOI 10.1264/jsme2.23.118; Henze M., 1987, ACTIVATED SLUDGE MOD; HILL DT, 1982, T ASAE, V25, P1374; HILL DT, 1984, T ASAE, V27, P530; Hinshelwood CN, 1947, CANCER RES, V7, P548; Im S, 2020, WASTE MANAGE, V101, P35, DOI 10.1016/j.wasman.2019.09.036; Jablonski S, 2015, INT J SYST EVOL MICR, V65, P1360, DOI 10.1099/ijs.0.000065; Jackson RB, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab9ed2; Jarvis GN, 2000, CURR MICROBIOL, V40, P327, DOI 10.1007/s002849910065; Jensen MB, 2019, BIORESOURCE TECHNOL, V291, DOI 10.1016/j.biortech.2019.121784; Karakashev D, 2006, APPL ENVIRON MICROB, V72, P5138, DOI 10.1128/AEM.00489-06; Kariyapperuma KA, 2018, AGR FOREST METEOROL, V258, P56, DOI 10.1016/j.agrformet.2017.12.185; Kip N., 2017, SCI REP-UK, V7, P1; Kovalovszki A, 2020, APPL ENERG, V263, DOI 10.1016/j.apenergy.2020.114646; Liamleam W, 2007, BIOTECHNOL ADV, V25, P452, DOI 10.1016/j.biotechadv.2007.05.002; LIN CY, 1987, WATER SCI TECHNOL, V19, P299, DOI 10.2166/wst.1987.0210; Lindorfer H, 2008, BIORESOURCE TECHNOL, V99, P7011, DOI 10.1016/j.biortech.2008.01.034; Liu ST, 2008, BIORESOURCE TECHNOL, V99, P6817, DOI 10.1016/j.biortech.2008.01.054; Mangino J., 2001, 11 INT EM INV C; Markfoged R., 2013, MICROBIAL CONTROL GA; Masse DI, 2008, T ASABE, V51, P1775, DOI 10.13031/2013.25311; Masse DI, 2016, AGR ECOSYST ENVIRON, V221, P109, DOI 10.1016/j.agee.2016.01.018; Masse DI, 2015, WASTE MANAGE, V36, P86, DOI 10.1016/j.wasman.2014.10.032; Moller HB, 2004, BIOMASS BIOENERG, V26, P485, DOI 10.1016/j.biombioe.2003.08.008; Moller HB, 2004, J ENVIRON QUAL, V33, P27, DOI 10.2134/jeq2004.0027; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Ngwabie NM, 2016, J ENVIRON QUAL, V45, P2023, DOI 10.2134/jeq2016.01.0004; Nielsen DA, 2013, APPL ENVIRON MICROB, V79, P407, DOI 10.1128/AEM.02278-12; Ortega L, 2008, J ENVIRON MANAGE, V88, P517, DOI 10.1016/j.jenvman.2007.03.032; Ottosen LDM, 2009, BIOSYST ENG, V102, P291, DOI 10.1016/j.biosystemseng.2008.12.003; Ozbayram EG, 2020, APPL MICROBIOL BIOT, V104, P489, DOI 10.1007/s00253-019-10239-w; PAVLOSTATHIS SG, 1991, CRIT REV ENV CONTR, V21, P411, DOI 10.1080/10643389109388424; Petersen E.E, 1965, CHEM REACTION ANAL; Petersen SO, 2014, J APPL MICROBIOL, V117, P160, DOI 10.1111/jam.12498; Petersen SO, 2005, J ENVIRON QUAL, V34, P455; Petersen SO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160968; Petersen SO, 2012, J ENVIRON QUAL, V41, P88, DOI 10.2134/jeq2011.0184; R Core Team, 2020, R LANG ENV STAT COMP; Raposo F, 2020, RENEW SUST ENERG REV, V127, DOI 10.1016/j.rser.2020.109890; Rittmann B.E., 2001, ENV BIOTECHNOLOGY PR, DOI [10.1016/S0958-1669(96)80047-4, DOI 10.1016/S0958-1669(96)80047-4]; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; ROSSO L, 1993, J THEOR BIOL, V162, P447, DOI 10.1006/jtbi.1993.1099; Sollinger A, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00038-18; Sokolov VK, 2021, ENVIRON TECHNOL, V42, P2797, DOI 10.1080/09593330.2020.1714744; Sommer SG, 2000, J ENVIRON QUAL, V29, P744, DOI 10.2134/jeq2000.00472425002900030009x; Sommer SG, 2017, J ENVIRON QUAL, V46, P514, DOI 10.2134/jeq2016.10.0409; Tian Z, 2015, WATER RES, V69, P9, DOI 10.1016/j.watres.2014.11.001; VanderZaag AC, 2019, J AIR WASTE MANAGE, V69, P1096, DOI 10.1080/10962247.2019.1629359; VanLier JB, 1996, WATER RES, V30, P199, DOI 10.1016/0043-1354(95)00107-V; Vavilin VA, 2008, WASTE MANAGE, V28, P939, DOI 10.1016/j.wasman.2007.03.028; Wade MJ, 2020, PROCESSES, V8, DOI 10.3390/pr8080888; Wang HZ, 2019, APPL BIOCHEM BIOTECH, V189, P233, DOI 10.1007/s12010-019-03005-1; Weinrich S, 2018, PRAXISNAHE MODELLIER, DOI [10.18453/rosdok_id00002016, DOI 10.18453/ROSDOK_ID00002016]; Weinrich S, 2021, BIORESOURCE TECHNOL, V333, DOI 10.1016/j.biortech.2021.125124; Wood JD, 2014, NUTR CYCL AGROECOSYS, V99, P95, DOI 10.1007/s10705-014-9620-2; Yenigun O, 2013, PROCESS BIOCHEM, V48, P901, DOI 10.1016/j.procbio.2013.04.012; ZEEMAN G, 1994, FERT RES, V37, P207, DOI 10.1007/BF00748939	88	4	4	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252881	10.1371/journal.pone.0252881	http://dx.doi.org/10.1371/journal.pone.0252881			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111183	Green Published, gold			2022-12-26	WOS:000664642700056
J	Curado, DDP; Gomes, DF; Silva, TBC; Almeida, PHRF; Tavares, NUL; Areda, CA; da Silva, EN				Pereira Curado, Daniel da Silva; Gomes, Dalila Fernandes; Castano Silva, Thales Brendon; Ribeiro Fernandes Almeida, Paulo Henrique; Leao Tavares, Noemia Urruth; Areda, Camila Alves; da Silva, Everton Nunes			Direct cost of systemic arterial hypertension and its complications in the circulatory system from the perspective of the Brazilian public health system in 2019	PLOS ONE			English	Article							CARE-SENSITIVE CONDITIONS; RISK-FACTORS; GLOBAL BURDEN; BLOOD-PRESSURE; POPULATION; COMMUNITY; INTERVENTIONS; PREVALENCE; HEMORRHAGE; STRATEGY	Introduction Systemic arterial hypertension (SAH), a global public health problem and the primary risk factor for cardiovascular diseases, has a significant financial impact on health systems. In Brazil, the prevalence of SAH is 23.7%, which caused 203,000 deaths and 3.9 million DALYs in 2015. Objective To estimate the cost of SAH and circulatory system diseases attributable to SAH from the perspective of the Brazilian public health system in 2019. Methods A prevalence-based cost-of-illness was conducted using a top-down approach. The population attributable risk (PAR) was used to estimate the proportion of circulatory system diseases attributable to SAH. The direct medical costs were obtained from official Ministry of Health of Brazil records and literature parameters, including the three levels of care (primary, secondary, and tertiary). Deterministic univariate analyses were also conducted. Results The total cost of SAH and the proportion of circulatory system diseases attributable to SAH was Int$ 581,135,374.73, varying between Int$ 501,553,022.21 and Int$ 776,183,338.06. In terms only of SAH costs at all healthcare levels (Int$ 493,776,445.89), 97.3% were incurred in primary care, especially for antihypertensive drugs provided free of charge by the Brazilian public health system (Int$ 363,888,540.14). Stroke accounted for the highest cost attributable to SAH and the third highest PAR, representing 47% of the total cost of circulatory diseases attributable to SAH. Prevalence was the parameter that most affected sensitivity analyses, accounting for 36% of all the cost variation. Conclusion Our results show that the main Brazilian strategy to combat SAH was implemented in primary care, namely access to free antihypertensive drugs and multiprofessional teams, acting jointly to promote care and prevent and control SAH.	[Pereira Curado, Daniel da Silva; Gomes, Dalila Fernandes; Leao Tavares, Noemia Urruth; da Silva, Everton Nunes] Univ Brasilia, Grad Program Publ Hlth, Brasilia, DF, Brazil; [Castano Silva, Thales Brendon] Univ Fed Bahia, Dept Med, Fac Pharm, Salvador, BA, Brazil; [Ribeiro Fernandes Almeida, Paulo Henrique] Univ Fed Minas Gerais, Fac Pharm, Grad Program Med & Pharmaceut Serv, Belo Horizonte, MG, Brazil; [Areda, Camila Alves; da Silva, Everton Nunes] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil	Universidade de Brasilia; Universidade Federal da Bahia; Universidade Federal de Minas Gerais; Universidade de Brasilia	Curado, DDP (corresponding author), Univ Brasilia, Grad Program Publ Hlth, Brasilia, DF, Brazil.	danielspcurado@gmail.com	Silva, Thales/HHM-4282-2022; Almeida, Paulo Henrique Ribeiro Fernandes/AAD-6484-2020; Almeida, Paulo Henrique Ribeiro Fernandes/K-7052-2017; Areda, Camila/N-9302-2014	Almeida, Paulo Henrique Ribeiro Fernandes/0000-0002-9369-0690; Almeida, Paulo Henrique Ribeiro Fernandes/0000-0002-9369-0690; Curado, Daniel/0000-0002-5965-4194; Areda, Camila/0000-0002-3613-1585; Silva, Everton/0000-0001-8747-4185				Alcocer Luis, 2008, Ther Adv Cardiovasc Dis, V2, P147, DOI 10.1177/1753944708090572; Alencar Tatiane de Oliveira Silva, 2018, Saúde debate, V42, P159, DOI 10.1590/0103-11042018s211; Ali MS, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00984; Alvares J, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051007027, 10.11606/s1518-8787.2017051007027]; Andrade MV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201723; Firmo JOA, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000646, 10.11606/s1518-8787.2018052000646]; Ariesen MJ, 2003, STROKE, V34, P2060, DOI 10.1161/01.STR.0000080678.09344.8D; Arredondo A, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000293, 10.11606/s1518-8787.2018052000293]; Atun R, 2013, LANCET, V381, P690, DOI 10.1016/S0140-6736(13)60063-X; Baker R, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019965; Barreto MD, 2018, CIENC SAUDE COLETIVA, V23, P795, DOI 10.1590/1413-81232018233.12132016; Bilcke J, 2011, MED DECIS MAKING, V31, P675, DOI 10.1177/0272989X11409240; Brasil. Instituto Brasileiro de Geografia e Estatistica, 2019, SIST IBGE REC AUT; Brasil. Ministerio da Saude, 2013, CADERNOS ATENCAO BAS, V37, P1; Brasil. Ministerio da Saude, 2020, SIST GER TAB PROC ME; Brasil. Ministerio da Saude, 2016, PROCEDIMENTOS SEREM, P1; Brasil. Ministerio da Saude, DATASUS TRANSF DOWNL; Brasil. Ministerio da Saude, 2012, POL NAC AT BAS, P1; Brasil Ministerio da Saude Secretaria de Vigilancia em Saude Departamento de Vigilancia de Doencas e Agravos nao Transmissiveis, 2020, VIG BRAS 2019 VIG FA; Castro MC, 2019, LANCET, V394, P345, DOI 10.1016/S0140-6736(19)31243-7; de Almeida ATC, 2019, REV SAUDE PUBL, V53, DOI [10.11606/s1518-8787.2019053000733, 10.11606/S1518-8787.2019053000733]; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Correia JC, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7842-6; Costa FF, 2018, J CLIN HYPERTENS, V20, P125, DOI 10.1111/jch.13139; da Silva EN, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2016-000242; Silva RM, 2016, REV SAUDE PUBL, V50, DOI [10.1590/s1518-8787.2016050006605, 10.1590/S1518-8787.2016050006605]; da Silva RM, 2015, CIENC SAUDE COLETIVA, V20, P2943, DOI 10.1590/1413-812320152010.17352014; Dantas RCD, 2019, CIENC SAUDE COLETIVA, V24, P295, DOI 10.1590/1413-81232018241.35362016; de Oliveira ML., 2014, REV NUTR ONLINE, V27, P585, DOI DOI 10.1590/1415-52732014000500007; Dib MW, 2010, REV PANAM SALUD PUBL, V27, P125, DOI 10.1590/S1020-49892010000200006; Dourado I, 2011, MED CARE, V49, P577, DOI 10.1097/MLR.0b013e31820fc39f; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; Flor LS, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-001959; Fontbonne A, 2013, CAD SAUDE PUBLICA, V29, P1195, DOI 10.1590/S0102-311X2013001000016; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Gheorghe A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5806-x; Jafar TH, 2020, NEW ENGL J MED, V382, P717, DOI 10.1056/NEJMoa1911965; Ji X, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.10.115; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kirkland EB, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008731; Kobeissi E, 2019, EUR J EPIDEMIOL, V34, P547, DOI 10.1007/s10654-019-00510-9; Krishnan A, 2019, LANCET GLOB HEALTH, V7, pE1367, DOI 10.1016/S2214-109X(19)30338-9; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lu CH, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1401-6; de Rezende LFM, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006269, 10.1590/s1518-8787.2016050006269]; Macinko J, 2010, HEALTH AFFAIR, V29, P2149, DOI 10.1377/hlthaff.2010.0251; Malta Deborah Carvalho, 2018, Rev. bras. epidemiol., V21, pe180004, DOI [10.1590/1980-549720180018.supl.1, 10.1590/1980-549720180020.supl.1, 10.1590/1980-549720180004.supl.1]; Massuda A, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000829; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Mion Jr. Décio, 2004, Arq. Bras. Cardiol., V82, P7, DOI 10.1590/S0066-782X2004001000004; NILSON E. A. F, 2020, REV PANAMERICANA SAL, V44, P1, DOI [10.26633/RPSP.2020.32, DOI 10.26633/RPSP.2020.32]; Optimity Matrix, 2014, COST EFFECTIVENESS R; Paim J, 2011, LANCET, V377, P1778, DOI 10.1016/S0140-6736(11)60054-8; Pinho ND, 2013, ARQ BRAS CARDIOL, V101, pE65, DOI 10.5935/abc.20130173; Pinto LF, 2018, CIENC SAUDE COLETIVA, V23, P1903, DOI 10.1590/1413-81232018236.05592018; Poorzand H, 2019, EUR J CLIN INVEST, V49, DOI 10.1111/eci.13124; Rego AD, 2018, REV BRAS ENFERM, V71, P1030, DOI 10.1590/0034-7167-2017-0297; RICE DP, 1967, AM J PUBLIC HEALTH N, V57, P424, DOI 10.2105/AJPH.57.3.424; Rocha R, 2010, HEALTH ECON, V19, P126, DOI 10.1002/hec.1607; Sarki AM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001959; Schwalm JD, 2019, LANCET, V394, P1231, DOI 10.1016/S0140-6736(19)31949-X; Shea BJ, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j4008; Song PG, 2019, LANCET GLOB HEALTH, V7, pE1020, DOI 10.1016/S2214-109X(19)30255-4; Stopa SR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051000074, 10.1590/s1518-8787.2017051000074]; The World Bank, 2020, WORLD DEV IND PPP CO; Thomas H, 2018, GLOB HEART, V13, P143, DOI 10.1016/j.gheart.2018.09.511; Unger T, 2020, HYPERTENSION, V75, P1334, DOI 10.1161/HYPERTENSIONAHA.120.15026; Wang J, 2017, J STROKE CEREBROVASC, V26, P509, DOI 10.1016/j.jstrokecerebrovasdis.2016.12.002; Weaver CG, 2015, HYPERTENSION, V66, P502, DOI 10.1161/HYPERTENSIONAHA.115.05702; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO, 2013, HANDBOOK ON HEALTH INEQUALITY MONITORING: WITH A SPECIAL FOCUS ON LOW- AND MIDDLE-INCOME COUNTRIES, P1; WHO, 2020, ANTIGEN DETECTION DI; WHO Collaborating Centre for Drug Statistics Methodology, 2020, ATC DDD IND 2021; Williams B, 2018, EUR HEART J, V39, P3021, DOI 10.1093/eurheartj/ehy339; World Health Organization, 2018, NONC DIS COUNTR PROF, P1; Xu K, 2018, PUBLIC SPENDING HLTH; Yang H, 2015, OPEN HEART, V2, DOI 10.1136/openhrt-2014-000222; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zhang DL, 2017, AM J PREV MED, V53, pS121, DOI 10.1016/j.amepre.2017.05.008; Zhou B, 2017, LANCET, V389, P37, DOI 10.1016/S0140-6736(16)31919-5; Zhou B, 2019, LANCET, V394, P639, DOI 10.1016/S0140-6736(19)31145-6	83	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0253063	10.1371/journal.pone.0253063	http://dx.doi.org/10.1371/journal.pone.0253063			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111216	Green Published, gold			2022-12-26	WOS:000664642700092
J	Arcencio, RA; Berra, TZ; Terena, NDM; Rocha, MP; Alecrim, TFD; Kihara, FMD; Mascarello, KC; Sales, CMM; Maciel, ELN				Arcencio, Ricardo Alexandre; Berra, Thais Zamboni; Marcos Terena, Nahari de Faria; Rocha, Matheus Piumbini; de Araujo Alecrim, Tatiana Ferraz; de Souza Kihara, Fernanda Miye; Mascarello, Keila Cristina; Martins Sales, Carolina Maia; Noia Maciel, Ethel Leonor			Spatial clustering and temporal trend analysis of international migrants diagnosed with tuberculosis in Brazil	PLOS ONE			English	Article							SAO-PAULO; MIGRATION; HEALTH; POLICIES	Background Tuberculosis (TB) in migrants is of concern to health authorities worldwide and is even more critical in Brazil, considering the countrys size and long land borders. The aim of the study was to identify critical areas in Brazil for migrants diagnosed with TB and to describe the temporal trend in this phenomenon in recent years. Methods This is an ecological study that used spatial analysis and time series analysis. As the study population, all cases of migrants diagnosed with TB from 2014 to 2019 were included, and Brazilian municipalities were considered as the unit of ecological analysis. The Getis-Ord Gi* technique was applied to identify critical areas, and based on the identified clusters, seasonal-trend decomposition based on loess (STL) and Prais-Winsten autoregression were used, respectively, to trace and classify temporal trend in the analyzed series. In addition, several municipal socioeconomic indicators were selected to verify the association between the identified clusters and social vulnerability. Results 2,471 TB cases were reported in migrants. Gi* analysis showed that areas with spatial association with TB in immigrants coincide with critical areas for TB in the general population (coast of the Southeast and North regions). Four TB clusters were identified in immigrants in the states of Amazonas, Roraima, SAo Paulo, and Rio de Janeiro, with an upward trend in most of these clusters. The temporal trend in TB in immigrants was classified as increasing in Brazil (+ 60.66% per year [95% CI: 27.21-91.85]) and in the clusters in the states of Amazonas, Roraima, and Rio de Janeiro (+1.01, +2.15, and + 2.90% per year, respectively). The cluster in the state of SAo Paulo was the only one classified as stationary. The descriptive data on the municipalities belonging to the clusters showed evidence of the association between TB incidence and conditions of social vulnerability. Conclusions The study revealed the critical situation of TB among migrants in the country. Based on the findings, health authorities might focus on actions in regions identified, stablishing an intensive monitoring and following up, ensuring that these cases concluded their treatment and avoiding that they could spread the disease to the other regions or scenarios. The population of migrants are very dynamic, therefore strategies for following up them across Brazil are really urgent to manage the tuberculosis among international migrants in an efficient and proper way.	[Arcencio, Ricardo Alexandre; Berra, Thais Zamboni] Univ Sao Paulo Ribeirao Preto, Sch Nursing, Dept Maternal Infant & Publ Hlth Nursing, Sao Paulo, Brazil; [Marcos Terena, Nahari de Faria] Univ Roma La Sapienza, Dept Stat, Rome, Italy; [Rocha, Matheus Piumbini; de Souza Kihara, Fernanda Miye; Martins Sales, Carolina Maia; Noia Maciel, Ethel Leonor] Univ Fed Espirito Santo, Hlth Sci Ctr, Epidemiol Lab, Vitoria, ES, Brazil; [de Araujo Alecrim, Tatiana Ferraz] Univ Fed Sao Carlos, Dept Nursing, Sao Paulo, Brazil; [Mascarello, Keila Cristina] Univ Fed Espirito Santo, Ctr Univ Norte Espirito Santo, Vitoria, ES, Brazil	Universidade de Sao Paulo; Sapienza University Rome; Universidade Federal do Espirito Santo; Universidade Federal de Sao Carlos; Universidade Federal do Espirito Santo	Arcencio, RA (corresponding author), Univ Sao Paulo Ribeirao Preto, Sch Nursing, Dept Maternal Infant & Publ Hlth Nursing, Sao Paulo, Brazil.	ricardo@eerp.usp.br			Pan American Health Organization (PAHO) [67278]	Pan American Health Organization (PAHO)	ELNM received funding from the Pan American Health Organization (PAHO) [award number: 67278].	Alene KA, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4099-8; Arakawa T, 2015, CIENC SAUDE COLETIVA, V20, P3877, DOI 10.1590/1413-812320152012.09382014; Becketti S., 2013, INTRO TIME SERIES US; Boudville DA, 2020, J CLIN TUBER OTH MYC, V18, DOI 10.1016/j.jctube.2020.100143; Boudville DA, 2019, DATA BRIEF, V25, DOI 10.1016/j.dib.2019.104042; Cavalcanti L, 2019, SERIE MIGRACOES OBSE; Chikovore J, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002255; Cleveland R.B., 1990, J OFF STAT, V6, P3; Gutierrez JD, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311x00118417, 10.1590/0102-311X00118417]; Environmental Systems Research Institute (Esri), HOT SPOT AN GET ORD; Antunes JLF, 2015, EPIDEMIOL SERV SAUDE, V24, P565, DOI 10.5123/S1679-49742015000300024; GETIS A, 1992, GEOGR ANAL, V24, P189, DOI 10.1111/j.1538-4632.1992.tb00261.x; Granada D, 2017, INTERFACE-BOTUCATU, V21, P285, DOI 10.1590/1807-57622016.0626; Guerra Katia, 2017, Cad. saúde colet., V25, P123, DOI 10.1590/1414-462x201700010185; Hargreaves S, 2017, CLIN MICROBIOL INFEC, V23, P141, DOI 10.1016/j.cmi.2016.09.009; Hemminki K, 2014, EUR J PUBLIC HEALTH, V24, P92, DOI 10.1093/eurpub/cku108; Hertz D, 2019, SEMIN IMMUNOPATHOL, V41, P225, DOI 10.1007/s00281-018-0725-6; Hollo V, 2016, EURO SURVEILL, V21; Horton KC, 2018, TUBERCULOSIS, V113, P249, DOI 10.1016/j.tube.2018.09.006; Instituto Brasileiro de Geografia e Estatistica (IBGE), MUN FAIX FRONT; INSTITUTO BRASILEIRO DE GEOGRAFIA E ESTATISTICA (IBGE), BRAS SINT; International Organisation for Migration (IOM), 2016, S AM REG MIGR CONT; IOM, 2013, WORLD MIGRATION REPO; Kodmon C, 2016, EUROSURVEILLANCE, V21, P23, DOI 10.2807/1560-7917.ES.2016.21.12.30164; Kristensen KL., 2019, EURO SURVEILL, V24; Kunst H, 2017, INT J TUBERC LUNG D, V21, P840, DOI 10.5588/ijtld.17.0036; Lotfy N, 2020, J EGYPT PUBLIC HEAL, V95, DOI 10.1186/s42506-020-00040-3; Lu QB, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16183454; Maroko AR, 2020, J URBAN HEALTH, V97, P461, DOI 10.1007/s11524-020-00468-0; Martin D, 2018, SAUDE SOC-SAO PAULO, V27, P26, DOI [10.1590/s0104-12902018170870, 10.1590/S0104-12902018170870]; MORGENSTERN H, 1995, ANNU REV PUBL HEALTH, V16, P61, DOI 10.1146/annurev.pu.16.050195.000425; Motta I, 2020, PULMONOLOGY, V26, P233, DOI 10.1016/j.pulmoe.2020.05.002; Pareek M, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0595-5; Pescarini JM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1055-1; Pescarini JM, 2017, GLOBALIZATION HEALTH, V13, DOI 10.1186/s12992-017-0236-6; Quaglio G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194766; Rendon A, 2018, PULMONOLOGY, V24, P99, DOI 10.1016/j.rppnen.2017.11.007; Sa PRC., 2016, VULNERABILIDADE SOCI; San Pedro A., 2013, REV PANAM SALUD PUBL, V33; Scandurra G, 2020, PNEUMONIA, V12, DOI 10.1186/s41479-020-00072-5; Silveira C, 2013, CAD SAUDE PUBLICA, V29, P2017, DOI 10.1590/0102-311X00113212; Sotgiu G, 2017, PRESSE MED, V46, pE5, DOI 10.1016/j.lpm.2017.01.013; UNDP (UN Dev. Programme), 2014, HUMAN DEV REPORT 201; World Health Organization, 2021, 10 THREATS GLOB HLTH	44	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252712	10.1371/journal.pone.0252712	http://dx.doi.org/10.1371/journal.pone.0252712			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106968	Green Published			2022-12-26	WOS:000664642200055
J	Nakphook, S; Patumanond, J; Shrestha, M; Prasert, K; Chittaganpitch, M; Mott, JA; Praphasiri, P				Nakphook, Sutthichai; Patumanond, Jayanton; Shrestha, Manash; Prasert, Kriengkrai; Chittaganpitch, Malinee; Mott, Joshua A.; Praphasiri, Prabda			Antibody responses induced by trivalent inactivated influenza vaccine among pregnant and non-pregnant women in Thailand: A matched cohort study	PLOS ONE			English	Article							IMMUNOGENICITY; TITERS; PROTECTION	Background We compared influenza antibody titers among vaccinated and unvaccinated pregnant and non-pregnant women. Methods During 1(st) June- 30(th) September 2018, four groups of cohort participants-vaccinated pregnant, unvaccinated pregnant, vaccinated non-pregnant, and unvaccinated non-pregnant women were selected by matching age, gestational age, and the week of vaccination. Serum antibody titers against each strain of 2018 Southern Hemisphere inactivated trivalent influenza vaccine (IIV3) were assessed by hemagglutination inhibition (HI) assay on Day 0 (pre-vaccination) and Day 28 (one month post-vaccination) serum samples. Geometric mean titer (GMT), GMT ratio (GMR), seroconversion (defined as >= 4 fold increase in HI titer), and seroprotection (i.e. HI titer >= 1:40) were compared across the study groups using multilevel regression analyses, controlling for previous year vaccination from medical records and baseline antibody levels. Results A total of 132 participants were enrolled in the study (33 in each of the four study groups). The baseline GMTs for influenza A(H1N1), A(H3N2), and B vaccine strains were not significantly different among all four groups (all p-values >0.05). After one month, both vaccinated groups had significantly higher GMT, GMR, seroconversion, and seroprotection than their unvaccinated controls (all p-values <0.05). The seroconversion rate was over 60% for any strain among the vaccinated groups, with the highest (88.8%) observed against A(H1N1) in the vaccinated pregnant group. Similarly, at least 75% of the vaccinated participants developed seroprotective antibody levels against all three strains; the highest seroprotection was found against A(H3N2) at 92.6% among vaccinated non-pregnant participants. Antibody responses (post-vaccination GMT, GMR, seroconversion, and seroprotection) were not significantly different between pregnant and non-pregnant women for all three strains of IIV3 (all p>0.05). Conclusions The 2018 seasonal IIV3 was immunogenic against all three vaccine strains and pregnancy did not seem to alter the immune response to IIV3. These findings support the current influenza vaccination recommendations for pregnant women.	[Nakphook, Sutthichai] Minist Publ Hlth, Inst Prevent Med, Dept Dis Control, Nonthaburi, Thailand; [Nakphook, Sutthichai] Thammasat Univ, Fac Med, Bangkok, Thailand; [Patumanond, Jayanton] Chiang Mai Univ, Ctr Clin Epidemiol & Clin Stat, Fac Med, Chiang Mai, Thailand; [Shrestha, Manash] Mahidol Univ, Fac Social Sci & Humanities, Dept Hlth & Soc, Nakhon Pathom, Thailand; [Prasert, Kriengkrai] Nakhon Phanom Prov Hosp, Dept Primary Care Unit & Family Med, Nakhon Phanom, Thailand; [Chittaganpitch, Malinee] Minist Publ Hlth, Natl Inst Hlth, Nonthaburi, Thailand; [Mott, Joshua A.; Praphasiri, Prabda] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Influenza Program, Nonthaburi, Thailand; [Mott, Joshua A.] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Ministry of Public Health - Thailand; Thammasat University; Chiang Mai University; Mahidol University; Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA	Shrestha, M (corresponding author), Mahidol Univ, Fac Social Sci & Humanities, Dept Hlth & Soc, Nakhon Pathom, Thailand.	dr.manashshrestha@gmail.com		Nakphook, Sutthichai/0000-0001-5247-0221; Shrestha, Manash/0000-0002-5110-3742	Nakhon Phanom Provincial Hospital Foundation; NP [0032.202.3/7]	Nakhon Phanom Provincial Hospital Foundation; NP	This study was supported by the Nakhon Phanom Provincial Hospital Foundation (ref no. NP 0032.202.3/7) secured by KP and SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Amin AB, 2020, VACCINE, V38, P6478, DOI 10.1016/j.vaccine.2020.07.020; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Anonymous, 2022, ZAV EPAR MED OV; Black S, 2011, PEDIATR INFECT DIS J, V30, P1081, DOI 10.1097/INF.0b013e3182367662; Buchy P, 2020, INT J INFECT DIS, V92, P1, DOI 10.1016/j.ijid.2019.12.019; Chittaganpitch M, 2019, SE ASIAN J TROP MED, V50, P500; Cobey S, 2018, CLIN INFECT DIS, V67, P327, DOI 10.1093/cid/ciy097; Coudeville L, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-18; Ditsungnoen D, 2016, VACCINE, V34, P2141, DOI 10.1016/j.vaccine.2016.01.056; Domnich A, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020325; Fleiss JL., 2013, STAT METHODS RATES P; Gelman A, 2012, J RES EDUC EFF, V5, P189, DOI 10.1080/19345747.2011.618213; Kaoiean S, 2019, INFLUENZA OTHER RESP, V13, P582, DOI 10.1111/irv.12674; Kay AW, 2015, J INFECT DIS, V212, P861, DOI 10.1093/infdis/jiv138; Kissling E, 2019, VACCINE-X, V3, DOI 10.1016/j.jvacx.2019.100042; Kittikraisak W, 2021, VACCINE, V39, P18, DOI 10.1016/j.vaccine.2020.11.032; Leewongtrakul T., THAI J OBSTET GYNAEC, V2017, P75, DOI [10.14456/tjog.2017.12, DOI 10.14456/TJOG.2017.12]; Munoz FM, 2020, VACCINE, V38, P5355, DOI 10.1016/j.vaccine.2020.05.059; Munoz FM, 2018, VACCINE, V36, P8054, DOI 10.1016/j.vaccine.2018.10.088; Nakphook S., 2021, CHIANGRAI MED J, V13, P106; Nunes MC, 2018, HUM VACC IMMUNOTHER, V14, P758, DOI 10.1080/21645515.2017.1345385; Nunes MC, 2016, AM J PERINAT, V33, P1104, DOI 10.1055/s-0036-1586101; Ohfuji S, 2011, J INFECT DIS, V203, P1301, DOI 10.1093/infdis/jir026; Owusu JT, 2015, VACCINE, V33, P742, DOI 10.1016/j.vaccine.2014.10.029; Praphasiri P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169221; Quach THT, 2020, MATERN CHILD HLTH J, V24, P229, DOI 10.1007/s10995-019-02844-y; Schlaudecker EP, 2018, VACCINE, V36, P4734, DOI 10.1016/j.vaccine.2018.05.117; Schlaudecker EP, 2012, J INFECT DIS, V206, P1670, DOI 10.1093/infdis/jis592; Skowronski DM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092153; Sperling RS, 2012, OBSTET GYNECOL, V119, P631, DOI 10.1097/AOG.0b013e318244ed20; Steinhoff MC, 2010, NEW ENGL J MED, V362, P1644, DOI 10.1056/NEJMc0912599; Thongnoi P, 2017, LANCET, V389, P571, DOI 10.1016/S0140-6736(16)31334-4; WHO, 2011, MAN LAB DIAGN VIR SU; ( WHO) WHO, 2017, DEPRESSION, DOI DOI 10.1109/IEEESTD.2017.7920364; Wijnans L, 2016, INFLUENZA OTHER RESP, V10, P2, DOI 10.1111/irv.12351	36	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0253028	10.1371/journal.pone.0253028	http://dx.doi.org/10.1371/journal.pone.0253028			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106994	Green Published, gold, Green Submitted			2022-12-26	WOS:000664642200070
J	Shariati, M; Evans, KW; Zheng, XF; Bristow, CA; Ng, PKS; Rizvi, YQ; Tapia, C; Yang, F; Carugo, A; Heffernan, TP; Peoples, MD; Tripathy, D; Meric-Bernstam, F				Shariati, Maryam; Evans, Kurt W.; Zheng, Xiaofeng; Bristow, Christopher A.; Ng, Patrick Kwok-Shing; Rizvi, Yasmeen Q.; Tapia, Coya; Yang, Fei; Carugo, Alessandro; Heffernan, Timothy P.; Peoples, Michael D.; Tripathy, Debu; Meric-Bernstam, Funda			Combined inhibition of DDR1 and CDK4/6 induces synergistic effects in ER-positive, HER2-negative breast cancer with PIK3CA/AKT1 mutations	ONCOGENE			English	Article							DOMAIN RECEPTOR 1; THERAPY; AKT; PHOSPHORYLATION; PALBOCICLIB; FULVESTRANT; COMBINATION; DISCOVERY; COMPLEX; POTENT	Molecular alterations in the PI3K/AKT pathway occur frequently in hormone receptor-positive breast tumors. Patients with ER-positive, HER2-negative metastatic breast cancer are often treated with CDK4/6 inhibitors such as palbociclib in combination with endocrine therapy. Although this is an effective regimen, most patients ultimately progress. The purpose of this study was identifying synthetic lethality partners that can enhance palbociclib's antitumor efficacy in the presence of PIK3CA/AKT1 mutations. We utilized a barcoded shRNA library to determine critical targets for survival in isogenic MCF7 cells with PIK3CA/AKT1 mutations. We demonstrated that the efficacy of palbociclib is reduced in the presence of PIK3CA/AKT1 mutations. We also identified that the downregulation of discoidin domain receptor 1 (DDR1) is synthetically lethal with palbociclib. DDR1 knockdown and DDR1 pharmacological inhibitor decreased cell growth and inhibited cell cycle progression in all cell lines, while enhanced the sensitivity of PIK3CA/AKT1 mutant cells to palbociclib. Combined treatment of palbociclib and 7rh further induced cell cycle arrest in PIK3CA/AKT1 mutant cell lines. In vivo, 7rh significantly enhanced palbociclib's antitumor efficacy. Our data indicates that DDR1 inhibition can augment cell cycle suppressive effect of palbociclib and could be effective strategy for targeted therapy of ER-positive, HER2-negative breast cancers with PI3K pathway activation.	[Shariati, Maryam; Evans, Kurt W.; Rizvi, Yasmeen Q.; Tapia, Coya; Yang, Fei; Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA; [Zheng, Xiaofeng] Univ Texas MD Anderson Canc Ctr, Dept Bioinformat & Computat Biol, Houston, TX 77030 USA; [Bristow, Christopher A.; Carugo, Alessandro; Heffernan, Timothy P.; Peoples, Michael D.] Univ Texas MD Anderson Canc Ctr, Ctr Coclin Trials, Houston, TX 77030 USA; [Bristow, Christopher A.; Carugo, Alessandro; Heffernan, Timothy P.; Peoples, Michael D.] Univ Texas MD Anderson Canc Ctr, Inst Appl Canc Sci, Houston, TX 77030 USA; [Ng, Patrick Kwok-Shing; Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Sheikh Khalifa Bin Zayed Inst Personalized Canc T, Houston, TX 77030 USA; [Tapia, Coya; Yang, Fei] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Tripathy, Debu] Univ Texas MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX 77030 USA; [Meric-Bernstam, Funda] Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Meric-Bernstam, F (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Houston, TX 77030 USA.; Meric-Bernstam, F (corresponding author), Univ Texas MD Anderson Canc Ctr, Sheikh Khalifa Bin Zayed Inst Personalized Canc T, Houston, TX 77030 USA.; Meric-Bernstam, F (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Breast Surg Oncol, Houston, TX 77030 USA.	fmeric@mdanderson.org		Carugo, Alessandro/0000-0001-5182-3320	Nellie B. Connally Breast Cancer Research Endowment; Center for Clinical and Translational Sciences (CTSA-Informatics) [1UL1TR003167-01]; MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer; Cancer Prevention Institute of Texas [RP150535]; Cancer Center Support Grant (CCSG) by National Cancer Institute (NCI) [CA-16672]	Nellie B. Connally Breast Cancer Research Endowment; Center for Clinical and Translational Sciences (CTSA-Informatics); MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer; Cancer Prevention Institute of Texas; Cancer Center Support Grant (CCSG) by National Cancer Institute (NCI)	This work was funded in part by the Nellie B. Connally Breast Cancer Research Endowment, The Center for Clinical and Translational Sciences (CTSA-Informatics) #1UL1TR003167-01, the MD Anderson Cancer Center Sheikh Khalifa Bin Zayed Al Nahyan Institute for Personalized Cancer, and the Cancer Prevention Institute of Texas Grant RP150535: Precision Oncology Decision Support Core. The MD Anderson Reverse Phase Protein Array Core Facility and Histology, Pathology, and Imaging Core were funded by the Cancer Center Support Grant (CCSG) funded by National Cancer Institute (NCI) #CA-16672.	Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Andre F., 2018, ANN ONCOL, V29, DOI 10.1093/annonc/mdy424.010; [Anonymous], 2018, N Engl J Med, V379, P2582, DOI 10.1056/NEJMx180043; [Anonymous], 2016, PALBOCICLIB PACKAGE; Assent D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116006; Beaver JA, 2013, CLIN CANCER RES, V19, P5413, DOI 10.1158/1078-0432.CCR-13-0884; Belfiore A, 2018, CELL ADHES MIGR, V12, P305, DOI 10.1080/19336918.2018.1445953; Brennan P, 1997, IMMUNITY, V7, P679, DOI 10.1016/S1074-7613(00)80388-X; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cortes J, 2017, CANCER TREAT REV, V61, P53, DOI 10.1016/j.ctrv.2017.09.011; Cristofanilli M, 2018, EUR J CANCER, V104, P21, DOI 10.1016/j.ejca.2018.08.011; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Das S, 2006, CANCER RES, V66, P8123, DOI 10.1158/0008-5472.CAN-06-1215; Day PJ, 2009, P NATL ACAD SCI USA, V106, P4166, DOI 10.1073/pnas.0809645106; Dean JL, 2010, ONCOGENE, V29, P4018, DOI 10.1038/onc.2010.154; Dogruluk T, 2015, CANCER RES, V75, P5341, DOI 10.1158/0008-5472.CAN-15-1654; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Franco J, 2014, ONCOTARGET, V5, P6512, DOI 10.18632/oncotarget.2270; Gadiya M, 2018, CELL ADHES MIGR, V12, P315, DOI 10.1080/19336918.2018.1520556; Gao MS, 2013, J MED CHEM, V56, P3281, DOI 10.1021/jm301824k; Gordus A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.72; Herrera-Abreu MT, 2016, CANCER RES, V76, P2301, DOI 10.1158/0008-5472.CAN-15-0728; HINDS PW, 1994, CURR OPIN GENET DEV, V4, P135, DOI 10.1016/0959-437X(94)90102-3; Hu J, 2007, BIOINFORMATICS, V23, P1986, DOI 10.1093/bioinformatics/btm283; Hyman DM, 2017, J CLIN ONCOL, V35, P2251, DOI 10.1200/JCO.2017.73.0143; Jansen VM, 2017, CANCER RES, V77, P2488, DOI 10.1158/0008-5472.CAN-16-2653; Ju ZL, 2015, BIOINFORMATICS, V31, P912, DOI 10.1093/bioinformatics/btu736; Juric D, 2016, CANCER RES, V76, DOI 10.1158/1538-7445.SABCS15-P3-14-01; Koh M, 2015, INT J CANCER, V136, pE508, DOI 10.1002/ijc.29154; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Mata R, 2016, ONCOTARGET, V7, P7683, DOI 10.18632/oncotarget.6524; Meric-Bernstam F, 2018, JCO PRECIS ONCOL, V2, P1, DOI 10.1200/PO.17.00245; Miller TW, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3039; O'Leary B, 2018, CANCER DISCOV, V8, P1390, DOI 10.1158/2159-8290.CD-18-0264; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Saby C, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00462; Shariati M, 2019, EXPERT OPIN INV DRUG, V28, P977, DOI 10.1080/13543784.2019.1676726; Toogood PL, 2005, J MED CHEM, V48, P2388, DOI 10.1021/jm049354h; Vehlow A, 2019, CELL REP, V26, P3672, DOI 10.1016/j.celrep.2019.02.096; VILLALBA M, 2019, SCI REP-UK, V9; Vora SR, 2014, CANCER CELL, V26, P136, DOI 10.1016/j.ccr.2014.05.020; Wander SA, 2020, CANCER DISCOV, V10, P1174, DOI 10.1158/2159-8290.CD-19-1390	44	4	4	7	12	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 1	2021	40	26					4425	4439		10.1038/s41388-021-01819-0	http://dx.doi.org/10.1038/s41388-021-01819-0		JUN 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TC8LA	34108622	Green Submitted			2022-12-26	WOS:000659470200002
J	Thomsen, HM; Balsby, TJS; Dabelsteen, T				Thomsen, Heidi M.; Balsby, Thorsten J. S.; Dabelsteen, Torben			Follow the leader? Orange-fronted conures eavesdrop on conspecific vocal performance and utilise it in social decisions	PLOS ONE			English	Article							FISSION-FUSION DYNAMICS; FEMALE MATE CHOICE; PUBLIC INFORMATION; CONTACT CALLS; GREAT TITS; BIRD SONG; DOMINANCE; BEHAVIOR; SEX; NEIGHBORS	Animals regularly use social information to make fitness-relevant decisions. Particularly in social interactions, social information can reduce uncertainty about the relative quality of conspecifics, thus optimising decisions on with whom and how to interact. One important resource for individuals living in social environments is the production of information by signalling conspecifics. Recent research has suggested that some species of parrots engage in affiliative contact call matching and that these interactions may be available to conspecific unintended receivers. However, it remains unclear what information third parties may gain from contact call matching and how it can be utilised during flock decisions. Here, using a combined choice and playback experiment, we investigated the flock fusion choices and vocal behaviour of a social parrot species, the orange-fronted conure (Eupsittula canicularis), to a contact call matching interaction between two individuals of different sexes and with different vocal roles. Our results revealed that orange-fronted conures chose to follow vocal leaders more often than vocal followers during fusions. Furthermore, flocks responded with higher call rates and matched the stimulus calls closer when subsequently choosing a vocal leader. Interestingly, orange-fronted conures also showed higher contact call rates and closer matches when choosing males over females. These results suggest that paying attention to conspecific contact call interactions can provide individuals with social information that can be utilised during fission and fusion events, significantly influencing the social dynamics of orange-fronted conures.	[Thomsen, Heidi M.; Dabelsteen, Torben] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Balsby, Thorsten J. S.] Aarhus Univ, Dept Biosci, Wildlife Ecol, Ronde, Denmark	University of Copenhagen; Aarhus University	Thomsen, HM (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	thomsenhm@gmail.com		Thomsen, Heidi Maria/0000-0003-4934-7729; Balsby, Thorsten J. S./0000-0001-6855-4040	Danish Council for Independent Research, Natural Sciences [DFF 1323-00105]	Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF))	This study was funded by the the Danish Council for Independent Research, Natural Sciences (https://dff.dk/) through a framework grant to Torben Dabelsteen (DFF 1323-00105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcay C, 2010, ANIM BEHAV, V80, P1041, DOI 10.1016/j.anbehav.2010.09.009; [Anonymous], 2006, SAS MIXED MODELS; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Balsby TJS, 2008, P ROY SOC B-BIOL SCI, V275, P2147, DOI 10.1098/rspb.2008.0517; Balsby TJS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049747; Balsby TJS, 2011, ANIM BEHAV, V81, P983, DOI 10.1016/j.anbehav.2011.01.034; Balsby TJS, 2009, BEHAV PROCESS, V82, P133, DOI 10.1016/j.beproc.2009.05.005; Barelli C, 2008, BEHAVIOUR, V145, P965, DOI 10.1163/156853908784089243; Bartsch C, 2014, BEHAV ECOL SOCIOBIOL, V68, P1163, DOI 10.1007/s00265-014-1727-6; Beecher MD, 2007, ANIM BEHAV, V73, P929, DOI 10.1016/j.anbehav.2006.10.013; Boykin D., 2010, C APPL STAT AGR, DOI [10.4148/2475-7772.1064, DOI 10.4148/2475-7772.1064]; Bradbury, 2001, J ACOUST SOC AM, V115, P2373, DOI [10.1121/1.4780035, DOI 10.1121/1.4780035]; Bradbury JW, 2016, BEHAV ECOL SOCIOBIOL, V70, P293, DOI 10.1007/s00265-016-2068-4; Bradbury JW, 2001, AUK, V118, P958, DOI 10.1642/0004-8038(2001)118[0958:GVITCC]2.0.CO;2; BROWN CR, 1986, SCIENCE, V234, P83, DOI 10.1126/science.234.4772.83; Buhrman-Deever SC, 2008, ANIM BEHAV, V76, P1715, DOI 10.1016/j.anbehav.2008.08.007; Cheney Dorothy L., 2005, P583, DOI 10.1017/CBO9780511610363.030; Connor RC., 2000, CETACEAN SOC FIELD S, P89, DOI [10.1023/A:1017339526569, DOI 10.1023/A:1017339526569]; Conradt L, 2005, TRENDS ECOL EVOL, V20, P449, DOI 10.1016/j.tree.2005.05.008; Conradt L, 2009, AM NAT, V173, P304, DOI 10.1086/596532; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Conradt L, 2009, PHILOS T R SOC B, V364, P807, DOI 10.1098/rstb.2008.0257; Cortopassi Kathryn A., 2000, Bioacoustics, V11, P89; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; Dabelsteen Torben, 2006, P38; Dall SRX, 2005, TRENDS ECOL EVOL, V20, P187, DOI 10.1016/j.tree.2005.01.010; Danchin E, 2004, SCIENCE, V305, P487, DOI 10.1126/science.1098254; Doligez B, 2003, ANIM BEHAV, V66, P973, DOI 10.1006/anbe.2002.2270; Dreiss AN, 2013, BEHAV ECOL, V24, P717, DOI 10.1093/beheco/ars210; DUGATKIN LA, 1992, AM NAT, V139, P1384, DOI 10.1086/285392; Dyer JRG, 2009, PHILOS T R SOC B, V364, P781, DOI 10.1098/rstb.2008.0233; Dyrcz A, 2004, IBIS, V146, P269, DOI 10.1046/j.1474-919X.2004.00256.x; Earley RL, 2010, PHILOS T R SOC B, V365, P2675, DOI 10.1098/rstb.2010.0147; Fleischmann D, 2014, BEHAV ECOL, V25, P1240, DOI 10.1093/beheco/aru117; Franks NR, 2003, P ROY SOC B-BIOL SCI, V270, P2457, DOI 10.1098/rspb.2003.2527; Freed-Brown G, 2009, P ROY SOC B-BIOL SCI, V276, P3319, DOI 10.1098/rspb.2009.0580; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; Godin JGJ, 2005, ANIM BEHAV, V69, P999, DOI 10.1016/j.anbehav.2004.07.016; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Harel R, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2654; Jones BC, 2011, ANIM BEHAV, V81, P1203, DOI 10.1016/j.anbehav.2011.03.003; Juniper T, 1998, PARROTS GUIDE PARROT; Kendal RL, 2005, ADV STUD BEHAV, V35, P333, DOI 10.1016/S0065-3454(05)35008-X; Kerth G, 2006, P ROY SOC B-BIOL SCI, V273, P2785, DOI 10.1098/rspb.2006.3647; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; King Andrew J., 2009, Communicative & Integrative Biology, V2, P147; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; King SL, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0666; King SL, 2014, ANIM BEHAV, V96, P79, DOI 10.1016/j.anbehav.2014.07.019; KRAMER HG, 1983, BEHAVIOUR, V85, P198, DOI 10.1163/156853983X00228; KRAUSE J, 1993, OECOLOGIA, V93, P356, DOI 10.1007/BF00317878; Krause J, 2002, LIVING GROUPS; Krause J, 2009, BEHAV ECOL SOCIOBIOL, V63, P967, DOI 10.1007/s00265-009-0747-0; KREBS JR, 1981, ANIM BEHAV, V29, P918, DOI 10.1016/S0003-3472(81)80029-2; Kulahci IG, 2019, TRENDS ECOL EVOL, V34, P545, DOI 10.1016/j.tree.2019.02.007; Kurvers RHJM, 2010, ECOL LETT, V13, P829, DOI 10.1111/j.1461-0248.2010.01473.x; Maransky BP, 2001, WILSON BULL, V113, P350, DOI 10.1676/0043-5643(2001)113[0350:FYEARD]2.0.CO;2; Marshall-Pescini S, 2011, ANIM BEHAV, V81, P1177, DOI 10.1016/j.anbehav.2011.02.029; Matuzak GD, 2008, WILSON J ORNITHOL, V120, P353, DOI 10.1676/07-038.1; McGregor Peter K., 1996, P409; MCGREGOR PK, 1992, ANIM BEHAV, V43, P987, DOI 10.1016/0003-3472(92)90012-X; Mennill DJ, 2002, SCIENCE, V296, P873, DOI 10.1126/science.296.5569.873; Picard AM, 2020, ETHOLOGY, V126, P207, DOI 10.1111/eth.12999; Naguib M, 2004, BEHAV ECOL, V15, P1011, DOI 10.1093/beheco/arh108; NIELSEN BMB, 1995, BEHAV ECOL SOCIOBIOL, V37, P109, DOI 10.1007/BF00164156; Oliveira RF, 1998, P ROY SOC B-BIOL SCI, V265, P1045, DOI 10.1098/rspb.1998.0397; Ortiz ST, 2020, ANIM COGN, V23, P265, DOI 10.1007/s10071-019-01331-9; Otter K, 1999, P ROY SOC B-BIOL SCI, V266, P1305, DOI 10.1098/rspb.1999.0779; Otter Ken A., 2005, P133, DOI 10.1017/CBO9780511610363.010; Palomera-Garcia C, 2010, STUD NEOTROP FAUNA E, V45, P139, DOI 10.1080/01650521.2010.523292; Peake TM, 2005, ANIM BEHAV, V69, P1063, DOI 10.1016/j.anbehav.2004.08.009; Peake Tom M., 2006, P13; Peron F, 2011, ANIM COGN, V14, P545, DOI 10.1007/s10071-011-0389-2; Peron F, 2013, ANIM COGN, V16, P197, DOI 10.1007/s10071-012-0564-0; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Podos J, 2004, ANNU REV ECOL EVOL S, V35, P55, DOI 10.1146/annurev.ecolsys.35.021103.105719; POYSA H, 1992, ORNIS SCAND, V23, P159, DOI 10.2307/3676444; PRUETTJONES S, 1992, AM NAT, V140, P1000, DOI 10.1086/285452; Ramos-Fernandez G, 2005, INT J PRIMATOL, V26, P1077, DOI 10.1007/s10764-005-6459-z; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; REYNOLDS JD, 1990, AM NAT, V136, P230, DOI 10.1086/285093; Scarl JC, 2009, ANIM BEHAV, V77, P1019, DOI 10.1016/j.anbehav.2008.11.024; Schmidt KA, 2010, OIKOS, V119, P304, DOI 10.1111/j.1600-0706.2009.17573.x; Seibert LM, 2001, APPL ANIM BEHAV SCI, V71, P155, DOI 10.1016/S0168-1591(00)00172-6; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Seyfarth RM, 2014, ANIM BEHAV, V87, P23, DOI 10.1016/j.anbehav.2013.10.008; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Soma M, 2004, BEHAVIOUR, V141, P1121, DOI 10.1163/1568539042664560; Subiaul F, 2008, ANIM COGN, V11, P611, DOI 10.1007/s10071-008-0151-6; Sueur C, 2011, OIKOS, V120, P1608, DOI 10.1111/j.1600-0706.2011.19685.x; Thomsen HM, 2019, BEHAVIOUR, V156, P787, DOI 10.1163/1568539X-00003548; VALONE TJ, 1989, OIKOS, V56, P357, DOI 10.2307/3565621; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Van Vugt M, 2008, PSYCHOL SCI, V19, P854, DOI 10.1111/j.1467-9280.2008.02168.x; Vehrencamp SL, 2007, BEHAV ECOL, V18, P849, DOI 10.1093/beheco/arm054; Vehrencamp SL, 2003, ETHOLOGY, V109, P37, DOI 10.1046/j.1439-0310.2003.00850.x; Vehrencamp SL, 2001, P ROY SOC B-BIOL SCI, V268, P1637, DOI 10.1098/rspb.2001.1714; Walloe S, 2015, BEHAVIOUR, V152, P1433, DOI 10.1163/1568539X-00003286; Wright J, 2003, J ANIM ECOL, V72, P1003, DOI 10.1046/j.1365-2656.2003.00771.x	100	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252374	10.1371/journal.pone.0252374	http://dx.doi.org/10.1371/journal.pone.0252374			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106975	Green Published, gold			2022-12-26	WOS:000664642200044
J	Wynn, A; Tweeten, S; McDonald, E; Wooten, W; Lucas, K; Cyr, CL; Hernandez, M; Ramirez, F; VanWormer, C; Suckow, S; Ramers, CB; Martin, NK				Wynn, Adriane; Tweeten, Samantha; McDonald, Eric; Wooten, Wilma; Lucas, Kimberley; Cyr, Cassandra L.; Hernandez, Maricris; Ramirez, Franchesca; VanWormer, Corey; Suckow, Scott; Ramers, Christian B.; Martin, Natasha K.			The estimated hepatitis C seroprevalence and key population sizes in San Diego in 2018	PLOS ONE			English	Article							SPONTANEOUS VIRAL CLEARANCE; INJECTION-DRUG USE; VIRUS-INFECTION; PEOPLE; RECOMMENDATIONS; INTERVENTIONS; IMPACT; HIV; MEN; SEX	Background The Eliminate Hepatitis C San Diego County Initiative was established to provide a roadmap to reduce new HCV infections by 80% and HCV-related deaths by 65% by 2030. An estimate of the burden of HCV infections in San Diego County is necessary to inform planning and evaluation efforts. Our analysis was designed to estimate the HCV burden in San Diego County in 2018. Methods We synthesized data from the American Community Survey, Centers for Disease Control and Prevention, California Department of Public Health, Public Health Branch of California Correctional Health Care Services, San Diego Blood Bank, and published literature. Burden estimates were stratified by subgroup (people who inject drugs in the community [PWID], men who have sex with men in the community [MSM], general population in the community [stratified by age and sex], and incarcerated individuals). To account for parameter uncertainty, 100,000 parameter sets were sampled from each parameter's uncertainty distribution, and used to calculate the mean and 95% confidence interval estimates of the number of HCV seropositive adults in San Diego in 2018. Findings We found there were 55,354 (95% CI: 25,411-93,329) adults with a history of HCV infection in San Diego County in 2018, corresponding to an HCV seroprevalence of 2.1% (95% CI: 1.1-3.4%). Over 40% of HCV infections were among the general population aged 55-74 and one-third were among PWID. Conclusion Our study found that the largest share of infections was among adults aged 55-74, indicating the importance of surveillance, prevention, testing, and linkages to care in this group to reduce mortality. Further, programs prioritizing PWID for increased HCV testing and linkage to care are important for reducing new HCV infections.	[Wynn, Adriane; Cyr, Cassandra L.; Hernandez, Maricris; Martin, Natasha K.] Univ Calif San Diego, Div Infect Dis & Global Publ Hlth, San Diego, CA 92103 USA; [Tweeten, Samantha; McDonald, Eric; Wooten, Wilma] San Diego Cty Hlth & Human Serv Agcy, San Diego, CA USA; [Lucas, Kimberley] Calif Correct Hlth Care Serv, San Diego, CA USA; [Ramirez, Franchesca] Rady Childrens Hosp San Diego, San Diego, CA USA; [VanWormer, Corey] San Diego Blood Bank, San Diego, CA USA; [Suckow, Scott] Amer Liver Fdn, Pacific Coast Div, New York, NY USA; [Ramers, Christian B.] Family Hlth Ctr San Diego, Laura Rodriguez Res Inst, San Diego, CA USA	University of California System; University of California San Diego; Rady Childrens Hospital San Diego	Wynn, A (corresponding author), Univ Calif San Diego, Div Infect Dis & Global Publ Hlth, San Diego, CA 92103 USA.	awynn@health.ucsd.edu		Martin, Natasha/0000-0001-8344-1810	National Institute for Allergy and Infectious Diseases; National Institute for Drug Abuse [R01 AI147490]; University of San Diego Center for AIDS Research (CFAR), a NIH [P30 AI036214]; National Institute on Alcohol Abuse and Alcoholism [K01 AA027733]; National Institute on Drug Abuse [T32 DA023356]	National Institute for Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute for Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); University of San Diego Center for AIDS Research (CFAR), a NIH; National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Natasha K Martin acknowledges funding from the National Institute for Allergy and Infectious Diseases and National Institute for Drug Abuse (R01 AI147490), and the University of San Diego Center for AIDS Research (CFAR), a NIH funded program (P30 AI036214). Adriane Wynn acknowledges funding from the National Institute on Alcohol Abuse and Alcoholism (K01 AA027733) and the National Institute on Drug Abuse (T32 DA023356).The funders of the study had no role in study design, data collection, data analysis, data interpretation, or writing of the report. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication.	Atsma F, 2011, TRANSFUSION, V51, P1883, DOI 10.1111/j.1537-2995.2011.03270.x; Buffington J, 2007, PUBLIC HEALTH REP, V122, P63, DOI 10.1177/00333549071220S212; Cachay ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102883; CDC, 2020, VIR HEP SURV REP 201; Centers for Disease Control and Prevention, CDC EST NEARL 240000; Centers for Disease Control and Prevention, 2016, HEP C KILLS MOR AM A; Chaillon A, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz160; Facente SN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195575; Fraser H, 2018, ADDICTION, V113, P173, DOI 10.1111/add.13948; Grebely J, 2018, LANCET GASTROENTEROL, V3, P153, DOI 10.1016/S2468-1253(17)30404-1; Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365; Hofmeister MG, 2019, HEPATOLOGY, V69, P1020, DOI 10.1002/hep.30297; Horyniak D, 2017, INT J DRUG POLICY, V47, P9, DOI 10.1016/j.drugpo.2017.06.006; Martin NK, 2013, CLIN INFECT DIS, V57, pS39, DOI 10.1093/cid/cit296; Micallef JM, 2006, J VIRAL HEPATITIS, V13, P34, DOI 10.1111/j.1365-2893.2005.00651.x; National HIV Behavioral Surveillance (NHBS), 2018, HIV INF PREV HLTH BE; Platt L, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012021.pub2; Schillie S, 2020, MMWR RECOMM REP, V69, P1, DOI 10.15585/mmwr.rr6902a1; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Smith DJ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1807-5; Tempalski B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064789; The National Academies of Sciences E Medicine., 2017, NATL STRATEGY ELIMIN; Trickey A, 2019, LANCET GASTROENTEROL, V4, P435, DOI 10.1016/S2468-1253(19)30085-8; United States Census Bureau/American Fact Finder, 2018, AG SEX 2018 AM COMM; Wingrove C, 2020, LANCET GASTROENTEROL, V5, P792, DOI 10.1016/S2468-1253(20)30238-7; World Health Organization, 2016, ADV BRIEF COMB HEP B; Yehia BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101554	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0251635	10.1371/journal.pone.0251635	http://dx.doi.org/10.1371/journal.pone.0251635			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106932	gold, Green Published			2022-12-26	WOS:000664642200015
J	Ghanbari, S; Salimi, A; Rahmani, S; Nafissi, N; Sharifi-Zarchi, A; Mowla, SJ				Ghanbari, Sogol; Salimi, Adel; Rahmani, Saeid; Nafissi, Nahid; Sharifi-Zarchi, Ali; Mowla, Seyed Javad			miR-361-5p as a promising qRT-PCR internal control for tumor and normal breast tissues	PLOS ONE			English	Article							PAN-CANCER ANALYSIS; REFERENCE GENES; HOUSEKEEPING GENES; EXPRESSION; IDENTIFICATION; MIRNA; NORMALIZATION; QUANTIFICATION; MICRORNAS; PROSTATE	Background One of the most widely used evaluation methods in miRNA experiments is qRT-PCR. However, selecting suitable internal controls (IC) is crucial for qRT-PCR experiments. Currently, there is no consensus on the ICs for miRNA qRT-PCR experiments in breast cancer. To this end, we tried to identify the most stable (the least expression alteration) and promising miRNAs in normal and tumor breast tissues by employing TCGA miRNA-Seq data and then experimentally validated them on fresh clinical samples. Methods A multi-component scoring system was used which takes into account multiple expression stability criteria as well as correlation with clinical characteristics. Furthermore, we extended the scoring system for more than two biological sub-groups. TCGA BRCA samples were analyzed based on two grouping criteria: Tumor & Normal samples and Tumor subtypes. The top 10 most stable miRNAs were further investigated by differential expression and survival analysis. Then, we examined the expression level of the top scored miRNA (hsa-miR-361-5p) along with two commonly used ICs hsa-miR-16-5p and U48 on 34 pairs of Primary breast tumor and their adjacent normal tissues using qRT-PCR. Results According to our multi-component scoring system, hsa-miR-361-5p had the highest stability score in both grouping criteria and hsa-miR-16-5p showed significantly lower scores. Based on our qRT-PCR assay, while U48 was the most abundant IC, hsa-miR-361-5p had lower standard deviation and also was the only IC capable of detecting a significant up-regulation of hsa-miR-21-5p in breast tumor tissue. Conclusions miRNA-Seq data is a great source to discover stable ICs. Our results demonstrated that hsa-miR-361-5p is a highly stable miRNA in tumor and non-tumor breast tissue and we recommend it as a suitable reference gene for miRNA expression studies in breast cancer. Additionally, although hsa-miR-16-5p is a commonly used IC, it's not a suitable one for breast cancer studies.	[Ghanbari, Sogol; Mowla, Seyed Javad] Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran; [Salimi, Adel; Rahmani, Saeid; Sharifi-Zarchi, Ali] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran; [Nafissi, Nahid] Iran Univ Med Sci, Sch Med, Dept Surg, Tehran, Iran	Tarbiat Modares University; Sharif University of Technology; Iran University of Medical Sciences	Mowla, SJ (corresponding author), Tarbiat Modares Univ, Fac Biol Sci, Dept Mol Genet, Tehran, Iran.	sjmowla@modares.ac.ir		Ghanbari, Sogol/0000-0001-7097-8328; Mowla, Seyed Javad/0000-0002-3300-6332; Salimi, Adel/0000-0003-2882-5664				Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Barra GB, 2020, GENES-BASEL, V11, DOI 10.3390/genes11101183; Benes V, 2010, METHODS, V50, P244, DOI 10.1016/j.ymeth.2010.01.026; Bianchi N, 2012, EPIGENOMICS-UK, V4, P51, DOI [10.2217/EPI.11.104, 10.2217/epi.11.104]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cai BL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0403-6; Cao ZG, 2016, J THORAC DIS, V8, P1772, DOI 10.21037/jtd.2016.06.29; Cascione L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055910; Chapman JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141853; Chen YX, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-407; Chugh P, 2012, WIRES RNA, V3, P601, DOI 10.1002/wrna.1120; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Dai Y, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-020-07318-y; Davoren PA, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-76; Drobna M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102858; Forterre A, 2020, CANCERS, V12, DOI 10.3390/cancers12071852; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Gharbi S, 2015, CELL J, V17, P494; Han JJ, 2019, BOSNIAN J BASIC MED, V19, P52, DOI 10.17305/bjbms.2018.3399; Heneghan HM, 2010, ANN SURG, V251, P499, DOI 10.1097/SLA.0b013e3181cc939f; Kolde R, 2012, BIOINFORMATICS, V28, P573, DOI 10.1093/bioinformatics/btr709; Kontomanolis EN, 2020, ANTICANCER RES, V40, P6009, DOI 10.21873/anticanres.14622; Krasnov GS, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00097; Lanczky A, 2016, BREAST CANCER RES TR, V160, P439, DOI 10.1007/s10549-016-4013-7; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lim QE, 2011, NEUROSCIENCE, V199, P32, DOI 10.1016/j.neuroscience.2011.10.024; Liu J, 2018, ONCOTARGETS THER, V11, P5239, DOI 10.2147/OTT.S171539; Liu T, 2019, J CELL PHYSIOL, V234, P5496, DOI 10.1002/jcp.27342; Lou G, 2015, INT J MOL MED, V36, P1400, DOI 10.3892/ijmm.2015.2338; Mattie MD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-24; McDermott AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083718; Nakazawa Minato., FUNCT MED STAT BOOK; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; R Core Team, 2020, R LANG ENV STAT COMP; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Schaefer A, 2010, EXP MOL MED, V42, P749, DOI 10.3858/emm.2010.42.11.076; Svec David, 2015, Biomol Detect Quantif, V3, P9, DOI 10.1016/j.bdq.2015.01.005; Taylor SC, 2019, TRENDS BIOTECHNOL, V37, P761, DOI 10.1016/j.tibtech.2018.12.002; Tilli TM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2946-1; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang H, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5951-3; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Wickham H, 2017, J STAT SOFTW, V80, P1; Xu T., 2018, BMC BIOINF, V19, P179; Yang ZG, 2020, J ONCOL, V2020, DOI 10.1155/2020/9160905; Zhan C, 2014, BIOCHEM BIOPH RES CO, V453, P375, DOI 10.1016/j.bbrc.2014.09.086; Zhang YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123691; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735	50	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0253009	10.1371/journal.pone.0253009	http://dx.doi.org/10.1371/journal.pone.0253009			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101749	Green Published, gold			2022-12-26	WOS:000664641500034
J	Gong, K; Xie, T; Luo, Y; Guo, H; Chen, JL; Tan, ZP; Yang, YF; Xie, L				Gong, Ke; Xie, Ting; Luo, Yong; Guo, Hui; Chen, Jinlan; Tan, Zhiping; Yang, Yifeng; Xie, Li			Comprehensive analysis of lncRNA biomarkers in kidney renal clear cell carcinoma by lncRNA-mediated ceRNA network	PLOS ONE			English	Article							LONG NONCODING RNAS; HEPATOCELLULAR-CARCINOMA; COMPLEX DISEASES; ENDOGENOUS RNA; UP-REGULATION; CANCER; IDENTIFICATION; PROMOTES; PROLIFERATION; CONSTRUCTION	Introduction Kidney renal clear cell carcinoma (KIRC) has a high incidence globally, and its pathogenesis remains unclear. Long non-coding RNA (lncRNA), as a molecular sponge, participates in the regulation of competitive endogenous RNA (ceRNA). We aimed to construct a ceRNA network and screened out possible lncRNAs to predict KIRC prognosis. Material and methods All KIRC data were downloaded from the TCGA database and screened to find the possible target lncRNA; a ceRNA network was designed. Next, GO functional enrichment and KEGG pathway of differentially expressed mRNA related to lncRNA were performed. We used Kaplan-Meier curve analysis to predict the survival of these RNAs. We used Cox regression analysis to construct a model to predict KIRC prognosis. Results In the KIRC datasets, 1457 lncRNA, 54 miRNA and 2307 mRNA were screened out. The constructed ceRNA network contained 81 lncRNAs, nine miRNAs, and 17 mRNAs differentially expressed in KIRC. Survival analysis of all differentially expressed RNAs showed that 21 lncRNAs, four miRNAs, and two mRNAs were related to the overall survival rate. Cox regression analysis was performed again, and we found that eight lncRNAs were related to prognosis and used to construct predictive models. Three lnRNAs from independent samples were meaningful. Conclusion The construction of ceRNA network was involved in the process and transfer of KIRC, and three lncRNAs may be potential targets for predicting KIRC prognosis.	[Gong, Ke; Xie, Ting; Luo, Yong; Guo, Hui; Chen, Jinlan; Yang, Yifeng; Xie, Li] Cent South Univ, Dept Cardiovasc Surg, Second Xiangya Hosp, Changsha, Peoples R China; [Tan, Zhiping] Cent South Univ, Clin Ctr Gene Diag & Therapy, State Key Lab Med Genet, Second Xiangya Hosp, Changsha, Hunan, Peoples R China	Central South University; Central South University	Xie, L (corresponding author), Cent South Univ, Dept Cardiovasc Surg, Second Xiangya Hosp, Changsha, Peoples R China.	xieli55@csu.edu.cn		Gong, Ke/0000-0003-0337-297X; xie, li/0000-0002-2634-6187	National Science Foundation for Young Scientists of China [8150020951]; Natural Science Foundation of Hunan Province [2016JJ4099]; Ministry of Science and Technology of China; Science and Technology Department of Hunan Province	National Science Foundation for Young Scientists of China; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Science and Technology Department of Hunan Province	This work was supported by the National Science Foundation for Young Scientists of China (No. 8150020951) and the Natural Science Foundation of Hunan Province (No. 2016JJ4099). LX is supported by the Ministry of Science and Technology of China and the Science and Technology Department of Hunan Province. The funder has no role in research design, data collection and analysis, publication decision, or manuscript preparation.	Abdollahzadeh R, 2019, J CELL PHYSIOL, V234, P10080, DOI 10.1002/jcp.27941; Cao Q, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01295-8; Chen X, 2019, BRIEF BIOINFORM, V20, P515, DOI 10.1093/bib/bbx130; Chen X, 2017, BRIEF BIOINFORM, V18, P558, DOI 10.1093/bib/bbw060; Chen X, 2019, BRIEF FUNCT GENOMICS, V18, P58, DOI 10.1093/bfgp/ely031; Chen X, 2018, BIOINFORMATICS, V34, P4256, DOI 10.1093/bioinformatics/bty503; Chen X, 2013, BIOINFORMATICS, V29, P2617, DOI 10.1093/bioinformatics/btt426; Chu YJ, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00503; Connerty P, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00285; Dai GC, 2020, J CELL MOL MED, V24, P9231, DOI 10.1111/jcmm.15564; Doncheva NT, 2019, J PROTEOME RES, V18, P623, DOI 10.1021/acs.jproteome.8b00702; Farouq MW, 2021, SENSORS-BASEL, V21, DOI 10.3390/s21062190; Feng B, 2020, J CELL MOL MED, V24, P8962, DOI 10.1111/jcmm.15530; Ferlay J, 2018, EUR J CANCER, V103, P356, DOI 10.1016/j.ejca.2018.07.005; Ge BH, 2020, J GENE MED, V22, DOI 10.1002/jgm.3247; Heller G, 2017, BIOSTATISTICS, V18, P260, DOI 10.1093/biostatistics/kxw045; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hu H, 2018, RNA BIOL, V15, P797, DOI 10.1080/15476286.2018.1457935; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jalal H, 2017, MED DECIS MAKING, V37, P735, DOI 10.1177/0272989X16686559; Jiang XQ, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-1146-6; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Jin KT, 2020, LIFE SCI, V252, DOI 10.1016/j.lfs.2020.117647; Kamarudin AN, 2017, BMC MED RES METHODOL, V17, DOI 10.1186/s12874-017-0332-6; Li BG, 2018, LIFE SCI, V197, P122, DOI 10.1016/j.lfs.2018.02.006; Li R, 2019, ARTIF CELL NANOMED B, V47, P3246, DOI 10.1080/21691401.2019.1647225; Lin CR, 2018, TRENDS CELL BIOL, V28, P287, DOI 10.1016/j.tcb.2017.11.008; Lin WY, 2020, INT J BIOL SCI, V16, P1194, DOI 10.7150/ijbs.40769; Liu HS, 2020, KNOWL-BASED SYST, V191, DOI 10.1016/j.knosys.2019.105261; Liu WL, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau059; Liu XM, 2020, ONCOL REP, V44, P599, DOI 10.3892/or.2020.7645; Luo LH, 2020, J CELL PHYSIOL, V235, P6154, DOI 10.1002/jcp.29544; Lv L, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0233-7; Ma YX, 2018, CANCER LETT, V419, P27, DOI 10.1016/j.canlet.2018.01.008; Piao HY, 2021, J CANCER, V12, P2336, DOI 10.7150/jca.49138; Qi MR, 2020, CANCER MED-US, V9, P1798, DOI 10.1002/cam4.2760; Qi XL, 2015, J MED GENET, V52, P710, DOI 10.1136/jmedgenet-2015-103334; Qin L, 2020, BRIEF BIOINFORM, V21, P73, DOI 10.1093/bib/bby101; Riffo-Campos AL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17121987; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Shen S, 2019, J CELL BIOCHEM, V120, P10069, DOI 10.1002/jcb.28290; Shuch B, 2015, EUR UROL, V67, P85, DOI 10.1016/j.eururo.2014.04.029; Sorensen A, 2019, NEUROIMAGE-CLIN, V21, DOI 10.1016/j.nicl.2018.101637; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wang H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0680-1; Wang LN, 2021, J CELL PHYSIOL, V236, P536, DOI 10.1002/jcp.29881; Wang XN, 2018, CANCER MANAG RES, V10, P5799, DOI 10.2147/CMAR.S178732; Wang YF, 2016, TRENDS GENET, V32, P211, DOI 10.1016/j.tig.2016.02.001; Weng WQ, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01243-6; Wong N, 2015, NUCLEIC ACIDS RES, V43, pD146, DOI 10.1093/nar/gku1104; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu J, 2015, NUCLEIC ACIDS RES, V43, P8169, DOI 10.1093/nar/gkv853; Yin G, 2020, CANCER MANAG RES, V12, P4227, DOI 10.2147/CMAR.S231042; Yin H, 2018, CANCER SCI, V109, P3336, DOI 10.1111/cas.13778; Yu G, 2014, MOL CANCER THER, V13, P3086, DOI 10.1158/1535-7163.MCT-14-0245; Yun ZN, 2021, AGING-US, V13, P6041, DOI 10.18632/aging.202540; Zhang JP, 2018, BIOINFORMATICS, V34, P4232, DOI 10.1093/bioinformatics/bty525; Zhang L, 2021, GENOMICS, V113, P874, DOI 10.1016/j.ygeno.2021.02.002; Zhang W, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00628; Zhang YX, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6264-2; Zhang Z, 2019, BRIEF BIOINFORM, V20, P1524, DOI 10.1093/bib/bby023; Zhao K, 2020, TRANSL ANDROL UROL, V9, P303, DOI 10.21037/tau.2020.02.17; Zhao Q, 2018, MOL THER-NUCL ACIDS, V13, P464, DOI 10.1016/j.omtn.2018.09.020; Zhao Q, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00239; Zhao WG, 2020, ONCOTARGETS THER, V13, P6027, DOI 10.2147/OTT.S249973; Zhou ZY, 2021, AGING-US, V13, P9838, DOI 10.18632/aging.202737; Zhu HH, 2018, MED SCI MONITOR, V24, P8250, DOI 10.12659/MSM.910773; Zhu R, 2021, BMC BIOINFORMATICS, V22, DOI 10.1186/s12859-021-04104-9	70	2	2	6	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252452	10.1371/journal.pone.0252452	http://dx.doi.org/10.1371/journal.pone.0252452			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101736	gold, Green Published			2022-12-26	WOS:000664641500015
J	Takahashi, S; Tanno, K; Yonekura, Y; Ohsawa, M; Kuribayashi, T; Ishibashi, Y; Omama, S; Tanaka, F; Onoda, T; Sakata, K; Koshiyama, M; Itai, K; Okayama, A				Takahashi, Shuko; Tanno, Kozo; Yonekura, Yuki; Ohsawa, Masaki; Kuribayashi, Toru; Ishibashi, Yasuhiro; Omama, Shinichi; Tanaka, Fumitaka; Onoda, Toshiyuki; Sakata, Kiyomi; Koshiyama, Makoto; Itai, Kazuyoshi; Okayama, Akira			Low educational level increases functional disability risk subsequent to heart failure in Japan: On behalf of the Iwate KENCO study group	PLOS ONE			English	Article							CARE INSURANCE SYSTEM; QUALITY-OF-LIFE; ELDERLY-PATIENTS; OUTCOMES; WOMEN; HOSPITALIZATION; CERTIFICATION; FRAILTY; COHORT; ADULTS	Objectives The risk factors that contribute to future functional disability after heart failure (HF) are poorly understood. The aim of this study was to determine potential risk factors to future functional disability after HF in the general older adult population in Japan. Methods The subjects who were community-dwelling older adults aged 65 or older without a history of cardiovascular diseases and functional disability were followed in this prospective study for 11 years. Two case groups were determined from the 4,644 subjects: no long-term care insurance (LTCI) after HF (n = 52) and LTCI after HF (n = 44). We selected the controls by randomly matching each case of HF with three of the remaining 4,548 subjects who were event-free during the period: those with no LTCI and no HF with age +/-1 years and of the same sex, control for the no LTCI after HF group (n = 156), and control for the LTCI after HF group (n = 132). HF was diagnosed according to the Framingham diagnostic criteria. Individuals with a functional disability were those who had been newly certified by the LTCI during the observation period. Objective data including blood samples and several socioeconomic items in the baseline survey were assessed using a self-reported questionnaire. Results Significantly associated risk factors were lower educational levels (odds ratio (OR) [95% confidence interval (CI)]: 3.72 [1.63-8.48]) in the LTCI after HF group and hypertension (2.20 [1.10-4.43]) in no LTCI after HF group. Regular alcohol consumption and unmarried status were marginally significantly associated with LTCI after HF (OR [95% CI]; drinker = 2.69 [0.95-7.66]; P = 0.063; unmarried status = 2.54 [0.91-7.15]; P = 0.076). Conclusion Preventive measures must be taken to protect older adults with unfavorable social factors from disability after HF via a multidisciplinary approach.	[Takahashi, Shuko] Iwate Med Univ, Div Med Educ, Yahaba, Iwate, Japan; [Takahashi, Shuko] Harvard TH Chan Sch Publ Hlth, Takemi Program Int Hlth, Boston, MA USA; [Takahashi, Shuko] Iwate Prefectural Govt, Dept Hlth & Welf, Morioka, Iwate, Japan; [Tanno, Kozo; Sakata, Kiyomi] Iwate Med Univ, Sch Med, Dept Hyg & Prevent Med, Yahaba, Iwate, Japan; [Yonekura, Yuki] St Lukes Int Univ, Tokyo, Japan; [Ohsawa, Masaki] Morioka Tsunagi Onsen Hosp, Morioka, Iwate, Japan; [Kuribayashi, Toru] Iwate Univ, Fac Humanities & Social Sci, Morioka, Iwate, Japan; [Ishibashi, Yasuhiro] Iwate Med Univ, Dept Neurol & Gerontol, Yahaba, Iwate, Japan; [Omama, Shinichi] Iwate Med Univ, Dept Neurosurg, Yahaba, Iwate, Japan; [Tanaka, Fumitaka] Iwate Med Univ, Sch Med, Div Nephrol & Hypertens, Yahaba, Iwate, Japan; [Onoda, Toshiyuki] Iwate Univ, Hlth Serv Ctr, Morioka, Iwate, Japan; [Koshiyama, Makoto] Iwate Hlth Serv Assoc, Morioka, Iwate, Japan; [Itai, Kazuyoshi] Morioka Univ, Dept Nutr Sci, Takizawa, Japan; [Okayama, Akira] Res Inst Strategy Prevent, Tokyo, Japan	Iwate Medical University; Harvard University; Harvard T.H. Chan School of Public Health; Iwate Medical University; St. Luke's International Hospital; Iwate University; Iwate Medical University; Iwate Medical University; Iwate Medical University; Iwate University	Takahashi, S (corresponding author), Iwate Med Univ, Div Med Educ, Yahaba, Iwate, Japan.; Takahashi, S (corresponding author), Harvard TH Chan Sch Publ Hlth, Takemi Program Int Hlth, Boston, MA USA.; Takahashi, S (corresponding author), Iwate Prefectural Govt, Dept Hlth & Welf, Morioka, Iwate, Japan.	shutakahashi-iwt@umin.ac.jp	Takahashi, Shuko/AAD-3461-2022; Tanno, Kozo/HDM-5952-2022; Tanno, Kozo/ABE-5165-2020; Yonekura, Yuki/C-5973-2013	Takahashi, Shuko/0000-0002-7384-1113; Tanno, Kozo/0000-0002-1264-0684; Tanno, Kozo/0000-0002-1264-0684; Yonekura, Yuki/0000-0002-2590-2022	JSPS KAKENHI [JP17K09126, JP16KT0009, JP20K18858]; Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Japan [H23Junkankitou [Seishuu]-Ippan-005, H26Junkankitou [Seisaku]-Ippan-001, H29Junkankitou-Ippan-003, 20FA1002]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by JSPS KAKENHI grant numbers JP17K09126 (KT), JP16KT0009 (KT), and JP20K18858 (ST). This research was also supported by a grant-in-aid from the Ministry of Health, Labour and Welfare, Health and Labour Sciences Research Grants, Japan (Comprehensive Research on Cardiovascular Disease and Life-Related Disease: H23Junkankitou [Seishuu]-Ippan-005 (SK); H26Junkankitou [Seisaku]-Ippan-001 (SK), H29Junkankitou-Ippan-003 (SK), and 20FA1002 (SK)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akune T, 2014, J ORTHOP SCI, V19, P489, DOI 10.1007/s00776-014-0537-z; Arai Y, 2003, INT J GERIATR PSYCH, V18, P346, DOI 10.1002/gps.836; Auerbach AD, 2000, J AM COLL CARDIOL, V36, P2119, DOI 10.1016/S0735-1097(00)01005-6; Barbareschi G, 2011, J CARD FAIL, V17, P47, DOI 10.1016/j.cardfail.2010.08.005; Blair AS, 2002, J FAM PRACTICE, V51, P169; Cabinet Office Government of Japan, 2016, SIT AG CAB OFF; Clark AL, 2012, AM J CARDIOL, V110, P77, DOI 10.1016/j.amjcard.2012.02.050; Corotto PS, 2013, HEART FAIL CLIN, V9, P49, DOI 10.1016/j.hfc.2012.09.004; Curtis LH, 2008, ARCH INTERN MED, V168, P2481, DOI 10.1001/archinte.168.22.2481; De Saint-Hubert M, 2010, J NUTR HEALTH AGING, V14, P394, DOI 10.1007/s12603-010-0086-x; Dunlay SM, 2015, CIRC-HEART FAIL, V8, P261, DOI 10.1161/CIRCHEARTFAILURE.114.001542; Fujiwara Yoshinori, 2006, Nihon Koshu Eisei Zasshi, V53, P77; Hirai Hiroshi, 2009, Nihon Koshu Eisei Zasshi, V56, P501; Hoshi Masayuki, 2012, Aging Clin Exp Res, V24, P345, DOI 10.3275/8104; Huei-Ru L, 2017, BMC GERIATR, V17, P1, DOI [10.1186/s12877-016-0400-5, DOI 10.1186/S12877-016-0400-5]; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Makizako H, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008462; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; Ministry of Health Labour and Welfare, 2017, HLTH MED SERV OV SYS; Ministry of Internal Affairs and Communications, 2018, EST POP OCT 1 2018 M; Mitsuaki I, 2019, JMA J, V2, P103, DOI [10.31662/jmaj.2018-0049, DOI 10.31662/JMAJ.2018-0049]; Nakane E, 2015, J AM COLL CARDIOL, V65, pA1033, DOI 10.1016/S0735-1097(15)61033-6; Nishiguchi S, 2013, DEMENT GER COGN D EX, V3, P312, DOI 10.1159/000354962; OECD, 2018, ELD POP OECD; Ogawa M, 2007, CIRC J, V71, P455, DOI 10.1253/circj.71.455; Ohsawa M, 2009, INT J CARDIOL, V137, P226, DOI 10.1016/j.ijcard.2008.06.052; Peterson PN, 2011, JAMA-J AM MED ASSOC, V305, P1695, DOI 10.1001/jama.2011.512; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Riedinger MS, 2000, J HEART LUNG TRANSPL, V19, P598, DOI 10.1016/S1053-2498(00)00117-0; Saito T, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0580-7; Savage PA, 2011, MED SCI SPORT EXER, V43, P1379, DOI 10.1249/MSS.0b013e31820eeea1; Savarese Gianluigi, 2017, Card Fail Rev, V3, P7, DOI 10.15420/cfr.2016:25:2; Takahashi K, 2016, OPEN HEART, V3, DOI 10.1136/openhrt-2016-000501; Takeda Shumpei, 2004, Nihon Koshu Eisei Zasshi, V51, P157; Tanaka F, 2016, J HYPERTENS, V34, P506, DOI 10.1097/HJH.0000000000000809; Taniguchi Yu, 2015, Nihon Ronen Igakkai Zasshi, V52, P86, DOI 10.3143/geriatrics.52.86; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Vidan MT, 2016, EUR J HEART FAIL, V18, P869, DOI 10.1002/ejhf.518; Volpato S, 2011, J GERONTOL A-BIOL, V66, P89, DOI 10.1093/gerona/glq167; Warraich HJ, 2018, CIRC-HEART FAIL, V11, DOI 10.1161/CIRCHEARTFAILURE.117.004830; WHO, 2017, COUNTR JAP WHO; Yamada S, 2018, BMC CARDIOVASC DISOR, V18, DOI 10.1186/s12872-018-0897-y; Yancy CW, 2013, CIRCULATION, V128, pE240, DOI 10.1161/CIR.0b013e31829e8776	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0253017	10.1371/journal.pone.0253017	http://dx.doi.org/10.1371/journal.pone.0253017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101763	Green Published, gold			2022-12-26	WOS:000664641500036
J	Abe, K; Tanaka, J; Mishima, K; Iijima, T				Abe, Kyoko; Tanaka, Junichi; Mishima, Kenji; Iijima, Takehiko			Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier	PLOS ONE			English	Article							ENDOTHELIAL GLYCOCALYX; DYSFUNCTION; FLUID; CELL; GLYCOSAMINOGLYCANS; LAYER; MICE	Pathological hyperpermeability is a morbidity involved in various systemic diseases, including sepsis. The endothelial glycocalyx layer (GCX) plays a key role in controlling vascular permeability and could be a useful therapeutic target. The purpose of the present study was to analyze the functional role of the GCX in vascular permeability and to elucidate its role in pathological conditions. First, male C57BL/6J wild-type mice were used as in vivo models to study the effects of sepsis and the pharmacological digestion of glycosaminoglycans (GAGs) on the GCX. Vascular permeability was evaluated using fluorescein isothiocyanate (FITC)-labeled dextran. Second, the changes in gene expression in vascular endothelial cells after GAGs digestion were compared between a control and a septic model using RNA sequencing. In the in vivo study, the glycocalyx was depleted in both the septic model and the group with pharmacological GAGs digestion. FITC-labeled dextran had leaked into the interstitium in the septic group, but not in the other groups. In the in vitro study, histamine decreased the transendothelial electrical resistance (TEER), indicating an increase in permeability. GAGs digestion alone did not change the TEER, and the effect of histamine on the TEER was not enhanced by GAGs digestion. The gene expression profiles after GAGs digestion differed from the control condition, indicating the initiation of signal transduction. In conclusion, we demonstrated that the structural barrier of the GCX does not solely determine the fluid permeability of the endothelial layer, since enzymatic depletion of the GCX did not increase the permeability. The gene expression findings suggest that the digestion of GAGs alone did not induce hyperpermeability either in vitro or in vivo, although sepsis did induce hyperpermeability. While GAGs degradation by itself does not appear to induce hyperpermeability, it may play an important role in initiating signal transductions.	[Abe, Kyoko; Iijima, Takehiko] Showa Univ, Sch Dent, Div Anesthesiol, Dept Perioperat Med, Ota, Tokyo, Japan; [Tanaka, Junichi; Mishima, Kenji] Showa Univ, Sch Dent, Div Pathol, Dept Oral Diagnost Sci, Tokyo, Japan	Showa University; Showa University	Iijima, T (corresponding author), Showa Univ, Sch Dent, Div Anesthesiol, Dept Perioperat Med, Ota, Tokyo, Japan.	iijima@dent.showa-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [392 16K11762]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We declare that our study was supported by Grants-in-Aid for Scientific Research [Grant 392 16K11762] from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	ADAMSON RH, 1992, J PHYSIOL-LONDON, V445, P473, DOI 10.1113/jphysiol.1992.sp018934; Adderley SP, 2015, MICROCIRCULATION, V22, P237, DOI 10.1111/micc.12189; Alfieri A, 2012, CRIT CARE, V16, DOI 10.1186/cc11666; Amerongen GPV, 1998, CIRC RES, V83, P1115, DOI 10.1161/01.RES.83.11.1115; Bentzer Peter, 2016, Intensive Care Med Exp, V4, P33; Chappell D, 2008, ANESTHESIOLOGY, V109, P723, DOI 10.1097/ALN.0b013e3181863117; Chappell D, 2009, CIRC RES, V104, P1313, DOI 10.1161/CIRCRESAHA.108.187831; Collins SR, 2013, ANESTH ANALG, V117, P664, DOI 10.1213/ANE.0b013e3182975b85; De Backer D, 2014, VIRULENCE, V5, P73, DOI 10.4161/viru.26482; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Donati A, 2013, CRIT CARE RES PRACT, V2013, DOI 10.1155/2013/892710; Egawa G, 2013, SCI REP-UK, V3, DOI 10.1038/srep01932; Franco-Molina MA, 2004, INT IMMUNOPHARMACOL, V4, P1577, DOI 10.1016/j.intimp.2004.06.014; Fu BMM, 2013, WIRES SYST BIOL MED, V5, P381, DOI 10.1002/wsbm.1211; JACKSON RL, 1991, PHYSIOL REV, V71, P481, DOI 10.1152/physrev.1991.71.2.481; Kataoka H, 2017, ANESTH ANALG, V125, P874, DOI 10.1213/ANE.0000000000002057; Kataoka H, 2016, MICROSC RES TECHNIQ, V79, P31, DOI 10.1002/jemt.22602; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McDonald KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167576; Nelson A, 2008, SHOCK, V30, P623, DOI 10.1097/SHK.0b013e3181777da3; Nishimura A, 2016, ANESTH ANALG, V123, P925, DOI 10.1213/ANE.0000000000001505; OOHIRA A, 1983, J BIOL CHEM, V258, P2014; Osterloh K, 2002, AM J PHYSIOL-HEART C, V283, pH398, DOI 10.1152/ajpheart.00558.2001; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Salmon AHJ, 2012, J PATHOL, V226, P562, DOI 10.1002/path.3964; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Secomb TW, 2001, AM J PHYSIOL-HEART C, V281, pH629, DOI 10.1152/ajpheart.2001.281.2.H629; Singh A, 2007, J AM SOC NEPHROL, V18, P2885, DOI 10.1681/ASN.2007010119; Stark H., 2007, BIOTREND REV, V11, P1; Thi MM, 2004, P NATL ACAD SCI USA, V101, P16483, DOI 10.1073/pnas.0407474101; Uhl B, 2017, ACS NANO, V11, P1498, DOI 10.1021/acsnano.6b06812; Ushiyama A, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0182-z; Wiesinger A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080905; Yang YM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23494	35	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252416	10.1371/journal.pone.0252416	http://dx.doi.org/10.1371/journal.pone.0252416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086745	Green Published, gold			2022-12-26	WOS:000664640100061
J	Bicchieri, C; Fatas, E; Aldama, A; Casas, A; Deshpande, I; Lauro, M; Parilli, C; Spohn, M; Pereira, P; Wen, RL				Bicchieri, Cristina; Fatas, Enrique; Aldama, Abraham; Casas, Andres; Deshpande, Ishwari; Lauro, Mariagiulia; Parilli, Cristina; Spohn, Max; Pereira, Paula; Wen, Ruiling			In science we (should) trust: Expectations and compliance across nine countries during the COVID-19 pandemic	PLOS ONE			English	Article							INTENTION; VIGNETTE	The magnitude and nature of the COVID-19 pandemic prevents public health policies from relying on coercive enforcement. Practicing social distancing, wearing masks and staying at home becomes voluntary and conditional on the behavior of others. We present the results of a large-scale survey experiment in nine countries with representative samples of the population. We find that both empirical expectations (what others do) and normative expectations (what others approve of) play a significant role in compliance, beyond the effect of any other individual or group characteristic. In our vignette experiment, respondents evaluate the likelihood of compliance with social distancing and staying at home of someone similar to them in a hypothetical scenario. When empirical and normative expectations of individuals are high, respondents' evaluation of the vignette's character's compliance likelihood goes up by 55% (relative to the low expectations condition). Similar results are obtained when looking at self-reported compliance among those with high expectations. Our results are moderated by individuals' trust in government and trust in science. Holding expectations high, the effect of trusting science is substantial and significant in our vignette experiment (22% increase in compliance likelihood), and even larger in self-reported compliance (76% and 127% increase before and after the lockdown). By contrast, trusting the government only generates modest effects. At the aggregate level, the country-level trust in science, and not in government, becomes a strong predictor of compliance.	[Bicchieri, Cristina; Fatas, Enrique; Aldama, Abraham; Casas, Andres; Deshpande, Ishwari; Lauro, Mariagiulia; Parilli, Cristina; Spohn, Max; Pereira, Paula; Wen, Ruiling] Univ Penn, Ctr Social Norms & Behav Dynam, Philadelphia, PA 19104 USA; [Fatas, Enrique] Univ ICESI, Management Dept, Cali, Colombia	University of Pennsylvania; Universidad ICESI	Bicchieri, C (corresponding author), Univ Penn, Ctr Social Norms & Behav Dynam, Philadelphia, PA 19104 USA.	cb36@sas.upenn.edu		Lauro, Mariagiulia/0000-0002-0799-5480; , Ruiling/0000-0003-1211-0541				Allcott H., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Allcott H., 2020, EC HLTH IMPACTS SOCI; Balog-Way DHP, 2020, J RISK RES, V23, P838, DOI 10.1080/13669877.2020.1758192; Banker S, 2020, JUDGM DECIS MAK, V15, P1037; Barcelo, APPL COGN PSYCHOL; Bargain O, 2020, J PUBLIC ECON, V192, DOI 10.1016/j.jpubeco.2020.104316; Bicchieri, 2016, NORMS WILD DIAGNOSE, DOI [10.1007/s00248-016-0913-7, DOI 10.1007/S00248-016-0913-7]; Bicchieri C., 2006, GRAMMAR SOC; Bicchieri C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01418; Bicchieri C, 2009, J BEHAV DECIS MAKING, V22, P191, DOI 10.1002/bdm.621; Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016; Briscese G, 2020, NBER WORKING PAPER S; Brzezinski Adam, 2020, 202056 BECK FREIDM I, DOI [DOI 10.2139/SSRN.3587990, 10.2139/ssrn.3587990]; Buchan NR, 2011, PSYCHOL SCI, V22, P821, DOI 10.1177/0956797611409590; Buchan NR, 2009, P NATL ACAD SCI USA, V106, P4138, DOI 10.1073/pnas.0809522106; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Chen CC, 2020, NAT REV CHEM, V4, P114, DOI [10.1038/s41562-020-0909-7, 10.1038/s41570-020-0163-6]; CIALDINI RB, 1991, ADV EXP SOC PSYCHOL, V24, P201; Cikara, 2020, INTENTIONS CO COVID; Croson R, 2005, ECON LETT, V87, P95, DOI 10.1016/j.econlet.2004.10.007; Daoust J.F, 2020, J EXP POL SCI; Eifler S, 2019, WILEY SER SURV METH, P393; Everett J.A., 2020, EFFECTIVENESS MORAL, DOI [10.31234/osf.io/9yqs8, DOI 10.31234/OSF.IO/9YQS8]; Fetzer T., 2020, HARVARD BUSINESS SCH, DOI [10.31234/osf.io/3kfmh, DOI 10.31234/OSF.IO/3KFMH]; FINCH J, 1987, SOCIOLOGY, V21, P105, DOI 10.1177/0038038587021001008; Galbiati R., 2020, LAWS AFFECT PERCEPTI, DOI [10.2139/ssrn.3684710, DOI 10.2139/SSRN.3684710]; Goldberg M., 2020, SOCIAL NORMS MOTIVAT, DOI [DOI 10.31234/OSF.IO/9WHP4, 10.31234/osf.io/9whp4]; Hagger MS, 2020, ANN BEHAV MED, V54, P713, DOI 10.1093/abm/kaaa073; Hainmueller J, 2015, P NATL ACAD SCI USA, V112, P2395, DOI 10.1073/pnas.1416587112; Halpern SD, 2020, JAMA-J AM MED ASSOC, V324, P337, DOI 10.1001/jama.2020.11623; Heffner J, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110420; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Khemani, 2020, RES POLICY BRIEFS, P32; Lunn PD, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113478; McFadden SM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231808; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Quinn SC, 2013, BIOSECUR BIOTERROR, V11, P96, DOI 10.1089/bsp.2012.0048; Rotondi P., 2020, TRUST SCI EXPERTS CO; Scartascini C., 2019, IDB WORKING PAPER SE; Simonov A, 2020, NATL BUREAU EC RES, DOI [10.3386/W27237, DOI 10.3386/W27237]; Sorenson SB, 2005, PSYCHOL WOMEN QUART, V29, P78, DOI 10.1111/j.1471-6402.2005.00170.x; Tankard ME, 2016, SOC ISS POLICY REV, V10, P181, DOI 10.1111/sipr.12022; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; van Rooij, 2020, PANDEMIC COMPLIANCE, DOI [10.31234/osf.io/c5x2k, DOI 10.31234/OSF.IO/C5X2K]; Van Rooij B., 2020, COMPLIANCE COVID 19, DOI [110.31234/osf.io/qymu3, DOI 10.31234/OSF.IO/QYMU3]; Vinck P, 2019, LANCET INFECT DIS, V19, P529, DOI 10.1016/S1473-3099(19)30063-5; Wright AL, 2020, J ECON BEHAV ORGAN, V180, P544, DOI 10.1016/j.jebo.2020.10.008; Yeager A., 2020, SCIENTIST	48	30	30	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252892	10.1371/journal.pone.0252892	http://dx.doi.org/10.1371/journal.pone.0252892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086823	gold, Green Published			2022-12-26	WOS:000664640100152
J	Chalar, C; Clivio, G; Montagne, J; Costabile, A; Lima, A; Papa, NG; Berois, N; Arezo, MJ				Chalar, Cora; Clivio, Graciela; Montagne, Jimena; Costabile, Alicia; Lima, Analia; Papa, Nicolas G.; Berois, Nibia; Jose Arezo, Maria			Embryonic developmental arrest in the annual killifish Austrolebias charrua: A proteomic approach to diapause III	PLOS ONE			English	Article							FISH NOTHOBRANCHIUS-KORTHAUSAE; HEAT-SHOCK PROTEINS; OVERWINTERING DIAPAUSE; EXPRESSION; GROWTH; METABOLISM; GLYCEROL; BIOLOGY; CYPRINODONTIFORMES; DEHYDROGENASE	Diapause is a reversible developmental arrest faced by many organisms in harsh environments. Annual killifish present this mechanism in three possible stages of development. Killifish are freshwater teleosts from Africa and America that live in ephemeral ponds, which dry up in the dry season. The juvenile and adult populations die, and the embryos remain buried in the bottom mud until the next rainy season. Thus, species survival is entirely embryo-dependent, and they are perhaps the most remarkable extremophile organisms among vertebrates. The aim of the present study was to gather information about embryonic diapauses with the use of a "shotgun" proteomics approach in diapause III and prehatching Austrolebias charrua embryos. Our results provide insight into the molecular mechanisms of diapause III. Data are available via ProteomeXchange with identifier PXD025196. We detected a diapause-dependent change in a large group of proteins involved in different functions, such as metabolic pathways and stress tolerance, as well as proteins related to DNA repair and epigenetic modifications. Furthermore, we observed a diapause-associated switch in cytoskeletal proteins. This first glance into global protein expression differences between prehatching and diapause III could provide clues regarding the induction/maintenance of this developmental arrest in A. charrua embryos. There appears to be no single mechanism underlying diapause and the present data expand our knowledge of the molecular basis of diapause regulation. This information will be useful for future comparative approaches among different diapauses in annual killifish and/or other organisms that experience developmental arrest.	[Chalar, Cora; Costabile, Alicia] Univ Republica, Fac Ciencias, Secc Bioquim, Montevideo, Uruguay; [Clivio, Graciela; Montagne, Jimena] Univ Republica, Fac Ciencias, Secc Biol Celular, Montevideo, Uruguay; [Lima, Analia] Inst Pasteur Montevideo, Unidad Bioquim & Proteom Analit, Montevideo, Uruguay; [Lima, Analia] Minist Educ & Cultura, Inst Invest Biol Clemente Estable, Montevideo, Uruguay; [Papa, Nicolas G.; Berois, Nibia; Jose Arezo, Maria] Univ Republica, Lab Biol Mol Organismos Acuat, Secc Biol Celular, Fac Ciencias, Montevideo, Uruguay	Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Instituto de Investigaciones Biologicas Clemente Estable Uruguay; Universidad de la Republica, Uruguay	Arezo, MJ (corresponding author), Univ Republica, Lab Biol Mol Organismos Acuat, Secc Biol Celular, Fac Ciencias, Montevideo, Uruguay.	maui@fcien.edu.uy	Lima, Analía/ABD-7806-2022	Lima, Analia/0000-0002-1855-2327; Costabile, Alicia/0000-0001-5974-2146	Facultad de Ciencias (Universidad de la Republica, Uruguay); Comision Sectorial de Investigacion Cientifica (CSIC, Universidad de la Republica, Uruguay); CSIC [Proyectos I+D 2014 C610-348]	Facultad de Ciencias (Universidad de la Republica, Uruguay); Comision Sectorial de Investigacion Cientifica (CSIC, Universidad de la Republica, Uruguay); CSIC	Funding: Facultad de Ciencias (Universidad de la Republica, Uruguay) and Comision Sectorial de Investigacion Cientifica (CSIC, Universidad de la Republica, Uruguay). CSIC grant number Proyectos I+D 2014 C610-348 to MJA and NB. URL: https://www.csic.edu.uy/content/proyectos-de-id The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLQUIST DA, 1984, J COMP PHYSIOL B, V155, P75, DOI 10.1007/BF00688794; ALBERTYN J, 1994, MOL CELL BIOL, V14, P4135, DOI 10.1128/MCB.14.6.4135; ALEXA A, 2016, TOPGO ENRICHMENT ANA, DOI DOI 10.18129/B9.BI0C.T0PG0; Amaya MJ, 2014, HEPATOLOGY, V59, P274, DOI 10.1002/hep.26609; [Anonymous], 2018, RES BIOSF CAL; Arezo MJ, 2007, TISSUE CELL, V39, P89, DOI 10.1016/j.tice.2007.01.004; Arrese EL, 2010, ANNU REV ENTOMOL, V55, P207, DOI 10.1146/annurev-ento-112408-085356; Berois N, 2012, WIRES DEV BIOL, V1, P595, DOI 10.1002/wdev.39; Blazek R, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-24; Bowman CJ, 2014, NAT CELL BIOL, V16, P1202, DOI 10.1038/ncb3062; Bozza William P, 2018, Oncotarget, V9, P23264, DOI 10.18632/oncotarget.25297; CARTER CA, 1990, J MORPHOL, V204, P209, DOI 10.1002/jmor.1052040209; Chang L, 2004, NAT REV MOL CELL BIO, V5, P601, DOI 10.1038/nrm1438; CHINO H, 1958, J INSECT PHYSIOL, V2, P1, DOI 10.1016/0022-1910(58)90024-6; CLEMMONS DR, 1991, J CLIN ENDOCR METAB, V73, P727, DOI 10.1210/jcem-73-4-727; Djudjaj S, 2016, KIDNEY INT, V89, P792, DOI 10.1016/j.kint.2015.10.015; Dominguez-Castanedo O, 2017, DEV DYNAM, V246, P802, DOI 10.1002/dvdy.24519; Du X, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.651317; Fan J, 2015, ACS CHEM BIOL, V10, P510, DOI 10.1021/cb500683c; Ferry RJ, 1999, HORM METAB RES, V31, P192, DOI 10.1055/s-2007-978719; Frescas D, 2017, P NATL ACAD SCI USA, V114, pE1668, DOI 10.1073/pnas.1614661114; Furness AI, 2016, BIOL REV, V91, P796, DOI 10.1111/brv.12194; Furness AI, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2189; Gajardo F., ACCELERATED GE UNPUB; Guldiken N, 2015, LIVER INT, V35, P1203, DOI 10.1111/liv.12608; Hahn DA, 2011, ANNU REV ENTOMOL, V56, P103, DOI 10.1146/annurev-ento-112408-085436; Hand SC, 2016, AM J PHYSIOL-REG I, V310, pR1193, DOI 10.1152/ajpregu.00250.2015; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Hu CK, 2020, SCIENCE, V367, P870, DOI 10.1126/science.aaw2601; Hu CK, 2018, AGING CELL, V17, DOI 10.1111/acel.12757; Hussein AM, 2020, DEV CELL, V52, P236, DOI 10.1016/j.devcel.2019.12.018; Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040; Jin LT, 2015, CANCER CELL, V27, P257, DOI 10.1016/j.ccell.2014.12.006; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kanehisa M, 2020, PROTEIN SCI, V29, P28, DOI 10.1002/pro.3711; Kim YM, 2002, J BIOL CHEM, V277, P16837, DOI 10.1074/jbc.M201379200; Kim YJ, 2009, CARCINOGENESIS, V30, P598, DOI 10.1093/carcin/bgp047; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; Klotz LO, 2015, REDOX BIOL, V6, P51, DOI 10.1016/j.redox.2015.06.019; Ku NO, 2002, P NATL ACAD SCI USA, V99, P4373, DOI 10.1073/pnas.072624299; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Lant B, 2010, INT J BIOL SCI, V6, P9; Lee DC, 2008, CANCER RES, V68, P4210, DOI 10.1158/0008-5472.CAN-07-5040; Lee P, 2020, NAT REV MOL CELL BIO, V21, P268, DOI 10.1038/s41580-020-0227-y; LEVELS PJ, 1988, ENVIRON BIOL FISH, V22, P211, DOI 10.1007/BF00005382; LEVELS PJ, 1986, COMP BIOCHEM PHYS A, V84, P767, DOI 10.1016/0300-9629(86)90403-2; Li AQ, 2007, J INSECT PHYSIOL, V53, P385, DOI 10.1016/j.jinsphys.2007.01.003; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00630-w; Loureiro M, 2018, NEOTROP ICHTHYOL, V16, DOI 10.1590/1982-0224-20180007; Lubzens E, 2010, TOP CURR GENET, V21, P1, DOI 10.1007/978-3-642-12422-8_1; Malik AI, 2009, GENE, V442, P99, DOI 10.1016/j.gene.2009.04.007; MATTERA R, 1989, J BIOL CHEM, V264, P465; Meller CL, 2012, J COMP PHYSIOL B, V182, P909, DOI 10.1007/s00360-012-0672-9; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Mor-Vaknin N, 2003, NAT CELL BIOL, V5, P59, DOI 10.1038/ncb898; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Morrow CS, 2020, CELL STEM CELL, V26, P558, DOI 10.1016/j.stem.2020.01.018; Murphy WJ, 1997, MOL BIOL EVOL, V14, P790, DOI 10.1093/oxfordjournals.molbev.a025819; Park YJ, 2007, BIOCHEM BIOPH RES CO, V363, P361, DOI 10.1016/j.bbrc.2007.08.195; Parkhitko AA, 2019, AGING CELL, V18, DOI 10.1111/acel.13034; Pennington KL, 2018, ONCOGENE, V37, P5587, DOI 10.1038/s41388-018-0348-3; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Peters N., 1963, Internationale Revue der Gesamten Hydrobiologie, V48, P257; Podrabsky JE, 2017, DEV DYNAM, V246, P779, DOI 10.1002/dvdy.24513; Podrabsky JE, 2016, ANNUAL FISHES: LIFE HISTORY STRATEGY, DIVERSITY, AND EVOLUTION, P63; Podrabsky JE, 2016, ANNUAL FISHES: LIFE HISTORY STRATEGY, DIVERSITY, AND EVOLUTION, P159; Podrabsky JE, 2015, J EXP BIOL, V218, P1897, DOI 10.1242/jeb.116194; Podrabsky JE, 2010, TOP CURR GENET, V21, P203, DOI 10.1007/978-3-642-12422-8_12; Podrabsky JE, 1999, J EXP BIOL, V202, P2567; Polacik M, 2021, ECOL EVOL, V11, P4945, DOI 10.1002/ece3.7402; R Core Team, 2020, R LANG ENV STAT COMP; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Reichard M, 2019, ELIFE, V8, DOI 10.7554/eLife.41548; Reynolds JA, 2017, ADV INSECT PHYSIOL, V53, P115, DOI 10.1016/bs.aiip.2017.03.003; Rinehart JP, 2007, P NATL ACAD SCI USA, V104, P11130, DOI 10.1073/pnas.0703538104; Romney AL, 2017, EVODEVO, V8, DOI 10.1186/s13227-017-0069-7; Romney ALT, 2018, P NATL ACAD SCI USA, V115, P12763, DOI 10.1073/pnas.1804590115; Rosa JC, 2016, CURR MOL PHARMACOL, V9, P320, DOI 10.2174/1874467209666160112123036; Ruhrberg C, 1997, J CELL BIOL, V139, P1835, DOI 10.1083/jcb.139.7.1835; Rusu P, 2019, CELL STEM CELL, V25, P241, DOI 10.1016/j.stem.2019.06.004; Sakaguchi M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09418-0; Sancar A, 2003, CHEM REV, V103, P2203, DOI 10.1021/cr0204348; Saravanakumar R, 2008, BIOLOGIA, V63, P737, DOI 10.2478/s11756-008-0124-x; Schiesari L, 2013, CURR TOP DEV BIOL, V105, P213, DOI 10.1016/B978-0-12-396968-2.00008-7; Shoshan-Barmatz V, 2009, BBA-BIOENERGETICS, V1787, P421, DOI 10.1016/j.bbabio.2008.11.009; Shoshan-Barmatzt V, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00164; Sim C, 2008, P NATL ACAD SCI USA, V105, P6777, DOI 10.1073/pnas.0802067105; Sim C, 2011, J INSECT PHYSIOL, V57, P628, DOI 10.1016/j.jinsphys.2011.01.012; Singh S, 2013, FREE RADICAL BIO MED, V56, P89, DOI 10.1016/j.freeradbiomed.2012.11.010; Snider NT, 2014, NAT REV MOL CELL BIO, V15, P163, DOI 10.1038/nrm3753; Tao GZ, 2009, J CELL SCI, V122, P3851, DOI 10.1242/jcs.051862; Thompson AW, 2016, MOL BIOL EVOL, V33, P2391, DOI 10.1093/molbev/msw110; Tiwari R, 2018, FEBS J, V285, P1251, DOI 10.1111/febs.14401; van den Heuvel APJ, 2004, THESIS UTRECHT U; Wagner JT, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.204347; Wagner JT, 2015, J EXP ZOOL PART A, V323, P10, DOI 10.1002/jez.1890; Wang WQ, 2015, DEV CELL, V32, P707, DOI 10.1016/j.devcel.2015.01.031; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilke C.O., 2020, COWPLOT STREAMLINED; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Woll SC, 2017, J EXP BIOL, V220, P2777, DOI 10.1242/jeb.151373; Wolschin F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006394; WOURMS JP, 1972, J EXP ZOOL, V182, P389, DOI 10.1002/jez.1401820310; WOURMS JP, 1972, J EXP ZOOL, V182, P143, DOI 10.1002/jez.1401820202; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; YAGINUMA T, 1978, J INSECT PHYSIOL, V24, P347, DOI 10.1016/0022-1910(78)90074-4; Yamamoto T., 1967, METHODS DEV BIOL, P101; Yang HC, 2017, SCIENCE, V357, P1142, DOI 10.1126/science.aan1121; Yocum GD, 2004, EUR J ENTOMOL, V101, P199, DOI 10.14411/eje.2004.025; Zajic DE, 2020, PHYSIOL GENOMICS, V52, P408, DOI 10.1152/physiolgenomics.00072.2020; Zajic DE., 2020, COMP BIOCH PHYSL A, V146, P621; Zhao Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200357; Ziv T, 2017, MOL CELL PROTEOMICS, V16, P1746, DOI 10.1074/mcp.RA117.000109; Zupancic T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099398	116	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251820	10.1371/journal.pone.0251820	http://dx.doi.org/10.1371/journal.pone.0251820			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086690	Green Published, gold			2022-12-26	WOS:000664640100021
J	Foreman, HCC; Kirillov, V; Paniccia, G; Catalano, D; Andrunik, T; Gupta, S; Krug, LT; Zhang, Y				Foreman, Hui-Chen Chang; Kirillov, Varvara; Paniccia, Gabrielle; Catalano, Demetra; Andrunik, Trevor; Gupta, Swati; Krug, Laurie T.; Zhang, Yue			RNA-guided gene editing of the murine gammaherpesvirus 68 genome reduces infectious virus production	PLOS ONE			English	Article							SCALE CRISPR-CAS9 KNOCKOUT; KAPOSIS-SARCOMA; CELL-CYCLE; V-CYCLIN; IN-VIVO; REACTIVATION; ESTABLISHMENT; IDENTIFICATION; REPLICATION; REGULATOR	Epstein-Barr virus (EBV) and Kaposi sarcoma herpesvirus (KSHV) are cancer-causing viruses that establish lifelong infections in humans. Gene editing using the Cas9-guideRNA (gRNA) CRISPR system has been applied to decrease the latent load of EBV in human Burkitt lymphoma cells. Validating the efficacy of Cas9-gRNA system in eradicating infection in vivo without off-target effects to the host genome will require animal model systems. To this end, we evaluated a series of gRNAs against individual genes and functional genomic elements of murine gammaherpesvirus 68 (MHV68) that are both conserved with KSHV and important for the establishment of latency or reactivation from latency in the host. gRNA sequences against ORF50, ORF72 and ORF73 led to insertion, deletion and substitution mutations in these target regions of the genome in cell culture. Murine NIH3T3 fibroblast cells that stably express Cas9 and gRNAs to ORF50 were most resistant to replication upon de novo infection. Latent murine A20 B cell lines that stably express Cas9 and gRNAs against MHV68 were reduced in their reactivation by approximately 50%, regardless of the viral gene target. Lastly, co-transfection of HEK293T cells with the vector expressing the Cas9-MHV68 gRNA components along with the viral genome provided a rapid read-out of gene editing and biological impact. Combinatorial, multiplex MHV68 gRNA transfections in HEK293T cells led to near complete ablation of infectious particle production. Our findings indicate that Cas9-gRNA editing of the murine gammaherpesvirus genome has a deleterious impact on productive replication in three independent infection systems.	[Foreman, Hui-Chen Chang; Kirillov, Varvara; Paniccia, Gabrielle; Catalano, Demetra; Andrunik, Trevor; Gupta, Swati; Krug, Laurie T.; Zhang, Yue] SUNY Stony Brook, Dept Microbiol & Immunol, Stony Brook, NY 11794 USA; [Krug, Laurie T.] NCI, HIV & AIDS Malignancy Branch, Ctr Canc Res, NHI, Bethesda, MD USA; [Foreman, Hui-Chen Chang] ATCC, Manassas, VA USA; [Paniccia, Gabrielle] Rockefeller Univ, Grad Program Biosci, 1230 York Ave, New York, NY 10021 USA; [Catalano, Demetra] New York Genome Ctr, Ctr Genom Neurodegenerat Dis, New York, NY USA; [Andrunik, Trevor] James Madison Univ, Dept Phys Assistant Studies, Harrisonburg, VA 22807 USA; [Gupta, Swati] New York Inst Technol, Coll Osteopath Med, Centereach, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rockefeller University; James Madison University	Zhang, Y (corresponding author), SUNY Stony Brook, Dept Microbiol & Immunol, Stony Brook, NY 11794 USA.	yue.zhang@stonybrook.edu	Krug, Laurie T/H-5315-2019; Foreman, Hui-Chen (Jane)/GMW-4448-2022	Krug, Laurie T/0000-0002-9648-522X; Foreman, Hui-Chen (Jane)/0000-0001-9640-9780; Zhang, Yue/0000-0002-0531-5568; Andrunik, Trevor/0000-0002-8637-2360	NIH; NIH [R43 AI31958]; Stony Brook Foundation Discovery Prize	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stony Brook Foundation Discovery Prize	This research was supported in part by the Intramural Research Program of the NIH, by the Stony Brook Foundation Discovery Prize and NIH R43 AI31958. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler H, 2007, J VIROL, V81, P7300, DOI 10.1128/JVI.02406-06; Aubert M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17936-5; Aubert M, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88468; Barton E, 2011, ANNU REV IMMUNOL, V29, P351, DOI 10.1146/annurev-immunol-072710-081639; Chen YC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060291; Cieniewicz B, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01202; Coen N, 2014, ANTIMICROB AGENTS CH, V58, P7312, DOI 10.1128/AAC.03957-14; Collins CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033230; Deng HY, 2004, J VIROL, V78, P9123, DOI 10.1128/JVI.78.17.9123-9131.2004; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Dunmire SK, 2015, CURR TOP MICROBIOL, V390, P211, DOI 10.1007/978-3-319-22822-8_9; Forrest JC, 2008, J VIROL, V82, P7688, DOI 10.1128/JVI.02689-07; Forrest JC, 2007, J VIROL, V81, P11957, DOI 10.1128/JVI.00111-07; Fowler P, 2003, J GEN VIROL, V84, P3405, DOI 10.1099/vir.0.19594-0; Frederico B, 2014, CELL HOST MICROBE, V15, P457, DOI 10.1016/j.chom.2014.03.010; Gray KS, 2009, J VIROL, V83, P314, DOI 10.1128/JVI.01444-08; Gupta A, 2017, J VIROL, V91, DOI 10.1128/JVI.00992-17; Haapaniemi E, 2018, NAT MED, V24, P927, DOI 10.1038/s41591-018-0049-z; Horlbeck MA, 2016, ELIFE, V5, DOI 10.7554/eLife.12677; Jiang FG, 2017, ANNU REV BIOPHYS, V46, P505, DOI 10.1146/annurev-biophys-062215-010822; Jones T, 2014, CELL CYCLE, V13, P845, DOI 10.4161/cc.27758; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Juillard F, 2020, P NATL ACAD SCI USA, V117, P22443, DOI 10.1073/pnas.2004809117; Lee KS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002496; Li G, 2017, SCI REP-UK, V7, DOI 10.1038/srep44404; Lin Cui Li, 2003, Journal of Virology, V77, P5578, DOI 10.1128/JVI.77.10.5578-5588.2003; Minhas V, 2014, VIRUSES-BASEL, V6, P4178, DOI 10.3390/v6114178; Moorman NJ, 2003, J VIROL, V77, P10295, DOI 10.1128/JVI.77.19.10295-10303.2003; Moser JA, 2006, J VIROL, V80, P1592, DOI 10.1128/JVI.80.3.1592-1598.2006; Paden CR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002906; Pavlova LV, 2003, J VIROL, V77, P5731, DOI 10.1128/JVI.77.10.5731-5739.2003; Polizzotto MN, 2016, J CLIN ONCOL, V34, P4125, DOI 10.1200/JCO.2016.69.3812; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Santana AL, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6010009; Sattler C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005510; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Sifford JM, 2016, J VIROL, V90, P2571, DOI 10.1128/JVI.02867-15; Tso FY, 2019, J VIROL, V93, DOI 10.1128/JVI.02183-18; Uhlin M, 2014, HAEMATOLOGICA, V99, P346, DOI 10.3324/haematol.2013.087338; Uppal T, 2014, VIRUSES-BASEL, V6, P4961, DOI 10.3390/v6124961; van Diemen FR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005701; van Dyk LF, 2000, J VIROL, V74, P7451, DOI 10.1128/JVI.74.16.7451-7461.2000; Van Dyk LF, 1999, J VIROL, V73, P5110, DOI 10.1128/JVI.73.6.5110-5122.1999; Verschuren EW, 2004, J GEN VIROL, V85, P1347, DOI 10.1099/vir.0.79812-0; Wakeman BS, 2014, J VIROL, V88, P5474, DOI 10.1128/JVI.03110-13; Wang CX, 2016, BLOOD, V127, P2546, DOI 10.1182/blood-2016-01-678144; Wang JB, 2014, P NATL ACAD SCI USA, V111, P13157, DOI 10.1073/pnas.1410785111; Williams LM, 2015, J VIROL, V89, P10821, DOI 10.1128/JVI.00891-15; Xu YY, 2005, J VIROL, V79, P3479, DOI 10.1128/JVI.79.6.3479-3487.2005; Yarchoan R, 2018, NEW ENGL J MED, V378, P2145, DOI 10.1056/NEJMc1804812; Yin CR, 2017, MOL THER, V25, P1168, DOI 10.1016/j.ymthe.2017.03.012	51	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252313	10.1371/journal.pone.0252313	http://dx.doi.org/10.1371/journal.pone.0252313			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086743	gold, Green Published			2022-12-26	WOS:000664640100045
J	Nomura, M; Unuma, K; Aki, T; Uemura, K				Nomura, Moeka; Unuma, Kana; Aki, Toshihiko; Uemura, Koichi			Sustained splenic contraction after daily cocaine administration in rats	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; HUMAN SPLEEN; HEMATOCRIT; DISEASE; HUMANS	The purpose of this study is to examine the effect of repeated cocaine administration on the whole body of rats. Rats (male, 6 weeks old, Sprague Dawley) were injected intraperitoneally with cocaine (50 mg/kg) once a day for 1, 3 or 7 days, and major organs (heart, liver, lung, brain, kidney, spleen) were excised from the sacrificed animals. During autopsy, we found a reduction in spleen size, but not other organs, in cocaine-administered rats as compared to control rats. This reduction became to be noticed at 3 day and easily perceived at 7 day. No marked changes were observed in other organs examined. H&E and EMG staining showed a tendency for a decrease in the number of red blood cells (RBCs) as well as an increase in collagen fibers in the spleens of rats treated repeatedly with cocaine. Transcriptome analysis indicated that repeated cocaine administration depletes RBCs from the spleen. Immunoblot analysis showed that cocaine increases the phosphorylation of myosin light chain (MYL) as well as the levels of transgelin, both of which are involved in the contraction of myofibrils. Collectively, these results show that repeated cocaine administration results in sustained contraction of the spleen, which leads to the release of RBCs from the spleen into circulation.	[Nomura, Moeka; Unuma, Kana; Aki, Toshihiko; Uemura, Koichi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Tokyo, Japan	Tokyo Medical & Dental University (TMDU)	Aki, T (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Forens Med, Tokyo, Japan.	aki.legm@tmd.ac.jp			MEXT KAKENHI [20H03955, 19K10680]	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid from MEXT KAKENHI (grant numbers 20H03955 to T.A. and 19K10680 to Ka.U.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHIJADO F, 1990, NEPHRON, V54, P268, DOI 10.1159/000185869; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Ballard DH, 2015, CLIN IMAG, V39, P1112, DOI 10.1016/j.clinimag.2015.06.012; BOELSTERLI UA, 1991, ARCH TOXICOL, V65, P351, DOI 10.1007/BF02284256; Boning D, 2011, INT J SPORTS MED, V32, P242, DOI 10.1055/s-0030-1255063; Boghdadi MS, 1997, HEART LUNG, V26, P466, DOI 10.1016/S0147-9563(97)90040-6; Bronte V, 2013, IMMUNITY, V39, P806, DOI 10.1016/j.immuni.2013.10.010; Brousse V, 2014, BRIT J HAEMATOL, V166, P165, DOI 10.1111/bjh.12950; BROWN DN, 1994, AM J GASTROENTEROL, V89, P1558; Cesta MF, 2006, TOXICOL PATHOL, V34, P455, DOI 10.1080/01926230600867743; Cohen GM, 1997, BIOCHEM J, V326, P1, DOI 10.1042/bj3260001; Dackis CA, 2001, J SUBST ABUSE TREAT, V21, P111, DOI 10.1016/S0740-5472(01)00192-1; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Espersen K, 2002, J APPL PHYSIOL, V92, P2071, DOI 10.1152/japplphysiol.00055.2001; Havakuk O, 2017, J AM COLL CARDIOL, V70, P101, DOI 10.1016/j.jacc.2017.05.014; HOFFMAN CK, 1989, RADIOLOGY, V172, P463, DOI 10.1148/radiology.172.2.2748827; Holmstrom P, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00647; Kantak KM, 2020, PHARMACOL BIOCHEM BE, V196, DOI 10.1016/j.pbb.2020.172994; Karthik N, 2016, CLINICS PRACT, V6, P65, DOI 10.4081/cp.2016.868; Kaufman MJ, 1998, J APPL PHYSIOL, V85, P1877, DOI 10.1152/jappl.1998.85.5.1877; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Khan AN, 2017, J SURG CASE REP, DOI 10.1093/jscr/rjx054; LAUB M, 1993, J APPL PHYSIOL, V74, P1024, DOI 10.1152/jappl.1993.74.3.1024; LEE HS, 1990, ANN SURG, V211, P15, DOI 10.1097/00000658-199001000-00003; Linder JD, 2000, SOUTHERN MED J, V93, P909; NILSSON S, 1976, EUR J PHARMACOL, V39, P41, DOI 10.1016/0014-2999(76)90111-4; Peacock A, 2018, ADDICTION, V113, P1905, DOI 10.1111/add.14234; Perper J A, 1992, Recent Dev Alcohol, V10, P343; Schagatay E, 2001, J APPL PHYSIOL, V90, P1623, DOI 10.1152/jappl.2001.90.4.1623; Schagatay E, 2020, EUR J APPL PHYSIOL, V120, P2693, DOI 10.1007/s00421-020-04471-w; Schwartz BG, 2010, CIRCULATION, V122, P2558, DOI 10.1161/CIRCULATIONAHA.110.940569; Segarra AC, 2010, HORM BEHAV, V58, P33, DOI 10.1016/j.yhbeh.2009.12.003; Sengupta P, 2013, INT J PREVENTIVE MED, V4, P624; SINGHAL P, 1989, NEPHRON, V52, P76, DOI 10.1159/000185585; Stewart IB, 2002, SPORTS MED, V32, P361, DOI 10.2165/00007256-200232060-00002; TAKEICHI M, 1988, CELL DIFFER DEV, V25, P91, DOI 10.1016/0922-3371(88)90104-9; Tiwari A, 2006, J ROY SOC MED, V99, P51, DOI 10.1258/jrsm.99.2.51; Ward AS, 1997, PSYCHOPHARMACOLOGY, V132, P375, DOI 10.1007/s002130050358; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003; White RE, 2002, VASC PHARMACOL, V38, P73, DOI 10.1016/S0306-3623(02)00129-5; Zakharova E, 2009, PHARMACOL BIOCHEM BE, V92, P131, DOI 10.1016/j.pbb.2008.11.002	42	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252853	10.1371/journal.pone.0252853	http://dx.doi.org/10.1371/journal.pone.0252853			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086815	Green Published, gold			2022-12-26	WOS:000664640100149
J	Pedersen, NR; Tovborg, M; Farjam, AS; Della Pia, EA				Pedersen, Ninfa Rangel; Tovborg, Morten; Farjam, Abdoreza Soleimani; Della Pia, Eduardo Antonio			Multicomponent carbohydrase system from Trichoderma reesei: A toolbox to address complexity of cell walls of plant substrates in animal feed	PLOS ONE			English	Article							ALPHA-L-ARABINOFURANOSIDASE; ACETYL XYLAN ESTERASE; BROILER-CHICKENS; ENZYME SUPPLEMENTATION; METABOLIZABLE ENERGY; MONOCLONAL-ANTIBODY; NUTRITIVE-VALUE; BARLEY; WHEAT; CELLULOSE	A diverse range of monocot and dicot grains and their by-products are commonly used in the animal feed industry. They all come with complex and variable cell wall structures which in turn contribute significant fiber to the complete feed. The cell wall is a highly interconnected matrix of various polysaccharides, proteins and lignin and, as such, requires a collaborative effort of different enzymes for its degradation. In this regard, we investigated the potential of a commercial multicomponent carbohydrase product from a wild type fermentation of Trichoderma reesei (T. reesei) (RONOZYME((R)) MultiGrain) in degrading cell wall components of wheat, barley, rye, de-oiled rice bran, sunflower, rapeseed and cassava. A total of thirty-one different enzyme proteins were identified in the T. Reesei carbohydrase product using liquid chromatography with tandem mass spectrometry LC-MS/MS including glycosyl hydrolases and carbohydrate esterases. As measured by in vitro incubations and non-starch polysaccharide component analysis, and visualization by immunocytochemistry and confocal microscopy imaging of immuno-labeled samples with confocal microscopy, the carbohydrase product effectively solubilized cellulolytic and hemicellulolytic polysaccharides present in the cell walls of all the feed ingredients evaluated. The T. reesei fermentation also decreased viscosity of arabinoxylan, xyloglucan, galactomannan and beta -glucan substrates. Combination of several debranching enzymes including arabinofuranosidase, xylosidase, alpha -galactosidase, acetyl xylan esterase, and 4-O-methyl-glucuronoyl methylesterase with both GH10 and GH11 xylanases in the carbohydrase product resulted in effective hydrolyzation of heavily branched glucuronoarabinoxylans. The different beta -glucanases (both endo-beta -1,3(4)-glucanase and endo-beta -1,3-glucanase), cellulases and a beta -glucosidase in the T. reesei fermentation effectively reduced polymerization of both beta -glucans and cellulose polysaccharides of viscous cereals grains (wheat, barley, rye and oat). Interestingly, the secretome of T. reesei contained significant amounts of an exceptional direct chain-cutting enzyme from the GH74 family (Cel74A, xyloglucan-specific beta -1,4-endoglucanase), that strictly cleaves the xyloglucan backbone at the substituted regions. Here, we demonstrated that the balance of enzymes present in the T. reesei secretome is capable of degrading various cell wall components in both monocot and dicot plant raw material used as animal feed.	[Pedersen, Ninfa Rangel; Tovborg, Morten; Della Pia, Eduardo Antonio] Novozymes AS Denmark, Lyngby, Denmark; [Pedersen, Ninfa Rangel] Fermentationexperts AS, Baekke, Denmark; [Farjam, Abdoreza Soleimani] Novozymes AS Malaysia, Kuala Lumpur, Malaysia		Della Pia, EA (corresponding author), Novozymes AS Denmark, Lyngby, Denmark.	eap@novozymes.com		Pedersen, Ninfa Rangel/0000-0002-0861-2728				AB Vista, REF GUID INTR FIBR A; Abel GJ., 2011, VISCOSITY PRESSURE A; Aires RD, 2012, CARBOHYD POLYM, V87, P1219, DOI 10.1016/j.carbpol.2011.09.001; Amandine G., 2010, EUKARYOT CELL, V9, P1294, DOI [10.1128/EC.00107-10, DOI 10.1128/EC.00107-10]; Anderson CT, 2010, PLANT PHYSIOL, V152, P787, DOI 10.1104/pp.109.150128; [Anonymous], 2020, GLOBAL FEED STAT INT; ARISANATAC I, 1993, APPL MICROBIOL BIOT, V39, P58, DOI 10.1007/BF00166849; Arnal G, 2019, J BIOL CHEM, V294, P13233, DOI 10.1074/jbc.RA119.009861; Austin SC, 1999, J CEREAL SCI, V29, P77, DOI 10.1006/jcrs.1998.0213; BACIC A, 1980, CARBOHYD RES, V82, P372, DOI 10.1016/S0008-6215(00)85713-4; Barnes WJ, 2018, MOL PLANT, V11, P31, DOI 10.1016/j.molp.2017.08.011; BIELY P, 1994, FEBS LETT, V356, P137, DOI 10.1016/0014-5793(94)01248-2; BRENES A, 1993, POULTRY SCI, V72, P1731, DOI 10.3382/ps.0721731; Burton RA, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00456; Chowdhury J, 2014, NEW PHYTOL, V204, P650, DOI 10.1111/nph.12974; Desmet T, 2007, FEBS J, V274, P356, DOI 10.1111/j.1742-4658.2006.05582.x; Dong JL, 2011, AFR J BIOTECHNOL, V10, P17424, DOI 10.5897/AJB11.1242; Fernandes VO, 2016, ANIM FEED SCI TECH, V211, P153, DOI 10.1016/j.anifeedsci.2015.11.007; FOWLER T, 1992, MOL MICROBIOL, V6, P3225, DOI 10.1111/j.1365-2958.1992.tb01777.x; Gastebois A, 2010, J BIOL CHEM, V285, P2386, DOI 10.1074/jbc.M109.077545; Gigli-Bisceglia N, 2020, CELL MOL LIFE SCI, V77, P2049, DOI 10.1007/s00018-019-03388-8; Glamocic D., 2011, Biotechnology in Animal Husbandry, V27, P583; Gong WL, 2015, APPL BIOCHEM BIOTECH, V177, P1252, DOI 10.1007/s12010-015-1811-z; Grishutin SG, 2004, BBA-GEN SUBJECTS, V1674, P268, DOI 10.1016/j.bbagen.2004.07.001; Guais O, 2010, APPL MICROBIOL BIOT, V87, P1007, DOI 10.1007/s00253-010-2532-4; Gutierrez R, 1998, FEBS LETT, V423, P35, DOI 10.1016/S0014-5793(98)00055-6; Hakkinen M, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-134; Hayashi T, 2011, MOL PLANT, V4, P17, DOI 10.1093/mp/ssq063; He J, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-56; HENRISSAT B, 1985, BIO-TECHNOL, V3, P722, DOI 10.1038/nbt0885-722; Herpoel-Gimbert I, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-18; Hsiao HY, 2006, POULTRY SCI, V85, P1430, DOI 10.1093/ps/85.8.1430; Im HL, 1999, J SCI FOOD AGR, V79, P1727, DOI 10.1002/(SICI)1097-0010(199909)79:12&lt;1727::AID-JSFA428&gt;3.0.CO;2-K; Jaaskelainen AS, 2013, J CEREAL SCI, V57, P543, DOI 10.1016/j.jcs.2013.02.007; Joaquin A, CARBOHYDRASES ARE EN; Karlsson J, 2002, J BIOTECHNOL, V99, P63, DOI 10.1016/S0168-1656(02)00156-6; Kuge T, 2015, BIOSCI BIOTECH BIOCH, V79, P1810, DOI 10.1080/09168451.2015.1046365; Kyu May Thin, 2019, J Nutr Sci Vitaminol (Tokyo), V65, pS143, DOI 10.3177/jnsv.65.S143; Lee J, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2046-3; Lehmann L, 2016, BIOTECHNOL BIOENG, V113, P1001, DOI 10.1002/bit.25871; Li XL, 2007, FEBS LETT, V581, P4029, DOI 10.1016/j.febslet.2007.07.041; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; MargollesClark E, 1996, APPL ENVIRON MICROB, V62, P3840, DOI 10.1128/AEM.62.10.3840-3846.1996; MargollesClark E, 1996, EUR J BIOCHEM, V237, P553, DOI 10.1111/j.1432-1033.1996.0553p.x; MargollesClark E, 1996, EUR J BIOCHEM, V240, P104, DOI 10.1111/j.1432-1033.1996.0104h.x; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; MEIKLE PJ, 1994, PLANT J, V5, P1, DOI 10.1046/j.1365-313X.1994.5010001.x; Monrad RN, 2018, CRIT REV BIOTECHNOL, V38, P1121, DOI 10.1080/07388551.2018.1468316; Muller G, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1199-4; O'Neill HVM, 2014, ASIAN AUSTRAL J ANIM, V27, P290, DOI 10.5713/ajas.2013.13261; Oladunjoye I., 2010, INT J ANIM VET ADV, V2, P5; Pedersen NR, 2017, ANIM FEED SCI TECH, V234, P244, DOI 10.1016/j.anifeedsci.2017.09.015; Perez-Ternero C, 2017, FOOD FUNCT, V8, P2165, DOI [10.1039/C7FO00243B, 10.1039/c7fo00243b]; PETTERSSON D, 1991, ANIM FEED SCI TECH, V33, P1, DOI 10.1016/0377-8401(91)90041-P; Rakszegi M, 2014, CARBOHYD POLYM, V102, P557, DOI 10.1016/j.carbpol.2013.12.005; Ravn JL, 2018, ANIM FEED SCI TECH, V236, P159, DOI 10.1016/j.anifeedsci.2017.12.012; Ravn JL., 2015, J AGR SCI TORONTO, V7, DOI [10.5539/jas.v7n9p1, DOI 10.5539/JAS.V7N9P1]; Ravn JL, 2016, ANIM FEED SCI TECH, V219, P216, DOI 10.1016/j.anifeedsci.2016.06.020; Schultink Alex, 2014, Plants (Basel), V3, P526, DOI 10.3390/plants3040526; Seiboth B, 2011, APPL MICROBIOL BIOT, V89, P1665, DOI 10.1007/s00253-010-3071-8; Sinitsyna OA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P41, DOI 10.1134/S0006297910010062; STALBRAND H, 1993, J BIOTECHNOL, V29, P229, DOI 10.1016/0168-1656(93)90055-R; Stals I, 2010, FEMS MICROBIOL LETT, V303, P9, DOI 10.1111/j.1574-6968.2009.01849.x; Tenkanen M, 2013, FEBS J, V280, P285, DOI 10.1111/febs.12069; Villca B, 2016, J ANIM SCI, V94, P230, DOI 10.2527/jas.2015-9747; Vincken JP, 1997, CARBOHYD RES, V298, P299, DOI 10.1016/S0008-6215(96)00325-4; Ward N., 2021, INT POULTRY SCI FORU; Ward NE, 2021, POULTRY SCI, V100, P765, DOI 10.1016/j.psj.2020.10.074; Willats WGT, 1998, CARBOHYD RES, V308, P149, DOI 10.1016/S0008-6215(98)00070-6; Xu J, 1998, APPL MICROBIOL BIOT, V49, P718, DOI 10.1007/s002530051237	70	3	4	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251556	10.1371/journal.pone.0251556	http://dx.doi.org/10.1371/journal.pone.0251556			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086701	Green Published, gold			2022-12-26	WOS:000664640100017
J	Shin, D; Lee, KW				Shin, Dayeon; Lee, Kyung Won			High pre-pregnancy BMI with a history of gestational diabetes mellitus is associated with an increased risk of type 2 diabetes in Korean women	PLOS ONE			English	Article							INSULIN SENSITIVITY; OBESITY; PREVALENCE; RESISTANCE; WEIGHT; MUSCLE; TERM	Despite the importance of pre-pregnancy body mass index (BMI) and a history of gestational diabetes mellitus (GDM) in the progression of GDM to type 2 diabetes, few studies have evaluated the combined effect of high pre-pregnancy BMI and GDM status on the future development of type 2 diabetes in Korean women. This study aimed to examine the relationship of pre-pregnancy BMI and GDM history with the risk of type 2 diabetes among Korean women. In addition, the effects of pre-pregnancy BMI and current BMI on the risk of type 2 diabetes were evaluated. Women who gave birth in the Health Examinees Study of the Korean Genome and Epidemiology Study from 2004 to 2013 (n = 59,258) were included in this study. Multivariable logistic regression was used to examine the association of pre-pregnancy BMI categories (underweight: <18.5 kg/m(2); normal: 18.5-22.9 kg/m(2); overweight: 23.0-24.9 kg/m(2); obese: <greater than or equal to>25.0 kg/m(2)) and GDM history with the risk of type 2 diabetes after controlling for the following covariates: age, education, income, smoking status before the first pregnancy, alcohol consumption, regular exercise, menarche age, first pregnancy age, and first pregnancy outcome. Compared to women with normal pre-pregnancy BMIs, women with overweight and obese pre-pregnancy BMIs had higher odds of developing type 2 diabetes (adjusted odds ratio [AOR]: 1.13, 95% confidence interval [CI]: 1.02-1.25 and AOR: 1.29, 95% CI: 1.10-1.50, respectively) after controlling for covariates. Women with pre-pregnancy BMIs <23 kg/m(2) and current BMIs <greater than or equal to>23 kg/m(2) had increased odds of developing type 2 diabetes (AOR: 1.64, 95% CI: 1.51-1.78) compared to those with pre-pregnancy BMIs <23 kg/m(2) and current BMIs <23 kg/m(2). Among women without a history of GDM, those with overweight and obese pre-pregnancy BMIs had increased odds of developing type 2 diabetes compared to those with normal pre-pregnancy BMIs (AOR: 1.12, 95% CI: 1.01-1.24 and AOR: 1.23, 95% CI: 1.05-1.44, respectively). Among women with GDM, those with obese pre-pregnancy BMIs had increased odds of developing type 2 diabetes (AOR: 3.84, 95% CI: 1.52-9.87). This study showed that there was a higher likelihood of developing type 2 diabetes in women who were overweight or obese before pregnancy with a history of GDM compared to their counterparts without a history of GDM. Furthermore, high pre-pregnancy BMI or high current BMI increased the risk of type 2 diabetes in Korean women, regardless of GDM history. This emphasizes the importance of maintaining a healthy weight status before and after pregnancy to prevent the future risk of type 2 diabetes.	[Shin, Dayeon] Inha Univ, Dept Food & Nutr, Incheon, South Korea; [Lee, Kyung Won] Korea Natl Univ Educ, Dept Home Econ Educ, Cheongju, South Korea	Inha University; Korea National University of Education	Lee, KW (corresponding author), Korea Natl Univ Educ, Dept Home Econ Educ, Cheongju, South Korea.	kwlee@knue.ac.kr			National Research Foundation of Korea (NRF) - Korean government (MSIT) [2020R1G1A1004940]	National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of Korea)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (No. 2020R1G1A1004940). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anna V, 2008, DIABETES CARE, V31, P2288, DOI 10.2337/dc08-1038; Bider-Canfield Z, 2017, PEDIATR OBES, V12, P171, DOI 10.1111/ijpo.12125; Casagrande SS, 2018, DIABETES RES CLIN PR, V141, P200, DOI 10.1016/j.diabres.2018.05.010; Catalano PM, 2012, DIABETES CARE, V35, P780, DOI 10.2337/dc11-1790; Catalano PM, 2003, J NUTR, V133, p1674S, DOI 10.1093/jn/133.5.1674S; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; Dall TM, 2019, DIABETES CARE, V42, P1661, DOI 10.2337/dc18-1226; Daly B, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002488; Day C., 2011, BR J DIABETES VASC D, V11, P55; Eckel RH, 2011, J CLIN ENDOCR METAB, V96, P1654, DOI 10.1210/jc.2011-0585; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Health Examinees Study Group, 2015, Asian Pac J Cancer Prev, V16, P1591; Herath H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179647; Jovanovic L, 2001, JAMA-J AM MED ASSOC, V286, P2516, DOI 10.1001/jama.286.20.2516; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kim Y, 2017, INT J EPIDEMIOL, V46, DOI 10.1093/ije/dyv316; Kolu P, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-71; Koo BK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153107; Kwon HS., 2019, TREATMENT GUIDELINE, V6th, P33; Martens DS, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0689-0; Meguro S, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/590569; Metzger BE, 1998, DIABETES CARE, V21, pB161; Metzger BE, 2007, CLIN OBSTET GYNECOL, V50, P972, DOI 10.1097/GRF.0b013e31815a61d6; Page KA, 2019, DIABETES CARE, V42, P1473, DOI 10.2337/dc18-2581; Park JY, 1997, DIABETES RES CLIN PR, V35, P49, DOI 10.1016/S0168-8227(96)01363-0; Pendergrass M, 2007, AM J PHYSIOL-ENDOC M, V292, pE92, DOI 10.1152/ajpendo.00617.2005; REAVEN GM, 1995, PHYSIOL REV, V75, P473, DOI 10.1152/physrev.1995.75.3.473; Ryder JW, 2001, FRONT BIOSCI-LANDMRK, V6, pD154, DOI 10.2741/Ryder; Shin D, 2015, J MATERN-FETAL NEO M, V28, P1679, DOI 10.3109/14767058.2014.964675; Shin D, 2014, MATERN CHILD HLTH J, V18, P1667, DOI 10.1007/s10995-013-1407-6; Spann MN, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.24661; Thangaratinam S., 2016, QUANTIFICATION TYPE; Torloni MR, 2009, OBES REV, V10, P194, DOI 10.1111/j.1467-789X.2008.00541.x; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Xiang AH, 2013, DIABETOLOGIA, V56, P2753, DOI 10.1007/s00125-013-3048-0	36	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252442	10.1371/journal.pone.0252442	http://dx.doi.org/10.1371/journal.pone.0252442			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086709	Green Published, gold			2022-12-26	WOS:000664640100066
J	Suh, HN; Kim, YK; Lee, JY; Kang, GH; Hwang, JH				Suh, Han Na; Kim, Young Kyu; Lee, Ju Young; Kang, Goo-Hwa; Hwang, Jeong Ho			Dissect the immunity using cytokine profiling and NF-kB target gene analysis in systemic inflammatory minipig model	PLOS ONE			English	Article							ANIMAL-MODELS; KAPPA-B; LUNG INJURY; TLR4; LIPOPOLYSACCHARIDE; EXPRESSION; ACTIVATION; INDUCTION; SEPSIS; CYCLOOXYGENASE-2	Minipigs have remarkably similar physiology to humans, therefore, they it can be a good animal model for inflammation study. Thus, the conventional (serum chemistry, histopathology) and novel analytic tools [immune cell identification in tissue, cytokine level in peripheral blood mononuclear cells (PBMC) and serum, NF-kB target gene analysis in tissue] were applied to determine inflammation in Chicago Miniature Swine (CMS) minipig. Lipopolysaccharide (LPS)-induced acute systemic inflammation caused liver and kidney damage in serum chemistry and histopathology. Immunohistochemistry (IHC) also showed an increase of immune cell distribution in spleen and lung during inflammation. Moreover, NF-kB-target gene expression was upregulated in lung and kidney in acute inflammation and in heart, liver, and intestine in chronic inflammation. Cytokine mRNA was elevated in PBMC under acute inflammation along with elevated absolute cytokine levels in serum. Overall, LPS-mediated systemic inflammation affects the various organs, and can be detected by IHC of immune cells, gene analysis in PBMC, and measuring the absolute cytokine in serum along with conventional inflammation analytic tools.	[Suh, Han Na; Kim, Young Kyu; Lee, Ju Young; Kang, Goo-Hwa; Hwang, Jeong Ho] Korea Inst Toxicol, Anim Model Res Grp, Jeongeup, Jeollabuk Do, South Korea	Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT)	Suh, HN; Hwang, JH (corresponding author), Korea Inst Toxicol, Anim Model Res Grp, Jeongeup, Jeollabuk Do, South Korea.	hanna.suh@kitox.re.kr; jeongho.hwang@kitox.re.kr		, Hanna/0000-0002-7647-7249; Hwang, Jeong Ho/0000-0002-4763-8373	Korea Institute of Toxicology [KK-1911, 2009-01]	Korea Institute of Toxicology	Korea Institute of Toxicology, KK-1911 & 2009-01, Mr Jeong Ho Hwang.	Ackerman WE, 2008, BIOL REPROD, V78, P68, DOI 10.1095/biolreprod.107.061663; Agrawal A, 2003, MOL IMMUNOL, V40, P373, DOI 10.1016/S0161-5890(03)00148-2; Ahmetaj-Shala B, 2015, CIRCULATION, V131, P633, DOI 10.1161/CIRCULATIONAHA.114.011591; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Chen LY, 2019, LAB ANIMAL, V48, P57, DOI 10.1038/s41684-018-0217-2; Chung HJ, 2010, J ETHNOPHARMACOL, V130, P450, DOI 10.1016/j.jep.2010.05.020; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; DAS KC, 1995, AM J PHYSIOL-LUNG C, V269, pL588, DOI 10.1152/ajplung.1995.269.5.L588; Dawson HD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-332; de Laat MA, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00120; DeMaria AN, 2003, J PAIN SYMPTOM MANAG, V25, pS41; FIEDLER VB, 1992, J LAB CLIN MED, V120, P574; Fink MP, 2014, VIRULENCE, V5, P143, DOI 10.4161/viru.26083; Guo JS, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-21; Haudek SB, 2003, SHOCK, V20, P431, DOI 10.1097/01.shk.0000090843.66556.74; HURLIMANN J, 1966, J EXP MED, V123, P365, DOI 10.1084/jem.123.2.365; Hyde DM, 1999, AM J PHYSIOL-LUNG C, V277, pL1190, DOI 10.1152/ajplung.1999.277.6.L1190; Jia HP, 2016, J IMMUNOL, V197, P859, DOI 10.4049/jimmunol.1600618; Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC; Kulkarni RG, 2006, CURR PHARM DESIGN, V12, P2437, DOI 10.2174/138161206777698945; Leturcq DJ, 1996, J CLIN INVEST, V98, P1533, DOI 10.1172/JCI118945; Liaudet L, 2002, INFECT IMMUN, V70, P192, DOI 10.1128/IAI.70.1.192-198.2002; Liu L, 2015, J CELL MOL MED, V19, P2728, DOI 10.1111/jcmm.12659; Norregaard R, 2015, KIDNEY RES CLIN PRAC, V34, P194, DOI 10.1016/j.krcp.2015.10.004; Patil KR, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184367; Plotnikov EY, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7080105; Price AE, 2018, IMMUNITY, V49, P560, DOI 10.1016/j.immuni.2018.07.016; Pulskens WP, 2010, J AM SOC NEPHROL, V21, P1299, DOI 10.1681/ASN.2009070722; Rose NR, 2009, J CLIN IMMUNOL, V29, P730, DOI 10.1007/s10875-009-9339-z; Seehase S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043709; Sheppard O, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1490-8; Son YH, 2008, J CARDIOVASC PHARM, V51, P71, DOI 10.1097/FJC.0b013e31815bd23d; Stortz JA, 2017, ILAR J, V58, P90, DOI 10.1093/ilar/ilx007; Wagner TL, 1997, CYTOKINE, V9, P837, DOI 10.1006/cyto.1997.0239; Warren HS, 2010, J INFECT DIS, V201, P223, DOI 10.1086/649557; Wernersson R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-70; Wu HL, 2007, J CLIN INVEST, V117, P2847, DOI 10.1172/JCI31008; Xu DH, 2015, CELL PHYSIOL BIOCHEM, V37, P27, DOI 10.1159/000430330; Yang Y, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.140; Zanotti-Cavazzoni SL, 2009, CRIT CARE CLIN, V25, P703, DOI 10.1016/j.ccc.2009.08.005; Zhao JY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42286-8	44	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252947	10.1371/journal.pone.0252947	http://dx.doi.org/10.1371/journal.pone.0252947			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086835	Green Published, gold			2022-12-26	WOS:000664640100156
J	van der Vlegel, M; Haagsma, JA; Havermans, RJM; de Munter, L; de Jongh, MAC; Polinder, S				van der Vlegel, Marjolein; Haagsma, Juanita A.; Havermans, Roos J. M.; de Munter, Leonie; de Jongh, Mariska A. C.; Polinder, Suzanne			Long-term medical and productivity costs of severe trauma: Results from a prospective cohort study	PLOS ONE			English	Article							QUALITY-OF-LIFE; MAJOR TRAUMA; INJURY; PREVALENCE; RETURN; WORK; CARE; DETERMINANTS; NETHERLANDS; POPULATION	Background Through improvements in trauma care there has been a decline in injury mortality, as more people survive severe trauma. Patients who survive severe trauma are at risk of long-term disabilities which may place a high economic burden on society. The purpose of this study was to estimate the health care and productivity costs of severe trauma patients up to 24 months after sustaining the injury. Furthermore, we investigated the impact of injury severity level on health care utilization and costs and determined predictors for health care and productivity costs. Methods This prospective cohort study included adult trauma patients with severe injury (ISS >= 16). Data on in-hospital health care use, 24-month post-hospital health care use and productivity loss were obtained from hospital registry data and collected with the iMTA Medical Consumption and Productivity Cost Questionnaire. The questionnaires were completed 1 week and 1, 3, 6, 12 and 24 months after injury. Log-linked gamma generalized linear models were used to investigate the drivers of health care and productivity costs. Results In total, 174 severe injury patients were included in this study. The median age of participants was 55 years and the majority were male (66.1%). The mean hospital stay was 14.2 (SD = 13.5) days. Patients with paid employment returned to work 21 weeks after injury. In total, the mean costs per patient were Euro24,760 with in-hospital costs of Euro11,930, post-hospital costs of Euro7,770 and productivity costs of Euro8,800. Having an ISS >= 25 and lower health status were predictors of high health care costs and male sex was associated with higher productivity costs. Conclusions Both health care and productivity costs increased with injury severity, although large differences were observed between patients. It is important for decision-makers to consider not only in-hospital health care utilization but also the long-term consequences and associated costs related to rehabilitation and productivity loss.	[van der Vlegel, Marjolein; Haagsma, Juanita A.; Polinder, Suzanne] Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Havermans, Roos J. M.] Network Emergency Care Brabant, Brabant Trauma Registry, Tilburg, Netherlands; [de Munter, Leonie; de Jongh, Mariska A. C.] ETZ Hosp, Dept Trauma TopCare, Tilburg, Netherlands	Erasmus University Rotterdam; Erasmus MC; Elisabeth-TweeSteden Ziekenhuis (ETZ)	van der Vlegel, M (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands.	m.vandervlegel@erasmusmc.nl		van der Vlegel, Marjolein/0000-0002-0217-9484	Netherlands Organisation for Health Research and Development (ZonMw) [80-84200-98-14225]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study was funded by The Netherlands Organisation for Health Research and Development (ZonMw) under grant number 80-84200-98-14225. (https://www.zonmw.nl/nl/).The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], KOSTENHANDLEIDING ME; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; Bouwmans C, 2013, HANDLEIDING IMTA MED; Bouwmans C, 2015, VALUE HEALTH, V18, P753, DOI 10.1016/j.jval.2015.05.009; CBS, WORK POP WORK TIM 20; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; de Jongh MAC, 2017, INJURY PREV, V23, P59, DOI 10.1136/injuryprev-2016-042032; de Putter CE, 2012, J BONE JOINT SURG AM, V94A, DOI 10.2106/JBJS.K.00561; Elkerliek, STAND PRIJSL OV ZORG; Erasmus MC., PASSANTENPRIJSLIJST; Gabbe BJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002322; Gabbe BJ, 2016, ANN SURG, V263, P623, DOI 10.1097/SLA.0000000000001564; Gennarelli TA, 2006, INJURY, V37, P1083, DOI 10.1016/j.injury.2006.07.009; Geraerds AJLM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227131; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Haeusler JMC, 2006, J TRAUMA, V61, P723, DOI 10.1097/01.ta.0000210453.70742.7f; Hartholt KA, 2012, INJURY, V43, P1199, DOI 10.1016/j.injury.2012.03.033; Havermans RJM, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00719-8; Holbrook TL, 1999, J TRAUMA, V46, P765, DOI 10.1097/00005373-199905000-00003; Holbrook TL, 2004, J TRAUMA, V56, P284, DOI 10.1097/01.TA.0000109758.75406.F8; Holtslag HR, 2008, B WORLD HEALTH ORGAN, V86, P111, DOI 10.2471/BLT.06.033803; Holtslag HR, 2007, CLIN REHABIL, V21, P373, DOI 10.1177/0269215507072084; Holtslag HR, 2007, J TRAUMA, V62, P919, DOI 10.1097/01.ta.0000224124.47646.62; Kaske S, 2014, INJURY, V45, pS100, DOI 10.1016/j.injury.2014.08.028; Lamers LM, 2006, HEALTH ECON, V15, P1121, DOI 10.1002/hec.1124; Landelijke Netwerk Acute Zorg (LNAZ), 2018, ANN REP DUTCH TRAUM; Livingston DH, 2009, J TRAUMA, V67, P341, DOI 10.1097/TA.0b013e3181a5cc34; Lyons RA, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001140; Meerding WJ, 2006, EUR J PUBLIC HEALTH, V16, P271, DOI 10.1093/eurpub/ckl006; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Nederlandse Zorgautoriteit, TAR EERSY 2014; Nederlandse Zorgautoriteit, NED ZORG ZORG 2017; Nederlandse Zorgautoriteit, 2015, BRCU 2015 BIJLAGE 2; Pape HC, 2009, EUR J TRAUMA EMERG S, V35, P61, DOI 10.1007/s00068-008-8013-0; Polinder S, 2007, J TRAUMA, V62, P133, DOI 10.1097/TA.0b013e31802b71c9; Polinder S, 2016, ACCIDENT ANAL PREV, V93, P92, DOI 10.1016/j.aap.2016.04.003; Rivas, BIOIMP 2019; Rowell D, 2011, J TRAUMA, V70, P1086, DOI 10.1097/TA.0b013e3181ed4d29; Scholten AC, 2015, ACCIDENT ANAL PREV, V81, P51, DOI 10.1016/j.aap.2015.04.022; Upatising B, 2015, TELEMED E-HEALTH, V21, P3, DOI 10.1089/tmj.2014.0021; van Beeck EF, 1998, PUBLIC HEALTH REP, V113, P427; van Delft-Schreurs CCHM, 2014, INJURY, V45, P320, DOI 10.1016/j.injury.2013.02.025; Vles WJ, 2005, J TRAUMA, V58, P126, DOI 10.1097/01.TA.0000112342.40296.1F; Willenberg L, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-267; Wilson SJ, 2017, QUAL LIFE RES, V26, P1831, DOI 10.1007/s11136-017-1521-9; World Health Organization, 2014, INJ VIOL FACTS; Zeelandcare, 2018, PASS PRIJSL DBC OVP	48	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252673	10.1371/journal.pone.0252673	http://dx.doi.org/10.1371/journal.pone.0252673			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086788	Green Published, gold			2022-12-26	WOS:000664640100105
J	Wang, ZH; Zhao, ZJ; Wang, CX				Wang, Zhaohan; Zhao, Zijie; Wang, Chengxin			Random forest analysis of factors affecting urban carbon emissions in cities within the Yangtze River Economic Belt	PLOS ONE			English	Article							DIOXIDE EMISSIONS; ENERGY-CONSUMPTION; DECOMPOSITION ANALYSIS; INDUSTRIAL-STRUCTURE; INTERNATIONAL-TRADE; VARIABLE IMPORTANCE; REGRESSION TREES; CO2 EMISSIONS; CHINA; IMPACT	China became the country with the largest global carbon emissions in 2007. Cities are regional population and economic centers and are the main sources of carbon emissions. However, factors influencing carbon emissions from cities can vary with geographic location and the development history of the cities, rendering it difficult to explicitly quantify the influence of individual factors on carbon emissions. In this study, random forest (RF) machine learning algorithms were applied to analyze the relationships between factors and carbon emissions in cities using real-world data from Chinese cities. Seventy-three cities in three urban agglomerations within the Yangtze River Economic Belt were evaluated with respect to urban carbon emissions using data from regional energy balance tables for the years 2000, 2007, 2012, and 2017. The RF algorithm was then used to select 16 prototypical cities based on 10 influencing factors that affect urban carbon emissions while considering five primary factors: population, industry, technology levels, consumption, and openness to the outside world. Subsequently, 18 consecutive years of data from 2000 to 2017 were used to construct RFs to investigate the temporal predictability of carbon emission variation in the 16 cities based on regional differences. Results indicated that the RF approach is a practical tool to study the connection between various influencing factors and carbon emissions in the Yangtze River Economic Belt from different perspectives. Furthermore, regional differences among the primary carbon emission influencing factors for each city were clearly observed and were related to urban population characteristics, urbanization level, industrial structures, and degree of openness to the outside world. These factors variably affected different cities, but the results indicate that regional emission reductions have achieved positive results, with overall simulation trends shifting from underestimation to overestimation of emissions.	[Wang, Zhaohan; Wang, Chengxin] Shandong Normal Univ, Coll Geog & Environm, Jinan, Shandong, Peoples R China; [Zhao, Zijie] Univ Melbourne, Sch Earth Sci, Melbourne, Vic 3010, Australia; [Zhao, Zijie] Australian Res Council, Ctr Excellence Climate Extremes, Melbourne, Vic, Australia	Shandong Normal University; University of Melbourne	Wang, CX (corresponding author), Shandong Normal Univ, Coll Geog & Environm, Jinan, Shandong, Peoples R China.	chengxin_w@163.com		Zhao, Zijie/0000-0003-3403-878X	National Key Research and Development Program of China [2016YFA0602500]	National Key Research and Development Program of China	The research is supported by the National Key Research and Development Program of China (Grant No. 2016YFA0602500).	Ahmad A, 2016, ENERG POLICY, V96, P131, DOI 10.1016/j.enpol.2016.05.032; Ajmi AN, 2015, ENERG ECON, V49, P629, DOI 10.1016/j.eneco.2015.02.007; Ang BW, 2005, ENERG POLICY, V33, P867, DOI 10.1016/j.enpol.2003.10.010; Higon DA, 2017, TELEMAT INFORM, V34, P85, DOI 10.1016/j.tele.2017.01.001; [Anonymous], General principles for calculation of the comprehensive energy consumption; Arneth A, 2017, NAT GEOSCI, V10, P79, DOI [10.1038/ngeo2882, 10.1038/NGEO2882]; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L, 2002, MANUAL SETTING USING, P58; Cai BF, 2019, APPL ENERG, V242, P994, DOI 10.1016/j.apenergy.2019.03.146; Cai BF, 2017, CHIN J POPUL RESOUR, V15, P58, DOI 10.1080/10042857.2017.1286143; Chen X., 2007, INT J COMP SOCIOL, V48, P167, DOI [10.1177/0020715207075399, DOI 10.1177/0020715207075399]; Chontanawat J, 2019, ENERGIES, V12, DOI 10.3390/en12040764; Churkina G, 2010, GLOBAL CHANGE BIOL, V16, P135, DOI 10.1111/j.1365-2486.2009.02002.x; Dong HJ, 2014, ENERGY, V64, P277, DOI 10.1016/j.energy.2013.11.005; Du KR, 2017, RENEW SUST ENERG REV, V73, P19, DOI 10.1016/j.rser.2017.01.102; Eccel E.M.A.N.U.E.L.E., 2007, PREDICTION MINIMUM T; Eggleston S., 2006, 2006 IPCC GUIDELINES, V5; Fang CL, 2015, APPL ENERG, V158, P519, DOI 10.1016/j.apenergy.2015.08.095; Fang ZX, 2012, J TRANSP GEOGR, V23, P44, DOI 10.1016/j.jtrangeo.2012.03.018; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gelenbe E., 2015, UBIQUITY, V2015, P1, DOI [10.1145/2755977, DOI 10.1145/2755977]; Gingrich S, 2011, ENERG POLICY, V39, P535, DOI 10.1016/j.enpol.2010.10.006; Gromping U, 2009, AM STAT, V63, P308, DOI 10.1198/tast.2009.08199; Guan RD, 2019, ENRGY PROCED, V158, P3234, DOI 10.1016/j.egypro.2019.01.998; Hayes T, 2015, PSYCHOL AGING, V30, P911, DOI 10.1037/pag0000046; [何立华 He Lihua], 2015, [中国人口·资源与环境, China Population Resources and Environment], V25, P89; Ho TK, 1998, IEEE T PATTERN ANAL, V20, P832, DOI 10.1109/34.709601; Ishwaran H, 2007, ELECTRON J STAT, V1, P519, DOI 10.1214/07-EJS039; Jiang XM, 2016, J IND ECOL, V20, P506, DOI 10.1111/jiec.12404; Lau LS, 2014, ENERG POLICY, V68, P490, DOI 10.1016/j.enpol.2014.01.002; Lenzen M, 2013, CLIMATIC CHANGE, V121, P815, DOI 10.1007/s10584-013-0930-1; Li N, 2020, J CLEAN PROD, V257, DOI 10.1016/j.jclepro.2020.120503; Li S., 2019, E3S WEB C, V118; Liddle B, 2014, POPUL ENVIRON, V35, P286, DOI 10.1007/s11111-013-0198-4; Lin BQ, 2016, RENEW SUST ENERG REV, V60, P173, DOI 10.1016/j.rser.2016.01.069; Lindmark M, 2002, ECOL ECON, V42, P333, DOI 10.1016/S0921-8009(02)00108-8; Liu QC, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/268286; Liu YL, 2020, CITIES, V104, DOI 10.1016/j.cities.2020.102801; Liu Z., 2009, URBAN STUD, V16, P1, DOI 10.3969/j.issn.1006-3862.2009.06.001; Lugauer S, 2014, ECON INQ, V52, P914, DOI 10.1111/ecin.12054; Mascaro J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085993; Mi ZF, 2015, J CLEAN PROD, V103, P455, DOI 10.1016/j.jclepro.2014.06.011; Tavares RLM, 2018, SCI AGR, V75, P281, DOI [10.1590/1678-992x-2017-0095, 10.1590/1678-992X-2017-0095]; Ouyang XL, 2017, J CLEAN PROD, V143, P356, DOI 10.1016/j.jclepro.2016.12.102; PANG S.S, 2017, THESIS DESTECH T SOC; Peters GP, 2008, CLIMATIC CHANGE, V86, P51, DOI 10.1007/s10584-007-9280-1; Redding SJ, 2011, PALGRAVE HANDBOOK OF INTERNATIONAL TRADE, P497; Ren SG, 2014, ENERG POLICY, V69, P624, DOI 10.1016/j.enpol.2014.02.032; SALL J, 1990, AM STAT, V44, P308, DOI 10.2307/2684358; Shahzad SJH, 2017, RENEW SUST ENERG REV, V70, P185, DOI 10.1016/j.rser.2016.11.042; Shi AQ, 2003, ECOL ECON, V44, P29, DOI 10.1016/S0921-8009(02)00223-9; Shu H, 2019, LAND USE POLICY, V81, P604, DOI 10.1016/j.landusepol.2018.11.034; Shuai CY, 2017, APPL ENERG, V187, P310, DOI 10.1016/j.apenergy.2016.11.029; Sinha A., 2018, INT J GREEN EC, V12, P228, DOI [DOI 10.1504/IJGE.2018.097869, 10.1504/IJGE.2018.097869]; Siroky DS, 2009, STAT SURV, V3, P147, DOI 10.1214/07-SS033; Song ML, 2015, J CLEAN PROD, V103, P620, DOI 10.1016/j.jclepro.2014.05.095; Sun W, 2018, ENVIRON SCI POLLUT R, V25, P28985, DOI 10.1007/s11356-018-2738-z; Tibshirani R., 2009, SPRINGER SERIES STAT, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Wang CJ, 2017, RENEW SUST ENERG REV, V67, P51, DOI 10.1016/j.rser.2016.09.006; Wang Q, 2019, J CLEAN PROD, V234, P702, DOI 10.1016/j.jclepro.2019.06.174; Wang Q, 2018, J CLEAN PROD, V197, P178, DOI 10.1016/j.jclepro.2018.05.285; [王韶华 Wang Shaohua], 2013, [资源科学, Resources Science], V35, P1438; Wang ZH, 2016, ECOL INDIC, V61, P634, DOI 10.1016/j.ecolind.2015.10.015; Wei S.H., 2015, IND EC RES, V1, P71; Welsch H., 2001, Structural Change and Economic Dynamics, V12, P425, DOI 10.1016/S0954-349X(01)00027-3; Witten I.H., 2002, ACM SIGMOD REC, V31, P76, DOI 10.1145/507338.507355; Worrell E, 2001, ANNU REV ENERG ENV, V26, P303, DOI 10.1146/annurev.energy.26.1.303; Xie HL, 2018, LAND USE POLICY, V75, P518, DOI 10.1016/j.landusepol.2018.04.027; Xu XB, 2017, J CLEAN PROD, V142, P3607, DOI 10.1016/j.jclepro.2016.10.107; Yang L, 2014, ENVIRON ENG MANAG J, V13, P1173; Yang L, 2013, SUSTAIN CITIES SOC, V9, P62, DOI 10.1016/j.scs.2013.03.001; Yu YT, 2020, ENERG POLICY, V139, DOI 10.1016/j.enpol.2020.111354; Zhang N, 2015, APPL ENERG, V146, P409, DOI 10.1016/j.apenergy.2015.01.072; Zhao X, 2017, J CLEAN PROD, V142, P3500, DOI 10.1016/j.jclepro.2016.10.117; Zheng B, 2018, ENVIRON SCI TECHNOL, V52, P6032, DOI 10.1021/acs.est.7b05654; Zheng YH, 2013, ENERGY, V57, P336, DOI 10.1016/j.energy.2013.05.004; Zhu XH, 2017, J CLEAN PROD, V168, P791, DOI 10.1016/j.jclepro.2017.09.014	77	1	1	16	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252337	10.1371/journal.pone.0252337	http://dx.doi.org/10.1371/journal.pone.0252337			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086729	Green Published, gold			2022-12-26	WOS:000664640100047
J	Ibanez-Lorente, C; Casans-Frances, R; Bellas-Cotan, S; Munoz-Alameda, LE				Ibanez-Lorente, Cristina; Casans-Frances, Ruben; Bellas-Cotan, Soledad; Munoz-Alameda, Luis E.			Implementation of a maternal early warning system during early postpartum. A prospective observational study	PLOS ONE			English	Article								Objective To evaluate the implementation of a maternal early warning system (MEWS) for monitoring patients during the first two hours after delivery in a tertiary level hospital. Methods Implementation of the criteria between 15 March and 15 September 2018 was evaluated in 1166 patients. The parameters collected were systolic and diastolic blood pressure, heart rate, oxygen saturation, urine output, uterine involution, and bleeding. Out-of-range values of any of these parameters triggered a warning, and an obstetrician was called to examine the patient. The obstetrician then decided whether to call the anesthesiologist. We carried out a sensitivity-specificity study of triggers and a multivariate analysis of the factors involved in developing potentially fatal disorders (PFD), reintervention, critical care admission, and stay. Results The MEWS was triggered in 75 patients (6.43%). Leading trigger was altered systolic blood pressure in 32 patients (42.7%), and 11 patients had a PFD. Twenty-eight triggers were false-negatives. Sensitivity and specificity of the system was 0.28 (0.15, 0.45) and 0.94 (0.93, 0.96), respectively. The multivariate analysis showed a correlation between trigger activation and PFD. Conclusion Our MEWS presented low sensitivity and high specificity, with a significant number of false-negatives.	[Ibanez-Lorente, Cristina; Bellas-Cotan, Soledad; Munoz-Alameda, Luis E.] Hosp Univ Fdn Jimenez Diaz, Dept Anesthesia, Madrid, Spain; [Casans-Frances, Ruben] Hosp Univ Infanta Elena, Dept Anesthesia, Madrid, Spain		Ibanez-Lorente, C (corresponding author), Hosp Univ Fdn Jimenez Diaz, Dept Anesthesia, Madrid, Spain.	cristinaibanez21@hotmail.com		Casans-Frances, Ruben/0000-0002-0620-9871; ibanez, cristina/0000-0002-1592-2281				Armitage M, 2007, BRIT MED J, V335, P258, DOI 10.1136/bmj.39272.679688.47; Behling Diana J, 2015, Nurs Womens Health, V19, P128, DOI 10.1111/1751-486X.12185; Bogod D., 2019, GUIDELINES PROVISION; Buderer NMF, 1996, ACAD EMERG MED, V3, P895, DOI 10.1111/j.1553-2712.1996.tb03538.x; Cueto Hernandez I., 2018, THESIS U COMPLUTENSE; de Miguel Sesmero JR, 2015, PROGR OBSTET GINECOL; Edwards SE, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2014.11.007; Friedman AM, 2015, OBSTET GYN CLIN N AM, V42, P289, DOI 10.1016/j.ogc.2015.01.006; McClure JH, 2011, BRIT J ANAESTH, V107, P127, DOI 10.1093/bja/aer192; Mhyre JM, 2014, OBSTET GYNECOL, V124, P782, DOI 10.1097/AOG.0000000000000480; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Singh S, 2012, ANAESTHESIA, V67, P12, DOI 10.1111/j.1365-2044.2011.06896.x; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Umar A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217864; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013	15	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252446	10.1371/journal.pone.0252446	http://dx.doi.org/10.1371/journal.pone.0252446			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081737	gold, Green Published			2022-12-26	WOS:000664639200020
J	Chen, SW; Liu, T; Bu, DF; Zhu, J; Wang, X; Pan, YS; Liu, YC; Lu, ZJ; Wang, PY				Chen, Shanwen; Liu, Tao; Bu, Dingfang; Zhu, Jing; Wang, Xin; Pan, Yisheng; Liu, Yucun; Lu, Zhi John; Wang, Pengyuan			Methylome profiling identifies TCHH methylation in CfDNA as a noninvasive marker of liver metastasis in colorectal cancer	FASEB JOURNAL			English	Article						CfDNA; colorectal cancer; liver metastasis; methylight; methylome; TCHH	DNA; PLASMA	Methylation of circulating free DNA (CfDNA) has emerged as an efficient marker of tumor screening and prognostics. However, no efficient methylation marker has been developed for monitoring liver metastasis (LM) in colorectal cancer (CRC). Utilizing methylome profiling and bisulfite sequencing polymerase chain reaction of paired primary and LM sites, significantly increased methylation of TCHH was identified in the process of LM in CRC in the present study. Methylight analysis of TCHH methylation in CfDNA displayed a promisingly discriminative power between CRC with and without LM. Besides, significant coefficient of TCHH methylation and LM tumor volume was also validated. Together, these results indicated the potential of TCHH methylation in CfDNA as a monitoring marker of LM in CRC.	[Chen, Shanwen; Liu, Tao; Zhu, Jing; Wang, Xin; Pan, Yisheng; Liu, Yucun; Wang, Pengyuan] Peking Univ First Hosp, Div Gen Surg, Beijing, Peoples R China; [Bu, Dingfang] Peking Univ First Hosp, Cent Lab, Beijing, Peoples R China; [Lu, Zhi John] Tsinghua Univ, Ctr Synthet & Syst Biol, Sch Life Sci, MOE Key Lab Bioinformat, Beijing, Peoples R China	Peking University; Tsinghua University	Wang, PY (corresponding author), Peking Univ First Hosp, Div Gen Surg, Beijing, Peoples R China.	wangpengyuan2014@126.com		Pan, Yisheng/0000-0002-8924-2342; Wang, Pengyuan/0000-0003-3884-0227	National Natural Science Foundation of China [81902384, 81770522]; Interdisciplinary Clinical Research Project of Peking University First Hospital, Scientific Research Seed Fund of Peking University First Hospital [2019SF01]; National Science and Technology Major Project of China [2018ZX10723204]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Interdisciplinary Clinical Research Project of Peking University First Hospital, Scientific Research Seed Fund of Peking University First Hospital; National Science and Technology Major Project of China	This work was supported by grants from the National Natural Science Foundation of China (No. 81902384, No. 81770522), Interdisciplinary Clinical Research Project of Peking University First Hospital, Scientific Research Seed Fund of Peking University First Hospital (No. 2019SF01) and National Science and Technology Major Project of China (2018ZX10723204).	Ansa BE, 2018, J CLIN MED, V7, DOI 10.3390/jcm7020022; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bhangu JS, 2018, ANN SURG, V268, P894, DOI 10.1097/SLA.0000000000002901; Brannon AR, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0454-7; Chan KCA, 2013, P NATL ACAD SCI USA, V110, P18761, DOI 10.1073/pnas.1313995110; Chen SW, 2019, J CROHNS COLITIS, V13, P1067, DOI 10.1093/ecco-jcc/jjz027; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Fan JW, 2011, CLIN CANCER RES, V17, P2908, DOI 10.1158/1078-0432.CCR-10-2552; Filip S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155255; Gai WX, 2018, CLIN CHEM, V64, P1239, DOI 10.1373/clinchem.2018.290304; Gruosso T, 2019, J CLIN INVEST, V129, P1785, DOI 10.1172/JCI96313; Hao XK, 2017, P NATL ACAD SCI USA, V114, P7414, DOI 10.1073/pnas.1703577114; Lamb YN, 2017, MOL DIAGN THER, V21, P225, DOI 10.1007/s40291-017-0259-y; Luo HY, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax7533; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; Morris TJ, 2014, BIOINFORMATICS, V30, P428, DOI 10.1093/bioinformatics/btt684; Nordlund J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r105; Orjuela S, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-06777-6; Petrova A, 2016, STEM CELLS DEV, V25, P1366, DOI 10.1089/scd.2016.0156; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Singh A, 2020, INT J CANCER, V147, P1740, DOI 10.1002/ijc.32984; Sun K, 2015, P NATL ACAD SCI USA, V112, pE5503, DOI 10.1073/pnas.1508736112; Van Cutsem E, 2016, ANN ONCOL, V27, P1386, DOI 10.1093/annonc/mdw235; Weisenberger DJ, 2008, NUCLEIC ACIDS RES, V36, P4689, DOI 10.1093/nar/gkn455; Xie H, 2021, ANN SURG ONCOL, V28, P1845, DOI 10.1245/s10434-020-09002-7; Zaimi I, 2018, EPIGENETICS-US, V13, P1056, DOI 10.1080/15592294.2018.1530008; Zhou WD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkw967	29	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21720	10.1096/fj.202100266R	http://dx.doi.org/10.1096/fj.202100266R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34110642				2022-12-26	WOS:000667814100052
J	Graf, F; Horn, P; Ho, AD; Boutros, M; Maercker, C				Graf, Fabian; Horn, Patrick; Ho, Anthony D.; Boutros, Michael; Maercker, Christian			The extracellular matrix proteins type I collagen, type III collagen, fibronectin, and laminin 421 stimulate migration of cancer cells	FASEB JOURNAL			English	Article						cancer cell migration; extracellular matrix proteins	MESENCHYMAL STEM-CELLS; STROMAL CELLS; STEM/PROGENITOR CELLS; METASTATIC NICHE; TUMOR-GROWTH; ADHESION; INVASION; CHEMOTAXIS; RECEPTORS; INTEGRIN	For metastasis formation, individual cells from a primary tumor must migrate toward other tissues. The aim of this study was to determine if mesenchymal stromal cells (MSCs) from human bone marrow are able to emit signals that induce this migratory activity in cancer cells. We separated the supernatant of MSCs derived from human bone marrow by size-exclusion and ion-exchange chromatography and have subsequently studied the migratory behavior of the prostate cancer cell line PC3 and the breast cancer cell line MDA-MB-231 toward the respective fractions in a transwell migration assay. We identified the extracellular matrix (ECM) proteins type I collagen, type III collagen, fibronectin, and laminin 421 as potential drivers of cancer cell migration. These results could be reproduced using the corresponding isolated or recombinant ECM proteins. Knockdown of the gene encoding beta 1 integrin, an important cell surface receptor for fibronectin, has led to inhibition of cancer cell migration. This supports the hypothesis that beta 1 integrin signaling represents an initial event that leads to metastasis, and that signaling is triggered by binding of integrin heterodimers to ECM molecules. Further characterization of signaling factors and their respective receptors will have implications for anticancer drug development.	[Graf, Fabian; Boutros, Michael; Maercker, Christian] German Canc Res Ctr, Div Signaling & Funct Genom, Neuenheimer Feld 580, D-69120 Heidelberg, Germany; [Graf, Fabian; Maercker, Christian] Mannheim Univ Appl Sci, Dept Biotechnol, Mannheim, Germany; [Horn, Patrick; Ho, Anthony D.] Heidelberg Univ, Dept Med 5, Heidelberg, Germany; [Boutros, Michael] Heidelberg Univ, Med Fac, Dept Cell & Mol Biol, Mannheim, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Maercker, C (corresponding author), German Canc Res Ctr, Div Signaling & Funct Genom, Neuenheimer Feld 580, D-69120 Heidelberg, Germany.	christian.maercker@gmail.com			State of Baden-Wuerttemberg; Albert and Anneliese Konanz Foundation	State of Baden-Wuerttemberg; Albert and Anneliese Konanz Foundation	State of Baden-Wuerttemberg; Albert and Anneliese Konanz Foundation	Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Castro F, 2013, INT J CANCER, V132, P308, DOI 10.1002/ijc.27675; Chaffer CL, 2016, CANCER METAST REV, V35, P645, DOI 10.1007/s10555-016-9648-7; Chen Hong-Chen, 2004, V294, P15; Djouad F, 2003, BLOOD, V102, P3837, DOI 10.1182/blood-2003-04-1193; Fang M, 2014, TUMOR BIOL, V35, P2871, DOI 10.1007/s13277-013-1511-7; Fidler IJ, 2008, LANCET ONCOL, V9, P808, DOI 10.1016/S1470-2045(08)70201-8; Fleisch H, 1998, ENDOCR REV, V19, P80, DOI 10.1210/er.19.1.80; Fu Guanyuan, 2012, Methods Mol Biol, V757, P81, DOI 10.1007/978-1-61779-166-6_7; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hall CL, 2008, NEOPLASIA, V10, P797, DOI 10.1593/neo.08380; Ho C S, 2003, Clin Biochem Rev, V24, P3; HOROSZEWICZ JS, 1983, CANCER RES, V43, P1809; Huang EH, 2009, J SURG RES, V155, P231, DOI 10.1016/j.jss.2008.06.044; Hullinger TG, 1998, PROSTATE, V36, P14, DOI 10.1002/(SICI)1097-0045(19980615)36:1<14::AID-PROS3>3.0.CO;2-B; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Hynes RO, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a004903; Ishikawa T, 2014, MATRIX BIOL, V38, P69, DOI 10.1016/j.matbio.2014.06.002; Joshi R, 2020, MOL CANCER RES, V18, P27, DOI 10.1158/1541-7786.MCR-19-0442; Joshi R, 2017, CELL ADHES MIGR, V11, P305, DOI 10.1080/19336918.2016.1212139; Kaplan RN, 2006, CANCER METAST REV, V25, P521, DOI 10.1007/s10555-006-9036-9; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Klopp AH, 2011, STEM CELLS, V29, P11, DOI 10.1002/stem.559; Korenchuk S, 2001, IN VIVO, V15, P163; Kulawig R, 2013, INT J BIOCHEM CELL B, V45, P1410, DOI 10.1016/j.biocel.2013.04.016; Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Lu PF, 2012, J CELL BIOL, V196, P395, DOI 10.1083/jcb.201102147; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Nabha SM, 2008, INT J CANCER, V122, P2482, DOI 10.1002/ijc.23431; Nilsson SK, 2005, BLOOD, V106, P1232, DOI 10.1182/blood-2004-11-4422; Nishimori H, 2012, J BIOL CHEM, V287, P20037, DOI 10.1074/jbc.M112.353094; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Peinado H, 2017, NAT REV CANCER, V17, P302, DOI 10.1038/nrc.2017.6; Pietras K, 2010, EXP CELL RES, V316, P1324, DOI 10.1016/j.yexcr.2010.02.045; Pouliot N, 2013, CELL ADHES MIGR, V7, P142, DOI 10.4161/cam.22125; Psaila B, 2009, NAT REV CANCER, V9, P285, DOI 10.1038/nrc2621; Ramasamy R, 2007, LEUKEMIA, V21, P304, DOI 10.1038/sj.leu.2404489; Reticker-Flynn NE, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2128; Ridge SM, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0597-8; Saito N, 2009, PIGM CELL MELANOMA R, V22, P601, DOI 10.1111/j.1755-148X.2009.00590.x; Schedin P, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003228; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Siler U, 2000, BLOOD, V96, P4194; Singh S, 2004, LAB INVEST, V84, P1666, DOI 10.1038/labinvest.3700181; Sottnik JL, 2013, CLIN EXP METASTAS, V30, P569, DOI 10.1007/s10585-012-9561-6; Taichman RS, 2007, J CLIN INVEST, V117, P2351, DOI 10.1172/JCI31791; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; Uphoff Cord C, 2014, Curr Protoc Mol Biol, V106, DOI 10.1002/0471142727.mb2804s106; van der Horst G, 2011, NEOPLASIA, V13, P516, DOI 10.1593/neo.11122; VanderVeldeZimmermann D, 1997, EXP CELL RES, V230, P111, DOI 10.1006/excr.1996.3405; Verfaillie CM, 1998, BLOOD, V92, P2609, DOI 10.1182/blood.V92.8.2609; Wang H, 2004, J CELL BIOL, V164, P935, DOI 10.1083/jcb.200309112; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu T, 2020, MOL BIOL REP, V47, P3937, DOI 10.1007/s11033-020-05487-3; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049	56	7	7	4	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21692	10.1096/fj.202002558RR	http://dx.doi.org/10.1096/fj.202002558RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34118087				2022-12-26	WOS:000667814100072
J	Dzudzor, B; Bimah, B; Amarh, V; Ocloo, A				Dzudzor, Bartholomew; Bimah, Bismarck; Amarh, Vincent; Ocloo, Augustine			Sperm parameters and mitochondrial DNA sequence variants among patients at a fertility clinic in Ghana	PLOS ONE			English	Article							MALE-INFERTILITY; MUTATIONS; MEN; SPERMATOZOA; DELETIONS	Purpose The present study sought to investigate the common abnormalities and mtDNA mutations in the sperm of Ghanaian men attending the fertility Clinic at the Korle-Bu Teaching Hospital (KBTH). The study therefore provides a baseline data mtDNA mutations in a cross-section of Ghanaian men on referral to the fertility clinic at the KBTH. Materials and methods The semen of 55 men attending the fertility clinic were collected from the Urology and the Obstetrics and Gynaecology Departments of the KBTH. Demographic and clinical data were also collected using questionnaires. Semen analyses were performed and were followed by amplification and purification of mtDNA from total DNA extracted from the semen. Sequencing of the mtDNA amplicons was performed using the next generation sequencer (Illumina-MiSeq). Results Asthenozoospermia, oligospermia and oligoasthenoteratozoospermia were observed in 1.79%, 5.36% and 28.57%, respectively, of the study participants. There was no association between drinking and/or smoking and history of gonorrhea infection on sperm status/morphology. A total of 785 point mutations were detected in the non-coding control regions, rRNA genes, tRNA genes and the coding regions of the mtDNA samples from the participants. Amongst these mutations, 16 transition mutations were predominantly detected in the mtDNA samples. Missense mutations that were present in only specific sperm abnormalities were identified and they may contribute to infertility in the study population. Conclusion The present study has identified various abnormal sperm phenotypes that are prevalent in the study population and provided a baseline data on mtDNA mutations in the spermatozoa of the patients. A wide range of sperm abnormalities were detected in the study population with no association with life style or history of gonorrhea infection. The mtDNA point mutations detected in the selected genes that were analysed were mostly transition mutations. These transition mutations might be critical for the development of abnormal sperm phenotypes underlying male infertility in the Ghanaian population.	[Dzudzor, Bartholomew; Bimah, Bismarck; Amarh, Vincent] Univ Ghana, Med Sch, Dept Med Biochem, Korle Bu, Accra, Ghana; [Ocloo, Augustine] Univ Ghana, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana	University of Ghana; University of Ghana	Ocloo, A (corresponding author), Univ Ghana, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana.	aocloo@ug.edu.gh	Amarh, Vincent/GRS-5009-2022; Ocloo, Augustine/AAD-6182-2020	Ocloo, Augustine/0000-0003-1249-5349; AMARH, VINCENT/0000-0002-6681-8118	University of Ghana Research Fund Grant [URF/7/ILG-032/2013-2014]	University of Ghana Research Fund Grant	The study was supported by funding from University of Ghana Research Fund Grant (URF/7/ILG-032/2013-2014).	Cummins JM, 1998, INT J ANDROL, V21, P47; FOLGERO T, 1993, HUM REPROD, V8, P1863, DOI 10.1093/oxfordjournals.humrep.a137950; GILES RE, 1980, P NATL ACAD SCI-BIOL, V77, P6715, DOI 10.1073/pnas.77.11.6715; Hahn A, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8090392; Hamada A, 2012, INT BRAZ J UROL, V38, P576, DOI 10.1590/S1677-55382012000500002; Holyoake AJ, 2001, INT J ANDROL, V24, P175, DOI 10.1046/j.1365-2605.2001.00292.x; Kumar D Prabhu, 2009, Indian J Hum Genet, V15, P93, DOI 10.4103/0971-6866.60183; Kumar N, 2015, INDIAN J OBSTET GYNE, V2, P132; La Vignera S, 2019, EUR REV MED PHARMACO, V23, P5994, DOI 10.26355/eurrev_201907_18346; Mao GH, 2015, MITOCHONDR DNA, V26, P20, DOI 10.3109/19401736.2013.840612; Martin-Odoom A, 2015, J OBSTET GYNAECOL, V35, P825, DOI 10.3109/01443615.2015.1009876; Menkveld R, 2010, ASIAN J ANDROL, V12, P47, DOI 10.1038/aja.2009.14; MILLER D, 1994, HUM REPROD, V9, P864, DOI 10.1093/oxfordjournals.humrep.a138607; Nakada K, 2006, P NATL ACAD SCI USA, V103, P15148, DOI 10.1073/pnas.0604641103; Ness RB, 1997, FERTIL STERIL, V68, P205, DOI 10.1016/S0015-0282(97)81502-6; Palanichamy Malliya Gounder, 2011, Indian J Med Res, V134, P447; Rovio AT, 2001, NAT GENET, V29, P261, DOI 10.1038/ng759; Ruiz-Pesini E, 2000, AM J HUM GENET, V67, P682, DOI 10.1086/303040; Sengupta P, 2017, AFR HEALTH SCI, V17, P418, DOI 10.4314/ahs.v17i2.16; Spiropoulos J, 2002, MOL HUM REPROD, V8, P719, DOI 10.1093/molehr/8.8.719; St John JC, 2001, MOL HUM REPROD, V7, P103, DOI 10.1093/molehr/7.1.103; Thangaraj K, 2003, J ANDROL, V24, P388; Ugwuja E I, 2008, Afr J Reprod Health, V12, P67; Venkatesh S, 2009, INDIAN J MED RES, V129, P127; Weissensteiner H, 2016, NUCLEIC ACIDS RES, V44, pW64, DOI 10.1093/nar/gkw247	25	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0252923	10.1371/journal.pone.0252923	http://dx.doi.org/10.1371/journal.pone.0252923			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129647	gold, Green Published			2022-12-26	WOS:000665475100017
J	Toth-Faber, E; Janacsek, K; Szollosi, A; Keri, S; Nemeth, D				Toth-Faber, Eszter; Janacsek, Karolina; Szollosi, Agnes; Keri, Szabolcs; Nemeth, Dezso			Regularity detection under stress: Faster extraction of probability-based regularities	PLOS ONE			English	Article							MULTIPLE MEMORY-SYSTEMS; DECLARATIVE MEMORY; SEQUENCE; CORTISOL; CONSOLIDATION; PERFORMANCE; BRAIN; AGE; DEPENDENCIES; FACILITATION	Acute stress can crucially influence learning and memory processes. One of the key processes underlying human learning and memory is the ability of our brain to rapidly detect and extract regularities from sensory input across time and space leading to effective predictive processing. Here, we aimed to get an in-depth look into the effect of stress on the acquisition of two aspects of regularity extraction. We examined whether and how stress affects the learning (1) of probability-based regularities and (2) of serial order-based regularities in the same experimental design, and (3) the explicit access to the acquired information. Considering that the acquisition of probability-based regularities is a relatively rapid process, we primarily focused on the early phase of the task. We induced stress with the Socially Evaluated Cold Pressor Test in 27 young adults, while 26 participants were enrolled in the control group. Salivary cortisol levels and subjective ratings of affective states showed successful stress induction. After the stress induction, we measured regularity extraction with the cued Alternating Serial Reaction Time task. We found that stress promoted the extraction of probability-based regularities measured by the learning performance in the early phase of the task and did not alter the learning of serial order-based regularities. Post-block reports showed weaker explicit access to the serial order-based regularities in the stress group. Our results can contribute to a process-level understanding on how stress alters learning and memory functions related to predictive processes.	[Toth-Faber, Eszter] Eotvos Lorand Univ, Doctoral Sch Psychol, Budapest, Hungary; [Toth-Faber, Eszter; Janacsek, Karolina; Nemeth, Dezso] Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary; [Toth-Faber, Eszter; Janacsek, Karolina; Szollosi, Agnes; Nemeth, Dezso] Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary; [Janacsek, Karolina] Univ Greenwich, Fac Educ Hlth & Human Sci, Sch Human Sci, Ctr Thinking & Learning,Inst Lifecourse Dev, London, England; [Szollosi, Agnes; Keri, Szabolcs] Budapest Univ Technol & Econ, Dept Cognit Sci, Budapest, Hungary; [Keri, Szabolcs] Nyiro Gyula Hosp, Natl Inst Psychiat & Addict, Budapest, Hungary; [Nemeth, Dezso] Univ Lyon, Univ Lyon 1, Lyon Neurosci Res Ctr CRNL, CNRS,INSERM,U1028,UMR5292, Lyon, France	Eotvos Lorand University; Eotvos Lorand University; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; University of Greenwich; Budapest University of Technology & Economics; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Nemeth, D (corresponding author), Eotvos Lorand Univ, Inst Psychol, Budapest, Hungary.; Nemeth, D (corresponding author), Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Budapest, Hungary.; Nemeth, D (corresponding author), Univ Lyon, Univ Lyon 1, Lyon Neurosci Res Ctr CRNL, CNRS,INSERM,U1028,UMR5292, Lyon, France.	dezso.nemeth@univ-lyon1.fr	Nemeth, Dezso/B-9142-2009	Nemeth, Dezso/0000-0002-9629-5856	National Brain Research Program [20171.2.1-NKP-2017-00002]; Hungarian Scientific Research Fund (NKFIH-OTKA) [K 128016, PD 124148]; Hungarian Academy of Sciences; University of Lyon [ANR-16-IDEX-0005]; New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund [UNKP20-4-II-BME-13]	National Brain Research Program; Hungarian Scientific Research Fund (NKFIH-OTKA)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Hungarian Academy of Sciences(Hungarian Academy of Sciences); University of Lyon; New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund	This research was supported by the National Brain Research Program (project 20171.2.1-NKP-2017-00002); Hungarian Scientific Research Fund (NKFIH-OTKA K 128016, to D.N., NKFIH-OTKA PD 124148 to K.J.); Ja ' nos Bolyai Research Scholarship of the Hungarian Academy of Sciences (to K.J.); IDEXLYON Fellowship of the University of Lyon as part of the Programme Investissements d'Avenir (ANR-16-IDEX-0005) (to D.N.). A ' gnes Szollosi was supported by theUNKP20-4-II-BME-13 New National Excellence Program of the Ministry for Innovation and Technology from the source of the National Research, Development and Innovation Fund.	Badrick E, 2008, J CLIN ENDOCR METAB, V93, P750, DOI 10.1210/jc.2007-0737; Badrick E, 2007, J CLIN ENDOCR METAB, V92, P819, DOI 10.1210/jc.2006-2155; Batterink LJ, 2019, TOP COGN SCI, V11, P482, DOI 10.1111/tops.12420; Brysbaert Marc, 2018, J Cogn, V1, P9, DOI 10.5334/joc.10; Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011; Contarino A, 1999, BRAIN RES, V835, P1, DOI 10.1016/S0006-8993(98)01158-5; Conway CM, 2020, NEUROSCI BIOBEHAV R, V112, P279, DOI 10.1016/j.neubiorev.2020.01.032; Dolfen N, 2019, NEUROBIOL LEARN MEM, V158, P32, DOI 10.1016/j.nlm.2019.01.009; Ehlers MR, 2017, NEUROBIOL LEARN MEM, V145, P84, DOI 10.1016/j.nlm.2017.09.003; Ell SW, 2011, PSYCHON B REV, V18, P96, DOI 10.3758/s13423-010-0018-0; Fine AB, 2013, COGNITIVE SCI, V37, P578, DOI 10.1111/cogs.12022; Flinn JT, 2016, MED TEACH, V38, P897, DOI 10.3109/0142159X.2015.1114597; Frost R, 2015, TRENDS COGN SCI, V19, P117, DOI 10.1016/j.tics.2014.12.010; Frost RLA, 2016, COGNITION, V147, P70, DOI 10.1016/j.cognition.2015.11.010; Guenzel FM, 2014, NEUROBIOL LEARN MEM, V109, P46, DOI 10.1016/j.nlm.2013.11.020; Hermans EJ, 2014, TRENDS NEUROSCI, V37, P304, DOI 10.1016/j.tins.2014.03.006; Hordacre B, 2016, HUM MOVEMENT SCI, V49, P36, DOI 10.1016/j.humov.2016.06.002; Horvath K., 2021, SCI REP-UK; Howard DV, 2004, PSYCHOL AGING, V19, P79, DOI 10.1037/0882-7974.19.1.79; Howard JH, 1997, PSYCHOL AGING, V12, P634, DOI 10.1037/0882-7974.12.4.634; Janacsek K, 2018, PROG NEURO-PSYCHOPH, V81, P17, DOI 10.1016/j.pnpbp.2017.09.021; Janacsek K, 2012, DEVELOPMENTAL SCI, V15, P496, DOI 10.1111/j.1467-7687.2012.01150.x; Joels M, 2011, TRENDS COGN SCI, V15, P280, DOI 10.1016/j.tics.2011.04.004; King M., 2013, ACUTE STRESSOR ENHAN; Kirschbaum C, 1999, PSYCHOSOM MED, V61, P154, DOI 10.1097/00006842-199903000-00006; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Kirschbaum C, 1996, LIFE SCI, V58, P1475, DOI 10.1016/0024-3205(96)00118-X; Kobor A, 2018, BIOL PSYCHOL, V135, P180, DOI 10.1016/j.biopsycho.2018.04.001; Lovallo WR, 2006, PHARMACOL BIOCHEM BE, V83, P441, DOI 10.1016/j.pbb.2006.03.005; Lupien SJ, 2007, BRAIN COGNITION, V65, P209, DOI 10.1016/j.bandc.2007.02.007; Lupien SJ, 2002, PSYCHONEUROENDOCRINO, V27, P401, DOI 10.1016/S0306-4530(01)00061-0; MARTENIU.RG, 1970, PERCEPT MOTOR SKILL, V31, P471, DOI 10.2466/pms.1970.31.2.471; Misyak JB, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00031; Nater UM, 2007, PSYCHONEUROENDOCRINO, V32, P758, DOI 10.1016/j.psyneuen.2007.05.006; Nemeth D, 2013, FRONT COMPUT NEUROSC, V7, DOI 10.3389/fncom.2013.00147; Nemeth D, 2011, J GERONTOL B-PSYCHOL, V66, P15, DOI [10.1093/geronb/gbq063, 10.1093/geronb/gby063]; Nitsche MA, 2003, J COGNITIVE NEUROSCI, V15, P619, DOI 10.1162/089892903321662994; Perruchet P, 2006, TRENDS COGN SCI, V10, P233, DOI 10.1016/j.tics.2006.03.006; Romer S, 2011, PSYCHOPHARMACOLOGY, V215, P33, DOI 10.1007/s00213-010-2112-4; Roozendaal B, 2006, P NATL ACAD SCI USA, V103, P6741, DOI 10.1073/pnas.0601874103; Saffran JR, 2018, ANNU REV PSYCHOL, V69, P181, DOI 10.1146/annurev-psych-122216-011805; SAGE G H, 1973, Research Quarterly American Association for Health Physical Education and Recreation, V44, P140; Schwabe L, 2008, PSYCHONEUROENDOCRINO, V33, P890, DOI 10.1016/j.psyneuen.2008.03.001; Schwabe L, 2013, TRENDS COGN SCI, V17, P60, DOI 10.1016/j.tics.2012.12.001; Schwabe L, 2012, J NEUROSCI, V32, P11042, DOI 10.1523/JNEUROSCI.1484-12.2012; Schwabe L, 2012, J NEUROSCI, V32, P10146, DOI 10.1523/JNEUROSCI.1304-12.2012; Schwabe L, 2011, BEHAV BRAIN RES, V219, P321, DOI 10.1016/j.bbr.2010.12.038; Siegelman N, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0059; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simor P, 2019, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02708; Smeets T, 2007, BIOL PSYCHOL, V76, P116, DOI 10.1016/j.biopsycho.2007.07.001; Song SB, 2007, J NEUROSCI, V27, P12475, DOI 10.1523/JNEUROSCI.2062-07.2007; Song SB, 2007, LEARN MEMORY, V14, P167, DOI 10.1101/lm.437407; Szegedi-Hallgato E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04500-3; Szollosi A, 2017, APPL COGNITIVE PSYCH, V31, P615, DOI 10.1002/acp.3363; Takacs A, 2021, HUM BRAIN MAPP, V42, P3182, DOI 10.1002/hbm.25427; Takacs A, 2018, CORTEX, V100, P84, DOI 10.1016/j.cortex.2017.08.037; Unoka Z, 2017, PSYCHIAT RES, V255, P373, DOI 10.1016/j.psychres.2017.06.072; Virag M, 2015, EXP BRAIN RES, V233, P2081, DOI 10.1007/s00221-015-4279-8; Wegner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092953; Wirz L, 2018, CURR OPIN BEHAV SCI, V20, P9, DOI 10.1016/j.cobeha.2017.08.009	61	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253123	10.1371/journal.pone.0253123	http://dx.doi.org/10.1371/journal.pone.0253123			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129623	Green Published, Green Accepted, gold			2022-12-26	WOS:000665475100028
J	Chen, PY; Chen, TY; Chao, PZ; Liu, WT; Bai, CH; Tsao, ST; Lin, YC				Chen, Po-Yueh; Chen, Tzu-Ying; Chao, Pin-Zhir; Liu, Wen-Te; Bai, Chyi-Huey; Tsao, Sheng-Teng; Lin, Yi-Chih			REM-related obstructive sleep apnea and vertigo: A retrospective case-control study	PLOS ONE			English	Article							GENDER; EPIDEMIOLOGY; CHILDREN; IMPACT	Background In recent population-based case-control studies, sleep apnea was significantly associated with a higher incidence (hazard ratio, 1.71) of vertigo and the risk of tinnitus was found to increase 1.36 times in patients with sleep apnea. The possibility that obstructive sleep apnea (OSA) might affect neurotological consequences was not noticed, until studies using polysomnography (PSG) for these patients. Objectives The purpose of this study was to investigate the relationship between vertigo and OSA. Methods The collected data among patients from May 1st, 2018 to October 31th, 2018 at Shuang Ho Hospital. Eligibility criteria included an age older than 20 years, a diagnosis of obstructive sleep apnea. The diagnosis of OSA was defined as an oxygen desaturation index of at least 5, was established with the use of polysomnographic examination at hospital. Patients were excluded from the study if they had head injury, brain tumour, headache history and hearing loss. Patients who had vertigo were labeled as Vertigo group. In the other hand, patients who had no dizziness were labeled as control group. 58 patients were in the Vertigo group, and 113 were in the control group. Results After PSG examination, 58 patients who had vertigo, were diagnosed OSA (29 males, average age = 57.07 years old, BMI = 26.64, RDI = 24.69, ESS = 8.65), and 24 patients of them (41.3%) were REM-related OSA. Meanwhile, in the control group, 113 patients had OSA (92male, average age = 49.66 years old, BMI = 26.06, RDI = 35.19, ESS = 11.43), and 18 patients of them (15.9%) were REM-related OSA (Table 1). Therefore, patient who had vertigo, would have higher proportion of REM OSA (P<0.001). Conclusions The vertigo patients have a higher rate of REM-related OSA, and the acceptance rate to CPAP use is low. Further research is needed to explore novel therapeutic approaches, or combination of currently available non-CPAP therapies, in patients with REM OSA.	[Chen, Po-Yueh] Taipei Med Univ, Taipei Municipal Wan Fang Hosp, Dept Otolaryngol, Taipei, Taiwan; [Chen, Po-Yueh; Chao, Pin-Zhir; Liu, Wen-Te; Lin, Yi-Chih] Taipei Med Univ, Shuang Ho Hosp, Sleep Ctr, New Taipei, Taiwan; [Chen, Tzu-Ying; Chao, Pin-Zhir; Lin, Yi-Chih] Taipei Med Univ, Shuang Ho Hosp, Dept Otolaryngol, New Taipei, Taiwan; [Liu, Wen-Te] Taipei Med Univ, Shuang Ho Hosp, Dept Chest, New Taipei, Taiwan; [Bai, Chyi-Huey; Tsao, Sheng-Teng; Lin, Yi-Chih] Taipei Med Univ, Coll Med, Dept Publ Hlth, Taipei, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University	Lin, YC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Sleep Ctr, New Taipei, Taiwan.; Lin, YC (corresponding author), Taipei Med Univ, Shuang Ho Hosp, Dept Otolaryngol, New Taipei, Taiwan.; Lin, YC (corresponding author), Taipei Med Univ, Coll Med, Dept Publ Hlth, Taipei, Taiwan.	15677@s.tmu.edu.tw						Al Oweidat K, 2018, CAN RESPIR J, V2018, DOI 10.1155/2018/9270329; Alzoubaidi M, 2016, CURR OPIN PULM MED, V22, P545, DOI 10.1097/MCP.0000000000000319; Baldwin CM, 2004, SLEEP, V27, P305, DOI 10.1093/sleep/27.2.305; Besnard S, 2018, SLEEP MED REV, V42, P220, DOI 10.1016/j.smrv.2018.09.001; Goh DYT, 2000, AM J RESP CRIT CARE, V162, P682, DOI 10.1164/ajrccm.162.2.9908058; Hoshino T, 2018, J INT MED RES, V46, P2238, DOI 10.1177/0300060518758583; Iannella G, 2020, POL ARCH INTERN MED, V130, P649, DOI 10.20452/pamw.15283; Kapur VK, 2017, J CLIN SLEEP MED, V13, P479, DOI 10.5664/jcsm.6506; Karamessinis L, 2007, SLEEP, V30, P837, DOI 10.1093/sleep/30.7.837; Lai YT, 2011, OTOLARYNG HEAD NECK, V145, P110, DOI 10.1177/0194599811400007; Lopez-Escamez JA, 2003, OTOL NEUROTOL, V24, P637, DOI 10.1097/00129492-200307000-00018; Mano M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16061068; Nakayama M, 2015, J CLIN SLEEP MED, V11, P1101, DOI 10.5664/jcsm.5080; Nakayama M, 2013, CURR OPIN OTOLARYNGO, V21, P503, DOI 10.1097/MOO.0b013e32836463bc; Neuhauser HK, 2016, HAND CLINIC, V137, P67, DOI 10.1016/B978-0-444-63437-5.00005-4; Neuhauser HK, 2005, NEUROLOGY, V65, P898, DOI 10.1212/01.wnl.0000175987.59991.3d; O'Connor C, 2000, AM J RESP CRIT CARE, V161, P1465, DOI 10.1164/ajrccm.161.5.9904121; Punjabi NM, 2002, SLEEP, V25, P307; Serra A, 2017, INT J PEDIATR OTORHI, V97, P245, DOI 10.1016/j.ijporl.2017.04.021; Tsai MS, 2018, LARYNGOSCOPE, V128, P763, DOI 10.1002/lary.26789; Valipour A, 2007, SLEEP, V30, P312, DOI 10.1093/sleep/30.3.312; Varga AW, 2019, SLEEP BREATH, V23, P413, DOI 10.1007/s11325-018-1727-2	22	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252844	10.1371/journal.pone.0252844	http://dx.doi.org/10.1371/journal.pone.0252844			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115792	Green Published, gold			2022-12-26	WOS:000664643000036
J	Vieira, MF; Rodrigues, FB; Assis, AD; Mesquita, ED; Lemes, TS; De Villa, GAG; Baptista, RR; Andrade, AD; da Costa, PHL				Vieira, Marcus Fraga; Rodrigues, Fabio Barbosa; Assis, Alfredo de Oliveira; Mesquita, Eduardo de Mendonca; Lemes, Thiago Santana; Gomes De Villa, Guilherme Augusto; Baptista, Rafael Reimann; Andrade, Adriano de Oliveira; Lobo da Costa, Paula Hentschel			Effects of additional load at different heights on gait initiation: A statistical parametric mapping of center of pressure and center of mass behavior	PLOS ONE			English	Article							ANTICIPATORY POSTURAL ADJUSTMENTS; LOCATION	The purpose of this study was to investigate the effects of different vertical positions of an asymmetrical load on the anticipatory postural adjustments phase of gait initiation. Sixty-eight college students (32 males, 36 females; age: 23.65 +/- 3.21 years old; weight: 69.98 +/- 8.15 kg; height: 1.74 +/- 0.08 m) were enrolled in the study. Ground reaction forces and moments were collected using two force platforms. The participants completed three trials under each of the following random conditions: no-load (NL), waist uniformly distributed load (WUD), shoulder uniformly distributed load (SUD), waist stance foot load (WST), shoulder stance foot load (SST), waist swing foot load (WSW), and shoulder swing foot load (SSW). The paired Hotelling's T-square test was used to compare the experimental conditions. The center of pressure (COP) time series were significantly different for the SUD vs. NL, SST vs. NL, WST vs. NL, and WSW vs. NL comparisons. Significant differences in COP time series were observed for all comparisons between waist vs. shoulder conditions. Overall, these differences were greater when the load was positioned at the shoulders. For the center of mass (COM) time series, significant differences were found for the WUD vs. NL and WSW vs. NL conditions. However, no differences were observed with the load positioned at the shoulders. In conclusion, only asymmetrical loading at the waist produced significant differences, and the higher the extra load, the greater the effects on COP behavior. By contrast, only minor changes were observed in COM behavior, suggesting that the changes in COP (the controller) behavior are adjustments to maintain the COM (controlled object) unaltered.	[Vieira, Marcus Fraga; Rodrigues, Fabio Barbosa; Assis, Alfredo de Oliveira; Mesquita, Eduardo de Mendonca; Lemes, Thiago Santana; Gomes De Villa, Guilherme Augusto] Univ Fed Goias, Bioengn & Biomech Lab, Goiania, Go, Brazil; [Rodrigues, Fabio Barbosa] State Univ Goias, Unidade Trindade, Goiania, Go, Brazil; [Baptista, Rafael Reimann] Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil; [Andrade, Adriano de Oliveira] Univ Fed Uberlandia, Ctr Innovat & Technol Assessment Hlth NIATS, Uberlandia, MG, Brazil; [Lobo da Costa, Paula Hentschel] Univ Fed Sao Carlos, Phys Educ Dept, Sao Carlos, Brazil	Universidade Federal de Goias; Universidade Estadual de Goias; Pontificia Universidade Catolica Do Rio Grande Do Sul; Universidade Federal de Uberlandia; Universidade Federal de Sao Carlos	Baptista, RR (corresponding author), Pontificia Univ Catolica Rio Grande do Sul, Porto Alegre, RS, Brazil.	baprafael@gmail.com	Baptista, Rafael Reimann/AAD-5898-2019; Andrade, Adriano de Oliveira/D-9721-2012; Vieira, Marcus Fraga/G-4840-2012	Baptista, Rafael Reimann/0000-0003-1937-6393; Andrade, Adriano de Oliveira/0000-0002-5689-6606; Vieira, Marcus Fraga/0000-0001-9096-1603; Mesquita, Eduardo/0000-0002-6336-929X	CAPES [001]; CNPq	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was partially supported by the governmental agencies CAPES (Finance Code 001), and CNPq.	Ambrose AF, 2013, MATURITAS, V75, P51, DOI 10.1016/j.maturitas.2013.02.009; Azuma T, 2007, GAIT POSTURE, V26, P526, DOI 10.1016/j.gaitpost.2006.11.203; Brunt D, 2005, GAIT POSTURE, V21, P297, DOI 10.1016/j.gaitpost.2004.03.003; BRUNT D, 1991, AM J PHYS MED REHAB, V70, P206, DOI 10.1097/00002060-199108000-00009; Buckley TA, 2008, MOVEMENT DISORD, V23, P1274, DOI 10.1002/mds.22079; Caderby T, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00127; Chen B, 2015, EXP BRAIN RES, V233, P3087, DOI 10.1007/s00221-015-4377-7; CRENNA P, 1991, J PHYSIOL-LONDON, V437, P635, DOI 10.1113/jphysiol.1991.sp018616; da Costa PHL., 2017, LOCOMOTION POSTURE O, P349, DOI [10.1007/978-3-319-48980-3%5F22, DOI 10.1007/978-3-319-48980-3%5F22]; Dalton E, 2011, MED SCI SPORT EXER, V43, P2352, DOI 10.1249/MSS.0b013e318222bc82; Fortin AP, 2015, GAIT POSTURE, V41, P378, DOI 10.1016/j.gaitpost.2014.09.019; Hansen C, 2016, J HUM KINET, V54, P5, DOI 10.1515/hukin-2016-0030; Hass CJ, 2012, GAIT POSTURE, V35, P669, DOI 10.1016/j.gaitpost.2011.12.022; Hiraoka K, 2014, J HUM KINET, V42, P7, DOI 10.2478/hukin-2014-0056; Honeine JL, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00445; JIAN Y, 1993, GAIT POSTURE, V1, P9, DOI DOI 10.1016/0966-6362(93)90038-3; Khanmohammadi R, 2017, GAIT POSTURE, V52, P194, DOI 10.1016/j.gaitpost.2016.11.042; Marigold DS, 2006, GAIT POSTURE, V23, P249, DOI 10.1016/j.gaitpost.2005.03.001; MCILROY WE, 1993, NEUROSCI LETT, V164, P199, DOI 10.1016/0304-3940(93)90891-N; Mouchnino L, 2012, GAIT POSTURE, V35, P616, DOI 10.1016/j.gaitpost.2011.12.009; Pataky T, 2016, J STAT SOFTW, V71, P1, DOI 10.18637/jss.v071.i07; Pataky TC, 2014, GAIT POSTURE, V40, P255, DOI 10.1016/j.gaitpost.2014.01.023; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Patchay S, 2003, GAIT POSTURE, V18, P85, DOI 10.1016/S0966-6362(02)00167-4; Robinovitch SN, 2013, LANCET, V381, P47, DOI 10.1016/S0140-6736(12)61263-X; Rodrigues FB, 2018, ERGONOMICS, V61, P720, DOI 10.1080/00140139.2017.1413213; Tessem S, 2007, PHYSIOTHER RES INT, V12, P82, DOI 10.1002/pri.362; Uemura K, 2012, GAIT POSTURE, V35, P282, DOI 10.1016/j.gaitpost.2011.09.100; Vieira MF, 2017, J BIOMECH, V56, P10, DOI 10.1016/j.jbiomech.2017.02.018; Vieira MF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135821; Vrieling AH, 2008, GAIT POSTURE, V27, P423, DOI 10.1016/j.gaitpost.2007.05.013; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Wu G, 2001, GAIT POSTURE, V13, P95, DOI 10.1016/S0966-6362(00)00102-8	33	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0242892	10.1371/journal.pone.0242892	http://dx.doi.org/10.1371/journal.pone.0242892			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115751	Green Published, Green Submitted, gold			2022-12-26	WOS:000664643000001
J	Johanson, SM; Ropstad, E; Ostby, GC; Aleksandersen, M; Zamaratskaia, G; Boge, GS; Halsne, R; Trangerud, C; Lyche, JL; Berntsen, HF; Zimmer, KE; Verhaegen, S				Johanson, Silje Modahl; Ropstad, Erik; Ostby, Gunn Charlotte; Aleksandersen, Mona; Zamaratskaia, Galia; Boge, Gudrun Seeberg; Halsne, Ruth; Trangerud, Cathrine; Lyche, Jan Ludvig; Berntsen, Hanne Friis; Zimmer, Karin Elisabeth; Verhaegen, Steven			Perinatal exposure to a human relevant mixture of persistent organic pollutants: Effects on mammary gland development, ovarian folliculogenesis and liver in CD-1 mice	PLOS ONE			English	Article							ENDOCRINE-DISRUPTING CHEMICALS; PREGNANE-X-RECEPTOR; PERFLUOROOCTANOIC ACID; LACTATIONAL EXPOSURE; PRENATAL EXPOSURE; IN-UTERO; DIPHENYL ETHERS; THYROID-HORMONE; MOUSE; RAT	The ability of persistent organic pollutants (POPs) with endocrine disrupting properties to interfere with the developing reproductive system is of increasing concern. POPs are transferred from dams to offspring and the high sensitivity of neonates to endocrine disturbances may be caused by underdeveloped systems of metabolism and excretion. The present study aimed to characterize the effect of in utero and lactational exposure to a human relevant mixture of POPs on the female mammary gland, ovarian folliculogenesis and liver function in CD-1 offspring mice. Dams were exposed to the mixture through the diet at Control, Low or High doses (representing 0x, 5000x and 100 000x human estimated daily intake levels, respectively) from weaning and throughout mating, gestation, and lactation. Perinatally exposed female offspring exhibited altered mammary gland development and a suppressed ovarian follicle maturation. Increased hepatic cytochrome P450 enzymatic activities indirectly indicated activation of nuclear receptors and potential generation of reactive products. Hepatocellular hypertrophy was observed from weaning until 30 weeks of age and could potentially lead to hepatotoxicity. Further studies should investigate the effects of human relevant mixtures of POPs on several hormones combined with female reproductive ability and liver function.	[Johanson, Silje Modahl; Ropstad, Erik; Ostby, Gunn Charlotte; Berntsen, Hanne Friis; Verhaegen, Steven] Norwegian Univ Life Sci, Dept Prod Anim Clin Sci, As, Norway; [Aleksandersen, Mona; Zimmer, Karin Elisabeth] Norwegian Univ Life Sci, Dept Preclin Sci & Pathol, As, Norway; [Zamaratskaia, Galia] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden; [Boge, Gudrun Seeberg; Trangerud, Cathrine] Norwegian Univ Life Sci, Dept Compan Anim Clin Sci, As, Norway; [Halsne, Ruth] Oslo Univ Hosp, Div Lab Med, Dept Forens Sci, Oslo, Norway; [Lyche, Jan Ludvig] Norwegian Univ Life Sci, Dept Paraclin Sci, As, Norway; [Berntsen, Hanne Friis] Natl Inst Occupat Hlth, Oslo, Norway	Norwegian University of Life Sciences; Norwegian University of Life Sciences; Swedish University of Agricultural Sciences; Norwegian University of Life Sciences; University of Oslo; Norwegian University of Life Sciences	Johanson, SM (corresponding author), Norwegian Univ Life Sci, Dept Prod Anim Clin Sci, As, Norway.	Silje.modahl.johanson@nmbu.no	; Zamaratskaia, Galia/I-6155-2016	Johanson, Silje Modahl/0000-0001-8377-7824; Zamaratskaia, Galia/0000-0003-0926-4849	Norwegian Research Council [21307, 204361]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The present study was funded by the Norwegian Research Council, Grant numbers 21307 and 204361 (ER). The funders played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina JE, 2004, J TOXICOL ENV HEAL A, V67, P1407, DOI 10.1080/15287390490483845; Allen DG, 2004, TOXICOL PATHOL, V32, P393, DOI 10.1080/01926230490440934; [Anonymous], 2019, WHAT AR POPS; Barr DB, 2007, REPROD TOXICOL, V23, P260, DOI 10.1016/j.reprotox.2007.03.003; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P1083, DOI 10.1289/ehp.7617; Berntsen HF, 2017, J TOXICOL ENV HEAL A, V80, P1002, DOI 10.1080/15287394.2017.1354439; Bondy GS, 2013, ENVIRON TOXICOL, V28, P215, DOI 10.1002/tox.20713; BONDY SC, 1994, BIOCHEM PHARMACOL, V48, P155, DOI 10.1016/0006-2952(94)90235-6; Bonfanti P, 2014, ENVIRON TOXICOL, V29, P856, DOI 10.1002/tox.21812; Bopp SK, 2018, ENVIRON INT, V120, P544, DOI 10.1016/j.envint.2018.07.037; BREVIK EM, 1978, B ENVIRON CONTAM TOX, V19, P281, DOI 10.1007/BF01685799; Butenhoff JL, 2012, TOXICOLOGY, V293, P1, DOI 10.1016/j.tox.2012.01.003; Chu I, 2005, TOXICOL SCI, V88, P645, DOI 10.1093/toxsci/kfi335; Chu I, 2008, J TOXICOL ENV HEAL A, V71, P93, DOI 10.1080/15287390701612811; Cooper GS, 2002, EPIDEMIOLOGY, V13, P729, DOI 10.1097/00001648-200211000-00021; COUGHTRIE MWH, 1988, MOL PHARMACOL, V34, P729; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; Du GZ, 2019, ECOTOX ENVIRON SAFE, V167, P412, DOI 10.1016/j.ecoenv.2018.10.025; Dunnick JK, 2018, ARCH TOXICOL, V92, P3415, DOI 10.1007/s00204-018-2292-y; Enoch RR, 2007, ENVIRON HEALTH PERSP, V115, P541, DOI 10.1289/ehp.9612; Faustman EM, 2000, ENVIRON HEALTH PERSP, V108, P13, DOI 10.2307/3454629; Fenton SE, 2002, TOXICOL SCI, V67, P63, DOI 10.1093/toxsci/67.1.63; Fenton SE, 2006, ENDOCRINOLOGY, V147, pS18, DOI 10.1210/en.2005-1131; Filgo AJ, 2015, TOXICOL PATHOL, V43, P558, DOI 10.1177/0192623314558463; Flaws JA, 2001, MENOPAUSE, V8, P175, DOI 10.1097/00042192-200105000-00006; Gao H, 2019, CHEMOSPHERE, V233, P174, DOI 10.1016/j.chemosphere.2019.05.277; Ge W, 2019, CELL MOL LIFE SCI, V76, P1729, DOI 10.1007/s00018-019-03028-1; Gore AC, 2015, ENDOCR REV, V36, pE1, DOI 10.1210/er.2015-1010; Grindler NM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116057; Gronnestad R, 2017, ENVIRON TOXICOL CHEM, V36, P763, DOI 10.1002/etc.3623; GUENGERICH FP, 1991, J BIOL CHEM, V266, P10019; Hall AP, 2012, TOXICOL PATHOL, V40, P971, DOI 10.1177/0192623312448935; Heimler I, 1998, REPROD TOXICOL, V12, P69, DOI 10.1016/S0890-6238(97)00101-9; Hernandez AF, 2013, TOXICOLOGY, V307, P136, DOI 10.1016/j.tox.2012.06.009; Ioannides C, 2004, CURR TOP MED CHEM, V4, P1767, DOI 10.2174/1568026043387188; Johanson SM, 2020, CHEMOSPHERE, V252, DOI 10.1016/j.chemosphere.2020.126484; Johri A, 2008, TOXICOL SCI, V101, P331, DOI 10.1093/toxsci/kfm269; Karmaus W, 2009, OCCUP ENVIRON MED, V66, P143, DOI 10.1136/oem.2008.041921; Kassambara A., 2020, GGPUBRGGPLOT2 BASED; Knox SS, 2011, J CLIN ENDOCR METAB, V96, P1747, DOI 10.1210/jc.2010-2401; Kodavanti PRS, 2010, TOXICOL SCI, V116, P297, DOI 10.1093/toxsci/kfq105; Landrigan PJ, 2011, HEALTH AFFAIR, V30, P842, DOI 10.1377/hlthaff.2011.0151; Lee DH, 2012, ENVIRON INT, V40, P170, DOI 10.1016/j.envint.2011.07.010; Lilienthal H, 2006, ENVIRON HEALTH PERSP, V114, P194, DOI 10.1289/ehp.8391; Macon MB, 2013, J MAMMARY GLAND BIOL, V18, P43, DOI 10.1007/s10911-013-9275-7; Macon MB, 2011, TOXICOL SCI, V122, P134, DOI 10.1093/toxsci/kfr076; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Markey CM, 2001, BIOL REPROD, V65, P1215, DOI 10.1093/biolreprod/65.4.1215; Maronpot RR, 2010, TOXICOL PATHOL, V38, P776, DOI 10.1177/0192623310373778; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; McGee EA, 2000, ENDOCR REV, V21, P200, DOI 10.1210/er.21.2.200; MILSAP RL, 1994, ENVIRON HEALTH PERSP, V102, P107, DOI 10.1289/ehp.94102s11107; Miret N, 2017, TOXICOL APPL PHARM, V334, P192, DOI 10.1016/j.taap.2017.09.012; Miret NV, 2019, ENVIRON RES, V173, P330, DOI 10.1016/j.envres.2019.03.054; Monika GBA, 2003, REPROD TOXICOL, V17, P567, DOI 10.1016/S0890-6238(03)00095-9; Muto T, 2003, TOXICOL LETT, V143, P271, DOI 10.1016/S0378-4274(03)00175-9; National Toxicology Program, 2006, Natl Toxicol Program Tech Rep Ser, P4; Nebert DW, 2002, LANCET, V360, P1155, DOI 10.1016/S0140-6736(02)11203-7; Osborne G, 2015, REPROD TOXICOL, V54, P148, DOI 10.1016/j.reprotox.2014.07.077; Pacyniak EK, 2007, TOXICOL SCI, V97, P94, DOI 10.1093/toxsci/kfm025; Patel S, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.130336; Pilipenko N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8472312; Pocar P, 2012, TOXICOL SCI, V126, P213, DOI 10.1093/toxsci/kfr327; Polder A, 2014, SCI TOTAL ENVIRON, V488, P252, DOI 10.1016/j.scitotenv.2014.04.085; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Quist EM, 2015, TOXICOL PATHOL, V43, P546, DOI 10.1177/0192623314551841; R Core Team, 2018, R LANG ENV STAT COMP; Rachon D, 2015, REV ENDOCR METAB DIS, V16, P359, DOI 10.1007/s11154-016-9332-9; Rasmussen MK, 2011, TOXICOL IN VITRO, V25, P343, DOI 10.1016/j.tiv.2010.10.007; Roos R, 2011, TOXICOLOGY, V284, P42, DOI 10.1016/j.tox.2011.03.013; Rudel RA, 2011, ENVIRON HEALTH PERSP, V119, P1053, DOI 10.1289/ehp.1002864; Sanders JM, 2005, TOXICOL SCI, V88, P127, DOI 10.1093/toxsci/kfi288; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Secretariat of the Stockholm Convention, 2010, RIDD WORLD POPS GUID; Shirota M, 2006, J REPROD DEVELOP, V52, P751, DOI 10.1262/jrd.18062; Stanko JP, 2017, JOVE-J VIS EXP, DOI 10.3791/55789; Stanko JP, 2015, REPROD TOXICOL, V54, P129, DOI 10.1016/j.reprotox.2014.11.004; Szabo DT, 2009, TOXICOL SCI, V107, P27, DOI 10.1093/toxsci/kfn230; Talsness CE, 2008, ENVIRON HEALTH PERSP, V116, P308, DOI 10.1289/ehp.10536; Taylor KW, 2014, ENVIRON HEALTH PERSP, V122, P145, DOI 10.1289/ehp.1306707; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Tolson AH, 2010, ADV DRUG DELIVER REV, V62, P1238, DOI 10.1016/j.addr.2010.08.006; Tseng LH, 2008, CHEMOSPHERE, V70, P640, DOI 10.1016/j.chemosphere.2007.06.078; Tucker DK, 2015, REPROD TOXICOL, V54, P26, DOI 10.1016/j.reprotox.2014.12.002; Uzumcu M, 2007, REPROD TOXICOL, V23, P337, DOI 10.1016/j.reprotox.2006.10.006; Vabre P, 2017, ENVIRON HEALTH-GLOB, V16, DOI 10.1186/s12940-017-0242-4; Valvi D, 2012, ENVIRON HEALTH PERSP, V120, P451, DOI 10.1289/ehp.1103862; van der Ven LTM, 2008, TOXICOLOGY, V245, P109, DOI 10.1016/j.tox.2007.12.016; Vizcaino E, 2014, ENVIRON INT, V65, P107, DOI 10.1016/j.envint.2014.01.004; Wade MG, 2002, TOXICOL SCI, V67, P131, DOI 10.1093/toxsci/67.1.131; Walton K, 2001, FOOD CHEM TOXICOL, V39, P667, DOI 10.1016/S0278-6915(01)00006-0; Wang DZ, 2018, ARCH TOXICOL, V92, P1847, DOI 10.1007/s00204-018-2177-0; Warner Marcella, 2018, Environ Epidemiol, V2, DOI 10.1097/EE9.0000000000000032; Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351; White SS, 2007, TOXICOL SCI, V96, P133, DOI 10.1093/toxsci/kfl177; White SS, 2011, ENVIRON HEALTH PERSP, V119, P1070, DOI 10.1289/ehp.1002741; White SS, 2009, REPROD TOXICOL, V27, P289, DOI 10.1016/j.reprotox.2008.11.054; WHITLOCK JP, 1990, ANNU REV PHARMACOL, V30, P251; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Winkens Kerstin, 2017, Emerging Contaminants, V3, P55, DOI 10.1016/j.emcon.2017.05.001; Wolf DC, 2008, TOXICOL PATHOL, V36, P632, DOI 10.1177/0192623308318216; Xie W, 2000, NATURE, V406, P435, DOI 10.1038/35019116; Yamada H, 2006, CURR DRUG METAB, V7, P397, DOI 10.2174/138920006776873508; YAMAJI T, 1972, ENDOCRINOLOGY, V90, P771, DOI 10.1210/endo-90-3-771; Yang CF, 2009, REPROD TOXICOL, V27, P299, DOI 10.1016/j.reprotox.2008.10.003; Zamaratskaia G, 2010, REPROD DOMEST ANIM, V45, pe269, DOI 10.1111/j.1439-0531.2009.01553.x; Zamaratskaia G, 2009, ANIMAL, V3, P1124, DOI 10.1017/S1751731109004510; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhou T, 2002, TOXICOL SCI, V66, P105, DOI 10.1093/toxsci/66.1.105	109	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252954	10.1371/journal.pone.0252954	http://dx.doi.org/10.1371/journal.pone.0252954			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111182	Green Published, gold			2022-12-26	WOS:000664642700073
J	Loughney, L; McGowan, R; O'Malley, K; McCaffrey, N; Furlong, B; Walsh, D				Loughney, Lisa; McGowan, Rachel; O'Malley, Kiaran; McCaffrey, Noel; Furlong, Brona; Walsh, Deirdre			Perceptions of wellbeing and quality of life following participation in a community-based pre-operative exercise programme in men with newly diagnosed prostate cancer: A qualitative pilot study	PLOS ONE			English	Article							BREAST-CANCER; HEALTH; SURVIVORS; INTERVENTION	Background Men with a newly diagnosed prostate cancer are often treated by surgery. The time window between cancer diagnosis and surgery causes high levels of uncertainty and stress, which negatively impact quality of life (QoL). We previously reported a larger intervention pilot study which demonstrated that participation in a community-based pre-operative exercise programme significantly improved physical fitness and health-related quality of life in men with prostate cancer prior to surgery. The aim of the current pilot study was to get an insight into men's perceptions of wellbeing and QoL following completion of the pre-operative exercise programme. Methods From November 2017 to June 2018, men scheduled for prostate cancer surgery were recruited and took part in a prescribed community-based pre-operative exercise programme in the time available between referral and surgery. Following completion of the pre-operative exercise programme (within 1 week before surgery), participants took part in one semi-structured interview which explored four broad QoL domains: physical, psychological, social, and spiritual wellbeing. Data were analysed using thematic analysis (a bottom up/inductive analysis). Results Eleven men were recruited: mean standard deviation (SD) age was 60 7 years. Data supported four main themes. Participation in the community-based pre-operative exercise training programme (over a mean (SD) of 4 +/- 2 weeks) provided participants with: 1) a teachable moment; 2) a journey of preparation; 3) a sense of optimism; and 4) social connectedness prior to surgery. Conclusion This study provides an insight into how the exercise programme impacted wellbeing and QoL in men preparing for prostate cancer surgery. These findings highlight the important role that exercise prehabilitation plays for men preparing for prostate cancer surgery. Such exercise programmes can be easily implemented into standard cancer pathways by establishing relationships between hospital teams and community exercise programmes.	[Loughney, Lisa; McCaffrey, Noel; Furlong, Brona] Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland; [Loughney, Lisa] Royal Coll Surgeons Ireland, Dublin, Ireland; [McGowan, Rachel] Natl Univ Ireland Galway, Sch Psychol, Galway, Ireland; [O'Malley, Kiaran] Mater Misericordiae Univ Hosp, Dept Urol Surg, Dublin, Ireland; [Walsh, Deirdre] Athlone Inst Technol, Dept Social Sci, Athlone, Ireland	Dublin City University; Royal College of Surgeons - Ireland; Ollscoil na Gaillimhe-University of Galway; Mater Misericordiae University Hospital; University College Dublin; Technological University of the Shannon: Midlands Midwest	Loughney, L (corresponding author), Dublin City Univ, Sch Hlth & Human Performance, Dublin, Ireland.; Loughney, L (corresponding author), Royal Coll Surgeons Ireland, Dublin, Ireland.	lisa.loughney@gmail.com		Kehoe, Brona/0000-0003-4552-0555				Bock D, 2020, SCAND J UROL, V54, P220, DOI 10.1080/21681805.2020.1754905; Boereboom CL, 2016, TECH COLOPROCTOL, V20, P375, DOI 10.1007/s10151-016-1455-1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burke S, 2017, CANCERS, V9, DOI 10.3390/cancers9050053; Burke SM, 2013, SUPPORT CARE CANCER, V21, P3345, DOI 10.1007/s00520-013-1908-2; Campbell KL, 2019, MED SCI SPORT EXER, V51, P2375, DOI 10.1249/MSS.0000000000002116; Cantwell M, 2018, EUR J CANCER CARE, V27, DOI 10.1111/ecc.12795; Cormie P, 2018, MED J AUSTRALIA, V209, P184, DOI 10.5694/mja18.00199; Cormie P, 2016, PSYCHO-ONCOLOGY, V25, P232, DOI 10.1002/pon.3867; Demark-Wahnefried W, 2005, J CLIN ONCOL, V23, P5814, DOI 10.1200/JCO.2005.01.230; Ferrell BR, 1995, QUAL LIFE RES, V4, P523, DOI 10.1007/BF00634747; Flocke SA, 2014, PATIENT EDUC COUNS, V96, P43, DOI 10.1016/j.pec.2014.03.014; Grimmett C, 2019, INT J BEHAV NUTR PHY, V16, DOI 10.1186/s12966-019-0787-4; Helgeson VS, 1996, HEALTH PSYCHOL, V15, P135, DOI 10.1037/0278-6133.15.2.135; Hinzey A, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0700-x; Hsiao Chao-Pin, 2007, Cancer Nurs, V30, pE19; Irish Cancer Society, 2018, CANC STAT; Kaushik V, 2019, SOC SCI-BASEL, V8, DOI 10.3390/socsci8090255; Levett DZH, 2019, ANAESTHESIA, V74, P36, DOI 10.1111/anae.14507; Loughney L, 2019, PERIOPER MED-LONDON, V8, DOI 10.1186/s13741-019-0126-y; Loughney L, 2017, PERIOPER MED-LONDON, V6, DOI 10.1186/s13741-017-0058-3; Loughney LA, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012280.pub2; Mavros MN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020306; Morgan D.L., 2017, INTEGRATING QUALITAT; National Cancer Registry Ireland, 2018, PROST CANC FACTSH; Robinson A, 2020, PERIOPER MED-LONDON, V9, DOI 10.1186/s13741-019-0133-z; Sabiston CM, 2007, J SPORT EXERCISE PSY, V29, P419, DOI 10.1123/jsep.29.4.419; Singh F, 2017, INTEGR CANCER THER, V16, P290, DOI 10.1177/1534735416666373; Tew GA, 2018, ANAESTHESIA, V73, P750, DOI 10.1111/anae.14177; Thorsteinsdottir T, 2013, HEALTH QUAL LIFE OUT, V11, DOI 10.1186/1477-7525-11-154; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tully R, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04311-4; Unruh Anita M, 2004, Can J Occup Ther, V71, P138; Watts S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-003901; West MA, 2015, BRIT J ANAESTH, V114, P244, DOI 10.1093/bja/aeu318; Yardley L, 2000, PSYCHOL HEALTH, V15, P215, DOI 10.1080/08870440008400302	36	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0253018	10.1371/journal.pone.0253018	http://dx.doi.org/10.1371/journal.pone.0253018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111218	Green Published, gold			2022-12-26	WOS:000664642700084
J	Shin, C; Kim, JM; Cheong, JH; Ryu, JI; Won, YD; Ko, Y; Han, MH				Shin, Chansub; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Won, Yu Deok; Ko, Yong; Han, Myung-Hoon			Association between tumor size and peritumoral brain edema in patients with convexity and parasagittal meningiomas	PLOS ONE			English	Article							STEREOTACTIC RADIOSURGERY; INTRACRANIAL MENINGIOMAS; RADIOTHERAPY; MRI	Background and purpose Peritumoral brain edema (PTBE) is a common complication in meningioma and disruption of the tumor-brain barrier in meningioma is crucial for PTBE formation. To evaluate the association between meningioma size and PTBE, we measured meningioma volumes using the 3D slicer in patients with convexity and parasagittal meningiomas. Methods Receiver operating characteristic curve analysis was used to determine the optimal cut-off meningioma volume values for predicting PTBE occurrence. Logistic regressions were used to estimate the odds ratios for PTBE occurrence in patients with convexity and parasagittal meningiomas according to several predictive factors. Results A total of 205 convexity or parasagittal meningioma patients with no other brain disease who underwent one or more contrast-enhanced brain MRIs were enrolled in this 10-year analysis in two hospitals. The optimal cut-off meningioma volume value for prediction of PTBE in all study patients was 13.953 cc (sensitivity = 76.1%; specificity = 92.5%). If a meningioma is assumed to be a complete sphere, 13.953 cc is about 2.987 cm in diameter. Conclusions Our study suggests a cut-off value of 3 cm meningioma diameter for prediction of PTBE in patients with convexity and parasagittal meningiomas. We believe that we have revealed why the meningioma diameter of 3 cm is clinically meaningful.	[Shin, Chansub; Kim, Jae Min; Cheong, Jin Hwan; Ryu, Je Il; Won, Yu Deok; Han, Myung-Hoon] Hanyang Univ, Dept Neurosurg, Guri Hosp, Guri, Gyonggi Do, South Korea; [Ko, Yong] Hanyang Univ, Med Ctr, Dept Neurosurg, Seoul, South Korea	Hanyang University; Hanyang University	Han, MH (corresponding author), Hanyang Univ, Dept Neurosurg, Guri Hosp, Guri, Gyonggi Do, South Korea.	gksmh80@gmail.com	Won, Yu Deok/CAF-2646-2022		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF2019R1G1A1085289]; Hanyang University [HY-201900000003370]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Hanyang University	This study was funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (NRF2019R1G1A1085289) and research funding from Hanyang University (HY-201900000003370).	Bae IS, 2019, AGING-US, V11, P8217, DOI 10.18632/aging.102316; Bang JH, 2017, WORLD NEUROSURG, V108, P859, DOI 10.1016/j.wneu.2017.08.076; Bo HK, 2017, J NEURO-ONCOL, V131, P393, DOI 10.1007/s11060-016-2312-9; Cai RS, 2010, NEUROSURGERY, V66, P513, DOI 10.1227/01.NEU.0000365366.53337.88; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; Conti A., 2020, CYBERKNIFE NEURORADI, P241, DOI [10.1007/978-3-030-50668-1%5F18, DOI 10.1007/978-3-030-50668-1%5F18]; Conti A, 2016, CUREUS, V8, DOI 10.7759/cureus.605; Fatima N, 2019, NEUROSURG FOCUS, V46, DOI 10.3171/2019.3.FOCUS1970; Gessler F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124534; Girvigian MR, 2008, NEUROSURGERY, V62, pA19, DOI 10.1227/01.neu.0000325933.34154.cb; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Han MH, 2018, STROKE, V49, P1850, DOI 10.1161/STROKEAHA.118.021063; Hou J, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.8.FOCUS13301; INAMURA T, 1992, NEUROSURGERY, V31, P179, DOI 10.1227/00006123-199208000-00002; Kim BW, 2011, J KOREAN NEUROSURG S, V49, P26, DOI 10.3340/jkns.2011.49.1.26; Lambertz N, 2013, J NEURO-ONCOL, V112, P297, DOI 10.1007/s11060-013-1064-z; Lee KJ, 2008, SURG NEUROL, V69, P350, DOI 10.1016/j.surneu.2007.03.027; Lee RH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226312; Manabe Y, 2017, NEUROL MED-CHIR, V57, P627, DOI 10.2176/nmc.oa.2017-0115; Mattei Tobias Alécio, 2005, Clinics, V60, P201, DOI 10.1590/S1807-59322005000300004; Nakano T, 2002, CLIN IMAG, V26, P243, DOI 10.1016/S0899-7071(02)00433-3; Nakasu Satoshi, 2005, Brain Tumor Pathol, V22, P53, DOI 10.1007/s10014-005-0187-0; Padole A, 2020, TRANSL LUNG CANCER R, V9, P1441, DOI 10.21037/tlcr-20-347; Paek SH, 2002, J NEURO-ONCOL, V60, P235; Patel D, 2016, AM J NEURORADIOL, V37, P2026, DOI 10.3174/ajnr.A4843; Pistolesi S, 2002, J NEURO-ONCOL, V60, P159, DOI 10.1023/A:1020624119944; Rashid A, 2012, J RADIOSURGERY SBRT, V2, P29; Reinert M, 2006, ACTA NEUROCHIR, V148, P1257, DOI 10.1007/s00701-006-0909-z; Saboori Parisa, 2015, Anat Res Int, V2015, P279814, DOI 10.1155/2015/279814; Simis A, 2008, SURG NEUROL, V70, P471, DOI 10.1016/j.surneu.2008.03.006; Sun CR, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01412; Takeguchi Takashi, 2003, Magn Reson Med Sci, V2, P165, DOI 10.2463/mrms.2.165; Tierney NJ., 2020, ARXIV180902264STAT; Won YD, 2018, WORLD NEUROSURG, V111, pE120, DOI 10.1016/j.wneu.2017.12.025; Yoshioka H., 1999, CANCER, V85, P936, DOI [10.1002/%28sici%291097-0142%2819990215%2985%3A4%26lt%3B936%3A%3Aaid-cncr23%26gt%3B3.0.co%3B2-j, DOI 10.1002/%28SICI%291097-0142%2819990215%2985%3A4%26LT%3B936%3A%3AAID-CNCR23%26GT%3B3.0.CO%3B2-J]	35	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252945	10.1371/journal.pone.0252945	http://dx.doi.org/10.1371/journal.pone.0252945			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111188	Green Published, gold			2022-12-26	WOS:000664642700071
J	Chen, L; Holder, R; Porter, C; Shah, Z				Chen, Lei; Holder, Rachel; Porter, Charles; Shah, Zubair			Vitamin D3 attenuates doxorubicin-induced senescence of human aortic endothelial cells by upregulation of IL-10 via the pAMPK alpha/Sirt1/Foxo3a signaling pathway	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; AMPK; SUPPLEMENTATION; ACTIVATION; SIRT1; PHOSPHORYLATION; SUSCEPTIBILITY; TRANSCRIPTION; DEFICIENCY; CANCER	The toxicity of doxorubicin to the cardiovascular system often limits its benefits and widespread use as chemotherapy. The mechanisms involved in doxorubicin-induced cardiovascular damage and possible protective interventions are not well-explored. Using human aortic endothelial cells, we show vitamin D3 strongly attenuates doxorubicin-induced senescence and cell cycle arrest. We further show the protective effects of vitamin D3 are mediated by the upregulation of IL-10 and FOXO3a expression through fine modulation of pAMPK alpha /SIRT1/FOXO3a complex activity. These results have great significance in finding a target for mitigating doxorubicin-induced cardiovascular toxicity.	[Chen, Lei; Holder, Rachel; Porter, Charles; Shah, Zubair] Univ Kansas, Med Ctr, Dept Cardiovasc Med, Kansas City, KS 66103 USA	University of Kansas; University of Kansas Medical Center	Shah, Z (corresponding author), Univ Kansas, Med Ctr, Dept Cardiovasc Med, Kansas City, KS 66103 USA.	zshah2@kumc.edu		Holder, Rachel/0000-0001-5684-4761	Cray Foundation Endowment; NIH/NIGMS COBRE grant [P30GM103326, P30GM122731]	Cray Foundation Endowment; NIH/NIGMS COBRE grant	This study was supported by internal funding from The Cray Foundation Endowment. We acknowledge the Flow Cytometry Core Laboratory, which is sponsored, in part, by the NIH/NIGMS COBRE grant P30GM103326. We also acknowledge the confocal core, which is supported, in part, by NIH/NIGMS COBRE grant P30GM122731. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazzoni F, 2010, EUR J IMMUNOL, V40, P2360, DOI 10.1002/eji.200940294; Cappetta D, 2018, PHARMACOL RES, V127, P4, DOI 10.1016/j.phrs.2017.03.016; Chang CM, 2015, MOL CELL, V60, P930, DOI 10.1016/j.molcel.2015.10.037; Chatterjee K, 2010, CARDIOLOGY, V115, P155, DOI 10.1159/000265166; Cui CM, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101295; DAVIES KJA, 1986, J BIOL CHEM, V261, P3060; Dong HW, 2018, EUR REV MED PHARMACO, V22, P2757, DOI 10.26355/eurrev_201805_14973; Fichtlscherer S, 2004, J AM COLL CARDIOL, V44, P44, DOI 10.1016/j.jacc.2004.02.054; Gil A, 2018, ANN NUTR METAB, V72, P87, DOI 10.1159/000486536; Greer EL, 2007, J BIOL CHEM, V282, P30107, DOI 10.1074/jbc.M705325200; Grundstrom J, 2012, CLIN EXP IMMUNOL, V169, P137, DOI 10.1111/j.1365-2249.2012.04600.x; Gunnett CA, 2000, AM J PHYSIOL-HEART C, V279, pH1555, DOI 10.1152/ajpheart.2000.279.4.H1555; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Hohaus S, 2018, CANCER MED-US, V7, P270, DOI 10.1002/cam4.1166; Hubert A, 2020, EUR CARDIOL REV, V15, P74, DOI 10.15420/ecr.2019.20; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; Jamali N, 2018, AM J PHYSIOL-HEART C, V314, pH753, DOI 10.1152/ajpheart.00319.2017; Kalivendi SV, 2001, J BIOL CHEM, V276, P47266, DOI 10.1074/jbc.M106829200; Khammissa RAG, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9276380; Kobayashi M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26489; Li L, 2019, INT IMMUNOPHARMACOL, V68, P81, DOI 10.1016/j.intimp.2018.12.051; Maayah ZH, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10030144; Mallat Z, 1999, CIRC RES, V85, pE17, DOI 10.1161/01.RES.85.8.e17; Marampon F, 2016, J ENDOCRINOL INVEST, V39, P411, DOI 10.1007/s40618-015-0381-9; Martorell S, 2016, ARTERIOSCL THROM VAS, V36, P1587, DOI 10.1161/ATVBAHA.116.307530; Matilainen JM, 2010, J STEROID BIOCHEM, V121, P142, DOI 10.1016/j.jsbmb.2010.03.020; McGowan JV, 2017, CARDIOVASC DRUG THER, V31, P63, DOI 10.1007/s10557-016-6711-0; Ng K, 2019, JAMA-J AM MED ASSOC, V321, P1370, DOI 10.1001/jama.2019.2402; Petrou S, 2018, INT J VITAM NUTR RES, V88, P100, DOI 10.1024/0300-9831/a000494; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Pries AR., HDB EXPT PHARM, P1, DOI [10.1007/3-540-32967-6%5F1, DOI 10.1007/3-540-32967-6%5F1]; Ravid A, 1999, CANCER RES, V59, P862; Regina C, 2016, MECH AGEING DEV, V159, P14, DOI 10.1016/j.mad.2016.05.003; Rohan JNP, 2009, ENDOCRINOLOGY, V150, P2046, DOI 10.1210/en.2008-1395; Schleithoff SS, 2006, AM J CLIN NUTR, V83, P754, DOI 10.1093/ajcn/83.4.754; Soultati A, 2012, CANCER TREAT REV, V38, P473, DOI 10.1016/j.ctrv.2011.09.002; Tishkoff DX, 2008, ENDOCRINOLOGY, V149, P558, DOI 10.1210/en.2007-0805; Wang XW, 2017, ONCOL LETT, V13, P2867, DOI 10.3892/ol.2017.5851; Wimalawansa SJ, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8020030; Witte KK, 2016, J AM COLL CARDIOL, V67, P2593, DOI 10.1016/j.jacc.2016.03.508; Zhao Y, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0648-1	41	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252816	10.1371/journal.pone.0252816	http://dx.doi.org/10.1371/journal.pone.0252816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101754	gold, Green Published			2022-12-26	WOS:000664641500025
J	Yan, X; Kang, ZF; Li, L; Guan, RJ				Yan Xin; Kang Zefeng; Li Ling; Guan Ruijuan			Association between NF-kB polymorphism and age-related macular degeneration in a high-altitude population	PLOS ONE			English	Article							KAPPA-B; INFLAMMATION; THERAPY; PATHWAY; IMPACT	Objective To investigate the association between the nuclear factor kappa B (NF-kB) gene polymorphism and age-related macular degeneration (AMD) in a high-altitude population. Methods Fifty-five patients with AMD and 57 control subjects were recruited from the Qinghai Provincial People's Hospital, China. Genomic DNA was extracted from the blood sample of each participant. Four NF-kB polymorphisms (rs3774959, rs3774932, rs3774937, and rs230526) were genotyped using a MassARRAY system. The genotype and allele frequencies were compared between the case and control groups using the chi-squared test or Fisher's exact test. Results There was no significant difference in sex, age, hypertension, diabetes, blood lipid level or smoking and drinking status between the AMD and control groups (P > 0.05). The genotype distributions of four NF-kB polymorphisms were in accordance with Hardy-Weinberg equilibrium in the control group (P > 0.05). The frequencies of genotype AA of rs3774932 and genotype CC of rs3774937 were nominally significantly higher in the AMD group than in the control group (P = 0.046 and 0.023, respectively), although these associations did not survive the Bonferroni correction (corrected P > 0.05). Genotype distributions of rs3774959 and rs230526 were not significantly different between the two groups (P = 0.08 and 0.16, respectively). No significant difference in the allele frequencies of the four polymorphisms was found between the AMD and control groups (P > 0.05). Conclusions Genotype AA of rs3774932 and genotype CC of rs3774937 in NF-kB might be risk factors for AMD.	[Yan Xin] Qinghai Univ, Coll Med, Xining, Qinghai, Peoples R China; [Kang Zefeng] Chinese Acad Tradit Chinese Med, Ophthalm Hosp, Beijing, Peoples R China; [Li Ling; Guan Ruijuan] Qinghai Prov Peoples Hosp, Dept Ophthalmol, Xining, Qinghai, Peoples R China	Qinghai University; China Academy of Chinese Medical Sciences	Kang, ZF (corresponding author), Chinese Acad Tradit Chinese Med, Ophthalm Hosp, Beijing, Peoples R China.; Guan, RJ (corresponding author), Qinghai Prov Peoples Hosp, Dept Ophthalmol, Xining, Qinghai, Peoples R China.	zefeng2531@163.com; grjchuer@163.com			Department of Science and Technology of Qinghai Province;  [13279497309];  [13552597717];  [13309712948];  [18997150572]	Department of Science and Technology of Qinghai Province; ; ; ; 	Ruijuan Guan; Xin Yan:13279497309 Zefeng Kang: 13552597717; Ling Li: 13309712948, Ruijuan Guan: 18997150572; Department of Science and Technology of Qinghai Province.	AAO, 2021, AM ACAD OPHTHALMOL; Chang CC, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9015765; Chen C, 2017, CANCER LETT, V388, P21, DOI 10.1016/j.canlet.2016.11.027; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Datta S, 2017, PROG RETIN EYE RES, V60, P201, DOI 10.1016/j.preteyeres.2017.03.002; De Simone V, 2015, ONCOGENE, V34, P3493, DOI 10.1038/onc.2014.286; DeAngelis MM, 2017, HUM MOL GENET, V26, pR45, DOI 10.1093/hmg/ddx228; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Ferris FL, 2013, OPHTHALMOLOGY, V120, P844, DOI 10.1016/j.ophtha.2012.10.036; Fine SL, 2000, NEW ENGL J MED, V342, P483, DOI 10.1056/NEJM200002173420707; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Grussel T, 1997, TIERAERZTL PRAX, V25, P28; Han XK, 2020, J HUM GENET, V65, P657, DOI 10.1038/s10038-020-0750-x; Hayden MS, 2012, GENE DEV, V26, P203, DOI 10.1101/gad.183434.111; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Khongthong P, 2019, ENDOCR-RELAT CANCER, V26, pR369, DOI 10.1530/ERC-19-0087; Klaver CCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1646, DOI 10.1001/archopht.116.12.1646; Mitchell JP, 2018, INT REV CEL MOL BIO, V335, P41, DOI 10.1016/bs.ircmb.2017.07.007; Nashine S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051102; Peng X, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1483-7; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Roubeix C, 2020, M S-MED SCI, V36, P886, DOI 10.1051/medsci/2020159; Sivaprasad S, 2005, CLIN EXP OPHTHALMOL, V33, P518, DOI 10.1111/j.1442-9071.2005.01074.x; Song PG, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020703; Tang XJ, 2018, CURR PROTEIN PEPT SC, V19, P172, DOI 10.2174/1389203718666171009111835; Vequaud E, 2015, ONCOTARGET, V6, P13476, DOI 10.18632/oncotarget.3638; Wang SB, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3632169; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Wei Q, 2020, LIFE SCI, V241, DOI 10.1016/j.lfs.2019.117142; Yi WW, 2019, AGING-US, V11, P7294, DOI 10.18632/aging.102266	30	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0251931	10.1371/journal.pone.0251931	http://dx.doi.org/10.1371/journal.pone.0251931			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101738	Green Published, gold			2022-12-26	WOS:000664641500006
J	Chaudhuri, T; Chintalapati, J; Hosur, MV				Chaudhuri, Tanusree; Chintalapati, Janaki; Hosur, Madhusoodan Vijayacharya			Identification of 3'-UTR single nucleotide variants and prediction of select protein imbalance in mesial temporal lobe epilepsy patients	PLOS ONE			English	Article							MISSENSE MUTATIONS; READ ALIGNMENT; RNA; MEMBERS; FORMAT; SYSTEM; GAIN	The genetic influence in epilepsy, characterized by unprovoked and recurrent seizures, is through variants in genes critical to brain development and function. We have carried out variant calling in Mesial Temporal Lobe Epilepsy (MTLE) patients by mapping the RNA-Seq data available at SRA, NCBI, USA onto human genome assembly hg-19. We have identified 1,75,641 SNVs in patient samples. These SNVs are distributed over 14700 genes of which 655 are already known to be associated with epilepsy. Large number of variants occur in the 3'-UTR, which is one of the regions involved in the regulation of protein translation through binding of miRNAs and RNA-binding proteins (RBP). We have focused on studying the structure-function relationship of the 3'-UTR SNVs that are common to at-least 10 of the 35 patient samples. For the first time we find SNVs exclusively in the 3'-UTR of FGF12, FAR1, NAPB, SLC1A3, SLC12A6, GRIN2A, CACNB4 and FBXO28 genes. Structural modelling reveals that the variant 3'-UTR segments possess altered secondary and tertiary structures which could affect mRNA stability and binding of RBPs to form proper ribonucleoprotein (RNP) complexes. Secondly, these SNVs have either created or destroyed miRNA-binding sites, and molecular modeling reveals that, where binding sites are created, the additional miRNAs bind strongly to 3'-UTR of only variant mRNAs. These two factors affect protein production thereby creating an imbalance in the amounts of select proteins in the cell. We suggest that in the absence of missense and nonsense variants, protein-activity imbalances associated with MTLE patients can be caused through 3'-UTR variants in relevant genes by the mechanisms mentioned above. 3'-UTR SNV has already been identified as causative variant in the neurological disorder, Tourette syndrome. Inhibition of these miRNA-mRNA bindings could be a novel way of treating drug-resistant MTLE patients. We also suggest that joint occurrence of these SNVs could serve as markers for MTLE. We find, in the present study, SNV-mediated destruction of miRNA binding site in the 3'-UTR of the gene encoding glutamate receptor subunit, and, interestingly, overexpression of one of this receptor subunit is also associated with Febrile Seizures.	[Chaudhuri, Tanusree; Hosur, Madhusoodan Vijayacharya] Natl Inst Adv Studies, Dept Nat Sci & Engn, IISc Campus, Bangalore, Karnataka, India; [Chintalapati, Janaki] CDAC Ctr Dev Adv Comp, Bangalore, Karnataka, India		Hosur, MV (corresponding author), Natl Inst Adv Studies, Dept Nat Sci & Engn, IISc Campus, Bangalore, Karnataka, India.	hosurmv@nias.res.in		Chaudhuri, Tanusree/0000-0003-1200-4853	Office of the Principal Scientific Advisor (PSA), Govt. of India	Office of the Principal Scientific Advisor (PSA), Govt. of India	This research was supported by the Office of the Principal Scientific Advisor (PSA), Govt. of India for the project on "Advanced Epilepsy research-AER".	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Aitken CE, 2012, NAT STRUCT MOL BIOL, V19, P568, DOI 10.1038/nsmb.2303; Asadi-Pooya AA, 2017, WORLD NEUROSURG, V99, P662, DOI 10.1016/j.wneu.2016.12.074; Bae B, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103413; Barrie ES, 2018, MOL GENET GENOM MED, V6, P565, DOI 10.1002/mgg3.407; Betel D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r90; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; Briellmann RS, 2001, NEUROLOGY, V57, P1800, DOI 10.1212/WNL.57.10.1800; Brooks-Kayal AR, 1998, NAT MED, V4, P1166, DOI 10.1038/2661; Buchert R, 2014, AM J HUM GENET, V95, P602, DOI 10.1016/j.ajhg.2014.10.003; Cersosimo R, 2011, SEIZURE-EUR J EPILEP, V20, P131, DOI 10.1016/j.seizure.2010.11.002; Cline MS, 2011, BIOINFORMATICS, V27, P441, DOI 10.1093/bioinformatics/btq695; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Conroy J, 2016, CLIN GENET, V89, pE1, DOI 10.1111/cge.12648; Cubillos-Rojas M., 2016, ONCOTARGET, P7, DOI [10.18632/oncotarget.6589, DOI 10.18632/ONCOTARGET.6589]; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/nmeth.1433, 10.1038/NMETH.1433]; Delay C, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-70; Deprez L, 2008, EPILEPSIA, V49, P500, DOI 10.1111/j.1528-1167.2007.01415.x; Devanna P, 2018, HUM GENET, V137, P717, DOI 10.1007/s00439-018-1925-9; Devinsky O, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/nrdp.2018.24; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fehlmann T, 2019, BRIEF BIOINFORM, V20, P1011, DOI 10.1093/bib/bbx155; Feng JC, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1096; Friedman JI, 2008, MOL PSYCHIATR, V13, P261, DOI 10.1038/sj.mp.4002049; Fukunaga T, 2017, BIOINFORMATICS, V33, P2666, DOI 10.1093/bioinformatics/btx287; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Guella I, 2016, NEUROL-GENET, V2, DOI 10.1212/NXG.0000000000000120; Guo Y, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00061; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hsu JBK, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-300; Huang YQ, 2017, NEUROPSYCH DIS TREAT, V13, DOI 10.2147/NDT.S132451; Kaya C, 2021, THYROID, V31, P589, DOI 10.1089/thy.2020.0307; Kettwig M, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0602-7; Kinoshita PF, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00195; Kjeldsen MJ, 2001, EPILEPSY RES, V44, P167, DOI 10.1016/S0920-1211(01)00196-6; Klassen T, 2011, CELL, V145, P1036, DOI 10.1016/j.cell.2011.05.025; Kobayashi E, 2003, NEUROLOGY, V60, P405, DOI 10.1212/WNL.60.3.405; Korotkov A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11510-8; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; Lam WWK, 2016, MOL GENET GENOM MED, V4, P465, DOI 10.1002/mgg3.219; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Y., ACTA EPILEPTOL, V2, P20, DOI [10.1186/s42494-020-00027-9, DOI 10.1186/S42494-020-00027-9]; Liu J., 2018, MATERIALS, V11, P1; Lu JS, 2018, BIOINFORMATICS, V34, P4297, DOI 10.1093/bioinformatics/bty468; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Mann M, 2017, NUCLEIC ACIDS RES, V45, pW435, DOI 10.1093/nar/gkx279; McLaren W, 2010, BIOINFORMATICS, V26, P2069, DOI 10.1093/bioinformatics/btq330; McTague A, 2016, LANCET NEUROL, V15, P304, DOI 10.1016/S1474-4422(15)00250-1; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; Moser D, 2009, NEUROPSYCHOPHARMACOL, V34, P458, DOI 10.1038/npp.2008.77; Mullier B, 2017, NEUROPHARMACOLOGY, V123, P322, DOI 10.1016/j.neuropharm.2017.05.017; Nissenkorn A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211901; Patterson KP, 2014, NEUROTHERAPEUTICS, V11, P242, DOI 10.1007/s13311-014-0263-4; Perenthaler E, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00352; Pirone A, 2017, EPILEPSY CURR, V17, P171, DOI 10.5698/1535-7511.17.3.171; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Sander JW, 2003, CURR OPIN NEUROL, V16, P165, DOI 10.1097/00019052-200304000-00008; Schaarschmidt S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21051720; Sheilabi MA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082955; Shinnar Shlomo, 2003, Epilepsy Curr, V3, P115, DOI 10.1046/j.1535-7597.2003.03401.x; Short PJ, 2018, NATURE, V555, P611, DOI 10.1038/nature25983; Siekierska A, 2016, NEUROLOGY, V86, P2162, DOI 10.1212/WNL.0000000000002752; Skotte L., 2020, MEDRXIV2020111820233, DOI [10.1101/2020.11.18.20233916, DOI 10.1101/2020.11.18.20233916]; Smallwood PM, 1996, P NATL ACAD SCI USA, V93, P9850, DOI 10.1073/pnas.93.18.9850; Steri M, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1474; Striano P, 2008, J NEUROL, V255, P16, DOI 10.1007/s00415-007-0653-1; Sun H, 2008, IEEE INT C BIO BIO W, P211, DOI 10.1109/BIBMW.2008.4686238; Uyanik G, 2006, NEUROLOGY, V66, P1044, DOI 10.1212/01.wnl.0000204181.31175.8b; Vonberg FW, 2016, JAMA NEUROL, V73, P125, DOI 10.1001/jamaneurol.2015.3480; Wang J, 2017, SEIZURE-EUR J EPILEP, V44, P11, DOI 10.1016/j.seizure.2016.11.030; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Wong JKL, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000245; Yuan SG, 2017, WIRES COMPUT MOL SCI, V7, DOI 10.1002/wcms.1298; Zhu Q, 2012, J MOL NEUROSCI, V46, P420, DOI 10.1007/s12031-011-9602-7	77	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252475	10.1371/journal.pone.0252475	http://dx.doi.org/10.1371/journal.pone.0252475			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086756	gold, Green Published			2022-12-26	WOS:000664640100073
J	Kowall, B; Lehnich, AT; Schramm, S; Schmidt, B; Erbel, R; Jockel, KH; Stang, A				Kowall, Bernd; Lehnich, Anna-Therese; Schramm, Sara; Schmidt, Boerge; Erbel, Raimund; Joeckel, Karl-Heinz; Stang, Andreas			Family aggregation of sleep characteristics: Results of the Heinz Nixdorf Recall and the Multi-Generation Study	PLOS ONE			English	Article							DURATION; RISK; METAANALYSIS; HYPERTENSION; INSOMNIA; QUALITY; ADULTS; POPULATION; APNEA	Introduction Poor sleep is a risk factor for adverse health events. For health prevention, it may be helpful to know whether poor sleep or sleep disorders in individuals are associated with sleep problems in their partners or children. Methods In the MultiGeneration Study (MGS, conducted from 2013 to 2016), 1237 partners (aged 27 to 90 years) and 1660 adult children (aged 18 to 66 years) of index persons were recruited. Index persons are participants of the Heinz Nixdorf Recall Study, a population-based cohort study in the Ruhr area (study start 1999-2001, 4841 participants aged 45-75 years). We used two analysis populations: one with 1181 index persons whose partners were in MGS, and one with 1083 index persons with at least one adult child in MGS. Sleep characteristics were assessed using questionnaires (including the Pittsburgh Sleep Quality Index). The exposure was the presence of a sleep characteristic of the index subject. Results Children showed the investigated sleep characteristics more often if these were also present in their parent (e.g., RR (relative risk) = 1.28 (95% CI: 1.06-1.55) for poor sleep quality). In partners, strong associations were observed for rising times and napping, but only weak associations for snoring, poor sleep quality and sleep disorders. Snoring of the bed partner is a risk factor for poor sleep (e.g., RR = 1.67 (0.91-3.07) for difficulties falling asleep). Conclusion Aggregation is observed for many sleep characteristics in people living in partnerships as well as in parents and their adult children.	[Kowall, Bernd; Lehnich, Anna-Therese; Schramm, Sara; Schmidt, Boerge; Erbel, Raimund; Joeckel, Karl-Heinz; Stang, Andreas] Univ Duisburg Essen, Fac Med, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Stang, Andreas] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	University of Duisburg Essen; Boston University	Kowall, B (corresponding author), Univ Duisburg Essen, Fac Med, Inst Med Informat Biometry & Epidemiol, Essen, Germany.	bernd.kowall@uk-essen.de			German Federal Ministry of Education and Science (BMBF) [01ER1704]; Heinz Nixdorf Foundation	German Federal Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF)); Heinz Nixdorf Foundation	AS 01ER1704 German Federal Ministry of Education and Science (BMBF) RE, KHJ, AS Heinz Nixdorf Foundation The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastien CH, 2000, J SLEEP RES, V9, P49, DOI 10.1046/j.1365-2869.2000.00182.x; Beaulieu-Bonneau S, 2007, SLEEP, V30, P1739, DOI 10.1093/sleep/30.12.1739; Beninati W, 1999, MAYO CLIN PROC, V74, P955; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; da Silva Andressa Alves, 2016, BMJ Open, V6, pe008119, DOI 10.1136/bmjopen-2015-008119; Dauvilliers Y, 2005, J PSYCHOSOM RES, V58, P271, DOI 10.1016/j.jpsychores.2004.08.012; Dauvilliers Y, 2013, GENETIC BASIS OF SLEEP AND SLEEP DISORDERS, P227; Ellis JG, 2019, SLEEP AND HEALTH, P137, DOI 10.1016/B978-0-12-815373-4.00011-3; Gangwisch JE, 2014, AM J HYPERTENS, V27, P1235, DOI 10.1093/ajh/hpu071; Gunn HE, 2015, SLEEP, V38, P933, DOI 10.5665/sleep.4744; Guo XF, 2013, SLEEP MED, V14, P324, DOI 10.1016/j.sleep.2012.12.001; Hernan MA, 2018, AM J PUBLIC HEALTH, V108, P616, DOI 10.2105/AJPH.2018.304337; Holliday EG, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0082305, 10.1371/journal.pone.0053830]; Iannella G, 2021, EUR ARCH OTO-RHINO-L, V278, P883, DOI 10.1007/s00405-020-06316-w; Iannella G, 2020, POL ARCH INTERN MED, V130, P649, DOI 10.20452/pamw.15283; Jarrin DC, 2017, SLEEP, V40, DOI 10.1093/sleep/zsw053; Larcher S, 2015, DIABETES METAB, V41, P263, DOI 10.1016/j.diabet.2014.12.004; Li JX, 2018, SLEEP MED CLIN, V13, P1, DOI 10.1016/j.jsmc.2017.09.001; Maniaci A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10020277; Meng L, 2013, HYPERTENS RES, V36, P985, DOI 10.1038/hr.2013.70; Ohayon MM, 2004, SLEEP, V27, P1255, DOI 10.1093/sleep/27.7.1255; Parish JM, 2013, CHEST, V143, P1489, DOI 10.1378/chest.12-1219; REDLINE S, 1995, AM J RESP CRIT CARE, V151, P682; Schlack R, 2013, BUNDESGESUNDHEITSBLA, V56, P740, DOI 10.1007/s00103-013-1689-2; Schmermund A, 2002, AM HEART J, V144, P212, DOI 10.1067/mhj.2002.123579; Shan ZL, 2015, DIABETES CARE, V38, P529, DOI 10.2337/dc14-2073; Sowho M, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz305; Stepanski EJ, 2003, SLEEP MED REV, V7, P215, DOI 10.1053/smrv.2001.0246; Ulfberg J, 2000, Health Care Women Int, V21, P81; Vitiello MV, 2006, SLEEP MED CLIN, V1, P171, DOI 10.1016/j.jsmc.2006.04.007; Wang QJ, 2012, HYPERTENS RES, V35, P1012, DOI 10.1038/hr.2012.91; Wang Y, 2015, J CLIN SLEEP MED, V11, P1047, DOI 10.5664/jcsm.5024; WIGGINS CL, 1990, SLEEP, V13, P245, DOI 10.1093/sleep/13.3.245; Yin JW, 2017, J AM HEART ASSOC, V6, DOI [10.1161/JAHA.117.005947, 10.1161/jaha.117.005947]	36	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252828	10.1371/journal.pone.0252828	http://dx.doi.org/10.1371/journal.pone.0252828			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086822	gold, Green Published			2022-12-26	WOS:000664640100142
J	Salia, SM; Afaya, A; Wuni, A; Ayanore, MA; Salia, E; Kporvi, DD; Adatara, P; Yakong, VN; Eduah-Quansah, SA; Quarshie, SS; Dey, EK; Akolga, DA; Alhassan, RK				Salia, Solomon Mohammed; Afaya, Agani; Wuni, Abubakari; Ayanore, Martin Amogre; Salia, Emmanuel; Kporvi, Doreen Dzidzor; Adatara, Peter; Yakong, Vida Nyagre; Eduah-Quansah, Sean Augustine; Quarshie, Shine Seyram; Dey, Eric Kwame; Akolga, Dominic Amoah; Alhassan, Robert Kaba			Knowledge, attitudes and practices regarding neonatal jaundice among caregivers in a tertiary health facility in Ghana	PLOS ONE			English	Article							PERCEPTION; MANAGEMENT	Background Neonatal jaundice is a major reason babies are frequently re-admitted after hospital discharge following delivery. One means of improving neonatal care and reducing potential mortality associated with neonatal jaundice in resource-limited settings is to create awareness among caregivers. Caregivers who tend to have higher knowledge and awareness, also have positive attitudes, and are not guided by outmoded socio-cultural beliefs and practices are more likely to seek early care and treatment for neonatal jaundice. Objective This study investigated caregivers' knowledge, attitude and practices regarding neonatal jaundice in a tertiary health facility in the Volta region of Ghana. Methods This was a descriptive cross-sectional study that employed a quantitative approach for data collection. A total of 202 caregivers from the Ho Teaching Hospital in the Volta region of Ghana were sampled using a systematic random sampling strategy where quantitative data was collected using a questionnaire and analyzed with STATA version 14.0. Ordered logistic regression was used to determine the factors that were associated with caregivers' knowledge regarding neonatal jaundice and attitude after controlling for relevant covariates. Results Less than half of the caregivers demonstrated good knowledge (45.5%) and attitude (47.5%) but 58.9% had good practices regarding neonatal jaundice. Caregivers who had prior awareness and education on neonatal jaundice were three times more likely to have good knowledge about jaundice than those without previous education [AOR = 3.02, (95%CI: 1.59-5.74), p = 0.001]. A caregiver employed in the public sector was two times more likely to have a good attitude about jaundice than those employed in the private sector [AOR = 2.08, (95%CI: 1.03-4.21), p = 0.042]. Conclusion Less than two thirds of the caregivers demonstrated good practice with limited knowledge and poor attitude. Efforts to promote well informed and improved caregivers' attitude will advance positive maternal health-seeking behavior and reduce disabilities and death through early detection and intervention of infants with neonatal jaundice. Public awareness and education about neonatal jaundice especially among caregivers in the private sector should also be intensified.	[Salia, Solomon Mohammed; Afaya, Agani; Kporvi, Doreen Dzidzor; Adatara, Peter; Eduah-Quansah, Sean Augustine; Quarshie, Shine Seyram; Dey, Eric Kwame; Akolga, Dominic Amoah] Univ Hlth & Allied Sci, Sch Nursing & Midwifery, Dept Nursing, Ho, Ghana; [Afaya, Agani] Yonsei Univ, Coll Nursing, Seoul, South Korea; [Wuni, Abubakari] Nurses & Midwives Training Coll, Tamale, Ghana; [Ayanore, Martin Amogre] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Hlth Policy Planning & Management, Ho, Ghana; [Salia, Emmanuel] Korle Bu Teaching Hosp, Cent Lab, Accra, Ghana; [Yakong, Vida Nyagre] Univ Dev Studies, Sch Nursing & Midwifery, Dept Midwifery, Tamale, Ghana; [Alhassan, Robert Kaba] Univ Hlth & Allied Sci, Inst Hlth Res, Ctr Hlth Policy & Implementat Res, Ho, Ghana	Yonsei University; Yonsei University Health System; University for Development Studies	Salia, SM (corresponding author), Univ Hlth & Allied Sci, Sch Nursing & Midwifery, Dept Nursing, Ho, Ghana.	ssmohammed@uhas.edu.gh		Ayanore, Martin/0000-0002-4095-3047; Salia, Solomon Mohammed/0000-0001-5271-3975				ADEEB MNA., 2016, J SAINS KESIHAT MALA, V14, P65, DOI DOI 10.17576/JSKM-2016-1402-08; Adoba P, 2018, INT J PEDIAT, V2018, DOI 10.1155/2018/3901505; Afaya A., 2020, CROSSSECTIONAL STUDY, V36, P1, DOI [10.1371/journal.pone.0234575, DOI 10.1371/JOURNAL.PONE.0234575]; Aggarwal B., 2017, INDIAN J CHILD HLTH, V04, P603; Alfouwais NM., 2018, EGYPT J HOSP MED, V70, P1586; Allahony DM, 2016, MENOUFIA MED J, V29, P743; Amegan-Aho Kokou H, 2019, Ghana Med J, V53, P267, DOI 10.4314/gmj.v53i4.3; Bello M., 2014, NEONATAL JAUNDICE KN, V1, P7; Bhutani VK, 2013, PEDIATR RES, V74, P86, DOI 10.1038/pr.2013.208; Blackburn ST, 2012, ELSEVIER HLTH SCI; Boo N Y, 2011, Med J Malaysia, V66, P239; Cox S, 2005, WILLIAMS OBSTET 22 E; Dash M, 2013, RES REV J MEDICAL HL, V2, P41; Data from Ghana Health Service, 2019, NEWB JAUND INCR 5 YE; Egube BA, 2013, NIGER J CLIN PRACT, V16, P188, DOI 10.4103/1119-3077.110147; Eneh AU, 2009, NIGER J CLIN PRACT, V12, P187; Ezeaka CV, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-192; George D., 2003, RELIABILITY ANAL SPS, V222, P232; Ghana Ministry of Health, 2014, GHAN NAT NEWB HLTH S; Goodman Olayinka O, 2015, Niger Postgrad Med J, V22, P158, DOI 10.4103/1117-1936.170741; Hockenberry MJ., 2015, WONGS NURSING CARE I, VIX; Huq S., 2017, ANWER KHAN MOD MED C, V8, P121; Khan RS., 2015, MED UK, V43, P573, DOI [10.1016/j.mpmed.2015.07.009, DOI 10.1016/J.MPMED.2015.07.009]; Kulkarni SK, 2014, INT J BASIC APPL MED, V4, P395; M Kliegman R., 2016, NELSON TXB PEDIAT, V2; Magfouri H, 2019, J CLIN NEONATOL, V8, P116, DOI 10.4103/jcn.JCN_119_18; Moawad EMI., 2016, MED US, V95; Ogunlesi TA, 2015, NIGER J CLIN PRACT, V18, P33, DOI 10.4103/1119-3077.146976; Olusanya BO, 2016, NIGER J CLIN PRACT, V19, P1, DOI 10.4103/1119-3077.173703; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; Onyearugha C, 2016, J HLTH SCI RES, V1, P42; Onyearugha CN., 2011, J CLIN MED RES, V3, P40; Owusu P, 2019, INAPHAS 2019 ANN M E; Reiser Diana J, 2004, Crit Care Nurs Clin North Am, V16, P257, DOI 10.1016/j.ccell.2004.02.010; Said N, 2018, ELEV INT J NURS ED P, V1, P40; Schuler C, 2019, J PEDIATR NURS, V45, pE44, DOI 10.1016/j.pedn.2018.12.017; Shrestha S, 2019, SRI LANKA J CHILD HE, V48, P215; Vandborg PK, 2012, PEDIATRICS, V130, P61, DOI 10.1542/peds.2011-2760; WHO, 2022, WHO RECOMMENDATIONS; Yamane T., 1967, PROBLEMS ACCOMPANY S; Yaqub A., 2016, ASSESS KNOWLEDGE MOT, V8, P28	41	2	2	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251846	10.1371/journal.pone.0251846	http://dx.doi.org/10.1371/journal.pone.0251846			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086736	Green Published, gold			2022-12-26	WOS:000664640100022
J	Thomas, BE; Thiruvengadam, K; Vedhachalam, C; Srividya, A; Rao, VG; Vijayachari, P; Rajiv, Y; Raghavi, V; Bansal, AK; Krishna, AKI; Joseph, A; Purty, JA; Hussain, T; Anand, P; Das, P; John, KR; Devi, KR; Sunish, P; Azhagendran, S; Dusthakeer, A; Bhat, J; Chadha, VK; Toteja, GS; Raghunath, D; Das, M; Khan, AM; Kaur, H				Thomas, Beena E.; Thiruvengadam, Kannan; Vedhachalam, Chandrasekaran; Srividya, A.; Rao, V. G.; Vijayachari, Paluru; Rajiv, Yadav; Raghavi, V; Bansal, Avi Kumar; Krishna, Anil Kumar Indira; Joseph, Alex; Purty, Anil J.; Hussain, Tahziba; Anand, Praveen; Das, Pradeep; John, K. R.; Devi, Rekha K.; Sunish, P.; Azhagendran, S.; Dusthakeer, Azger; Bhat, J.; Chadha, Vineet K.; Toteja, G. S.; Raghunath, Dasarathy; Das, Madhuchhanda; Khan, A. M.; Kaur, Hapreet			Prevalence of pulmonary tuberculosis among the tribal populations in India	PLOS ONE			English	Article							MADHYA-PRADESH; TRANSMISSION; MAHARASHTRA; SITUATION; SMOKING; RISK	Importance There is no concrete evidence on the burden of TB among the tribal populations across India except for few studies mainly conducted in Central India with a pooled estimation of 703/100,000 with a high degree of heterogeneity. Objective To estimate the prevalence of TB among the tribal populations in India. Design, participants, setting A survey using a multistage cluster sampling design was conducted between April 2015 and March 2020 covering 88 villages (clusters) from districts with over 70% tribal majority populations in 17 States across 6 zones of India. The sample populations included individuals >= 15 years old. Main outcome and measures Eligible participants who were screened through an interview for symptoms suggestive of pulmonary TB (PTB); Two sputum specimens were examined by smear and culture. Prevalence was estimated after multiple imputations for non-coverage and a correction factor of 1.31 was then applied to account for non-inclusion of X-ray screening. Results A total of 74532 (81.0%) of the 92038 eligible individuals were screened; 2675 (3.6%) were found to have TB symptoms or h/o ATT. The overall prevalence of PTB was 432 per 100,000 populations. The PTB prevalence per 100,000 populations was highest 625 [95% CI: 496-754] in the central zone and least 153 [95% CI: 24-281] in the west zone. Among the 17 states that were covered in this study, Odisha recorded the highest prevalence of 803 [95% CI: 504-1101] and Jammu and Kashmir the lowest 127 [95% CI: 0-310] per 100,000 populations. Findings from multiple logistic regression analysis reflected that those aged 35 years and above, with BMI <18.5 Kgs /m(2), h/o ATT, smoking, and/or consuming alcohol had a higher risk of bacteriologically positive PTB. Weight loss was relatively more important symptom associated with tuberculosis among this tribal populations followed by night sweats, blood in sputum, and fever. Conclusion and relevance The overall prevalence of PTB among tribal groups is higher than the general populations with a wide variation of prevalence of PTB among the tribal groups at zone and state levels. These findings call for strengthening of the TB control efforts in tribal areas to reduce TB prevalence through tribal community/site-specific intervention programs.	[Thomas, Beena E.; Raghavi, V; Azhagendran, S.] ICMR Natl Inst Res TB, Dept Social & Behav Res, Chennai, Tamil Nadu, India; [Thiruvengadam, Kannan; Vedhachalam, Chandrasekaran] ICMR Natl Inst Res TB, Dept Stat, Epidemiol Unit, Chennai, Tamil Nadu, India; [Srividya, A.] ICMR Vector Control Res Ctr, Dept Biostat, Pondicherry, India; [Rao, V. G.; Rajiv, Yadav; Bhat, J.] ICMR Natl Inst Res Tribal Hlth, Div Communicable Dis, Jabalpur, India; [Vijayachari, Paluru; Sunish, P.] ICMR Reg Med Res Ctr, Port Blair, Andaman And Nic, India; [Bansal, Avi Kumar] ICMR Natl JALMA Inst Leprosy & Other Mycobacteria, Dept Epidemiol, Agra, Uttar Pradesh, India; [Krishna, Anil Kumar Indira; Joseph, Alex] SRM Inst Sci & Technol, Sch Publ Hlth, Kattankulathur, Tamil Nadu, India; [Purty, Anil J.] Pondicherry Inst Med Sci, Dept Community Med, Pondicherry, India; [Hussain, Tahziba] ICMR Reg Med Res Ctr, Bhuvaneshwar, India; [Anand, Praveen; Toteja, G. S.] ICMR Desert Med Res Ctr, Dept Epidemiol, Jodhpur, Rajasthan, India; [Das, Pradeep] Rajendra Mem Res Inst Med Sci, Patna, Bihar, India; [John, K. R.] Apollo Inst Med Sci & Res, Dept Community Med, Chittoor, India; [Devi, Rekha K.] ICMR Reg Med Res Ctr, Dibrugarh, Assam, India; [Dusthakeer, Azger] ICMR Natl Inst Res TB, Dept Bacteriol, Chennai, Tamil Nadu, India; [Chadha, Vineet K.] Cent Leprosy Teaching & Training Inst, Chengalpet, India; [Raghunath, Dasarathy] Armed Forces Med Coll, ICMR, Tribal Task Force, Pune, Maharashtra, India; [Das, Madhuchhanda; Khan, A. M.; Kaur, Hapreet] Indian Council Med Res, Div Communicable Dis ECD, New Delhi, India	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tribal Health (NIRTH); Indian Council of Medical Research (ICMR); ICMR - Regional Medical Research Centre, Port Blair (RMRCPB); Indian Council of Medical Research (ICMR); ICMR - National JALMA Institute for Leprosy & Other Mycobacterial Diseases, Agra; SRM Institute of Science & Technology Chennai; Pondicherry Institute of Medical Sciences; Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Armed Forces Medical College; Indian Council of Medical Research (ICMR); Indian Council of Medical Research (ICMR)	Thomas, BE (corresponding author), ICMR Natl Inst Res TB, Dept Social & Behav Res, Chennai, Tamil Nadu, India.	beenaelli09@gmail.com	Thiruvengadam, Kannan/AAQ-8532-2021; Joseph, Alex/U-6957-2019	Thiruvengadam, Kannan/0000-0002-3758-1094; Joseph, Alex/0000-0002-9053-4895; , Jyothi/0000-0001-8788-2250	ICMR (Indian Council of Medical Research) Task Force	ICMR (Indian Council of Medical Research) Task Force	This study was funded by ICMR (Indian Council of Medical Research) Task Force.	[Anonymous], 2017, Wkly Epidemiol Rec, V92, P749; [Anonymous], 2003, Saudi Med J, V24, P1154; Bhat J, 2015, INDIAN J MED RES, V141, P636; Bhat J, 2009, INT J EPIDEMIOL, V38, P1026, DOI 10.1093/ije/dyp222; Bothamley GH, 2005, THORAX, V60, P527, DOI 10.1136/thx.2004.036012; Central TB Division, 2016, TB IND 2016 ANN STAT; Chadha VK., 2019, SUBNATIONAL TB PREVA; Chakma T., 1996, Indian Journal of Tuberculosis, V43, P85; Datta M, 2001, INT J TUBERC LUNG D, V5, P240; Dhanaraj B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124260; Glaziou P, 2008, INT J TUBERC LUNG D, V12, P1003; Government of Indian, 2011, OVERVIEW CENSUS 2011, P1; Huang CC, 2014, INT J TUBERC LUNG D, V18, P1285, DOI 10.5588/ijtld.14.0309; ICMR, 1959, TUB IND SAMPL SURV 1; International Institute for Population Sciences, 2017, INT I POPUL SCI ICF; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; MAYURNATH S, 1984, INDIAN J MED RES, V80, P129; Murhekar MV, 2004, B WORLD HEALTH ORGAN, V82, P836; Narang P, 1999, INT J TUBERC LUNG D, V3, P478; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Neyrolles O, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000199; Purty AJ, 2019, INDIAN J COMMUN MED, V44, P17, DOI 10.4103/ijcm.IJCM_120_18; Rao VG, 2008, TROP MED INT HEALTH, V13, P1372, DOI 10.1111/j.1365-3156.2008.02152.x; Rao VG, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3815-8; Rao VG, 2010, INT J TUBERC LUNG D, V14, P368; Rao VG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043225; Rao VG, 2010, INT J INFECT DIS, V14, pE713, DOI 10.1016/j.ijid.2010.02.2243; Sathiyamoorthy R, 2020, LUNG INDIA, V37, P45, DOI 10.4103/lungindia.lungindia_181_19; Thomas BE, 2015, INDIAN J MED RES, V141, P614; Turner RD, 2015, J INFECT DIS, V211, P1367, DOI 10.1093/infdis/jiu625; Yadav R, 2010, Indian J Tuberc, V57, P114	33	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251519	10.1371/journal.pone.0251519	http://dx.doi.org/10.1371/journal.pone.0251519			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086684	gold, Green Published, Green Accepted			2022-12-26	WOS:000664640100016
J	Pastore, AJ; Teo, RD; Montoya, A; Burg, MJ; Twahir, UT; Bruner, SD; Beratan, DN; Angerhofer, A				Pastore, Anthony J.; Teo, Ruijie D.; Montoya, Alvaro; Burg, Matthew J.; Twahir, Umar T.; Bruner, Steven D.; Beratan, David N.; Angerhofer, Alexander			Oxalate decarboxylase uses electron hole hopping for catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS YVRK; ACTIVE-SITE; SPECIFICITY SWITCH; CALCIUM-OXALATE; CHARGE-TRANSFER; SIGMA-FACTOR; TRYPTOPHAN; MANGANESE; PROTEINS; ACID	The hexameric low-pH stress response enzyme oxalate decarboxylase catalyzes the decarboxylation of the oxalate mono-anion in the soil bacterium Bacillus subtilis. A single protein subunit contains two Mn-binding cupin domains, and catalysis depends on Mn(III) at the N-terminal site. The present study suggests a mechanistic function for the C-terminal Mn as an electron hole donor for the N-terminal Mn. The resulting spatial separation of the radical intermediates directs the chemistry toward decarboxylation of the substrate. A pi-stacked tryptophan pair (W96/W274) links two neighboring protein subunits together, thus reducing the Mn-to-Mn distance from 25.9 angstrom (intrasubunit) to 21.5 angstrom (intersubunit). Here, we used theoretical analysis of electron hole-hopping paths through redox-active sites in the enzyme combined with site-directed mutagenesis and X-ray crystallography to demonstrate that this tryptophan pair supports effective electron hole hopping between the C-terminal Mn of one subunit and the N-terminal Mn of the other subunit through two short hops of similar to 8.5 angstrom. Replacement of W96, W274, or both with phenylalanine led to a large reduction in catalytic efficiency, whereas replacement with tyrosine led to recovery of most of this activity. W96F and W96Y mutants share the wildtype tertiary structure. Two additional hole-hopping networks were identified leading from the Mn ions to the protein surface, potentially protecting the enzyme from high Mn oxidation states during turnover. Our findings strongly suggest that multistep hole-hopping transport between the two Mn ions is required for enzymatic function, adding to the growing examples of proteins that employ aromatic residues as hopping stations.	[Pastore, Anthony J.; Montoya, Alvaro; Burg, Matthew J.; Twahir, Umar T.; Bruner, Steven D.; Angerhofer, Alexander] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Teo, Ruijie D.; Beratan, David N.] Duke Univ, Dept Chem, Durham, NC 27706 USA	State University System of Florida; University of Florida; Duke University	Angerhofer, A (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.; Beratan, DN (corresponding author), Duke Univ, Dept Chem, Durham, NC 27706 USA.	david.beratan@duke.edu; alex@chem.ufl.edu	Pastore, Anthony/GQZ-4544-2022		National Science Foundation [CHE-2002950]; NIH [GM-48043]	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Science Foundation (Grant CHE-2002950 to A. A.) and the NIH (Grant GM-48043 to D. N. B. and R. D. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albert A, 2017, J ENZYM INHIB MED CH, V32, P426, DOI 10.1080/14756366.2016.1256884; Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Angerhofer A., 2017, RCSB PDB 5VG3 STRUCT, DOI [10.2210/pdb5VG3/pdb, DOI 10.2210/PDB5VG3/PDB]; [Anonymous], 2020, PYMOL MOL GRAPHICS S; Barry BA, 2015, BBA-BIOENERGETICS, V1847, P46, DOI 10.1016/j.bbabio.2014.09.003; Beratan DN, 2015, ACCOUNTS CHEM RES, V48, P474, DOI 10.1021/ar500271d; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burg M. J., 2018, STRUCTURE OXALATE DE, DOI [10.1101/426874, DOI 10.1101/426874]; Burrell MR, 2007, BIOCHEMISTRY-US, V46, P12327, DOI 10.1021/bi700947s; Byrdin M, 2003, P NATL ACAD SCI USA, V100, P8676, DOI 10.1073/pnas.1531645100; Campomanes P, 2014, J AM CHEM SOC, V136, P2313, DOI 10.1021/ja408138f; Capobianco A, 2015, J PHYS CHEM B, V119, P5462, DOI 10.1021/acs.jpcb.5b02940; Chang CH, 2004, J BIOL CHEM, V279, P52840, DOI 10.1074/jbc.M402345200; Conter C, 2019, IUBMB LIFE, V71, P917, DOI 10.1002/iub.2027; Cowley AB, 2010, INT J TOXICOL, V29, P20, DOI 10.1177/1091581809353611; Davidson VL, 2012, BBA-PROTEINS PROTEOM, V1824, P1299, DOI 10.1016/j.bbapap.2012.01.008; Dempsey JL, 2010, CHEM REV, V110, P7024, DOI 10.1021/cr100182b; DUNNING TH, 1971, J CHEM PHYS, V55, P716, DOI 10.1063/1.1676139; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; EMILIANI E, 1968, BIOCHIM BIOPHYS ACTA, V167, P414, DOI 10.1016/0005-2744(68)90221-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ener ME, 2017, BIOCHEMISTRY-US, V56, P3531, DOI 10.1021/acs.biochem.7b00432; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Glover SD, 2018, J AM CHEM SOC, V140, P185, DOI 10.1021/jacs.7b08032; Gray HB, 2018, ACCOUNTS CHEM RES, V51, P1850, DOI 10.1021/acs.accounts.8b00245; Gray HB, 2015, P NATL ACAD SCI USA, V112, P10920, DOI 10.1073/pnas.1512704112; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; HAGLER L, 1973, AM J CLIN NUTR, V26, P758; HAGLER L, 1973, AM J CLIN NUTR, V26, P882, DOI 10.1093/ajcn/26.8.882; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Ichiye T, 2013, ENCY BIOPHYSICS, P614; JAKOBY WB, 1956, J BIOL CHEM, V222, P435; Jiang N, 2013, J PHYS CHEM B, V117, P9129, DOI 10.1021/jp401551t; JOHNSON DA, 1995, INORG CHEM, V34, P5666, DOI 10.1021/ic00126a041; Junge W, 2019, Q REV BIOPHYS, V52, DOI 10.1017/S0033583518000112; Just VJ, 2007, BIOCHEM J, V407, P397, DOI 10.1042/BJ20070708; Just VJ, 2004, J BIOL CHEM, V279, P19867, DOI 10.1074/jbc.M313820200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kozlov YN, 2004, PHYS CHEM CHEM PHYS, V6, P4905, DOI 10.1039/b406569g; Kumar V, 2019, PHYTOCHEMISTRY, V158, P103, DOI 10.1016/j.phytochem.2018.10.029; Lubitz W, 2019, PHOTOSYNTH RES, V142, P105, DOI 10.1007/s11120-019-00648-3; MacLellan SR, 2008, MOL MICROBIOL, V69, P954, DOI 10.1111/j.1365-2958.2008.06331.x; MacLellan SR, 2009, J BACTERIOL, V191, P931, DOI 10.1128/JB.01435-08; Mahmoudi L, 2016, BIOCHEMISTRY-US, V55, P2849, DOI 10.1021/acs.biochem.6b00019; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEHTA A, 1991, J BIOL CHEM, V266, P23548; Melin F, 2020, CHEM REV, V120, P10244, DOI 10.1021/acs.chemrev.0c00249; Migliore A, 2014, CHEM REV, V114, P3381, DOI 10.1021/cr4006654; Moghadam SA, 2020, BIOSYSTEMS, V195, DOI 10.1016/j.biosystems.2020.104148; Moomaw EW, 2009, BIOCHEMISTRY-US, V48, P6116, DOI 10.1021/bi801856k; Neese F, 2020, J CHEM PHYS, V152, DOI 10.1063/5.0004608; Neese F, 2018, WIRES COMPUT MOL SCI, V8, DOI 10.1002/wcms.1327; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; ONUCHIC JN, 1992, ANNU REV BIOPH BIOM, V21, P349, DOI 10.1146/annurev.biophys.21.1.349; Paul E, 2018, MICROBIOL RES, V215, P65, DOI 10.1016/j.micres.2018.06.009; Polizzi NF, 2015, P NATL ACAD SCI USA, V112, P10821, DOI 10.1073/pnas.1513520112; Qi ZQ, 2017, PLANT SCI, V265, P51, DOI 10.1016/j.plantsci.2017.09.014; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Reinhardt LA, 2003, J AM CHEM SOC, V125, P1244, DOI 10.1021/ja0286977; Rosso KM, 2004, J PHYS CHEM A, V108, P5242, DOI 10.1021/jp037470a; Roy A, 2018, J PHYS CHEM B, V122, P3723, DOI 10.1021/acs.jpcb.7b11762; Ru XY, 2019, J PHYS CHEM B, V123, P5035, DOI 10.1021/acs.jpcb.9b01086; SAITO I, 1995, J AM CHEM SOC, V117, P6406, DOI 10.1021/ja00128a050; Saylor BT, 2012, BIOCHEMISTRY-US, V51, P2911, DOI 10.1021/bi300001q; Shen YH, 2008, J MICROBIOL BIOTECHN, V18, P1245; Sjode A, 2008, ENZYME MICROB TECH, V43, P78, DOI 10.1016/j.enzmictec.2007.11.014; Strobel BW, 2001, GEODERMA, V99, P169, DOI 10.1016/S0016-7061(00)00102-6; Svedruzic D, 2007, ARCH BIOCHEM BIOPHYS, V464, P36, DOI 10.1016/j.abb.2007.03.016; Tabares LC, 2009, J PHYS CHEM B, V113, P9016, DOI 10.1021/jp9021807; Tanner A, 2000, J BACTERIOL, V182, P5271, DOI 10.1128/JB.182.18.5271-5273.2000; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; Teo RD, 2019, PHYS CHEM CHEM PHYS, V21, P22869, DOI 10.1039/c9cp04805g; Teo RD, 2018, PHYS CHEM CHEM PHYS, V20, P26063, DOI 10.1039/c8cp04816a; Twahir UT, 2016, BIOCHEMISTRY-US, V55, P6505, DOI 10.1021/acs.biochem.6b00891; Twahir UT, 2015, FREE RADICAL BIO MED, V80, P59, DOI 10.1016/j.freeradbiomed.2014.12.012; Uren NC, 2018, SOIL RES, V56, P443, DOI 10.1071/SR17244; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winestrand S, 2012, J CHEM TECHNOL BIOT, V87, P1600, DOI 10.1002/jctb.3801; Winkler JR, 2015, Q REV BIOPHYS, V48, P411, DOI 10.1017/S0033583515000062; Winkler JR, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0178; Winkler JR, 2014, CHEM REV, V114, P3369, DOI 10.1021/cr4004715; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Zanetti-Polzi L, 2019, J PHYS CHEM LETT, V10, P1450, DOI 10.1021/acs.jpclett.9b00403; Zhao CM, 2018, UROLOGY, V113, DOI 10.1016/j.urology.2017.11.038; Zhu W, 2018, BIOCHEMISTRY-US, V57, P3425, DOI 10.1021/acs.biochem.8b00214; Zhu W, 2017, ESSAYS BIOCHEM, V61, P259, DOI 10.1042/EBC20160070; Zhu W, 2016, BIOCHEMISTRY-US, V55, P2163, DOI 10.1021/acs.biochem.6b00043; Zhu W, 2016, BIOCHEMISTRY-US, V55, P429, DOI 10.1021/acs.biochem.5b01340	97	3	3	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100857	10.1016/j.jbc.2021.100857	http://dx.doi.org/10.1016/j.jbc.2021.100857			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097877	Green Published, gold			2022-12-26	WOS:000678068400057
J	Kaya, M; Stein, F; Rouwkema, J; Khalil, ISM; Misra, S				Kaya, Mert; Stein, Fabian; Rouwkema, Jeroen; Khalil, Islam S. M.; Misra, Sarthak			Serial imaging of micro-agents and cancer cell spheroids in a microfluidic channel using multicolor fluorescence microscopy	PLOS ONE			English	Article							VISIBILITY	Multicolor fluorescence microscopy is a powerful technique to fully visualize many biological phenomena by acquiring images from different spectrum channels. This study expands the scope of multicolor fluorescence microscopy by serial imaging of polystyrene micro-beads as surrogates for drug carriers, cancer spheroids formed using HeLa cells, and microfluidic channels. Three fluorophores with different spectral characteristics are utilized to perform multicolor microscopy. According to the spectrum analysis of the fluorophores, a multicolor widefield fluorescence microscope is developed. Spectral crosstalk is corrected by exciting the fluorophores in a round-robin manner and synchronous emitted light collection. To report the performance of the multicolor microscopy, a simplified 3D tumor model is created by placing beads and spheroids inside a channel filled with the cell culture medium is imaged at varying exposure times. As a representative case and a method for bio-hybrid drug carrier fabrication, a spheroid surface is coated with beads in a channel utilizing electrostatic forces under the guidance of multicolor microscopy. Our experiments show that multicolor fluorescence microscopy enables crosstalk-free and spectrally-different individual image acquisition of beads, spheroids, and channels with the minimum exposure time of 5.5 ms. The imaging technique has the potential to monitor drug carrier transportation to cancer cells in real-time.	[Kaya, Mert; Misra, Sarthak] Univ Twente, Surg Robot Lab, Dept Biomech Engn, Enschede, Netherlands; [Kaya, Mert; Khalil, Islam S. M.; Misra, Sarthak] Univ Groningen, Dept Biomed Engn, Surg Robot Lab, Groningen, Netherlands; [Stein, Fabian; Rouwkema, Jeroen] Univ Groningen, Univ Med Ctr Groningen, Groningen, Netherlands; [Stein, Fabian; Rouwkema, Jeroen] Univ Twente, Dept Biomech Engn, Vascularizat Lab, Enschede, Netherlands	University of Twente; University of Groningen; University of Groningen; University of Twente	Kaya, M (corresponding author), Univ Twente, Surg Robot Lab, Dept Biomech Engn, Enschede, Netherlands.; Kaya, M (corresponding author), Univ Groningen, Dept Biomed Engn, Surg Robot Lab, Groningen, Netherlands.	m.kaya@utwente.nl	Rouwkema, Jeroen/H-8440-2019	Rouwkema, Jeroen/0000-0001-9666-9064	European Research Council under the European Union's Horizon 2020 Research and Innovation programme [638428]	European Research Council under the European Union's Horizon 2020 Research and Innovation programme(European Research Council (ERC))	This work was supported by the European Research Council under the European Union's Horizon 2020 Research and Innovation programme under Grant 638428-project ROBOTAR: Robot-Assisted Flexible Needle Steering for Targeted Delivery of Magnetic Agents - European Research Council (ERC) Starting Grant.	Abdeladim L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09552-9; Abrahamsson S, 2013, NAT METHODS, V10, P60, DOI [10.1038/NMETH.2277, 10.1038/nmeth.2277]; Aguilar-Avelar C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50241-w; Ahn J, 2018, ADV DRUG DELIVER REV, V128, P29, DOI 10.1016/j.addr.2018.04.001; Alapan Y, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aar4423; Avci O, 2017, OPTICA, V4, P247, DOI 10.1364/OPTICA.4.000247; Aydogan F, 2016, TURK J SURG, V32, P50, DOI 10.5152/UCD.2015.2832; Bates M, 2012, CHEMPHYSCHEM, V13, P99, DOI 10.1002/cphc.201100735; Bernas T, 2004, J MICROSC-OXFORD, V215, P281, DOI 10.1111/j.0022-2720.2004.01377.x; Doronina-Amitonova LV, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4767386; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Jung BS, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2013.2278674; Larson DR, 2003, SCIENCE, V300, P1434, DOI 10.1126/science.1083780; Li JY, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aat8829; Li KC, 2016, BIOMED OPT EXPRESS, V7, P4803, DOI 10.1364/BOE.7.004803; Li QL, 2016, ANAL CHEM, V88, P8610, DOI 10.1021/acs.analchem.6b01775; Licea-Rodriguez J, 2019, J BIOMED OPT, V24, DOI 10.1117/1.JBO.24.1.016501; Lucas B. D., ITERATIVE IMAGE REGI; Magdanz V, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba5855; Mudanyali O, 2013, NAT PHOTONICS, V7, P247, DOI [10.1038/nphoton.2012.337, 10.1038/NPHOTON.2012.337]; Nelson BJ, 2010, ANNU REV BIOMED ENG, V12, P55, DOI 10.1146/annurev-bioeng-010510-103409; Pane S, 2019, ADV MATER TECHNOL-US, V4, DOI 10.1002/admt.201800575; Park KS, 2016, BIOMED OPT EXPRESS, V7, P2285, DOI 10.1364/BOE.7.002285; Park S, 2014, SENSORS-BASEL, V14, P19660, DOI 10.3390/s141019660; Pouponneau P, 2014, ANN BIOMED ENG, V42, P929, DOI 10.1007/s10439-014-0972-1; Rakhymzhan A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07165-0; Reits EAJ, 2001, NAT CELL BIOL, V3, pE145, DOI 10.1038/35078615; Rivron NC, 2012, P NATL ACAD SCI USA, V109, P6886, DOI 10.1073/pnas.1201626109; Rosenholm JM, 2010, NANOSCALE, V2, P1870, DOI 10.1039/c0nr00156b; Ruhi MK, 2018, PHOTODIAGN PHOTODYN, V21, P334, DOI 10.1016/j.pdpdt.2018.01.008; Servant A, 2015, ADV MATER, V27, P2981, DOI 10.1002/adma.201404444; Srivastava SK, 2016, ADV MATER, V28, P832, DOI 10.1002/adma.201504327; Stringari C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03359-8; Sung YL, 2017, BIOMED OPT EXPRESS, V8, P5075, DOI 10.1364/BOE.8.005075; Tristan-Landin SB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215114; Verkhovskii RA, 2021, BIOMED OPT EXPRESS, V12, P380, DOI 10.1364/BOE.413845; Wang K, 2012, BIOMED OPT EXPRESS, V3, P1972, DOI 10.1364/BOE.3.001972; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Webb SED, 2012, BIOMED OPT EXPRESS, V3, P400, DOI 10.1364/BOE.3.000400; Wu JG, 2012, LAB CHIP, V12, P3566, DOI 10.1039/c2lc40517b; Xia YN, 1998, ANNU REV MATER SCI, V28, P153, DOI 10.1146/annurev.matsci.28.1.153; Xu HF, 2018, ACS NANO, V12, P327, DOI 10.1021/acsnano.7b06398; Yan XH, 2019, APPL MATER TODAY, V15, P242, DOI 10.1016/j.apmt.2019.02.006; Yang CY, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.8.086012; Yang LB, 2018, IEEE INT SYMP CIRC S, DOI 10.1109/ISCAS.2018.8351297; Zhou X, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.9.096009; Zimmermann T, 2003, FEBS LETT, V546, P87, DOI 10.1016/S0014-5793(03)00521-0	47	1	1	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253222	10.1371/journal.pone.0253222	http://dx.doi.org/10.1371/journal.pone.0253222			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129617	gold, Green Published			2022-12-26	WOS:000665475100034
J	Launonen, KM; Paakinaho, V; Sigismondo, G; Malinen, M; Sironen, R; Hartikainen, JM; Laakso, H; Visakorpi, T; Krijgsveld, J; Niskanen, EA; Palvimo, JJ				Launonen, Kaisa-Mari; Paakinaho, Ville; Sigismondo, Gianluca; Malinen, Marjo; Sironen, Reijo; Hartikainen, Jaana M.; Laakso, Hanna; Visakorpi, Tapio; Krijgsveld, Jeroen; Niskanen, Einari A.; Palvimo, Jorma J.			Chromatin-directed proteomics-identified network of endogenous androgen receptor in prostate cancer cells	ONCOGENE			English	Article							TRANSCRIPTION FACTOR SIM2; RESPONSE ELEMENT; LUNG-CANCER; GENE; COREGULATOR; METASTASIS; THERAPY; INHIBITION; EXPRESSION; PHENOTYPE	Treatment of prostate cancer confronts resistance to androgen receptor (AR)-targeted therapies. AR-associated coregulators and chromatin proteins hold a great potential for novel therapy targets. Here, we employed a powerful chromatin-directed proteomics approach termed ChIP-SICAP to uncover the composition of chromatin protein network, the chromatome, around endogenous AR in castration resistant prostate cancer (CRPC) cells. In addition to several expected AR coregulators, the chromatome contained many nuclear proteins not previously associated with the AR. In the context of androgen signaling in CRPC cells, we further investigated the role of a known AR-associated protein, a chromatin remodeler SMARCA4 and that of SIM2, a transcription factor without a previous association with AR. To understand their role in chromatin accessibility and AR target gene expression, we integrated data from ChIP-seq, RNA-seq, ATAC-seq and functional experiments. Despite the wide co-occurrence of SMARCA4 and AR on chromatin, depletion of SMARCA4 influenced chromatin accessibility and expression of a restricted set of AR target genes, especially those involved in cell morphogenetic changes in epithelial-mesenchymal transition. The depletion also inhibited the CRPC cell growth, validating SMARCA4's functional role in CRPC cells. Although silencing of SIM2 reduced chromatin accessibility similarly, it affected the expression of a much larger group of androgen-regulated genes, including those involved in cellular responses to external stimuli and steroid hormone stimulus. The silencing also reduced proliferation of CRPC cells and tumor size in chick embryo chorioallantoic membrane assay, further emphasizing the importance of SIM2 in CRPC cells and pointing to the functional relevance of this potential prostate cancer biomarker in CRPC cells. Overall, the chromatome of AR identified in this work is an important resource for the field focusing on this important drug target.	[Launonen, Kaisa-Mari; Paakinaho, Ville; Laakso, Hanna; Niskanen, Einari A.; Palvimo, Jorma J.] Univ Eastern Finland, Fac Hlth Sci, Inst Biomed, Kuopio, Finland; [Sigismondo, Gianluca; Krijgsveld, Jeroen] German Canc Res Ctr, Heidelberg, Germany; [Malinen, Marjo] Univ Eastern Finland, Dept Environm & Biol Sci, Joensuu, Finland; [Sironen, Reijo; Hartikainen, Jaana M.] Univ Eastern Finland, Inst Clin Med Clin Pathol & Forens Med, Kuopio, Finland; [Sironen, Reijo] Kuopio Univ Hosp, Dept Clin Pathol, Kuopio, Finland; [Visakorpi, Tapio] Tampere Univ, Fac Med & Hlth Technol, Tampere, Finland; [Visakorpi, Tapio] Tampere Univ Hosp, Tays Canc Ctr, Tampere, Finland; [Visakorpi, Tapio] Fimlab Labs, Tampere, Finland; [Krijgsveld, Jeroen] Heidelberg Univ, Fac Med, Heidelberg, Germany	University of Eastern Finland; Helmholtz Association; German Cancer Research Center (DKFZ); University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Tampere University; Tampere University; Tampere University Hospital; Ruprecht Karls University Heidelberg	Palvimo, JJ (corresponding author), Univ Eastern Finland, Fac Hlth Sci, Inst Biomed, Kuopio, Finland.	jorma.palvimo@uef.fi	Niskanen, Einari/F-2883-2017; Hartikainen, Jaana/E-6256-2015	Niskanen, Einari/0000-0001-9471-7026; Paakinaho, Ville/0000-0003-4204-1436; Hartikainen, Jaana/0000-0001-8267-1905; Launonen, Kaisa-Mari/0000-0003-2770-0464; Palvimo, Jorma/0000-0003-2373-0578	Excellence Cluster CellNetworks [EXC81]; UEF DPMM; Academy of Finland; Sigrid Juselius Foundation; Cancer Foundation Finland; Paavo Koistinen Foundation; University of Eastern Finland (UEF); Kuopio University Hospital	Excellence Cluster CellNetworks; UEF DPMM; Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Foundation Finland; Paavo Koistinen Foundation; University of Eastern Finland (UEF); Kuopio University Hospital	G.S. and J.K. acknowledge the Excellence Cluster CellNetworks (EXC81). This paper was supported by UEF DPMM, Academy of Finland, Sigrid Juselius Foundation, Cancer Foundation Finland, and Paavo Koistinen Foundation. Open access funding provided by University of Eastern Finland (UEF) including Kuopio University Hospital.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Agoulnik IU, 2009, STEROIDS, V74, P669, DOI 10.1016/j.steroids.2009.02.007; Ailiken G, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0205-4; Aleman MJ, 2005, P NATL ACAD SCI USA, V102, P12765, DOI 10.1073/pnas.0505484102; Annala M, 2015, ONCOTARGET, V6, P6235, DOI 10.18632/oncotarget.3359; Arredouani MS, 2009, CLIN CANCER RES, V15, P5794, DOI 10.1158/1078-0432.CCR-09-0911; Centenera MM, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a030478; Cyrta J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19328-1; DAHMANE N, 1995, P NATL ACAD SCI USA, V92, P9191, DOI 10.1073/pnas.92.20.9191; DeYoung MP, 2003, CANCER LETT, V200, P25, DOI 10.1016/S0304-3835(03)00409-9; DeYoung MP, 2003, P NATL ACAD SCI USA, V100, P4760, DOI 10.1073/pnas.0831000100; Ding YF, 2019, J CLIN INVEST, V129, P759, DOI 10.1172/JCI123557; Fine SW, 2018, MODERN PATHOL, V31, pS122, DOI 10.1038/modpathol.2017.164; Giles KA, 2021, CLIN EPIGENETICS, V13, DOI 10.1186/s13148-021-01023-7; Halvorsen OJ, 2007, CLIN CANCER RES, V13, P892, DOI 10.1158/1078-0432.CCR-06-1207; Hankey W, 2020, CANCER RES, V80, P2427, DOI 10.1158/0008-5472.CAN-19-3447; Heemers HV, 2007, ENDOCR REV, V28, P778, DOI 10.1210/er.2007-0019; Heemers HV, 2009, MOL ENDOCRINOL, V23, P572, DOI 10.1210/me.2008-0363; Hu J, 2020, ARCH PATHOL LAB MED, V144, P320, DOI 10.5858/arpa.2019-0434-RA; Huang Y, 2010, CANCER BIOL THER, V9, P204, DOI 10.4161/cbt.9.3.10960; Karvonen U, 1997, J BIOL CHEM, V272, P15973, DOI 10.1074/jbc.272.25.15973; Kron KJ, 2017, NAT GENET, V49, P1336, DOI 10.1038/ng.3930; Kwak HI, 2007, CARCINOGENESIS, V28, P259, DOI 10.1093/carcin/bgl122; Labrecque MP, 2019, J CLIN INVEST, V129, P4492, DOI 10.1172/JCI128212; Lambert JP, 2014, J PROTEOMICS, V100, P55, DOI 10.1016/j.jprot.2013.12.022; Lambert JP, 2012, PROTEOMICS, V12, P1609, DOI 10.1002/pmic.201100547; Lazar JE, 2020, CELL REP, V31, DOI [10.1015/j.celrep.2020.107788, 10.1016/j.celrep.2020.107788]; Lempiainen JK, 2017, MOL CELL PROTEOMICS, V16, P1462, DOI 10.1074/mcp.M117.067488; Lu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028837; Lv DJ, 2019, THERANOSTICS, V9, P5166, DOI 10.7150/thno.33972; Matsubara D, 2013, CANCER SCI, V104, P266, DOI 10.1111/cas.12065; Metz RP, 2006, J BIOL CHEM, V281, P10839, DOI 10.1074/jbc.M508858200; Morris SA, 2014, NAT STRUCT MOL BIOL, V21, P73, DOI 10.1038/nsmb.2718; Muthuswami R, 2019, J CELL PHYSL; O'Rourke DJ, 2012, CLIN CHIM ACTA, V413, P561, DOI 10.1016/j.cca.2011.11.027; Paakinaho V, 2019, CELL REP, V28, P3523, DOI 10.1016/j.celrep.2019.08.039; Paakinaho V, 2014, NUCLEIC ACIDS RES, V42, P1575, DOI 10.1093/nar/gkt1033; Paltoglou S, 2017, CANCER RES, V77, P3417, DOI 10.1158/0008-5472.CAN-16-1616; Pearson SJ, 2019, ONCOGENE, V38, P2611, DOI 10.1038/s41388-018-0622-4; Pomerantz MM, 2015, NAT GENET, V47, P1346, DOI 10.1038/ng.3419; Qin Q, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1934-6; Rachidi M, 2005, INT J DEV NEUROSCI, V23, P475, DOI 10.1016/j.ijdevneu.2005.05.004; Rafiee MR, 2020, MOL SYST BIOL, V16, DOI 10.15252/msb.20199370; Rafiee MR, 2016, MOL CELL, V64, P624, DOI 10.1016/j.molcel.2016.09.019; Rajaram P, 2020, MOLECULES, V25, DOI 10.3390/molecules25102448; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Roesley SNA, 2018, CELL CYCLE, V17, P1559, DOI 10.1080/15384101.2018.1493414; Roy N, 2015, GENE DEV, V29, P658, DOI 10.1101/gad.256628.114; Sahu B, 2011, EMBO J, V30, P3962, DOI 10.1038/emboj.2011.328; Sandoval GJ, 2018, MOL CELL, V71, P554, DOI 10.1016/j.molcel.2018.06.040; Schick S, 2019, NAT GENET, V51, P1399, DOI 10.1038/s41588-019-0477-9; Sharma A, 2017, MOL ONCOL, V11, P655, DOI 10.1002/1878-0261.12059; Sharma NL, 2014, NUCLEIC ACIDS RES, V42, P6256, DOI 10.1093/nar/gku281; Stelloo S, 2018, ONCOGENE, V37, P313, DOI 10.1038/onc.2017.330; Swinstead EE, 2016, BIOESSAYS, V38, P1150, DOI 10.1002/bies.201600137; Toropainen S, 2015, NUCLEIC ACIDS RES, V43, P848, DOI 10.1093/nar/gku1375; Wang GC, 2018, GENE DEV, V32, P1105, DOI 10.1101/gad.315739.118; Wong YNS, 2014, NAT REV CLIN ONCOL, V11, P365, DOI 10.1038/nrclinonc.2014.72; Woods SL, 2002, J BIOL CHEM, V277, P10236, DOI 10.1074/jbc.M110752200; Woods S, 2008, NUCLEIC ACIDS RES, V36, P3716, DOI 10.1093/nar/gkn247; Wu DL, 2017, CURR OPIN STRUC BIOL, V43, P1, DOI 10.1016/j.sbi.2016.09.011; Xu LY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221051; Yang YY, 2019, BBA-GENE REGUL MECH, V1862, P834, DOI 10.1016/j.bbagrm.2019.05.005; Yu ZY, 2014, CLIN CANCER RES, V20, P1590, DOI 10.1158/1078-0432.CCR-13-1863; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; Zhou Z, 2015, ONCOTARGETS THER, V8, P3603, DOI 10.2147/OTT.S95500	67	9	9	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2021	40	27					4567	4579		10.1038/s41388-021-01887-2	http://dx.doi.org/10.1038/s41388-021-01887-2		JUN 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TG4PV	34127815	hybrid, Green Published			2022-12-26	WOS:000661408100003
J	Lee, J; Bartholmai, B; Peikert, T; Chun, J; Kim, H; Kim, JS; Park, SY				Lee, Juyoung; Bartholmai, Brian; Peikert, Tobias; Chun, Jaehee; Kim, Hojin; Kim, Jin Sung; Park, Seong Yong			Evaluation of Computer-Aided Nodule Assessment and Risk Yield (CANARY) in Korean patients for prediction of invasiveness of ground-glass opacity nodule	PLOS ONE			English	Article							CORRELATION-COEFFICIENT MCC; LUNG ADENOCARCINOMAS; CLASSIFICATION; STRATIFICATION; PERFORMANCE	Differentiating the invasiveness of ground-glass nodules (GGN) is clinically important, and several institutions have attempted to develop their own solutions by using computed tomography images. The purpose of this study is to evaluate Computer-Aided Analysis of Risk Yield (CANARY), a validated virtual biopsy and risk-stratification machine-learning tool for lung adenocarcinomas, in a Korean patient population. To this end, a total of 380 GGNs from 360 patients who underwent pulmonary resection in a single institution were reviewed. Based on the Score Indicative of Lung Cancer Aggression (SILA), a quantitative indicator of CANARY analysis results, all of the GGNs were classified as "indolent" (atypical adenomatous hyperplasia, adenocarcinomas in situ, or minimally invasive adenocarcinoma) or "invasive" (invasive adenocarcinoma) and compared with the pathology reports. By considering the possibility of uneven class distribution, statistical analysis was performed on the 1) entire cohort and 2) randomly extracted six sets of class-balanced samples. For each trial, the optimal cutoff SILA was obtained from the receiver operating characteristic curve. The classification results were evaluated using several binary classification metrics. Of a total of 380 GGNs, the mean SILA for 65 (17.1%) indolent and 315 (82.9%) invasive lesions were 0.195 +/- 0.124 and 0.391 +/- 0.208 (p < 0.0001). The area under the curve (AUC) of each trial was 0.814 and 0.809, with an optimal threshold SILA of 0.229 for both. The macro F1-score and geometric mean were found to be 0.675 and 0.745 for the entire cohort, while both scored 0.741 in the class-equalized dataset. From these results, CANARY could be confirmed acceptable in classifying GGN for Korean patients after the cutoff SILA was calibrated. We found that adjusting the cutoff SILA is needed to use CANARY in other countries or races, and geometric mean could be more objective than F1-score or AUC in the binary classification of imbalanced data.	[Lee, Juyoung; Chun, Jaehee; Kim, Hojin; Kim, Jin Sung] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea; [Lee, Juyoung] Yonsei Univ, Coll Med, Major Digital Healthcare, Dept Integrat Med, Seoul, South Korea; [Bartholmai, Brian] Mayo Clin, Dept Radiol, Rochester, MN USA; [Peikert, Tobias] Mayo Clin, Dept Med, Div Pulm & Crit Care Med, Rochester, MN USA; [Park, Seong Yong] Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Mayo Clinic; Mayo Clinic; Yonsei University; Yonsei University Health System	Kim, JS (corresponding author), Yonsei Univ, Coll Med, Yonsei Canc Ctr, Dept Radiat Oncol, Seoul, South Korea.; Park, SY (corresponding author), Yonsei Univ, Coll Med, Dept Thorac & Cardiovasc Surg, Seoul, South Korea.	jinsung@yuhs.ac; syparkcs@yuhs.ac	Kim, Hojin/AAS-2315-2021	Kim, Hojin/0000-0002-4652-8682; Park, Seong Yong/0000-0002-5180-3853; Lee, Juyoung/0000-0001-5371-3707; Kim, Jin Sung/0000-0003-1415-6471	Korea Medical Device Development Fund - Korea government (Ministry of Science and ICT) [202012E01-03]; Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy) [202012E01-03]; Korea Medical Device Development Fund - Korea government ( Ministry of Health & Welfare, Republic of Korea) [202012E01-03]; Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety) [202012E01-03]; Yonsei University College of Medicine [6-2019-0095]	Korea Medical Device Development Fund - Korea government (Ministry of Science and ICT)(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Medical Device Development Fund - Korea government (Ministry of Trade, Industry and Energy); Korea Medical Device Development Fund - Korea government ( Ministry of Health & Welfare, Republic of Korea); Korea Medical Device Development Fund - Korea government (Ministry of Food and Drug Safety); Yonsei University College of Medicine(General Electric)	This work was supported by the Korea Medical Device Development Fund grant funded by the Korea government (https://www.kmdf.org/, the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health & Welfare, Republic of Korea, the Ministry of Food and Drug Safety) (Project Number: 202012E01-03) and the faculty research grant of Yonsei University College of Medicine (https://medicine.yonsei.ac.kr/medicine/index.do, 6-2019-0095). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Asch VV, 2013, MACRO AND MICROAVERA; Chicco D, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-019-6413-7; Clay R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17659-6; Gianfrancesco MA, 2018, JAMA INTERN MED, V178, P1544, DOI 10.1001/jamainternmed.2018.3763; Gomathi S, 2022, WORLD J ENG, V19, P21, DOI 10.1108/WJE-09-2020-0450; Gu Q., EVALUATION MEASURES; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; Kubat M, 1998, MACH LEARN, V30, P195, DOI 10.1023/A:1007452223027; Luque A, 2019, PATTERN RECOGN, V91, P216, DOI 10.1016/j.patcog.2019.02.023; Maldonado F, 2015, AM J RESP CRIT CARE, V192, P737, DOI 10.1164/rccm.201503-0443OC; Maldonado F, 2013, J THORAC ONCOL, V8, P452, DOI 10.1097/JTO.0b013e3182843721; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Nakajima EC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198118; Nemec U, 2018, EUR RADIOL, V28, P235, DOI 10.1007/s00330-017-4937-2; Popejoy AB, 2016, NATURE, V538, P161, DOI 10.1038/538161a; Raghunath S, 2014, J THORAC ONCOL, V9, P1698, DOI 10.1097/JTO.0000000000000319; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Siegel Rebecca L, 2019, CA Cancer J Clin, V69, P7, DOI 10.3322/caac.21551; Sokolova M., LECT NOTES COMPUT SC; TAGUESUTCLIFFE J, 1992, INFORM PROCESS MANAG, V28, P467, DOI 10.1016/0306-4573(92)90005-K; Thilakarathne N., 2020, ROLE INTERNET THINGS, V10, P145, DOI 10.31033/ijemr.10.4.22; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Varghese C, 2019, J THORAC ONCOL, V14, P1419, DOI 10.1016/j.jtho.2019.04.022; Ye T, 2019, J THORAC ONCOL, V14, P617, DOI 10.1016/j.jtho.2018.12.030; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang J, 2013, J THORAC ONCOL, V8, P1196, DOI 10.1097/JTO.0b013e31829f09a7; Zhu QM, 2020, PATTERN RECOGN LETT, V136, P71, DOI 10.1016/j.patrec.2020.03.030	28	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0253204	10.1371/journal.pone.0253204	http://dx.doi.org/10.1371/journal.pone.0253204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125856	gold, Green Published			2022-12-26	WOS:000664643500028
J	Yoshikawa, K; Ishida, M; Yanai, H; Tsuta, K; Sekimoto, M; Sugie, T				Yoshikawa, Katsuhiro; Ishida, Mitsuaki; Yanai, Hirotsugu; Tsuta, Koji; Sekimoto, Mitsugu; Sugie, Tomoharu			Immunohistochemical analysis of CD155 expression in triple-negative breast cancer patients	PLOS ONE			English	Article							PROGNOSTIC VALUE; OVEREXPRESSION; POLIOVIRUS; RECEPTOR	Introduction CD155 is an immune checkpoint protein. Its overexpression is an indicator of poor prognosis in some types of cancer. However, the significance of CD155 expression in patients with triple-negative breast cancer, and the relationship between CD155 and programmed death-ligand 1 (PD-L1) expression, have not yet been analyzed in detail. Methods Using immunohistochemical staining and tissue microarrays, we analyzed the expression profiles of CD155 and PD-L1 in 61 patients with triple-negative breast cancer. Relapse-free survival and overall survival rates were compared according to CD155 expression. The correlation between CD155 expression and clinicopathological factors, including PD-L1 expression (using SP142 and 73-10 assays), was also examined. Results CD155 expression was noted in 25 patients (41.0%) in this cohort. CD155 expression did not correlate with pathological stage, histological grade, Ki-67 labeling index, or stromal tumor-infiltrating lymphocytes. Only PD-L1 expression in tumor cells by SP142 assay significantly correlated with CD155 expression (p = 0.035); however, PD-L1 expression in tumor cells by 73-10 assay did not show a correlation (p = 0.115). Using the 73-10 assay, 59% of patients showed CD155 and/or PD-L1 expression in tumor cells. Moreover, using the SP142 assay, 63.3% of patients showed CD155 and/or PD-L1 expression in immune cells. CD155 expression did not correlate with either relapse-free survival or overall survival (p = 0.485 and 0.843, respectively). Conclusions CD155 may be a novel target for antitumor immunotherapy. The results of this study indicate that CD155 may expand the pool of candidates with triple-negative breast cancer who could benefit from antitumor immunotherapy.	[Yoshikawa, Katsuhiro; Ishida, Mitsuaki; Tsuta, Koji] Kansai Med Univ, Dept Pathol & Clin Lab, Osaka, Japan; [Yoshikawa, Katsuhiro; Yanai, Hirotsugu; Sekimoto, Mitsugu; Sugie, Tomoharu] Kansai Med Univ, Dept Surg, Osaka, Japan	Kansai Medical University; Kansai Medical University	Ishida, M (corresponding author), Kansai Med Univ, Dept Pathol & Clin Lab, Osaka, Japan.	ishidamt@hirakata.kmu.ac.jp			Kansai Medical University	Kansai Medical University	This study was partially supported by a research grant D2 from Kansai Medical University (awarded to K.Y.). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bowers JR, 2017, VIRUS RES, V242, P1, DOI 10.1016/j.virusres.2017.09.001; Brlic PK, 2019, CELL MOL IMMUNOL, V16, P40, DOI 10.1038/s41423-018-0168-y; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Denkert C, 2018, LANCET ONCOL, V19, P40, DOI 10.1016/S1470-2045(17)30904-X; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Duan XG, 2019, MOL MED REP, V20, P3773, DOI 10.3892/mmr.2019.10641; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Gao J, 2018, APOPTOSIS, V23, P512, DOI 10.1007/s10495-018-1473-8; Gettinger S, 2018, J CLIN ONCOL, V36, P1675, DOI 10.1200/JCO.2017.77.0412; Harjunpaa H, 2020, CLIN EXP IMMUNOL, V200, P108, DOI 10.1111/cei.13407; He WL, 2017, CANCER RES, V77, P6375, DOI 10.1158/0008-5472.CAN-17-0381; Lawson NL, 2020, MODERN PATHOL, V33, P518, DOI 10.1038/s41379-019-0372-z; Lepletier A, 2020, CLIN CANCER RES, V26, P3671, DOI 10.1158/1078-0432.CCR-19-3925; Li YC, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/3948928; Masson D, 2001, GUT, V49, P236, DOI 10.1136/gut.49.2.236; MENDELSOHN CL, 1989, CELL, V56, P855, DOI 10.1016/0092-8674(89)90690-9; Molfetta R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030922; Nakai R, 2010, CANCER SCI, V101, P1326, DOI 10.1111/j.1349-7006.2010.01530.x; Nanda R, 2016, J CLIN ONCOL, V34, P2460, DOI 10.1200/JCO.2015.64.8931; Nishiwada S, 2015, ANTICANCER RES, V35, P2287; Rikitake Y, 2012, J CELL SCI, V125, P3713, DOI 10.1242/jcs.099572; Saito T, 2018, LUNG CANCER, V125, P230, DOI 10.1016/j.lungcan.2018.10.005; Salgado R, 2015, ANN ONCOL, V26, P259, DOI 10.1093/annonc/mdu450; Schmid P, 2018, NEW ENGL J MED, V379, P2108, DOI 10.1056/NEJMoa1809615; Teramoto K, 2021, CANCER IMMUNOL IMMUN, V70, P1063, DOI 10.1007/s00262-020-02755-w; Topalian SL, 2019, JAMA ONCOL, V5, P1411, DOI 10.1001/jamaoncol.2019.2187; Triki H, 2019, LIFE SCI, V231, DOI 10.1016/j.lfs.2019.116543; Wu Q, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01068; Xu F, 2017, CANCER IMMUNOL IMMUN, V66, P1367, DOI 10.1007/s00262-017-2031-x; Yong HM, 2019, BIOMED PHARMACOTHER, V115, DOI 10.1016/j.biopha.2019.108884; Yoshikawa K, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-07970-x; Yoshikawa K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242563	32	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253176	10.1371/journal.pone.0253176	http://dx.doi.org/10.1371/journal.pone.0253176			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115802	Green Published, gold			2022-12-26	WOS:000664643000054
J	Kuhla, K; Willner, SN; Otto, C; Wenz, L; Levermann, A				Kuhla, Kilian; Willner, Sven Norman; Otto, Christian; Wenz, Leonie; Levermann, Anders			Future heat stress to reduce people's purchasing power	PLOS ONE			English	Article							CLIMATE-CHANGE; TEMPERATURE; MODEL; CONSUMPTION; FORMULATION; SIMULATION	With increasing carbon emissions rising temperatures are likely to impact our economies and societies profoundly. In particular, it has been shown that heat stress can strongly reduce labor productivity. The resulting economic perturbations can propagate along the global supply network. Here we show, using numerical simulations, that output losses due to heat stress alone are expected to increase by about 24% within the next 20 years, if no additional adaptation measures are taken. The subsequent market response with rising prices and supply shortages strongly reduces the consumers' purchasing power in almost all countries including the US and Europe with particularly strong effects in India, Brazil, and Indonesia. As a consequence, the producing sectors in many regions temporarily benefit from higher selling prices while decreasing their production in quantity, whereas other countries suffer losses within their entire national economy. Our results stress that, even though climate shocks may stimulate economic activity in some regions and some sectors, their unpredictability exerts increasing pressure on people's livelihood.	[Kuhla, Kilian; Willner, Sven Norman; Otto, Christian; Wenz, Leonie; Levermann, Anders] Potsdam Inst Climate Impact Res, Potsdam, Germany; [Kuhla, Kilian; Levermann, Anders] Potsdam Univ, Inst Phys, Potsdam, Germany; [Wenz, Leonie] Mercator Res Inst Global Commons & Climate Change, Berlin, Germany; [Wenz, Leonie] Univ Calif Berkeley, Dept Agr & Resource Econ, Berkeley, CA 94720 USA; [Levermann, Anders] Columbia Univ, New York, NY USA	Potsdam Institut fur Klimafolgenforschung; University of Potsdam; University of California System; University of California Berkeley; Columbia University	Willner, SN (corresponding author), Potsdam Inst Climate Impact Res, Potsdam, Germany.	sven.willner@pik-potsdam.de	Levermann, Anders/G-4666-2011	Levermann, Anders/0000-0003-4432-4704; Kuhla, Kilian/0000-0002-8698-1246; Wenz, Leonie/0000-0002-8500-1568; Willner, Sven/0000-0001-6798-6247	German Academic Scholarship Foundation; German Federal Ministry of Education and Research (BMBF) [FKZ: 01LA1817C, FKZ: 01LA1829A]; Horizon 2020 Framework Programme of the European Union [820712]; Volkswagen foundation; Open Access Fund of the Leibniz Association	German Academic Scholarship Foundation; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Horizon 2020 Framework Programme of the European Union; Volkswagen foundation(Volkswagen); Open Access Fund of the Leibniz Association	This research has received funding from the German Academic Scholarship Foundation, the German Federal Ministry of Education and Research (BMBF) under the research projects CLIC (FKZ: 01LA1817C) and SLICE (FKZ: 01LA1829A), the Horizon 2020 Framework Programme of the European Union (grant agreement 820712), and from the Volkswagen foundation. The publication of this article was funded by the Open Access Fund of the Leibniz Association.	Acemoglu D, 2012, ECONOMETRICA, V80, P1977, DOI 10.3982/ECTA9623; ALAM MS, 2020, INT J FINANCE EC; Auffhammer M, 2018, J ECON PERSPECT, V32, P33, DOI 10.1257/jep.32.4.33; Auffhammer M, 2017, P NATL ACAD SCI USA, V114, P1886, DOI 10.1073/pnas.1613193114; Boulding KE, 1945, AM ECON REV, V35, P1; Burke M, 2015, NATURE, V527, P235, DOI 10.1038/nature15725; Cachon G, 2012, SSRN ELECT J; Center for International Earth Science Information Network-CIESIN-Columbia University, 2016, GRIDDED POPULATION W, DOI 10.7927/H4X63JVC; de Ruiter MC, 2020, EARTHS FUTURE, V8, DOI 10.1029/2019EF001425; Dell M, 2009, AM ECON REV, V99, P198, DOI 10.1257/aer.99.2.198; Deryng D, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/3/034011; Deryugina T., 2014, DAILY TEMPERATURE IN, P20750; Dufresne JL, 2013, CLIM DYNAM, V40, P2123, DOI 10.1007/s00382-012-1636-1; Dunne JP, 2013, NAT CLIM CHANGE, V3, P563, DOI 10.1038/NCLIMATE1827; Dunne JP, 2012, J CLIMATE, V25, P6646, DOI 10.1175/JCLI-D-11-00560.1; Fang JC, 2019, ENVIRON SCI POLLUT R, V26, P12181, DOI 10.1007/s11356-019-04513-7; Frieler K, 2017, GEOSCI MODEL DEV, V10, P4321, DOI 10.5194/gmd-10-4321-2017; Global Administrative Areas, 2018, GLOB ADM GADMMAPS DA; Haile MG., 2016, FOOD PRICE VOLATILIT, P139, DOI [10.1007/978-3-319-28201-5_7, DOI 10.1007/978-3-319-28201-5_7]; Hallegatte S, 2008, RISK ANAL, V28, P779, DOI 10.1111/j.1539-6924.2008.01046.x; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Hempel S, 2013, EARTH SYST DYNAM, V4, P219, DOI 10.5194/esd-4-219-2013; Henriet F, 2012, J ECON DYN CONTROL, V36, P150, DOI 10.1016/j.jedc.2011.10.001; Hertel T., 2016, GLOBAL TRADE ASSISTA; Hsiang SM, 2010, P NATL ACAD SCI USA, V107, P15367, DOI 10.1073/pnas.1009510107; Ianchovichina E, 2000, THEORETICAL STRUCTUR, P17; Inoue H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213648; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jones CD, 2011, GEOSCI MODEL DEV, V4, P543, DOI 10.5194/gmd-4-543-2011; Khokhar T., 2019, CHART GLOBAL WEALTH; Kim L, 2010, BLOOMBERG ARE YOU RO; Kovats RS, 2008, ANNU REV PUBL HEALTH, V29, P41, DOI 10.1146/annurev.publhealth.29.020907.090843; Lenssen NJL, 2019, J GEOPHYS RES-ATMOS, V124, P6307, DOI 10.1029/2018JD029522; Lenzen M, 2013, ECON SYST RES, V25, P20, DOI 10.1080/09535314.2013.769938; Levermann A, 2014, NATURE, V506, P27, DOI 10.1038/506027a; Malerba D, 2020, SOC INDIC RES, V150, P587, DOI 10.1007/s11205-020-02332-9; Mannakkara S, 2014, INT J MANAG PROJ BUS, V7, P327, DOI 10.1108/IJMPB-10-2013-0054; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; National Bureau of Statistics of China, 2010, GROSS REG PROD PROV; Okuyama Y., 2013, MODELING SPATIAL EC; Orlov Anton., 2019, EC DISASTERS CLIMATE, V3, P191, DOI [10.1007/s41885-019-00044-0, DOI 10.1007/S41885-019-00044-0]; Otto C, 2017, J ECON DYN CONTROL, V83, P232, DOI 10.1016/j.jedc.2017.08.001; Poledna S., 2018, ESTIMATING INDIRECT; Rahmstorf S, 2011, P NATL ACAD SCI USA, V108, P17905, DOI 10.1073/pnas.1101766108; Reimer J., 2004, GTAP TECHNICAL PAPER, V23; Rose A., 2004, MODELING SPATIAL EC, P13; Roson Roberto, 2012, International Journal of Sustainable Economy, V4, P270, DOI 10.1504/IJSE.2012.047933; Takakura J, 2017, ENVIRON RES LETT, V12, DOI 10.1088/1748-9326/aa72cc; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Team G, 2021, GISS SURF TEMP AN GI; U S Bureau of Economic Analysis, 2010, GROSS REG PROD STAT; Van Der Veen A, 2004, DISASTER PREV MANAG, V13, P274, DOI [10.1108/09653560410556483, DOI 10.1108/09653560410556483]; Watanabe M, 2010, J CLIMATE, V23, P6312, DOI 10.1175/2010JCLI3679.1; Wenz L, 2017, P NATL ACAD SCI USA, V114, pE7910, DOI 10.1073/pnas.1704339114; Wenz L, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501026; Wenz Leonie, 2014, Environment Systems & Decisions, V34, P525, DOI 10.1007/s10669-014-9521-6; Willner SN, 2018, NAT CLIM CHANGE, V8, P594, DOI 10.1038/s41558-018-0173-2; Zander KK, 2015, NAT CLIM CHANGE, V5, P647, DOI [10.1038/nclimate2623, 10.1038/NCLIMATE2623]; Zhang P, 2018, J ENVIRON ECON MANAG, V88, P1, DOI 10.1016/j.jeem.2017.11.001; Zivin JG, 2018, J ASSOC ENVIRON RESO, V5, P77, DOI 10.1086/694177; Zivin JG, 2014, J LABOR ECON, V32, P1, DOI 10.1086/671766	61	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0251210	10.1371/journal.pone.0251210	http://dx.doi.org/10.1371/journal.pone.0251210			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111129	Green Published, gold			2022-12-26	WOS:000664642700007
J	Jurado, MDM; Herrera-Peco, I; Perez-Fuentes, MD; Ruiz, NFO; Martinez, AM; Ayuso-Murillo, D; Linares, JJG				Molero Jurado, Maria del Mar; Herrera-Peco, Ivan; del Carmen Perez-Fuentes, Maria; Oropesa Ruiz, Nieves Fatima; Martos Martinez, Africa; Ayuso-Murillo, Diego; Gazquez Linares, Jose Jesus			Communication and humanization of care: Effects over burnout on nurses	PLOS ONE			English	Article							JOB-SATISFACTION; SELF-EFFICACY; HEALTH; SKILLS; MODEL	Background Healthcare professionals may have certain psychological characteristics which contribute to increasing the quality of their professional performance. Objective Study the effect that humanization of care and communication have on the burnout syndrome in nursing personal. Methods The sample included a total of 330 Spanish nurses. Analytical instruments used were the Health Professional's Humanization Scale (HUMAS), Communication Styles Inventory Revised (CSI-R) and Brief Burnout Questionnaire Revised (CBB-R). Results Two broad nursing profiles could be differentiated by their level of humanization (those with scores over the mean and those with scores below it in optimistic disposition, openness to sociability, emotional understanding, self-efficacy, and affection), where the largest group had the high scores. A communication repertoire based on verbal aggressiveness impacted indirectly on the effect of humanization on burnout, mainly in the personal impact component. We observed the relation of humanization profiles in nursing staff with the job dissatisfaction and burnout components. Besides that, some communication styles, verbal aggressiveness and questioningness, have an indirect effect on the relationship between humanization profiles and job dissatisfaction. Conclusions The results on the relationship between communication styles and burnout, and the mediator effect of communication styles on the relationship between humanization of care and burnout in nursing personnel are discussed.	[Molero Jurado, Maria del Mar; del Carmen Perez-Fuentes, Maria; Oropesa Ruiz, Nieves Fatima; Martos Martinez, Africa] Univ Almeria, Fac Psychol, Dept Psychol, Almeria, Spain; [Herrera-Peco, Ivan] Alfonso X El Sabio Univ, Fac Hlth Sci, Nursing Dept, Madrid, Spain; [Herrera-Peco, Ivan] Alfonso X El Sabio Fdn, Madrid, Spain; [Ayuso-Murillo, Diego] Consejo Gen Enfermeria, Madrid, Spain; [Gazquez Linares, Jose Jesus] Univ Autonoma Chile, Dept Psychol, Providencia, Chile	Universidad de Almeria; Universidad Alfonso X el Sabio (UAX); Universidad Autonoma de Chile	Martinez, AM (corresponding author), Univ Almeria, Fac Psychol, Dept Psychol, Almeria, Spain.	amm521@ual.es	Molero Jurado, María del Mar/X-7805-2018; GAZQUEZ, JOSE JESUS/AAZ-7371-2021; del Carmen Pérez-Fuentes, María/C-3018-2011	Molero Jurado, María del Mar/0000-0001-9187-1474; del Carmen Pérez-Fuentes, María/0000-0001-5950-5175				de Oliveira RAA, 2017, REV LAT-AM ENFERM, V25, DOI 10.1590/1518-8345.2253.2972; Bakker AB, 2012, PSICOTHEMA, V24, P66; Bautista Rodríguez Luz Marina, 2016, Rev Cuid, V7, P1297, DOI 10.15649/cuidarte.v7i2.330; Belsley D. A., 1991, Computer Science in Economics and Management, V4, P33; Brown R, 2009, ACAD MED, V84, P1595, DOI 10.1097/ACM.0b013e3181baf537; Busch IM, 2019, PATIENT, V12, P461, DOI 10.1007/s40271-019-00370-1; Campos C, 2017, PSILOGOS, V15, P91; Espinoza SC, 2018, REV PANAM SALUD PUBL, V42, DOI 10.26633/RPSP.2018.65; Morais GSD, 2009, ACTA PAUL ENFERM, V22, P323, DOI 10.1590/S0103-21002009000300014; Da Silva FLF., 2014, CIENC CUID SAUDE, V13, P210, DOI [10.4025/cienccuidsaude.v13i2.22015, DOI 10.4025/CIENCCUIDSAUDE.V13I2.22015]; Darban F, 2016, J CLIN DIAGN RES, V10, pIO1, DOI 10.7860/JCDR/2016/19312.7667; de la Fuente-Martos C, 2018, MED INTENSIVA, V42, P99, DOI 10.1016/j.medin.2017.08.002; de Vries RE, 2013, COMMUN RES, V40, P506, DOI 10.1177/0093650211413571; Perez-Fuentes MD, 2021, INT J HEALTH PLAN M, V36, P1486, DOI 10.1002/hpm.3188; Perez-Fuentes MD, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11205745; Perez-Fuentes MD, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122718; Perez-Fuentes MD, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091915; Molero MD, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02605; Dill J, 2016, SOC SCI MED, V167, P99, DOI 10.1016/j.socscimed.2016.07.028; Dominguez-Lara S, 2018, ACTAS UROL ESP, V42, P140, DOI 10.1016/j.acuro.2017.07.002; Azevedo AVD, 2017, CIENC SAUDE COLETIVA, V22, P3653, DOI 10.1590/1413-812320172211.26362015; Oliden PE, 2008, PSICOTHEMA, V20, P896; Fallowfield L, 1999, EUR J CANCER, V35, P1592, DOI 10.1016/S0959-8049(99)00212-9; Flickinger TE, 2016, PATIENT EDUC COUNS, V99, P220, DOI 10.1016/j.pec.2015.09.001; Gerteis M, 1993, Health Manage Q, V15, P2; Gerteis M., 1993, UNDERSTANDING PROMOT; Giambra BK, 2014, WORLDV EVID-BASED NU, V11, P369, DOI 10.1111/wvn.12065; Gorgulu O, 2017, NIGER J CLIN PRACT, V20, P48, DOI 10.4103/1119-3077.180051; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Jurado MDM, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120525; Kind N, 2018, PSYCHONEUROENDOCRINO, V94, P11, DOI 10.1016/j.psyneuen.2018.05.001; Leal-Costa C, 2015, AN SIST SANIT NAVAR, V38, P213, DOI 10.4321/S1137-66272015000200005; Lorenzo-Seva U, 2006, BEHAV RES METHODS, V38, P88, DOI 10.3758/BF03192753; Jurado MDM, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55060237; Jurado MDM, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00424; 근효근, 2019, [Journal of Korean Academy of Community Health Nursing, 지역사회간호학회지], V30, P226; Perez-Fuentes MD, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16203999; Prado Roberta Teixeira, 2019, Texto contexto - enferm., V28, pe20170336, DOI 10.1590/1980-265x-tce-2017-0336; Riviere M, 2019, INT J NURS STUD, V92, P154, DOI 10.1016/j.ijnurstu.2019.02.004; Schneider K.J., 2014, HDB HUMANISTIC PSYCH; Tripodi M, 2019, EUR J PEDIATR, V178, P607, DOI 10.1007/s00431-019-03370-3; Vasquez G.J., 2018, REV INCLUSIONES, V5, P187; Vermeir P, 2018, WORKPLACE HEALTH SAF, V66, P16, DOI 10.1177/2165079917703411; Wang XX, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5284628	44	3	3	7	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0251936	10.1371/journal.pone.0251936	http://dx.doi.org/10.1371/journal.pone.0251936			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6SA	34111138	gold, Green Published			2022-12-26	WOS:000664642700014
J	Saib, A; Amara, W; Wang, P; Cattan, S; Dellal, A; Regaieg, K; Nahon, S; Nallet, O; Nguyen, LS				Saib, Anis; Amara, Walid; Wang, Pascal; Cattan, Simon; Dellal, Azeddine; Regaieg, Kais; Nahon, Stephane; Nallet, Olivier; Nguyen, Lee S.			Lack of efficacy of hydroxychloroquine and azithromycin in patients hospitalized for COVID-19 pneumonia: A retrospective study	PLOS ONE			English	Article								Background Hydroxychloroquine combined with azithromycin (HCQ/AZI) has initially been used against coronavirus disease-2019 (COVID-19). In this retrospective study, we assessed the clinical effects of HCQ/AZI, with a 28-days follow-up. Methods In a registry-study which included patients hospitalized for COVID-19 between March 15 and April 2, 2020, we compared patients who received HCQ/AZI to those who did not, regarding a composite outcome of mortality and mechanical ventilation with a 28-days follow-up. QT was monitored for patients treated with HCQ/AZI. Were excluded patients in intensive care units, palliative care and ventilated within 24 hours of admission. Three analyses were performed to adjust for selection bias: propensity score matching, multivariable survival, and inverse probability score weighting (IPSW) analyses. Results Overall, 203 patients were included: 60 patients treated by HCQ/AZI and 143 control patients. During the 28-days follow-up, 32 (16.3%) patients presented the primary outcome and 23 (12.3%) patients died. Propensity-score matching identified 52 unique pairs of patients with similar characteristics. In the matched cohort (n = 104), HCQ/AZI was not associated with the primary composite outcome (log-rank p-value = 0.16). In the overall cohort (n = 203), survival and IPSW analyses also found no benefit from HCQ/AZI. In the HCQ/AZI group, 11 (18.3%) patients prolonged QT interval duration, requiring treatment cessation. Conclusions HCQ/AZI combination therapy was not associated with lower in-hospital mortality and mechanical ventilation rate, with a 28-days follow-up. In the HCQ/AZI group, 18.3% of patients presented a prolonged QT interval requiring treatment cessation, however, control group was not monitored for this adverse event, making comparison impossible.	[Saib, Anis; Amara, Walid; Cattan, Simon; Nallet, Olivier] Grp Hosp Intercommunal Le Raincy Montfermeil, Cardiol Dept, Montfermeil, France; [Wang, Pascal] Grp Hosp Intercommunal Le Raincy Montfermeil, Pneumol Dept, Montfermeil, France; [Dellal, Azeddine] Grp Hosp Intercommunal Le Raincy Montfermeil, Rheumatol Dept, Montfermeil, France; [Regaieg, Kais] Grp Hosp Intercommunal Le Raincy Montfermeil, Intens Care Med Dept, Montfermeil, France; [Nahon, Stephane] Grp Hosp Intercommunal Le Raincy Montfermeil, Gastroenterol Dept, Montfermeil, France; [Nguyen, Lee S.] CMC Ambroise Pare, Res & Innovat Dept RICAP, Neuilly Sur Seine, France		Nguyen, LS (corresponding author), CMC Ambroise Pare, Res & Innovat Dept RICAP, Neuilly Sur Seine, France.	nguyen.lee@icloud.com		WANG, Pascal/0000-0002-4057-3765; NGUYEN, Lee S./0000-0002-6014-6269				[Anonymous], DECRET N 2020 314 25; Aromolaran AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208321; Austin PC, 2017, STAT METHODS MED RES, V26, P1654, DOI 10.1177/0962280215584401; Capel RA, 2015, HEART RHYTHM, V12, P2186, DOI 10.1016/j.hrthm.2015.05.027; Cavalcanti AB, 2020, NEW ENGL J MED, V383, P2041, DOI 10.1056/NEJMoa2019014; Choi Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1574806; Cortegiani A, 2020, J CRIT CARE, V59, P176, DOI 10.1016/j.jcrc.2020.06.019; Costedoat-Chalumeau N, 2007, RHEUMATOLOGY, V46, P808, DOI 10.1093/rheumatology/kel402; Danial P, 2018, INTENS CARE MED, V44, P2153, DOI 10.1007/s00134-018-5442-z; Gautret P, 2020, INT J ANTIMICROB AG, V56, DOI 10.1016/j.ijantimicag.2020.105949; Gautret P, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101663; Geleris J, 2020, NEW ENGL J MED, V382, P2411, DOI 10.1056/NEJMoa2012410; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Knirsch CA, 2012, NEW ENGL J MED, V367, P772, DOI [10.1056/NEJMoa1003833, 10.1056/NEJMc1207269]; Lunceford JK, 2004, STAT MED, V23, P2937, DOI 10.1002/SIM.1903; Mahevas M., 2020, NO EVIDENCE CLIN EFF, DOI [10.1101/2020.04.10.20060699, DOI 10.1101/2020.04.10.20060699]; Nguyen LS, 2020, CIRCULATION, V142, P303, DOI 10.1161/CIRCULATIONAHA.120.048238; Nguyen LS, 2020, AM J TRANSPLANT, V20, P2791, DOI 10.1111/ajt.15849; Rosenberg ES, 2020, JAMA-J AM MED ASSOC, V323, P2493, DOI 10.1001/jama.2020.8630; Rossi B, 2020, PHARMACEUTICALS-BASE, V13, DOI 10.3390/ph13100317; Salem, 2020, LANCET LONDON ENGLAN, V396, P2, DOI DOI 10.1016/S0140-6736%2820%2931528-2; Trinkley KE, 2013, CURR MED RES OPIN, V29, P1719, DOI 10.1185/03007995.2013.840568; Vandenberk B, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003264; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang M., 2020, CELL RES, V30, P269, DOI [DOI 10.1038/s41422-020-0282-0, 10.1038/s41422-020-0282-0, 10.1038/s41422-020-0282-02020]; WHO Solidarity Trial Consortium, 2021, NEW ENGL J MED, V384, P497, DOI 10.1056/NEJMoa2023184; YANG X, 2020, LANCET RESP MED, DOI [10.1016/S2213-2600(20)30079, DOI 10.1016/S2213-2600(20)30079-5, 10.1016/S2213-2600(20)30079-5]; Yao XT, 2020, CLIN INFECT DIS, V71, P732, DOI 10.1093/cid/ciaa237; Yazdany J, 2020, ANN INTERN MED, V172, P754, DOI 10.7326/M20-1334; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	31	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252388	10.1371/journal.pone.0252388	http://dx.doi.org/10.1371/journal.pone.0252388			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106964	Green Published, gold			2022-12-26	WOS:000664642200047
J	Siriwardane-de Zoysa, R; Schone, T; Herbeck, J; Illigner, J; Haghighi, M; Simarmata, H; Porio, E; Rovere, A; Hornidge, AK				Siriwardane-de Zoysa, Rapti; Schoene, Tilo; Herbeck, Johannes; Illigner, Julia; Haghighi, Mahmud; Simarmata, Hendricus; Porio, Emma; Rovere, Alessio; Hornidge, Anna-Katharina			The 'wickedness' of governing land subsidence: Policy perspectives from urban Southeast Asia	PLOS ONE			English	Article							SEA-LEVEL RISE; CLIMATE-CHANGE; GREAT-GARUDA; SINGAPORE; GROUNDWATER; JAKARTA; MANILA; GEOGRAPHIES; MANAGEMENT; POLITICS	Drawing on Jakarta, Metro Manila and Singapore as case studies, we explore the paradox of slow political action in addressing subsiding land, particularly along high-density urban coastlines with empirical insights from coastal geography, geodesy analysis, geology, and urban planning. In framing land subsidence as a classic 'wicked' policy problem, and also as a hybrid geological and anthropogenic phenomenon that is unevenly experienced across urban contexts, the paper uses a three-step analysis. First, satellite-derived InSAR maps are integrated with Sentinel-1A data in order to reveal the socio-temporal variability of subsidence rates which in turn pose challenges in uniformly applying regulatory action. Second, a multi-sectoral mapping of diverse policies and practices spanning urban water supply, groundwater extraction, land use zoning, building codes, tenurial security, and land reclamation reveal the extent to which the broader coastal governance landscape remains fragmented and incongruous, particularly in arresting a multi-dimensional phenomenon such as subsidence. Finally, in reference to distinct coastal identities of each city-the 'Sinking Capital' (Jakarta), 'Fortress Singapore', and the 'Disaster Capital' (Manila) the paper illustrates how land subsidence is portrayed across the three metropolises in markedly similar ways: as a reversible, quasi-natural, and/or a highly individualized problem.	[Siriwardane-de Zoysa, Rapti] Leibniz Ctr Trop Marine Res ZMT, Dept Social Sci, Bremen, Germany; [Schoene, Tilo] GFZ German Res Ctr Geosci, Sect Global Geomonitoring & Grav Field, Geodet Hazard Monitoring Grp, Potsdam, Germany; [Herbeck, Johannes] Univ Bremen, Artec Sustainabil Res Ctr, Bremen, Germany; [Illigner, Julia] GFZ German Res Ctr Geosci, Sect Global Geomonitoring & Grav Field, Geodet Hazard Monitoring Grp, Potsdam, Germany; [Haghighi, Mahmud] GFZ German Res Ctr Geosci, Helmholtz Ctr Potsdam, Potsdam, Germany; [Simarmata, Hendricus] Univ Indonesia, Ctr Urban & Reg Studies, Jakarta, Indonesia; [Porio, Emma] Ateneo Manila Univ, Quezon City, Metro Manila, Philippines; [Porio, Emma] Manila Observ, Quezon City, Metro Manila, Philippines; [Rovere, Alessio] Univ Bremen, Ctr Marine Environm Sci MARUM, Bremen, Germany; [Hornidge, Anna-Katharina] Univ Bremen, Inst Sociol, Bremen, Germany; [Hornidge, Anna-Katharina] Leibniz Ctr Trop Marine Res ZMT, Bremen, Germany	Leibniz Zentrum fur Marine Tropenforschung (ZMT); Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Bremen; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences; University of Indonesia; Ateneo de Manila University; University of Bremen; University of Bremen; Leibniz Zentrum fur Marine Tropenforschung (ZMT)	Siriwardane-de Zoysa, R (corresponding author), Leibniz Ctr Trop Marine Res ZMT, Dept Social Sci, Bremen, Germany.	rapti.siriwardane@leibniz-zmt.de	Siriwardane-de Zoysa, Rapti/GVU-4236-2022; Schöne, Tilo/C-7403-2019; Haghshenas Haghighi, Mahmud/AAD-7570-2019; Rovere, Alessio/C-4262-2011	Schöne, Tilo/0000-0003-4118-9578; Haghshenas Haghighi, Mahmud/0000-0002-2512-3934; Simarmata, Hendricus Andy/0000-0001-7883-5233; Hornidge, Anna-Katharina/0000-0002-9599-4348; Siriwardane-de Zoysa, Rapti/0000-0003-3891-3158; Rovere, Alessio/0000-0001-5575-1168	Deutsche Forschungsgemeinschaft/the German Science Foundation (DFG)	Deutsche Forschungsgemeinschaft/the German Science Foundation (DFG)(German Research Foundation (DFG))	This study was generously funded by the Deutsche Forschungsgemeinschaft/the German Science Foundation (DFG), through the first phase of the Special Priority Program (SPP) - 1889 "Regional Sea Level Change and Society." The paper integrates interdisciplinary work of three SPP 1889 research projects - "Epistemic Mobilities and the Governance of Environmental Risks in Island Southeast Asia" (EMERSA), the "Hazardous Potential in Indonesia and South East Asia" (CoRSEA), and "Holocene Sea-level Changes in Southeast Asia" (SEASchange).	Abidin H., 2005, GIM INT, V19, P12; Abidin HZ, 2015, P INT ASS HYDROL SCI, V372, P115, DOI 10.5194/piahs-372-115-2015; Abidin HZ, 2013, GEOMAT NAT HAZ RISK, V4, P226, DOI 10.1080/19475705.2012.692336; Abidin HZ, 2008, GPS SOLUT, V12, P23, DOI 10.1007/s10291-007-0061-0; Abidin HZ, 2011, NAT HAZARDS, V59, P1753, DOI 10.1007/s11069-011-9866-9; Adigue A., 2015, COST CLEAN WATER WAT, P26; Aichi M, 2008, CSUR UT SER LIB SUST, V2, P105; Alvarez MK, 2019, INT J URBAN REGIONAL, V43, P227, DOI 10.1111/1468-2427.12757; Andreas H, 2008, ENG J, V22, P207; [Anonymous], 2012, PHILIPPINE DAILY INQ; Barba PF., 2004, P 2 INT C HYDR WAT R; Beck S, 2017, NAT CLIM CHANGE, V7, P311, DOI 10.1038/nclimate3264; Bird E.C., 1996, SEA LEVEL RISE COAST, P87; Boori MS, 2016, DATA BRIEF, V7, P1576, DOI 10.1016/j.dib.2016.04.028; Brain MJ, 2016, CURR CLIM CHANGE REP, V2, P75, DOI 10.1007/s40641-016-0038-6; Bredehoeft JD, 2002, GROUND WATER, V40, P340, DOI 10.1111/j.1745-6584.2002.tb02511.x; Bunnell T, 2006, INT J URBAN REGIONAL, V30, P3, DOI 10.1111/j.1468-2427.2006.00647.x; Caldwell P.C., 2015, 0019568 NCEI NOAA, V10, DOI [10.7289/V5V40S7W, DOI 10.7289/V5V40S7W]; Carbognin L, 2004, J MARINE SYST, V51, P345, DOI 10.1016/j.jmarsys.2004.05.021; Castellazzi P, 2016, INT J APPL EARTH OBS, V47, P102, DOI 10.1016/j.jag.2015.12.002; Catalao J., 2013, P SING US SAR GPS ES, P54; Channel News Asia, 2013, CHANNEL NEWS ASIA; Chaussard E, 2013, REMOTE SENS ENVIRON, V128, P150, DOI 10.1016/j.rse.2012.10.015; Ching L, 2018, WATER ALTERN, V11, P61; Clemente RS, 2001, DISCUSSION PAPER SER, P1; Colven E, 2020, CRIT ASIAN STUD, V52, P311, DOI 10.1080/14672715.2020.1793210; Colven E, 2017, WATER ALTERN, V10, P250; DELAUNE RD, 1990, CATENA, V17, P277, DOI 10.1016/0341-8162(90)90021-5; DELTARES Task Force, 2015, SINK CIT INT APPR SO; Djaja R., 2004, P 3 FIG REG C JAK IN; Dobraszczyk P, 2017, INT J URBAN REGIONAL, V41, P868, DOI 10.1111/1468-2427.12510; DPWH, 2001, CONS SERV KAMANAVA A; Dye TR., 2012, UNDERSTANDING PUBLIC, V2018; Ebarvia CM., 1997, PHILIPPINES EEPSEA R; Erban LE, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/8/084010; Erkens G, 2018, DOSSIERES; Foley R, 2015, HEALTH PLACE, V35, P157, DOI 10.1016/j.healthplace.2015.07.003; Furlong K, 2017, INT J URBAN REGIONAL, V41, P888, DOI 10.1111/1468-2427.12582; Galloway D.L., 1999, LAND SUBSIDENCE US, VVolume 1182; Gambolati G., 2005, EOS T AM GEOPHYS UN, V86, P217, DOI [10. 1029/2005EO230001, DOI 10.1029/2005EO230001]; Gao ML, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10030365; Gies E., 2018, SCI AM; Greenpeace Southeast Asia, 2007, STAT WAT RES PHIL; Gurevich AE, 1993, J PETROL SCI ENG, V9, P239, DOI 10.1016/0920-4105(93)90017-9; Hajer M, 2003, DELIBERATIVE POLICY, DOI [10.1078/0944-2006-00117, DOI 10.1078/0944-2006-00117]; Hansen JE, 2007, ENVIRON RES LETT, V2, DOI 10.1088/1748-9326/2/2/024002; Hermaputi R.L., 2017, INDONESIAN J PLANNIN, V2, P1, DOI [DOI 10.14710/IJPD.2.1.1-10, 10.14710/ijpd.2.1.1-10]; Holgate SJ, 2013, J COASTAL RES, V29, P493, DOI 10.2112/JCOASTRES-D-12-00175.1; Holman I, 1999, IAHS-AISH P, P125; Hooper A, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021737; Hooper A, 2012, TECTONOPHYSICS, V514, P1, DOI 10.1016/j.tecto.2011.10.013; Hudson C., 2014, GREEN CONSUMPTION GL; Hulme TW, 1999, TUNN UNDERGR SP TECH, V14, P409, DOI 10.1016/S0886-7798(00)00004-3; Illigner J, 2016, IAG SYMP, V143, P451, DOI 10.1007/1345_2015_23; Ingebritsen SE, 2014, ENVIRON RES LETT, V9, DOI 10.1088/1748-9326/9/9/091002; Irsyam Masyhur, 2020, VIRT FGD MRT PHAS 2; Jong HN., 2019, BUSINESS USUAL RECLA; Kimmelman M., 2017, NEW YORK TIMES; Kong L., 2003, POLITICS LANDSCAPE S; Kooy M, 2014, WATER ALTERN, V7, P35; Levin K, 2012, POLICY SCI, V45, P123, DOI 10.1007/s11077-012-9151-0; Lim TS., 2017, LAND SAND SINGAPORE; Lin M, 2018, BBC ASIA 0813; Loh KS, 2015, NAT CULT, V10, P36, DOI 10.3167/nc.2015.100103; Lui PC, 2001, J URBAN TECHNOL, V8, P49, DOI 10.1080/10630730120052172; Maierbrugger A., 2018, INVESTVINE; McConnell A, 2018, POLICY POLIT, V46, P165, DOI 10.1332/030557317X15072085902640; Mendez C., 2012, ABS CBN NEWS; MND, 2013, HIGH QUAL LIV ENV AL; Molle F, 2018, WATER ALTERN, V11, P445; Moya GP., 2014, FLOATING WORLD ARTEX; Nerem RS, 2018, P NATL ACAD SCI USA, V115, P2022, DOI 10.1073/pnas.1717312115; Norgaard Kari Marie., 2011, LIVING DENIAL CLIMAT; Octavianti T, 2018, WATER ALTERN, V11, P394; Official Gazette-Philippines, 2015, OFFICIAL GAZETT 0924; Pacheco-Martinez J, 2013, ENG GEOL, V164, P172, DOI 10.1016/j.enggeo.2013.06.015; Paguican EMR, 2009, B VOLCANOL, V71, P845, DOI 10.1007/s00445-009-0268-8; Parriaux A, 2004, ENERG BUILDINGS, V36, P335, DOI 10.1016/j.enbuild.2004.01.026; Pascual FD., 2006, PHILIPPINES STA 0316; Pelling M, 2013, MEGACITIES AND THE COAST: RISK, RESILIENCE AND TRANSFORMATION, P200; PSMSL, 2018, TID GAUG DAT; Public Utilities Board (PUB), 2018, OUR WAT OUR FUT; Public Utility Board (PUB), 2011, COD PRACT SURF WAT D, V6th ed.; Raucoules D, 2013, REMOTE SENS ENVIRON, V139, P386, DOI 10.1016/j.rse.2013.08.021; RITTEL HWJ, 1973, POLICY SCI, V4, P155, DOI 10.1007/BF01405730; Robertson MLB., 2015, WATERWORLDS ANTHR FL, P141; Rodolfo KS, 2006, DISASTERS, V30, P118, DOI 10.1111/j.1467-9523.2006.00310.x; Rosenthal S., 2001, MANILA WATER CONCESS; Rovere A, 2016, CURR CLIM CHANGE REP, V2, P221, DOI 10.1007/s40641-016-0045-7; Safai NM, 1979, ADV WATER RESOUR, V2, P19, DOI 10.1016/0309-1708(79)90003-4; Saputra E., 2017, AM J CLIM CHANGE, V6, DOI [10.4236/ajcc.2017.61001, DOI 10.4236/AJCC.2017.61001]; Schepers JHG., 2008, NAUWKEURRIGHEIDSWATE; Schone T, 2010, ADV TECHNOL EARTH SC, P317, DOI 10.1007/978-3-642-10228-8_25; Schone T, 2009, J GEODESY, V83, P249, DOI 10.1007/s00190-008-0269-y; Shirzaei M, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aap9234; Simarmata HendricusAndy., 2018, PHENOMENOLOGY ADAPTA; Siringan FP., 2003, SCI DILIMAN, V15, P1; Siriwardane-de Zoysa R, 2020, MAR POLICY, V112, DOI 10.1016/j.marpol.2019.103661; Stocker TF, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P1, DOI 10.1017/cbo9781107415324; STONE DA, 1989, POLIT SCI QUART, V104, P281, DOI 10.2307/2151585; Tang CP, 2006, ENVIRON PLANN A, V38, P1131, DOI 10.1068/a37375; Tarrant Bill, 2014, REUTERS; Tilley L., 2019, ASIA PAC VIEWP, V60, P1; Tornqvist TE, 2008, NAT GEOSCI, V1, P173, DOI 10.1038/ngeo129; van Steenbergen F, 2006, HYDROGEOL J, V14, P380, DOI 10.1007/s10040-005-0015-y; Varrani A, 2018, INT J RIVER BASIN MA, V16, P439, DOI 10.1080/15715124.2017.1387125; Vasco DW, 2019, SCI REP-UK, V9, P1, DOI [10.1038/s41598-018-37186-2, DOI 10.1038/S41598-019-52371-7, DOI 10.1038/S41598-018-37186-2]; Villholth KG, 2017, ADV GROUNDWATER GOVE; Wade M, 2019, SINGAPORE J TROP GEO, V40, P158, DOI 10.1111/sjtg.12262; Wang C.M., 2015, LARGE FLOATING STRUC; Woon KL., 2009, GEOLOGY OF SINGAPORE, V2nd ed; World Bank, METR MAN WAT SEC STU; Yeoh B.S.A., 2003, CONTESTING SPACE COL; Zhang XS, 2013, NAT HAZARDS, V69, P473, DOI 10.1007/s11069-013-0718-7; Zhao J, 2007, TUNN UNDERGR SP TECH, V22, P388, DOI 10.1016/j.tust.2006.10.002; Zhao J, 1999, TUNN UNDERGR SP TECH, V14, P449, DOI 10.1016/S0886-7798(00)00007-9	116	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0250208	10.1371/journal.pone.0250208	http://dx.doi.org/10.1371/journal.pone.0250208			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106961	Green Published, gold			2022-12-26	WOS:000664642200011
J	Dhayat, SA; Tamim, ANJ; Jacob, M; Ebeling, G; Kerschke, L; Kabar, I; Senninger, N				Dhayat, Sameer A.; Tamim, Ahmad N. J.; Jacob, Marius; Ebeling, Georg; Kerschke, Laura; Kabar, Iyad; Senninger, Norbert			Postoperative pancreatic fistula affects recurrence-free survival of pancreatic cancer patients	PLOS ONE			English	Article							INTERNATIONAL STUDY-GROUP; PREOPERATIVE CT-SCAN; RISK-FACTORS; SURGICAL COMPLICATIONS; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; RANDOMIZED-TRIAL; PANCREATICODUODENECTOMY; SURGERY; PREDICT	Purpose Postoperative pancreatic fistula (POPF) with reported incidence rates up to 45% contributes substantially to overall morbidity. In this study, we conducted a retrospective evaluation of POPF along with its potential perioperative clinical risk factors and its effect on tumor recurrence. Methods Clinical data on patients who had received pancreatoduodenectomy (PD), distal pancreatectomy (DP), or duodenum-preserving pancreatic head resection (DPPHR) were prospectively collected between 2007 and 2016. A Picrosirius red staining score was developed to enable morphological classification of the resection margin of the pancreatic stump. The primary end point was the development of major complications. The secondary end points were overall and recurrence-free survival. Results 340 patients underwent pancreatic resection including 222 (65.3%) PD, 87 (25.6%) DP, and 31 (9.1%) DPPHR. Postoperative major complications were observed in 74 patients (21.8%). In multivariable logistic regression analysis, POPF correlated with body mass index (BMI) (p = 0.025), prolonged stay in hospital (p<0.001), high Picrosirius red staining score (p = 0.049), and elevated postoperative levels of amylase or lipase in drain fluid (p<less than or equal to>0.001). Multivariable Cox regression analysis identified UICC stage (p<0.001), tumor differentiation (p<0.001), depth of invasion (p = 0.001), nodal invasion (p = 0.001), and the incidence of POPF grades B and C (p = 0.006) as independent prognostic markers of recurrence-free survival. Conclusion Besides the known clinicopathological risk factors BMI and amylase in the drain fluid, the incidence of POPF correlates with high Picrosirius red staining score in the resection margins of the pancreatic stumps of curatively resected pancreatic ductal adenocarcinoma (PDAC). Furthermore, clinically relevant POPF seems to be a prognostic factor for tumor recurrence in PDAC.	[Dhayat, Sameer A.; Tamim, Ahmad N. J.; Jacob, Marius; Ebeling, Georg; Senninger, Norbert] Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany; [Kerschke, Laura] Univ Munster, Inst Biostat & Clin Res, Munster, Germany; [Kabar, Iyad] Univ Hosp Muenster, Dept Internal Med Gastroenterol & Hepatol B, Munster, Germany	University of Munster; University of Munster; University of Munster	Dhayat, SA (corresponding author), Univ Hosp Muenster, Dept Gen & Visceral Surg, Munster, Germany.	sameer.dhayat@ukmuenster.de	Kerschke, Laura/S-5289-2016	Kerschke, Laura/0000-0002-1195-7399; Dhayat, SA/0000-0002-5314-9736				Ansorge C, 2012, BRIT J SURG, V99, P1076, DOI 10.1002/bjs.8784; Assifi MM, 2013, J AM COLL SURGEONS, V217, P621, DOI 10.1016/j.jamcollsurg.2013.05.014; Bassi C, 2005, SURGERY, V138, P8, DOI 10.1016/j.surg.2005.05.001; Bassi C, 2003, SURGERY, V134, P766, DOI 10.1016/S0039-6060(03)00345-3; Bassi C, 2017, SURGERY, V161, P584, DOI 10.1016/j.surg.2016.11.014; Berger AC, 2009, J AM COLL SURGEONS, V208, P738, DOI 10.1016/j.jamcollsurg.2008.12.031; Besselink MG, 2017, SURGERY, V161, P365, DOI 10.1016/j.surg.2016.06.058; Buchler MW, 2000, BRIT J SURG, V87, P883, DOI 10.1046/j.1365-2168.2000.01465.x; Callery MP, 2013, J AM COLL SURGEONS, V216, P1, DOI 10.1016/j.jamcollsurg.2012.09.002; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Connor S, 2016, HPB, V18, P642, DOI 10.1016/j.hpb.2016.05.006; de Castro SMM, 2005, BRIT J SURG, V92, P1117, DOI 10.1002/bjs.5047; DeOliveira ML, 2006, ANN SURG, V244, P931, DOI 10.1097/01.sla.0000246856.03918.9a; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Friess H, 1996, PANCREAS, V13, P202; Gaujoux S, 2010, SURGERY, V148, P15, DOI 10.1016/j.surg.2009.12.005; Greenblatt DY, 2011, ANN SURG ONCOL, V18, P2126, DOI 10.1245/s10434-011-1594-6; Grobmyer SR, 2007, J AM COLL SURGEONS, V204, P356, DOI 10.1016/j.jamcollsurg.2006.11.017; Hamanaka Y, 1996, SURGERY, V119, P281, DOI 10.1016/S0039-6060(96)80114-0; Ishikawa O, 2003, ANN SURG, V238, P103, DOI 10.1097/01.SLA.0000074982.51763.d6; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Keck T, 2016, ANN SURG, V263, P440, DOI 10.1097/SLA.0000000000001240; Kleeff J, 2007, ANN SURG, V245, P573, DOI 10.1097/01.sla.0000251438.43135.fb; Koch M, 2011, SURGERY, V149, P680, DOI 10.1016/j.surg.2010.12.002; Lillemoe KD, 2004, J GASTROINTEST SURG, V8, P766, DOI 10.1016/j.gassur.2004.06.011; Lowy AM, 1997, ANN SURG, V226, P632, DOI 10.1097/00000658-199711000-00008; Maggino L, 2019, ANN SURG, V269, P337, DOI 10.1097/SLA.0000000000002532; McMillan DC, 2003, BRIT J SURG, V90, P215, DOI 10.1002/bjs.4038; Miller BC, 2014, J GASTROINTEST SURG, V18, P172, DOI 10.1007/s11605-013-2337-8; Mirnezami A, 2011, ANN SURG, V253, P890, DOI 10.1097/SLA.0b013e3182128929; Mungroop TH, 2019, ANN SURG, V269, P937, DOI 10.1097/SLA.0000000000002620; Murakami Y, 2008, J GASTROINTEST SURG, V12, P51, DOI 10.1007/s11605-007-0340-7; Murakami Y, 2013, CANCER CHEMOTH PHARM, V71, P419, DOI 10.1007/s00280-012-2029-1; Nagai S, 2011, ANN SURG ONCOL, V18, P2329, DOI 10.1245/s10434-011-1604-8; Neary WD, 2003, BRIT J SURG, V90, P157, DOI 10.1002/bjs.4041; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Oehme F, 2021, J GASTROINTEST SURG, V25, P2572, DOI 10.1007/s11605-021-04917-2; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Pedrazzoli S, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000006858; Pugalenthi A, 2016, J SURG ONCOL, V113, P188, DOI 10.1002/jso.24125; Ridolfi C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/641239; Roberts KJ, 2016, CLIN RADIOL, V71, P986, DOI 10.1016/j.crad.2016.06.108; Roberts KJ, 2015, ANN SURG, V261, P1191, DOI 10.1097/SLA.0000000000000997; Rungsakulkij N, 2017, WORLD J GASTRO SURG, V9, P270, DOI 10.4240/wjgs.v9.i12.270; Shrikhande SV, 2017, SURGERY, V161, P1221, DOI 10.1016/j.surg.2016.11.021; Tranchart H, 2012, ANN SURG, V256, P139, DOI 10.1097/SLA.0b013e318256c32c; Tzedakis S, 2020, PANCREATOLOGY, V20, DOI 10.1016/j.pan.2020.10.036; Uzunoglu FG, 2014, ANN SURG, V260, P857, DOI 10.1097/SLA.0000000000000946; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; Wente MN, 2007, SURGERY, V142, P20, DOI 10.1016/j.surg.2007.02.001; Winter JM, 2006, J GASTROINTEST SURG, V10, P1280, DOI 10.1016/j.gassur.2006.07.020; YEO CJ, 1995, ANN SURG, V222, P580; Yeo CJ, 2000, ANN SURG, V232, P419, DOI 10.1097/00000658-200009000-00014; Yoon JH, 2016, RADIOLOGY, V279, P140, DOI 10.1148/radiol.2015142254; Yue YF, 2020, PANCREATOLOGY, V20, P1558, DOI 10.1016/j.pan.2020.09.009	56	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252727	10.1371/journal.pone.0252727	http://dx.doi.org/10.1371/journal.pone.0252727			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086792	gold, Green Published			2022-12-26	WOS:000664640100120
J	Hopf, S; Hennermann, JB; Schuster, AK; Pfeiffer, N; Pitz, S				Hopf, Susanne; Hennermann, Julia B.; Schuster, Alexander K.; Pfeiffer, Norbert; Pitz, Susanne			Vertical saccadic palsy and foveal retinal thinning in Niemann-Pick disease type C	PLOS ONE			English	Article							MIGLUSTAT THERAPY; EYE-MOVEMENT; ABNORMALITIES	Introduction Niemann-Pick type C (NPC) is a lysosomal storage disease that is progressive and life-limiting, with an estimated incidence of 1:120,000 live births. In addition to systemic manifestation with (hepato-)splenomegaly, there are a number of neurological manifestations (ataxia, dysarthria, dementia, cataplexy, epileptic seizures, and psychiatric disorders). Characteristic is vertical supranuclear gaze palsy, which is often overlooked. Early diagnosis and start of therapy improve quality of life. This study aimed to characterize oculomotor dysfunction of NPC patients, and to provide ophthalmologic data including retinal imaging. Methods Eighteen patients with biochemically or genetically diagnosed NPC completed oculomotor and ophthalmologic examination. Ten of them performed saccadometry by infrared based video-oculography. Saccadic parameters were compared to 100 healthy controls, and were correlated with clinical variables. Another subgroup of eight patients received optical coherence tomography (OCT) of the optic disc and the macula, of which the segmented layers were analysed using a crude linear mixed model, and one adjusted for age, sex, and spherical equivalent. Results Saccadometry revealed slowed peak velocity compared to controls most evident vertically. Peak velocity correlated negatively with SARA-Score, but correlation with clinical assessment of saccades was not significant. Clinical features in the assessment of vertical saccades were intensive blinking and head movements to initiate gaze changes, and lateral trajectory of the eyes. Macular OCT revealed significant total retinal thinning in the fovea, specifically of the outer nuclear layer and outer retinal layer. Para- and perifoveal retinal thicknesses, as well as peripapillary retinal nerve fibre layer were normal. Conclusions Foveal thinning was revealed in NPC. It remains to be shown, whether OCT will prove to be useful to monitor progression. Saccadic impairment reflects CNS involvement and therefore is a parameter to demonstrate the progression of NPC, and potentially also the efficacy of new therapies. Saccadometry, in contrast to clinical investigation, allows the precise evaluation of saccades.	[Hopf, Susanne; Schuster, Alexander K.; Pfeiffer, Norbert; Pitz, Susanne] Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany; [Hennermann, Julia B.] Univ Med Ctr Mainz, Dept Pediat & Adolescent Med, Mainz, Germany; [Pitz, Susanne] Burger Hosp, Ophthalm Clin, Orbital Ctr, Frankfurt, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Hopf, S (corresponding author), Univ Med Ctr Mainz, Dept Ophthalmol, Mainz, Germany.	susanne.hopf@unimedizin-mainz.de		Hopf, Susanne/0000-0002-7989-9420				Abel LA, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0377-8; Abel LA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050947; Blundell J, 2018, MOL GENET METAB, V123, P159, DOI 10.1016/j.ymgme.2017.11.004; Bremova T, 2017, PEDIATR NEUROL, V72, P94, DOI 10.1016/j.pediatrneurol.2017.01.005; Bremova-Ertl T, 2020, NEUROLOGY, V94, pE1702, DOI 10.1212/WNL.0000000000009290; Chamova T, 2016, EUR NEUROL, V75, P113, DOI 10.1159/000444480; Claudepierre T, 2010, MOL CELL NEUROSCI, V43, P164, DOI 10.1016/j.mcn.2009.10.007; Eggink H, 2016, NEUROLOGY, V86, pE202, DOI 10.1212/WNL.0000000000002660; Geberhiwot T, 2018, ORPHANET J RARE DIS, V13, DOI 10.1186/s13023-018-0785-7; Greenberg CR, 2015, MOLEC GENET METAB RE, V3, P18, DOI 10.1016/j.ymgmr.2015.02.004; Gupta DK, 2018, TREMOR OTHER HYPERK, V8, DOI 10.7916/D8XS7BGD; Havla J, 2020, J NEUROL, V267, P2070, DOI 10.1007/s00415-020-09796-2; Hopf S, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1244-9; Hopf S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204008; Kianersi Farzan, 2017, Adv Biomed Res, V6, P168, DOI 10.4103/2277-9175.221859; Lengyel D, 1999, KLIN MONATSBL AUGENH, V214, P50, DOI 10.1055/s-2008-1034748; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Patterson MC, 2020, ORPHANET J RARE DIS, V15, DOI 10.1186/s13023-020-01363-2; Patterson MC, 2020, J INHERIT METAB DIS, V43, P1060, DOI 10.1002/jimd.12245; Patterson MC, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0284-z; Phokaewvarangkul O, 2019, TRANSL NEURODEGENER, V8, DOI 10.1186/s40035-019-0160-1; Pineda M, 2010, MOL GENET METAB, V99, P358, DOI 10.1016/j.ymgme.2009.11.007; Salsano E, 2012, NEUROL SCI, V33, P1225, DOI 10.1007/s10072-012-1155-1; Scheel M, 2010, MOL GENET METAB, V99, P291, DOI 10.1016/j.ymgme.2009.10.180; Shawkat F S, 1994, Eur J Neurol, V1, P93, DOI 10.1111/j.1468-1331.1994.tb00056.x; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Walterfang M, 2011, AM J NEURORADIOL, V32, P1340, DOI 10.3174/ajnr.A2490; Walterfang M, 2013, MOL GENET METAB, V108, P85, DOI 10.1016/j.ymgme.2012.11.009	28	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252825	10.1371/journal.pone.0252825	http://dx.doi.org/10.1371/journal.pone.0252825			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086834	gold, Green Published			2022-12-26	WOS:000664640100141
J	Liebl, AL; Wesner, JS; Russell, AF; Schrey, AW				Liebl, Andrea L.; Wesner, Jeff S.; Russell, Andrew F.; Schrey, Aaron W.			Methylation patterns at fledging predict delayed dispersal in a cooperatively breeding bird	PLOS ONE			English	Article							DNA METHYLATION; NATAL DISPERSAL; READ ALIGNMENT; MATERNAL-CARE; SEX-RATIO; EVOLUTION; PHILOPATRY; DETERMINANTS; CONSEQUENCES; CONCORDANT	Individuals may delay dispersing from their natal habitat, even after maturation to adulthood. Such delays can have broad consequences from determining population structure to allowing an individual to gain indirect fitness by helping parents rear future offspring. Dispersal in species that use delayed dispersal is largely thought to be opportunistic; however, how individuals, particularly inexperienced juveniles, assess their environments to determine the appropriate time to disperse is unknown. One relatively unexplored possibility is that dispersal decisions are the result of epigenetic mechanisms interacting between a genome and environment during development to generate variable dispersive phenotypes. Here, we tested this using epiRADseq to compare genome-wide levels of DNA methylation of blood in cooperatively breeding chestnut-crowned babblers (Pomatostomus ruficeps). We measured dispersive and philopatric individuals at hatching, before fledging, and at 1 year (following when first year dispersal decisions would be made). We found that individuals that dispersed in their first year had a reduced proportion of methylated loci than philopatric individuals before fledging, but not at hatching or as adults. Further, individuals that dispersed in the first year had a greater number of loci change methylation state (i.e. gain or lose) between hatching and fledging. The existence and timing of these changes indicate some influence of development on epigenetic changes that may influence dispersal behavior. However, further work needs to be done to address exactly how developmental environments may be associated with dispersal decisions and which loci in particular are manipulated to generate such changes.	[Liebl, Andrea L.; Wesner, Jeff S.] Univ South Dakota, Dept Biol, Vermillion, SD 57069 USA; [Russell, Andrew F.] Univ Exeter, Ctr Ecol & Conservat, Penryn, England; [Schrey, Aaron W.] Georgia Southern Univ, Dept Biol, Savannah, GA USA	University of South Dakota; University of Exeter	Liebl, AL (corresponding author), Univ South Dakota, Dept Biol, Vermillion, SD 57069 USA.	andrea.liebl@usd.edu	Liebl, Andrea/GNM-6443-2022		Natural Environment Research Council [NE/K005766]; USD's Arts and Sciences; National Science Foundation [1504662]; GSU-Armstrong's Department of Biology and College of Science and Mathematics	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); USD's Arts and Sciences; National Science Foundation(National Science Foundation (NSF)); GSU-Armstrong's Department of Biology and College of Science and Mathematics	This project was funded by the Natural Environment Research Council to AFR (NE/K005766), USD's Arts and Sciences to ALL, the National Science Foundation (1504662) to AWS, and GSU-Armstrong's Department of Biology and College of Science and Mathematics to AWS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers B, 2010, MOL ECOL, V19, P1283, DOI 10.1111/j.1365-294X.2010.04580.x; Armenta TC, 2019, BEHAV ECOL, V30, P267, DOI 10.1093/beheco/ary175; Beery AK, 2016, HORM BEHAV, V77, P42, DOI 10.1016/j.yhbeh.2015.05.022; Bossdorf O, 2010, EVOL ECOL, V24, P541, DOI 10.1007/s10682-010-9372-7; Browning LE, 2012, P ROY SOC B-BIOL SCI, V279, P3861, DOI 10.1098/rspb.2012.1080; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Cote J, 2010, PHILOS T R SOC B, V365, P4065, DOI 10.1098/rstb.2010.0176; Covas R, 2007, P ROY SOC B-BIOL SCI, V274, P1349, DOI 10.1098/rspb.2007.0117; De Fraipont M, 2000, J ANIM ECOL, V69, P404, DOI 10.1046/j.1365-2656.2000.00405.x; Dimond JL, 2017, MOL ECOL, V26, P5031, DOI 10.1111/mec.14252; Dingemanse NJ, 2003, P ROY SOC B-BIOL SCI, V270, P741, DOI 10.1098/rspb.2002.2300; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dufty Alfred M. Jr, 2001, P217; DUPLESSIS MA, 1992, OECOLOGIA, V90, P205, DOI 10.1007/BF00317177; Ekman Jan, 2016, P6; EMLEN ST, 1995, P NATL ACAD SCI USA, V92, P8092, DOI 10.1073/pnas.92.18.8092; Farre P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0011-y; Gabry J, 2019, J R STAT SOC A STAT, V182, P389, DOI 10.1111/rssa.12378; Gao LX, 2010, PLANT CELL ENVIRON, V33, P1820, DOI 10.1111/j.1365-3040.2010.02186.x; Griesser M, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2000483; Groleau P, 2014, J PSYCHIATR RES, V48, P121, DOI 10.1016/j.jpsychires.2013.10.003; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; Hanson H. E., 2022, AM NAT, DOI [10.1101/2020.03.07.981886, DOI 10.1101/2020.03.07.981886, 10.5061/dryad.v41ns1rt2, DOI 10.5061/DRYAD.V41NS1RT2]; Hansson B, 2003, ECOL LETT, V6, P290, DOI 10.1046/j.1461-0248.2003.00436.x; Hasselquist D, 2002, PHILOS T R SOC B, V357, P363, DOI 10.1098/rstb.2001.0924; Heg D, 2004, P ROY SOC B-BIOL SCI, V271, P2367, DOI 10.1098/rspb.2004.2855; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Husby A, 2020, INTEGR COMP BIOL, V60, P1558, DOI 10.1093/icb/icaa123; Kilvitis HJ, 2017, INTEGR COMP BIOL, V57, P385, DOI 10.1093/icb/icx082; Koenig W.D., 2004, ECOLOGY EVOLUTION CO; KOENIG WD, 1992, Q REV BIOL, V67, P111, DOI 10.1086/417552; KOMDEUR J, 1995, ANIM BEHAV, V49, P695; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liebl AL, 2016, ANIM BEHAV, V115, P47, DOI 10.1016/j.anbehav.2016.02.024; Lukas D, 2012, P ROY SOC B-BIOL SCI, V279, P2151, DOI 10.1098/rspb.2011.2468; Mascher M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076925; Masliah E, 2013, EPIGENETICS-US, V8, P1030, DOI 10.4161/epi.25865; Meylan S, 2002, HORM BEHAV, V42, P319, DOI 10.1006/hbeh.2002.1827; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Pasinelli G, 2004, AM NAT, V164, P660, DOI 10.1086/424765; Pasinelli G, 2002, ECOLOGY, V83, P2229, DOI 10.1890/0012-9658(2002)083[2229:SAEFAN]2.0.CO;2; Provencal N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089839; Provenzi L, 2020, GENES BRAIN BEHAV, V19, DOI 10.1111/gbb.12616; PRUETTJONES SG, 1990, NATURE, V348, P541, DOI 10.1038/348541a0; Puglia MH, 2015, P NATL ACAD SCI USA, V112, P3308, DOI 10.1073/pnas.1422096112; Richards CL, 2010, BIOSCIENCE, V60, P232, DOI 10.1525/bio.2010.60.3.9; Rollins LA, 2012, MOL ECOL, V21, P1727, DOI 10.1111/j.1365-294X.2012.05492.x; Rubenstein DR, 2016, MOL ECOL, V25, P1714, DOI 10.1111/mec.13483; Russell A., 2016, Cooperative Breeding in Vertebrates: Studies of Ecology, Evolution and Behaviour; Russell AF, 2007, P R SOC B, V274, P513, DOI 10.1098/rspb.2006.3698; Russell AF, 2010, EMU, V110, P324, DOI 10.1071/MU10028; Saastamoinen M, 2018, BIOL REV, V93, P574, DOI 10.1111/brv.12356; Schield DR, 2016, METHODS ECOL EVOL, V7, P60, DOI 10.1111/2041-210X.12435; Schultz MD, 2015, NATURE, V523, P212, DOI 10.1038/nature14465; Siller SJ., 2019, INTEGR COMP BIOL; Sinervo B, 2006, AM NAT, V168, P88, DOI 10.1086/505765; SLAGSVOLD T, 1986, ORNIS SCAND, V17, P117, DOI 10.2307/3676860; SMITH JM, 1964, NATURE, V201, P1145, DOI 10.1038/2011145a0; Szyf M, 2007, REPROD TOXICOL, V24, P9, DOI 10.1016/j.reprotox.2007.05.001; Team SD, 2019, RSTAN R INT STAN VER; Tschirren B, 2007, AM NAT, V169, P87, DOI 10.1086/509945; Ursini G, 2011, J NEUROSCI, V31, P6692, DOI 10.1523/JNEUROSCI.6631-10.2011; Verhoeven KJF, 2010, MOL ECOL, V19, P315, DOI 10.1111/j.1365-294X.2009.04460.x; Vogt G, 2008, J EXP BIOL, V211, P510, DOI 10.1242/jeb.008755; WALTERS JR, 1992, AUK, V109, P90, DOI 10.2307/4088269; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zhang YY, 2013, NEW PHYTOL, V197, P314, DOI 10.1111/nph.12010	70	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252227	10.1371/journal.pone.0252227	http://dx.doi.org/10.1371/journal.pone.0252227			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086730	gold, Green Published			2022-12-26	WOS:000664640100037
J	Park, J; Joo, MA; Choi, HJ; Hong, SH; Park, CS; Choi, JH; Chae, MS				Park, Jaesik; Joo, Min A.; Choi, Ho Joong; Hong, Sang Hyun; Park, Chul Soo; Choi, Jong Ho; Chae, Min Suk			Predictive utility of fibrinogen in acute kidney injury in living donor liver transplantation: A propensity score-matching analysis	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; SERUM FIBRINOGEN; RISK-FACTORS; MORTALITY; DISEASE; INFLAMMATION; DYSFUNCTION; PREVALENCE; INSIGHTS	Background This study investigated the association between the fibrinogen level and the risk of acute kidney injury (AKI) in patients who have undergone living donor liver transplantation (LDLT). Patients and methods A total of 676 patients who underwent LDLT were analyzed retrospectively. Exclusion criteria included a history of severe kidney dysfunction, emergency operation, deceased donor, ABO-incompatible transplantation, and missing data. The study population was divided into low and normal fibrinogen groups. A 1:1 propensity score (PS) matching analysis was used to evaluate the association between a low fibrinogen level (< 160 mg/dL) and postoperative development of AKI. Results In total, 142 patients (23.1%) developed AKI after LDLT. The PS matching analysis showed that the probability of AKI was two-fold higher in the low fibrinogen group than in the normal fibrinogen group. In addition, patients with AKI had poorer postoperative outcomes such as longer hospitalization, longer ICU stay, and higher mortality than patients without AKI. Conclusions The preoperative fibrinogen level may be useful for risk stratification of patients undergoing LDLT in terms postoperative development of AKI.	[Park, Jaesik; Joo, Min A.; Hong, Sang Hyun; Park, Chul Soo; Choi, Jong Ho; Chae, Min Suk] Catholic Univ Korea, Seoul St Marys Hosp, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea; [Choi, Ho Joong] Catholic Univ Korea, Seoul St Marys Hosp, Dept Surg, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Seoul St. Mary's Hospital	Chae, MS (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Anesthesiol & Pain Med, Coll Med, Seoul, South Korea.	shscms@gmail.com		Chae, Min Suk/0000-0002-1426-4651				Abdel-Khalek EE, 2018, J TRANSPLANT, V2018, DOI 10.1155/2018/5910372; Amer Soc Anesthesiologists, 2015, ANESTHESIOLOGY, V122, P241, DOI 10.1097/ALN.0000000000000463; Arif Saatea, 2002, J Ayub Med Coll Abbottabad, V14, P19; Barri YM, 2009, LIVER TRANSPLANT, V15, P475, DOI 10.1002/lt.21682; Barsoum RS, 2017, J ADV RES, V8, P113, DOI 10.1016/j.jare.2016.07.004; Bell S, 2017, QJM-INT J MED, V110, P695, DOI 10.1093/qjmed/hcw175; Bucsics T, 2017, GASTROENTEROL REP, V5, P127, DOI 10.1093/gastro/gox009; Cabezuelo JB, 2006, KIDNEY INT, V69, P1073, DOI 10.1038/sj.ki.5000216; Cantaluppi V, 2014, NEPHROL DIAL TRANSPL, V29, P2004, DOI 10.1093/ndt/gfu046; Cash WJ, 2010, QJM-INT J MED, V103, P9, DOI 10.1093/qjmed/hcp152; Celik IE, 2016, CORONARY ARTERY DIS, V27, P13, DOI 10.1097/MCA.0000000000000295; Chae MS, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/8256193; Chae MS, 2018, LIVER TRANSPLANT, V24, P623, DOI 10.1002/lt.25022; Chan Tak Mao, 2010, Curr Hepat Rep, V9, P99, DOI 10.1007/s11901-010-0042-6; Cong Yu-Long, 2005, Zhonghua Gan Zang Bing Za Zhi, V13, P31; Davalos D, 2012, SEMIN IMMUNOPATHOL, V34, P43, DOI 10.1007/s00281-011-0290-8; de Haan JE, 2017, BEST PRACT RES CL GA, V31, P161, DOI 10.1016/j.bpg.2017.03.004; Dellepiane S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1219-3; Feng S, 2017, LIVER TRANSPLANT, V23, pS9, DOI 10.1002/lt.24819; Fenger-Eriksen C, 2009, EXPERT OPIN BIOL TH, V9, P1325, DOI 10.1517/14712590903193051; Gad EH, 2015, ANN MED SURG, V4, P162, DOI 10.1016/j.amsu.2015.04.021; Gameiro J, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0369-7; Garcia-Fernandez N, 2000, THROMB RES, V100, P19, DOI 10.1016/S0049-3848(00)00306-6; Habib S, 2006, LIVER TRANSPLANT, V12, P440, DOI 10.1002/lt.20721; Han SS, 2014, TOHOKU J EXP MED, V232, P177, DOI 10.1620/tjem.232.177; Hilmi I, 2008, LIVER TRANSPLANT, V14, P504, DOI 10.1002/lt.21381; Hilmi IA, 2015, LIVER TRANSPLANT, V21, P1179, DOI 10.1002/lt.24166; Hobson C, 2015, ANN SURG, V261, P1207, DOI 10.1097/SLA.0000000000000732; Hoffmann D, 2012, AM J PATHOL, V181, P818, DOI 10.1016/j.ajpath.2012.06.004; Horoldt BS, 2006, LIVER TRANSPLANT, V12, P1144, DOI 10.1002/lt.20779; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Luyendyk JP, 2019, BLOOD, V133, P511, DOI 10.1182/blood-2018-07-818211; Marchi R, 2017, BMC Hematol, V17, P22, DOI 10.1186/s12878-017-0086-8; Murashima M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56615-4; Murugan R, 2010, KIDNEY INT, V77, P527, DOI 10.1038/ki.2009.502; Park J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215603; Park JT, 2017, KOREAN J ANESTHESIOL, V70, P258, DOI 10.4097/kjae.2017.70.3.258; Rahman S, 2017, WORLD J HEPATOL, V9, P823, DOI 10.4254/wjh.v9.i18.823; Rymarz A, 2009, TRANSPL P, V41, P3123, DOI 10.1016/j.transproceed.2009.08.026; Senzolo M, 2006, WORLD J GASTROENTERO, V12, P7725, DOI 10.3748/wjg.v12.i48.7725; Shah Neeral L, 2016, Clin Liver Dis (Hoboken), V7, P26, DOI 10.1002/cld.528; Shao ZX, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/468596; Shukla A, 2013, J CLIN EXP HEPATOL, V3, P243, DOI 10.1016/j.jceh.2013.08.004; Singhal A, 2012, CLIN APPL THROMB-HEM, V18, P594, DOI 10.1177/1076029612440034; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Stuart EA, 2010, STAT SCI, V25, P1, DOI 10.1214/09-STS313; Tang Y, 2014, CLIN SCI, V126, P645, DOI 10.1042/CS20130471; Thongprayoon C, 2019, J CLIN MED, V8, DOI 10.3390/jcm8030372; Tsai TY, 2017, J FORMOS MED ASSOC, V116, P844, DOI 10.1016/j.jfma.2017.08.004; Vagefi PA, 2012, LIVER TRANSPLANT, V18, P160, DOI 10.1002/lt.22455; Wadei HM, 2016, AM J TRANSPLANT, V16, P850, DOI 10.1111/ajt.13527; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Wiesen Patricia, 2016, World J Transplant, V6, P220, DOI 10.5500/wjt.v6.i1.220; Yang JJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63522-6; Zhang WR, 2015, J AM SOC NEPHROL, V26, P3123, DOI 10.1681/ASN.2014080764; Zhou J, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000018527	56	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252715	10.1371/journal.pone.0252715	http://dx.doi.org/10.1371/journal.pone.0252715			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086798	Green Published, gold			2022-12-26	WOS:000664640100115
J	Yu, GC; Yu, WF; Xu, XD; Ye, B; Yao, LW				Yu, Guocan; Yu, Wenfeng; Xu, Xudong; Ye, Bo; Yao, Liwei			Neoadjuvant immunotherapy for resectable esophageal cancer: A protocol of meta-analysis	PLOS ONE			English	Article							SURVIVAL	Background Esophageal cancer is a highly malignant cancer with a very poor prognosis. For resectable esophageal cancer, neoadjuvant treatment could improve the prognosis of esophageal cancer. However, current clinical neoadjuvant treatment options for esophageal cancer are still limited. The application of immunotherapy is a potentially beneficial new neoadjuvant treatment option for esophageal cancer. The objective of this meta-analysis is to evaluate the efficacy and safety of immunotherapy for the neoadjuvant treatment of esophageal cancer. Methods We will search Wanfang Database, SinoMed, China National Knowledge Infrastructure, Embase, Web of Science, Pubmed, and Cochrane Library for relevant articles published before July, 2021. We will also search the unpublished clinical trials of neoadjuvant immunotherapy in esophageal cancer in preprint website (such as bioRXiv and medRxiv) up to July, 2021. We will perform a meta-analysis to evaluate the efficacy and safety of neoadjuvant immunotherapy for resectable esophageal cancer. Randomized controlled trials (RCTs) will be included in this study. The risk of bias will be evaluated for each included study using the Cochrane Handbook for Systematic Reviews of Interventions. We will use RevMan 5.3 software for statistical analysis of the data. Results The results of this study will provide evidence of immunotherapy using as neoadjuvant treatment for esophageal cancer. This meta-analysis will be submitted to a peer-reviewed journal seeking for publication. Conclusion The results of this study will provide a reliable basis for clinicians and patients to formulate the best pre-surgical treatment plan for resectable esophageal cancer. Systematic review registration INPLASY202120026.	[Yu, Guocan; Yu, Wenfeng; Xu, Xudong; Ye, Bo] Zhejiang Univ, Sch Med, Affiliated Hangzhou Chest Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China; [Yao, Liwei] Zhejiang Univ, Sch Med, Affiliated Hangzhou Chest Hosp, Dept Nursing, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Ye, B (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hangzhou Chest Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China.; Yao, LW (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hangzhou Chest Hosp, Dept Nursing, Hangzhou, Zhejiang, Peoples R China.	yeboboye@126.com; ylwmed@163.com			Hangzhou Science and Technology Bureau [20201203B179]	Hangzhou Science and Technology Bureau	Guocan Yu, 20201203B179, Hangzhou Science and Technology Bureau, http://kj.hangzhou.gov.cn.The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop BR, 2016, GASTROENTEROL CLIN N, V45, P399, DOI 10.1016/j.gtc.2016.04.001; Babic B, 2020, CHIRURG, V91, P379, DOI 10.1007/s00104-020-01150-6; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Buderi SI, 2017, INTERACT CARDIOV TH, V24, P115, DOI 10.1093/icvts/ivw281; Faggion CM, 2015, J EVID-BASED DENT PR, V15, P164, DOI 10.1016/j.jebdp.2015.09.002; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Ilson DH, 2018, GASTROENTEROLOGY, V154, P437, DOI 10.1053/j.gastro.2017.09.048; Jia XH, 2020, LUNG CANCER, V147, P143, DOI 10.1016/j.lungcan.2020.07.001; Jing SW, 2019, FUTURE ONCOL, V15, P2413, DOI 10.2217/fon-2019-0024; Kakeji Y, 2021, ESOPHAGUS-TOKYO, V18, P25, DOI 10.1007/s10388-020-00782-1; Kojima T, 2017, CURR ONCOL REP, V19, DOI 10.1007/s11912-017-0590-9; Kono K, 2018, ESOPHAGUS-TOKYO, V15, P1, DOI 10.1007/s10388-017-0596-2; Malthaner R, 2010, CLIN ONCOL-UK, V22, P250, DOI 10.1016/j.clon.2010.02.005; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moher D, 2015, SYST REV, V4, DOI [10.1186/s13643-015-0087-2, 10.1186/2046-4053-4-1]; Pennathur A, 2013, LANCET, V381, P400, DOI 10.1016/S0140-6736(12)60643-6; Rouvelas I, 2005, LANCET ONCOL, V6, P864, DOI 10.1016/S1470-2045(05)70347-8; Shen YQ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243765; Watanabe M, 2020, SURG TODAY, V50, P12, DOI 10.1007/s00595-019-01878-7; Yang H, 2018, J CLIN ONCOL, V36, P2796, DOI 10.1200/JCO.2018.79.1483; Yu G., 2021, NEOADJUVANT IMMUNOTH, DOI [10.37766/inplasy2021.2.0026, DOI 10.37766/INPLASY2021.2.0026]; Yu GC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243161; Yu GC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242982; Zhao Q, 2019, CANCER MED-US, V8, P4519, DOI 10.1002/cam4.2336	25	1	1	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252829	10.1371/journal.pone.0252829	http://dx.doi.org/10.1371/journal.pone.0252829			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086821	Green Published, gold			2022-12-26	WOS:000664640100143
J	Zhu, LL; Cui, K; Weng, LL; Yu, P; Du, YB; Zhang, TF; Liu, H; Li, BJ; Ma, W				Zhu, Lili; Cui, Kang; Weng, Lanling; Yu, Pu; Du, Yabing; Zhang, Tengfei; Liu, Hong; Li, Bingjie; Ma, Wang			A panel of 8-lncRNA predicts prognosis of breast cancer patients and migration of breast cancer cells	PLOS ONE			English	Article							LONG NONCODING RNA; TUMOR RECURRENCE; LNCRNA MNX1-AS1; GASTRIC-CANCER; BIOMARKERS; SIGNATURE; PROMOTES; SURVIVAL; PROLIFERATION; DISCOVERY	Background Breast cancer (BCa) is the most commonly diagnosed cancer and the leading cause of cancer death among females around the world. Recent studies have indicated that long non-coding RNAs (lncRNAs) can serve as an independent biomarker for diagnosis and prognosis in many types of cancer, including pancreatic adenocarcinoma, gastric cancer, liver cancer, and lung cancer. Previous studies have shown that many lncRNAs are associated with the occurrence and development of BCa. However, few studies have combined multiple lncRNAs to predict the prognosis of early-stage BCa patients. Methods Systematic and comprehensive analysis of data from The Cancer Genome Atlas (TCGA) was conducted to identify lncRNA signatures with prognostic value in BCa. Additionally, the relative expression levels of the 8 lncRNA of several BCa cell lines were detected by quantitative real-time PCR (qPCR) and the results were substituted into a risk score formula. Finally, migration assays were used to verify the result from prognostic analysis according to the risk scores among cell lines with different risk scores. Results Our study included 808 BCa patients with complete clinical data. A panel of 8 lncRNAs was identified using Wilcox tests as different between normal and tumor tissue of the BCa patients. This panel was used to analyze the survival of BCa patients. Patients with low risk scores had greater overall survival (OS) than those with high risk scores. Multivariate Cox regression analyses demonstrated that the lncRNA signature was an independent prognostic factor. Gene Set Enrichment Analysis (GSEA) suggested that the lncRNAs might be involved in several molecular signaling pathways implicated in BCa such as the DNA replication pathway, the cell cycle pathway, and the pentose phosphate pathway. Validation experiments in breast cancer cells to test cell migration by using wound-healing assays supported the results of the model. Conclusion Our study demonstrated that a panel of 8 lncRNAs has the potential to be used as an independent prognostic biomarker of BCa.	[Zhu, Lili; Cui, Kang; Weng, Lanling; Yu, Pu; Du, Yabing; Zhang, Tengfei; Liu, Hong; Li, Bingjie; Ma, Wang] Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Zhu, Lili; Weng, Lanling] Zhengzhou Univ, Acad Med Sci, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University	Li, BJ; Ma, W (corresponding author), Zhengzhou Univ, Dept Oncol, Affiliated Hosp 1, Zhengzhou, Peoples R China.	bingjie.li@monash.edu; doctormawang@126.com			National Natural Science Foundation of China [31570917]; Doctoral team foundation of the First Affiliated Hospital of Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral team foundation of the First Affiliated Hospital of Zhengzhou University	This work was supported by the National Natural Science Foundation of China (31570917), and the Doctoral team foundation of the First Affiliated Hospital of Zhengzhou University. The owner of the fundings is MW. He joined the study design.	Alboukadel Kassambara, 2019, DRAWING SURVIVAL CUR; Almnaseer ZA, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180704; Bao SQ, 2020, BRIEF BIOINFORM, V21, P1742, DOI 10.1093/bib/bbz118; Bolha L, 2017, DIS MARKERS, V2017, DOI 10.1155/2017/7243968; Boughey JC, 2017, ANN SURG, V266, P667, DOI 10.1097/SLA.0000000000002373; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen C, 2016, CANCER MED-US, V5, P3489, DOI 10.1002/cam4.863; Claverie JM, 2005, SCIENCE, V309, P1529, DOI 10.1126/science.1116800; Fernandes JCR, 2019, NON-CODING RNA, V5, DOI 10.3390/ncrna5010017; Ferreira AR, 2019, ANN ONCOL, V30, P1784, DOI 10.1093/annonc/mdz298; Gao Y, 2019, ONCOL RES, V27, P341, DOI 10.3727/096504018X15228909735079; Guo WN, 2016, SCI REP-UK, V6, DOI 10.1038/srep27931; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hirukawa A, 2019, CELL REP, V29, P249, DOI 10.1016/j.celrep.2019.08.105; Huang SK, 2018, MED SCI MONITOR, V24, DOI 10.12659/MSM.909453; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kim KW, 2020, INT J RADIAT ONCOL, V108, P115, DOI 10.1016/j.ijrobp.2019.09.041; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kolde R., 2018, PRETTY HEATMAPS; Li AH, 2017, EUR REV MED PHARMACO, V21, P5618, DOI 10.26355/eurrev_201712_14003; Li N, 2019, EPMA J, V10, P273, DOI 10.1007/s13167-019-00175-0; Liang YR, 2018, CANCER BIOL THER, V19, P120, DOI 10.1080/15384047.2017.1394543; Liu GF, 2019, ONCOTARGETS THER, V12, P3129, DOI 10.2147/OTT.S198014; Liu X, 2019, J CELL BIOCHEM, V120, P4268, DOI 10.1002/jcb.27712; Low SK, 2018, CANCER SCI, V109, P497, DOI 10.1111/cas.13463; Lv Y, 2017, CANCER BIOTHER RADIO, V32, P91, DOI 10.1089/cbr.2017.2178; Ma JX, 2019, EUR REV MED PHARMACO, V23, P4756, DOI 10.26355/eurrev_201906_18057; Meng J, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0084-7; O'Shaughnessy J, 2005, ONCOLOGIST, V10, P20, DOI 10.1634/theoncologist.10-90003-20; Redig AJ, 2013, J INTERN MED, V274, P113, DOI 10.1111/joim.12084; Ricciuti B, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0731-2; Serghiou S, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0535-1; Sun M, 2015, ENDOCR REV, V36, P25, DOI 10.1210/er.2014-1034; Sun M, 2019, BREAST CANCER RES TR, V175, P59, DOI 10.1007/s10549-019-05147-6; Tang JN, 2019, J CELL MOL MED, V23, P6775, DOI 10.1111/jcmm.14556; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wahlestedt C, 2013, NAT REV DRUG DISCOV, V12, P433, DOI 10.1038/nrd4018; Wang K, 2019, J CELL BIOCHEM, V120, P13509, DOI 10.1002/jcb.28626; Yang ZG, 2016, CANCER LETT, V371, P62, DOI 10.1016/j.canlet.2015.11.011; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang YX, 2019, EUR REV MED PHARMACO, V23, P6045, DOI 10.26355/eurrev_201907_18417; Zheng DN, 2019, EUR REV MED PHARMACO, V23, P6179, DOI 10.26355/eurrev_201907_18431; Zhou M, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0580-4; Zhou M, 2016, SCI REP-UK, V6, DOI 10.1038/srep31038; Zhou M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0556-3; Zhou P, 2019, MOL MED REP, V19, P861, DOI 10.3892/mmr.2018.9763	46	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0249174	10.1371/journal.pone.0249174	http://dx.doi.org/10.1371/journal.pone.0249174			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086679	Green Published, gold			2022-12-26	WOS:000664640100010
J	Hin, V; Harwood, J; de Roos, AM				Hin, Vincent; Harwood, John; de Roos, Andre M.			Density dependence can obscure nonlethal effects of disturbance on life history of medium-sized cetaceans	PLOS ONE			English	Article							ATLANTIC FIN WHALES; MARINE MAMMALS; ANTHROPOGENIC DISTURBANCE; POPULATION CONSEQUENCES; FORAGING BEHAVIOR; LARGE HERBIVORES; BODY CONDITION; DYNAMICS; GROWTH; SHIFTS	Nonlethal disturbance of animals can cause behavioral and physiological changes that affect individual health status and vital rates, with potential consequences at the population level. Predicting these population effects remains a major challenge in ecology and conservation. Monitoring fitness-related traits may improve detection of upcoming population changes, but the extent to which individual traits are reliable indicators of disturbance exposure is not well understood, especially for populations regulated by density dependence. Here we study how density dependence affects a population's response to disturbance and modifies the disturbance effects on individual health and vital rates. We extend an energy budget model for a medium-sized cetacean (the long-finned pilot whale Globicephala melas) to an individual-based population model in which whales feed on a self-replenishing prey base and disturbance leads to cessation of feeding. In this coupled predator-prey system, the whale population is regulated through prey depletion and the onset of yearly repeating disturbances on the whale population at carrying capacity decreased population density and increased prey availability due to reduced top-down control. In populations faced with multiple days of continuous disturbance each year, female whales that were lactating their first calf experienced increased mortality due to depletion of energy stores. However, increased prey availability led to compensatory effects and resulted in a subsequent improvement of mean female body condition, mean age at first reproduction and higher age-specific reproductive output. These results indicate that prey-mediated density dependence can mask negative effects of disturbance on fitness-related traits and vital rates, a result with implications for the monitoring and management of marine mammal populations.	[Hin, Vincent; de Roos, Andre M.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Theoret & Computat Ecol, Amsterdam, Netherlands; [Harwood, John] Univ St Andrews, Ctr Res Ecol & Environm Modelling, St Andrews, Fife, Scotland	University of Amsterdam; University of St Andrews	Hin, V (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Dept Theoret & Computat Ecol, Amsterdam, Netherlands.	vincent.hin@gmail.com			Office of Naval Research [N00014-16-1-2858]; European Research Council under the European Union [322814]	Office of Naval Research(Office of Naval Research); European Research Council under the European Union(European Research Council (ERC))	This research was supported by the Office of Naval Research (https://www.onr.navy.mil/) grant N00014-16-1-2858: "PCoD+: Developing widely-applicable models of the population consequences of disturbance" awarded to SMRU Consulting Ltd (http://www.smruconsulting.com/).VH and AMdR benefitted from funding from the European Research Council https://erc.europa.eu/) under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant Agreement No. 322814 awarded to AMdR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts G, 2019, ECOSPHERE, V10, DOI 10.1002/ecs2.2538; Andre M, 2011, FRONT ECOL ENVIRON, V9, P489, DOI 10.1890/100124; Aoki K, 2013, BEHAV PROCESS, V99, P12, DOI 10.1016/j.beproc.2013.06.002; BARLOW J, 1991, MAR MAMMAL SCI, V7, P50, DOI 10.1111/j.1748-7692.1991.tb00550.x; Baruah G, 2019, AM NAT, V193, P633, DOI 10.1086/702849; Bester MN, 2014, HDB GLOBAL ENV POLLU, V1, P167, DOI DOI 10.1007/978-94-007-5784-4-40; Bloch D., 1993, Reports of the International Whaling Commission Special Issue, V14, P1; Bloch Dorete, 1993, Reports of the International Whaling Commission Special Issue, V14, P163; Bonenfant C, 2009, ADV ECOL RES, V41, P313, DOI 10.1016/S0065-2504(09)00405-X; Booth CG, 2020, FRONT MAR SCI, V7, DOI 10.3389/fmars.2020.00115; Braithwaite JE, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov001; Brondizio E, 2019, SUMMARY POLICYMAKERS; Clements CF, 2018, ECOL LETT, V21, P905, DOI 10.1111/ele.12948; Clements CF, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0188; Clements CF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10984; Costa DP, 2016, ADV EXP MED BIOL, V875, P161, DOI 10.1007/978-1-4939-2981-8_19; de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099; de Roos A., 1988, NUMER METH PART D E, V4, P173, DOI [10.1002/num.1690040303, DOI 10.1002/NUM.1690040303]; De Roos AM, 2009, ECOLOGY, V90, P945, DOI 10.1890/07-1153.1; Desportes G., 1988, INT COUNCIL EXPLORAT, P1; Desportes Genevieve, 1993, Reports of the International Whaling Commission Special Issue, V14, P305; Engas A, 1996, CAN J FISH AQUAT SCI, V53, P2238, DOI 10.1139/cjfas-53-10-2238; Erbe C, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00606; Farmer NA, 2018, BIOL CONSERV, V227, P189, DOI 10.1016/j.biocon.2018.09.006; Farmer NA, 2018, MAR ECOL PROG SER, V589, P241, DOI 10.3354/meps12457; Fleishman E, 2016, MAR MAMMAL SCI, V32, P1004, DOI 10.1111/mms.12310; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Fowler C.W., 1984, Reports of the International Whaling Commission Special Issue, P373; FOWLER CW, 1988, EVOL ECOL, V2, P197, DOI 10.1007/BF02214283; FOWLER CW, 1990, MAR MAMMAL SCI, V6, P171, DOI 10.1111/j.1748-7692.1990.tb00242.x; Gaillard JM, 1998, TRENDS ECOL EVOL, V13, P58, DOI 10.1016/S0169-5347(97)01237-8; GERRODETTE T, 1990, MAR MAMMAL SCI, V6, P1, DOI 10.1111/j.1748-7692.1990.tb00221.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Harris CM, 2018, J APPL ECOL, V55, P396, DOI 10.1111/1365-2664.12955; HARWOOD J, 1978, J APPL ECOL, V15, P401, DOI 10.2307/2402600; Hin V, 2019, ECOL APPL, V29, DOI 10.1002/eap.1903; Illius AW, 2000, OIKOS, V89, P283, DOI 10.1034/j.1600-0706.2000.890209.x; Isojunno S, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2044; Isojunno S, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01462; KASUYA T, 1991, MAR MAMMAL SCI, V7, P230, DOI 10.1111/j.1748-7692.1991.tb00100.x; Klanjscek T, 2007, ECOL APPL, V17, P2233, DOI 10.1890/06-0426.1; Kooijman B., 2009, DYNAMIC ENERGY BUDGE, V3rd ed, DOI [10.1017/CBO9780511805400, DOI 10.1017/CBO9780511805400]; Laws R.M., 1977, ADAPTATIONS ANTARCTI, P411; Lockyer C., 1984, Reports of the International Whaling Commission Special Issue, P27; LOCKYER C, 1986, CAN J FISH AQUAT SCI, V43, P142, DOI 10.1139/f86-015; Lockyer Christina, 1993, Reports of the International Whaling Commission Special Issue, V14, P325; Martin A.R., 1993, Reports of the International Whaling Commission Special Issue, V14, P263; Maxwell SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3688; McHuron EA, 2017, METHODS ECOL EVOL, V8, P552, DOI 10.1111/2041-210X.12701; Moore SE, 2001, MAR MAMMAL SCI, V17, P954, DOI 10.1111/j.1748-7692.2001.tb01310.x; Nabe-Nielsen J, 2018, CONSERV LETT, V11, DOI 10.1111/conl.12563; Nabe-Nielsen J, 2014, ECOL MODEL, V272, P242, DOI 10.1016/j.ecolmodel.2013.09.025; National Academic of Sciences Engineering and Medicine, 2017, APPROACHES UNDERSTAN, DOI [10.17226/23479, DOI 10.17226/23479]; National Research Council, 2005, MAR MAMM POP OC NOIS; New LF, 2014, MAR ECOL PROG SER, V496, P99, DOI 10.3354/meps10547; New LF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068725; Pettis HM, 2017, ENDANGER SPECIES RES, V32, P237, DOI 10.3354/esr00800; Pettis HM, 2004, CAN J ZOOL, V82, P8, DOI [10.1139/z03-207, 10.1139/Z03-207]; Pettorelli N, 2002, P ROY SOC B-BIOL SCI, V269, P747, DOI 10.1098/rspb.2001.1791; Pike DG., 2019, NAMMCO SCI PUBLICATI, DOI [10.7557/3.4643, DOI 10.7557/3.4643]; Pirotta E, 2019, OIKOS, V128, P1340, DOI 10.1111/oik.06146; Pirotta E, 2018, ECOL EVOL, V8, P9934, DOI 10.1002/ece3.4458; Pirotta E, 2018, AM NAT, V191, pE40, DOI 10.1086/695135; Pitcher KW, 1998, CAN J ZOOL, V76, P2075, DOI 10.1139/cjz-76-11-2075; Punt AE, 2007, ICES J MAR SCI, V64, P603, DOI 10.1093/icesjms/fsm035; R Core Team, 2020, R LANG ENV STAT COMP; Rolland RM, 2016, MAR ECOL PROG SER, V542, P265, DOI 10.3354/meps11547; Rosen DAS, 2007, PHILOS T R SOC B, V362, P2151, DOI 10.1098/rstb.2007.2108; Saether BE, 1997, TRENDS ECOL EVOL, V12, P143, DOI 10.1016/S0169-5347(96)10068-9; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Sibly RM, 2005, SCIENCE, V309, P607, DOI 10.1126/science.1110760; SILER W, 1979, ECOLOGY, V60, P750, DOI 10.2307/1936612; Sinclair ARE, 2003, PHILOS T R SOC B, V358, P1729, DOI 10.1098/rstb.2003.1359; Sinclair ARE, 1996, FRONTIERS OF POPULATION ECOLOGY, P127; Slotte A, 2004, FISH RES, V67, P143, DOI 10.1016/j.fishres.2003.09.046; TAYLOR BL, 1993, MAR MAMMAL SCI, V9, P360, DOI 10.1111/j.1748-7692.1993.tb00469.x; Villegas-Amtmann S, 2017, ENDANGER SPECIES RES, V34, P167, DOI 10.3354/esr00843; Villegas-Amtmann S, 2015, ECOSPHERE, V6, DOI 10.1890/ES15-00146.1; Visser F, 2014, BEHAVIOUR, V151, P1453, DOI 10.1163/1568539X-00003195; Williams R, 2013, ICES J MAR SCI, V70, P1273, DOI 10.1093/icesjms/fst059	81	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 3	2021	16	6							e0252677	10.1371/journal.pone.0252677	http://dx.doi.org/10.1371/journal.pone.0252677			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6QS	34081741	Green Published, gold			2022-12-26	WOS:000664639200044
J	Leverrier-Penna, S; Michel, A; Lecante, LL; Costet, N; Suglia, A; Desdoits-Lethimonier, C; Boulay, H; Viel, R; Chemouny, JM; Becker, E; Lavoue, V; Rolland, AD; Dejucq-Rainsford, N; Vigneau, C; Mazaud-Guittot, S				Leverrier-Penna, Sabrina; Michel, Alain; Lecante, Laetitia L.; Costet, Nathalie; Suglia, Antonio; Desdoits-Lethimonier, Christele; Boulay, Hugoline; Viel, Roselyne; Chemouny, Jonathan M.; Becker, Emmanuelle; Lavoue, Vincent; Rolland, Antoine D.; Dejucq-Rainsford, Nathalie; Vigneau, Cecile; Mazaud-Guittot, Severine			Exposure of human fetal kidneys to mild analgesics interferes with early nephrogenesis	FASEB JOURNAL			English	Article						acetaminophen; fetal kidney; nephrogenesis; NSAIDs; prostaglandins	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ACUTE-RENAL-FAILURE; LOW-BIRTH-WEIGHT; TUBULAR INJURY; NEPHRON NUMBER; ACETAMINOPHEN; PARACETAMOL; IBUPROFEN; RECEPTOR; ASPIRIN	Acetaminophen, aspirin, and ibuprofen are mild analgesics commonly used by pregnant women, the sole current recommendation being to avoid ibuprofen from the fifth month of gestation. The nephrotoxicity of these three analgesics is well documented in adults, as is their interference with prostaglandins biosynthesis. Here we investigated the effect of these analgesics on human first trimester kidneys ex vivo. We first evaluated prostaglandins biosynthesis functionality by performing a wide screening of prostaglandin expression patterns in first trimester human kidneys. We demonstrated that prostaglandins biosynthesis machinery is functional during early nephrogenesis. Human fetal kidney explants aged 7-12 developmental weeks were exposed ex vivo to ibuprofen, aspirin or acetaminophen for 7 days, and analyzed by histology, immunohistochemistry, and flow cytometry. This study has revealed that these analgesics induced a spectrum of abnormalities within early developing structures, ranging from cell death to a decline in differentiating glomeruli density. These results warrant caution for the use of these medicines during the first trimester of pregnancy.	[Leverrier-Penna, Sabrina; Lecante, Laetitia L.; Costet, Nathalie; Suglia, Antonio; Desdoits-Lethimonier, Christele; Becker, Emmanuelle; Rolland, Antoine D.; Dejucq-Rainsford, Nathalie; Vigneau, Cecile; Mazaud-Guittot, Severine] Univ Rennes, Irset Inst Rech Sante Environm & Travail, UMR S 1085, EHESP,INSERM, Rennes, France; [Michel, Alain; Boulay, Hugoline; Chemouny, Jonathan M.; Vigneau, Cecile] Univ Rennes, CHU Rennes, INSERM, EHESP,Irset Inst Rech Sante Environm & Travail,UM, Rennes, France; [Viel, Roselyne] Univ Rennes 1, CNRS, Inserm UMS Biosit, Core Facil H2P2, Rennes, France; [Lavoue, Vincent] CHU Rennes, Serv Gynecol & Obstet, Rennes, France; [Leverrier-Penna, Sabrina] Univ Poitiers, Stem, CNRS, ERL7003, Poitiers, France	Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Ecole des Hautes Etudes en Sante Publique (EHESP); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; CHU Rennes; Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers	Vigneau, C; Mazaud-Guittot, S (corresponding author), CHU Pontchaillou, Serv Nephrol, F-35033 Rennes 9, France.	Cecile.VIGNEAU@chu-rennes.fr; severine.mazaud@univ-rennes1.fr	Mazaud-Guittot, Severine/I-4694-2015; ROLLAND, Antoine D/B-2611-2012	Mazaud-Guittot, Severine/0000-0003-0566-4124; ROLLAND, Antoine D/0000-0002-9758-4406; Desdoits-Lethimonier, Christele/0000-0003-4232-2107; Dejucq-Rainsford, Nathalie/0000-0002-1788-2690; Lecante, Laetitia/0000-0002-3185-7803	Inserm, University of Rennes 1, EHESP-School of Public Health; Agence Nationale de Securite du Medicament et des Produits de Sante (ANSM) [HAP-2014-073]; Agence Nationale de la Recherche [ANR-15-CE34-0001-01]; French Society of Nephrology	Inserm, University of Rennes 1, EHESP-School of Public Health; Agence Nationale de Securite du Medicament et des Produits de Sante (ANSM)(French National Research Agency (ANR)); Agence Nationale de la Recherche(French National Research Agency (ANR)); French Society of Nephrology	We thank the entire staff of the Obstetrics and Gynecology Department of the Rennes Sud Hospital (Rennes, France), along with the participating women, without whom this study would have been impossible. We thank Pauline Le Faouder from the MetaToul-Lipidomique core facility (I2MC, Inserm 1048, Toulouse, France), MetaboHUB-ANR-11-INBS-0010 for prostaglandin measurements. Thanks to the staff at the Biosit histopathology platform (Biogenouest, Universite de Rennes 1, Rennes, France). We are grateful to Isabelle Coiffec for help with organ collection, and to Juliana Berland for American editing. This study was funded by Inserm, University of Rennes 1, EHESP-School of Public Health. SLP was a recipient of a stipend from the Agence Nationale de Securite du Medicament et des Produits de Sante (ANSM; HAP-2014-073), LL from the Agence Nationale de la Recherche (ANR-15-CE34-0001-01) and AM from The French Society of Nephrology.	Abe K, 2003, BIRTH DEFECTS RES A, V67, P911, DOI 10.1002/bdra.10130; Akinola O, 2003, Niger Postgrad Med J, V10, P46; Akiyama K, 2013, PATHOL INT, V63, P37, DOI 10.1111/pin.12031; Aminoshariae A, 2015, J ENDODONT, V41, P588, DOI 10.1016/j.joen.2015.01.024; Anderson BJ, 2008, PEDIATR ANESTH, V18, P915, DOI 10.1111/j.1460-9592.2008.02764.x; Andersson S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15840; Azzarello J, 2008, J HISTOCHEM CYTOCHEM, V56, P853, DOI 10.1369/jhc.2008.951384; BLAKELY P, 1995, J AM SOC NEPHROL, V6, P48; BRANDON RA, 1986, CEPHALALGIA, V6, P19, DOI 10.1046/j.1468-2982.1986.0601019.x; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; BRIERE N, 1991, BIOCHEM CELL BIOL, V69, P256, DOI 10.1139/o91-039; Brune K, 2015, J PAIN RES, V8, P105, DOI 10.2147/JPR.S75160; Bueters RRG, 2015, BIRTH DEFECTS RES B, V104, P218, DOI 10.1002/bdrb.21161; Carmody JB, 2013, PEDIATRICS, V131, P1168, DOI 10.1542/peds.2013-0009; Cataldi L, 2005, ARCH DIS CHILD-FETAL, V90, pF514, DOI 10.1136/adc.2004.060434; Cuzzolin L, 2001, DRUG SAFETY, V24, P9, DOI 10.2165/00002018-200124010-00002; Daniel S, 2012, J RHEUMATOL, V39, P2163, DOI 10.3899/jrheum.120453; Deleage C, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-017-0387-9; Drukker Alfred, 2002, Paediatr Child Health, V7, P538; Duncan K, 2012, IUBMB LIFE, V64, P636, DOI 10.1002/iub.1035; Ericson A, 2001, REPROD TOXICOL, V15, P371, DOI 10.1016/S0890-6238(01)00137-X; Espiridiao S, 2002, Clin Exp Obstet Gynecol, V29, P37; Eyers S, 2011, CLIN EXP ALLERGY, V41, P482, DOI 10.1111/j.1365-2222.2010.03691.x; Fored CM, 2001, NEW ENGL J MED, V345, P1801, DOI 10.1056/NEJMoa010323; Frances F, 2007, CLIN CHIM ACTA, V386, P53, DOI 10.1016/j.cca.2007.07.020; Frolich S, 2012, AM J PHYSIOL-RENAL, V303, pF209, DOI 10.1152/ajprenal.00418.2011; Gaskell TL, 2004, BIOL REPROD, V71, P2012, DOI 10.1095/biolreprod.104.028381; GOVINDARAJAN S, 1987, HEPATOLOGY, V7, P654, DOI 10.1002/hep.1840070407; Guignard JP, 2005, ARCH PEDIATRIE, V12, P726, DOI 10.1016/j.arcped.2005.04.060; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; Hinz B, 2012, ANN RHEUM DIS, V71, P20, DOI 10.1136/ard.2011.200087; Hochane M, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000152; Hodgin JB, 2009, CLIN J AM SOC NEPHRO, V4, P71, DOI 10.2215/CJN.01700408; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; KALLSTROM E, 1988, J INT MED RES, V16, P44; KARTTUNEN P, 1990, INT J CLIN PHARM TH, V28, P251; Kent AL, 2007, PEDIATR RES, V62, P307, DOI 10.1203/PDR.0b013e318123f6e3; Khan KNM, 2001, PEDIATR DEVEL PATHOL, V4, P461, DOI 10.1007/s10024001-0041-2; Klein T., 2015, MEDIAT INFLAMM, V2015; Komhoff M, 1997, AM J PHYSIOL-RENAL, V272, pF460, DOI 10.1152/ajprenal.1997.272.4.F460; Komhoff M, 2000, KIDNEY INT, V57, P414; Komhoff M, 1998, KIDNEY INT, V54, P1899, DOI 10.1046/j.1523-1755.1998.00213.x; Kristensen DM, 2016, NAT REV ENDOCRINOL, V12, P381, DOI 10.1038/nrendo.2016.55; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Leverrier-Penna S, 2018, HUM REPROD, V33, P482, DOI 10.1093/humrep/dex383; LEVY G, 1981, ARCH INTERN MED, V141, P279, DOI 10.1001/archinte.141.3.279; Lindstrom NO, 2018, DEV CELL, V45, P651, DOI 10.1016/j.devcel.2018.05.010; Lorz C, 2004, J AM SOC NEPHROL, V15, P380, DOI 10.1097/01.ASN.0000111289.91206.B0; Luyckx VA, 2005, KIDNEY INT, V68, pS68, DOI 10.1111/j.1523-1755.2005.09712.x; Mazaud-Guittot S, 2013, J CLIN ENDOCR METAB, V98, pE1757, DOI 10.1210/jc.2013-2531; Morath R, 1999, J AM SOC NEPHROL, V10, P1851; Naga Rani M A, 1989, J Indian Med Assoc, V87, P182; Norwood VF, 2000, KIDNEY INT, V58, P2291, DOI 10.1046/j.1523-1755.2000.00413.x; O'Connor T, 1999, BIOCHEM J, V343, P487, DOI 10.1042/0264-6021:3430487; Olliges A, 2011, BRIT J PHARMACOL, V163, P927, DOI 10.1111/j.1476-5381.2011.01313.x; Rainsford K. D., 2009, Inflammopharmacology, V17, P275, DOI 10.1007/s10787-009-0016-x; RAYBURN W, 1986, AM J OBSTET GYNECOL, V155, P1353, DOI 10.1016/0002-9378(86)90173-0; REGAZZI BM, 1986, INT J CLIN PHARM RES, V6, P469; Roberts E, 2016, ANN RHEUM DIS, V75, P552, DOI 10.1136/annrheumdis-2014-206914; Sales KJ, 2003, PROSTAG OTH LIPID M, V71, P97, DOI 10.1016/S1098-8823(03)00050-9; Slattery P, 2016, AM J PHYSIOL-RENAL, V310, pF1113, DOI 10.1152/ajprenal.00430.2015; Smith WL, 2001, J CLIN INVEST, V107, P1491, DOI 10.1172/JCI13271; Therland KL, 2004, J AM SOC NEPHROL, V15, P1189, DOI 10.1097/01.ASN.0000124673.79934.24; Thiele K, 2013, J REPROD IMMUNOL, V97, P128, DOI 10.1016/j.jri.2012.10.014; Tsujii M, 1998, CELL, V93, P705, DOI 10.1016/S0092-8674(00)81433-6; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; van den Driesche S, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4097; Vieira LD, 2008, FUND CLIN PHARMACOL, V22, P379, DOI 10.1111/j.1472-8206.2008.00604.x; Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002; Welham Simon J M, 2017, World J Nephrol, V6, P21, DOI 10.5527/wjn.v6.i1.21; White SL, 2009, AM J KIDNEY DIS, V54, P248, DOI 10.1053/j.ajkd.2008.12.042; Yamamoto E, 2011, J TOXICOL PATHOL, V24, P257, DOI 10.1293/tox.24.257	76	1	1	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21718	10.1096/fj.202100050R	http://dx.doi.org/10.1096/fj.202100050R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34105801				2022-12-26	WOS:000667814100041
J	Okutsu, M; Yamada, M; Tokizawa, K; Marui, S; Suzuki, K; Lira, VA; Nagashima, K				Okutsu, Mitsuharu; Yamada, Mami; Tokizawa, Ken; Marui, Shuri; Suzuki, Katsuhiko; Lira, Vitor A.; Nagashima, Kei			Regular exercise stimulates endothelium autophagy via IL-1 signaling in ApoE deficient mice	FASEB JOURNAL			English	Article						atherosclerosis; autophagy; cholesterol; exercise; inflammation; interleukine-1	ATHEROSCLEROSIS; MECHANISMS; ATHEROGENESIS; CHOLESTEROL; MACROPHAGES; ADAPTATION; LESIONS; FAT	Regular exercise maintains arterial endothelial cell homeostasis and protects the arteries from vascular disease, such as peripheral artery disease and atherosclerosis. Autophagy, which is a cellular process that degrades misfolded or aggregate proteins and damaged organelles, plays an important role in maintaining organ and cellular homeostasis. However, it is unknown whether regular exercise stimulates autophagy in aorta endothelial cells of mice prone to atherosclerosis independently of their circulating lipid profile. Here, we observed that 16 weeks of voluntary exercise reduced high-fat diet-induced atherosclerotic plaque formation in the aortic root of ApoE deficient mice, and that this protection occurred without changes in circulating triglycerides, total cholesterol, and lipoproteins. Immunofluorescence analysis indicated that voluntary exercise increased levels of the autophagy protein LC3 in aortic endothelial cells. Interestingly, human umbilical vein endothelial cells (HUVECs) exposed to serum from voluntarily exercised mice displayed significantly increased LC3-I and LC3-II protein levels. Analysis of circulating cytokines demonstrated that voluntary exercise caused changes directly relevant to IL-1 signaling (ie, decreased interleukin-1 receptor antagonist [IL-1ra] while also increasing IL-1 alpha). HUVECs exposed to IL-1 alpha and IL-1 beta recombinant protein significantly increased LC3 mRNA expression, LC3-I and LC3-II protein levels, and autophagy flux. Collectively, these results suggest that regular exercise protects arteries from ApoE deficient mice against atherosclerosis at least in part by stimulating endothelial cell autophagy via enhanced IL-1 signaling.	[Okutsu, Mitsuharu; Yamada, Mami] Nagoya City Univ, Grad Sch Sci, Nagoya, Aichi, Japan; [Tokizawa, Ken] Natl Inst Occupat Safety & Hlth, Tokyo, Japan; [Marui, Shuri; Nagashima, Kei] Waseda Univ, Fac Human Sci, Tokorozawa, Saitama, Japan; [Suzuki, Katsuhiko] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Lira, Vitor A.] Univ Iowa, Fraternal Order Eagles Diabet Res Ctr, Dept Hlth & Human Physiol, Iowa City, IA USA	Nagoya City University; Waseda University; Waseda University; University of Iowa	Okutsu, M (corresponding author), Nagoya City Univ, Grad Sch Sci, Mizuho Ku, Yamanohata 1,Mizuho Cho, Nagoya, Aichi 4678501, Japan.	okutsu@nsc.nagoya-cu.ac.jp		Lira, Vitor A./0000-0002-3162-3804	MEXT \ Japan Society for the Promotion of Science (JSPS) [16K13019, 18H03153, 21H03326, 20J15551]; Meiji Yasuda Life Foundation of Health and Welfare; Kao Foundation for Health and Science	MEXT \ Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Meiji Yasuda Life Foundation of Health and Welfare(Meiji Yasuda Life Foundation of Health and Welfare); Kao Foundation for Health and Science	MEXT vertical bar Japan Society for the Promotion of Science (JSPS), Grant/Award Number: 16K13019, 18H03153, 21H03326 and 20J15551; The Meiji Yasuda Life Foundation of Health and Welfare; The Kao Foundation for Health and Science	Ajijola OA, 2009, ANTIOXID REDOX SIGN, V11, P15, DOI 10.1089/ars.2008.2092; Alexander MR, 2012, J CLIN INVEST, V122, P70, DOI 10.1172/JCI43713; Antunes BMM, 2016, CURR CARDIOL REV, V12, P47, DOI 10.2174/1573403X12666160126115317; Basterfield L, 2009, INT J OBESITY, V33, P212, DOI 10.1038/ijo.2008.253; Cahill PA, 2016, ATHEROSCLEROSIS, V248, P97, DOI 10.1016/j.atherosclerosis.2016.03.007; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Cesar L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017263; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Green DJ, 2017, PHYSIOL REV, V97, P495, DOI 10.1152/physrev.00014.2016; Grumati P, 2011, AUTOPHAGY, V7, P1415, DOI 10.4161/auto.7.12.17877; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li Y, 2020, OBES RES CLIN PRACT, V14, P264, DOI 10.1016/j.orcp.2020.04.008; Libby P, 2011, NATURE, V473, P317, DOI 10.1038/nature10146; Libby P, 2009, J AM COLL CARDIOL, V54, P2129, DOI 10.1016/j.jacc.2009.09.009; Lira VA, 2013, FASEB J, V27, P4184, DOI 10.1096/fj.13-228486; Matsushima Y, 2001, J Atheroscler Thromb, V8, P71; Matsushima Y, 1999, MAMM GENOME, V10, P352, DOI 10.1007/s003359901000; Menon P, 2015, METHODS MOL BIOL, V1339, P131, DOI 10.1007/978-1-4939-2929-0_9; Missiou A, 2010, CIRC RES, V107, P757, DOI 10.1161/CIRCRESAHA.110.219295; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Muscella A, 2020, AM J PHYSIOL-HEART C, V319, pH76, DOI 10.1152/ajpheart.00708.2019; NAKASHIMA Y, 1994, ARTERIOSCLER THROMB, V14, P133, DOI 10.1161/01.ATV.14.1.133; Niebauer J, 1996, J AM COLL CARDIOL, V28, P1652, DOI 10.1016/S0735-1097(96)00393-2; Okutsu M, 2008, BRAIN BEHAV IMMUN, V22, P1066, DOI 10.1016/j.bbi.2008.03.006; Okutsu M, 2014, CIRC-HEART FAIL, V7, P519, DOI 10.1161/CIRCHEARTFAILURE.113.000841; Okutsu M, 2014, ATHEROSCLEROSIS, V232, P414, DOI 10.1016/j.atherosclerosis.2013.11.076; Pellegrin M, 2007, ATHEROSCLEROSIS, V190, P35, DOI 10.1016/j.atherosclerosis.2006.02.001; Ravikumar B, 2010, PHYSIOL REV, V90, P1383, DOI 10.1152/physrev.00030.2009; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; SLYPER AH, 1994, JAMA-J AM MED ASSOC, V272, P305, DOI 10.1001/jama.272.4.305; Smith DD, 2010, J PHYSIOL PHARMACOL, V61, P309; Tanaka G, 2015, BIOCHEM BIOPH RES CO, V466, P512, DOI 10.1016/j.bbrc.2015.09.061; Usui S, 2002, J LIPID RES, V43, P805; Vieira VJ, 2009, CYTOKINE, V46, P339, DOI 10.1016/j.cyto.2009.03.006; Vion AC, 2017, P NATL ACAD SCI USA, V114, pE8675, DOI 10.1073/pnas.1702223114; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; Yamada M, 2019, AM J PHYSIOL-REG I, V317, pR770, DOI 10.1152/ajpregu.00155.2019; Yamada M, 2019, FASEB J, V33, P8022, DOI 10.1096/fj.201900133R; Zhang CB, 2013, AM J PHYSIOL-ENDOC M, V305, pE530, DOI 10.1152/ajpendo.00640.2012; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	43	5	6	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2021	35	7							e21698	10.1096/fj.202002790RR	http://dx.doi.org/10.1096/fj.202002790RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	TB2YH	34085350				2022-12-26	WOS:000667814100076
J	Amirkhiz, GDH; Babaei, MR; Madani, NH; Khamseh, ME				Amirkhiz, Gisoo Darban Hosseini; Babaei, Mohammad Reza; Madani, Nahid Hashemi; Khamseh, Mohammad Ebrahim			Toe-brachial index is beyond a peripheral issue in patients with type 2 diabetes	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CARDIOVASCULAR EVENTS; MORTALITY; DISEASE; ATHEROSCLEROSIS; POPULATION	Background Atherosclerosis is the leading cause of death in patients with diabetes. We aimed to evaluate the association between ankle-brachial index (ABI) and toe-brachial index (TBI) with carotid intima-media thickness (CIMT) in patients with type 2 diabetes (T2DM). Methods This cross sectional study included 296 patients with T2DM who met the American Diabetes Association criteria for the assessment of peripheral arterial atherosclerosis. The ABI <= 0.9 and TBI <= 0.7 were considered as abnormal values. Linear and logistic regression analyses were performed to evaluate the association between TBI/ABI and CIMT. Results Right CIMT was significantly greater in the low TBI group (p = 0.03) while, left CIMT did not show a significant difference. Each 0.1-unit decrease in TBI value was independently associated with 0.017 mm increase in the right CIMT (beta SE; -0.017 +/- 0.005, p = 0.002) and with odds of the presence of increased CIMT [odds ratio and 95% confidence interval: 1.21 (1.02, 1.44)] after adjustment with all traditional risk factors. There was not any significant association between ABI and increased CIMT. Conclusions Beyond a suitable tool for the diagnosis of peripheral artery disease in patients with T2DM, TBI can be applied for prediction of subclinical carotid atherosclerosis.	[Amirkhiz, Gisoo Darban Hosseini] Iran Univ Med Sci IUMS, Inst Endocrinol & Metab, Res Ctr Prevent Cardiovasc Dis, Tehran, Iran; [Babaei, Mohammad Reza] Iran Univ Med Sci IUMS, Firouzgar Hosp, Dept Intervent Radiol, Tehran, Iran; [Madani, Nahid Hashemi; Khamseh, Mohammad Ebrahim] Iran Univ Med Sci IUMS, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran	Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences	Madani, NH (corresponding author), Iran Univ Med Sci IUMS, Inst Endocrinol & Metab, Endocrine Res Ctr, Tehran, Iran.	nahid.hashemimadani@gmail.com		Darban Hosseini Amirkhiz, Gisoo/0000-0001-5847-2244				Amer Diabet Assoc, 2016, DIABETES CARE, V39, pS72, DOI 10.2337/dc16-S012; [Anonymous], 2017, 10 MICROVASCULAR COM, V40, pS88; Azarkish Kamran, 2014, Acta Med Iran, V52, P884; Babaei MR., 2019, PRIM CARE DIABETES; Cao P, 2011, EUR J VASC ENDOVASC, V42, pS13, DOI 10.1016/S1078-5884(11)60010-5; Creager MA, 2008, CIRCULATION, V118, P2811, DOI 10.1161/CIRCULATIONAHA.108.191170; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Gepner AD, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.002262; HEISS G, 1991, AM J EPIDEMIOL, V134, P250, DOI 10.1093/oxfordjournals.aje.a116078; Hyun Suzanne, 2014, J Vasc Surg, V60, P390, DOI 10.1016/j.jvs.2014.02.008; Alvaro-Afonso FJ, 2018, DIABETES VASC DIS RE, V15, P344, DOI 10.1177/1479164118767599; Alvaro-Afonso FJ, 2015, INT J LOW EXTR WOUND, V14, P372, DOI 10.1177/1534734615596906; Kassem A., 2018, A3005 CAROTID INTIMA, V36, pE142; Brasileiro ACL, 2013, ARQ BRAS CARDIOL, V100, P422, DOI 10.5935/abc.20130057; Liu DM, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/9879463; Lopez-Cancio E, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-22; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Luo X, 2011, CLIN RADIOL, V66, P393, DOI 10.1016/j.crad.2010.12.002; Martin-Fuentes M, 2018, J Assoc Physicians India, V66, P36; Mitu F, 2013, MED-SURG J, V117, P59; Morillas P, 2009, AM J CARDIOL, V104, P1494, DOI 10.1016/j.amjcard.2009.07.014; Nicolucci Antonio, 2007, Diabetes Care, V30, pe58, DOI 10.2337/dc07-0220; Nishimura RA, 2017, CIRCULATION, V135, pE1159, DOI 10.1161/CIR.0000000000000503; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Polak JF, 2016, GLOB HEART, V11, P295, DOI 10.1016/j.gheart.2016.08.006; Spangeus A, 2013, DIABETES RES CLIN PR, V100, P195, DOI 10.1016/j.diabres.2013.03.004; Wang Y, 2011, INT ANGIOL, V30, P451; Weir-McCall JR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099190; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wickstrom JE, 2017, EUR J VASC ENDOVASC, V53, P696, DOI 10.1016/j.ejvs.2017.02.012; Wyman Rachael A, 2006, WMJ, V105, P50; Zhang YF, 2018, DIABETES RES CLIN PR, V144, P245, DOI 10.1016/j.diabres.2018.08.017	33	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253138	10.1371/journal.pone.0253138	http://dx.doi.org/10.1371/journal.pone.0253138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129625	gold, Green Published			2022-12-26	WOS:000665475100029
J	Zhang, Y; Wang, Y; Zhou, D; Wang, K; Wang, X; Wang, X; Jiang, Y; Zhao, M; Yu, RT; Zhou, XP				Zhang, Yu; Wang, Yan; Zhou, Ding; Wang, Kai; Wang, Xu; Wang, Xiang; Jiang, Yang; Zhao, Min; Yu, Rutong; Zhou, Xiuping			Radiation-induced YAP activation confers glioma radioresistance via promoting FGF2 transcription and DNA damage repair	ONCOGENE			English	Article							FIBROBLAST-GROWTH-FACTOR; GLIOBLASTOMA RADIORESISTANCE; HIPPO PATHWAY; CELLS; INVASION; PROTEIN; EXPRESSION; MIGRATION; AKT	Although radiotherapy is a well-known effective non-surgical treatment for malignant gliomas, the therapeutic efficacy is severely limited due to the radioresistance of tumor cells. Previously, we demonstrated that Yes-associated protein (YAP) promotes glioma malignant progression. However, whether YAP plays a role in radioresistance and its potential value in cancer treatment are still unclear. In this study, we found that high YAP expression is associated with poor prognosis in malignant glioma patients undergoing radiotherapy. Research in immortalized cell lines and primary cells from GBM patients revealed that YAP exhibited a radioresistant effect on gliomas via promoting DNA damage repair. Mechanistically, after radiation, YAP was translocated into the nucleus, where it promoted the expression and secretion of FGF2, leading to MAPK-ERK pathway activation. FGF2 is a novel target gene of YAP. Inhibition of YAP-FGF2-MAPK signaling sensitizes gliomas to radiotherapy and prolongs the survival of intracranial cell-derived and patient-derived xenograft models. These results suggest that YAP-FGF2-MAPK is a key mechanism of radioresistance and is an actionable target for improving radiotherapy efficacy.	[Zhang, Yu; Wang, Yan; Zhou, Ding; Wang, Kai; Wang, Xu; Wang, Xiang; Jiang, Yang; Zhao, Min; Yu, Rutong; Zhou, Xiuping] Xuzhou Med Univ, Inst Nervous Syst Dis, Xuzhou, Jiangsu, Peoples R China; [Zhang, Yu; Wang, Yan; Zhou, Ding; Wang, Kai; Wang, Xu; Wang, Xiang; Jiang, Yang; Zhao, Min; Yu, Rutong; Zhou, Xiuping] Xuzhou Med Univ, Affiliated Hosp, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China; [Zhang, Yu; Wang, Yan; Zhou, Ding; Wang, Kai; Wang, Xu; Wang, Xiang; Jiang, Yang; Zhao, Min; Yu, Rutong; Zhou, Xiuping] Xuzhou Med Univ, Grad Sch, Xuzhou, Jiangsu, Peoples R China	Xuzhou Medical University; Xuzhou Medical University; Xuzhou Medical University	Yu, RT; Zhou, XP (corresponding author), Xuzhou Med Univ, Inst Nervous Syst Dis, Xuzhou, Jiangsu, Peoples R China.; Yu, RT; Zhou, XP (corresponding author), Xuzhou Med Univ, Affiliated Hosp, Dept Neurosurg, Xuzhou, Jiangsu, Peoples R China.; Yu, RT; Zhou, XP (corresponding author), Xuzhou Med Univ, Grad Sch, Xuzhou, Jiangsu, Peoples R China.	yu.rutong@163.com; xpzhou@xzhmu.edu.cn			National Natural Science Foundation of China [81872053, 81902526, 82072770]; Natural Science Foundation of Jiangsu province [BK20201458]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX19_2225]; Social Development Project of XuZhou [KC20125]; Youth Science and Technology Innovation Team Cultivation Program of Xuzhou Medical University [TD2020002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu province(Natural Science Foundation of Jiangsu Province); Postgraduate Research & Practice Innovation Program of Jiangsu Province; Social Development Project of XuZhou; Youth Science and Technology Innovation Team Cultivation Program of Xuzhou Medical University	We thank the supports from Professor Longzhen Zhang and Professor Lingyu Zeng at the Affiliated Hospital of Xuzhou Medical University. This work was supported by the National Natural Science Foundation of China (numbers 81872053, 81902526, and 82072770); Natural Science Foundation of Jiangsu province (number BK20201458); the Postgraduate Research & Practice Innovation Program of Jiangsu Province (number KYCX19_2225), Social Development Project of XuZhou (number KC20125), and Youth Science and Technology Innovation Team Cultivation Program of Xuzhou Medical University (number TD2020002).	Ader I, 2002, ONCOGENE, V21, P6471, DOI 10.1038/sj.onc.1205838; Ader I, 2014, EUR J CANCER, V50, P2351, DOI 10.1016/j.ejca.2014.05.012; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Ciamporcero E, 2016, ONCOGENE, V35, P1541, DOI 10.1038/onc.2015.219; CohenJonathan E, 1997, CANCER RES, V57, P1364; Edgar BA, 2006, CELL, V124, P267, DOI 10.1016/j.cell.2006.01.005; Fernandez A, 2012, ONCOGENE, V31, P1923, DOI 10.1038/onc.2011.379; Georgiou V, 2019, REV NEUROSCIENCE, V30, P543, DOI 10.1515/revneuro-2018-0051; Golding SE, 2009, CANCER BIOL THER, V8, P730, DOI 10.4161/cbt.8.8.7927; Gouaze-Andersson V, 2016, CANCER RES, V76, P3036, DOI 10.1158/0008-5472.CAN-15-2058; Gulston M, 2002, NUCLEIC ACIDS RES, V30, P3464, DOI 10.1093/nar/gkf467; Han D, 2020, STEM CELLS DEV, V29, P1240, DOI 10.1089/scd.2019.0281; Han XT, 2017, ONCOTARGET, V8, P100931, DOI 10.18632/oncotarget.21753; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Hu HM, 2018, CELL, V175, P1665, DOI 10.1016/j.cell.2018.09.038; Hua G, 2016, ONCOGENE, V35, P2247, DOI 10.1038/onc.2015.288; Ibrahimi OA, 2004, BIOCHEMISTRY-US, V43, P4724, DOI 10.1021/bi0352320; Jiang T, 2021, CANCER LETT, V499, P60, DOI 10.1016/j.canlet.2020.10.050; Katoh M, 2014, MED RES REV, V34, P280, DOI 10.1002/med.21288; Kim MH, 2017, CELL MOL LIFE SCI, V74, P1457, DOI 10.1007/s00018-016-2412-x; Liu XJ, 2015, J NEURO-ONCOL, V125, P113, DOI 10.1007/s11060-015-1901-3; Liu YP, 2016, CELL MOL NEUROBIOL, V36, P737, DOI 10.1007/s10571-015-0254-y; Ma JH, 2019, CANCER CELL, V35, P504, DOI [10.1016/j.ccell.2019.01.020, 10.1016/j.ccell.2019.04.011]; Marampon F, 2014, INT J ONCOL, V44, P2121, DOI 10.3892/ijo.2014.2358; Miao FA, 2019, J NEURO-ONCOL, V143, P221, DOI 10.1007/s11060-019-03163-6; Morgenroth A, 2014, ONCOTARGET, V5, P5483, DOI 10.18632/oncotarget.2123; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Sudol M, 2012, SEMIN CELL DEV BIOL, V23, P827, DOI 10.1016/j.semcdb.2012.05.002; Toyoda K, 2013, CELL MOL NEUROBIOL, V33, P489, DOI 10.1007/s10571-013-9913-z; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang X, 2019, CELL PROLIFERAT, V52, DOI 10.1111/cpr.12636; Wang Y, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0606-1; Yan JF, 2019, J CELL PHYSIOL, V234, P13014, DOI 10.1002/jcp.27971; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhang L, 2019, ONCOGENE, V38, P2788, DOI 10.1038/s41388-018-0626-0; Zhang Y, 2018, J MOL NEUROSCI, V64, P262, DOI 10.1007/s12031-017-1018-6; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhou XP, 2017, NEURO-ONCOLOGY, V19, P1628, DOI 10.1093/neuonc/nox104; Zhou Z, 2011, HEPATO-GASTROENTEROL, V58, P2156, DOI 10.5754/hge11234	39	17	17	2	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 8	2021	40	27					4580	4591		10.1038/s41388-021-01878-3	http://dx.doi.org/10.1038/s41388-021-01878-3		JUN 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	TG4PV	34127812	hybrid, Green Published			2022-12-26	WOS:000661408100004
J	Abu, P; Badu-Apraku, B; Ifie, BE; Tongoona, P; Melomey, LD; Offei, SK				Abu, Pearl; Badu-Apraku, Baffour; Ifie, Beatrice E.; Tongoona, Pangirayi; Melomey, Leander D.; Offei, Samuel K.			Genetic diversity and inter-trait relationship of tropical extra-early maturing quality protein maize inbred lines under low soil nitrogen stress	PLOS ONE			English	Article							DROUGHT TOLERANCE; GRAIN-YIELD; POPULATIONS REVEALS; SECONDARY TRAITS; HETEROTIC GROUPS; USE EFFICIENCY; ZEA-MAYS; IDENTIFICATION; PERFORMANCE; GERMPLASM	Information on the genetic diversity, population structure, and trait associations of germplasm resources is crucial for predicting hybrid performance. The objective of this study was to dissect the genetic diversity and population structure of extra-early yellow and orange quality protein maize (QPM) inbred lines and identify secondary traits for indirect selection for enhanced grain yield under low-soil nitrogen (LN). One hundred and ten inbred lines were assessed under LN (30 kg ha (-1)) and assayed for tryptophan content. The lines were genotyped using 2500 single nucleotide polymorphism (SNP) markers. Majority (85.4%) of the inbred lines exhibited wide pairwise genetic distances between 0.4801 and 0.600. Genetic distances were wider between yellow and orange endosperm lines and predicted high heterosis in crosses between parents of different endosperm colors. The unweighted pair group method with arithmetic mean (UPGMA) and the admixture model-based population structure method both grouped the lines into five clusters. The clustering was based on endosperm color, pedigree, and selection history but not on LN tolerance or tryptophan content. Genotype by trait biplot analysis revealed association of grain yield with plant height and ear height. TZEEQI 394 and TZEEIORQ 73A had high expressivity for these traits. Indirect selection for high grain yield among the inbred lines could be achieved using plant and ear heights as selection criteria. The wide genetic variability observed in this study suggested that the inbred lines could be important sources of beneficial alleles for LN breeding programs in SSA.	[Abu, Pearl; Ifie, Beatrice E.; Tongoona, Pangirayi; Melomey, Leander D.; Offei, Samuel K.] Univ Ghana, West Africa Ctr Crop Improvement, Legon, Ghana; [Badu-Apraku, Baffour] Int Inst Trop Agr IITA, Ibadan, Nigeria	University of Ghana; CGIAR; International Institute of Tropical Agriculture (IITA)	Badu-Apraku, B (corresponding author), Int Inst Trop Agr IITA, Ibadan, Nigeria.	b.badu-apraku@cgiar.org	Tongoona, Pangirayi/GSJ-0016-2022	Tongoona, Pangirayi/0000-0003-1030-8589; BADU-APRAKU, BAFFOUR/0000-0003-0113-5487; Abu, Pearl/0000-0002-3786-9485	USAID; DAAD through WACCI; Bill and Melinda Gates Foundation [OPP1134248]; African Union-European Union through the West Africa Centre for Crop Improvement (WACCI) [AURGII-1-209-2016]; Africa Centers of Excellence for Development Impact (ACE Impact) project	USAID(United States Agency for International Development (USAID)); DAAD through WACCI; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); African Union-European Union through the West Africa Centre for Crop Improvement (WACCI); Africa Centers of Excellence for Development Impact (ACE Impact) project	Financial support for this research was provided by the USAID and DAAD through WACCI which sponsored the first author for her PhD studies and the STMA funding by the Bill and Melinda Gates Foundation [Grant/Award Number: OPP1134248]. The genotyping was funded by African Union-European Union through the West Africa Centre for Crop Improvement (WACCI). Grant number AURGII-1-209-2016. This work is partially supported through the Africa Centers of Excellence for Development Impact (ACE Impact) project.	Abu P, 2021, CROP SCI, V61, P1052, DOI 10.1002/csc2.20384; Aci MM, 2018, BMC GENET, V19, DOI 10.1186/s12863-018-0655-2; Adu GB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214810; Almeida GD, 2014, MOL BREEDING, V34, P701, DOI 10.1007/s11032-014-0068-5; Almeida GD, 2013, THEOR APPL GENET, V126, P583, DOI 10.1007/s00122-012-2003-7; Amegbor IK, 2017, EUPHYTICA, V213, DOI 10.1007/s10681-016-1823-y; Annor B, 2016, EUPHYTICA, V212, P213, DOI 10.1007/s10681-016-1757-4; Badu-Apraku B, 2006, MAYDICA, V51, P551; Badu-Apraku B, 2004, J AGR SCI, V142, P445, DOI 10.1017/S0021859604004538; Badu-Apraku B, 2016, CROP SCI, V56, P183, DOI 10.2135/cropsci2015.05.0276; Badu-Apraku B, 2017, ADV GENETIC ENHANCEM, DOI [10.1017/S0021859617000636, DOI 10.1017/S0021859617000636]; Badu-Apraku B, 2011, MAYDICA, V56, P141; Banziger M., 2000, MEX DF CIMMYT, P68; Betran FJ, 2003, CROP SCI, V43, P807, DOI 10.2135/cropsci2003.0807; Bouchet S, 2017, HEREDITY, V118, P249, DOI 10.1038/hdy.2016.88; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Bremner J. M., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P595; Cai HG, 2012, MOL BREEDING, V30, P251, DOI 10.1007/s11032-011-9615-5; Cochran WG., 1960, EXPT DESIGNS J WILEY; Dao A, 2014, BMC GENET, V15, DOI 10.1186/s12863-014-0127-2; Das B, 2019, EUPHYTICA, V215, DOI 10.1007/s10681-019-2406-5; Ertiro BT, 2020, EUPHYTICA, V216, DOI 10.1007/s10681-020-02668-w; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Frankham R., 2002, INTRO CONSERVATION G, DOI [10.1016/s0031-9384%2802%2900783-7, DOI 10.1016/S0031-9384%2802%2900783-7]; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Govindaraj M, 2015, GENET RES INT, V2015, DOI 10.1155/2015/431487; Hao ZF, 2011, J INTEGR PLANT BIOL, V53, P641, DOI 10.1111/j.1744-7909.2011.01051.x; IFA, 2021, IFA DAT; Ifie BE, 2015, CROP SCI, V55, P610, DOI 10.2135/cropsci2014.07.0470; Jambrovic A, 2008, PERIOD BIOL, V110, P251; Jones ES, 2007, THEOR APPL GENET, V115, P361, DOI 10.1007/s00122-007-0570-9; Kondwakwenda A, 2020, ACTA AGR SCAND B-S P, V70, P265, DOI 10.1080/09064710.2020.1718198; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Landon J.R., 1991, HDB SOIL SURVEY AGR; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Lawson DJ, 2012, ANNU REV GENOM HUM G, V13, P337, DOI 10.1146/annurev-genom-082410-101510; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Liu NN, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1287-4; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Makumbi D, 2011, EUPHYTICA, V180, P143, DOI 10.1007/s10681-010-0334-5; Mandolino CI, 2018, MAYDICA, V63; Marsan PA, 1998, THEOR APPL GENET, V96, P219; Meseka SK, 2006, MAYDICA, V51, P487; Morosini JS, 2017, PLANT SOIL, V421, P453, DOI 10.1007/s11104-017-3479-3; Nei M., 1983, P 5 WORLD C GEN APPL, V21, P405; Nurit E, 2009, J AGR FOOD CHEM, V57, P7233, DOI 10.1021/jf901315x; Nyombayire A, 2016, MAYDICA, V61; Obeng-Bio E, 2018, THESIS U GHANA ACCRA; Oyekunle M, 2015, FIELD CROP RES, V170, P55, DOI 10.1016/j.fcr.2014.10.005; Prasanna BM, 2001, CURR SCI INDIA, V81, P1308; Presterl T, 2003, CROP SCI, V43, P1259, DOI 10.2135/cropsci2003.1259; Pritchard JK, 2000, GENETICS, V155, P945; Reif JC, 2004, CROP SCI, V44, P326, DOI 10.2135/cropsci2004.0326; Ribeiro PF, 2018, CROP SCI, V58, P321, DOI 10.2135/cropsci2017.02.0117; SAS Institute Inc, 2012, SAS SYSTEM WINDOWS R; Semagn K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-113; Suwarno WB, 2014, CROP SCI, V54, P14, DOI 10.2135/cropsci2013.02.0096; Trachsel S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149636; Vivek BS., 2008, BREEDING QUALITY PRO, P1; Warburton ML, 2008, CROP SCI, V48, P617, DOI 10.2135/cropsci2007.02.0103; Warburton ML, 2002, CROP SCI, V42, P1832, DOI 10.2135/cropsci2002.1832; Wu X, 2014, THEOR APPL GENET, V127, P621, DOI 10.1007/s00122-013-2246-y; Yan WK, 2008, CROP SCI, V48, P417, DOI 10.2135/cropsci2007.05.0254; Yan WeiKai, 2003, GGE biplot analysis: a graphical tool for breeders, geneticists, and agronomists; Yang XH, 2011, GENETICA, V139, P1045, DOI 10.1007/s10709-011-9606-9; Yang XH, 2011, MOL BREEDING, V28, P511, DOI 10.1007/s11032-010-9500-7; Zhang X, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3041-3; Ziyomo C, 2013, CROP SCI, V53, P1269, DOI 10.2135/cropsci2012.11.0651	69	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252506	10.1371/journal.pone.0252506	http://dx.doi.org/10.1371/journal.pone.0252506			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115794	gold, Green Published			2022-12-26	WOS:000664643000022
J	Mascarello, M; Amalfi, M; Asselman, P; Smets, E; Hardy, OJ; Beeckman, H; Janssens, SB				Mascarello, Maurizio; Amalfi, Mario; Asselman, Pieter; Smets, Erik; Hardy, Olivier J.; Beeckman, Hans; Janssens, Steven B.			Genome skimming reveals novel plastid markers for the molecular identification of illegally logged African timber species	PLOS ONE			English	Article							CHLOROPLAST DNA; PHYLOGENY; SEQUENCE; EVOLUTION; ALIGNMENT; BARCODES; INSIGHTS; TOOLS	Tropical forests represent vast carbon stocks and continue to be key carbon sinks and buffer climate changes. The international policy constructed several mechanisms aiming at conservation and sustainable use of these forests. Illegal logging is an important threat of forests, especially in the tropics. Several laws and regulations have been set up to combat illegal timber trade. Despite significant enforcement efforts of these regulations, illegal logging continues to be a serious problem and impacts for the functioning of the forest ecosystem and global biodiversity in the tropics. Microscopic analysis of wood samples and the use of conventional plant DNA barcodes often do not allow to distinguish closely-related species. The use of novel molecular technologies could make an important contribution for the identification of tree species. In this study, we used high-throughput sequencing technologies and bioinformatics tools to obtain the complete de-novo chloroplast genome of 62 commercial African timber species using the genome skimming method. Then, we performed a comparative genomic analysis that revealed new candidate genetic regions for the discrimination of closely-related species. We concluded that genome skimming is a promising method for the development of plant genetic markers to combat illegal logging activities supporting CITES, FLEGT and the EU Timber Regulation.	[Mascarello, Maurizio; Amalfi, Mario; Janssens, Steven B.] Meise Bot Garden, Meise, Belgium; [Mascarello, Maurizio; Janssens, Steven B.] Katholieke Univ Leuven, Dept Biol, Leuven, Belgium; [Amalfi, Mario] Federat Wallonie Bruxelles, Serv Gen Enseignement Univ & Rech Sci, Brussels, Belgium; [Asselman, Pieter] Univ Ghent, Dept Biol, Mycol & Systemat & Evolutionary Bot, Ghent, Belgium; [Smets, Erik] Nat Biodivers Ctr, Leiden, Netherlands; [Hardy, Olivier J.] Univ Libre Bruxelles, Evolutionary Biol & Ecol, Brussels, Belgium; [Beeckman, Hans] Royal Museum Cent Africa, Dept Biol, Wood Biol, Tervuren, Belgium	KU Leuven; Ghent University; Naturalis Biodiversity Center; Universite Libre de Bruxelles; Royal Museum for Central Africa	Mascarello, M (corresponding author), Meise Bot Garden, Meise, Belgium.; Mascarello, M (corresponding author), Katholieke Univ Leuven, Dept Biol, Leuven, Belgium.	maurizio.mascarello.88@gmail.com	Smets, Erik F/A-9875-2011	Smets, Erik F/0000-0002-9416-983X; Amalfi, Mario/0000-0002-1792-7828; asselman, pieter/0000-0003-3491-2174	Plant.ID project; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [765000]; SYNTHESYS Plus project [823827, H2020-EU.1.4.1.2]	Plant.ID project; European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa); SYNTHESYS Plus project	This study is supported by the Plant.ID project. Plant.ID has received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 765000. In addition, this research received support from the SYNTHESYS Plus project (https://www.synthesys.info/) funded under H2020-EU.1.4.1.2. grant agreement 823827.	Andrews S., 2010, FASTQC QUALITY CONTR; [Anonymous], 2012, GREEN CARBON BLACK T; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bi Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19591-9; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cardoso D, 2017, MOL PHYLOGENET EVOL, V107, P431, DOI 10.1016/j.ympev.2016.12.012; Cardoso D, 2012, AM J BOT, V99, P1991, DOI 10.3732/ajb.1200380; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; da Silva NR, 2017, ANN FOREST SCI, V74, DOI 10.1007/s13595-017-0619-0; Doyle JJ, 1997, AM J BOT, V84, P541, DOI 10.2307/2446030; Doyle JJ, 1996, MOL PHYLOGENET EVOL, V5, P429, DOI 10.1006/mpev.1996.0038; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; GANTT JS, 1991, EMBO J, V10, P3073, DOI 10.1002/j.1460-2075.1991.tb07859.x; Gasson P, 2011, IAWA J, V32, P137, DOI 10.1163/22941932-90000049; Halperin J, 2011, LESSONS REDD MEASURE; Hartvig I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138231; HILDEBRAND M, 1988, P NATL ACAD SCI USA, V85, P372, DOI 10.1073/pnas.85.2.372; Hollingsworth PM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0338; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; INTERPOL. INTERPOOL, 2016, MODUS OPERANDI ILL T; Jin JJ, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02154-5; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kazakoff SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051687; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lawson S, 2014, ILLEGAL LOGGING DEMO, V29; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; LIU C, 2019, NUCLEIC ACIDS RES, V47, pW65, DOI DOI 10.1093/NAR/GKZ345; Liu HS, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7265030; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Mader M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030701; Male PJG, 2014, MOL ECOL RESOUR, V14, P966, DOI 10.1111/1755-0998.12246; Mansourian S, 2016, IUFRO WORLD SERIES; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Parmentier I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054921; Rozas J, 2017, MOL BIOL EVOL, V34, P3299, DOI 10.1093/molbev/msx248; Song Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56727-x; Staats M, 2016, ANAL BIOANAL CHEM, V408, P4615, DOI 10.1007/s00216-016-9595-8; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tacconi L., 2016, IUFRO World Series, V35, P23; Twyford AD, 2017, MOL ECOL RESOUR, V17, P858, DOI 10.1111/1755-0998.12626; Valentini A, 2009, MOL ECOL RESOUR, V9, P51, DOI 10.1111/j.1755-0998.2008.02352.x; Vlam M, 2018, BIOL CONSERV, V220, P262, DOI 10.1016/j.biocon.2018.01.031; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4	46	1	1	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0251655	10.1371/journal.pone.0251655	http://dx.doi.org/10.1371/journal.pone.0251655			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115787	Green Published, gold			2022-12-26	WOS:000664643000012
J	Gallard, A; Galli, E; Hubert, A; Bidaut, A; Le Rolle, V; Smiseth, O; Voigt, JU; Donal, E; Hernandez, AI				Gallard, Alban; Galli, Elena; Hubert, Arnaud; Bidaut, Auriane; Le Rolle, Virginie; Smiseth, Otto; Voigt, Jens-Uwe; Donal, Erwan; Hernandez, Alfredo I.			Echocardiographic view and feature selection for the estimation of the response to CRT	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; LONG-TERM SURVIVAL; LEFT-VENTRICULAR DYSSYNCHRONY; HEART-FAILURE; PREDICTORS; PROGNOSIS	Cardiac resynchronization therapy (CRT) is an implant-based therapy applied to patients with a specific heart failure (HF) profile. The identification of patients that may benefit from CRT is a challenging task and the application of current guidelines still induce a non-responder rate of about 30%. Several studies have shown that the assessment of left ventricular (LV) mechanics by speckle tracking echocardiography can provide useful information for CRT patient selection. A comprehensive evaluation of LV mechanics is normally performed using three different echocardioraphic views: 4, 3 or 2-chamber views. The aim of this study is to estimate the relative importance of strain-based features extracted from these three views, for the estimation of CRT response. Several features were extracted from the longitudinal strain curves of 130 patients and different methods of feature selection (out-of-bag random forest, wrapping and filtering) have been applied. Results show that more than 50% of the 20 most important features are calculated from the 4-chamber view. Although features from the 2- and 3-chamber views are less represented in the most important features, some of the former have been identified to provide complementary information. A thorough analysis and interpretation of the most informative features is also provided, as a first step towards the construction of a machine-learning chain for an improved selection of CRT candidates.	[Gallard, Alban; Galli, Elena; Hubert, Arnaud; Bidaut, Auriane; Le Rolle, Virginie; Donal, Erwan; Hernandez, Alfredo I.] Univ Rennes, CHU Rennes, INSERM, LTSI,UMR 1099, Rennes, France; [Smiseth, Otto] Oslo Univ Hosp, Ctr Cardiol Innovat, Oslo, Norway; [Smiseth, Otto] Oslo Univ Hosp, Dept Cardiol, Oslo, Norway; [Voigt, Jens-Uwe] Katholieke Univ Leuven, Dept Cardiovasc Sci, Leuven, Belgium	CHU Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; University of Oslo; University of Oslo; KU Leuven	Donal, E (corresponding author), Univ Rennes, CHU Rennes, INSERM, LTSI,UMR 1099, Rennes, France.	erwan.donal@chu-rennes.fr		Voigt, Jens-Uwe/0000-0002-0575-1888				Akhtar N, 2018, IEEE ACCESS, V6, P14410, DOI 10.1109/ACCESS.2018.2807385; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; Bernard A, 2015, J AM SOC ECHOCARDIOG, V28, P700, DOI 10.1016/j.echo.2015.02.017; Bleumink GS, 2004, EUR HEART J, V25, P1614, DOI 10.1016/j.ehj.2004.06.038; Bonadei I, 2016, MINERVA CARDIOANGIOL, V64, P572; Bron EE, 2015, IEEE J BIOMED HEALTH, V19, P1617, DOI 10.1109/JBHI.2015.2432832; Carita P, 2016, INT J CARDIOL, V225, P402, DOI 10.1016/j.ijcard.2016.09.037; Chandrashekar G, 2014, COMPUT ELECTR ENG, V40, P16, DOI 10.1016/j.compeleceng.2013.11.024; Chung ES, 2008, CIRCULATION, V117, P2608, DOI 10.1161/CIRCULATIONAHA.107.743120; Cikes M, 2019, EUR J HEART FAIL, V21, P74, DOI 10.1002/ejhf.1333; Delgado V, 2011, CIRCULATION, V123, P70, DOI 10.1161/CIRCULATIONAHA.110.945345; Delgado-Montero A, 2016, CIRC-CARDIOVASC IMAG, V9, DOI 10.1161/CIRCIMAGING.115.004241; Dickstein K, 2010, EUR HEART J, V31, P2677, DOI 10.1093/eurheartj/ehq337; Doltra A, 2014, JACC-CARDIOVASC IMAG, V7, P969, DOI 10.1016/j.jcmg.2014.03.022; Donal E., 2019, JACC-CARDIOVASC IMAG; Galli E, 2018, J AM SOC ECHOCARDIOG, V31, P220, DOI 10.1016/j.echo.2017.10.009; Galli E, 2018, EUR HEART J-CARD IMG, V19, P1010, DOI 10.1093/ehjci/jex191; Genuer R, 2010, PATTERN RECOGN LETT, V31, P2225, DOI 10.1016/j.patrec.2010.03.014; Gorcsan J, 2010, CIRCULATION, V122, P1910, DOI 10.1161/CIRCULATIONAHA.110.954768; Hu SY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222397; Kalscheur MM., 2019, CIRC ARRHYTHM ELECTR; Khan FZ, 2012, J AM COLL CARDIOL, V59, P1509, DOI 10.1016/j.jacc.2011.12.030; Lang RM, 2015, J AM SOC ECHOCARDIOG, V28, P1, DOI 10.1016/j.echo.2014.10.003; Lecoq G, 2005, EUR HEART J, V26, P1094, DOI 10.1093/eurheartj/ehi146; Lim P, 2008, CIRCULATION, V118, P1130, DOI 10.1161/CIRCULATIONAHA.107.750190; Linde C, 2016, INT J CARDIOL, V202, P349, DOI 10.1016/j.ijcard.2015.09.023; Lumens J, 2015, INT J CARDIOL, V184, P6, DOI 10.1016/j.ijcard.2015.01.090; Morgan JM, 2009, EUROPACE, V11, P22, DOI 10.1093/europace/eup306; Mullens W, 2020, EUR J HEART FAIL, V22, P2349, DOI 10.1002/ejhf.2046; Omar AMS, 2018, JACC-CARDIOVASC IMAG, V11, P509, DOI 10.1016/j.jcmg.2017.05.003; Pitzalis MV, 2002, J AM COLL CARDIOL, V40, P1615, DOI 10.1016/S0735-1097(02)02337-9; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Probst P, 2019, WIRES DATA MIN KNOWL, V9, DOI 10.1002/widm.1301; Rickard J, 2017, J CARDIOVASC ELECTR, V28, P410, DOI 10.1111/jce.13175; Risum N, 2015, J AM COLL CARDIOL, V66, P631, DOI 10.1016/j.jacc.2015.06.020; Salaun E, 2018, EUR HEART J-CARD IMG, V19, P868, DOI 10.1093/ehjci/jex203; Sweeney MO, 2008, CIRC-ARRHYTHMIA ELEC, V1, P127, DOI 10.1161/CIRCEP.108.777904; Voigt JU, 2015, EUR HEART J-CARD IMG, V16, P1, DOI 10.1093/ehjci/jeu184; Waldrop MM, 2019, P NATL ACAD SCI USA, V116, P1074, DOI 10.1073/pnas.1821594116; Yu CM, 2003, AM J CARDIOL, V91, P684, DOI 10.1016/S0002-9149(02)03404-5; Zareba W, 2011, CIRCULATION, V123, P1061, DOI 10.1161/CIRCULATIONAHA.110.960898	41	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252857	10.1371/journal.pone.0252857	http://dx.doi.org/10.1371/journal.pone.0252857			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111154	Green Published, gold			2022-12-26	WOS:000664642700051
J	Carter, AM; Hsieh, ST; Dodson, P; Sallan, L				Carter, Aja Mia; Hsieh, S. Tonia; Dodson, Peter; Sallan, Lauren			Early amphibians evolved distinct vertebrae for habitat invasions	PLOS ONE			English	Article							TEMNOSPONDYL ARCHEGOSAURUS-DECHENI; PERIVERTEBRAL MUSCULATURE; MORPHOLOGICAL VARIATION; POSTCRANIAL SKELETON; HYPAXIAL MUSCULATURE; THRESHOLD-MODEL; FUNCTIONAL-ROLE; TRUNK MUSCLES; R PACKAGE; LOCOMOTION	Living tetrapods owe their existence to a critical moment 360-340 million years ago when their ancestors walked on land. Vertebrae are central to locomotion, yet systematic testing of correlations between vertebral form and terrestriality and subsequent reinvasions of aquatic habitats is lacking, obscuring our understanding of movement capabilities in early tetrapods. Here, we quantified vertebral shape across a diverse group of Paleozoic amphibians (Temnospondyli) encompassing different habitats and nearly the full range of early tetrapod vertebral shapes. We demonstrate that temnospondyls were likely ancestrally terrestrial and had several early reinvasions of aquatic habitats. We find a greater diversity in temnospondyl vertebrae than previously known. We also overturn long-held hypotheses centered on weight-bearing, showing that neural arch features, including muscle attachment, were plastic across the water-land divide and do not provide a clear signal of habitat preferences. In contrast, intercentra traits were critical, with temnospondyls repeatedly converging on distinct forms in terrestrial and aquatic taxa, with little overlap between. Through our geometric morphometric study, we have been able to document associations between vertebral shape and environmental preferences in Paleozoic tetrapods and to reveal morphological constraints imposed by vertebrae to locomotion, independent of ancestry.	[Carter, Aja Mia; Dodson, Peter; Sallan, Lauren] Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA; [Hsieh, S. Tonia] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA; [Dodson, Peter] Univ Penn, Sch Vet Med, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Sallan, Lauren] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; University of Pennsylvania	Carter, AM (corresponding author), Univ Penn, Dept Earth & Environm Sci, Philadelphia, PA 19104 USA.	caja@seas.upenn.edu	Sallan, Lauren/AGZ-1308-2022	Sallan, Lauren/0000-0002-4441-1456; Hsieh, Shi-Tong/0000-0003-2233-3327; Carter, Aja/0000-0003-2285-8668	Greg and Susan Walker Fund; Paul Bond Fellowship from the Delaware Valley Paleontological Society; University of Pennsylvania Benjamin Franklin Fellowship; Philip Orville Fellowship; Paleontology Summer Stipend	Greg and Susan Walker Fund; Paul Bond Fellowship from the Delaware Valley Paleontological Society; University of Pennsylvania Benjamin Franklin Fellowship; Philip Orville Fellowship; Paleontology Summer Stipend	AMC was supported by the Greg and Susan Walker Fund, the Paleontology Summer Stipend, the Paul Bond Fellowship from the Delaware Valley Paleontological Society, and the University of Pennsylvania Benjamin Franklin Fellowship and Philip Orville Fellowship.	Adams DC, 2013, METHODS ECOL EVOL, V4, P393, DOI 10.1111/2041-210X.12035; ANDREWS S M, 1970, Transactions of the Royal Society of Edinburgh, V68, P391; Arratia G, 2001, J MORPHOL, V250, P101, DOI 10.1002/jmor.1062; Bell MA, 2015, PALAEONTOLOGY, V58, P379, DOI 10.1111/pala.12142; Bennett WO, 2001, J EXP BIOL, V204, P1979; BIEWENER AA, 1989, SCIENCE, V245, P45, DOI 10.1126/science.2740914; Boszczyk BM, 2001, ANAT RECORD, V264, P157, DOI 10.1002/ar.1156; Brainerd EL, 2005, J EXP BIOL, V208, P3249, DOI 10.1242/jeb.01770; Buchholtz EA, 2005, MAR MAMMAL SCI, V21, P411, DOI 10.1111/j.1748-7692.2005.tb01241.x; Buchholtz EA, 2004, ZOOL J LINN SOC-LOND, V140, P383, DOI 10.1111/j.1096-3642.2003.00105.x; Buchholtz EA, 2001, J ZOOL, V253, P175, DOI 10.1017/S0952836901000164; Cardini A, 2014, HYSTRIX, V25, P73, DOI 10.4404/hystrix-25.2-10993; Carrizo LV, 2014, J ANAT, V224, P469, DOI 10.1111/joa.12152; Clack J. A., 2012, GAINING GROUND ORIGI; Cope E. D., 1888, Transactions of the American Philosophical Society, V(2), P243; Danto M, 2017, J MORPHOL, V278, P1262, DOI 10.1002/jmor.20709; Danto M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152586; Deban SM, 2009, J EXP BIOL, V212, P2949, DOI 10.1242/jeb.032961; DeFauw S.L., 1989, Michigan Academician, V21, P7; Dilkes D, 2007, J ZOOL, V271, P396, DOI 10.1111/j.1469-7998.2006.00221.x; Dilkes D.W., 1990, Journal of Vertebrate Paleontology, V10, P222; Dilkes DW, 2009, J VERTEBR PALEONTOL, V29, P1013, DOI 10.1671/039.029.0410; FALCONER DS, 1965, ANN HUM GENET, V29, P51, DOI 10.1111/j.1469-1809.1965.tb00500.x; Felsenstein J, 2005, PHILOS T R SOC B, V360, P1427, DOI 10.1098/rstb.2005.1669; Fortuny J, 2011, J EVOLUTION BIOL, V24, P2040, DOI 10.1111/j.1420-9101.2011.02338.x; Frobisch NB, 2010, SEMIN CELL DEV BIOL, V21, P424, DOI 10.1016/j.semcdb.2009.11.001; Fronimos JA, 2017, AMEGHINIANA, V54, P151, DOI 10.5710/AMGH.12.09.2016.3007; Fruciano C, 2016, DEV GENES EVOL, V226, P139, DOI 10.1007/s00427-016-0537-4; Gadow H., 1895, Proceedings of the Royal Society, Vlviii, P257; GAL JM, 1993, J EXP BIOL, V174, P281; Gardner JD, 2003, J VERTEBR PALEONTOL, V23, P769, DOI 10.1671/1828-4; Goodrich E.S., 1986, STUDIES STRUCTURE DE; GREGORY WILLIAM K., 1928, PROC AMER PHIL SOC, V67, P339; Holmes R., 1989, Historical Biology, V2, P111; JOLLIFFE IT, 1972, J ROY STAT SOC C-APP, V21, P160; Karakasiliotis K, 2013, BIOL CYBERN, V107, P529, DOI 10.1007/s00422-012-0540-4; Konietzko-Meier D, 2013, NETH J GEOSCI, V92, P97, DOI 10.1017/S0016774600000020; Konietzko-Meier D, 2012, EARTH ENV SCI T R SO, V103, P237, DOI 10.1017/S1755691013000273; Konietzko-Meier D, 2014, BIOL J LINN SOC, V112, P747, DOI 10.1111/bij.12301; Kuiper RM, 2013, SOCIOL METHOD RES, V42, P60, DOI 10.1177/0049124112464867; LAERM J, 1979, J PALEONTOL, V53, P175; Long JH, 1997, J EXP BIOL, V200, P65; Long JH, 2011, INTEGR COMP BIOL, V51, P158, DOI 10.1093/icb/icr020; Maxwell EE, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3570; Molnar JL, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150439; Molnar JL, 2014, J EXP BIOL, V217, P758, DOI 10.1242/jeb.089904; Moritz S, 2013, J MORPHOL, V274, P294, DOI 10.1002/jmor.20091; Motani R, 1996, NATURE, V382, P347, DOI 10.1038/382347a0; Nowroozi BN, 2012, J MORPHOL, V273, P441, DOI 10.1002/jmor.11034; Nyakatura JA, 2019, NATURE, V565, P351, DOI 10.1038/s41586-018-0851-2; O'Reilly JC, 2000, AM ZOOL, V40, P123, DOI 10.1668/0003-1569(2000)040[0123:TEOTFR]2.0.CO;2; Olsen AM, 2017, FUNCT ECOL, V31, P1985, DOI 10.1111/1365-2435.12890; Olson E.C., 1976, Linnean Soc Symp Ser, V3, P1; Olson EC, 1936, J MORPHOL, V59, P265, DOI 10.1002/jmor.1050590204; PANCHEN AL, 1966, J ZOOL, V150, P199; PANCHEN AL, 1967, EVOLUTION, V21, P24, DOI 10.1111/j.1558-5646.1967.tb00127.x; PANCHEN AL, 1959, PHILOS T ROY SOC B, V242, P207, DOI 10.1098/rstb.1959.0005; Panchen AL, 1977, ORIGIN EARLY EVOLUTI, P289; Pardo JD, 2017, NATURE, V546, P642, DOI 10.1038/nature22966; Parrington FR, 1967, C INT CTR NATL RES S, V163, P271; Parrington FR, 1977, LINNEAN SOC S SERIES, V4; Pawley K, 2007, J PALEONTOL, V81, P873, DOI 10.1666/pleo05-131.1; Pennell MW, 2014, BIOINFORMATICS, V30, P2216, DOI 10.1093/bioinformatics/btu181; Peskin B, 2020, CURR BIOL, V30, P2805, DOI 10.1016/j.cub.2020.05.037; Pierce SE, 2011, J ANAT, V219, P502, DOI 10.1111/j.1469-7580.2011.01406.x; Pierce SE, 2013, INTEGR COMP BIOL, V53, P209, DOI 10.1093/icb/ict022; Pierce SE, 2013, NATURE, V494, P226, DOI 10.1038/nature11825; Randau M, 2016, ZOOL J LINN SOC-LOND, V178, P183, DOI 10.1111/zoj.12403; Reisz RR, 2009, NATURWISSENSCHAFTEN, V96, P789, DOI 10.1007/s00114-009-0533-x; Revell LJ, 2014, EVOLUTION, V68, P743, DOI 10.1111/evo.12300; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rockwell H, 1938, J MORPHOL, V63, P87, DOI 10.1002/jmor.1050630105; Romer A, 1956, OSTEOLOGY REPTILES; ROMER A. S., 1947, BULL MUS COMP ZOOL HARVARD UNIV, V99, P1; Romer AS, 1942, J GEOL, V50, P925, DOI 10.1086/625101; Russo GA, 2010, AM J PHYS ANTHROPOL, V142, P600, DOI 10.1002/ajpa.21283; Ruta M, 2007, P ROY SOC B-BIOL SCI, V274, P3087, DOI 10.1098/rspb.2007.1250; Ruta M, 2008, PALAEONTOLOGY, V51, P1261, DOI 10.1111/j.1475-4983.2008.00808.x; S?ve-S?derbergh G., 1934, ARK ZOOL A, V26A, P1; Salisbury S., 2000, CROCODILIAN BIOL EVO; Sallan L, 2018, SCIENCE, V362, P460, DOI 10.1126/science.aar3689; Sallan LC, 2012, P ROY SOC B-BIOL SCI, V279, P3264, DOI 10.1098/rspb.2012.0784; SCHAEFFER BOBB, 1967, J LINN SOC ZOOL, V47, P185; Schilling N, 2011, FRONT ZOOL, V8, DOI 10.1186/1742-9994-8-4; Schilling N, 2010, J MORPHOL, V271, P200, DOI 10.1002/jmor.10791; Schoch RR, 2014, PALAEONTOLOGY, V57, P517, DOI 10.1111/pala.12100; Schoch RR, 2013, J SYST PALAEONTOL, V11, P673, DOI 10.1080/14772019.2012.699006; Schoch RR, 2012, FOSS REC, V15, P121, DOI 10.1002/mmng.201200010; Schoch RR, 2003, PALAEONTOLOGY, V46, P1055, DOI 10.1111/1475-4983.00333; Shapiro LJ, 2007, AM J PRIMATOL, V69, P86, DOI 10.1002/ajp.20329; Shapiro LJ, 2002, J HUM EVOL, V42, P753, DOI 10.1006/jhev.2002.0560; Shishkin M.A., 1987, Trudy Paleontologicheskogo Instituta, V225, P1; Sigurdsen T, 2010, J VERTEBR PALEONTOL, V30, P1360, DOI 10.1080/02724634.2010.501445; Simons RS, 1999, J MORPHOL, V241, P153, DOI 10.1002/(SICI)1097-4687(199908)241:2<153::AID-JMOR5>3.3.CO;2-5; Slijper E. J., 1946, Verh K nod Akad Wet Amsterdam (2), V42, P1; Steyer JS, 2006, J VERTEBR PALEONTOL, V26, P18, DOI 10.1671/0272-4634(2006)26[18:TVFOTU]2.0.CO;2; Sulej Tomasz, 2007, PALAEONTOLOGIA POLONICA, P29; Sutton AJ, 2001, STAT METHODS MED RES, V10, P277, DOI 10.1191/096228001678227794; Van Damme R, 2002, J ZOOL, V258, P327, DOI 10.1017/S0952836902001462; Viglino M, 2014, J ZOOL, V294, P267, DOI 10.1111/jzo.12177; WARREN A, 1991, ALCHERINGA, V15, P43, DOI 10.1080/03115519108619009; Warren A, 1998, ZOOL J LINN SOC-LOND, V122, P167, DOI 10.1006/zjls.1997.0117; Watanabe A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198341; Werneburg R, 2012, ANN CARNEGIE MUS, V81, P33, DOI 10.2992/007.081.0103; WILLIAMS EE, 1959, Q REV BIOL, V34, P1; Witzmann F, 2006, J VERTEBR PALEONTOL, V26, P7, DOI 10.1671/0272-4634(2006)26[7:DPAOSI]2.0.CO;2; Witzmann F, 2014, ANAT HISTOL EMBRYOL, V43, P90, DOI 10.1111/ahe.12050; Witzmann F, 2017, FOSS REC, V20, P105, DOI 10.5194/fr-20-105-2017; Witzmann F, 2010, ACTA ZOOL-STOCKHOLM, V91, P96, DOI 10.1111/j.1463-6395.2008.00385.x; Witzmann F, 2006, T ROY SOC EDIN-EARTH, V96, P365, DOI 10.1017/S0263593300001358	110	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0251983	10.1371/journal.pone.0251983	http://dx.doi.org/10.1371/journal.pone.0251983			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106947	Green Published, gold			2022-12-26	WOS:000664642200024
J	Salwa, M; Subaita, F; Choudhury, SR; Khalequzzaman, M; Al Mamun, MA; Bhuiyan, MR; Haque, MA				Salwa, Marium; Subaita, Fatima; Choudhury, Sohel Reza; Khalequzzaman, Md; Al Mamun, Mohammad Abdullah; Bhuiyan, Mahfuzur Rahman; Haque, M. Atiqul			Fruit and vegetables consumption among school-going adolescents: Findings from the baseline survey of an intervention program in a semi-urban area of Dhaka, Bangladesh	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CARDIOVASCULAR RISK; SLEEP DURATION; DIETARY-INTAKE; PATTERNS; ASSOCIATION; PREDICTORS; CHILDHOOD; NUTRITION; BEHAVIOR	Introduction Interventions aimed at promoting healthy eating habits in adolescence can help prevent chronic diseases and promote healthy ageing. The aim of this paper is to describe the fruit and vegetables consumption habits of adolescents in Dhaka, Bangladesh as well as to identify the socio-environmental, personal, and behavioral factors that influence these habits. Materials and methods The baseline data from an intervention study involving 823 grade ten students from two randomly selected secondary schools in a semi-urban area of Dhaka were analyzed. The intake of fruit and vegetables was measured in terms of serving size per day. Hierarchical multiple regression was used to assess the ability of socio-environmental factors such as social support, perceived barriers, and living with patient with chronic diseases; personal factors such as knowledge, self-rated practice, behavioral intention, and body mass index; and behavioral factors such as physical activity, sedentary hours, and sleep duration to predict the level of daily fruit and vegetables intake, after controlling the effect of demographic characteristics of adolescents. Results The average daily consumption of fruit and vegetables was 1.22 and 1.99 servings, respectively. Only one-fifth of the respondents (21%) reported eating five servings of fruit and vegetables a day. Inaccessibility at home was reported as the most perceived barrier for both fruit and vegetables intake. Adolescents' higher fruit and vegetables intake was found to be associated with higher maternal educational attainment, more social support, adequate self-rated practice, positive behavioral intention, higher body mass index, better physical activity, and adequate daily sleeping. Conclusion The findings revealed insufficient fruit and vegetables intake among adolescents in a semi-urban area of Bangladesh and associated socio-environmental, personal, and behavioral factors that were utilized in developing an intervention program for this transient age group. Trial registration Trial was registered at ClinicalTrials.gov (NCT03975335) https://clinicaltrials.gov/ct2/show/NCT03975335 on June 01, 2019.	[Salwa, Marium; Subaita, Fatima; Khalequzzaman, Md; Haque, M. Atiqul] Bangabandhu Sheikh Mujib Med Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh; [Choudhury, Sohel Reza; Al Mamun, Mohammad Abdullah; Bhuiyan, Mahfuzur Rahman] Natl Heart Fdn Hosp & Res Inst, Dept Epidemiol & Res, Dhaka, Bangladesh; [Subaita, Fatima] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada	Bangabandhu Sheikh Mujib Medical University (BSMMU); University of Alberta	Salwa, M (corresponding author), Bangabandhu Sheikh Mujib Med Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh.	mariumsalwa@gmail.com	Haque, Atiqul/ACD-5508-2022	Haque, Atiqul/0000-0002-7598-2550; Salwa, Marium/0000-0001-7869-3343	Directorate General of Health Services, Ministry of Health & Family Welfare, Mohakhali, Dhaka, Bangladesh [DGHS/LD/NCDC/Procurement Plan/GOB(Service)/2017-2018/539/SP-06]	Directorate General of Health Services, Ministry of Health & Family Welfare, Mohakhali, Dhaka, Bangladesh	Mohammad Abdullah Al Mamun received financial assistance for this study from Directorate General of Health Services, Ministry of Health & Family Welfare, Mohakhali, Dhaka-1212, Bangladesh (DGHS/LD/NCDC/Procurement Plan/GOB(Service)/2017-2018/539/SP-06 Dated: 13.11.2017). URL: https://dghs.gov.bd/index.php/en/home The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AJZEN I, 1974, HUM RELAT, V27, P1, DOI 10.1177/001872677402700101; Ashton LM, 2019, NUTRIENTS, V11, DOI 10.3390/nu11040825; Beal T, 2019, FOOD NUTR BULL, V40, P444, DOI 10.1177/0379572119848287; Bel S, 2013, BRIT J NUTR, V110, P949, DOI 10.1017/S0007114512006046; Berenson GS, 2009, AM J PREV MED, V37, pS1, DOI 10.1016/j.amepre.2009.04.018; Biswas T, 2017, PUBLIC HEALTH, V142, P94, DOI 10.1016/j.puhe.2016.10.010; Browner WS., 2013, DESIGNING CLIN RES, P57; Bruening M, 2010, J AM DIET ASSOC, V110, P1542, DOI 10.1016/j.jada.2010.07.001; Canova L, 2020, APPETITE, V145, DOI 10.1016/j.appet.2019.104490; Carfora V, 2016, APPETITE, V106, P23, DOI 10.1016/j.appet.2015.12.020; Chaput JP, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0428-0; Cutler GJ, 2011, J AM DIET ASSOC, V111, P230, DOI 10.1016/j.jada.2010.10.052; Darfour-Oduro SA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19956-0; Das JK, 2017, ANN NY ACAD SCI, V1393, P21, DOI 10.1111/nyas.13330; Dizon F, 2019, GLOB FOOD SECUR-AGR, V21, P38, DOI 10.1016/j.gfs.2019.07.003; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.2307/3088292; Fleary SA, 2020, APPETITE, V147, DOI 10.1016/j.appet.2019.104546; GAIN, 2018, NUTR AD BANGL; Gourlan M, 2013, PSYCHOL HEALTH, V28, P1265, DOI 10.1080/08870446.2013.800518; Granner ML, 2011, AM J HEALTH BEHAV, V35, P591; Haddad MR, 2020, APPETITE, V144, DOI 10.1016/j.appet.2019.104454; Hirshkowitz M, 2015, SLEEP HEALTH, V1, P233, DOI 10.1016/j.sleh.2015.10.004; Khan A, 2019, HEALTH POLICY TECHN, V8, P386, DOI 10.1016/j.hlpt.2019.09.003; Larson N, 2012, J ACAD NUTR DIET, V112, P1216, DOI 10.1016/j.jand.2012.03.035; Leroy JL, 2018, ANN NY ACAD SCI, V1416, P18, DOI 10.1111/nyas.13530; Lien N, 2002, AM J HEALTH PROMOT, V16, P189, DOI 10.4278/0890-1171-16.4.189; Luszczynska A, 2004, PSYCHOL HEALTH, V19, P577, DOI 10.1080/0887044042000205844; Mikkila V, 2005, BRIT J NUTR, V93, P923, DOI 10.1079/BJN20051418; Omidvar N, 2003, ECOL FOOD NUTR, V42, P385, DOI 10.1080/03670240390268424; Pearson N, 2009, PUBLIC HEALTH NUTR, V12, P267, DOI 10.1017/S1368980008002589; Rasmussen M, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-22; Salwa M, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7229-8; Velazquez CE, 2011, J AM DIET ASSOC, V111, P1735, DOI 10.1016/j.jada.2011.08.003; Viner RM, 2012, LANCET, V379, P1641, DOI 10.1016/S0140-6736(12)60149-4; WHO, 2003, WHO TECH REP SER, V916, P1; WHO, 2014, GLOBAL STATUS REPORT ON VIOLENCE PREVENTION 2014, P1; WHO (World Health Organization), 2011, NITR NITR DRINK WAT, P1; Wills TA, 2007, J ADOLESCENT HEALTH, V41, P551, DOI 10.1016/j.jadohealth.2007.06.013; Wilson DK, 2009, J PEDIATR PSYCHOL, V34, P231, DOI 10.1093/jpepsy/jsn137; World Health Organization, 2014, CONS REG CONS VACC C	40	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252297	10.1371/journal.pone.0252297	http://dx.doi.org/10.1371/journal.pone.0252297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101740	gold, Green Published			2022-12-26	WOS:000664641500011
J	Hartmann, B; Muller, M; Seyler, L; Bauerle, T; Wilferth, T; Avdievitch, N; Ruhm, L; Henning, A; Lesiv, A; Ivashkin, P; Uder, M; Nagel, AM				Hartmann, Benedikt; Mueller, Max; Seyler, Lisa; Bauerle, Tobias; Wilferth, Tobias; Avdievitch, Nikolai; Ruhm, Loreen; Henning, Anke; Lesiv, Alexei; Ivashkin, Pavel; Uder, Michael; Nagel, Armin M.			Feasibility of deuterium magnetic resonance spectroscopy of 3-O-Methylglucose at 7 Tesla	PLOS ONE			English	Article							QUANTITATIVE ASSESSMENT; IN-VIVO; NMR; MUSCLE; TUMOR; H-2	Deuterium Magnetic Resonance Spectroscopy (DMRS) is a non-invasive technique that allows the detection of deuterated compounds in vivo. DMRS has a large potential to analyze uptake, perfusion, washout or metabolism, since deuterium is a stable isotope and therefore does not decay during biologic processing of a deuterium labelled substance. Moreover, DMRS allows the distinction between different deuterated substances. In this work, we performed DMRS of deuterated 3-O-Methylglucose (OMG). OMG is a non-metabolizable glucose analog which is transported similar to D-glucose. DMRS of OMG was performed in phantom and in vivo measurements using a preclinical 7 Tesla MRI system. The chemical shift (3.51 +/- 0.1 ppm) and relaxation times were determined. OMG was injected intravenously and spectra were acquired over a period of one hour to monitor the time evolution of the deuterium signal in tumor-bearing rats. The increase and washout of OMG could be observed. Three different exponential functions were compared in terms of how well they describe the OMG washout. A mono-exponential model with offset seems to describe the observed time course best with a time constant of 1910 +/- 770 s and an offset of 2.5 +/- 1.2 mmol/l (mean +/- std, N = 3). Chemical shift imaging could be performed with a voxel size of 7.1 mm x 7.1 mm x 7.9 mm. The feasibility of DMRS with deuterium labelled OMG could be demonstrated. These data might serve as basis for future studies that aim to characterize glucose transport using DMRS.	[Hartmann, Benedikt; Mueller, Max; Seyler, Lisa; Bauerle, Tobias; Wilferth, Tobias; Uder, Michael; Nagel, Armin M.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany; [Avdievitch, Nikolai; Ruhm, Loreen; Henning, Anke] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Henning, Anke] UT Southwestern Med Ctr, Adv Imaging Res Ctr, Dallas, TX USA; [Lesiv, Alexei; Ivashkin, Pavel] Solvex Ltd Liabil Co, Moscow, Russia; [Nagel, Armin M.] German Canc Res Ctr, Div Med Phys Radiol, Heidelberg, Germany	University of Erlangen Nuremberg; Max Planck Society; University of Texas System; University of Texas Southwestern Medical Center Dallas; Helmholtz Association; German Cancer Research Center (DKFZ)	Hartmann, B (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Hosp Erlangen, Inst Radiol, Erlangen, Germany.	benedikt.hartmann@fau.de	Nagel, Armin M/C-4671-2016	Nagel, Armin M/0000-0003-0948-1421; Bauerle, Tobias/0000-0002-0206-6199; Mueller, Max/0000-0001-6731-9583				ACKERMAN JJH, 1987, P NATL ACAD SCI USA, V84, P4099, DOI 10.1073/pnas.84.12.4099; Bauerle T, 2005, INT J CANCER, V115, P177, DOI 10.1002/ijc.20840; Bertoldo A, 2005, J CLIN ENDOCR METAB, V90, P1752, DOI 10.1210/jc.2004-1092; Buxbaum NP, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92851; CAMPBELL PN, 1952, BIOCHEM J, V52, P439, DOI 10.1042/bj0520439; Chang MH, 2004, J EXP BIOL, V207, P3109, DOI 10.1242/jeb.01154; COPE FW, 1969, BIOPHYS J, V9, P303, DOI 10.1016/S0006-3495(69)86388-5; CSAKY TZ, 1957, AM J PHYSIOL, V188, P159, DOI 10.1152/ajplegacy.1956.188.1.159; CSAKY TZ, 1965, ANN NY ACAD SCI, V131, P868, DOI 10.1111/j.1749-6632.1965.tb34851.x; De Feyter HM, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat7314; EVELHOCH JL, 1989, MAGNET RESON MED, V9, P402, DOI 10.1002/mrm.1910090313; EWY C S, 1986, Magnetic Resonance Imaging, V4, P407, DOI 10.1016/0730-725X(86)90047-0; FUKUDA H, 1982, EUR J NUCL MED, V7, P294, DOI 10.1007/BF00253423; Harris RK, 2001, PURE APPL CHEM, V73, P1795, DOI 10.1351/pac200173111795; Holden NE, 2018, PURE APPL CHEM, V90, P1833, DOI 10.1515/pac-2015-0703; HWANG YC, 1992, CANCER RES, V52, P1259; Kreis F, 2020, RADIOLOGY, V294, P289, DOI 10.1148/radiol.2019191242; Ladd ME, 2018, PROG NUCL MAG RES SP, V109, P1, DOI 10.1016/j.pnmrs.2018.06.001; Lu M, 2017, J CEREBR BLOOD F MET, V37, P3518, DOI 10.1177/0271678X17706444; McWhorter TJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P376, DOI 10.1086/597524; NuDat, NUDAT 2 8 DAT; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Rivlin M, 2018, MAGN RESON MED, V79, P1061, DOI 10.1002/mrm.26752; Schunke M., 2018, PROMETHEUS ALLGEMEIN, V5 ed; Yamamoto Norio, 2015, Curr Protoc Pharmacol, V71, DOI 10.1002/0471141755.ph1214s71	25	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252935	10.1371/journal.pone.0252935	http://dx.doi.org/10.1371/journal.pone.0252935			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097707	Green Published, gold			2022-12-26	WOS:000664640700023
J	Kim, HB; Kim, GJ; Han, KD; Joo, YH				Kim, Hyun-Bum; Kim, Geun-Jeon; Han, Kyung-do; Joo, Young-Hoon			Changes in metabolic syndrome status and risk of laryngeal cancer: A nationwide cohort study	PLOS ONE			English	Article							OBESITY; INFLAMMATION	Background Whether dynamic changes of metabolic syndrome (MetS) affects the subsequent laryngeal cancer occurrence remains unknown. Objective This study investigated the effects of changes of MetS on the incidence of laryngeal cancer due to a lack of knowledge regarding the development of MetS in Korean population. Methods A total of 6,757,048 individuals who received national health checkup in 2009 and follow-up health examination in 2011 were analyzed and followed up until 2018. MetS status included the following categories: MetS-chronic (n = 941,609), MetS-developed (n = 614,229), MetS-recovery (n = 455,835), and MetS-free (n = 4,745,375). Results With a median follow-up duration of 6.403 years, 1,350 subjects were newly diagnosed with laryngeal cancer. Compared to participants without MetS, adjusted hazard ratios (HR) (95% confidence interval) for those with MetS were 1.320 (1.17-1.489) for laryngeal cancer. The HR of laryngeal cancer was found to be increased with increasing number of MetS components. The MetS-developed group had a significantly higher risk of laryngeal cancer than the MetS-free group (HR: 1.296; 95% CI: 1.093-1.537). The MetS-recovery group within two years also had an increased risk of laryngeal cancer compared with the MetS-free group (HR: 1.220; 95% CI: 1.008-1.476). Among MetS components, abdominal obesity had the highest risk of laryngeal cancer (HR: 1.374; 95% CI: 1.123-1.681). Conclusion Changes in MetS status were associated with the risk of laryngeal cancer. Results of this study have implications for etiological investigations and prevention strategies.	[Kim, Hyun-Bum; Kim, Geun-Jeon; Joo, Young-Hoon] Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Han, Kyung-do] Catholic Univ Korea, Coll Med, Dept Biostat, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea	Joo, YH (corresponding author), Catholic Univ Korea, Dept Otolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea.	joodoct@catholic.ac.kr		Joo, Young-hoon/0000-0002-1158-0974				Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Cohen N, 2018, ORAL MAXIL SURG CLIN, V30, P381, DOI 10.1016/j.coms.2018.06.001; Deedwania P C, 2006, J Assoc Physicians India, V54, P797; Deng T, 2016, ANNU REV PATHOL-MECH, V11, P421, DOI 10.1146/annurev-pathol-012615-044359; Esposito K, 2012, DIABETES CARE, V35, P2402, DOI 10.2337/dc12-0336; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grundy SM, 2006, J AM COLL CARDIOL, V47, P1093, DOI 10.1016/j.jacc.2005.11.046; Haller H., 1975, LIPIDSTOFFWECHSELSTO, P254; Hashibe M, 2007, J NATL CANCER I, V99, P777, DOI 10.1093/jnci/djk179; Kim DS, 2010, SOC WORK PUBLIC HLTH, V25, P127, DOI 10.1080/19371910903070333; Kim SY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37061-0; Kolb R, 2016, CURR OPIN PHARMACOL, V29, P77, DOI 10.1016/j.coph.2016.07.005; Korea National Statistical Office, 61 KINDS CANC SEX CA; Kuriki K, 2007, EUR J CANCER PREV, V16, P83, DOI 10.1097/01.cej.0000228404.37858.40; Mishra M, 2014, INVEST OPHTH VIS SCI, V55, P7256, DOI 10.1167/iovs.14-15193; Nakamura K, 2013, CANCER SCI, V104, P1362, DOI 10.1111/cas.12235; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; National Center for Health Statistics Division of Health Interview Statistics, 2012, CRUD AG ADJ PERC CIV, P2643; Oh TR, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091329; Park S, 2019, ANN INTERN MED, V171, P875, DOI 10.7326/M19-0563; Rajasekar P, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/436879; Renehan AG, 2006, TRENDS ENDOCRIN MET, V17, P328, DOI 10.1016/j.tem.2006.08.006; Sarras MP, 2015, COMP BIOCHEM PHYS C, V178, P3, DOI 10.1016/j.cbpc.2015.07.001; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Tkac I, 2005, DIABETES RES CLIN PR, V68, pS2, DOI 10.1016/j.diabres.2005.03.002	25	1	1	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2021	16	6							e0252872	10.1371/journal.pone.0252872	http://dx.doi.org/10.1371/journal.pone.0252872			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RH	34097712	gold, Green Published			2022-12-26	WOS:000664640700021
J	Begum, A; Hamid, SA				Begum, Afroza; Hamid, Syed Abdul			Impoverishment impact of out-of-pocket payments for healthcare in rural Bangladesh: Do the regions facing different climate change risks matter?	PLOS ONE			English	Article							CATASTROPHIC PAYMENTS; POVERTY; EXPENDITURE; INCOME; COUNTRIES; HOUSEHOLDS; POLICY; SCHEME; CHINA; URBAN	Introduction Out-of-pocket (OOP) payments for healthcare severely affect the current consumption, future health and earnings capacity of poor/underprivileged households and hence it is crucial for priority setting. This study assesses the variation in overall as well as disease-specific impoverishment impact of OOP payments between the regions experiencing different climate change risks, defined as high disaster-prone (HDP) areas and low-disaster-prone (LDP) areas, in Bangladesh. Materials and methods This paper estimated three poverty measures, such as poverty headcount, poverty intensity and normalized poverty gap for all ailments, catastrophic events, diseases types (communicable, non-communicable (NCDs), and accident and injury), illness conditions (acute and chronic) and hospitalization using 3,791 randomly selected rural households (1,203 from HDP and 2,588 from LDP areas) across the regions. Cost of basic need approach was used for estimating poverty line expenditure. Results About 13 percent households annually fall into poverty due to OOP outlays for healthcare. Despite having significantly (p-value <= 0.01) less OOP payments (HDP areas: BDT 5,117; LDP areas: BDT5,811) the impoverishment impact of OOP payments for healthcare in HDP areas (16.5%) has substantially higher than LDP areas (11.3%). Population in HDP areas, especially char (river island; 19.55 percent) and haor (water submerged; 16.80 percent) are more susceptible to any level of OOP payments due to low level of earnings. Catastrophic healthcare expenditure (61.79%) and NCDs (14.29 percent) are exacerbating the poverty level in Bangladesh. Both absolute and relative average poverty gap are more widen in HDP than LDP areas due to catastrophic OOP outlays for healthcare. Conclusion The impoverishment effect due to OOP payments for healthcare in both HDP and LDP areas are high, especially for NCDs and catastrophic healthcare expenditure. However, the situation is bit worse in HDP areas. Preventing the escalation of NCDs as well as catastrophic expenditure and hence reducing the level of impoverishment thereof call for restricting tobacco use, increasing physical activity, encouraging to intake healthy diets, ensuring food safety, controlling air pollution, and improving mental health. Moreover, government should give more emphasis, especially in the HDP areas, on making community clinics more functional through providing screening equipment and training to the Community Health Care Providers for early detection of NCDs, and ensuring availability of medicine all the time. Note that other than community clinics, there is little option for providing healthcare in HDP areas due to poor functionality of public facilities as well as lack of private facilities in HDP areas.	[Begum, Afroza] Univ Chittagong, Dept Stat, Chittagong, Bangladesh; [Hamid, Syed Abdul] Univ Dhaka, Inst Hlth Econ, Dhaka, Bangladesh	University of Chittagong; University of Dhaka	Begum, A (corresponding author), Univ Chittagong, Dept Stat, Chittagong, Bangladesh.	afroza_stat@cu.ac.bd		Begum, Afroza/0000-0002-3477-3955				Ahmed S, 2022, INT HEALTH, V14, P84, DOI 10.1093/inthealth/ihab015; Ahmed S, 2018, INT J EQUITY HEALTH, V17, DOI 10.1186/s12939-018-0757-5; Ahsan SM, 2012, 13 I MICR; [Anonymous], 2018, MULT ACT PLAN PREV C; Bangladesh Bureau of Statistics (BBS), 2019, REP HOUS INC EXP SUR; Bangladesh Bureau of Statistics (BBS), 2006, REP HOUS INC EXP SUR; BBS, 2018, REP HOUS INC EXP SUR; Berman P., 2010, Economic and Political Weekly, V45, P65; Biswas T, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4494-2; Bredenkamp C, 2011, HEALTH POLICY PLANN, V26, P349, DOI 10.1093/heapol/czq070; Chou WL, 2009, HEALTH ECON, V18, pS137, DOI 10.1002/hec.1511; Chuma J, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-413; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Datta BK, 2018, SSM-POPUL HLTH, V6, P252, DOI 10.1016/j.ssmph.2018.10.001; Dorjdagva J, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0395-8; Fahim SM, 2019, INT J HEALTH PLAN M, V34, pE11, DOI 10.1002/hpm.2666; Falkingham J, 2004, SOC SCI MED, V58, P247, DOI 10.1016/S0277-9536(03)00008-X; Flores G, 2008, HEALTH ECON, V17, P1393, DOI 10.1002/hec.1338; Garg CC, 2009, HEALTH POLICY PLANN, V24, P116, DOI 10.1093/heapol/czn046; Gertler P, 2002, AM ECON REV, V92, P51, DOI 10.1257/000282802760015603; Ghosh S, 2011, ECON POLIT WEEKLY, VXLVI; Giannoni M., 2010, APPL ECON, V34; Hamid SA, 2019, OXFORD RES ENCY EC F, DOI [10.1093/acrefore/9780190625979.013.436, DOI 10.1093/ACREFORE/9780190625979.013.436]; Hamid SA, 2014, APPL HEALTH ECON HEA, V12, P421, DOI 10.1007/s40258-014-0100-2; Hamid SA, 2015, J INT DEV, V27, P36, DOI 10.1002/jid.3026; Minh VH, 2013, SOC SCI MED, V96, P258, DOI 10.1016/j.socscimed.2012.11.028; Huq NM, 2015, IRAN J PUBLIC HEALTH, V44, P1024; Khan JAM, 2017, HEALTH POLICY PLANN, V32, P1102, DOI 10.1093/heapol/czx048; KOCHAR A, 1995, AM ECON REV, V85, P159; Kostova D, 2017, PREV MED, V105, pS1, DOI 10.1016/j.ypmed.2017.09.027; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Liu YL, 2003, J HEALTH POPUL NUTR, V21, P216; Lopez-Casasnovas G, 2005, HEALTH ECON, V14, pS221, DOI 10.1002/hec.1038; Mahumud Rashidul Alam, 2017, J Prev Med Public Health, V50, P91, DOI 10.3961/jpmph.16.089; Mills A, 2014, NEW ENGL J MED, V370, P552, DOI 10.1056/NEJMra1110897; Molla A, 2020, J POVERTY, V24, P627, DOI 10.1080/10875549.2020.1742269; Molla AA, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2047-0; O'Donnell O., 2008, Analyzing health equity using household survey data: a guide to techniques and their implementation; Patel V, 2007, BRIT MED BULL, V81-82, P81, DOI 10.1093/bmb/ldm010; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pavel MS, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0458-x; Qosaj FA, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0111-1; Rahman MM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227565; Rahman MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056873; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Ravallion M, 1996, ECON DEV CULT CHANGE, V44, P761, DOI 10.1086/452244; Shi WX, 2011, HEALTH RES POLICY SY, V9, DOI 10.1186/1478-4505-9-16; Somkotra T, 2008, SOC SCI MED, V67, P2027, DOI 10.1016/j.socscimed.2008.09.047; Stein DJ, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.l295; Sun XY, 2010, HEALTH POLICY PLANN, V25, P419, DOI 10.1093/heapol/czq010; Tomini SM, 2013, HEALTH POLICY PLANN, V28, P419, DOI 10.1093/heapol/czs073; Vaishnavi SD, 2009, J INT DEV, V21, P169, DOI 10.1002/jid.1554; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; van Doorslaer E, 2006, LANCET, V368, P1357, DOI 10.1016/S0140-6736(06)69560-3; Wagstaff A, 2003, HEALTH ECON, V12, P921, DOI 10.1002/hec.776; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; World Health Organization, 2017, UPD APP 3 WHO GLOB N; World Health Organization (WHO), 2006, MED PRIC SURV PROP I; World Health Organization (WHO), 2019, INDEPENDENT EVALUATI; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006	62	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252706	10.1371/journal.pone.0252706	http://dx.doi.org/10.1371/journal.pone.0252706			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086781	Green Published, gold			2022-12-26	WOS:000664640100112
J	Carter, B; Hayes, C; Smith, A; Pennington, A; Price, M; Pearson, O; Vitoratou, S; Hewitt, J				Carter, Ben; Hayes, Chloe; Smith, Alexander; Pennington, Anna; Price, Michelle; Pearson, Owen; Vitoratou, Silia; Hewitt, Jonathan			A single patient reported outcome measure for acquired brain injury, multiple sclerosis & Parkinson's disease	PLOS ONE			English	Article							INFORMATION-SYSTEM PROMIS; QUALITY-OF-LIFE; HEALTH; EQ-5D; VALIDATION	Objective To determine psychometric properties of the PROMIS-10 and Standard Stroke Question Set (by International Consortium for Health Outcome Measures) presented as a new 15-item Patient Related Outcome (PRO), for patients with: acquired Brain Injury (ABI), Multiple sclerosis (MS) and Parkinson's disease (PD). Methods In an eight centre, UK wide, cross-sectional study we approached patients during their routine follow-up to complete: a disease-specific instrument (European Brain Injury Questionnaire, Multiple Sclerosis Impact Scale, and Parkinson's disease questionnaire); General Health questionnaire with a Quality of life measure (EQ-5D); and PRO. We validated the PRO using factor analysis to define the latent construct domains, then calculated the internal consistency (Cronbach's-alpha), and construct validity (correlation). Results There were 340 patients with ABI (N = 91, median age = 55.1, 41% female), MS (N = 99, age = 58.9, 69%) and PD (N = 150, age = 74.5, 40%). Factor analysis suggested the PRO offered three domains of: physical health; functionality-capacity and mental health. All factors correlated strongly with the three disease-specific instruments, and the overall PRO had a large correlation with the EQ-5D (correlation>0.8) offering good construct validity and excellent internal consistency (>0.89). Interpretation The PRO offered promising psychometric properties and could be used in place of disease specific questionnaires for patients with ABI, MS, and PD. The PRO has three construct domains, describing patients': mental health; physical health; and functional-capacity, and may be used in routine clinical practice. The PRO offered both relevance to each of the three separate neurological conditions and generalisability across all the conditions, increasing its utility.	[Carter, Ben; Hayes, Chloe; Vitoratou, Silia] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Biostat & Hlth Informat, London, England; [Hayes, Chloe] Loughborough Univ, Sch Sport Exercise & Hlth Sci, Loughborough, Leics, England; [Smith, Alexander; Hewitt, Jonathan] Cardiff Univ, Sch Med, Div Populat Med, Cardiff, Wales; [Pennington, Anna; Hewitt, Jonathan] Aneurin Bevan Univ Hlth Board, South Wales, Wales; [Price, Michelle] Powys Teaching Hlth Board, Mid Wales, Wales; [Pearson, Owen] Swansea Bay Univ Hlth Board, Port Talbot, Wales	University of London; King's College London; Loughborough University; Cardiff University	Hewitt, J (corresponding author), Cardiff Univ, Sch Med, Div Populat Med, Cardiff, Wales.; Hewitt, J (corresponding author), Aneurin Bevan Univ Hlth Board, South Wales, Wales.	HewittJ2@Cardiff.ac.uk		Vitoratou, Silia/0000-0003-1209-8167; Carter, Ben/0000-0003-0318-8865; Hayes, Chloe/0000-0002-8528-8167	Stroke Implementation group of Welsh Government; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London	Stroke Implementation group of Welsh Government; National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London(General Electric)	Unrestricted competitive funding was obtained from the Stroke Implementation group of Welsh Government. The funder had no role whatsoever in any part of the delivery of the study or interpretation of the data or results. This paper represents independent research part funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at South London and Maudsley NHS Foundation Trust and King's College London. The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care (BC, CH, SV).	Alvarado-Bolanos A, 2015, J NEUROL SCI, V358, P53, DOI 10.1016/j.jns.2015.08.010; Asplund K, 2011, INT J STROKE, V6, P99, DOI 10.1111/j.1747-4949.2010.00557.x; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Bevans M, 2014, NURS OUTLOOK, V62, P339, DOI 10.1016/j.outlook.2014.05.009; BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; Cella D, 2010, J CLIN EPIDEMIOL, V63, P1179, DOI 10.1016/j.jclinepi.2010.04.011; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Efthymiadou O, 2019, HEALTH POLICY, V123, P159, DOI 10.1016/j.healthpol.2018.12.003; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; Evans JP, 2018, PATIENT-RELAT OUTCOM, V9, P345, DOI 10.2147/PROM.S141378; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Gorsuch R., 1983, FACTOR ANAL; Greenhalgh J, 2017, FUNCTIONALITY FEEDBA; Greenhalgh J, 2018, J HEALTH SERV RES PO, V23, P57, DOI 10.1177/1355819617740925; Hays RD, 2009, QUAL LIFE RES, V18, P873, DOI 10.1007/s11136-009-9496-9; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Hewitt J, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1350-5; Hobart J, 2001, BRAIN, V124, P962, DOI 10.1093/brain/124.5.962; HOELTER JW, 1983, SOCIOL METHOD RES, V11, P325, DOI 10.1177/0049124183011003003; Hooper D., 2008, EJBRM, V6, P53, DOI DOI 10.21427/D7CF7R; Hunt C, 2019, QUAL LIFE RES, V28, P3137, DOI 10.1007/s11136-019-02297-4; Hunter C, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006986; IBM Corp, REL 2017 IBM SPSS ST; Jenkinson C, 1997, AGE AGEING, V26, P353, DOI 10.1093/ageing/26.5.353; KAISER HF, 1974, EDUC PSYCHOL MEAS, V34, P111, DOI 10.1177/001316447403400115; Khurana V, 2017, EUR J NEUROL, V24, P1099, DOI 10.1111/ene.13339; Kuspinar A, 2019, PARKINSONISM RELAT D, V62, P112, DOI 10.1016/j.parkreldis.2019.01.014; Martinez-Martin P, 2017, MOVEMENT DISORD, V32, P382, DOI 10.1002/mds.26885; Muthen B., 1997, PSYCHOMETRIKA; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Nunnally J.C., 1967, PSYCHOMETRIC THEORY, V226; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Parmar KL, 2021, ANN SURG, V273, P709, DOI 10.1097/SLA.0000000000003402; Payakachat N, 2015, PHARMACOECONOMICS, V33, P1137, DOI 10.1007/s40273-015-0295-6; Pedhazur, 1991, MEASUREMENT DESIGN A; Porter ME, 2016, NEW ENGL J MED, V374, P504, DOI 10.1056/NEJMp1511701; Salinas J, 2016, STROKE, V47, P180, DOI 10.1161/STROKEAHA.115.010898; Schrag A, 2000, J NEUROL NEUROSUR PS, V69, P67, DOI 10.1136/jnnp.69.1.67; Sopena S, 2007, BRAIN INJURY, V21, P1063, DOI 10.1080/02699050701630342; Tabachnick B, 2001, USING MULTIVARIATE A; Tordrup D, 2014, INT J TECHNOL ASSESS, V30, P10, DOI 10.1017/S0266462313000640; van Hout B, 2012, VALUE HEALTH, V15, P708, DOI 10.1016/j.jval.2012.02.008; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; WASSERTHEIL S, 1970, BIOMETRICS, V26, P588, DOI 10.2307/2529115; Weldring T, 2013, HEALTH SERV INSIGHTS, V6, P61, DOI 10.4137/HSI.S11093	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0251484	10.1371/journal.pone.0251484	http://dx.doi.org/10.1371/journal.pone.0251484			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RB	34086698	Green Accepted, Green Published, gold			2022-12-26	WOS:000664640100015
J	Carvalho, AL; Treyball, A; Brooks, DJ; Costa, S; Neilson, RJ; Reagan, MR; Bouxsein, ML; Motyl, KJ				Lelis Carvalho, Adriana; Treyball, Annika; Brooks, Daniel J.; Costa, Samantha; Neilson, Ryan J.; Reagan, Michaela R.; Bouxsein, Mary L.; Motyl, Katherine J.			TRPM8 modulates temperature regulation in a sex-dependent manner without affecting cold-induced bone loss	PLOS ONE			English	Article							BROWN ADIPOCYTES; RECEPTOR TRPM8; FEMALE; THERMOGENESIS; ACTIVATION; EXPRESSION; CHANNELS; REVEALS; MOUSE; FAT	Trpm8 (transient receptor potential cation channel, subfamily M, member 8) is expressed by sensory neurons and is involved in the detection of environmental cold temperatures. TRPM8 activity triggers an increase in uncoupling protein 1 (Ucp1)-dependent brown adipose tissue (BAT) thermogenesis. Bone density and marrow adipose tissue are both influenced by rodent housing temperature and brown adipose tissue, but it is unknown if TRPM8 is involved in the co-regulation of thermogenesis and bone homeostasis. To address this, we examined the bone phenotypes of one-year-old Trpm8 knockout mice (Trpm8-KO) after a 4-week cold temperature challenge. Male Trpm8-KO mice had lower bone mineral density than WT, with smaller bone size (femur length and cross-sectional area) being the most striking finding, and exhibited a delayed cold acclimation with increased BAT expression of Dio2 and Cidea compared to WT. In contrast to males, female Trpm8-KO mice had low vertebral bone microarchitectural parameters, but no genotype-specific alterations in body temperature. Interestingly, Trpm8 was not required for cold-induced trabecular bone loss in either sex, but bone marrow adipose tissue in females was significantly suppressed by Trpm8 deletion. In summary, we identified sex differences in the role of TRPM8 in maintaining body temperature, bone microarchitecture and marrow adipose tissue. Identifying mechanisms through which cold temperature and BAT influence bone could help to ameliorate potential bone side effects of obesity treatments designed to stimulate thermogenesis.	[Lelis Carvalho, Adriana; Treyball, Annika; Costa, Samantha; Neilson, Ryan J.; Reagan, Michaela R.; Motyl, Katherine J.] Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA; [Brooks, Daniel J.; Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Ctr Adv Orthopaed Studies, Boston, MA 02215 USA; [Reagan, Michaela R.; Motyl, Katherine J.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Reagan, Michaela R.; Motyl, Katherine J.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA; [Bouxsein, Mary L.] Harvard Med Sch, Dept Orthoped Surg, Boston, MA 02115 USA	Maine Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Tufts University; University of Maine System; University of Maine Orono; Harvard University; Harvard Medical School	Motyl, KJ (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, Scarborough, ME 04074 USA.; Motyl, KJ (corresponding author), Tufts Univ, Sch Med, Boston, MA 02111 USA.; Motyl, KJ (corresponding author), Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME 04469 USA.	motylk@mmc.org		Reagan, Michaela/0000-0003-2884-6481; Costa, Samantha/0000-0001-5257-0898	NIH/NIAMS [K01AR067858]; NIH/NIGMS [P20GM121301]; NIH/NCI [R37CA245330]	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH/NIAMS K01AR067858 to Katherine Motyl, PhD, Principal Investigator. NIH/NIGMS P20GM121301 to Katherine Motyl, PhD, Project Leader, and Michaela Reagan, PhD, Project Leader. NIH/NCI R37CA245330 to Michaela Reagan, PhD, Principal Investigator. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abed E, 2009, MOL MEMBR BIOL, V26, P146, DOI 10.1080/09687680802612721; Acharya TK, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81041-w; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cankar K, 2016, MICROVASC RES, V108, P34, DOI 10.1016/j.mvr.2016.07.006; Caudle RM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176753; Clookey SL., 2019, FRONT PHYSIOL, V10, P1, DOI [10.3389/fphys.2019.00001, DOI 10.3389/FPHYS.2019.00001]; Contreras GA, 2014, AM J PHYSIOL-ENDOC M, V307, pE793, DOI 10.1152/ajpendo.00033.2014; Cooper MP, 2008, J BIOL CHEM, V283, P31960, DOI 10.1074/jbc.M805431200; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Elefteriou F, 2005, CELL MOL LIFE SCI, V62, P2339, DOI 10.1007/s00018-005-5175-3; Fedorenko A, 2012, CELL, V151, P400, DOI 10.1016/j.cell.2012.09.010; Feketa VV, 2013, AM J PHYSIOL-REG I, V305, pR1040, DOI 10.1152/ajpregu.00296.2013; Fischer AW, 2018, MOL METAB, V7, P161, DOI 10.1016/j.molmet.2017.10.009; Iwaniec UT, 2016, OSTEOPOROSIS INT, V27, P3091, DOI 10.1007/s00198-016-3634-3; Jiang CY, 2017, ONCOTARGET, V8, P75114, DOI 10.18632/oncotarget.20540; Kim SN, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0121-7; Kubo T, 2017, EXP ANIM TOKYO, V66, P337, DOI 10.1538/expanim.17-0028; Lanske B, 2017, J BONE MINER RES, V32, P1153, DOI 10.1002/jbmr.3140; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Martin SA, 2019, ENDOCR CONNECT, V8, P1455, DOI 10.1530/EC-19-0359; McCoy DD, 2013, AM J PHYSIOL-ENDOC M, V305, pE78, DOI 10.1152/ajpendo.00542.2012; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Moraes MN, 2017, BBA-MOL CELL RES, V1864, P2415, DOI 10.1016/j.bbamcr.2017.09.011; Motyl KJ, 2015, ENDOCRINOLOGY, V156, P2374, DOI 10.1210/en.2015-1099; Motyl KJ, 2013, J BONE MINER RES, V28, P1885, DOI 10.1002/jbmr.1943; Nilius Bernd, 2005, Sci STKE, V2005, pre8, DOI 10.1126/stke.2952005re8; Noguchi W, 2013, J UROLOGY, V189, P1975, DOI 10.1016/j.juro.2012.10.014; Reimundez A, 2018, J NEUROSCI, V38, P3643, DOI 10.1523/JNEUROSCI.3002-17.2018; Rosell M, 2014, AM J PHYSIOL-ENDOC M, V306, pE945, DOI 10.1152/ajpendo.00473.2013; Rossato M, 2014, MOL CELL ENDOCRINOL, V383, P137, DOI 10.1016/j.mce.2013.12.005; Sanchez-Gurmaches J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5099; Scheller EL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8808; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Shin HS, 2017, CELL METAB, V26, P764, DOI 10.1016/j.cmet.2017.09.002; Smeester BA, 2016, NEUROSCIENCE, V324, P344, DOI 10.1016/j.neuroscience.2016.03.030; Takahashi N, 2016, SCI REP-UK, V6, DOI 10.1038/srep29294; Takashima Y, 2010, NEUROSCIENCE, V169, P828, DOI 10.1016/j.neuroscience.2010.05.039; Tan CL, 2018, NEURON, V98, P31, DOI 10.1016/j.neuron.2018.02.022; Turner RT, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00117; Vengellur A, 2004, TOXICOL SCI, V82, P638, DOI 10.1093/toxsci/kfh278; Wee NKY, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00668; Weyer AD, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020037; Winter Z, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00209; Yirmiya R, 2006, P NATL ACAD SCI USA, V103, P16876, DOI 10.1073/pnas.0604234103	45	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0231060	10.1371/journal.pone.0231060	http://dx.doi.org/10.1371/journal.pone.0231060			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086678	gold, Green Published			2022-12-26	WOS:000664640100001
J	Tulka, S; Knippschild, S; Funck, S; Goetjes, I; Uluk, Y; Baulig, C				Tulka, Sabrina; Knippschild, Stephanie; Funck, Sina; Goetjes, Isabelle; Uluk, Yasmin; Baulig, Christine			Reporting of statistical sample size calculations in publications of trials on age-related macular degeneration, glaucoma and cataract	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; QUALITY; JOURNALS	Background Transparent and complete publications of randomised controlled trials (RCT) ought to comply with the guidelines of the CONSORT Statement, which stipulates sample size calculation as an important aspect of trial planning. The objective of this study was to analyse and compare the reporting of statistical sample size calculations in RCT papers on the treatment of age-related macular degeneration (AMD), glaucoma and cataract published in 2018. Material and methods This study comprises a total of 113 RCT papers (RCT-P) published in 2018 (AMD: 14, glaucoma: 28, cataract: 71), in English or German, and identified through an internet-based literature search in PubMed and EMBASE. The primary outcome measure of the study was the number of trials providing a complete description of the underlying sample case calculation on the basis of the variables required (significance level, expected outcomes, power, and resulting sample size). Results Of the RCTs reviewed, 64% (AMD), 61% (glaucoma) and 31% (cataract) provided a justification of the number of patients included. A complete description of the described studies' sample size calculation including all the necessary values (primary outcome measure of this study) was described by 21% of the AMD, 29% of the cataract and 18% of the glaucoma RCT publications (in total: 24 of 113 (21%) at a confidence interval of 95%: [13%; 29%]). Conclusion All three treatment areas analysed lacked reporting quality regarding the justification of the number of patients included in a clinical trial based on a sample size calculation required for ethical reasons. More than half of all RCT publications reviewed did not provide all of the required information on statistical sample size calculation, and thus lacked transparency and completeness. It is therefore urgently required to involve methodologists in a study's planning and publishing processes to ensure that methodology descriptions are transparent and of high quality.	[Tulka, Sabrina; Knippschild, Stephanie; Funck, Sina; Goetjes, Isabelle; Uluk, Yasmin; Baulig, Christine] Witten Herdecke Univ, Fac Hlth, Chair Med Biometry & Epidemiol IMBE, Witten, Germany		Tulka, S (corresponding author), Witten Herdecke Univ, Fac Hlth, Chair Med Biometry & Epidemiol IMBE, Witten, Germany.	Sabrina.Tulka@uni-wh.de	Prof. Dr. Baulig, Christine/HDN-2311-2022					Abdulatif M, 2015, BRIT J ANAESTH, V115, P699, DOI 10.1093/bja/aev166; Bariani GM, 2015, AM J CLIN ONCOL-CANC, V38, P570, DOI 10.1097/01.coc.0000436085.23342.2d; Charles P, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1732; Chow JTY, 2018, CAN J ANESTH, V65, P611, DOI 10.1007/s12630-018-1109-z; Huang YQ, 2018, J OTOLARYNGOL-HEAD N, V47, DOI 10.1186/s40463-018-0277-8; Koletsi D, 2014, EUR J ORTHODONT, V36, P67, DOI 10.1093/ejo/cjt005; Koletsi D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085949; Krummenauer F, 2002, KLIN MONBL AUGENHEIL, V202, P362; Lee PH, 2020, EUR J INTERN MED, V77, P139, DOI 10.1016/j.ejim.2020.04.057; Lee PH, 2017, EUR J INTERN MED, V40, P16, DOI 10.1016/j.ejim.2016.10.008; Loguercio AD, 2017, BRAZ ORAL RES, V31, P100, DOI 10.1590/1807-3107BOR-2017.vol31.0060; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Rohrig B, 2010, DTSCH ARZTEBL INT, V107, P552, DOI 10.3238/arztebl.2010.0552; Satpute Sachin, 2016, Perspect Clin Res, V7, P128, DOI 10.4103/2229-3485.184816; Schumacher M., 2007, METHODIK KLINISCHER, P3; Tulka S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030312; Tulka S, 2020, OPHTHALMOLOGE, V117, P125, DOI 10.1007/s00347-019-0924-0; Zhang J, 2016, ORTHOP TRAUMATOL-SUR, V102, P933, DOI 10.1016/j.otsr.2016.05.018	18	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252640	10.1371/journal.pone.0252640	http://dx.doi.org/10.1371/journal.pone.0252640			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086796	Green Published, gold			2022-12-26	WOS:000664640100099
J	Duong, P; Ma, KH; Ramesh, R; Moran, JJ; Won, S; Svaren, J				Duong, Phu; Ma, Ki H.; Ramesh, Raghu; Moran, John J.; Won, Seongsik; Svaren, John			H3K27 demethylases are dispensable for activation of Polycomb-regulated injury response genes in peripheral nerve	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWANN-CELL DIFFERENTIATION; C-JUN; SCIATIC-NERVE; COMPLEX; MYELINATION; CHROMATIN; PRC2; ENZYMES; JMJD3; TRANSCRIPTION	The induction of nerve injury response genes in Schwann cells depends on both transcriptional and epigenomic reprogramming. The nerve injury response program is regulated by the repressive histone mark H3K27 trimethylation (H3K27me3), deposited by Polycomb repressive complex 2 (PRC2). Loss of PRC2 function leads to early and augmented induction of the injury response gene network in peripheral nerves, suggesting H3K27 demethylases are required for derepression of Polycomb-regulated nerve injury genes. To determine the function of H3K27 demethylases in nerve injury, we generated Schwann cell-specific knockouts of H3K27 demethylase Kdm6b and double knockouts of Kdm6b/Kdm6a (encoding JMJD3 and UTX). We found that H3K27 demethylases are largely dispensable for Schwann cell development and myelination. In testing the function of H3K27 demethylases after injury, we found early induction of some nerve injury genes was diminished compared with control, but most injury genes were largely unaffected at 1 and 7 days post injury. Although it was proposed that H3K27 demethylases are required to activate expression of the cyclin-dependent kinase inhibitor Cdkn2a in response to injury, Schwann cell-specific deletion of H3K27 demethylases affected neither the expression of this gene nor Schwann cell proliferation after nerve injury. To further characterize the regulation of nerve injury response genes, we found that injury genes are associated with repressive histone H2AK119 ubiquitination catalyzed by PRC1, which declines after injury. Overall, our results indicate H3K27 demethylation is not required for induction of injury response genes and that other mechanisms likely are involved in activating Polycomb-repressed injury genes in peripheral nerve.	[Duong, Phu; Ma, Ki H.; Ramesh, Raghu; Moran, John J.; Won, Seongsik; Svaren, John] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Duong, Phu; Ma, Ki H.] Univ Wisconsin, Cellular & Mol Pathol Grad Program, Madison, WI USA; [Svaren, John] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Svaren, J (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	john.svaren@wisc.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921; Ma, Ki/0000-0003-3474-7287	National Institutes of Health [NS100510, HD090256, T32GM007215]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health: NS100510 to J. S., U54 core grant HD090256, and training grant T32GM007215 to P. D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Gomez-Sanchez JA, 2013, BRAIN, V136, P2262, DOI 10.1093/brain/awt130; Arcipowski KM, 2016, CURR OPIN GENET DEV, V36, P59, DOI 10.1016/j.gde.2016.03.010; Arthur-Farraj PJ, 2017, CELL REP, V20, P2719, DOI 10.1016/j.celrep.2017.08.064; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barrette B, 2010, BRAIN BEHAV IMMUN, V24, P1254, DOI 10.1016/j.bbi.2010.07.249; Belle JI, 2014, INT J BIOCHEM CELL B, V50, P161, DOI 10.1016/j.biocel.2014.03.004; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Campagne A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08255-x; Cheng HL, 1996, J NEUROCHEM, V66, P525; Clements MP, 2017, NEURON, V96, P98, DOI 10.1016/j.neuron.2017.09.008; Cohen I, 2021, GENE DEV, V35, P354, DOI 10.1101/gad.345363.120; Conway E, 2015, CURR OPIN CELL BIOL, V37, P42, DOI 10.1016/j.ceb.2015.10.003; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Estaras C, 2013, MOL BIOL CELL, V24, P351, DOI 10.1091/mbc.E12-07-0561; Fazal SV, 2017, J NEUROSCI, V37, P12297, DOI 10.1523/JNEUROSCI.0986-17.2017; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; Gomez-Sanchez JA, 2017, J NEUROSCI, V37, P9086, DOI 10.1523/JNEUROSCI.1453-17.2017; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Hashimoto M, 2008, J NEUROCHEM, V107, P918, DOI 10.1111/j.1471-4159.2008.05666.x; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hung H, 2012, J NEUROSCI, V32, P1517, DOI 10.1523/JNEUROSCI.2895-11.2012; Hung HA, 2015, J BIOL CHEM, V290, P6937, DOI 10.1074/jbc.M114.622878; Iwamori N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072689; Jacob C, 2017, CURR OPIN NEUROBIOL, V47, P24, DOI 10.1016/j.conb.2017.08.007; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Jessen KR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020487; Kehrer-Sawatzki H, 2017, HUM GENET, V136, P349, DOI 10.1007/s00439-017-1766-y; Kresak JL, 2016, J PEDIATR GENET, V5, P98, DOI 10.1055/s-0036-1579766; Kuroda MI, 2020, ANNU REV BIOCHEM, V89, P235, DOI 10.1146/annurev-biochem-120219-103641; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Lin HP, 2015, J BIOL CHEM, V290, P24294, DOI 10.1074/jbc.M115.636407; Lindborg JA, 2017, J NEUROSCI, V37, P10258, DOI 10.1523/JNEUROSCI.2085-17.2017; Lutz AB, 2017, P NATL ACAD SCI USA, V114, pE8072, DOI 10.1073/pnas.1710566114; Ma KH, 2018, GLIA, V66, P2487, DOI 10.1002/glia.23500; Ma KH, 2018, NEUROSCIENTIST, V24, P627, DOI 10.1177/1073858417751112; Ma KH, 2016, J NEUROSCI, V36, P9135, DOI 10.1523/JNEUROSCI.1370-16.2016; Ma KH, 2015, J NEUROSCI, V35, P8640, DOI 10.1523/JNEUROSCI.2257-14.2015; Manna S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9152; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Niemi JP, 2013, J NEUROSCI, V33, P16236, DOI 10.1523/JNEUROSCI.3319-12.2013; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Quintes S, 2016, NAT NEUROSCI, V19, P1050, DOI 10.1038/nn.4321; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Shan YL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14028-x; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Simon CM, 2015, ACTA NEUROPATHOL, V130, P373, DOI 10.1007/s00401-015-1446-8; Sohier P, 2017, GENE CHROMOSOME CANC, V56, P421, DOI 10.1002/gcc.22446; Stassart RM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00467; Stierli S, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.170316; Tamburri S, 2020, MOL CELL, V77, P840, DOI 10.1016/j.molcel.2019.11.021; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wu LMN, 2016, NAT NEUROSCI, V19, P1060, DOI 10.1038/nn.4322; Zigrnond RE, 2019, PROG NEUROBIOL, V173, P102, DOI 10.1016/j.pneurobio.2018.12.001	61	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100852	10.1016/j.jbc.2021.100852	http://dx.doi.org/10.1016/j.jbc.2021.100852			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34090875	gold, Green Published			2022-12-26	WOS:000678068400052
J	Axelrad, I; Safrin, M; Cahan, R; Suh, SJ; Ohman, DE; Kessler, E				Axelrad, Itschak; Safrin, Mary; Cahan, Rivka; Suh, Sang-Jin; Ohman, Dennis E.; Kessler, Efrat			Extracellular proteolytic activation of Pseudomonas aeruginosa aminopeptidase (PaAP) and insight into the role of its non-catalytic N-terminal domain	PLOS ONE			English	Article							INTRAMOLECULAR CHAPERONE; LEUCINE AMINOPEPTIDASE; PROTEASE-IV; ELASTASE; PURIFICATION; PROPEPTIDE; SECRETION; IDENTIFICATION; EXPRESSION; ALGINATE	Pseudomonas aeruginosa secretes several endopeptidases, including elastase, alkaline proteinase (Apr), a lysine-specific endopeptidase (LysC), and an aminopeptidase (PaAP), all of which are important virulence factors. Activation of the endopeptidases requires removal of an inhibitory N-terminal propeptide. Activation of pro-PaAP, in contrast, requires C-terminal processing. The activating proteases of pro-PaAP and their cleavage site(s) have not yet been defined. Studying pro-PaAP processing in a wild type P. aeruginosa strain and strains lacking either elastase or both elastase and Apr, we detected three processing variants, each similar to 56 kDa in size (AP56). Activity assays and N- and C-terminal sequence analyses of these variants pointed at LysC as the principal activating protease, cleaving a Lys(512)-Ala(513) peptide bond at the C-terminal end of pro-PaAP. Elastase and/or Apr are required for activation of LysC, suggesting both are indirectly involved in activation of PaAP. To shed light on the function(s) of the N-terminal domain of AP56, we purified recombinant AP56 and generated from it the 28 kDa catalytic domain (AP28). The kinetic constants (K-m and K-cat) for hydrolysis of Leu-, Lys-, Arg- and Met-p-nitroanilide (pNA) derivatives by AP56 and AP28 were then determined. The catalytic coefficients (K-cat/K-m) for hydrolysis of all four substrates by AP28 and AP56 were comparable, indicating that the non-catalytic domain is not involved in hydrolysis of small substrates. It may, however, regulate hydrolysis of natural peptides/proteins. Lys-pNA was hydrolyzed 2 to 3-fold more rapidly than Leu-pNA and similar to 8-fold faster than Arg- or Met-pNA, indicating that Lys-pNA was the preferred substrate.	[Axelrad, Itschak; Safrin, Mary; Cahan, Rivka; Kessler, Efrat] Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Maurice & Gabriela Goldschleger Eye Res Inst, Ramat Gan, Israel; [Suh, Sang-Jin] Texas A&M Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Ohman, Dennis E.] Virginia Commonwealth Univ, Med Ctr, Dept Microbiol & Immunol, Richmond, VA USA; [Ohman, Dennis E.] McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Cahan, Rivka] Ariel Univ, Dept Chem Engn & Biotechnol, Ariel, Israel	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Virginia Commonwealth University; Hunter Holmes McGuire Veterinary Affairs Medical Center; Ariel University	Kessler, E (corresponding author), Tel Aviv Univ, Sackler Fac Med, Sheba Med Ctr, Maurice & Gabriela Goldschleger Eye Res Inst, Ramat Gan, Israel.	ekessler@tauex.tau.ac.il		Cahan, Rivka/0000-0001-9783-4033	Veterans Affairs Merit Award [I01 BX000477]; NIH/NIAID [AI19146]	Veterans Affairs Merit Award(US Department of Veterans Affairs); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by Veterans Affairs Merit Award I01 BX000477 (to D.E.O.) and NIH/NIAID grant AI19146 (to D.E.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam MW, 2019, DRUG DISCOV TODAY, V24, P350, DOI 10.1016/j.drudis.2018.07.003; Bauman SJ, 2006, MICROBES INFECT, V8, P2400, DOI 10.1016/j.micinf.2006.05.001; Ben-Shahar S, 1999, J BIOL CHEM, V274, P21963, DOI 10.1074/jbc.274.31.21963; Bleves S, 2010, INT J MED MICROBIOL, V300, P534, DOI 10.1016/j.ijmm.2010.08.005; Braun P, 1998, J BACTERIOL, V180, P3467, DOI 10.1128/JB.180.13.3467-3469.1998; Bzymek KP, 2004, PROTEIN EXPRES PURIF, V37, P294, DOI 10.1016/j.pep.2004.05.004; Cahan R, 2001, J BIOL CHEM, V276, P43645, DOI 10.1074/jbc.M106950200; Demidyuk Ilya V, 2010, Biomol Concepts, V1, P305, DOI 10.1515/bmc.2010.025; DUONG F, 1992, GENE, V121, P47, DOI 10.1016/0378-1119(92)90160-Q; ELLIOTT BW, 1986, J BIOL CHEM, V261, P1259; Engel LS, 1998, J BIOL CHEM, V273, P16792, DOI 10.1074/jbc.273.27.16792; Esoda CN, 2019, MBIO, V10, DOI 10.1128/mBio.02548-19; FRANKLIN MJ, 1994, J BACTERIOL, V176, P1821, DOI 10.1128/JB.176.7.1821-1830.1994; Galdino A. C. M., 2017, PATHOPHYSIOLOGICAL A, P381, DOI [10.1007/978-981-10-6141-7_16, DOI 10.1007/978-981-10-6141-7_16, 10.1007/978-981, DOI 10.1007/978-981]; Gao XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092357; Gaur R, 2010, PROCESS BIOCHEM, V45, P757, DOI 10.1016/j.procbio.2010.01.017; George AM, 2009, FEMS MICROBIOL LETT, V300, P153, DOI 10.1111/j.1574-6968.2009.01704.x; Gonzales T, 1996, FEMS MICROBIOL REV, V18, P319, DOI 10.1111/j.1574-6976.1996.tb00247.x; Hoge R, FORMATEX MICROBIOLOG, V2, P383; Honek JF, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P867, DOI 10.1016/B978-0-12-382219-2.00181-2; Kerr KG, 2009, J HOSP INFECT, V73, P338, DOI DOI 10.1016/j.jhin.2009.04.020; KESSLER E, 1988, J BACTERIOL, V170, P5241, DOI 10.1128/jb.170.11.5241-5247.1988; KESSLER E, 1993, J BIOL CHEM, V268, P7503; KESSLER E, 1982, INFECT IMMUN, V38, P716, DOI 10.1128/IAI.38.2.716-723.1982; Kessler E, 1997, J BIOL CHEM, V272, P9884; Kessler E, 1998, J BIOL CHEM, V273, P30225, DOI 10.1074/jbc.273.46.30225; KESSLER E, 1994, J BIOL CHEM, V269, P22726; Kessler E, 2014, METHODS MOL BIOL, V1149, P135, DOI 10.1007/978-1-4939-0473-0_13; Kessler E, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P582, DOI 10.1016/B978-0-12-382219-2.00120-4; Kida Y, 2013, CELL MICROBIOL, V15, P1168, DOI 10.1111/cmi.12106; Li XH, 2019, J BIOL CHEM, V294, P19635, DOI 10.1074/jbc.RA119.011047; Luo XM, 2001, TRENDS BIOCHEM SCI, V26, P147, DOI 10.1016/S0968-0004(00)01768-0; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; MCIVER K, 1991, J BACTERIOL, V173, P7781, DOI 10.1128/jb.173.24.7781-7789.1991; McIver KS, 1995, MOL MICROBIOL, V18, P877, DOI 10.1111/j.1365-2958.1995.18050877.x; MORIHARA K, 1995, METHOD ENZYMOL, V248, P242; Nirasawa S, 1999, BIOCHEM J, V341, P25, DOI 10.1042/0264-6021:3410025; Nouwens AS, 2003, MICROBIOL-SGM, V149, P1311, DOI 10.1099/mic.0.25967-0; O'Callaghan R, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7090281; Oh J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03733-6; OHMAN DE, 1982, INFECT IMMUN, V37, P662, DOI 10.1128/IAI.37.2.662-669.1982; OHMAN DE, 1981, INFECT IMMUN, V33, P142, DOI 10.1128/IAI.33.1.142-148.1981; Robinson T, 2020, MBIO, V11, DOI 10.1128/mBio.03090-19; Sarnovsky R, 2009, J BIOL CHEM, V284, P10243, DOI 10.1074/jbc.M808686200; Schuster M, 2004, MOL MICROBIOL, V51, P973, DOI 10.1046/j.1365-2958.2003.03886.x; Strateva T, 2011, ANN MICROBIOL, V61, P717, DOI 10.1007/s13213-011-0273-y; Suh SJ, 1999, J BACTERIOL, V181, P3890, DOI 10.1128/JB.181.13.3890-3897.1999; Tan-Wilson A, 2012, PLANT PHYSIOL BIOCH, V53, P27, DOI 10.1016/j.plaphy.2012.01.005; Tang AX, 2017, J AGR FOOD CHEM, V65, P9412, DOI 10.1021/acs.jafc.7b03288; Tang AH, 2018, INVEST OPHTH VIS SCI, V59, P5993, DOI 10.1167/iovs.18-25834; Toma C, 1996, INFECT IMMUN, V64, P4495, DOI 10.1128/IAI.64.11.4495-4500.1996; Toyofuku M, 2012, J PROTEOME RES, V11, P4906, DOI 10.1021/pr300395j; Traidej M, 2003, INVEST OPHTH VIS SCI, V44, P190, DOI 10.1167/iovs.02-0458; Wu YT, 2014, J BASIC MICROB, V54, P1110, DOI 10.1002/jobm.201300752; Zhang ZZ, 2000, BIOCHEM J, V350, P671, DOI 10.1042/0264-6021:3500671; Zhao TH, 2018, ENV MICROBIOL REP, V10, P583, DOI 10.1111/1758-2229.12682	56	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2021	16	6							e0252970	10.1371/journal.pone.0252970	http://dx.doi.org/10.1371/journal.pone.0252970			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	TG8YE	34133429	Green Published, gold			2022-12-26	WOS:000671682700025
J	Ben Gharsa, H; Bouri, M; Mougou Hamdane, A; Schuster, C; Leclerque, A; Rhouma, A				Ben Gharsa, Haifa; Bouri, Meriam; Hamdane, Amira Mougou; Schuster, Christina; Leclerque, Andreas; Rhouma, Ali			Bacillus velezensis strain MBY2, a potential agent for the management of crown gall disease	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; BIOCONTROL AGENT; AGROBACTERIUM SPP.; LIPOPEPTIDES; TUMEFACIENS; SUBTILIS; SOIL; K84; RHIZOSPHERE; PHYLOGENY	The reduction of the use chemical pesticides in agriculture is gaining importance as an objective of decision-makers in both politics and economics. Consequently, the development of technically efficient and economically affordable alternatives as, e.g., biological control agents or practices is highly solicited. Crown gall disease of dicotyledonous plants is caused by ubiquitous soil borne pathogenic bacteria of the Agrobacterium tumefaciens species complex, that comprises the species Agrobacterium fabrum and represents a globally relevant plant protection problem. Within the framework of a screening program for bacterial Agrobacterium antagonists a total of 14 strains were isolated from Tunisian soil samples and assayed for antagonistic activity against pathogenic agrobacteria. One particularly promising isolate, termed strain MBY2, was studied more in depth. Using a Multilocus Sequence Analysis (MLSA) approach, the isolate was assigned to the taxonomic species Bacillus velezensis. Strain MBY2 was shown to display antagonistic effects against the pathogenic A. fabrum strain C58 in vitro and to significantly decrease pathogen populations under sterile and non-sterile soil conditions as well as in the rhizosphere of maize and, to a lower extent, tomato plants. Moreover, the ability of B. velezensis MBY2 to reduce C58-induced gall development has been demonstrated in vivo on stems of tomato and almond plants. The present study describes B. velezensis MBY2 as a newly discovered strain holding potential as a biological agent for crown gall disease management.	[Ben Gharsa, Haifa; Bouri, Meriam; Rhouma, Ali] Olive Tree Inst, Lab Protect & Improvement Genet Resources Olive, Tunis, Tunisia; [Ben Gharsa, Haifa] Univ Tunis El Manar, Fac Sci Tunis, Tunis, Tunisia; [Ben Gharsa, Haifa; Schuster, Christina; Leclerque, Andreas] Hsch Geisenheim Univ, Inst Microbiol & Biochem, Geisenheim, Germany; [Ben Gharsa, Haifa; Schuster, Christina; Leclerque, Andreas] Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany; [Bouri, Meriam] Yeditepe Univ, Fac Engn, Dept Genet & Bioengn, Istanbul, Turkey; [Hamdane, Amira Mougou] Univ Carthage, Natl Inst Agron Tunis, Tunis, Tunisia; [Leclerque, Andreas] CNR, Ist Protez Sostenibile Piante IPSP, Portici, Italy	Institut de l'Olivier; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Technical University of Darmstadt; Yeditepe University; Universite de Carthage; Consiglio Nazionale delle Ricerche (CNR)	Ben Gharsa, H (corresponding author), Olive Tree Inst, Lab Protect & Improvement Genet Resources Olive, Tunis, Tunisia.; Ben Gharsa, H (corresponding author), Univ Tunis El Manar, Fac Sci Tunis, Tunis, Tunisia.; Ben Gharsa, H; Leclerque, A (corresponding author), Hsch Geisenheim Univ, Inst Microbiol & Biochem, Geisenheim, Germany.; Ben Gharsa, H; Leclerque, A (corresponding author), Tech Univ Darmstadt, Dept Biol, Darmstadt, Germany.; Leclerque, A (corresponding author), CNR, Ist Protez Sostenibile Piante IPSP, Portici, Italy.	haifa.gharsa@tu-darmstadt.de; leclerque@hotmail.com	BOURI, Meriam/AAX-5818-2021	BOURI, Meriam/0000-0002-2391-8768; LECLERQUE, ANDREAS/0000-0003-0688-4137	German Academic Exchange Service (DAAD) from funds of the German Federal Foreign Office (AA) [57247235, 57556890, 57587958]	German Academic Exchange Service (DAAD) from funds of the German Federal Foreign Office (AA)(Deutscher Akademischer Austausch Dienst (DAAD))	Part of this study including the open access publication of its results has been funded under grant numbers 57247235, 57556890 and 57587958 by the German Academic Exchange Service (DAAD) from funds of the German Federal Foreign Office (AA); grant 57247235 comprises a research scholarship to HBG. The authors declare that the funding body was not involved in study design, data collection, analysis, interpretation and writing of the study.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2002, ONLINE J BIOL SCI; Ben Abdallah D, 2015, J APPL MICROBIOL, V119, P196, DOI 10.1111/jam.12797; Ben Abdallah D, 2018, ENVIRON SCI POLLUT R, V25, P36518, DOI 10.1007/s11356-018-3570-1; Ben Abdallah D, 2018, BIOL CONTROL, V124, P61, DOI 10.1016/j.biocontrol.2018.01.013; Ben Gharsa H, 2018, J PLANT PATHOL, V100, P505, DOI 10.1007/s42161-018-0114-y; Bonmatin JM, 2003, ANAL CHEM, V75, P2027, DOI 10.1021/ac020600b; Borriss R, 2011, INT J SYST EVOL MICR, V61, P1786, DOI 10.1099/ijs.0.023267-0; Bouri M, 2017, PHYTOPATHOL MEDITERR, V56, P1, DOI 10.14601/Phytopathol_Mediterr-18072; Costechareyre D, 2009, MOL BIOL EVOL, V26, P167, DOI 10.1093/molbev/msn236; DECLEENE M, 1976, BOT REV, V42, P389, DOI 10.1007/BF02860827; Deep IW., 1968, PLANT DIS REP, V52, P506; DONNER SC, 1993, PHYSIOL MOL PLANT P, V42, P185, DOI 10.1006/pmpp.1993.1017; Dunlap CA, 2016, INT J SYST EVOL MICR, V66, P1212, DOI 10.1099/ijsem.0.000858; Eastwell KC, 2006, CROP PROT, V25, P1191, DOI 10.1016/j.cropro.2006.03.004; Fan B, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00022; Fira D, 2018, J BIOTECHNOL, V285, P44, DOI 10.1016/j.jbiotec.2018.07.044; Frikha-Gargouri O, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01363; GRIMM R, 1987, Bulletin OEPP, V17, P269, DOI 10.1111/j.1365-2338.1987.tb00038.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta AK, 2007, SCI HORTIC-AMSTERDAM, V112, P51, DOI 10.1016/j.scienta.2006.12.004; Gupta AK, 2006, INDIAN J AGR SCI, V76, P426; Gupta R, 2002, APPL MICROBIOL BIOT, V59, P15, DOI 10.1007/s00253-002-0975-y; Hammami I, 2009, LETT APPL MICROBIOL, V48, P253, DOI 10.1111/j.1472-765X.2008.02524.x; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Huang L, 2017, BIOCONTROL SCI TECHN, V27, P636, DOI 10.1080/09583157.2017.1319910; JONES DA, 1989, PLANT DIS, V73, P15, DOI 10.1094/PD-73-0015; Kim JG, 2006, P NATL ACAD SCI USA, V103, P8846, DOI 10.1073/pnas.0602965103; Ksentini I, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223943; Kubo Y., 2011, ANTIMICROB AGENTS CH, V55, P1475, DOI 10.1128/AAC.01646-10; Larcher W, 2001, BIOCHEM CELL BIOL, V64, P675; Lassalle F, 2011, GENOME BIOL EVOL, V3, P762, DOI 10.1093/gbe/evr070; Lu SF, 1994, THESIS OREG STATE; Meng QX, 2016, BIOL CONTROL, V98, P18, DOI 10.1016/j.biocontrol.2016.03.010; Moore LW, 1996, PRINCIPLES PRACTICE, P151; Ongena M, 2008, TRENDS MICROBIOL, V16, P115, DOI 10.1016/j.tim.2007.12.009; Palazzini JM, 2016, MICROBIOL RES, V192, P30, DOI 10.1016/j.micres.2016.06.002; Penyalver R, 1999, APPL ENVIRON MICROB, V65, P1936; Penyalver R, 2001, APPL ENVIRON MICROB, V67, P654, DOI 10.1128/AEM.67.2.654-664.2001; Peypoux F, 1999, APPL MICROBIOL BIOT, V51, P553, DOI 10.1007/s002530051432; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Radhakrishnan R, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00667; Rajkumar M, 2005, J BASIC MICROB, V45, P55, DOI 10.1002/jobm.200410445; Reader JS, 2005, SCIENCE, V309, P1533, DOI 10.1126/science.1116841; Rhouma A, 2008, J PLANT PATHOL, V90, P517; Rooney AP, 2009, INT J SYST EVOL MICR, V59, P2429, DOI 10.1099/ijs.0.009126-0; Ruiz-Garcia C, 2005, INT J SYST EVOL MICR, V55, P191, DOI 10.1099/ijs.0.63310-0; Sabate DC, 2017, BIOL CONTROL, V113, P1, DOI 10.1016/j.biocontrol.2017.06.008; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Stockwell VO, 1996, PHYTOPATHOLOGY, V86, P31, DOI 10.1094/Phyto-86-31; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; UTKHEDE RS, 1993, SOIL BIOL BIOCHEM, V25, P383, DOI 10.1016/0038-0717(93)90138-2; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; YANG ZH, 1993, MOL BIOL EVOL, V10, P1396; Yu ZQ, 2015, J INVERTEBR PATHOL, V125, P73, DOI 10.1016/j.jip.2014.12.011; Zeriouh H, 2011, MOL PLANT MICROBE IN, V24, P1540, DOI 10.1094/MPMI-06-11-0162; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	58	3	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0252823	10.1371/journal.pone.0252823	http://dx.doi.org/10.1371/journal.pone.0252823			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129651	gold, Green Published			2022-12-26	WOS:000665475100013
J	Haitas, N; Amiri, M; Wilson, M; Joanette, Y; Steffener, J				Haitas, Niobe; Amiri, Mahnoush; Wilson, Maximiliano; Joanette, Yves; Steffener, Jason			Age-preserved semantic memory and the CRUNCH effect manifested as differential semantic control networks: An fMRI study	PLOS ONE			English	Article							HEMISPHERIC-ASYMMETRY REDUCTION; MIDDLE TEMPORAL GYRUS; ADULT LIFE-SPAN; WORKING-MEMORY; OLDER-ADULTS; POTENTIALS REVEAL; PREFRONTAL CORTEX; BRAIN NETWORKS; DEFAULT MODE; AGING BRAIN	Semantic memory representations are overall well-maintained in aging whereas semantic control is thought to be more affected. To explain this phenomenon, this study aims to test the predictions of the Compensation Related Utilization of Neural Circuits Hypothesis (CRUNCH) focusing on task demands in aging as a possible framework. The CRUNCH effect would manifest itself in semantic tasks through a compensatory increase in neural activation in semantic control network regions but only up to a certain threshold of task demands. This study will compare 40 young (20-35 years old) with 40 older participants (60-75 years old) in a triad-based semantic judgment task performed in an fMRI scanner while manipulating levels of task demands (low vs. high) through semantic distance. In line with the CRUNCH predictions, differences in neurofunctional activation and behavioral performance (accuracy and response times) are expected in young vs. old participants in the low- vs. high-demand conditions manifested in semantic control Regions of Interest.	[Haitas, Niobe; Amiri, Mahnoush; Joanette, Yves] Inst Univ Geriatrie Montreal, Lab Commun & Aging, Montreal, PQ, Canada; [Haitas, Niobe; Joanette, Yves] Univ Montreal, Fac Med, Montreal, PQ, Canada; [Wilson, Maximiliano] Univ Laval, Ctr Rech CERVO CIUSSS Capitale Natl, Quebec City, PQ, Canada; [Wilson, Maximiliano] Univ Laval, Dept Readaptat, Quebec City, PQ, Canada; [Steffener, Jason] Univ Ottawa, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada	Universite de Montreal; Universite de Montreal; Laval University; Laval University; University of Ottawa	Haitas, N (corresponding author), Inst Univ Geriatrie Montreal, Lab Commun & Aging, Montreal, PQ, Canada.; Haitas, N (corresponding author), Univ Montreal, Fac Med, Montreal, PQ, Canada.	niobe.haitas@gmail.com		Joanette, Yves/0000-0001-9212-1827	Canadian Institutes of Health Research (CIHR)	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	The study was funded by the Canadian Institutes of Health Research (CIHR).	Agbangla NF, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9020038; Ansado J, 2013, EUR J NEUROSCI, V37, P1887, DOI 10.1111/ejn.12252; Axelrod BN, 2002, ASSESSMENT, V9, P17, DOI 10.1177/1073191102009001003; Baciu M, 2016, AGE, V38, DOI 10.1007/s11357-015-9857-y; Badre D, 2005, NEURON, V47, P907, DOI 10.1016/j.neuron.2005.07.023; Badre David, 2002, Behav Cogn Neurosci Rev, V1, P206, DOI 10.1177/1534582302001003002; Balota DA, 2004, J EXP PSYCHOL GEN, V133, P283, DOI 10.1037/0096-3445.133.2.283; Baltes PB, 1997, PSYCHOL AGING, V12, P12, DOI 10.1037/0882-7974.12.1.12; Barulli D, 2013, TRENDS COGN SCI, V17, P502, DOI 10.1016/j.tics.2013.08.012; Beeman MJ, 1998, CURR DIR PSYCHOL SCI, V7, P2, DOI 10.1111/1467-8721.ep11521805; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berlingeri M, 2013, EXP BRAIN RES, V224, P393, DOI 10.1007/s00221-012-3319-x; Bernard JA, 2012, NEUROBIOL AGING, V33, P1890, DOI 10.1016/j.neurobiolaging.2011.06.021; Binder JR, 2011, TRENDS COGN SCI, V15, P527, DOI 10.1016/j.tics.2011.10.001; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Binney R.J., 2016, CEREB CORTEX, P1; Bonner MF, 2013, NEUROIMAGE, V71, P175, DOI 10.1016/j.neuroimage.2013.01.006; Boudiaf N, 2018, AGING NEUROPSYCHOL C, V25, P1, DOI 10.1080/13825585.2016.1257100; Brett M., 2002, 8 INT C FUNCT HUM BR; Cabeza R, 2002, PSYCHOL AGING, V17, P85, DOI 10.1037//0882-7974.17.1.85; Cabeza R., 2009, PRINCIPLES FRONTAL L, V2, P628; Cabeza R, 2018, NAT REV NEUROSCI, V19, P701, DOI 10.1038/s41583-018-0068-2; Cappell KA, 2010, CORTEX, V46, P462, DOI 10.1016/j.cortex.2009.11.009; Carp J, 2011, NEUROIMAGE, V56, P736, DOI 10.1016/j.neuroimage.2010.04.267; Carp J, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00217; Chiou R, 2018, CORTEX, V103, P100, DOI 10.1016/j.cortex.2018.02.018; Davey J, 2016, NEUROIMAGE, V137, P165, DOI 10.1016/j.neuroimage.2016.05.051; Davey J, 2015, J NEUROSCI, V35, P15230, DOI 10.1523/JNEUROSCI.4705-14.2015; Davey J, 2015, BRAIN LANG, V142, P24, DOI 10.1016/j.bandl.2015.01.002; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Dennis N. A., 2008, HDB AGING COGNITION, P1, DOI DOI 10.4324/9780203837665.CH1; Desrochers A, 2009, BEHAV RES METHODS, V41, P546, DOI 10.3758/BRM.41.2.546; Diaz M.T., 2018, COGN AFFECT BEHAV NE; Diaz MT, 2016, LANG LINGUIST COMPAS, V10, P314, DOI 10.1111/lnc3.12199; Duncan J, 2010, TRENDS COGN SCI, V14, P172, DOI 10.1016/j.tics.2010.01.004; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Fabiani M, 2012, PSYCHOPHYSIOLOGY, V49, P283, DOI 10.1111/j.1469-8986.2011.01331.x; Falkenstein M, 2006, INT J PSYCHOPHYSIOL, V59, P22, DOI 10.1016/j.ijpsycho.2005.08.004; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Ferre P., 2020, NEUROBIOL LANG CAMB, V1, P161, DOI 10.1162/nol_a_00007; Ferreira F, 2002, CURR DIR PSYCHOL SCI, V11, P11, DOI 10.1111/1467-8721.00158; Ferreira F, 2007, LANG LINGUIST COMPAS, V1, P71, DOI 10.1111/j.1749-818x.2007.00007.x; Festini S.B., 2018, OXFORD RES ENCYCL PS, P1; Geng JY, 2016, CORTEX, V78, P174, DOI 10.1016/j.cortex.2016.01.006; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; GRADY CL, 1994, J NEUROSCI, V14, P1450, DOI 10.1523/JNEUROSCI.14-03-01450.1994; Grady CL, 2006, J COGNITIVE NEUROSCI, V18, P227, DOI 10.1162/jocn.2006.18.2.227; Greenwood PM, 2007, NEUROPSYCHOLOGY, V21, P657, DOI 10.1037/0894-4105.21.6.657; Gutchess AH, 2010, SOC COGN AFFECT NEUR, V5, P254, DOI 10.1093/scan/nsp059; Harada CN, 2013, CLIN GERIATR MED, V29, P737, DOI 10.1016/j.cger.2013.07.002; Helder EJ, 2016, COGENT PSYCHOL, V3, DOI 10.1080/23311908.2016.1182687; Hoffman P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26569-0; Hoffman P, 2018, NEUROSCI BIOBEHAV R, V84, P134, DOI 10.1016/j.neubiorev.2017.11.010; Howard D., 1992, PYRAMID PALM TREES T; Hoyau E, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00125; Huang HW, 2012, NEUROPSYCHOLOGIA, V50, P26, DOI 10.1016/j.neuropsychologia.2011.10.018; Humphreys GF, 2015, P NATL ACAD SCI USA, V112, P7857, DOI 10.1073/pnas.1422760112; Jackson RL, 2021, NEUROIMAGE, V224, DOI 10.1016/j.neuroimage.2020.117444; Jamadar SD, 2020, NEUROPSYCHOLOGIA, V142, DOI 10.1016/j.neuropsychologia.2020.107446; Jefferies E, 2006, BRAIN, V129, P2132, DOI 10.1093/brain/awl153; Jefferies E, 2013, CORTEX, V49, P611, DOI 10.1016/j.cortex.2012.10.008; Jiang X, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00103; Joanette Y., 1990, RIGHT HEMISPHERE VER, V31, P42; Kahlaoui K, 2012, BRAIN LANG, V121, P164, DOI 10.1016/j.bandl.2011.11.002; Karimi H, 2016, Q J EXP PSYCHOL, V69, P1013, DOI 10.1080/17470218.2015.1053951; Katzev M, 2013, J NEUROSCI, V33, P7837, DOI 10.1523/JNEUROSCI.3147-12.2013; Kave G, 2009, PSYCHOL AGING, V24, P17, DOI 10.1037/a0014579; Kemper S., 1989, ANNU REV APPL LINGUI, V10, P37; Kenett YN, 2017, J EXP PSYCHOL LEARN, V43, P1470, DOI 10.1037/xlm0000391; Kennedy KM, 2015, NEUROIMAGE, V104, P21, DOI 10.1016/j.neuroimage.2014.09.056; Lacombe J, 2015, BRAIN LANG, V149, P118, DOI 10.1016/j.bandl.2015.07.003; Laver GD, 2009, PSYCHOL AGING, V24, P28, DOI 10.1037/a0014642; Li HJ, 2015, NEUROSCI BIOBEHAV R, V57, P156, DOI 10.1016/j.neubiorev.2015.08.013; Lovden M, 2010, NEUROPSYCHOLOGIA, V48, P3878, DOI 10.1016/j.neuropsychologia.2010.08.026; Lovden M, 2010, PSYCHOL BULL, V136, P659, DOI 10.1037/a0020080; Logan JM, 2002, NEURON, V33, P827, DOI 10.1016/S0896-6273(02)00612-8; Martin CO, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00069; Mattay VS, 2006, NEUROSCI LETT, V392, P32, DOI 10.1016/j.neulet.2005.09.025; Meinzer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033631; Meinzer M, 2009, J COGNITIVE NEUROSCI, V21, P2007, DOI 10.1162/jocn.2009.21219; Methqal I, 2019, AGING NEUROPSYCHOL C, V26, P190, DOI 10.1080/13825585.2017.1423021; Meyer AM, 2010, PSYCHOPHYSIOLOGY, V47, P673, DOI 10.1111/j.1469-8986.2010.00983.x; Morcom A.M., 2015, J COGN NEUROSCI, V24; Morcom AM, 2018, J NEUROSCI, V38, P7303, DOI 10.1523/JNEUROSCI.1701-17.2018; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nenert R, 2017, BRAIN RES, V1674, P20, DOI 10.1016/j.brainres.2017.08.021; New B, 2001, ANN PSYCHOL, V101, P447; Nichols TE, 2016, BEST PRACTICES DATA; Noonan KA, 2013, J COGNITIVE NEUROSCI, V25, P1824, DOI 10.1162/jocn_a_00442; Noppeney U, 2004, NEUROIMAGE, V22, P164, DOI 10.1016/j.neuroimage.2003.12.010; Nyberg L, 2017, J INTERN MED, V281, P65, DOI 10.1111/joim.12533; Nyberg L, 1996, PSYCHON B REV, V3, P135, DOI 10.3758/BF03212412; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Peelle JE, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00046; Peelle JE, 2010, CEREB CORTEX, V20, P773, DOI 10.1093/cercor/bhp142; Perquin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062030; Persson J, 2007, J COGNITIVE NEUROSCI, V19, P1021, DOI 10.1162/jocn.2007.19.6.1021; Poldrack RA, 2008, NEUROIMAGE, V40, P409, DOI 10.1016/j.neuroimage.2007.11.048; Prinz AA, 2004, NAT NEUROSCI, V7, P1345, DOI 10.1038/nn1352; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralph MAL, 2017, NAT REV NEUROSCI, V18, P42, DOI 10.1038/nrn.2016.150; Ramscar M, 2017, PSYCHOL SCI, V28, P1171, DOI 10.1177/0956797617706393; Reilly J, 2011, CORTEX, V47, P645, DOI 10.1016/j.cortex.2010.05.005; Reuter-Lorenz PA, 2005, CURR OPIN NEUROBIOL, V15, P245, DOI 10.1016/j.conb.2005.03.016; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Rice GE, 2015, CEREB CORTEX, V25, P4374, DOI 10.1093/cercor/bhv024; Sabsevitz DS, 2005, NEUROIMAGE, V27, P188, DOI 10.1016/j.neuroimage.2005.04.012; Sachs O, 2008, NEUROPSYCHOLOGIA, V46, P409, DOI 10.1016/j.neuropsychologia.2007.08.015; Sala-Llonch R., 2015, REORGANIZATION BRAIN, V6, P1; Sala-Llonch R, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00663; Salthouse T., 2009, MAJOR ISSUES COGNITI; Salthouse TA, 2004, INTELLIGENCE, V32, P541, DOI 10.1016/j.intell.2004.07.003; Salthouse TA, 2003, J EXP PSYCHOL GEN, V132, P566, DOI 10.1037/0096-3445.132.4.566; Schneider-Garces NJ, 2010, J COGNITIVE NEUROSCI, V22, P655, DOI 10.1162/jocn.2009.21230; Schrimsher GW, 2008, J PSYCHOPATHOL BEHAV, V30, P235, DOI 10.1007/s10862-007-9066-9; Smith S, 2007, NEUROIMAGE, V34, P127, DOI 10.1016/j.neuroimage.2006.09.019; Spreng RN, 2010, NEUROSCI BIOBEHAV R, V34, P1178, DOI 10.1016/j.neubiorev.2010.01.009; Stern Y, 2005, CEREB CORTEX, V15, P394, DOI 10.1093/cercor/bhh142; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Thompson-Schill SL, 1997, P NATL ACAD SCI USA, V94, P14792, DOI 10.1073/pnas.94.26.14792; Turner GR, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.06.005; Vatansever D, 2017, NEUROIMAGE, V158, P1, DOI 10.1016/j.neuroimage.2017.06.067; Verhaegen C, 2013, J INT NEUROPSYCH SOC, V19, P119, DOI 10.1017/S1355617712001178; Vincent JL, 2008, J NEUROPHYSIOL, V100, P3328, DOI 10.1152/jn.90355.2008; Waldron-Perrine B, 2012, INT J GERIATR PSYCH, V27, P1189, DOI 10.1002/gps.3768; Wierenga CE, 2008, NEUROBIOL AGING, V29, P436, DOI 10.1016/j.neurobiolaging.2006.10.024; Wilson RS, 2012, NEUROLOGY, V78, P1116, DOI 10.1212/WNL.0b013e31824f7ff2; Wilson RS, 2003, J CLIN EXP NEUROPSYC, V25, P634, DOI 10.1076/jcen.25.5.634.14572; Wingfield A, 2006, J NEUROPHYSIOL, V96, P2830, DOI 10.1152/jn.00628.2006; Zacks R.T., 1989, PSYCHOL LEARN, V22; Zhang HY, 2019, NEUROPSYCHOLOGIA, V124, P254, DOI 10.1016/j.neuropsychologia.2018.11.017; Zhuang J, 2016, NEUROPSYCHOLOGIA, V93, P189, DOI 10.1016/j.neuropsychologia.2016.10.016	138	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0249948	10.1371/journal.pone.0249948	http://dx.doi.org/10.1371/journal.pone.0249948			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129605	gold, Green Published			2022-12-26	WOS:000665475100001
J	Kim, LG; Sweeting, MJ; Armer, M; Jacomelli, J; Nasim, A; Harrison, SC				Kim, Lois G.; Sweeting, Michael J.; Armer, Morag; Jacomelli, Jo; Nasim, Akhtar; Harrison, Seamus C.			Modelling the impact of changes to abdominal aortic aneurysm screening and treatment services in England during the COVID-19 pandemic	PLOS ONE			English	Article							RUPTURE	Background The National Health Service (NHS) abdominal aortic aneurysm (AAA) screening programme (NAAASP) in England screens 65-year-old men. The programme monitors those with an aneurysm, and early intervention for large aneurysms reduces ruptures and AAA-related mortality. AAA screening services have been disrupted following COVID-19 but it is not known how this may impact AAA-related mortality, or where efforts should be focussed as services resume. Methods We repurposed a previously validated discrete event simulation model to investigate the impact of COVID-19-related service disruption on key outcomes. This model was used to explore the impact of delayed invitation and reduced attendance in men invited to screening. Additionally, we investigated the impact of temporarily suspending scans, increasing the threshold for elective surgery to 7cm and increasing drop-out in the AAA cohort under surveillance, using data from NAAASP to inform the population. Findings Delaying invitation to primary screening up to two years had little impact on key outcomes whereas a 10% reduction in attendance could lead to a 2% lifetime increase in AAA-related deaths. In surveillance patients, a 1-year suspension of surveillance or increase in the elective threshold resulted in a 0.4% increase in excess AAA-related deaths (8% in those 5-5.4cm at the start). Longer suspensions or a doubling of drop-out from surveillance would have a pronounced impact on outcomes. Interpretation Efforts should be directed towards encouraging men to attend AAA screening service appointments post-COVID-19. Those with AAAs on surveillance should be prioritised as the screening programme resumes, as changes to these services beyond one year are likely to have a larger impact on surgical burden and AAA-related mortality.	[Kim, Lois G.; Sweeting, Michael J.; Harrison, Seamus C.] Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cardiovasc Epidemiol Unit, Cambridge, England; [Sweeting, Michael J.] Univ Leicester, George Davies Ctr, Dept Hlth Sci, Leicester, Leics, England; [Armer, Morag; Jacomelli, Jo] Publ Hlth England, Wellington House, London, England; [Nasim, Akhtar] Northern Gen Hosp, Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England	University of Cambridge; University of Leicester; Public Health England; Northern General Hospital; University of Sheffield	Kim, LG (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cardiovasc Epidemiol Unit, Cambridge, England.	lois.kim@medschl.cam.ac.uk		Kim, Lois/0000-0002-4552-3820; Sweeting, Michael/0000-0003-0980-8965	UK Medical Research Council [MR/L003120/1]; British Heart Foundation [RG/13/13/30194]; NIHR Cambridge Biomedical Research Centre (BRC); NIHR Blood and Transplant Research Unit in Donor Health and Genomics (NIHR) [BTRU-2014-10024]; MRC CARP Fellowship [Mr/T023783/1]	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); NIHR Cambridge Biomedical Research Centre (BRC); NIHR Blood and Transplant Research Unit in Donor Health and Genomics (NIHR); MRC CARP Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by core funding from: the UK Medical Research Council (MR/L003120/1), the British Heart Foundation (RG/13/13/30194) and the NIHR Cambridge Biomedical Research Centre (BRC) [The views expressed are those of the author(s) and not necessarily those of the NIHR or the Department of Health and Social Care]. LGK is funded by the NIHR Blood and Transplant Research Unit in Donor Health and Genomics (NIHR BTRU-2014-10024). SCH is funded by an MRC CARP Fellowship (Mr/T023783/1). https://mrc.ukri.org/https://www.bhf.org.uk/for-professionals https://cambridgebrc.nihr.ac.uk/http://www.donorhealth-btru.nihr.ac.uk/.The sponsors and funders played no role in study design. data collection, decision to publish or preparation of the manuscript.	[Anonymous], 2021, COVID SITUATION UPDA; Ball S, 2020, HEART, V106, P1890, DOI 10.1136/heartjnl-2020-317870; England NHS., 2019, SERV SPEC 23 NHS ABD; Glover MJ, 2014, BRIT J SURG, V101, P976, DOI 10.1002/bjs.9528; Glover MJ, 2018, MED DECIS MAKING, V38, P439, DOI 10.1177/0272989X17753380; Grootes I, 2018, BRIT J SURG, V105, P1294, DOI 10.1002/bjs.10964; Jacomelli J, 2017, J MED SCREEN, V24, P166, DOI 10.1177/0969141316667409; Jewkes SV, 2020, CLIN MED, V20, pE173, DOI 10.7861/clinmed.2020-0422; McGuinness B, 2021, J VASC SURG, V73, P780, DOI 10.1016/j.jvs.2020.08.115; National Joint Vascular Implementation Board, 2020, COVID 19 RESP GUID R; National Vascular Registry, 2020, IMP COV 19 DIS PROV; NHS England and NHS Improvement, 2020, NHS ABD AORT ANE SCR; Office for National Statistics, 2020, POPULATION ESTIMATES; Rhee C, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.20498; Rickman HM, 2020, CLIN INFECT DIS; Selway WG, 2020, BRIT J SURG, V107, pE646, DOI 10.1002/bjs.12059; Statistics OoN, 2020, COR COVID 19 INF SUR; Thompson SG, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17410; Thompson SG, 2012, BRIT J SURG, V99, P1649, DOI 10.1002/bjs.8897; Thompson SG, 2018, HEALTH TECHNOL ASSES, V22, P1, DOI 10.3310/hta22430; Waton SJ A., 2020, NATL VASCULAR REGIST; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4	22	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253327	10.1371/journal.pone.0253327	http://dx.doi.org/10.1371/journal.pone.0253327			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129649	Green Submitted, gold, Green Published			2022-12-26	WOS:000665475100044
J	Strodel, R; Dayton, L; Garrison-Desany, HM; Eber, G; Beyrer, C; Arscott, J; Rubenstein, L; Sufrin, C				Strodel, Rachel; Dayton, Lauren; Garrison-Desany, Henri M.; Eber, Gabriel; Beyrer, Chris; Arscott, Joyell; Rubenstein, Leonard; Sufrin, Carolyn			COVID-19 vaccine prioritization of incarcerated people relative to other vulnerable groups: An analysis of state plans	PLOS ONE			English	Article							UNITED-STATES; PRISON	Background Carceral facilities are epicenters of the COVID-19 pandemic, placing incarcerated people at an elevated risk of COVID-19 infection. Due to the initial limited availability of COVID-19 vaccines in the United States, all states have developed allocation plans that outline a phased distribution. This study uses document analysis to compare the relative prioritization of incarcerated people, correctional staff, and other groups at increased risk of COVID-19 infection and morbidity. Methods and findings We conducted a document analysis of the vaccine dissemination plans of all 50 US states and the District of Columbia using a triple-coding method. Documents included state COVID-19 vaccination plans and supplemental materials on vaccine prioritization from state health department websites as of December 31, 2020. We found that 22% of states prioritized incarcerated people in Phase 1, 29% of states in Phase 2, and 2% in Phase 3, while 47% of states did not explicitly specify in which phase people who are incarcerated will be eligible for vaccination. Incarcerated people were consistently not prioritized in Phase 1, while other vulnerable groups who shared similar environmental risk received this early prioritization. States' plans prioritized in Phase 1: prison and jail workers (49%), law enforcement (63%), seniors (65+ years, 59%), and long-term care facility residents (100%). Conclusions This study demonstrates that states' COVID-19 vaccine allocation plans do not prioritize incarcerated people and provide little to no guidance on vaccination protocols if they fall under other high-risk categories that receive earlier priority. Deprioritizing incarcerated people for vaccination misses a crucial opportunity for COVID-19 mitigation. It also raises ethical and equity concerns. As states move forward with their vaccine distribution, further work must be done to prioritize ethical allocation and distribution of COVID-19 vaccines to incarcerated people.	[Strodel, Rachel; Beyrer, Chris; Sufrin, Carolyn] Johns Hopkins Sch Med, Baltimore, MD 21205 USA; [Dayton, Lauren; Beyrer, Chris; Sufrin, Carolyn] Johns Hopkins Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA; [Garrison-Desany, Henri M.; Eber, Gabriel; Beyrer, Chris; Arscott, Joyell; Rubenstein, Leonard] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Beyrer, Chris] Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Strodel, R (corresponding author), Johns Hopkins Sch Med, Baltimore, MD 21205 USA.	rstrode3@jhmi.edu		Sufrin, Carolyn/0000-0003-2739-9296	NIH [NIDA-5K23DA045934-02]; Society of Family Planning Research Fund; Desmond M. Tutu Endowment in Health and Human Rights; Judy and Peter Bloom Kovler Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Family Planning Research Fund; Desmond M. Tutu Endowment in Health and Human Rights; Judy and Peter Bloom Kovler Foundation	Carolyn Sufrin is supported by grants from the NIH (NIDA-5K23DA045934-02) and the Society of Family Planning Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Websites: https://www.societyfp.org/, https://www.nih.gov/This work is supported in part by the Desmond M. Tutu Endowment in Health and Human Rights. HGD and RJS are supported by the Judy and Peter Bloom Kovler Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama MJ, 2020, NEW ENGL J MED, V382, P2075, DOI 10.1056/NEJMp2005687; Alaszewski A, 2021, STAT COVID 19 DAT PO; Anderson C., 2021, BAY BAY NEWS 0108; Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P421; [Anonymous], VACCINE HESITANCY IS; Associated Press , WASH POST; Baillargeon J, 2000, ANN EPIDEMIOL, V10, P74, DOI 10.1016/S1047-2797(99)00033-2; Barsky BA, 2021, NEW ENGL J MED, V384, P1583, DOI 10.1056/NEJMp2100609; Baussano I, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000381; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Binswanger IA, 2016, PUBLIC HEALTH REP, V131, P574, DOI 10.1177/0033354916662216; Buck J. M., 2006, Journal of Correctional Health Care, V12, P12, DOI 10.1177/1078345806287937; Centers for Disease Control and Prevention, 2020, PHARM PARTN LONG TER; Centers for Disease Control and Prevention (CDC), 2012, MMWR MORB MORTAL WKL, V61, P229; Dalglish SL, 2020, HEALTH POLICY PLANN, V35, P1424, DOI 10.1093/heapol/czaa064; Dooling K, 2020, MMWR-MORBID MORTAL W, V69, P1857, DOI [10.15585/mmwr.mm6949e1, 10.15585/mmwr.mm695152e2]; Fazel S, 2006, EUR J PUBLIC HEALTH, V16, P441, DOI 10.1093/eurpub/cki223; Fda.gov, 2021, FDA ISS EM US AUTH 3; Hagan LM, 2020, MMWR-MORBID MORTAL W, V69, P1139, DOI 10.15585/mmwr.mm6933a3; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; HSE, 2020, COVID 19 VACC PROGR; HUTTON MD, 1993, PUBLIC HEALTH REP, V108, P305; Khavjou OA, 2007, WOMEN HEALTH ISS, V17, P193, DOI 10.1016/j.whi.2007.02.008; Kronfli N, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100659; Lee M., 2020, WFXRTV 0918; Lewis N., 2021, MARSHALL PROJEC 0301; Lofgren E, 2021, EPIDEMIOLOGICAL IMPL, DOI [10.1101/2020.04.08.20058842, DOI 10.1101/2020.04.08.20058842]; Maruschak LM, 2020, 252157 NCJ US DEP JU; NASEM (National Academies of Sciences Engineering and Medicine), 2020, VISION NSF EARTH SCI, P144, DOI [DOI 10.17226/25761, 10.17226/25761]; ODonoghue J, 2020, LOUISIANA ILLUM 1112; Office of the Commissioner, 2021, MOD COVID 19 VACC; Office of the Commissioner, 2021, PFIZ BIONTECH COVID; Ojikutu BO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198258; Prison Policy Initiative, INC PEOPL CORR STAFF; Reinhart E, 2020, HEALTH AFFAIR, V39, P1412, DOI 10.1377/hlthaff.2020.00652; Rocha A., 2020, TEXAS TRIBUNE 1115; Saloner B, 2020, JAMA-J AM MED ASSOC, V324, P602, DOI 10.1001/jama.2020.12528; Siva N, 2020, LANCET, V396, P1870, DOI 10.1016/S0140-6736(20)32663-5; Stavola M., 2020, WICHITA EAGLE 1204; Stern MF, 2021, MMWR-MORBID MORTAL W, V70, P473, DOI 10.15585/mmwr.mm7013a3; Stern MF, 2010, AM J PUBLIC HEALTH, V100, P2103, DOI 10.2105/AJPH.2009.184242; Strassle C, 2020, NEW ENGL J MED, V383, P1807, DOI 10.1056/NEJMp2025955; Toner E., 2020, INTERIM FRAMEWORK CO; UN General Assembly, 2015, N MAND RUL; Vogel M, 2016, J QUANT CRIMINOL, V32, P515, DOI 10.1007/s10940-015-9265-6; Wang E, 2020, RECOMMENDATIONS PRIO; Wang J, 2020, ENVIRON POLLUT, V266, DOI 10.1016/j.envpol.2020.115161; Watson C, 2020, COVID 19 US CRIMINAL; World Health Organization (WHO), 2020, ANAL PROPORTIONS	49	9	9	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253208	10.1371/journal.pone.0253208	http://dx.doi.org/10.1371/journal.pone.0253208			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129620	gold, Green Published			2022-12-26	WOS:000665475100033
J	Busch, C; Katzmann, JL; Jochmann, C; Unterlauft, JD; Vollhardt, D; Wiedemann, P; Laufs, U; Rehak, M				Busch, Catharina; Katzmann, Julius L.; Jochmann, Claudia; Unterlauft, Jan Darius; Vollhardt, Daniela; Wiedemann, Peter; Laufs, Ulrich; Rehak, Matus			General health of patients with diabetic macular edema-The LIPSIA study	PLOS ONE			English	Article							AMBULATORY BLOOD-PRESSURE; RISK-FACTORS; EUROPEAN-SOCIETY; RETINOPATHY; TYPE-1; ASSOCIATION; PROGRESSION; LIPOPROTEIN(A); MELLITUS; COMPLICATIONS	Purpose Cardiovascular risk factors such as hypertension or dyslipidemia can influence the incidence and progression of diabetic retinopathy (DR) and diabetic macular edema (DME). The aim of this study is to describe the comorbidities in patients with DME. Methods Prospective, monocentric observational study. Patients presenting for the treatment of DME received laboratory and clinical examinations including 24-hour blood pressure measurement. Results Seventy-five consecutive patients were included in the study. The mean age was 61.0 14.5 years, and 83% had type 2 diabetes. The mean body mass index (BMI) was 32.8 +/- 6.0 kg/m(2). Overweight (BMI >= 25 kg/m(2)) was present in 92% of all patients. HbA1c values were > 7.0% in 57%. Although 87% of the patients already received antihypertensive therapy, the blood pressure (BP) of 82% was still above the recommended target values of systolic < 140 mmHg and diastolic < 80 mmHg. An insufficient nocturnal fall of the systolic BP (< 10%, non-dipping or reverse dipping) was observed in 62%. In 83% of the patients the glomerular filtration rate was <less than or equal to> 90 ml/min/1.73m(2). Despite 65% of the cohort already receiving lipid-lowering therapy, LDL cholesterol was above the target value of 1.4 mmol/l in 93%. All patients had at least one cardiovascular risk factor in addition to diabetes (overweight, hypertension, insufficient nocturnal BP fall, dyslipidemia, or renal dysfunction) and 86% had >= 3 risk factors. Conclusion DME patients are characterized by highly prevalent cardiovascular risk factors that are poorly controlled. These comorbidities reduce the prognosis and negatively influence existing DR and DME. The data reveal an important opportunity for improving patient care by interaction of the ophthalmologist with the general practitioner and internal specialists for the detection and treatment of these conditions.	[Busch, Catharina; Jochmann, Claudia; Unterlauft, Jan Darius; Vollhardt, Daniela; Wiedemann, Peter; Rehak, Matus] Univ Hosp Leipzig, Dept Ophthalmol, Leipzig, Germany; [Katzmann, Julius L.; Laufs, Ulrich] Univ Hosp Leipzig, Dept Cardiol, Leipzig, Germany	Leipzig University; Leipzig University	Busch, C (corresponding author), Univ Hosp Leipzig, Dept Ophthalmol, Leipzig, Germany.	busch.catharina@gmail.com	Rehak, Matus/ABC-1073-2021		Novartis Pharma [MRTH258A_FVMR002]	Novartis Pharma	The study was funded by an grant to MR by Novartis Pharma (Grant number: MRTH258A_FVMR002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cardoso CRL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05159-6; Cegla J, 2019, ATHEROSCLEROSIS, V291, P62, DOI 10.1016/j.atherosclerosis.2019.10.011; Cho NH, 2018, DIABETES RES CLIN PR, V138, P271, DOI 10.1016/j.diabres.2018.02.023; Chung YR, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-016-0486-2; Cosentino F., 2020, EUR HEART J, V41, P255, DOI [10.1093/eurheartj/ehz486, DOI 10.1093/eurheartj/ehz486]; Do DV, 2015, COCHRANE DB SYST REV, DOI [10.1590/1516-3180.20151333T1, 10.1002/14651858.CD006127.pub2]; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Funatsu H, 2009, ACTA OPHTHALMOL, V87, P501, DOI 10.1111/j.1755-3768.2008.01298.x; Gori M, 2016, DIABETES CARE, V39, P677, DOI 10.2337/dc15-1760; Gross JG, 2018, JAMA OPHTHALMOL, V136, P1138, DOI 10.1001/jamaophthalmol.2018.3255; Haffner S M, 1995, Eur J Ophthalmol, V5, P119; Hsieh YT, 2018, JAMA OPHTHALMOL, V136, P68, DOI 10.1001/jamaophthalmol.2017.5202; Hwang IC, 2019, EYE, V33, P980, DOI 10.1038/s41433-019-0352-z; Iglay K, 2016, CURR MED RES OPIN, V32, P1243, DOI 10.1185/03007995.2016.1168291; Jovin IS, 2004, ATHEROSCLEROSIS, V174, P225, DOI 10.1016/j.atherosclerosis.2004.01.026; Kang EYC, 2019, JAMA OPHTHALMOL, V137, P363, DOI 10.1001/jamaophthalmol.2018.6399; Kawasaki R, 2019, DIABETOL INT, V10, P3, DOI 10.1007/s13340-018-0357-z; Kim CH, 1998, DIABETES CARE, V21, P2149, DOI 10.2337/diacare.21.12.2149; Klein BEK, 2015, JAMA OPHTHALMOL, V133, P503, DOI 10.1001/jamaophthalmol.2014.5108; Klein R, 1998, OPHTHALMOLOGY, V105, P1801, DOI 10.1016/S0161-6420(98)91020-X; Klein R, 1997, ARCH INTERN MED, V157, P650, DOI 10.1001/archinte.157.6.650; Klein R, 2002, BRIT J OPHTHALMOL, V86, P365, DOI 10.1136/bjo.86.4.365; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; Klein R, 2016, JAMA-J AM MED ASSOC, V315, P1778, DOI 10.1001/jama.2016.3849; Klein R, 2006, OPHTHALMOLOGY, V113, P2231, DOI 10.1016/j.ophtha.2006.06.003; Klein R, 2009, OPHTHALMOLOGY, V116, P497, DOI 10.1016/j.ophtha.2008.10.016; Landgraf R, 2019, EXP CLIN ENDOCR DIAB, V127, pS73, DOI 10.1055/a-1018-9106; Man REK, 2016, JAMA OPHTHALMOL, V134, P251, DOI 10.1001/jamaophthalmol.2015.5103; MASER RE, 1993, DIABETES CARE, V16, P755, DOI 10.2337/diacare.16.5.755; Merlotti C, 2017, OBES REV, V18, P309, DOI 10.1111/obr.12490; O'Brien E, 2013, J HYPERTENS, V31, P1731, DOI 10.1097/HJH.0b013e328363e964; Pacella E, 2013, CLIN TER, V164, pE121, DOI 10.7417/CT.2013.1543; Pawlak K, 2008, CYTOKINE, V43, P98, DOI 10.1016/j.cyto.2008.03.011; Qaseem A, 2018, ANN INTERN MED, V168, P569, DOI 10.7326/M17-0939; Rajalakshmi R., 2020, BMJ OPEN DIAB RES CA, V8; Salles GF, 2016, HYPERTENSION, V67, P693, DOI 10.1161/HYPERTENSIONAHA.115.06981; Sarrafan-chaharsoughi Z, 2018, J DIABETES METAB DIS, V17, P63, DOI 10.1007/s40200-018-0339-5; Schmidt-Erfurth U, 2017, OPHTHALMOLOGICA, V237, P185, DOI 10.1159/000458539; Stefanutti C, 2019, ATHEROSCLEROSIS SUPP, V40, P49, DOI 10.1016/j.atherosclerosissup.2019.08.031; Tang O, 2020, DIABETES CARE, V43, P1200, DOI 10.2337/dc19-2043; van Leiden HA, 2003, ARCH OPHTHALMOL-CHIC, V121, P245, DOI 10.1001/archopht.121.2.245; Yau JWY, 2012, DIABETES CARE, V35, P556, DOI 10.2337/dc11-1909; Yoon YH, 2019, GRAEF ARCH CLIN EXP, V257, P2639, DOI 10.1007/s00417-019-04464-2	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0252321	10.1371/journal.pone.0252321	http://dx.doi.org/10.1371/journal.pone.0252321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115786	gold, Green Published			2022-12-26	WOS:000664643000016
J	Chiang, CH; Weng, CL; Chiu, HW				Chiang, Chen-Hua; Weng, Chi-Lun; Chiu, Hung-Wen			Automatic classification of medical image modality and anatomical location using convolutional neural network	PLOS ONE			English	Article								Modern radiologic images comply with DICOM (digital imaging and communications in medicine) standard, which, upon conversion to other image format, would lose its image detail and information such as patient demographics or type of image modality that DICOM format carries. As there is a growing interest in using large amount of image data for research purpose and acquisition of large amount of medical image is now a standard practice in the clinical setting, efficient handling and storage of large amount of image data is important in both the clinical and research setting. In this study, four classes of images were created, namely, CT (computed tomography) of abdomen, CT of brain, MRI (magnetic resonance imaging) of brain and MRI of spine. After converting these images into JPEG (Joint Photographic Experts Group) format, our proposed CNN architecture could automatically classify these 4 groups of medical images by both their image modality and anatomic location. We achieved excellent overall classification accuracy in both validation and test sets (> 99.5%), specificity and F1 score (> 99%) in each category of this dataset which contained both diseased and normal images. Our study has shown that using CNN for medical image classification is a promising methodology and could work on non-DICOM images, which could potentially save image processing time and storage space.	[Chiang, Chen-Hua] Taipei Med Univ, Shuang Ho Hosp, Dept Radiol, New Taipei, Taiwan; [Chiang, Chen-Hua] Taipei Med Univ, Coll Med, Sch Med, Dept Radiol, Taipei, Taiwan; [Weng, Chi-Lun] Tainan Municipal Hosp, Tainan, Taiwan; [Chiu, Hung-Wen] Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan	Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; Taipei Medical University	Chiu, HW (corresponding author), Taipei Med Univ, Coll Med Sci & Technol, Grad Inst Biomed Informat, Taipei, Taiwan.	hwchiu@tmu.edu.tw		Chiang, Chen-Hua/0000-0001-8650-4119				[Anonymous], 2015, ARXIV150404003; Bhattacharya S, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102589; Chung KJ, 2020, IEEE SIGNAL PROC LET, V27, P141, DOI 10.1109/LSP.2019.2961072; Graham RNJ, 2005, CLIN RADIOL, V60, P1133, DOI 10.1016/j.crad.2005.07.003; Guld M., 2002, P SPIE INT SOC OPTIC, V4685; Khan S, 2017, ASIAPAC SIGN INFO PR, P1661; Kim I, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9020038; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Maruyama T, 2018, J X-RAY SCI TECHNOL, V26, P885, DOI 10.3233/XST-18386; Pizarro RA-O., USING DEEP LEARNING; Remedios S., 2018, CLASSIFYING MAGNETIC; Ren NN, 2017, J HEALTHC ENG, V2017, DOI 10.1155/2017/2727686; Sugimori H, 2018, J HEALTHC ENG, V2018, DOI 10.1155/2018/1753480; Varma Dandu Ravi, 2012, Indian J Radiol Imaging, V22, P4, DOI 10.4103/0971-3026.95396; Wang SH, 2020, NEURAL COMPUT APPL, V32, P665, DOI 10.1007/s00521-018-3924-0; Zhang YD, 2019, MULTIMED TOOLS APPL, V78, P3613, DOI 10.1007/s11042-017-5243-3	16	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253205	10.1371/journal.pone.0253205	http://dx.doi.org/10.1371/journal.pone.0253205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115822	gold, Green Published			2022-12-26	WOS:000664643000057
J	Teshale, AB; Tessema, ZT; Alem, AZ; Yeshaw, Y; Liyew, AM; Alamneh, TS; Tesema, GA; Worku, MG				Teshale, Achamyeleh Birhanu; Tessema, Zemenu Tadesse; Alem, Adugnaw Zeleke; Yeshaw, Yigizie; Liyew, Alemneh Mekuriaw; Alamneh, Tesfa Sewunet; Tesema, Getayeneh Antehunegn; Worku, Misganaw Gebrie			Knowledge about mother to child transmission of HIV/AIDS, its prevention and associated factors among reproductive-age women in sub-Saharan Africa: Evidence from 33 countries recent Demographic and Health Surveys	PLOS ONE			English	Article							HIV	Background In sub-Saharan Africa (SSA) 90 percent of babies acquired HIV/AIDS from infected mothers. Maternal knowledge about mother to child transmission (MTCT) of HIV/AIDS and its prevention is a cornerstone for elimination of MTCT of HIV/AIDS. Despite this, there is limited evidence about knowledge about MTCT of HIV/AIDS and its prevention and associated factors in SSA. Therefore, this study aimed to assess knowledge of MTCT of HIV/AIDS, its prevention (PMTCT) and, associated factors among reproductive-age women in sub-Saharan Africa. Objective To assess Knowledge about mother to child transmission of HIV/AIDS and its prevention and associated factors among reproductive-age women in Sub-Saharan Africa. Methods The recent SSA countries' Demographic and Health Surveys (DHS), which were conducted from 2008/09 to 2018/19, was our data source. We appended 33 countries' DHS data for our analysis. For our study, a total weighted sample of 350,888 reproductive-age women was used. Due to the hierarchical nature of the DHS data, we conducted a multilevel analysis. Finally, the adjusted odds ratio with its 95% confidence interval was reported, and variables with p-value <= 0.05 were considered as significant predictors of knowledge of MTCT of HIV/AIDS and its prevention. Results In this study, 56.21% (95% CI: 56.05-56.38) of respondents had correct knowledge about MTCT of HIV/AIDS and its prevention among reproductive-age women in SSA. In the multilevel logistic regression analysis: being in the older age group, better education level, being from a rich household, having mass media exposure, having parity of one and above were associated with higher odds of knowledge about MTCT of HIV/AIDS and its prevention. However, being perceiving distance from the health facility as a big problem was associated with lower odds of knowledge about MTCT of HIV/AIDS and its prevention. Conclusion Knowledge about MTCT of HIV/AIDS and its prevention among reproductive-age women in SSA was low. Therefore, it is better to consider the high-risk groups during the intervention to increase awareness about this essential public health issue and to tackle its devastating outcome.	[Teshale, Achamyeleh Birhanu; Tessema, Zemenu Tadesse; Alem, Adugnaw Zeleke; Yeshaw, Yigizie; Liyew, Alemneh Mekuriaw; Alamneh, Tesfa Sewunet; Tesema, Getayeneh Antehunegn] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Yeshaw, Yigizie] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Physiol, Gondar, Ethiopia; [Worku, Misganaw Gebrie] Univ Gondar, Sch Med, Coll Med & Hlth Sci, Dept Human Anat, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Teshale, AB (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	achambir08@gmail.com	Teshale, Achamyeleh/HHN-8416-2022; Yeshaw, Yigizie/L-6336-2019; Tadesse, Zemenu/ABG-1690-2021	Teshale, Achamyeleh/0000-0002-7572-9993; Yeshaw, Yigizie/0000-0003-4587-7925; Alemneh, Tesfa Sewunet/0000-0002-4830-931X				Abebe AM, 2020, HIV AIDS-RES PALLIAT, V12, P79, DOI 10.2147/HIV.S242166; Abiodun MO, 2007, J NATL MED ASSOC, V99, P758; Abtew S, 2016, HIV AIDS-RES PALLIAT, V8, P101, DOI 10.2147/HIV.S100301; Ahmed I, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6482-1; Alemu YM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203043; Anderson JE, 2004, OBSTET GYNECOL, V103, P165, DOI 10.1097/01.AOG.0000101285.25133.5A; Ashimi A O, 2014, West Afr J Med, V33, P68; Byamugisha R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-52; Fitzgerald FC, 2010, SAMJ S AFR MED J, V100, P827, DOI 10.7196/SAMJ.4045; Haile ZT, 2016, AIDS CARE, V28, P70, DOI 10.1080/09540121.2015.1062465; Joint United Nations Programme on HIV/AIDS, 2014, GAP REP, V7; Liyeh TM., 2020, BMC RES NOTES, V13, P1, DOI [10.1186/s13104-019-4871-2, DOI 10.1186/S13104-019-4871-2]; Luba TR, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.020414; Malaju MT, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-73; Masaka A, 2019, ALEX J MED, V55, P68, DOI 10.1080/20905068.2019.1667114; Mukhtar M, 2020, INT J COMMUNITY MED, V7, P2622, DOI [10.18203/ 2394-6040. ijcmph20202987, DOI 10.18203/2394-6040.IJCMPH20202987]; Nyarko V., 2019, PAMJ CLIN MED, V1; Patel D, 2007, CLIN INFECT DIS, V44, P1647, DOI 10.1086/518284; Singh PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031666; The DHS Program, 2015, SAMPL WEIGHT DHS DAT; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; UNAIDS, 2017, START FREE STAY FREE; UNAIDS, 2018, MIL GO GLOB AIDS UPD; UNAIDS, GLOB H AIDS STAT 201, P31; UNICEF, 2019, CHILDR HIV AIDS REG; Wangwe P J T, 2013, Afr Health Sci, V13, P914, DOI 10.4314/ahs.v13i4.8	26	3	3	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0253164	10.1371/journal.pone.0253164	http://dx.doi.org/10.1371/journal.pone.0253164			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115798	gold, Green Published			2022-12-26	WOS:000664643000053
J	Watanabe, T; Yabu, T				Watanabe, Tsutomu; Yabu, Tomoyoshi			Japan's voluntary lockdown	PLOS ONE			English	Article								Japan's government has taken a number of measures, including declaring a state of emergency, to combat the spread COVID-19. We examine the mechanisms through which the government's policies have led to changes in people's behavior. Using smartphone location data, we construct a daily prefecture-level stay-at-home measure to identify the following two effects: (1) the effect that citizens refrained from going out in line with the government's request, and (2) the effect that government announcements reinforced awareness with regard to the seriousness of the pandemic and people voluntarily refrained from going out. Our main findings are as follows. First, the declaration of the state of emergency reduced the number of people leaving their homes by 8.5% through the first channel, which is of the same order of magnitude as the estimates obtained for lockdowns in the United States. Second, a 1% increase in new infections in a prefecture reduces people's outings in that prefecture by 0.027%. Third, the government's requests are responsible for about one quarter of the decrease in outings in Tokyo, while the remaining three quarters are the result of citizens obtaining new information through government announcements and the daily release of the number of infections. The findings suggest that what mattered for containing the spread of COVID-19 was not strong, legally binding measures but the provision of appropriate information that encouraged people to change their behavior.	[Watanabe, Tsutomu] Univ Tokyo, Grad Sch Econ, Bunkyo Ku, Tokyo, Japan; [Yabu, Tomoyoshi] Keio Univ, Fac Business & Commerce, Minato Ku, Tokyo, Japan	University of Tokyo; Keio University	Watanabe, T (corresponding author), Univ Tokyo, Grad Sch Econ, Bunkyo Ku, Tokyo, Japan.	watanabe@e.u-tokyo.ac.jp			JSPS [20K01594]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	TW acknowledges financial support from JSPS through the Grant-in-Aid for Scientific Research No. 18H05217. TY acknowledges financial support from the JSPS through the Grant-in-Aid for Scientific Research No. 20K01594.	Alexander Diane, 2020, 202012 FRB; Aum S., 2020, COVID 19 DOESNT NEED; Barrios J.M, 2020, RISK PERCEPTION LENS; Chetty R., 2020, 27431 NBER; Chiou Lesley, 2020, 26982 NAT BUR EC RES; Coibion O., 2020, COST COVID 19 CRISIS; Couture Victor, 2020, 27560 NAT BUR EC RES; Fang Hanming, 2020, 26906 NAT BUR EC RES; Forsythe E, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104238; Goolsbee Austan, 2020, 27432 NAT BUR EC RES; Gupta Sumedha, 2020, 27027 NAT BUR EC RES; Rojas Felipe Lozano, 2020, 27127 NAT BUR EC RES; Sheridan A, 2020, P NATL ACAD SCI USA, V117, P20468, DOI 10.1073/pnas.2010068117; Takayuki. Mizuno, 2020, ARTIF INTELL, V35; Watanabe T., 2020, COVID EC VETTED REAL, V46, P1	15	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252468	10.1371/journal.pone.0252468	http://dx.doi.org/10.1371/journal.pone.0252468			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111163	Green Submitted, gold, Green Published			2022-12-26	WOS:000664642700030
J	Ahinkorah, BO; Seidu, AA; Budu, E; Agbaglo, E; Adu, C; Dickson, KS; Ameyaw, EK; Hagan, JE; Schack, T				Ahinkorah, Bright Opoku; Seidu, Abdul-Aziz; Budu, Eugene; Agbaglo, Ebenezer; Adu, Collins; Dickson, Kwamena Sekyi; Ameyaw, Edward Kwabena; Hagan, John Elvis, Jr.; Schack, Thomas			Which factors predict fertility intentions of married men and women? Results from the 2012 Niger Demographic and Health Survey	PLOS ONE			English	Article							UNMET NEED; PROXIMATE DETERMINANTS; CHILDHOOD MORTALITY; CONTRACEPTIVE USE; FAMILY-SIZE; EDUCATION; PREFERENCES; BEHAVIOR; DECLINE; PATTERNS	Introduction Niger is the country with the highest total fertility rate in the world. In the present study, we investigated factors associated with the desire for more children among married men and women in Niger. Materials and methods We utilised data from the 2012 Niger Demographic and Health Survey. The outcome variable for the study was fertility intentions. The data were analysed with Stata version 14.0. Both descriptive (frequencies and percentages) and inferential (binary logistic regression) analyses were carried out. Results Desire for more children was 97.2% and 87.2% among men and women respectively. Women aged 45-49 were less likely to desire more children, compared to those aged 25-39 [aOR = 0.13, CI = 0.11-0.16]. The odds of desire for more children were high in rural areas, compared to urban areas [aOR = 1.61, CI = 1.20-2.17]. Childbearing women with seven or more births were less likely to desire more children, compared to those with 1-3 births [aOR = 0.09, CI = 0.06-0.14]. Men aged 50-59 were less likely to desire more children, compared to those aged 25-39 [aOR = 0.13, CI = 0.05-0.35]. Men with secondary/higher level of education were less likely to desire more children, compared to those with no formal education [aOR = 0.24, CI = 0.11-0.52]. Childbearing men with seven or more births were less likely to desire more children, compared to those with 1-3 births [aOR = 0.06, CI = 0.01-0.30]. Conclusion This study shows high fertility desire among men and women in Niger. However, the prevalence of fertility desire among men is higher than that of women. A number of socio-economic and demographic factors were found to be associated with desire for more children among men and women in Niger. This calls for a collective effort to educate women and men in Niger on the negative consequences of rapid population growth and large family sizes.	[Ahinkorah, Bright Opoku; Ameyaw, Edward Kwabena] Univ Technol Sydney, Sch Publ Hlth, Fac Hlth, Sydney, NSW, Australia; [Seidu, Abdul-Aziz; Budu, Eugene; Dickson, Kwamena Sekyi] Univ Cape Coast, Coll Humanities & Legal Studies, Dept Populat & Hlth, Cape Coast, Ghana; [Seidu, Abdul-Aziz] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Townsville, Qld, Australia; [Agbaglo, Ebenezer] Univ Cape Coast, Dept English, Cape Coast, Ghana; [Adu, Collins] Kwame Nkrumah Univ Sci & Technol, Dept Hlth Promot Educ & Disabil Studies, Kumasi, Ghana; [Hagan, John Elvis, Jr.] Univ Cape Coast, Dept Hlth Phys Educ & Recreat, Cape Coast, Ghana; [Hagan, John Elvis, Jr.; Schack, Thomas] Bielefeld Univ, Neurocognit & Act Biomech Res Grp, Fac Psychol & Sport Sci, Bielefeld, Germany	University of Technology Sydney; University of Cape Coast; James Cook University; University of Cape Coast; Kwame Nkrumah University Science & Technology; University of Cape Coast; University of Bielefeld	Hagan, JE (corresponding author), Univ Cape Coast, Dept Hlth Phys Educ & Recreat, Cape Coast, Ghana.; Hagan, JE (corresponding author), Bielefeld Univ, Neurocognit & Act Biomech Res Grp, Fac Psychol & Sport Sci, Bielefeld, Germany.	elvis.hagan@ucc.edu.gh	Dickson, Kwamena Sekyi/AEP-5571-2022; Dickson, Kwamena Sekyi/AFF-8066-2022; Dickson, Kwamena Sekyi/AAE-9964-2022	Dickson, Kwamena Sekyi/0000-0002-3152-2317; Dickson, Kwamena Sekyi/0000-0002-3152-2317; Dickson, Kwamena Sekyi/0000-0002-3152-2317; Budu, Eugene/0000-0002-8484-9225; Ameyaw, Edward Kwabena/0000-0002-6617-237X; Seidu, Abdul-Aziz/0000-0001-9734-9054; Hagan Jnr., Dr. John Elvis/0000-0003-3530-6133				Adebowale S. A., 2013, African Population Studies, V27, P127, DOI 10.11564/27-2-435; Ahinkorah BO, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03470-1; Ahinkorah BO, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236352; Ajaero CK, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2979-z; Akonor ON., 2017, REGIONAL I POPULATIO; Alaba OO, 2017, S AFR FAM PRACT, V59, P143, DOI 10.1080/20786190.2017.1292693; Aliaga A, 2006, DHS WORKING PAPERS, V30; Ashraf QH, 2013, POPUL DEV REV, V39, P97, DOI 10.1111/j.1728-4457.2013.00575.x; Atake EH, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0747-9; Babalola S, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4934-z; Bagheri A, 2019, J MIDWIFERY REPROD H, V7, P1536, DOI [10.22038/jmrh.2018.25186.1275, DOI 10.22038/JMRH.2018.25186.1275]; Basu AM, 2005, SOC SCI MED, V60, P2011, DOI 10.1016/j.socscimed.2004.08.057; Basu AM, 2002, WORLD DEV, V30, P1779, DOI 10.1016/S0305-750X(02)00072-4; Beguy D, 2015, CULT HEALTH SEX, V17, P1074, DOI 10.1080/13691058.2015.1038731; Behrman JA, 2015, DEMOGRAPHY, V52, P787, DOI 10.1007/s13524-015-0392-3; Berrington A, 2014, ADV LIFE COURSE RES, V21, P10, DOI 10.1016/j.alcr.2013.12.003; Beyeza-Kashesya J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-247; Casterline JB, 2017, POPUL DEV REV, V43, P84, DOI 10.1111/padr.12030; Casterline JB, 2014, STUD FAMILY PLANN, V45, P227, DOI 10.1111/j.1728-4465.2014.00386.x; Channon MD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219736; Conteh-Khali N, 2014, THESIS BOWLING GREEN; Corsi DJ, 2012, INT J EPIDEMIOL, V41, P1602, DOI 10.1093/ije/dys184; Creanga AA, 2011, B WORLD HEALTH ORGAN, V89, P258, DOI 10.2471/BLT.10.083329; Dalglish SL, 2018, STUD FAMILY PLANN, V49, P367, DOI 10.1111/sifp.12078; De Silva W I, 1992, Asia Pac Popul J, V7, P41; Dyer SJ, 2004, HUM REPROD, V19, P960, DOI 10.1093/humrep/deh195; Eklund L., 2016, INTERSECTIONS GENDER, V39, P1, DOI [DOI 10.1177/1457496915583201, 10.1177/1457496915583201]; Fenn N.S., 2015, PATTERNS TRENDS DRIV; Gerland P, 2017, POPUL DEV REV, V43, P21, DOI 10.1111/padr.12011; Hacettepe University Institute of Population Studies, 2014, TURK DEM HLTH SURV 2; Ifelunini AI, 2018, AFRICAN POPULATION S, V32; Jiang L, 2014, INT J POPUL RES, V2014, P2014; Knoema, 2015, GROSS ENR RAT PRIM E; Kodzi IA, 2010, STUD FAMILY PLANN, V41, P45, DOI 10.1111/j.1728-4465.2010.00223.x; Kravdal O, 2008, AM SOCIOL REV, V73, P854, DOI 10.1177/000312240807300508; Laelago T, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0677-x; Lesthaeghe R., FERTILITY TRANSITION, V2014, P14; Machiyama K, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0268-z; Mahmud S, 2012, WORLD DEV, V40, P610, DOI 10.1016/j.worlddev.2011.08.003; Maralani V, 2008, DEMOGRAPHY, V45, P693, DOI 10.1353/dem.0.0013; MARTIN TC, 1995, STUD FAMILY PLANN, V26, P187, DOI 10.2307/2137845; MASON KO, 1987, POPUL DEV REV, V13, P611, DOI 10.2307/1973025; Mather M., 2019, FACT SHEET AGING US; Matovu JKB, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0272-3; May JF, 2017, POPUL DEV REV, V43, P308, DOI 10.1111/j.1728-4457.2016.00165.x; National Institute of Statistics (INS) ICF International, 2013, DEM HLTH SURV MULT N; National Population Council, 2014, GHAN DEM TRANS DEM D; Nations United, 2015, SUSTAINABLE DEV GOAL; Novignon J, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0798-2; Ocalan D, 2018, CLIN EXPT MED SCI, V6, P13; Odewale BJ, 3 INT C AFR DE ISS; Otieno V, 1748, F1000RESEARCH, V2019, P8; Population Reference Bureau, 2009, NIG SUMM; Potts M, 2011, INT PERSPECT SEX R H, V37, P95, DOI 10.1363/3709511; Prusty RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104598; Rabbi AFJJoSR., 2012, J SCI RES, V4, P383; Rahman M, 2017, SSM-POPUL HLTH, V3, P525, DOI 10.1016/j.ssmph.2017.06.001; Rocca CH, 2013, PERSPECT SEX REPRO H, V45, P23, DOI 10.1363/4502313; Roser M, 2014, OUR WORLD DATA; Rutaremwa Gideon, 2015, Fertil Res Pract, V1, P16, DOI 10.1186/s40738-015-0009-y; Schoumaker B, 2017, DEMOGR RES, V36, P803, DOI 10.4054/DemRes.2017.36.28; Senderowicz L, 2020, STUD FAMILY PLANN, V51, P161, DOI 10.1111/sifp.12114; Senderowicz L, 2019, SOC SCI MED, V239, DOI 10.1016/j.socscimed.2019.112531; Sennott C, 2012, INT PERSPECT SEX R H, V38, P34, DOI 10.1363/3803412; Shapiro D, 2017, DEMOGR RES, V37, P669, DOI [10.4054/DemRes.2017.37.21, 10.4054/demres.2017.37.21]; Spoorenberg T, 2018, DEMOGR RES, V39, P685, DOI 10.4054/DemRes.2018.39.24; Testa MR, 2014, ADV LIFE COURSE RES, V21, P28, DOI 10.1016/j.alcr.2014.01.005; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; United Nations Department of Economic and Social Affairs, 2013, FERT LE TRENDS ASS 2; United Nations Population Division (UNPD), 2017, ESAPWP248 UNPD; Ushie MA., 2011, J GEOGRAPHY REGIONAL, V4, P383; Westoff C F., 2010, DESIRED NUMBER CHILD; Westoff CF, 2013, POPUL DEV REV, V38, P169, DOI 10.1111/j.1728-4457.2013.00558.x; Withers M, 2010, J BIOSOC SCI, V42, P549, DOI 10.1017/S0021932010000052; Yaya S, 2019, BMC INT HEALTH HUM R, V19, DOI 10.1186/s12914-019-0219-1; Yeatman S, 2013, DEMOGRAPHY, V50, P1715, DOI 10.1007/s13524-013-0214-4	76	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252281	10.1371/journal.pone.0252281	http://dx.doi.org/10.1371/journal.pone.0252281			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	SW6RW	34106940	gold, Green Published, Green Accepted			2022-12-26	WOS:000664642200036
J	Weinberg, SH; Saini, N; Lemmon, CA				Weinberg, Seth H.; Saini, Navpreet; Lemmon, Christopher A.			Effects of substrate stiffness and actin velocity on in silico fibronectin fibril morphometry and mechanics	PLOS ONE			English	Article							MATRIX; FIBRILLOGENESIS; MECHANOTRANSDUCTION; ELASTICITY; MIGRATION; DYNAMICS; INTEGRIN; CELLS; SITE	Assembly of the extracellular matrix protein fibronectin (FN) into insoluble, viscoelastic fibrils is a critical step during embryonic development and wound healing; misregulation of FN fibril assembly has been implicated in many diseases, including fibrotic diseases and cancer. We have previously developed a computational model of FN fibril assembly that recapitulates the morphometry and mechanics of cell-derived FN fibrils. Here we use this model to probe two important questions: how is FN fibril formation affected by the contractile phenotype of the cell, and how is FN fibril formation affected by the stiffness of the surrounding tissue? We show that FN fibril formation depends strongly on the contractile phenotype of the cell, but only weakly on in vitro substrate stiffness, which is an analog for in vivo tissue stiffness. These results are consistent with previous experimental data and provide a better insight into conditions that promote FN fibril assembly. We have also investigated two distinct phenotypes of FN fibrils that we have previously identified; we show that the ratio of the two phenotypes depends on both substrate stiffness and contractile phenotype, with intermediate contractility and high substrate stiffness creating an optimal condition for stably stretched fibrils. Finally, we have investigated how re-stretch of a fibril affects cellular response. We probed how the contractile phenotype of the re-stretching cell affects the mechanics of the fibril; results indicate that the number of myosin motors only weakly affects the cellular response, but increasing actin velocity results in a decrease in the apparent stiffness of the fibril and a decrease in the stably-applied force to the fibril. Taken together, these results give novel insights into the combinatorial effects of substrate stiffness and cell contractility on FN fibril assembly.	[Weinberg, Seth H.] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Saini, Navpreet; Lemmon, Christopher A.] Virginia Commonwealth Univ, Dept Biomed Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA	University System of Ohio; Ohio State University; Virginia Commonwealth University	Weinberg, SH (corresponding author), Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA.; Lemmon, CA (corresponding author), Virginia Commonwealth Univ, Dept Biomed Engn, Med Coll Virginia Campus, Richmond, VA 23284 USA.	clemmon@vcu.edu; weinberg147@osu.edu	Lemmon, Christopher/GPP-1470-2022	Weinberg, Seth/0000-0003-1170-0419; Lemmon, Christopher/0000-0002-9049-6366	National Institutes of Health [R01GM115678, R01GM122855]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (www.nih.gov) via grant award R01GM115678 (SHW, CAL) and R01GM122855 (SHW, CAL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Lail NI, 2006, MATRIX BIOL, V25, P175, DOI 10.1016/j.matbio.2005.10.007; Califano JP, 2010, CELL MOL BIOENG, V3, P68, DOI 10.1007/s12195-010-0102-6; Chan CE, 2008, SCIENCE, V322, P1687, DOI 10.1126/science.1163595; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Clark RAF, 2003, J INVEST DERMATOL, V121, P695, DOI 10.1046/j.1523-1747.2003.12484.x; CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075; Cuda G, 1997, BIOPHYS J, V72, P1767, DOI 10.1016/S0006-3495(97)78823-4; DZAMBA BJ, 1993, J CELL BIOL, V121, P1165, DOI 10.1083/jcb.121.5.1165; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Erickson HP, 2002, J MUSCLE RES CELL M, V23, P575, DOI 10.1023/A:1023427026818; Feinberg AW, 2010, NANO LETT, V10, P2184, DOI 10.1021/nl100998p; Fu JP, 2010, NAT METHODS, V7, P733, DOI 10.1038/nmeth.1487; Gao M, 2002, J MOL BIOL, V323, P939, DOI 10.1016/S0022-2836(02)01001-X; Griggs LA, 2017, MATRIX BIOL, V60-61, P157, DOI 10.1016/j.matbio.2017.01.001; GRINNEL F, 1980, EXPERIENTIA, V36, P505, DOI 10.1007/BF01965766; Lemmon Christopher A, 2005, Mech Chem Biosyst, V2, P1; Lemmon CA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18328-4; Lemmon CA, 2009, BIOPHYS J, V96, P729, DOI 10.1016/j.bpj.2008.10.009; Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Marsden M, 2001, DEVELOPMENT, V128, P3635; Nelea V, 2010, J STRUCT BIOL, V170, P50, DOI 10.1016/j.jsb.2010.01.009; Pernodet N, 2003, J BIOMED MATER RES A, V64A, P684, DOI 10.1002/jbm.a.10394; Saez A, 2005, BIOPHYS J, V89, pL52, DOI 10.1529/biophysj.105.071217; Salmeron-Sanchez M, 2011, BIOMATERIALS, V32, P2099, DOI 10.1016/j.biomaterials.2010.11.057; Scott LE, 2015, INTEGR BIOL-UK, V7, P1454, DOI 10.1039/c5ib00217f; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Weinberg SH, 2017, BIOPHYS J, V112, P1962, DOI 10.1016/j.bpj.2017.02.027; Wu CY, 1996, CELL ADHES COMMUN, V4, P149, DOI 10.3109/15419069609014219; Zhong CL, 1998, J CELL BIOL, V141, P539, DOI 10.1083/jcb.141.2.539	30	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0248256	10.1371/journal.pone.0248256	http://dx.doi.org/10.1371/journal.pone.0248256			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106923	gold, Green Published			2022-12-26	WOS:000664642200007
J	Watanabe, T; Oba, T; Tanimoto, K; Shibata, T; Kamijo, S; Ito, K				Watanabe, Takayuki; Oba, Takaaki; Tanimoto, Keiji; Shibata, Tomohiro; Kamijo, Shinobu; Ito, Ken-ichi			Tamoxifen resistance alters sensitivity to 5-fluorouracil in a subset of estrogen receptor-positive breast cancer	PLOS ONE			English	Article							ANTI-TUMOR ACTIVITY; ENDOCRINE RESISTANCE; CAPECITABINE; THERAPY; EXPRESSION; MODULATION; MECHANISMS; MIRNAS; URACIL; ROLES	Sequential treatment with endocrine or chemotherapy is generally used in the treatment of estrogen receptor (ER)-positive recurrent breast cancer. To date, few studies have investigated the effect of long-term endocrine therapy on the response to subsequent chemotherapy in ER-positive breast cancer. We examined whether a preceding endocrine therapy affects the sensitivity to subsequent chemotherapy in ER-positive breast cancer cells. Three ER-positive breast cancer cell lines (T47D, MCF7, BT474) and tamoxifen-resistant sublines (T47D/T, MCF7/T, BT474/T) were analyzed for sensitivity to 5-fluorouracil, paclitaxel, and doxorubicin. The mRNA levels of factors related to drug sensitivity were analyzed by RT-PCR. MCF7/T cells became more sensitive to 5-fluorouracil than wild-type (wt)-MCF7 cells. In addition, the apoptosis induced by 5-fluorouracil was significantly increased in MCF7/T cells. However, no difference in sensitivity to chemotherapeutic agents was observed in T47D/T and BT474/T cells compared with their wt cells. Dihydropyrimidine dehydrogenase (DPYD) mRNA expression was significantly decreased in MCF7/T cells compared with wt-MCF7 cells. The expression of DPYD mRNA was restored with 5-azacytidine treatment in MCF7/T cells. In addition, DPYD 3 ' -UTR luciferase activity was significantly reduced in MCF7/T cells. These data indicated that the expression of DPYD mRNA was repressed by methylation of the DPYD promoter region and post-transcriptional regulation by miRNA in MCF7/T cells. In the mouse xenograft model, capecitabine significantly reduced the tumor volume in MCF7/T compared with MCF7. The results of this study indicate that endocrine therapy could alter the sensitivity to chemotherapeutic agents in a subset of breast cancers, and 5-fluorouracil may be effective in tamoxifen-resistant breast cancers.	[Watanabe, Takayuki; Oba, Takaaki; Shibata, Tomohiro; Kamijo, Shinobu; Ito, Ken-ichi] Shinshu Univ, Sch Med, Dept Surg, Div Breast & Endocrine Surg, Matsumoto, Nagano, Japan; [Tanimoto, Keiji] Hiroshima Univ, Dept Radiat Med, Res Inst Radiat Biol & Med, Hiroshima, Hiroshima, Japan	Shinshu University; Hiroshima University	Ito, K (corresponding author), Shinshu Univ, Sch Med, Dept Surg, Div Breast & Endocrine Surg, Matsumoto, Nagano, Japan.	kenito@shinshu-u.ac.jp						Abdel-Hafiz Hany A, 2017, Diseases, V5, DOI 10.3390/diseases5030016; Andreetta C, 2010, CRIT REV ONCOL HEMAT, V76, P99, DOI 10.1016/j.critrevonc.2010.01.007; [Anonymous], 2020, CANCER TODAY DAT VIS; Barrett-Lee P, 2009, CANCER TREAT REV, V35, P582, DOI 10.1016/j.ctrv.2009.06.003; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; BENZ C, 1983, CANCER RES, V43, P5304; Biganzoli L, 2002, ONCOLOGIST, V7, P29; Cristofanilli M, 2016, LANCET ONCOL, V17, P425, DOI 10.1016/S1470-2045(15)00613-0; Fitzmaurice C, 2019, JAMA ONCOL, V5, P1749, DOI 10.1001/jamaoncol.2019.2996; FUJII S, 1978, GANN, V69, P763; FUJII S, 1979, GANN, V70, P209; Fujita T, 2005, CLIN CANCER RES, V11, P8837, DOI 10.1158/1078-0432.CCR-05-0945; Goetz MP, 2017, J CLIN ONCOL, V35, P3638, DOI 10.1200/JCO.2017.75.6155; Grem JL, 1997, SEMIN RADIAT ONCOL, V7, P249, DOI 10.1016/S1053-4296(97)80023-9; Grem JL, 2001, CLIN CANCER RES, V7, P999; Hirota T, 2012, LUNG CANCER, V77, P16, DOI 10.1016/j.lungcan.2011.12.018; Hortobagyi GN, 2016, NEW ENGL J MED, V375, P1738, DOI 10.1056/NEJMoa1609709; Ishikawa T, 1998, BIOCHEM PHARMACOL, V55, P1091, DOI 10.1016/S0006-2952(97)00682-5; Ito T, 2012, BREAST CANCER RES TR, V133, P145, DOI 10.1007/s10549-011-1731-8; Kurebayashi J, 2007, CANCER CHEMOTH PHARM, V59, P515, DOI 10.1007/s00280-006-0293-7; Kurebayashi J, 2010, CANCER CHEMOTH PHARM, V65, P219, DOI 10.1007/s00280-009-1024-7; Lam SW, 2016, CANCER TREAT REV, V50, P9, DOI 10.1016/j.ctrv.2016.08.001; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; Muluhngwi P, 2015, ENDOCR-RELAT CANCER, V22, pR279, DOI 10.1530/ERC-15-0355; NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines&REG;), BREAST CANC 2020; Noguchi T, 2004, CLIN CANCER RES, V10, P7100, DOI 10.1158/1078-0432.CCR-04-0337; Nozawa K, 2013, PSYCHO-ONCOLOGY, V22, P2140, DOI 10.1002/pon.3268; Nukatsuka M, 2019, IN VIVO, V33, P1439, DOI 10.21873/invivo.11622; Robson M, 2017, NEW ENGL J MED, V377, P523, DOI 10.1056/NEJMoa1706450; Seidman AD, 2002, ONCOLOGIST, V7, P20; Stockler MR, 2011, J CLIN ONCOL, V29, P4498, DOI 10.1200/JCO.2010.33.9101; Takashima T, 2016, LANCET ONCOL, V17, P90, DOI 10.1016/S1470-2045(15)00411-8; Turner NC, 2019, J CLIN ONCOL, V37, P1169, DOI 10.1200/JCO.18.00925; Worldwide cancer data, GLOB CANC STAT MOST; Zhou JC, 2013, ONCOL LETT, V6, P295, DOI 10.3892/ol.2013.1405	35	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2021	16	6							e0252822	10.1371/journal.pone.0252822	http://dx.doi.org/10.1371/journal.pone.0252822			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RP	34101751	Green Published, Green Submitted, gold			2022-12-26	WOS:000664641500026
J	Kragstrup, TW; Singh, HS; Grundberg, I; Nielsen, ALL; Rivellese, F; Mehta, A; Goldberg, MB; Filbin, MR; Qvist, P; Bibby, BM				Kragstrup, Tue W.; Singh, Helene Sogaard; Grundberg, Ida; Nielsen, Ane Langkilde-Lauesen; Rivellese, Felice; Mehta, Arnav; Goldberg, Marcia B.; Filbin, Michael R.; Qvist, Per; Bibby, Bo Martin			Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; FUNCTIONAL RECEPTOR; SARS CORONAVIRUS; INFECTION; INHIBITION; EXPRESSION; SARS-COV-2; DISEASES; PROTEIN; KIDNEY	Aims Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) binds to angiotensin converting enzyme 2 (ACE2) enabling entrance of the virus into cells and causing the infection termed coronavirus disease of 2019 (COVID-19). Here, we investigate associations between plasma ACE2 and outcome of COVID-19. Methods and results This analysis used data from a large longitudinal study of 306 COVID-19 positive patients and 78 COVID-19 negative patients (MGH Emergency Department COVID-19 Cohort). Comprehensive clinical data were collected on this cohort, including 28-day outcomes. The samples were run on the Olink (R) Explore 1536 platform which includes measurement of the ACE2 protein. High admission plasma ACE2 in COVID-19 patients was associated with increased maximal illness severity within 28 days with OR = 1.8, 95%-CI: 1.4-2.3 (P < 0.0001). Plasma ACE2 was significantly higher in COVID-19 patients with hypertension compared with patients without hypertension (P = 0.0045). Circulating ACE2 was also significantly higher in COVID-19 patients with pre-existing heart conditions and kidney disease compared with patients without these pre-existing conditions (P = 0.0363 and P = 0.0303, respectively). Conclusion This study suggests that measuring plasma ACE2 is potentially valuable in predicting COVID-19 outcomes. Further, ACE2 could be a link between COVID-19 illness severity and its established risk factors hypertension, pre-existing heart disease and pre-existing kidney disease.	[Kragstrup, Tue W.; Singh, Helene Sogaard; Nielsen, Ane Langkilde-Lauesen; Qvist, Per] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Kragstrup, Tue W.] Aarhus Univ Hosp, Dept Rheumatol, Aarhus, Denmark; [Grundberg, Ida] Olink Prote, Uppsala, Sweden; [Nielsen, Ane Langkilde-Lauesen] Randers Reg Hosp, Randers, Denmark; [Rivellese, Felice] Queen Mary Univ London, Ctr Expt Med & Rheumatol, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Mehta, Arnav] Massachusetts Gen Hosp, Dept Med Oncol, Boston, MA 02114 USA; [Mehta, Arnav] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Goldberg, Marcia B.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Goldberg, Marcia B.] Harvard Med Sch, Dept Microbiol, Boston, MA 02115 USA; [Filbin, Michael R.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Qvist, Per] IPSYCH, Lundbeck Fdn Initiat Integrat Psychiat Res, Aarhus, Denmark; [Qvist, Per] Aarhus Univ, Ctr Genom & Personalized Med, Aarhus, Denmark; [Bibby, Bo Martin] Aarhus Univ, Dept Biostat, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; University of London; Queen Mary University London; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Aarhus University; Aarhus University	Kragstrup, TW (corresponding author), Aarhus Univ, Dept Biomed, Aarhus, Denmark.; Kragstrup, TW (corresponding author), Aarhus Univ Hosp, Dept Rheumatol, Aarhus, Denmark.	kragstrup@biomed.au.dk	Qvist, Per/H-4238-2019	Qvist, Per/0000-0002-0750-0089; Mehta, Arnav/0000-0002-0313-2848; RIVELLESE, Felice/0000-0002-6759-7521; Kragstrup, Tue Wenzel/0000-0002-6439-397X	American Lung Association COVID-19 Action Initiative award; Independent Research Fund Denmark clinician scientist award [9039-00015B]; Olink Proteomics	American Lung Association COVID-19 Action Initiative award; Independent Research Fund Denmark clinician scientist award; Olink Proteomics	American Lung Association COVID-19 Action Initiative award (MBG). Independent Research Fund Denmark clinician scientist award 9039-00015B, TWK). Olink Proteomics financed and performed the proteomics assays presented in this work as part of the collaboration with Massachusetts General Hospital (MGH and the Broad Institute on the MGH Emergency Department COVID-19 Cohort. Olink Proteomics provided support in the form of salaries for IG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the 'author contributions' section.	Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Atlas SA, 2007, J MANAGE CARE PHARM, V13, pS9, DOI 10.18553/jmcp.2007.13.s8-b.9; Banerjee A, 2020, LANCET, V395, P1715, DOI 10.1016/S0140-6736(20)30854-0; Batlle D, 2020, CLIN SCI, V134, P543, DOI 10.1042/CS20200163; Boulpaep WBE., 2017, MED PHYSL, V3; Chan KK, 2020, SCIENCE, V369, P1261, DOI 10.1126/science.abc0870; Cummings Matthew J, 2020, medRxiv, DOI [10.1016/S0140-6736(20)31189-2, 10.1101/2020.04.15.20067157]; Emilsson Valur, 2020, medRxiv, DOI 10.1101/2020.06.04.20122044; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Fagyas M, 2021, GEROSCIENCE, V43, P19, DOI 10.1007/s11357-020-00300-2; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Ferrario CM, 2005, CIRCULATION, V111, P2605, DOI 10.1161/CIRCULATIONAHA.104.510461; Filbin Michael R, 2020, bioRxiv, DOI 10.1101/2020.11.02.365536; Forrester SJ, 2018, PHYSIOL REV, V98, P1627, DOI 10.1152/physrev.00038.2017; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hofmann H, 2004, BIOCHEM BIOPH RES CO, V319, P1216, DOI 10.1016/j.bbrc.2004.05.114; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Khan A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1823-x; Kintscher U, 2020, HYPERTENSION, V76, pE34, DOI 10.1161/HYPERTENSIONAHA.120.15841; Kreutz R, 2020, CARDIOVASC RES, V116, P1688, DOI 10.1093/cvr/cvaa097; Lee IT, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19145-6; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Lores E, 2020, CLIN SCI, V134, P2791, DOI 10.1042/CS20200484; Lundstrom A, 2021, J MED VIROL, V93, P5908, DOI 10.1002/jmv.27144; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Monteil V, 2020, CELL, V181, P905, DOI 10.1016/j.cell.2020.04.004; Munker D, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.02724-2020; Nagy B, 2021, INT J INFECT DIS, V103, P412, DOI 10.1016/j.ijid.2020.11.184; Narula S, 2020, LANCET, V396, P968, DOI 10.1016/S0140-6736(20)31964-4; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Patel SK, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03730-2020; Pavel AB, 2021, ALLERGY, V76, P875, DOI 10.1111/all.14522; Ocaranza MP, 2020, NAT REV CARDIOL, V17, P116, DOI 10.1038/s41569-019-0244-8; Perrotta F, 2020, RESP MED, V168, DOI 10.1016/j.rmed.2020.105996; Putman M, 2021, ARTHRITIS RHEUMATOL, V73, P36, DOI 10.1002/art.41469; Reynolds HR, 2020, NEW ENGL J MED, V382, P2441, DOI 10.1056/NEJMoa2008975; Rieder M, 2021, AM J HYPERTENS, V34, P278, DOI 10.1093/ajh/hpaa169; Rivellese F, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102536; Sama IE, 2020, EUR HEART J, V41, P1810, DOI 10.1093/eurheartj/ehaa373; Serfozo P, 2020, HYPERTENSION, V75, P173, DOI 10.1161/HYPERTENSIONAHA.119.14071; Tikellis C, 2008, DIABETES, V57, P1018, DOI 10.2337/db07-1212; van Lier D, 2021, ERJ OPEN RES, V7, DOI 10.1183/23120541.00848-2020; Verdecchia P, 2020, EUR J INTERN MED, V76, P14, DOI 10.1016/j.ejim.2020.04.037; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; Wysocki J, 2021, J AM SOC NEPHROL, V32, P795, DOI 10.1681/ASN.2020101537; Wysocki J, 2020, J AM SOC NEPHROL, V31, P1941, DOI 10.1681/ASN.2020050667; Yamaleyeva LM, 2012, AM J PHYSIOL-RENAL, V302, pF1374, DOI 10.1152/ajprenal.00656.2011; Yang CW, 2017, RENAL FAILURE, V39, P719, DOI 10.1080/0886022X.2017.1398665; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zou X, 2020, FRONT MED-PRC, V14, P185, DOI 10.1007/s11684-020-0754-0	51	52	52	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252799	10.1371/journal.pone.0252799	http://dx.doi.org/10.1371/journal.pone.0252799			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086837	gold, Green Published			2022-12-26	WOS:000664640100135
J	Rump, MT; Kozma, MT; Pawar, SD; Derby, CD				Rump, Matthew T.; Kozma, Mihika T.; Pawar, Shrikant D.; Derby, Charles D.			G protein-coupled receptors as candidates for modulation and activation of the chemical senses in decapod crustaceans	PLOS ONE			English	Article							RNA-SEQ DATA; CENTRAL-NERVOUS-SYSTEM; LEUCINE-RICH REPEAT; SIGNALING SYSTEM; MOLECULAR-IDENTIFICATION; PHEROMONE TRANSDUCTION; CHEMOSENSORY ORGANS; CHEMORECEPTOR GENES; PEPTIDE RECEPTOR; MULTIGENE FAMILY	Many studies have characterized class A GPCRs in crustaceans; however, their expression in crustacean chemosensory organs has yet to be detailed. Class A GPCRs comprise several subclasses mediating diverse functions. In this study, using sequence homology, we classified all putative class A GPCRs in two chemosensory organs (antennular lateral flagellum [LF] and walking leg dactyls) and brain of four species of decapod crustaceans (Caribbean spiny lobster Panulirus argus, American lobster Homarus americanus, red-swamp crayfish Procambarus clarkii, and blue crab Callinectes sapidus). We identified 333 putative class A GPCRs- 83 from P. argus, 81 from H. americanus, 102 from P. clarkii, and 67 from C. sapidus-which belong to five distinct subclasses. The numbers of sequences for each subclass in the four decapod species are (in parentheses): opsins (19), small-molecule receptors including biogenic amine receptors (83), neuropeptide receptors (90), leucine-rich repeat-containing GPCRs (LGRs) (24), orphan receptors (117). Most class A GPCRs are predominately expressed in the brain; however, we identified multiple transcripts enriched in the LF and several in the dactyl. In total, we found 55 sequences with higher expression in the chemosensory organs relative to the brain across three decapod species. We also identified novel transcripts enriched in the LF including a metabotropic histamine receptor and numerous orphan receptors. Our work establishes expression patterns for class A GPCRs in the chemosensory organs of crustaceans, providing insight into molecular mechanisms mediating neurotransmission, neuromodulation, and possibly chemoreception.	[Rump, Matthew T.; Kozma, Mihika T.; Derby, Charles D.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Pawar, Shrikant D.] Yale Univ, Yale Ctr Genom Anal, New Haven, CT USA; [Kozma, Mihika T.] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA	University System of Georgia; Georgia State University; Yale University; Colorado State University	Derby, CD (corresponding author), Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA.	cderby@gsu.edu	Pawar, Shrikant/AAE-4462-2021	Pawar, Shrikant/0000-0002-6157-2462; Kozma, Mihika/0000-0002-4474-4138	Brains & Behavior seed grant; Brains & Behavior Program, Center for Neuromics; Neuroscience Institute of Georgia State University	Brains & Behavior seed grant; Brains & Behavior Program, Center for Neuromics; Neuroscience Institute of Georgia State University	Support was provided by a Brains & Behavior seed grant to CDD and student research fellowships from the Brains & Behavior Program, Center for Neuromics, and Neuroscience Institute of Georgia State University to MTR and MTK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrieux A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00312; Alexander JL, 2018, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00752; Averbeck BB, 2006, NAT REV NEUROSCI, V7, P358, DOI 10.1038/nrn1888; Babatz F, 2018, DEV CELL, V47, P697, DOI 10.1016/j.devcel.2018.10.002; Bachtel ND, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25855-1; Bainton RJ, 2005, CELL, V123, P145, DOI 10.1016/j.cell.2005.07.029; Bauknecht P, 2017, BMC BIOL, V15, DOI 10.1186/s12915-016-0341-7; Beckmann H, 2015, J EXP BIOL, V218, P915, DOI 10.1242/jeb.116780; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boppana S, 2014, J EXP BIOL, V217, P3006, DOI 10.1242/jeb.106708; Bruysters M, 2005, MOL PHARMACOL, V67, P1045, DOI 10.1124/mol.104.008847; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Minh BQ, 2013, MOL BIOL EVOL, V30, P1188, DOI 10.1093/molbev/mst024; Caers Jelle, 2012, Front Endocrinol (Lausanne), V3, P151, DOI 10.3389/fendo.2012.00151; Carr AL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071563; Chung JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046299; Cummins SF, 2009, J EXP BIOL, V212, P2036, DOI 10.1242/jeb.026427; Cummins SF, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-28; de Mendoza A, 2014, GENOME BIOL EVOL, V6, P606, DOI 10.1093/gbe/evu038; Diaz MM, 2019, CURR BIOL, V29, P13, DOI 10.1016/j.cub.2018.11.005; Dong CH, 2012, COMP BIOCHEM PHYS A, V161, P95, DOI 10.1016/j.cbpa.2011.09.006; Donohue MW, 2017, BIOL BULL-US, V233, P58, DOI 10.1086/694421; Eriksson BJ, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-186; FINGERMAN M, 1994, J CRUSTACEAN BIOL, V14, P413, DOI 10.2307/1548990; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Flecke C, 2009, J COMP PHYSIOL A, V195, P529, DOI 10.1007/s00359-009-0429-4; Frank TM, 2012, J EXP BIOL, V215, P3344, DOI 10.1242/jeb.072033; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fujioka K, 2013, SENSORS-BASEL, V13, P736, DOI 10.3390/s130100736; Garelli A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9732; Gawalek P, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00218; Gether U, 2000, ENDOCR REV, V21, P90, DOI 10.1210/er.21.1.90; Gilbert D., 2013, 7 ANN ARTHR GEN S, V5, P1695, DOI [10.7490/f1000research.1112594.1, DOI 10.7490/F1000RESEARCH.1112594.1]; Gontijo AM, 2018, MECH DEVELOP, V154, P44, DOI 10.1016/j.mod.2018.04.005; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Greene JS, 2016, NATURE, V539, P254, DOI 10.1038/nature19848; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hanlon CD, 2015, J CELL SCI, V128, P3533, DOI 10.1242/jcs.175158; Hansen KK, 2010, J BIOL CHEM, V285, P10736, DOI 10.1074/jbc.M109.045369; Hering L, 2012, MOL BIOL EVOL, V29, P3451, DOI 10.1093/molbev/mss148; Hertel W, 1995, ACTA BIOL HUNG, V46, P491; Hewes RS, 2001, GENOME RES, V11, P1126, DOI 10.1101/gr.169901; Hillier NK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143179; Honegger HW, 2008, J COMP PHYSIOL A, V194, P989, DOI 10.1007/s00359-008-0386-3; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Inagaki HK, 2012, CELL, V148, P583, DOI 10.1016/j.cell.2011.12.022; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Julius D, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005991; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]; Kang XL, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008331; Kato A, 2009, CELL MOL LIFE SCI, V66, P3743, DOI 10.1007/s00018-009-0111-6; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kingston ACN, 2016, INTEGR COMP BIOL, V56, P820, DOI 10.1093/icb/icw022; Kingston ACN, 2015, J COMP PHYSIOL A, V201, P1137, DOI 10.1007/s00359-015-1043-2; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kojima D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026388; Kozma MT, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-07034-7; Kozma MT, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230266; Kozma MT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203935; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kwon H, 2020, INSECT BIOCHEM MOLEC, V117, DOI 10.1016/j.ibmb.2019.103290; Lackovic Zdravko, 2004, EJIFCC, V15, P61; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Latorre-Estivalis JM, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6514-3; LeBlanc MG, 2017, J CELL BIOL, V216, P2945, DOI 10.1083/jcb.201612053; Leguia M, 2006, MOL REPROD DEV, V73, P1550, DOI 10.1002/mrd.20586; Leung NY, 2020, CURR BIOL, V30, P1367, DOI 10.1016/j.cub.2020.01.068; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li WZ, 2001, BIOINFORMATICS, V17, P282, DOI 10.1093/bioinformatics/17.3.282; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liu A, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.207985; Lodish H, 2000, MOL CELL BIOL; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo CW, 2005, P NATL ACAD SCI USA, V102, P2820, DOI 10.1073/pnas.0409916102; Lutek K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22397-4; Luu P, 2016, GENETICS, V202, P1043, DOI 10.1534/genetics.115.183061; Marco HG, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06805-9; Marquet N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60167-3; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; MCCLINTOCK TS, 1989, P NATL ACAD SCI USA, V86, P8137, DOI 10.1073/pnas.86.20.8137; McLaughlin CN, 2021, ELIFE, V10, DOI 10.7554/eLife.63856; Mohapatra P, 2019, G3-GENES GENOM GENET, V9, P3753, DOI 10.1534/g3.119.400669; Mykles DL, 2010, PHYSIOL BIOCHEM ZOOL, V83, P836, DOI 10.1086/648470; Nadim F, 2014, CURR OPIN NEUROBIOL, V29, P48, DOI 10.1016/j.conb.2014.05.003; Nguyen TV, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00430; Niimura Y, 2012, CURR GENOMICS, V13, P103, DOI 10.2174/138920212799860706; Northcutt AJ, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3215-z; Oliphant A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-5057-3; Paluzzi JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086386; Panzeri S, 2015, TRENDS COGN SCI, V19, P162, DOI 10.1016/j.tics.2015.01.002; Peabody NC, 2008, J NEUROSCI, V28, P14379, DOI 10.1523/JNEUROSCI.2842-08.2008; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Porter ML, 2007, MOL BIOL EVOL, V24, P253, DOI 10.1093/molbev/msl152; Qi YX, 2018, GEN COMP ENDOCR, V262, P59, DOI 10.1016/j.ygcen.2018.03.012; Reilly DK., 2017, OXFORD RES ENCY NEUR, DOI [10.1093/acrefore/9780190264086.013.191, DOI 10.1093/ACREFORE/9780190264086.013.191]; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Rocco DA, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00266; Roeding F, 2007, MOL PHYLOGENET EVOL, V45, P942, DOI 10.1016/j.ympev.2007.09.002; Sarajlic S, 2016, PROCEEDINGS OF XSEDE16: DIVERSITY, BIG DATA, AND SCIENCE AT SCALE, DOI 10.1145/2949550.2952770; Sarajlic Semir, 2017, P PRACTICE EXPERIENC, DOI [10.1145/3093338.3104178, DOI 10.1145/3093338.3104178]; Schendzielorz T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121230; Schmidt M, 1997, BRAIN RES, V746, P71, DOI 10.1016/S0006-8993(96)01187-0; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Senthilan PR, 2016, PEERJ, V4, DOI 10.7717/peerj.2427; Senthilan PR, 2012, CELL, V150, P1042, DOI 10.1016/j.cell.2012.06.043; Sokabe T, 2016, CELL REP, V17, P336, DOI 10.1016/j.celrep.2016.09.028; Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036; Srinivasan J, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001237; Stengl M, 2010, FRONT CELL NEUROSCI, V4, DOI 10.3389/fncel.2010.00133; STRANGE PG, 1988, BIOCHEM J, V249, P309, DOI 10.1042/bj2490309; Sun LL, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00424; Takayama J, 2010, NUCLEIC ACIDS RES, V38, P131, DOI 10.1093/nar/gkp868; Taparia T, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3779-2; Thuma L, 2018, J CELL BIOL, V217, P3045, DOI 10.1083/jcb.201801013; Tran NM, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-018-5363-9; Trifinopoulos J, 2016, NUCLEIC ACIDS RES, V44, pW232, DOI 10.1093/nar/gkw256; Urlacher E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174321; Vallejo DM, 2015, SCIENCE, V350, DOI 10.1126/science.aac6767; Van Hiel MB, 2012, PEPTIDES, V34, P193, DOI 10.1016/j.peptides.2011.11.004; Vandersmissen HP, 2014, GEN COMP ENDOCR, V209, P135, DOI 10.1016/j.ygcen.2014.08.006; Veenstra JA, 2020, PEERJ, V8, DOI 10.7717/peerj.9534; Wahedi A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20517-8; Wang D, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-06950-y; Wang TM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40247; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WILKENS LA, 1976, J COMP PHYSIOL, V106, P69, DOI 10.1007/BF00606572; Wolf S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123533; Xu HB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052249; Yamashita T, 2014, J BIOL CHEM, V289, P3991, DOI 10.1074/jbc.M113.514075; Yasuda-Kamatani Y, 2002, GEN COMP ENDOCR, V125, P25, DOI 10.1006/gcen.2001.7730; Zandawala M, 2015, FEBS J, V282, P3603, DOI 10.1111/febs.13366; Zbinden M, 2017, CHEM SENSES, V42, P319, DOI 10.1093/chemse/bjx007; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhukovskaya MI, 2012, CHEM SENSES, V37, P421, DOI 10.1093/chemse/bjr121	137	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 4	2021	16	6							e0252066	10.1371/journal.pone.0252066	http://dx.doi.org/10.1371/journal.pone.0252066			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RB	34086685	Green Published, gold			2022-12-26	WOS:000664640100032
J	Sohlenkamp, C				Sohlenkamp, Christian			Crossing the lipid divide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BIOSYNTHESIS; BACTERIAL	Archaeal membrane lipids are structurally different from bacterial and eukaryotic membrane lipids, but little is known about the enzymes involved in their synthesis. In a recent study, Exterkate et al. identified and characterized a cardiolipin synthase from the archaeon Methanospirillum hungatei. This enzyme can synthesize archaeal, bacterial, and mixed archaeal/bacterial cardiolipin species from a wide variety of substrates, some of which are not even naturally occurring. This discovery could revolutionize synthetic lipid biology, being used to construct a variety of lipids with nonnatural head groups and mixed archaeal/bacterial hydrophobic chains.	[Sohlenkamp, Christian] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Sohlenkamp, C (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca, Morelos, Mexico.	chsohlen@ccg.unam.mx		Sohlenkamp, Christian/0000-0002-9962-2859	CONACYT [425886]; PAPIIT-UNAM [IN208116, IN208319]; UC MEXUS-CONACYT [CN-20-107]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); UC MEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Research in our group is supported by grants from CONACYT (425886) and PAPIIT-UNAM (IN208116 and IN208319) and UC MEXUS-CONACYT (CN-20-107).	Corcelli A, 2009, BBA-BIOMEMBRANES, V1788, P2101, DOI 10.1016/j.bbamem.2009.05.010; Exterkate M., 2021, J BIOL CHEM, V296; Jain S, 2014, CHEM BIOL, V21, P1392, DOI 10.1016/j.chembiol.2014.07.022; Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Sohlenkamp C, 2016, FEMS MICROBIOL REV, V40, P133, DOI 10.1093/femsre/fuv008; Villanueva L, 2021, ISME J, V15, P168, DOI 10.1038/s41396-020-00772-2	8	1	1	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100859	10.1016/j.jbc.2021.100859	http://dx.doi.org/10.1016/j.jbc.2021.100859			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097872	Green Published, gold			2022-12-26	WOS:000678068400059
J	Hatsusaka, N; Yamamoto, N; Miyashita, H; Shibuya, E; Mita, N; Yamazaki, M; Shibata, T; Ishida, H; Ukai, Y; Kubo, E; Cheng, HM; Sasaki, H				Hatsusaka, Natsuko; Yamamoto, Naoki; Miyashita, Hisanori; Shibuya, Eri; Mita, Norihiro; Yamazaki, Mai; Shibata, Teppei; Ishida, Hidetoshi; Ukai, Yuki; Kubo, Eri; Cheng, Hong-Ming; Sasaki, Hiroshi			Association among pterygium, cataracts, and cumulative ocular ultraviolet exposure: A cross-sectional study in Han people in China and Taiwan	PLOS ONE			English	Article							LIGHT EXPOSURE; RACIAL-DIFFERENCES; LENS OPACITIES; RADIATION; RISK; PREVALENCE; WATERCLEFTS; NUCLEAR; FIBROBLASTS; POPULATIONS	Purpose Pterygium is an ocular surface disorder mainly caused by ultraviolet (UV) light exposure. This study explored the relationships between six cataract types with pterygium and UV exposure. Methods We have previously studied cataracts in residents of three regions in China and Taiwan with different UV intensities. From that study, we identified 1,547 subjects with information on the presence or absence of pterygium. Pterygium severity was graded by corneal progress rate. Cataracts were graded by classification systems as three main types (cortical, nuclear, posterior subcapsular) and three subtypes (retrodots, waterclefts, fiber folds) with high prevalence in middle-aged and elderly people. We calculated the cumulative ocular UV exposure (COUV) based on subject data and National Aeronautics and Space Administration data on UV intensities and used logistic regression to calculate odds ratios for the associations of COUV, cataract, and pterygium. Results We found an overall pterygium prevalence of 23.3%, with significant variation among the three regions. Four cataract types (cortical, nuclear, posterior subcapsular, and retrodots) were significantly associated with the presence of pterygium. Conclusions There was a significant association between COUV and pterygium, indicating that COUV is associated with the risk of pterygium development and that pterygium is useful as an index of UV exposure. Furthermore, the type of cataract in eyes with pterygium may indicate the level of UV exposure.	[Hatsusaka, Natsuko; Yamamoto, Naoki; Miyashita, Hisanori; Shibuya, Eri; Mita, Norihiro; Yamazaki, Mai; Shibata, Teppei; Ishida, Hidetoshi; Ukai, Yuki; Kubo, Eri; Sasaki, Hiroshi] Kanazawa Med Univ, Dept Ophthalmol, Uchinada, Ishikawa, Japan; [Hatsusaka, Natsuko; Yamamoto, Naoki; Sasaki, Hiroshi] Kanazawa Med Univ, Med Res Inst, Project Res Ctr, Div Vis Res Environm Hlth, Uchinada, Ishikawa, Japan; [Cheng, Hong-Ming] Asia Univ, Dept Optometry, Taichung, Taiwan	Kanazawa Medical University; Kanazawa Medical University; Asia University Taiwan	Sasaki, H (corresponding author), Kanazawa Med Univ, Dept Ophthalmol, Uchinada, Ishikawa, Japan.; Sasaki, H (corresponding author), Kanazawa Med Univ, Med Res Inst, Project Res Ctr, Div Vis Res Environm Hlth, Uchinada, Ishikawa, Japan.	mogu@kanazawa-med.ac.jp			JICA Partnership Program [033-5125-N-0]; Health Labour Sciences Research Grant [H21]	JICA Partnership Program; Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan)	We were supported by the following funders: JICA Partnership Program (No. 033-5125-N-0) for the study in China: The funders had a role in study design; Health Labour Sciences Research Grant (Research on Global Health Issues No. H21, Global Health-General-007) for the study in Taiwan: The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2012, OPHTHALMOLOGY, V119, P1509, DOI 10.1016/j.ophtha.2012.02.009; BOCHOW TW, 1989, ARCH OPHTHALMOL-CHIC, V107, P369, DOI 10.1001/archopht.1989.01070010379027; BROWN NP, 1993, EYE, V7, P672, DOI 10.1038/eye.1993.154; Cao XG, 2017, INT J CLIN EXP MED, V10, P3494; Chen T, 2015, INVEST OPHTH VIS SCI, V56, P1109, DOI 10.1167/iovs.14-15994; Chiang CWK, 2018, MOL BIOL EVOL, V35, P2736, DOI 10.1093/molbev/msy170; CRUICKSHANKS KJ, 1992, AM J PUBLIC HEALTH, V82, P1658, DOI 10.2105/AJPH.82.12.1658; Delcourt C, 2000, ARCH OPHTHALMOL-CHIC, V118, P385, DOI 10.1001/archopht.118.3.385; DETELS R, 1967, ARCH OPHTHALMOL-CHIC, V78, P485; Dimitry TJ., 1937, AM J OPHTHALMOL, V20, P40, DOI [10.1016/S0002-9394%2837%2992726-0., DOI 10.1016/S0002-9394%2837%2992726-0]; Fernandes AG, 2020, BRIT J OPHTHALMOL, V104, P757, DOI 10.1136/bjophthalmol-2019-314131; Frost NA, 2002, INVEST OPHTH VIS SCI, V43, P2105; Gao YL, 2020, J CELL MOL MED, V24, P14139, DOI 10.1111/jcmm.16024; Garzon-Chavez DR, 2018, PHOTOCH PHOTOBIO SCI, V17, P1075, DOI 10.1039/c8pp00023a; GRAY RH, 1992, SURV OPHTHALMOL, V36, P241, DOI 10.1016/0039-6257(92)90093-9; Hashemi H, 2017, J CURR OPHTHALMOL, V29, P194, DOI 10.1016/j.joco.2016.09.002; Hayashi LC, 2003, SCI TOTAL ENVIRON, V302, P53, DOI 10.1016/S0048-9697(02)00320-0; He SY, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02499-2; HILLER R, 1986, AM J EPIDEMIOL, V124, P916, DOI 10.1093/oxfordjournals.aje.a114481; Khoo J, 1998, INT OPHTHALMOL, V22, P293, DOI 10.1023/A:1006340822308; Lim R, 1998, AM J OPHTHALMOL, V126, P717, DOI 10.1016/S0002-9394(98)00140-8; Liu JP, 2004, EXP EYE RES, V79, P393, DOI 10.1016/j.exer.2004.06.015; Loots MAM, 1999, ARCH DERMATOL RES, V291, P93, DOI 10.1007/s004030050389; MACKENZIE FD, 1992, OPHTHALMOLOGY, V99, P1056, DOI 10.1016/s0161-6420(92)31850-0; MASAKI H, 1995, BIOCHEM BIOPH RES CO, V206, P474, DOI 10.1006/bbrc.1995.1067; McCarty CA, 2000, INVEST OPHTH VIS SCI, V41, P3720; McCarty CA, 2000, BRIT J OPHTHALMOL, V84, P289, DOI 10.1136/bjo.84.3.289; McCarty CA, 2002, DEV OPHTHALMOL, V35, P21; McPeters R., 2000, NASATP2000209896, P1; Mercut Nicolcescu M F, 2019, Curr Health Sci J, V45, P263, DOI 10.12865/CHSJ.45.03.03; Miyashita H, 2019, PLOS ONE, V14, DOI [10.1371/journal.pone.0215338, 10.1371/journal.pone.0222679]; Miyata K., 2018, NIPPON GANKA GAKKAI, V122, P586; Modenese A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102063; Modenese A, 2019, INT ARCH OCC ENV HEA, V92, P1, DOI 10.1007/s00420-018-1355-y; Modenese A, 2018, ACTA OPHTHALMOL, V96, P779, DOI 10.1111/aos.13734; Modenese A, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010037; MORAN DJ, 1984, BRIT J OPHTHALMOL, V68, P343, DOI 10.1136/bjo.68.5.343; Munoz B, 1999, ANN EPIDEMIOL, V9, P53, DOI 10.1016/S1047-2797(98)00026-X; Nakaishi H, 1997, IND HEALTH, V35, P325, DOI 10.2486/indhealth.35.325; Nakazawa Y, 2020, OPEN MED-WARSAW, V15, P1163, DOI 10.1515/med-2020-0249; Nejima R, 2015, EYE CONTACT LENS, V41, P58, DOI 10.1097/ICL.0000000000000065; Ono M, 2002, DEV OPHTHALMOL, V35, P32; Pan ZX, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025725; Pham TQ, 2005, AM J OPHTHALMOL, V139, P1126, DOI 10.1016/j.ajo.2004.12.004; Qu Jingtao, 2005, Rinsho Ganka, V59, P903; Sasaki H, 2003, INVEST OPHTH VIS SCI, V44, P4210, DOI 10.1167/iovs.01-1221; Saw S M, 1999, Ophthalmic Epidemiol, V6, P219, DOI 10.1076/opep.6.3.219.1504; Sekelj S, 2007, COLLEGIUM ANTROPOL, V31, P45; Sherwin JC, 2013, ACTA OPHTHALMOL, V91, P363, DOI 10.1111/j.1755-3768.2011.02314.x; Shibata N, 2020, EXP EYE RES, V199, DOI 10.1016/j.exer.2020.108194; Shui YB, 2000, EXP EYE RES, V71, P609, DOI 10.1006/exer.2000.0917; SHUNSHIN GA, 1992, EYE, V6, P407, DOI 10.1038/eye.1992.84; Taylor H R, 1989, Trans Am Ophthalmol Soc, V87, P802; TAYLOR HR, 1989, ARCH OPHTHALMOL-CHIC, V107, P1481, DOI 10.1001/archopht.1989.01070020555039; TAYLOR HR, 1988, NEW ENGL J MED, V319, P1429, DOI 10.1056/NEJM198812013192201; Thylefors B, 2002, OPHTHALMIC EPIDEMIOL, V9, P83, DOI 10.1076/opep.9.2.83.1523; Turan M, 2020, EUR J OPHTHALMOL, V30, P1232, DOI 10.1177/1120672120945903; Wanzeler ACV, 2019, ARQ BRAS OFTALMOL, V82, P528, DOI 10.5935/0004-2749.20190103; Wang YH, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-1324-6; West SK, 1998, JAMA-J AM MED ASSOC, V280, P714, DOI 10.1001/jama.280.8.714; Xu N, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.8.12; Xu YT, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/2383516; Zhong H, 2012, INVEST OPHTH VIS SCI, V53, P6617, DOI 10.1167/iovs.11-8947; Zhou WP, 2016, MOL MED REP, V14, P3, DOI 10.3892/mmr.2016.5223	64	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 15	2021	16	6							e0253093	10.1371/journal.pone.0253093	http://dx.doi.org/10.1371/journal.pone.0253093			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SX8VJ	34129614	gold, Green Published			2022-12-26	WOS:000665475100024
J	Osman, M; Meehan, SA; von Delft, A; Du Preez, K; Dunbar, R; Marx, FM; Boulle, A; Welte, A; Naidoo, P; Hesseling, AC				Osman, Muhammad; Meehan, Sue-Ann; von Delft, Arne; Du Preez, Karen; Dunbar, Rory; Marx, Florian M.; Boulle, Andrew; Welte, Alex; Naidoo, Pren; Hesseling, Anneke C.			Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; CHILDHOOD TUBERCULOSIS; PRETREATMENT LOSS; DELAYS; DEATH; REGISTRATION; ADULTS; RISK	In South Africa, low tuberculosis (TB) treatment coverage and high TB case fatality remain important challenges. Following TB diagnosis, patients must link with a primary health care (PHC) facility for initiation or continuation of antituberculosis treatment and TB registration. We aimed to evaluate mortality among TB patients who did not link to a TB treatment facility for TB treatment within 30 days of their TB diagnosis, i.e. who were "initial loss to follow-up (ILTFU)" in Cape Town, South Africa. We prospectively included all patients with a routine laboratory or clinical diagnosis of TB made at PHC or hospital level in Khayelitsha and Tygerberg sub-districts in Cape Town, using routine TB data from an integrated provincial health data centre between October 2018 and March 2020. Overall, 74% (10,208/13,736) of TB patients were diagnosed at PHC facilities and ILTFU was 20.0% (2,742/13,736). Of ILTFU patients, 17.1% (468/2,742) died, with 69.7% (326/468) of deaths occurring within 30 days of diagnosis. Most ILTFU deaths (85.5%; 400/468) occurred in patients diagnosed in hospital. Multivariable logistic regression identified increasing age, HIV positive status, and hospital-based TB diagnosis (higher in the absence of TB treatment initiation and being ILTFU) as predictors of mortality. Although hospitals account for a modest proportion of diagnosed TB patients they have high TB-associated mortality. A hospital-based TB diagnosis is a critical opportunity to identify those at high risk of early and overall mortality. Interventions to diagnose TB before hospital admission, improve linkage to TB treatment following diagnosis, and reduce mortality in hospital-diagnosed TB patients should be prioritised.	[Osman, Muhammad; Meehan, Sue-Ann; Du Preez, Karen; Dunbar, Rory; Marx, Florian M.; Naidoo, Pren; Hesseling, Anneke C.] Stellenbosch Univ, Fac Med & Hlth Sci, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Cape Town, South Africa; [von Delft, Arne; Boulle, Andrew] Univ Cape Town, Fac Hlth Sci, Ctr Infect Dis Epidemiol & Res, Sch Publ Hlth & Family Med, Cape Town, South Africa; [von Delft, Arne; Boulle, Andrew] Western Cape Govt, Hlth Impact Assessment Directorate, Dept Hlth, Cape Town, South Africa; [Marx, Florian M.; Welte, Alex] Stellenbosch Univ, DSI NRF South African Ctr Excellence Epidemiol Mo, Stellenbosch, South Africa	Stellenbosch University; University of Cape Town; Stellenbosch University	Osman, M (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Desmond Tutu TB Ctr, Dept Paediat & Child Hlth, Cape Town, South Africa.	mosman@sun.ac.za	Osman, Muhammad/AAW-1530-2021; Osman, Muhammad/ADC-7568-2022; Boulle, Andrew/C-1413-2008	Osman, Muhammad/0000-0003-3818-9729; Boulle, Andrew/0000-0002-7713-8062; Meehan, Sue-Ann/0000-0002-0826-1833	Bill and Melinda Gates Foundation (BMGF) [OPP1191594]; South African Medical Research Council (SA MRC); Public Health Enhancement Fund/South African National Department of Health; South African National Research Foundation through a South African Research Chairs Initiative (SARChI); South African National Research Foundation; Fogarty International Center of the National Institutes of Health [K43TW011006]; US National Institutes for Health [R01 HD080465, U01 AI069924]; Bill and Melinda Gates Foundation [1164272, 119327]; Wellcome Trust [203135/Z/16/Z]	Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation); South African Medical Research Council (SA MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Public Health Enhancement Fund/South African National Department of Health; South African National Research Foundation through a South African Research Chairs Initiative (SARChI); South African National Research Foundation(National Research Foundation - South Africa); Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); US National Institutes for Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)	This research and publication was supported by the Bill and Melinda Gates Foundation (BMGF), Investment ID: OPP1191594. The contents are the responsibility of the authors and do not necessarily reflect the views of the BMGF. The work reported herein was made possible through funding by the South African Medical Research Council (SA MRC) through its Division of Research Capacity Development under the Bongani Mayosi National Health Scholars Program from funding received from the Public Health Enhancement Fund/South African National Department of Health to MO. The contents of any Publications from any studies during this Degree are solely the responsibility of the authors and do not necessarily represent the official views of the SA MRC or the funders. ACH is financially supported by the South African National Research Foundation through a South African Research Chairs Initiative (SARChI). FMM and AW are supported financially by a grant from the South African National Research Foundation through its funding of the Centre of Excellence in Epidemiological Modelling and Analysis. The financial assistance of the NRF towards this research is hereby acknowledged. Opinions expressed, and conclusions arrived at, are those of the authors and are not necessarily to be attributed to the NRF. KDP is supported by the Fogarty International Center of the National Institutes of Health under Award Number K43TW011006. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. AB was further supported by US National Institutes for Health (grant numbers R01 HD080465 and U01 AI069924), the Bill and Melinda Gates Foundation (grant numbers 1164272 and 119327), and the Wellcome Trust (grant number 203135/Z/16/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asres A, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-018-0628-2; Bello S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7026-4; Boulle A, 2019, Int J Popul Data Sci, V4, P1143, DOI 10.23889/ijpds.v4i2.1143; Cheng SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067516; Dowdy DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070485; du Preez K, 2020, PUBLIC HEALTH ACTION, V10, P38, DOI 10.5588/pha.19.0053; du Preez K, 2011, PUBLIC HEALTH ACTION, V1, P19, DOI 10.5588/pha.11.0010; Gebreegziabher SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159579; Getnet F, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0551-y; Gupta A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028691; Gupta-Wright A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0603-9; Johnson LF, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.20628; MacPherson P, 2014, B WORLD HEALTH ORGAN, V92, P126, DOI 10.2471/BLT.13.124800; Mugauri H, 2018, INT J INFECT DIS, V76, P6, DOI 10.1016/j.ijid.2018.07.012; Mwansa-Kambafwile J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168659; National Department of Health, 2014, NAT TUB MAN GUID 201; Odone A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112017; Osman M, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1914-z; Puren A., 2019, 2017 NATL ANTENATAL; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; Statistics South Africa, 2018, MORT CAUS DEATH S AF; Thomas BE, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3039-3; Virenfeldt J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004818; Waitt CJ, 2011, INT J TUBERC LUNG D, V15, P871, DOI 10.5588/ijtld.10.0352; Western Cape Government, 2018, CAP METR HLTH PLAN 2; World Health Organization, 2020, 9789241505345 WHO; World Health Organization, 2021, 10 THREATS GLOB HLTH; Zawedde-Muyanja S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241611	28	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252084	10.1371/journal.pone.0252084	http://dx.doi.org/10.1371/journal.pone.0252084			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125843	Green Published, gold, Green Accepted			2022-12-26	WOS:000664643500004
J	Tan, SMY; Zhang, Y; Chen, Y; See, KC; Feng, ML				Tan, Sandra M. Y.; Zhang, Yuan; Chen, Ying; See, Kay Choong; Feng, Mengling			Association of fluid balance with mortality in sepsis is modified by admission hemoglobin levels: A large database study	PLOS ONE			English	Article							PULSE CO-OXIMETRY; SEPTIC SHOCK; CRITICALLY-ILL; RESUSCITATION; OUTCOMES; VOLUME; EPIDEMIOLOGY; TRANSFUSION; GUIDELINES; PHYSIOLOGY	Purpose Sepsis involves a dysregulated inflammatory response to infection that leads to organ dysfunction. Early fluid resuscitation has been advocated by the Surviving Sepsis Campaign guidelines. However, recent studies have shown that a positive fluid balance is associated with increased mortality in septic patients. We investigated if haemoglobin levels on admission to the intensive care unit (ICU) could modify the association of fluid balance with mortality in patients with sepsis. We hypothesized that with increasing fluid balance, patients with moderate anemia (hemoglobin 7-10g/dL) would have poorer outcomes compared to those without moderate anemia (hemoglobin >10g/dL). Materials and methods This retrospective study utilized the Medical Information Mart for Intensive Care-III (MIMIC-III) database. Patients with sepsis, as identified by the International Classification of Diseases, 9th, Clinical Modification codes, were studied. Patients were stratified into those with and without moderate anemia at ICU admission. We investigated the influence of fluid balance measured within 24 hours of ICU admission on 28-day mortality for both patient groups using multivariable logistic regression models. Subgroup and sensitivity analyses were conducted. Results 8,132 patients (median age 68.6 years, interquartile range 55.1-79.8 years; 52.8% female) were included. Increasing fluid balance (in L) was associated with a significantly decreased risk of 28-day mortality in patients without moderate anemia (OR 0.91, 95%CI 0.84-0.97, p = 0.005, at 6-hour). Conversely, increasing fluid balance was associated with a significantly increased risk of 28-day mortality in patients with moderate anemia (OR 1.05, 95% CI 1.01-1.1, p = 0.022, at 24-hour). Interaction analyses showed that mortality was highest when haemoglobin decreased in patients with moderate anemia who had the most positive fluid balance. Multiple subgroups and sensitivity analyses yielded consistent results. Conclusions In septic patients admitted to ICU, admission hemoglobin levels modified the association between fluid balance and mortality and are an important consideration for future fluid therapy trials.	[Tan, Sandra M. Y.] Natl Univ Singapore Hosp, Div Adv Internal Med, Dept Med, Singapore, Singapore; [Zhang, Yuan] Ping An Healthcare Technol, Beijing, Peoples R China; [Chen, Ying] Genome Inst Singapore, Computat & Syst Biol, Singapore, Singapore; [See, Kay Choong] Natl Univ Singapore Hosp, Div Resp & Crit Care Med, Dept Med, Singapore, Singapore; [Feng, Mengling] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Feng, Mengling] Natl Univ Hlth Syst, Singapore, Singapore	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; National University of Singapore	Tan, SMY (corresponding author), Natl Univ Singapore Hosp, Div Adv Internal Med, Dept Med, Singapore, Singapore.; See, KC (corresponding author), Natl Univ Singapore Hosp, Div Resp & Crit Care Med, Dept Med, Singapore, Singapore.	sandra_tan@nuhs.edu.sg; kay_choong_see@nuhs.edu.sg	Ying, Chen/GRX-5695-2022	Chen, Ying/0000-0001-7876-4877; Feng, Mengling/0000-0002-5338-6248	National Research Foundation Singapore under its AI Singapore Programme [AISG-100E-2020-055]	National Research Foundation Singapore under its AI Singapore Programme(National Research Foundation, Singapore)	This study is partially supported by the National Research Foundation Singapore under its AI Singapore Programme (Award Number: AISG-100E-2020-055). The National Research Foundation Singapore did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. And the funder, Ping An Healthcare Technology, Beijing, China, provided support in the form of salaries for author Yuan Zhang, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the author are articulated in the 'author contributions' section.	Andrews B, 2017, JAMA-J AM MED ASSOC, V318, P1233, DOI 10.1001/jama.2017.10913; Angus Derek C., 2006, Endocrine Metabolic & Immune Disorders-Drug Targets, V6, P207; Ba VN, 2003, CRIT CARE MED, V31, P406, DOI 10.1097/01.CCM.0000048623.00778.3F; Barie PS, 2004, CRIT CARE, V8, pS34, DOI 10.1186/cc2454; Bubenek-Turconi SI., 2019, ANESTH ANALG; Chang DW, 2014, J CRIT CARE, V29, P1011, DOI 10.1016/j.jcrc.2014.06.005; Cros J, 2020, J CLIN MONIT COMPUT, V34, P683, DOI 10.1007/s10877-019-00367-z; Effenberger-Neidnicht K, 2018, INFLAMMATION, V41, P1569, DOI 10.1007/s10753-018-0810-y; FAQUIN WC, 1992, BLOOD, V79, P1987; Guarracino F, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2414-9; HADFIELD RJ, 1995, AM J RESP CRIT CARE, V152, P1545, DOI 10.1164/ajrccm.152.5.7582291; Hayden SJ, 2012, AM J RESP CRIT CARE, V185, P1049, DOI 10.1164/rccm.201110-1915CI; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Holst LB, 2014, NEW ENGL J MED, V371, P1381, DOI 10.1056/NEJMoa1406617; Jaffee W, 2018, J INTENSIVE CARE MED, V33, P502, DOI 10.1177/0885066617742832; Jansma G, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0035-7; JARDIN F, 1990, CRIT CARE MED, V18, P1055, DOI 10.1097/00003246-199010000-00001; Johnson AEW, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.35; Johnson AEW, 2013, CRIT CARE MED, V41, P1711, DOI 10.1097/CCM.0b013e31828a24fe; Kaukonen KM, 2014, JAMA-J AM MED ASSOC, V311, P1308, DOI 10.1001/jama.2014.2637; Lumb AB, 2015, ANESTHESIOLOGY, V122, P932, DOI 10.1097/ALN.0000000000000569; Macknet MR, 2010, ANESTH ANALG, V111, P1424, DOI 10.1213/ANE.0b013e3181fc74b9; Maiden MJ, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2029-6; Maitland K, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-68; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Malbrain MLNG, 2014, ANAESTH INTENSIVE TH, V46, P361, DOI 10.5603/AIT.2014.0060; Marik P, 2016, BRIT J ANAESTH, V116, P339, DOI 10.1093/bja/aev349; Marik PE, 2017, INTENS CARE MED, V43, P625, DOI 10.1007/s00134-016-4675-y; Merx MW, 2007, CIRCULATION, V116, P793, DOI 10.1161/CIRCULATIONAHA.106.678359; Monnet X, 2018, ANN INTENSIVE CARE, V8, DOI 10.1186/s13613-018-0400-z; Murphy SM, 2018, ANESTH ANALG, V126, P1519, DOI 10.1213/ANE.0000000000002721; Payen D, 2008, CRIT CARE, V12, DOI 10.1186/cc6916; Perel A, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1872-1; Qi DS, 2021, SHOCK, V55, P215, DOI 10.1097/SHK.0000000000001612; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sadaka F, 2014, J INTENSIVE CARE MED, V29, P213, DOI 10.1177/0885066613478899; Sakr Y, 2005, CHEST, V128, P3098, DOI 10.1378/chest.128.5.3098; Shen YF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28781-4; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	42	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 14	2021	16	6							e0252629	10.1371/journal.pone.0252629	http://dx.doi.org/10.1371/journal.pone.0252629			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SI	34125858	gold, Green Published			2022-12-26	WOS:000664643500010
J	Sofela, S; Sahloul, S; Song, YA				Sofela, Samuel; Sahloul, Sarah; Song, Yong-Ak			Biophysical analysis of drug efficacy on C. elegans models for neurodegenerative and neuromuscular diseases	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; PARKINSONS-DISEASE; MUSCLE DEGENERATION; MUTATIONS	Caenorhabditis elegans has emerged as a powerful model organism for drug screening due to its cellular simplicity, genetic amenability and homology to humans combined with its small size and low cost. Currently, high-throughput drug screening assays are mostly based on image-based phenotyping with the focus on morphological-descriptive traits not exploiting key locomotory parameters of this multicellular model with muscles such as its thrashing force, a critical biophysical parameter when screening drugs for muscle-related diseases. In this study, we demonstrated the use of a micropillar-based force assay chip in combination with a fluorescence assay to evaluate the efficacy of various drugs currently used in treatment of neurodegenerative and neuromuscular diseases. Using this two-dimensional approach, we showed that the force assay was generally more sensitive in measuring efficacy of drug treatment in Duchenne Muscular Dystrophy and Parkinson's Disease mutant worms as well as partly in Amyotrophic Lateral Sclerosis model. These results underline the potential of our force assay chip in screening of potential drug candidates for the treatment of neurodegenerative and neuromuscular diseases when combined with a fluorescence assay in a two-dimensional analysis approach.	[Sofela, Samuel; Sahloul, Sarah; Song, Yong-Ak] New York Univ Abu Dhabi, Div Engn, Abu Dhabi, U Arab Emirates; [Sofela, Samuel; Song, Yong-Ak] NYU, Tandon Sch Engn, 550 1St Ave, New York, NY 10003 USA	New York University; New York University Tandon School of Engineering	Song, YA (corresponding author), New York Univ Abu Dhabi, Div Engn, Abu Dhabi, U Arab Emirates.; Song, YA (corresponding author), NYU, Tandon Sch Engn, 550 1St Ave, New York, NY 10003 USA.	rafael.song@nyu.edu			Al Jalila Foundation [AJF201633]; NYUAD Global PhD Student Fellowship program	Al Jalila Foundation(Al Jalila Foundation (AJF)); NYUAD Global PhD Student Fellowship program	Y.-A. Song received grant support for this work from the Al Jalila Foundation [AJF201633]. S. Sofela was supported by the NYUAD Global PhD Student Fellowship program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone P, 2010, LANCET NEUROL, V9, P573, DOI 10.1016/S1474-4422(10)70106-X; Berri S, 2009, HFSP J, V3, P186, DOI 10.2976/1.3082260; Bessou C, 1998, NEUROGENETICS, V2, P61, DOI 10.1007/s100480050053; Bidkar PU., 2017, NEUROMUSCULAR DISORD, DOI [10.1016/B978-0-12-805299-0.00045%26%23x2013%3B2, DOI 10.1016/B978-0-12-805299-0.00045%26%23X2013%3B2]; Boyle JH, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00010; Braungart E, 2004, NEURODEGENER DIS, V1, P175, DOI 10.1159/000080983; Brouilly N, 2015, HUM MOL GENET, V24, P6428, DOI 10.1093/hmg/ddv353; Chalorak P, 2018, NUTR NEUROSCI, V21, P427, DOI 10.1080/1028415X.2017.1299437; Chen S, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-28; Chuang HS, 2016, SCI REP-UK, V6, DOI 10.1038/srep28064; Cornaglia M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0083-6; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; Doble A, 1996, NEUROLOGY, V47, pS233, DOI 10.1212/WNL.47.6_Suppl_4.233S; Dong L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193989; Driscoll M.., 2008, WORMBOOK; Gaud A, 2004, NEUROMUSCULAR DISORD, V14, P365, DOI 10.1016/j.nmd.2004.02.011; Gieseler K, 2000, CURR BIOL, V10, P1092, DOI 10.1016/S0960-9822(00)00691-6; Gupta DK, 2016, NEURODEGENER DIS, V16, P179, DOI 10.1159/000440845; Hewitt JE, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036137; Hibaoui Y, 2011, J PINEAL RES, V51, P163, DOI 10.1111/j.1600-079X.2011.00871.x; IKenaka K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46642-6; Johari S, 2013, LAB CHIP, V13, P1699, DOI 10.1039/c3lc41403e; Khare SM, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4906905; Laranjeiro R, 2019, P NATL ACAD SCI USA, V116, P23829, DOI 10.1073/pnas.1909210116; LeWitt PA, 2016, NEUROLOGY, V86, pS3, DOI 10.1212/WNL.0000000000002509; Markaki M, 2010, BIOTECHNOL J, V5, P1261, DOI 10.1002/biot.201000183; Marvanova M, 2007, J MOL NEUROSCI, V31, P127, DOI 10.1385/JMN/31:02:127; McDonald CM, 2002, AM J PHYS MED REHAB, V81, pS108, DOI 10.1097/00002060-200211001-00012; MENDELL JR, 1989, NEW ENGL J MED, V320, P1592, DOI 10.1056/NEJM198906153202405; Mizuta I, 2001, NEUROSCI LETT, V310, P117, DOI 10.1016/S0304-3940(01)02098-5; Morris ME, 2006, PHYS THER, V86, P1426, DOI 10.2522/ptj.20050277; Qiu ZC, 2015, BIOMICROFLUIDICS, V9, DOI 10.1063/1.4908595; Rahman M, 2018, LAB CHIP, V18, P2187, DOI 10.1039/c8lc00103k; Salam Sangeena, 2013, Worm, V2, pe24558, DOI 10.4161/worm.24558; Sleigh JN, 2010, TRANSL NEUROSCI, V1, P214, DOI 10.2478/v10134-010-0032-9; Sofela S., 2018, 22 INT C MIN SYST CH; Sofela S, 2020, INTEGR BIOL-UK, V12, P150, DOI 10.1093/intbio/zyaa011; Sofela S, 2019, LAB CHIP, V19, P3685, DOI 10.1039/c9lc00660e; Sofela S, 2018, LAB CHIP, V18, P679, DOI 10.1039/c7lc00998d; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Srivanitchapoom P, 2014, PARKINSONISM RELAT D, V20, P1109, DOI [10.1016/S1353-8020(13)70029-4, 10.1016/j.parkreldis.2014.08.013]; Stiernagle Theresa, 2006, WormBook, P1; Young AT, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.035709	43	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2021	16	6							e0246496	10.1371/journal.pone.0246496	http://dx.doi.org/10.1371/journal.pone.0246496			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SD	34115761	Green Published, gold			2022-12-26	WOS:000664643000003
J	Kato, T; Ono, H; Fujii, M; Akahoshi, K; Ogura, T; Ogawa, K; Ban, D; Kudo, A; Tanaka, S; Tanabe, M				Kato, Tomotaka; Ono, Hiroaki; Fujii, Mikiya; Akahoshi, Keiichi; Ogura, Toshiro; Ogawa, Kosuke; Ban, Daisuke; Kudo, Atsushi; Tanaka, Shinji; Tanabe, Minoru			Cytoplasmic RRM1 activation as an acute response to gemcitabine treatment is involved in drug resistance of pancreatic cancer cells	PLOS ONE			English	Article							RIBONUCLEOTIDE REDUCTASE; DNA-DAMAGE; ADJUVANT CHEMOTHERAPY; INDUCED APOPTOSIS; EXPRESSION; MARKERS; REPAIR; ERCC1; M1	Background RRM1 is functionally associated with DNA replication and DNA damage repair. However, the biological activity of RRM1 in pancreatic cancer remains undetermined. Methods To determine relationships between RRM1 expression and the prognosis of pancreatic cancer, and to explore RRM1 function in cancer biology, we investigated RRM1 expression levels in 121 pancreatic cancer patients by immunohistochemical staining and performed in vitro experiments to analyze the functional consequences of RRM1 expression. Results Patients with high RRM1 expression had significantly poorer clinical outcomes (overall survival; p = 0.006, disease-free survival; p = 0.0491). In particular, high RRM1 expression was also associated with poorer overall survival on adjuvant chemotherapy (p = 0.008). We found that RRM1 expression was increased 24 hours after exposure to gemcitabine and could be suppressed by histone acetyltransferase inhibition. RRM1 activation in response to gemcitabine exposure was induced mainly in the cytoplasm and cytoplasmic RRM1 activation was related to cancer cell viability. In contrast, cancer cells lacking cytoplasmic RRM1 activation were confirmed to show severe DNA damage. RRM1 inhibition with specific siRNA or hydroxyurea enhanced the cytotoxic effects of gemcitabine for pancreatic cancer cells. Conclusions Cytoplasmic RRM1 activation is involved in biological processes related to drug resistance in response to gemcitabine exposure and could be a potential target for pancreatic cancer treatment.	[Kato, Tomotaka; Ono, Hiroaki; Fujii, Mikiya; Akahoshi, Keiichi; Ogura, Toshiro; Ogawa, Kosuke; Ban, Daisuke; Kudo, Atsushi; Tanabe, Minoru] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hepatobiliary & Pancreat Surg, Tokyo, Japan; [Tanaka, Shinji] Tokyo Med & Dent Univ, Grad Sch Med, Dept Mol Oncol, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Ono, H (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med, Dept Hepatobiliary & Pancreat Surg, Tokyo, Japan.	ono.msrg@tmd.ac.jp	Ogura, Toshiro/ABB-6420-2021	Ban, Daisuke/0000-0003-0868-8519; Ono, Hiroaki/0000-0001-9230-5714	JSHPS KAKENHI [18K15267]	JSHPS KAKENHI	This work was supported by JSHPS KAKENHI for Grant-Aid for Young Scientists 18K15267. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamska Aleksandra, 2018, Advances in Biological Regulation, V68, P77, DOI 10.1016/j.jbior.2017.11.007; Akita H, 2009, ONCOGENE, V28, P2903, DOI 10.1038/onc.2009.158; Amrutkar M, 2017, CANCERS, V9, DOI 10.3390/cancers9110157; Aoki Y, 2013, INT J ONCOL, V42, P1951, DOI 10.3892/ijo.2013.1899; Bergman AM, 2005, CANCER RES, V65, P9510, DOI 10.1158/0008-5472.CAN-05-0989; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Fujita H, 2010, NEOPLASIA, V12, P807, DOI 10.1593/neo.10458; Han QL, 2018, J CLIN PHARM THER, V43, P163, DOI 10.1111/jcpt.12655; HUANG P, 1991, CANCER RES, V51, P6110; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kamisawa T, 2016, LANCET, V388, P73, DOI 10.1016/S0140-6736(16)00141-0; Malvezzi M, 2018, ANN ONCOL, V29, P1016, DOI 10.1093/annonc/mdy033; Mannargudi MB, 2017, J CANCER RES CLIN, V143, P1499, DOI 10.1007/s00432-017-2457-8; Minami K, 2015, J PHARMACOL SCI, V127, P319, DOI 10.1016/j.jphs.2015.01.006; Mini E, 2006, ANN ONCOL, V17, pV7, DOI 10.1093/annonc/mdj941; Nakano Y, 2007, BRIT J CANCER, V96, P457, DOI 10.1038/sj.bjc.6603559; Niida H, 2010, GENE DEV, V24, P333, DOI 10.1101/gad.1863810; Nozoe T, 2011, AM J SURG, V201, P186, DOI 10.1016/j.amjsurg.2010.01.030; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Ono H, 2016, ONCOTARGET, V7, P51301, DOI 10.18632/oncotarget.10117; Ono H, 2015, MOL CANCER RES, V13, P1174, DOI 10.1158/1541-7786.MCR-15-0034; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Schoffski P, 2004, ANTI-CANCER DRUG, V15, P85, DOI 10.1097/01.cad.0000114631.91268.39; Sierzega M, 2017, PANCREAS, V46, P684, DOI 10.1097/MPA.0000000000000807; Suker M, 2016, LANCET ONCOL, V17, P801, DOI 10.1016/S1470-2045(16)00172-8; Ueno H, 2007, BRIT J CANCER, V97, P145, DOI 10.1038/sj.bjc.6603860; Uesaka K, 2016, LANCET, V388, P248, DOI 10.1016/S0140-6736(16)30583-9; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Wang QC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070191; Wei CH, 2013, PANCREAS, V42, P1303, DOI 10.1097/MPA.0b013e3182a23ae4; Xie H, 2013, CANCER-AM CANCER SOC, V119, P173, DOI 10.1002/cncr.27715; Zheng Z, 2007, NEW ENGL J MED, V356, P800, DOI 10.1056/NEJMoa065411	32	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0252917	10.1371/journal.pone.0252917	http://dx.doi.org/10.1371/journal.pone.0252917			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111175	Green Published, gold			2022-12-26	WOS:000664642700061
J	Rauch, J; Barton, J; Kwiatkowski, M; Wunderlich, M; Steffen, P; Moderzynski, K; Papp, S; Hohn, K; Schwanke, H; Witt, S; Richardt, U; Mehlhoop, U; Schluter, H; Pianka, V; Fleischer, B; Tappe, D; Osterloh, A				Rauch, Jessica; Barton, Jessica; Kwiatkowski, Marcel; Wunderlich, Malte; Steffen, Pascal; Moderzynski, Kristin; Papp, Stefanie; Hoehn, Katharina; Schwanke, Hella; Witt, Susanne; Richardt, Ulricke; Mehlhoop, Ute; Schlueter, Hartmut; Pianka, Verena; Fleischer, Bernhard; Tappe, Dennis; Osterloh, Anke			GroEL is an immunodominant surface-exposed antigen of Rickettsia typhi	PLOS ONE			English	Article							MEMBRANE PROTEIN ROMPB; BRILL-ZINSSER-DISEASE; SPOTTED-FEVER; MURINE TYPHUS; BACILLUS-ANTHRACIS; ORIENTIA-TSUTSUGAMUSHI; SEROLOGICAL EVIDENCE; FUNCTIONAL-ANALYSIS; PROTEOMIC ANALYSIS; CHAPERONIN GROEL	Rickettsioses are neglected and emerging potentially fatal febrile diseases that are caused by obligate intracellular bacteria, rickettsiae. Rickettsia (R.) typhi and R. prowazekii constitute the typhus group (TG) of rickettsiae and are the causative agents of endemic and epidemic typhus, respectively. We recently generated a monoclonal antibody (BNI52) against R. typhi. Characterization of BNI52 revealed that it specifically recognizes TG rickettsiae but not the members of the spotted fever group (SFG) rickettsiae. We further show that BNI52 binds to protein fragments of +/- 30 kDa that are exposed on the bacterial surface and also present in the periplasmic space. These protein fragments apparently derive from the cytosolic GroEL protein of R. typhi and are also recognized by antibodies in the sera from patients and infected mice. Furthermore, BNI52 opsonizes the bacteria for the uptake by antigen presenting cells (APC), indicating a contribution of GroEL-specific antibodies to protective immunity. Finally, it is interesting that the GroEL protein belongs to 32 proteins that are differentially downregulated by R. typhi after passage through immunodeficient BALB/c CB17 SCID mice. This could be a hint that the rickettsia GroEL protein may have immunomodulatory properties as shown for the homologous protein from several other bacteria, too. Overall, the results of this study provide evidence that GroEL represents an immunodominant antigen of TG rickettsiae that is recognized by the humoral immune response against these pathogens and that may be interesting as a vaccine candidate. Apart from that, the BNI52 antibody represents a new tool for specific detection of TG rickettsiae in various diagnostic and experimental setups.	[Rauch, Jessica; Barton, Jessica; Wunderlich, Malte; Moderzynski, Kristin; Papp, Stefanie; Hoehn, Katharina; Schwanke, Hella; Witt, Susanne; Richardt, Ulricke; Mehlhoop, Ute; Pianka, Verena; Fleischer, Bernhard; Tappe, Dennis; Osterloh, Anke] Bernhard Nocht Inst Trop Med, Hamburg, Germany; [Kwiatkowski, Marcel; Steffen, Pascal; Schlueter, Hartmut] Univ Med Ctr Hamburg Eppendorf, Hamburg, Germany; [Kwiatkowski, Marcel] Univ Innsbruck, Inst Biochem, Funct Prote & Metabol, Innsbruck, Austria; [Steffen, Pascal] Univ Sydney, Royal North Shore Hosp, Kolling Inst, Sydney, NSW, Australia; [Moderzynski, Kristin; Papp, Stefanie] Robert Koch Inst, Berlin, Germany; [Schwanke, Hella] Helmholtz Ctr Infect, Braunschweig, Germany; [Witt, Susanne] DESY Campus, Ctr Struct Syst Biol, Hamburg, Germany; [Pianka, Verena] Fair Med Healthcare, Hamburg, Germany; [Osterloh, Anke] Res Ctr Borstel, Borstel, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Innsbruck; Royal North Shore Hospital; University of Sydney; Kolling Institute of Medical Research; Robert Koch Institute; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); Forschungszentrum Borstel	Rauch, J (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.	rauch@bnitm.de	Osterloh, Anke/ABA-8626-2021		Deutsche Forschungsgemeinschaft (DFG) [OS 583/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work of AO is funded by the Deutsche Forschungsgemeinschaft (DFG, #OS 583/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjemian J, 2010, EMERG INFECT DIS, V16, P412, DOI 10.3201/eid1603.091028; Anacker RL., 1981, RICKETTSIAE RICKETTS, P71; Andre E, 1998, Acta Med Port, V11, P81; Gonzalez-Lopez MA, 2013, FEBS LETT, V587, P1823, DOI 10.1016/j.febslet.2013.04.048; Arora G, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0015-4; Asmar AT, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004303; Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; Bacellar F, 1998, Euro Surveill, V3, P18; Badiaga S, 2012, COMP IMMUNOL MICROB, V35, P39, DOI 10.1016/j.cimid.2011.09.008; Bansal A, 2010, MOL CELL BIOCHEM, V337, P213, DOI 10.1007/s11010-009-0301-4; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Bernabeu-Wittel M, 2006, EUR J CLIN MICROBIOL, V25, P375, DOI 10.1007/s10096-006-0147-6; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; Bochkareva ES, 1998, P NATL ACAD SCI USA, V95, P478, DOI 10.1073/pnas.95.2.478; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; Bragantini B, 2016, J MOL BIOL, V428, P2488, DOI 10.1016/j.jmb.2016.04.028; Brouqui, 1999, RICKETTSIAE RICKETTS, P116; Campbell J., 2009, Morbidity and Mortality Weekly Report, V58, P1267; Castanie-Cornet MP, 2014, BBA-MOL CELL RES, V1843, P1442, DOI 10.1016/j.bbamcr.2013.11.007; Centers for Disease Control and Prevention (CDC), 2003, MMWR Morb Mortal Wkly Rep, V52, P1224; Chaliotis G, 2012, INT J INFECT DIS, V16, pE591, DOI 10.1016/j.ijid.2012.03.010; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chan YGY, 2011, INFECT IMMUN, V79, P2303, DOI 10.1128/IAI.01324-10; Chauhan JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040155; Chitlaru T, 2004, PROTEOMICS, V4, P677, DOI 10.1002/pmic.200300575; Chitlaru T, 2007, INFECT IMMUN, V75, P2841, DOI 10.1128/IAI.02029-06; Chung MH, 2012, J KOREAN MED SCI, V27, P231, DOI 10.3346/jkms.2012.27.3.231; Claywell JE, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00197; Dill T, 2013, EMERG INFECT DIS, V19, P317, DOI 10.3201/eid1902.120601; DUPONT HT, 1995, CLIN INFECT DIS, V21, P1126, DOI 10.1093/clinids/21.5.1126; Espinosa N, 2010, ENFERM INFEC MICR CL, V28, P416, DOI 10.1016/j.eimc.2009.07.014; Faucher JF, 2012, EMERG INFECT DIS, V18, P171, DOI 10.3201/eid1801.111057; Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; Fenton WA, 1997, PROTEIN SCI, V6, P743; Fratazzi C, 2000, J EXP MED, V192, P183, DOI 10.1084/jem.192.2.183; Gaywee J, 2002, INFECT IMMUN, V70, P6346, DOI 10.1128/IAI.70.11.6346-6354.2002; Gillespie Joseph J, 2015, FEMS Microbiol Rev, V39, P47, DOI 10.1111/1574-6976.12084; Gong WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100253; Hajem N, 2009, APMIS, V117, P253, DOI 10.1111/j.1600-0463.2009.02435.x; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hasan MM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44548-x; He ZG, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-121; He ZG, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-21; Hickey TBM, 2010, CELL MICROBIOL, V12, P1634, DOI 10.1111/j.1462-5822.2010.01496.x; Hickey TBM, 2009, INFECT IMMUN, V77, P3389, DOI 10.1128/IAI.00143-09; Hillman RD, 2013, CELL MICROBIOL, V15, P727, DOI 10.1111/cmi.12068; HOVE MGM, 1995, ARCH PATHOL LAB MED, V119, P429; Jensenius M, 2004, CLIN INFECT DIS, V39, P1493, DOI 10.1086/425365; Jiao J, 2014, MICROBIOL-SGM, V160, P2718, DOI 10.1099/mic.0.082131-0; Jyot J, 1999, FEMS MICROBIOL LETT, V172, P165; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Khan MN, 2009, FEMS IMMUNOL MED MIC, V56, P56, DOI 10.1111/j.1574-695X.2009.00548.x; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Kleba B, 2010, INFECT IMMUN, V78, P2240, DOI 10.1128/IAI.00100-10; Kobir A, 2011, BBA-GEN SUBJECTS, V1810, P989, DOI 10.1016/j.bbagen.2011.01.006; Koliou M, 2007, EUR J CLIN MICROBIOL, V26, P491, DOI 10.1007/s10096-007-0310-8; Kuloglu, 2013, DIS MOL MED, V1, P39; Kumar CMS, 2009, J BACTERIOL, V191, P6525, DOI 10.1128/JB.00652-09; Kwiatkowski M, 2016, J PROTEOMICS, V134, P193, DOI 10.1016/j.jprot.2015.12.029; La Scola B, 2000, CLIN DIAGN LAB IMMUN, V7, P612, DOI 10.1128/CDLI.7.4.612-616.2000; Lamason RL, 2016, CELL, V167, P670, DOI 10.1016/j.cell.2016.09.023; Lee BY, 2006, INFECT IMMUN, V74, P4002, DOI 10.1128/IAI.00257-06; Li H, 1998, MICROB PATHOGENESIS, V24, P289, DOI 10.1006/mpat.1997.0197; Lledo L, 2005, VECTOR-BORNE ZOONOT, V5, P157, DOI 10.1089/vbz.2005.5.157; Lutwick LI, 2001, LANCET, V357, P1198, DOI 10.1016/S0140-6736(00)04339-7; Mansueto P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/967852; Mao CF, 2013, P NATL ACAD SCI USA, V110, P11815, DOI 10.1073/pnas.1303289110; Marcelino I, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00450; Maude RR, 2014, AM J TROP MED HYG, V91, P580, DOI 10.4269/ajtmh.13-0570; McBride JW, 2000, INFECT IMMUN, V68, P13, DOI 10.1128/IAI.68.1.13-18.2000; McLeod MP, 2004, J BACTERIOL, V186, P5842, DOI 10.1128/JB.186.17.5842-5855.2004; Mustafa AS, 2002, MOL IMMUNOL, V39, P113, DOI 10.1016/S0161-5890(02)00048-2; Nilsson CL, 2000, ANAL CHEM, V72, P2148, DOI 10.1021/ac9912754; Nogueras MM, 2006, AM J TROP MED HYG, V74, P123, DOI 10.4269/ajtmh.2006.74.123; Ogawa M, 2007, PROTEOMICS, V7, P1232, DOI 10.1002/pmic.200600721; Osterloh A, 2016, INFECT IMMUN, V84, P1615, DOI 10.1128/IAI.00034-16; Pahwal PK, 2008, CLIN IMMUNOL, V126, P89, DOI 10.1016/j.clim.2007.09.004; Papp S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004935; Park H, 2011, J BIOL CHEM, V286, P35096, DOI 10.1074/jbc.M111.263855; PARKER RT, 1954, J IMMUNOL, V73, P383; Parola P, 2003, EMERG INFECT DIS, V9, P592, DOI 10.3201/eid0905.020511; Phongmany S, 2006, EMERG INFECT DIS, V12, P256; Pornwiroon W, 2015, TICKS TICK-BORNE DIS, V6, P829, DOI 10.1016/j.ttbdis.2015.07.012; Pornwiroon W, 2009, INFECT IMMUN, V77, P5262, DOI 10.1128/IAI.00911-09; Psaroulaki A, 2012, T ROY SOC TROP MED H, V106, P489, DOI 10.1016/j.trstmh.2012.02.010; PUGSLEY AP, 1993, MICROBIOL REV, V57, P50, DOI 10.1128/MMBR.57.1.50-108.1993; Qi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070440; Radulovic S, 2002, GENE, V298, P41, DOI 10.1016/S0378-1119(02)00922-8; Raoult D, 2004, INFECT DIS CLIN N AM, V18, P127, DOI 10.1016/S0891-5520(03)00093-X; RAOULT D, 1994, EUR J EPIDEMIOL, V10, P37, DOI 10.1007/BF01717449; Rathi N, 2010, INDIAN PEDIATR, V47, P157, DOI 10.1007/s13312-010-0024-3; Rauch J, 2018, EMERG INFECT DIS, V24, P1213, DOI 10.3201/eid2407.180093; Reeves WK, 2008, J VECTOR ECOL, V33, P205, DOI 10.3376/1081-1710(2008)33[205:SEOTGR]2.0.CO;2; Renesto P, 2005, ANN NY ACAD SCI, V1063, P90, DOI 10.1196/annals.1355.014; Renesto P, 2005, FEMS MICROBIOL LETT, V245, P231, DOI 10.1016/j.femsle.2005.03.004; Riley SP, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv101; Riley SP, 2010, INFECT IMMUN, V78, P1895, DOI 10.1128/IAI.01165-09; Sahni SK, 2009, FUTURE MICROBIOL, V4, P323, DOI 10.2217/FMB.09.6; Schroeder CLC, 2017, TICKS TICK-BORNE DIS, V8, P827, DOI 10.1016/j.ttbdis.2017.06.008; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; Sinha K, 2010, MOL IMMUNOL, V48, P264, DOI 10.1016/j.molimm.2010.08.001; Stein A, 1999, LANCET, V353, P1936, DOI 10.1016/S0140-6736(99)01995-9; SUMNER JW, 1995, VACCINE, V13, P29, DOI 10.1016/0264-410X(95)80007-Z; Suputtamongkol Y, 2009, ANN NY ACAD SCI, V1166, P172, DOI 10.1111/j.1749-6632.2009.04514.x; Tan L, 2015, ARCH MICROBIOL, V197, P235, DOI 10.1007/s00203-014-1047-2; Thomas S, 2009, PARASITE IMMUNOL, V31, P296, DOI 10.1111/j.1365-3024.2009.01099.x; Tucker AM, 2011, APPL ENVIRON MICROB, V77, P4712, DOI 10.1128/AEM.05140-11; Turcinov D, 2000, ANTIMICROB AGENTS CH, V44, P1737, DOI 10.1128/AAC.44.6.1737-1738.2000; Uchiyama T, 2003, ANN NY ACAD SCI, V990, P585, DOI 10.1111/j.1749-6632.2003.tb07431.x; Uchiyama T, 1997, MICROBIOL IMMUNOL, V41, P815, DOI 10.1111/j.1348-0421.1997.tb01933.x; Uchiyama T, 2006, MICROBES INFECT, V8, P801, DOI 10.1016/j.micinf.2005.10.003; VISHWANATH S, 1990, INFECT IMMUN, V58, P646, DOI 10.1128/IAI.58.3.646-653.1990; WATANABE T, 1988, J BACTERIOL, V170, P4001, DOI 10.1128/jb.170.9.4001-4007.1988; Weber K, 2008, MOL THER, V16, P698, DOI 10.1038/mt.2008.6; Yamaguchi H, 2003, CLIN DIAGN LAB IMMUN, V10, P808, DOI 10.1128/CDLI.10.5.808-812.2003; Yang CK, 2011, J BACTERIOL, V193, P5607, DOI 10.1128/JB.05897-11; Zeller T, 2006, NATURWISSENSCHAFTEN, V93, P259, DOI 10.1007/s00114-006-0106-1; Zhou MX, 2009, MICROBIOL-SGM, V155, P317, DOI 10.1099/mic.0.025221-0	118	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 10	2021	16	6							e0253084	10.1371/journal.pone.0253084	http://dx.doi.org/10.1371/journal.pone.0253084			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6SA	34111210	Green Published, gold			2022-12-26	WOS:000664642700096
J	Delgado, AHS; Young, AM				Delgado, Antonio H. S.; Young, Anne M.			Methacrylate peak determination and selection recommendations using ATR-FTIR to investigate polymerisation of dental methacrylate mixtures	PLOS ONE			English	Article							POLYACID NEUTRALIZATION KINETICS; SELF-ADHESIVE; PROPERTY EVOLUTION; RESIN COMPOSITES; BOND STRENGTH; CONVERSION; RAMAN; SPECTROSCOPY; CURE; PHOTOPOLYMERIZATION	Investigation of polymerisation kinetics using ATR-FTIR systems is common in many dental studies. However, peak selection methods to calculate monomer-polymer conversion can vary, consequently affecting final results. Thus, the aim of this study is to experimentally confirm which method is less prone to systematic errors. Three commercial restorative materials were tested-Vertise Flow (VF), Constic and Activa Bioactive Restorative Kids. Firstly, Attenuated Total Reflectance Fourier Transform Infra-Red (ATR-FTIR) (Spectrum One, Perkin-Elmer, UK) spectra of monomers were acquired-10-methacryloyloxy decyl dihydrogen phosphate (10-MDP), bisphenol-A glycidyl dimethacrylate (Bis-GMA), 2-hydroxyethyl methacrylate (HEMA), triethyelene glycol dimethacrylate (TEGDMA) and urethane dimethacrylate (UDMA) to investigate proportionality of methacrylate peak heights versus concentration. Spectral changes upon light exposure of 2 mm discs of the restorative materials (irradiated for 20 s, LED curing unit 1100-1330 mW/cm(2)) were assessed to study polymerisation kinetics (n = 3), with continuous acquisition of spectra, before, during and after light exposure. Peak differences and degrees of conversion (D-C %) were calculated using 1320/1336, 1320/1350 and 1636/1648 cm(-1) as reaction/reference peaks. Inferential statistics included a MANOVA and within-subjects repeated measures ANOVA design (5% significance level). Proportionality of methacrylate peak height to concentration was confirmed, with the 1320/1352 cm(-1) peak combination showing the lowest coefficient of variation (8%). Difference spectra of the polymerisation reaction showed noise interference around the 1500-1800 cm(-1) region. Across the different materials, D-C % results are highly dependent upon peak selection (p<0.001), with higher variability associated to the 1636 cm(-1). Significant differences in the materials were only detected when the 1320 cm(-1) peak was used (p<0.05). Within the same materials, methods were significantly different for Constic and Activa (p<0.05). It is possible to conclude that the 1320 cm(-1) peak is more adequate to assess polymerisation of methacrylates and is therefore recommended.	[Delgado, Antonio H. S.; Young, Anne M.] UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London, England; [Delgado, Antonio H. S.] Inst Univ Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz CiiEM, Monte De Caparica, Portugal	University of London; University College London; Instituto Superior de Ciencias da Saude Egas Moniz	Delgado, AHS (corresponding author), UCL Eastman Dent Inst, Div Biomat & Tissue Engn, London, England.; Delgado, AHS (corresponding author), Inst Univ Egas Moniz, Ctr Invest Interdisciplinar Egas Moniz CiiEM, Monte De Caparica, Portugal.	antonio.delgado.17@ucl.ac.uk		Delgado, Antonio/0000-0001-7902-6104; Young, Anne/0000-0001-8485-2056	Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BD/136406/2018]	Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	A.D. thanks Fundacao para a Ciencia e Tecnologia (FCT), Portugal for the PhD Grant SFRH/BD/136406/2018 which supported this research.	Abu-elenain DA, 2013, DENT MATER, V29, P1173, DOI 10.1016/j.dental.2013.09.002; Agha A, 2020, DENT MATER, V36, P893, DOI 10.1016/j.dental.2020.04.010; Algamaiah H, 2020, DENT MATER, V36, P1266, DOI 10.1016/j.dental.2020.07.008; Aljabo A, 2015, DENT MATER, V31, P1279, DOI 10.1016/j.dental.2015.08.149; Alotaibi J, 2018, DENT MATER, V34, P1645, DOI 10.1016/j.dental.2018.08.294; Aminoroaya A, 2020, ACS BIOMATER SCI ENG, V6, P3713, DOI 10.1021/acsbiomaterials.0c00051; Arrais Cesar Augusto Galvão, 2007, Braz. Dent. J., V18, P54, DOI 10.1590/S0103-64402007000100012; Bandeca MC, 2009, LASER PHYS, V19, P1050, DOI 10.1134/S1054660X09050302; Barbosa MO, 2015, J MATER SCI-MATER M, V26, DOI 10.1007/s10856-014-5370-6; Barszczewska-Rybarek IM, 2019, MATERIALS, V12, DOI 10.3390/ma12244057; Bolanos-Carmona V, 2020, OPER DENT, V45, P92, DOI 10.2341/18-095-L; Borges BCD, 2012, OPER DENT, V37, P246, DOI 10.2341/11-248-L; Carvalho CN, 2019, INT J DENT, V2019, DOI 10.1155/2019/5496784; Cateto CA, 2008, IND CROP PROD, V27, P168, DOI 10.1016/j.indcrop.2007.07.018; Chalmers JM, 1996, TRAC-TREND ANAL CHEM, V15, P18, DOI 10.1016/0165-9936(96)88033-2; Collares FM, 2014, BRAZ ORAL RES, V28, P9, DOI 10.1590/S1806-83242013000600002; Croll Theodore P, 2015, Compend Contin Educ Dent, V36, P60; Czasch P, 2013, J ADHES DENT, V15, P229, DOI 10.3290/j.jad.a29530; de Araujo LOF., 2015, APPL ADHES SCI, V3, P26, DOI [10.1186/s40563-015-0055-z, DOI 10.1186/S40563-015-0055-Z]; Delgado AHS, 2021, MATERIALS, V14, DOI 10.3390/ma14040760; Denis AB, 2016, J SPECTROSC, V2016, DOI 10.1155/2016/6524901; Derenne A, 2012, ANALYST, V137, P3255, DOI 10.1039/c2an35116a; Ferracane JL, 2017, DENT MATER, V33, P1171, DOI 10.1016/j.dental.2017.08.188; Ferracane JL, 2011, DENT MATER, V27, P29, DOI 10.1016/j.dental.2010.10.020; Gezici O, 2012, SPECTROCHIM ACTA A, V96, P63, DOI 10.1016/j.saa.2012.05.004; Guerra RM, 1996, J ORAL REHABIL, V23, P632; Hofko B, 2018, MATER STRUCT, V51, DOI 10.1617/s11527-018-1170-7; Hofko B, 2017, MATER STRUCT, V50, DOI 10.1617/s11527-017-1059-x; Hofmann MP, 2006, J MATER CHEM, V16, P3199, DOI 10.1039/b603554j; Jones RR, 2019, NANOSCALE RES LETT, V14, DOI 10.1186/s11671-019-3039-2; Kangwankai K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187757; Khan AS, 2017, APPL SPECTROSC REV, V52, P507, DOI 10.1080/05704928.2016.1244069; Kim YK, 2015, J SPECTROSC, V2015, DOI 10.1155/2015/462687; Koutroulis A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55288-3; Liaqat S, 2015, MATERIALS, V8, P2110, DOI 10.3390/ma8052110; Liu L, 2019, POLYM DEGRAD STABIL, V168, DOI 10.1016/j.polymdegradstab.2019.108952; Lohbauer U, 2020, J ADHES DENT, V22, P47, DOI 10.3290/j.jad.a43997; Makkar H, 2018, TOXICOL RES-UK, V7, P959, DOI 10.1039/c8tx00112j; Makkar H, 2018, CHEM RES TOXICOL, V31, P914, DOI 10.1021/acs.chemrestox.8b00129; Okulus Z, 2014, MATER CHEM PHYS, V145, P304, DOI 10.1016/j.matchemphys.2014.02.012; Panpisut P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164653; Par M, 2015, OPER DENT, V40, pE92, DOI 10.2341/14-091-L; Pianelli C, 1999, J BIOMED MATER RES, V48, P675, DOI 10.1002/(SICI)1097-4636(1999)48:5<675::AID-JBM11>3.0.CO;2-P; Pratap B, 2019, JPN DENT SCI REV, V55, P126, DOI 10.1016/j.jdsr.2019.09.004; Scherzer T, 2002, APPL SPECTROSC, V56, P1403, DOI 10.1366/00037020260377698; Stansbury JW, 2012, DENT MATER, V28, P13, DOI 10.1016/j.dental.2011.09.005; Tichy A., 2020, Oper Dent, DOI 10.2341/18-230-C; Walters NJ, 2016, DENT MATER, V32, P264, DOI 10.1016/j.dental.2015.11.017; Yan YL, 2010, OPER DENT, V35, P203, DOI 10.2341/09-174-L; Yao CM, 2020, J ADHES DENT, V22, P85, DOI 10.3290/j.jad.a44000; Young AM, 2004, BIOMATERIALS, V25, P823, DOI 10.1016/S0142-9612(03)00599-4; Young AM, 2002, BIOMATERIALS, V23, P3289, DOI 10.1016/S0142-9612(02)00092-3; Zhang Y, 2013, DENT MATER J, V32, P10, DOI 10.4012/dmj.2012-108; Zou Y, 2014, INT J MOL SCI, V15, P10018, DOI 10.3390/ijms150610018	54	12	11	4	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0252999	10.1371/journal.pone.0252999	http://dx.doi.org/10.1371/journal.pone.0252999			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106972	Green Published, gold			2022-12-26	WOS:000664642200068
J	Naceradska, M; Pekova, S; Danesi, P; Furlanello, T; Calleo, R; Martin, P; Ike, F; Malik, R				Naceradska, Martina; Pekova, Sona; Danesi, Patrizia; Furlanello, Tommaso; Calleo, Roberta; Martin, Patricia; Ike, Fumio; Malik, Richard			A novel Filobacterium sp can cause chronic bronchitis in cats	PLOS ONE			English	Article							RESPIRATORY CAR BACILLUS; INFECTION ABCD GUIDELINES; BRONCHOALVEOLAR LAVAGE; RATS; DISEASE; PREVENTION; PNEUMONIA; MICE; PIGS; MYCOPLASMA	Background Cilia-associated respiratory bacillus (CARB; now known as Filobacterium rodentium gen. nov., sp. nov.) is a primary pathogen of rodents. A CARB-like organism was reported in post-mortem lung samples of cats using light and electron microscopy. Here we explore by molecular procedures if a Filobacterium sp. is a part of the normal feline lower respiratory microbiome and whether it could in some cats contribute to the development of chronic bronchial disease. Methodology A Filobacterium sp. was identified in three Czech cats clinically diagnosed as having chronic neutrophilic bronchitis. Bronchoalveolar lavage fluid (BALF) specimens obtained from these cats were subjected to panbacterial 16S rDNA PCR followed by Sanger sequencing of the V5 to V8 region. After these cats were treated with specific antimicrobials, their clinical signs resolved promptly, without recurrence. Next, BALF specimens from 13 Australian and 11 Italian cats with lower respiratory disease and an additional 16 lung samples of Italian cats who died of various causes were examined using next generation sequencing (NGS). Subsequently, a Filobacterium-specific qPCR assay was developed and used to re-test BALF specimens from the 11 Italian cats and lung tissue homogenates from the additional 16 deceased cats. Principal findings An amplicon of 548 bp with 91.24% sequence agreement with Filobacterium rodentium was obtained from all three patients, suggesting the novel Filobacterium sp. was the cause of their lower respiratory disease. The novel Filobacterium sp., which we propose to call F. felis, was detected in 3/3 Czech cats with chronic neutrophilic bronchitis, 13/13 Australian cats and 6/11 Italian cats with chronic lower respiratory disease, and 14/16 necropsy lung specimens from Italian cats. NGS and qPCR results all showed identical sequences. The Filobacterium sp. was sometimes the preponderant bacterial species in BALF specimens from cats with lower airway disease. There was an association between the presence of large numbers (greater than 10(5) organisms/mL) of Filobacterium and the presence of neutrophilic and/or histiocytic inflammation, although only a subset of inflammatory BALF specimens had F. felis as the preponderant organism. Conclusion The novel Filobacterium sp. comprises a finite part of the normal feline lower respiratory microbiome. Under certain circumstances it can increase in absolute and relative abundance and give rise to neutrophilic and/or histiocytic bronchitis, bronchiolitis and bronchopneumonia. These findings strongly suggest that F. felis could be an underdiagnosed cause of feline bronchial disease.	[Naceradska, Martina] Czech Univ Sci Prague, Dept Vet Sci, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic; [Naceradska, Martina] Vet Clin MVDr Martina Naceradska, Prague, Czech Republic; [Pekova, Sona] Tilia Labs, Lab Mol Diagnost, Pchery, Czech Republic; [Danesi, Patrizia] Ist Zooprofilatt Sperimentale Venezie, Legnaro, PD, Italy; [Furlanello, Tommaso; Calleo, Roberta] San Marco Vet Clin & Lab, Veggiano, Italy; [Martin, Patricia] Univ Sydney, Sydney Sch Vet Sci, Vet Pathol Diagnost Serv, Sydney, NSW, Australia; [Ike, Fumio] RIKEN BioResource Res Ctr, Expt Anim Div, Tsukuba, Ibaraki, Japan; [Malik, Richard] Univ Sydney, Ctr Vet Educ, Sydney, NSW, Australia	IZS delle Venezie; University of Sydney; RIKEN; University of Sydney	Naceradska, M (corresponding author), Czech Univ Sci Prague, Dept Vet Sci, Fac Agrobiol Food & Nat Resources, Prague, Czech Republic.; Naceradska, M (corresponding author), Vet Clin MVDr Martina Naceradska, Prague, Czech Republic.	naceradska@af.czu.cz	Naceradska, Martina/D-6472-2019	Naceradska, Martina/0000-0002-2404-7060	Valentine Charlton Bequest of the Centre for Veterinary Education of the University of Sydney	Valentine Charlton Bequest of the Centre for Veterinary Education of the University of Sydney(University of Sydney)	Richard Malik is supported by the Valentine Charlton Bequest of the Centre for Veterinary Education of the University of Sydney. Fumio Ike would like to thank Dr. Toshiaki Kokubo (National Institute of Radiological Sciences, QST, Japan) for his help regarding cat lung pathology.	Ahmed B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201156; Aliouat-Denis CM, 2008, INFECT GENET EVOL, V8, P708, DOI 10.1016/j.meegid.2008.05.001; Andreasen CB, 2003, VET CLIN N AM-SMALL, V33, P69, DOI 10.1016/S0195-5616(02)00056-6; [Anonymous], 2015, VET NURSE, V6, P488; Bannasch MJ, 2005, J FELINE MED SURG, V7, P109, DOI 10.1016/j.jfms.2004.07.004; Barthold SW, 2016, PATHOLOGY LAB RODENT; Bergottini R, 2005, J WILDLIFE DIS, V41, P459, DOI 10.7589/0090-3558-41.2.459; Boltin D, 2019, HELICOBACTER, V24, DOI 10.1111/hel.12637; BROGDEN KA, 1993, J WILDLIFE DIS, V29, P123, DOI 10.7589/0090-3558-29.1.123; Brook I, 2013, CLIN MICROBIOL REV, V26, P526, DOI 10.1128/CMR.00086-12; Caniatti M, 1998, J VET MED B, V45, P363, DOI 10.1111/j.1439-0450.1998.tb00805.x; Caverly LJ, 2019, CHEST, V156, P376, DOI 10.1016/j.chest.2019.05.011; CUNDIFF DD, 1994, J CLIN MICROBIOL, V32, P1930, DOI 10.1128/JCM.32.8.1930-1934.1994; Dorn ES, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180299; Egberink H, 2009, J FELINE MED SURG, V11, P610, DOI 10.1016/j.jfms.2009.05.010; Faner R, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02086-2016; Fastres A, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e02802; Fernandez A, 1996, VET PATHOL, V33, P445, DOI 10.1177/030098589603300415; Foster SF, 1998, AUST VET J, V76, P460, DOI 10.1111/j.1751-0813.1998.tb10178.x; Foster SF, 2004, J FELINE MED SURG, V6, P189, DOI 10.1016/j.jfms.2003.12.001; Foster SF, 2011, J FELINE MED SURG, V13, P313, DOI 10.1016/j.jfms.2011.03.009; GANAWAY JR, 1985, INFECT IMMUN, V47, P472, DOI 10.1128/IAI.47.2.472-479.1985; GOTO K, 1995, EXP ANIM TOKYO, V44, P333, DOI 10.1538/expanim.44.333; GRIFFITH JW, 1988, VET PATHOL, V25, P72, DOI 10.1177/030098588802500110; Grotheer M, 2020, J FELINE MED SURG, V22, P649, DOI 10.1177/1098612X19872428; HABERMANN R T, 1963, Lab Anim Care, V13, P28; Hafner S, 1998, J VET DIAGN INVEST, V10, P373, DOI 10.1177/104063879801000414; HASTIE AT, 1993, VET PATHOL, V30, P12, DOI 10.1177/030098589303000102; HAWKINS EC, 1990, J VET INTERN MED, V4, P267, DOI 10.1111/j.1939-1676.1990.tb03120.x; Ike F, 2016, INT J SYST EVOL MICR, V66, P150, DOI 10.1099/ijsem.0.000685; ITOH T, 1987, EXP ANIM TOKYO, V36, P387, DOI 10.1538/expanim1978.36.4_387; Jacoby RO, 1997, FASEB J, V11, P609, DOI 10.1096/fasebj.11.8.9240962; Kakrada MK, 2002, NEW ZEAL VET J, V50, P81, DOI 10.1080/00480169.2002.36255; Kendall LV, 2000, INFECT IMMUN, V68, P4961, DOI 10.1128/IAI.68.9.4961-4967.2000; Langan GP, 2000, VET CLIN N AM-SMALL, V30, P1309, DOI 10.1016/S0195-5616(00)06009-5; Lappin MR, 2017, J VET INTERN MED, V31, P279, DOI 10.1111/jvim.14627; Lee EA, 2020, J VET INTERN MED, V34, P1291, DOI 10.1111/jvim.15772; MACKENZIE WF, 1981, VET PATHOL, V18, P836, DOI 10.1177/030098588101800616; Mathieu E, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01168; MATSUSHITA S, 1995, LAB ANIM SCI, V45, P503; MATSUSHITA S, 1987, LAB ANIM, V21, P356, DOI 10.1258/002367787781363327; MATSUSHITA S, 1989, LAB ANIM, V23, P96, DOI 10.1258/002367789780863664; MATSUSHITA S, 1989, LAB ANIM, V23, P89, DOI 10.1258/002367789780863600; Naceradska M., 2019, J FELINE MED SURG, P843, DOI [10.1177/1098612X19870390, DOI 10.1177/1098612X19870390]; Neiger R, 2000, J VET INTERN MED, V14, P125, DOI 10.1892/0891-6640(2000)014&lt;0125:IIDACF&gt;2.3.CO;2; NIETFELD JC, 1995, J VET DIAGN INVEST, V7, P338, DOI 10.1177/104063879500700307; Nietfeld JC, 1999, J VET DIAGN INVEST, V11, P252, DOI 10.1177/104063879901100308; Oros J, 1997, J COMP PATHOL, V117, P289, DOI 10.1016/S0021-9975(97)80025-4; Oros J, 1997, J VET MED B, V44, P99, DOI 10.1111/j.1439-0450.1997.tb00955.x; Padrid PH, 2009, CHRONIC BRONCHITIS A, P650; Pekova S, 2011, DIAGN MICR INFEC DIS, V69, P266, DOI 10.1016/j.diagmicrobio.2010.10.004; Radford AD, 2009, J FELINE MED SURG, V11, P556, DOI 10.1016/j.jfms.2009.05.004; Ramos-Vara JA, 2002, VET PATHOL, V39, P501, DOI 10.1354/vp.39-4-501; Reinero CR, 2019, J VET INTERN MED, V33, P1201, DOI 10.1111/jvim.15473; Rozanski EA, 1999, CLIN TECH SMALL AN P, V14, P237, DOI 10.1016/S1096-2867(99)80017-6; SCHOEB TR, 1993, J CLIN MICROBIOL, V31, P2751, DOI 10.1128/JCM.31.10.2751-2757.1993; Schoeb TR, 1997, J CLIN MICROBIOL, V35, P1667, DOI 10.1128/JCM.35.7.1667-1670.1997; Schoeb TR, 1997, VET PATHOL, V34, P263, DOI 10.1177/030098589703400401; Schoeb TR., 2000, RESP DIS RODENTS, P481; SHOJIDARKYE Y, 1991, LAB ANIM SCI, V41, P567; Singletary GE, 2012, J VET INTERN MED, V26, P542, DOI 10.1111/j.1939-1676.2012.00916.x; St Clair MB, 1999, LAB ANIM SCI, V49, P421; Thiry E, 2009, J FELINE MED SURG, V11, P547, DOI 10.1016/j.jfms.2009.05.003; Trzil JE, 2020, VET CLIN N AM-SMALL, V50, P375, DOI 10.1016/j.cvsm.2019.10.002; van Eeden ME, 2020, J FELINE MED SURG, V22, P1129, DOI 10.1177/1098612X20907178; Van N.I, 2006, UK VET COMPANION ANI, V11, P45; Vientos-Plotts AI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173818; WILSON R, 1988, AM REV RESPIR DIS, V138, pS49, DOI 10.1164/ajrccm/138.6_Pt_2.S49	68	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2021	16	6							e0251968	10.1371/journal.pone.0251968	http://dx.doi.org/10.1371/journal.pone.0251968			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	SW6RW	34106938	Green Published, gold			2022-12-26	WOS:000664642200023
